PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hingorani, MM; O'Donnell, M				Hingorani, MM; O'Donnell, M			ATP binding to the Escherichia coli clamp loader powers opening of the ring-shaped clamp of DNA polymerase III holoenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL REPLICATION MACHINE; LAGGING-STRAND REPLICATION; CELL NUCLEAR ANTIGEN; SLIDING CLAMPS; ACCESSORY PROTEINS; PRIMER-TEMPLATE; COMPLEX; SUBUNIT; MECHANISM; PARTICLE	The Escherichia coli gamma complex serves as a clamp loader, catalyzing ATP-dependent assembly of beta protein clamps onto primed DNA templates during DNA replication. These ring-shaped clamps tether DNA polymerase III holoenzyme to the template, facilitating rapid and processive DNA synthesis. This report focuses on the role of ATP binding and hydrolysis catalyzed by the gamma complex during clamp loading. We show that the energy from ATP binding to gamma complex powers several initial events in the clamp loading pathway. The gamma complex ((gamma 2)delta delta'(chi)psi) binds two ATP molecules (one per gamma subunit in the complex) with high affinity (K-d = 1-2.5 x 10(-6) M) or two adenosine 5'-O-(3-thiotriphosphate) (ATP gamma S) molecules with slightly lower affinity (K-d = 5-6.5 x 10(-6) nr). Experiments performed prior to the first ATP turnover (k(cat) = 4 x 10(-3) s(-1) at 4 degrees C), or in the presence of ATP gamma S (k(cat) = 1 x 10(-4) s(-1) at 37 degrees C), demonstrate that upon interaction with ATP the gamma complex undergoes a change in conformation. This ATP-bound gamma complex binds beta and opens the ring at the dimer interface. Still prior to ATP hydrolysis, the composite of gamma complex and the open beta ring binds with high affinity to primer-template DNA. Thus ATP binding powers all the steps in the clamp loading pathway leading up to the assembly of a gamma complex open beta ring.DNA intermediate, setting the stage for ring closing and turnover of the clamp loader, steps that may be linked to subsequent hydrolysis of ATP.	Rockefeller Univ, New York, NY 10021 USA; Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Howard Hughes Medical Institute	O'Donnell, M (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	manju@mod.rockefeller.edu; odonnel@rockvax.rockefeller.edu		O'Donnell, Michael/0000-0001-9002-4214	NIGMS NIH HHS [GM 38839] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038839, R01GM038839] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berdis AJ, 1997, BIOCHEMISTRY-US, V36, P2733, DOI 10.1021/bi962139l; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; Bertram JG, 1998, J BIOL CHEM, V273, P24564, DOI 10.1074/jbc.273.38.24564; BISWAS SB, 1984, J BIOL CHEM, V259, P7990; Bloom LB, 1996, J BIOL CHEM, V271, P30699, DOI 10.1074/jbc.271.48.30699; BURGERS PMJ, 1991, J BIOL CHEM, V266, P22698; CAPSON TL, 1991, CELL, V65, P249, DOI 10.1016/0092-8674(91)90159-V; DALLMANN HG, 1995, J BIOL CHEM, V270, P29563, DOI 10.1074/jbc.270.49.29563; DIFRANCESCO R, 1984, J BIOL CHEM, V259, P5567; DONG ZM, 1993, J BIOL CHEM, V268, P11758; FAY PJ, 1981, J BIOL CHEM, V256, P976; Guenther B, 1997, CELL, V91, P335, DOI 10.1016/S0092-8674(00)80417-1; KABOORD BF, 1995, CURR BIOL, V5, P149, DOI 10.1016/S0960-9822(95)00036-4; Kelman Z, 1998, EMBO J, V17, P2436, DOI 10.1093/emboj/17.8.2436; KELMAN Z, 1995, ANNU REV BIOCHEM, V64, P171, DOI 10.1146/annurev.bi.64.070195.001131; Kelman Z, 1995, METHOD ENZYMOL, V262, P430; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; KURIYAN J, 1993, J MOL BIOL, V234, P915, DOI 10.1006/jmbi.1993.1644; LEE SH, 1987, P NATL ACAD SCI USA, V84, P2713, DOI 10.1073/pnas.84.9.2713; LEE SH, 1990, P NATL ACAD SCI USA, V87, P5672, DOI 10.1073/pnas.87.15.5672; MAKI H, 1985, J BIOL CHEM, V260, P2987; MAKI H, 1988, J BIOL CHEM, V263, P6570; MAKI S, 1988, J BIOL CHEM, V263, P6555; MAKI S, 1988, J BIOL CHEM, V263, P6561; MCHENRY CS, 1991, J BIOL CHEM, V266, P19127; MCHENRY CS, 1979, J BIOL CHEM, V254, P1748; MUNN MM, 1991, J BIOL CHEM, V266, P20034; Naktinis V, 1996, CELL, V84, P137, DOI 10.1016/S0092-8674(00)81000-4; NAKTINIS V, 1995, J BIOL CHEM, V270, P13358, DOI 10.1074/jbc.270.22.13358; ODONNELL M, 1990, J BIOL CHEM, V265, P1179; OLSON MW, 1995, J BIOL CHEM, V270, P29570, DOI 10.1074/jbc.270.49.29570; ONRUST R, 1991, J BIOL CHEM, V266, P21681; ONRUST R, 1995, J BIOL CHEM, V270, P13366, DOI 10.1074/jbc.270.22.13366; ONRUST R, 1995, J BIOL CHEM, V270, P13348, DOI 10.1074/jbc.270.22.13348; ONRUST R, 1993, THESIS CORNELL U MED, P198; Pietroni P, 1997, J BIOL CHEM, V272, P31666, DOI 10.1074/jbc.272.50.31666; REEMS JA, 1995, J BIOL CHEM, V270, P5606, DOI 10.1074/jbc.270.10.5606; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SANCAR A, 1993, SCIENCE, V259, P1415, DOI 10.1126/science.8451638; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHEUERMANN RH, 1984, P NATL ACAD SCI-BIOL, V81, P7747, DOI 10.1073/pnas.81.24.7747; Sexton DJ, 1996, J BIOL CHEM, V271, P28045, DOI 10.1074/jbc.271.45.28045; SINHA NK, 1980, J BIOL CHEM, V255, P4290; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; STILLMAN B, 1994, CELL, V78, P725, DOI 10.1016/S0092-8674(94)90362-X; STUDWELL PS, 1990, J BIOL CHEM, V265, P1171; STUDWELLVAUGHAN PS, 1991, J BIOL CHEM, V266, P19833; STUDWELLVAUGHAN PS, 1993, J BIOL CHEM, V268, P11785; STUKENBERG PT, 1994, CELL, V78, P877, DOI 10.1016/S0092-8674(94)90662-9; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; STUKENBERG PT, 1995, J BIOL CHEM, V270, P13384, DOI 10.1074/jbc.270.22.13384; TSUCHIHASHI Z, 1989, J BIOL CHEM, V264, P17790; Turner J, 1995, METHOD ENZYMOL, V262, P442; WU CA, 1992, J BIOL CHEM, V267, P4064; XIAO H, 1995, J BIOL CHEM, V270, P13378, DOI 10.1074/jbc.270.22.13378; XIAO H, 1993, J BIOL CHEM, V268, P11779; XIAO H, 1993, J BIOL CHEM, V268, P11773; XIAO H, 1996, THESIS CORNELL U MED; Yuzhakov A, 1996, CELL, V86, P877, DOI 10.1016/S0092-8674(00)80163-4	59	117	117	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24550	24563		10.1074/jbc.273.38.24550	http://dx.doi.org/10.1074/jbc.273.38.24550			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733750	hybrid			2022-12-27	WOS:000076007300042
J	Pasheva, EA; Pashev, IG; Favre, A				Pasheva, EA; Pashev, IG; Favre, A			Preferential binding of high mobility group 1 protein to UV-damaged - DNA role of the COOH-terminal domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTITUMOR DRUG CIS-DIAMMINEDICHLOROPLATINUM(II); NUCLEOPROTEIN STRUCTURES; TRANSCRIPTION FACTOR; THERMAL-DENATURATION; DEFINED-SEQUENCE; NUCLEAR-PROTEIN; HUMAN-CELLS; HMG DOMAIN; CISPLATIN; COMPLEX	Binding of chromosomal high mobility group 1 protein (HMG1) to UV-damaged DNA has been studied with oligonucleotides containing a single dipyrimidine site for formation of UV photolesions, Irradiation of an oligonucleotide with unique TT dinucleotide resulted in generation of cyclobutane pyrimidine dimer with no evidence for induction of (6-4) photoproducts, whereas the analysis of irradiated TC-containing oligonucleotide detected (6-4) photoproducts but not cyclobutane pyrimidine dimers, Mobility shift assays have revealed that HMG1 protein binds preferentially to irradiated TT and TC oligonucleotides. Photoreversal of cyclobutane pyrimidine dimers with DNA photolyase and hydrolysis of the (6-4) photoproducts with hot alkali substantially reduced but did not eliminate binding of HMG1. The protein, therefore, appears to bind the two main types of UV damages in DNA, but some other photolesion(s) contributes to the preferential binding of HMG1 to irradiated DNA, By quantifying gel shift assays and considering the efficiencies of lesion formation, we determined dissociation constants of 1.2 +/- 0.5 and 4.0 +/- 1.5 mu M for irradiated TT and TC oligonucleotides, respectively, and 70 +/- 20 mu M for the control non-irradiated probes. Tryptic removal of the acidic COOH-terminal domain of HMG1 significantly affected binding of the protein to both irradiated and intact oligonucleotides, The potential role of HMG1 in recognition of the UV lesions in DNA is discussed.	Bulgarian Acad Sci, Inst Mol Biol, BU-1113 Sofia, Bulgaria; Univ Paris 07, CNRS, Inst Jacques Monod, F-75251 Paris, France	Bulgarian Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Pasheva, EA (corresponding author), Bulgarian Acad Sci, Inst Mol Biol, BU-1113 Sofia, Bulgaria.	eva@obzor.bio2l.bas.bg						BAZETTJONES DP, 1994, SCIENCE, V264, P1134, DOI 10.1126/science.8178172; BELLON SF, 1991, BIOCHEMISTRY-US, V30, P8026, DOI 10.1021/bi00246a021; BIANCHI ME, 1992, EMBO J, V11, P1055, DOI 10.1002/j.1460-2075.1992.tb05144.x; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; BOURRE F, 1985, BIOCHIMIE, V67, P293, DOI 10.1016/S0300-9084(85)80071-7; BUSTIN M, 1990, BIOCHIM BIOPHYS ACTA, V1049, P231, DOI 10.1016/0167-4781(90)90092-G; BUTLER AP, 1985, J BIOL CHEM, V260, P613; CADET J, 1990, BIOORGANIC PHOTOCHEM, V1, P1; CARBALLO M, 1984, EMBO J, V2, P17559; CHURCHILL MEA, 1995, EMBO J, V14, P1264, DOI 10.1002/j.1460-2075.1995.tb07110.x; CIARROCCHI G, 1982, J MOL BIOL, V155, P177, DOI 10.1016/0022-2836(82)90445-4; DOETSCH PW, 1995, BIOCHEMISTRY-US, V34, P737, DOI 10.1021/bi00003a005; DYSON M, 1984, INT J PEPT PROT RES, V24, P201; FICHTINGERSCHEPMAN AMJ, 1985, BIOCHEMISTRY-US, V24, P707, DOI 10.1021/bi00324a025; FRANKLIN WA, 1982, J BIOL CHEM, V257, P13533; FRIEDBERG EC, 1972, MUTAT RES, V15, P113, DOI 10.1016/0027-5107(72)90024-3; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; GORDON LK, 1980, J BIOL CHEM, V255, P2047; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; HUGHES EN, 1992, J BIOL CHEM, V267, P13520; HUSAIN I, 1988, P NATL ACAD SCI USA, V85, P2558, DOI 10.1073/pnas.85.8.2558; ISACKSON PJ, 1979, J BIOL CHEM, V254, P5569; JACKSON JB, 1981, BIOCHEMISTRY-US, V20, P1042, DOI 10.1021/bi00507a060; JANTZEN HM, 1990, NATURE, V344, P830, DOI 10.1038/344830a0; JAVAHERIAN K, 1979, NUCLEIC ACIDS RES, V6, P3569, DOI 10.1093/nar/6.11.3569; Johns EW, 1982, HMG CHROMOSOMAL PROT; KIM JK, 1995, EUR J BIOCHEM, V228, P849, DOI 10.1111/j.1432-1033.1995.0849m.x; KOHLSTAEDT LA, 1987, J BIOL CHEM, V262, P524; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDSMAN D, 1993, BIOESSAYS, V15, P539, DOI 10.1002/bies.950150807; LILLEY DMJ, 1992, NATURE, V357, P282, DOI 10.1038/357282a0; LIPPKE JA, 1981, P NATL ACAD SCI-BIOL, V78, P3388, DOI 10.1073/pnas.78.6.3388; MAREKOV LN, 1984, BIOCHIM BIOPHYS ACTA, V789, P63, DOI 10.1016/0167-4838(84)90061-X; MITCHELL DL, 1990, NUCLEIC ACIDS RES, V18, P963, DOI 10.1093/nar/18.4.963; NER SS, 1994, TRENDS BIOCHEM SCI, V19, P185, DOI 10.1016/0968-0004(94)90017-5; ONATE SA, 1994, MOL CELL BIOL, V14, P3376, DOI 10.1128/MCB.14.5.3376; PAULL TT, 1993, GENE DEV, V7, P1521, DOI 10.1101/gad.7.8.1521; PIL PM, 1993, P NATL ACAD SCI USA, V90, P9465, DOI 10.1073/pnas.90.20.9465; PIL PM, 1992, SCIENCE, V256, P234, DOI 10.1126/science.1566071; Schultz TF, 1996, J BIOL CHEM, V271, P25742, DOI 10.1074/jbc.271.42.25742; SHEFLIN LG, 1993, BIOCHEMISTRY-US, V32, P3238, DOI 10.1021/bi00064a005; SHYKIND BM, 1995, GENE DEV, V9, P1354, DOI 10.1101/gad.9.11.1354; Smerdon MJ, 1991, CURR OPIN CELL BIOL, V3, P422, DOI 10.1016/0955-0674(91)90069-B; SPIVAK G, 1988, MUTAT RES, V193, P97, DOI 10.1016/0167-8817(88)90040-5; STROS M, 1990, INT J BIOL MACROMOL, V12, P282, DOI 10.1016/0141-8130(90)90014-2; STROS M, 1994, NUCLEIC ACIDS RES, V22, P1044, DOI 10.1093/nar/22.6.1044; Tornaletti S, 1996, BIOESSAYS, V18, P221, DOI 10.1002/bies.950180309; TRAVERS AA, 1994, CELL, V77, P167, DOI 10.1016/0092-8674(94)90306-9; Turchi JJ, 1996, BIOCHEMISTRY-US, V35, P2992, DOI 10.1021/bi951843j; UMLAS ME, 1985, PHOTOCHEM PHOTOBIOL, V42, P265, DOI 10.1111/j.1751-1097.1985.tb08941.x; VANASSENDELFT GB, 1993, NUCLEIC ACIDS RES, V21, P3399, DOI 10.1093/nar/21.15.3399; VARGAWEISZ P, 1994, BIOCHEM BIOPH RES CO, V203, P1904, DOI 10.1006/bbrc.1994.2410; WANG CI, 1991, P NATL ACAD SCI USA, V88, P9072, DOI 10.1073/pnas.88.20.9072; WISNIEWSKI JR, 1994, J BIOL CHEM, V269, P10713; Zappavigna V, 1996, EMBO J, V15, P4981, DOI 10.1002/j.1460-2075.1996.tb00878.x; ZWILLING S, 1995, EMBO J, V14, P1198, DOI 10.1002/j.1460-2075.1995.tb07103.x	56	81	82	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24730	24736		10.1074/jbc.273.38.24730	http://dx.doi.org/10.1074/jbc.273.38.24730			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733773	hybrid			2022-12-27	WOS:000076007300065
J	Wang, TF; Ou, Y; Guidotti, G				Wang, TF; Ou, Y; Guidotti, G			The transmembrane domains of ectoapyrase (CD39) affect its enzymatic activity and quaternary structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL ACTIVATION ANTIGEN; ECTO-ATPASE; MEMBRANE-PROTEINS; DIPHOSPHOHYDROLASE; PURIFICATION; CLONING; IDENTIFICATION; APYRASE; GENE; HOMOLOGY	Mammalian ectoapyrase (CD39) is an integral membrane protein with two transmembrane domains and a large extracellular region. The enzymatic activity of ectoapyrase is inhibited by most detergents used for membrane protein solubilization. In contrast, the enzymatic activities of soluble E-type ATPases, including potato tuber (Solanum tuberosum) apyrase and parasite ecto-ATPase, are not affected by detergents. Here we show that ectoapyrase is a tetramer and that detergents that reduce the activity of the enzyme promote dissociation of the tetramer to monomers. We expressed a secreted form of the ectoapyrase in COS-7 cells by fusing the signal peptide of murine CD4 with the extracellular domain of the ectoapyrase. The soluble ectoapyrase is catalytically active and its activity is not affected by detergents. Mutants of the ectoapyrase with only the NH2- or the COOH-terminal transmembrane domain are membrane-bound, and their activity is no longer affected by detergents. The enzymatic activity of all of the mutant proteins is less than that of the native enzyme. These results suggest that the proper contacts between the transmembrane domains of the monomers in the tetramer are necessary for full enzymatic activity.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Guidotti, G (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	guidotti@ifas.harvard.edu	Wang, Ting-Fang/ABI-3818-2020	Wang, Ting-Fang/0000-0001-6306-9505	NHLBI NIH HHS [HL08893] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABEIJON C, 1993, J CELL BIOL, V122, P307, DOI 10.1083/jcb.122.2.307; AIYER RA, 1983, J BIOL CHEM, V258, P4992; Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; BERMUDES D, 1994, J BIOL CHEM, V269, P29252; CANESSA CM, 1994, AM J PHYSIOL-CELL PH, V267, pC1682, DOI 10.1152/ajpcell.1994.267.6.C1682; Chadwick BP, 1997, MAMM GENOME, V8, P668, DOI 10.1007/s003359900534; CLARKE S, 1975, J BIOL CHEM, V250, P5459; Coppi MV, 1997, ARCH BIOCHEM BIOPHYS, V346, P312, DOI 10.1006/abbi.1997.0332; EDSALL JT, 1970, CRC HDB BIOCH SELECT, pC10; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; Handa M, 1996, BIOCHEM BIOPH RES CO, V218, P916, DOI 10.1006/bbrc.1996.0162; HARLOW E, 1988, ANTIBODIES LABORATOR, P494; Hsieh HL, 1996, PLANT MOL BIOL, V30, P135, DOI 10.1007/BF00017808; Kaczmarek E, 1996, J BIOL CHEM, V271, P33116, DOI 10.1074/jbc.271.51.33116; Kegel B, 1997, NEUROPHARMACOLOGY, V36, P1189, DOI 10.1016/S0028-3908(97)00115-9; Kim M, 1997, BIOCHEM BIOPH RES CO, V240, P618, DOI 10.1006/bbrc.1997.7713; Kirley TL, 1997, J BIOL CHEM, V272, P1076, DOI 10.1074/jbc.272.2.1076; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; KYTE J, 1995, STRUCTURE PROTEIN CH, P520; LewisCarl S, 1997, J BIOL CHEM, V272, P23645, DOI 10.1074/jbc.272.38.23645; LITTMAN DR, 1987, NATURE, V325, P453, DOI 10.1038/325453a0; Liu JY, 1997, BBA-GEN SUBJECTS, V1336, P370, DOI 10.1016/S0304-4165(96)00153-5; Lu KH, 1996, MOL BIOL CELL, V7, P679, DOI 10.1091/mbc.7.5.679; MALISZEWSKI CR, 1994, J IMMUNOL, V153, P3574; Marcus AJ, 1997, J CLIN INVEST, V99, P1351, DOI 10.1172/JCI119294; NEER EJ, 1974, J BIOL CHEM, V249, P6527; North RA, 1996, CURR OPIN CELL BIOL, V8, P474, DOI 10.1016/S0955-0674(96)80023-8; OHTA T, 1986, P NATL ACAD SCI USA, V83, P2071, DOI 10.1073/pnas.83.7.2071; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PLESNER L, 1995, INT REV CYTOL, V158, P141; SABBADINI RA, 1989, J BIOENERG BIOMEMBR, V21, P163, DOI 10.1007/BF00812068; SEMENZA G, 1986, ANNU REV CELL BIOL, V2, P255, DOI 10.1146/annurev.cellbio.2.1.255; SEVIGNY J, 1995, BIOCHEM J, V312, P351, DOI 10.1042/bj3120351; Smith TM, 1997, ARCH BIOCHEM BIOPHYS, V337, P351, DOI 10.1006/abbi.1996.9779; Stout JG, 1996, BIOCHEMISTRY-US, V35, P8289, DOI 10.1021/bi960563g; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Tanford C., 1961, PHYS CHEM MACROMOLEC, P356; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; VONHEIJNE G, 1988, BIOCHIM BIOPHYS ACTA, V947, P307, DOI 10.1016/0304-4157(88)90013-5; Wang TF, 1997, MOL BRAIN RES, V47, P295, DOI 10.1016/S0169-328X(97)00066-1; Wang TF, 1998, J BIOL CHEM, V273, P11392, DOI 10.1074/jbc.273.18.11392; Wang TF, 1996, J BIOL CHEM, V271, P9898, DOI 10.1074/jbc.271.17.9898; YOON KL, 1994, J BIOL CHEM, V269, P28249; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345; ZIMMERMANN H, 1994, TRENDS NEUROSCI, V17, P420, DOI 10.1016/0166-2236(94)90016-7	46	119	125	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24814	24821		10.1074/jbc.273.38.24814	http://dx.doi.org/10.1074/jbc.273.38.24814			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733785	Green Published, hybrid			2022-12-27	WOS:000076007300077
J	Beglova, N; LeSauteur, L; Ekiel, I; Saragovi, HU; Gehring, K				Beglova, N; LeSauteur, L; Ekiel, I; Saragovi, HU; Gehring, K			Solution structure and internal motion of a bioactive peptide derived from nerve growth factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR MAGNETIC-RESONANCE; HETERONUCLEAR NMR-SPECTROSCOPY; TRK PROTOONCOGENE PRODUCT; RECEPTOR-BINDING; NATURAL-ABUNDANCE; BACKBONE DYNAMICS; CRYSTAL-STRUCTURE; BIOLOGICAL-ACTIVITY; CARBOXYL-TERMINUS; AFFINITY RECEPTOR	The conformation and internal dynamics of a bioactive cyclic peptide, N-acetyl-YCTDEKQCY, derived from the C-D loop of beta-nerve growth factor (beta-NGF) were analyzed by solution NMR spectroscopy. NMR experimental data were used to calculate an ensemble of peptide structures. All of the structures had a beta-turn at residues Asp(4)-Gln(7) but could be divided into two families according the presence or absence of a hydrogen bond at Gln(7). Comparison of the calculated structures with the corresponding C-D loops from the x-ray structures of the NGF revealed striking similarity. The orientation of Glu(5), Lys(6), and Gln7 side chains in the NGF mimetic was very similar to the C-D loop of NGF. These residues are known to participate in interactions with the TrkA receptor. Relaxation measurements of the peptidomimetic alpha-carbons at C-13 natural abundance and calculated dynamic parameters suggest that the loop region of peptide is well structured but that residues Thr(3), Asp(4), Glu(5), and Lys(6) undergo slow conformational exchange. These results suggest that conformational similarity and possibly peptide dynamics are responsible for the bioactivity of the peptide.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Montreal Joint Ctr Struct Biol, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Oncol, Montreal, PQ H3G 1Y6, Canada; Natl Res Council Canada, Pharmaceut Biotechnol Sector, Biomol NMR Grp, Montreal, PQ H4P 2R2, Canada; Natl Res Council Canada, Biotechnol Res Inst, Montreal Joint Ctr Struct Biol, Montreal, PQ H4P 2R2, Canada	McGill University; McGill University; McGill University; McGill University; National Research Council Canada; National Research Council Canada	Gehring, K (corresponding author), McGill Univ, Dept Biochem, 3655 Drummond St,McIntyre Med Sci Bldg, Montreal, PQ H3G 1Y6, Canada.	kalle.gehring@bri.nrc.ca	Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184				Alattia T, 1996, EUR J BIOCHEM, V237, P561, DOI 10.1111/j.1432-1033.1996.0561p.x; ALLERHAN.A, 1972, J CHEM PHYS, V56, P3718, DOI 10.1063/1.1677754; ALLERHAN.A, 1971, J AM CHEM SOC, V93, P544, DOI 10.1021/ja00731a053; ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Bax B, 1997, STRUCTURE, V5, P1275, DOI 10.1016/S0969-2126(97)00280-3; BENEDETTI M, 1993, P NATL ACAD SCI USA, V90, P7859, DOI 10.1073/pnas.90.16.7859; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; BOTHWELL MA, 1977, J BIOL CHEM, V252, P8532; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P7387, DOI 10.1021/bi00484a006; Cuello AC, 1996, PROG BRAIN RES, V109, P347; DRINKWATER CC, 1993, J BIOL CHEM, V268, P23202; Ekiel I, 1997, J MOL BIOL, V271, P266, DOI 10.1006/jmbi.1997.1150; ENGLANDER SW, 1987, BIOCHEMISTRY-US, V26, P5953, DOI 10.1021/bi00393a001; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HOLLAND DR, 1994, J MOL BIOL, V239, P385, DOI 10.1006/jmbi.1994.1380; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; IBANEZ CF, 1991, EMBO J, V10, P2105, DOI 10.1002/j.1460-2075.1991.tb07743.x; IBANEZ CF, 1993, EMBO J, V12, P2281, DOI 10.1002/j.1460-2075.1993.tb05882.x; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; ILAG LL, 1994, J BIOL CHEM, V269, P19941; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; KAHLE P, 1992, J BIOL CHEM, V267, P22707; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; Kramer K, 1996, CLIN CANCER RES, V2, P1361; Kruttgen A, 1997, J BIOL CHEM, V272, P29222, DOI 10.1074/jbc.272.46.29222; KULLANDER K, 1994, J NEUROSCI RES, V39, P195, DOI 10.1002/jnr.490390210; Kullander K, 1997, J BIOL CHEM, V272, P9300; KUSZEWSKI J, 1992, J BIOMOL NMR, V2, P33, DOI 10.1007/BF02192799; LeSauteur L, 1996, NAT BIOTECHNOL, V14, P1120, DOI 10.1038/nbt0996-1120; LESAUTEUR L, 1995, J BIOL CHEM, V270, P6564, DOI 10.1074/jbc.270.12.6564; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Longsworth LG, 1960, J PHYS CHEM-US, V64, P1914, DOI 10.1021/j100841a027; LUO Y, 1992, J BIOL CHEM, V267, P12275; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Marchetti D, 1996, CANCER RES, V56, P2856; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0; MILLS R, 1973, J PHYS CHEM-US, V77, P685, DOI 10.1021/j100624a025; Mufson EJ, 1997, EXP NEUROL, V146, P91, DOI 10.1006/exnr.1997.6504; NAKAGAWARA A, 1992, CANCER RES, V52, P1364; NAKAGAWARA A, 1993, NEW ENGL J MED, V328, P847, DOI 10.1056/NEJM199303253281205; NILGES M, 1988, FEBS LETT, V229, P317, DOI 10.1016/0014-5793(88)81148-7; OEFNER C, 1992, EMBO J, V11, P3921, DOI 10.1002/j.1460-2075.1992.tb05485.x; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pons JL, 1996, J BIOMOL NMR, V8, P445, DOI 10.1007/BF00228146; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; ROBINSON RC, 1995, BIOCHEMISTRY-US, V34, P4139, DOI 10.1021/bi00013a001; Ryden M, 1997, J BIOL CHEM, V272, P33085, DOI 10.1074/jbc.272.52.33085; SCHLUNEGGER MP, 1992, NATURE, V358, P430, DOI 10.1038/358430a0; SHIH A, 1994, J BIOL CHEM, V269, P27679; STICKLE DF, 1992, J MOL BIOL, V226, P1143, DOI 10.1016/0022-2836(92)91058-W; STONE MJ, 1992, BIOCHEMISTRY-US, V31, P4394, DOI 10.1021/bi00133a003; TORCHIA DA, 1975, BIOCHEMISTRY-US, V14, P887, DOI 10.1021/bi00676a004; TORCHIA DA, 1974, BIOPOLYMERS, V13, P97, DOI 10.1002/bip.1974.360130106; WILMOT CM, 1990, PROTEIN ENG, V3, P479, DOI 10.1093/protein/3.6.479; WOO SB, 1995, J BIOL CHEM, V270, P6278, DOI 10.1074/jbc.270.11.6278; Woo SB, 1996, J BIOL CHEM, V271, P24433, DOI 10.1074/jbc.271.40.24433; [No title captured]; [No title captured]	66	34	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23652	23658		10.1074/jbc.273.37.23652	http://dx.doi.org/10.1074/jbc.273.37.23652			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726969	hybrid			2022-12-27	WOS:000075893100010
J	Garcia-Cozar, FJ; Okamura, H; Aramburu, JF; Shaw, KTY; Pelletier, L; Showalter, R; Villafranca, E; Rao, A				Garcia-Cozar, FJ; Okamura, H; Aramburu, JF; Shaw, KTY; Pelletier, L; Showalter, R; Villafranca, E; Rao, A			Two-site interaction of nuclear factor of activated T cells with activated calcineurin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR NFAT1; CYCLOSPORINE-A; NF-AT; LIMITED PROTEOLYSIS; FAMILY; DOMAIN; EXPRESSION; BINDING; COMPLEX; FK506	Transcription factors belonging to the nuclear factor of activated T cells (NFAT) family regulate the expression of cytokine genes and other inducible genes during the immune response. The functions of NFAT proteins are directly controlled by the calcium- and calmodulin-dependent phosphatase calcineurin, Here we show that the binding of calcineurin to NFAT is substantially increased when calcineurin is activated with calmodulin and calcium. FK506-FKBP12 drug-immunophilin complexes inhibited the interaction of NFAT with activated calcineurin much more effectively than they inhibited the interaction with inactive calcineurin, suggesting that part of the interaction with activated calcineurin involved the enzyme active site. We have previously shown that NFAT is targeted to inactive calcineurin at a region distinct from the calcineurin active site (Aramburu, J,, Garcia-Cozar, F, J,, Raghavan, A, Okamura, H,, Rao, A., and Hogan, P, G, (1998) Mel. Cell 1, 627-637); this region is also involved in NFAT binding to activated calcineurin, since binding is inhibited by an NFAT peptide spanning the calcineurin docking site on NFAT, The interacting surfaces are located on the catalytic domain of the calcineurin A chain and on an 86-amino acid fragment of the NFAT regulatory domain. NFAT binding to the calcineurin catalytic domain was inhibited by the calcineurin autoinhibitory domain and the RII substrate peptide, which bind in the calcineurin active site, as well as by the NFAT docking site peptide, which binds to a region of calcineurin distinct from the active site.; We propose that, in resting cells, NFAT is targeted to a region of the calcineurin catalytic domain that does not overlap the calcineurin active site, Upon cell activation, displacement of the autoinhibitory domain by calmodulin binding allows NFAT to bind additionally to the calcineurin active site, thus positioning NFAT for immediate dephosphorylation at functional phosphoserine residues.	Harvard Univ, Sch Med, Dept Pathol, Ctr Blood Res, Boston, MA 02115 USA; Agouron Pharmaceut Inc, San Diego, CA 92121 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Pfizer	Rao, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Ctr Blood Res, 200 Longwood Ave, Boston, MA 02115 USA.		Aramburu, J/G-8991-2014; Garcia-Cozar, Francisco/A-6212-2013	Aramburu, J/0000-0001-9279-9523; Garcia-Cozar, Francisco/0000-0003-3720-259X	NIAID NIH HHS [AI 40127] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040127] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARAMBURU J, 1995, J EXP MED, V182, P801, DOI 10.1084/jem.182.3.801; Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; BIERER BE, 1993, CURR OPIN IMMUNOL, V5, P763, DOI 10.1016/0952-7915(93)90135-F; BLUMENTHAL DK, 1986, J BIOL CHEM, V261, P8140; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Chytil M, 1996, CURR OPIN STRUC BIOL, V6, P91, DOI 10.1016/S0959-440X(96)80100-X; COCKERILL GW, 1995, BLOOD, V86, P2689; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.bi.63.070194.005145; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; HASHIMOTO Y, 1990, J BIOL CHEM, V265, P1924; HO AM, 1994, J BIOL CHEM, V269, P28181; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; HUBBARD MJ, 1989, BIOCHEMISTRY-US, V28, P1868, DOI 10.1021/bi00430a066; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; LIU J, 1993, IMMUNOL TODAY, V14, P290, DOI 10.1016/0167-5699(93)90048-P; Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884; Loh C, 1996, MOL CELL BIOL, V16, P3945; Luo C, 1996, J EXP MED, V184, P141, DOI 10.1084/jem.184.1.141; Luo C, 1996, MOL CELL BIOL, V16, P3955; Luo C, 1996, P NATL ACAD SCI USA, V93, P8907, DOI 10.1073/pnas.93.17.8907; MANALAN AS, 1983, P NATL ACAD SCI-BIOL, V80, P4291, DOI 10.1073/pnas.80.14.4291; Masuda ES, 1997, MOL CELL BIOL, V17, P2066, DOI 10.1128/MCB.17.4.2066; MASUDA ES, 1995, MOL CELL BIOL, V15, P2697; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; Mondragon A, 1997, BIOCHEMISTRY-US, V36, P4934, DOI 10.1021/bi9631935; NALEFSKI EA, 1995, J BIOL CHEM, V270, P22351, DOI 10.1074/jbc.270.38.22351; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; SHIRRA MK, 1994, MOL CELL BIOL, V14, P5076, DOI 10.1128/MCB.14.8.5076; SIKKINK R, 1995, BIOCHEMISTRY-US, V34, P8348, DOI 10.1021/bi00026a016; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Wesselborg S, 1996, J BIOL CHEM, V271, P1274, DOI 10.1074/jbc.271.3.1274	40	85	88	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23877	23883		10.1074/jbc.273.37.23877	http://dx.doi.org/10.1074/jbc.273.37.23877			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727000	hybrid			2022-12-27	WOS:000075893100041
J	Kato, A; Ozawa, F; Saitoh, Y; Fukazawa, Y; Sugiyama, H; Inokuchi, K				Kato, A; Ozawa, F; Saitoh, Y; Fukazawa, Y; Sugiyama, H; Inokuchi, K			Novel members of the Vesl/Homer family of PDZ proteins that bind metabotropic glutamate receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; MESSENGER-RNA; LATE-PHASE; PSD-95; LTP; HIPPOCAMPUS; MAINTENANCE; INDUCTION; DOMAIN; CAMP	Vesl-1S (186 amino acids, also called Homer) is a protein containing EVH1- and PDZ-like domains whose expression in the hippocampus is regulated during long term potentiation (LTP), one form of synaptic plasticity thought to underlie memory formation (Kato, A., Ozawa, F., Saitoh, Y., Hirai, K., and Inokuchi, K. (1997) FEBS Lett. 412, 183-189; Brakeman, P. R., Lanahan, A. A., O'Brien, R., Roche, K., Barnes, C. A., Huganir, R. L., and Worley, P. F. (1997) Nature 386, 284-288). Here we report additional members of the Veal/Homer family of proteins, Vesl-1L and Vesl-2. Vesl-1L (366 amino acids), a splicing variant of Vesl-1S, shares N-terminal 175 amino acids with Vesl-1S and contains additional amino acids at the C terminus. Vesl-2 (354 amino acids) was highly related to Vesl-1L in that both contain EVH1- and PDZ-like domains at the N terminus (86% conservation) and an MCC (mutated in colorectal cancer)-like domain and a leucine zipper at the C terminus. In contrast to vesl-1S, we observed no changes in the levels of vesl-1L and vesl-2 mRNAs during dentate gyrus LTP. All these proteins interacted with metabotropic glutamate receptors (mGluR1 and mGluR5) as well as several hippocampal proteins in vitro. Vesl-1L and Vesl-2, but not Vesl-1S, interacted with each other through the C-terminal portion that was absent in Vesl-1S. Vesl-1L and Vesl-2 may mediate clustering of mGluRs at synaptic junctions. We propose that Vesl-1S may be involved in the structural changes that occur at metabotropic glutamatergic synapses during the maintenance phase of LTP by modulating the redistribution of synaptic components.	Mitsubishi Kasei Inst Life Sci, Machida, Tokyo 1948511, Japan; Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, Fukuoka 81281, Japan	Kyushu University	Inokuchi, K (corresponding author), Mitsubishi Kasei Inst Life Sci, 11 Minamiooya, Machida, Tokyo 1948511, Japan.		Inokuchi, Kaoru/AAI-9693-2020; Fukazawa, Yugo/H-9899-2012	Inokuchi, Kaoru/0000-0002-5393-3133; Fukazawa, Yugo/0000-0001-7436-8797				ABRAHAM WC, 1993, NEUROSCIENCE, V56, P717, DOI 10.1016/0306-4522(93)90369-Q; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Geinisman Y, 1996, J COMP NEUROL, V368, P413; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; Inokuchi K, 1996, FEBS LETT, V382, P48, DOI 10.1016/0014-5793(96)00135-4; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Kato A, 1997, FEBS LETT, V412, P183, DOI 10.1016/S0014-5793(97)00775-8; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Nguyen PV, 1996, J NEUROSCI, V16, P3189; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; OTANI S, 1989, NEUROSCIENCE, V28, P519, DOI 10.1016/0306-4522(89)90001-8; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; ROMANO C, 1995, J COMP NEUROL, V355, P455, DOI 10.1002/cne.903550310; Sambrook J., 2002, MOL CLONING LAB MANU; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2	24	250	257	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23969	23975		10.1074/jbc.273.37.23969	http://dx.doi.org/10.1074/jbc.273.37.23969			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727012	hybrid			2022-12-27	WOS:000075893100053
J	Kinoshita, N; Ghaedi, K; Shimozawa, N; Wanders, RJA; Matsuzono, Y; Imanaka, T; Okumoto, K; Suzuki, Y; Kondo, N; Fujiki, Y				Kinoshita, N; Ghaedi, K; Shimozawa, N; Wanders, RJA; Matsuzono, Y; Imanaka, T; Okumoto, K; Suzuki, Y; Kondo, N; Fujiki, Y			Newly identified Chinese hamster ovary cell mutants are defective in biogenesis of peroxisomal membrane vesicles (peroxisomal ghosts), representing a novel complementation group in mammals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHIZOMELIC CHONDRODYSPLASIA PUNCTATA; TARGETING SIGNAL-1 RECEPTOR; ASSEMBLY FACTOR-II; ZELLWEGER SYNDROME; PROTEIN IMPORT; PTS2 RECEPTOR; PLASMALOGEN BIOSYNTHESIS; ENDOPLASMIC-RETICULUM; NUCLEOTIDE-SEQUENCE; HUMAN PEX7	We isolated peroxisome biogenesis-defective mutants from Chinese hamster ovary cells by the 9-(1'-pyrene)nonanol/ultraviolet (P90H/UV) method. Seven cell mutants, ZP116, ZP119, ZP160, ZP161, ZP162, ZP164, and ZP165, of 11 P90H/UV-resistant cell clones showed cytosolic localization of catalase, a peroxisomal matrix enzyme, apparently indicating a defect of peroxisome biogenesis. By transfection of PEX cDNAs and cell fusion analysis, mutants ZP119 and ZP165 were found to belong to a novel complementation group (CG), distinct from earlier mutants. CG analysis by cell fusion with fibroblasts from patients with peroxisome biogenesis disorders such as Zellweger syndrome indicated that ZP119 and ZP165 were in the same CG as the most recently identified human CG-J. The peroxisomal matrix proteins examined, including PTS1 proteins as well as a PTS2 protein, 3-ketoacyl-CoA thiolase, were also found in the cytosol its ZP119 and ZP165. Furthermore, these mutants showed typical percdxisorne assembly-defective phenotype such as severe loss of resistance to 12-(1'-pyrene)dodecanoic acid/UV treatment. Most strikingly, peroxisomal reminiscent vesicular structures, so-called peroxisomal ghosts noted in all CGs of earlier Chinese hamster ovary cell mutants as well as in eight CGs of patients' fibroblasts, were not discernible ire ZP119 and ZP165, despite normal synthesis of peroxisomal membrane proteins. Accordingly, ZP119 and ZP165 are the first cell mutants defective in import of both soluble and membrane proteins, representing the 14th peroxisome-deficient CG in mammals, including humans.	Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, Fukuoka 8128581, Japan; Gifu Univ, Fac Med, Dept Pediat, Gifu 5008076, Japan; Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1100 DE Amsterdam, Netherlands; Teikyo Univ, Fac Pharmaceut Sci, Dept Microbiol & Mol Pathol, Sagamiko, Kanagawa 1990211, Japan; Japan Sci & Technol Corp, CREST, Tokyo 1700013, Japan	Kyushu University; Gifu University; University of Amsterdam; Academic Medical Center Amsterdam; Teikyo University; Japan Science & Technology Agency (JST)	Fujiki, Y (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.		Ghaedi, Kamran/X-9824-2018	Ghaedi, Kamran/0000-0002-9790-5644; Imanaka, Tsuneo/0000-0003-4677-1356; Shimozawa, Nobuyuki/0000-0003-3040-5458				Baerends RJS, 1996, J BIOL CHEM, V271, P8887, DOI 10.1074/jbc.271.15.8887; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; BRUL S, 1988, J CLIN INVEST, V81, P1710, DOI 10.1172/JCI113510; Chang CC, 1997, NAT GENET, V15, P385, DOI 10.1038/ng0497-385; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Distel B, 1996, J CELL BIOL, V135, P1, DOI 10.1083/jcb.135.1.1; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Elgersma Y, 1997, EMBO J, V16, P7326, DOI 10.1093/emboj/16.24.7326; Erdmann R, 1997, TRENDS CELL BIOL, V7, P400, DOI 10.1016/S0962-8924(97)01126-4; Fujiki Y, 1997, BBA-MOL BASIS DIS, V1361, P235, DOI 10.1016/S0925-4439(97)00051-3; FUJIKI Y, 1982, J CELL BIOL, V93, P103, DOI 10.1083/jcb.93.1.103; Fukuda S, 1996, AM J HUM GENET, V59, P1210; Imanaka T, 1996, J BIOL CHEM, V271, P3706; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; KAMIJO K, 1992, BIOCHIM BIOPHYS ACTA, V1129, P323, DOI 10.1016/0167-4781(92)90510-7; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; LAZAROW PB, 1995, DISORDERS PEROXISOME, P2287; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; MIYAZAWA S, 1989, MOL CELL BIOL, V9, P83, DOI 10.1128/MCB.9.1.83; MIYAZAWA S, 1987, J BIOL CHEM, V262, P8131; MORAND OH, 1990, BIOCHIM BIOPHYS ACTA, V1034, P132, DOI 10.1016/0304-4165(90)90066-6; MOSER AB, 1995, J PEDIATR-US, V127, P13, DOI 10.1016/S0022-3476(95)70250-4; Motley AM, 1997, NAT GENET, V15, P377, DOI 10.1038/ng0497-377; Okumoto K, 1997, EXP CELL RES, V233, P11, DOI 10.1006/excr.1997.3552; Okumoto K, 1997, NAT GENET, V17, P265, DOI 10.1038/ng1197-265; Okumoto K, 1998, MOL CELL BIOL, V18, P4324, DOI 10.1128/MCB.18.7.4324; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Portsteffen H, 1997, NAT GENET, V17, P449, DOI 10.1038/ng1297-449; POULOS A, 1995, J PEDIATR-US, V127, P596, DOI 10.1016/S0022-3476(95)70121-4; Purdue PE, 1997, NAT GENET, V15, P381, DOI 10.1038/ng0497-381; Reuber BE, 1997, NAT GENET, V17, P445, DOI 10.1038/ng1297-445; SANTOS MJ, 1992, J CELL PHYSIOL, V151, P103, DOI 10.1002/jcp.1041510115; SANTOS MJ, 1988, J BIOL CHEM, V263, P10502; Shimozawa N, 1998, BIOCHEM BIOPH RES CO, V243, P368, DOI 10.1006/bbrc.1997.8067; SHIMOZAWA N, 1992, J CLIN INVEST, V90, P1864, DOI 10.1172/JCI116063; SHIMOZAWA N, 1988, PEDIATR RES, V24, P723, DOI 10.1203/00006450-198812000-00015; SHIMOZAWA N, 1992, SCIENCE, V255, P1132, DOI 10.1126/science.1546315; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; Subramani S, 1997, NAT GENET, V15, P331, DOI 10.1038/ng0497-331; Tamura S, 1998, P NATL ACAD SCI USA, V95, P4350, DOI 10.1073/pnas.95.8.4350; Tateishi K, 1997, EUR J CELL BIOL, V73, P352; THIERINGER R, 1993, J BIOL CHEM, V268, P12631; Titorenko VI, 1997, MOL CELL BIOL, V17, P5210, DOI 10.1128/MCB.17.9.5210; Tsukamoto T, 1997, BIOCHEM BIOPH RES CO, V230, P402, DOI 10.1006/bbrc.1996.5971; TSUKAMOTO T, 1994, MOL CELL BIOL, V14, P5458, DOI 10.1128/MCB.14.8.5458; TSUKAMOTO T, 1990, J CELL BIOL, V110, P651, DOI 10.1083/jcb.110.3.651; TSUKAMOTO T, 1995, NAT GENET, V11, P395, DOI 10.1038/ng1295-395; TSUKAMOTO T, 1991, NATURE, V350, P77, DOI 10.1038/350077a0; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; Waterham HR, 1997, BIOESSAYS, V19, P57, DOI 10.1002/bies.950190110; WENDLAND M, 1993, J CLIN INVEST, V92, P2462, DOI 10.1172/JCI116854; WIEMER EAC, 1995, J CELL BIOL, V130, P51, DOI 10.1083/jcb.130.1.51; Wiemer EAC, 1996, J BIOL CHEM, V271, P18973, DOI 10.1074/jbc.271.31.18973; WIEMER EAC, 1989, EUR J CELL BIOL, V50, P407; Yahraus T, 1996, EMBO J, V15, P2914, DOI 10.1002/j.1460-2075.1996.tb00654.x; YAJIMA S, 1992, HUM GENET, V88, P491, DOI 10.1007/BF00219334; ZOELLER RA, 1986, P NATL ACAD SCI USA, V83, P5170, DOI 10.1073/pnas.83.14.5170; ZOELLER RA, 1989, J BIOL CHEM, V264, P21872; ZOELLER RA, 1988, J BIOL CHEM, V263, P11590; ZOELLER RA, 1992, J BIOL CHEM, V267, P8299	60	54	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24122	24130		10.1074/jbc.273.37.24122	http://dx.doi.org/10.1074/jbc.273.37.24122			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727033	hybrid			2022-12-27	WOS:000075893100074
J	Penney, M; Wilkinson, C; Wallace, M; Javerzat, JP; Ferrell, K; Seeger, M; Dubiel, W; McKay, S; Allshire, R; Gordon, C				Penney, M; Wilkinson, C; Wallace, M; Javerzat, JP; Ferrell, K; Seeger, M; Dubiel, W; McKay, S; Allshire, R; Gordon, C			The pad1(+) gene encodes a subunit of the 26 S proteasome in fission yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DEGRADATION; UBIQUITIN; MITOSIS; TRANSCRIPTION; THIAMINE; MUTANTS; ARREST; END	We have isolated a fission yeast mutant, mfs5-1, in a screen for mutations that confer both methyl 5-benzimidazolecarbamate resistance (MBCR) and temperature sensitivity (ts) on Schizosaccharomyces pombe. This screen has previously isolated mutations in the 26 S proteasome subunits Mts2, Mts3, and Mts4. We show that the mutation in the mts5-1 strain occurs in the pad1(+) gene. pad1(+) was originally isolated on a multicopy plasmid that was capable of conferring staurosporine resistance on a wild type strain. mts5-1/pad1-1 has a similar phenotype to 26 S proteasome mutants previously isolated in the same screen and we show that Pad1 interacts genetically with two of these subunits, Mts3 and Mts4. In this study we describe the identification of Pad1 as a subunit of the 26 S proteasome in fission yeast.	Western Gen Hosp, Human Genet Unit, MRC, Edinburgh EH4 2XU, Midlothian, Scotland; Inst Biochem & Genet Cellulaires, F-33077 Bordeaux, France; Humboldt Univ, Med Fac Charite, Inst Biochem, D-10117 Berlin, Germany	University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Gordon, C (corresponding author), Western Gen Hosp, Human Genet Unit, MRC, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	colin.gordon@hgu.mrc.ac.uk		Dubiel, Wolfgang/0000-0002-3393-0701; Allshire, Robin/0000-0002-8005-3625				CHEN P, 1995, EMBO J, V14, P2620, DOI 10.1002/j.1460-2075.1995.tb07260.x; CIECHANOVER A, 1994, BIOL CHEM H-S, V375, P565; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; DUBIEL W, 1995, MOL BIOL REP, V21, P27, DOI 10.1007/BF00990967; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; GORDON C, 1993, NATURE, V366, P355, DOI 10.1038/366355a0; Gordon C, 1996, J BIOL CHEM, V271, P5704, DOI 10.1074/jbc.271.10.5704; HAGAN IM, 1988, J CELL SCI, V89, P343; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; JENTSCH S, 1995, CELL, V82, P881, DOI 10.1016/0092-8674(95)90021-7; KEENEY JB, 1994, GENETICS, V136, P849; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MURRAY A, 1995, CELL, V81, P149, DOI 10.1016/0092-8674(95)90322-4; RINALDI T, 1995, GENE, V160, P135, DOI 10.1016/0378-1119(95)00212-O; RUBIN DM, 1995, CURR BIOL, V5, P854, DOI 10.1016/S0960-9822(95)00172-2; Rubin DM, 1996, NATURE, V379, P655, DOI 10.1038/379655a0; SAZER S, 1990, J CELL SCI, V97, P509; Seeger M, 1996, J MOL BIOL, V263, P423, DOI 10.1006/jmbi.1996.0586; Seeger M, 1998, FASEB J, V12, P469, DOI 10.1096/fasebj.12.6.469; SHIMANUKI M, 1995, J CELL SCI, V108, P569; Spataro V, 1997, J BIOL CHEM, V272, P30470, DOI 10.1074/jbc.272.48.30470; Wilkinson CRM, 1997, J BIOL CHEM, V272, P25768, DOI 10.1074/jbc.272.41.25768; WOODS A, 1989, J CELL SCI, V93, P491	28	43	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23938	23945		10.1074/jbc.273.37.23938	http://dx.doi.org/10.1074/jbc.273.37.23938			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727008	hybrid			2022-12-27	WOS:000075893100049
J	Wright, MB; Hugo, C; Seifert, R; Disteche, CM; Bowen-Pope, DF				Wright, MB; Hugo, C; Seifert, R; Disteche, CM; Bowen-Pope, DF			Proliferating and migrating mesangial cells responding to injury express a novel receptor protein-tyrosine phosphatase in experimental mesangial proliferative glomerulonephritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST GROWTH-FACTOR; SMOOTH MUSCLE ACTIN; EXTRACELLULAR-MATRIX; MOLECULAR-CLONING; FOCAL ADHESIONS; RAT; DROSOPHILA; FIBRONECTIN; NEPHRITIS; ALPHA	The mesangial cell provides structural support to the kidney glomerulus, A polymerase chain reaction-based cDNA display approach identified a novel protein-tyrosine phosphatase, rPTP-GMC1, whose transcript expression is transiently and dramatically up-regulated during the period of mesangial cell migration and proliferation that follows mesangial cell injury in the anti-Thy 1 model of mesangial proliferative glomerulonephritis in the rat. In situ hybridization analysis confirmed that rPTP-GMC1 mRNA is up-regulated specifically by mesangial cells responding to the injury and is not detectable in other cells in the kidney or in many normal tissues. In cell culture, rPTP-GMC1 is expressed by mesangial cells but not by glomerular endothelial or epithelial cells (podocytes), The longest transcript (7.5 kilobases) encodes a receptor-like protein-tyrosine phosphatase consisting of a single catalytic domain, a transmembrane segment, and 18 fibronectin type like repeats in the extracellular segment. A splice variant predicts a truncated molecule missing the catalytic domain. rPTP-GMC1 maps to human chromosome 12q15 and to the distal end of mouse chromosome 10, The predicted structure of rPTP-GMC1 and its pattern of expression in vivo and in culture suggest that it prays a role in regulating the adhesion and migration of mesangial cells in response to injury.	Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Div Nephrol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bowen-Pope, DF (corresponding author), Univ Washington, Dept Pathol, Box 357470, Seattle, WA 98195 USA.			Wright, matthewwright/0000-0002-0532-3381				ADLER S, 1986, J CLIN INVEST, V77, P762, DOI 10.1172/JCI112372; ADLER S, 1993, KIDNEY INT, V44, P278, DOI 10.1038/ki.1993.242; ALPERS CE, 1992, KIDNEY INT, V41, P1134, DOI 10.1038/ki.1992.173; BARNES JL, 1994, AM J PATHOL, V145, P585; BARNES JL, 1990, LAB INVEST, V62, P379; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; BOEHM T, 1993, ONCOGENE, V8, P1385; BORDER WA, 1990, NATURE, V346, P371, DOI 10.1038/346371a0; Borson N D, 1992, PCR Methods Appl, V2, P144; BRADYKALNAY SM, 1995, CURR OPIN CELL BIOL, V7, P650, DOI 10.1016/0955-0674(95)80106-5; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; CHAREST A, 1995, GENOMICS, V28, P501, DOI 10.1006/geno.1995.1181; Desai CJ, 1997, DEVELOPMENT, V124, P1941; EDELHOFF S, 1994, ONCOGENE, V9, P665; FLOEGE J, 1993, J CLIN INVEST, V92, P2952, DOI 10.1172/JCI116918; FLOEGE J, 1992, J CLIN INVEST, V90, P2362, DOI 10.1172/JCI116126; FLOEGE J, 1995, MINER ELECTROL METAB, V21, P271; HUGO C, 1995, KIDNEY INT, V48, P1846, DOI 10.1038/ki.1995.483; Hugo C, 1997, J CLIN INVEST, V100, P786, DOI 10.1172/JCI119592; Hugo C, 1996, J CLIN INVEST, V97, P2499, DOI 10.1172/JCI118697; IIDA H, 1991, P NATL ACAD SCI USA, V88, P6560, DOI 10.1073/pnas.88.15.6560; IVANOVA NB, 1995, NUCLEIC ACIDS RES, V23, P2954, DOI 10.1093/nar/23.15.2954; JOHNSON R, 1992, J AM SOC NEPHROL, V2, P1388; JOHNSON RJ, 1991, J CLIN INVEST, V87, P847, DOI 10.1172/JCI115089; JOHNSON RJ, 1992, J EXP MED, V175, P1413, DOI 10.1084/jem.175.5.1413; JOHNSON RJ, 1994, KIDNEY INT, V45, P1769, DOI 10.1038/ki.1994.230; KRUEGER NX, 1990, EMBO J, V9, P3241, DOI 10.1002/j.1460-2075.1990.tb07523.x; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; MAIN AL, 1992, CELL, V71, P671, DOI 10.1016/0092-8674(92)90600-H; MANLY KF, 1993, MAMM GENOME, V4, P303, DOI 10.1007/BF00357089; MATOZAKI T, 1994, J BIOL CHEM, V269, P2075; MORITA T, 1983, KIDNEY INT, V24, P1, DOI 10.1038/ki.1983.119; OKUDA S, 1990, J CLIN INVEST, V86, P453, DOI 10.1172/JCI114731; OSTMAN A, 1994, P NATL ACAD SCI USA, V91, P9680, DOI 10.1073/pnas.91.21.9680; ROWE LB, 1994, MAMM GENOME, V5, P253, DOI 10.1007/BF00389540; Sambrook J., 2002, MOL CLONING LAB MANU; SCHLONDORFF D, 1987, FASEB J, V1, P272, DOI 10.1096/fasebj.1.4.3308611; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; SKALLI O, 1986, J CELL BIOL, V103, P2787, DOI 10.1083/jcb.103.6.2787; TARABOLETTI G, 1992, LAB INVEST, V67, P566; Taylor BA, 1997, MAMM GENOME, V7, pS176, DOI 10.1007/s003359900322; THOMAS PE, 1994, J BIOL CHEM, V269, P19953; TIAN SS, 1991, CELL, V67, P675, DOI 10.1016/0092-8674(91)90063-5; WIGGINS RC, 1995, GENOMICS, V27, P174, DOI 10.1006/geno.1995.1021; Yang DH, 1996, LAB INVEST, V74, P571; YANG XH, 1991, CELL, V67, P661, DOI 10.1016/0092-8674(91)90062-4; Zinn Kai, 1993, Seminars in Cell Biology, V4, P397, DOI 10.1006/scel.1993.1047	49	32	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23929	23937		10.1074/jbc.273.37.23929	http://dx.doi.org/10.1074/jbc.273.37.23929			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727007	hybrid			2022-12-27	WOS:000075893100048
J	Ghedin, E; Charest, H; Zhang, WW; Debrabant, A; Dwyer, D; Matlashewski, G				Ghedin, E; Charest, H; Zhang, WW; Debrabant, A; Dwyer, D; Matlashewski, G			Inducible expression of suicide genes in Leishmania donovani amastigotes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3'-NUCLEOTIDASE NUCLEASE; THYMIDINE KINASE; PROMASTIGOTES; CLONING; DNA; A2; 5'-NUCLEOTIDASE; INFECTION; PROTEINS; REGION	This study tests the feasibility of using the A2 gene regulatory system to create a Leishmania cell line in which attenuation is developmentally regulated when the parasite differentiates from promastigotes to amastigotes. The Leishmania donovani- inducible A2 gene regulatory system was used to differentially express in amastigotes two potential suicide genes: a truncated version of the L. donovani 3'-nucleotidase/nuclease expressed in the cytoplasm and the herpes simplex virus thymidine kinase gene. These genes were inserted between A2 noncoding regulatory sequences for up-regulation of expression in amastigotes. The accumulation of toxic products affected L. donovani cell replication and viability both in vitro and in vivo. The inducible expression of toxic gene products represents a valuable tool for the development of safe and effective vaccines.	McGill Univ, Inst Parasitol, St Anne Bellevue, PQ H9X 3V9, Canada; NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; NIAID, Cell Biol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	McGill University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Matlashewski, G (corresponding author), McGill Univ, Inst Parasitol, 21111 Lakeshore Rd,Macdonald Campus, St Anne Bellevue, PQ H9X 3V9, Canada.		Ghedin, Elodie/Y-5654-2019	Ghedin, Elodie/0000-0002-1515-725X; Zhang, Wenwei/0000-0003-1996-876X				CAMPBELL TA, 1991, MOL BIOCHEM PARASIT, V47, P109, DOI 10.1016/0166-6851(91)90153-W; Charest H, 1996, J BIOL CHEM, V271, P17081, DOI 10.1074/jbc.271.29.17081; CHAREST H, 1994, MOL CELL BIOL, V14, P2975, DOI 10.1128/MCB.14.5.2975; COBURN CM, 1991, MOL BIOCHEM PARASIT, V46, P169, DOI 10.1016/0166-6851(91)90210-W; COLBEREGARAPIN F, 1979, P NATL ACAD SCI USA, V76, P3755, DOI 10.1073/pnas.76.8.3755; DEBRABANT A, 1995, MOL BIOCHEM PARASIT, V71, P51, DOI 10.1016/0166-6851(95)00035-Y; DWYER DM, 1984, MOL BIOCHEM PARASIT, V10, P139, DOI 10.1016/0166-6851(84)90002-1; DWYER DM, 1977, EXP PARASITOL, V41, P341, DOI 10.1016/0014-4894(77)90107-2; ELLENBERGER TE, 1989, J BIOL CHEM, V264, P15094; GOTTLIEB M, 1983, MOL BIOCHEM PARASIT, V7, P303, DOI 10.1016/0166-6851(83)90013-0; GOTTLIEB M, 1986, COMP BIOCHEM PHYS B, V83, P63, DOI 10.1016/0305-0491(86)90332-9; JOSHI M, 1993, MOL BIOCHEM PARASIT, V58, P345, DOI 10.1016/0166-6851(93)90057-5; LABAN A, 1990, NATURE, V343, P572, DOI 10.1038/343572a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBOWITZ JH, 1992, MOL BIOCHEM PARASIT, V51, P321, DOI 10.1016/0166-6851(92)90082-U; MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L; Molyneux DH, 1987, LEISHMANIASES BIOL M, V1, P121; MOORE KJ, 1993, J IMMUNOL, V150, P4457; MURRAY HW, 1989, J CLIN INVEST, V83, P1253, DOI 10.1172/JCI114009; Muyombwe A, 1997, EXP PARASITOL, V85, P35, DOI 10.1006/expr.1996.4115; Muyombwe A, 1998, J INFECT DIS, V177, P188, DOI 10.1086/513821; PAPADOPOULOU B, 1994, MOL BIOCHEM PARASIT, V65, P39, DOI 10.1016/0166-6851(94)90113-9; SACCI JB, 1990, EXP PARASITOL, V71, P158, DOI 10.1016/0014-4894(90)90018-8; STAUBER LA, 1966, EXP PARASITOL, V18, P1, DOI 10.1016/0014-4894(66)90002-6; Zhang WW, 1996, MOL BIOCHEM PARASIT, V78, P79, DOI 10.1016/S0166-6851(96)02612-6; Zhang WW, 1997, P NATL ACAD SCI USA, V94, P8807, DOI 10.1073/pnas.94.16.8807; ZHANG WW, 1995, NUCLEIC ACIDS RES, V23, P4073, DOI 10.1093/nar/23.20.4073; ZLOTNICK GW, 1987, COMP BIOCHEM PHYS B, V87, P629, DOI 10.1016/0305-0491(87)90063-0	28	26	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					22997	23003		10.1074/jbc.273.36.22997	http://dx.doi.org/10.1074/jbc.273.36.22997			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722523	hybrid			2022-12-27	WOS:000075778100023
J	Moore, MS				Moore, MS			Ran and nuclear transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ACTIVATING PROTEIN RANGAP1; BINDING-PROTEIN; IMPORT SUBSTRATE; RAN/TC4 GTPASE; PORE COMPLEX; NUCLEOCYTOPLASMIC TRANSPORT; SACCHAROMYCES-CEREVISIAE; EXPORT; IDENTIFICATION; DISTINCT	The last several years have witnessed an explosion in our understanding of how proteins and RNAs traffic into and out of the nucleus. Although an increasing number of proteins have been implicated in different nuclear transport pathways, the small GTPase Ran appears to play a central role in coordinating and driving much of this nuclear traffic. Recently there have been several excellent reviews describing the multiple pathways of nuclear transport (1-5); consequently this review will focus on what is currently known about Ran and its biochemical properties and what is presently understood of the role of the Ran GTPase cycle during nuclear transport.	Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA	Baylor College of Medicine	Moore, MS (corresponding author), Baylor Coll Med, Dept Cell Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	mmoore@bcm.tmc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053678] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM53678] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAM EJH, 1994, J CELL BIOL, V125, P547, DOI 10.1083/jcb.125.3.547; ADAM SA, 1991, CELL, V66, P837, DOI 10.1016/0092-8674(91)90431-W; Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624; BISCHOFF FR, 1991, P NATL ACAD SCI USA, V88, P10830, DOI 10.1073/pnas.88.23.10830; BISCHOFF FR, 1995, P NATL ACAD SCI USA, V92, P1749, DOI 10.1073/pnas.92.5.1749; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; Bischoff FR, 1997, FEBS LETT, V419, P249, DOI 10.1016/S0014-5793(97)01467-1; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Bonifaci N, 1997, P NATL ACAD SCI USA, V94, P5055, DOI 10.1073/pnas.94.10.5055; CHI NC, 1995, J CELL BIOL, V130, P265, DOI 10.1083/jcb.130.2.265; Chi NC, 1996, J CELL BIOL, V135, P559, DOI 10.1083/jcb.135.3.559; Corbett AH, 1997, MICROBIOL MOL BIOL R, V61, P193, DOI 10.1128/.61.2.193-211.1997; Corbett AH, 1996, J BIOL CHEM, V271, P18477, DOI 10.1074/jbc.271.31.18477; DRIVAS GT, 1990, MOL CELL BIOL, V10, P1793, DOI 10.1128/MCB.10.4.1793; ENENKEL C, 1995, J BIOL CHEM, V270, P16499, DOI 10.1074/jbc.270.28.16499; Feldherr C, 1998, J CELL SCI, V111, P1889; FELDHERR CM, 1994, INT REV CYTOL, V151, P183, DOI 10.1016/S0074-7696(08)62633-9; Floer M, 1997, J BIOL CHEM, V272, P19538, DOI 10.1074/jbc.272.31.19538; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; GORLICH D, 1995, NATURE, V377, P246, DOI 10.1038/377246a0; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Gorlich D, 1997, J CELL BIOL, V138, P65, DOI 10.1083/jcb.138.1.65; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; Kiseleva E, 1996, J MOL BIOL, V260, P304, DOI 10.1006/jmbi.1996.0401; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Kutay U, 1998, MOL CELL, V1, P359, DOI 10.1016/S1097-2765(00)80036-2; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Lounsbury KM, 1996, J BIOL CHEM, V271, P32834, DOI 10.1074/jbc.271.51.32834; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; MATTAJ IW, 1998, IN PRESS ANN REV BIO; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; MELCHIOR F, 1993, J CELL BIOL, V123, P1649, DOI 10.1083/jcb.123.6.1649; MOORE MS, 1993, NATURE, V365, P661, DOI 10.1038/365661a0; MOORE MS, 1994, P NATL ACAD SCI USA, V91, P10212, DOI 10.1073/pnas.91.21.10212; MOROIANU J, 1995, P NATL ACAD SCI USA, V92, P2008, DOI 10.1073/pnas.92.6.2008; MOROIANU J, 1995, P NATL ACAD SCI USA, V92, P6532, DOI 10.1073/pnas.92.14.6532; Nakielny S, 1998, CURR BIOL, V8, P89, DOI 10.1016/S0960-9822(98)70039-9; Nehrbass U, 1996, SCIENCE, V272, P120, DOI 10.1126/science.272.5258.120; NEWMEYER DD, 1988, CELL, V52, P641, DOI 10.1016/0092-8674(88)90402-3; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Ohno M, 1998, CELL, V92, P327, DOI 10.1016/S0092-8674(00)80926-5; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; PASCHAL BM, 1995, J CELL BIOL, V129, P925, DOI 10.1083/jcb.129.4.925; Pemberton LF, 1997, J CELL BIOL, V139, P1645, DOI 10.1083/jcb.139.7.1645; Pemberton LF, 1998, CURR OPIN CELL BIOL, V10, P392, DOI 10.1016/S0955-0674(98)80016-1; Pennisi E, 1998, SCIENCE, V279, P1129, DOI 10.1126/science.279.5354.1129; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; RADU A, 1995, P NATL ACAD SCI USA, V92, P1769, DOI 10.1073/pnas.92.5.1769; REN MD, 1994, MOL CELL BIOL, V14, P4216, DOI 10.1128/MCB.14.6.4216; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; RICHARDS SA, 1995, J BIOL CHEM, V270, P14405, DOI 10.1074/jbc.270.24.14405; Richards SA, 1997, SCIENCE, V276, P1842, DOI 10.1126/science.276.5320.1842; RICHARDSON WD, 1988, CELL, V52, P655, DOI 10.1016/0092-8674(88)90403-5; Rosenblum JS, 1997, J CELL BIOL, V139, P1655, DOI 10.1083/jcb.139.7.1655; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Rush MG, 1996, BIOESSAYS, V18, P103, DOI 10.1002/bies.950180206; Saavedra C, 1996, GENE DEV, V10, P1608, DOI 10.1101/gad.10.13.1608; SCHEFFZEK K, 1995, NATURE, V374, P378, DOI 10.1038/374378a0; Schlenstedt G, 1997, EMBO J, V16, P6237, DOI 10.1093/emboj/16.20.6237; Seki T, 1996, J BIOCHEM, V120, P207; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Sweet DJ, 1996, J CELL BIOL, V133, P971, DOI 10.1083/jcb.133.5.971; Traglia HM, 1996, P NATL ACAD SCI USA, V93, P7667, DOI 10.1073/pnas.93.15.7667; WEIS K, 1995, SCIENCE, V268, P1049, DOI 10.1126/science.7754385; Weis K, 1996, EMBO J, V15, P7120, DOI 10.1002/j.1460-2075.1996.tb01103.x	71	145	151	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					22857	22860		10.1074/jbc.273.36.22857	http://dx.doi.org/10.1074/jbc.273.36.22857			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722501	hybrid			2022-12-27	WOS:000075778100001
J	Ouyang, L; Chen, XY; Bieker, JJ				Ouyang, L; Chen, XY; Bieker, JJ			Regulation of erythroid Kruppel-like factor (EKLF) transcriptional activity by phosphorylation of a protein kinase casein kinase II site within its interaction domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOBIN GENE-EXPRESSION; HUMAN GAMMA-GLOBIN; DNA-BINDING; BETA-THALASSEMIA; ACTIVATION; CELLS; CHROMATIN; SUBUNIT; RESIDUE; GATA-1	Erythroid Kruppel-like factor (EKLF) is a red cell-specific activator whose presence is crucial for establishing high levels of adult beta-globin expression in definitive cells during erythroid ontogeny, However, its simple presence within the erythroid lineage is not sufficient to activate the beta-globin promoter. One explanation that may account for this is that post-translational modification of EKLF differs within erythroid cell populations and regulates its activity. We have therefore addressed whether phosphorylation plays a role in modulating EKLF action. First, in vivo analyses implicate serine/threonine kinases as important players in the terminal differentiation of MEL cells, and demonstrate that EKLF is phosphorylated at serine and threonine residues within its transactivation region, Second, directed disruption of a protein kinase casein kinase (CK) II site, located within the EKLF interaction domain, abolishes EKLF transactivation and in vivo competition activity, Third, in vitro assays demonstrate that CKII alpha interacts with EKLF, and that the EKLF interaction domain is phosphorylated by CKII only at Thr-41; however, the CKII-site mutant is not phosphorylated. Finally, the transactivation capability of EKLF is augmented by cotransfection of CKII alpha. We conclude that EKLF is a phosphoprotein whose ability to transcriptionally activate an adjacent promoter is critically dependent on the phosphorylation status of a specific site located within the EKLF interaction domain, and that serine/threonine kinases play an important role in this process.	CUNY Mt Sinai Sch Med, Brookdale Ctr Mol Biol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Biochem, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Bieker, JJ (corresponding author), CUNY Mt Sinai Sch Med, Brookdale Ctr Mol Biol, Box 1126,1 Gustave L Levy Pl, New York, NY 10029 USA.	jbieker@smtplink.mssm.edu			NIDDK NIH HHS [DK46865] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046865] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; Bieker JJ, 1996, DNA CELL BIOL, V15, P347, DOI 10.1089/dna.1996.15.347; BIEKER JJ, 1995, MOL CELL BIOL, V15, P852; Bresnick EH, 1997, P NATL ACAD SCI USA, V94, P4566, DOI 10.1073/pnas.94.9.4566; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; Chen XY, 1996, EMBO J, V15, P5888, DOI 10.1002/j.1460-2075.1996.tb00975.x; DONZE D, 1995, J BIOL CHEM, V270, P1955, DOI 10.1074/jbc.270.4.1955; ENGEL JD, 1993, TRENDS GENET, V9, P304, DOI 10.1016/0168-9525(93)90248-G; Felsenfeld G, 1996, CELL, V86, P13, DOI 10.1016/S0092-8674(00)80073-2; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; FENG WC, 1994, J BIOL CHEM, V269, P1493; GONZATTIHACES MI, 1982, J BIOL CHEM, V257, P6642; Gregory RC, 1996, BLOOD, V87, P1793, DOI 10.1182/blood.V87.5.1793.bloodjournal8751793; HATHAWAY GM, 1981, J BIOL CHEM, V256, P1442; HELLERHARRISON RA, 1991, J BIOL CHEM, V266, P14435; HIDAKA H, 1991, METHOD ENZYMOL, V201, P328; HOEFFLER WK, 1994, NUCLEIC ACIDS RES, V22, P1305, DOI 10.1093/nar/22.7.1305; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; HUPP TR, 1994, CURR BIOL, V4, P865, DOI 10.1016/S0960-9822(00)00195-0; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Jaffe L, 1997, GENE DEV, V11, P1327, DOI 10.1101/gad.11.10.1327; KAMESHITA I, 1989, ANAL BIOCHEM, V183, P139, DOI 10.1016/0003-2697(89)90181-4; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Lim SK, 1997, BLOOD, V90, P1291, DOI 10.1182/blood.V90.3.1291.1291_1291_1299; LIN AN, 1992, CELL, V70, P777, DOI 10.1016/0092-8674(92)90311-Y; Lin RT, 1996, MOL CELL BIOL, V16, P1401; Martin DIK, 1996, CURR OPIN GENET DEV, V6, P488, DOI 10.1016/S0959-437X(96)80072-4; Massimi P, 1996, ONCOGENE, V12, P2325; Meisner H, 1991, CURR OPIN CELL BIOL, V3, P474, DOI 10.1016/0955-0674(91)90076-B; MERIKA M, 1995, MOL CELL BIOL, V15, P2437; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; OELGESCHLAGER M, 1995, MOL CELL BIOL, V15, P5966; OReilly D, 1997, EMBO J, V16, P2420, DOI 10.1093/emboj/16.9.2420; ORKIN SH, 1995, EUR J BIOCHEM, V231, P271, DOI 10.1111/j.1432-1033.1995.tb20697.x; ORKIN SH, 1995, J BIOL CHEM, V270, P4955, DOI 10.1074/jbc.270.10.4955; Pazin MJ, 1997, CELL, V89, P325, DOI 10.1016/S0092-8674(00)80211-1; PERKINS AC, 1995, NATURE, V375, P318; Perkins AC, 1996, P NATL ACAD SCI USA, V93, P12267, DOI 10.1073/pnas.93.22.12267; Reese TT, 1997, GROWTH FACTORS, V14, P161, DOI 10.3109/08977199709021518; RIHS HP, 1991, EMBO J, V10, P633, DOI 10.1002/j.1460-2075.1991.tb07991.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schwarz EM, 1996, MOL CELL BIOL, V16, P3554; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; SHOJI W, 1994, J BIOL CHEM, V269, P5078; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Southwood CM, 1996, DEV DYNAM, V206, P248, DOI 10.1002/(SICI)1097-0177(199607)206:3<248::AID-AJA3>3.0.CO;2-I; STAMATOYANNOPOU.G, 1994, HEMOGLOBIN SWITCHING, P107; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; Wijgerde M, 1996, GENE DEV, V10, P2894, DOI 10.1101/gad.10.22.2894; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Willert K, 1997, EMBO J, V16, P3089, DOI 10.1093/emboj/16.11.3089; Wolffe AP, 1996, CELL, V84, P817, DOI 10.1016/S0092-8674(00)81059-4; Wood WG, 1996, TRENDS GENET, V12, P204, DOI 10.1016/0168-9525(96)30043-7; YAN ZF, 1994, J BIOL CHEM, V269, P13231; ZHENG CF, 1993, J BIOL CHEM, V268, P11435	57	50	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23019	23025		10.1074/jbc.273.36.23019	http://dx.doi.org/10.1074/jbc.273.36.23019			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722526	hybrid			2022-12-27	WOS:000075778100026
J	Ruiz-Arguello, MB; Goni, FM; Alonso, A				Ruiz-Arguello, MB; Goni, FM; Alonso, A			Vesicle membrane fusion induced by the concerted activities of sphingomyelinase and phospholipase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE DILUTION KINETICS; PHASE-TRANSITIONS; CELLULAR-RESPONSES; LIPOSOME FUSION; CUBIC PHASES; DIACYLGLYCEROL; MECHANISMS; CERAMIDE; LIPIDS; PHOSPHATIDYLETHANOLAMINE	When vesicles composed of an equimolar mixture of sphingomyelin, phosphatidylcholine, phosphatidylethanolamine, and cholesterol are treated with phospholipase C, phospholipid hydrolysis occurs without major changes in vesicle architecture. In the same way, addition of sphingomyelinase leads only to sphingomyelin cleavage. However, when both enzymes are added together, their joint hydrolytic activities give rise to leakage-free vesicle aggregation, lipid mixing, and aqueous contents mixing, i.e. vesicle fusion, The contribution of both enzymes is unequal, the main role of sphingomyelinase being the production of relatively large amounts of ceramide that will facilitate the lamellar-to-nonlamellar transition in the formation of the fusion pore, whereas phospholipase C provides mainly a localized, asymmetric, high concentration of diacylglycerol that constitutes the trigger for the fusion process. The lipidic endproducts of both enzymes cooperate in destabilizing and fusing the membranes in a way that is never achieved through the action of any of the enzymes individually, nor by the products themselves when premixed with the other lipids during liposome preparation. Thus the enzymes appear to be coupled through their reaction products. This is the first observation of membrane fusion induced by the concerted activities of two enzymes. Besides, considering that both diacylglycerol and ceramide are important metabolites involved in cell signaling, it may also provide new ideas in the exploration of "cross-talk" phenomena between different signal transduction pathways.	Univ Basque Country, Dept Bioquim, CSIC, Unidad Asociada,Grp Biomembranas, E-48080 Bilbao, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country	Alonso, A (corresponding author), Univ Basque Country, Dept Bioquim, CSIC, Unidad Asociada,Grp Biomembranas, Aptdo 644, E-48080 Bilbao, Spain.	gbpaliza@lg.ehu.es	Alonso, Alicia/E-5310-2012; Goni, Felix M/M-5425-2015	Alonso, Alicia/0000-0002-2730-7470; Goni, Felix M/0000-0001-6270-9216				Basanez G, 1997, BIOPHYS J, V72, P2630, DOI 10.1016/S0006-3495(97)78906-9; Basanez G, 1996, BIOPHYS J, V70, P2299, DOI 10.1016/S0006-3495(96)79795-3; Basanez G, 1998, BIOCHEMISTRY-US, V37, P3901, DOI 10.1021/bi9728497; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; Bottcher C, 1961, ANAL CHIM ACTA, V1061, P297; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Chernomordik L, 1996, CHEM PHYS LIPIDS, V81, P203, DOI 10.1016/0009-3084(96)02583-2; CHERNOMORDIK L, 1995, BIOPHYS J, V69, P922, DOI 10.1016/S0006-3495(95)79966-0; Chernomordik LV, 1997, J CELL BIOL, V136, P81, DOI 10.1083/jcb.136.1.81; DENNIS EA, 1973, ARCH BIOCHEM BIOPHYS, V158, P485, DOI 10.1016/0003-9861(73)90540-7; ELLENS H, 1986, BIOCHEMISTRY-US, V25, P4141, DOI 10.1021/bi00362a023; Fanani ML, 1997, MOL MEMBR BIOL, V14, P25, DOI 10.3109/09687689709048166; Ghosh S, 1997, FASEB J, V11, P45, DOI 10.1096/fasebj.11.1.9034165; GOMEZMUNOZ A, 1997, SPHINGOLIPID MEDIATE, P103; GUNTHERAUSBORN S, 1995, J BIOL CHEM, V270, P29279; HAMILTON JA, 1991, J BIOL CHEM, V266, P1177; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; HOEKSTRA D, 1984, BIOCHEMISTRY-US, V23, P5675, DOI 10.1021/bi00319a002; IKEZAWA H, 1978, BIOCHIM BIOPHYS ACTA, V528, P247; KOZLOV GV, 1983, PHYS REV B, V28, P255, DOI 10.1103/PhysRevB.28.255; Luzzati V, 1997, CURR OPIN STRUC BIOL, V7, P661, DOI 10.1016/S0959-440X(97)80075-9; MALLABIABARRENA A, 1995, CELL, V83, P667, DOI 10.1016/0092-8674(95)90177-9; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; MONCK JR, 1994, NEURON, V12, P707, DOI 10.1016/0896-6273(94)90325-5; NIEVA JL, 1993, BIOCHEMISTRY-US, V32, P1054, DOI 10.1021/bi00055a009; NIEVA JL, 1995, FEBS LETT, V368, P143, DOI 10.1016/0014-5793(95)00631-I; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; OBEID LM, 1995, J CELL BIOCHEM, V58, P191, DOI 10.1002/jcb.240580208; RuizArguello MB, 1996, J BIOL CHEM, V271, P26616, DOI 10.1074/jbc.271.43.26616; SASAKI T, 1995, BIOCHEM J, V311, P829, DOI 10.1042/bj3110829; SIEGEL DP, 1993, BIOPHYS J, V65, P2124, DOI 10.1016/S0006-3495(93)81256-6; Siegel DP, 1997, BIOPHYS J, V73, P3089, DOI 10.1016/S0006-3495(97)78336-X; Spiegel S, 1996, CURR OPIN CELL BIOL, V8, P159, DOI 10.1016/S0955-0674(96)80061-5; Tong SG, 1996, BIOCHEMISTRY-US, V35, P4956, DOI 10.1021/bi9526903; ZIMMERBERG J, 1993, ANNU REV BIOPH BIOM, V22, P433, DOI 10.1146/annurev.bb.22.060193.002245	35	78	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					22977	22982		10.1074/jbc.273.36.22977	http://dx.doi.org/10.1074/jbc.273.36.22977			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722520	hybrid			2022-12-27	WOS:000075778100020
J	Seno, K; Kishigami, A; Ihara, S; Maeda, T; Bondarenko, VA; Nishizawa, Y; Usukura, J; Yamazaki, A; Hayashi, F				Seno, K; Kishigami, A; Ihara, S; Maeda, T; Bondarenko, VA; Nishizawa, Y; Usukura, J; Yamazaki, A; Hayashi, F			A possible role of RGS9 in phototransduction - A bridge between the cGMP-phosphodiesterase system and the guanylyl cyclase system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEBRATE ROD PHOTORECEPTORS; INHIBITORY SUBUNIT; PROTEIN-KINASE; CALCIUM; CLONING; PHOSPHORYLATION; SENSITIVITY; EXPRESSION; HYDROLYSIS; IONS	In the current concept of phototransduction, the concentration of cGMP in retinal rod outer segments is controlled by the balance of two enzyme activities: cGMP phosphodiesterase (PDE) and guanylyl cyclase (GC). However, no protein directly mediates these two enzyme systems. Here we show that RGS9, which is suggested to control PDE activity through regulation of transducin GTPase activity (He, W., Cowan, C. W., and Wensel, T, G. (1998) Neuron 20, 95-102), directly interacts with GC, When proteins in the Triton X-100-insoluble fraction of bovine rod outer segments were isolated by two-dimensional gel electrophoresis and binding of GC to these proteins was examined using a GC-specific antibody, proteins (55 and 32 kDa) were found to interact with GC. However, the activity of GC bound to the 55-kDa protein was not detected. This observation was elucidated by the finding that the 55-kDa protein inhibited GC activity in a dose-dependent manner. Amino acid sequence showed that five peptides derived from the 55-kDa protein were identical to corresponding peptides of RGS9. Together with other biochemical characterization of the 55-kDa protein, these observations indicate that the 55-kDa protein is RGS9 and that RGS9 inhibits GC. RGS9 may serve as a mediator between the PDE and GC systems.	Kobe Univ, Fac Sci, Dept Biol, Kobe, Hyogo 657, Japan; Kobe Univ, Grad Sch Sci & Technol, Kobe, Hyogo 657, Japan; Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Kresge Eye Inst, Detroit, MI 48201 USA; Nagoya Univ, Sch Med, Dept Anat, Nagoya, Aichi 466, Japan	Kobe University; Kobe University; Wayne State University; Wayne State University; Wayne State University; Nagoya University	Hayashi, F (corresponding author), Kobe Univ, Fac Sci, Dept Biol, Kobe, Hyogo 657, Japan.		Bondarenko, Vladimir/AFY-8370-2022; kishigami, Akio/B-5906-2018	kishigami, Akio/0000-0001-8333-5794; Usukura, Jiro/0000-0003-2286-5403	NEI NIH HHS [EY09631, EY07546] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009631, R01EY007546] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aparicio JG, 1996, J BIOL CHEM, V271, P27083, DOI 10.1074/jbc.271.43.27083; Cowan CW, 1998, P NATL ACAD SCI USA, V95, P5351, DOI 10.1073/pnas.95.9.5351; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; ERICKSON MA, 1992, SCIENCE, V257, P1255, DOI 10.1126/science.1519062; GORACZNIAK RM, 1994, BIOCHEM J, V302, P455, DOI 10.1042/bj3020455; GORCZYCA WA, 1995, J BIOL CHEM, V270, P22029, DOI 10.1074/jbc.270.37.22029; HAKKI S, 1990, BIOCHEMISTRY-US, V29, P1088, DOI 10.1021/bi00456a035; Harlow E, 1988, ANTIBODIES LABORATOR, P521; HAYASHI F, 1991, P NATL ACAD SCI USA, V88, P4746, DOI 10.1073/pnas.88.11.4746; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; KAWAMURA S, 1991, NATURE, V349, P420, DOI 10.1038/349420a0; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; Koutalos Y, 1996, TRENDS NEUROSCI, V19, P73; Li N, 1998, EUR J BIOCHEM, V252, P591, DOI 10.1046/j.1432-1327.1998.2520591.x; LIU XR, 1994, EXP EYE RES, V59, P761, DOI 10.1006/exer.1994.1162; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; MATSUDAIRA P, 1993, PRACTICAL GUIDE PROT, P54; MOOS M, 1988, J BIOL CHEM, V263, P6005; NISHIZAWA Y, 1998, INVEST OPHTHALMOL  S, V39, P4855; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; SHYJAN AW, 1992, NEURON, V9, P727, DOI 10.1016/0896-6273(92)90035-C; TSUBOI S, 1994, J BIOL CHEM, V269, P15024; TSUBOI S, 1994, J BIOL CHEM, V269, P15016; Wolbring G, 1996, BIOCHEMISTRY-US, V35, P11013, DOI 10.1021/bi960699e; Yamazaki A, 1996, J BIOL CHEM, V271, P32495, DOI 10.1074/jbc.271.51.32495; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602	27	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22169	22172		10.1074/jbc.273.35.22169	http://dx.doi.org/10.1074/jbc.273.35.22169			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712827	hybrid			2022-12-27	WOS:000075616600003
J	Takei, Y; Tsujimoto, G				Takei, Y; Tsujimoto, G			Identification of a novel MCM3-associated protein that facilitates MCM3 nuclear localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; DNA-REPLICATION; POSSIBLE INVOLVEMENT; IMPORTIN-ALPHA; RAT-LIVER; IN-VIVO; COMPLEX; EXPRESSION; CHROMATIN; COMPONENT	MCM3 is essential for the initiation of DNA replication and also participates in controls that ensure DNA replication is initiated once per cell cycle. In a two-hybrid screen for proteins that interact with human MCM3, we identified and cloned a novel protein of which the calculated molecular weight is 80,291. A specific antibody against the protein identified a 80-kDa protein in HeLa cell extract, indicating the protein actually expressed in cells. The interaction of these proteins was confirmed by immunoprecipitation assay. Moreover, we clarified a nuclear localization signal of human MCM3, and we find that mutagenesis on the nuclear localization signal of MCM3 affected the binding of newly isolated MCM3-assosiated protein, Map80. Map80 was expressed in Escherichia coli as a fusion with His, tag and purified with sequential column chromatographies. The addition of recombinant Map80 stimulated the amount of nuclear localized MCM3. These results suggest that Map80 is involved in the nuclear localization pathway of MCM3.	Natl Childrens Med Res Ctr, Dept Mol Cell Pharmacol, Setagaya Ku, Tokyo 154, Japan	National Center for Child Health & Development - Japan	Takei, Y (corresponding author), Natl Childrens Med Res Ctr, Dept Mol Cell Pharmacol, Setagaya Ku, Taishido 3-35-31, Tokyo 154, Japan.	ytakei@nch.go.jp						ADAM SA, 1991, METHOD CELL BIOL, V35, P469; Bonifaci N, 1997, P NATL ACAD SCI USA, V94, P5055, DOI 10.1073/pnas.94.10.5055; Carpenter PB, 1996, NATURE, V379, P357, DOI 10.1038/379357a0; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; COLEMAN TR, 1996, SCIENCE, V270, P1667; Diffley TFX, 1996, GENE DEV, V10, P2819, DOI 10.1101/gad.10.22.2819; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; DOWELL SJ, 1994, SCIENCE, V265, P1243, DOI 10.1126/science.8066465; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fujita M, 1997, J BIOL CHEM, V272, P10928; JACKSON AL, 1993, MOL CELL BIOL, V13, P2899, DOI 10.1128/MCB.13.5.2899; Kimura H, 1996, GENES CELLS, V1, P977, DOI 10.1046/j.1365-2443.1996.840284.x; KITADA K, 1992, GENETICS, V131, P21; Kohler M, 1997, FEBS LETT, V417, P104, DOI 10.1016/S0014-5793(97)01265-9; KUBOTA Y, 1995, CELL, V81, P601, DOI 10.1016/0092-8674(95)90081-0; Kubota Y, 1997, EMBO J, V16, P3320, DOI 10.1093/emboj/16.11.3320; LIANG C, 1995, CELL, V81, P667, DOI 10.1016/0092-8674(95)90528-6; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Pemberton LF, 1997, J CELL BIOL, V139, P1645, DOI 10.1083/jcb.139.7.1645; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Rowles A, 1996, CELL, V87, P287, DOI 10.1016/S0092-8674(00)81346-X; TAKEI Y, 1992, J BIOL CHEM, V267, P5085; TAKEI Y, 1994, J BIOCHEM-TOKYO, V115, P578, DOI 10.1093/oxfordjournals.jbchem.a124378; Thommes P, 1997, EMBO J, V16, P3312, DOI 10.1093/emboj/16.11.3312; Tsuji L, 1997, FEBS LETT, V416, P30, DOI 10.1016/S0014-5793(97)01092-2; Yaseen NR, 1997, P NATL ACAD SCI USA, V94, P4451, DOI 10.1073/pnas.94.9.4451; Young MR, 1997, MOL BIOL CELL, V8, P1587, DOI 10.1091/mbc.8.8.1587	28	27	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22177	22180		10.1074/jbc.273.35.22177	http://dx.doi.org/10.1074/jbc.273.35.22177			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712829	hybrid			2022-12-27	WOS:000075616600005
J	Fouts, DL; Stryker, GA; Gorski, KS; Miller, MJ; Nguyen, TV; Wrightsman, RA; Manning, JE				Fouts, DL; Stryker, GA; Gorski, KS; Miller, MJ; Nguyen, TV; Wrightsman, RA; Manning, JE			Evidence for four distinct major protein components in the paraflagellar rod of Trypanosoma cruzi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-COMPOSITION; SURFACE-ANTIGEN GENE; STRUCTURAL CLASSES; BRUCEI; STAGE; IDENTIFICATION; EXPRESSION; DROSOPHILA; SEQUENCE	The major structural proteins present inn the paraflagellar rod of Trypanosoma cruzi migrate on SDS-polyacrylamide gels as two distinct electrophoretic bands. The gene encoding a protein present in the faster migrating band, designated PAR 2, has been identified previously. Here we report the isolation and partial characterization of three genes, designated par I, par 3, and pal 4, that encode proteins present in the two paraflagellar rod protein bands. Peptide-specific polyclonal antibodies and monoclonal antibodies against the four proteins encoded by these genes shows that PAR 1 and PAR 3 are present only in the slower migrating paraflagellar rod band, and that PAR 2 and PAR 4 are present only in the faster migrating band. Analysis of the nucleotide sequence of these genes and the amino acid sequence of the conceptual proteins encoded by them indicates that par 2 shares high sequence similarity with par 3 and both are members of a common gene family, of which par I may be a distant member. Analysis of gene copy number and steady-state RNA levels suggest that the close stoichiometric ratio of the four PAR proteins is likely maintained by homeostatic regulation of RNA levels rather than gene dosage.	Univ Calif Irvine, Dept Biochem & Mol Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Manning, JE (corresponding author), Univ Calif Irvine, Dept Biochem & Mol Biol, Irvine, CA 92697 USA.			Stryker, Gabrielle/0000-0002-5658-0054; Miller, Mark/0000-0001-5676-389X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018873] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 18873] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bastin P, 1996, PARASITOL TODAY, V12, P302, DOI 10.1016/0169-4758(96)10031-4; BEARD CA, 1988, MOL BIOCHEM PARASIT, V28, P227, DOI 10.1016/0166-6851(88)90007-2; BIRKETT CR, 1992, GENE, V110, P65, DOI 10.1016/0378-1119(92)90445-U; BRENER Z, 1973, ANNU REV MICROBIOL, V27, P347, DOI 10.1146/annurev.mi.27.100173.002023; CHOU KC, 1992, EUR J BIOCHEM, V207, P429, DOI 10.1111/j.1432-1033.1992.tb17067.x; CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406; DEFLORIN J, 1994, J BIOL CHEM, V269, P28745; DELAFAILLE MAC, 1992, J BIOL CHEM, V267, P23839; DESOUZA W, 1980, J PARASITOL, V66, P229, DOI 10.2307/3280809; FOUTS DL, 1991, MOL BIOCHEM PARASIT, V46, P189, DOI 10.1016/0166-6851(91)90043-6; FOUTS DL, 1981, NUCLEIC ACIDS RES, V9, P7053, DOI 10.1093/nar/9.24.7053; GALLO JM, 1985, EUR J CELL BIOL, V36, P163; Hunger-Glaser I, 1997, MOL BIOCHEM PARASIT, V90, P347, DOI 10.1016/S0166-6851(97)00139-4; ISMACH R, 1989, J PROTOZOOL, V36, P616; KING RD, 1990, J MOL BIOL, V216, P441, DOI 10.1016/S0022-2836(05)80333-X; LEVIN JM, 1988, BIOCHIM BIOPHYS ACTA, V955, P283, DOI 10.1016/0167-4838(88)90206-3; MAO BY, 1994, PROTEIN ENG, V7, P319, DOI 10.1093/protein/7.3.319; Moore LL, 1996, MOL BIOCHEM PARASIT, V80, P125, DOI 10.1016/0166-6851(96)02688-6; PERRY DAD, 1995, INTERMEDIATE FILAMEN; ROZEK CE, 1983, CELL, V32, P23, DOI 10.1016/0092-8674(83)90493-2; SABORIO JL, 1990, EXP PARASITOL, V70, P411, DOI 10.1016/0014-4894(90)90125-V; SABORIO JL, 1989, J BIOL CHEM, V264, P4071; Sambrook J., 2002, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHLAEPPI K, 1989, J CELL BIOL, V109, P1695, DOI 10.1083/jcb.109.4.1695; Summers MD, 1987, MANUAL METHODS BACUL; WRIGHTSMAN RA, 1994, J IMMUNOL, V153, P3148; WRIGHTSMAN RA, 1986, INFECT IMMUN, V53, P235, DOI 10.1128/IAI.53.2.235-239.1986	28	33	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21846	21855		10.1074/jbc.273.34.21846	http://dx.doi.org/10.1074/jbc.273.34.21846			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705323	hybrid, Green Published			2022-12-27	WOS:000075492600057
J	Moriyama, T; Sather, SK; McGee, TP; Simoni, RD				Moriyama, T; Sather, SK; McGee, TP; Simoni, RD			Degradation of HMG-CoA reductase in vitro - Cleavage in the membrane domain by a membrane-bound cysteine protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A REDUCTASE; ENDOPLASMIC-RETICULUM; 3-HYDROXY-3-METHYLGLUTARYL COENZYME; REGULATED DEGRADATION; APOLIPOPROTEIN B100; HEPG2 CELLS; PATHWAY; INHIBITOR; STEROL; ENZYME	We have recently shown that the endoplasmic reticulum (ER) membrane protein, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, is cleaved in isolated membrane fractions enriched for endoplasmic reticulum, Importantly, the cleavage rate is accelerated when the membranes are prepared from cells that have been pretreated with mevalonate or sterols, physiological regulators of the degradation process in vivo (McGee, T. P., Cheng, H. H., Kumagai, H., Omura, S., and Simoni, R. D. (1996) J. Biol. Chem. 271, 25630-25638). In the current study, we further characterize this in vitro cleavage of HMG-CoA reductase, E64, a specific inhibitor of cysteine-proteases, inhibits HMG-CoA reductase cleavage in vitro. In contrast, lactacystin, ale inhibitor of the proteasome, inhibits HMG-CoA reductase degradation in vivo but does not inhibit the in vitro cleavage. Purified ER fractions contain lactacystin-sensitive and E64-insensitive proteasome activity as measured by succinyl-Leu-Leu-Val-Tyr-7-amino-4-methylcoumarin hydrolysis. We removed the proteasome from purified ER fractions by solubilization with heptylthioglucoside and observed that the detergent extracted, proteasome-depleted membrane fractions retain regulated cleavage of HMG-CoA reductase, This indicates that ER-associated proteasome is not involved in degradation of HMG-CoA reductase in vitro. In order to determine the site(s) of proteolysis of HMG-CoA reductase in vitro, four antisera were prepared against peptide sequences representing various domains of HMG-CoA reductase and used for detection of proteolytic intermediates. The sizes and antibody reactivity of the intermediates suggest that HMG-CoA reductase is cleaved in the in vitro degradation system near the span 8 membrane region, which links the N-terminal membrane domain to the C-terminal catalytic domain of the protein. We conclude that HMG-CoA reductase can be cleaved in the membrane-span 8 region by a cysteine protease(s) tightly associated with ER membranes.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Simoni, RD (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	rdsimoni@leland.stanford.edu		McGee, Todd/0000-0002-3901-1001; Moriyama, Tatsuya/0000-0002-6861-926X	NHLBI NIH HHS [HL26502] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL026502] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Benoist F, 1997, J BIOL CHEM, V272, P20435, DOI 10.1074/jbc.272.33.20435; BIEDER T, 1997, SCIENCE, V278, P1801; CHUN KT, 1992, J BIOL CHEM, V267, P4236; CORRELL CC, 1994, J BIOL CHEM, V269, P633; EDWARDS PA, 1991, BIOCH LIPIDS LIPOPRO, P383; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; FIGUEIREDOPEREIRA ME, 1994, J NEUROCHEM, V63, P1578; Fisher EA, 1997, J BIOL CHEM, V272, P20427, DOI 10.1074/jbc.272.33.20427; GIL G, 1985, CELL, V41, P249, DOI 10.1016/0092-8674(85)90078-9; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hampton RY, 1997, P NATL ACAD SCI USA, V94, P12944, DOI 10.1073/pnas.94.24.12944; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; HANADA K, 1978, AGR BIOL CHEM TOKYO, V42, P523, DOI 10.1080/00021369.1978.10863014; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; INOUE S, 1992, J BIOL CHEM, V267, P9080; INOUE S, 1993, J BIOL CHEM, V268, P5894; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; KUMAGAI H, 1995, J BIOL CHEM, V270, P19107, DOI 10.1074/jbc.270.32.19107; LISCUM L, 1985, J BIOL CHEM, V260, P522; McGee TP, 1996, J BIOL CHEM, V271, P25630, DOI 10.1074/jbc.271.41.25630; MEIGS TE, 1992, J BIOL CHEM, V267, P13547; NAKANISHI M, 1988, J BIOL CHEM, V263, P8929; OLENDER EH, 1992, J BIOL CHEM, V267, P4223; Palmer A, 1996, BIOCHEM J, V316, P401, DOI 10.1042/bj3160401; RIVETT AJ, 1994, METHOD ENZYMOL, V244, P331; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; ROITELMAN J, 1992, J CELL BIOL, V117, P959, DOI 10.1083/jcb.117.5.959; ROITELMAN J, 1992, J BIOL CHEM, V267, P25264; ROTHBLAT GH, 1976, IN VITRO CELL DEV B, V12, P554; SKALNIK DG, 1988, J BIOL CHEM, V263, P6836; SKALNIK DG, 1985, J BIOL CHEM, V260, P1991; Sommer T, 1997, FASEB J, V11, P1227, DOI 10.1096/fasebj.11.14.9409541; TANAKA RD, 1986, J LIPID RES, V27, P261; URADE R, 1992, J BIOL CHEM, V267, P15152; URBANI L, 1990, J BIOL CHEM, V265, P1919; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wu XJ, 1997, J BIOL CHEM, V272, P11575; Yeung SJ, 1996, BIOCHEMISTRY-US, V35, P13843, DOI 10.1021/bi9618777	39	49	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					22037	22043		10.1074/jbc.273.34.22037	http://dx.doi.org/10.1074/jbc.273.34.22037			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705346	hybrid			2022-12-27	WOS:000075492600080
J	Najimi, M; Souaze, F; Mendez, M; Hermans, E; Berbar, T; Rostene, W; Forgez, P				Najimi, M; Souaze, F; Mendez, M; Hermans, E; Berbar, T; Rostene, W; Forgez, P			Activation of receptor gene transcription is required to maintain cell sensitization after agonist exposure - Study on neurotensin receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-HYDROXYLASE GENE; BOND PSEUDOPEPTIDE ANALOGS; MESSENGER-RNA LEVELS; SMOOTH-MUSCLE CELLS; QUANTITATIVE RT-PCR; CALCIUM MOBILIZATION; DOWN-REGULATION; G-PROTEIN; DIFFERENTIAL REGULATION; RAPID DESENSITIZATION	Neurotensin (NT) acts through specific G protein-coupled receptors to induce effects in the central nervous system and periphery. In this study we have shown that in the human neuroblastoma cell Line CHP 212, an NT agonist, JMV 449, induced high affinity neurotensin receptor (NTR) gene activation. I-125-NT binding of cells challenged with JMV 449 rapidly decreased then reappeared and subsequently stabilized at 50% of the control values after 48 h of agonist exposure. These receptors, which reappeared at the cell surface, are as active as those found in control cells as demonstrated by Ca2+ mobilization. Furthermore, the tyrosine hydroxylase (TH) gene, a known NT target gene, remained activated after prolonged NT agonist exposure in this cell line. In the murine neuroblastoma cell line, N1E-115, NT did not stimulate NTR gene activation but induced NTR mRNA destabilization after long term agonist exposure. In this cell line, NT binding dropped to 15% of control values and remained at this value after agonist treatment. The TH expression, which was originally activated upon NT agonist exposure, decreased to control values after prolonged agonist exposure. These observations combined with the data obtained from a complementary study with HT-29 cells (Souaze, F., Rostene, W., and Forgez, P. (1997) J. Biol. Chem. 272, 10087-10094) revealed the crucial role of agonist-induced receptor gene transcription in the maintenance of cell sensitivity. A model for G protein-coupled receptor regulation induced by prolong and intense agonist stimulation is proposed.	Hop St Antoine, INSERM U339, F-75012 Paris, France; Univ Catholique Louvain, Pharmacol Lab, B-1200 Brussels, Belgium; Inst Mexicano Psiquiat, Mexico City 14370, DF, Mexico	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Catholique Louvain; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz	Forgez, P (corresponding author), Hop St Antoine, INSERM U339, 184 Rue Faubourg St Antoine, F-75012 Paris, France.		Hermans, Emmanuel/V-3040-2019; Hermans, Emmanuel/A-1654-2015; souazé, frédérique/AAE-6478-2021; Rostene, William/F-2754-2017; Souazé, Frédérique/K-7937-2015; FORGEZ, Patricia/N-2960-2018	Frederique, Souaze/0000-0003-0476-2603; ROSTENE, WILLIAM/0000-0003-0409-5361				AMAR S, 1987, J NEUROCHEM, V49, P999, DOI 10.1111/j.1471-4159.1987.tb09986.x; BOUDIN H, 1995, BIOCHEM J, V305, P277, DOI 10.1042/bj3050277; BOZOU JC, 1986, MOL PHARMACOL, V29, P489; BOZOU JC, 1989, BIOCHEM J, V264, P871, DOI 10.1042/bj2640871; BURGEVIN MC, 1992, NEUROSCIENCE, V49, P627, DOI 10.1016/0306-4522(92)90232-Q; CARRAWAY R, 1976, J BIOL CHEM, V251, P7045; Chae HD, 1996, J NEUROCHEM, V66, P1264; Chalon P, 1996, FEBS LETT, V386, P91, DOI 10.1016/0014-5793(96)00397-3; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Chuang TT, 1996, TRENDS PHARMACOL SCI, V17, P416, DOI 10.1016/S0165-6147(96)10048-1; Clapham DE, 1996, NATURE, V379, P297, DOI 10.1038/379297a0; COLLINS S, 1989, P NATL ACAD SCI USA, V86, P4853, DOI 10.1073/pnas.86.13.4853; DIPAOLA ED, 1993, J PHARMACOL EXP THER, V264, P1; DOULUT S, 1992, PEPTIDE RES, V5, P30; FRASER CM, 1995, LIFE SCI, V56, P899, DOI 10.1016/0024-3205(95)00026-3; GULLY D, 1993, P NATL ACAD SCI USA, V90, P65, DOI 10.1073/pnas.90.1.65; HADCOCK JR, 1988, P NATL ACAD SCI USA, V85, P5021, DOI 10.1073/pnas.85.14.5021; HEIN L, 1995, NEUROPHARMACOLOGY, V34, P357, DOI 10.1016/0028-3908(95)00018-2; HERMANS E, 1995, J NEUROCHEM, V64, P2518; HERMANS E, 1994, BIOCHEM BIOPH RES CO, V198, P400, DOI 10.1006/bbrc.1994.1056; HIREMAGALUR B, 1993, J BIOL CHEM, V268, P23704; HOSADA K, 1994, J NEUROCHEM, V63, P16345; IZZO NJ, 1990, P NATL ACAD SCI USA, V87, P6268, DOI 10.1073/pnas.87.16.6268; KARDOOR V, 1996, PROG NEUROBIOL, V48, P555; KASCKOW J, 1991, REGUL PEPTIDES, V36, P153, DOI 10.1016/0167-0115(91)90053-J; KITABGI P, 1987, EUR J PHARMACOL, V140, P285, DOI 10.1016/0014-2999(87)90285-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert PD, 1996, NEUROSCIENCE, V75, P1141, DOI 10.1016/0306-4522(96)00210-2; LUGRIN D, 1991, EUR J PHARMACOL, V205, P191, DOI 10.1016/0014-2999(91)90819-C; Mendez M, 1997, J MOL NEUROSCI, V9, P93, DOI 10.1007/BF02736853; NEMEROFF CB, 1980, BRAIN RES, V195, P69, DOI 10.1016/0006-8993(80)90867-7; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; RENSDOMIANO S, 1995, FASEB J, V9, P1059, DOI 10.1096/fasebj.9.11.7649405; RYDELEKFITZGERALD L, 1993, MOL CELL ENDOCRINOL, V92, P253, DOI 10.1016/0303-7207(93)90016-D; SATO M, 1991, DEV BRAIN RES, V58, P97, DOI 10.1016/0165-3806(91)90241-A; Scarceriaux V, 1996, J NEUROENDOCRINOL, V8, P587; SNIDER RM, 1986, J NEUROCHEM, V47, P1214; Souaze F, 1996, BIOTECHNIQUES, V21, P280; Souaze F, 1997, J BIOL CHEM, V272, P10087; STEEL MC, 1993, MOL PHARMACOL, V43, P694; TANAKA K, 1990, NEURON, V4, P847, DOI 10.1016/0896-6273(90)90137-5; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TURNER JT, 1990, J PHARMACOL EXP THER, V253, P1049; VITA N, 1993, FEBS LETT, V317, P139, DOI 10.1016/0014-5793(93)81509-X; WESSELSREIKER M, 1993, J NEUROCHEM, V60, P1018, DOI 10.1111/j.1471-4159.1993.tb03250.x; Yu K, 1996, ENDOCRINOLOGY, V137, P3566, DOI 10.1210/en.137.8.3566	46	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21634	21641		10.1074/jbc.273.34.21634	http://dx.doi.org/10.1074/jbc.273.34.21634			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705296	Green Published, hybrid			2022-12-27	WOS:000075492600030
J	Underwood, KW; Song, CZ; Kriz, RW; Chang, XJ; Knopf, JL; Lin, LL				Underwood, KW; Song, CZ; Kriz, RW; Chang, XJ; Knopf, JL; Lin, LL			A novel calcium-independent phospholipase A(2), cPLA(2)-gamma, that is prenylated and contains homology to cPLA(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE-A(2); P388D(1) MACROPHAGES; GENE-EXPRESSION; PROTEIN; CELLS; ACID; IDENTIFICATION; TRANSLOCATION; PURIFICATION; CYSTEINE	We report the cloning and characterization of a novel membrane-bound, calcium-independent PLA(2), named cPLA(2)-gamma. The sequence encodes a 541-amino acid protein containing a domain with significant homology to the catalytic domain of the 85-kDa cPLA(2) (cPLA(2)-alpha). cPLA(2)-gamma does not contain the regulatory calcium-dependent lipid binding (CaLB) domain found in cPLA(2)-alpha. However, cPLA(2)-gamma does contain two consensus motifs for lipid modification, a prenylation motif (-CCLA) at the C terminus and a myristoylation site at the N terminus. We present evidence that the isoprenoid precursor [H-3]mevalonolactone is incorporated into the prenylation motif of cPLA(2)-gamma. Interestingly, cPLA(2)-gamma demonstrates a preference for arachidonic acid at the sn-2 position of phosphatidylcholine as compared with palmitic acid. cPLA(2)-gamma encodes a 3-kilobase message, which is highly expressed in heart and skeletal muscle, suggesting a specific role in these tissues. identification of cPLA(2)-gamma reveals a newly defined family of phospholipases A(2) with homology to CPLA(2)-alpha.	Genet Inst, Small Mol Drug Discovery Grp, Cambridge, MA 02140 USA		Lin, LL (corresponding author), Genet Inst, Small Mol Drug Discovery Grp, 87 Cambridge Pk Dr, Cambridge, MA 02140 USA.							ACKERMANN EJ, 1995, BBA-LIPID LIPID MET, V1259, P125, DOI 10.1016/0005-2760(95)00143-Z; Balboa MA, 1997, J BIOL CHEM, V272, P8576, DOI 10.1074/jbc.272.13.8576; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; CLARK JD, 1990, P NATL ACAD SCI USA, V87, P7708, DOI 10.1073/pnas.87.19.7708; CLARKE S, 1992, ANNU REV BIOCHEM, V61, P355, DOI 10.1146/annurev.bi.61.070192.002035; DAVIES MV, 1992, J VIROL, V66, P1924, DOI 10.1128/JVI.66.4.1924-1932.1992; Dennis EA, 1997, TRENDS BIOCHEM SCI, V22, P1, DOI 10.1016/S0968-0004(96)20031-3; DEREWENDA ZS, 1993, TRENDS BIOCHEM SCI, V18, P20, DOI 10.1016/0968-0004(93)90082-X; GHOMASHCHI F, 1992, BIOCHEMISTRY-US, V31, P3814, DOI 10.1021/bi00130a012; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; HAZEN SL, 1990, J BIOL CHEM, V265, P10622; HAZEN SL, 1991, J BIOL CHEM, V266, P5629; HOECK WG, 1993, P NATL ACAD SCI USA, V90, P4475, DOI 10.1073/pnas.90.10.4475; JOHNSON RD, 1994, ANNU REV BIOCHEM, V63, P869; KIM CM, 1992, J BIOL CHEM, V267, P23113; LIN LL, 1992, J BIOL CHEM, V267, P23451; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; McHowat J, 1997, AM J PHYSIOL-HEART C, V272, pH1972, DOI 10.1152/ajpheart.1997.272.4.H1972; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Otto JC, 1996, J BIOL CHEM, V271, P4569; Pickard RT, 1996, J BIOL CHEM, V271, P19225, DOI 10.1074/jbc.271.32.19225; Schievella AR, 1995, J BIOL CHEM, V270, P30749, DOI 10.1074/jbc.270.51.30749; SHARP JD, 1991, J BIOL CHEM, V266, P14850; SHARP JD, 1994, J BIOL CHEM, V269, P23250; Shen F, 1996, J BIOL CHEM, V271, P3692; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	31	200	211	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21926	21932		10.1074/jbc.273.34.21926	http://dx.doi.org/10.1074/jbc.273.34.21926			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705332	hybrid			2022-12-27	WOS:000075492600066
J	Ju, H; Venema, VJ; Marrero, MB; Venema, RC				Ju, H; Venema, VJ; Marrero, MB; Venema, RC			Inhibitory interactions of the bradykinin B2 receptor with endothelial nitric-oxide synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; BINDING DOMAIN; CAVEOLIN; EXPRESSION; CALMODULIN; IDENTIFICATION; CLONING; MUSCLE; CELLS	It has been shown previously that the endothelial nitric-oxide synthase (eNOS) interacts reversibly with the plasmalemmal caveolae structural protein, caveolin-1. The eNOS-caveolin-1 interaction inhibits eNOS catalytic activity. In the present study, we show that eNOS also participates in reversible inhibitory interactions with the G protein-coupled bradykinin B2 receptor, eNOS and the B2 receptor are coimmunoprecipitated from endothelial cell lysates by antibodies directed against either of the two proteins. A glutathione S-transferase fusion protein containing intracellular domain 4 of the receptor is bound by purified recombinant eNOS in in vitro binding assays. The fusion protein selectively inhibits the activity of purified eNOS. A synthetic peptide corresponding to membrane-proximal residues 310-334 in intracellular domain 4 also potently inhibits eNOS activity (IC50 < 1 mu M). Treatment of cultured endothelial cells with bradykinin or Ca2+ ionophore promotes a rapid dissociation of the eNOS B2 receptor complex. These data demonstrate that the bradykinin B2 receptor physically associates with eNOS in a ligand- and Ca2+ dependent manner. Reversible and inhibitory membrane-docking interactions of eNOS, therefore, are not restricted to those with caveolin-1 but also occur with the bradykinin B2 receptor.	Med Coll Georgia, Dept Pediat, Vasc Biol Ctr, Augusta, GA 30912 USA; Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Venema, RC (corresponding author), Med Coll Georgia, Dept Pediat, Vasc Biol Ctr, Augusta, GA 30912 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL057201, R01HL057201] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL57201] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABDALLA S, 1993, J BIOL CHEM, V268, P17277; Busse R, 1996, DIABETES, V45, pS8, DOI 10.2337/diab.45.1.S8; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; FEENER EP, 1995, J CLIN INVEST, V95, P1353, DOI 10.1172/JCI117786; Feron O, 1998, J BIOL CHEM, V273, P3125, DOI 10.1074/jbc.273.6.3125; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; HESS JF, 1992, BIOCHEM BIOPH RES CO, V184, P260, DOI 10.1016/0006-291X(92)91187-U; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; MCEACHERN AE, 1991, P NATL ACAD SCI USA, V88, P7724, DOI 10.1073/pnas.88.17.7724; Michel JB, 1997, J BIOL CHEM, V272, P25907, DOI 10.1074/jbc.272.41.25907; Michel JB, 1997, J BIOL CHEM, V272, P15583, DOI 10.1074/jbc.272.25.15583; MONCADA S, 1991, PHARMACOL REV, V43, P109; Pueyo ME, 1998, AM J PHYSIOL-CELL PH, V274, pC214, DOI 10.1152/ajpcell.1998.274.1.C214; VAUGHAN DE, 1995, J CLIN INVEST, V95, P995, DOI 10.1172/JCI117809; VENEMA RC, 1995, J BIOL CHEM, V270, P14705, DOI 10.1074/jbc.270.24.14705; Venema RC, 1998, J BIOL CHEM, V273, P7703, DOI 10.1074/jbc.273.13.7703; Venema RC, 1996, J BIOL CHEM, V271, P6435, DOI 10.1074/jbc.271.11.6435; Venema VJ, 1998, BIOCHEM BIOPH RES CO, V246, P70, DOI 10.1006/bbrc.1998.8574; Venema VJ, 1997, J BIOL CHEM, V272, P28187, DOI 10.1074/jbc.272.45.28187	19	132	140	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24025	24029		10.1074/jbc.273.37.24025	http://dx.doi.org/10.1074/jbc.273.37.24025			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727019	hybrid			2022-12-27	WOS:000075893100060
J	Kudoh, S; Komuro, I; Hiroi, Y; Zou, YZ; Harada, K; Sugaya, T; Takekoshi, N; Murakami, K; Kadowaki, T; Yazaki, Y				Kudoh, S; Komuro, I; Hiroi, Y; Zou, YZ; Harada, K; Sugaya, T; Takekoshi, N; Murakami, K; Kadowaki, T; Yazaki, Y			Mechanical stretch induces hypertrophic responses in cardiac myocytes of angiotensin II type 1a receptor knockout mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; COUPLED RECEPTORS; CELL HYPERTROPHY; TYROSINE KINASE; EGF RECEPTOR; MUSCLE-CELLS; STRESS; INHIBITION; PHOSPHORYLATION	Many lines of evidence have suggested that angiotensin II (AngII) plays an important role in the development of cardiac hypertrophy through AngII type 1 receptor (AT1). To determine whether AngII is indispensable for the development of mechanical stress-induced cardiac hypertrophy, we examined the activity of mitogen-activated protein kinase (MAPK) family and the expression of the c-fos gene as hypertrophic responses after stretching cultured cardiac myocytes of AT1a knockout (KO) mice. When cardiac myocytes were stretched by 20% for 10 min, extracellular signal-regulated protein kinases (ERKs) were strongly activated in KO cardiomyocytes as well as wild type (WT) myocytes. Both basal and stimulated levels of ERKs were higher in cardiomyocytes of KO mice than in those of WT mice. Activation of another member of the MAPK family, p38(MAPK), and expression of the c-fos gene were also induced by stretching cardiac myocytes of both types of mice. An AT1 antagonist attenuated stretch-induced activation of ERKs in WT cardiomyocytes but not in KO cardiomyocytes, Down-regulation of protein kinase C inhibited stretch-induced ERK activation in WT cardiomyocytes, whereas a broad spectrum tyrosine kinase inhibitor (genistein) and selective inhibitors of epidermal growth factor receptor (tyrphostin, AG1478, and B42) suppressed stretch-induced activation of ERKs in KO cardiac myocytes. Epidermal growth factor receptor was phosphorylated at tyrosine residues by stretching cardiac myocytes of KO mice. These results suggest that mechanical stretch could evoke hypertrophic responses in cardiac myocytes that lack the AT1 signaling pathway possibly through tyrosine kinase activation.	Univ Tokyo, Sch Med, Dept Cardiovasc Med, Tokyo 1138655, Japan; Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 3050005, Japan; Kanazawa Med Univ, Dept Cardiol, Kanazawa, Ishikawa 9200265, Japan	University of Tokyo; University of Tsukuba; Kanazawa Medical University	Komuro, I (corresponding author), Univ Tokyo, Sch Med, Dept Med 3, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.							BAKER KM, 1990, AM J PHYSIOL, V259, pH324, DOI 10.1152/ajpheart.1990.259.2.H324; BAKER KM, 1992, ANNU REV PHYSIOL, V54, P227, DOI 10.1146/annurev.physiol.54.1.227; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Glennon PE, 1996, CIRC RES, V78, P954, DOI 10.1161/01.RES.78.6.954; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Harada K, 1998, CIRCULATION, V97, P1952, DOI 10.1161/01.CIR.97.19.1952; Harada K, 1998, CIRC RES, V82, P779, DOI 10.1161/01.RES.82.7.779; ITO H, 1991, CIRC RES, V69, P209, DOI 10.1161/01.RES.69.1.209; IWAI N, 1991, BIOCHEM BIOPH RES CO, V177, P299, DOI 10.1016/0006-291X(91)91982-I; KAMBAYASHI Y, 1993, J BIOL CHEM, V268, P24543; Kent RL, 1996, CIRC RES, V78, P829, DOI 10.1161/01.RES.78.5.829; KOMURO I, 1990, J BIOL CHEM, V265, P3595; KOMURO I, 1993, ANNU REV PHYSIOL, V55, P55, DOI 10.1146/annurev.ph.55.030193.000415; KOMURO I, 1991, J BIOL CHEM, V266, P1265; Komuro I, 1996, FASEB J, V10, P631, DOI 10.1096/fasebj.10.5.8621062; Kudoh S, 1997, CIRC RES, V80, P139, DOI 10.1161/01.RES.80.1.139; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; LINDPAINTNER K, 1991, CIRC RES, V68, P905, DOI 10.1161/01.RES.68.4.905; LINSEMAN DA, 1995, J BIOL CHEM, V270, P12563, DOI 10.1074/jbc.270.21.12563; MANN DL, 1989, CIRC RES, V64, P1079, DOI 10.1161/01.RES.64.6.1079; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; MUKOYAMA M, 1993, J BIOL CHEM, V268, P24539; PARKER TG, 1991, ANNU REV PHYSIOL, V53, P179; Post GR, 1996, J BIOL CHEM, V271, P8452, DOI 10.1074/jbc.271.14.8452; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; SADOSHIMA J, 1993, EMBO J, V12, P1681, DOI 10.1002/j.1460-2075.1993.tb05813.x; SADOSHIMA J, 1993, CELL, V75, P977, DOI 10.1016/0092-8674(93)90541-W; SADOSHIMA J, 1995, CIRC RES, V76, P1; SASAMURA H, 1992, BIOCHEM BIOPH RES CO, V185, P253, DOI 10.1016/S0006-291X(05)80983-0; SIMPSON P, 1983, J CLIN INVEST, V72, P732, DOI 10.1172/JCI111023; SUGAYA T, 1995, J BIOL CHEM, V270, P18719, DOI 10.1074/jbc.270.32.18719; THORBURN J, 1995, MOL BIOL CELL, V6, P1479, DOI 10.1091/mbc.6.11.1479; THORBURN J, 1994, J CELL BIOL, V126, P1565, DOI 10.1083/jcb.126.6.1565; Velloso LA, 1996, P NATL ACAD SCI USA, V93, P12490, DOI 10.1073/pnas.93.22.12490; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamauchi T, 1997, NATURE, V390, P91, DOI 10.1038/36369; Yamazaki T, 1996, J BIOL CHEM, V271, P3221, DOI 10.1074/jbc.271.6.3221; YAMAZAKI T, 1995, CIRC RES, V77, P258, DOI 10.1161/01.RES.77.2.258; YAMAZAKI T, 1995, J CLIN INVEST, V96, P438, DOI 10.1172/JCI118054; YAMAZAKI T, 1993, J BIOL CHEM, V268, P12069; Zou YZ, 1996, J BIOL CHEM, V271, P33592, DOI 10.1074/jbc.271.52.33592	45	109	110	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24037	24043		10.1074/jbc.273.37.24037	http://dx.doi.org/10.1074/jbc.273.37.24037			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727021	hybrid			2022-12-27	WOS:000075893100062
J	Martins, LJ; Jensen, LT; Simons, JR; Keller, GL; Winge, DR				Martins, LJ; Jensen, LT; Simons, JR; Keller, GL; Winge, DR			Metalloregulation of FRE1 and FRE2 homologs in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPPER TRANSPORT PROTEIN; IRON UPTAKE; NADPH OXIDASE; FERRIC REDUCTASE; MOLECULAR CHARACTERIZATION; TRANSCRIPTIONAL CONTROL; FET3 GENE; YEAST; BINDING; REPRESSION	The high affinity uptake systems for iron and copper ions in Saccharomyces cerevisiae involve metal-specific permeases and two known cell surface Cu(II) and Fe(III) metalloreductases, Fre1 and Fre2, Five novel genes found in the S. cerevisiae genome exhibit marked sequence similarity to Fre1 and Fre2, suggesting that the homologs are part of a family of proteins related to Fre1 and Fre2, The homologs are expressed genes in S. cerevisiae, and their expression is metalloregulated as is true with FRE1 and FRE2. Four of the homologs (FRE3-FRE6) are specifically hen-regulated through the Aft1 transcription factor. These genes are expressed either in cells limited for iron ion uptake by treatment with a chelator or in cells lacking the high affinity iron uptake system. Expression of FRE3-FRE6 is elevated in AFT1-1(up) cells and attenuated in aft1 null cells, showing that iron modulation occurs through the Aft1 transcriptional activator. The fifth homolog FRE7 is specifically copper-metalloregulated, FRE7 is expressed in cells limited in copper ion uptake by a Cu(I)-specific chelator or in cells lacking the high affinity Cu(I) permeases, The constitutive expression of FRE7 in MAC1(up1) cells and the lack of expression in mac1-1 cells are consistent with Mad being the critical transcriptional activator of FRE7 expression, The 5' promoter sequence of FRE7 contains three copper-responsive promoter elements. Two elements are critical for Mad-dependent FRE7 expression. Combinations of either the distal and central elements or the central and proximal elements result in copper-regulated FRE7 expression. Spacing between Mac1-responsive sites is important as shown by the attenuated expression of FRE7 and CTR1 when two elements are separated by over 100 base pairs. From the three Mac1-responsive elements in FRE7, a new consensus sequence for Mad binding can be established as TTTGC(T/G)C(A/G).	Univ Utah, Hlth Sci Ctr, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Winge, DR (corresponding author), Univ Utah, Hlth Sci Ctr, Salt Lake City, UT 84132 USA.		Winge, Dennis/G-3611-2010	Jensen, Laran/0000-0003-3199-1743; Martins, Laura/0000-0001-8535-5350	NATIONAL CANCER INSTITUTE [P30CA042014, R01CA061286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007115] Funding Source: NIH RePORTER; NCI NIH HHS [5P30-CA 42014, CA61286] Funding Source: Medline; NIDDK NIH HHS [T32 DK07115] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; BACHHAWAT N, 1995, J BIOL CHEM, V270, P25087, DOI 10.1074/jbc.270.42.25087; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CROSS AR, 1994, J BIOL CHEM, V269, P21448; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; DANCIS A, 1992, P NATL ACAD SCI USA, V89, P3869, DOI 10.1073/pnas.89.9.3869; DANCIS A, 1994, J BIOL CHEM, V269, P25660; DANCIS A, 1990, MOL CELL BIOL, V10, P2294, DOI 10.1128/MCB.10.5.2294; DESILVA DM, 1995, J BIOL CHEM, V270, P1098, DOI 10.1074/jbc.270.3.1098; Finegold AA, 1996, J BIOL CHEM, V271, P31021, DOI 10.1074/jbc.271.49.31021; Georgatsou E, 1997, J BIOL CHEM, V272, P13786, DOI 10.1074/jbc.272.21.13786; GEORGATSOU E, 1994, MOL CELL BIOL, V14, P3065, DOI 10.1128/MCB.14.5.3065; Graden JA, 1997, P NATL ACAD SCI USA, V94, P5550, DOI 10.1073/pnas.94.11.5550; HASSETT R, 1995, J BIOL CHEM, V270, P128, DOI 10.1074/jbc.270.1.128; HENDERSON LM, 1995, J BIOL CHEM, V270, P5909, DOI 10.1074/jbc.270.11.5909; Iyer V, 1996, P NATL ACAD SCI USA, V93, P5208, DOI 10.1073/pnas.93.11.5208; JUNGMANN J, 1993, EMBO J, V12, P5051, DOI 10.1002/j.1460-2075.1993.tb06198.x; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; Labbe S, 1997, J BIOL CHEM, V272, P15951, DOI 10.1074/jbc.272.25.15951; LESK AM, 1991, PROTEIN ARCHITECTURE, P68; Lesuisse E, 1996, J BIOL CHEM, V271, P13578, DOI 10.1074/jbc.271.23.13578; Moore DD, 1995, GLOB MOB SURV; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; Shatwell KP, 1996, J BIOL CHEM, V271, P14240, DOI 10.1074/jbc.271.24.14240; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; VANDERHELM D, 1994, HYDROXAMATES POLYCAB, P39; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; YamaguchiIwai Y, 1997, J BIOL CHEM, V272, P17711, DOI 10.1074/jbc.272.28.17711; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632	32	156	169	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23716	23721		10.1074/jbc.273.37.23716	http://dx.doi.org/10.1074/jbc.273.37.23716			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726978	hybrid			2022-12-27	WOS:000075893100019
J	Parsonage, D; Luba, J; Mallett, TC; Claiborne, A				Parsonage, D; Luba, J; Mallett, TC; Claiborne, A			The soluble alpha-glycerophosphate oxidase from Enterococcus casseliflavus - Sequence homology with the membrane-associated dehydrogenase and kinetic analysis of the recombinant enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID OXIDASE; SN-GLYCEROL 3-PHOSPHATE; ACTIVE-SITE PROBES; L-LACTATE OXIDASE; GLYCEROL-3-PHOSPHATE DEHYDROGENASE; ESCHERICHIA-COLI; GLUCOSE-OXIDASE; NUCLEOTIDE-SEQUENCE; CRYSTAL-STRUCTURE; SN-GLYCEROL-3-PHOSPHATE DEHYDROGENASE	The soluble flavoprotein cr-glycerophosphate oxidase fi om Enterococcus casseliflavus catalyzes the oxidation of a "non-activated" secondary alcohol, in contrast to the flavin-dependent alpha-hydroxy- and cy-amino acid oxidases. Surprisingly, the cr-glycerophosphate oxidase sequence is 43% identical to that of the membrane-associated cu-glycerophosphate dehydrogenase from Bacillus subtilis; only low levels of identity (17-22%) result hom comparisons with other FAD-dependent oxidases. The recombinant alpha-glycerophosphate oxidase is fully active and stabilizes a flavin N(ti)-sulfite adduct, but only small amounts of intermediate flavin semiquinone are observed during reductive titrations. Direct determination of the redox potential for the FAD/FADH(2) couple yields a value of -118 mV; the protein environment raises the flavin potential by 100 mV in order to provide for a productive interaction with the reducing substrate, Steady-state kinetic analysis, using the enzyme-monitored turnover method, indicates that a ping-pong mechanism applies and also allows the determination of the corresponding kinetic constants, In addition, stopped-flow studies of the reductive half-reaction provide for the measurement of the dissociation constant for the enzyme alpha-glycerophosphate complex and the rate constant for reduction of the enzyme flavin. These and other results demonstrate that this enzyme offers a very promising paradigm for examining the protein determinants for flavin reactivity and mechanism in the energy-yielding metabolism of alpha-glycerophosphate.	Wake Forest Univ, Med Ctr, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University	Claiborne, A (corresponding author), Wake Forest Univ, Med Ctr, Dept Biochem, Med Ctr Blvd, Winston Salem, NC 27157 USA.				NIGMS NIH HHS [GM-35394] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035394] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AUSTIN D, 1991, J BACTERIOL, V173, P101, DOI 10.1128/jb.173.1.101-107.1991; BRIGHT HJ, 1969, J BIOL CHEM, V244, P3625; BRIGHT HJ, 1967, J BIOL CHEM, V242, P994; BROWN LJ, 1994, J BIOL CHEM, V269, P14363; BULL C, 1981, J BIOL CHEM, V256, P2673; CAPARON MG, 1991, METHOD ENZYMOL, V204, P556; Charrier V, 1997, J BIOL CHEM, V272, P14166, DOI 10.1074/jbc.272.22.14166; CLAIBORNE A, 1986, J BIOL CHEM, V261, P4398; Cornish-Bowden A., 1995, FUNDAMENTALS ENZYME; CRANE EJ, 1995, BIOCHEMISTRY-US, V34, P14114, DOI 10.1021/bi00043a016; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOLIN MI, 1961, BACTERIA, V2, P425; EDGAR JR, 1978, J BIOL CHEM, V253, P6354; Erlandson K, 1997, APPL ENVIRON MICROB, V63, P2702, DOI 10.1128/AEM.63.7.2702-2707.1997; FREDERICK KR, 1990, J BIOL CHEM, V265, P3793; Gadda G, 1997, EUR J BIOCHEM, V250, P369, DOI 10.1111/j.1432-1033.1997.0369a.x; GARRIB A, 1986, J BIOL CHEM, V261, P8042; GHISLA S, 1986, BIOCHEM J, V239, P1; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; GIBSON QH, 1964, J BIOL CHEM, V239, P3927; Gutfreund H., 1972, ENZYMES PHYSICAL PRI; Hardie J. M., 1986, BERGEYS MANUAL SYSTE, V2, P1043; Harris CM, 1997, J BIOL CHEM, V272, P8370, DOI 10.1074/jbc.272.13.8370; HATEFI Y, 1976, ENZYMES            C, V13, P175; HECHT HJ, 1993, J MOL BIOL, V229, P153, DOI 10.1006/jmbi.1993.1015; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; HOLMBERG C, 1990, J GEN MICROBIOL, V136, P2367, DOI 10.1099/00221287-136-12-2367; JACOBS NJ, 1960, ARCH BIOCHEM BIOPHYS, V88, P250, DOI 10.1016/0003-9861(60)90230-7; LEHN DA, 1994, GENE, V150, P417, DOI 10.1016/0378-1119(94)90469-3; LI JY, 1993, BIOCHEMISTRY-US, V32, P11507, DOI 10.1021/bi00094a006; LIN ECC, 1996, ESCHERICHIA COLI SAL, V1, P217; Loach P. A., 1976, HDB BIOCH MOL BIOL, V1, P122; MAEDAYORITA K, 1995, BIOCHIMIE, V77, P631, DOI 10.1016/0300-9084(96)88178-8; Mallett TC, 1998, BIOCHEMISTRY-US, V37, P8790, DOI 10.1021/bi9803630; MASSEY V, 1995, FASEB J, V9, P473, DOI 10.1096/fasebj.9.7.7737454; MASSEY V, 1991, FLAVINS AND FLAVOPROTEINS 1990, P59; MASSEY V, 1979, J BIOL CHEM, V254, P9640; MASSEY V, 1969, J BIOL CHEM, V244, P3999; MASSEY V, 1969, PYRIDINE NUCLEOTIDE, P393; Massey V, 1980, BIOCHEM SOC T, V8, P246, DOI 10.1042/bst0080246; Mattevi A, 1996, P NATL ACAD SCI USA, V93, P7496, DOI 10.1073/pnas.93.15.7496; Mattevi A, 1997, CURR OPIN STRUC BIOL, V7, P804, DOI 10.1016/S0959-440X(97)80150-9; MITRA B, 1993, BIOCHEMISTRY-US, V32, P12959, DOI 10.1021/bi00211a003; MULLER F, 1969, J BIOL CHEM, V244, P4007; Nakamura Y, 1996, NUCLEIC ACIDS RES, V24, P214, DOI 10.1093/nar/24.1.214; PARSONAGE D, 1995, BIOCHEMISTRY-US, V34, P435, DOI 10.1021/bi00002a007; PARSONAGE D, 1993, J BIOL CHEM, V268, P3161; PEARCE BJ, 1993, MOL MICROBIOL, V9, P1037, DOI 10.1111/j.1365-2958.1993.tb01233.x; Pollegioni L, 1997, J BIOL CHEM, V272, P4924, DOI 10.1074/jbc.272.8.4924; ROE BA, 1998, STREPTOCOCCAL GENOME; SALUJA SK, 1995, MOL MICROBIOL, V16, P215, DOI 10.1111/j.1365-2958.1995.tb02294.x; SCHRYVERS A, 1978, J BIOL CHEM, V253, P783; SCHWEIZER HP, 1994, J BACTERIOL, V176, P2184, DOI 10.1128/JB.176.8.2184-2193.1994; STANKOVICH M, 1983, BIOCHEMISTRY-US, V22, P4466, DOI 10.1021/bi00288a018; STANKOVICH MT, 1978, J BIOL CHEM, V253, P4971; STRATHMANN M, 1991, P NATL ACAD SCI USA, V88, P1247, DOI 10.1073/pnas.88.4.1247; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Todone F, 1997, BIOCHEMISTRY-US, V36, P5853, DOI 10.1021/bi9630570; Vrielink A, 1994, FLAVINS AND FLAVOPROTEINS 1993, P175; WALSH CT, 1971, J BIOL CHEM, V246, P6855; WEIBEL MK, 1971, J BIOL CHEM, V246, P2734; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; Yorita K, 1997, P NATL ACAD SCI USA, V94, P9590, DOI 10.1073/pnas.94.18.9590	64	30	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23812	23822		10.1074/jbc.273.37.23812	http://dx.doi.org/10.1074/jbc.273.37.23812			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726992	hybrid			2022-12-27	WOS:000075893100033
J	Scheller, A; Hughes, E; Golden, KL; Robins, DM				Scheller, A; Hughes, E; Golden, KL; Robins, DM			Multiple receptor domains interact to permit, or restrict, androgen-specific gene activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING SPECIFICITY; AMINO-TERMINAL DOMAIN; GLUCOCORTICOID RECEPTOR; RESPONSE ELEMENT; TRANSACTIVATION DOMAIN; HORMONE RECEPTOR; STEROID-BINDING; PROBASIN GENE; INSECT CELLS; IN-VIVO	A critical problem within transcription factor families is how diverse regulatory programs are directed by highly related members. Androgen and glucocorticoid receptors (AR, GR) recognize a consensus DNA hormone response element (HRE), but they activate target genes with precise specificity, largely dependent on the promoter and cell context. We have assessed the role of different receptor domains in hormone-specific response by testing chimeras of AR and GR for their ability to activate the androgen-specific enhancer of the mouse sex-limited protein (Slp) gene Although all of the mutant receptors activated simple HREs, only a few activated the androgen-specific element. One component shared by receptors functional on the AR-specific target was the AR DNA binding domain. Activation was not due to differential DNA affinity but rather to the AR DNA binding domain escaping suppression directed at the GR DNA binding domain in this enhancer context. A further mechanism increasing specific activation was cooperation of receptors at multiple and weak HREs, which was accentuated in the presence of both the AR N terminus and ligand binding domain, These domains together increased recognition of weak HREs, as demonstrated by in vitro DNase I footprinting and transactivation of mutant enhancers. Further, AR N-terminal subdomains reported to interact directly with the ligand binding domain relieved an inhibitory effect imposed by that domain. Therefore, functions intrinsic to AR augment steroid-specific gene activation, by evading negative regulation operating on the domains of other receptors and by enhancing cooperativity through intra- and inter-receptor domain interactions. These subtle distinctions in AR and GR behavior enforce transcriptional specificity established by the context of nonreceptor factors.	Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Robins, DM (corresponding author), Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA.			Robins, Diane M./0000-0001-6727-6309	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031546] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-31546] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADLER AJ, 1993, MOL CELL BIOL, V13, P6326, DOI 10.1128/MCB.13.10.6326; ADLER AJ, 1991, MOL ENDOCRINOL, V5, P1587, DOI 10.1210/mend-5-11-1587; ADLER AJ, 1992, P NATL ACAD SCI USA, V89, P11660, DOI 10.1073/pnas.89.24.11660; Andersson S, 1996, TRENDS ENDOCRIN MET, V7, P121, DOI 10.1016/1043-2760(96)00034-3; BODWELL JE, 1991, J BIOL CHEM, V266, P7549; Bubulya A, 1996, J BIOL CHEM, V271, P24583, DOI 10.1074/jbc.271.40.24583; Chamberlain NL, 1996, J BIOL CHEM, V271, P26772, DOI 10.1074/jbc.271.43.26772; CHAN SK, 1994, CELL, V78, P603, DOI 10.1016/0092-8674(94)90525-8; Chandran UR, 1996, J BIOL CHEM, V271, P20412, DOI 10.1074/jbc.271.34.20412; Claessens F, 1996, J BIOL CHEM, V271, P19013, DOI 10.1074/jbc.271.32.19013; Cleutjens KBJM, 1996, J BIOL CHEM, V271, P6379, DOI 10.1074/jbc.271.11.6379; Doesburg P, 1997, BIOCHEMISTRY-US, V36, P1052, DOI 10.1021/bi961775g; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FABRE S, 1994, J BIOL CHEM, V269, P5857; Fang YF, 1996, J BIOL CHEM, V271, P28697, DOI 10.1074/jbc.271.45.28697; GODOWSKI PJ, 1988, SCIENCE, V241, P812, DOI 10.1126/science.3043662; HE WW, 1990, BIOCHEM BIOPH RES CO, V171, P697, DOI 10.1016/0006-291X(90)91202-4; HO KC, 1993, J BIOL CHEM, V268, P27226; Horwitz KB, 1996, MOL ENDOCRINOL, V10, P1167, DOI 10.1210/me.10.10.1167; Ikonen T, 1997, J BIOL CHEM, V272, P29821, DOI 10.1074/jbc.272.47.29821; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; KALLIO PJ, 1994, J BIOL CHEM, V269, P11514; KASPER S, 1994, J BIOL CHEM, V269, P31763; KATO S, 1995, MOL CELL BIOL, V15, P5858; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; LANGLEY E, 1995, J BIOL CHEM, V270, P29983; MARCELLI M, 1990, MOL ENDOCRINOL, V4, P1105, DOI 10.1210/mend-4-8-1105; MCBROOM LDB, 1995, MOL CELL BIOL, V15, P796; MCEWAN IJ, 1993, MOL CELL BIOL, V13, P399, DOI 10.1128/MCB.13.1.399; MIESFELD R, 1987, SCIENCE, V236, P423, DOI 10.1126/science.3563519; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; MURTHA P, 1993, BIOCHEMISTRY-US, V32, P6459, DOI 10.1021/bi00076a020; Nelson SA, 1997, MOL CELL ENDOCRINOL, V133, P89, DOI 10.1016/S0303-7207(97)00150-0; NISHIO Y, 1993, MOL CELL BIOL, V13, P1854, DOI 10.1128/MCB.13.3.1854; PALVIMO JJ, 1993, MOL ENDOCRINOL, V7, P1399, DOI 10.1210/me.7.11.1399; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; RENNIE PS, 1993, MOL ENDOCRINOL, V7, P23, DOI 10.1210/me.7.1.23; Scheller A, 1996, MOL CELL ENDOCRINOL, V121, P75, DOI 10.1016/0303-7207(96)03854-3; SCHMID W, 1989, EMBO J, V8, P2257, DOI 10.1002/j.1460-2075.1989.tb08350.x; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; Shibata H, 1997, RECENT PROG HORM RES, V52, P141; Snoek R, 1996, J STEROID BIOCHEM, V59, P243, DOI 10.1016/S0960-0760(96)00116-1; TAN JA, 1992, J BIOL CHEM, V267, P4456; TSAI SY, 1988, CELL, V55, P361, DOI 10.1016/0092-8674(88)90059-1; VANDIJK MA, 1994, CELL, V78, P617, DOI 10.1016/0092-8674(94)90526-6; WIELAND S, 1991, EMBO J, V10, P2513, DOI 10.1002/j.1460-2075.1991.tb07791.x; WONG CI, 1993, J BIOL CHEM, V268, P19004; XIE YB, 1992, J BIOL CHEM, V267, P4939; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yeh SY, 1996, P NATL ACAD SCI USA, V93, P5517, DOI 10.1073/pnas.93.11.5517; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208	51	46	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24216	24222		10.1074/jbc.273.37.24216	http://dx.doi.org/10.1074/jbc.273.37.24216			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727045	hybrid			2022-12-27	WOS:000075893100086
J	Lemasson, I; Thebault, S; Sardet, C; Devaux, C; Mesnard, JM				Lemasson, I; Thebault, S; Sardet, C; Devaux, C; Mesnard, JM			Activation of E2F-mediated transcription by human T-cell leukemia virus type I tax protein in a p16(INK4A)-negative T-cell line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOBLASTOMA GENE-PRODUCT; NF-KAPPA-B; E2F FAMILY MEMBERS; S-PHASE ENTRY; HTLV-I; TRANSACTIVATOR TAX; CONSTITUTIVE ACTIVATION; INTERLEUKIN-2 RECEPTOR; RAT FIBROBLASTS; LYMPHOMA VIRUS	The human T-cell leukemia virus type I (HTLV-I) is a causative agent of adult T-cell leukemia. Although the exact mechanism by which HTLV-I contributes to leukemogenesis is still unclear, the Tax protein is thought to play a major role in this process. This 40-kDa polypeptide is able to interact with the tumor suppressor p16(INK4A). Consequently, Tax can activate the signaling pathway that lead to the release of E2F that in turn induces expression of factors required for cell cycle progression. In this paper, we demonstrate that Tax can also activate E2F-mediated transcription independently of p16(INK4A). Indeed, when Tax is coexpressed with the E2F-1 transcription factor in CEM T-cells, which lack expression of p16(INK4A), it strongly potentiates the E2F-dependent activation of a reporter construct driven by a promoter containing E2F binding sites. This stimulation is abrogated by mutations affecting the E2F-binding sites. In addition, Tax also stimulates the transcription of the E2F-1 gene itself. Using Tax mutants that fail to activate either ATF- or NF-kappa B-dependent promoters and different 5' truncation mutants of the E2F-1 promoter, we show that the Tax-dependent transcriptional control of the E2F1 gene involves, at least in part, the ATF binding site located in the E2F-1 promoter.	Inst Biol, Lab Infect Retrovirales & Signalisat Cellulaire, CRBM, CNRS,UPR 1086, F-34060 Montpellier, France; Inst Genet Mol Montpellier, CNRS, UMR 5535, F-34033 Montpellier 1, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Mesnard, JM (corresponding author), Inst Biol, Lab Infect Retrovirales & Signalisat Cellulaire, CRBM, CNRS,UPR 1086, 4 Bd Henri IV, F-34060 Montpellier, France.	mesnard@crbm.cnrs-mop.fr	Lemasson, Isabelle/N-1355-2013	Mesnard, Jean-Michel/0000-0003-3344-5367				ADAMS PD, 1995, SEMIN CANCER BIOL, V6, P99, DOI 10.1006/scbi.1995.0013; Brennan P, 1997, IMMUNITY, V7, P679, DOI 10.1016/S1074-7613(00)80388-X; CHELLAPPAN S, 1992, P NATL ACAD SCI USA, V89, P4549, DOI 10.1073/pnas.89.10.4549; Corbeil J, 1996, J EXP MED, V183, P39, DOI 10.1084/jem.183.1.39; Dittmer J, 1997, J BIOL CHEM, V272, P4953, DOI 10.1074/jbc.272.8.4953; DUYAO MP, 1992, J BIOL CHEM, V267, P16288; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; FRANCHINI G, 1995, BLOOD, V86, P3619, DOI 10.1182/blood.V86.10.3619.bloodjournal86103619; FRANKLIN AA, 1993, J BIOL CHEM, V268, P21225; FUJII M, 1992, GENE DEV, V6, P2066, DOI 10.1101/gad.6.11.2066; FUJISAWA J, 1986, EMBO J, V5, P713, DOI 10.1002/j.1460-2075.1986.tb04272.x; Geng Y, 1996, ONCOGENE, V12, P1173; GIRLING R, 1993, NATURE, V362, P83, DOI 10.1038/362083a0; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; HISCOTT J, 1995, VIROLOGY, V214, P3, DOI 10.1006/viro.1995.9960; HOLLSBERG P, 1992, J IMMUNOL, V148, P3256; HOSHINO H, 1983, P NATL ACAD SCI-BIOL, V80, P6061, DOI 10.1073/pnas.80.19.6061; HUBER HE, 1993, P NATL ACAD SCI USA, V90, P3525, DOI 10.1073/pnas.90.8.3525; JEANG KT, 1988, J VIROL, V62, P4499, DOI 10.1128/JVI.62.12.4499-4509.1988; JEANG KT, 1990, SCIENCE, V247, P1082, DOI 10.1126/science.2309119; JOHNSON DG, 1994, P NATL ACAD SCI USA, V91, P12823, DOI 10.1073/pnas.91.26.12823; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; KREK W, 1993, SCIENCE, V262, P1557, DOI 10.1126/science.8248803; KREK W, 1994, CELL, V78, P161, DOI 10.1016/0092-8674(94)90582-7; Kwok RPS, 1996, NATURE, V380, P642, DOI 10.1038/380642a0; Langton B., 1988, MED VIROL, V8, P295; LATHANGUE NB, 1994, TRENDS BIOCHEM SCI, V19, P108, DOI 10.1016/0968-0004(94)90202-X; Lemasson I, 1996, J IMMUNOL, V156, P859; Lemasson I, 1997, J VIROL, V71, P1975, DOI 10.1128/JVI.71.3.1975-1983.1997; Low KG, 1997, J VIROL, V71, P1956, DOI 10.1128/JVI.71.3.1956-1962.1997; Lukas J, 1996, MOL CELL BIOL, V16, P1047; MARUYAMA M, 1987, CELL, V48, P343, DOI 10.1016/0092-8674(87)90437-5; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; MILLS GB, 1992, INT IMMUNOL, V4, P1233, DOI 10.1093/intimm/4.11.1233; MIYATAKE S, 1988, MOL CELL BIOL, V8, P5581, DOI 10.1128/MCB.8.12.5581; Miyoshi I., 1982, GANN MONOGR, V28, P219; Moberg K, 1996, MOL CELL BIOL, V16, P1436; Mori N, 1997, EUR J HAEMATOL, V58, P114; NAGATA K, 1989, J VIROL, V63, P3220, DOI 10.1128/JVI.63.8.3220-3226.1989; NEUMAN E, 1994, MOL CELL BIOL, V14, P6607, DOI 10.1128/MCB.14.10.6607; Neuveut C, 1998, MOL CELL BIOL, V18, P3620, DOI 10.1128/MCB.18.6.3620; NEVINS JR, 1992, SCIENCE, V258, P424; ORMONDROYD E, 1995, ONCOGENE, V11, P1437; Pajovic S, 1997, MOL CELL BIOL, V17, P6459, DOI 10.1128/MCB.17.11.6459; PASKALIS H, 1986, P NATL ACAD SCI USA, V83, P6558, DOI 10.1073/pnas.83.17.6558; PAUL NL, 1990, J VIROL, V64, P5412, DOI 10.1128/JVI.64.11.5412-5419.1990; Pise-Masison CA, 1998, J VIROL, V72, P1165, DOI 10.1128/JVI.72.2.1165-1170.1998; PiseMasison CA, 1997, MOL CELL BIOL, V17, P1236, DOI 10.1128/MCB.17.3.1236; POPOVIC M, 1983, P NATL ACAD SCI-BIOL, V80, P5402, DOI 10.1073/pnas.80.17.5402; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; Richardson JH, 1997, VIROLOGY, V237, P209, DOI 10.1006/viro.1997.8779; Rosin O, 1998, J BIOL CHEM, V273, P6698, DOI 10.1074/jbc.273.12.6698; Rousset R, 1996, NATURE, V381, P328, DOI 10.1038/381328a0; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; SALAHUDDIN SZ, 1983, VIROLOGY, V129, P51, DOI 10.1016/0042-6822(83)90395-1; SARDET C, 1995, P NATL ACAD SCI USA, V92, P2403, DOI 10.1073/pnas.92.6.2403; SHIMOTOHNO K, 1986, P NATL ACAD SCI USA, V83, P8112, DOI 10.1073/pnas.83.21.8112; SMITH MR, 1991, J CLIN INVEST, V88, P1038, DOI 10.1172/JCI115364; SMITH MR, 1990, GENE DEV, V4, P1875, DOI 10.1101/gad.4.11.1875; Suzuki T, 1996, EMBO J, V15, P1607, DOI 10.1002/j.1460-2075.1996.tb00505.x; SUZUKI T, 1993, P NATL ACAD SCI USA, V90, P610, DOI 10.1073/pnas.90.2.610; Takemoto S, 1997, P NATL ACAD SCI USA, V94, P13897, DOI 10.1073/pnas.94.25.13897; TANIGUCHI T, 1995, SCIENCE, V268, P251, DOI 10.1126/science.7716517; Trejo SR, 1997, J BIOL CHEM, V272, P27411, DOI 10.1074/jbc.272.43.27411; UITTENBOGAARD MN, 1995, J BIOL CHEM, V270, P28503, DOI 10.1074/jbc.270.48.28503; UITTENBOGAARD MN, 1994, J BIOL CHEM, V269, P22466; WADE M, 1995, J BIOL CHEM, V270, P9783, DOI 10.1074/jbc.270.17.9783; WAGNER S, 1993, SCIENCE, V262, P395, DOI 10.1126/science.8211160; WHYTE P, 1989, CELL, V56, P67, DOI 10.1016/0092-8674(89)90984-7; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; XU GF, 1995, P NATL ACAD SCI USA, V92, P1357, DOI 10.1073/pnas.92.5.1357; Yamaoka S, 1996, EMBO J, V15, P873, DOI 10.1002/j.1460-2075.1996.tb00422.x; Yang Xiao-He, 1995, Gene Expression, V4, P195; Yoshida M, 1996, J ACQ IMMUN DEF SYND, V13, pS63, DOI 10.1097/00042560-199600001-00012; ZHANG YH, 1995, ONCOGENE, V10, P2085; ZHAO LJ, 1992, P NATL ACAD SCI USA, V89, P7070, DOI 10.1073/pnas.89.15.7070	77	56	57	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23598	23604		10.1074/jbc.273.36.23598	http://dx.doi.org/10.1074/jbc.273.36.23598			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722600	hybrid			2022-12-27	WOS:000075778100100
J	Shriver, Z; Hu, YN; Pojasek, K; Sasiseskharan, R				Shriver, Z; Hu, YN; Pojasek, K; Sasiseskharan, R			Heparinase II from Flavobacterium heparinum - Role of cysteine in enzymatic activity as probed by chemical, modification and site-directed mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; EXPRESSION; GLYCOSAMINOGLYCANS; PURIFICATION; CATALYSIS; RESIDUE; CLONING; LYASES	Heparinase II (no EC number) is one of three lyases isolated from Flavobacterium heparinum that degrade heparin-like complex polysaccharides. Heparinase II is unique among the heparinases in that it has broad substrate requirements and possesses the ability to degrade both heparin and heparan sulfate-like regions of glycosaminoglycans. This study set out to investigate the role of cysteines in heparinase II activity. Through a series of chemical modification experiments, it was found that one of the three cysteines in heparinase II is surface-accessible and possesses unusual chemical reactivity toward cysteine-specific chemical modifying reagents. Substrate protection experiments suggest that this surface-accessible cysteine is proximate to the active site, since addition of substrate shields the cysteine from modifying reagents. The cysteine, present in an ionic environment, was mapped by radiolabeling with N-[H-3]ethylmaleimide and identified as cysteine 348. Site-directed mutagenesis of cysteine 348 to an alanine resulted in loss of activity toward heparin but not heparan sulfate, indicating that cysteine 348 is required for heparinase II activity toward heparin but is not essential for the breakdown of heparan sulfate. Furthermore, we show in this study that cysteine 164 and cysteine 189 are functionally unimportant for heparinase II.	MIT, Div Bioengn & Environm Hlth, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80310 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Colorado System; University of Colorado Boulder	Sasiseskharan, R (corresponding author), MIT, Div Bioengn & Environm Hlth, 77 Massachusetts Ave,Bldg 16-561, Cambridge, MA 02139 USA.	ramnat@mit.edu						BERNSTEIN H, 1988, METHOD ENZYMOL, V137, P515; BOYER PD, 1954, J AM CHEM SOC, V76, P4331, DOI 10.1021/ja01646a025; CONRAD HE, 1989, ANN NY ACAD SCI, V556, P18; DESAI UR, 1993, ARCH BIOCHEM BIOPHYS, V306, P461, DOI 10.1006/abbi.1993.1538; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; Ernst S, 1996, BIOCHEM J, V315, P589, DOI 10.1042/bj3150589; GLAZER A, 1975, LAB TECHNIQUES BIOCH, P69; Godavarti R, 1998, J BIOL CHEM, V273, P248, DOI 10.1074/jbc.273.1.248; Godavarti R, 1996, BIOCHEM BIOPH RES CO, V225, P751, DOI 10.1006/bbrc.1996.1246; Godavarti R, 1996, BIOCHEM BIOPH RES CO, V229, P770, DOI 10.1006/bbrc.1996.1879; Godavarti R, 1996, BIOCHEMISTRY-US, V35, P6846, DOI 10.1021/bi960356g; HASCALL VC, 1989, KERATAN SULPHATE CHE, P66; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HORIIKE K, 1979, J THEOR BIOL, V79, P403, DOI 10.1016/0022-5193(79)90355-2; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; LINDAHL U, 1994, THROMB RES, V75, P1, DOI 10.1016/0049-3848(94)90136-8; LINHARDT RJ, 1988, BIOCHEM J, V254, P781, DOI 10.1042/bj2540781; LINHARDT RJ, 1994, CURRENT PROTOCOLS MO, pCH17; LOHSE DL, 1992, J BIOL CHEM, V267, P24347; LUNDBLAD RL, 1995, TECHNIQUES PROTEIN M, P63; SASISEKHARAN R, 1994, P NATL ACAD SCI USA, V91, P1524, DOI 10.1073/pnas.91.4.1524; SASISEKHARAN R, 1995, BIOCHEMISTRY-US, V34, P14441, DOI 10.1021/bi00044a022; SASISEKHARAN R, 1993, P NATL ACAD SCI USA, V90, P3660, DOI 10.1073/pnas.90.8.3660; Shriver Z, 1998, J BIOL CHEM, V273, P10160, DOI 10.1074/jbc.273.17.10160; Torchinsky Y, 1981, SULFUR PROTEINS; TSOU C, 1962, SCI SINICA, V11, P1535; YAMADA S, 1995, J BIOL CHEM, V270, P8696	27	30	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					22904	22912		10.1074/jbc.273.36.22904	http://dx.doi.org/10.1074/jbc.273.36.22904			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722510	hybrid			2022-12-27	WOS:000075778100010
J	Vadiveloo, PK; Vairo, G; Royston, AK; Novak, U; Hamilton, JA				Vadiveloo, PK; Vairo, G; Royston, AK; Novak, U; Hamilton, JA			Proliferation-independent induction of macrophage cyclin D2, and repression of cyclin D1, by lipopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; STIMULATING FACTOR-I; CELL-CYCLE; GENE-EXPRESSION; GROWTH-FACTOR; ANTIPROLIFERATIVE AGENTS; D1-DEPENDENT KINASE; DEPENDENT KINASES; PHASE PROGRESSION; NUCLEAR-PROTEIN	D-type cyclins are induced in response to mitogens and are essential, and rate-limiting for G(1) phase progression in normal mammalian cells. Macrophages proliferating in response to colony-stimulating factor-1 (CSF-1) express cyclin D1 and to a lesser extent cyclin D2 but not cyclin D3, Previously we showed that the macrophage-activating agent lipopolysaccharide (LPS) blocks CSF-1-induced proliferation and cyclin D1 expression in macrophages, Here we report upon the effect of LPS on expression of cyclin D2 in normal mouse bone marrow-derived macrophages (BMM). Unexpectedly me found that this anti-mitogen raised levels of CSF-1-stimulated cyclin D2 mRNA and protein. Furthermore, LPS alone induced cyclin Ha but not cyclin D1. Inhibition of the MEK/ERK (MAPK/ERK kinase/extracellular signal-regulated kinase) mitogen-activated protein kinase pathway repressed LPS-induced cyclin D2 mRNA, whereas inhibition of the p38 mitogen-activated protein kinase enhanced expression. However, in contrast to cyclin D1, cyclin D2 in bone marrow-derived macrophages did not appear to be regulated by protein kinase A pathways. The present data (a) show elevation of a D-type cyclin in the absence of proliferation, (b) demonstrate inverse regulation of two distinct D-type cyclins under identical conditions, and (c) suggest that cyclin D2 plays a role in macrophage activation by LPS.	Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia; Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	Royal Melbourne Hospital; University of Melbourne; Walter & Eliza Hall Institute	Vadiveloo, PK (corresponding author), St Vincents Hosp, Bernard OBrien Inst Microsurg, Fitzroy, Vic 3065, Australia.			Hamilton, John A/0000-0002-9493-9224				Adachi M, 1997, BLOOD, V90, P126; ADAMS DO, 1992, MACROPHAGE, P76; AJCHENBAUM F, 1993, J BIOL CHEM, V268, P4113; ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; ANDO K, 1993, P NATL ACAD SCI USA, V90, P9571, DOI 10.1073/pnas.90.20.9571; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COCKS BG, 1992, J BIOL CHEM, V267, P12307; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; HAMILTON JA, 1992, J IMMUNOL, V148, P4028; Jaworowski A, 1996, BIOCHEM J, V320, P1011, DOI 10.1042/bj3201011; JIANG W, 1993, ONCOGENE, V8, P3447; KATO J, 1993, GENE DEV, V7, P331; KATO JY, 1993, P NATL ACAD SCI USA, V90, P11513, DOI 10.1073/pnas.90.24.11513; LABORDA J, 1991, NUCLEIC ACIDS RES, V19, P3998, DOI 10.1093/nar/19.14.3998; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lee JC, 1996, J LEUKOCYTE BIOL, V59, P152, DOI 10.1002/jlb.59.2.152; LUKAS J, 1995, ONCOGENE, V10, P2125; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; MUSGROVE EA, 1994, P NATL ACAD SCI USA, V91, P8022, DOI 10.1073/pnas.91.17.8022; Neuman E, 1997, MOL CELL BIOL, V17, P5338, DOI 10.1128/MCB.17.9.5338; OKADA F, 1995, BBA-MOL CELL RES, V1265, P201, DOI 10.1016/0167-4889(94)00228-7; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; RADDASSI K, 1993, CELL IMMUNOL, V149, P50, DOI 10.1006/cimm.1993.1135; RAO SS, 1995, J BIOL CHEM, V270, P4093, DOI 10.1074/jbc.270.8.4093; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; SEWING A, 1993, J CELL SCI, V104, P545; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; SKAPEK SX, 1995, SCIENCE, V267, P1022, DOI 10.1126/science.7863328; Sweeney KJ, 1997, ONCOGENE, V14, P1329, DOI 10.1038/sj.onc.1200951; Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8, DOI 10.1002/jlb.60.1.8; Vadiveloo PK, 1996, ONCOGENE, V13, P599; VAIRO G, 1985, BIOCHEM BIOPH RES CO, V132, P430, DOI 10.1016/0006-291X(85)91040-X; VAIRO G, 1991, J IMMUNOL, V146, P3469; VAIRO G, 1990, J BIOL CHEM, V265, P2692; VAIRO G, 1988, J CELL PHYSIOL, V134, P13, DOI 10.1002/jcp.1041340103; VAIRO G, 1992, J CELL PHYSIOL, V151, P630, DOI 10.1002/jcp.1041510324; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Watanabe G, 1996, J BIOL CHEM, V271, P22570, DOI 10.1074/jbc.271.37.22570; Watanabe G, 1996, P NATL ACAD SCI USA, V93, P12861, DOI 10.1073/pnas.93.23.12861; WILLIAMS JG, 1993, SURGERY, V114, P314; Zwijsen RML, 1997, CELL, V88, P405, DOI 10.1016/S0092-8674(00)81879-6	48	17	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23104	23109		10.1074/jbc.273.36.23104	http://dx.doi.org/10.1074/jbc.273.36.23104			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722538	hybrid			2022-12-27	WOS:000075778100038
J	Kunapuli, P; Lawson, JA; Rokach, JA; Meinkoth, JL; FitzGerald, GA				Kunapuli, P; Lawson, JA; Rokach, JA; Meinkoth, JL; FitzGerald, GA			Prostaglandin F-2 alpha (PGF(2 alpha)) and the isoprostane, 8,12-iso-isoprostane F-2 alpha-III, induce cardiomyocyte hypertrophy - Differential activation of downstream signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); CARDIAC MYOCYTE HYPERTROPHY; MUSCLE CELL HYPERTROPHY; STRESS IN-VIVO; PROTEIN-KINASE; GENE-EXPRESSION; OXIDANT STRESS; ALPHA(1)-ADRENERGIC RECEPTOR; 8-EPI PROSTAGLANDIN-F2-ALPHA; CORONARY REPERFUSION	Prostaglandin receptors may be activated by their cognate ligand or by free radical catalyzed isoprostanes, products of arachidonic acid peroxidation. For example, prostaglandin F-2 alpha (PGF(2 alpha)) causes hypertrophy of neonatal rat ventricular myocytes, via the PGF(2 alpha) receptor (FP). However, the FP may also be activated by the isoprostane, 8,12-iso-iPF(2 alpha)-III (Kunapuli, P., Lawson, J. A, Rokach, J., and FitzGerald, G. A. (1997) J. Biol. Chem 272, 27147-27154). Both ligands induce myocyte hypertrophy with overlapping potencies. Interestingly, the hypertrophic effects of these two agonists on cardiomyocytes are additive. Furthermore, the preference of these two agonists for activation of intracellular signal transduction pathways differs in several respects. Thus, PGF(2 alpha) and 8,12-iso-iPF(2 alpha)-III stimulate inositol phosphate formation with EC50 values of 50 +/- 12 nM and 3.5 +/- 0.6 mu M, respectively. Moreover, PGF(2 alpha) causes a robust activation (similar to 50-fold) of Erk2, whereas 9,12-iso-iPF(2 alpha)-III has no effect. Similarly, PGF(2 alpha) causes translocation of cytosolic phospholipase A, and also results in a 7-fold increment in the formation of 6-keto-PGF(1 alpha), whereas 8,12-iso-iPF(2 alpha)-III exerts no effect on this pathway. On the other hand, both agonists are equally potent in activating JNK1 and c-Jun, whereas neither activates the p38 kinase. Both PGF(2 alpha) and 8,12-iso-iPF(2 alpha)-III activate the p70S6 kinase (p70(S6K)), but not Akt, downstream of phosphatidylinositol-3-kinase (PI3K). However, both wortmannin, a PI3K inhibitor, and rapamycin, an inhibitor of p70(S6K) activity, inhibit 8,12-iso-iPF(2 alpha)-III-induced myocyte hypertrophy, with IC50 values of 60 +/- 12 and 3 +/- 1.7 nM, respectively, whereas neither compound abrogates the PGF(2 alpha)-mediated response. Thus, both PGF(2 alpha) and 8,12-iso-iPF(2 alpha)-III induce myocyte hypertrophy via discrete signaling pathways. Although both agonists signal via the JNK pathway to initiate changes in c-Jun-dependent gene transcription, PGF(2 alpha) preferentially activates the MEH-Erk2- cytosolic phospholipase A(2) pathway. In contrast, the PI3K-p70(S6K) pathway appears to be essential for 8,12-iso-iPF(2 alpha)-III-induced myocyte hypertrophy.	Univ Penn, Ctr Expt Therapeut, Philadelphia, PA 19104 USA; Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; Florida Inst Technol, Claude Pepper Inst, Melbourne, FL 32901 USA; Florida Inst Technol, Dept Chem, Melbourne, FL 32901 USA	University of Pennsylvania; University of Pennsylvania; Florida Institute of Technology; Florida Institute of Technology	FitzGerald, GA (corresponding author), Univ Penn, Ctr Expt Therapeut, 153 Johnson Pavil, Philadelphia, PA 19104 USA.	garret@spirit.gcrc.upenn.edu	Meinkoth, Judy L/G-2900-2010; FitzGerald, Garret A/A-4222-2010	Rokach, Joshu/0000-0003-1814-7505	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044730, R01DK045696] Funding Source: NIH RePORTER; NHLBI NIH HHS [T-32-HL07843-02] Funding Source: Medline; NIDDK NIH HHS [DK45696, DK44730] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABRAMOVITZ M, 1994, J BIOL CHEM, V269, P2632; Adams JW, 1996, J BIOL CHEM, V271, P1179, DOI 10.1074/jbc.271.2.1179; Adiyaman M, 1996, TETRAHEDRON LETT, V37, P4849, DOI 10.1016/0040-4039(96)00973-2; Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Barr AJ, 1997, J BIOL CHEM, V272, P2223; Boluyt MO, 1997, CIRC RES, V81, P176, DOI 10.1161/01.RES.81.2.176; BRASS LF, 1977, THROMB HAEMOSTASIS, V77, P233; CHAZOV EI, 1979, CIRC RES, V45, P205, DOI 10.1161/01.RES.45.2.205; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; CLARK JD, 1995, J LIPID MEDIAT CELL, V12, P83, DOI 10.1016/0929-7855(95)00012-F; CSEPLI J, 1975, PROSTAGLANDINS, V10, P689, DOI 10.1016/S0090-6980(75)80017-7; DAngelo DD, 1997, P NATL ACAD SCI USA, V94, P8121, DOI 10.1073/pnas.94.15.8121; Delanty N, 1997, CIRCULATION, V95, P2492, DOI 10.1161/01.CIR.95.11.2492; FRANCIS GS, 1993, EUR HEART J, V14, P49; FUKUNAGA M, 1993, AM J PHYSIOL, V264, pC1619, DOI 10.1152/ajpcell.1993.264.6.C1619; FUKUNAGA M, 1993, BIOCHEM BIOPH RES CO, V195, P507, DOI 10.1006/bbrc.1993.2075; GILLESPIEBROWN J, 1995, J BIOL CHEM, V270, P28092; Grammer TC, 1996, CANCER SURV, V27, P271; Hill MF, 1997, CIRCULATION, V96, P2414; Hoshijima M, 1998, J BIOL CHEM, V273, P7725, DOI 10.1074/jbc.273.13.7725; Hwang SW, 1996, TETRAHEDRON LETT, V37, P779, DOI 10.1016/0040-4039(95)02390-9; ITO S, 1994, BIOCHEM BIOPH RES CO, V200, P756, DOI 10.1006/bbrc.1994.1515; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; KARIN M, 1994, CURR OPIN CELL BIOL, V6, P415, DOI 10.1016/0955-0674(94)90035-3; KARMAZYN M, 1989, CAN J PHYSIOL PHARM, V67, P912, DOI 10.1139/y89-144; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; KENAKIN T, 1995, TRENDS PHARMACOL SCI, V16, P232, DOI 10.1016/S0165-6147(00)89032-X; KENTERA D, 1979, RESPIRATION, V37, P192, DOI 10.1159/000194026; Kinsella BT, 1997, J PHARMACOL EXP THER, V281, P957; KIRSHENBAUM LA, 1995, J MOL CELL CARDIOL, V27, P263, DOI 10.1016/S0022-2828(08)80025-9; KNOWLTON KU, 1991, J BIOL CHEM, V266, P7759; Kunapuli P, 1997, J BIOL CHEM, V272, P27147, DOI 10.1074/jbc.272.43.27147; Lai J, 1996, AM J PHYSIOL-HEART C, V271, pH2197, DOI 10.1152/ajpheart.1996.271.6.H2197; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; MCCRACKEN JA, 1970, J CLIN ENDOCR METAB, V30, P544, DOI 10.1210/jcem-30-4-544; MENTZ P, 1988, BIOMED BIOCHIM ACTA, V47, pS244; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; OUDOT F, 1995, AM J PHYSIOL-HEART C, V268, pH308, DOI 10.1152/ajpheart.1995.268.1.H308; Page C, 1996, MOL CELL BIOCHEM, V157, P49; Pratico D, 1996, J BIOL CHEM, V271, P14916, DOI 10.1074/jbc.271.25.14916; Ramirez MT, 1997, J BIOL CHEM, V272, P14057, DOI 10.1074/jbc.272.22.14057; Reilly M, 1996, CIRCULATION, V94, P19, DOI 10.1161/01.CIR.94.1.19; Reilly MP, 1997, CIRCULATION, V96, P3314; SADOSHIMA J, 1995, CIRC RES, V77, P1040, DOI 10.1161/01.RES.77.6.1040; SADOSHIMA J, 1993, CIRC RES, V73, P413, DOI 10.1161/01.RES.73.3.413; Schievella AR, 1995, J BIOL CHEM, V270, P30749, DOI 10.1074/jbc.270.51.30749; SEUWEN K, 1988, EMBO J, V7, P161, DOI 10.1002/j.1460-2075.1988.tb02796.x; SHUBEITA HE, 1990, J BIOL CHEM, V265, P20555; SIMPSON P, 1982, CIRC RES, V50, P101, DOI 10.1161/01.RES.50.1.101; SIMPSON P, 1983, J CLIN INVEST, V72, P732, DOI 10.1172/JCI111023; Stoyanova S, 1997, BIOCHEM J, V324, P489, DOI 10.1042/bj3240489; Sugimoto Y, 1997, SCIENCE, V277, P681, DOI 10.1126/science.277.5326.681; TAKAHASHI K, 1992, J CLIN INVEST, V90, P136, DOI 10.1172/JCI115826; THORBURN A, 1993, J BIOL CHEM, V268, P2244; THORBURN J, 1994, BIOCHEM BIOPH RES CO, V202, P1586, DOI 10.1006/bbrc.1994.2113; THORBURN J, 1994, J BIOL CHEM, V269, P30580; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; WATANABE T, 1995, J BIOL CHEM, V270, P8984, DOI 10.1074/jbc.270.15.8984	62	104	107	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22442	22452		10.1074/jbc.273.35.22442	http://dx.doi.org/10.1074/jbc.273.35.22442			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712868	hybrid			2022-12-27	WOS:000075616600044
J	McFerran, BW; Graham, ME; Burgoyne, RD				McFerran, BW; Graham, ME; Burgoyne, RD			Neuronal Ca2+ sensor 1, the mammalian homologue of frequenin, is expressed in chromaffin and PC12 cells and regulates neurosecretion from dense-core granules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEIN; NERVOUS-SYSTEM; CA2+-DEPENDENT EXOCYTOSIS; TRANSMITTER RELEASE; MOLECULAR-CLONING; DROSOPHILA; NEUROCALCIN; RECOVERIN; HIPPOCALCIN; SECRETION	Neuronal Ca2+ sensor 1 (NCS-1) is the mammalian homologue of the Ca2+-binding protein frequenin previously implicated in regulation of neurotransmission in Drosophila (Pongs, O., Lindemeier, J., Zhu, X. R., Theil, T., Endelkamp, D., Krah-Jentgens, I., Lambrecht, H.-G., Koch, R. W., Schwemer, J., Rivosecchi, R., Mallart, A., Galceran, J., Canal, I., Barbas, J. A., and Ferrus, A. (1993) Neuron 11, 15-28). NCS-1 has been considered to be expressed only in neurons, but we show that NCS-1 expression can be detected in bovine adrenal chromaffin and PC12 cells, two widely studied model neuroendocrine cells. NCS-1 was present in both cytosolic and membrane fractions including purified chromaffin granules, and in immunofluorescence, its distribution overlapped with peripheral punctate staining seen with the synaptic-like microvesicle marker synaptophysin in PC12 cells. The possible functional role of NCS-1 in exocytosis of dense core granules was tested using transient transfection in PC12 cells and assay of co-transfected growth hormone (GH) release. Overexpression of NCS-1 increased evoked GH release in intact cells in response to ATP. No effect of overexpression was seen on GH release because of Ca2+ in permeabilized cells suggesting that NCS-1 may have a regulatory but not direct role in neurosecretion.	Univ Liverpool, Physiol Lab, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Burgoyne, RD (corresponding author), Univ Liverpool, Physiol Lab, Crown St, Liverpool L69 3BX, Merseyside, England.	burgoyne@liverpool.ac.uk	Burgoyne, Robert D/P-6641-2019; Burgoyne, Robert/C-6706-2008	Burgoyne, Robert D/0000-0002-9219-0387; Burgoyne, Robert/0000-0002-9219-0387	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Burgoyne RD, 1998, BIOESSAYS, V20, P328, DOI 10.1002/(SICI)1521-1878(199804)20:4<328::AID-BIES9>3.0.CO;2-L; BURGOYNE RD, 1995, TRENDS NEUROSCI, V18, P191, DOI 10.1016/0166-2236(95)93900-I; BURGOYNE RD, 1992, NEUROMETHODS, V20, P433; Calakos N, 1996, PHYSIOL REV, V76, P1; CHUNG SH, 1995, J BIOL CHEM, V270, P16714, DOI 10.1074/jbc.270.28.16714; COX JA, 1994, J BIOL CHEM, V269, P32807; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Graham ME, 1997, MOL BIOL CELL, V8, P431, DOI 10.1091/mbc.8.3.431; Graham ME, 1997, J NEUROCHEM, V69, P2369; IINO, 1997, CELL TISSUE RES, V289, P439; KAWAMURA S, 1992, BIOCHEM BIOPH RES CO, V186, P411, DOI 10.1016/S0006-291X(05)80823-X; KOBAYASHI M, 1992, BIOCHEM BIOPH RES CO, V189, P511, DOI 10.1016/0006-291X(92)91587-G; KOBAYASHI M, 1993, J BIOL CHEM, V268, P18898; LADANT D, 1995, J BIOL CHEM, V270, P3179; LENZ SE, 1992, MOL BRAIN RES, V15, P133, DOI 10.1016/0169-328X(92)90160-D; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; Martin TFJ, 1997, TRENDS CELL BIOL, V7, P271, DOI 10.1016/S0962-8924(97)01060-X; Morgan A, 1997, SEMIN CELL DEV BIOL, V8, P141, DOI 10.1006/scdb.1996.0133; NEF S, 1995, J RECEPT SIGNAL TR R, V15, P365, DOI 10.3109/10799899509045227; OKAZAKI K, 1992, BIOCHEM BIOPH RES CO, V185, P147, DOI 10.1016/S0006-291X(05)80968-4; Olafsson P, 1997, MOL BRAIN RES, V44, P73, DOI 10.1016/S0169-328X(96)00188-X; OLAFSSON P, 1995, P NATL ACAD SCI USA, V92, P8001, DOI 10.1073/pnas.92.17.8001; Orita S, 1997, J BIOL CHEM, V272, P16081, DOI 10.1074/jbc.272.26.16081; Orita S, 1996, J BIOL CHEM, V271, P7257, DOI 10.1074/jbc.271.13.7257; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; POULAIN C, 1994, PFLUG ARCH EUR J PHY, V427, P71, DOI 10.1007/BF00585944; RIVOSECCHI R, 1994, J PHYSIOL-LONDON, V474, P223, DOI 10.1113/jphysiol.1994.sp020015; ROTH D, 1994, BIOCHEM J, V301, P305, DOI 10.1042/bj3010305; SCHWEITZER ES, 1985, J CELL BIOL, V101, P667, DOI 10.1083/jcb.101.2.667; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Weber E, 1996, J BIOL CHEM, V271, P6963, DOI 10.1074/jbc.271.12.6963; WICK PF, 1993, J BIOL CHEM, V268, P10983; YAMAGATA K, 1990, NEURON, V4, P469, DOI 10.1016/0896-6273(90)90059-O	35	135	141	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22768	22772		10.1074/jbc.273.35.22768	http://dx.doi.org/10.1074/jbc.273.35.22768			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712909	hybrid			2022-12-27	WOS:000075616600085
J	Kramata, P; Downey, KM; Paborsky, LR				Kramata, P; Downey, KM; Paborsky, LR			Incorporation and excision of 9-(2-phosphonylmethoxyethyl)guanine (PMEG) by DNA polymerase delta and epsilon in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE ANALOGS; NUCLEOSIDE PHOSPHONATES; ENZYMOLOGIC MECHANISM; REPLICATION FORK; IN-VITRO; CELLS; ALPHA; INHIBITION; REPAIR; BETA	PMEG (9-(2-phosphonylmethoxyethyl)guanine) is an acyclic nucleotide analog being evaluated for its antiproliferative activity. We examined the inhibitory effects of PMEG diphosphate (PMEGpp) toward DNA polymerases (pol) delta and epsilon and found it to be a competitive inhibitor of both these enzymes. The apparent Ki values for PMEGpp were 3-4 times lower than the K(m) values for dGTP. The analog was shown to function as a substrate and to be incorporated into DNA by both enzymes. Examination of the ability of pol delta and pol epsilon to repair the incorporated PMEG revealed that pol epsilon could elongate PMEG-tterianated primers ire both matched and mismatched positions with an efficiency equal to 27 and 85% that observed for dGMP-terminated control template-primers. Because PMEG acts as an absolute DNA chain terminator, the elongation of PMEG-terminated primers is possible only by cooperation of the 3'-5'-exonuclease and DNA polymerase activities of the enzyme. In contrast to pol epsilon, pol delta exhibited negligible activity on these template-primers, indicating that pol epsilon, but not pol delta, can repair the incorporated analog.	Gilead Sci Inc, Foster City, CA 94404 USA; Univ Miami, Sch Med, Dept Med, Miami, FL 33101 USA	Gilead Sciences; University of Miami	Kramata, P (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	Pavel_Kramata@gilead.com						APBORSKY LR, 1997, P AM ASSOC CANC RES, V38, P100; Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHUI G, 1995, J BIOL CHEM, V270, P7799, DOI 10.1074/jbc.270.14.7799; Cihlar T, 1997, ANTIVIR CHEM CHEMOTH, V8, P187, DOI 10.1177/095632029700800302; DECLERCQ E, 1991, BIOCHEM PHARMACOL, V42, P963, DOI 10.1016/0006-2952(91)90276-B; GANDHI V, 1995, CANCER RES, V55, P1517; HEINEMANN V, 1990, MOL PHARMACOL, V38, P567; HENTOSH P, 1990, J BIOL CHEM, V265, P4033; HO HT, 1992, ADV EXP MED BIOL, V312, P159; HOLY A, 1987, COLLECT CZECH CHEM C, V52, P2801, DOI 10.1135/cccc19872801; HUANG P, 1991, CANCER RES, V51, P6110; HUANG P, 1990, J BIOL CHEM, V265, P16617; JESSBERGER R, 1993, J BIOL CHEM, V268, P15070; Kamiya K, 1996, J BIOL CHEM, V271, P19428, DOI 10.1074/jbc.271.32.19428; Kramata P, 1996, MOL PHARMACOL, V49, P1005; KRIEDER JW, 1990, ANTIVIR RES, V14, P51; KUNKEL TA, 1992, BIOESSAYS, V14, P303, DOI 10.1002/bies.950140503; Longley MJ, 1997, J BIOL CHEM, V272, P10917; Mozzherin DJ, 1996, BIOCHEMISTRY-US, V35, P3572, DOI 10.1021/bi952142p; NAVAS TA, 1995, CELL, V80, P29, DOI 10.1016/0092-8674(95)90448-4; NG L, 1991, J BIOL CHEM, V266, P11699; NISHIDA C, 1988, J BIOL CHEM, V263, P501; PETRUSKA J, 1988, P NATL ACAD SCI USA, V85, P6252, DOI 10.1073/pnas.85.17.6252; Pisarev VM, 1997, MOL PHARMACOL, V52, P63, DOI 10.1124/mol.52.1.63; PODUST VN, 1993, NUCLEIC ACIDS RES, V21, P841, DOI 10.1093/nar/21.4.841; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; ROBBINS BL, 1995, MOL PHARMACOL, V47, P391; ROSE WC, 1990, J NATL CANCER I, V82, P510, DOI 10.1093/jnci/82.6.510; SABATINO RD, 1990, CANCER RES, V50, P5340; Sancar A, 1995, ANNU REV GENET, V29, P69, DOI 10.1146/annurev.ge.29.120195.000441; SYVAOJA J, 1989, J BIOL CHEM, V264, P2489; TAN CK, 1986, J BIOL CHEM, V261, P2310; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; Xie KC, 1996, CANCER RES, V56, P3030; ZENG XR, 1994, J BIOL CHEM, V269, P13748; Zlotkin T, 1996, EMBO J, V15, P2298, DOI 10.1002/j.1460-2075.1996.tb00583.x	37	39	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21966	21971		10.1074/jbc.273.34.21966	http://dx.doi.org/10.1074/jbc.273.34.21966			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705337	hybrid			2022-12-27	WOS:000075492600071
J	Liao, H; Li, YR; Brautigan, DL; Gundersen, GG				Liao, H; Li, YR; Brautigan, DL; Gundersen, GG			Protein phosphatase 1 is targeted to microtubules by the microtubule-associated protein Tau	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLASE-PHOSPHATASE; ALZHEIMERS-DISEASE; CATALYTIC SUBUNIT; OKADAIC ACID; MAP KINASE; DYNAMIC INSTABILITY; CELLULAR-REGULATION; P34(CDC2) KINASE; NERVOUS-SYSTEM; IN-VITRO	Phosphorylation has been implicated in the regulation of microtubule (MT) stability and function by controlling the interactions between MTs and MT-associated proteins. We found previously that protein phosphatase inhibitors selectively break down stable MTs, suggesting that protein phosphatases may be involved in regulating MT stability. To identify the protein phosphatases involved, we examined purified calf brain MTs and found a protein phosphatase activity that co-purified with MTs to constant stoichiometry, Western blot analysis and inhibitor profiles demonstrated that the MT-associated phosphatase was a type 1 protein phosphatase (PP1), which we named PP1(MT). Recombinant PP1 catalytic subunit (PP1c) did not bind to MTs, whereas PP1(MT) did bind, suggesting the presence of proteins that target PP1 to MTs, By Sepharose CL-GB chromatography, the phosphatase activity of PP1(MT) eluted as a large protein complex of similar to 400 kDa, High salt (2 RI NaCl) treatment followed by CL-GB chromatography dissociated PP1(MT) into PP1c and the MT-targeting subunit(s), The MT-targeting subunit was shown to be the MT-associated protein tau by PP1 blot overlays and other assays. Also, recombinant tau reconstituted the binding of PP1c to MTs, These results identify PPI as the first tau binding protein and suggest that tau is a novel PP1-targeting subunit.	Columbia Univ Coll Phys & Surg, Dept Anat & Cell Biol, New York, NY 10032 USA; Univ Virginia, Hlth Sci Ctr, Ctr Cell Signaling, Charlottesville, VA 22908 USA	Columbia University; University of Virginia	Gundersen, GG (corresponding author), Columbia Univ Coll Phys & Surg, Dept Anat & Cell Biol, 630 W 168th St, New York, NY 10032 USA.	ggg1@columbia.edu		JOHNSON, HEATHER/0000-0001-7468-0705	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056362] Funding Source: NIH RePORTER; NIA NIH HHS [AG10926] Funding Source: Medline; NIGMS NIH HHS [GM56362] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALESSI D, 1992, EUR J BIOCHEM, V210, P1023, DOI 10.1111/j.1432-1033.1992.tb17508.x; BERLING B, 1994, EUR J CELL BIOL, V64, P120; BEULLENS M, 1993, J BIOL CHEM, V268, P13172; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BOLLEN M, 1992, CRIT REV BIOCHEM MOL, V27, P227, DOI 10.3109/10409239209082564; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; BRAUTIGAN DL, 1985, J BIOL CHEM, V260, P4295; BRAUTIGAN DL, 1993, ADV PROTEIN PHOSPHAT, V7, P43; BRION JP, 1988, NEUROSCIENCE, V25, P139, DOI 10.1016/0306-4522(88)90013-9; CASSIMERIS L, 1993, CELL MOTIL CYTOSKEL, V26, P275, DOI 10.1002/cm.970260402; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COHEN P, 1989, J BIOL CHEM, V264, P21435; CROWTHER RA, 1992, FEBS LETT, V309, P199, DOI 10.1016/0014-5793(92)81094-3; DEGUZMAN A, 1988, METHOD ENZYMOL, V159, P356; DEPENNART H, 1993, DEV BIOL, V157, P170, DOI 10.1006/dbio.1993.1121; DICKSON DW, 1992, NEUROBIOL AGING, V13, P179, DOI 10.1016/0197-4580(92)90027-U; DRESCHEL DN, 1992, MOL BIOL CELL, V3, P1141; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; FELLOUS A, 1994, INT J DEV BIOL, V38, P651; GARVER TD, 1994, J NEUROCHEM, V63, P2279; GLIKSMAN NR, 1992, J CELL BIOL, V119, P1271, DOI 10.1083/jcb.119.5.1271; GOEDERT M, 1992, FEBS LETT, V312, P95, DOI 10.1016/0014-5793(92)81418-L; GONG CX, 1994, FEBS LETT, V341, P94, DOI 10.1016/0014-5793(94)80247-5; GRATECOS D, 1977, BIOCHEMISTRY-US, V16, P4812, DOI 10.1021/bi00641a009; GRUPPUSO PA, 1985, J BIOL CHEM, V260, P4288; GURLAND G, 1993, P NATL ACAD SCI USA, V90, P8827, DOI 10.1073/pnas.90.19.8827; HIORKAWA N, 1991, NEURONAL CYTOSKELETO, P5; HIRANO K, 1995, J BIOL CHEM, V270, P19786, DOI 10.1074/jbc.270.34.19786; HIROKAWA N, 1994, CURR OPIN CELL BIOL, V6, P74, DOI 10.1016/0955-0674(94)90119-8; HIROKAWA N, 1985, J CELL BIOL, V101, P227, DOI 10.1083/jcb.101.1.227; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; JAGIELLO I, 1995, J BIOL CHEM, V270, P17257, DOI 10.1074/jbc.270.29.17257; JAMESON L, 1980, BIOCHEMISTRY-US, V19, P2472, DOI 10.1021/bi00552a027; KNOPS J, 1991, J CELL BIOL, V114, P725, DOI 10.1083/jcb.114.4.725; LI HC, 1979, J BIOL CHEM, V254, P3368; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; MANDELKOW E, 1995, CURR OPIN CELL BIOL, V7, P72, DOI 10.1016/0955-0674(95)80047-6; MATUS A, 1983, COLD SPRING HARB SYM, V48, P775, DOI 10.1101/SQB.1983.048.01.079; MATUS A, 1988, ANNU REV NEUROSCI, V466, P167; MorishimaKawashima M, 1996, MOL BIOL CELL, V7, P893, DOI 10.1091/mbc.7.6.893; NICHOLAS RH, 1995, FEBS LETT, V377, P295; OHKURA H, 1991, CELL, V64, P149, DOI 10.1016/0092-8674(91)90216-L; OLMSTED JB, 1986, ANNU REV CELL BIOL, V2, P421, DOI 10.1146/annurev.cb.02.110186.002225; OOKATA K, 1995, J CELL BIOL, V128, P849, DOI 10.1083/jcb.128.5.849; PELECH S, 1985, EUR J BIOCHEM, V148, P245, DOI 10.1111/j.1432-1033.1985.tb08832.x; RATTNER JB, 1990, CELL MOTIL CYTOSKEL, V17, P227, DOI 10.1002/cm.970170309; RUBINO HM, 1989, NEURON, V3, P631, DOI 10.1016/0896-6273(89)90273-0; SANO M, 1992, J NEUROCHEM, V59, P1263, DOI 10.1111/j.1471-4159.1992.tb08436.x; SCHOENFELD TA, 1994, INT REV CYTOL, V151, P67, DOI 10.1016/S0074-7696(08)62631-5; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SHELDEN E, 1993, J CELL BIOL, V120, P935, DOI 10.1083/jcb.120.4.935; SHENOLIKAR S, 1994, ANNU REV CELL BIOL, V10, P55, DOI 10.1146/annurev.cellbio.10.1.55; SONTAG E, 1995, J CELL BIOL, V128, P1131, DOI 10.1083/jcb.128.6.1131; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; STRALFORS P, 1985, EUR J BIOCHEM, V149, P295, DOI 10.1111/j.1432-1033.1985.tb08926.x; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; Trojanowski JQ, 1995, FASEB J, V9, P1570, DOI 10.1096/fasebj.9.15.8529836; TU JL, 1995, EMBO J, V14, P5939, DOI 10.1002/j.1460-2075.1995.tb00282.x; VALLEE RB, 1986, METHOD ENZYMOL, V134, P89; VALLEE RB, 1986, METHOD ENZYMOL, V134, P116; YOSHITAKE S, 1979, EUR J BIOCHEM, V101, P395, DOI 10.1111/j.1432-1033.1979.tb19731.x; ZHANG ZJ, 1992, J BIOL CHEM, V267, P1484; Zhao SM, 1997, J BIOL CHEM, V272, P28368, DOI 10.1074/jbc.272.45.28368	66	129	131	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21901	21908		10.1074/jbc.273.34.21901	http://dx.doi.org/10.1074/jbc.273.34.21901			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705329	hybrid			2022-12-27	WOS:000075492600063
J	Pan, CJ; Lei, KJ; Chou, JY				Pan, CJ; Lei, KJ; Chou, JY			Asparagine-linked oligosaccharides are localized to a luminal hydrophilic loop in human glucose-6-phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-STORAGE-DISEASE; ENDOPLASMIC-RETICULUM; ENZYME-DEFICIENT; GENE; MUTATIONS; 1A; GLYCOPROTEINS; MEMBRANE; TYPE-1A	yDeficiency of glucose-6-phosphatase (G6Pase), an endoplasmic reticulum transmembrane glycoprotein, causes glycogen storage disease type la, We have recently shown that human G6Pase contains an odd number of transmembrane segments, supporting a nine-transmembrane helical model for this enzyme. Sequence analysis predicts the presence of three potential asparagine (N)-linked glycosylation sites, (NTS)-T-96, N(203)AS, and (NSS)-S-276, conserved among mammalian G6Pases. According to this model, Asn(96), located in a 37-residue luminal loop, is a potential acceptor for oligosaccharides, whereas Asn(203) and Asn(276), located in a 12-residue cytoplasmic loop and helix 7, respectively, would not be utilized for this purpose. We therefore characterized mutant G6Pases lacking one, two, or all three potential N-linked glycosylation sites. Western blot and in vitro translation studies showed that G6Pase is glycosylated only at Asn(96), further validating the nine-transmembrane topology model. Substituting Asn96 with an Ala (N96A) moderately reduced enzymatic activity and had no effect on G6Pase synthesis or degradation, suggesting that oligosaccharide chains do not play a major role in protecting the enzyme from proteolytic degradation. Ln contrast, mutation of Asn(276) to an Ala (N276A) destabilized the enzyme and markedly reduced enzymatic activity. We present additional evidence suggesting that the integrity of transmembrane helices is essential for C6Pase stability and catalytic activity.	NICHD, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Chou, JY (corresponding author), NICHD, Heritable Disorders Branch, NIH, Bldg 10,Rm 98241, Bethesda, MD 20892 USA.	chou@helix.nih.gov						Ausubel FM, 1992, CURRENT PROTOCOLS MO; BURCHELL A, 1988, CLIN CHIM ACTA, V173, P183, DOI 10.1016/0009-8981(88)90256-2; Chen Y-T, 1995, METABOLIC MOL BASES, P935; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; HERS H. G., 1964, ADVAN METAB DISORDERS, V1, P1; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Kishnani PS, 1997, BIOCHEM MOL MED, V61, P168, DOI 10.1006/bmme.1997.2600; LANDOLTMARTICORENA C, 1994, BIOCHEM J, V302, P253, DOI 10.1042/bj3020253; LANGE AJ, 1994, BIOCHEM BIOPH RES CO, V201, P302, DOI 10.1006/bbrc.1994.1702; LEI KJ, 1995, J CLIN INVEST, V95, P234, DOI 10.1172/JCI117645; LEI KJ, 1995, J BIOL CHEM, V270, P11882, DOI 10.1074/jbc.270.20.11882; LEI KJ, 1995, AM J HUM GENET, V57, P766; LEI KJ, 1993, SCIENCE, V262, P580, DOI 10.1126/science.8211187; MOSES SW, 1990, J PEDIATR GASTR NUTR, V11, P155, DOI 10.1097/00005176-199008000-00004; NILSSON I, 1993, J BIOL CHEM, V268, P5798; NORDLIE RC, 1985, ENZYMES BIOL MEMBR, P349; OLDEN K, 1985, TRENDS BIOCHEM SCI, V10, P78, DOI 10.1016/0968-0004(85)90238-5; Pan CJ, 1998, J BIOL CHEM, V273, P6144, DOI 10.1074/jbc.273.11.6144; Parvari R, 1997, AM J MED GENET, V72, P286, DOI 10.1002/(SICI)1096-8628(19971031)72:3<286::AID-AJMG6>3.0.CO;2-P; Parvari R, 1997, EUR J HUM GENET, V5, P191, DOI 10.1159/000484762; PAULSON JC, 1989, TRENDS BIOCHEM SCI, V14, P272, DOI 10.1016/0968-0004(89)90062-5; SHELLY LL, 1993, J BIOL CHEM, V268, P21482; STRUCK DK, 1977, J BIOL CHEM, V252, P1007; WADDELL ID, 1991, BIOCHEM J, V275, P133, DOI 10.1042/bj2750133	24	22	26	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21658	21662		10.1074/jbc.273.34.21658	http://dx.doi.org/10.1074/jbc.273.34.21658			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705299	hybrid			2022-12-27	WOS:000075492600033
J	Colussi, PA; Harvey, NL; Kumar, S				Colussi, PA; Harvey, NL; Kumar, S			Prodomain-dependent nuclear localization of the caspase-2 (Nedd2) precursor - A novel function for a caspase prodomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ICE-LIKE PROTEASES; CELL-DEATH; CYSTEINE PROTEASE; GRANZYME-B; APOPTOSIS; ENZYME; EXPRESSION; FAMILY; CED-3; CPP32	Caspases are cysteine proteases that play an essential role in apoptosis by cleaving several key cellular proteins. Despite their function in apoptosis, little is known about where in the cell they are localized and whether they are translocated to specific cellular compartments upon activation. In the present paper, using Aequorea victoria green fluorescent protein fusion constructs, we have determined the localization of Nedd2 (mouse caspase-2) and show that both precursor and processed caspase-2 localize to the cytoplasmic and the nuclear compartments. We demonstrate that the nuclear localization of caspase-2 is strictly dependent on the presence of the prodomain. A caspase-2 prodomain-green fluorescent protein localized to dot- and fiber-like structures mostly in the nucleus, whereas a protein lacking the prodomain was largely concentrated in the cytoplasm, We also show that an amino-terminal fusion of the prodomain of caspase-2 to caspase-3 mediates nuclear transport of caspase-3, which is normally localized in the cytoplasm. These results suggest that, in addition to roles in dimerization and recruitment through adaptors, the caspase-2 prodomain has a novel function in nuclear transport.	Inst Med & Vet Sci, Hanson Ctr Canc Res, Adelaide, SA 5000, Australia	Institute Medical & Veterinary Science Australia	Kumar, S (corresponding author), Inst Med & Vet Sci, Hanson Ctr Canc Res, POB 14,Rundle Mall,Frome Rd, Adelaide, SA 5000, Australia.		Kumar, Sharad/AAX-7787-2020	Kumar, Sharad/0000-0001-7126-9814; Harvey, Natasha/0000-0001-9839-8966				ALLET B, 1996, J CELL BIOL, V135, P480; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Butt AJ, 1998, J BIOL CHEM, V273, P6763, DOI 10.1074/jbc.273.12.6763; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; COLUSSI PA, 1998, IN PRESS J BIOL CHEM; Dorstyn L, 1997, CELL DEATH DIFFER, V4, P570, DOI 10.1038/sj.cdd.4400281; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; FLAWS JA, 1995, ENDOCRINOLOGY, V136, P5042, DOI 10.1210/en.136.11.5042; Harvey KF, 1998, J BIOL CHEM, V273, P13524, DOI 10.1074/jbc.273.22.13524; Harvey NL, 1997, J BIOL CHEM, V272, P13134, DOI 10.1074/jbc.272.20.13134; Harvey NL, 1996, GENES CELLS, V1, P673, DOI 10.1046/j.1365-2443.1996.00255.x; Hofmann K, 1997, TRENDS BIOCHEM SCI, V22, P155, DOI 10.1016/S0968-0004(97)01043-8; Kinoshita M, 1997, J CEREBR BLOOD F MET, V17, P507, DOI 10.1097/00004647-199705000-00004; KUMAR S, 1995, TRENDS BIOCHEM SCI, V20, P198, DOI 10.1016/S0968-0004(00)89007-6; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; Kumar S, 1996, CELL DEATH DIFFER, V3, P255; Kumar S, 1997, CELL DEATH DIFFER, V4, P378, DOI 10.1038/sj.cdd.4400251; KUMAR S, 1995, FEBS LETT, V368, P69, DOI 10.1016/0014-5793(95)00602-6; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Mancini M, 1998, J CELL BIOL, V140, P1485, DOI 10.1083/jcb.140.6.1485; MARTIN SJ, 1995, CELL, V82, P349, DOI 10.1016/0092-8674(95)90422-0; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nakagawara A, 1997, CANCER RES, V57, P4578; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Song QZ, 1996, EMBO J, V15, P3238, DOI 10.1002/j.1460-2075.1996.tb00688.x; Srinivasula SM, 1996, J BIOL CHEM, V271, P27099, DOI 10.1074/jbc.271.43.27099; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Troy CM, 1997, J NEUROSCI, V17, P1911; Van de Craen M, 1997, FEBS LETT, V403, P61, DOI 10.1016/S0014-5793(97)00026-4; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Waterhouse N, 1996, J BIOL CHEM, V271, P29335, DOI 10.1074/jbc.271.46.29335; Xue D, 1996, GENE DEV, V10, P1073, DOI 10.1101/gad.10.9.1073; Yang XL, 1998, MOL CELL, V1, P319, DOI 10.1016/S1097-2765(00)80032-5	39	133	133	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24535	24542		10.1074/jbc.273.38.24535	http://dx.doi.org/10.1074/jbc.273.38.24535			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733748	hybrid			2022-12-27	WOS:000076007300040
J	Shukla, D; Zhu, XY; Matsumura, P				Shukla, D; Zhu, XY; Matsumura, P			Flagellar motor-switch finding face of CheY and the biochemical basis of suppression by CheY mutants that compensate for motor-switch defects in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION-DEPENDENT BINDING; CHEMOTAXIS PROTEIN CHEY; BACTERIAL CHEMOTAXIS; SIGNAL-TRANSDUCTION; SALMONELLA-TYPHIMURIUM; 3-DIMENSIONAL STRUCTURE; CONSERVED ASPARTATE; RESPONSE REGULATOR; GENES; COMPLEX	CheY is a response regulator protein of Escherichia coli that interacts with the flagellar motor-switch complex to modulate flagellar rotation during chemotaxis. The switch complex is composed of three proteins, FliG, FliM, and FliN, Recent biochemical data suggest a direct interaction of CheY with FliM. In order to determine the FliM binding face of CheY, we isolated dominant suppressors of fliM mutations in cheY with limited allele specificity. The protein products of suppressor cheY alleles were purified and assayed for FliM binding. Six out of nine CheY mutants were defective in FliM binding. Suppressor amino acid substitutions were mapped on the crystal structure of CheY showing clustering of reduced binding mutations on a solvent-accessible face of CheY, thus revealing a FliM binding face of CheY. To examine the basis of genetic suppression, we cloned, purified, and tested FliM mutants for CheY binding. Like the wild-type FliM, the mutants were also defective in binding to various CheY suppressor mutants. This was not expected if CheY suppressors were compensatory conformational suppressors. Furthermore, a comparison of flagellar rotation patterns indicated that the cheY suppressors had readjusted the clockwise bias of the fliM strains. However, a chemotaxis assay revealed that the readjustment of the clockwise bias was not sufficient to make cells chemotactic. Although the suppressors did not restore chemotaxis, they did increase swarming on motility plates by a process called "pseudotaxis." Therefore, our genetic selection scheme generated suppressors of pseudotaxis or switch bias adjustment. The binding results suggest that the mechanism for this adjustment is the reduction in binding affinity of activated CheY, Therefore, these suppressors identified the switch-binding surface of CheY by loss-of-function defects rather than gain-of-function compensatory conformational changes.	Univ Illinois, Dept Microbiol & Immunol MC 790, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Matsumura, P (corresponding author), Univ Illinois, Dept Microbiol & Immunol MC 790, 835 S Wolcott Ave, Chicago, IL 60612 USA.	Philip.Matsumura@uic.edu		Shukla, Deepak/0000-0002-3039-6953	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018985] Funding Source: NIH RePORTER; NIAID NIH HHS [AI18985] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ames P, 1996, MOL MICROBIOL, V19, P737, DOI 10.1046/j.1365-2958.1996.408930.x; AMSLER CD, 1993, J BACTERIOL, V175, P6238, DOI 10.1128/JB.175.19.6238-6244.1993; Amsler CD., 1995, 2 COMPONENT SIGNAL T, P89; Bellsolell L, 1996, J MOL BIOL, V257, P116, DOI 10.1006/jmbi.1996.0151; BLAIR DF, 1995, ANNU REV MICROBIOL, V49, P489, DOI 10.1146/annurev.mi.49.100195.002421; BLAT Y, 1994, BIOCHEMISTRY-US, V33, P902, DOI 10.1021/bi00170a008; BOURRET RB, 1990, P NATL ACAD SCI USA, V87, P41, DOI 10.1073/pnas.87.1.41; DRAKE SK, 1993, J BIOL CHEM, V268, P13081; GEGNER JA, 1992, CELL, V70, P975, DOI 10.1016/0092-8674(92)90247-A; HAZELBAUER GL, 1993, CELL, V73, P15, DOI 10.1016/0092-8674(93)90156-K; HESS JF, 1988, CELL, V53, P79, DOI 10.1016/0092-8674(88)90489-8; HESS JF, 1988, NATURE, V336, P139, DOI 10.1038/336139a0; HESS JF, 1987, P NATL ACAD SCI USA, V84, P7609, DOI 10.1073/pnas.84.21.7609; KAR L, 1992, BIOCHEM J, V287, P521, DOI 10.1042/bj2870521; KOOP AH, 1987, GENE, V52, P245, DOI 10.1016/0378-1119(87)90051-5; LOWRY DF, 1994, J BIOL CHEM, V269, P26358; LUKAT GS, 1991, J BIOL CHEM, V266, P8348; MACNAB RM, 1995, 2 COMPONENT SIGNAL T, P181; MAGARIYAMA Y, 1990, J BACTERIOL, V172, P4359, DOI 10.1128/jb.172.8.4359-4369.1990; MATSUMURA P, 1984, J BACTERIOL, V160, P36, DOI 10.1128/JB.160.1.36-41.1984; MCNALLY DF, 1991, P NATL ACAD SCI USA, V88, P6269, DOI 10.1073/pnas.88.14.6269; NICHOLS BP, 1983, METHOD ENZYMOL, V101, P155; OOSAWA K, 1988, CELL, V53, P89, DOI 10.1016/0092-8674(88)90490-4; PARKINSON JS, 1982, J BACTERIOL, V151, P106, DOI 10.1128/JB.151.1.106-113.1982; PARKINSON JS, 1983, J BACTERIOL, V155, P265, DOI 10.1128/JB.155.1.265-274.1983; PARKINSON JS, 1976, J BACTERIOL, V126, P758, DOI 10.1128/JB.126.2.758-770.1976; PARKINSON JS, 1978, J BACTERIOL, V135, P45, DOI 10.1128/JB.135.1.45-53.1978; PARKINSON JS, 1993, CELL, V73, P857, DOI 10.1016/0092-8674(93)90267-T; PARKINSON JS, 1979, P NATL ACAD SCI USA, V76, P2390, DOI 10.1073/pnas.76.5.2390; PARKINSON JS, 1993, CELL, V337, P745; RAVID S, 1986, P NATL ACAD SCI USA, V83, P7157, DOI 10.1073/pnas.83.19.7157; ROMAN SJ, 1992, J BACTERIOL, V174, P6247, DOI 10.1128/JB.174.19.6247-6255.1992; SCHUSTER SC, 1993, NATURE, V365, P343, DOI 10.1038/365343a0; SHUKLA D, 1995, J BIOL CHEM, V270, P24414, DOI 10.1074/jbc.270.41.24414; SOCKETT H, 1992, J BACTERIOL, V174, P793, DOI 10.1128/jb.174.3.793-806.1992; STOCK AM, 1989, NATURE, V337, P745, DOI 10.1038/337745a0; SWANSON RV, 1995, NAT STRUCT BIOL, V2, P906, DOI 10.1038/nsb1095-906; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TREPTOW NA, 1988, J MOL BIOL, V202, P809, DOI 10.1016/0022-2836(88)90560-8; VOLZ K, 1991, J BIOL CHEM, V266, P15511; VOLZ K, 1993, BIOCHEMISTRY-US, V32, P11741, DOI 10.1021/bi00095a001; WELCH M, 1993, P NATL ACAD SCI USA, V90, P8787, DOI 10.1073/pnas.90.19.8787; WELCH M, 1994, BIOCHEMISTRY-US, V33, P10270; YAMAGUCHI S, 1986, J BACTERIOL, V168, P1172, DOI 10.1128/jb.168.3.1172-1179.1986; YAMAGUCHI S, 1986, J BACTERIOL, V166, P187, DOI 10.1128/jb.166.1.187-193.1986; ZHU X, 1996, J BACTERIOL, V176, P4208; ZHULIN IB, 1991, CURR MICROBIOL, V22, P307, DOI 10.1007/BF02091959	47	28	28	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23993	23999		10.1074/jbc.273.37.23993	http://dx.doi.org/10.1074/jbc.273.37.23993			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727015	hybrid			2022-12-27	WOS:000075893100056
J	Swanson, DJ; Zellmer, E; Lewis, EJ				Swanson, DJ; Zellmer, E; Lewis, EJ			AP1 proteins mediate the cAMP response of the dopamine beta-hydroxylase gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; NEUROTRANSMITTER BIOSYNTHETIC GENES; C-JUN ACTIVATION; CYCLIC-AMP; SIGNAL-TRANSDUCTION; REGULATORY ELEMENT; FOS TRANSCRIPTION; CHROMAFFIN CELLS; MAMMALIAN-CELLS; TRANSGENIC MICE	Neurotransmitter biosynthesis is regulated by environmental stimuli, which transmit intracellular signals via second messengers and protein kinase pathways, For the catecholamine biosynthetic enzymes, dopamine beta-hydroxylase and tyrosine hydroxylase, regulation of gene expression by cyclic AMP, diacyl glycerol, and Ca2+ leads to increased neurotransmitter biosynthesis, In this report, we demonstrate that the cAMP-mediated regulation of transcription from the dopamine beta-hydroxylase promoter is mediated by the AP1 proteins c-Fos, c-Jun, and JunD, Following treatment of cultured cells with cAMP, protein complexes bound to the dopamine beta-hydroxylase AP1/cAMP response element element change from consisting of c-Jun and JunD to include c-Fos, c-Jun, and JunD. The homeodomain protein Arix is also a component of this DNA-protein complex, binding to the adjacent homeodomain recognition sites. Transfection of a dominant negative JunD expression plasmid inhibits cAMP-mediated expression of the dopamine beta-hydroxylase promoter construct in PC12 and CATH.a cells. In addition to the role of c-Fos in regulating dopamine beta-hydroxylase gene expression in response to cAMP, a second pathway, involving Rap1/BRaf is involved. These experiments illustrate an unusual divergence of cAMP-dependent protein kinase signaling through multiple pathways that then reconverge on a single element in the dopamine beta-hydroxylase promoter to elicit activation of gene expression.	Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA	Oregon Health & Science University	Lewis, EJ (corresponding author), Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, L224, Portland, OR 97201 USA.				NIGMS NIH HHS [GM38696] Funding Source: Medline; NINDS NIH HHS [NS33159] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038696, R29GM038696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033159] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Afar R, 1996, MOL BRAIN RES, V36, P79, DOI 10.1016/0169-328X(95)00247-P; AGARWAL S, 1995, ONCOGENE, V11, P427; Anderson DJ, 1997, TRENDS GENET, V13, P276, DOI 10.1016/S0168-9525(97)01187-6; ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; Ausbel F.M., 1995, CURRENT PROTOCOLS MO; Bacher B, 1996, J NEUROCHEM, V66, P2264; BANNISTER AJ, 1995, EMBO J, V14, P4758, DOI 10.1002/j.1460-2075.1995.tb00157.x; BOUTILLIER AL, 1992, J BIOL CHEM, V267, P23520; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; COLLINSHICOK J, 1994, MOL CELL BIOL, V14, P2837, DOI 10.1128/MCB.14.5.2837; COMB M, 1986, NATURE, V323, P353, DOI 10.1038/323353a0; DENG TL, 1994, NATURE, V371, P171, DOI 10.1038/371171a0; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GIZANGGINSBERG E, 1990, GENE DEV, V4, P477, DOI 10.1101/gad.4.4.477; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GRUENEBERG DA, 1995, MOL CELL BIOL, V15, P3318; Hahm SH, 1996, J NEUROCHEM, V67, P1872; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; ICARDLIEPKALNS C, 1992, J NEUROSCI RES, V32, P290, DOI 10.1002/jnr.490320219; KERPPOLA TK, 1991, CELL, V66, P317, DOI 10.1016/0092-8674(91)90621-5; KONRADI C, 1993, P NATL ACAD SCI USA, V90, P7005, DOI 10.1073/pnas.90.15.7005; LAZAROFF M, 1995, J BIOL CHEM, V270, P21579, DOI 10.1074/jbc.270.37.21579; LEWIS EJ, 1987, P NATL ACAD SCI USA, V84, P3550, DOI 10.1073/pnas.84.11.3550; Lo LC, 1998, DEVELOPMENT, V125, P609; MacArthur L, 1996, J NEUROCHEM, V67, P2256; MAURER RA, 1989, J BIOL CHEM, V264, P6870; Messersmith DJ, 1996, MOL BRAIN RES, V40, P15; MEYER TE, 1993, ENDOCR REV, V14, P269, DOI 10.1210/er.14.3.269; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; NANKOVA B, 1993, J NEUROCHEM, V61, P776; NORRIS ML, 1995, J BIOL CHEM, V270, P23774, DOI 10.1074/jbc.270.40.23774; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Robert JJ, 1997, J NEUROCHEM, V68, P2152; SASSONECORSI P, 1988, GENE DEV, V2, P1529, DOI 10.1101/gad.2.12a.1529; SEASHOLTZ AF, 1988, MOL ENDOCRINOL, V2, P1311, DOI 10.1210/mend-2-12-1311; Serova LI, 1998, J NEUROCHEM, V70, P1935; SHASKUS J, 1992, J BIOL CHEM, V267, P18821; SURI C, 1993, J NEUROSCI, V13, P1280; Swanson DJ, 1997, J BIOL CHEM, V272, P27382, DOI 10.1074/jbc.272.43.27382; TRATNER I, 1992, MOL CELL BIOL, V12, P998, DOI 10.1128/MCB.12.3.998; VELCICH A, 1990, MOL CELL BIOL, V10, P6273, DOI 10.1128/MCB.10.12.6273; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; YOON JK, 1994, MOL CELL BIOL, V14, P7731, DOI 10.1128/MCB.14.12.7731; Youssoufian H, 1998, BIOTECHNIQUES, V24, P198, DOI 10.2144/98242bm05; Zellmer E, 1995, J NEUROSCI, V15, P8109	50	53	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24065	24074		10.1074/jbc.273.37.24065	http://dx.doi.org/10.1074/jbc.273.37.24065			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727025	hybrid			2022-12-27	WOS:000075893100066
J	Ganju, RK; Brubaker, SA; Meyer, J; Dutt, P; Yang, YM; Qin, SX; Newman, W; Groopman, JE				Ganju, RK; Brubaker, SA; Meyer, J; Dutt, P; Yang, YM; Qin, SX; Newman, W; Groopman, JE			The alpha-chemokine, stromal cell-derived factor-1 alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; NF-KAPPA-B; TYROSINE KINASE; HIV-1 ENTRY; PHOSPHATIDYLINOSITOL 3-KINASE; LYMPHOCYTE CHEMOATTRACTANT; HUMAN NEUTROPHILS; T-LYMPHOCYTES; CLONING; PHOSPHORYLATION	The alpha-chemokine stromal cell-derived factor (SDF)-1 alpha binds to the seven transmembrane G-protein-coupled CXCR-4 receptor and acts to modulate cell migration and proliferation. The signaling pathways that mediate the effects of SDF-1 alpha are not well. characterized. We studied events following SDF-1 alpha binding to CXCR-4 in a model murine pre-B cell line transfected with human CXCR-4. There was enhanced tyrosine phosphorylation and association of components of focal adhesion complexes such as the related adhesion focal tyrosine kinase, paxillin, and Crk. We also observed activation of phosphatidylinositol 3-kinase. Wortmannin, a selective inhibitor of phosphatidylinositol 3-kinase, partially in hibited the SDF-1 alpha-induced migration and tyrosine phosphorylation of paxillin. SDF-1 alpha treatment selectively activated p44/42 mitogen-activated protein kinase (Erk 1 and Erk 2) and its upstream kinase mitogen-activated protein kinase kinase but not p38 mitogen-activated protein kinase, c-Jun amino-terminal kinase or mitogen activated protein kinase kinase. We also observed that SDF-1 alpha treatment increased NF-kappa B activity in nuclear extracts from the CXCR-4 transfectants. Taken together, these studies revealed that SDF-1 alpha activates distinct signaling pathways that may mediate cell growth, migration, and transcriptional activation.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Expt Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA; LeukoSite Inc, Cambridge, MA 02142 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Groopman, JE (corresponding author), Harvard Univ, Inst Med, BIDMC, Div Expt Med, 4 Blackfan Circle, Boston, MA 02115 USA.	jgroopma@west.bidmc.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055187, R01HL053745] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 53745, HL 43510, HL 55187] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; AVRAHAM S, 1995, J BIOL CHEM, V270, P27742, DOI 10.1074/jbc.270.46.27742; Bacon KB, 1996, J EXP MED, V184, P873, DOI 10.1084/jem.184.3.873; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; BOKOCH GM, 1995, BLOOD, V86, P1649, DOI 10.1182/blood.V86.5.1649.bloodjournal8651649; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; Cowin P, 1996, CURR OPIN CELL BIOL, V8, P56, DOI 10.1016/S0955-0674(96)80049-4; Craig SW, 1996, CURR OPIN CELL BIOL, V8, P74, DOI 10.1016/S0955-0674(96)80051-2; Davis CB, 1997, J EXP MED, V186, P1793, DOI 10.1084/jem.186.10.1793; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Derman MP, 1996, J BIOL CHEM, V271, P4251; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Forster R, 1998, J IMMUNOL, V160, P1522; Ganju RK, 1997, J EXP MED, V185, P1055, DOI 10.1084/jem.185.6.1055; Ganju RK, 1998, BLOOD, V91, P791, DOI 10.1182/blood.V91.3.791.791_791_797; GERARD C, 1994, CURR OPIN IMMUNOL, V6, P140, DOI 10.1016/0952-7915(94)90045-0; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Heesen M, 1996, J IMMUNOL, V157, P5455; Hesselgesser J, 1998, J IMMUNOL, V160, P877; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; King WG, 1997, MOL CELL BIOL, V17, P4406, DOI 10.1128/MCB.17.8.4406; Knall C, 1996, J BIOL CHEM, V271, P2832, DOI 10.1074/jbc.271.5.2832; Knall C, 1997, P NATL ACAD SCI USA, V94, P3052, DOI 10.1073/pnas.94.7.3052; KUNDRA V, 1994, NATURE, V367, P474, DOI 10.1038/367474a0; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Li JZ, 1996, BLOOD, V88, P417, DOI 10.1182/blood.V88.2.417.bloodjournal882417; Liu ZY, 1997, BLOOD, V90, P2253, DOI 10.1182/blood.V90.6.2253.2253_2253_2259; LOETSCHER M, 1994, J BIOL CHEM, V269, P232; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Moore JP, 1997, CURR OPIN IMMUNOL, V9, P551, DOI 10.1016/S0952-7915(97)80110-0; Murakami T, 1997, J EXP MED, V186, P1389, DOI 10.1084/jem.186.8.1389; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; OLIVEIRA IC, 1994, MOL CELL BIOL, V14, P5300, DOI 10.1128/MCB.14.8.5300; Ponath PD, 1996, J EXP MED, V183, P2437, DOI 10.1084/jem.183.6.2437; Premack BA, 1996, NAT MED, V2, P1174, DOI 10.1038/nm1196-1174; Rankin S, 1996, J BIOL CHEM, V271, P7829, DOI 10.1074/jbc.271.13.7829; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; SALGIA R, 1995, J BIOL CHEM, V270, P29145, DOI 10.1074/jbc.270.49.29145; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Sanchez X, 1997, J BIOL CHEM, V272, P27529, DOI 10.1074/jbc.272.44.27529; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Taub D D, 1994, Ther Immunol, V1, P229; Thelen M, 1995, BIOCHEM BIOPH RES CO, V217, P1255, DOI 10.1006/bbrc.1995.2903; Tokiwa G, 1996, SCIENCE, V273, P792, DOI 10.1126/science.273.5276.792; Ueda H, 1997, J BIOL CHEM, V272, P24966, DOI 10.1074/jbc.272.40.24966; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wu LJ, 1996, J BIOL CHEM, V271, P31202, DOI 10.1074/jbc.271.49.31202; YAN MH, 1994, NATURE, V372, P798; YANG YM, 1993, CELL GROWTH DIFFER, V4, P595; Yi YJ, 1998, J VIROL, V72, P772, DOI 10.1128/JVI.72.1.772-777.1998	61	538	555	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23169	23175		10.1074/jbc.273.36.23169	http://dx.doi.org/10.1074/jbc.273.36.23169			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722546	hybrid			2022-12-27	WOS:000075778100046
J	Li, QD; Gardner, K; Zhang, LJ; Tsang, B; Bostick-Bruton, F; Reed, E				Li, QD; Gardner, K; Zhang, LJ; Tsang, B; Bostick-Bruton, F; Reed, E			Cisplatin induction of ERCC-1 mRNA expression in A2780/CP70 human ovarian cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA EXCISION-REPAIR; INTERSTRAND CROSS-LINKS; PROTEIN-KINASE PATHWAY; PIGMENTOSUM GROUP-F; C-JUN; HA-RAS; GENE-EXPRESSION; ACTIVATION DOMAIN; ADDUCT FORMATION; TUMOR-CELLS	ERCC-1 is a critical gene within the nucleotide excision repair pathway, and cells without a functional ERCC-1 do not perform cisplatin-DNA adduct repair. We therefore investigated the cisplatin effect on ERCC-1 mRNA expression in vitro. In response to a l-h cisplatin exposure, A2780/CP70 human ovarian cancer cells showed a B-fold increase in steady-state level of ERCC-1 mRNA This rise was attributable to increased transcription as measured by nuclear run-on assays and a 60% increase in ERCC-1 mRNA half-life. The increase in ERCC-1 mRNA was preceded by a 4-5-fold rise in mRNA expressions of c-fos and c-jun, a 14-fold increase in c-Jun protein phosphorylation, and an increase in in vitro nuclear extract binding activity to the AP-1-like site of ERCC-1, These data suggest that the induction of ERCC-1 expression in A2780/CP70 cells exposed to cisplatin results from two major factors: (a) an increase in the expression of transactivating factors that bind the AP-1-like site in the 5'-flanking region of ERCC-1 and (b) an increase in the level of c-Jun phosphorylation that enhances its transactivation property.	NCI, Med Ovarian Canc Sect, Dept Dev Therapeut, Med Branch,NIH, Bethesda, MD 20892 USA; NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; NCI, Mol Oncol Sect, Pediat Branch, Div Clin Sci,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Reed, E (corresponding author), NCI, Med Ovarian Canc Sect, Dept Dev Therapeut, Med Branch,NIH, Bldg 10,Rm 13N248,9000 Rockville Pike, Bethesda, MD 20892 USA.	reed92@helix.nih.gov						ABATE C, 1991, MOL CELL BIOL, V11, P3624, DOI 10.1128/MCB.11.7.3624; Aboussekhra A., 1996, Cellular Pharmacology, V3, P221; ADLER V, 1992, P NATL ACAD SCI USA, V89, P5341, DOI 10.1073/pnas.89.12.5341; BEHRENS BC, 1987, CANCER RES, V47, P414; Belasco J. G., 1993, CONTROL MESSENGER RN, P475; BIGGERSTAFF M, 1993, EMBO J, V12, P3685, DOI 10.1002/j.1460-2075.1993.tb06043.x; BINETRUY B, 1991, NATURE, V351, P122, DOI 10.1038/351122a0; CALSOU P, 1993, EUR J BIOCHEM, V211, P403, DOI 10.1111/j.1432-1033.1993.tb17563.x; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CHEN G, 1995, CELL BIOL TOXICOL, V11, P273, DOI 10.1007/BF00757625; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cooper G.M., 1995, ONCOGENES; Dabholkar M, 1996, Cancer Chemother Biol Response Modif, V16, P88; DABHOLKAR M, 1994, J CLIN INVEST, V94, P703, DOI 10.1172/JCI117388; DePooter CM, 1996, BIOCHEM PHARMACOL, V51, P629, DOI 10.1016/S0006-2952(95)02229-5; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Gosland M, 1996, PHARMACOTHERAPY, V16, P16; GOTTLICHER M, 1997, TRANSCRIPTION FACTOR, P67; HAMAGUCHI K, 1993, CANCER RES, V53, P5225; HILL BT, 1994, EUR J CANCER, V30A, P832, DOI 10.1016/0959-8049(94)90301-8; ISONISHI S, 1991, CANCER RES, V51, P5903; JOHNSON SW, 1994, CANCER RES, V54, P5911; JOHNSON SW, 1994, BIOCHEM PHARMACOL, V47, P689, DOI 10.1016/0006-2952(94)90132-5; JONES JC, 1991, J BIOL CHEM, V266, P7101; KASHANISABET M, 1990, EUR J CANCER, V26, P383, DOI 10.1016/0277-5379(90)90238-O; KASHANISABET M, 1990, J BIOL CHEM, V265, P11285; Kharbanda S, 1995, J BIOL CHEM, V270, P30278, DOI 10.1074/jbc.270.51.30278; LEE KB, 1993, CARCINOGENESIS, V14, P2177, DOI 10.1093/carcin/14.10.2177; LEE KB, 1995, CANCER LETT, V88, P57, DOI 10.1016/0304-3835(94)03626-T; LEPRE CA, 1990, NUCL ACIDS MOL BIOL, V4, P9, DOI [DOI 10.1007/978-3-642-84150-7-2, DOI 10.1007/978-3-642-84150-7]; LEWIN B, 1994, GENES, V5; Li Q., 1998, Proceedings of the American Association for Cancer Research Annual Meeting, V39, P241; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; MACGREGOR PF, 1990, ONCOGENE, V5, P451; MASUDA H, 1988, CANCER RES, V48, P5713; Moggs JG, 1996, J BIOL CHEM, V271, P7177, DOI 10.1074/jbc.271.12.7177; PARK CH, 1995, J BIOL CHEM, V270, P22657, DOI 10.1074/jbc.270.39.22657; PARKER RJ, 1991, J CLIN INVEST, V87, P772, DOI 10.1172/JCI115080; PETERS GJ, 1993, INT J CANCER, V54, P450, DOI 10.1002/ijc.2910540316; Potapova O, 1997, J BIOL CHEM, V272, P14041, DOI 10.1074/jbc.272.22.14041; Powers C, 1996, J BIOL CHEM, V271, P30089, DOI 10.1074/jbc.271.47.30089; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Rabo YB, 1996, INT J CANCER, V65, P821; RAJ NBK, 1983, P NATL ACAD SCI-BIOL, V80, P3923, DOI 10.1073/pnas.80.13.3923; REED E, 1996, CANC CHEMOTHERAPY BI, P357; REED E, 1993, CANC PRINCIPLES PRAC, P390; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANCAR A, 1994, SCIENCE, V266, P1954, DOI 10.1126/science.7801120; SCANLON KJ, 1989, ANTICANCER RES, V9, P1301; SCANLON KJ, 1991, PHARMACOL THERAPEUT, V52, P385, DOI 10.1016/0163-7258(91)90033-I; SKLAR MD, 1988, CANCER RES, V48, P793; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; TAVERNA P, 1994, CARCINOGENESIS, V15, P2053, DOI 10.1093/carcin/15.9.2053; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDAM H, 1993, EMBO J, V12, P479, DOI 10.1002/j.1460-2075.1993.tb05680.x; VANDUIN M, 1987, NUCLEIC ACIDS RES, V15, P9195, DOI 10.1093/nar/15.22.9195; VANDUIN M, 1986, CELL, V44, P913, DOI 10.1016/0092-8674(86)90014-0; VANVUUREN AJ, 1993, EMBO J, V12, P3693, DOI 10.1002/j.1460-2075.1993.tb06044.x; ZHEN WP, 1992, MOL CELL BIOL, V12, P3689, DOI 10.1128/MCB.12.9.3689; [No title captured]; [No title captured]	64	110	114	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23419	23425		10.1074/jbc.273.36.23419	http://dx.doi.org/10.1074/jbc.273.36.23419			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722577	hybrid			2022-12-27	WOS:000075778100077
J	Okajima, Y; Matsumura, I; Nishiura, T; Hashimoto, K; Yoshida, H; Ishikawa, J; Wakao, H; Yoshimura, A; Kanakura, Y; Tomiyama, Y; Matsuzawa, Y				Okajima, Y; Matsumura, I; Nishiura, T; Hashimoto, K; Yoshida, H; Ishikawa, J; Wakao, H; Yoshimura, A; Kanakura, Y; Tomiyama, Y; Matsuzawa, Y			Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; RECOMBINANT HUMAN THROMBOPOIETIN; MYELOBLASTIC-LEUKEMIA CELLS; ERYTHROID-DIFFERENTIATION; PROGENITOR CELLS; MESSENGER-RNA; RECEPTOR; ACTIVATION; TRANSCRIPTION; INTERLEUKIN-3	Insulin-like growth factor (IGF-I) is known to synergistically stimulate the proliferation of hematopoietic cells in combination with other hematopoietic growth factors. However, the precise mechanism underlying the cooperative effects of IGF-I is unknown. In a human interleukin-3 or erythropoietin (EPO)-dependent cell line, F-36P, IGF-I alone failed to stimulate DNA synthesis but did augment the EPO dependent DNA synthesis of F-36P cells. The treatment of F-36P cells with a combination of EPO and IGF-I (EPO/IGF-I) was found to enhance EPO-induced tyrosine phosphorylation of STATE, whereas IGF-I alone did not. Furthermore, c-CIS mRNA expression, one of the target molecules of STATE, was more effectively induced by EPO/IGF-I than by EPO alone. To examine the mechanisms of the EPO- and EPO/ IGF-I-induced proliferation of F-36P cells, we expressed dominant negative (dn) mutants of STATE and Ras in an inducible system. The EPO-induced DNA synthesis and the cooperative effect of EPO/IGF-I were significantly inhibited by the inducible expression of dn-STAT5 or dn-Ras. In addition, the inducible expression of dn-Ras abolished the IGF-I-enhanced tyrosine phosphorylation of STATE. These results suggest that IGF-I may augment EPO-induced proliferation by enhancing tyrosine phosphorylation of STATE and raise the possibility that Ras may be involved in the augmentation of STATE tyrosyl phosphorylation.	Osaka Univ, Sch Med, Dept Internal Med 2, Osaka 5650871, Japan; Osaka Univ, Sch Med, Dept Hematol & Oncol, Osaka 5650871, Japan; Helix Res Inst, Kisarazu, Chiba, Japan; Inst Life Sci, Kurume, Fukuoka 839, Japan	Osaka University; Osaka University	Nishiura, T (corresponding author), Osaka Univ, Sch Med, Dept Internal Med 2, 2-2 Yamada Oka, Osaka 5650871, Japan.		Yoshimura, Akihiko/K-5515-2013; WAKAO, Hiroshi/A-4242-2012	Tomiyama, Yoshiaki/0000-0001-7645-0989				AKAHANE K, 1987, EXP HEMATOL, V15, P797; AZAM M, 1995, EMBO J, V14, P1402, DOI 10.1002/j.1460-2075.1995.tb07126.x; BASERGA R, 1995, CANCER RES, V55, P249; BOYER SH, 1992, BLOOD, V80, P2503; Ceresa BP, 1996, J BIOL CHEM, V271, P12121, DOI 10.1074/jbc.271.21.12121; Chen J, 1997, P NATL ACAD SCI USA, V94, P2295, DOI 10.1073/pnas.94.6.2295; CHIBA S, 1991, BLOOD, V78, P2261; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; CHIOU ST, 1992, BIOCHEM BIOPH RES CO, V183, P524, DOI 10.1016/0006-291X(92)90513-K; Chretien S, 1996, EMBO J, V15, P4174, DOI 10.1002/j.1460-2075.1996.tb00792.x; CORREA PN, 1991, BLOOD, V78, P2823; CREWS CM, 1993, CELL, V74, P215, DOI 10.1016/0092-8674(93)90411-I; Feldman GM, 1997, BLOOD, V90, P1768, DOI 10.1182/blood.V90.5.1768; FUJII H, 1995, P NATL ACAD SCI USA, V92, P5482, DOI 10.1073/pnas.92.12.5482; Fujitani Y, 1997, ONCOGENE, V14, P751, DOI 10.1038/sj.onc.1200907; FURLANETTO RW, 1994, MOL ENDOCRINOL, V8, P510, DOI 10.1210/me.8.4.510; GIBSON LF, 1993, BLOOD, V82, P3005; GOLDRING M B, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P301; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; Hoefsloot LH, 1997, BLOOD, V89, P1690, DOI 10.1182/blood.V89.5.1690.1690_1690_1700; HUMBEL RE, 1990, EUR J BIOCHEM, V190, P445, DOI 10.1111/j.1432-1033.1990.tb15595.x; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Iwatsuki K, 1997, J BIOL CHEM, V272, P8149, DOI 10.1074/jbc.272.13.8149; KRANTZ SB, 1991, BLOOD, V77, P419; LANDRETH KS, 1992, BLOOD, V80, P1207; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Matsumura I, 1996, BLOOD, V88, P3074, DOI 10.1182/blood.V88.8.3074.bloodjournal8883074; MATSUMURA I, 1995, BLOOD, V86, P703, DOI 10.1182/blood.V86.2.703.bloodjournal862703; MERCHAV S, 1988, J CLIN INVEST, V81, P791, DOI 10.1172/JCI113385; Miyakawa Y, 1996, BLOOD, V87, P439, DOI 10.1182/blood.V87.2.439.bloodjournal872439; MUI ALF, 1995, J LEUKOCYTE BIOL, V57, P799, DOI 10.1002/jlb.57.5.799; MULI AL, 1996, EMBO J, V15, P2425; MUTA K, 1994, J CLIN INVEST, V94, P34, DOI 10.1172/JCI117327; NAKAJIMA K, 1993, MOL CELL BIOL, V13, P3027, DOI 10.1128/MCB.13.5.3027; Quelle FW, 1996, MOL CELL BIOL, V16, P1622; SANDERS M, 1993, EXP HEMATOL, V21, P25; Shuai K, 1996, MOL CELL BIOL, V16, P4932; SUGAHARA H, 1994, J EXP MED, V179, P1757, DOI 10.1084/jem.179.6.1757; SURMACZ E, 1992, EXP CELL RES, V199, P275, DOI 10.1016/0014-4827(92)90435-B; TERADA K, 1995, J BIOL CHEM, V270, P27880, DOI 10.1074/jbc.270.46.27880; Vignais ML, 1996, MOL CELL BIOL, V16, P1759; Wakao H, 1997, BIOCHEM BIOPH RES CO, V234, P198, DOI 10.1006/bbrc.1997.6486; WAKAO H, 1995, EMBO J, V14, P2527, DOI 10.1002/j.1460-2075.1995.tb07250.x; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; WEILAND M, 1991, J CELL PHYSIOL, V149, P428, DOI 10.1002/jcp.1041490311; WHITE MF, 1994, J BIOL CHEM, V269, P1; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; ZHOU LF, 1997, ONCOGENE, V15, P961	51	27	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					22877	22883		10.1074/jbc.273.36.22877	http://dx.doi.org/10.1074/jbc.273.36.22877			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722506	hybrid			2022-12-27	WOS:000075778100006
J	Carreira, CM; LaVallee, TM; Tarantini, F; Jackson, A; Lathrop, JT; Hampton, B; Burgess, WH; Maciag, T				Carreira, CM; LaVallee, TM; Tarantini, F; Jackson, A; Lathrop, JT; Hampton, B; Burgess, WH; Maciag, T			S100A13 is involved in the regulation of fibroblast growth factor-1 and p40 synaptotagmin-1 release in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEINS; FACTOR-I; ANTIALLERGIC AGENT; ANNEXIN-II; SUBCELLULAR-DISTRIBUTION; PHOSPHOLIPID-BINDING; STRUCTURAL-ANALYSIS; CYSTEINE RESIDUES; NEURITE EXTENSION; SEQUENCE HOMOLOGY	We have previously characterized the release of the signal peptide sequence-less fibroblast growth factor (FGF) prototype, FGF-1, in vitro as a stress-induced pathway in which FGF-1 is released as a latent homodimer with the p40 extravesicular domain of p65 synaptotagmin (Syn)-1. To determine the biologic relevance of the FGF-1 release pathway in vivo, we sought to resolve and characterize fi om ovine brain a purified fraction that contained both FGF-1 and p40 Syn-1 and report that the brain-derived FGF-1:p40 Syn-1 aggregate is associated with the calcium-binding protein, S100A13, Since S100A13 binds the anti-inflammatory compound amlexanox and FGF-1 is involved in inflammation, we examined the effects of amlexanox on the release of FGF-1 and p40 Syn-1 in response to stress in vitro. We report that while amlexanox was able to repress the heat shock-induced release of FGF-1 and p40 Syn-1 in a concentration-dependent manner, it had no effect on the constitutive release of p40 Syn-1 from p40 Syn-1 NIH 3T3 cell transfectants. These data suggest the following: (i) FGF-1 is associated with Syn-1 and S100A13 in vivo; (ii) S100A13 may be involved in the regulation of FGF-1 and p40 Syn-1 release in response to temperature stress in vitro; and (iii) the FGF-1 release pathway may be accessible to pharmacologic regulation.	Maine Med Ctr, Res Inst, Ctr Mol Med, S Portland, ME 04106 USA; Amer Red Cross, Holland Lab, Dept Mol Biol, Rockville, MD 20855 USA	Maine Medical Center; American Red Cross	Maciag, T (corresponding author), Maine Med Ctr, Res Inst, Ctr Mol Med, 125 John Roberts Rd, S Portland, ME 04106 USA.	maciat@mail.mmc.org	Tarantini, Francesca/I-6332-2012; Hampton, Brian/G-8427-2015	Hampton, Brian/0000-0003-4650-2869; TARANTINI, FRANCESCA/0000-0002-1390-2965	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035627, P01HL054710, R01HL032348] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL32348, HL35627, HL54710] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BENNETT MK, 1993, J NEUROSCI, V13, P1701; Bergmeyer H.U., 1965, METHODS ENZYMATIC AN, P736, DOI [10.1016/b978-0-12-395630-9.50134-1, DOI 10.1016/B978-0-12-395630-9.50134-1]; BERMAN BA, 1983, CLIN REV ALLERG, V1, P105; Burgess W. H., 1996, P154; BURGESS WH, 1985, J BIOL CHEM, V260, P1389; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; COCHRAN AJ, 1993, MELANOMA RES, V3, P325, DOI 10.1097/00008390-199310000-00004; CREUTZ CE, 1992, SCIENCE, V258, P924, DOI 10.1126/science.1439804; CROMPTON MR, 1988, CELL, V55, P1, DOI 10.1016/0092-8674(88)90002-5; DAMON DH, 1989, J CELL PHYSIOL, V138, P221, DOI 10.1002/jcp.1041380202; DAVIES BR, 1993, ONCOGENE, V8, P999; DINARELLO CA, 1991, CURR OPIN IMMUNOL, V3, P941, DOI 10.1016/S0952-7915(05)80018-4; DONATO R, 1991, CELL CALCIUM, V12, P713, DOI 10.1016/0143-4160(91)90040-L; DONATO R, 1986, CELL CALCIUM, V7, P123, DOI 10.1016/0143-4160(86)90017-5; DONATO R, 1990, ADV EXP MED BIOL, V269, P103; Donnelly SR, 1997, CELL MOL LIFE SCI, V53, P533, DOI 10.1007/s000180050068; EGERTON M, 1992, J IMMUNOL, V149, P1847; ENGLEKA KA, 1992, J BIOL CHEM, V267, P11307; FANO G, 1995, PROG NEUROBIOL, V46, P71, DOI 10.1016/0301-0082(94)00062-M; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Folkman J, 1992, Semin Cancer Biol, V3, P65; FOROUGH R, 1993, J BIOL CHEM, V268, P2960; FRIESEL RE, 1995, FASEB J, V9, P919, DOI 10.1096/fasebj.9.10.7542215; GLENNEY JR, 1989, J CELL BIOL, V108, P569, DOI 10.1083/jcb.108.2.569; GOLDFARB AR, 1951, J BIOL CHEM, V193, P397; GOSPODAROWICZ D, 1986, J CELL PHYSIOL, V128, P475, DOI 10.1002/jcp.1041280317; HAJJAR KA, 1994, J BIOL CHEM, V269, P21191; HARDER T, 1993, J CELL BIOL, V123, P1119, DOI 10.1083/jcb.123.5.1119; HEIZMAN CW, 1995, CALCIUM REGULATION C; Ilg EC, 1996, INT J CANCER, V68, P325, DOI 10.1002/(SICI)1097-0215(19961104)68:3<325::AID-IJC10>3.0.CO;2-7; JACKSON A, 1995, J BIOL CHEM, V270, P33, DOI 10.1074/jbc.270.1.33; JACKSON A, 1992, P NATL ACAD SCI USA, V89, P10691, DOI 10.1073/pnas.89.22.10691; JOHNSSON N, 1990, PROG CLIN BIOL RES, V349, P123; KAHN HJ, 1983, AM J CLIN PATHOL, V79, P341, DOI 10.1093/ajcp/79.3.341; KLEE CB, 1988, BIOCHEMISTRY-US, V27, P6645, DOI 10.1021/bi00418a001; KLIGMAN D, 1988, TRENDS BIOCHEM SCI, V13, P437, DOI 10.1016/0968-0004(88)90218-6; KLIGMAN D, 1985, P NATL ACAD SCI USA, V82, P7136, DOI 10.1073/pnas.82.20.7136; LACKMANN M, 1992, J BIOL CHEM, V267, P7499; LaVallee TM, 1998, J BIOL CHEM, V273, P22217, DOI 10.1074/jbc.273.35.22217; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; MACIAG T, 1979, P NATL ACAD SCI USA, V76, P5674, DOI 10.1073/pnas.76.11.5674; MACIAG T, 1982, J BIOL CHEM, V257, P5333; MAKINO H, 1987, INT ARCH ALLER A IMM, V82, P66, DOI 10.1159/000234292; MERGIA A, 1989, BIOCHEM BIOPH RES CO, V164, P1121, DOI 10.1016/0006-291X(89)91785-3; NAKA M, 1994, BBA-MOL CELL RES, V1223, P348, DOI 10.1016/0167-4889(94)90094-9; NISHIKI T, 1994, J BIOL CHEM, V269, P10498; Oyama Y, 1997, BIOCHEM BIOPH RES CO, V240, P341, DOI 10.1006/bbrc.1997.7476; PERIN MS, 1991, J BIOL CHEM, V266, P623; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Rammes A, 1997, J BIOL CHEM, V272, P9496; SAIJO T, 1985, INT ARCH ALLER A IMM, V78, P43, DOI 10.1159/000233861; SAIJO T, 1985, INT ARCH ALLER A IMM, V77, P315, DOI 10.1159/000233837; SAIJO T, 1986, INT ARCH ALLER A IMM, V79, P231, DOI 10.1159/000233978; SANO H, 1990, J CELL BIOL, V110, P1417, DOI 10.1083/jcb.110.4.1417; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; SCHAFER BW, 1995, GENOMICS, V25, P638, DOI 10.1016/0888-7543(95)80005-7; SELINFREUND RH, 1991, P NATL ACAD SCI USA, V88, P3554, DOI 10.1073/pnas.88.9.3554; SHAPIRO GG, 1985, PHARMACOTHERAPY, V5, P156; Shi JP, 1997, J BIOL CHEM, V272, P1142, DOI 10.1074/jbc.272.2.1142; TAGENAKA K, 1994, J CELL BIOL, V124, P757; TAGENAKA K, 1994, JPN J CANCER RES, V85, P831; TAGENAKA K, 1997, ONCOGENE, V14, P331; Tarantini F, 1998, J BIOL CHEM, V273, P22209, DOI 10.1074/jbc.273.35.22209; TARANTINI F, 1995, J BIOL CHEM, V270, P29039, DOI 10.1074/jbc.270.49.29039; THOMAS KA, 1985, P NATL ACAD SCI USA, V82, P6409, DOI 10.1073/pnas.82.19.6409; THOMAS KA, 1986, TRENDS BIOCHEM SCI, V11, P81, DOI 10.1016/0968-0004(86)90271-9; WAISMAN DM, 1995, MOL CELL BIOCHEM, V149, P301, DOI 10.1007/BF01076592; WATANABE M, 1993, BIOCHEM BIOPH RES CO, V196, P1376, DOI 10.1006/bbrc.1993.2405; WETLAUFER DB, 1962, ADV PROTEIN CHEM, V17, P303; Wicki R, 1996, BIOCHEM BIOPH RES CO, V227, P594, DOI 10.1006/bbrc.1996.1551; WINNINGHAMMAJOR F, 1989, J CELL BIOL, V109, P3063, DOI 10.1083/jcb.109.6.3063; ZENG FY, 1993, INT J BIOCHEM, V25, P1019, DOI 10.1016/0020-711X(93)90116-V; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1; ZHU X, 1991, SCIENCE, V251, P90, DOI 10.1126/science.1702556; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	75	99	99	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22224	22231		10.1074/jbc.273.35.22224	http://dx.doi.org/10.1074/jbc.273.35.22224			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712836	hybrid			2022-12-27	WOS:000075616600012
J	Lovric, J; Dammeier, S; Kieser, A; Mischak, H; Kolch, W				Lovric, J; Dammeier, S; Kieser, A; Mischak, H; Kolch, W			Activated Raf induces the hyperphosphorylation of stathmin and the reorganization of the microtubule network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; MAP KINASE KINASE; CELL-CYCLE ARREST; MAJOR CYTOSOLIC TARGET; PROTEIN-KINASE; DNA-SYNTHESIS; IN-VITRO; REGULATED PHOSPHORYLATION; MULTISITE PHOSPHORYLATION; TUBULIN POLYMERIZATION	Raf kinases are regulators of cellular proliferation, transformation, differentiation, and apoptosis. To identify downstream targets of Raf-1 in vivo, we used NIR 3T3 fibroblasts expressing a Raf-1 kinase domain-estrogen receptor fusion protein (BXB-ER), whose activity can be acutely regulated by estrogen, Proteins differentially phosphorylated 20 min after BXB-ER activation in Living cells were displayed by two-dimensional electrophoresis. The protein with the most prominent newly induced phosphorylation was identified as stathmin, a phosphorylation-sensitive regulator of microtubule dynamics. Stathmin is rapidly phosphorylated on two ERK phosphorylation sites (serines 25 and 38) upon BXB-ER activation. The mitogen-activated protein kinase/extracellular signal-regulated kinase-kinase (MEK) inhibitor PD98059 abolished this phosphorylation, demonstrating that stathmin is targeted by BXB-ER via the MEK/ERK pathway. Prolonged BXB-ER activation resulted in the accumulation of a stathmin phosphoisomer with impaired microtubule-destabilizing activity. The appearance of this phosphoisomer after BXB-ER activation correlated with rearrangements in the microtubule network, resulting in the formation of long bundled microtubules extending toward the rim of the cells. Our results identify stathmin as a main target of the Raf/MEK/ERK kinase cascade in vivo and strongly suggest that ERK-mediated stathmin phosphorylation plays an important role for the microtubule reorganization induced by acute activation of Raf-1.	GSF Munich, Inst Klin Mol Biol & Tumorgenet, D-81377 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Lovric, J (corresponding author), GSF Munich, Inst Klin Mol Biol & Tumorgenet, Marchioninistr 25, D-81377 Munich, Germany.	Lovric@gsf.de	Admin, SBI/HGB-2738-2022; Kolch, Walter/ABF-2102-2021; Kieser, Arnd/M-4616-2014; Mischak, Harald/E-8685-2011	Kieser, Arnd/0000-0003-0783-1950; Mischak, Harald/0000-0003-0323-0306; Kolch, Walter/0000-0001-5777-5016; Lovric, Josip/0000-0002-0338-6581				ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; BALL RL, 1992, CELL MOTIL CYTOSKEL, V23, P265, DOI 10.1002/cm.970230406; Belmont L, 1996, TRENDS BIOCHEM SCI, V21, P197, DOI 10.1016/S0968-0004(96)80013-2; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BERETTA L, 1993, J BIOL CHEM, V268, P20076; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1357, DOI 10.1002/elps.11501401209; BOCKUS BJ, 1984, EXP CELL RES, V153, P186, DOI 10.1016/0014-4827(84)90460-9; BRATTSAND G, 1994, EUR J BIOCHEM, V220, P359, DOI 10.1111/j.1432-1033.1994.tb18632.x; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; BRUNET A, 1994, ONCOGENE, V9, P3379; COBB MH, 1994, CELL MOL BIOL RES, V40, P253; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; CREWS CM, 1992, CELL GROWTH DIFFER, V3, P135; CROSSIN KL, 1981, CELL, V23, P61, DOI 10.1016/0092-8674(81)90270-1; CROSSIN KL, 1981, CELL, V27, P341, DOI 10.1016/0092-8674(81)90417-7; Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; GALLEGO C, 1992, P NATL ACAD SCI USA, V89, P7355, DOI 10.1073/pnas.89.16.7355; GARDNER AM, 1993, J BIOL CHEM, V268, P17896; GOODNIGHT J, 1995, J BIOL CHEM, V270, P9991, DOI 10.1074/jbc.270.17.9991; GORG A, 1988, ELECTROPHORESIS, V9, P681, DOI 10.1002/elps.1150091103; Gradin HM, 1998, J CELL BIOL, V140, P131, DOI 10.1083/jcb.140.1.131; Gradin HM, 1997, MOL CELL BIOL, V17, P3459, DOI 10.1128/MCB.17.6.3459; HAFNER S, 1994, MOL CELL BIOL, V14, P6696; HEIDECKER G, 1990, MOL CELL BIOL, V10, P2503, DOI 10.1128/MCB.10.6.2503; HIROKAWA N, 1994, CURR OPIN CELL BIOL, V6, P74, DOI 10.1016/0955-0674(94)90119-8; Horwitz SB, 1997, J BIOL CHEM, V272, P8129, DOI 10.1074/jbc.272.13.8129; Joshi HC, 1998, CURR OPIN CELL BIOL, V10, P35, DOI 10.1016/S0955-0674(98)80084-7; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; KOLCH W, 1990, ONCOGENE, V5, P713; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; KOPPEL J, 1990, J BIOL CHEM, V265, P3703; KORTENJANN M, 1994, MOL CELL BIOL, V14, P4815, DOI 10.1128/MCB.14.7.4815; Kuo WL, 1996, MOL CELL BIOL, V16, P1458; LAIRD AD, 1995, J BIOL CHEM, V270, P26742, DOI 10.1074/jbc.270.45.26742; LARSSON N, 1995, J BIOL CHEM, V270, P14175, DOI 10.1074/jbc.270.23.14175; Larsson N, 1997, MOL CELL BIOL, V17, P5530, DOI 10.1128/MCB.17.9.5530; LEIGHTON IA, 1993, MOL CELL BIOCHEM, V128, P151, DOI 10.1007/BF01076766; Lovric J, 1996, ONCOGENE, V12, P1109; LUO XN, 1994, J BIOL CHEM, V269, P10312; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MARKLUND U, 1993, J BIOL CHEM, V268, P15039; MARKLUND U, 1994, J BIOL CHEM, V269, P30626; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; MARKLUND U, 1994, EUR J BIOCHEM, V225, P53, DOI 10.1111/j.1432-1033.1994.00053.x; McNally FJ, 1996, CURR OPIN CELL BIOL, V8, P23, DOI 10.1016/S0955-0674(96)80044-5; NGUYEN DN, 1995, J CHROMATOGR A, V705, P21, DOI 10.1016/0021-9673(94)01256-E; Pumiglia KM, 1997, P NATL ACAD SCI USA, V94, P448, DOI 10.1073/pnas.94.2.448; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; RESZKA AA, 1995, P NATL ACAD SCI USA, V92, P8881, DOI 10.1073/pnas.92.19.8881; ROBINSON JM, 1995, J CELL SCI, V108, P645; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; SAMUELS ML, 1994, MOL CELL BIOL, V14, P7855, DOI 10.1128/MCB.14.12.7855; SAMUELS ML, 1993, MOL CELL BIOL, V13, P6241, DOI 10.1128/MCB.13.10.6241; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; SHAW JP, 1988, J BIOL CHEM, V263, P1459; SIUZDAK G, 1994, P NATL ACAD SCI USA, V91, P11290, DOI 10.1073/pnas.91.24.11290; THYBERG J, 1984, EXP CELL RES, V155, P1, DOI 10.1016/0014-4827(84)90761-4; Weissinger EM, 1997, MOL CELL BIOL, V17, P3229, DOI 10.1128/MCB.17.6.3229; Weyman CM, 1997, ONCOGENE, V14, P697, DOI 10.1038/sj.onc.1200874; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598	62	46	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22848	22855						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712920				2022-12-27	WOS:000075616600096
J	Rajagopalan, PTR; Pei, D				Rajagopalan, PTR; Pei, D			Oxygen-mediated inactivation of peptide deformylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; METHIONYL-TRNA(F)(MET) FORMYLTRANSFERASE; TRANSLATION; ENZYMES	Peptide deformylase catalyzes the removal of the N-formyl group from newly synthesized polypeptides in prokaryotes. Its essential character and unique presence in prokaryotes make it an attractive target for antibacterial chemotherapy, However, purification and characterization of the peptide deformylase have remained a major challenge because this enzyme is extraordinarily labile under a variety of conditions (t(1/2) similar to 1 min at room temperature). In this work, we show that this unusual instability is because of oxidation of the catalytic Fe2+ ion of the deformylase into catalytically inactive Fe3+ ion by atmospheric oxygen. Oxidation of Fe2+ is accompanied by the conversion of O-2 into a yet unidentified reactive species, which covalently modifies the deformylase protein, most likely by oxidizing cysteine-90, a ligand residue of the Fe2+ ion, into a cysteine sulfonic acid. Enzymatic exclusion of O-2 from the deformylase assays renders the deformylase highly stable under otherwise identical conditions. An improved, readily reproducible purification procedure has been developed that produces approximately 10 mg of pure, fully active Fe2+ deformylase from a liter of cells. In addition, active peptide deformylase can be reconstituted in vitro from the denatured deformylase.	Ohio State Univ, Dept Chem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Pei, D (corresponding author), Ohio State Univ, Dept Chem, 100 W 18th Ave, Columbus, OH 43210 USA.		Pei, Dehua/P-4594-2016	Pei, Dehua/0000-0002-2057-6934	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040575] Funding Source: NIH RePORTER; NIAID NIH HHS [AI40575] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADAMS JM, 1968, J MOL BIOL, V33, P571, DOI 10.1016/0022-2836(68)90307-0; Becker A, 1998, J BIOL CHEM, V273, P11413, DOI 10.1074/jbc.273.19.11413; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan MK, 1997, BIOCHEMISTRY-US, V36, P13904, DOI 10.1021/bi9711543; ENGLANDER SW, 1987, ANAL BIOCHEM, V161, P300, DOI 10.1016/0003-2697(87)90454-4; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; KOZAK M, 1983, MICROBIOL REV, V47, P1; Larisch B, 1997, BIOORG MED CHEM LETT, V7, P2681, DOI 10.1016/S0960-894X(97)10056-7; LIVINGSTON DM, 1968, BIOCHEMISTRY-US, V8, P435; MAZEL D, 1994, EMBO J, V13, P914, DOI 10.1002/j.1460-2075.1994.tb06335.x; Meinnel T, 1996, J MOL BIOL, V262, P375, DOI 10.1006/jmbi.1996.0521; MEINNEL T, 1993, BIOCHIMIE, V75, P1061, DOI 10.1016/0300-9084(93)90005-D; MEINNEL T, 1994, J BACTERIOL, V176, P7387, DOI 10.1128/JB.176.23.7387-7390.1994; MEINNEL T, 1993, J BACTERIOL, V175, P7737, DOI 10.1128/JB.175.23.7737-7740.1993; Que L, 1996, CHEM REV, V96, P2607, DOI 10.1021/cr960039f; Rajagopalan PTR, 1997, BIOCHEMISTRY-US, V36, P13910, DOI 10.1021/bi971155v; Rajagopalan PTR, 1997, J AM CHEM SOC, V119, P12418, DOI 10.1021/ja9734096; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; STRYER L, 1981, BIOCHEMISTRY-US, P43; TAKEDA M, 1968, P NATL ACAD SCI USA, V60, P1487, DOI 10.1073/pnas.60.4.1487; Tsujimura M, 1997, J BIOL CHEM, V272, P29454, DOI 10.1074/jbc.272.47.29454; VOGEL AI, 1961, TXB QUANTITATIVE INO, P785; Wei YM, 1997, ANAL BIOCHEM, V250, P29, DOI 10.1006/abio.1997.2194; YAMAGUCHI K, 1987, METHOD ENZYMOL, V143, P395	24	80	83	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22305	22310		10.1074/jbc.273.35.22305	http://dx.doi.org/10.1074/jbc.273.35.22305			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712848	hybrid			2022-12-27	WOS:000075616600024
J	Stuart, JK; Myszka, DG; Joss, L; Mitchell, RS; McDonald, SM; Xie, ZH; Takayama, S; Reed, JC; Ely, KR				Stuart, JK; Myszka, DG; Joss, L; Mitchell, RS; McDonald, SM; Xie, ZH; Takayama, S; Reed, JC; Ely, KR			Characterization of interactions between the anti-apoptotic protein BAG-1 and Hsc70 molecular chaperones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENTS; NUCLEOTIDE-EXCHANGE FACTOR; HEAT-SHOCK PROTEINS; PEPTIDE-BINDING; SECONDARY STRUCTURE; UNFOLDED PROTEINS; SELF-ASSOCIATION; ATPASE ACTIVITY; CELL-DEATH; CLONING	The anti-cell death protein BAG-1 binds to 70-kDa heat shock proteins (Hsp70/Hsc70) and modulates their chaperone activity. Among other facilitory roles, BAG-1 may serve as a nucleotide exchange factor for Hsp10/Hsc70 family proteins and thus represents the first example of a eukaryotic homologue of the bacterial co-chaperone GrpE. In this study, the interactions between BAG-1 and Hsc70 are characterized and compared with the analogous GrpE-DnaK bacterial system. In contrast to GrpE, which binds DnaK as a dimer, BAG-1 binds to Hsc70 as a monomer with a 1:1 stoichiometry. Dynamic light scattering, sedimentation equilibrium, and circular dichroism measurements provided evidence that BAG-1 exists as an elongated, highly helical monomer in solution. Isothermal titration microcalorimetry was used to determine the complex stoichiometry and an equilibrium dissociation constant, K-D, of 100 nM. Kinetic analysis using surface plasmon resonance yielded a K-D consistent with the calorimetrically determined value. Molecular modeling permitted a comparison of structural features between the functionally homologous BAG-1 and GrpE proteins. These data were used to propose a mechanism for BAG-1 in the regulation of Hsp70/Hsc70 chaperone activity.	Burnham Inst, Canc Res Ctr, La Jolla, CA 92037 USA; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Sanford Burnham Prebys Medical Discovery Institute; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Ely, KR (corresponding author), Burnham Inst, Canc Res Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ely@burnham-inst.org			NATIONAL CANCER INSTITUTE [R01CA067329] Funding Source: NIH RePORTER; NCI NIH HHS [CA-67329] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bardelli A, 1996, EMBO J, V15, P6205, DOI 10.1002/j.1460-2075.1996.tb01009.x; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Benaroudj N, 1996, J BIOL CHEM, V271, P18471, DOI 10.1074/jbc.271.31.18471; Benaroudj N, 1997, J BIOL CHEM, V272, P8744, DOI 10.1074/jbc.272.13.8744; Cantor C. R., 1980, BIOPHYSICAL CHEM 2, P560; CHAPPELL TG, 1987, J BIOL CHEM, V262, P746; COOK WJ, 1992, J BIOL CHEM, V267, P16467; Doyle ML, 1997, CURR OPIN BIOTECH, V8, P31, DOI 10.1016/S0958-1669(97)80154-1; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; FERREDAMARE AR, 1994, STRUCTURE, V2, P357, DOI 10.1016/S0969-2126(00)00037-X; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; FREEMAN BC, 1995, EMBO J, V14, P2281, DOI 10.1002/j.1460-2075.1995.tb07222.x; Froesch BA, 1998, J BIOL CHEM, V273, P11660, DOI 10.1074/jbc.273.19.11660; Fung KL, 1996, J BIOL CHEM, V271, P21559, DOI 10.1074/jbc.271.35.21559; Gebauer M, 1997, FEBS LETT, V417, P109, DOI 10.1016/S0014-5793(97)01267-2; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Greenfield NJ, 1996, ANAL BIOCHEM, V235, P1, DOI 10.1006/abio.1996.0084; HA JH, 1995, BIOCHEMISTRY-US, V34, P11635, DOI 10.1021/bi00036a040; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; HOHFELD J, 1995, CELL, V83, P589; Hohfeld J, 1997, EMBO J, V16, P6209, DOI 10.1093/emboj/16.20.6209; Hu SM, 1996, ARCH BIOCHEM BIOPHYS, V332, P163, DOI 10.1006/abbi.1996.0328; Irmer H, 1997, J BIOL CHEM, V272, P2230; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; Karlsson Robert, 1994, Methods (Orlando), V6, P99, DOI 10.1006/meth.1994.1013; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Liu R, 1998, J BIOL CHEM, V273, P16985, DOI 10.1074/jbc.273.27.16985; MacColl R, 1996, J BIOL CHEM, V271, P17157, DOI 10.1074/jbc.271.29.17157; MORIMOTO RI, 1994, BIOL HEAT SHOCK PROT; MORTON TA, 1998, IN PRESS METHODS ENZ, V295; Myszka DG, 1997, CURR OPIN BIOTECH, V8, P50, DOI 10.1016/S0958-1669(97)80157-7; Naylor DJ, 1996, FEBS LETT, V396, P181, DOI 10.1016/0014-5793(96)01100-3; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Packham G, 1997, BIOCHEM J, V328, P807, DOI 10.1042/bj3280807; PALLEROS DR, 1991, P NATL ACAD SCI USA, V88, P5719, DOI 10.1073/pnas.88.13.5719; Prapapanich V, 1996, MOL ENDOCRINOL, V10, P420, DOI 10.1210/me.10.4.420; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Takayama S, 1996, GENOMICS, V35, P494, DOI 10.1006/geno.1996.0389; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; Wang HG, 1996, P NATL ACAD SCI USA, V93, P7063, DOI 10.1073/pnas.93.14.7063; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Zeiner M, 1997, EMBO J, V16, P5483, DOI 10.1093/emboj/16.18.5483; ZEINER M, 1995, P NATL ACAD SCI USA, V92, P11465, DOI 10.1073/pnas.92.25.11465; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	53	96	97	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22506	22514		10.1074/jbc.273.35.22506	http://dx.doi.org/10.1074/jbc.273.35.22506			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712876	hybrid			2022-12-27	WOS:000075616600052
J	Morelon, E; Dautry-Varsat, A				Morelon, E; Dautry-Varsat, A			Endocytosis of the common cytokine receptor gamma(c) chain - Identification of sequences involved in internalization and degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; TYROSINE KINASE-ACTIVITY; HUMAN T-LYMPHOCYTES; JAK-3 JANUS KINASE; BETA-CHAIN; IL-2 RECEPTOR; DOWN-REGULATION; INTERLEUKIN-2 RECEPTORS; CYTOPLASMIC DOMAIN; FUNCTIONAL COMPONENT	The common cytokine receptor gamma(c), shared by interleukin 2, 4, 7, 9, and 15 receptors, has a major role in lymphocyte proliferation and differentiation, leading, when mutated, to a genetic disease, X-linked severe combined immunodeficiency. In this study, we report that gamma(c) is internalized and degraded in lymphoid cells. To identify gamma(c) regions involved in sorting along the endocytic pathway, we have studied a chimeric protein composed of the extracellular part of interleukin 2-receptor alpha and transmembrane and intracellular part of gamma(c) alpha gamma gamma(wt). When transfected in Jurkat T cells, alpha gamma gamma(wt) is as efficiently internalized and degraded as gamma(c), demonstrating that the transmembrane and cytosolic tail of gamma(c) carry sequences involved in this process. To identify these motifs, we have analyzed the trafficking of chimeric proteins with serial truncations in their cytosolic tail. Internalization studies showed that the cytosolic tail of gamma(c) contains three regions located between cytosolic amino acids 1-35, 35-40, and 40-65 involved in gamma(c) endocytosis. Successive deletions of these motifs result in reduced endocytosis. One region containing the 5 cytosolic amino acids 36-40 is essential to direct gamma(c) to the degradation pathway. These sorting sequences, by participating in the fine tuning of cell surface gamma(c) expression, might somewhat regulate the cell responsiveness to interleukins whose receptors share this component.	Inst Pasteur, Unite Biol Interact Cellulaires, URA CNRS 1960, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Morelon, E (corresponding author), Inst Pasteur, Unite Biol Interact Cellulaires, URA CNRS 1960, 25 Rue Dr Roux, F-75724 Paris 15, France.							AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; ALCOVER A, 1988, EMBO J, V7, P1973, DOI 10.1002/j.1460-2075.1988.tb03035.x; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; DANDREA A, 1989, CELL, V58, P1023, DOI 10.1016/0092-8674(89)90499-6; DISANTO JP, 1994, EUR J IMMUNOL, V24, P475, DOI 10.1002/eji.1830240232; DUPREZ V, 1988, J BIOL CHEM, V263, P12860; DUPREZ V, 1986, J BIOL CHEM, V261, P5450; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GREEN SA, 1994, J CELL BIOL, V124, P435, DOI 10.1083/jcb.124.4.435; HEMAR A, 1995, J CELL BIOL, V129, P55, DOI 10.1083/jcb.129.1.55; HEMAR A, 1994, EUR J IMMUNOL, V24, P1951, DOI 10.1002/eji.1830240902; HEMAR A, 1990, EUR J IMMUNOL, V20, P2629, DOI 10.1002/eji.1830201216; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; KONDO M, 1994, SCIENCE, V263, P1453, DOI 10.1126/science.8128231; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; LUND KA, 1990, J BIOL CHEM, V265, P15713; MARKS MS, 1995, J CELL BIOL, V131, P351, DOI 10.1083/jcb.131.2.351; Marks MS, 1997, TRENDS CELL BIOL, V7, P124, DOI 10.1016/S0962-8924(96)10057-X; Marks MS, 1996, J CELL BIOL, V135, P341, DOI 10.1083/jcb.135.2.341; MCCLAIN DA, 1987, J BIOL CHEM, V262, P14663; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; MONTESANO R, 1982, NATURE, V296, P651, DOI 10.1038/296651a0; MORELON E, 1995, TRANSPLANT P, V27, P2477; Morelon E, 1996, BLOOD, V88, P1708; MOYA M, 1985, J CELL BIOL, V101, P548, DOI 10.1083/jcb.101.2.548; MURAKAMI M, 1991, P NATL ACAD SCI USA, V88, P11349, DOI 10.1073/pnas.88.24.11349; NAKAMURA Y, 1994, NATURE, V369, P330, DOI 10.1038/369330a0; Nelson BH, 1996, MOL CELL BIOL, V16, P309; Noguchi M, 1997, P NATL ACAD SCI USA, V94, P11534, DOI 10.1073/pnas.94.21.11534; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; ODORIZZI CG, 1994, J CELL BIOL, V126, P317, DOI 10.1083/jcb.126.2.317; RUSSELL DS, 1987, J BIOL CHEM, V262, P11833; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; Sandoval Ignacio V., 1994, Trends in Cell Biology, V4, P292, DOI 10.1016/0962-8924(94)90220-8; SANDVIG K, 1987, J CELL BIOL, V105, P679, DOI 10.1083/jcb.105.2.679; SETIADI H, 1995, J BIOL CHEM, V270, P26818, DOI 10.1074/jbc.270.45.26818; Subtil A, 1998, EUR J BIOCHEM, V253, P525, DOI 10.1046/j.1432-1327.1998.2530525.x; Subtil A, 1997, J CELL BIOL, V136, P583, DOI 10.1083/jcb.136.3.583; SUBTIL A, 1994, J CELL SCI, V107, P3461; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; TRAN D, 1987, P NATL ACAD SCI USA, V84, P7957, DOI 10.1073/pnas.84.22.7957; VIJAYASARADHI S, 1995, J CELL BIOL, V130, P807, DOI 10.1083/jcb.130.4.807; Vincent V, 1997, J BIOL CHEM, V272, P7062, DOI 10.1074/jbc.272.11.7062; VOSS SD, 1992, J EXP MED, V176, P531, DOI 10.1084/jem.176.2.531; WILEY HS, 1991, J BIOL CHEM, V266, P11083; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; YAMAGUCHI M, 1992, J BIOL CHEM, V267, P22035	50	35	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					22044	22051		10.1074/jbc.273.34.22044	http://dx.doi.org/10.1074/jbc.273.34.22044			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705347	hybrid			2022-12-27	WOS:000075492600081
J	Zimmerman, JW; Lindermuth, J; Fish, PA; Palace, GP; Stevenson, TT; DeMong, DE				Zimmerman, JW; Lindermuth, J; Fish, PA; Palace, GP; Stevenson, TT; DeMong, DE			A novel carbohydrate-glycosphingolipid interaction between a beta-(1-3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONIZATION MASS-SPECTROMETRY; RISK SURGICAL PATIENTS; CELL-LINES; BINDING CHARACTERISTICS; GALACTOSYL CERAMIDE; RESPONSE MODIFIER; RECEPTOR-BINDING; HUMAN MONOCYTES; ANTIGENS; VEROTOXIN-1	The immunomodulator Betafectin(R) PGG-glucan is a homopolymer of glucose derived from yeast cell walls which has been demonstrated to enhance leukocyte anti-infective activity in vitro and in vivo, without the induction of proinflammatory cytokines. We report here the purification of a PGG-glucan-binding element from human leukocytes and its identification as lactosylceramide, a major glycosphingolipid of neutrophils, which includes the CDw17 epitope, The binding of radiolabeled PGG-glucan to purified lactosylceramide was saturable, specific, and time- and temperature-dependent, Lactosylceramides from human leukocytes were fractionated by high performance liquid chromatography in order to analyze the effect of ceramide structure on binding, a variety of fatty acid chain lengths with varying degrees of unsaturation were found to support binding to radiolabeled PGG-glucan. However, DL-lactosylceramides containing dihydrosphingosine did not bind. Radiolabeled PGG-glucan bound several other neutral glycosphingolipids with a terminal galactose, including galactosylceramide, globotriaosylceramide, and gangliotetraosylceramide. The binding of radiolabeled PGG-glucan to lactosylceramide was not inhibited by glycogen, dextran, mannan, pustulan, laminarin, or a low molecular weight beta-(1-3)-glucan, but was inhibited by high molecular weight beta-(1-3)-glucans and by a monoclonal antibody to lactosylceramide. Although this glycosphingolipid has been shown in numerous reports to bind various microorganisms, this represents the first report of lactosylceramide binding to a a macromolecular carbohydrate.	Alpha Beta Technol Inc, Worcester, MA 01605 USA		Zimmerman, JW (corresponding author), Alpha Beta Technol Inc, 1 Innovat Dr, Worcester, MA 01605 USA.	jzimme@abti.com						Adams DS, 1997, J LEUKOCYTE BIOL, V62, P865, DOI 10.1002/jlb.62.6.865; ANDREWS RG, 1983, BLOOD, V62, P124; BABINEAU TJ, 1994, ANN SURG, V220, P601, DOI 10.1097/00000658-199411000-00002; BABINEAU TJ, 1994, ARCH SURG-CHICAGO, V129, P1204; Bast DJ, 1997, INFECT IMMUN, V65, P2019, DOI 10.1128/IAI.65.6.2019-2028.1997; Bhunia AK, 1996, J BIOL CHEM, V271, P10660, DOI 10.1074/jbc.271.18.10660; BLEICHER P, 1995, J BIOTECHNOL HEALTHC, V2, P207; Bohn JA, 1995, CARBOHYD POLYM, V28, P3, DOI 10.1016/0144-8617(95)00076-3; Chatterjee SB, 1997, GLYCOBIOLOGY, V7, P57, DOI 10.1093/glycob/7.1.57; ENGSTAD RE, 1994, DEV COMP IMMUNOL, V18, P397, DOI 10.1016/0145-305X(94)90005-1; Fantini J, 1997, J BIOL CHEM, V272, P7245, DOI 10.1074/jbc.272.11.7245; FUKUDA MN, 1985, J BIOL CHEM, V260, P1067; HAKOMORI S, 1972, METHOD ENZYMOL, V28, P232; HAROUSE JM, 1991, SCIENCE, V253, P320, DOI 10.1126/science.1857969; HERRMANN JE, 1995, J CLIN MICROBIOL, V33, P2511, DOI 10.1128/JCM.33.9.2511-2513.1995; HILDEBRAND J, 1971, J LIPID RES, V12, P361; IRIE A, 1990, J BIOCHEM-TOKYO, V108, P531, DOI 10.1093/oxfordjournals.jbchem.a123237; JIMENEZLUCHO V, 1990, INFECT IMMUN, V58, P2085, DOI 10.1128/IAI.58.7.2085-2090.1990; KARLSSON KA, 1989, ANNU REV BIOCHEM, V58, P309, DOI 10.1146/annurev.bi.58.070189.001521; KIARASH A, 1994, J BIOL CHEM, V269, P11138; Kniep B, 1998, J LEUKOCYTE BIOL, V63, P83, DOI 10.1002/jlb.63.1.83; KONOPSKI Z, 1994, BBA-MOL CELL RES, V1221, P61, DOI 10.1016/0167-4889(94)90216-X; Koshy KM, 1996, J BIOL CHEM, V271, P3496; KUSHI Y, 1989, ANAL BIOCHEM, V182, P405, DOI 10.1016/0003-2697(89)90615-5; LIANG J, 1998, IN PRESS INT J IMMUN; LUNDJOHANSEN F, 1992, J IMMUNOL, V148, P3221; MACHER BA, 1980, J BIOL CHEM, V255, P2092; MARCUS AJ, 1972, J CLIN INVEST, V51, P2602, DOI 10.1172/JCI107078; MCCLUER RH, 1986, ADV CHROMATOGR, V25, P309; MELICAN D, 1998, IN PRESS J LEUK BIOL; Muller A, 1996, J IMMUNOL, V156, P3418; ONDERDONK AB, 1992, INFECT IMMUN, V60, P1642, DOI 10.1128/IAI.60.4.1642-1647.1992; PATCHEN ML, 1998, IN PRESS STEM CELLS; Ramegowda B, 1996, INFECT IMMUN, V64, P1173, DOI 10.1128/IAI.64.4.1173-1180.1996; *REC NOM COMM INT, 1977, LIPIDS, V12, P455; SCHNAAR RL, 1994, METHOD ENZYMOL, V230, P348; STASHENKO P, 1995, J DENT RES, V74, P323, DOI 10.1177/00220345950740010701; STEIN KE, 1977, BIOCHEMISTRY-US, V16, P5285, DOI 10.1021/bi00643a019; STONE BA, 1992, CHEM BIOL 1 3 BETA G, P525; STROMBERG N, 1990, J BIOL CHEM, V265, P11244; SYMINGTON FW, 1985, J IMMUNOL, V134, P2498; SYMINGTON FW, 1986, LEUKOCYTE TYPING 2, V3, P47; SZABO T, 1995, J BIOL CHEM, V270, P2145, DOI 10.1074/jbc.270.5.2145; TAO RVP, 1973, J LIPID RES, V14, P16; TETTEROO PAT, 1986, LEUKOCYTE TYPING 2, V3, P27; Thornton BP, 1996, J IMMUNOL, V156, P1235; VANCE DE, 1967, J LIPID RES, V8, P621; vanSetten PA, 1996, BLOOD, V88, P174, DOI 10.1182/blood.V88.1.174.bloodjournal881174; WILLIAMS DL, 1991, CARBOHYD RES, V219, P203, DOI 10.1016/0008-6215(91)89052-H; YADNAK MA, 1994, MOL CHEM NEUROPATHOL, V21, P369; YAHI N, 1992, J VIROL, V66, P4848, DOI 10.1128/JVI.66.8.4848-4854.1992	51	185	203	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					22014	22020		10.1074/jbc.273.34.22014	http://dx.doi.org/10.1074/jbc.273.34.22014			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705343	hybrid			2022-12-27	WOS:000075492600077
J	Batinic-Haberle, I; Benov, L; Spasojevic, I; Fridovich, I				Batinic-Haberle, I; Benov, L; Spasojevic, I; Fridovich, I			The ortho effect makes Manganese(III) Meso-Tetrakis(N-Methylpyridinium-2-yl) porphyrin a powerful and potentially useful superoxide dismutase mimic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-BINDING HEMOPROTEINS; WATER-SOLUBLE PORPHYRINS; SYNTHETIC MODELS; NUCLEIC-ACIDS; METALLOPORPHYRINS; ELECTROCHEMISTRY; REDUCTION; DERIVATIVES; COMPLEXES; DIANION	The ortho, meta, and para isomers of manganese(III) 5,10,15,20-tetrakis(N-methylpyridyl)porphyrin MnTM-2-PyP5+, MnTM-3-PyP5+, and MnTM-4-PyP5+, respectively, were analyzed in terms of their superoxide dismutase (SOD) activity in vitro and in vivo. The impact of their interaction with DNA and RNA on the SOD activity in vivo and in vitro has also been analyzed. Differences in their behavior are due to the combined steric and electrostatic factors. In vitro catalytic activities are closely related to their redox potentials. The half-wave potentials (E-1/2) are +0.220 mV, +0.052 mV, and +0.060 V versus normal hydrogen electrode, whereas the rates of dismutation (k(cat)) are 6.0 x 10(7), 4.1 x 10(6), and 3.8 x 10(6) M-1 s(-1) for the ortho, meta, and para isomers, respectively. However, the in vitro activity is not a sufficient predictor of in vivo efficacy. The ortho and meta isomers, although of significantly different in vitro SOD activities, have fairly close in vivo SOD efficacy due to their similarly weak interactions with DNA. In contrast, due to a higher degree of interaction with DNA, the para isomer inhibited growth of SOD-deficient Escherichia coli.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Dept Chem, Durham, NC 27708 USA	Duke University; Duke University	Fridovich, I (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.		Benov, Ludmil/AAD-3714-2020	Benov, Ludmil/0000-0002-0205-0146				Autret M, 1996, J CHEM SOC DALTON, P2793, DOI 10.1039/dt9960002793; BARRETTE WC, 1983, BIOCHEMISTRY-US, V22, P624, DOI 10.1021/bi00272a015; BatinicHaberle I, 1997, ARCH BIOCHEM BIOPHYS, V343, P225, DOI 10.1006/abbi.1997.0157; BHATTI W, 1973, J PHARM SCI, V62, P1574, DOI 10.1002/jps.2600620951; BIELSKI BHJ, 1985, J PHYS CHEM REF DATA, V14, P1041, DOI 10.1063/1.555739; BINSTEAD RA, 1991, INORG CHEM, V30, P1259, DOI 10.1021/ic00006a019; BOSCHI T, 1986, INORG CHIM ACTA, V119, P191, DOI 10.1016/S0020-1693(00)84339-X; BUTLER J, 1982, J BIOL CHEM, V257, P747; COLLMAN JP, 1977, ACCOUNTS CHEM RES, V10, P265, DOI 10.1021/ar50115a006; COLLMAN JP, 1975, J AM CHEM SOC, V97, P1427, DOI 10.1021/ja00839a026; DAVILA J, 1987, J CHEM SOC CHEM COMM, P525, DOI 10.1039/c39870000525; EATON SS, 1974, J CHEM SOC CHEM COMM, P576, DOI 10.1039/c39740000576; EATON SS, 1972, J ORGANOMET CHEM, V39, P179, DOI 10.1016/S0022-328X(00)88918-4; EATON SS, 1975, J AM CHEM SOC, V97, P3660, DOI 10.1021/ja00846a016; FAULKNER KM, 1994, J BIOL CHEM, V269, P23471; GIRAUDEAU A, 1979, J AM CHEM SOC, V101, P3857, DOI 10.1021/ja00508a024; HAMBRIGHT P, 1976, INORG CHEM, V15, P2314, DOI 10.1021/ic50163a072; HAMBRIGHT P, 1970, INORG CHEM, V9, P1757, DOI 10.1021/ic50089a030; HAMBRIGHT P, 1977, J INORG NUCL CHEM, V39, P1102, DOI 10.1016/0022-1902(77)80282-0; Hariprasad G, 1996, J CHEM SOC DALTON, P3429, DOI 10.1039/dt9960003429; HARRIMAN A, 1979, J CHEM SOC FARAD T 2, V75, P1532, DOI 10.1039/f29797501532; HODGSON EK, 1973, ANAL BIOCHEM, V51, P470, DOI 10.1016/0003-2697(73)90502-2; IMLAY JA, 1987, J BACTERIOL, V169, P2967, DOI 10.1128/jb.169.7.2967-2976.1987; KADISH KM, 1990, J AM CHEM SOC, V112, P8364, DOI 10.1021/ja00179a021; KALYANASUNDARAM K, 1984, INORG CHEM, V23, P2453, DOI 10.1021/ic00184a019; KAUFMANN T, 1995, INORG CHEM, V34, P5073, DOI 10.1021/ic00124a025; Koppenol W. H., 1985, ADV FREE RADICALS BI, V1, P91, DOI DOI 10.1016/8755-9668(85)90005-5; KOPPENOL WH, 1987, BIOELECTROCH BIOENER, V18, P3, DOI 10.1016/0302-4598(87)85002-X; LEE WA, 1984, CHEM PHYS LETT, V107, P308, DOI 10.1016/0009-2614(84)85135-0; LONGO FR, 1973, ANN NY ACAD SCI, V206, P420, DOI 10.1111/j.1749-6632.1973.tb43227.x; MCADAM ME, 1977, BIOCHEM J, V161, P697, DOI 10.1042/bj1610697; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MEOTNER M, 1975, J AM CHEM SOC, V97, P5107, DOI 10.1021/ja00851a014; MIN L, 1990, BIOCHEMISTRY-US, V29, P1614; MULLER W, 1973, EUR J BIOCHEM, V39, P223, DOI 10.1111/j.1432-1033.1973.tb03120.x; PASTERNACK RF, 1995, SCIENCE, V269, P935, DOI 10.1126/science.7638615; PASTERNACK RF, 1985, J AM CHEM SOC, V107, P8179, DOI 10.1021/ja00312a061; PASTERNACK RF, 1983, BIOCHEMISTRY-US, V22, P2406, DOI 10.1021/bi00279a016; PASTERNACK RF, 1983, BIOCHEMISTRY-US, V22, P5409, DOI 10.1021/bi00292a024; QUIMBY DJ, 1975, J AM CHEM SOC, V97, P5110; Richards RA, 1996, INORG CHEM, V35, P1940, DOI 10.1021/ic941434w; SAWADA Y, 1973, BIOCHIM BIOPHYS ACTA, V327, P257, DOI 10.1016/0005-2744(73)90408-7; Sen A, 1997, J CHEM SOC FARADAY T, V93, P4281, DOI 10.1039/a704663d; STRICKLAND JA, 1988, BIOCHEMISTRY-US, V27, P8870, DOI 10.1021/bi00424a027; Tabata M, 1996, B CHEM SOC JPN, V69, P673, DOI 10.1246/bcsj.69.673; Tagliatesta P, 1996, INORG CHEM, V35, P5570, DOI 10.1021/ic960148c; TAKEUCHI T, 1994, J AM CHEM SOC, V116, P9730, DOI 10.1021/ja00100a043; TROFIMOV BA, 1980, KHIM GETEROTSIKL+, P632; Uno T, 1997, INORG CHEM, V36, P1676, DOI 10.1021/ic960824a; VALIOTTI A, 1981, J INORG NUCL CHEM, V43, P2653, DOI 10.1016/0022-1902(81)80593-3; VERGELDT FJ, 1995, J PHYS CHEM-US, V99, P4397, DOI 10.1021/j100013a007; Warburg O, 1939, BIOCHEM Z, V303, P40; WARD B, 1986, BIOCHEMISTRY-US, V25, P6875, DOI 10.1021/bi00370a021; WAUD WR, 1975, ARCH BIOCHEM BIOPHYS, V169, P695, DOI 10.1016/0003-9861(75)90214-3; YU CH, 1994, J ELECTROANAL CHEM, V368, P323, DOI 10.1016/0022-0728(93)03073-X	55	238	248	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24521	24528		10.1074/jbc.273.38.24521	http://dx.doi.org/10.1074/jbc.273.38.24521			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733746	hybrid			2022-12-27	WOS:000076007300038
J	Flores-Diaz, M; Alape-Giron, A; Titball, RW; Moos, M; Guillouard, I; Cole, S; Howells, AM; von Eichel-Streiber, C; Florin, I; Thelestam, M				Flores-Diaz, M; Alape-Giron, A; Titball, RW; Moos, M; Guillouard, I; Cole, S; Howells, AM; von Eichel-Streiber, C; Florin, I; Thelestam, M			UDP-glucose deficiency causes hypersensitivity to the cytotoxic effect of Clostridium perfringens phospholipase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; DIFFICILE TOXIN-B; ALPHA-TOXIN; GAS-GANGRENE; BACTERIAL PHOSPHOLIPASES; HEMOLYTIC ACTIVITIES; MOLECULAR-CLONING; ARACHIDONIC-ACID; BACILLUS-CEREUS; MAMMALIAN-CELLS	A Chinese hamster cell line with a mutation in the UDP-glucose pyrophosphorylase (UDPG:PP) gene leading to UDP-glucose deficiency as well as a revertant cell were previously isolated. We now show that the mutant cell is 10(5) times more sensitive to the cytotoxic effect of Clostridium perfringens phospholipase C (PLC) than the revertant cell. To clarify whether there is a connection between the UDP-glucose deficiency and the hypersensitivity to C. perfringens PLC, stable transfectant cells were prepared using a wild type UDPG:PP cDNA. Clones of the mutant transfected with a construct having the insert in the sense orientation had increased their UDP-glucose level, whereas those of the revertant transfected with a UDPG:PP antisense had reduced their level of UDP-glucose compared with control clones transfected with the vector. Exposure of these two types of transfectant clones to C. perfringens PLC demonstrated that a cellular UDP-glucose deficiency causes hypersensitivity to the cytotoxic effect of this phospholipase. Further experiments with genetically engineered C. perfringens PLC variants showed that the sphingomyelinase activity and the C-domain are required for its cytotoxic effect in UDP-glucose-deficient cells.	Karolinska Inst, Microbiol & Tumorbiol Ctr, S-17177 Stockholm, Sweden; Univ Costa Rica, Fac Med, Dept Bioquim, San Jose, Costa Rica; Chem & Biol Def Estab, Def Evaluat & Res Agcy, Salisbury SP4 0JQ, Wilts, England; Inst Med Mikrobiol & Hyg, D-55101 Mainz, Germany; Inst Pasteur, Unite Genet Mol Bacterienne, F-75724 Paris 15, France	Karolinska Institutet; Universidad Costa Rica; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Thelestam, M (corresponding author), Karolinska Inst, Microbiol & Tumorbiol Ctr, Box 280, S-17177 Stockholm, Sweden.	monica.thelestam@mtc.ki.se						AW TY, 1984, BIOCHEM J, V219, P707, DOI 10.1042/bj2190707; AWAD MM, 1995, MOL MICROBIOL, V15, P191, DOI 10.1111/j.1365-2958.1995.tb02234.x; BASAK AK, 1994, J MOL BIOL, V244, P648, DOI 10.1006/jmbi.1994.1758; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BONADONNA RC, 1993, J CLIN INVEST, V92, P486, DOI 10.1172/JCI116592; Bunting M, 1997, J CLIN INVEST, V100, P565, DOI 10.1172/JCI119566; Buse MG, 1996, J BIOL CHEM, V271, P23197, DOI 10.1074/jbc.271.38.23197; Chapnick EK, 1996, INFECT DIS CLIN N AM, V10, P835, DOI 10.1016/S0891-5520(05)70329-9; ChavesOlarte E, 1996, J BIOL CHEM, V271, P6925, DOI 10.1074/jbc.271.12.6925; ESKO JD, 1980, P NATL ACAD SCI-BIOL, V77, P5192, DOI 10.1073/pnas.77.9.5192; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FloresDiaz M, 1997, J BIOL CHEM, V272, P23784, DOI 10.1074/jbc.272.38.23784; FLORIN I, 1991, MICROB PATHOGENESIS, V11, P337, DOI 10.1016/0882-4010(91)90019-7; Franks SE, 1996, ANTICANCER RES, V16, P1365; Guillouard I, 1996, INFECT IMMUN, V64, P2440, DOI 10.1128/IAI.64.7.2440-2444.1996; Guillouard I, 1997, MOL MICROBIOL, V26, P867, DOI 10.1046/j.1365-2958.1997.6161993.x; HOUGH E, 1989, NATURE, V338, P357, DOI 10.1038/338357a0; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; KENT C, 1986, ARCH BIOCHEM BIOPHYS, V250, P519, DOI 10.1016/0003-9861(86)90757-5; KONISHI Y, 1993, J BIOCHEM-TOKYO, V114, P61, DOI 10.1093/oxfordjournals.jbchem.a124141; LESLIE D, 1989, MOL MICROBIOL, V3, P383, DOI 10.1111/j.1365-2958.1989.tb00183.x; LOGAN AJ, 1991, INFECT IMMUN, V59, P4338, DOI 10.1128/IAI.59.12.4338-4342.1991; MOLLBY R, 1974, J MEMBRANE BIOL, V16, P313, DOI 10.1007/BF01872421; NAGAHAMA M, 1995, J BACTERIOL, V177, P1179, DOI 10.1128/jb.177.5.1179-1185.1995; Nagahama M, 1997, INFECT IMMUN, V65, P3489, DOI 10.1128/IAI.65.8.3489-3492.1997; NAGAHAMA M, 1994, FEMS MICROBIOL LETT, V120, P297, DOI 10.1016/0378-1097(94)90487-1; NINOMIYA M, 1994, INFECT IMMUN, V62, P5032, DOI 10.1128/IAI.62.11.5032-5039.1994; PELSRIJCKEN WR, 1995, GLYCOBIOLOGY, V5, P495; ROBINSON KA, 1995, DIABETES, V44, P1438, DOI 10.2337/diabetes.44.12.1438; ROGSTAD B, 1993, INFECTION, V21, P54, DOI 10.1007/BF01739316; ROTHMAN DL, 1995, P NATL ACAD SCI USA, V92, P983, DOI 10.1073/pnas.92.4.983; SAKURAI J, 1993, INFECT IMMUN, V61, P3711, DOI 10.1128/IAI.61.9.3711-3718.1993; SAKURAI J, 1994, INFECT IMMUN, V62, P717, DOI 10.1128/IAI.62.2.717-721.1994; SCHIESS K, 1992, BIOCHIM BIOPHYS ACTA, V1137, P82, DOI 10.1016/0167-4889(92)90104-J; SHEED SF, 1993, NMR BIOMED, V6, P254; SHOSHAN MC, 1990, EUR J CELL BIOL, V53, P357; SLEIGHT R, 1983, J BIOL CHEM, V258, P824; SOCHOR M, 1991, DIABETES, V40, P1467, DOI 10.2337/diabetes.40.11.1467; Songer JG, 1997, TRENDS MICROBIOL, V5, P156, DOI 10.1016/S0966-842X(97)01005-6; SPIRO MJ, 1984, DIABETOLOGIA, V26, P70; Stevens DL, 1997, J INFECT DIS, V176, P189, DOI 10.1086/514022; STEVENS DL, 1997, CLIN INFECT DIS   S2, V25, P160; SUNG SSJ, 1985, BIOCHIM BIOPHYS ACTA, V845, P204, DOI 10.1016/0167-4889(85)90178-8; SWEITZER TD, 1994, ARCH BIOCHEM BIOPHYS, V311, P107, DOI 10.1006/abbi.1994.1215; TITBALL RW, 1993, FEMS MICROBIOL LETT, V110, P45, DOI 10.1016/0378-1097(93)90240-3; TITBALL RW, 1991, INFECT IMMUN, V59, P1872, DOI 10.1128/IAI.59.5.1872-1874.1991; TITBALL RW, 1989, INFECT IMMUN, V57, P367, DOI 10.1128/IAI.57.2.367-376.1989; TITBALL RW, 1993, MICROBIOL REV, V57, P347, DOI 10.1128/MMBR.57.2.347-366.1993; TSO JY, 1989, INFECT IMMUN, V57, P468, DOI 10.1128/IAI.57.2.468-476.1989; VONEICHELSTREIBER C, 1987, MICROB PATHOGENESIS, V2, P307, DOI 10.1016/0882-4010(87)90073-8; WICE BM, 1985, J BIOL CHEM, V260, P139; WILLIAMSON ED, 1993, VACCINE, V11, P1253, DOI 10.1016/0264-410X(93)90051-X	52	30	30	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24433	24438		10.1074/jbc.273.38.24433	http://dx.doi.org/10.1074/jbc.273.38.24433			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733734	hybrid			2022-12-27	WOS:000076007300026
J	Granovsky, AE; Natochin, M; McEntaffer, RL; Haik, TL; Francis, SH; Corbin, JD; Artemyev, NO				Granovsky, AE; Natochin, M; McEntaffer, RL; Haik, TL; Francis, SH; Corbin, JD; Artemyev, NO			Probing domain functions of chimeric PDE6 alpha'/PDE5 cGMP-phosphodiesterase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-GMP PHOSPHODIESTERASE; ROD OUTER SEGMENTS; GAMMA-SUBUNIT; CATALYTIC SUBUNITS; BINDING-SITES; PHOTORECEPTOR PHOSPHODIESTERASE; NUCLEOTIDE PHOSPHODIESTERASE; VISUAL TRANSDUCTION; HIGH-AFFINITY; RETINAL RODS	Chimeric cGMP phosphodiesterases (PDEs) have been constructed using components of the cGMP-binding PDE (PDE5) and cone photoreceptor phosphodiesterase (PDE6 alpha') in order to study structure and function of the photoreceptor enzyme. A fully functional chimeric PDE6 alpha'/PDE5 enzyme containing the PDE6 alpha' noncatalytic cGMP-binding sites, and the PDE5 catalytic domain has been efficiently expressed in the baculovirus/High Five cell system. The catalytic properties of this chimera were practically indistinguishable from those of PDE5, whereas the noncatalytic cGMP binding was similar to that of native purified PDE6 alpha'. The inhibitory gamma subunit of PDE6 (P gamma) enhanced the affinity of cGMP binding at noncatalytic sites of native PDE6 alpha' by similar to 6-fold, The polycationic region of P gamma, P gamma-24-45, was mainly responsible for this effect, while the inhibitory domain of P gamma, P gamma-63-87, was ineffective. On the contrary, Py failed to inhibit catalytic activity of the chimeric PDE6 alpha'/PDE5 or to modulate its noncatalytic cGMP binding. Substitutions of Ala residues for the conserved Asn, Asn(193) or Asn(402), in the two N(K/R)XD-like motifs of the chimeric PDE noncatalytic cGMP-binding sites, each led to a loss of the noncatalytic cGMP binding. Our data suggest that both putative noncatalytic sites of PDE6 alpha' are important for binding of cGMP, and that the two binding sites are coupled, Furthermore, mutation Asn402 --> Ala resulted in an approximately 10-fold increase of the K-m value for cGMP, indicating that occupation of the noncatalytic cGMP- binding sites of PDE6 alpha' may regulate catalytic properties of the enzyme.	Univ Iowa, Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Vanderbilt Univ, Dept Physiol & Mol Biophys, Sch Med, Nashville, TN 37232 USA	University of Iowa; Vanderbilt University	Artemyev, NO (corresponding author), Univ Iowa, Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA.	nikolai-artemyev@uiowa.edu		Artemyev, Nikolai/0000-0002-5266-6854	NATIONAL EYE INSTITUTE [R01EY010843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041269] Funding Source: NIH RePORTER; NEI NIH HHS [EY-10843] Funding Source: Medline; NIDDK NIH HHS [DK40029] Funding Source: Medline; NIGMS NIH HHS [GM 41269] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Artemyev NO, 1996, P NATL ACAD SCI USA, V93, P5407, DOI 10.1073/pnas.93.11.5407; ARTEMYEV NO, 1992, BIOCHEM J, V283, P273, DOI 10.1042/bj2830273; BAEHR W, 1979, J BIOL CHEM, V254, P1669; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN RL, 1992, BIOCHEMISTRY-US, V31, P5918, DOI 10.1021/bi00140a031; CHABRE M, 1989, EUR J BIOCHEM, V179, P255, DOI 10.1111/j.1432-1033.1989.tb14549.x; COTE RH, 1994, P NATL ACAD SCI USA, V91, P4845, DOI 10.1073/pnas.91.11.4845; DETERRE P, 1988, P NATL ACAD SCI USA, V85, P2424, DOI 10.1073/pnas.85.8.2424; Florio SK, 1996, J BIOL CHEM, V271, P24036, DOI 10.1074/jbc.271.39.24036; FUNG BKK, 1990, BIOCHEMISTRY-US, V29, P2657, DOI 10.1021/bi00463a006; GILLESPIE PG, 1989, P NATL ACAD SCI USA, V86, P4311, DOI 10.1073/pnas.86.11.4311; GILLESPIE PG, 1988, J BIOL CHEM, V263, P8133; GILLESPIE PG, 1989, MOL PHARMACOL, V36, P773; Granovsky AE, 1997, J BIOL CHEM, V272, P11686, DOI 10.1074/jbc.272.18.11686; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HAMILTON SE, 1990, J BIOL CHEM, V265, P11259; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI T, 1990, P NATL ACAD SCI USA, V87, P293, DOI 10.1073/pnas.87.1.293; LIPKIN VM, 1988, FEBS LETT, V234, P287, DOI 10.1016/0014-5793(88)80100-5; LIPKIN VM, 1990, J BIOL CHEM, V265, P12955; Lochhead A, 1997, J BIOL CHEM, V272, P18397, DOI 10.1074/jbc.272.29.18397; MARTINS TJ, 1982, J BIOL CHEM, V257, P1973; McAllisterLucas LM, 1995, J BIOL CHEM, V270, P30671, DOI 10.1074/jbc.270.51.30671; MCALLISTERLUCAS LM, 1993, J BIOL CHEM, V268, P22863; Natochin M, 1996, J BIOL CHEM, V271, P19964, DOI 10.1074/jbc.271.33.19964; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; PIRIEV NI, 1993, P NATL ACAD SCI USA, V90, P9340, DOI 10.1073/pnas.90.20.9340; QIN N, 1994, J BIOL CHEM, V269, P3265; SKIBA NP, 1995, J BIOL CHEM, V270, P13210, DOI 10.1074/jbc.270.22.13210; STROOP SD, 1991, J BIOL CHEM, V266, P23802; Stryer L, 1996, P NATL ACAD SCI USA, V93, P557, DOI 10.1073/pnas.93.2.557; TAKEMOTO DJ, 1992, BIOCHEM J, V281, P637, DOI 10.1042/bj2810637; THOMAS MK, 1990, J BIOL CHEM, V265, P14964; THOMPSON WJ, 1971, BIOCHEMISTRY-US, V10, P311; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Turko IV, 1996, J BIOL CHEM, V271, P22240, DOI 10.1074/jbc.271.36.22240; YAMAZAKI A, 1982, P NATL ACAD SCI-BIOL, V79, P3702, DOI 10.1073/pnas.79.12.3702; YAMAZAKI A, 1980, J BIOL CHEM, V255, P1619; Yamazaki A, 1996, J BIOL CHEM, V271, P32495, DOI 10.1074/jbc.271.51.32495; YARFITZ S, 1994, J BIOL CHEM, V269, P14329	43	48	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24485	24490		10.1074/jbc.273.38.24485	http://dx.doi.org/10.1074/jbc.273.38.24485			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733741	hybrid			2022-12-27	WOS:000076007300033
J	Olcott, MC; Andersson, J; Sjoberg, BM				Olcott, MC; Andersson, J; Sjoberg, BM			Localization and characterization of two nucleotide-binding sites on the anaerobic ribonucleotide reductase from bacteriophage T4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; DIPHOSPHATE REDUCTASE; SUBSTRATE-SPECIFICITY; ALLOSTERIC REGULATION; PHENOTYPIC SELECTION; CATALYTIC ACTIVITY; CREATINE-KINASE; PROTEIN R1; IDENTIFICATION; TRIPHOSPHATE	We have used 8-azidoadenosine 5'-triphosphate (8-N(3)ATP) to investigate the nucleotide-binding sites on the NrdD subunit of the anaerobic ribonucleotide reductase from T4 phage, Saturation studies revealed two saturable sites for this photoaffinity analog of ATP. One site exhibited half-maximal saturation at approximately 5 mu M [gamma-P-32]8-N(3)ATP, whereas the other site required 45 mu M. To localize the sites of photoinsertion, photolabeled peptides from tryptic and chymotryptic digests were isolated by immobilized Al3+ affinity chromatography and high performance liquid chromatography and subjected to amino acid sequence and mass spectrometric analyses. The molecular masses of the photolabeled products of cyanogen bromide cleavage were estimated using tricine-SDS-polyacrylamide gel electrophoresis, Overlapping sequence analysis localized the higher affinity site to the region corresponding to residues 289-291 and the other site to the region corresponding to residues 147-160, Site-directed mutagenesis of Cys(290), a residue conserved in all known class ill reductases, resulted in a protein that exhibited less than 10% of wild type enzymatic activity. These observations indicate that Cys(290) may reside in or near the active site. High performance liquid chromatography analysis revealed that photoinsertion of [gamma-P-32]8-N(3)ATP into the site corresponding to residues 147-160 was almost completely abolished when 100 mu M dATP, dGTP, or dTTP was included in the photolabeling reaction mixture, whereas 100 mu M ATP, GTP, CTP, or dCTP had virtually no effect. Based on these nucleotide binding properties, we conclude that this site is an allosteric site analogous to the one that has been shown to regulate substrate specificity of other ribonucleotide reductases. There was no evidence for a second allosteric nucleotide-binding site as observed in the anaerobic ribonucleotide reductase from Escherichia coli.	Swedish Univ Agr Sci, Dept Vet Med Chem, S-75123 Uppsala, Sweden	Swedish University of Agricultural Sciences	Olcott, MC (corresponding author), Swedish Univ Agr Sci, Dept Vet Med Chem, S-75123 Uppsala, Sweden.	Mike.Olcott@bmc.uu.se		Sjoberg, Britt-Marie/0000-0001-5953-3360				ABERG A, 1989, J BIOL CHEM, V264, P12249; BERGLUND O, 1972, J BIOL CHEM, V247, P7276; Bramhall EA, 1997, EUR J BIOCHEM, V244, P627, DOI 10.1111/j.1432-1033.1997.00627.x; BROWN NC, 1969, J MOL BIOL, V46, P39, DOI 10.1016/0022-2836(69)90056-4; Eklund H, 1997, BIOL CHEM, V378, P821; ELIASSON R, 1994, J BIOL CHEM, V269, P26052; Eriksson M, 1997, STRUCTURE, V5, P1077, DOI 10.1016/S0969-2126(97)00259-1; ERIKSSON S, 1986, J BIOL CHEM, V261, P1878; Hendricks SP, 1997, J BIOL CHEM, V272, P2861, DOI 10.1074/jbc.272.5.2861; JI JP, 1991, J BIOL CHEM, V266, P16289; KING DS, 1995, BIOCHEM BIOPH RES CO, V206, P731, DOI 10.1006/bbrc.1995.1103; KING SM, 1991, METHOD ENZYMOL, V196, P449; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; KUNZ BA, 1994, MUTAT RES-REV GENET, V318, P1, DOI 10.1016/0165-1110(94)90006-X; Kussmann M, 1997, J MASS SPECTROM, V32, P593; LIN ANI, 1987, BIOCHEMISTRY-US, V26, P6905, DOI 10.1021/bi00396a006; MAGGIO ET, 1977, J BIOL CHEM, V252, P1202; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9752, DOI 10.1021/bi00155a031; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9744, DOI 10.1021/bi00155a030; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9733, DOI 10.1021/bi00155a029; MATHEWS CK, 1992, BIOESSAYS, V14, P295, DOI 10.1002/bies.950140502; OLCOTT MC, 1994, BIOCHEMISTRY-US, V33, P11935, DOI 10.1021/bi00205a032; Olcott MC, 1997, EUR J BIOCHEM, V247, P762, DOI 10.1111/j.1432-1033.1997.t01-1-00762.x; POTTER RL, 1983, METHOD ENZYMOL, V91, P613; RADOMINSKA A, 1994, METHOD ENZYMOL, V230, P330; Rechtin TM, 1996, ANAL BIOCHEM, V237, P135, DOI 10.1006/abio.1996.0211; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; REICHARD P, 1997, TRENDS BIOCHEM SCI, V19, P15; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SJOBERG BM, 1997, STRUCT BOND, V88, P140; Sun XY, 1996, J BIOL CHEM, V271, P6827, DOI 10.1074/jbc.271.12.6827; THELANDER L, 1974, J BIOL CHEM, V249, P4858; THELANDER L, 1979, ANNU REV BIOCHEM, V48, P133, DOI 10.1146/annurev.bi.48.070179.001025; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; Uhlin U, 1996, J MOL BIOL, V262, P358, DOI 10.1006/jmbi.1996.0519; Young P, 1996, J BIOL CHEM, V271, P20770, DOI 10.1074/jbc.271.34.20770; YOUNG P, 1994, J BIOL CHEM, V269, P27815; YOUNG P, 1994, J BIOL CHEM, V269, P20229	39	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24853	24860		10.1074/jbc.273.38.24853	http://dx.doi.org/10.1074/jbc.273.38.24853			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733790	hybrid			2022-12-27	WOS:000076007300082
J	Richter, MF; Dumenil, G; Uze, G; Fellous, M; Pellegrini, S				Richter, MF; Dumenil, G; Uze, G; Fellous, M; Pellegrini, S			Specific contribution of Tyk2 JH regions to the binding and the expression of the interferon alpha/beta receptor component IFNAR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; SIGNAL-TRANSDUCTION; PHOSPHORYLATION; JAK1; SUBUNIT; PATHWAY; CHAIN; INTERLEUKIN-6; ASSOCIATION; P135(TYK2)	Cytokine signaling involves the activation of the Janus kinase (JAK) family of tyrosine kinases. These enzymes are physically associated with cytokine receptor components. Here, we sought to define the molecular basis of the interaction between Tyk2 and IFNAR1, a component of the interferon alpha/beta receptor, by delimiting a minimal IFNAR1 binding region in the Tyk2 protein. Using an in vitro assay system, we narrowed down the interaction domain to a region comprising the JH7 and part of the JH6 homology boxes (amino acids 22-221). When expressed in Tyk2-negative cells, the JH7-6 region was unable to stabilize IFNAR1 protein levels, a critical function that we previously attributed to the N region (amino acids 1-591) of Tyk2. Moreover, substitution of the JR7-JH6 domain in JAK1 with that of Tyk2 did not restore IFNAR1 level nor interferon Lu signaling in Tyk2-negative cells. Thus, the major interaction surface lies within JH7-6, but additional JH regions (JH5-4-3) contribute in a specific manner to the in vivo assembly of Tyk2 and IFNAR1. Evidence is also provided of the lack of specificity of the Tyk2 kinase-like and tyrosine kinase domains in interferon alpha/beta receptor signaling.	Inst Pasteur, INSERM, U276, F-75724 Paris 15, France; CNRS, UMR 9942, Inst Mol Genet, F-34033 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Pellegrini, S (corresponding author), Inst Pasteur, INSERM, U276, 25 Rue Dr Roux, F-75724 Paris 15, France.		Dumenil, Guillaume/F-7567-2015; Dumenil, Guillaume/N-3377-2019; Pellegrini, Sandra/Y-6351-2019; Richter, Marc François/AAC-6105-2020; Uzé, Gilles/O-6383-2019; Pellegrini, Sandra -/G-5546-2015	Dumenil, Guillaume/0000-0001-9174-9110; Dumenil, Guillaume/0000-0001-9174-9110; Pellegrini, Sandra/0000-0001-5837-7589; Richter, Marc François/0000-0002-0868-9127; Pellegrini, Sandra -/0000-0001-5837-7589; Uze, Gilles/0000-0002-4150-5772				BACON CM, 1995, J EXP MED, V181, P399, DOI 10.1084/jem.181.1.399; Briscoe J, 1996, EMBO J, V15, P799, DOI 10.1002/j.1460-2075.1996.tb00415.x; Chen M, 1997, P NATL ACAD SCI USA, V94, P6910, DOI 10.1073/pnas.94.13.6910; COLAMONICI O, 1994, MOL CELL BIOL, V14, P8133, DOI 10.1128/MCB.14.12.8133; COLAMONICI OR, 1994, J BIOL CHEM, V269, P3518; FINBLOOM DS, 1995, J IMMUNOL, V155, P1070; FRANK SJ, 1995, J BIOL CHEM, V270, P14776, DOI 10.1074/jbc.270.24.14776; Gauzzi MC, 1997, P NATL ACAD SCI USA, V94, P11839, DOI 10.1073/pnas.94.22.11839; Gauzzi MC, 1996, J BIOL CHEM, V271, P20494, DOI 10.1074/jbc.271.34.20494; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; Kohlhuber F, 1997, MOL CELL BIOL, V17, P695, DOI 10.1128/MCB.17.2.695; Kotenko SV, 1997, EMBO J, V16, P5894, DOI 10.1093/emboj/16.19.5894; LUTFALLA G, 1995, EMBO J, V14, P5100, DOI 10.1002/j.1460-2075.1995.tb00192.x; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; NOVICK D, 1994, CELL, V77, P391, DOI 10.1016/0092-8674(94)90154-6; PELLEGRINI S, 1989, MOL CELL BIOL, V9, P4605, DOI 10.1128/MCB.9.11.4605; Pellegrini S, 1997, EUR J BIOCHEM, V248, P615, DOI 10.1111/j.1432-1033.1997.00615.x; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; UZE G, 1990, CELL, V60, P225, DOI 10.1016/0092-8674(90)90738-Z; UZE G, 1995, J INTERF CYTOK RES, V15, P3, DOI 10.1089/jir.1995.15.3; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; VELAZQUEZ L, 1995, J BIOL CHEM, V270, P3327, DOI 10.1074/jbc.270.7.3327; Yan H, 1998, J BIOL CHEM, V273, P4046, DOI 10.1074/jbc.273.7.4046; Yan H, 1996, MOL CELL BIOL, V16, P2074; ZHAO YM, 1995, J BIOL CHEM, V270, P13814, DOI 10.1074/jbc.270.23.13814; Ziemiecki Andrew, 1994, Trends in Cell Biology, V4, P207, DOI 10.1016/0962-8924(94)90143-0; Zou J, 1997, J BIOL CHEM, V272, P6073, DOI 10.1074/jbc.272.9.6073	29	76	77	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24723	24729		10.1074/jbc.273.38.24723	http://dx.doi.org/10.1074/jbc.273.38.24723			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733772	Green Published, hybrid			2022-12-27	WOS:000076007300064
J	Okazaki, IJ; Moss, J				Okazaki, IJ; Moss, J			Glycosylphosphatidylinositol-anchored and secretory isoforms of mono-ADP-ribosyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NICOTINAMIDE ADENINE-DINUCLEOTIDE; RIBOSYLATING BACTERIAL TOXINS; LYMPHOCYTE ALLOANTIGEN RT6.1; NAD GLYCOHYDROLASE ACTIVITY; SKELETAL-MUSCLE CELLS; POLY(ADP-RIBOSE) POLYMERASE; NITRIC-OXIDE; MOLECULAR CHARACTERIZATION; TURKEY ERYTHROCYTES; ADENYLATE-CYCLASE		NHLBI, Pulm Crit Care Med Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Okazaki, IJ (corresponding author), NHLBI, Pulm Crit Care Med Branch, NIH, Bldg 10,Rm 5N307,10 Ctr Dr MSC 1434, Bethesda, MD 20892 USA.							Allport JR, 1996, BRIT J CLIN PHARMACO, V42, P99, DOI 10.1046/j.1365-2125.1996.37014.x; Allport JR, 1996, BRIT J PHARMACOL, V118, P1111, DOI 10.1111/j.1476-5381.1996.tb15513.x; BANASIK M, 1992, J BIOL CHEM, V267, P1569; Bell CE, 1996, BIOCHEMISTRY-US, V35, P1137, DOI 10.1021/bi9520848; Boulias C, 1995, NEUROCHEM RES, V20, P1269, DOI 10.1007/BF00992501; BURSTEIN D, 1989, DIABETES, V38, P24, DOI 10.2337/diabetes.38.1.24; CARROLL SF, 1987, J BIOL CHEM, V262, P8707; CHAO D, 1994, BIOCHEM CELL BIOL, V72, P391, DOI 10.1139/o94-052; COGGINS PJ, 1993, FEBS LETT, V335, P109, DOI 10.1016/0014-5793(93)80450-9; DAVIS T, 1995, GENE, V164, P371, DOI 10.1016/0378-1119(95)00504-Y; DEMATTEIS MA, 1994, P NATL ACAD SCI USA, V91, P1114, DOI 10.1073/pnas.91.3.1114; DEMURCIA G, 1994, MOL CELL BIOCHEM, V138, P15, DOI 10.1007/BF00928438; Domenighini M, 1996, MOL MICROBIOL, V21, P667, DOI 10.1046/j.1365-2958.1996.321396.x; DONNELLY LE, 1992, BIOCHEM J, V288, P331, DOI 10.1042/bj2880331; DUMAN RS, 1991, J NEUROCHEM, V57, P2124, DOI 10.1111/j.1471-4159.1991.tb06431.x; FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; Fishman P.H., 1990, ADP RIBOSYLATING TOX, P127; FUJITA H, 1995, INT J BIOCHEM CELL B, V27, P1065, DOI 10.1016/1357-2725(95)00070-6; GREINER DL, 1987, J EXP MED, V166, P461, DOI 10.1084/jem.166.2.461; GREINER DL, 1986, J IMMUNOL, V136, P148; GUNTER KC, 1987, NATURE, V326, P505, DOI 10.1038/326505a0; HAAG F, 1995, EUR J IMMUNOL, V25, P2355, DOI 10.1002/eji.1830250835; Hara N, 1996, J BIOL CHEM, V271, P29552, DOI 10.1074/jbc.271.47.29552; JACOBSON MK, 1990, J BIOL CHEM, V265, P10825; KHARADIA SV, 1992, EXP CELL RES, V201, P33, DOI 10.1016/0014-4827(92)90345-9; Kim HJ, 1997, J BIOL CHEM, V272, P8918; KochNolte F, 1997, GENOMICS, V39, P370, DOI 10.1006/geno.1996.4520; KochNolte F, 1996, IMMUNOL TODAY, V17, P402, DOI 10.1016/0167-5699(96)30023-6; KochNolte F, 1996, J BIOL CHEM, V271, P7686, DOI 10.1074/jbc.271.13.7686; KochNolte F, 1996, GENOMICS, V36, P215, DOI 10.1006/geno.1996.0451; Levy I, 1996, FEBS LETT, V382, P276, DOI 10.1016/0014-5793(96)00183-4; Li M, 1996, P NATL ACAD SCI USA, V93, P6902, DOI 10.1073/pnas.93.14.6902; Maehama T, 1996, FEBS LETT, V388, P189, DOI 10.1016/0014-5793(96)00568-6; MAEHAMA T, 1995, J BIOL CHEM, V270, P22747, DOI 10.1074/jbc.270.39.22747; MARSISCHKY GT, 1992, ADP RIBOSYLATION REA, P47; MATSUYAMA S, 1991, J NEUROCHEM, V57, P1380, DOI 10.1111/j.1471-4159.1991.tb08304.x; MCDONALD LJ, 1993, P NATL ACAD SCI USA, V90, P6238, DOI 10.1073/pnas.90.13.6238; MCDONALD LJ, 1992, BIOCHEMISTRY-US, V31, P11881, DOI 10.1021/bi00162a029; MCDONALD LJ, 1993, J BIOL CHEM, V268, P17878; MOSS J, 1978, P NATL ACAD SCI USA, V75, P3621, DOI 10.1073/pnas.75.8.3621; MOSS J, 1980, J BIOL CHEM, V255, P5838; MOSS J, 1992, J BIOL CHEM, V267, P10481; Moss J, 1997, J BIOL CHEM, V272, P4342, DOI 10.1074/jbc.272.7.4342; MOSS J, 1995, J BIOL CHEM, V270, P12327, DOI 10.1074/jbc.270.21.12327; Nemoto E, 1996, J IMMUNOL, V157, P3341; NESTLER EJ, 1995, J NEUROCHEM, V64, P2319; Okazaki IJ, 1996, J BIOL CHEM, V271, P22052, DOI 10.1074/jbc.271.36.22052; Okazaki IJ, 1996, BLOOD, V88, P915; OKAZAKI IJ, 1994, BIOCHEMISTRY-US, V33, P12828, DOI 10.1021/bi00209a014; QUIST EE, 1994, J MOL CELL CARDIOL, V26, P251, DOI 10.1006/jmcc.1994.1028; Rigby MR, 1996, J IMMUNOL, V156, P4259; ROBINSON PJ, 1989, NATURE, V342, P85, DOI 10.1038/342085a0; Ruf A, 1996, P NATL ACAD SCI USA, V93, P7481, DOI 10.1073/pnas.93.15.7481; SAXTY BA, 1995, BIOCHEM J, V310, P931, DOI 10.1042/bj3100931; SCHUMAN EM, 1994, P NATL ACAD SCI USA, V91, P11958, DOI 10.1073/pnas.91.25.11958; SIXMA TK, 1993, J MOL BIOL, V230, P890, DOI 10.1006/jmbi.1993.1209; TAKADA T, 1994, J BIOL CHEM, V269, P9420; TAKADA T, 1995, J BIOL CHEM, V270, P541, DOI 10.1074/jbc.270.2.541; TAKADA T, 1993, J BIOL CHEM, V268, P17837; TANUMA S, 1988, J BIOL CHEM, V263, P5485; Trucco C, 1996, FEBS LETT, V399, P313, DOI 10.1016/S0014-5793(96)01347-6; TSUCHIYA M, 1994, MOL CELL BIOCHEM, V138, P113, DOI 10.1007/BF00928451; VEDIA LMY, 1989, BIOCHEM J, V261, P841, DOI 10.1042/bj2610841; Wang J, 1996, J IMMUNOL, V156, P2819; WEST RE, 1986, BIOCHEMISTRY-US, V25, P8057, DOI 10.1021/bi00372a039; Williamson K., 1990, ADP RIBOSYLATING TOX, P493; YOST DA, 1983, J BIOL CHEM, V258, P4926; ZOLKIEWSKA A, 1993, J BIOL CHEM, V268, P25273; ZOLKIEWSKA A, 1995, J BIOL CHEM, V270, P9227, DOI 10.1074/jbc.270.16.9227; ZOLKIEWSKA A, 1992, P NATL ACAD SCI USA, V89, P11352, DOI 10.1073/pnas.89.23.11352	70	70	74	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23617	23620		10.1074/jbc.273.37.23617	http://dx.doi.org/10.1074/jbc.273.37.23617			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726960	hybrid			2022-12-27	WOS:000075893100001
J	Thomas, NSB; Pizzey, AR; Tiwari, SJ; Williams, CD; Yang, JW				Thomas, NSB; Pizzey, AR; Tiwari, SJ; Williams, CD; Yang, JW			p130, p107, and pRb are differentially regulated in proliferating cells and during cell cycle arrest by alpha-interferon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE HEMATOPOIETIC-CELLS; KINASE INHIBITOR P21; S-PHASE ENTRY; RETINOBLASTOMA PROTEIN; DAUDI CELLS; GROWTH SUPPRESSION; RB PROTEIN; IN-VIVO; C-MYC; DEREGULATED EXPRESSION	We have determined how the phosphorylation of the retinoblastoma family (pRb, p107, and p130) is governed in individual cell cycle phases of Daudi B-cells during cell cycle exit triggered by alpha-interferon (alpha-IFN). alpha-IFN causes dephosphorylation of pRb and loss of p130 phosphorylated Form 3. However, the change in p130 phosphorylation in response to alpha-IFN occurs before dephosphorylation of pRb is complete because loss of p130 Form 3 occurs throughout the cell cycle prior to complete arrest in G(1), whereas pRb is dephosphorylated only in G(1). In contrast, p107 is dephosphorylated and is then depleted from cells as they exit the cell cycle. p130, predominantly in Form 1, and hypophosphorylated pRb bind an E2F DNA binding site; p130 complexes E2F-4, whereas pRb binds both E2F-4 and E2F-1, The phosphorylated forms of E2F-4 that bind to the E2F DNA site are different from hyperphosphorylated E2F-4, which predominates in primary hemopoietic cells in G(1). We conclude that although cell cycle arrest induced by alpha-IFN may be mediated in part by formation of a complex containing p130 and E2F-4, alpha-IFN does not induce hyperphosphorylation of E2F-4, which characterizes primary hemopoietic cells in G(1).	Univ Coll & Middlesex Sch Med, Dept Haematol, London WC1E 6HX, England	University of London; University College London	Thomas, NSB (corresponding author), Univ Coll & Middlesex Sch Med, Dept Haematol, 98 Chenie Mews, London WC1E 6HX, England.		Tiwari, Sanjay/Q-1853-2016; Pizzey, Arnold/E-6301-2015	Tiwari, Sanjay/0000-0002-3804-3300; Pizzey, Arnold/0000-0003-1850-1121				ARANY I, 1994, ANTIVIR RES, V23, P131, DOI 10.1016/0166-3542(94)90040-X; BARON S, 1991, JAMA-J AM MED ASSOC, V266, P1375, DOI 10.1001/jama.266.10.1375; BEIJERSBERGEN RL, 1994, EMBO J, V13, P4080, DOI 10.1002/j.1460-2075.1994.tb06725.x; BEIJERSBERGEN RL, 1995, GENE DEV, V9, P1340, DOI 10.1101/gad.9.11.1340; BEIJERSBERGEN RL, 1994, GENE DEV, V8, P2680, DOI 10.1101/gad.8.22.2680; BURKE LC, 1992, ONCOGENE, V7, P783; CHITTENDEN T, 1993, MOL CELL BIOL, V13, P3975, DOI 10.1128/MCB.13.7.3975; Choubey D, 1996, EMBO J, V15, P5668, DOI 10.1002/j.1460-2075.1996.tb00951.x; CLAUDIO PP, 1994, CANCER RES, V54, P5556; DALTON S, 1992, EMBO J, V11, P1797, DOI 10.1002/j.1460-2075.1992.tb05231.x; DARZYNKIEWICZ Z, 1982, J CELL PHYSIOL, V113, P465, DOI 10.1002/jcp.1041130316; DECAPRIO JA, 1992, P NATL ACAD SCI USA, V89, P1796; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; DENT CL, 1991, J BIOL CHEM, V266, P20888; DEVALIA V, 1992, BLOOD, V80, P68; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; DYSON N, 1993, J VIROL, V67, P7641, DOI 10.1128/JVI.67.12.7641-7647.1993; EINAT M, 1985, NATURE, V313, P597, DOI 10.1038/313597a0; EWEN ME, 1992, SCIENCE, V255, P85, DOI 10.1126/science.1532457; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; FAHA B, 1992, SCIENCE, V255, P87, DOI 10.1126/science.1532458; GINSBERG D, 1994, GENE DEV, V8, P2665, DOI 10.1101/gad.8.22.2665; GOODRICH DW, 1993, BIOCHIM BIOPHYS ACTA, V1155, P43, DOI 10.1016/0304-419X(93)90021-4; HAASKOGAN DA, 1995, EMBO J, V14, P461, DOI 10.1002/j.1460-2075.1995.tb07022.x; HAMEL PA, 1993, FASEB J, V7, P846, DOI 10.1096/fasebj.7.10.8344484; HANNON GJ, 1993, GENE DEV, V7, P2378, DOI 10.1101/gad.7.12a.2378; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Haspel RL, 1996, EMBO J, V15, P6262, DOI 10.1002/j.1460-2075.1996.tb01016.x; HIJMANS EM, 1995, MOL CELL BIOL, V15, P3082; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Hobeika AC, 1997, ONCOGENE, V14, P1165, DOI 10.1038/sj.onc.1200939; Ikeda M, 1996, P NATL ACAD SCI USA, V93, P3215, DOI 10.1073/pnas.93.8.3215; Iwase S, 1997, J BIOL CHEM, V272, P12406, DOI 10.1074/jbc.272.19.12406; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; Kim TK, 1996, SCIENCE, V273, P1717, DOI 10.1126/science.273.5282.1717; KOWALIK TF, 1995, J VIROL, V69, P2491, DOI 10.1128/JVI.69.4.2491-2500.1995; Kuniyasu H, 1997, CELL GROWTH DIFFER, V8, P47; LAM EWF, 1994, CURR OPIN CELL BIOL, V6, P859; LEES E, 1992, GENE DEV, V6, P1874, DOI 10.1101/gad.6.10.1874; LEES JA, 1993, MOL CELL BIOL, V13, P7813, DOI 10.1128/MCB.13.12.7813; LI Y, 1993, GENE DEV, V7, P2366, DOI 10.1101/gad.7.12a.2366; Lukas J, 1996, MOL CELL BIOL, V16, P1047; Mayol X, 1996, ONCOGENE, V13, P237; MAYOL X, 1995, ONCOGENE, V11, P801; MELAMED D, 1993, MOL CELL BIOL, V13, P5255, DOI 10.1128/MCB.13.9.5255; Moberg K, 1996, MOL CELL BIOL, V16, P1436; Nasmyth K, 1996, NATURE, V382, P28, DOI 10.1038/382028a0; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; QUIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918; Raveh T, 1996, J BIOL CHEM, V271, P25479, DOI 10.1074/jbc.271.41.25479; RESNITZKY D, 1992, P NATL ACAD SCI USA, V89, P402, DOI 10.1073/pnas.89.1.402; Sangfelt O, 1997, ONCOGENE, V14, P415, DOI 10.1038/sj.onc.1200832; SHAN B, 1994, MOL CELL BIOL, V14, P8166, DOI 10.1128/MCB.14.12.8166; SHIRODKAR S, 1992, CELL, V68, P157, DOI 10.1016/0092-8674(92)90214-W; Smith EJ, 1996, MOL CELL BIOL, V16, P6965; Subramaniam PS, 1997, J INTERF CYTOK RES, V17, P11, DOI 10.1089/jir.1997.17.11; Taya Y, 1997, TRENDS BIOCHEM SCI, V22, P14, DOI 10.1016/S0968-0004(96)10070-0; THOMAS NSB, 1991, ONCOGENE, V6, P317; Thomas NSB, 1999, TEXTBOOK OF MALIGNANT HAEMATOLOGY, P133; THOMAS NSB, 1989, J BIOL CHEM, V264, P13697; Tiefenbrun N, 1996, MOL CELL BIOL, V16, P3934; TIWARI S, 1996, PROTEIN PHOSPHORYLAT, P255; TOMMASI S, 1995, MOL CELL BIOL, V15, P6901; VARIO G, 1995, GENE DEV, V9, P869; Verona R, 1997, MOL CELL BIOL, V17, P7268, DOI 10.1128/MCB.17.12.7268; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WELCH PJ, 1992, P NATL ACAD SCI USA, V89, P3093, DOI 10.1073/pnas.89.7.3093; WHYTE P, 1995, APOPTOSIS CELL CYCLE, P77; Williams CD, 1997, BRIT J HAEMATOL, V96, P688, DOI 10.1046/j.1365-2141.1997.d01-2086.x; Williams CD, 1997, BLOOD, V90, P194; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; YAMADA H, 1994, MOL CELL BIOCHEM, V136, P117, DOI 10.1007/BF00926071; Yamada H, 1995, MOL CELL BIOCHEM, V152, P149, DOI 10.1007/BF01076077; Zetterberg A, 1996, APOPTOSIS CELL CYCLE, P17; ZHANG KR, 1994, BIOCHEM BIOPH RES CO, V200, P522, DOI 10.1006/bbrc.1994.1479; ZHU L, 1995, EMBO J, V14, P1904, DOI 10.1002/j.1460-2075.1995.tb07182.x; ZHU L, 1993, GENE DEV, V7, P1111, DOI 10.1101/gad.7.7a.1111	77	43	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23659	23667		10.1074/jbc.273.37.23659	http://dx.doi.org/10.1074/jbc.273.37.23659			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726970	hybrid			2022-12-27	WOS:000075893100011
J	Lorenzo, P; Neame, P; Sommarin, Y; Heinegard, D				Lorenzo, P; Neame, P; Sommarin, Y; Heinegard, D			Cloning and deduced amino acid sequence of a novel cartilage protein (CILP) identifies a preform including a nucleotide pyrophosphohydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTICULAR-CARTILAGE; MESSENGER-RNA; THROMBOSPONDIN; CHONDROCYTE; CLEAVAGE; EXPRESSION; COLLAGEN; BINDING; SIGNAL; SITES	The cDNA cloning and expression in vitro and in eukaryotic cells of a novel protein isolated from human articular cartilage, cartilage intermediate layer protein (CILP) is described. A single 4.2-kilobase mRNA detected in human articular cartilage encodes a polypeptide of 1184 amino acids with a calculated molecular mass of 132.5 kDa, The protein has a putative signal peptide of 21 amino acids, and is a preform of two polypeptides. The amino-terminal half corresponds to CILP (molecular mass of 78.5 kDa, not including post-translational modifications) and the carboxyl-terminal half corresponds to a protein homologous to a porcine nucleotide pyrophosphohydrolase, NTPPHase (molecular mass of 51.8 kDa, not including post-translational modifications). CILP has SO cysteines and six putative N-glycosylation sites. The human homolog of porcine NTPPHase described here contains 10 cysteine residues and two putative N-glycosylation sites. In the precursor protein the NTPPHase region is immediately preceded by a tetrapeptide conforming to a furin proteinase cleavage consensus sequence. Expression of the full-length cDNA in a cell-free translation system and in COS-7 or EBNA cells indicates that the precursor protein is synthesized as a single polypeptide chain that is processed, possibly by a furin-like protease, into two polypeptides upon or preceding secretion.	Lund Univ, Dept Cell & Mol Biol, Sect Connect Tissue Biol, S-22100 Lund, Sweden; Shriners Hosp Crippled Children, Dept Biochem & Mol Biol, Tampa, FL 33612 USA	Lund University	Heinegard, D (corresponding author), Lund Univ, Dept Cell & Mol Biol, Sect Connect Tissue Biol, POB 94, S-22100 Lund, Sweden.	Dick.Heinegard@medkem.lu.se						ADAMS ME, 1992, ANAL BIOCHEM, V202, P89, DOI 10.1016/0003-2697(92)90211-O; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BENGTSSON E, 1995, J BIOL CHEM, V270, P25639, DOI 10.1074/jbc.270.43.25639; CHAMBERLAIN JP, 1979, ANAL BIOCHEM, V98, P132, DOI 10.1016/0003-2697(79)90716-4; CHARLES IG, 1993, P NATL ACAD SCI USA, V90, P11419, DOI 10.1073/pnas.90.23.11419; GUO NH, 1992, J BIOL CHEM, V267, P19349; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; HEDLUND H, 1993, APMIS, V101, P133, DOI 10.1111/j.1699-0463.1993.tb00092.x; Heinegard D, 1998, WENN GR INT, V72, P113; Heinegard D, 1998, OSTEOARTHRITIS, P74; HOSAKA M, 1991, J BIOL CHEM, V266, P12127; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWLER J, 1986, J CELL BIOL, V103, P1635, DOI 10.1083/jcb.103.5.1635; LEE CC, 1992, METHOD ENZYMOL, V216, P69; Lorenzo P, 1998, J BIOL CHEM, V273, P23463, DOI 10.1074/jbc.273.36.23463; Masuda I, 1997, GENE, V197, P277, DOI 10.1016/S0378-1119(97)00272-2; MASUDA I, 1995, J CLIN INVEST, V95, P699, DOI 10.1172/JCI117716; MILLER RR, 1988, BIOCHEM BIOPH RES CO, V153, P708, DOI 10.1016/S0006-291X(88)81152-5; NEAME PJ, 1994, J BIOL CHEM, V269, P21547; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; Sambrook J., 2002, MOL CLONING LAB MANU; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683	24	56	65	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23469	23475		10.1074/jbc.273.36.23469	http://dx.doi.org/10.1074/jbc.273.36.23469			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722584	hybrid			2022-12-27	WOS:000075778100084
J	Park, JI; Grant, CM; Davies, MJ; Dawes, IW				Park, JI; Grant, CM; Davies, MJ; Dawes, IW			The cytoplasmic Cu,Zn superoxide dismutase of Saccharomyces cerevisiae is required for resistance to freeze-thaw stress - Generation of free radicals during freezing and thawing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL RESPIRATORY-CHAIN; OXIDATIVE STRESS; IN-VIVO; YEAST; GENE; GLUTATHIONE; PROTECTION; ANTIOXIDANTS; BIOLOGY; GROWTH	The involvement of oxidative stress in freeze-thaw injury to yeast cells was analyzed using mutants defective in a range of antioxidant functions, including Cu,Zn superoxide dismutase (encoded by SOD1), Mn superoxide dismutase (SOD2), catalase A, catalase T, glutathione reductase, gamma-glutamylcysteine synthetase and Yap1 transcription factor. Only those affecting superoxide dismutases showed decreased freeze-thaw tolerance, with the sod1 mutant and the sod1 sod2 double mutant being most affected. This indicated that superoxide anions were formed during freezing and thawing. This was confirmed since the sod1 mutant could be made more resistant by treatment with the superoxide anion scavenger MnCl2, or by freezing in the absence of oxygen, or by the generation of a rho(0) petite. Increased expression of SOD2 conferred freeze-thaw tolerance on the sod1 mutant indicating the ability of the mitochondrial superoxide dismutase to compensate for the lack of the cytoplasmic enzyme. Free radicals generated as a result of freezing and thawing were detected in cells directly using electron paramagnetic resonance spectroscopy with either alpha-phenyl-N-tert-butylnitrone or 5,5-dimethyl-1-pyrroline-N-oxide as spin trap. Highest levels were formed in the sod1 and sod1 sod2 mutant strains, but lower levels were detected in the wild type. The results show that oxidative stress causes major injury to cells during aerobic freezing and thawing and that this is mainly initiated in the cytoplasm by an oxidative burst of superoxide radicals formed from oxygen and electrons leaked from the mitochondrial electron transport chain.	Univ New S Wales, Sch Biochem & Mol Genet, Sydney, NSW 2052, Australia; Univ New S Wales, Cooperat Res Ctr Food Ind Innovat, Sydney, NSW 2052, Australia; Heart Res Inst, Sydney, NSW 2050, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; Heart Research Institute	Dawes, IW (corresponding author), Univ New S Wales, Sch Biochem & Mol Genet, Sydney, NSW 2052, Australia.	I.Dawes@unsw.edu.au	Davies, Michael J/H-4939-2011; Davies, Michael/GWV-2527-2022; Davies, Michael/AGX-9184-2022	Davies, Michael J/0000-0002-5196-6919; Davies, Michael/0000-0002-5196-6919; Park, Jong-In/0000-0001-7248-4735; Grant, Chris/0000-0002-0616-6576				AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; ARCHIBALD FS, 1982, ARCH BIOCHEM BIOPHYS, V214, P452, DOI 10.1016/0003-9861(82)90049-2; BUETTNER GR, 1987, FREE RADICAL BIO MED, V3, P259, DOI 10.1016/S0891-5849(87)80033-3; CHANG EC, 1991, J BIOL CHEM, V266, P4417; CHAPUT M, 1983, BIOCHIMIE, V65, P501, DOI 10.1016/S0300-9084(83)80132-1; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; CLEGG JS, 1982, CRYOBIOLOGY, V19, P306, DOI 10.1016/0011-2240(82)90159-6; CULOTTA VC, 1995, J BIOL CHEM, V270, P29991; DEVRIES S, 1987, BIOCHIM BIOPHYS ACTA, V895, P205, DOI 10.1016/S0304-4173(87)80003-4; FlatteryOBrien JA, 1997, MOL MICROBIOL, V23, P303, DOI 10.1046/j.1365-2958.1997.2121581.x; FRANKS F, 1983, CRYOBIOLOGY, V20, P298, DOI 10.1016/0011-2240(83)90018-4; FRIDOVICH I, 1989, J BIOL CHEM, V264, P7761; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; GEITZ D, 1992, NUCLEIC ACIDS RES, V20, P1425; Gille G, 1995, FOLIA MICROBIOL, V40, P131, DOI 10.1007/BF02815413; GOUNALAKI N, 1994, EMBO J, V13, P4036, DOI 10.1002/j.1460-2075.1994.tb06720.x; GRALLA EB, 1997, OXIDATIVE STRESS MOL, P495; Grant CM, 1996, REDOX REP, V2, P223, DOI 10.1080/13510002.1996.11747054; Grant CM, 1996, CURR GENET, V29, P511, DOI 10.1007/BF02426954; Grant CM, 1996, MOL MICROBIOL, V21, P171, DOI 10.1046/j.1365-2958.1996.6351340.x; GUIDOT DM, 1993, J BIOL CHEM, V268, P26699; GUTTERIDGE JMC, 1994, CHEM-BIOL INTERACT, V91, P133, DOI 10.1016/0009-2797(94)90033-7; HALLIWELL B, 1995, FOOD CHEM TOXICOL, V33, P601, DOI 10.1016/0278-6915(95)00024-V; HALLIWELL B, 1986, ARCH BIOCHEM BIOPHYS, V246, P501, DOI 10.1016/0003-9861(86)90305-X; HALLIWELL B, 1987, FREE RADICAL BIO MED, P20; Jacob RA, 1996, AM J CLIN NUTR, V63, P985; LEVITT J, 1966, CRYOBIOLOGY, P495; LIU XF, 1994, MOL CELL BIOL, V14, P7037, DOI 10.1128/MCB.14.11.7037; Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275; LYNCH RE, 1978, J BIOL CHEM, V253, P4697; MAZUR P, 1970, SCIENCE, V168, P939, DOI 10.1126/science.168.3934.939; MoradasFerreira P, 1996, MOL MICROBIOL, V19, P651, DOI 10.1046/j.1365-2958.1996.403940.x; Park JI, 1997, APPL ENVIRON MICROB, V63, P3818, DOI 10.1128/AEM.63.10.3818-3824.1997; Rock CL, 1996, J AM DIET ASSOC, V96, P693, DOI 10.1016/S0002-8223(96)00190-3; ROSE M, 1983, METHOD ENZYMOL, V101, P167; Roy R.S., 1983, CELLULAR MED ASPECTS, VII, P145; RUIS H, 1997, OXIDATIVE STRESS MOL, P309; Sambrook J., 2002, MOL CLONING LAB MANU; Scandalios JG, 1992, MOL BIOL FREE RADICA, P117; SCOTT MD, 1987, J BIOL CHEM, V262, P3640; Sherman F., 1986, METHODS YEAST GENETI; SPENCER JFT, 1988, YEAST PRACTICAL APPR, P65; STAVELEY BE, 1990, GENOME, V33, P867, DOI 10.1139/g90-130; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; WU AL, 1993, J BIOL CHEM, V268, P18850; [No title captured]	48	109	111	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					22921	22928		10.1074/jbc.273.36.22921	http://dx.doi.org/10.1074/jbc.273.36.22921			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722512	hybrid			2022-12-27	WOS:000075778100012
J	Pouponnot, C; Jayaraman, L; Massague, J				Pouponnot, C; Jayaraman, L; Massague, J			Physical and functional interaction of SMADs and p300/CBP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; MAD-RELATED PROTEIN; ADENOVIRUS E1A PROTEINS; FAMILY MEDIATOR SMAD1; SIGNALING PATHWAYS; TUMOR-SUPPRESSOR; BINDING; TRANSCRIPTION; RECEPTOR; CBP	SMADs are transforming growth factor beta (TGF-beta) receptor substrates and mediators of TGF-beta transcriptional responses. Here we provide evidence that the coactivators p300 and CBP interact with Smads 1 through 4. The biological relevance of this interaction is shown in vivo by overexpression of the adenovirus E1A protein and mutant forms of E1A that lack p300-binding sites. Wild-type EIA, but not the mutants, inhibits SMAD-dependent transcriptional responses to TGF-beta. E1A also inhibits the intrinsic transactivating function of the Smad4 MH2 domain. In addition, overexpression of p300 enhances SMAD-dependent transactivation. Our results suggest a role for p300/CBP in SMAD-mediated transcriptional activation and provide an explanation for the observed ability of E1A to interfere with TGF-beta action.	Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, Box 116,1275 York Ave, New York, NY 10021 USA.			Massague, Joan/0000-0001-9324-8408	NATIONAL CANCER INSTITUTE [R01CA034610, R37CA034610] Funding Source: NIH RePORTER; NCI NIH HHS [CA34610] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABRAHAM SE, 1992, MOL BIOL CELL, V3, P655, DOI 10.1091/mbc.3.6.655; Baker JC, 1996, GENE DEV, V10, P1880, DOI 10.1101/gad.10.15.1880; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; BANNISTER AJ, 1995, EMBO J, V14, P4758, DOI 10.1002/j.1460-2075.1995.tb00157.x; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; COUSSENS LM, 1994, J CELL PHYSL, V160, P534; Das P, 1998, DEVELOPMENT, V125, P1519; Datto MB, 1997, MOL CELL BIOL, V17, P2030, DOI 10.1128/MCB.17.4.2030; DEGROOT RP, 1995, CELL GROWTH DIFFER, V6, P531; Eckner R, 1996, BIOL CHEM, V377, P685; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; EGAN C, 1988, MOL CELL BIOL, V8, P3955, DOI 10.1128/MCB.8.9.3955; Graff JM, 1996, CELL, V85, P479, DOI 10.1016/S0092-8674(00)81249-0; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Hata A, 1997, NATURE, V388, P82, DOI 10.1038/40424; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; HUANG HC, 1995, EMBO J, V14, P5965, DOI 10.1002/j.1460-2075.1995.tb00285.x; Hudson JB, 1998, DEVELOPMENT, V125, P1407; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Janknecht R, 1996, CURR BIOL, V6, P951, DOI 10.1016/S0960-9822(02)00636-X; Kim DH, 1997, J BIOL CHEM, V272, P688; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; LILLIE JW, 1989, NATURE, V338, P39, DOI 10.1038/338039a0; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Lo RS, 1998, EMBO J, V17, P996, DOI 10.1093/emboj/17.4.996; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MISSERO C, 1991, P NATL ACAD SCI USA, V88, P3489, DOI 10.1073/pnas.88.8.3489; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nakao A, 1997, J BIOL CHEM, V272, P2896, DOI 10.1074/jbc.272.5.2896; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; PIETENPOL JA, 1990, CELL, V61, P777, DOI 10.1016/0092-8674(90)90188-K; SEKELSKY JJ, 1995, GENETICS, V139, P1347; Shi YG, 1997, NATURE, V388, P87, DOI 10.1038/40431; Shikama N, 1997, TRENDS CELL BIOL, V7, P230, DOI 10.1016/S0962-8924(97)01048-9; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; WHYTE P, 1989, CELL, V56, P67, DOI 10.1016/0092-8674(89)90984-7; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; Wisotzkey RG, 1998, DEVELOPMENT, V125, P1433; WONG HK, 1994, J VIROL, V68, P4910, DOI 10.1128/JVI.68.8.4910-4920.1994; Yingling JM, 1996, P NATL ACAD SCI USA, V93, P8940, DOI 10.1073/pnas.93.17.8940; Yingling JM, 1997, MOL CELL BIOL, V17, P7019, DOI 10.1128/MCB.17.12.7019; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	51	281	289	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					22865	22868		10.1074/jbc.273.36.22865	http://dx.doi.org/10.1074/jbc.273.36.22865			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722503	hybrid			2022-12-27	WOS:000075778100003
J	Worth, L; Bader, T; Yang, J; Clark, S				Worth, L; Bader, T; Yang, J; Clark, S			Role of MutS ATPase activity in MutS,L-dependent block of in vitro strand transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECTED MISMATCH REPAIR; DNA-BASE PAIRS; NEGATIVE MUTATOR MUTATIONS; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; SACCHAROMYCES-CEREVISIAE; GENE; RECOMBINATION; PROTEIN; HOMOLOG	In addition to mismatch recognition, Escherichia coli MutS has an associated ATPase activity that is fundamental to repair. Hence, we have characterized two MutS mutant gene products to define the role of ATP hydrolysis in homeologous recombination. These mutants, denoted MutS501 and MutS506, have single point mutations within the Walker A motif, and rate constants for ATP hydrolysis are down 60-100-fold as compared with wild type. Both MutS501 and MutS506 retain mismatch binding and,unlike wild type, fail to relinquish this specificity in the presence of ATP, adenosine 5'-O-(thiotriphosphate), and adenosine 5'-(beta,gamma-imino)triphosphate. Both MutS501 and MutS506 blocked the level of strand transfer between M13 and fd DNAs, The level of inhibition varied between the mutants and corresponded with the relative affinities to a G/T mispair. Neither MutS501 nor MutS506, however, would afford complete block of full-length heteroduplex in the presence of MutL. DNase I footprinting data are consistent with these results, as the region of protection by MutS501 and MutS506 was unchanged in the presence of ATP and MutL. Taken together, these studies suggest that 1) MutS impedes RecA-mediated homeologous exchange as a distinct mismatch-provoked event and 2) the role of MutL is coupled to MutS-dependent ATP hydrolysis, These observations are in good agreement with the present model for E. coli methyl-directed mismatch repair.	NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA; Inst Mol Pathol, Res Inst Mol Pathol, A-1030 Vienna, Austria	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Worth, L (corresponding author), NIEHS, Mol Genet Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.							Abdulkarim F, 1996, J MOL BIOL, V260, P506, DOI 10.1006/jmbi.1996.0418; ALANI E, 1995, GENE DEV, V9, P234, DOI 10.1101/gad.9.2.234; Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; Aronshtam A, 1996, NUCLEIC ACIDS RES, V24, P2498, DOI 10.1093/nar/24.13.2498; AU KG, 1992, J BIOL CHEM, V267, P12142; Bawa S, 1997, CANCER RES, V57, P2715; Brosh RM, 1997, J BIOL CHEM, V272, P572; Buning H, 1996, ANAL BIOCHEM, V234, P227, DOI 10.1006/abio.1996.0078; COOPER DL, 1993, J BIOL CHEM, V268, P11823; Duckett DR, 1996, P NATL ACAD SCI USA, V93, P6443, DOI 10.1073/pnas.93.13.6443; FENG G, 1995, BIOTECHNIQUES, V19, P956; FENG WY, 1991, GENETICS, V129, P1007; FISHEL RA, 1986, J MOL BIOL, V188, P147, DOI 10.1016/0022-2836(86)90300-1; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; GRILLEY M, 1993, J BIOL CHEM, V268, P11830; HABER LT, 1991, EMBO J, V10, P2707, DOI 10.1002/j.1460-2075.1991.tb07815.x; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; HUGHES MJ, 1992, J BIOL CHEM, V267, P23876; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; LAHUE RS, 1988, MUTAT RES, V198, P37, DOI 10.1016/0027-5107(88)90037-1; LANGLEROUAULT F, 1987, EMBO J, V6, P1121, DOI 10.1002/j.1460-2075.1987.tb04867.x; LeClerc JE, 1996, SCIENCE, V274, P1208, DOI 10.1126/science.274.5290.1208; MATIC I, 1994, GENETICS, V136, P17; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; PaquisFlucklinger V, 1997, GENOMICS, V44, P188, DOI 10.1006/geno.1997.4857; PETIT MA, 1991, GENETICS, V129, P327; RAYSSIGUIER C, 1991, BIOCHIMIE, V73, P371, DOI 10.1016/0300-9084(91)90103-8; ROBERTS JD, 1991, P NATL ACAD SCI USA, V88, P3465, DOI 10.1073/pnas.88.8.3465; ROCA AI, 1990, CRIT REV BIOCHEM MOL, V25, P415, DOI 10.3109/10409239009090617; Roca AI, 1997, PROG NUCLEIC ACID RE, V56, P129, DOI 10.1016/S0079-6603(08)61005-3; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Schar P, 1997, GENETICS, V146, P1275; SELVA EM, 1995, GENETICS, V139, P1175; Smith J, 1996, P NATL ACAD SCI USA, V93, P4374, DOI 10.1073/pnas.93.9.4374; SU SS, 1986, P NATL ACAD SCI USA, V83, P5057, DOI 10.1073/pnas.83.14.5057; SU SS, 1988, J BIOL CHEM, V263, P6829; WATERS S, 1994, PROTEIN EXPRES PURIF, V5, P534, DOI 10.1006/prep.1994.1073; WINGFIELD PT, 1995, CURR PROTOCOLS PROTE, V1; WORTH L, 1994, P NATL ACAD SCI USA, V91, P3238, DOI 10.1073/pnas.91.8.3238; WU TH, 1994, J BACTERIOL, V176, P5393, DOI 10.1128/JB.176.17.5393-5400.1994; ZAHRT TC, 1994, J BACTERIOL, V176, P1527, DOI 10.1128/jb.176.5.1527-1529.1994	42	45	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23176	23182		10.1074/jbc.273.36.23176	http://dx.doi.org/10.1074/jbc.273.36.23176			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722547	hybrid			2022-12-27	WOS:000075778100047
J	Rouault, JP; Prevot, D; Berthet, C; Birot, AM; Billaud, M; Magaud, JP; Corbo, L				Rouault, JP; Prevot, D; Berthet, C; Birot, AM; Billaud, M; Magaud, JP; Corbo, L			Interaction of BTG1 and p53-regulated BTG2 gene products with mCaf1, the murine homolog of a component of the yeast CCR4 transcriptional regulatory complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL TRANSLOCATION GENE-1; NEURONAL PC12 CELLS; NERVE GROWTH-FACTOR; SACCHAROMYCES-CEREVISIAE; DEVELOPMENTAL EXPRESSION; PROTEIN; IDENTIFICATION; FAMILY; CLONING; SPT10	Both BTG1 and BTG2 are involved in cell-growth control. BTG2 expression is regulated by p53, and its inactivation in embryonic stem cells leads to the disruption of DNA damage-induced G(2)/M cell-cycle arrest. In order to investigate the mechanism underlying Btg-mediated functions, we looked for possible functional partners of Btg1 and Btg2. Using yeast two-hybrid screening, protein-binding assays, and transient transfection assays in HeLa cells, we demonstrated the physical in vitro and in vivo interaction of both Btg1 and Btg2 with the mouse protein mCaf1 (i.e. mouse CCR4-associated factor 1). mCaf1 was identified through its interaction with the CCR4 protein, a component of a general transcription multisubunit complex, which, in yeast, regulates the expression of different genes involved in cell-cycle regulation and progression, These data suggest that Btg proteins, through their association with mCaf1, may participate, either directly or indirectly, in the transcriptional regulation of the genes involved in the control of the cell cycle. Finally, we found that box B, one of two conserved domains which define the Btg family, plays a functional role, namely that it is essential to the Btg-mCaf1 interaction.	Ctr Leon Berard, INSERM, U453, F-69373 Lyon 08, France; Hop Edouard Herriot, Lab Cytogenet Mol, F-69373 Lyon, France; Univ Lyon 1, UMR 5641 CNRS, Genet Lab, F-69365 Lyon 1, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Corbo, L (corresponding author), Ctr Leon Berard, INSERM, U453, 28 Rue Laennec, F-69373 Lyon 08, France.		Billaud, Marc N/M-6954-2013; berthet, cyril/T-4842-2017	berthet, cyril/0000-0003-3166-3141				Abramovich C, 1997, EMBO J, V16, P260, DOI 10.1093/emboj/16.2.260; BRADBURY A, 1991, P NATL ACAD SCI USA, V88, P3353, DOI 10.1073/pnas.88.8.3353; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; DENIS CL, 1994, GENETICS, V138, P1005; DENIS CL, 1984, GENETICS, V108, P833; DENIS CL, 1990, GENETICS, V124, P283; Desbois C, 1996, SCIENCE, V273, P951, DOI 10.1126/science.273.5277.951; DOLLARD C, 1994, MOL CELL BIOL, V14, P5223, DOI 10.1128/MCB.14.8.5223; DRAPER MP, 1995, MOL CELL BIOL, V15, P3487; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FLETCHER BS, 1991, J BIOL CHEM, V266, P14511; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; Guehenneux F, 1997, LEUKEMIA, V11, P370, DOI 10.1038/sj.leu.2400599; HARPER JW, 1993, CELL, V75, P805; Holland ND, 1997, DEV DYNAM, V210, P11, DOI 10.1002/(SICI)1097-0177(199709)210:1<11::AID-AJA2>3.0.CO;2-4; IACOPETTI P, 1994, MECH DEVELOP, V47, P127, DOI 10.1016/0925-4773(94)90085-X; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Liu HY, 1997, EMBO J, V16, P5289, DOI 10.1093/emboj/16.17.5289; Liu HY, 1998, EMBO J, V17, P1096, DOI 10.1093/emboj/17.4.1096; Matsuda S, 1996, ONCOGENE, V12, P705; MCKENZIE EA, 1993, MOL GEN GENET, V240, P374, DOI 10.1007/BF00280389; MESNER PW, 1995, J NEUROSCI, V15, P7357; Montagnoli A, 1996, CELL GROWTH DIFFER, V7, P1327; Moser MJ, 1997, NUCLEIC ACIDS RES, V25, P5110, DOI 10.1093/nar/25.24.5110; NATSOULIS G, 1991, NEW BIOL, V3, P1249; RABURN DJ, 1995, ENDOCRINOLOGY, V136, P5769, DOI 10.1210/en.136.12.5769; RIMOKH R, 1991, GENE CHROMOSOME CANC, V3, P24, DOI 10.1002/gcc.2870030106; ROUAULT JP, 1992, EMBO J, V11, P1663, DOI 10.1002/j.1460-2075.1992.tb05213.x; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; SCHILD D, 1995, GENETICS, V140, P115; Suk K, 1997, IMMUNOLOGY, V91, P121, DOI 10.1046/j.1365-2567.1997.00235.x; Verdone L, 1997, J BIOL CHEM, V272, P30828, DOI 10.1074/jbc.272.49.30828; Waltzer L, 1996, J VIROL, V70, P5909, DOI 10.1128/JVI.70.9.5909-5915.1996; Wang SL, 1997, DEV BIOL, V188, P322, DOI 10.1006/dbio.1997.8655	35	119	126	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22563	22569		10.1074/jbc.273.35.22563	http://dx.doi.org/10.1074/jbc.273.35.22563			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712883	hybrid			2022-12-27	WOS:000075616600059
J	Potempa, J; Mikolajczyk-Pawlinska, J; Brassell, D; Nelson, D; Thogersen, IB; Enghild, JJ; Travis, J				Potempa, J; Mikolajczyk-Pawlinska, J; Brassell, D; Nelson, D; Thogersen, IB; Enghild, JJ; Travis, J			Comparative properties of two cysteine proteinases (gingipains R), the products of two related but individual genes of Porphyromonas gingivalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM DODECYL-SULFATE; BACTEROIDES-GINGIVALIS; ARG-GINGIPAIN; STRUCTURAL CHARACTERIZATION; POSSIBLE INVOLVEMENT; PERIODONTAL-DISEASE; MOLECULAR-CLONING; ACTIVE-SITE; PROTEASE; W50	Proteolytic enzymes produced by Porphyromonas gingivalis are important virulence factors of this periodontopathogen, Two of these enzymes, referred to as arginine-specific cysteine proteinases (gingipains R), are the product of two related genes, Here, we describe the purification of an enzyme translated hom the rgpB/rgp-2 gene (gingipain R2, RGP-S) and secreted as a single chain protein of 422 residues. The enzyme occurs in several isoforms differing in pI, molecular mass, mobility in gelatin zymography gels, and affinity to arginine-Sepharose. In comparison to the 95-kDa gingipain R1, a complex of catalytic and hemagglutinin/adhesin domains, RGP-2 showed five times lower proteolytic activity, although its activity on various P-1-arginine p-nitroanity, substrates was generally higher, Gingipains R amidolytic activity, but not general proteolytic activity, was stimulated by glycyl-glycine. However, in cases of limited proteolysis, such as the inactivation of alpha-1-anti-chymotrypsin, glycyl-glycine potentiated inhibitor cleavage, In contrast, alpha-1-proteinase inhibitor was not inactivated by gingipains R and only underwent proteolytic degradation during boiling in reducing SDS-polyacrylamide gel electrophoresis treatment buffer. Similarly, native type I collagen was completely resistant to cleavage by gingipains but readily degraded after denaturation, Together, these data explain much of the controversy regarding gingipains structure and substrate specificity and indicate that these enzymes function as P. gingivalis virulence factors by proteolysis of selected target proteins rather than random degradation of host connective tissue components.	Jagiellonian Univ, Inst Mol Biol, Dept Immunol & Microbiol, PL-31120 Krakow, Poland; Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	Jagiellonian University; Duke University; University System of Georgia; University of Georgia	Potempa, J (corresponding author), Jagiellonian Univ, Inst Mol Biol, Dept Immunol & Microbiol, PL-31120 Krakow, Poland.	potempa@arches.uga.edu	Nelson, Daniel C./I-2198-2012	Nelson, Daniel C./0000-0003-3248-4831; Enghild, Jan Johannes/0000-0001-9292-9172	NIDCR NIH HHS [DE 09761] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE009761] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Abrahamson M, 1997, J CLIN PATHOL-MOL PA, V50, P291, DOI 10.1136/mp.50.6.291; ADUSEOPOKU J, 1995, INFECT IMMUN, V63, P4744, DOI 10.1128/IAI.63.12.4744-4754.1995; BarkocyGallagher GA, 1996, J BACTERIOL, V178, P2734, DOI 10.1128/jb.178.10.2734-2741.1996; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; BEDI GS, 1994, J BIOL CHEM, V269, P599; BERGE A, 1995, J BIOL CHEM, V270, P9862, DOI 10.1074/jbc.270.17.9862; BLEEG HS, 1991, FEMS MICROBIOL ECOL, V85, P125; CHEN ZX, 1991, INFECT IMMUN, V59, P2846, DOI 10.1128/IAI.59.8.2846-2850.1991; CHEN ZX, 1992, J BIOL CHEM, V267, P18896; Curtis MA, 1996, INFECT IMMUN, V64, P2532, DOI 10.1128/IAI.64.7.2532-2539.1996; CURTIS MA, 1993, FEMS MICROBIOL LETT, V110, P167, DOI 10.1016/0378-1097(93)90461-A; Cutler Christopher W., 1995, Trends in Microbiology, V3, P45, DOI 10.1016/S0966-842X(00)88874-5; FLETCHER HM, 1994, INFECT IMMUN, V62, P4279, DOI 10.1128/IAI.62.10.4279-4286.1994; GRENIER D, 1989, INFECT IMMUN, V57, P3265, DOI 10.1128/IAI.57.11.3265-3269.1989; HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3; HINODE D, 1992, ARCH ORAL BIOL, V37, P859, DOI 10.1016/0003-9969(92)90120-W; HOLT SC, 1988, SCIENCE, V239, P55, DOI 10.1126/science.3336774; IMAMURA T, 1995, INFECT IMMUN, V63, P4877, DOI 10.1128/IAI.63.12.4877-4882.1995; IMAMURA T, 1994, J CLIN INVEST, V94, P361, DOI 10.1172/JCI117330; KADOWAKI T, 1994, J BIOL CHEM, V269, P21371; KAMINISHI H, 1993, FEMS MICROBIOL LETT, V114, P109, DOI 10.1016/0378-1097(93)90150-Z; KIRSZBAUM L, 1995, BIOCHEM BIOPH RES CO, V207, P424, DOI 10.1006/bbrc.1995.1205; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Mikolajczyk-Pawlinska J, 1998, BIOL CHEM, V379, P205, DOI 10.1515/bchm.1998.379.2.205; Nakayama K, 1996, J BACTERIOL, V178, P2818, DOI 10.1128/jb.178.10.2818-2824.1996; NAKAYAMA K, 1995, J BIOL CHEM, V270, P23619, DOI 10.1074/jbc.270.40.23619; Nakayama K, 1997, MICROBIOL IMMUNOL, V41, P185, DOI 10.1111/j.1348-0421.1997.tb01189.x; NISHIKATA M, 1991, BIOCHEM BIOPH RES CO, V178, P336, DOI 10.1016/0006-291X(91)91819-X; Nishikata M, 1995, BIOCHEM MOL BIOL INT, V37, P547; Okamoto K, 1996, J BIOCHEM-TOKYO, V120, P398; OKAMOTO K, 1995, ARCH BIOCHEM BIOPHYS, V316, P917, DOI 10.1006/abbi.1995.1123; Onoe T, 1995, MICROB PATHOGENESIS, V19, P351, DOI 10.1016/S0882-4010(96)80006-4; PAVLOFF N, 1995, J BIOL CHEM, V270, P1007, DOI 10.1074/jbc.270.3.1007; Pavloff N, 1997, J BIOL CHEM, V272, P1595, DOI 10.1074/jbc.272.3.1595; PERSSON CR, 1994, INFECT IMMUN, V62, P1026, DOI 10.1128/IAI.62.3.1026-1031.1994; PIKE R, 1994, J BIOL CHEM, V269, P406; Pike RN, 1996, J BACTERIOL, V178, P2876, DOI 10.1128/jb.178.10.2876-2882.1996; Potempa J, 1997, BIOL CHEM, V378, P223, DOI 10.1515/bchm.1997.378.3-4.223; POTEMPA J, 1995, INFECT IMMUN, V63, P1176, DOI 10.1128/IAI.63.4.1176-1182.1995; POTEMPA J, 1995, TRENDS MICROBIOL, V3, P430, DOI 10.1016/S0966-842X(00)88996-9; Potempa Jan, 1995, Perspectives in Drug Discovery and Design, V2, P445, DOI 10.1007/BF02172037; Rangarajan M, 1997, MOL MICROBIOL, V23, P955, DOI 10.1046/j.1365-2958.1997.2831647.x; Rangarajan M, 1997, BIOCHEM J, V323, P701, DOI 10.1042/bj3230701; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHAW JH, 1987, NEW ENGL J MED, V317, P996, DOI 10.1056/NEJM198710153171605; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; WIKSTROM M, 1994, J PERIODONTOL, V65, P47, DOI 10.1902/jop.1994.65.1.47; WILLIAMS DM, 1992, PATHOLOGY PERIODONTA; WILLIAMS RC, 1990, NEW ENGL J MED, V322, P373, DOI 10.1056/NEJM199002083220606; WINGROVE JA, 1992, J BIOL CHEM, V267, P18902	51	137	142	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21648	21657		10.1074/jbc.273.34.21648	http://dx.doi.org/10.1074/jbc.273.34.21648			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705298	hybrid			2022-12-27	WOS:000075492600032
J	Pomerance, M; Multon, MC; Parker, F; Venot, C; Blondeau, JP; Tocque, B; Schweighoffer, F				Pomerance, M; Multon, MC; Parker, F; Venot, C; Blondeau, JP; Tocque, B; Schweighoffer, F			Grb2 interaction with MEK-kinase 1 is involved in regulation of Jun-kinase activities in response to epidermal growth factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; RECEPTOR TYROSINE KINASES; MAP KINASE; SIGNAL-TRANSDUCTION; SH3 DOMAIN; RAS; PATHWAY; STRESS; BINDS; PHOSPHORYLATION	Epidermal growth factor (EGF) receptor was shown to be involved in the activation pathway of the stress-activated protein kinase/c-Jun NH2-terminal kinase (SAPK/JNK) cascade not only by EGF, but also by UV radiation or osmotic stress. This paper describes a specific interaction between the COOH-terminal SH3 domain of Grb2 and the NH2-terminal regulatory domain of MEKK1 in ER22 cells overexpressing the EGF receptor. This interaction results in the formation of a constitutive complex between Grb2 and MEKK1 in both proliferating and resting cells. EGF stimulation causes this complex to be rapidly and transiently recruited by Shc proteins. The subsequent release of the Grb2-MEKK1 complex from Shc proteins correlates with JNK activation. Transfection of the NH2-terminal regulatory domain of MEKK1 specifically inhibits EGF-dependent JNK activation indicating that Grb2 is involved in MEKK1 activation. Thus, adaptor proteins have a new role in the regulation of the SAPK/JNK cascade after EGF stimulation.	Fac Pharm Chatenay Malabry, INSERM, U486, F-92296 Chatenay Malabry, France; Rhone Poulenc Rorer, Ctr Rech Vitry Alfortville, F-94403 Vitry Sur Seine, France; Exonhit Therapeut, F-75013 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Sanofi-Aventis; Sanofi France	Pomerance, M (corresponding author), Fac Pharm Chatenay Malabry, INSERM, U486, Tour D1,5 Rue Jean Baptiste Clement, F-92296 Chatenay Malabry, France.		Blondeau, Jean-Paul/AAH-6395-2019	Blondeau, Jean-Paul/0000-0003-4520-6822				ANALFI M, 1997, J BIOL CHEM, V272, P27804; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Diener K, 1997, P NATL ACAD SCI USA, V94, P9687, DOI 10.1073/pnas.94.18.9687; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; Fanger GR, 1998, J BIOL CHEM, V273, P3476, DOI 10.1074/jbc.273.6.3476; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; FATH I, 1994, SCIENCE, V264, P971, DOI 10.1126/science.8178156; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Holt KH, 1996, J BIOL CHEM, V271, P8300, DOI 10.1074/jbc.271.14.8300; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P533, DOI 10.1006/bbrc.1997.6849; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LANGECARTER CA, 1994, SCIENCE, V265, P1458, DOI 10.1126/science.8073291; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; Logan SK, 1997, MOL CELL BIOL, V17, P5784, DOI 10.1128/MCB.17.10.5784; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Minden A., 1997, BIOCHIM BIOPHYS ACTA, V1333, P85, DOI DOI 10.1016/S0304-419X(97)00018-8; Parker F, 1996, MOL CELL BIOL, V16, P2561; Pomerance M, 1996, MOL CELL BIOL, V16, P3179; Rodrigues GA, 1997, EMBO J, V16, P2634, DOI 10.1093/emboj/16.10.2634; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; RUSSELL M, 1995, J BIOL CHEM, V270, P11757, DOI 10.1074/jbc.270.20.11757; SARDET C, 1991, J BIOL CHEM, V266, P19166; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; WESTWICK JK, 1995, METHOD ENZYMOL, V255, P342; Xu SC, 1996, P NATL ACAD SCI USA, V93, P5291, DOI 10.1073/pnas.93.11.5291; YAN MH, 1994, NATURE, V372, P798	37	40	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24301	24304		10.1074/jbc.273.38.24301	http://dx.doi.org/10.1074/jbc.273.38.24301			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733714	hybrid			2022-12-27	WOS:000076007300006
J	Wang, F; Gao, JX; Mimura, J; Kobayashi, A; Sogawa, K; Fujii-Kuriyama, Y				Wang, F; Gao, JX; Mimura, J; Kobayashi, A; Sogawa, K; Fujii-Kuriyama, Y			Structure and expression of the mouse AhR nuclear translocator (mArnt) gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHARACTERIZATION; GAMMA-SUBUNIT; CDNA CLONING; DNA-BINDING; RECEPTOR; SEQUENCE; ARNT; PROTEINS; MUSCLE; DROSOPHILA	Aryl hydrocarbon receptor (AhR) nuclear translocator (Amt) gene has been isolated and characterized from a mouse genomic DNA library. The gene is about 60 kilobases long and split into 22 exons, An unusual exon/intron junctional sequence was found in the 11th intron of the gene that begins with GC at its 5'-end, The exon/intron arrangement of mArnt gene differs greatly from those of the other members of the same basic-helix-loop-helix/PAS family. The gene is TATA-less and has several transcription start sites. The promoter region of the mArnt gene is GC-rich and contains a number of putative regulatory DNA sequences such as two GC-boxes, a cAMP-responsive element, E-box, AP-1 site, and CAAT-box. Deletion experiments revealed that all these DNA elements made substantial contributions to a high level of expression of the gene, except for the cAMP-responsive element. Of all, two GC-boxes displayed the most dominant enhancing effects. It was demonstrated that there exist specific factors binding to these DNA elements in the nuclear extracts of HeLa cells. Among them, Sp1 and Sp3, and CAAT-box binding factor-A were identified to bind the GC-boxes and CAAT-box, respectively. Expression of MyoD in HeLa cells stimulated the Amt promoter activity by binding to the E-box.	Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan	Tohoku University	Fujii-Kuriyama, Y (corresponding author), Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan.	ykfujii@mail.cc.tohoku.ac.jp	Kobayashi, Akira/AAN-8003-2020; Mimura, Junsei/E-7893-2013	Kobayashi, Akira/0000-0001-9727-1218				BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BLAKE MC, 1990, MOL CELL BIOL, V10, P6632, DOI 10.1128/MCB.10.12.6632; DEUTSCH PJ, 1988, J BIOL CHEM, V263, P18466; DODGSON JB, 1983, J BIOL CHEM, V258, P4623; Ema M, 1996, MOL CELL BIOL, V16, P5865; EMA M, 1992, BIOCHEM BIOPH RES CO, V184, P246, DOI 10.1016/0006-291X(92)91185-S; EMIN M, 1997, NATURE, V386, P403; FYRBERG EA, 1981, CELL, V24, P107, DOI 10.1016/0092-8674(81)90506-7; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; GOTOH O, 1993, COMPUT APPL BIOSCI, V9, P361; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; Hirose K, 1996, MOL CELL BIOL, V16, P1706; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; Horton R M, 1993, Methods Mol Biol, V15, P251, DOI 10.1385/0-89603-244-2:251; Isaac DD, 1996, GENE DEV, V10, P103, DOI 10.1101/gad.10.1.103; JUNSEI M, 1994, PHARMACOGENETICS, V4, P349; Kim IS, 1996, MOL CELL BIOL, V16, P4003; KING CR, 1983, CELL, V32, P707, DOI 10.1016/0092-8674(83)90056-9; Kobayashi A, 1996, J BIOL CHEM, V271, P12310, DOI 10.1074/jbc.271.21.12310; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; LEVANON D, 1985, EMBO J, V4, P77, DOI 10.1002/j.1460-2075.1985.tb02320.x; Luo G, 1997, GENE EXPRESSION, V6, P287; MOROHASHI K, 1987, J BIOCHEM-TOKYO, V101, P879, DOI 10.1093/oxfordjournals.jbchem.a121955; Motohashi H, 1996, GENES CELLS, V1, P223, DOI 10.1046/j.1365-2443.1996.d01-230.x; MULLER MM, 1989, NUCLEIC ACIDS RES, V17, P6420, DOI 10.1093/nar/17.15.6420; NUMBERGER M, 1991, EMBO J, V10, P2957, DOI 10.1002/j.1460-2075.1991.tb07846.x; PIETTE J, 1988, P NATL ACAD SCI USA, V85, P3401, DOI 10.1073/pnas.85.10.3401; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; SCHMIDT JV, 1993, J BIOL CHEM, V268, P22203; SHIBAHARA S, 1985, EUR J BIOCHEM, V146, P15, DOI 10.1111/j.1432-1033.1985.tb08614.x; SOGAWA K, 1995, P NATL ACAD SCI USA, V92, P1936, DOI 10.1073/pnas.92.6.1936; Sogawa K, 1997, J BIOCHEM, V122, P1075; SWANSON HI, 1993, PHARMACOGENETICS, V3, P213, DOI 10.1097/00008571-199310000-00001; SWANSON HI, 1995, J BIOL CHEM, V270, P26292, DOI 10.1074/jbc.270.44.26292; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WATANABE N, 1993, EUR J BIOCHEM, V214, P521, DOI 10.1111/j.1432-1033.1993.tb17950.x	36	22	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24867	24873		10.1074/jbc.273.38.24867	http://dx.doi.org/10.1074/jbc.273.38.24867			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733792	hybrid			2022-12-27	WOS:000076007300084
J	Akhmedov, AT; Frei, C; Tsai-Pflugfelder, M; Kemper, B; Gasser, SM; Jessberger, R				Akhmedov, AT; Frei, C; Tsai-Pflugfelder, M; Kemper, B; Gasser, SM; Jessberger, R			Structural maintenance of chromosomes protein C-terminal domains bind preferentially to DNA with secondary structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MITOTIC CHROMOSOME; SMC FAMILY; DROSOPHILA-MELANOGASTER; DOSAGE COMPENSATION; NUCLEAR SCAFFOLD; IN-VITRO; CONDENSATION; COMPLEX; GENE	Structural maintenance of chromosomes (SMC) proteins interact with DNA in chromosome condensation, sister chromatid cohesion, DNA recombination, and gene dosage compensation. How individual SMC proteins and their functional domains bind DNA has not been described. We demonstrate the ability of the C-terminal domains of Saccharomyces cerevisiae snarl and SMC2 proteins, representing two major subfamilies with different functions, to bind DNA in an ATP-independent manner. Three levels of DNA binding specificity were observed: I) a >100-fold preference for double-stranded vel-sus single-stranded DNA; 2) a high affinity for DNA fragments able to form secondary structures and for synthetic cruciform DNA molecules; and 3) a strong preference for AT-rich DNA fragments of particular types, These include fragments from the scaffold-associated regions, and an alternating poly(dT-dA)poly(dT-dA) synthetic polymer, as opposed to a variety of other polymers. Reannealing of complementary DNA strands is also promoted primarily by the C-terminal domains. Consistent with their in vitro DNA binding activity, we show that overexpression of the SMC C termini increases plasmid loss without altering viability or cell cycle progression.	Basel Inst Immunol, CH-4005 Basel, Switzerland; ISREC, CH-1066 Epalinges, Switzerland; Univ Cologne, Inst Genet, D-50674 Cologne, Germany	Swiss Institute Experimental Cancer Research; University of Cologne	Jessberger, R (corresponding author), Basel Inst Immunol, Grenzacherstr 487, CH-4005 Basel, Switzerland.	jessberger@bii.ch		Gasser, Susan/0000-0003-3610-9123				AMATI B, 1990, EMBO J, V9, P4007, DOI 10.1002/j.1460-2075.1990.tb07622.x; AMATI BB, 1988, CELL, V54, P967, DOI 10.1016/0092-8674(88)90111-0; BASTIA D, 1996, MONOGRAPH, V31, P177; Chuang PT, 1996, SCIENCE, V274, P1736, DOI 10.1126/science.274.5293.1736; DOYE V, 1994, EMBO J, V13, P6062, DOI 10.1002/j.1460-2075.1994.tb06953.x; FERRARI S, 1992, EMBO J, V11, P4497, DOI 10.1002/j.1460-2075.1992.tb05551.x; GASSER SM, 1986, CELL, V46, P521, DOI 10.1016/0092-8674(86)90877-9; Golz S, 1997, EUR J BIOCHEM, V245, P573, DOI 10.1111/j.1432-1033.1997.00573.x; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Heck MMS, 1997, CELL, V91, P5, DOI 10.1016/S0092-8674(01)80002-7; HIETER P, 1985, CELL, V40, P381, DOI 10.1016/0092-8674(85)90152-7; HIRANO T, 1995, TRENDS BIOCHEM SCI, V20, P357, DOI 10.1016/S0968-0004(00)89076-3; HIRANO T, 1995, CURR OPIN CELL BIOL, V7, P329, DOI 10.1016/0955-0674(95)80087-5; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; HIRANO T, 1994, CELL, V79, P449, DOI 10.1016/0092-8674(94)90254-2; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; HOMBERGER HP, 1989, CHROMOSOMA, V98, P99, DOI 10.1007/BF00291044; JESSBERGER R, 1993, J BIOL CHEM, V268, P15070; Jessberger R, 1998, CURR OPIN GENET DEV, V8, P254, DOI 10.1016/S0959-437X(98)80149-4; Jessberger R, 1996, EMBO J, V15, P4061, DOI 10.1002/j.1460-2075.1996.tb00779.x; Kimura K, 1997, CELL, V90, P625, DOI 10.1016/S0092-8674(00)80524-3; KNIGHT KL, 1985, J BIOL CHEM, V260, P867; Koshland D, 1996, ANNU REV CELL DEV BI, V12, P305, DOI 10.1146/annurev.cellbio.12.1.305; Kupfer C, 1996, EUR J BIOCHEM, V238, P77, DOI 10.1111/j.1432-1033.1996.0077q.x; Laemmli UK, 1992, CURR OPIN GENET DEV, V2, P275, DOI 10.1016/S0959-437X(05)80285-0; LEHMANN AR, 1995, MOL CELL BIOL, V15, P7067; Lieb JD, 1998, CELL, V92, P265, DOI 10.1016/S0092-8674(00)80920-4; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Mussmann R, 1997, EUR J IMMUNOL, V27, P2610, DOI 10.1002/eji.1830271021; PAULL TT, 1993, GENE DEV, V7, P1521, DOI 10.1101/gad.7.8.1521; PETERSON CL, 1994, CELL, V79, P389, DOI 10.1016/0092-8674(94)90247-X; PIL PM, 1992, SCIENCE, V256, P234, DOI 10.1126/science.1566071; Pohler JRG, 1998, EMBO J, V17, P817, DOI 10.1093/emboj/17.3.817; Quinn J, 1996, NATURE, V379, P844, DOI 10.1038/379844a0; ROCQUES PJ, 1995, HUM MOL GENET, V4, P243, DOI 10.1093/hmg/4.2.243; SAITOH N, 1994, J CELL BIOL, V127, P303, DOI 10.1083/jcb.127.2.303; SAKA Y, 1994, EMBO J, V13, P4938, DOI 10.1002/j.1460-2075.1994.tb06821.x; STOTZ A, 1990, GENE, V95, P91, DOI 10.1016/0378-1119(90)90418-Q; Strick R, 1995, CELL, V83, P1137, DOI 10.1016/0092-8674(95)90140-X; STRUNNIKOV AV, 1993, J CELL BIOL, V123, P1635, DOI 10.1083/jcb.123.6.1635; STRUNNIKOV AV, 1995, GENE DEV, V9, P587, DOI 10.1101/gad.9.5.587; Sutani T, 1997, NATURE, V388, P798, DOI 10.1038/42062; TINOCO I, 1973, NATURE-NEW BIOL, V246, P40, DOI 10.1038/newbio246040a0; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x	44	91	92	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24088	24094		10.1074/jbc.273.37.24088	http://dx.doi.org/10.1074/jbc.273.37.24088			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727028	hybrid			2022-12-27	WOS:000075893100069
J	Chang, XB; Hou, YX; Riordan, JR				Chang, XB; Hou, YX; Riordan, JR			Stimulation of ATPase activity of purified multidrug resistance-associated protein by nucleoside diphosphates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER P-GLYCOPROTEIN; CONJUGATE EXPORT PUMP; MRP GENE; LEUKOTRIENE C-4; PHARMACOLOGICAL CHARACTERIZATION; ADENOSINE-TRIPHOSPHATASE; TRANSPORT; GLUTATHIONE; BINDING; OVEREXPRESSION	Membrane vesicles prepared from cells expressing the multidrug resistance-associated protein (MRP) transport glutathione S-conjugates of hydrophobic substrates in an ATP dependent manner. Purified MRP possesses ATPase activity which can be further stimulated by anticancer drugs or leukotriene C4. However, the detailed relationship between ATP hydrolysis and drug transport has not been established. How the ATPase activity of MRP is regulated in the cell is also not known, In this report, we have examined the effects of different nucleotides on the ATPase activity of purified MRP. We have found that pyrimidine nucleoside triphosphates have little effect on enzymatic activity. In contrast, purine nucleotides dATP, dGTP, and adenosine 5'-(beta,gamma-imido)triphosphate function as competitive inhibitors. Somewhat unexpectedly, low concentrations of all the nucleoside diphosphates (NDPs) tested, except UDP, stimulate the ATPase activity severalfold. ADP or GDP at higher concentrations was inhibitory, reflecting NDP binding to the substrate site. On the other hand, the enhancement of hydrolysis at low NDP concentrations must reflect interactions with a separate site. Therefore, we postulate the presence of at least two types of nucleotide binding sites on the MRP, a catalytic site(s) to which ATP preferentially binds and is hydrolyzed and a regulatory site to which NDPs preferentially bind and stimulate hydrolysis, Interestingly, the stimulatory effects of drugs transported by MRP and NDPs are not additive, i.e. drugs are not able to further stimulate the NDP-activated enzyme. Hence, the two activation pathways intersect at some point. Since both nucleotide binding domains of MRP are likely to be required for drug stimulation of ATPase activity, the two sites that we postulate may also involve both domains.	Mayo Clin Scottsdale, SC Johnson Med Res Ctr, Scottsdale, AZ 85259 USA	Mayo Clinic; Mayo Clinic Phoenix; SC Johnson & Son	Chang, XB (corresponding author), Mayo Clin Scottsdale, SC Johnson Med Res Ctr, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.							ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197; Bakos E, 1996, J BIOL CHEM, V271, P12322, DOI 10.1074/jbc.271.21.12322; Chang XB, 1997, J BIOL CHEM, V272, P30962, DOI 10.1074/jbc.272.49.30962; COLE SPC, 1994, CANCER RES, V54, P5902; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Evers R, 1997, FEBS LETT, V419, P112, DOI 10.1016/S0014-5793(97)01442-7; Gao M, 1998, J BIOL CHEM, V273, P10733, DOI 10.1074/jbc.273.17.10733; Gao M, 1996, J BIOL CHEM, V271, P27782, DOI 10.1074/jbc.271.44.27782; GRANT CE, 1994, CANCER RES, V54, P357; Heijn M, 1997, BBA-BIOMEMBRANES, V1326, P12, DOI 10.1016/S0005-2736(97)00003-5; Hooijberg JH, 1997, FEBS LETT, V413, P344, DOI 10.1016/S0014-5793(97)00940-X; ISSARTEL JP, 1992, EXPERIENTIA, V48, P351, DOI 10.1007/BF01923429; Jedlitschky G, 1996, CANCER RES, V56, P988; Keppler D, 1996, ADV ENZYME REGUL, V36, P17, DOI 10.1016/0065-2571(95)00011-9; KRUH GD, 1994, CANCER RES, V54, P1649; Leier I, 1996, BIOCHEM J, V314, P433, DOI 10.1042/bj3140433; LEIER I, 1994, J BIOL CHEM, V269, P27807; Loe DW, 1997, MOL PHARMACOL, V51, P1034, DOI 10.1124/mol.51.6.1034; Loe DW, 1996, J BIOL CHEM, V271, P9683, DOI 10.1074/jbc.271.16.9683; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; Loo TW, 1997, J BIOL CHEM, V272, P20986, DOI 10.1074/jbc.272.34.20986; Loo TW, 1997, J BIOL CHEM, V272, P31945, DOI 10.1074/jbc.272.51.31945; MULLER M, 1994, P NATL ACAD SCI USA, V91, P13033, DOI 10.1073/pnas.91.26.13033; PERLIN DS, 1984, BIOCHEMISTRY-US, V23, P4998, DOI 10.1021/bi00316a026; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Shen HX, 1996, BIOCHEMISTRY-US, V35, P5719, DOI 10.1021/bi960098n; Stride BD, 1997, MOL PHARMACOL, V52, P344, DOI 10.1124/mol.52.3.344; Stride BD, 1996, MOL PHARMACOL, V49, P962; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; URBATSCH IL, 1994, BIOCHEMISTRY-US, V33, P7069, DOI 10.1021/bi00189a008; URBATSCH IL, 1995, J BIOL CHEM, V270, P26956, DOI 10.1074/jbc.270.45.26956; ZAMAN GJR, 1994, P NATL ACAD SCI USA, V91, P8822, DOI 10.1073/pnas.91.19.8822; Zaman GJR, 1996, FEBS LETT, V391, P126, DOI 10.1016/0014-5793(96)00718-1; Zhu QC, 1997, ONCOL RES, V9, P229	34	35	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23844	23848		10.1074/jbc.273.37.23844	http://dx.doi.org/10.1074/jbc.273.37.23844			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726996	hybrid			2022-12-27	WOS:000075893100037
J	Peterson, CL; Zhao, YM; Chait, BT				Peterson, CL; Zhao, YM; Chait, BT			Subunits of the yeast SWI/SNF complex are members of the actin-related protein (ARP) family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MULTISUBUNIT COMPLEX; NUCLEOSOMAL DNA; GENE-PRODUCTS; BINDING; TRANSCRIPTION; ACTIVATOR; ENHANCEMENT; EXPRESSION; SWI2/SNF2	The yeast SWI/SNF chromatin remodeling complex is comprised of 11 tightly associated polypeptides (SWI1, SWI2, SWI3, SNF5, SNF6, SNF11, SWP82, SWP73, SWP59, SWP61, and SWP29), We have used matrix-assisted laser desorption ionization time-of-flight mass spectrometry to identify the genes that encode the SWP59 and SWP61 subunits. Surprisingly, we find that SWP59 and SWP61 are encoded by the ARP9 and ARP7 genes, respectively, which encode members of the actin-related protein (ARP) family. Sequence analyses have shown that ARP9 and ARP7 are 24-26% identical (48-51% similar) to yeast actin and that they are likely to maintain the overall actin fold. Deletion of either the ARP9 or ARP7 gene causes typical swi/snf phenotypes, including growth defects on media containing galactose, glycerol, or sucrose as sole carbon sources. ARP9 and ARP7 are also required for expression of an HO-lacZ fusion gene and for full transcriptional enhancement by the GAL4 activator. The identification of two ARP family members as crucial subunits of the SWI/SNF complex suggests that the complex may contain a total of three different ATPase subunits; furthermore, the similarity of ARP7 and ARP9 to the HSP and HSC family of ATPases suggests the possibility that chromatin remodeling by SWI/SNF may involve chaperone-like activities.	Univ Massachusetts, Med Ctr, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Med Ctr, Dept Biochem & Mol Biol, Worcester, MA 01605 USA; Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Rockefeller University	Peterson, CL (corresponding author), Univ Massachusetts, Med Ctr, Program Mol Med, 373 Plantat st,Biotech 2,Suite 301, Worcester, MA 01605 USA.	craig.peterson@ummed.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049650, R37GM049650] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00862] Funding Source: Medline; NIGMS NIH HHS [R01 GM049650, GM49650-05, R37 GM049650] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cairns BR, 1996, MOL CELL BIOL, V16, P3308; Cairns BR, 1996, GENE DEV, V10, P2131, DOI 10.1101/gad.10.17.2131; CAIRNS BR, 1994, P NATL ACAD SCI USA, V91, P1950, DOI 10.1073/pnas.91.5.1950; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Fenyo D, 1996, ANAL CHEM, V68, pA721, DOI 10.1021/ac9621579; Fenyo D, 1998, ELECTROPHORESIS, V19, P998, DOI 10.1002/elps.1150190615; Frankel S, 1996, CURR OPIN CELL BIOL, V8, P30, DOI 10.1016/S0955-0674(96)80045-7; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; HENZEL WJ, 1993, P NATL ACAD SCI USA, V90, P5011, DOI 10.1073/pnas.90.11.5011; Holmes Ken C., 1993, Trends in Cell Biology, V3, P53, DOI 10.1016/0962-8924(93)90161-S; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Jensen ON, 1996, RAPID COMMUN MASS SP, V10, P1371, DOI 10.1002/(SICI)1097-0231(199608)10:11<1371::AID-RCM682>3.0.CO;2-5; Jiang YW, 1996, GENE DEV, V10, P604, DOI 10.1101/gad.10.5.604; KABSCH W, 1995, FASEB J, V9, P167, DOI 10.1096/fasebj.9.2.7781919; Kasten MM, 1997, MOL CELL BIOL, V17, P4852, DOI 10.1128/MCB.17.8.4852; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; LAURENT BC, 1993, GENE DEV, V7, P583, DOI 10.1101/gad.7.4.583; Logie C, 1997, EMBO J, V16, P6772, DOI 10.1093/emboj/16.22.6772; OwenHughes T, 1996, SCIENCE, V273, P513, DOI 10.1126/science.273.5274.513; PETERSON CL, 1992, CELL, V68, P573, DOI 10.1016/0092-8674(92)90192-F; PETERSON CL, 1994, P NATL ACAD SCI USA, V91, P2905, DOI 10.1073/pnas.91.8.2905; PETERSON CL, 1995, TRENDS BIOCHEM SCI, V20, P143, DOI 10.1016/S0968-0004(00)88990-2; Poch O, 1997, YEAST, V13, P1053, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1053::AID-YEA164>3.0.CO;2-4; Qin J, 1997, ANAL CHEM, V69, P3995, DOI 10.1021/ac970488v; Quinn J, 1996, NATURE, V379, P844, DOI 10.1038/379844a0; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Russell R, 1998, BIOCHEMISTRY-US, V37, P596, DOI 10.1021/bi972025p; SIKORSKI RS, 1989, GENETICS, V122, P19; STERN M, 1984, J MOL BIOL, V178, P853, DOI 10.1016/0022-2836(84)90315-2; STILLMAN DJ, 1994, GENETICS, V136, P781; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; TREICH I, 1995, MOL CELL BIOL, V15, P4240; VIDAL M, 1991, MOL CELL BIOL, V11, P6317, DOI 10.1128/MCB.11.12.6317; WEBER V, 1995, MOL BIOL CELL, V6, P1263, DOI 10.1091/mbc.6.10.1263	35	119	124	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23641	23644		10.1074/jbc.273.37.23641	http://dx.doi.org/10.1074/jbc.273.37.23641			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726966	Green Published, hybrid			2022-12-27	WOS:000075893100007
J	Schafer, C; Ross, SE; Bragado, MJ; Groblewski, GE; Ernst, SA; Williams, JA				Schafer, C; Ross, SE; Bragado, MJ; Groblewski, GE; Ernst, SA; Williams, JA			A role for the p38 mitogen-activated protein kinase Hsp 27 pathway in cholecystokinin-induced changes in the actin cytoskeleton in rat pancreatic acini	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; SIGNAL-TRANSDUCTION PATHWAY; MAP KINASE; TYROSINE PHOSPHORYLATION; IN-VITRO; C-FOS; CELLS; CASCADE; STRESS; CERULEIN	Cholecystokinin (CCK) and other pancreatic secretagogues have recently been shown to activate signaling kinase cascades in pancreatic acinar cells, leading to the activation of extracellular signal-regulated kinases and Jun N-terminal kinases. We now show the presence of a third kinase cascade activating p38 mitogen-activated protein (MAP) kinase in isolated rat pancreatic acini, CCK and osmotic stress induced by sorbitol activated p38 MAP kinase within minutes; their effects were dose-dependent, with maximal activation of 2.8- and 4.4-fold, respectively. The effects of carbachol and bombesin on p38 MAP kinase activity were similar to those of CCK, whereas phorbol eater, epidermal growth factor, and vasoactive intestinal polypeptide stimulated p38 MAP kinase by 8-fold or less. Both CCK and sorbitol also increased the tyrosyl phosphorylation of p38 MAP kinase. Using the specific inhibitor of p38 MAP kinase, SE 203580, we found that p38 MAP kinase activity was required for MAP kinase-activated protein kinase-a activation in pancreatic acini. SE 203580 reduced the level of basal phosphorylation and blocked the increased phosphorylation of Hsp 27 after stimulation with either CCK or sorbitol. CCK treatment induced an initial rapid decrease in total F-actin content of acini, followed by an increase after 40 min. Preincubation with SE 203580 significantly inhibited these changes in F-actin content. Staining of the actin cytoskeleton with rhodamine-conjugated phalloidin and analysis by confocal fluorescence microscopy showed disruption of the actin cytoskeleton after 10 and 40 min of CCK stimulation. Pretreatment with SE 203580 reduced these changes. These findings demonstrate that the activation of p38 MAP kinase is involved not only in response to stress, but also in physiological signaling by gastrointestinal hormones such as CCK, where activation of G(q)-coupled receptors stimulates a cascade in which pas MAP kinase activates MAP kinase-activated protein kinase-2, resulting in Hsp 27 phosphorylation. Activation of p38 MAP kinase, most likely through phosphorylation of Hsp 27, plays a role in the organization of the actin cytoskeleton in pancreatic acini.	Univ Michigan, Dept Physiol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Anat & Cell Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Schafer, C (corresponding author), Univ Michigan, Dept Physiol, 7737 Med Sci 2, Ann Arbor, MI 48109 USA.	claussch@umich.edu	Bragado, M Julia/L-6988-2014	Bragado, M Julia/0000-0001-7770-0775; Williams, John/0000-0002-6063-7615	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041122, R37DK041122, R01DK052860, P30DK034933] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 52860, DK 41122, DK 34933] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHLERS A, 1994, BLOOD, V83, P1791; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; Bragado MJ, 1997, AM J PHYSIOL-CELL PH, V273, pC101, DOI 10.1152/ajpcell.1997.273.1.C101; Bragado MJ, 1997, AM J PHYSIOL-GASTR L, V272, pG401, DOI 10.1152/ajpgi.1997.272.3.G401; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; CONDEELIS J, 1991, METHOD ENZYMOL, V196, P486; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Dabrowski A, 1997, AM J PHYSIOL-CELL PH, V273, pC1472, DOI 10.1152/ajpcell.1997.273.5.C1472; Dabrowski A, 1996, J BIOL CHEM, V271, P5686, DOI 10.1074/jbc.271.10.5686; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; DING G, 1991, AM J PHYSIOL, V260, pC9, DOI 10.1152/ajpcell.1991.260.1.C9; DOZA YN, 1995, FEBS LETT, V364, P223, DOI 10.1016/0014-5793(95)00346-B; DUAN RD, 1995, AM J PHYSIOL-GASTR L, V268, pG1060, DOI 10.1152/ajpgi.1995.268.6.G1060; DUAN RD, 1994, AM J PHYSIOL, V267, pG401, DOI 10.1152/ajpgi.1994.267.3.G401; Foltz IN, 1997, J BIOL CHEM, V272, P3296, DOI 10.1074/jbc.272.6.3296; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Garcia LJ, 1997, BBA-MOL CELL RES, V1358, P189, DOI 10.1016/S0167-4889(97)00056-6; Groblewski GE, 1997, GASTROENTEROLOGY, V112, P1354, DOI 10.1016/S0016-5085(97)70149-5; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Krump E, 1997, J BIOL CHEM, V272, P937, DOI 10.1074/jbc.272.2.937; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; LOGSDON CD, 1986, AM J PHYSIOL, V250, pG440, DOI 10.1152/ajpgi.1986.250.4.G440; LU L, 1992, AM J PHYSIOL, V263, pG327, DOI 10.1152/ajpgi.1992.263.3.G327; McLaughlin MM, 1996, J BIOL CHEM, V271, P8488, DOI 10.1074/jbc.271.14.8488; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Molnar A, 1997, J BIOL CHEM, V272, P13229, DOI 10.1074/jbc.272.20.13229; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; OKONSKI MS, 1990, J CLIN INVEST, V86, P1649, DOI 10.1172/JCI114887; OKONSKI MS, 1993, PANCREAS, V8, P638, DOI 10.1097/00006676-199309000-00018; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Piotrowicz RS, 1997, J BIOL CHEM, V272, P25920, DOI 10.1074/jbc.272.41.25920; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; SCHICK J, 1984, J CELL BIOL, V99, P1559; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SEUFFERLEIN T, 1994, J BIOL CHEM, V269, P27610; SEUFFERLEIN T, 1995, J BIOL CHEM, V270, P24343, DOI 10.1074/jbc.270.41.24343; SOLOMON TE, 1983, AM J PHYSIOL, V245, pG99, DOI 10.1152/ajpgi.1983.245.1.G99; SOLOMON TE, 1994, PHYSL GASTROINTESTIN, V2, P1499; Stein B, 1996, J BIOL CHEM, V271, P11427, DOI 10.1074/jbc.271.19.11427; STOKOE D, 1993, BIOCHEM J, V296, P843, DOI 10.1042/bj2960843; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; WILLIAMS JA, 1978, AM J PHYSIOL, V253, pE517; WILLIAMS JA, 1993, EXOCRINE PANCREAS, P167; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamauchi JJ, 1997, J BIOL CHEM, V272, P27771, DOI 10.1074/jbc.272.44.27771; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934	57	136	138	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24173	24180		10.1074/jbc.273.37.24173	http://dx.doi.org/10.1074/jbc.273.37.24173			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727040	hybrid			2022-12-27	WOS:000075893100081
J	Smith, MF; Carl, VS; Lodie, T; Fenton, MJ				Smith, MF; Carl, VS; Lodie, T; Fenton, MJ			Secretory interleukin-1 receptor antagonist gene expression requires both a PU.1 and a novel composite NF-kappa B/PU.1/GA-binding protein binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR PU.1; NF-KAPPA-B; NEUTROPHIL ELASTASE PROMOTER; FAMILY MEMBER PU.1; DOMAIN-DNA COMPLEX; IL-1 RECEPTOR; NUCLEAR-LOCALIZATION; SIGNAL-TRANSDUCTION; REGULATORY REGIONS; ETS ONCOGENE	The human secretory interleukin-1 receptor antagonist (secretory IL-1Ra) gene is controlled through three lipopolysaccharide (LPS)-responsive promoter elements, one of which was identified as an NF-kappa B binding site. Sequence analysis of the secretory IL-1Ra promoter identified a potential PU.1 binding site located between positions -80 and -90 on the complementary strand overlapping the NF-kappa B site. Gel shift analysis using this potential binding site with nuclear extracts from RAW 264.7 macrophages demonstrated the formation of three complexes, one LPS-inducible and two constitutive. The inducible factor was identified as NF-KB, and the constitutive factors were identified as PU.1 and GA-binding protein. Site-directed mutagenesis of the -93 to -79 promoter region demonstrated that mutation of either the NF-kappa B 5'-half site or the PU.1/GA-binding protein half-site alone did not significantly decrease LPS responsiveness. However, a mutation that disrupted the binding of all three factors resulted in a 50% decrease in LPS responsiveness. A second PU.1 binding site centered at -230 was identified by gel shift and supershift assays. Mutation of the core GGAA region resulted ill a 50% decrease in LPS-responsive promoter activity. Mutation of both the distal and proximal LPS response elements led to an almost complete loss of responsiveness. These data therefore suggest that the regulation of IL-1Ra gene expression is a complex event involving the interactions of three different transcription factors with a single cis-acting element and that the two PU.1 binding sites are the major response elements for LPS-induced IL-1Ra gene expression.	Univ Virginia, Hlth Sci Ctr, Dept Med, Div Gastroenterol, Charlottesville, VA 22908 USA; Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA	University of Virginia; Boston University	Smith, MF (corresponding author), Div Gastroenterol & Hepatol, Lane Rd,Bldg MR4,Rm 1031, Charlottesville, VA 22908 USA.	mfs3k@virginia.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI034358, R01AI034358] Funding Source: NIH RePORTER; NIAID NIH HHS [AI34358] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AREND WP, 1994, J IMMUNOL, V153, P4766; AREND WP, 1989, J IMMUNOL, V143, P1851; AREND WP, 1993, ADV IMMUNOL, V54, P167, DOI 10.1016/S0065-2776(08)60535-0; Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; BROWN TA, 1992, GENE DEV, V6, P2502, DOI 10.1101/gad.6.12b.2502; BURAS JA, 1995, MOL IMMUNOL, V32, P541, DOI 10.1016/0161-5890(95)00018-A; BUTCHER C, 1994, J IMMUNOL, V153, P701; CARTER DB, 1990, NATURE, V344, P633, DOI 10.1038/344633a0; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; DELUDE RL, 1995, P NATL ACAD SCI USA, V92, P9288, DOI 10.1073/pnas.92.20.9288; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DINARELLO CA, 1991, BLOOD, V77, P1627; DRIPPS DJ, 1991, J BIOL CHEM, V266, P10331; EICHBAUM QG, 1994, J EXP MED, V179, P1985, DOI 10.1084/jem.179.6.1985; EISENBERG SP, 1991, P NATL ACAD SCI USA, V88, P5232, DOI 10.1073/pnas.88.12.5232; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; Flory E, 1996, J VIROL, V70, P2260, DOI 10.1128/JVI.70.4.2260-2268.1996; Gabay C, 1997, J CLIN INVEST, V99, P2930, DOI 10.1172/JCI119488; GRANOWITZ EV, 1991, J BIOL CHEM, V266, P14147; Guthridge CJ, 1997, MOL CELL BIOL, V17, P1118, DOI 10.1128/MCB.17.3.1118; HASKILL S, 1991, P NATL ACAD SCI USA, V88, P3681, DOI 10.1073/pnas.88.9.3681; HROMAS R, 1993, BLOOD, V82, P2998; HUNNINGHAKE GW, 1992, MOL CELL BIOL, V12, P3439, DOI 10.1128/MCB.12.8.3439; Jenkins JK, 1997, J IMMUNOL, V158, P748; Kamura T, 1997, J BIOL CHEM, V272, P11361; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; KOMINATO Y, 1995, MOL CELL BIOL, V15, P58; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; LAMARCO K, 1991, SCIENCE, V253, P789, DOI 10.1126/science.1876836; LENNARD AC, 1995, CRIT REV IMMUNOL, V15, P77, DOI 10.1615/CritRevImmunol.v15.i1.30; Lodie TA, 1997, J IMMUNOL, V158, P1848; Lodie TA, 1998, J IMMUNOL, V161, P268; MOREAUGACHELIN F, 1989, ONCOGENE, V4, P1449; MOREAUGACHELIN F, 1994, BBA-REV CANCER, V1198, P149, DOI 10.1016/0304-419X(94)90011-6; MOREAUGACHELIN F, 1990, CELL, V61, P1166, DOI 10.1016/0092-8674(90)90677-7; MOULTON KS, 1994, MOL CELL BIOL, V14, P4408, DOI 10.1128/MCB.14.7.4408; Nuchprayoon I, 1997, BLOOD, V89, P4546, DOI 10.1182/blood.V89.12.4546; Oelgeschlager M, 1996, MOL CELL BIOL, V16, P4717; PAHL HL, 1993, J BIOL CHEM, V268, P5014; Pio F, 1996, J BIOL CHEM, V271, P23329, DOI 10.1074/jbc.271.38.23329; RICE NR, 1993, EMBO J, V12, P4685, DOI 10.1002/j.1460-2075.1993.tb06157.x; ROSMARIN AG, 1995, J BIOL CHEM, V270, P23627, DOI 10.1074/jbc.270.40.23627; Sawa C, 1996, NUCLEIC ACIDS RES, V24, P4954, DOI 10.1093/nar/24.24.4954; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; SHACKELFORD R, 1995, J IMMUNOL, V154, P1374; SMITH MF, 1994, J IMMUNOL, V153, P3584; SMITH MF, 1992, J IMMUNOL, V149, P2000; Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8, DOI 10.1002/jlb.60.1.8; THOMPSON CC, 1991, SCIENCE, V253, P762, DOI 10.1126/science.1876833; WATANABE M, 1993, ONCOGENE, V8, P2949; ZAHEDI KA, 1994, CYTOKINE, V6, P1, DOI 10.1016/1043-4666(94)90001-9; ZHANG DE, 1994, MOL CELL BIOL, V14, P373, DOI 10.1128/MCB.14.1.373	53	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24272	24279		10.1074/jbc.273.37.24272	http://dx.doi.org/10.1074/jbc.273.37.24272			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727052	hybrid			2022-12-27	WOS:000075893100093
J	Kahn, ML; Hammes, SR; Botka, C; Coughlin, SR				Kahn, ML; Hammes, SR; Botka, C; Coughlin, SR			Gene and locus structure and chromosomal localization of the protease-activated receptor gene family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET THROMBIN RECEPTOR; ENDONUCLEASE RARE CLEAVAGE; HEAVY-CHAIN GENES; MOLECULAR-CLONING; FUNCTIONAL EXPRESSION; PEPTIDES; NOMENCLATURE; GUIDELINES; MECHANISM; REVEALS	Protease-activate receptors (PARs) mediate activation of platelets and other cells by thrombin and other proteases, Such protease-triggered signaling events are thought to be critical for hemostasis, thrombosis, and other normal and pathological processes. We report here the structure of the mouse and human PAR3 genes as well as the organization of a PAR gene cluster encompassing the genes encoding PARs 1, 2, and 3. We also report the structure of the mouse and human PARA genes, which map to distinct chromosomal locations and encode a new thrombin receptor. PARs 1-4 are all encoded by genes with the same two exon structure. In each case, exon 1 encodes a signal peptide, and exon 2 encodes the mature receptor protein. These are separated by an intron of variable size. The genes encoding PARs 1-3 all map to chromosome 13D2 in mouse and chromosome 5q13 in human. In mouse, all three genes are located within 80 kilobases of each other. The PAR1 gene is located centrally and is flanked upstream by the PAR3 gene and downstream by the PAR2 gene in both species. The proximity of the PAR1 and PAR3 genes suggests the possibility that these genes might share regulatory elements. A comparison of the structures of the PAR amino acid sequences, gene structures, locus organization, and chromosomal locations suggests a working model for PAR gene evolution.	Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Daiichi Res Ctr, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Comp Graph Lab, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Coughlin, SR (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, HSW-1300,Box 0130,505 Parnassus Ave, San Francisco, CA 94143 USA.							BRASS LF, 1992, J BIOL CHEM, V267, P13795; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; CONNOLLY TM, 1994, THROMB HAEMOSTASIS, V72, P627; FERRIN LJ, 1994, NAT GENET, V6, P379, DOI 10.1038/ng0494-379; FERRIN LJ, 1991, SCIENCE, V254, P1494, DOI 10.1126/science.1962209; GULICK J, 1991, J BIOL CHEM, V266, P9180; HUNG DT, 1992, J CLIN INVEST, V89, P1350, DOI 10.1172/JCI115721; Ishihara H, 1998, BLOOD, V91, P4152, DOI 10.1182/blood.V91.11.4152.411k22_4152_4157; Ishihara H, 1997, NATURE, V386, P502, DOI 10.1038/386502a0; Kahn M, 1996, MOL MED, V2, P349, DOI 10.1007/BF03401632; KAHN MK, 1998, IN PRESS NATURE; Maltais LJ, 1997, GENOMICS, V45, P471, DOI 10.1006/geno.1997.5010; MCCORMICK SPA, 1995, P NATL ACAD SCI USA, V92, P10147, DOI 10.1073/pnas.92.22.10147; Molino M, 1997, J BIOL CHEM, V272, P4043, DOI 10.1074/jbc.272.7.4043; NYSTEDT S, 1995, J BIOL CHEM, V270, P5950, DOI 10.1074/jbc.270.11.5950; NYSTEDT S, 1995, EUR J BIOCHEM, V232, P84, DOI 10.1111/j.1432-1033.1995.tb20784.x; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; SCARBOROUGH RM, 1992, J BIOL CHEM, V267, P13146; Schmidt VA, 1998, J BIOL CHEM, V273, P15061, DOI 10.1074/jbc.273.24.15061; Schmidt VA, 1996, J BIOL CHEM, V271, P9307, DOI 10.1074/jbc.271.16.9307; Schmidt VA, 1997, BRIT J HAEMATOL, V97, P523, DOI 10.1046/j.1365-2141.1997.922907.x; SHOWS TB, 1987, CYTOGENET CELL GENET, V46, P11; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; VASSALLO RR, 1992, J BIOL CHEM, V267, P6081; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; YAMAUCHITAKIHARA K, 1989, P NATL ACAD SCI USA, V86, P3504, DOI 10.1073/pnas.86.10.3504	28	80	87	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23290	23296		10.1074/jbc.273.36.23290	http://dx.doi.org/10.1074/jbc.273.36.23290			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722561	hybrid			2022-12-27	WOS:000075778100061
J	Meagher, JL; Beechem, JM; Olson, ST; Gettins, PGW				Meagher, JL; Beechem, JM; Olson, ST; Gettins, PGW			Deconvolution of the fluorescence emission spectrum of human antithrombin and identification of the tryptophan residues that are responsive to heparin binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY HEPARIN; CONFORMATIONAL CHANGE; H-1-NMR SPECTROSCOPY; PROTEINASE REACTIONS; CRYSTAL-STRUCTURE; ANTI-THROMBIN; SITE; ACTIVATION; PENTASACCHARIDE; MECHANISM	Heparin causes an allosterically transmitted conformational change in the reactive center loop of antithrombin and a 40% enhancement of tryptophan fluorescence. We have expressed four human antithrombins containing single Trp --> Phe mutations and determined that the fluorescence of antithrombin is a linear combination of the four tryptophans, The contributions to the spectrum of native antithrombin at 340 nm were 8% for Trp-49, 10% for Trp-189, 19% for Trp-225, and 63% for Trp-307, Trp-225 and Trp-307 accounted for the majority of the heparin-induced fluorescence enhancement, contributing 37 and 36%, respectively. Trp-49 and Trp-225 underwent spectral shifts of 15 nm to blue and 5 nm to red, respectively, in the antithrombin-heparin complex. The blue shift for Trp-49 is consistent with partial burial by contact with heparin, whereas the red shift for Trp-225 and large enhancement probably result from increased solvent access upon heparin-induced displacement of the contact residue Ser-380, The enhancement for Trp-307 may result from the heparin-induced movement of helix H seen in the crystal structure. The time-resolved fluorescence properties of individual tryptophans of wild-type antithrombin were also determined using the four variants and showed that Trp-225 and Trp-307 experienced the largest change in lifetime upon heparin binding, providing support for the steady-state fluorescence deconvolution.	Univ Illinois, Coll Med, Dept Biochem & Mol Biol, Chicago, IL 60612 USA; Univ Illinois, Coll Dent, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA; Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Vanderbilt University	Gettins, PGW (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Biol, Chicago, IL 60612 USA.	pgettins@tigger.cc.uic.edu			NHLBI NIH HHS [HL49234, HL39888] Funding Source: Medline; NIGMS NIH HHS [GM45990] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049234, R37HL049234, R01HL039888, R37HL039888, R29HL039888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045990] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beechem J.M., 1991, TOPICS FLUORESCENCE, P241; BLACKBURN MN, 1984, J BIOL CHEM, V259, P939; BRENNAN SO, 1987, FEBS LETT, V219, P431, DOI 10.1016/0014-5793(87)80266-1; CARRELL RW, 1994, STRUCTURE, V2, P257, DOI 10.1016/S0969-2126(00)00028-9; ERSDALBADJU E, 1995, BIOCHEM J, V310, P323, DOI 10.1042/bj3100323; FAN BQ, 1994, BIOCHEMISTRY-US, V33, P14156, DOI 10.1021/bi00251a026; FAN BQ, 1993, J BIOL CHEM, V268, P17588; GETTINS P, 1987, BIOCHEMISTRY-US, V26, P1391, DOI 10.1021/bi00379a027; GETTINS P, 1987, BIOCHEMISTRY-US, V26, P4403, DOI 10.1021/bi00388a032; GETTINS P, 1992, J BIOL CHEM, V267, P21946; GETTINS PGW, 1993, BIOCHEMISTRY-US, V32, P8385, DOI 10.1021/bi00084a001; HASSELBACHER CA, 1995, BIOPHYS J, V69, P20, DOI 10.1016/S0006-3495(95)79891-5; HORNE A, 1992, BIOCHEMISTRY-US, V31, P2286, DOI 10.1021/bi00123a011; Huntington JA, 1998, BIOCHEMISTRY-US, V37, P3272, DOI 10.1021/bi972182o; Huntington JA, 1996, BIOCHEMISTRY-US, V35, P8495, DOI 10.1021/bi9604643; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; JORDAN R, 1979, J BIOL CHEM, V254, P2902; Kridel SJ, 1997, J BIOL CHEM, V272, P7656, DOI 10.1074/jbc.272.12.7656; Kridel SJ, 1996, J BIOL CHEM, V271, P20935, DOI 10.1074/jbc.271.34.20935; LANCHANTIN GF, 1973, J BIOL CHEM, V248, P5956; LOCKE BC, 1992, BIOCHEMISTRY-US, V31, P2376, DOI 10.1021/bi00123a024; Meagher JL, 1996, J BIOL CHEM, V271, P29353, DOI 10.1074/jbc.271.46.29353; MILETICH JP, 1980, ANAL BIOCHEM, V105, P304, DOI 10.1016/0003-2697(80)90462-5; MOUREY L, 1993, J MOL BIOL, V232, P223, DOI 10.1006/jmbi.1993.1378; NORDENMAN B, 1978, EUR J BIOCHEM, V90, P1, DOI 10.1111/j.1432-1033.1978.tb12567.x; NORDENMAN B, 1978, BIOCHEMISTRY-US, V17, P3339, DOI 10.1021/bi00609a026; OLSON ST, 1986, J BIOL CHEM, V261, P3151; OLSON ST, 1992, J BIOL CHEM, V267, P12528; OLSON ST, 1981, J BIOL CHEM, V256, P1073; OLSON ST, 1981, J BIOL CHEM, V256, P1065; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; PAJOT P, 1976, EUR J BIOCHEM, V63, P263, DOI 10.1111/j.1432-1033.1976.tb10228.x; SCHREUDER HA, 1994, NAT STRUCT BIOL, V1, P48, DOI 10.1038/nsb0194-48; SHEFFIELD WP, 1994, FEBS LETT, V339, P147, DOI 10.1016/0014-5793(94)80403-6; Skinner R, 1997, J MOL BIOL, V266, P601, DOI 10.1006/jmbi.1996.0798; STREUSAND VJ, 1995, J BIOL CHEM, V270, P9043, DOI 10.1074/jbc.270.16.9043; TURKO IV, 1993, FEBS LETT, V335, P9, DOI 10.1016/0014-5793(93)80429-X; VANBOECKEL CAA, 1994, NAT STRUCT BIOL, V1, P423, DOI 10.1038/nsb0794-423; WATTON J, 1993, BIOCHEMISTRY-US, V32, P7286, DOI 10.1021/bi00079a027; Whisstock J, 1998, TRENDS BIOCHEM SCI, V23, P63, DOI 10.1016/S0968-0004(97)01172-9; Zettlmeissl G, 1988, Behring Inst Mitt, P26	41	44	61	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23283	23289		10.1074/jbc.273.36.23283	http://dx.doi.org/10.1074/jbc.273.36.23283			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722560	hybrid			2022-12-27	WOS:000075778100060
J	Guillonneau, X; Bryckaert, M; Launay-Longo, C; Courtois, Y; Mascarelli, F				Guillonneau, X; Bryckaert, M; Launay-Longo, C; Courtois, Y; Mascarelli, F			Endogenous FGF1-induced activation and synthesis of extracellular signal-regulated kinase 2 reduce cell apoptosis in retinal-pigmented epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST GROWTH-FACTOR; SMOOTH-MUSCLE CELLS; PROTEIN-KINASE; FACTOR FAMILY; TYROSINE PHOSPHORYLATION; ENDOTHELIAL-CELLS; BINDING; RECEPTOR; INHIBITION; EXPRESSION	Retinal-pigmented epithelial (RPE) cell survival is critical to the maintenance of the function of the neural retinal and in the development of various retina degenerations. We investigated molecular mechanisms involved in this function by assessing apoptosis in RPE cells following serum deprivation. Apoptosis induced by serum withdrawal is lower in aged RPE cells because of higher endogenous acidic fibroblast growth factor (FGF1) synthesis and secretion. These experiments examined several aspects of FGF signaling and the contribution of endogenous FGF1 to activation of the extracellular signal-regulated kinase 2 (ERK2). In aged RPE cells, FGFR1 was rapidly activated, and its autophosphorylation followed the kinetics of endogenous FGF1 secretion, before the onset of apoptosis. ERK2 phosphorylation, activity, and de novo synthesis increased at the same time. In marked contrast, no de novo JNK1 synthesis was observed. MEK1 inhibition resulted in lower levels of ERK2 activation and synthesis and higher levels of apoptosis. Treatment with neutralizing anti-FGF1 or blocking anti-FGFR1 antibodies mimics these effects. Thus, this study strongly suggests that the survival-increasing effect of FGF1 in aged RPE cells is because of an autocrine/paracrine loop in which the ERK2 cascade plays a pivotal role.	CNRS, INSERM, U450, Assoc Claude Bernard, F-75016 Paris, France; INSERM, U348, IFR Circulat, F-75010 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Mascarelli, F (corresponding author), CNRS, INSERM, U450, Assoc Claude Bernard, 29 Rue Wilhem, F-75016 Paris, France.		Mascarelli, Frederic/L-8916-2018; guillonneau, xavier/AAF-9495-2021; Guillonneau, xavier/E-3995-2017	guillonneau, xavier/0000-0001-7379-3935; Guillonneau, xavier/0000-0001-7379-3935; Bryckaert, Marijke/0000-0003-3398-0976				ABRAHAM JA, 1986, EMBO J, V5, P2523, DOI 10.1002/j.1460-2075.1986.tb04530.x; BAIRD A, 1991, CANCER CELL-MON REV, V3, P239; BURGESS WH, 1990, MOL CELL BIOL, V10, P4770, DOI 10.1128/MCB.10.9.4770; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; CARUELLE D, 1989, J CELL BIOCHEM, V39, P117, DOI 10.1002/jcb.240390204; Chen J, 1996, P NATL ACAD SCI USA, V93, P7042, DOI 10.1073/pnas.93.14.7042; COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965; COLLINS MKL, 1994, BIOESSAYS, V16, P133, DOI 10.1002/bies.950160210; COUGHLIN SR, 1988, J BIOL CHEM, V263, P988; Estival A, 1996, J BIOL CHEM, V271, P5663, DOI 10.1074/jbc.271.10.5663; FACTOROVICH EG, 1992, J NEUROSCI, V12, P3554; Fox JC, 1996, J BIOL CHEM, V271, P12578, DOI 10.1074/jbc.271.21.12578; FRIESEL R, 1989, MOL CELL BIOL, V9, P1857, DOI 10.1128/MCB.9.5.1857; Gardner AM, 1996, J BIOL CHEM, V271, P14560, DOI 10.1074/jbc.271.24.14560; Garfinkel S, 1996, J CELL BIOL, V134, P783, DOI 10.1083/jcb.134.3.783; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GIVOL D, 1992, FASEB J, V6, P3362, DOI 10.1096/fasebj.6.15.1464370; Guillonneau X, 1997, EXP CELL RES, V233, P198, DOI 10.1006/excr.1997.3542; Guillonneau X, 1996, J CELL PHYSIOL, V166, P170, DOI 10.1002/(SICI)1097-4652(199601)166:1<170::AID-JCP19>3.0.CO;2-J; Guillonneau X, 1998, GROWTH FACTORS, V15, P95, DOI 10.3109/08977199809117186; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; HUANG JT, 1995, J BIOL CHEM, V270, P5065, DOI 10.1074/jbc.270.10.5065; JAYE M, 1992, BIOCHIM BIOPHYS ACTA, V1135, P185, DOI 10.1016/0167-4889(92)90136-Y; JAYE M, 1986, SCIENCE, V233, P241; Konig A, 1997, LEUKEMIA, V11, P258, DOI 10.1038/sj.leu.2400556; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leverrier Y, 1997, ONCOGENE, V14, P425, DOI 10.1038/sj.onc.1200845; MALECAZE F, 1993, J CELL PHYSIOL, V154, P631, DOI 10.1002/jcp.1041540323; MASCARELLI F, 1993, GROWTH FACTORS, V8, P211, DOI 10.3109/08977199309011024; MIYAMOTO M, 1993, MOL CELL BIOL, V13, P4251, DOI 10.1128/MCB.13.7.4251; MOHAMMADI M, 1991, MOL CELL BIOL, V11, P5068, DOI 10.1128/MCB.11.10.5068; MOSCATELLI D, 1987, J CELL PHYSIOL, V131, P123, DOI 10.1002/jcp.1041310118; Moscatelli D, 1990, GROWTH FACTORS, V3, DOI 10.3109/08977199009037499; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Oliver L, 1992, GROWTH FACTORS, V7, P97, DOI 10.3109/08977199209046399; Park J, 1997, J BIOL CHEM, V272, P16725, DOI 10.1074/jbc.272.27.16725; PARTANEN J, 1992, Progress in Growth Factor Research, V4, P69, DOI 10.1016/0955-2235(92)90005-3; Renaud F, 1996, J BIOL CHEM, V271, P2801, DOI 10.1074/jbc.271.5.2801; RENAUD F, 1994, J CELL PHYSIOL, V158, P435, DOI 10.1002/jcp.1041580307; RIFKIN DB, 1989, J CELL BIOL, V109, P1, DOI 10.1083/jcb.109.1.1; SATO Y, 1988, J CELL BIOL, V107, P1129; SCHWEIGERER L, 1987, BIOCHEM BIOPH RES CO, V143, P934, DOI 10.1016/0006-291X(87)90340-8; Servant MJ, 1996, J BIOL CHEM, V271, P16047, DOI 10.1074/jbc.271.27.16047; Sheng ZL, 1997, J BIOL CHEM, V272, P5783, DOI 10.1074/jbc.272.9.5783; SIEVERS J, 1987, NEUROSCI LETT, V76, P157, DOI 10.1016/0304-3940(87)90708-7; STERNFELD MD, 1989, CURR EYE RES, V8, P1029, DOI 10.3109/02713688908997395; TANAKA A, 1992, P NATL ACAD SCI USA, V89, P8928, DOI 10.1073/pnas.89.19.8928; VENKATESWARAN S, 1992, HYBRIDOMA, V11, P729, DOI 10.1089/hyb.1992.11.729; VLODAVSKY I, 1982, EXP CELL RES, V140, P149, DOI 10.1016/0014-4827(82)90166-5; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	51	43	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22367	22373		10.1074/jbc.273.35.22367	http://dx.doi.org/10.1074/jbc.273.35.22367			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712857	hybrid			2022-12-27	WOS:000075616600033
J	Mazaki, Y; Uchida, H; Hino, O; Hashimoto, S; Sabe, H				Mazaki, Y; Uchida, H; Hino, O; Hashimoto, S; Sabe, H			Paxillin isoforms in mouse - Lack of the gamma isoform and developmentally specific beta isoform expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION PROTEIN; CELL-ADHESION; TYROSINE PHOSPHORYLATION; EXTRACELLULAR-MATRIX; MOLECULAR-CLONING; BINDING; ACTIVATION; RECEPTOR; LIGAND; DOMAIN	Paxillin, a focal adhesion protein, exists as multiple isoforms in humans (alpha, beta, and gamma), To understand more about the physiological role of each isoform, we have employed the mouse system. We found that although the alpha and beta isoforms are present in the mouse, the gamma isoform is not. The alpha isoform protein was detected clearly in most adult tissues, whereas the beta isoform protein was almost undetectable except in spleen, testis, thymus, and lung. On the other hand, mRNAs of both isoforms were detectable in all tissues we examined. High levels of the beta isoform protein was detected in peritoneal exudate macrophage cells in adult mouse as well as in cultured fibroblasts, together with the alpha isoform, The alpha isoform was expressed at a constant level throughout the embryonic stages we examined, whereas the beta isoform protein was detected at the mid-stages of development and increased to levels almost equal to those of the a isoform during the late stages of embryogenesis, Therefore, unlike the alpha isoform, expression of the beta isoform protein is restricted in adult tissues. Moreover, we showed that alpha and beta isoforms were colocalized within the same focal adhesion plaques, and cytoplasmic pools of both isoforms exist in the perinuclear area, colocalized with the Gels apparatus.	Osaka Biosci Inst, Dept Mol Biol, Suita, Osaka 5650874, Japan; Japan Sci & Technol Corp, Precursory Res Embryon Sci & Technol, Kyoto 61902, Japan; Kyoto Univ, Inst Virus Res, Kyoto 606, Japan; Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan; Japanese Fdn Canc Res, Inst Canc, Tokyo 170, Japan	Japan Science & Technology Agency (JST); Kyoto University; Keio University; Japanese Foundation for Cancer Research	Sabe, H (corresponding author), Osaka Biosci Inst, Dept Mol Biol, Suita, Osaka 5650874, Japan.	sabe@obi.or.jp	Sabe, Hisataka/GPF-4385-2022; Sabe, Hisataka/A-4066-2012	Mazaki, Yuichi/0000-0003-4192-0834				ARULANANDAM ARN, 1993, J EXP MED, V177, P1439, DOI 10.1084/jem.177.5.1439; BLOOM GS, 1989, J BIOL CHEM, V264, P16083; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; DALTON SL, 1995, MOL BIOL CELL, V6, P1781, DOI 10.1091/mbc.6.12.1781; DUSTIN ML, 1991, ANNU REV IMMUNOL, V9, P27, DOI 10.1146/annurev.iy.09.040191.000331; Gething M J, 1990, Semin Cell Biol, V1, P65; GLENNEY JR, 1989, J CELL BIOL, V108, P2401, DOI 10.1083/jcb.108.6.2401; HINO O, 1991, JPN J CANCER RES, V82, P1226, DOI 10.1111/j.1349-7006.1991.tb01785.x; KATO K, 1992, J EXP MED, V176, P1241, DOI 10.1084/jem.176.5.1241; LE PT, 1990, J IMMUNOL, V144, P4541; Mazaki Y, 1997, J BIOL CHEM, V272, P7437, DOI 10.1074/jbc.272.11.7437; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; Muller RT, 1997, MOL BIOL CELL, V8, P2039, DOI 10.1091/mbc.8.10.2039; NAGATA T, 1989, 10TH P POST C SEM SM, V2, P1; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; RAUB TJ, 1989, EXP CELL RES, V184, P407, DOI 10.1016/0014-4827(89)90340-6; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Sabe H, 1995, J BIOL CHEM, V270, P31219, DOI 10.1074/jbc.270.52.31219; SABE H, 1994, P NATL ACAD SCI USA, V91, P3984, DOI 10.1073/pnas.91.9.3984; SALGIA R, 1995, J BIOL CHEM, V270, P5039, DOI 10.1074/jbc.270.10.5039; SAMBROOK J, 1989, MOL CLONING LAB MANA; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; SINGER KH, 1990, J INVEST DERMATOL, V94, P85; STAUNTON DE, 1987, EMBO J, V6, P3695, DOI 10.1002/j.1460-2075.1987.tb02703.x; TACHIBANA K, 1995, J EXP MED, V182, P1089, DOI 10.1084/jem.182.4.1089; Tong X, 1997, J BIOL CHEM, V272, P33373, DOI 10.1074/jbc.272.52.33373; Tong XA, 1997, P NATL ACAD SCI USA, V94, P4412, DOI 10.1073/pnas.94.9.4412; TURNER CE, 1991, J CELL BIOL, V115, P201, DOI 10.1083/jcb.115.1.201; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; TURNER CE, 1994, J CELL SCI, V107, P1583; WALLNER BP, 1987, J EXP MED, V166, P923, DOI 10.1084/jem.166.4.923; WENG ZG, 1993, J BIOL CHEM, V268, P14956; Yamaguchi R, 1997, ONCOGENE, V15, P1753, DOI 10.1038/sj.onc.1201345	36	45	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22435	22441		10.1074/jbc.273.35.22435	http://dx.doi.org/10.1074/jbc.273.35.22435			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712867	hybrid			2022-12-27	WOS:000075616600043
J	Yuasa, T; Ohno, S; Kehrl, JH; Kyriakis, JM				Yuasa, T; Ohno, S; Kehrl, JH; Kyriakis, JM			Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38 - Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstream of MKK6 and p38	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; C-JUN; CELL-DEATH; TERMINAL KINASE; TNF RECEPTOR-1; TRANSDUCTION PATHWAYS; CYTOPLASMIC DOMAIN; FACTOR-ALPHA; EXPRESSION; APOPTOSIS	Tumor necrosis factor (TNF) elicits a diverse array of inflammatory responses through engagement of its type-1 receptor (TNFR1). Many of these responses require de novo gene expression mediated by the activator protein-1 (AP-1) transcription factor. We investigated the mechanism by which TNFR1 recruits the stress-activated protein kinases (SAPKs) and the p38s, two mitogen-activated protein kinase (MAPK) families that together regulate AP-1. We show that the human SPS1 homologue germinal center kinase (GCK) can interact in vivo with the TNFR1 signal transducer TNFR-associated factor-2 (TRAF2) and with MAPK/ERK kinase kinase 1 (MEKK1), a MAPK kinase kinase (MAPKKK) upstream of the SAPKs, thereby coupling TRAF2 to the SAPKs. Receptor interacting protein (RIP) is a second TNFR1 signal transducer which can bind TRAF2. We show that RIP activates both p38 and SAPK; and that TRAF2 activation of p38 requires RIP. We also demonstrate that the RIP noncatalytic intermediate domain associates in vivo with an endogenous MAPKKK that can activate the p38 pathway in vitro. Thus, TRAF2 initiates SAPK and p38 activation by binding two proximal protein kinases: GCK and RIP. GCK and RIP, in turn, signal by binding MAPKKKs upstream of the SAPKs and p38s.	Massachusetts Gen Hosp E, Diabet Res Lab, Med Res Lab, Charlestown, MA 02129 USA; Yokohama City Univ, Sch Med, Dept Mol Biol, Kanazawa Ku, Yokohama, Kanagawa 236, Japan; NIAID, Cell Mol Immunol Sect B, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	Yokohama City University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kyriakis, JM (corresponding author), Massachusetts Gen Hosp E, Diabet Res Lab, Med Res Lab, 149 13th St, Charlestown, MA 02129 USA.	kyriakis@helix.mgh.harvard.edu	Yuasa, Takashi/B-2595-2010; Ohno, Shigeo/B-1768-2010; Kehrl, John/AAE-6292-2019	Ohno, Shigeo/0000-0002-1294-5269; Kehrl, John/0000-0002-6526-159X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046577, R29GM046577] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM46577] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; BAZZONI F, 1996, TUMOR NECROSIS FACTO, P1717; BRENNER DA, 1989, NATURE, V337, P661, DOI 10.1038/337661a0; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; CHENG GH, 1995, SCIENCE, V267, P1494, DOI 10.1126/science.7533327; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Diener K, 1997, P NATL ACAD SCI USA, V94, P9687, DOI 10.1073/pnas.94.18.9687; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Gerwins P, 1997, J BIOL CHEM, V272, P8288, DOI 10.1074/jbc.272.13.8288; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Han WH, 1997, NATURE, V386, P563, DOI 10.1038/386563a0; HATZ P, 1994, J BIOL CHEM, V269, P16802; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; Holland PM, 1997, J BIOL CHEM, V272, P24994, DOI 10.1074/jbc.272.40.24994; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; HU HM, 1994, J BIOL CHEM, V269, P30069; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Nakano H, 1996, J BIOL CHEM, V271, P14661, DOI 10.1074/jbc.271.25.14661; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; POMBO CM, 1995, NATURE, V377, P750, DOI 10.1038/377750a0; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Rana A, 1996, J BIOL CHEM, V271, P19025, DOI 10.1074/jbc.271.32.19025; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Salmeron A, 1996, EMBO J, V15, P817, DOI 10.1002/j.1460-2075.1996.tb00417.x; SAMBROOK J, 1989, MOL CLONING LAB MANA; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; Shi CS, 1997, J BIOL CHEM, V272, P32102, DOI 10.1074/jbc.272.51.32102; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Stancovski I, 1997, CELL, V91, P299, DOI 10.1016/S0092-8674(00)80413-4; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Su YC, 1997, EMBO J, V16, P1279, DOI 10.1093/emboj/16.6.1279; Takekawa M, 1997, EMBO J, V16, P4973, DOI 10.1093/emboj/16.16.4973; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; Tung RM, 1997, ONCOGENE, V14, P653, DOI 10.1038/sj.onc.1200877; VANDENABEELE P, 1995, TRENDS CELL BIOL, V5, P392, DOI 10.1016/S0962-8924(00)89088-1; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Xu SC, 1996, P NATL ACAD SCI USA, V93, P5291, DOI 10.1073/pnas.93.11.5291; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; YAN MH, 1994, NATURE, V372, P798; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X	58	240	246	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22681	22692		10.1074/jbc.273.35.22681	http://dx.doi.org/10.1074/jbc.273.35.22681			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712898	hybrid			2022-12-27	WOS:000075616600074
J	Meng, TC; Lin, MF				Meng, TC; Lin, MF			Tyrosine phosphorylation of c-ErbB-2 is regulated by the cellular form of prostatic acid phosphatase in human prostate cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; CARCINOMA-CELLS; NEU-ONCOGENE; PROTEIN-PHOSPHORYLATION; INSULIN-RECEPTOR; HUMAN-BREAST; EXPRESSION; HER-2/NEU; TRANSFORMATION; KINASES	Human Prostatic acid phosphatase (PAcP) is a prostate epithelium-specific differentiation antigen. In prostate carcinomas, the cellular PAcP is decreased. We investigated its functional role in these cells. Several lines of evidence support the hypothesis that cellular PAcP functions as a neutral protein-tyrosine phosphatase and is involved in regulating prostate cell growth. In this study, we identify its in vivo substrate. Our results demonstrated that, in different human prostate cancer cell lines, the phosphotyrosine (Tyr(P)) level of a 185-kDa phosphoprotein (pp185) inversely correlates with the cellular activity of PAcP. On SDS-PAGE, this pp185 comigrates with the c-ErbB-2 oncoprotein. Immunodepletion experiments revealed that c-ErbB-2 protein is the major pp185 in cells. Results from subclones of LNCaP cells indicated the lower the cellular PAcP activity, the higher the Tyr(P) levels of c-ErbB-2. This inverse correlation was further observed in PAcP cDNA-transfected cells. In clone 33 LNCaP cells, L-(+)-tartrate suppresses the cellular PAcP activity and causes an elevated Tyr(P) level of: c-ErbB-2 protein. Epidermal growth factor stimulates the proliferation of LNCaP cells, which concurs with a decreased cellular PAcP activity as well as an increased Tyr(P) level of c-ErbB-2. Biochemically, PAcP dephosphorylates c-ErbB-2 at pH 7.0. The results thus suggest that cellular PAcP down-regulates prostate cell growth by dephosphorylating Tyr(P) on c-ErbB-2 oncoprotein in those cells.	Univ Nebraska, Med Ctr, Coll Med, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Coll Med, Sect Urol Surg, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Eppley Canc Inst, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Lin, MF (corresponding author), Univ Nebraska, Med Ctr, Coll Med, Dept Biochem & Mol Biol, 600 S 42nd St, Omaha, NE 68198 USA.		Meng, Tzu-Ching/G-5426-2019	Meng, Tzu-Ching/0000-0001-7693-2021	NATIONAL CANCER INSTITUTE [R01CA072274] Funding Source: NIH RePORTER; NCI NIH HHS [CA 72274] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmad F, 1997, J BIOL CHEM, V272, P448; Arai Y, 1997, PROSTATE, V30, P195, DOI 10.1002/(SICI)1097-0045(19970215)30:3<195::AID-PROS8>3.0.CO;2-L; Bandyopadhyay D, 1997, J BIOL CHEM, V272, P1639, DOI 10.1074/jbc.272.3.1639; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BROWNSHIMER S, 1992, CANCER RES, V52, P478; CARRAWAY KL, 1994, CELL, V78, P5, DOI 10.1016/0092-8674(94)90564-9; CROSS M, 1991, CELL, V64, P271, DOI 10.1016/0092-8674(91)90638-F; DOUGALL WC, 1994, ONCOGENE, V9, P2109; FOTI AG, 1977, CANCER RES, V37, P4120; GARCIAARENAS R, 1995, MOL CELL ENDOCRINOL, V111, P29, DOI 10.1016/0303-7207(95)03544-H; Grasso AW, 1997, ONCOGENE, V15, P2705, DOI 10.1038/sj.onc.1201447; Gu KF, 1996, CANCER LETT, V99, P185, DOI 10.1016/0304-3835(95)04061-7; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; Keane MM, 1996, CANCER RES, V56, P4236; Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; KUHN EJ, 1993, J UROLOGY, V150, P1427, DOI 10.1016/S0022-5347(17)35799-3; Landry F, 1996, J UROLOGY, V155, P386, DOI 10.1016/S0022-5347(01)66665-5; LATIL A, 1994, INT J CANCER, V59, P637, DOI 10.1002/ijc.2910590510; LI HC, 1984, EUR J BIOCHEM, V138, P45, DOI 10.1111/j.1432-1033.1984.tb07879.x; Lin MF, 1996, BIOCHEM BIOPH RES CO, V226, P206, DOI 10.1006/bbrc.1996.1334; LIN MF, 1988, MOL CELL BIOL, V8, P5477, DOI 10.1128/MCB.8.12.5477; LIN MF, 1986, MOL CELL BIOL, V6, P4753, DOI 10.1128/MCB.6.12.4753; LIN MF, 1993, ARCH BIOCHEM BIOPHYS, V300, P384, DOI 10.1006/abbi.1993.1052; LIN MF, 1986, BIOCHEM J, V235, P351, DOI 10.1042/bj2350351; Lin MF, 1998, J BIOL CHEM, V273, P5939, DOI 10.1074/jbc.273.10.5939; LIN MF, 1992, CANCER RES, V52, P4600; LIN MF, 1994, DIFFERENTIATION, V57, P143, DOI 10.1046/j.1432-0436.1994.5720143.x; LIN MF, 1993, BIOCHEM BIOPH RES CO, V192, P413, DOI 10.1006/bbrc.1993.1431; LIN MF, 1983, BIOCHEMISTRY-US, V22, P1055, DOI 10.1021/bi00274a009; LOOR R, 1981, CANC LETT, V14, P61; MACOSKA JA, 1992, J UROLOGY, V147, P1142, DOI 10.1016/S0022-5347(17)37504-3; PEEHL DM, 1996, DEV BIOL, V22, P82; Robinson D, 1996, P NATL ACAD SCI USA, V93, P5958, DOI 10.1073/pnas.93.12.5958; SADASIVAN R, 1993, J UROLOGY, V150, P126, DOI 10.1016/S0022-5347(17)35413-7; SCHNEIDER G, 1993, EMBO J, V12, P2609, DOI 10.1002/j.1460-2075.1993.tb05921.x; SHARIEF FS, 1989, BIOCHEM BIOPH RES CO, V160, P79, DOI 10.1016/0006-291X(89)91623-9; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SUN H, 1994, TRENDS BIOCHEM SCI, V19, P480, DOI 10.1016/0968-0004(94)90134-1; TESSIER S, 1989, MOL CELL ENDOCRINOL, V64, P87, DOI 10.1016/0303-7207(89)90068-3; VANETTEN RL, 1991, J BIOL CHEM, V266, P2313; VIHKO P, 1979, INVEST UROL, V16, P349; WALTON KM, 1993, ANNU REV BIOCHEM, V62, P101; Yin TG, 1997, J BIOL CHEM, V272, P1032, DOI 10.1074/jbc.272.2.1032; ZHAI YF, 1995, MOL CARCINOGEN, V14, P103, DOI 10.1002/mc.2940140206	46	77	78	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					22096	22104		10.1074/jbc.273.34.22096	http://dx.doi.org/10.1074/jbc.273.34.22096			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705354	hybrid, Green Published			2022-12-27	WOS:000075492600088
J	Chen, J; Ruley, HE				Chen, J; Ruley, HE			An enhancer element in the EphA2 (Eck) gene sufficient for rhombomere-specific expression is activated by HOXA1 and HOXB1 homeobox proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; NEURAL CREST MIGRATION; EMBRYONIC EXPRESSION; IN-VITRO; HINDBRAIN; LIGANDS; SEGMENTATION; GUIDANCE; PATTERN; FAMILY	In the hindbrain of the mouse embryo, there is often coincident rhombomere-restricted expression of Eph receptor tyrosine kinases and Hox homeobox genes, raising the possibility of regulatory interactions. In this paper, we have identified cis-acting regulatory sequences of the EphA2 (Ech) gene, which direct node and hindbrain-specific expression in transgenic embryos. An 8-kilobase region of mouse genomic DNA element was sufficient to drive rhombomere 4 (r4)-specific expression while conferring patchy expression in the node. Further analysis localized the rhombomere-specific enhancer to a 0.9-kilobase sequence. This element contains multiple Hox-Pbx consensus binding sites that bind to both HOXA1/Pbx1 and HOXB1/Pbx1 proteins in vitro. Go-expression of either HOXA1 or HOXB1 with Pbx1 transactivated EphA2 enhancer-dependent reporter gene expression. These results, together with observations of reduced EphA2 expression in hoxa1 and hoxb1 double mutant mice, suggest that expression of EphA2 gene in rhombomere 4 is directly regulated by Hoxa1 and Hoxb1 homeobox transcription factors.	Vanderbilt Univ, Sch Med, Dept Med Rheumatol, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Cell Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Immunol Microbiol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Chen, J (corresponding author), Vanderbilt Univ, Sch Med, Dept Med Rheumatol, A4323 Med Ctr N, Nashville, TN 37232 USA.	Jin.Chen@mcmail.vanderbilt.edu		Chen, Jin/0000-0002-5557-2079	NCI NIH HHS [P30 CA68485] Funding Source: Medline; NHGRI NIH HHS [R01 HG00684] Funding Source: Medline; NIGMS NIH HHS [F32 GM17003] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM017003] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BECKER N, 1994, MECH DEVELOP, V47, P3, DOI 10.1016/0925-4773(94)90091-4; CARPENTER EM, 1993, DEVELOPMENT, V118, P1063; Chen J, 1996, ONCOGENE, V12, P979; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; DOLLE P, 1993, P NATL ACAD SCI USA, V90, P7666, DOI 10.1073/pnas.90.16.7666; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Flenniken AM, 1996, DEV BIOL, V179, P382, DOI 10.1006/dbio.1996.0269; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; FROHMAN MA, 1990, DEVELOPMENT, V110, P589; FROHMAN MA, 1992, MECH DEVELOP, V38, P55, DOI 10.1016/0925-4773(92)90038-L; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; GANJU P, 1994, ONCOGENE, V9, P1613; Gavalas A, 1998, DEVELOPMENT, V125, P1123; Goddard JM, 1996, DEVELOPMENT, V122, P3217; HENKEMEYER M, 1994, ONCOGENE, V9, P1001; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Hogan B, 1994, MANIPULATING MOUSE E; HUNT P, 1991, NATURE, V353, P861, DOI 10.1038/353861a0; Krull CE, 1997, CURR BIOL, V7, P571, DOI 10.1016/S0960-9822(06)00256-9; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3; MURPHY P, 1989, NATURE, V341, P156, DOI 10.1038/341156a0; MURPHY P, 1991, DEVELOPMENT, V111, P61; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; NIETO MA, 1992, DEVELOPMENT, V116, P1137; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; ROCCO DG, 1997, EMBO J, V16, P3644; RUIZ JC, 1994, MECH DEVELOP, V46, P87; Sasaki H, 1996, GENES CELLS, V1, P59, DOI 10.1046/j.1365-2443.1996.04004.x; Scherer CA, 1996, CELL GROWTH DIFFER, V7, P1393; Smith A, 1997, CURR BIOL, V7, P561, DOI 10.1016/S0960-9822(06)00255-7; Studer M, 1996, NATURE, V384, P630, DOI 10.1038/384630a0; Studer M, 1998, DEVELOPMENT, V125, P1025; Taneja R, 1996, DEV BIOL, V177, P397, DOI 10.1006/dbio.1996.0173; Theil T, 1998, DEVELOPMENT, V125, P443; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; Xu QL, 1995, DEVELOPMENT, V121, P4005	39	87	92	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24670	24675		10.1074/jbc.273.38.24670	http://dx.doi.org/10.1074/jbc.273.38.24670			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733765	hybrid			2022-12-27	WOS:000076007300057
J	Lin, SW; Kochendoerfer, GG; Carroll, KS; Wang, D; Mathies, RA; Sakmar, TP				Lin, SW; Kochendoerfer, GG; Carroll, KS; Wang, D; Mathies, RA; Sakmar, TP			Mechanisms of spectral tuning in blue cone visual pigments - Visible and raman spectroscopy of blue-shifted rhodopsin mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIFF-BASE COUNTERION; CONGENITAL NIGHT BLINDNESS; HUMAN COLOR-VISION; BOVINE RHODOPSIN; RESONANCE RAMAN; WAVELENGTH REGULATION; RETINAL CHROMOPHORE; AMINO-ACIDS; WATER MOLECULE; GREEN	Spectral tuning by visual pigments involves the modulation of the physical properties of the chromophore (Il-cis-retinal) by amino acid side chains that compose the chromophore-binding pocket, We identified 12 amino acid residues in the human blue cone pigment that might induce the required green-to blue opsin shift. The simultaneous substitution of nine of these sites in rhodopsin (M86L, G90S, A117G, E122L, A124T, W265Y, A292S, A295S, and A299C) shifted the absorption maximum from 500 to 438 nn, accounting for 2,830 cm(-1), or 80%, of the opsin shift between rhodopsin and the blue cone pigment. Raman spectroscopy of mutant pigments shows that the dielectric character and architecture of the chromophore-binding pocket are specifically altered, An increase in the number of dipolar side chains near the protonated Schiff base of retinal increases the ground-excited state energy gap via long range dipole-dipole Coulomb interaction. In addition, the W265Y substitution causes a decrease in solvent polarizability near the chromophore ring structure. Finally, two substitutions on transmembrane helix 3 (A117G and E122L) act in combination with the other substitutions to alter the binding-pocket structure, resulting in stronger interaction of the protonated Schiff base group with the surrounding dipolar groups and the counterion, Taken together, these results identify the amino acid side chains and the underlying physical mechanisms responsible for a majority of the opsin shift in blue visual pigments.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Biol & Biochem, New York, NY 10021 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; Rockefeller University; University of California System; University of California Berkeley	Sakmar, TP (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Biol & Biochem, 1230 York Ave, New York, NY 10021 USA.	sakmar@rockvax.rockefeller.edu	Sakmar, Thomas P/D-1833-2015	Sakmar, Thomas P/0000-0002-2836-8953; Carroll, Kate/0000-0002-7624-9617				ASENJO AB, 1994, NEURON, V12, P1131, DOI 10.1016/0896-6273(94)90320-4; ATON B, 1977, BIOCHEMISTRY-US, V16, P2995, DOI 10.1021/bi00632a029; BEPPU Y, 1994, PHOTOCHEM PHOTOBIOL, V59, P660; BIRGE RR, 1980, J AM CHEM SOC, V102, P2195, DOI 10.1021/ja00527a008; BIRGE RR, 1985, P NATL ACAD SCI USA, V82, P4117, DOI 10.1073/pnas.82.12.4117; BLATZ PE, 1972, BIOCHEMISTRY-US, V11, P848, DOI 10.1021/bi00755a026; BRUNGER AT, 1992, X PLOR; CHAN T, 1992, J BIOL CHEM, V267, P9478; Chang BSW, 1995, MOL PHYLOGENET EVOL, V4, P31, DOI 10.1006/mpev.1995.1004; CHIU MI, 1994, GENOMICS, V21, P440, DOI 10.1006/geno.1994.1292; DENG H, 1994, BIOPHYS J, V66, P1129, DOI 10.1016/S0006-3495(94)80893-8; Fahmy K, 1996, BIOCHEMISTRY-US, V35, P15065, DOI 10.1021/bi961486s; Fasick JI, 1998, BIOCHEMISTRY-US, V37, P433, DOI 10.1021/bi972500j; HAN M, 1993, BIOPHYS J, V65, P899, DOI 10.1016/S0006-3495(93)81117-2; HARGRAVE PA, 1983, BIOPHYS STRUCT MECH, V9, P235, DOI 10.1007/BF00535659; HONIG B, 1979, J AM CHEM SOC, V101, P7084, DOI 10.1021/ja00517a060; Hope AJ, 1997, P ROY SOC B-BIOL SCI, V264, P155, DOI 10.1098/rspb.1997.0023; IRVING CS, 1970, BIOCHEMISTRY-US, V9, P858, DOI 10.1021/bi00806a020; KAKITANI H, 1985, PHOTOCHEM PHOTOBIOL, V41, P471, DOI 10.1111/j.1751-1097.1985.tb03514.x; KLEINSCHMIDT J, 1992, P NATL ACAD SCI USA, V89, P9181, DOI 10.1073/pnas.89.19.9181; Kochendoerfer GG, 1997, BIOCHEMISTRY-US, V36, P6577, DOI 10.1021/bi970322o; Lin SW, 1996, BIOCHEMISTRY-US, V35, P11149, DOI 10.1021/bi960858u; LIN SW, 1994, BIOCHEMISTRY-US, V33, P2151, DOI 10.1021/bi00174a023; LIVNAH N, 1993, J AM CHEM SOC, V115, P351, DOI 10.1021/ja00054a054; LOPPNOW GR, 1989, P NATL ACAD SCI USA, V86, P1515, DOI 10.1073/pnas.86.5.1515; Lythgoe J.N., 1972, HDB SENSORY PHYSL, VVII/1, P604; Mathies R. A., 1987, BIOL APPLICATIONS RA, P59; MERBS SL, 1992, NATURE, V356, P433, DOI 10.1038/356433a0; MOTTO MG, 1980, J AM CHEM SOC, V102, P7947, DOI 10.1021/ja00547a029; Nagata T, 1997, BIOCHEMISTRY-US, V36, P6164, DOI 10.1021/bi962920t; NAKAYAMA TA, 1991, J BIOL CHEM, V266, P4269; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P937, DOI 10.1021/bi00456a013; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P9746, DOI 10.1021/bi00493a034; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NEITZ M, 1991, SCIENCE, V252, P971, DOI 10.1126/science.1903559; OPRIAN DD, 1991, BIOCHEMISTRY-US, V30, P11367, DOI 10.1021/bi00112a002; OVCHINNIKOV YA, 1982, BIOORG KHIM+, V8, P1011; PALINGS I, 1987, BIOCHEMISTRY-US, V26, P2544, DOI 10.1021/bi00383a021; RAO VR, 1994, NATURE, V367, P639, DOI 10.1038/367639a0; RIDGE KD, 1995, BIOCHEMISTRY-US, V34, P3261, DOI 10.1021/bi00010a016; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Shieh T, 1997, J MOL BIOL, V269, P373, DOI 10.1006/jmbi.1997.1035; Sun H, 1997, P NATL ACAD SCI USA, V94, P8860, DOI 10.1073/pnas.94.16.8860; THOMAS DD, 1982, J MOL BIOL, V154, P145, DOI 10.1016/0022-2836(82)90422-3; WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; WANG ZY, 1993, BIOCHEMISTRY-US, V32, P2125, DOI 10.1021/bi00060a001; YOKOYAMA R, 1990, P NATL ACAD SCI USA, V87, P9315, DOI 10.1073/pnas.87.23.9315; YOSHIZAWA T, 1992, PHOTOCHEM PHOTOBIOL, V56, P859, DOI 10.1111/j.1751-1097.1992.tb09707.x; ZHANG HZ, 1994, J AM CHEM SOC, V116, P10165, DOI 10.1021/ja00101a040; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154	51	114	114	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24583	24591		10.1074/jbc.273.38.24583	http://dx.doi.org/10.1074/jbc.273.38.24583			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733753	hybrid			2022-12-27	WOS:000076007300045
J	Nagano, F; Sasaki, T; Fukui, K; Asakura, T; Imazumi, K; Takai, Y				Nagano, F; Sasaki, T; Fukui, K; Asakura, T; Imazumi, K; Takai, Y			Molecular cloning and characterization of the noncatalytic subunit of the Rab3 subfamily-specific GTPase-activating protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; CA2+-DEPENDENT EXOCYTOSIS; TARGET PROTEIN; PC12 CELLS; SMG P25A; PURIFICATION; RABPHILIN-3A; REGULATORS; EXPRESSION; TRANSPORT	We recently purified and characterized from rat brain a GTPase-activating protein (GAP) specific for the Rab3 small G protein subfamily implicated in Ca2+-dependent exocytosis. Rab3 GAP showed two bands with M-r of about 130,000 (p130) and 150,000 (p150) on SDS-polyacrylamide gel electrophoresis. p130, but not p150, showed the catalytic activity. Because p150 was likely the subunit of Rab3 GAP, here we cloned the cDNA of p150, determined its primary structure, and characterized it. The tissue and subcellular distribution patterns of p150 and p130 were similar, and both the proteins were enriched in the synaptic soluble fraction. p150 was co-immunoprecipitated with p130 from this fraction. Recombinant p150 formed a heterodimer with recombinant p130 as estimated by sucrose density gradient ultracentrifugation. Recombinant p150 neither showed the Rab3A GAP activity nor affected the activity of recombinant p130. When p150 and p130 were co-expressed in the cells, the subcellular localization of each protein did not change. These results indicate that p150 is the noncatalytic subunit of Rab3 GAP.	Osaka Univ, Sch Med, Dept Mol Biol & Biochem, Suita, Osaka 5650871, Japan	Osaka University	Takai, Y (corresponding author), Osaka Univ, Sch Med, Dept Mol Biol & Biochem, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.							BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; Du LL, 1998, J BIOL CHEM, V273, P3253, DOI 10.1074/jbc.273.6.3253; Fukui K, 1997, J BIOL CHEM, V272, P4655, DOI 10.1074/jbc.272.8.4655; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; HOLZ RW, 1994, J BIOL CHEM, V269, P10229; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; IMAZUMI K, 1994, BIOCHEM BIOPH RES CO, V205, P1409, DOI 10.1006/bbrc.1994.2822; JOHANNES L, 1994, EMBO J, V13, P2029, DOI 10.1002/j.1460-2075.1994.tb06476.x; KIKUCHI A, 1995, METHOD ENZYMOL, V257, P57; KISHIDA S, 1993, J BIOL CHEM, V268, P22259; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MIZOGUCHI A, 1990, J BIOL CHEM, V265, P11872; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; NUOFFER C, 1994, ANNU REV BIOCHEM, V63, P949, DOI 10.1146/annurev.bi.63.070194.004505; Orita S, 1996, J BIOL CHEM, V271, P7257, DOI 10.1074/jbc.271.13.7257; PFEFFER SR, 1994, CURR OPIN CELL BIOL, V6, P522, DOI 10.1016/0955-0674(94)90071-X; Sambrook J., 2002, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANO K, 1989, BIOCHEM BIOPH RES CO, V158, P377, DOI 10.1016/S0006-291X(89)80058-0; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; SIMONS K, 1993, NEURON, V11, P789, DOI 10.1016/0896-6273(93)90109-5; STAHL B, 1994, J BIOL CHEM, V269, P24770; STROM M, 1993, NATURE, V361, P736, DOI 10.1038/361736a0; Takai Y, 1996, GENES CELLS, V1, P615, DOI 10.1046/j.1365-2443.1996.00257.x; TAKAI Y, 1993, CIBA F SYMP, V176, P128; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; TOMBIN H, 1979, P NATL ACAD SCI USA, V76, P4350; VOLLMER P, 1995, METHOD ENZYMOL, V257, P118; VONMOLLARD GF, 1994, TRENDS BIOCHEM SCI, V19, P164, DOI 10.1016/0968-0004(94)90278-X; Wada M, 1997, J BIOL CHEM, V272, P3875, DOI 10.1074/jbc.272.7.3875	32	52	60	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24781	24785		10.1074/jbc.273.38.24781	http://dx.doi.org/10.1074/jbc.273.38.24781			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733780	hybrid			2022-12-27	WOS:000076007300072
J	Boxenbaum, N; Daly, SE; Javaid, ZZ; Lane, LK; Blostein, R				Boxenbaum, N; Daly, SE; Javaid, ZZ; Lane, LK; Blostein, R			Changes in steady-state conformational equilibrium resulting from cytoplasmic mutations of the Na,K-ATPase alpha-subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE H+-ATPASE; SARCOPLASMIC-RETICULUM; TRANSPORT; POTASSIUM; DOMAIN; NA+; TRIPHOSPHATASE; SUBSTITUTIONS; CA-2+-ATPASE; PURIFICATION	Mutations comprising either deletion of 32 amino acids from the NH2 terminus (alpha 1M32) or a Glu(233) --> Lys substitution in the first M2-M3 cytoplasmic loop (E233K) of the alpha 1-subunit of the Na,K-ATPase result in a shift in the steady-state E-1 <-> E-2 conformational equilibrium toward E-1 form(s), In the present study, the functional consequences of both NH2-terminal deletion and Glu(233) substitution provide evidence for mutual interactions of these cytoplasmic regions. Following transfection and selection of HeLa cells expressing the ouabain-resistant alpha 1M32E233K double mutant, growth was markedly reduced unless the K+ concentration in the culture medium was increased to at least 10 mM. Marked changes effected by this double mutation included 1) a 15-fold reduction in catalytic turnover (V-max/EPmax) a 70-fold increase in apparent affinity for ATP, 3) a marked decrease in vanadate sensitivity, and 4) marked (approximate to 10-fold) K+ activation of the Na-ATPase activity measured at micromolar ATP under which condition the E-2(K) --> --> E-1 pathway is normally (alpha 1) rate-limiting and K+ is inhibitory. The decrease in catalytic turnover was associated with a 5-fold decrease in V-max and a compensatory approximate to 3-fold increase in expressed alpha 1M32E233K protein. In contrast to the behavior of either alpha 1M32 or E233K, alpha 1M32E233K also showed alterations in apparent cation affinities. K-Na' was decreased approximate to 2-fold and K-K' was increased approximate to 2-fold. The importance of the charge at residue 233 is underscored by the consequences of single and double mutations comprising either a conservative change (E233D) or neutral substitution (E233Q). Thus, whereas mutation to a positively charged residue (E233K) causes a drastic change in enzymatic behavior, a conservative change causes only a minor change and the neutral substitution, an intermediate effect. Overall, the combined effects of the NH2-terminal deletion and the Glu(233) substitutions are synergistic rather than additive, consistent with an interaction between the NH2-terminal region, the first cytoplasmic loop, and possibly the large M4-M5 cytoplasmic loop bearing the nucleotide binding and phosphorylation sites.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Expt Med, Montreal, PQ H3G 1A4, Canada; Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA	McGill University; McGill University; University System of Ohio; University of Cincinnati	Blostein, R (corresponding author), Montreal Gen Hosp, 1650 Cedar Ave,Rm L11-132, Montreal, PQ H3G 1A4, Canada.	mirb@musica.mcgill.ca		MacAulay, Nanna/0000-0002-7800-6600	NHLBI NIH HHS [HL 49204] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049204] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSEN JP, 1995, FEBS LETT, V359, P101, DOI 10.1016/0014-5793(95)00019-6; ANDERSEN JP, 1989, J BIOL CHEM, V264, P21018; ARGUELLO JM, 1995, J BIOL CHEM, V270, P22764, DOI 10.1074/jbc.270.39.22764; Bandell M, 1996, BBA-BIOMEMBRANES, V1280, P81, DOI 10.1016/0005-2736(95)00280-4; BLOSTEIN R, 1988, METHOD ENZYMOL, V156, P171; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Colonna TE, 1997, J BIOL CHEM, V272, P12366, DOI 10.1074/jbc.272.19.12366; Daly SE, 1996, J BIOL CHEM, V271, P23683, DOI 10.1074/jbc.271.39.23683; EISNER DA, 1981, J PHYSIOL-LONDON, V319, P403, DOI 10.1113/jphysiol.1981.sp013917; ELLISDAVIES GCR, 1993, J BIOL CHEM, V268, P11622; ESMANN M, 1985, BIOCHEM BIOPH RES CO, V127, P857, DOI 10.1016/S0006-291X(85)80022-X; FAHN S, 1966, J BIOL CHEM, V241, P1882; FORBUSH B, 1979, BIOCHEMISTRY-US, V18, P2308, DOI 10.1021/bi00578a027; FORBUSH B, 1989, P NATL ACAD SCI USA, V81, P5310; GHISLAIN M, 1987, J BIOL CHEM, V262, P17549; Goldshleger R, 1997, P NATL ACAD SCI USA, V94, P9596, DOI 10.1073/pnas.94.18.9596; GREEN NM, 1992, ACTA PHYSIOL SCAND, V146, P59; HARRIS SL, 1991, J BIOL CHEM, V266, P24439; IMAMURA Y, 1989, J BIOCHEM-TOKYO, V105, P775, DOI 10.1093/oxfordjournals.jbchem.a122743; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; JORGENSEN PL, 1982, ANN NY ACAD SCI, V402, P207, DOI 10.1111/j.1749-6632.1982.tb25743.x; JORGENSEN PL, 1975, BIOCHIM BIOPHYS ACTA, V401, P399, DOI 10.1016/0005-2736(75)90239-4; JORGENSEN PL, 1988, NA PLUS K PLUS PUM A, P85; JORGENSEN PL, 1992, MOL ASPECTS TRANSPOR, P1; LANE LK, 1993, J BIOL CHEM, V268, P17930; LEMAIRE M, 1990, J BIOL CHEM, V265, P1111; LINGREL JB, 1990, PROG NUCLEIC ACID RE, V38, P37; LUTSENKO S, 1994, J BIOL CHEM, V269, P4555; Markwell M A, 1981, Methods Enzymol, V72, P296; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; PICK U, 1982, J BIOL CHEM, V257, P6111; POST RL, 1972, J BIOL CHEM, V247, P6530; SACHS JR, 1986, J PHYSIOL-LONDON, V381, P149, DOI 10.1113/jphysiol.1986.sp016319; Vilsen B, 1997, BIOCHEMISTRY-US, V36, P13312, DOI 10.1021/bi971030q; VILSEN B, 1988, CLIN BIOL RES A, V268, P383; WIERZBICKI W, 1993, P NATL ACAD SCI USA, V90, P70, DOI 10.1073/pnas.90.1.70	37	36	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23086	23092		10.1074/jbc.273.36.23086	http://dx.doi.org/10.1074/jbc.273.36.23086			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722535	hybrid			2022-12-27	WOS:000075778100035
J	Hellqvist, M; Mahlapuu, M; Blixt, A; Enerback, S; Carlsson, P				Hellqvist, M; Mahlapuu, M; Blixt, A; Enerback, S; Carlsson, P			The human forkhead protein FREAC-2 contains two functionally redundant activation domains and interacts with TBP and TFIIB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-TFIIB; CO-CRYSTAL STRUCTURE; DNA-BINDING; ALVEOLAR RHABDOMYOSARCOMA; NUCLEAR-PROTEIN; FUSION PROTEIN; TATA-ELEMENT; MOUSE EMBRYO; HELIX; HEAD	Forkhead-related activator 2 (FREAC-2) is a human transcription factor expressed in lung and placenta that binds to cia-elements in several lung-specific genes. We have identified the parts of FREAC-2 responsible for trans-activation and found two functionally redundant activation domains on the C-terminal side of the DNA binding forkhead domain. Activation domain 1 consists of the most C-terminal 23 amino acids of FREAC-2 and contains a sequence motif conserved in an activation domain of another forkhead protein, FREAC-1. Activation domain 2 is built up by three synergistic subdomains in the central part of the FREAC-2 protein. FREAC-2 was shown to interact in vitro with TBP and TFIIB. The target site for FREAC-2 on TBP was localized to the N-terminal repeat in the core domain of TBP. TFIIB binds FREAC-2 close to the cleft between its two globular domains, The part of FREAC-2 that binds TBP was mapped to 21 amino acids in the C-terminal end of the forkhead domain. This sequence is well conserved among forkhead proteins, raising the possibility that interaction with TBP may be a general characteristic of this family of transcription factors. Overexpression of TFIIB potentiates activation by FREAC-2 in a manner dependent on the FREAC-2 activation domains, Nuclear localization of FREAC-2 was found to depend on sequences from both ends of the forkhead domain.	Univ Goteborg, Dept Mol Biol, S-40530 Goteborg, Sweden	University of Gothenburg	Carlsson, P (corresponding author), Univ Goteborg, Dept Mol Biol, Medicinaregatan 9C,Box 462, S-40530 Goteborg, Sweden.		Carlsson, Peter/B-5551-2008	Carlsson, Peter/0000-0001-6535-5927; Mahlapuu, Margit/0000-0001-8740-8874				ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; [Anonymous], 1997, NATURE, V387, pS; Bennicelli JL, 1996, P NATL ACAD SCI USA, V93, P5455, DOI 10.1073/pnas.93.11.5455; Boulikas Teni, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P193; CADIGAN KM, 1994, P NATL ACAD SCI USA, V91, P6324, DOI 10.1073/pnas.91.14.6324; CARLSSON P, 1993, GENE DEV, V7, P2418, DOI 10.1101/gad.7.12a.2418; Chang HW, 1996, ONCOGENE, V13, P441; CHASMAN DI, 1993, P NATL ACAD SCI USA, V90, P8174, DOI 10.1073/pnas.90.17.8174; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Dou CL, 1997, NEURON, V18, P539, DOI 10.1016/S0896-6273(00)80296-2; Ernstsson S, 1997, GENOMICS, V46, P78, DOI 10.1006/geno.1997.4986; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; GROSSNIKLAUS U, 1992, GENE DEV, V6, P1030, DOI 10.1101/gad.6.6.1030; HACKER U, 1995, EMBO J, V14, P5306, DOI 10.1002/j.1460-2075.1995.tb00215.x; Hatini V, 1996, GENE DEV, V10, P1467, DOI 10.1101/gad.10.12.1467; Hellqvist M, 1996, J BIOL CHEM, V271, P4482; HOFFMANN A, 1990, NATURE, V346, P387, DOI 10.1038/346387a0; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; KAUFMANN E, 1995, J MOL BIOL, V248, P239, DOI 10.1006/jmbi.1995.0218; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; Labosky PA, 1997, DEVELOPMENT, V124, P1263; LACASSE EC, 1995, NUCLEIC ACIDS RES, V23, P1647, DOI 10.1093/nar/23.10.1647; LI C, 1991, P NATL ACAD SCI USA, V88, P7739, DOI 10.1073/pnas.88.17.7739; LI J, 1995, CANCER RES, V55, P5540; LI J, 1993, P NATL ACAD SCI USA, V90, P4490, DOI 10.1073/pnas.90.10.4490; LIN YS, 1991, NATURE, V353, P569, DOI 10.1038/353569a0; MALIK S, 1991, P NATL ACAD SCI USA, V88, P9553, DOI 10.1073/pnas.88.21.9553; MATTHIAS P, 1989, NUCLEIC ACIDS RES, V17, P6418, DOI 10.1093/nar/17.15.6418; MCPHERSON CE, 1993, CELL, V75, P387, DOI 10.1016/0092-8674(93)80079-T; MILLER LM, 1993, GENE DEV, V7, P933, DOI 10.1101/gad.7.6.933; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; NERLOV C, 1995, EMBO J, V14, P4318, DOI 10.1002/j.1460-2075.1995.tb00106.x; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; NIKOLOV DB, 1992, NATURE, V360, P40, DOI 10.1038/360040a0; OSBORNE MA, 1993, ANNU REV BIOCHEM, V62, P219; OVERDIER DG, 1994, MOL CELL BIOL, V14, P2755, DOI 10.1128/MCB.14.4.2755; Paal K, 1997, NUCLEIC ACIDS RES, V25, P1050, DOI 10.1093/nar/25.5.1050; PANI L, 1992, MOL CELL BIOL, V12, P3723, DOI 10.1128/MCB.12.9.3723; PIERROU S, 1995, ANAL BIOCHEM, V229, P99, DOI 10.1006/abio.1995.1384; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; QIAN XB, 1995, NUCLEIC ACIDS RES, V23, P1184, DOI 10.1093/nar/23.7.1184; Scheidler S, 1996, P NATL ACAD SCI USA, V93, P9805, DOI 10.1073/pnas.93.18.9805; Schlake T, 1997, P NATL ACAD SCI USA, V94, P3842, DOI 10.1073/pnas.94.8.3842; Schuddekopf K, 1996, P NATL ACAD SCI USA, V93, P9661, DOI 10.1073/pnas.93.18.9661; STRINGER KF, 1990, NATURE, V345, P783, DOI 10.1038/345783a0; SUBLETT JE, 1995, ONCOGENE, V11, P545; Sutton J, 1996, J BIOL CHEM, V271, P23126, DOI 10.1074/jbc.271.38.23126; TAO W, 1992, NEURON, V8, P957, DOI 10.1016/0896-6273(92)90210-5; WEIGEL D, 1989, CELL, V57, P645, DOI 10.1016/0092-8674(89)90133-5; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; Winnier GE, 1997, GENE DEV, V11, P926, DOI 10.1101/gad.11.7.926; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7; YLIKOMI T, 1992, EMBO J, V11, P3681, DOI 10.1002/j.1460-2075.1992.tb05453.x	59	51	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23335	23343		10.1074/jbc.273.36.23335	http://dx.doi.org/10.1074/jbc.273.36.23335			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722567	hybrid			2022-12-27	WOS:000075778100067
J	Jeziorski, MC; Greenberg, RM; Clark, KS; Anderson, PAV				Jeziorski, MC; Greenberg, RM; Clark, KS; Anderson, PAV			Cloning and functional expression of a voltage-gated calcium channel alpha(1) subunit from jellyfish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED IONIC CURRENTS; DEPENDENT CA2+ CHANNELS; AMINO-ACID-RESIDUES; BAG CELL NEURONS; BETA-SUBUNIT; SKELETAL-MUSCLE; SODIUM-CHANNEL; 1,4-DIHYDROPYRIDINE SENSITIVITY; MOLECULAR DETERMINANTS; APLYSIA-CALIFORNICA	Voltage-gated Ca2+ channels in vertebrates comprise at least seven molecular subtypes, each of which produces a current with distinct kinetics and pharmacology. Although several invertebrate Ca2+ channel cu, subunits have also been cloned, their functional characteristics remain unclear, as heterologous expression of a full-length invertebrate channel has not previously been reported. We have cloned a cDNA encoding the cu, subunit of a voltage-gated Ca2+ channel from the scyphozoan jellyfish Cyanea capillata, one of the earliest existing organisms to possess neural and muscle tissue. The deduced amino acid sequence of this subunit, named CyCa alpha(1), is more similar to vertebrate L-type channels (alpha(1S), alpha(1C), and alpha(1D)) than to non-1-type channels (alpha(1A), alpha(1B), and alpha(1E)) or low voltage-activated channels (alpha(1G)) Expression of CyCa alpha(1) in Xenopus oocytes produces a high voltage-activated Ca2+ current that, unlike vertebrate L-type currents, is only weakly sensitive to 1,4-dihydropyridine or phenylalkylamine Ca2+ channel blockers and is not potentiated by the agonist S(-)-BayK: 8644. In addition, the channel is less permeable to Ba2+ than to Ca2+ and is more permeable to Sr2+. CyCa alpha(1) thus represents an ancestral L-type alpha(1) subunit with significant functional differences from mammalian L-type channels.	Univ Florida, Whitney Lab, St Augustine, FL 32086 USA; Univ Florida, Dept Physiol, St Augustine, FL 32086 USA; Univ Florida, Dept Neurosci, St Augustine, FL 32086 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Anderson, PAV (corresponding author), Univ Florida, Whitney Lab, 9505 Ocean Shore Blvd, St Augustine, FL 32086 USA.	paa@whitney.ufl.edu			NIMH NIH HHS [MH 10625] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDERSON PAV, 1987, J EXP BIOL, V133, P231; ANDERSON PAV, 1987, J EXP BIOL, V133, P215; ANDERSON PAV, 1993, P NATL ACAD SCI USA, V90, P7419, DOI 10.1073/pnas.90.15.7419; BABITCH J, 1990, NATURE, V346, P321, DOI 10.1038/346321b0; BLAIR KL, 1993, J EXP BIOL, V185, P267; Bourinet E, 1996, J NEUROSCI, V16, P4983; BRUSCA RC, 1990, INTERVETRATES; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; DeWaard M, 1996, FEBS LETT, V380, P272, DOI 10.1016/0014-5793(96)00007-5; DEWAARD M, 1995, J BIOL CHEM, V270, P12056, DOI 10.1074/jbc.270.20.12056; EHRLICH BE, 1988, P NATL ACAD SCI USA, V85, P5718, DOI 10.1073/pnas.85.15.5718; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Frohman M.A., 1990, PCR PROTOCOLS GUIDE, P28; GRABNER M, 1994, FEBS LETT, V339, P189, DOI 10.1016/0014-5793(94)80413-3; GRABNER M, 1994, J BIOL CHEM, V269, P23668; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HILLE B, 1992, IONIC CURRENTS EXCIT; HOLMAN MA, 1991, J EXP BIOL, V161, P333; HORNE WA, 1993, P NATL ACAD SCI USA, V90, P3787, DOI 10.1073/pnas.90.9.3787; Ito H, 1997, MOL PHARMACOL, V52, P735, DOI 10.1124/mol.52.4.735; Kimura T, 1997, BIOCHEM BIOPH RES CO, V230, P147, DOI 10.1006/bbrc.1996.5732; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KUNG C, 1989, NATO ADV SCI I A-LIF, V188, P203; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; MACKIE GO, 1985, NATURE, V313, P791, DOI 10.1038/313791a0; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; Mitterdorfer J, 1996, J BIOL CHEM, V271, P30330, DOI 10.1074/jbc.271.48.30330; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Naitoh Y., 1982, P1; NEELY A, 1994, BIOPHYS J, V66, P1895, DOI 10.1016/S0006-3495(94)80983-X; NERBONNE JM, 1987, J NEUROSCI, V7, P882; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; PEREZREYES E, 1995, KIDNEY INT, V48, P1111, DOI 10.1038/ki.1995.395; Peterson BZ, 1997, J BIOL CHEM, V272, P18752, DOI 10.1074/jbc.272.30.18752; Peterson BZ, 1996, J BIOL CHEM, V271, P5293, DOI 10.1074/jbc.271.10.5293; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; PRZYSIEZNIAK J, 1992, J NEUROSCI, V12, P2065; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANFORD J, 1991, J BIOL CHEM, V266, P9570; SATHER WA, 1993, NEURON, V11, P291, DOI 10.1016/0896-6273(93)90185-T; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; SHUBA YM, 1991, J PHYSIOL-LONDON, V443, P25, DOI 10.1113/jphysiol.1991.sp018820; Sinnegger MJ, 1997, J BIOL CHEM, V272, P27686, DOI 10.1074/jbc.272.44.27686; Skeer JM, 1996, BIOL REV, V71, P137, DOI 10.1111/j.1469-185X.1996.tb00744.x; Smith LA, 1996, J NEUROSCI, V16, P7868; SOLDATOV NM, 1995, J BIOL CHEM, V270, P10540, DOI 10.1074/jbc.270.18.10540; SOONG TW, 1993, SCIENCE, V260, P1133, DOI 10.1126/science.8388125; STEA A, 1995, HDB RECEPTORS CHANNE, P113; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; Tareilus E, 1997, P NATL ACAD SCI USA, V94, P1703, DOI 10.1073/pnas.94.5.1703; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THULEAU P, 1994, EMBO J, V13, P2970, DOI 10.1002/j.1460-2075.1994.tb06595.x; TUFTY RM, 1975, SCIENCE, V187, P167, DOI 10.1126/science.1111094; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; WEI XY, 1991, J BIOL CHEM, V266, P21943; White BH, 1997, J NEUROSCI, V17, P1582; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WILLIAMS ME, 1994, J BIOL CHEM, V269, P22347; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zamponi GW, 1996, PFLUG ARCH EUR J PHY, V431, P470; ZHENG W, 1995, J NEUROSCI, V15, P1132	65	53	56	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22792	22799		10.1074/jbc.273.35.22792	http://dx.doi.org/10.1074/jbc.273.35.22792			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712913	hybrid			2022-12-27	WOS:000075616600089
J	Levy, O; De la Vieja, A; Ginter, CS; Riedel, C; Dai, G; Carrasco, N				Levy, O; De la Vieja, A; Ginter, CS; Riedel, C; Dai, G; Carrasco, N			N-linked glycosylation of the thyroid Na+/I- symporter (NIS) - Implications for its secondary structure model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NOREPINEPHRINE TRANSPORTER; AMINOBUTYRIC-ACID TRANSPORTER; MEMBRANE TOPOLOGY; ANTIPEPTIDE ANTIBODIES; IODIDE TRANSPORTER; CELLS; EXPRESSION	The Na+/I- symporter (NIS), a 618-amino acid membrane glycoprotein that catalyzes the active accumulation of I- into thyroid cells, was identified and characterized at the molecular level in our laboratory (Dai, G., Levy, O., and Carrasco, N. (1996) Nature 379, 458-460), Because mature MS is highly glycosylated, it migrates in SDS-polyacrylamide gel electrophoresis as a broad polypeptide of higher molecular mass (similar to 90-110 kDa) than nonglycosylated NIS (similar to 50 kDa), Using site-directed mutagenesis, we substituted both separately and simultaneously the asparagine residues in all three putative N-linked glycosylation consensus sequences of NIS with glutamine and assessed the effects of the mutations on function and stability of NIS in COS cells. All mutants were active and displayed 50-90% of wild-type NIS activity, including the completely nonglycosylated triple mutant. This demonstrates that to a considerable extent, function and stability of NIS are preserved in the partial or even total absence of N-linked glycosylation. We also found that Asn(225) is glycosylated, thus proving that the hydrophilic loop that contains this amino acid residue faces the extracellular milieu rather than the cytosol as previously suggested. We demonstrated that the NH, terminus faces extracellularly as well, A new secondary structure model consistent with these findings is proposed,	Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Carrasco, N (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave,F-209, Bronx, NY 10461 USA.	carrasco@aecom.yu.edu	Carrasco, Nancy/AAH-1053-2019; De la Vieja, Antonio/I-4774-2013	Carrasco, Nancy/0000-0003-4137-6162; De la Vieja, Antonio/0000-0002-1187-1907; Riedel, Claudia/0000-0001-6168-8601	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE007218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041544] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE-07218] Funding Source: Medline; NIDDK NIH HHS [DK-41544] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bennett ER, 1997, J BIOL CHEM, V272, P1203, DOI 10.1074/jbc.272.2.1203; BRUSS M, 1995, J BIOL CHEM, V270, P9197; CARRASCO N, 1993, BIOCHIM BIOPHYS ACTA, V1154, P65, DOI 10.1016/0304-4157(93)90017-I; Dai G, 1996, NATURE, V379, P458, DOI 10.1038/379458a0; Dai G, 1996, HDB BIOL PHYS, VII, P343; Eskandari S, 1997, J BIOL CHEM, V272, P27230, DOI 10.1074/jbc.272.43.27230; Fujiwara H, 1997, NAT GENET, V16, P124, DOI 10.1038/ng0697-124; KAMINSKY SM, 1994, P NATL ACAD SCI USA, V91, P3789, DOI 10.1073/pnas.91.9.3789; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; Levy O, 1997, P NATL ACAD SCI USA, V94, P5568, DOI 10.1073/pnas.94.11.5568; Levy O, 1998, J BIOENERG BIOMEMBR, V30, P195, DOI 10.1023/A:1020577426732; Levy O., 1997, CURR OPIN ENDOCRINOL, V4, P364, DOI DOI 10.1097/00060793-199710000-00008; Matsuda A, 1997, J CLIN ENDOCR METAB, V82, P3966, DOI 10.1210/jc.82.12.3966; MELIKIAN HE, 1994, J BIOL CHEM, V269, P12290; NEWMAN MJ, 1981, J BIOL CHEM, V256, P1804; Olivares L, 1997, J BIOL CHEM, V272, P1211, DOI 10.1074/jbc.272.2.1211; Paire A, 1997, J BIOL CHEM, V272, P18245, DOI 10.1074/jbc.272.29.18245; Pohlenz J, 1997, BIOCHEM BIOPH RES CO, V240, P488, DOI 10.1006/bbrc.1997.7594; Pohlenz J, 1998, J CLIN INVEST, V101, P1028, DOI 10.1172/JCI1504; Turk E, 1997, J MEMBRANE BIOL, V159, P1, DOI 10.1007/s002329900264; Turk E, 1996, J BIOL CHEM, V271, P1925, DOI 10.1074/jbc.271.4.1925; Wahle S, 1996, J CELL BIOL, V135, P1867, DOI 10.1083/jcb.135.6.1867; WU JSR, 1994, BBA-BIOMEMBRANES, V1192, P289, DOI 10.1016/0005-2736(94)90131-7	23	154	158	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22657	22663		10.1074/jbc.273.35.22657	http://dx.doi.org/10.1074/jbc.273.35.22657			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712895	hybrid			2022-12-27	WOS:000075616600071
J	McCallum, SJ; Erickson, JW; Cerione, RA				McCallum, SJ; Erickson, JW; Cerione, RA			Characterization of the association of the actin-binding protein, IQGAP, and activated Cdc42 with Golgi membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WISKOTT-ALDRICH SYNDROME; ADP-RIBOSYLATION FACTOR; RASGAP-RELATED PROTEIN; RHO-FAMILY GTPASES; MOLECULAR CHARACTERIZATION; TYROSINE KINASE; MATRIX PROTEIN; BOVINE BRAIN; IDENTIFICATION; GTP	IQGAP is a recently identified actin-binding protein, which is a putative target for the Cdc42 and Rac GTP-binding proteins. Cdc42 was localized to the Golgi (Erickson, J. W., Zhang, C., Kahn, R. A., Evans, T., and Cerione, R. A. (1996) J. Biol. Chem. 271, 26850-26854), and here we show by immunofluorescence that IQGAP has a perinuclear localization, that it can be co-immunoprecipitated with Cdc42 from Golgi-enriched fractions, and that purified Golgi membranes are recognized by specific antibodies raised against IQGAP and Cdc42 in negative-stain immunogold electron microscopy experiments. Addition of activated, recombinant Cdc42 or solubilization of endogenous Cdc42 from Golgi membranes by the Rho-GDP dissociation inhibitor protein fails to solubilize IQGAP, suggesting that it associates with these membranes in a Cdc42-independent manner. Detergent solubilization of Golgi membranes leaves IQGAP and actin in an insoluble pellet but releases Cdc42 to the supernatant, whereas treatments that release actin from this detergent-insoluble pellet also release IQGAP. Addition of the COOH-terminal half of the IQGAP protein, which contains the Cdc42-binding domain, removes Cdc42 from Golgi membranes in a dose-dependent manner. These data suggest that IQGAP and Cdc42 are part of a cytoskeletal complex in Golgi membranes that may mediate Cdc42-regulated effects on the actin cytoskeleton in these membranes.	Cornell Univ, Ctr Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; Cornell Univ, Dept Biochem & Mol Cell Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Ctr Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.							Aspenstrom P, 1996, CURR BIOL, V6, P70, DOI 10.1016/S0960-9822(02)00423-2; BACKLUND PS, 1993, BIOCHEM BIOPH RES CO, V196, P534, DOI 10.1006/bbrc.1993.2283; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; BALCH WE, 1992, J BIOL CHEM, V267, P13053; Bashour AM, 1997, J CELL BIOL, V137, P1555, DOI 10.1083/jcb.137.7.1555; Beck KA, 1996, AM J PHYSIOL-CELL PH, V270, pC1263, DOI 10.1152/ajpcell.1996.270.5.C1263; BECK KA, 1994, J CELL BIOL, V127, P707, DOI 10.1083/jcb.127.3.707; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brill S, 1996, MOL CELL BIOL, V16, P4869; BROWN WJ, 1995, J CELL BIOL, V130, P781, DOI 10.1083/jcb.130.4.781; CANO ML, 1992, J CELL BIOL, V116, P1123, DOI 10.1083/jcb.116.5.1123; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Devarajan P, 1996, J CELL BIOL, V133, P819, DOI 10.1083/jcb.133.4.819; EPP A, 1997, CURR BIOL, V7, P921; Erickson JW, 1996, J BIOL CHEM, V271, P26850, DOI 10.1074/jbc.271.43.26850; Erickson JW, 1997, J BIOL CHEM, V272, P24443, DOI 10.1074/jbc.272.39.24443; Erlich R, 1996, J BIOL CHEM, V271, P8328, DOI 10.1074/jbc.271.14.8328; FRITZLER MJ, 1993, J EXP MED, V178, P49, DOI 10.1084/jem.178.1.49; Fritzler MJ, 1995, J BIOL CHEM, V270, P31262, DOI 10.1074/jbc.270.52.31262; HART MJ, 1994, J BIOL CHEM, V269, P62; HART MJ, 1990, J BIOL CHEM, V265, P5990; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Joyal JL, 1997, J BIOL CHEM, V272, P15419, DOI 10.1074/jbc.272.24.15419; Jung E, 1996, EMBO J, V15, P1238, DOI 10.1002/j.1460-2075.1996.tb00465.x; KELLOKUMPU S, 1988, SCIENCE, V242, P1308, DOI 10.1126/science.2461589; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; LENHARD JM, 1992, J BIOL CHEM, V267, P13047; LEONARD D, 1992, J BIOL CHEM, V267, P22860; Lippincott J, 1998, J CELL BIOL, V140, P355, DOI 10.1083/jcb.140.2.355; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; McCallum SJ, 1996, J BIOL CHEM, V271, P21732, DOI 10.1074/jbc.271.36.21732; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Nomanbhoy TK, 1996, BIOCHEMISTRY-US, V35, P4602, DOI 10.1021/bi951743d; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; ROBERTSON D, 1986, J IMMUNOL, V136, P4565; SINGER WD, 1995, J BIOL CHEM, V270, P14944, DOI 10.1074/jbc.270.25.14944; SLUSAREWICZ P, 1994, J CELL BIOL, V124, P405, DOI 10.1083/jcb.124.4.405; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; UEDA T, 1990, J BIOL CHEM, V265, P9373; WEINER OH, 1993, J CELL BIOL, V123, P23, DOI 10.1083/jcb.123.1.23; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517; WEST D W, 1981, Biochemical Society Transactions, V9, P77; Yang WN, 1997, J BIOL CHEM, V272, P24819, DOI 10.1074/jbc.272.40.24819; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934; ZHENG Y, 1994, J BIOL CHEM, V269, P18727	54	50	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22537	22544		10.1074/jbc.273.35.22537	http://dx.doi.org/10.1074/jbc.273.35.22537			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712880	hybrid			2022-12-27	WOS:000075616600056
J	Redell, JB; Tempel, BL				Redell, JB; Tempel, BL			Multiple promoter elements interact to control the transcription of the potassium channel gene, KCNJ2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX-BINDING-PROTEINS; RNA POLYMERASE-II; DNA-BINDING; NF-Y; FACTOR AP-2; K+ CHANNEL; FUNCTIONAL EXPRESSION; FAMILY MEMBERS; SUBUNIT GENE; CPG ISLANDS	Potassium channels play important roles in shaping the electrical properties of excitable cells. Toward understanding the transcriptional regulation of a member of the inwardly rectifying potassium channel family, we have characterized the genomic structure and 5'-proximal promoter of the murine Kcnj2 gene (also referred to as IRK1 and Kir2.1). The Kcnj2 transcription unit is composed of two exons separated by a 5.5-kilobase pair intron. Deletion analysis of 5'-flanking sequences identified a promiscuously active 172-base pair minimal promoter, whereas expression from a construct containing additional upstream sequences was cell type-restricted. The minimal promoter contained an E box, a Y box, and three GC box consensus elements but lacked both TATA and CCAAT box elements. The activity of the minimal promoter was found to be controlled by a combination of the activities of the transcription factors Sp1, Sp3, and NF-Y. The interplay between Sp1, Sp3, and NF-Y within the architecture of the Kcnj2 promoter, the ubiquitous nature of these trans-acting factors, and the action of tissue selective repressor element(s) may combine to enable a wide variety of cell types to differentially regulate Kcnj2 expression through transcriptional control.	Univ Washington, Sch Med, Virginia Merrill Bloedel Hearing Res Ctr, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Otolaryngol Head & Neck Surg, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Tempel, BL (corresponding author), Univ Washington, Sch Med, Virginia Merrill Bloedel Hearing Res Ctr, Box 357923, Seattle, WA 98195 USA.	tempel@u.washington.edu			NHLBI NIH HHS [HL44948] Funding Source: Medline; NIDCD NIH HHS [DC/NS02739] Funding Source: Medline; NIGMS NIH HHS [T32GM07270] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002739] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Apt D, 1996, VIROLOGY, V224, P281, DOI 10.1006/viro.1996.0530; ARKETT SA, 1994, RECEPTOR CHANNEL, V2, P281; Ausubel FM, 1991, CURRENT PROTOCOLS MO; Azizkhan Jane C., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P229; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; BECKMANN H, 1990, GENE DEV, V4, P167, DOI 10.1101/gad.4.2.167; BENDALL AJ, 1994, NUCLEIC ACIDS RES, V22, P2801, DOI 10.1093/nar/22.14.2801; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; BIRD AP, 1987, TRENDS GENET, V3, P342, DOI 10.1016/0168-9525(87)90294-0; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; Bock JH, 1997, GENE, V188, P9, DOI 10.1016/S0378-1119(96)00759-7; BORDONARO M, 1994, BIOTECHNIQUES, V16, P428; BORELLINI F, 1991, J BIOL CHEM, V266, P15850; BORELLINI F, 1990, MOL CELL BIOL, V10, P5541, DOI 10.1128/MCB.10.10.5541; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; CHANDY KG, 1990, SCIENCE, V247, P973, DOI 10.1126/science.2305265; CHANG ZF, 1994, J BIOL CHEM, V269, P17893; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; DeLuca P, 1996, J BIOL CHEM, V271, P8533, DOI 10.1074/jbc.271.15.8533; DIDIER DK, 1988, P NATL ACAD SCI USA, V85, P7322, DOI 10.1073/pnas.85.19.7322; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOUPNIK CA, 1995, CURR OPIN NEUROBIOL, V5, P268, DOI 10.1016/0959-4388(95)80038-7; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; FRAMSON P, 1993, J BIOL CHEM, V268, P4989; Gan L, 1996, J BIOL CHEM, V271, P5859, DOI 10.1074/jbc.271.10.5859; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GHOSH D, 1993, NUCLEIC ACIDS RES, V21, P3117, DOI 10.1093/nar/21.13.3117; GRANT CE, 1993, MOL CELL BIOL, V13, P4186, DOI 10.1128/MCB.13.7.4186; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; Hille B., 1992, IONIC CHANNELS EXCIT, V2 ed, P115; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; ISHII K, 1994, FEBS LETT, V338, P107, DOI 10.1016/0014-5793(94)80126-6; KAMP TJ, 1995, CELL MOL NEUROBIOL, V15, P307, DOI 10.1007/BF02089942; Kennett SB, 1997, NUCLEIC ACIDS RES, V25, P3110, DOI 10.1093/nar/25.15.3110; KERKHOFF E, 1991, P NATL ACAD SCI USA, V88, P4323, DOI 10.1073/pnas.88.10.4323; Kim DS, 1997, J BIOL CHEM, V272, P5098, DOI 10.1074/jbc.272.8.5098; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; KUBO T, 1995, CANCER RES, V55, P3860; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Kumar AP, 1997, NUCLEIC ACIDS RES, V25, P2012, DOI 10.1093/nar/25.10.2012; LADOMERY M, 1995, BIOESSAYS, V17, P9, DOI 10.1002/bies.950170104; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; LATCHMAN DS, 1993, PRACTICAL APPROACH S; MACDONALD GH, 1995, J BIOL CHEM, V270, P3527, DOI 10.1074/jbc.270.8.3527; MAJELLO B, 1995, ONCOGENE, V10, P1841; MAJELLO B, 1994, NUCLEIC ACIDS RES, V22, P4914, DOI 10.1093/nar/22.23.4914; Majello B, 1997, J BIOL CHEM, V272, P4021, DOI 10.1074/jbc.272.7.4021; MAUE RA, 1990, NEURON, V4, P223, DOI 10.1016/0896-6273(90)90097-Y; MCLARNON JG, 1993, GLIA, V9, P120, DOI 10.1002/glia.440090205; Mi HY, 1996, J NEUROSCI, V16, P2421; MITCHELL PJ, 1991, GENE DEV, V5, P105, DOI 10.1101/gad.5.1.105; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; MORI Y, 1995, J BIOL CHEM, V270, P27788, DOI 10.1074/jbc.270.46.27788; MORI Y, 1993, J BIOL CHEM, V268, P26482; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Noti JD, 1997, J BIOL CHEM, V272, P24038, DOI 10.1074/jbc.272.38.24038; Roder K, 1997, J BIOL CHEM, V272, P21616, DOI 10.1074/jbc.272.34.21616; Rohlff C, 1997, J BIOL CHEM, V272, P21137, DOI 10.1074/jbc.272.34.21137; SAKURA H, 1995, FEBS LETT, V367, P193, DOI 10.1016/0014-5793(95)00498-X; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SAWADOGO M, 1988, J BIOL CHEM, V263, P11985; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; Schoots O, 1997, GENOMICS, V39, P279, DOI 10.1006/geno.1996.4495; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; SCHRODER K, 1995, MOL MICROBIOL, V16, P699, DOI 10.1111/j.1365-2958.1995.tb02431.x; SHENG ZH, 1994, DNA CELL BIOL, V13, P9, DOI 10.1089/dna.1994.13.9; SIMONCINI L, 1990, DEV BIOL, V138, P194, DOI 10.1016/0012-1606(90)90189-P; Spauschus A, 1996, J NEUROSCI, V16, P930; STANFIELD PR, 1994, J PHYSIOL-LONDON, V475, P1; Sundseth R, 1997, MOL PHARMACOL, V51, P963, DOI 10.1124/mol.51.6.963; TAKIMOTO K, 1994, CIRC RES, V75, P1006, DOI 10.1161/01.RES.75.6.1006; Tanizawa Y, 1996, DIABETOLOGIA, V39, P447, DOI 10.1007/BF00400676; TING JPY, 1994, J EXP MED, V179, P1605, DOI 10.1084/jem.179.5.1605; UDVADIA AJ, 1995, P NATL ACAD SCI USA, V92, P3953, DOI 10.1073/pnas.92.9.3953; VANHUIJSDUIJNEN RAMH, 1987, NUCLEIC ACIDS RES, V15, P7265, DOI 10.1093/nar/15.18.7265; VOSTROV AA, 1995, NUCLEIC ACIDS RES, V23, P2734, DOI 10.1093/nar/23.14.2734; WAHLE E, 1992, ANNU REV BIOCHEM, V61, P419; WICKENS M, 1990, TRENDS BIOCHEM SCI, V15, P320, DOI 10.1016/0968-0004(90)90022-4; Wickman K, 1997, GENOMICS, V40, P395, DOI 10.1006/geno.1997.4599; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557; WINNING RS, 1991, NUCLEIC ACIDS RES, V19, P3709, DOI 10.1093/nar/19.13.3709; WOLFFE AP, 1994, BIOESSAYS, V16, P245, DOI 10.1002/bies.950160407; WRIGHT KL, 1994, EMBO J, V13, P4042, DOI 10.1002/j.1460-2075.1994.tb06721.x; WRIGHT KL, 1995, J BIOL CHEM, V270, P20978, DOI 10.1074/jbc.270.36.20978; WRIGHT WE, 1991, MOL CELL BIOL, V11, P4104, DOI 10.1128/MCB.11.8.4104; Wymore RS, 1996, J BIOL CHEM, V271, P15629, DOI 10.1074/jbc.271.26.15629; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0	96	22	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22807	22818		10.1074/jbc.273.35.22807	http://dx.doi.org/10.1074/jbc.273.35.22807			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712915	hybrid			2022-12-27	WOS:000075616600091
J	Brindley, DN; Waggoner, DW				Brindley, DN; Waggoner, DW			Mammalian lipid phosphate phosphohydrolases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							FUNGUS CURVULARIA-INAEQUALIS; DIACYLGLYCEROL PYROPHOSPHATE PHOSPHATASE; VANADIUM-CONTAINING ENZYME; ACID-PHOSPHATASE; RAT-LIVER; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; LYSOPHOSPHATIDIC ACID; CERAMIDE 1-PHOSPHATE; ESCHERICHIA-COLI		Univ Alberta, Heritage Med Res Ctr 357, Signal Transduct Labs, Edmonton, AB T6G 2S2, Canada; Univ Alberta, Lipid & Lipoprot Res Grp, Edmonton, AB T6G 2S2, Canada; Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta; University of Alberta	Brindley, DN (corresponding author), Univ Alberta, Heritage Med Res Ctr 357, Signal Transduct Labs, Edmonton, AB T6G 2S2, Canada.	david.brindley@uarberta.ca						An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; Barila D, 1996, J BIOL CHEM, V271, P29928, DOI 10.1074/jbc.271.47.29928; Brindley DN, 1996, CHEM PHYS LIPIDS, V80, P45, DOI 10.1016/0009-3084(96)02545-5; BRINDLEY DN, 1988, PHOSPHATIDATE PHOSPH, V1, P1; Carman GM, 1997, BBA-LIPID LIPID MET, V1348, P45, DOI 10.1016/S0005-2760(97)00095-7; Dillon DA, 1997, J BIOL CHEM, V272, P10361; DILLON DA, 1996, J BIOL CHEM, V271, P30549; EGAWA K, 1995, FEBS LETT, V372, P74, DOI 10.1016/0014-5793(95)00957-B; English D, 1997, BIOCHEM J, V324, P941, DOI 10.1042/bj3240941; FLEMING IN, 1995, BIOCHEM J, V308, P983, DOI 10.1042/bj3080983; FOURCADE O, 1995, CELL, V80, P919, DOI 10.1016/0092-8674(95)90295-3; Frank DW, 1998, J BIOL CHEM, V273, P11791, DOI 10.1074/jbc.273.19.11791; GOMEZMUNOZ A, 1997, SPHINGOLIPID MEDIATE, P103; HA KS, 1993, J CELL BIOL, V123, P1789, DOI 10.1083/jcb.123.6.1789; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hemrika W, 1997, P NATL ACAD SCI USA, V94, P2145, DOI 10.1073/pnas.94.6.2145; HOFFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166; Hooks SB, 1998, FEBS LETT, V427, P188, DOI 10.1016/S0014-5793(98)00421-9; ICHO T, 1983, J BACTERIOL, V153, P722, DOI 10.1128/JB.153.2.722-730.1983; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; Jenkins GM, 1997, J BIOL CHEM, V272, P32566, DOI 10.1074/jbc.272.51.32566; Kai M, 1997, J BIOL CHEM, V272, P24572, DOI 10.1074/jbc.272.39.24572; Kai M, 1996, J BIOL CHEM, V271, P18931, DOI 10.1074/jbc.271.31.18931; Kanoh H, 1997, BBA-LIPID LIPID MET, V1348, P56, DOI 10.1016/S0005-2760(97)00094-5; Ktistakis NT, 1996, J CELL BIOL, V134, P295, DOI 10.1083/jcb.134.2.295; LEI KJ, 1995, J CLIN INVEST, V95, P234, DOI 10.1172/JCI117645; LEI KJ, 1995, J BIOL CHEM, V270, P11882, DOI 10.1074/jbc.270.20.11882; LEI KJ, 1993, SCIENCE, V262, P580, DOI 10.1126/science.8211187; Leung DW, 1998, DNA CELL BIOL, V17, P377, DOI 10.1089/dna.1998.17.377; Mandala SM, 1998, P NATL ACAD SCI USA, V95, P150, DOI 10.1073/pnas.95.1.150; Mao CG, 1997, J BIOL CHEM, V272, P28690, DOI 10.1074/jbc.272.45.28690; Martin A, 1997, ONCOGENE, V14, P1571, DOI 10.1038/sj.onc.1200987; MARTIN A, 1993, J BIOL CHEM, V268, P23924; Messerschmidt A, 1997, BIOL CHEM, V378, P309, DOI 10.1515/bchm.1997.378.3-4.309; Messerschmidt A, 1996, P NATL ACAD SCI USA, V93, P392, DOI 10.1073/pnas.93.1.392; MOOLENAAR WH, 1995, J BIOL CHEM, V270, P12949, DOI 10.1074/jbc.270.22.12949; Munnik T, 1996, J BIOL CHEM, V271, P15708, DOI 10.1074/jbc.271.26.15708; Neuwald AF, 1997, PROTEIN SCI, V6, P1764, DOI 10.1002/pro.5560060817; Pan CJ, 1998, J BIOL CHEM, V273, P6144, DOI 10.1074/jbc.273.11.6144; PERRY DK, 1993, J BIOL CHEM, V268, P25302; Roberts R, 1998, J BIOL CHEM, V273, P22059, DOI 10.1074/jbc.273.34.22059; SHELLY LL, 1993, J BIOL CHEM, V268, P21482; SHINGHAL R, 1993, J NEUROCHEM, V61, P2279, DOI 10.1111/j.1471-4159.1993.tb07470.x; SIDDIQUI RA, 1997, BIOCHIM BIOPHYS ACTA, V1349, P82; Siess EA, 1996, FEBS LETT, V381, P169, DOI 10.1016/0014-5793(96)00111-1; SIMONS BH, 1995, EUR J BIOCHEM, V229, P566, DOI 10.1111/j.1432-1033.1995.tb20499.x; STANKIEWICZ PJ, 1995, MET IONS BIOL SYST, V31, P660; Stukey J, 1997, PROTEIN SCI, V6, P469; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Ulrix W, 1998, J BIOL CHEM, V273, P4660, DOI 10.1074/jbc.273.8.4660; Waggoner DW, 1996, J BIOL CHEM, V271, P16506, DOI 10.1074/jbc.271.28.16506; WAGGONER DW, 1995, J BIOL CHEM, V270, P19422, DOI 10.1074/jbc.270.33.19422; Wu WI, 1996, J BIOL CHEM, V271, P1868, DOI 10.1074/jbc.271.4.1868; XIE MS, 1994, ARCH BIOCHEM BIOPHYS, V312, P254, DOI 10.1006/abbi.1994.1307; Zhang N, 1997, NATURE, V385, P64, DOI 10.1038/385064a0	56	213	217	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24281	24284		10.1074/jbc.273.38.24281	http://dx.doi.org/10.1074/jbc.273.38.24281			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733709	hybrid			2022-12-27	WOS:000076007300001
J	Cao, TT; Mays, RW; von Zastrow, M				Cao, TT; Mays, RW; von Zastrow, M			Regulated endocytosis of G-protein-coupled receptors by a biochemically and functionally distinct subpopulation of clathrin-coated pits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2)-ADRENERGIC RECEPTOR; TRANSFERRIN RECEPTORS; MONOCLONAL-ANTIBODIES; GROWTH-FACTOR; INTERNALIZATION; MEMBRANE; DYNAMIN; RESENSITIZATION; SEQUESTRATION; BIOGENESIS	beta-2 Adrenergic receptors (B2ARs) are endocytosed by clathrin coated pits. This process serves specialized functions in signal transduction and receptor regulation, raising the question of whether B2ARs are associated with biochemically specialized membrane vesicles during their endocytic trafficking. Here we show that B2ARs are endocytosed by a distinct subpopulation of clathrin-coated pits, which represent a limited subset of coated pits present in the plasma membrane, even in cells overexpressing both B2ARs and p-arrestin. Coated pits mediating agonist-induced endocytosis of B2ARs differ from other coated pits mediating constitutive endocytosis of transferrin receptors in their temperature dependence for fission from the plasma membrane and in the association of their membrane coats with p-arrestin. Endocytosis of these coated pits generates endocytic vesicles selectively enriched in B2ARs, which fuse within similar to 10 min after their formation with a common population of endosomes containing both B2ARs and transferrin receptors. These observations demonstrate, for the first time, the existence of a functionally and biochemically distinct subpopulation of clathrin-coated pits that mediate the agonist-regulated endocytosis of G-protein-coupled receptors, and they suggest a new model for the formation of compositionally specialized membrane vesicles at the earliest stage of the endocytic pathway.	Univ Calif San Francisco, Nina Ireland Lab, Cell Biol Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	von Zastrow, M (corresponding author), Univ Calif San Francisco, Nina Ireland Lab, Cell Biol Program, Rm LP-A104,401 Parnassus Ave, San Francisco, CA 94143 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008120] Funding Source: NIH RePORTER; NIDA NIH HHS [DA00218] Funding Source: Medline; NIGMS NIH HHS [T32GM08120] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barak LS, 1997, MOL PHARMACOL, V51, P177, DOI 10.1124/mol.51.2.177; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; BRODSKY FM, 1985, J CELL BIOL, V101, P2047, DOI 10.1083/jcb.101.6.2047; CAMERON PL, 1991, J CELL BIOL, V115, P151, DOI 10.1083/jcb.115.1.151; CARPENTIER JL, 1982, J CELL BIOL, V95, P73, DOI 10.1083/jcb.95.1.73; CLIFTOGRADY L, 1990, J CELL BIOL, V110, P1693, DOI 10.1083/jcb.110.5.1693; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GUAN XM, 1992, J BIOL CHEM, V267, P21995; HARLOW E, 1988, ANTIBODIES LABORATOR, P340; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; HOPKINS CR, 1983, CELL, V35, P321, DOI 10.1016/0092-8674(83)90235-0; HOPKINS CR, 1985, CELL, V40, P199, DOI 10.1016/0092-8674(85)90323-X; KOBILKA BK, 1987, P NATL ACAD SCI USA, V84, P46, DOI 10.1073/pnas.84.1.46; Krueger KM, 1997, J BIOL CHEM, V272, P5; Livingstone C, 1996, BIOCHEM J, V315, P487, DOI 10.1042/bj3150487; MUNDIGL O, 1994, CURR OPIN CELL BIOL, V6, P561, DOI 10.1016/0955-0674(94)90077-9; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; PITCHER JA, 1995, P NATL ACAD SCI USA, V92, P8343, DOI 10.1073/pnas.92.18.8343; SANAN DA, 1991, J HISTOCHEM CYTOCHEM, V39, P1017, DOI 10.1177/39.8.1906908; SCHMID SL, 1991, J CELL BIOL, V114, P869, DOI 10.1083/jcb.114.5.869; VONZASTROW M, 1994, J BIOL CHEM, V269, P18448; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; WHITE S, 1992, BIOCHIM BIOPHYS ACTA, V1136, P28, DOI 10.1016/0167-4889(92)90081-L; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	28	117	117	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24592	24602		10.1074/jbc.273.38.24592	http://dx.doi.org/10.1074/jbc.273.38.24592			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733754	hybrid			2022-12-27	WOS:000076007300046
J	Cronin, CN				Cronin, CN			Redesign of choline acetyltransferase specificity by protein engineering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; SUBSTRATE-SPECIFICITY; COENZYME SPECIFICITY; CONVERTING TRYPSIN; CARNITINE; DEHYDROGENASE; SEQUENCE; CHYMOTRYPSIN; EXPRESSION; BINDING	Since the development of site-directed mutagenesis techniques over 15 years ago (Zoller, M.J,, and Smith, M, (1982) Nucleic Acids Res. 10, 6487-6500), it has been a goal of protein engineering to utilize the procedure to redesign existing enzyme structures to produce proteins with altered or novel catalytic properties. To date, however, the more successful achievements have relied exclusively on the availability of three-dimensional protein structure maps to direct the redesign strategies. Presently, such maps are unavailable for choline acetyltransferase and carnitine acetyltransferase, enzymes that catalyze the reversible transfer of an acetyl group from acetyl-CoA to choline and L-carnitine, respectively. A more empirical approach, based on cross-referencing substrate structure comparisons with protein alignment data, was used to redesign choline acetyltransferase to accommodate L-carnitine as an acceptor of the acetyl group. A mutant choline acetyltransferase that incorporates four amino acid substitutions from wild type, shows a substantial increase in catalytic efficiency (k(cat)/K-m) toward L-carnitine (1,620-fold) and shifts the catalytic discrimination between choline and L-carnitine by >390,000 in favor of the latter substrate. These dramatic alterations in catalytic function demonstrate that significant success in protein redesign can be achieved in the absence of three-dimensional protein structure data.	Vet Affairs Med Ctr, Div Mol Biol, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Cronin, CN (corresponding author), Vet Affairs Med Ctr, Div Mol Biol, Mail Stop 151-S,4150 Clement St, San Francisco, CA 94121 USA.	ciaran@itsa.ucsf.edu			NHLBI NIH HHS [HL16251] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL016251] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bergman J., 1988, STUDIES NATURAL PR A, V1, P3; BLOISI W, 1990, EUR J BIOCHEM, V189, P539, DOI 10.1111/j.1432-1033.1990.tb15520.x; BRADLEY M, 1991, BIOCHEMISTRY-US, V30, P6124, DOI 10.1021/bi00239a006; BRICE A, 1989, J NEUROSCI RES, V23, P266, DOI 10.1002/jnr.490230304; BROWN NF, 1994, J BIOL CHEM, V269, P19157; CARBINI LA, 1993, J NEUROCHEM, V61, P247, DOI 10.1111/j.1471-4159.1993.tb03561.x; CHASE JFA, 1966, BIOCHEM J, V99, P32, DOI 10.1042/bj0990032; CHEN RD, 1995, P NATL ACAD SCI USA, V92, P11666, DOI 10.1073/pnas.92.25.11666; CHOTHIA C, 1984, ANNU REV BIOCHEM, V53, P537; Cronin CN, 1997, BIOCHEM BIOPH RES CO, V238, P784, DOI 10.1006/bbrc.1997.7390; Cronin CN, 1997, BIOCHEM BIOPH RES CO, V241, P803, DOI 10.1006/bbrc.1997.7865; Cronin CN, 1997, EUR J BIOCHEM, V247, P1029, DOI 10.1111/j.1432-1033.1997.01029.x; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DIXON M, 1979, ENZYMES, P88; FEENEY R, 1990, BIOCHEM BIOPH RES CO, V166, P667, DOI 10.1016/0006-291X(90)90861-G; GANDOUR RD, 1985, BIOORG CHEM, V13, P197, DOI 10.1016/0045-2068(85)90022-7; HEDSTROM L, 1994, BIOCHEMISTRY-US, V33, P8764, DOI 10.1021/bi00195a018; HEDSTROM L, 1992, SCIENCE, V255, P1249, DOI 10.1126/science.1546324; HERSH LB, 1982, J BIOL CHEM, V257, P2820; HERSH LB, 1977, J BIOL CHEM, V252, P4796; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; Kawachi H, 1996, EUR J BIOCHEM, V238, P845, DOI 10.1111/j.1432-1033.1996.0845w.x; KLEANTHOUS C, 1984, BIOCHEM J, V223, P211, DOI 10.1042/bj2230211; ONUFFER JJ, 1995, PROTEIN SCI, V4, P1750, DOI 10.1002/pro.5560040910; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Rost B, 1996, METHOD ENZYMOL, V266, P525; SCRUTTON NS, 1990, NATURE, V343, P38, DOI 10.1038/343038a0; WILKS HM, 1988, SCIENCE, V242, P1541, DOI 10.1126/science.3201242; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0	29	24	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24465	24469		10.1074/jbc.273.38.24465	http://dx.doi.org/10.1074/jbc.273.38.24465			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733738	hybrid			2022-12-27	WOS:000076007300030
J	Huber, I; Cukierman, E; Rotman, M; Aoe, T; Hsu, VW; Cassel, D				Huber, I; Cukierman, E; Rotman, M; Aoe, T; Hsu, VW; Cassel, D			Requirement for both the amino-terminal catalytic domain and a noncatalytic domain for in vivo activity of ADP-ribosylation factor GTPase-activating protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCHANGE PROTEIN; GUANINE-NUCLEOTIDE; GOLGI MEMBRANES; BREFELDIN-A; ORGANELLE STRUCTURE; ARF PROTEIN; BETA-COP; BINDING; COATOMER; CONTAINS	The small GTP-binding protein ADP-ribosylation factor-1 (ARF1) regulates intracellular transport by modulating the interaction of coat proteins with the Golgi complex. Coat protein association with Golgi membranes requires activated, GTP-bound ARF1, whereas GTP hydrolysis catalyzed by an ARF1-directed GTPase-activating protein (GAP) deactivates ARF1 and results in coat protein dissociation. We have recently cloned a Golgi-associated ARF GAP. Overexpression of GAP was found to result in a phenotype that reflects ARF1 deactivation (Aoe, T, Cukierman, E, Lee, A., Cassel, D, Peters, P, J, and Hsu, V, W, (1997) EMBO J. 16, 7305-7316). In this study, we used this phenotype to define domains in GAP that are required for its function in vivo. As expected, mutations in the amino-terminal part of GAP that were previously found to abolish ARF GAP catalytic activity in vitro abrogated ARF1 deactivation in vivo. Significantly, truncations at the carboxyl-terminal part of GAP that did not affect GAP catalytic activity in vitro also diminished ARF1 deactivation. Thus, a noncatalytic domain is required for GAP activity in vivo. This domain may be involved in the targeting of GAP to the Golgi membrane.	Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA	Technion Israel Institute of Technology; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Cassel, D (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.		cukierman, edna/AAU-8932-2020; Cukierman, Edna/A-3951-2013	cukierman, edna/0000-0002-1452-9576; 				Antonny B, 1997, J BIOL CHEM, V272, P30848, DOI 10.1074/jbc.272.49.30848; Aoe T, 1997, EMBO J, V16, P7305, DOI 10.1093/emboj/16.24.7305; Aoe T, 1998, P NATL ACAD SCI USA, V95, P1624, DOI 10.1073/pnas.95.4.1624; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; CHU G, 1987, NUCLEIC ACIDS RES, V15, P1311, DOI 10.1093/nar/15.3.1311; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; DASCHER C, 1994, J BIOL CHEM, V269, P1437; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; DONALDSON JG, 1994, CURR OPIN CELL BIOL, V6, P527, DOI 10.1016/0955-0674(94)90072-8; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; FRANCO M, 1995, J BIOL CHEM, V270, P1337, DOI 10.1074/jbc.270.3.1337; HammondsOdie LP, 1996, J BIOL CHEM, V271, P18859, DOI 10.1074/jbc.271.31.18859; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; MAKLER V, 1995, J BIOL CHEM, V270, P5232, DOI 10.1074/jbc.270.10.5232; Meacci E, 1997, P NATL ACAD SCI USA, V94, P1745, DOI 10.1073/pnas.94.5.1745; Morinaga N, 1996, P NATL ACAD SCI USA, V93, P12856, DOI 10.1073/pnas.93.23.12856; PALMER DJ, 1993, J BIOL CHEM, V268, P12083; PETERS PJ, 1995, J CELL BIOL, V128, P1003, DOI 10.1083/jcb.128.6.1003; Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0; Randazzo PA, 1997, BIOCHEM J, V324, P413, DOI 10.1042/bj3240413; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; TEAL SB, 1994, J BIOL CHEM, V269, P3135; WEISS O, 1989, J BIOL CHEM, V264, P21066	27	36	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24786	24791		10.1074/jbc.273.38.24786	http://dx.doi.org/10.1074/jbc.273.38.24786			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733781	hybrid			2022-12-27	WOS:000076007300073
J	Itoh, Y; Ito, A; Iwata, K; Tanzawa, K; Mori, Y; Nagase, H				Itoh, Y; Ito, A; Iwata, K; Tanzawa, K; Mori, Y; Nagase, H			Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (Gelatinase A) activated on the cell surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IV COLLAGENASE; 4-AMINOPHENYLMERCURIC ACETATE; INTERSTITIAL COLLAGENASE; 72-KDA GELATINASE; PROGELATINASE-A; BINDING; COMPLEX; TIMP-2; FIBROBLASTS; DOMAIN	The cell-surface activation of pro-matrix metalloproteinase 2 (pro-MMP-2) is considered to be critical for cell. migration and invasion. Treatment of human uterine cervical fibroblasts with concanavalin A activates pro-MMP-2 on the cell surface by converting it to the 65-kDa form with a minor form of 45 kDa. However, the 65-kDa MMP-2 was inactivated by tissue inhibitor of metalloproteinases (TIMP)-2 that was bound to the plasma membrane upon concanavalin A treatment. TIMP-2 binds to the plasma membrane through its N-terminal domain by two different modes of interaction as follows: one is sensitive to a hydroxamate (HXM) inhibitor of MMPs and the other is HXM-insensitive. TIMP-2 bound to the membrane in a HXM-insensitive manner, comprising about 40-50% of TIMP-2 on the membrane, is the inhibitor of the cell surface-activated MMP-2. It, however, does not inhibit MMP-3, MMP-9, and the 45-kDa MMP-2 lacking the C-terminal domain. The inhibition of the 65-kDa MMP-2 by TIMP-2 is initiated by the interaction of their C-terminal domains. Subsequently, the MMP-2 .TIMP-2 complex is released from the membrane, and the activity of MMP-2 is blocked by TIMP-2. In the presence of collagen types I, II, III, V, or gelatin, the rate of inhibition of the 65-kDa MMP-2 by the membrane-bound TIMP-2 decreased considerably. These results suggest that the pericellular activity of MMP-2 is tightly regulated by membrane-bound TIMP-2 and surrounding extracellular matrix components.	Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; Tokyo Univ Pharm & Life Sci, Sch Pharm, Tokyo 1920392, Japan; Fuji Chem Ind Ltd, Dept Biopharmaceut, Toyama 9338511, Japan; Sankyo Co Ltd, Biol Res Labs, Shinagawa Ku, Tokyo 1408710, Japan	University of Kansas; University of Kansas Medical Center; Tokyo University of Pharmacy & Life Sciences; Daiichi Sankyo Company Limited	Nagase, H (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.			Itoh, Yoshifumi/0000-0002-2128-2823	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039189, R01AR040994] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR 39189, AR 40994] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; APTE SS, 1994, DEV DYNAM, V200, P177, DOI 10.1002/aja.1002000302; Banyai L, 1996, J BIOL CHEM, V271, P12003, DOI 10.1074/jbc.271.20.12003; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P737; Benbow U, 1996, J BIOL CHEM, V271, P10715, DOI 10.1074/jbc.271.18.10715; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Brooks PC, 1998, CELL, V92, P391, DOI 10.1016/S0092-8674(00)80931-9; BROWN PD, 1990, CANCER RES, V50, P6184; Butler GS, 1998, J BIOL CHEM, V273, P871, DOI 10.1074/jbc.273.2.871; Butler GS, 1997, EUR J BIOCHEM, V244, P653, DOI 10.1111/j.1432-1033.1997.t01-1-00653.x; Coussens LM, 1996, CHEM BIOL, V3, P895, DOI 10.1016/S1074-5521(96)90178-7; DOCHERTY AJP, 1985, NATURE, V318, P66, DOI 10.1038/318066a0; EMMERTBUCK MR, 1995, FEBS LETT, V364, P28, DOI 10.1016/0014-5793(95)00345-A; FRIDMAN R, 1992, J BIOL CHEM, V267, P15398; FUJIMOTO N, 1993, CLIN CHIM ACTA, V220, P31, DOI 10.1016/0009-8981(93)90004-N; Greene J, 1996, J BIOL CHEM, V271, P30375, DOI 10.1074/jbc.271.48.30375; GROBELNY D, 1992, BIOCHEMISTRY-US, V31, P7152, DOI 10.1021/bi00146a017; Imai K, 1996, CANCER RES, V56, P2707; ITOH Y, 1995, BIOCHEM J, V308, P645, DOI 10.1042/bj3080645; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; LELIEVRE Y, 1990, MATRIX, V10, P292, DOI 10.1016/S0934-8832(11)80184-8; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; MORODOMI T, 1992, BIOCHEM J, V285, P603, DOI 10.1042/bj2850603; MURPHY G, 1994, J BIOL CHEM, V269, P6632; NAGASE H, 1995, METHOD ENZYMOL, V248, P449; Nagase H, 1996, ZINC METALLOPROTEASE, P153; OGATA Y, 1995, J BIOL CHEM, V270, P18506, DOI 10.1074/jbc.270.31.18506; OGATA Y, 1992, J BIOL CHEM, V267, P3581; OJIMA Y, 1989, BIOCHIM BIOPHYS ACTA, V1011, P61, DOI 10.1016/0167-4889(89)90079-7; OKADA Y, 1990, EUR J BIOCHEM, V194, P721, DOI 10.1111/j.1432-1033.1990.tb19462.x; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; OVERALL CM, 1990, J BIOL CHEM, V265, P21141; PAVLOFF N, 1992, J BIOL CHEM, V267, P17321; Rankin CA, 1996, KIDNEY INT, V50, P835, DOI 10.1038/ki.1996.383; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Shipley JM, 1996, J BIOL CHEM, V271, P4335; STETLERSTEVENSON WG, 1989, J BIOL CHEM, V264, P17374; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; STRONGIN AY, 1993, J BIOL CHEM, V268, P14033; TAKINO T, 1995, J BIOL CHEM, V270, P23013, DOI 10.1074/jbc.270.39.23013; TANZAWA K, 1992, J ANTIBIOT, V45, P1733, DOI 10.7164/antibiotics.45.1733; Wallon UM, 1997, J BIOL CHEM, V272, P7473, DOI 10.1074/jbc.272.11.7473; WARD RV, 1991, BIOCHIM BIOPHYS ACTA, V1079, P242, DOI 10.1016/0167-4838(91)90132-J; WILHELM SM, 1989, J BIOL CHEM, V264, P17213; WILL H, 1995, EUR J BIOCHEM, V231, P602, DOI 10.1111/j.1432-1033.1995.0602d.x; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; Zucker S, 1998, J BIOL CHEM, V273, P1216, DOI 10.1074/jbc.273.2.1216	47	123	124	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24360	24367		10.1074/jbc.273.38.24360	http://dx.doi.org/10.1074/jbc.273.38.24360			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733724	hybrid			2022-12-27	WOS:000076007300016
J	Wistedt, AC; Kotarsky, H; Marti, D; Ringdahl, U; Castellino, FJ; Schaller, J; Sjobring, U				Wistedt, AC; Kotarsky, H; Marti, D; Ringdahl, U; Castellino, FJ; Schaller, J; Sjobring, U			Kringle 2 mediates high affinity binding of plasminogen to an internal sequence in streptococcal surface protein PAM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ASSOCIATED PLASMINOGEN; PROTON MAGNETIC-RESONANCE; RECOMBINANT KRINGLE-1; ACTIVATOR; IDENTIFICATION; DOMAIN; EXPRESSION; PYOGENES; RECEPTOR; PURIFICATION	Many cells express receptors for plasminogen (Pg), although the responsible molecules in most cases are poorly defined. In contrast, the group A streptococcal surface protein PAM contains a domain with two 13-amino acid residue long repeated sequences (a1 and a2) responsible for Pg binding. Here we identify the region in Pg that interacts with PAM. A radiolabeled proteolytic plasminogen fragment containing the first three kringles (K1-K3) interacted with streptococci expressing PAM or a chimeric surface protein harboring the a1a2 sequence. In contrast, plasminogen fragments containing kringle 4 or kringle 5 and the activable serine proteinase domain failed to bind to PAM expressing group A streptococci. A synthetic and a recombinant polypeptide containing the a1a2 sequence both bound to immobilized recombinant K2 (rK2) but not to rK1 or rK3. The interaction between the a repeat region and rK2 was reversible, and rK2 completely blocked the binding of Pg to the a1a2 region. The binding of the a repeat containing polypeptide to K2 occurred with an equilibrium association constant of 4.5 x 10(7) M-1, as determined by surface plasmon resonance, a value close to that (1.6 x 10(7) M-1) calculated for the a1a2-Pg interaction. Inhibition experiments suggested involvement of the lysine-binding site of K2 in the interaction. These data demonstrate that K2 contains the major Pg-binding site for PAM, providing the first well defined example of an interaction between an internal Pg-binding region in a protein and a single kringle domain.	Univ Lund, Dept Lab Med, S-22362 Lund, Sweden; Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland; Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA; Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	Lund University; University of Bern; Carnegie Mellon University; University of Notre Dame	Sjobring, U (corresponding author), Univ Lund, Dept Lab Med, Solvegatan 23, S-22362 Lund, Sweden.	ulf.sjobring@mmb.lu.se						BERGE A, 1993, J BIOL CHEM, V268, P25417; Bugge TH, 1996, CELL, V87, P709, DOI 10.1016/S0092-8674(00)81390-2; Cao YH, 1996, J BIOL CHEM, V271, P29461, DOI 10.1074/jbc.271.46.29461; CAPARON MG, 1992, J BACTERIOL, V174, P5693, DOI 10.1128/JB.174.17.5693-5701.1992; CASTELLINO FJ, 1984, SEMIN THROMB HEMOST, V10, P18, DOI 10.1055/s-2007-1004404; Cedervall T, 1997, BIOCHEMISTRY-US, V36, P4987, DOI 10.1021/bi962971q; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Coleman JL, 1997, CELL, V89, P1111, DOI 10.1016/S0092-8674(00)80298-6; FORSGREN M, 1987, FEBS LETT, V213, P254, DOI 10.1016/0014-5793(87)81501-6; HAJJAR KA, 1994, J BIOL CHEM, V269, P21191; Hembrough TA, 1996, J BIOL CHEM, V271, P25684, DOI 10.1074/jbc.271.41.25684; HUSMANN LK, 1995, INFECT IMMUN, V63, P345, DOI 10.1128/IAI.63.1.345-348.1995; JOHNSSON E, 1994, J IMMUNOL, V153, P3557; KASTERN W, 1992, J BIOL CHEM, V267, P12820; MANGEL WF, 1990, SCIENCE, V248, P69, DOI 10.1126/science.2108500; MARTI D, 1994, EUR J BIOCHEM, V219, P455, DOI 10.1111/j.1432-1033.1994.tb19959.x; Marti DN, 1997, BIOCHEMISTRY-US, V36, P11591, DOI 10.1021/bi971316v; Mathews II, 1996, BIOCHEMISTRY-US, V35, P2567, DOI 10.1021/bi9521351; MEISSAUER A, 1992, EXP CELL RES, V199, P179, DOI 10.1016/0014-4827(92)90423-6; MENHART N, 1991, BIOCHEMISTRY-US, V30, P1948, DOI 10.1021/bi00221a031; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034; MOSER TL, 1993, J BIOL CHEM, V268, P18917; MOTTA A, 1987, BIOCHEMISTRY-US, V26, P3827, DOI 10.1021/bi00387a014; NILSON BHK, 1995, BIOCHEMISTRY-US, V34, P13688, DOI 10.1021/bi00041a051; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; PLOW EF, 1991, THROMB HAEMOSTASIS, V66, P32; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; RAMESH V, 1987, J MOL BIOL, V198, P481, DOI 10.1016/0022-2836(87)90295-6; REINARTZ J, 1995, J IMMUNOL, V154, P844; Ringdahl U, 1998, J BIOL CHEM, V273, P6424, DOI 10.1074/jbc.273.11.6424; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; SOTTRUPJENSEN L, 1978, PROGR CHEM FIBRINOLY, P191; TOMLINSON JE, 1989, J BIOL CHEM, V264, P5957; ULLBERG M, 1992, APMIS, V100, P21, DOI 10.1111/j.1699-0463.1992.tb00835.x; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; WISTEDT AC, 1995, MOL MICROBIOL, V18, P569, DOI 10.1111/j.1365-2958.1995.mmi_18030569.x	37	64	66	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24420	24424		10.1074/jbc.273.38.24420	http://dx.doi.org/10.1074/jbc.273.38.24420			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733732	hybrid			2022-12-27	WOS:000076007300024
J	Watanabe, M; Nishino, T; Takio, K; Sofuni, T; Nohmi, T				Watanabe, M; Nishino, T; Takio, K; Sofuni, T; Nohmi, T			Purification and characterization of wild-type and mutant "Classical" nitroreductases of Salmonella typhimurium - L33R mutation greatly diminishes binding of FMN to the nitroreductase of S-typhimurium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI-B; VIBRIO-FISCHERI ATCC-7744; THERMUS-THERMOPHILUS HB8; MAJOR FLAVIN REDUCTASE; AMINO-ACID SEQUENCE; DT-DIAPHORASE; NUCLEOTIDE-SEQUENCE; NADH OXIDASE; RAT-LIVER; NAD(P)H-MENADIONE OXIDOREDUCTASE	"Classical" nitroreductase of Salmonella typhimurium is a flavoprotein that catalyzes the reduction of nitroaromatics to metabolites that are toxic, mutagenic, or carcinogenic. This enzyme represents a new class of flavin-dependent enzymes, which includes nitroreductases of Enterobacter cloacae and Escherichia coli, flavin oxidoreductase of Vibrio fischeri, and NADH oxidase of Thermus thermophilus. To investigate the structure-function relation of this class of enzymes, the gene encoding a mutant nitroreductase was cloned from S. typhimurium strain TA1538NR, and the enzymatic properties were compared with those of the wild-type. DNA sequence analysis revealed a T to G mutation in the mutant nitroreductase gene, predicting a replacement of leucine 33 with arginine. in contrast to the wild-type enzyme, the purified protein with a mutation of leucine 33 to arginine has no detectable nitroreductase activities in the standard assay conditions and easily lost FMN by dialysis or ultrafiltration. in the presence of an excess amount of FMN, however, the mutant protein exhibited a weak but measurable enzyme activity, and the substrate specificity was similar to that of the wild-type enzyme. Possible mechanisms by which the mutation greatly diminishes binding of FMN to the nitroreductase are discussed.	Natl Inst Hlth Sci, Div Genet & Mutagenesis, Setagaya Ku, Tokyo 1588501, Japan; RIKEN, Inst Phys & Chem Res, Dept Res Fundamentals Technol, Wako, Saitama 3510198, Japan	National Institute of Health Sciences - Japan; RIKEN	Nohmi, T (corresponding author), Natl Inst Hlth Sci, Div Genet & Mutagenesis, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	nohmi@nihs.go.jp		nishino, tatsuya/0000-0001-8017-8762				ANLEZARK GM, 1995, BIOCHEM PHARMACOL, V50, P609, DOI 10.1016/0006-2952(95)00187-5; BAYNEY RM, 1987, J BIOL CHEM, V262, P572; BAYNEY RM, 1989, J BIOL CHEM, V264, P21793; BRUNMARK A, 1988, FREE RADICAL BIO MED, V5, P133, DOI 10.1016/0891-5849(88)90076-7; BRYANT C, 1991, J BIOL CHEM, V266, P4119; BRYANT C, 1991, J BIOL CHEM, V266, P4126; DI MD, 1984, ARCH BIOCHEM BIOPHYS, V235, P334; DIMONTE D, 1984, ARCH BIOCHEM BIOPHYS, V235, P343, DOI 10.1016/0003-9861(84)90207-8; EINISTO P, 1991, MUTAT RES, V259, P95, DOI 10.1016/0165-1218(91)90113-Z; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; HECHT HJ, 1995, NAT STRUCT BIOL, V2, P1109, DOI 10.1038/nsb1295-1109; HOSODA S, 1974, J BIOL CHEM, V249, P6416; JAISWAL AK, 1988, J BIOL CHEM, V263, P13572; Kaneko T, 1996, DNA Res, V3, P109; KITAMURA M, 1994, J BIOL CHEM, V269, P5566; KNOX RJ, 1992, BIOCHEM PHARMACOL, V44, P2297, DOI 10.1016/0006-2952(92)90672-6; KNOX RJ, 1995, CLIN IMMUNOTHER, V3, P136, DOI 10.1007/BF03259275; Koike H, 1996, J STRUCT BIOL, V117, P70, DOI 10.1006/jsbi.1996.0070; LIND C, 1990, METHOD ENZYMOL, V186, P287; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; MASSEY V, 1966, J BIOL CHEM, V241, P3417; MCCALLA DR, 1970, J BACTERIOL, V104, P1126, DOI 10.1128/JB.104.3.1126-1134.1970; MCCALLA DR, 1978, J BACTERIOL, V133, P10, DOI 10.1128/JB.133.1.10-16.1978; MCCOY EC, 1983, MUTAT RES, V121, P17, DOI 10.1016/0165-7992(83)90081-7; MCCOY EC, 1981, ENVIRON MUTAGEN, V3, P421, DOI 10.1002/em.2860030403; MICHAEL NP, 1994, FEMS MICROBIOL LETT, V124, P195, DOI 10.1111/j.1574-6968.1994.tb07284.x; MORRISON H, 1984, BIOCHEM PHARMACOL, V33, P1763, DOI 10.1016/0006-2952(84)90347-2; NOHMI T, 1984, MUTAT RES, V136, P159, DOI 10.1016/0165-1218(84)90049-1; PARK HJ, 1992, EUR J BIOCHEM, V205, P875, DOI 10.1111/j.1432-1033.1992.tb16852.x; PARK HJ, 1993, EUR J BIOCHEM, V211, P909; PARK HJ, 1992, EUR J BIOCHEM, V205, P881, DOI 10.1111/j.1432-1033.1992.tb16853.x; PETERSON FJ, 1979, J BIOL CHEM, V254, P4009; RASE B, 1976, ARCH BIOCHEM BIOPHYS, V172, P380, DOI 10.1016/0003-9861(76)90089-8; ROBERTSON JA, 1986, J BIOL CHEM, V261, P5794; ROSENKRANZ HS, 1975, BIOCHEM BIOPH RES CO, V66, P520, DOI 10.1016/0006-291X(75)90541-0; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SKELLY JV, 1994, J MOL BIOL, V238, P852, DOI 10.1006/jmbi.1994.1340; THORNTONMANNING JR, 1991, CARCINOGENESIS, V12, P2317, DOI 10.1093/carcin/12.12.2317; WATANABE M, 1990, NUCLEIC ACIDS RES, V18, P1059, DOI 10.1093/nar/18.4.1059; WATANABE M, 1992, J BIOL CHEM, V267, P8429; WATANABE M, 1989, MUTAT RES, V216, P211, DOI 10.1016/0165-1161(89)90007-1; ZENNO S, 1994, J BACTERIOL, V176, P3536, DOI 10.1128/JB.176.12.3536-3543.1994; Zenno S, 1996, J BIOCHEM-TOKYO, V120, P736; ZENNO S, 1994, J BACTERIOL, V176, P3544, DOI 10.1128/JB.176.12.3544-3551.1994; Zenno SH, 1996, J BACTERIOL, V178, P4731, DOI 10.1128/jb.178.15.4731-4733.1996	45	53	54	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23922	23928		10.1074/jbc.273.37.23922	http://dx.doi.org/10.1074/jbc.273.37.23922			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727006	hybrid			2022-12-27	WOS:000075893100047
J	Chinchilla, D; Schwarz, FP; Eisenstein, E				Chinchilla, D; Schwarz, FP; Eisenstein, E			Amino acid substitutions in the C-terminal regulatory domain disrupt allosteric effector binding to biosynthetic threonine deaminase from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARTATE TRANSCARBAMOYLASE; LIGAND-BINDING; ISOLEUCINE; MECHANISM; VALINE; SITE	Shifts in the sigmoidal kinetics of allosteric threonine deaminase promoted by isoleucine and valine binding control branched chain amino acid biosynthesis in Escherichia coli. A highly conserved alpha-helix in the C-terminal regulatory domain of the tetrameric enzyme was previously implicated in effector binding and feedback inhibition. Double (447, 451) and triple (447, 451, 454) alanine replacements for the conserved amino acids leucine 447, leucine 451, and leucine 454 in this region yield enzyme variants that show increased sigmoidality in steady-state kinetics, and which are less sensitive to the allosteric modifiers isoleucine and valine, Equilibrium binding studies using fluorescence, enzyme kinetic, and calorimetric approaches indicate that the enzyme variants possess reduced affinity for isoleucine and valine, and suggest that heterotropic ligands can bind to the same site to promote their different effects. The increase in sigmoidal kinetics for the mutants relative to wildtype threonine deaminase may be attributable to the elimination of L-threonine binding to the effector sites, which activates the wild-type enzyme, Enzyme kinetic data and isotherms for active site ligand binding to the mutants can be analyzed in terms of a simple two-state model to yield values for allosteric parameters that are consistent with previous estimates based on an expanded two-state model for homotropic cooperativity for threonine deaminase.	Univ Maryland, Inst Biotechnol, Ctr Adv Res Biotechnol, Rockville, MD 20850 USA; Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21228 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore County	Eisenstein, E (corresponding author), Univ Maryland, Inst Biotechnol, Ctr Adv Res Biotechnol, 9600 Gudelsky Dr, Rockville, MD 20850 USA.							Adair GS, 1925, J BIOL CHEM, V63, P529; BURNS RO, 1979, J BIOL CHEM, V254, P1074; DAVIS L, 1965, ANAL BIOCHEM, V12, P36, DOI 10.1016/0003-2697(65)90139-9; DECEDUE CJ, 1975, J BIOL CHEM, V250, P1563; EISENSTEIN E, 1995, ARCH BIOCHEM BIOPHYS, V316, P311, DOI 10.1006/abbi.1995.1042; EISENSTEIN E, 1991, J BIOL CHEM, V266, P5801; EISENSTEIN E, 1990, BIOCHEMISTRY-US, V29, P3724, DOI 10.1021/bi00467a019; EISENSTEIN E, 1995, BIOCHEMISTRY-US, V34, P9403, DOI 10.1021/bi00029a016; EISENSTEIN E, 1994, J BIOL CHEM, V269, P29423; EISENSTEIN E, 1994, J BIOL CHEM, V269, P29416; FISHER KE, 1993, J BACTERIOL, V175, P6605, DOI 10.1128/jb.175.20.6605-6613.1993; Gallagher DT, 1998, STRUCTURE, V6, P465, DOI 10.1016/S0969-2126(98)00048-3; Hill A.V., 1910, J PHYSIOL-LONDON, V40, piv; HOFLER JG, 1978, J BIOL CHEM, V253, P1245; JOHNSON ML, 1985, METHOD ENZYMOL, V117, P301; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; PARMENTIER LE, 1992, BIOCHEMISTRY-US, V31, P6570, DOI 10.1021/bi00143a029; Perutz M. F., 1990, MECH COOPERATIVITY; STEVENS RC, 1992, P NATL ACAD SCI USA, V89, P5281, DOI 10.1073/pnas.89.12.5281; UMBARGER HE, 1973, ADV ENZYMOL RAMB, V37, P349; Umbarger HE, 1987, ESCHERICHIA COLI SAL, P352; WILD JR, 1989, P NATL ACAD SCI USA, V86, P46, DOI 10.1073/pnas.86.1.46; ZHANG Y, 1992, BIOCHEMISTRY-US, V31, P792, DOI 10.1021/bi00118a022	23	13	14	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23219	23224		10.1074/jbc.273.36.23219	http://dx.doi.org/10.1074/jbc.273.36.23219			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722552	hybrid			2022-12-27	WOS:000075778100052
J	Deng, J; Szyf, M				Deng, J; Szyf, M			Multiple isoforms of DNA methyltransferase are encoded by the vertebrate cytosine DNA methyltransferase gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE CELLS; METHYLATION; EXPRESSION; MECHANISM; SEQUENCE; ENZYMES; DOMAIN	This manuscript tests the hypothesis that multiple forms of cytosine-DNA methyltransferase (MeTase) are expressed in vertebrates in vivo. Vertebrate genomes are distinguished by tissue- tend gene-specific DNA methylation patterns. Specific methylation patterns are believed to encode epigenetic information. In distinction from the remarkable diversity of DNA methylation patterns, only one functional DNA MeTase cDNA has been identified to date in different vertebrate organisms. Using reverse transcription-polymerase chain reaction and RNase protection analyses, we show that the methyltransferase domain of the rat DNA MeTase is alternatively spliced in vivo, generating different in-frame variants of DNA MeTase in specific tissues. This process is developmentally regulated and is induced in PC12 cells by a known inducer of neuronal differentiation, nerve growth factor. The data presented here point toward a new mechanism for generating diversity of DNA MeTases and possibly diverse DNA methylation patterns.	McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada	McGill University	Szyf, M (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.							BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; BESTOR TH, 1992, EMBO J, V11, P2611, DOI 10.1002/j.1460-2075.1992.tb05326.x; CHOI E, 1980, NATURE, V286, P776, DOI 10.1038/286776a0; ELDEIRY WS, 1991, P NATL ACAD SCI USA, V88, P3470, DOI 10.1073/pnas.88.8.3470; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; KAWASAKI ES, 1989, PCR TECHNOLOGY PRINC, P89; KUMAR S, 1994, NUCLEIC ACIDS RES, V22, P1, DOI 10.1093/nar/22.1.1; Lei H, 1996, DEVELOPMENT, V122, P3195; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; Mertineit C, 1998, DEVELOPMENT, V125, P889; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; NEBERT DW, 1979, MOL CELL BIOCHEM, V27, P27, DOI 10.1007/BF00849277; Ramchandani S, 1998, BIOL CHEM, V379, P535; RAZIN A, 1984, BIOCHIM BIOPHYS ACTA, V782, P331, DOI 10.1016/0167-4781(84)90043-5; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; RAZIN A, 1991, MICROBIOL REV, V55, P451, DOI 10.1128/MMBR.55.3.451-458.1991; ROBERTSON M, 1982, NATURE, V297, P184, DOI 10.1038/297184a0; SZYF M, 1992, J BIOL CHEM, V267, P12831; SZYF M, 1994, TRENDS PHARMACOL SCI, V15, P233, DOI 10.1016/0165-6147(94)90317-4; YEN RWC, 1992, NUCLEIC ACIDS RES, V20, P2287, DOI 10.1093/nar/20.9.2287; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125; Yoder JA, 1998, HUM MOL GENET, V7, P279, DOI 10.1093/hmg/7.2.279	23	25	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					22869	22872		10.1074/jbc.273.36.22869	http://dx.doi.org/10.1074/jbc.273.36.22869			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722504	hybrid			2022-12-27	WOS:000075778100004
J	Hocker, M; Rosenberg, I; Xavier, R; Henihan, RJ; Wiedenmann, B; Rosewicz, S; Podolsky, DK; Wang, TC				Hocker, M; Rosenberg, I; Xavier, R; Henihan, RJ; Wiedenmann, B; Rosewicz, S; Podolsky, DK; Wang, TC			Oxidative stress activates the human histidine decarboxylase promoter in AGS gastric cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL 12-MYRISTATE 13-ACETATE; OXYGEN METABOLITE PRODUCTION; ISCHEMIA-REPERFUSION; LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; ORNITHINE DECARBOXYLASE; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; PROTEIN-KINASE; OXIDANT STRESS	Oxidant stress is thought to play a role in the pathogenesis of many gastric disorders. We have recently reported that histidine decarboxylase (HDC) promoter activity is stimulated by gastrin through a protein kinase C- and extracellular signal-regulating kinase (ERK)-dependent pathway in gastric cancer (AGS-B) cells, and this transcriptional response is mediated by a downstream cis-acting element, the gastrin response element (GAS-RE). To study the mechanism through which oxidant stress affects gastric cells, we examined the effects of hydrogen peroxide (H2O2) on HDC promoter activity and intracellular signaling in AGS-B cells. H2O2 (10 mM) specifically activated the HDC promoter 10-12-fold, and this activation was blocked by both mannitol and N-acetylcysteine. Hydrogen peroxide treatment of AGS-B cells increased the phosphorylation and kinase activity of ERK-1 and ERK-2, but did not affect Jun kinase tyrosine phosphorylation or kinase activity. In addition, treatment of AGS-B cells with H2O2 resulted in increased c-fos/c-jun mRNA expression and AP-1 activity, and also led to increased phosphorylation of epidermal growth factor receptor (EGFR) and Shc. H2O2-dependent stimulation of HDC promoter activity was completely inhibited by kinase-deficient ERKs, dominant-negative (N17 and N15) Ras, and dominant-negative Raf, and partially blocked by a dominant-negative EGFR mutant. In contrast, protein kinase C blockade did not inhibit H2O2-dependent induction of the HDC promoter. Finally, deletion analysis demonstrated that the H2O2 response element could be mapped to the GAS-RE (nucleotides 2 to 24) of the basal HDC promoter. Overall, these studies suggest that oxidant stress activates the HDC promoter through the GAS-RE, and through an Ras-, Raf-, and ERK-dependent pathway at least partially involving the EGFR.	Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Free Univ Berlin, Klinikum Benjamin Franklin, Berlin, Germany; Humboldt Univ, Klinikum Charite, Med Klin, Schwerpunkt Hepatol & Gastroenterol, Berlin, Germany	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Wang, TC (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, GRJ 724,32 Fruit St, Boston, MA 02114 USA.	Wang@Helix.MGH.Harvard.Edu		Wiedenmann, Bertram/0000-0002-7890-2552	NIDDK NIH HHS [DK41557, DK48077] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK041557, R01DK041557, R01DK048077] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMSTAD P, 1990, B CANCER, V77, P501; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Baeuerle PA, 1996, PATHOL BIOL, V44, P29; Baik SC, 1996, CANCER RES, V56, P1279; Bandyopadhyay U, 1997, BIOCHEM PHARMACOL, V54, P241, DOI 10.1016/S0006-2952(97)00156-1; BOUCLIER M, 1983, EUR J PHARMACOL, V90, P129, DOI 10.1016/0014-2999(83)90224-8; CAI H, 1993, MOL CELL BIOL, V13, P7645, DOI 10.1128/MCB.13.12.7645; CHING TL, 1995, INFLAMM RES, V44, P99, DOI 10.1007/BF01782018; Dalton TP, 1996, J BIOL CHEM, V271, P26233, DOI 10.1074/jbc.271.42.26233; DAVIES GR, 1994, GUT, V35, P179, DOI 10.1136/gut.35.2.179; DAVIES GR, 1992, GUT, V33, P1467, DOI 10.1136/gut.33.11.1467; Drake IM, 1996, CARCINOGENESIS, V17, P559, DOI 10.1093/carcin/17.3.559; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; FUJIMOTO K, 1992, J CLIN INVEST, V89, P126, DOI 10.1172/JCI115552; FUJIMOTO K, 1995, DIGEST DIS SCI, V40, P717, DOI 10.1007/BF02064967; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; HIRAISHI H, 1994, GASTROENTEROLOGY, V106, P1199, DOI 10.1016/0016-5085(94)90010-8; HIRAISHI H, 1994, J CLIN INVEST, V93, P331, DOI 10.1172/JCI116964; Hocker M, 1997, AM J PHYSIOL-GASTR L, V272, pG822, DOI 10.1152/ajpgi.1997.272.4.G822; Hocker M, 1997, J BIOL CHEM, V272, P27015, DOI 10.1074/jbc.272.43.27015; Hocker M, 1996, AM J PHYSIOL-GASTR L, V270, pG619, DOI 10.1152/ajpgi.1996.270.4.G619; Hocker M, 1996, YALE J BIOL MED, V69, P21; Jacobson MD, 1996, TRENDS BIOCHEM SCI, V21, P83, DOI 10.1016/0968-0004(96)20008-8; KEHRER JP, 1993, CRIT REV TOXICOL, V23, P21, DOI 10.3109/10408449309104073; KOYAMA T, 1995, P SOC EXP BIOL MED, V209, P27, DOI 10.3181/00379727-209-43873; Lander HM, 1997, FASEB J, V11, P118, DOI 10.1096/fasebj.11.2.9039953; MIROSSAY L, 1994, AM J PHYSIOL, V267, pR602, DOI 10.1152/ajpregu.1994.267.2.R602; Nose K, 1996, BIOCHEM J, V316, P381, DOI 10.1042/bj3160381; PAHL HL, 1994, BIOESSAYS, V16, P497, DOI 10.1002/bies.950160709; Pai R, 1998, GASTROENTEROLOGY, V114, P706, DOI 10.1016/S0016-5085(98)70584-0; Rao GN, 1996, J BIOL CHEM, V271, P27760, DOI 10.1074/jbc.271.44.27760; Rao GN, 1996, ONCOGENE, V13, P713; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; SEN C, 1990, FASEB J, V10, P709; Smith GS, 1996, DIGEST DIS SCI, V41, P1157, DOI 10.1007/BF02088232; SZERBERENYI J, 1990, MOL CELL BIOL, V10, P5324; Taniguchi Y, 1996, NUCLEIC ACIDS RES, V24, P2746, DOI 10.1093/nar/24.14.2746; Wagner M, 1996, INT J CANCER, V68, P782, DOI 10.1002/(SICI)1097-0215(19961211)68:6<782::AID-IJC16>3.0.CO;2-2; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; WHISLER RL, 1995, ARCH BIOCHEM BIOPHYS, V319, P23, DOI 10.1006/abbi.1995.1263; YAJIMA N, 1995, DIGEST DIS SCI, V40, P879, DOI 10.1007/BF02064995; YOSHIKAWA T, 1993, GUT, V34, P732, DOI 10.1136/gut.34.6.732; Zhang ZS, 1996, J BIOL CHEM, V271, P14188, DOI 10.1074/jbc.271.24.14188; ZOR U, 1993, BIOCHEM J, V295, P879, DOI 10.1042/bj2950879	46	57	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23046	23054		10.1074/jbc.273.36.23046	http://dx.doi.org/10.1074/jbc.273.36.23046			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722530	hybrid			2022-12-27	WOS:000075778100030
J	Konrat, R; Krautler, B; Weiskirchen, R; Bister, K				Konrat, R; Krautler, B; Weiskirchen, R; Bister, K			Structure of cysteine- and glycine-rich protein CRP2 - Backbone dynamics reveal motional freedom and independent spatial orientation of the LIM domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODEL-FREE APPROACH; MAGNETIC-RESONANCE RELAXATION; ZINC-FINGER MOTIF; NMR-SPECTROSCOPY; SENSITIVITY IMPROVEMENT; LARGER PROTEINS; CHEMICAL-SHIFTS; N-15 NMR; BINDING; SPECTRA	Members of the cysteine- and glycine-rich protein family (CRP1, CRP2, and CRP3) contain two zinc-binding LIM domains, LIM1 (amino-terminal) and LIM2 (carboxyl-terminal), and are implicated in diverse cellular processes linked to differentiation, growth control, and pathogenesis. Here we report the solution structure of full-length recombinant quail CRP2 as determined by multi-dimensional triple-resonance NMR spectroscopy. The structural analysis revealed that the global fold of the two LIM domains in the context of the full-length protein is identical to the recently determined solution structures of the isolated individual LIM domains of quail CRP2, There is no preference in relative spatial orientation of the two domains. This supports the view that the two LIM domains are independent structural and presumably functional modules of CRP proteins. This is also reflected by the dynamic properties of CRP2 probed by (15)N relaxation values (T(1), T(2), and nuclear Overhauser effect). A model-free analysis revealed local variations in mobility along the backbone of the two LIM domains in the native protein, similar to those observed for the isolated domains. Interestingly, fast and slow motions observed in the 58-amino acid linker region between the two LIM domains endow extensive motional freedom to CRP2, The dynamic analysis indicates independent backbone mobility of the two LIM domains and rules out correlated LIM domain motion in full-length CRP2, The finding that the LIM domains in a protein encompassing multiple LIM motifs are structurally and dynamically independent from each other supports the notion that these proteins may function as adaptor molecules arranging two or more protein constituents into a macromolecular complex.	Univ Innsbruck, Inst Organ Chem, A-6020 Innsbruck, Austria; Univ Innsbruck, Inst Biochem, A-6020 Innsbruck, Austria	University of Innsbruck; University of Innsbruck	Konrat, R (corresponding author), Univ Innsbruck, Inst Organ Chem, Innrain 52A, A-6020 Innsbruck, Austria.	robert.konrat@uibk.ac.at	Bister, Klaus/AFA-9400-2022; Weiskirchen, Ralf/O-1734-2018	Weiskirchen, Ralf/0000-0003-3888-0931; Bister, Klaus/0000-0001-6545-5653				Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Arber S, 1996, GENE DEV, V10, P289, DOI 10.1101/gad.10.3.289; ARBER S, 1994, CELL, V79, P221, DOI 10.1016/0092-8674(94)90192-9; Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAVANAGH J, 1991, J MAGN RESON, V91, P429, DOI 10.1016/0022-2364(91)90209-C; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P7387, DOI 10.1021/bi00484a006; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Dayie KT, 1996, ANNU REV PHYS CHEM, V47, P243, DOI 10.1146/annurev.physchem.47.1.243; DELAGLIO F, 1993, NMRPIPE SYSTEM SOFTW; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FEUERSTEIN R, 1994, P NATL ACAD SCI USA, V91, P10655, DOI 10.1073/pnas.91.22.10655; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Jurata LW, 1998, J BIOL CHEM, V273, P3152, DOI 10.1074/jbc.273.6.3152; Jurata LW, 1996, P NATL ACAD SCI USA, V93, P11693, DOI 10.1073/pnas.93.21.11693; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; Kong YF, 1997, MOL CELL BIOL, V17, P4750, DOI 10.1128/MCB.17.8.4750; Konrat R, 1997, J BIOL CHEM, V272, P12001, DOI 10.1074/jbc.272.18.12001; Kontaxis G, 1998, BIOCHEMISTRY-US, V37, P7127, DOI 10.1021/bi973055v; Koradi R, 1996, J MOL GRAPHICS, V14, P29; KOSA JL, 1994, BIOCHEMISTRY-US, V33, P468, DOI 10.1021/bi00168a011; KRAULIS PJ, 1989, J MAGN RESON, V84, P627, DOI 10.1016/0022-2364(89)90130-3; KRAULIS PJ, 1994, BIOCHEMISTRY-US, V33, P3515, DOI 10.1021/bi00178a008; KUPCE E, 1995, J MAGN RESON SER A, V115, P273, DOI 10.1006/jmra.1995.1179; LIEBHABER SA, 1990, NUCLEIC ACIDS RES, V18, P3871, DOI 10.1093/nar/18.13.3871; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Louis HA, 1997, J BIOL CHEM, V272, P27484, DOI 10.1074/jbc.272.43.27484; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; MCCOY MA, 1992, J AM CHEM SOC, V114, P2108, DOI 10.1021/ja00032a026; MICHELSEN JW, 1993, P NATL ACAD SCI USA, V90, P4404, DOI 10.1073/pnas.90.10.4404; MICHELSEN JW, 1994, J BIOL CHEM, V269, P11108; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; OMICHINSKI JG, 1993, SCIENCE, V261, P438, DOI 10.1126/science.8332909; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; PEREZALVARADO GC, 1994, NAT STRUCT BIOL, V1, P388, DOI 10.1038/nsb0694-388; PerezAlvarado GC, 1996, J MOL BIOL, V257, P153, DOI 10.1006/jmbi.1996.0153; Pomies P, 1997, J CELL BIOL, V139, P157, DOI 10.1083/jcb.139.1.157; RUCKER SP, 1989, MOL PHYS, V68, P509, DOI 10.1080/00268978900102331; SANCHEZGARCIA I, 1994, TRENDS GENET, V10, P315, DOI 10.1016/0168-9525(94)90034-5; SCHLEUCHER J, 1993, ANGEW CHEM INT EDIT, V32, P1489, DOI 10.1002/anie.199314891; Schmeichel KL, 1997, MOL BIOL CELL, V8, P219, DOI 10.1091/mbc.8.2.219; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; SHAKA AJ, 1985, J MAGN RESON, V64, P547, DOI 10.1016/0022-2364(85)90122-2; STONEHOUSE J, 1994, J MAGN RESON SER A, V107, P178, DOI 10.1006/jmra.1994.1066; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TAIRA M, 1995, TRENDS GENET, V11, P431, DOI 10.1016/S0168-9525(00)89139-8; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Weiskirchen R, 1997, GENOMICS, V44, P83, DOI 10.1006/geno.1997.4855; WEISKIRCHEN R, 1995, J BIOL CHEM, V270, P28946, DOI 10.1074/jbc.270.48.28946; WEISKIRCHEN R, 1993, ONCOGENE, V8, P2317; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Wu RY, 1996, J BIOL CHEM, V271, P15934, DOI 10.1074/jbc.271.27.15934; ZUIDERWEG ERP, 1989, BIOCHEMISTRY-US, V28, P2387, DOI 10.1021/bi00432a008	65	39	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23233	23240		10.1074/jbc.273.36.23233	http://dx.doi.org/10.1074/jbc.273.36.23233			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722554	hybrid			2022-12-27	WOS:000075778100054
J	Li, XY; McClure, WR				Li, XY; McClure, WR			Stimulation of open complex formation by nicks and apurinic sites suggests a role for nucleation of DNA melting in Escherichia coli promoter function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPRESSOR-OPERATOR INTERACTIONS; DEPENDENT RNA-POLYMERASE; LAMBDA-PR PROMOTER; LAC UV5 PROMOTER; TRANSCRIPTION INITIATION; GEL-ELECTROPHORESIS; MECHANISM; STABILITY; RECOGNITION; KINETICS	We report the effects of depurination and prenicking at various positions of the phage lambda prmup-1 Delta 265 promoter DNA on the rate of open complex formation. We have found that depurination and prenicking at positions around the -10 region strongly stimulated the rate of open complex formation. Since nicking and depurination are known to destabilize DNA helical structure, our observations indicate that the instability of the -10 region is important for open complex formation. We further infer that (i) the nucleation of DNA melting, which occurs during the isomerization from the closed complex into the open complex, contributes to the rate of open complex formation; (ii) the nucleation of melting occurs around the -10 region; and (iii) the propagation of DNA melting from the nucleation region is not rate-limiting. In addition, we have found that depurination at several positions inhibited open complex formation. We used dimethyl sulfate modification protection studies to show that most of the guanine bases that are among these positions are in contact with RNA polymerase in the open complex.	Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University	McClure, WR (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.				NIGMS NIH HHS [GM 30375] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030375] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMOUYAL M, 1987, J MOL BIOL, V195, P795, DOI 10.1016/0022-2836(87)90485-2; ANDERSON JE, 1987, NATURE, V326, P846, DOI 10.1038/326846a0; AUBLE DT, 1988, J MOL BIOL, V202, P471, DOI 10.1016/0022-2836(88)90279-3; AUSUBEL KFM, 1987, CURRENT PROTOCOLS MO; AYERS DG, 1989, J MOL BIOL, V207, P749, DOI 10.1016/0022-2836(89)90241-6; BOROWIEC JA, 1986, BIOCHEMISTRY-US, V25, P5051, DOI 10.1021/bi00366a012; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; BRUNELLE A, 1987, P NATL ACAD SCI USA, V84, P6673, DOI 10.1073/pnas.84.19.6673; BUC H, 1985, BIOCHEMISTRY-US, V24, P2712, DOI 10.1021/bi00332a018; BURGESS RR, 1975, BIOCHEMISTRY-US, V14, P4634, DOI 10.1021/bi00692a011; Chen YF, 1997, J MOL BIOL, V267, P47, DOI 10.1006/jmbi.1996.0853; COWING DW, 1989, J MOL BIOL, V210, P513, DOI 10.1016/0022-2836(89)90127-7; CRAIG ML, 1995, BIOCHEMISTRY-US, V34, P15624, DOI 10.1021/bi00048a004; DEHASETH PL, 1995, MOL MICROBIOL, V16, P817, DOI 10.1111/j.1365-2958.1995.tb02309.x; DeHaseth PL, 1998, J BACTERIOL, V180, P3019, DOI 10.1128/JB.180.12.3019-3025.1998; DUVALVALENTIN G, 1986, NUCLEIC ACIDS RES, V14, P1967, DOI 10.1093/nar/14.5.1967; ERIE DA, 1989, BIOCHEMISTRY-US, V28, P268, DOI 10.1021/bi00427a037; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3047, DOI 10.1093/nar/9.13.3047; GOLJER I, 1992, BIOCHEMISTRY-US, V31, P11614, DOI 10.1021/bi00161a047; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; HAWLEY DK, 1982, J MOL BIOL, V157, P493, DOI 10.1016/0022-2836(82)90473-9; JORDAN SR, 1988, SCIENCE, V242, P893, DOI 10.1126/science.3187530; JORGENSEN ED, 1991, J BIOL CHEM, V266, P645; KOUDELKA GB, 1988, P NATL ACAD SCI USA, V85, P4633, DOI 10.1073/pnas.85.13.4633; Li XY, 1998, J BIOL CHEM, V273, P23549, DOI 10.1074/jbc.273.36.23549; LOWE PA, 1979, BIOCHEMISTRY-US, V18, P1344, DOI 10.1021/bi00574a034; MARGALIT H, 1988, BIOCHEMISTRY-US, V27, P5179, DOI 10.1021/bi00414a035; Maxam A M, 1980, Methods Enzymol, V65, P499; MCCLURE WR, 1985, ANNU REV BIOCHEM, V54, P171, DOI 10.1146/annurev.bi.54.070185.001131; MILLICAN TA, 1984, NUCLEIC ACIDS RES, V12, P7435, DOI 10.1093/nar/12.19.7435; MINCHIN S, 1993, BIOCHEM J, V289, P771, DOI 10.1042/bj2890771; PIETERS JML, 1989, NUCLEIC ACIDS RES, V17, P4551, DOI 10.1093/nar/17.12.4551; Roberts CW, 1996, CELL, V86, P495; ROE JH, 1985, J MOL BIOL, V184, P441, DOI 10.1016/0022-2836(85)90293-1; ROE JH, 1984, J MOL BIOL, V176, P495, DOI 10.1016/0022-2836(84)90174-8; SASSEDWIGHT S, 1989, J BIOL CHEM, V264, P8074; Severinov K, 1997, P NATL ACAD SCI USA, V94, P13481, DOI 10.1073/pnas.94.25.13481; SIEBENLIST U, 1979, NATURE, V279, P651, DOI 10.1038/279651a0; SIEBENLIST U, 1980, CELL, V20, P270; SPASSKY A, 1985, BIOCHEMISTRY-US, V24, P2723, DOI 10.1021/bi00332a019; VESNAVER G, 1989, P NATL ACAD SCI USA, V86, P3614, DOI 10.1073/pnas.86.10.3614; WEREL W, 1991, EMBO J, V10, P2589, DOI 10.1002/j.1460-2075.1991.tb07800.x; Zaychikov E, 1997, J BIOL CHEM, V272, P2259	44	29	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23558	23566		10.1074/jbc.273.36.23558	http://dx.doi.org/10.1074/jbc.273.36.23558			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722595	hybrid			2022-12-27	WOS:000075778100095
J	Nishikawa, K; Toker, A; Wong, K; Marignani, PA; Johannes, FJ; Cantley, LC				Nishikawa, K; Toker, A; Wong, K; Marignani, PA; Johannes, FJ; Cantley, LC			Association of protein kinase c mu with type II phosphatidylinositol 4-kinase and type I phosphatidylinositol-4-phosphate 5-kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE EPIDERMAL-CELLS; SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; 3-KINASE COMPLEX; YEAST; FAMILY; ACTIVATION; SUBSTRATE; ISOFORMS; POLYPHOSPHOINOSITIDES	Protein kinase C mu (PKC mu), also named protein kinase D, is an unusual member of the PKC family that has a putative transmembrane domain and pleckstrin homology domain. This enzyme has a substrate specificity distinct from other PKC isoforms (Nishikawa, K., Toker, A., Johannes, F. J., Songyang, Z., and Cantley, L. C. (1997) J. Biol. Chem. 272, 952-960), and its mechanism of regulation is not yet clear. Here we show that PKC mu forms a complex in vivo with a phosphatidylinositol 4-kinase and a phosphatidylinositol-4-phosphate 5-kinase. A region of PKC mu between the amino-terminal transmembrane domain and the pleckstrin homology domain is shown to be involved in the association with the lipid kinases. Interestingly, a kinase-dead point mutant of PKC mu. failed to associate with either lipid kinase activity, indicating that autophosphorylation may be required to expose the Lipid kinase interaction domain. Furthermore, the subcellular distribution of the PKC mu-associated lipid kinases to the particulate fraction depends on the presence of the amino-terminal. region of PKC mu including the predicted transmembrane region. These results suggest a novel model in which the noncatalytic region of PKC mu acts as a scaffold for assembly of enzymes involved in phosphoinositide synthesis at specific membrane locations.	Harvard Univ, Sch Med, Div Signal Transduct, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Boston Biomed Res Inst, Boston, MA 02114 USA; Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Boston Biomedical Research Institute; University of Stuttgart	Nishikawa, K (corresponding author), Harvard Univ, Inst Med, Div Signal Transduct, Beth Israel Deaconess Med Ctr, 10th Fl,330 Brookline Ave, Boston, MA 02215 USA.	knishika@ri.imcj.go.jp	Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653; Marignani, Paola/0000-0001-8070-905X	NHLBI NIH HHS [P50-HL56993] Funding Source: Medline; NIGMS NIH HHS [R01-GM36624] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036624] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKIMOTO K, 1994, J BIOL CHEM, V269, P12677; AUGER KR, 1991, CANCER CELL-MON REV, V3, P263; AUGER KR, 1991, METHODS INOSITIDE RE, P155; CARPENTER CL, 1990, BIOCHEMISTRY-US, V29, P11147, DOI 10.1021/bi00503a001; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; Dieterich S, 1996, FEBS LETT, V381, P183, DOI 10.1016/0014-5793(96)00116-0; ENDEMANN G, 1987, BIOCHEMISTRY-US, V26, P6845, DOI 10.1021/bi00395a039; ENDEMANN GC, 1991, BIOCHEM J, V273, P63, DOI 10.1042/bj2730063; FRUMAN D, 1998, IN PRESS ANN REV BIO; HERMAN PK, 1991, EMBO J, V10, P4049, DOI 10.1002/j.1460-2075.1991.tb04981.x; HUG H, 1993, BIOCHEM J, V291, P329, DOI 10.1042/bj2910329; Ishihara H, 1996, J BIOL CHEM, V271, P23611, DOI 10.1074/jbc.271.39.23611; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; JOHANNES FJ, 1995, EUR J BIOCHEM, V227, P303, DOI 10.1111/j.1432-1033.1995.tb20389.x; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; LISCOVITCH M, 1995, CELL, V81, P659, DOI 10.1016/0092-8674(95)90525-1; Loijens JC, 1996, J BIOL CHEM, V271, P32937, DOI 10.1074/jbc.271.51.32937; Meyers R, 1997, J BIOL CHEM, V272, P4384, DOI 10.1074/jbc.272.7.4384; NISHIKAWA K, 1992, CELL SIGNAL, V4, P757, DOI 10.1016/0898-6568(92)90057-F; NISHIKAWA K, 1994, CELL SIGNAL, V6, P503, DOI 10.1016/0898-6568(94)90004-3; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; OGITA K, 1991, METHOD ENZYMOL, V200, P228; Panaretou C, 1997, J BIOL CHEM, V272, P2477; Prestle J, 1996, J CELL BIOL, V134, P1401, DOI 10.1083/jcb.134.6.1401; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; SELBIE LA, 1993, J BIOL CHEM, V268, P24296; Sidorenko SP, 1996, IMMUNITY, V5, P353, DOI 10.1016/S1074-7613(00)80261-7; STACK JH, 1994, J BIOL CHEM, V269, P31552; STACK JH, 1995, J CELL BIOL, V129, P321, DOI 10.1083/jcb.129.2.321; STACK JH, 1993, EMBO J, V12, P2195, DOI 10.1002/j.1460-2075.1993.tb05867.x; TOKER A, 1994, J BIOL CHEM, V269, P32358; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; VANLINT J, 1995, J BIOL CHEM, V270, P1455, DOI 10.1074/jbc.270.3.1455; VOLINIA S, 1995, EMBO J, V14, P3339, DOI 10.1002/j.1460-2075.1995.tb07340.x; Wong K, 1997, J BIOL CHEM, V272, P13236, DOI 10.1074/jbc.272.20.13236; WONG K, 1994, J BIOL CHEM, V269, P28878; Zugaza JL, 1997, J BIOL CHEM, V272, P23952, DOI 10.1074/jbc.272.38.23952	39	75	76	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23126	23133		10.1074/jbc.273.36.23126	http://dx.doi.org/10.1074/jbc.273.36.23126			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722541	hybrid			2022-12-27	WOS:000075778100041
J	Fotinou, C; Beauchamp, J; Emsley, P; deHaan, A; Schielen, WJG; Bos, E; Isaacs, NW				Fotinou, C; Beauchamp, J; Emsley, P; deHaan, A; Schielen, WJG; Bos, E; Isaacs, NW			Structure of an Fab fragment against a C-terminal peptide of hCG at 2.0 angstrom resolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CHORIONIC-GONADOTROPIN; ANTIBODY-ANTIGEN INTERACTIONS; PROTEIN MODELS; BINDING-SITE; IMMUNOGLOBULINS	3A2 is an antibody raised against human chorionic gonadotropin and recognizes a linear epitope on the C-terminal peptide of the human chorionic gonadotropin P-subunit. Its three-dimensional structure has been determined to 2-Angstrom resolution using molecular replacement and refined to a conventional R-factor of 18.2%, The protein exhibits the typical immunoglobulin fold, and the model contains 944 ordered water molecules and one sulfate ion. A comparison of the complementarity-determining regions of the Fab3A2 with those from the Protein Data Bank following the canonical structure method reveals a canonical main chain conformation. This antibody belongs to the canonical structure class (combination of canonical conformations of the complementarity determining loops) that shows a preference for haptens and not for peptides, However, the shape of the surface of the antigen binding loops resembles that of an anti-peptide antibody.	Univ Glasgow, Dept Chem, Glasgow G12 8QQ, Lanark, Scotland; NV Organon, Dept Biochem & Biotechnol, NL-5340 BH Oss, Netherlands; Organon Teknika BV, Chem Res Unit, NL-5280 AB Boxtel, Netherlands	University of Glasgow; Merck & Company	Isaacs, NW (corresponding author), Univ Glasgow, Dept Chem, Glasgow G12 8QQ, Lanark, Scotland.	neil@chem.gla.ac.uk						AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banfield MJ, 1996, ACTA CRYSTALLOGR D, V52, P1107, DOI 10.1107/S0907444996007494; BERGER P, 1993, J CLIN ENDOCR METAB, V77, P347, DOI 10.1210/jc.77.2.347; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BRUNGER AT, 1988, XPLOR REFERENCE MANU; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Davies C, 1997, ACTA CRYSTALLOGR D, V53, P186, DOI 10.1107/S0907444996012048; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Fotinou C, 1998, ACTA CRYSTALLOGR D, V54, P405, DOI 10.1107/S0907444997011074; HUSSA RO, 1981, LIGAND REV S2, V3, P6; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABAT EA, 1991, 913242 NIH; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LAPTHORN AJ, 1994, NATURE, V369, P455, DOI 10.1038/369455a0; MacCallum RM, 1996, J MOL BIOL, V262, P732, DOI 10.1006/jmbi.1996.0548; MANN K, 1983, CANCER, V52, P654, DOI 10.1002/1097-0142(19830815)52:4<654::AID-CNCR2820520415>3.0.CO;2-S; MARIUZZA RA, 1994, RES IMMUNOL, V145, P70, DOI 10.1016/S0923-2494(94)80048-0; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; Mikol V, 1996, ACTA CRYSTALLOGR D, V52, P534, DOI 10.1107/S0907444996000704; MORGAN FJ, 1975, J BIOL CHEM, V250, P5247; Murshudov GN, 1996, P CCP4 STUDY WEEKEND, P93; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OTWINOWSKI Z, 1992, DATA COLLECTION PROC, P56; Padlan EA, 1996, ADV PROTEIN CHEM, V49, P57, DOI 10.1016/S0065-3233(08)60488-X; PADLAN EA, 1995, FASEB J, V9, P133, DOI 10.1096/fasebj.9.1.7821752; PADLAN EA, 1990, PROTEINS, V7, P112, DOI 10.1002/prot.340070203; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; RYAN RJ, 1987, RECENT PROG HORM RES, V43, P383; Shirai H, 1996, FEBS LETT, V399, P1, DOI 10.1016/S0014-5793(96)01252-5; STANFIELD RL, 1990, SCIENCE, V248, P712, DOI 10.1126/science.2333521; VARGASMADRAZO E, 1995, J MOL BIOL, V254, P497, DOI 10.1006/jmbi.1995.0633; WEBSTER DM, 1994, CURR OPIN STRUC BIOL, V4, P123, DOI 10.1016/S0959-440X(94)90070-1; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; WU TT, 1993, PROTEINS, V16, P1, DOI 10.1002/prot.340160102	37	10	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22515	22518		10.1074/jbc.273.35.22515	http://dx.doi.org/10.1074/jbc.273.35.22515			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712877	hybrid			2022-12-27	WOS:000075616600053
J	Johanning, K; Juliano, MA; Juliano, L; Lazure, C; Lamango, NS; Steiner, DF; Lindberg, I				Johanning, K; Juliano, MA; Juliano, L; Lazure, C; Lamango, NS; Steiner, DF; Lindberg, I			Specificity of prohormone convertase 2 on proenkephalin and proenkephalin-related substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUENCHED FLUOROGENIC SUBSTRATE; HAMSTER OVARY CELLS; ENZYMATIC CHARACTERIZATION; PROCESSING ENZYME; HUMAN FURIN; AMINO-ACID; IN-VITRO; PROPROTEIN CONVERTASES; MOLECULAR-FORMS; RECOMBINANT PC1	In the central and peripheral nervous systems, the neuropeptide precursor proenkephalin must be endoproteolytically cleaved by enzymes known as prohormone convertases 1 and 2 (PC1 and PC2) to generate opioid-active enkephalins. In this study, we have investigated the specificity of recombinant mouse PC2 for proenkephalin-related internally quenched (IQ) peptides, for methylcoumarin amide-based fluorogenic peptides, and for recombinant rat proenkephalin. IQ peptides exhibited specificity constants (k(cat)/K-m) between 9.4 x 10(4) M-1 s(-1)(Abz-Val-Pro-Arg-Met-Glu-Lys-Arg-Tyr-Gly-Gly-Phe-Met-Gln-EDDnp; where Abz is ortho-aminobenzoic acid and EDDnp is N-(2,4-dinitrophenyl)ethylenediamine)) and 0.24 x 10(4) M-1 s(-1) (Abz-Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-EDDnp), with the peptide B to Met-enk-Arg-Phe cleavage preferred (Met-enk is met-enkephalin). Fluorogenic substrates with P1, P2, and P4 basic amino acids were hydrolyzed with specificity constants ranging between 2.0 x 10(3) M-1 s(-1) (Ac-Orn-Ser-Lys-Arg-MCA; where MCA is methylcoumarin amide) and 1.8 x 10(4) M-1 s(-1) (<Glu-Arg-Thr-Lys-Arg-MCA; where <Glu is pyroglutamic acid). Substrates containing only a single basic residue were not appreciably hydrolyzed, and substrates lacking a P4 Arg exhibited k(cat) of less than 0.05 s(-1). Substitution of ornithine for Lys at the P4 position did not significantly affect the k(cat) but increased the K-m 2-fold. Data from both sets of fluorogenic substrates supported the contribution of a P4 Arg to PC2 preference. Analysis of proenkephalin reaction products using immunoblotting and gel permeation chromatography demonstrated that PC2 can directly cleave proenkephalin and that the generation of small opioid peptides from intermediates is mediated almost entirely by PC2 rather than by PC1, These results are in accord with the analysis of PC2 knock-out brains, in which the amounts of three mature enkephalins were depleted by more than three-quarters.	Louisiana State Univ, Med Ctr, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; Escola Paulista Med, Dept Biophys, BR-04044020 Sao Paulo, Brazil; Inst Rech Clin Montreal, Neuropeptide Struct & Metab Lab, Quebec City, PQ 2W 1R7, Canada; Univ Chicago, Sch Med, Howard Hughes Med Inst, Chicago, IL 60637 USA; Univ Chicago, Sch Med, Dept Biochem, Chicago, IL 60637 USA	Louisiana State University System; Universidade Federal de Sao Paulo (UNIFESP); Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Howard Hughes Medical Institute; University of Chicago; University of Chicago	Lindberg, I (corresponding author), Louisiana State Univ, Med Ctr, Sch Med, Dept Biochem, 1901 Perdido St, New Orleans, LA 70112 USA.	ilindb@lsumc.edu	Lamango, Nazarius/W-8459-2019; Juliano, Luiz/D-7204-2012; Lindberg, Iris/Q-3825-2019	Juliano, Luiz/0000-0002-5589-2822; 	NIDA NIH HHS [R56 DA005084, DA00204, DA05084, R01 DA005084] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA005084, R56DA005084] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ANGLIKER H, 1995, ANAL BIOCHEM, V224, P409, DOI 10.1006/abio.1995.1058; BAILYES EM, 1995, BIOCHEM J, V309, P587, DOI 10.1042/bj3090587; BASAK A, 1995, INT J PEPT PROT RES, V46, P228; BIRCH NP, 1986, J BIOL CHEM, V261, P2213; Brakch N, 1997, BIOCHEMISTRY-US, V36, P16309, DOI 10.1021/bi9714767; BRAKCH N, 1993, BIOCHEMISTRY-US, V32, P4925, DOI 10.1021/bi00069a029; BRENNER C, 1992, P NATL ACAD SCI USA, V89, P922, DOI 10.1073/pnas.89.3.922; BRESLIN MB, 1993, J BIOL CHEM, V268, P27084; CHRISTIE DL, 1991, J BIOL CHEM, V266, P15679; CHRISTIE DL, 1984, BIOCHEM BIOPH RES CO, V120, P650, DOI 10.1016/0006-291X(84)91305-6; Day R, 1998, J BIOL CHEM, V273, P829, DOI 10.1074/jbc.273.2.829; DAY R, 1992, MOL ENDOCRINOL, V6, P485, DOI 10.1210/me.6.3.485; DelNery E, 1997, BIOCHEM J, V323, P427, DOI 10.1042/bj3230427; DUPUY A, 1994, FEBS LETT, V337, P60, DOI 10.1016/0014-5793(94)80630-6; FRIEDMAN TC, 1994, ENDOCRINOLOGY, V135, P854, DOI 10.1210/en.135.3.854; FRIEDMAN TC, 1995, ARCH BIOCHEM BIOPHYS, V316, P5, DOI 10.1006/abbi.1995.1002; Furuta M, 1998, J BIOL CHEM, V273, P3431, DOI 10.1074/jbc.273.6.3431; Furuta M, 1997, P NATL ACAD SCI USA, V94, P6646, DOI 10.1073/pnas.94.13.6646; GIRAUD P, 1981, NEUROPEPTIDES, V1, P237, DOI 10.1016/0143-4179(81)90002-0; HATSUZAWA K, 1992, J BIOL CHEM, V267, P16094; Hirata IY, 1995, LETT PEPT SCI, V1, P299, DOI DOI 10.1007/BF00119771; Hook VYH, 1996, ARCH BIOCHEM BIOPHYS, V328, P107, DOI 10.1006/abbi.1996.0149; JEAN F, 1995, BIOCHEM J, V307, P689, DOI 10.1042/bj3070689; JEAN F, 1993, BIOCHEM J, V292, P891, DOI 10.1042/bj2920891; JEAN F, 1995, J BIOL CHEM, V270, P19225, DOI 10.1074/jbc.270.33.19225; Johanning K, 1996, J NEUROCHEM, V66, P898; Johanning K, 1996, J BIOL CHEM, V271, P27871, DOI 10.1074/jbc.271.44.27871; Lamango NS, 1996, ARCH BIOCHEM BIOPHYS, V330, P238, DOI 10.1006/abbi.1996.0249; Lazure C, 1998, J BIOL CHEM, V273, P8572, DOI 10.1074/jbc.273.15.8572; Ledgerwood EC, 1996, BIOCHEM MOL BIOL INT, V39, P1167; LEDUC R, 1992, J BIOL CHEM, V267, P14304; LINDBERG I, 1984, BRAIN RES, V299, P73, DOI 10.1016/0006-8993(84)90789-3; LINDBERG I, 1990, ENDOCRINOLOGY, V126, P480, DOI 10.1210/endo-126-1-480; LINDBERG I, 1986, BIOCHEM BIOPH RES CO, V139, P1024, DOI 10.1016/S0006-291X(86)80280-7; LINDBERG I, 1992, J NEUROCHEM, V58, P448, DOI 10.1111/j.1471-4159.1992.tb09742.x; LINDBERG I, 1991, ENDOCRINOLOGY, V128, P1849, DOI 10.1210/endo-128-4-1849; MAINS RE, 1990, FRONT NEUROENDOCRIN, V11, P52; MATHIS JP, 1992, ENDOCRINOLOGY, V131, P2287, DOI 10.1210/en.131.5.2287; MATTHEWS DJ, 1994, PROTEIN SCI, V3, P1197, DOI 10.1002/pro.5560030805; MATTHEWS G, 1994, J BIOL CHEM, V269, P588; MOCCHETTI I, 1984, EUR J PHARMACOL, V106, P427, DOI 10.1016/0014-2999(84)90734-9; NILLNI EA, 1995, J NEUROCHEM, V65, P2462; Rockwell NC, 1997, BIOCHEMISTRY-US, V36, P1912, DOI 10.1021/bi961779l; ROEBROEK AJM, 1994, BIOCHIMIE, V76, P210, DOI 10.1016/0300-9084(94)90148-1; ROTHENBERG ME, 1995, J BIOL CHEM, V270, P10136, DOI 10.1074/jbc.270.17.10136; Rouille Y, 1997, FEBS LETT, V413, P119, DOI 10.1016/S0014-5793(97)00892-2; ROUILLE Y, 1995, FRONT NEUROENDOCRIN, V16, P322, DOI 10.1006/frne.1995.1012; RUFAUT NW, 1993, J BIOL CHEM, V268, P20291; SEIDAH NG, 1990, DNA CELL BIOL, V9, P415, DOI 10.1089/dna.1990.9.415; SIEZEN RJ, 1994, EUR J BIOCHEM, V222, P255, DOI 10.1111/j.1432-1033.1994.tb18864.x; UDENFRIEND S, 1983, ARCH BIOCHEM BIOPHYS, V221, P309, DOI 10.1016/0003-9861(83)90149-2; Wang WG, 1997, BIOCHEM BIOPH RES CO, V231, P149, DOI 10.1006/bbrc.1997.6065; YI Z, 1993, J BIOL CHEM, V268, P5615; ZHOU A, 1994, J BIOL CHEM, V269, P17440; ZHOU Y, 1994, J BIOL CHEM, V269, P18408	55	91	91	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22672	22680		10.1074/jbc.273.35.22672	http://dx.doi.org/10.1074/jbc.273.35.22672			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712897	hybrid			2022-12-27	WOS:000075616600073
J	Heiska, L; Alfthan, K; Gronholm, M; Vilja, P; Vaheri, A; Carpen, O				Heiska, L; Alfthan, K; Gronholm, M; Vilja, P; Vaheri, A; Carpen, O			Association of ezrin with intercellular adhesion molecule-1 and -2 (ICAM-1 and ICAM-2) - Regulation by phosphatidylinositol 4,5-bisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING-SITE; ENDOTHELIAL-CELLS; ALPHA-ACTININ; INTRAMOLECULAR ASSOCIATION; INFLAMMATORY CYTOKINES; EXTRACELLULAR-MATRIX; SIGNALING PATHWAY; KINASE SUBSTRATE; MEMBRANE-PROTEIN; PLASMA-MEMBRANE	Ezrin is a cytoplasmic linker molecule between plasma membrane components and the actin-containing cytoskeleton. We studied whether ezrin is associated with intercellular adhesion molecule (ICAM)-1, 2, and -3. In transfected cells, ICAM-1 and ICAM-2 colocalized with ezrin in microvillar projections, whereas an ICAM-2 construct attached to cell membrane via a glycophosphatidyl-inositol anchor was uniformly distributed on the cell surface. An interaction of ICAM-2 and ezrin was seen by affinity precipitation, microtiter binding assay, coimmunoprecipitation, and surface plasmon resonance methods. The calculated K-D, value was 3.3 x 10(-7) M. Phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2) induced an interaction of ezrin and ICAM-1 and enhanced the interaction of ezrin and ICAM-2, but ICAM-3 did not bind ezrin even in the presence of PtdIns(4,5)P-2. PtdIns(4,5)P-2 was shown to bind to cytoplasmic tails of ICAM-1 and ICAM-2, which are the first adhesion proteins demonstrated to interact with PtdIns(4,5)P-2. The results indicate an interaction of ezrin with ICAM-1 and ICAM-2 and suggest a regulatory role of phosphoinositide signaling pathways in regulation of ICAM-ezrin interaction.	Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland; Univ Helsinki, Haartman Inst, Dept Virol, FIN-00014 Helsinki, Finland; VTT Biotechnol & Food Res, FIN-02044 Espoo, Finland; Univ Tampere, Sch Med, FIN-33101 Tampere, Finland	University of Helsinki; University of Helsinki; VTT Technical Research Center Finland; Tampere University	Carpen, O (corresponding author), Univ Helsinki, Haartman Inst, Dept Pathol, POB 21 Haartmanink 3, FIN-00014 Helsinki, Finland.		Vaheri, Antti/AAV-1523-2020; Gronholm, Mikaela/B-4225-2010	Gronholm, Mikaela/0000-0002-2378-8924				ANDREOLI C, 1994, J CELL SCI, V107, P2509; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BERRYMAN M, 1995, J CELL BIOL, V131, P1231, DOI 10.1083/jcb.131.5.1231; BERRYMAN M, 1993, J CELL SCI, V105, P1025; Bohling T, 1996, AM J PATHOL, V148, P367; BRETSCHER A, 1983, J CELL BIOL, V97, P425, DOI 10.1083/jcb.97.2.425; BRETSCHER A, 1989, J CELL BIOL, V108, P921, DOI 10.1083/jcb.108.3.921; CAMPANERO MR, 1994, J CELL BIOL, V127, P867, DOI 10.1083/jcb.127.3.867; CARPEN O, 1992, J CELL BIOL, V118, P1223, DOI 10.1083/jcb.118.5.1223; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; DEFOUGEROLLES AR, 1994, J EXP MED, V179, P619, DOI 10.1084/jem.179.2.619; DEFOUGEROLLES AR, 1991, J EXP MED, V174, P253, DOI 10.1084/jem.174.1.253; DELPOZO MA, 1995, J CELL BIOL, V131, P495, DOI 10.1083/jcb.131.2.495; DIACOVO TG, 1994, J CLIN INVEST, V94, P1243, DOI 10.1172/JCI117442; DIVECHA N, 1995, CELL, V80, P269, DOI 10.1016/0092-8674(95)90409-3; DUSTIN ML, 1986, J IMMUNOL, V137, P245; FAWCETT J, 1992, NATURE, V360, P481, DOI 10.1038/360481a0; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; GARY R, 1993, P NATL ACAD SCI USA, V90, P10846, DOI 10.1073/pnas.90.22.10846; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; GILMORE AP, 1992, J CELL SCI, V103, P719; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Glaser M, 1996, J BIOL CHEM, V271, P26187, DOI 10.1074/jbc.271.42.26187; GOULD KL, 1989, EMBO J, V8, P4133, DOI 10.1002/j.1460-2075.1989.tb08598.x; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Heiska L, 1996, J BIOL CHEM, V271, P26214, DOI 10.1074/jbc.271.42.26214; Helander TS, 1996, NATURE, V382, P265, DOI 10.1038/382265a0; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; JANMEY PA, 1989, J BIOL CHEM, V264, P4825; JANMEY PA, 1992, J BIOL CHEM, V267, P11818; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; LI R, 1993, J BIOL CHEM, V268, P17513; Lu PJ, 1997, J BIOL CHEM, V272, P466; Mackay DJG, 1997, J CELL BIOL, V138, P927, DOI 10.1083/jcb.138.4.927; McNamee HP, 1996, EXP CELL RES, V224, P116, DOI 10.1006/excr.1996.0118; NIGGLI V, 1995, FEBS LETT, V376, P172, DOI 10.1016/0014-5793(95)01270-1; NORTAMO P, 1991, EUR J IMMUNOL, V21, P2629, DOI 10.1002/eji.1830211049; NORTAMO P, 1991, J IMMUNOL, V146, P2530; Nunomura W, 1997, J BIOL CHEM, V272, P30322, DOI 10.1074/jbc.272.48.30322; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; PAKKANEN R, 1988, EUR J CELL BIOL, V46, P435; PAKKANEN R, 1988, J CELL BIOCHEM, V38, P65, DOI 10.1002/jcb.240380107; Patey N, 1996, AM J PATHOL, V148, P465; PESTONJAMASP K, 1995, MOL BIOL CELL, V6, P247, DOI 10.1091/mbc.6.3.247; ROTHLEIN R, 1988, J IMMUNOL, V141, P1665; SAMSON ML, 1989, CELL, V57, P1045, DOI 10.1016/0092-8674(89)90342-5; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; Serrador JM, 1997, J CELL BIOL, V138, P1409, DOI 10.1083/jcb.138.6.1409; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; TIISALA S, 1994, SCAND J IMMUNOL, V39, P249, DOI 10.1111/j.1365-3083.1994.tb03368.x; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; TSUKITA S, 1997, CURR OPIN CELL BIOL, V9, P79; TURUNEN O, 1989, J BIOL CHEM, V264, P16727; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; Vaheri A, 1997, CURR OPIN CELL BIOL, V9, P659, DOI 10.1016/S0955-0674(97)80119-6; VAZEUX R, 1992, NATURE, V360, P485, DOI 10.1038/360485a0; Weekes J, 1996, BIOCHEM J, V314, P827, DOI 10.1042/bj3140827; Xian WJ, 1995, BIOPHYS J, V69, P2695, DOI 10.1016/S0006-3495(95)80140-2; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; YU FX, 1992, J BIOL CHEM, V267, P14616; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A	62	271	276	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21893	21900		10.1074/jbc.273.34.21893	http://dx.doi.org/10.1074/jbc.273.34.21893			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705328	hybrid			2022-12-27	WOS:000075492600062
J	Du, M; Sansores-Garcia, L; Zu, ZF; Wu, KKY				Du, M; Sansores-Garcia, L; Zu, ZF; Wu, KKY			Cloning and expression analysis of a novel salicylate suppressible gene, Hs-CUL-3, a member of cullin/Cdc53 family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; KAPPA-B; F-BOX; INHIBITION; PROTEINS; COMPLEX; CYCLOOXYGENASE-2; INFLAMMATION; TRANSLATION; TRANSITION	By using a mRNA differential display technique to search for salicylate suppressible genes, we identified a cDNA in human foreskin fibroblasts, which by Gen-Bank(TM) DNA data base search shows sequence homology to the recently reported cullin/Cdc53 (CUL) family genes, especially CUL-3, We have cloned the full-length human CUL-3 (Hs-CUL-3) cDNA, It encodes a 768-amino acid polypeptide and has a predicted molecular weight of 88,939, The amino acid sequence of Hs-CUL-3 shows 46% homology to that of its Caenorhabditis elegans ortholog, Ce-CUL-3, and 27 and 23% to that of Hs-CUL-1 and Hs-CUL-2, respectively. Northern blot analysis showed that phorbol 12-myristate 13-acetate increased the expression of Hs-CUL-3 mRNA in a concentration- and time-dependent manner, and this increase was inhibited by sodium salicylate, Hs-CUL-3 widely expressed in human tissues and its expression in cultured COLO205 colon cancer cells was increased when compared with that in normal colon cells, It is Likely that Hs-CUL-3 is involved in cell proliferation control.	Univ Texas, Hlth Sci Ctr, Sch Med, Div Hematol, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Sch Med, Vasc Biol Res Ctr, Houston, TX 77030 USA; Acad Sinica, Inst Biomed Sci, Vasc Biol Res Program, Taipei 11529, Taiwan	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Academia Sinica - Taiwan	Wu, KKY (corresponding author), Univ Texas, Hlth Sci Ctr, Sch Med, Div Hematol, 6431 Fannin,MSB 5-016, Houston, TX 77030 USA.		Wu, Kenneth Kun-Yu/B-1070-2010	Sansores-Garcia, Leticia/0000-0003-2510-225X	NHLBI NIH HHS [HL-50675] Funding Source: Medline; NINDS NIH HHS [NS-23327] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS023327] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BARRAL Y, 1995, GENE DEV, V9, P399, DOI 10.1101/gad.9.4.399; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Lisztwan J, 1998, EMBO J, V17, P368, DOI 10.1093/emboj/17.2.368; Lonergan KM, 1998, MOL CELL BIOL, V18, P732, DOI 10.1128/MCB.18.2.732; Mathias N, 1996, MOL CELL BIOL, V16, P6634; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Pause A, 1997, P NATL ACAD SCI USA, V94, P2156, DOI 10.1073/pnas.94.6.2156; Pierce JW, 1996, J IMMUNOL, V156, P3961; Schwenger P, 1998, MOL CELL BIOL, V18, P78, DOI 10.1128/MCB.18.1.78; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; Sheng HM, 1997, J CLIN INVEST, V99, P2254, DOI 10.1172/JCI119400; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; VANE JR, 1994, P NATL ACAD SCI USA, V91, P2046, DOI 10.1073/pnas.91.6.2046; Willems AR, 1996, CELL, V86, P453, DOI 10.1016/S0092-8674(00)80118-X; Yu HT, 1998, SCIENCE, V279, P1219, DOI 10.1126/science.279.5354.1219; Zachariae W, 1998, SCIENCE, V279, P1216, DOI 10.1126/science.279.5354.1216; ZEMBOWICZ A, 1995, J BIOL CHEM, V270, P17006, DOI 10.1074/jbc.270.28.17006	25	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24289	24292		10.1074/jbc.273.38.24289	http://dx.doi.org/10.1074/jbc.273.38.24289			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733711	hybrid			2022-12-27	WOS:000076007300003
J	Efimova, T; LaCelle, P; Welter, JF; Eckert, RL				Efimova, T; LaCelle, P; Welter, JF; Eckert, RL			Regulation of human involucrin promoter activity by a protein kinase C, Ras, MEKK1, MEK3, p38/RK, AP1 signal transduction pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUN ACTIVATION DOMAIN; NERVE GROWTH-FACTOR; NIH 3T3 CELLS; MAP KINASE; SUBSTRATE-SPECIFICITY; SUSTAINED ACTIVATION; CELLULAR STRESSES; GENE-EXPRESSION; PLASMA-MEMBRANE; PC12 CELLS	Involucrin is a marker of keratinocyte terminal differentiation. Our previous studies show that involucrin mRNA levels are increased by the keratinocyte differentiating agent, 12-O-tetradecanoylphorbol-13-acetate (TPA) (Welter, J.F., Crish, J. F., Agarwal, C., and Eckert, R. L. (1995) J. Biol. Chem, 270, 12614-12622). We now study the signaling cascade responsible for this regulation. Protein kinase C and tyrosine kinase inhibitors inhibit both the TPA-dependent mRNA increase and the TPA-dependent increase in hINV promoter activity. The relevant response element is located within the promoter proximal regulatory region and includes an AP1 site, AP1-1. Co-transfection of the hINV promoter with dominant negative forms of Ras, MEKK1, MEK1, MEK7, MEK3, p38/RK, and c-Jun inhibit the TPA-dependent increase. Wild type MEKK1 enhances promoter activity and the activity can be inhibited by dominant negative MEKK1, MEK1, MEK7, MEK3, p38/RK, and c-Jun. In contrast, wild type Raf-1, ERK1, ERK2, MEK4, or JNK1 produced no change in activity and the dominant negative forms of these kinases failed to suppress TPA-dependent transcription. Treatment with an S6 kinase (S6K) inhibitor, or transfection with constitutively active S6K produced relatively minor changes in promoter activity, ruling out a regulatory role for S6K. These results suggest that activation of involucrin transcription involves a pathway that includes protein kinase C, Pas, MEKK1, MEK3, and p38/RK. Additional pathways that transfer MEKK1 activation via MEK1 and MEK7 also may function, but the downstream targets of these kinases need to be identified. AP1 transcription factors appear to be the ultimate target of this regulation.	Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Dermatol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Reprod Biol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Oncol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Orthoped, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Eckert, RL (corresponding author), Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Rm E532, Cleveland, OH 44106 USA.			Efimova, Tatiana/0000-0002-9869-1545	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR039750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007678] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR39750] Funding Source: Medline; NIDDK NIH HHS [DK07678] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; BALLOU LM, 1991, NATURE, V349, P348, DOI 10.1038/349348a0; Banks EB, 1998, BIOCHEM J, V331, P61, DOI 10.1042/bj3310061; BANKSSCHLEGEL S, 1981, J CELL BIOL, V90, P732, DOI 10.1083/jcb.90.3.732; BROWN PH, 1994, ONCOGENE, V9, P791; BROWN PH, 1993, ONCOGENE, V8, P877; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; CARROLL JM, 1992, J CELL SCI, V103, P925; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; CRISH JF, 1993, DIFFERENTIATION, V53, P191, DOI 10.1111/j.1432-0436.1993.tb00708.x; Cuenda A, 1997, EMBO J, V16, P295, DOI 10.1093/emboj/16.2.295; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; ECKERT RL, 1989, ENVIRON HEALTH PERSP, V80, P109, DOI 10.2307/3430736; ECKERT RL, 1993, J INVEST DERMATOL, V100, P613, DOI 10.1111/1523-1747.ep12472288; Eckert RL, 1997, J INVEST DERMATOL, V109, P501, DOI 10.1111/1523-1747.ep12336477; Eckert RL, 1996, CELL DEATH DIFFER, V3, P373; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; ECKERT RL, 1986, CELL, V46, P583, DOI 10.1016/0092-8674(86)90884-6; Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; GILFIX BM, 1985, J BIOL CHEM, V260, P4026; Goedert M, 1997, EMBO J, V16, P3563, DOI 10.1093/emboj/16.12.3563; Gredinger E, 1998, J BIOL CHEM, V273, P10436, DOI 10.1074/jbc.273.17.10436; GRUDA MC, 1994, ONCOGENE, V9, P2537; Guan ZH, 1998, J BIOL CHEM, V273, P12901, DOI 10.1074/jbc.273.21.12901; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hazzalin CA, 1997, ONCOGENE, V15, P2321, DOI 10.1038/sj.onc.1201403; HERMAN WH, 1995, J BIOL CHEM, V270, P11654, DOI 10.1074/jbc.270.19.11654; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Holland PM, 1997, J BIOL CHEM, V272, P24994, DOI 10.1074/jbc.272.40.24994; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P533, DOI 10.1006/bbrc.1997.6849; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LANGECARTER CA, 1994, SCIENCE, V265, P1458, DOI 10.1126/science.8073291; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LaPres JJ, 1996, J BIOL CHEM, V271, P23154, DOI 10.1074/jbc.271.38.23154; LEBOWITZ JH, 1989, GENE DEV, V3, P1625, DOI 10.1101/gad.3.10.1625; Lechner C, 1996, P NATL ACAD SCI USA, V93, P4355, DOI 10.1073/pnas.93.9.4355; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; LopezBayghen E, 1996, J BIOL CHEM, V271, P512, DOI 10.1074/jbc.271.1.512; Mahalingam M, 1996, MOL CELL BIOL, V16, P405; Marais R, 1998, SCIENCE, V280, P109, DOI 10.1126/science.280.5360.109; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Moriguchi T, 1997, EMBO J, V16, P7045, DOI 10.1093/emboj/16.23.7045; NIXON JS, 1992, BIOCHEM SOC T, V20, P419, DOI 10.1042/bst0200419; Racke FK, 1997, J BIOL CHEM, V272, P23366, DOI 10.1074/jbc.272.37.23366; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; RICE RH, 1992, MONOGR NATL CANC I, P87; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; TAKAHASHI H, 1993, J INVEST DERMATOL, V100, P10, DOI 10.1111/1523-1747.ep12349867; THOMAS G, 1993, BIOCHEM SOC T, V21, P901, DOI 10.1042/bst0210901; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; WARHOL MJ, 1985, J HISTOCHEM CYTOCHEM, V33, P141, DOI 10.1177/33.2.2578499; Welter JF, 1996, J BIOL CHEM, V271, P14727, DOI 10.1074/jbc.271.25.14727; WELTER JF, 1995, J BIOL CHEM, V270, P12614, DOI 10.1074/jbc.270.21.12614; XU SC, 1995, P NATL ACAD SCI USA, V92, P6808, DOI 10.1073/pnas.92.15.6808; Xu SC, 1996, P NATL ACAD SCI USA, V93, P5291, DOI 10.1073/pnas.93.11.5291; YAN MH, 1994, NATURE, V372, P798; YAN MH, 1994, J BIOL CHEM, V269, P19067; Yao ZB, 1997, J BIOL CHEM, V272, P32378, DOI 10.1074/jbc.272.51.32378	82	143	145	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24387	24395		10.1074/jbc.273.38.24387	http://dx.doi.org/10.1074/jbc.273.38.24387			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733728	hybrid			2022-12-27	WOS:000076007300020
J	Miyazawa, K; Mori, A; Miyata, H; Akahane, M; Ajisawa, Y; Okudaira, H				Miyazawa, K; Mori, A; Miyata, H; Akahane, M; Ajisawa, Y; Okudaira, H			Regulation of interleukin-beta-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by p38 mitogen-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DEGRADATION; TERNARY COMPLEX FACTORS; NECROSIS-FACTOR-ALPHA; UA-RICH SEQUENCES; MAP KINASE; RHEUMATOID-ARTHRITIS; CELLULAR STRESSES; SUBSTRATE-SPECIFICITY; SYNOVIAL FIBROBLASTS; PYRIDINYL IMIDAZOLES	Involvement of p38 mitogen-activated protein (MAP) kinase in interleukin (IL)-6 gene expression of human fibroblast-like synoviocytes (FLSs) was assessed. p38 MAP kinase was constitutively expressed in human FLSs and activated in response to IL-1 beta. A pyridinylimidazole compound, SB203580, inhibited p38 MAP kinase activity in vivo, since the activity of MAPKAP kinase-2 (a substrate of p38 MAP kinase) in IL-1 beta-stimulated FLSs was totally suppressed by it. SB203580 concentration-dependently inhibited protein production and gene expression of IL-6 by human FLSs. The effect of SB203580 was dependent on de novo protein synthesis. SB203580 significantly reduced the stability of IL-6 mRNA without affecting the rate of IL-6 gene transcription. Here, we provide evidence that p38 MAP kinase is activated in response to IL-1 beta in human FLSs and is involved in IL-6 synthesis by stabilizing IL-6 mRNA.	Kissei Pharmaceut Co Ltd, Cent Res Labs, Matsumoto, Nagano 3998304, Japan; Natl Sagamihara Hosp, Clin Res Ctr Allergy & Rheumatol, Kanagawa 2888522, Japan; Univ Tokyo, Fac Med, Dept Med & Phys Therapy, Tokyo 1130033, Japan	Kissei Pharmaceutical Co Ltd; University of Tokyo	Miyazawa, K (corresponding author), Kissei Pharmaceut Co Ltd, Cent Res Labs, 4365-1 Kashiwabara, Matsumoto, Nagano 3998304, Japan.	keijimiya@aol.com						ADAMS JL, 1993, Patent No. 14081; AKIRA S, 1993, ADV IMMUNOL, V56, P1; Badger AM, 1996, J PHARMACOL EXP THER, V279, P1453; BAYAERT R, 1996, EMBO J, V15, P1914; Blanque R, 1997, DRUG EXP CLIN RES, V23, P63; BROZIK M, 1992, J RHEUMATOL, V19, P63; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; CHIN JE, 1990, ARTHRITIS RHEUM, V33, P1776, DOI 10.1002/art.1780331204; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Cuenda A, 1997, EMBO J, V16, P295, DOI 10.1093/emboj/16.2.295; DeMaria CT, 1996, J BIOL CHEM, V271, P12179, DOI 10.1074/jbc.271.21.12179; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; FIRESTEIN GS, 1990, J IMMUNOL, V144, P3347; Firestein GS, 1996, ARTHRITIS RHEUM, V39, P1781, DOI 10.1002/art.1780391103; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Goedert M, 1997, FEBS LETT, V409, P57, DOI 10.1016/S0014-5793(97)00483-3; Goedert M, 1997, EMBO J, V16, P3563, DOI 10.1093/emboj/16.12.3563; Griswold DE, 1996, PHARM COMMUN, V7, P323; GUERNE PA, 1989, J CLIN INVEST, V83, P585, DOI 10.1172/JCI113921; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; GUY GR, 1991, J BIOL CHEM, V266, P14343; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; HIRANO T, 1990, IMMUNOL TODAY, V11, P443, DOI 10.1016/0167-5699(90)90173-7; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; HOUSSIAU FA, 1988, ARTHRITIS RHEUM, V31, P784, DOI 10.1002/art.1780310614; Ivashkiv LB, 1996, ADV IMMUNOL, V63, P337, DOI 10.1016/S0065-2776(08)60859-7; Janknecht R, 1997, EMBO J, V16, P1620, DOI 10.1093/emboj/16.7.1620; KISHIMOTO T, 1992, SCIENCE, V258, P593, DOI 10.1126/science.1411569; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; KRUYS V, 1994, BIOCHIMIE, V76, P862, DOI 10.1016/0300-9084(94)90188-0; KRUYS V, 1989, SCIENCE, V245, P852, DOI 10.1126/science.2672333; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P533, DOI 10.1006/bbrc.1997.6849; Lee JC, 1996, J LEUKOCYTE BIOL, V59, P152, DOI 10.1002/jlb.59.2.152; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MACNAUL KL, 1990, J BIOL CHEM, V265, P17238; MAINI RN, 1995, IMMUNOL REV, V144, P195, DOI 10.1111/j.1600-065X.1995.tb00070.x; MANICOURT DH, 1995, ARTHRITIS RHEUM, V38, P1031, DOI 10.1002/art.1780380803; MIHARA M, 1995, BRIT J RHEUMATOL, V34, P321; Miyazawa K, 1996, BRIT J PHARMACOL, V118, P915, DOI 10.1111/j.1476-5381.1996.tb15486.x; Miyazawa K, 1998, AM J PATHOL, V152, P793; Miyazawa K, 1998, J BIOL CHEM, V273, P7620, DOI 10.1074/jbc.273.13.7620; ONEILL LAJ, 1995, BBA-MOL CELL RES, V1266, P31, DOI 10.1016/0167-4889(94)00217-3; Paul A, 1997, CELL SIGNAL, V9, P403, DOI 10.1016/S0898-6568(97)00042-9; Price MA, 1996, EMBO J, V15, P6552, DOI 10.1002/j.1460-2075.1996.tb01046.x; PRICHETT W, 1995, J INFLAMM, V45, P97; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; RAJAGOPALAN LE, 1994, J BIOL CHEM, V269, P23882; Ridley SH, 1997, J IMMUNOL, V158, P3165; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Sirenko OI, 1997, MOL CELL BIOL, V17, P3898, DOI 10.1128/MCB.17.7.3898; Stein B, 1997, J BIOL CHEM, V272, P19509, DOI 10.1074/jbc.272.31.19509; SUTHERLAND GR, 1988, HUM GENET, V79, P335; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Wang XS, 1997, J BIOL CHEM, V272, P23668, DOI 10.1074/jbc.272.38.23668; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; WENDLING D, 1993, J RHEUMATOL, V20, P259; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360; YASUKAWA K, 1987, EMBO J, V6, P2939, DOI 10.1002/j.1460-2075.1987.tb02598.x; YOSHIZAKI K, 1996, JPN SOC IMMUNOL, V26, pI115; YOUNG P, 1993, AGENTS ACTIONS, V39, pC67, DOI 10.1007/BF01972723; ZERVOS AS, 1995, P NATL ACAD SCI USA, V92, P10531, DOI 10.1073/pnas.92.23.10531	67	196	204	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24832	24838		10.1074/jbc.273.38.24832	http://dx.doi.org/10.1074/jbc.273.38.24832			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733787	hybrid			2022-12-27	WOS:000076007300079
J	Casareno, RLB; Waggoner, D; Gitlin, JD				Casareno, RLB; Waggoner, D; Gitlin, JD			The copper chaperone CCS directly interacts with copper/zinc superoxide dismutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; P-TYPE ATPASES; HUMAN-CELLS; GENE; MUTATIONS; PROTEIN; DISEASE; MICE; DEGENERATION; HOMEOSTASIS	Dominantly inherited mutations in the gene encoding copper/zinc superoxide dismutase (SOD1) result in the fatal motor neuron disease familial amyotrophic lateral sclerosis (FALS), These mutations confer a gain-of-function to SOD1 with neuronal degeneration resulting from enhanced free radical generating activity of the copper present in the mutant enzyme. The delivery of copper to SOD1 is mediated through a soluble factor identified as the copper chaperone for SOD1 (CCS). Amino acid sequence alignment of SOD1 and CCS reveals a striking homology with conservation of the amino acids essential for mediating SOD1 homodimerization. Here we demonstrate that CCS and SOD1 directly interact in vitro and in vivo and that this interaction is mediated via the homologous domains in each protein. Importantly, CCS interacts not only with wild-type SOD1 but also with SOD1 containing the common missense mutations resulting in FALS. Our findings therefore reveal a common mechanism whereby different SOD1 FALS mutants may result in neuronal injury and suggest a novel therapeutic approach in patients affected by this fatal disease.	Washington Univ, Sch Med, Edward Mallinckrodt Dept Pediat, St Louis, MO 63110 USA	Washington University (WUSTL)	Gitlin, JD (corresponding author), St Louis Childrens Hosp, 1 Childrens Pl, St Louis, MO 63110 USA.	gitlin@kidsa1.wustl.edu			NIDDK NIH HHS [DK44464] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044464, R01DK044464] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; BRENNER AJ, 1995, ANAL BIOCHEM, V226, P80, DOI 10.1006/abio.1995.1194; CARRI MT, 1994, FEBS LETT, V356, P314, DOI 10.1016/0014-5793(94)01295-4; CHANG LY, 1988, J CELL BIOL, V107, P2169, DOI 10.1083/jcb.107.6.2169; Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361; CRAPO JD, 1992, P NATL ACAD SCI USA, V89, P10405, DOI 10.1073/pnas.89.21.10405; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Elgersma Y, 1996, BBA-REV BIOMEMBRANES, V1286, P269, DOI 10.1016/S0304-4157(96)00012-3; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Ho YS, 1998, J BIOL CHEM, V273, P7765, DOI 10.1074/jbc.273.13.7765; Hottinger AF, 1997, EUR J NEUROSCI, V9, P1548, DOI 10.1111/j.1460-9568.1997.tb01511.x; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Hung IH, 1998, J BIOL CHEM, V273, P1749, DOI 10.1074/jbc.273.3.1749; Klomp LWJ, 1997, J BIOL CHEM, V272, P9221, DOI 10.1074/jbc.272.14.9221; LIN SJ, 1995, P NATL ACAD SCI USA, V92, P3784, DOI 10.1073/pnas.92.9.3784; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Lyons TJ, 1996, P NATL ACAD SCI USA, V93, P12240, DOI 10.1073/pnas.93.22.12240; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Moreno S, 1997, J HISTOCHEM CYTOCHEM, V45, P1611, DOI 10.1177/002215549704501204; PUFAHL R, 1997, SCIENCE, V238, P853; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SIDDIQUE T, 1996, HUM MOL GENET, V271, P1406; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Solioz M, 1996, TRENDS BIOCHEM SCI, V21, P237; TAINER JA, 1983, NATURE, V306, P284, DOI 10.1038/306284a0; Valentine JS, 1997, SCIENCE, V278, P817, DOI 10.1126/science.278.5339.817; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Yamaguchi Y, 1996, P NATL ACAD SCI USA, V93, P14030, DOI 10.1073/pnas.93.24.14030; Yim MB, 1996, P NATL ACAD SCI USA, V93, P5709, DOI 10.1073/pnas.93.12.5709	34	190	197	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23625	23628		10.1074/jbc.273.37.23625	http://dx.doi.org/10.1074/jbc.273.37.23625			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726962	hybrid			2022-12-27	WOS:000075893100003
J	Grasso, L; Huang, MX; Sullivan, CD; Messler, CJ; Kiser, MB; Dragwa, CR; Holroyd, KJ; Renauld, JC; Levitt, RC; Nicolaides, NC				Grasso, L; Huang, MX; Sullivan, CD; Messler, CJ; Kiser, MB; Dragwa, CR; Holroyd, KJ; Renauld, JC; Levitt, RC; Nicolaides, NC			Molecular analysis of human interleukin-9 receptor transcripts in peripheral blood mononuclear cells - Identification of a splice variant encoding for a nonfunctional cell surface receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-9 RECEPTOR; PSEUDOAUTOSOMAL REGION; GENOMIC ORGANIZATION; B-LYMPHOCYTES; ALPHA CHAIN; GENE; ASTHMA; MURINE; LOCALIZATION; ACTIVATION	Genetic studies on mouse models of asthma have identified interleukin-9 (IL9) as a determining factor in controlling bronchial hyperresponsiveness, a hallmark of the disease. Recently, the human IL9 receptor (hIL9R) gene locus has also been implicated in determining susceptibility to bronchial hyperresponsiveness and asthma. in order to evaluate the structure and function of the encoded product, we analyzed receptor transcripts derived from peripheral blood mononuclear cells of 50 unrelated donors. Sequence analysis of time entire coding region identified a splice variant that contains an in frame deletion of a single residue at codon 173 (Delta Q). This variant could be permanently expressed in a cytokine-dependent murine T-cell line but lacked the ability to induce proliferation in response to human IL9. In situ analyses of cells expressing the wild-type and Delta Q receptors found both forms to be expressed at the cell surface, but the Delta Q receptor was unable to bind hIL9 and could not be recognized by N-terminal specific antibodies. These findings demonstrate that hIL9R Delta Q presents an altered structure and function and suggests its potential role in down-regulating IL9 signaling in effector cells and associated biological processes.	Magainin Pharmaceut Inc, Magainin Inst Mol Med, Plymouth Meeting, PA 19462 USA; Univ Catholique Louvain, Ludwig Inst Canc Res, B-1200 Brussels, Belgium; Univ Catholique Louvain, Expt Med Unit, B-1200 Brussels, Belgium	Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain	Nicolaides, NC (corresponding author), Magainin Pharmaceut Inc, Magainin Inst Mol Med, 5110 Campus Dr, Plymouth Meeting, PA 19462 USA.	nnicolaides@magainin.com	Renauld, Jean-Christophe/B-7268-2012	Renauld, Jean-Christophe/0000-0003-1736-2131; Holroyd, Kenneth/0000-0001-6050-3935				CHANG MS, 1994, BLOOD, V83, P3199; COFANO F, 1990, J BIOL CHEM, V265, P4064; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; DELPRETE GF, 1993, EUR J IMMUNOL, V23, P1445, DOI 10.1002/eji.1830230707; Demoulin JB, 1996, MOL CELL BIOL, V16, P4710; DESANCTIS G, 1997, NAT GENET, V11, P150; DONAHUE RE, 1990, BLOOD, V75, P2271; DUGAS B, 1993, EUR J IMMUNOL, V23, P1687, DOI 10.1002/eji.1830230743; EWART S, 1995, J APPL PHYSIOL, V79, P560, DOI 10.1152/jappl.1995.79.2.560; GARRONE P, 1991, EUR J IMMUNOL, V21, P1365, DOI 10.1002/eji.1830210606; GESSNER A, 1994, INFECT IMMUN, V62, P4112, DOI 10.1128/IAI.62.10.4112-4117.1994; GODFRAIND C, 1998, IN PRESS J IMMUNOL; Holgate ST, 1997, NAT GENET, V15, P227, DOI 10.1038/ng0397-227; HOLGATE ST, 1995, INT ARCH ALLERGY IMM, V107, P29, DOI 10.1159/000236921; HOPP RJ, 1990, AM REV RESPIR DIS, V141, P2, DOI 10.1164/ajrccm/141.1.2; Kammer W, 1996, J BIOL CHEM, V271, P23634, DOI 10.1074/jbc.271.39.23634; KERMOUNI A, 1995, GENOMICS, V29, P371, DOI 10.1006/geno.1995.9992; KIMURA Y, 1995, INT IMMUNOL, V7, P115, DOI 10.1093/intimm/7.1.115; LEVITT RC, 1988, FASEB J, V2, P2605, DOI 10.1096/fasebj.2.10.3384240; LEVITT RC, 1998, IN PRESS J ALLERG CL; Marsh DG, 1997, NAT GENET, V15, P389; MCFADDEN ER, 1992, NEW ENGL J MED, V327, P1928, DOI 10.1056/NEJM199212313272708; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; Nicolaides NC, 1997, P NATL ACAD SCI USA, V94, P13175, DOI 10.1073/pnas.94.24.13175; NICOLAIDES NC, 1995, GENOMICS, V30, P195, DOI 10.1006/geno.1995.9885; PETITFRERE C, 1993, IMMUNOLOGY, V79, P146; POSTMA DS, 1995, NEW ENGL J MED, V333, P894, DOI 10.1056/NEJM199510053331402; Reed R, 1996, CURR OPIN GENET DEV, V6, P215, DOI 10.1016/S0959-437X(96)80053-0; RENAULD JC, 1990, J IMMUNOL, V144, P4235; RENAULD JC, 1992, P NATL ACAD SCI USA, V89, P5690, DOI 10.1073/pnas.89.12.5690; RENAULD JC, 1994, ONCOGENE, V9, P1327; RENAULD JC, 1995, J LEUKOCYTE BIOL, V57, P353, DOI 10.1002/jlb.57.3.353; ROBINSON DS, 1992, NEW ENGL J MED, V326, P289; Ross RJM, 1997, MOL ENDOCRINOL, V11, P265, DOI 10.1210/me.11.3.265; SANGER JW, 1975, P NATL ACAD SCI USA, V72, P1913, DOI 10.1073/pnas.72.5.1913; STOECKERT CJ, 1990, EXP HEMATOL, V18, P1164; TAVERNIER J, 1992, P NATL ACAD SCI USA, V89, P7041, DOI 10.1073/pnas.89.15.7041; Vermeesch JR, 1997, HUM MOL GENET, V6, P1, DOI 10.1093/hmg/6.1.1; VRIZ S, 1992, MOL CELL BIOL, V12, P3548, DOI 10.1128/MCB.12.8.3548; WILLIAMS DE, 1990, BLOOD, V76, P906; Yang YZ, 1996, J BIOL CHEM, V271, P28235, DOI 10.1074/jbc.271.45.28235; YIN TG, 1995, J BIOL CHEM, V270, P20497, DOI 10.1074/jbc.270.35.20497; Zhu YX, 1997, J BIOL CHEM, V272, P21334, DOI 10.1074/jbc.272.34.21334	44	22	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24016	24024		10.1074/jbc.273.37.24016	http://dx.doi.org/10.1074/jbc.273.37.24016			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727018	hybrid			2022-12-27	WOS:000075893100059
J	Yan, J; Roy, S; Apolloni, A; Lane, A; Hancock, JF				Yan, J; Roy, S; Apolloni, A; Lane, A; Hancock, JF			Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISTINCT BINDING DOMAINS; PROTEIN-KINASE; PLASMA-MEMBRANE; PHOSPHATIDYLINOSITOL 3-KINASE; TYROSINE PHOSPHORYLATION; N-RAS; CELLS; 14-3-3-PROTEINS; ASSOCIATION; SIGNAL	Ha-, N-, and Ki-Ras are ubiquitously expressed in mammalian cells and can all interact with the same set of effector proteins. We show here, however, that in vivo there are marked quantitative differences in the ability of Ki- and Ha-Ras to activate Raf-1 and phosphoinositide 3-kinase, Thus, Ki-Ras both recruits Raf-1 to the plasma membrane more efficiently than Ha-Res and is a more potent activator of membrane-recruited Raf-1 than Ha-Res. in contrast, Ha-Bas is a more potent activator of phosphoinositide 3-kinase than Ki-Ras. interestingly, the ability of Ha-Ras to recruit Rak-1 to the plasma membrane is significantly increased when the Ba-Ras hypervariable region is shortened so that the spacing of the Ha-Ras GTPase domains from the inner surface of the plasma membrane mimicks that of Ki-Ras, Importantly, these data show for the first time that the activation of different Ras isoforms can have distinct biochemical consequences for the cell, The mutation of specific Ras isoforms in different human tumors can, therefore, also be rationalized.	Univ Queensland, Sch Med, Dept Pathol, Queensland Canc Fund Lab Expt Oncol, Brisbane, Qld 4006, Australia	University of Queensland	Hancock, JF (corresponding author), Univ Queensland, Sch Med, Dept Pathol, Queensland Canc Fund Lab Expt Oncol, Herston Rd, Brisbane, Qld 4006, Australia.		Yan, Jun/F-1224-2010	Yan, Jun/0000-0001-9617-0335; Hancock, John/0000-0003-0542-4710				AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BOS JL, 1989, CANCER RES, V49, P4682; CARROLL MP, 1994, J BIOL CHEM, V269, P1249; CLARK SF, 1988, J CELL BIOL, P1211; Drugan JK, 1996, J BIOL CHEM, V271, P233, DOI 10.1074/jbc.271.1.233; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; FANTL WJ, 1994, NATURE, V371, P612, DOI 10.1038/371612a0; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; FREED E, 1994, SCIENCE, V265, P1713, DOI 10.1126/science.8085158; FU H, 1994, SCIENCE, V266, P126, DOI 10.1126/science.7939632; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; GHOSH SJ, 1994, J BIOL CHEM, V269, P10000; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; HANCOCK JF, 1991, EMBO J, V10, P641, DOI 10.1002/j.1460-2075.1991.tb07992.x; HARA K, 1994, P NATL ACAD SCI USA, V91, P7415, DOI 10.1073/pnas.91.16.7415; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; HU P, 1994, MOL CELL BIOL, V14, P2577, DOI 10.1128/MCB.14.4.2577; HUANG DCS, 1993, MOL CELL BIOL, V13, P2420, DOI 10.1128/MCB.13.4.2420; IRIE K, 1994, SCIENCE, V265, P1716, DOI 10.1126/science.8085159; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; KIKUCHI A, 1994, MOL CELL BIOL, V14, P7483, DOI 10.1128/MCB.14.11.7483; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Kuriyama M, 1996, J BIOL CHEM, V271, P607, DOI 10.1074/jbc.271.2.607; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LI SF, 1995, EMBO J, V14, P685, DOI 10.1002/j.1460-2075.1995.tb07047.x; LUO Z, 1996, J NATURE, V383, P181; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; Mineo C, 1997, J BIOL CHEM, V272, P10345; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; PHILLIPS W, 1998, IN PRESS CANCER; Roy S, 1997, J BIOL CHEM, V272, P20139, DOI 10.1074/jbc.272.32.20139; Roy S, 1998, MOL CELL BIOL, V18, P3947, DOI 10.1128/MCB.18.7.3947; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; TRAVERSE S, 1993, ONCOGENE, V8, P3175; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; UMANOFF H, 1995, P NATL ACAD SCI USA, V92, P1709, DOI 10.1073/pnas.92.5.1709; VICIANA PR, 1996, EMBO J, V15, P2442; VICIANA PR, 1994, NATURE, V370, P527; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; WARTMANN M, 1994, J BIOL CHEM, V269, P6695; YAO B, 1995, NATURE, V378, P307, DOI 10.1038/378307a0	48	364	367	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24052	24056		10.1074/jbc.273.37.24052	http://dx.doi.org/10.1074/jbc.273.37.24052			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727023	hybrid			2022-12-27	WOS:000075893100064
J	del Arco, A; Satrustegui, J				del Arco, A; Satrustegui, J			Molecular cloning of Aralar, a new member of the mitochondrial carrier superfamily that binds calcium and is present in human muscle and brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWN FAT MITOCHONDRIA; ADP ATP TRANSLOCASE; TRANSPORT PROTEIN; SACCHAROMYCES-CEREVISIAE; STRUCTURAL RELATIONSHIP; UNCOUPLING PROTEIN; MAMMALIAN-CELLS; SEQUENCE; EXPRESSION; YEAST	We have identified a new calcium-dependent subfamily of mitochondrial carrier proteins with members in Saccharomyces cerevisiae, Caenorhabditis elegans, and various mammalian species. The members of this subfamily have a bipartite structure: a carboxyl-terminal half with the characteristic features of the mitochondrial solute carrier superfamily and an amino-terminal extension harboring various EF-hand domains. A member of this subfamily (that we have termed Aralar) was cloned from a human heart cDNA library. The corresponding cDNA comprises an open reading frame of 2037 base pairs encoding a polypeptide of 678 amino acids. The carboxyl-terminal half of Aralar (amino acids 321-678) has high similarity with the oxoglutarate, citrate, and adenine nucleotide carriers (28-29% identity), whereas the amino-terminal half (amino acids 1-320) contains three canonical EF-hands. Aralar amino-terminal half was shown to bind calcium by Ca-45(2+) overlay and calcium-dependent mobility shift assays. The sub cellular localization of the protein in COS cells transfected with Aralar was exclusively mitochondrial. Antibodies against Aralar amino-terminal fusion protein recognized a 70-kDa protein in brain mitochondrial fractions. Northern blot analysis showed that the protein was expressed in heart, brain, and skeletal muscle. The domain structure, mitochondrial localization, and presence in excitable tissues suggests a possible function of Aralar as calcium-dependent mitochondrial solute carrier.	Univ Autonoma Madrid, Fac Ciencias, CSIC, Ctr Biol Mol Severo Ochoa,Dept Biol Mol, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Satrustegui, J (corresponding author), Univ Autonoma Madrid, Fac Ciencias, CSIC, Ctr Biol Mol Severo Ochoa,Dept Biol Mol, E-28049 Madrid, Spain.		Satrustegui, Jorgina/R-6732-2019; del Arco, Araceli/R-5653-2019	del Arco, Araceli/0000-0002-6839-542X; Satrustegui Gil Delgado, Jorgina/0000-0003-3377-2667				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AQUILA H, 1982, H-S Z PHYSIOL CHEM, V363, P345; AQUILA H, 1985, EMBO J, V4, P2369, DOI 10.1002/j.1460-2075.1985.tb03941.x; BARRIO R, 1994, BIOCHEM J, V302, P237, DOI 10.1042/bj3020237; Chubet RG, 1996, BIOTECHNIQUES, V20, P136; DELALUNA S, 1992, METHOD ENZYMOL, V216, P376; Dyer JM, 1996, J CELL BIOL, V133, P269, DOI 10.1083/jcb.133.2.269; ElMoualij B, 1997, YEAST, V13, P573, DOI 10.1002/(SICI)1097-0061(199705)13:6<573::AID-YEA107>3.0.CO;2-I; Hernando R, 1997, EUR J BIOCHEM, V243, P460, DOI 10.1111/j.1432-1033.1997.0460a.x; Kakhniashvili D, 1997, J BIOL CHEM, V272, P4516, DOI 10.1074/jbc.272.7.4516; KAPLAN RS, 1993, J BIOENERG BIOMEMBR, V25, P503, DOI 10.1007/BF01108407; KAWASAKI H, 1994, PROTEIN PROFILE, V1, P343; KLINGENBERG M, 1989, ARCH BIOCHEM BIOPHYS, V270, P1, DOI 10.1016/0003-9861(89)90001-5; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KRAMER R, 1989, BIOCHIM BIOPHYS ACTA, V974, P1, DOI 10.1016/S0005-2728(89)80160-4; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Leiper JM, 1996, J CELL BIOL, V135, P939, DOI 10.1083/jcb.135.4.939; LEVITSKY DO, 1994, J BIOL CHEM, V269, P22847; Maniatis T., 1982, MOL CLONING LAB MANU; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; Muller V, 1996, BIOCHEMISTRY-US, V35, P16132, DOI 10.1021/bi960667r; NAKAYAMA S, 1992, J MOL EVOL, V34, P416, DOI 10.1007/BF00162998; Palmieri L, 1996, FEBS LETT, V399, P299, DOI 10.1016/S0014-5793(96)01350-6; Palmieri L, 1997, FEBS LETT, V410, P447, DOI 10.1016/S0014-5793(97)00630-3; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Rosse T, 1998, NATURE, V391, P496, DOI 10.1038/35160; RUNSWICK MJ, 1994, DNA SEQUENCE, V4, P281, DOI 10.3109/10425179409020854; RUNSWICK MJ, 1987, EMBO J, V6, P1367, DOI 10.1002/j.1460-2075.1987.tb02377.x; RUNSWICK MJ, 1990, BIOCHEMISTRY-US, V29, P11033, DOI 10.1021/bi00502a004; SARASTE M, 1982, FEBS LETT, V144, P250, DOI 10.1016/0014-5793(82)80648-0; Simpson PB, 1997, J BIOL CHEM, V272, P22654, DOI 10.1074/jbc.272.36.22654; SolerMira A, 1996, YEAST, V12, P485, DOI 10.1002/(SICI)1097-0061(199604)12:5<485::AID-YEA928>3.0.CO;2-U; SULLIVAN TD, 1991, PLANT CELL, V3, P1337, DOI 10.1105/tpc.3.12.1337; VILLA A, IN PRESS BIOCH BIOPH; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521; VITORICA J, 1986, BRAIN RES, V378, P36, DOI 10.1016/0006-8993(86)90284-2; WALKER JE, 1993, J BIOENERG BIOMEMBR, V25, P435, DOI 10.1007/BF01108401; Weber FE, 1997, P NATL ACAD SCI USA, V94, P8509, DOI 10.1073/pnas.94.16.8509; WIESENBERGER G, 1991, J MOL BIOL, V217, P23, DOI 10.1016/0022-2836(91)90608-9; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; ZARRILLI R, 1989, MOL ENDOCRINOL, V3, P1498, DOI 10.1210/mend-3-9-1498; Zhou JM, 1997, P NATL ACAD SCI USA, V94, P2301, DOI 10.1073/pnas.94.6.2301; [No title captured]	43	135	142	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23327	23334		10.1074/jbc.273.36.23327	http://dx.doi.org/10.1074/jbc.273.36.23327			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722566	hybrid			2022-12-27	WOS:000075778100066
J	Doring, F; Will, J; Amasheh, S; Clauss, W; Ahlbrecht, H; Daniel, H				Doring, F; Will, J; Amasheh, S; Clauss, W; Ahlbrecht, H; Daniel, H			Minimal molecular determinants of substrates for recognition by the intestinal peptide transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-LACTAM ANTIBIOTICS; EXPRESSION CLONING; FREE-ENERGIES; ZWITTERION; SOLVATION; OOCYTES; GLYCINE; MODEL	Proton-dependent electrogenic transporters for di- and tripeptides have been identified in bacteria, fungi, plants, and mammalian cells. They all show sequence-independent transport of all possible di- and tripeptides as well as of a variety of peptidomimetics, We used the mammalian intestinal peptide transporter PEPT1 as a model to define the molecular basis for its multisubstrate specificity. By employing computational analysis of possible substrate conformations in combination with transport assays using transgenic yeast cells and Xenopus laevis oocytes expressing PEPT1, the minimal structural requirements for substrate binding and transport were determined. Based on a series of medium chain fatty acids bearing an amino group as a head group (omega-amino fatty acids, omega-AFA), we show that electrogenic transport by PEPT1 requires as a minimum the two ionized head groups separated by at least four methylene groups. Consequently, a > 500 pm < 630 pm distance between the two charged centers (carboxylic carbon and amino nitrogen) is sufficient for substrate recognition and transport. Removal of either the amino group or the carboxyl group in omega-AFA maintained the affinity of the compound for interaction with the transporter but abolished the capability for electrogenic transport, Additional groups in the omega-AFA backbone that provide more hydrogen bonding sites appear to increase substrate affinity but are not essential. The information provided here does (a) explain the capability of the peptide carrier for sequence-independent transport of thousands of different substrates and (b) set the molecular basis for a rational drug design to increase the absorption of peptide-based drugs mediated by PEPT1.	Univ Giessen, Inst Nutr Sci, Mol Nutr Ctr, D-35392 Giessen, Germany; Univ Giessen, Inst Anim Physiol, D-35392 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Daniel, H (corresponding author), Univ Giessen, Inst Nutr Sci, Mol Nutr Ctr, Wilhelmstr 20, D-35392 Giessen, Germany.	hannelore.daniel@ernaehrung.uni-giessen.de	Daniel, Hannelore/B-8982-2009; Döring, Frank/E-9483-2010; Amasheh, Salah/AAG-4035-2021					Amasheh S, 1997, J MEMBRANE BIOL, V155, P247, DOI 10.1007/s002329900177; BOLL M, 1994, PFLUG ARCH EUR J PHY, V429, P146, DOI 10.1007/BF02584043; Brandsch M, 1998, J BIOL CHEM, V273, P3861, DOI 10.1074/jbc.273.7.3861; CRAMER CJ, 1991, J AM CHEM SOC, V113, P8305, DOI 10.1021/ja00022a017; CRAMER CJ, 1992, SCIENCE, V256, P213, DOI 10.1126/science.256.5054.213; Daniel H, 1996, J MEMBRANE BIOL, V154, P197, DOI 10.1007/s002329900144; Daniel H, 1997, AM J PHYSIOL-RENAL, V273, pF1, DOI 10.1152/ajprenal.1997.273.1.F1; Doring F, 1997, BIOCHEM BIOPH RES CO, V232, P656, DOI 10.1006/bbrc.1997.6351; Doring F, 1996, J PHYSIOL-LONDON, V497, P773; Doring F, 1998, J CLIN INVEST, V101, P2761, DOI 10.1172/JCI1909; Enjoh M, 1996, BIOSCI BIOTECH BIOCH, V60, P1893, DOI 10.1271/bbb.60.1893; FEI YJ, 1994, NATURE, V368, P563, DOI 10.1038/368563a0; FRISCH MJ, 1995, GAUSSIAN 94; Gordon MS, 1996, ACCOUNTS CHEM RES, V29, P536, DOI 10.1021/ar9600594; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; JENSEN JH, 1995, J AM CHEM SOC, V117, P8159, DOI 10.1021/ja00136a013; MIERTUS S, 1981, CHEM PHYS, V55, P117, DOI 10.1016/0301-0104(81)85090-2; Price WD, 1997, J AM CHEM SOC, V119, P11988, DOI 10.1021/ja9711627; RONG LA, 1995, J BIOL CHEM, V270, P6456, DOI 10.1074/jbc.270.12.6456; Saito H, 1995, J PHARMACOL EXP THER, V275, P1631; SCHULDINER S, 1995, PHYSIOL REV, V75, P369, DOI 10.1152/physrev.1995.75.2.369; Simon Craw JD, 1997, J CHEM SOC P1, V2, P869; STEINER HY, 1995, MOL MICROBIOL, V16, P825, DOI 10.1111/j.1365-2958.1995.tb02310.x; SUENRAM RD, 1978, J MOL SPECTROSC, V72, P372, DOI 10.1016/0022-2852(78)90137-6; Ullrich KJ, 1997, J MEMBRANE BIOL, V158, P95, DOI 10.1007/s002329900247; Wenzel U, 1996, J PHARMACOL EXP THER, V277, P831; WENZEL U, 1995, BRIT J PHARMACOL, V116, P3021, DOI 10.1111/j.1476-5381.1995.tb15958.x	27	120	123	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23211	23218		10.1074/jbc.273.36.23211	http://dx.doi.org/10.1074/jbc.273.36.23211			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722551	hybrid			2022-12-27	WOS:000075778100051
J	Hassett, RF; Yuan, DS; Kosman, DJ				Hassett, RF; Yuan, DS; Kosman, DJ			Spectral and kinetic properties of the Fet3 protein from Saccharomyces cerevisiae, a multinuclear copper ferroxidase enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASCORBATE OXIDASE; IRON UPTAKE; CERULOPLASMIN; YEAST; PURIFICATION; LACCASE; GENE; SITE; STELLACYANIN; MECHANISM	High affinity iron uptake in Saccharomyces cerevisiae requires Fet3p. Fet3p is proposed to facilitate iron uptake by catalyzing the oxidation of Fe(II) to Fe(III) by O-2; in this model, Fe(III) is the substrate for the iron permease, encoded by FTR1. Here, a recombinant Fet3p has been produced in yeast that, lacking the C-terminal membrane-spanning domain, is secreted directly into the growth medium. Solutions of this Fet3p at >1 mg/ml have the characteristic blue color of a type 1 Cu(II)-containing protein, consistent with the sequence homology that placed this protein in the class of multinuclear copper oxidases that includes ceruloplasmin. Fet3p has an intense absorption at 607 nm (epsilon = 5500 M-1 cm(-1)) due to this type 1 Cu(II) and a shoulder in the near UV at 330 nm (epsilon = 5000 M-1 cm(-1)) characteristic of a type 3 binuclear Cu(II) cluster. The EPR spectrum of this Fet3p showed the presence of one type 1 Cu(II) and one type 2. Cu(II) (A(parallel to) = 91 and 190 x 10(-4) cm(-1), respectively). Copper analysis showed this protein to have 3.85 g atom copper/mol, consistent with the presence of one each of the three types of Cu(II) sites found in multinuclear copper oxidases. N-terminal analysis demonstrated that cleavage of a signal peptide occurred after Ala-21 in the primary translation product. Mass spectral and carbohydrate analysis of the protein following Endo H treatment indicated that the preparation was still 15% (w/w) carbohydrate, probably O-linked. Kinetic analysis of the in vitro ferroxidase reaction catalyzed by this soluble Fet3p yielded precise kinetic constants. The K-m values for Fe(II) and O-2 were 4.8 and 1.3 mu M, respectively, while k(cat) values for Fe(II) and O-2 turnover were 9.5 and 2.3 min(-1), consistent with an Fe(II):O-2 reaction stoichiometry of 4:1.	SUNY Buffalo, Sch Med & Biomed Sci, Dept Biochem, Buffalo, NY 14214 USA; NICHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Kosman, DJ (corresponding author), SUNY Buffalo, Sch Med & Biomed Sci, Dept Biochem, 140 Farber Hall,3435 Main St, Buffalo, NY 14214 USA.	camkos@acsu.buffalo.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046787] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM46787] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDREASSON L-E, 1970, Biochimica et Biophysica Acta, V200, P247, DOI 10.1016/0005-2795(70)90168-6; ANDREASSON LE, 1979, BIOCHIM BIOPHYS ACTA, V568, P145, DOI 10.1016/0005-2744(79)90282-1; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; Askwith CC, 1996, MOL MICROBIOL, V20, P27, DOI 10.1111/j.1365-2958.1996.tb02485.x; Badsberg U, 1996, BIOCHEMISTRY-US, V35, P7021, DOI 10.1021/bi960621y; Bonomi F, 1996, J BIOL INORG CHEM, V1, P67, DOI 10.1007/s007750050024; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRIZZARD BL, 1994, BIOTECHNIQUES, V16, P730; CALABRESE L, 1981, BIOCHEM J, V199, P667, DOI 10.1042/bj1990667; CHIDAMBARAM MV, 1983, FEBS LETT, V159, P137, DOI 10.1016/0014-5793(83)80432-3; COLE JL, 1991, J AM CHEM SOC, V113, P9080, DOI 10.1021/ja00024a008; deSilva D, 1997, J BIOL CHEM, V272, P14208, DOI 10.1074/jbc.272.22.14208; DESILVA DM, 1995, J BIOL CHEM, V270, P1098, DOI 10.1074/jbc.270.3.1098; DIBILIO AJ, 1992, INORG CHIM ACTA, V198, P145, DOI 10.1016/S0020-1693(00)92355-7; DISCHE Z, 1962, CARBOHYDR CHEM, V1, P479; EIDE D, 1992, J BIOL CHEM, V267, P20774; FANKHAUSER C, 1991, EUR J BIOCHEM, V195, P439, DOI 10.1111/j.1432-1033.1991.tb15723.x; FERRIGE AG, 1992, RAPID COMMUN MASS SP, V6, P707, DOI 10.1002/rcm.1290061115; FRIEDEN E, 1965, J GEN PHYSIOL, V49, P213, DOI 10.1085/jgp.49.1.213; Frieden E., 1976, IRON COPPER PROTEINS, V74, P89; GREEN BN, 1991, BIOCHEM SOC T, V19, P929, DOI 10.1042/bst0190929; GUTTERIDGE JMC, 1989, CLIN HAEMATOL, V2, P195; HASSETT R, 1995, J BIOL CHEM, V270, P128, DOI 10.1074/jbc.270.1.128; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; KOSMAN DJ, 1985, BIOL APPL SPECTROSCO, P89; LEHLE L, 1984, BIOCHIM BIOPHYS ACTA, V799, P246, DOI 10.1016/0304-4165(84)90267-8; LERCH K, 1978, BIOCHIM BIOPHYS ACTA, V534, P7, DOI 10.1016/0005-2795(78)90470-1; Levi S, 1996, BIOCHEM J, V317, P467, DOI 10.1042/bj3170467; Lindley PF, 1997, J BIOL INORG CHEM, V2, P454, DOI 10.1007/s007750050156; MALMSTRO.BG, 1970, BIOCHIM BIOPHYS ACTA, V205, P48, DOI 10.1016/0005-2728(70)90060-5; MALMSTROM BG, 1982, ANNU REV BIOCHEM, V51, P21, DOI 10.1146/annurev.bi.51.070182.000321; MARCHESINI A, 1979, EUR J BIOCHEM, V101, P65, DOI 10.1111/j.1432-1033.1979.tb04217.x; MESSERSCHMIDT A, 1993, J MOL BIOL, V230, P997, DOI 10.1006/jmbi.1993.1215; MESSERSCHMIDT A, 1990, EUR J BIOCHEM, V187, P341, DOI 10.1111/j.1432-1033.1990.tb15311.x; MESSERSCHMIDT A, 1992, J MOL BIOL, V224, P179, DOI 10.1016/0022-2836(92)90583-6; Miyajima H, 1996, FREE RADICAL BIO MED, V20, P757, DOI 10.1016/0891-5849(95)02178-7; NAKANO M, 1993, EUR NEUROL, V33, P44, DOI 10.1159/000118537; Okamoto N, 1996, HUM GENET, V97, P755; OSAKI S, 1966, J BIOL CHEM, V241, P5053; OSAKI S, 1966, J BIOL CHEM, V241, P2746; OSAKI S, 1967, J BIOL CHEM, V242, P2653; ROMERO A, 1993, J MOL BIOL, V229, P1007, DOI 10.1006/jmbi.1993.1101; SCHOSINSKY KH, 1974, CLIN CHEM, V20, P1556; Segel IH, 1975, ENZYME KINETICS, P54; SHIN W, 1996, J AM CHEM SOC, V118, P3203; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; SOLOMON EI, 1993, SCIENCE, V259, P1575, DOI 10.1126/science.8384374; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; STRANGE RW, 1995, BIOCHEMISTRY-US, V34, P220, DOI 10.1021/bi00001a026; TANNER W, 1987, BIOCHIM BIOPHYS ACTA, V906, P81, DOI 10.1016/0304-4157(87)90006-2; TREFFRY A, 1993, BIOCHEM J, V296, P721, DOI 10.1042/bj2960721; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x; Yuan DS, 1997, J BIOL CHEM, V272, P25787, DOI 10.1074/jbc.272.41.25787; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632; Zaitseva I, 1996, J BIOL INORG CHEM, V1, P15, DOI 10.1007/s007750050018; ZITOMER RS, 1992, MICROBIOL REV, V56, P1	58	87	88	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23274	23282		10.1074/jbc.273.36.23274	http://dx.doi.org/10.1074/jbc.273.36.23274			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722559	hybrid			2022-12-27	WOS:000075778100059
J	Ito, N; Wernstedt, C; Engstrom, U; Claesson-Welsh, L				Ito, N; Wernstedt, C; Engstrom, U; Claesson-Welsh, L			Identification of vascular endothelial growth factor receptor-1 tyrosine phosphorylation sites and binding of SH2 domain-containing molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE C-GAMMA; HIGH-AFFINITY BINDING; SIGNAL-TRANSDUCTION; TUMOR ANGIOGENESIS; KINASE RECEPTOR; PLC-GAMMA; PROTEIN; CELLS; RAS; FLT-1	Receptor tyrosine phosphorylation is crucial for sig nal transduction by creating high affinity binding sites for Src homology 2 domain-containing molecules. By expressing the intracellular domain of Flt-1/vascular endothelial growth factor receptor-1 in the baculosystem, we identified two major tyrosine phosphorylation sites at Tyr-1213 and Tyr-1242 and two minor tyrosine phosphorylation sites at Tyr-1327 and Tyr-1333 in this receptor. This pattern of phosphorylation of Flt-1 was also detected in vascular endothelial growth factor-stimulated cells expressing intact Flt-1. In vitro protein binding studies using synthetic peptides and immunoblotting showed that phospholipase C-gamma binds to both Y(p)1213 and Y(p)1333, whereas Grb2 and SHP2-containing tyrosine protein phosphatase (SHP-2) bind to Y(p)1213, and Nck and Crk bind to Y(p)1333 in a phosphotyrosine-dependent manner. In addition, unidentified proteins with molecular masses around 74 and 27 kDa bound to Y(p)1213 and another of 75 kDa bound to Y(p)1333 in a phosphotyrosine-dependent manner. SHP-2, phospholipase C-gamma, and Grb2 could also be shown to bind to the intact Flt-1 intracellular domain. These results indicate that a spectrum of already known as well as novel phosphotyrosine-binding molecules are involved in signal transduction by Flt-1.	Uppsala Univ, Ctr Biomed, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden; Biomed Ctr, Ludwig Inst Canc Res, Uppsala Branch, S-75124 Uppsala, Sweden	Uppsala University; Ludwig Institute for Cancer Research	Claesson-Welsh, L (corresponding author), Uppsala Univ, Ctr Biomed, Dept Med Biochem & Microbiol, Box 575, S-75123 Uppsala, Sweden.	lena.welsh.@medkem.uu.se		Claesson-Welsh, Lena/0000-0003-4275-2000				AEBERSOLD RH, 1987, P NATL ACAD SCI USA, V84, P6970, DOI 10.1073/pnas.84.20.6970; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; ANDERSON D, 1990, SCIENCE, V250, P979, DOI 10.1126/science.2173144; Arbiser JL, 1997, P NATL ACAD SCI USA, V94, P861, DOI 10.1073/pnas.94.3.861; BENNETT AM, 1994, P NATL ACAD SCI USA, V91, P7335, DOI 10.1073/pnas.91.15.7335; Birge RB, 1996, GENES CELLS, V1, P595, DOI 10.1046/j.1365-2443.1996.00258.x; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CUNNINGHAM SA, 1995, J BIOL CHEM, V270, P20254, DOI 10.1074/jbc.270.35.20254; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; DOUGHERVERMAZEN M, 1994, BIOCHEM BIOPH RES CO, V205, P728, DOI 10.1006/bbrc.1994.2726; ERIKSSON A, 1995, J BIOL CHEM, V270, P7773, DOI 10.1074/jbc.270.13.7773; Feng GS, 1996, J BIOL CHEM, V271, P12129, DOI 10.1074/jbc.271.21.12129; FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; GUO DQ, 1995, J BIOL CHEM, V270, P6729, DOI 10.1074/jbc.270.12.6729; HSU CYJ, 1990, CELL GROWTH DIFFER, V1, P191; HU QJ, 1995, MOL CELL BIOL, V15, P1169; HUYER G, 1995, BIOCHEMISTRY-US, V34, P1040, DOI 10.1021/bi00003a039; Joukov V, 1996, EMBO J, V15, P290; KOCH AE, 1994, J IMMUNOL, V152, P4149; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Landgren E, 1998, ONCOGENE, V16, P359, DOI 10.1038/sj.onc.1201545; LEE CH, 1993, P NATL ACAD SCI USA, V90, P11713, DOI 10.1073/pnas.90.24.11713; Lee J, 1996, P NATL ACAD SCI USA, V93, P1988, DOI 10.1073/pnas.93.5.1988; MAGLIONE D, 1993, ONCOGENE, V8, P925; MANDRIOTA SJ, 1995, J BIOL CHEM, V270, P9709, DOI 10.1074/jbc.270.17.9709; MATSUDA M, 1994, MOL CELL BIOL, V14, P5495, DOI 10.1128/MCB.14.8.5495; MATTHEWS W, 1991, P NATL ACAD SCI USA, V88, P9026, DOI 10.1073/pnas.88.20.9026; Mohammadi M, 1996, MOL CELL BIOL, V16, P977; Olofsson B, 1996, P NATL ACAD SCI USA, V93, P2576, DOI 10.1073/pnas.93.6.2576; PARK JE, 1994, J BIOL CHEM, V269, P25646; PETERS KG, 1993, P NATL ACAD SCI USA, V90, P8915, DOI 10.1073/pnas.90.19.8915; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; Sawano A, 1997, BIOCHEM BIOPH RES CO, V238, P487, DOI 10.1006/bbrc.1997.7327; SCHLESSINGER J, 1993, TRENDS BIOCHEM SCI, V18, P273, DOI 10.1016/0968-0004(93)90031-H; SEETHARAM L, 1995, ONCOGENE, V10, P135; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SHIBUYA M, 1990, ONCOGENE, V5, P519; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; SONYANG Z, 1993, CELL, V72, P767; Takahashi T, 1997, ONCOGENE, V14, P2079, DOI 10.1038/sj.onc.1201047; Tanaka S, 1997, P NATL ACAD SCI USA, V94, P2356, DOI 10.1073/pnas.94.6.2356; TERMAN BI, 1991, ONCOGENE, V6, P1677; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988	48	90	103	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23410	23418		10.1074/jbc.273.36.23410	http://dx.doi.org/10.1074/jbc.273.36.23410			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722576	hybrid			2022-12-27	WOS:000075778100076
J	Pierce, HH; Schachat, F; Brandt, PW; Lombardo, CR; Kay, BK				Pierce, HH; Schachat, F; Brandt, PW; Lombardo, CR; Kay, BK			Identification of troponin C antagonists from a phage-displayed random peptide library	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-PLASMON RESONANCE; EQUILIBRIUM BINDING CONSTANTS; INHIBITORY REGION; SKELETAL-MUSCLE; MACROMOLECULAR INTERACTIONS; BIOLOGICAL-ACTIVITY; SYNTHETIC PEPTIDES; KINETIC-ANALYSIS; SH3 LIGANDS; CALMODULIN	Affinity purification of a phage-displayed library, expressing random peptide 12-mers at the N terminus of protein III, has identified 10 distinct novel sequences which bind troponin C specifically. The troponin C-selected peptides yield a consensus binding sequence of (V/L)(D/E)XLKXXLXXLA. Sequence comparison revealed as much as a 62.5% similarity between phi T5, the peptide sequence of the phage clone with the highest level of binding to troponin C, and the N-terminal region of troponin I isoforms. Biotinylated peptides corresponding to library-derived sequences and similar sequences from various isoforms of troponin I were synthesized shown to bind troponin C specifically. Alkaline phosphatase fusion proteins of two of the phage clone sequences bound troponin C specifically, and were specifically competed by both library-derived and native troponin I peptides. Measurement of equilibrium dissociation constants of the peptides by surface plasmon resonance yielded dissociation constants for troponin C as low as 0.43 mu M for pT5; in contrast, dissociation constants for calmodulin were greater than 6 mu M for all peptides studied. Nondenaturing polyacrylamide gel electrophoresis demonstrated that pT5 formed a stable complex with troponin C in the presence of calcium. We also found that the pT5 peptide inhibited the maximal calcium-activated tension of rabbit psoas muscle fibers.	Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA; Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Macromol Interact Facil, Chapel Hill, NC 27599 USA; Columbia Univ, Sch Med, Dept Anat & Cell Biol, New York, NY 10032 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Columbia University	Schachat, F (corresponding author), Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA.				NEI NIH HHS [R01 EY11377] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011377] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adey NB, 1996, METHOD MOL CELL BIOL, V6, P34; ADEY NB, 1996, PHAGE DISPLAY PEPTID, P68; BEALL CJ, 1991, J CELL BIOL, V114, P941, DOI 10.1083/jcb.114.5.941; Bevington PR., 2002, DATA REDUCTION ERROR; BRANDT PW, 1984, J MOL BIOL, V180, P379, DOI 10.1016/S0022-2836(84)80010-8; BRANDT PW, 1980, P NATL ACAD SCI-BIOL, V77, P4717, DOI 10.1073/pnas.77.8.4717; CACHIA PJ, 1986, BIOCHEMISTRY-US, V25, P3553, DOI 10.1021/bi00360a013; CACHIA PJ, 1983, BIOCHEMISTRY-US, V22, P4145, DOI 10.1021/bi00286a024; CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378; DEDMAN JR, 1993, J BIOL CHEM, V268, P23025; FARAH CS, 1994, J BIOL CHEM, V269, P5230; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; FELICI F, 1993, GENE, V128, P21, DOI 10.1016/0378-1119(93)90148-V; Fisher Robert J., 1994, Current Opinion in Biotechnology, V5, P389, DOI 10.1016/0958-1669(94)90047-7; FOWLKES DM, 1992, BIOTECHNIQUES, V13, P422; GEORGE SE, 1990, J BIOL CHEM, V265, P9228; HEAD JF, 1974, BIOCHEM J, V137, P145, DOI 10.1042/bj1370145; KALININ NL, 1995, ANAL BIOCHEM, V228, P238, DOI 10.1006/abio.1995.1345; KATAYAMA E, 1982, J BIOCHEM-TOKYO, V91, P1449, DOI 10.1093/oxfordjournals.jbchem.a133835; KAY BK, 1993, GENE, V128, P59, DOI 10.1016/0378-1119(93)90153-T; Kay BK, 1995, PERSPECT DRUG DISCOV, V2, P251; KOIVUNEN E, 1994, J CELL BIOL, V124, P373, DOI 10.1083/jcb.124.3.373; MEANS AR, 1994, FEBS LETT, V347, P1, DOI 10.1016/0014-5793(94)00492-7; MORELOCK MM, 1995, J MED CHEM, V38, P1309, DOI 10.1021/jm00008a009; MOTTI C, 1994, GENE, V146, P191, DOI 10.1016/0378-1119(94)90292-5; Myszka DG, 1997, CURR OPIN BIOTECH, V8, P50, DOI 10.1016/S0958-1669(97)80157-7; Myszka DG, 1996, PROTEIN SCI, V5, P2468, DOI 10.1002/pro.5560051209; NGAI SM, 1992, J BIOL CHEM, V267, P15715; O'Shannessy D J, 1994, Curr Opin Biotechnol, V5, P65, DOI 10.1016/S0958-1669(05)80072-2; ONEIL KT, 1995, CURR OPIN STRUC BIOL, V5, P443, DOI 10.1016/0959-440X(95)80027-1; Pierce HH, 1996, MOL DIVERS, V1, P259, DOI 10.1007/BF01715530; PRADO A, 1995, MOL BIOL CELL, V6, P1433, DOI 10.1091/mbc.6.11.1433; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; SPARKS AB, 1994, J BIOL CHEM, V269, P23853; SPARKS AB, 1995, METHOD ENZYMOL, V255, P498; TALBOT JA, 1979, J BIOL CHEM, V254, P3720; TALBOT JA, 1981, J BIOL CHEM, V256, P2374; TALBOT JA, 1981, J BIOL CHEM, V256, P2798; VANEYK JE, 1988, J BIOL CHEM, V263, P1726; VANEYK JE, 1987, BIOCHEM CELL BIOL, V65, P982; Vassylyev DG, 1998, P NATL ACAD SCI USA, V95, P4847, DOI 10.1073/pnas.95.9.4847; Yamabhai M, 1997, ANAL BIOCHEM, V247, P143, DOI 10.1006/abio.1997.2040	42	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23448	23453		10.1074/jbc.273.36.23448	http://dx.doi.org/10.1074/jbc.273.36.23448			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722581	hybrid, Green Published			2022-12-27	WOS:000075778100081
J	Post, SR; Rump, LC; Zambon, A; Hughes, RJ; Buda, MD; Jacobson, JP; Kao, CC; Insel, PA				Post, SR; Rump, LC; Zambon, A; Hughes, RJ; Buda, MD; Jacobson, JP; Kao, CC; Insel, PA			ATP activates cAMP production via multiple purinergic receptors in MDCK-D1 epithelial cells - Blockade of an autocrine/paracrine pathway to define receptor preference of an agonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CANINE KIDNEY-CELLS; ARACHIDONIC-ACID; PHOSPHOINOSITIDE HYDROLYSIS; EXTRACELLULAR ATP; ADENYLYL-CYCLASE; ION-TRANSPORT; PROSTAGLANDINS; PURINOCEPTORS; ACCUMULATION	Extracellular nucleotides regulate function in many cell types via activation of multiple P-2-purinergic receptor subtypes, However, it has been difficult to define which individual subtypes mediate responses to the physiological agonist ATP, We report a novel means to determine this by exploiting the differential activation of an autocrine/paracrine signaling pathway. We used Madin-Darby canine kidney epithelial cells (MDCK-D1) and assessed the regulation of cAMP formation by nucleotides, We found that ATP, 2-methylthio-ATP (MT-ATP) and UTP increase cAMP production. The cyclooxygenase inhibitor indomethacin completely inhibited UTP-stimulated, did not inhibit MT-ATP-stimulated, and only partially blocked ATP-stimulated cAMP formation. In parallel studies, ATP and UTP but not MT-ATP stimulated prostaglandin production. By pretreating cells with indomethacin to eliminate the P-2Y2/prostaglandin component of cAMP formation, we could assess the indomethacin-insensitive P-2 receptor component. Under these conditions, ATP displayed a ten-fold lower potency for stimulation of cAMP formation compared with untreated cells. These data indicate that ATP preferentially activates P-2Y2 relative to other P-2 receptors in MDCK-D1 cells (P-2Y1 and P-2Y11, as shown by reverse transcriptase polymerase chain reaction) and that P-2Y2 receptor activation is the principal means by which ATP increases cAMP formation in these cells. Blockade of autocrine/paracrine signaling can aid in dissecting the contribution of multiple receptor subtypes activated by an agonist.	Univ Calif San Diego, Dept Pharmacol 0636, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Insel, PA (corresponding author), Univ Freiburg, Innere Med Klin 4, Hugstetter Str 55, D-79106 Freiburg, Germany.	pinsel@ucsd.edu		Post, Steven/0000-0002-4711-1723; Jacobson, Jon/0000-0002-7535-8539	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL053773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040781, R01GM031987] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 53773] Funding Source: Medline; NIGMS NIH HHS [GM 40781, GM 31987] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALEXANDER SPH, 1997, TRENDS PHARM SCI S, P1; BALBOA MA, 1994, J BIOL CHEM, V269, P10511; BAREIS DL, 1983, P NATL ACAD SCI-BIOL, V80, P2514, DOI 10.1073/pnas.80.9.2514; BOARDER MR, 1995, TRENDS PHARMACOL SCI, V16, P133, DOI 10.1016/S0165-6147(00)89001-X; BOYER JL, 1993, J PHARMACOL EXP THER, V267, P1140; BURNSTOCK G, 1985, GEN PHARMACOL, V16, P433, DOI 10.1016/0306-3623(85)90001-1; Choi SY, 1997, BIOCHEM PHARMACOL, V53, P429, DOI 10.1016/S0006-2952(96)00719-8; COLEMAN RA, 1994, PHARMACOL REV, V46, P205; Communi D, 1997, J BIOL CHEM, V272, P31969, DOI 10.1074/jbc.272.51.31969; Esqueda EE, 1996, BIOCHEM PHARMACOL, V52, P643, DOI 10.1016/0006-2952(96)00339-5; Firestein BL, 1996, AM J PHYSIOL-RENAL, V271, pF610, DOI 10.1152/ajprenal.1996.271.3.F610; FIRESTEIN BL, 1995, FASEB J, V9, pA553; FREDHOLM BB, 1994, PHARMACOL REV, V46, P143; HARDEN TK, 1995, ANNU REV PHARMACOL, V35, P541, DOI 10.1146/annurev.pharmtox.35.1.541; HASSID A, 1983, J CELL PHYSIOL, V116, P297, DOI 10.1002/jcp.1041160306; HUGHES RJ, 1996, FASEB J, V10, pA697; Jiang LL, 1997, BIOCHEM BIOPH RES CO, V232, P626, DOI 10.1006/bbrc.1997.6345; KEPPENS S, 1992, BRIT J PHARMACOL, V105, P475, DOI 10.1111/j.1476-5381.1992.tb14278.x; Marathe GK, 1996, BIOCHEM PHARMACOL, V52, P1261, DOI 10.1016/0006-2952(96)00481-9; MUNSHI R, 1993, MOL PHARMACOL, V44, P1185; OKAJIMA F, 1987, J BIOL CHEM, V262, P13483; PARTINGTON CR, 1980, P NATL ACAD SCI-BIOL, V77, P3024, DOI 10.1073/pnas.77.5.3024; Post SR, 1996, J BIOL CHEM, V271, P2029, DOI 10.1074/jbc.271.4.2029; SIMMONS NL, 1981, BRIT J PHARMACOL, V73, P379, DOI 10.1111/j.1476-5381.1981.tb10432.x; VALEINS H, 1992, MOL PHARMACOL, V42, P1033; WEISS BA, 1989, MOL PHARMACOL, V36, P317; Xing MZ, 1997, J CLIN INVEST, V99, P805, DOI 10.1172/JCI119227; YAMADA M, 1992, CIRC RES, V70, P477, DOI 10.1161/01.RES.70.3.477; ZEGARRAMORAN O, 1995, BRIT J PHARMACOL, V114, P1052, DOI 10.1111/j.1476-5381.1995.tb13312.x; [No title captured]	30	64	65	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23093	23097		10.1074/jbc.273.36.23093	http://dx.doi.org/10.1074/jbc.273.36.23093			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722536	hybrid			2022-12-27	WOS:000075778100036
J	Slater, SJ; Taddeo, FJ; Mazurek, A; Stagliano, BA; Milano, SK; Kelly, MB; Ho, CJ; Stubbs, CD				Slater, SJ; Taddeo, FJ; Mazurek, A; Stagliano, BA; Milano, SK; Kelly, MB; Ho, CJ; Stubbs, CD			Inhibition of membrane lipid-independent protein kinase C alpha activity by phorbol esters, diacylglycerols, and bryostatin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMYELOCYTIC LEUKEMIA-CELLS; TRANSFERASE FUSION PROTEINS; CYSTEINE-RICH DOMAIN; BINDING DOMAIN; INDUCED DIFFERENTIATION; INDUCED TRANSLOCATION; REGULATORY DOMAIN; RAT-BRAIN; ACTIVATION; GAMMA	The activity of membrane-associated protein kinase C (PKC) has previously been shown to be regulated by two discrete high and low affinity binding regions for diacylglycerols and phorbol esters (Slater, S. J., Ho, C., Kelly, M. B., Larkin, J. D., Taddeo, F. J., Yeager, M. D., and Stubbs, C. D. (1996) J. Biol. Chem. 271, 4627-4631). PKC is also known to interact with both cytoskeletal and nuclear proteins; however, less is known concerning the mode of activation of this non-membrane form of PKC. By using the fluorescent phorbol ester, sapintoxin D (SAPD), PKC alpha, alone, was found to possess both low and high affinity phorbol ester-binding sites, showing that interaction with these sites does not require association with the membrane. Importantly, a fusion protein containing the isolated C1A/C1B (C1) domain of PKC alpha also bound SAPD with low and high affinity, indicating that the sites may be confined to this domain rather than residing elsewhere on the enzyme molecule. Both high and low affinity interactions with native PKC alpha were enhanced by protamine sulfate, which activates the enzyme without requiring Ca2+ or membrane lipids. However, this "non-membrane" PKC activity was inhibited by the phorbol ester 4 beta-12-O-tetradecanoylphorbol-13-acetate (TPA) and also by the fluorescent analog, SAPD, opposite to its effect on membrane-associated PKC alpha. Bryostatin-1 and the soluble diacylglycerol, 1-oleoyl-2-acetylglycerol, both potent activators of membrane-associated PKC, also competed for both low and high affinity SAPD binding and inhibited protamine sulfate-induced activity. Furthermore, the inactive phorbol ester analog 4 alpha-TPA (4 alpha-12-O-tetradecanoylphorbol-13-acetate) also inhibited non-membrane-associated PKC. In keeping with these observations, although TPA could displace high affinity SAPD binding from both forms of the enzyme, 4 alpha-TPA was only effective at displacing high affinity SAPD binding from nonmembrane-associated PHC. 4 alpha-TPA also displaced SAPD from the isolated C1 domain. These results show that although high and low affinity phorbol ester-binding sites are found on non-membrane-associated PKC, the phorbol ester binding properties change significantly upon association with membranes.	Thomas Jefferson Univ, Dept Pathol & Cell Biol, Philadelphia, PA 19107 USA	Jefferson University	Stubbs, CD (corresponding author), Thomas Jefferson Univ, Dept Pathol & Cell Biol, Rm 271 JAH, Philadelphia, PA 19107 USA.				NIAAA NIH HHS [AA07215, AA07186, AA08022] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R29AA008022, R01AA008022, P50AA007186] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		BAZZI MD, 1987, BIOCHEMISTRY-US, V26, P5002, DOI 10.1021/bi00390a018; BAZZI MD, 1990, BIOCHEMISTRY-US, V29, P7624, DOI 10.1021/bi00485a012; BAZZI MD, 1987, BIOCHEMISTRY-US, V26, P1974, DOI 10.1021/bi00381a029; BECKMANN R, 1992, EUR J BIOCHEM, V210, P45, DOI 10.1111/j.1432-1033.1992.tb17388.x; Blobe GC, 1996, J BIOL CHEM, V271, P15823, DOI 10.1074/jbc.271.26.15823; Bruins RH, 1995, ARCH BIOCHEM BIOPHYS, V324, P216, DOI 10.1006/abbi.1995.0033; BUCHNER K, 1995, EUR J BIOCHEM, V228, P211; BURNS DJ, 1991, J BIOL CHEM, V266, P18330; BURNS DJ, 1990, J BIOL CHEM, V265, P12044; CARDELLINI E, 1993, BIOCHEM J, V291, P303, DOI 10.1042/bj2910303; CORNISHBOWDEN A, 1976, PRINCIPLES ENZYME KI; DASILVA C, 1990, CANCER RES, V50, P2081; DELLAQUILA ML, 1987, CANCER RES, V47, P6006; DELLAQUILA ML, 1988, CANCER RES, V48, P3702; DIMITRIJEVIC SM, 1995, MOL PHARMACOL, V48, P259; FERRARI S, 1987, EUR J BIOCHEM, V163, P481, DOI 10.1111/j.1432-1033.1987.tb10894.x; GLYNN B, 1985, BIOCHEM J, V231, P489, DOI 10.1042/bj2310489; GOSS VL, 1994, J BIOL CHEM, V269, P19074; HENNINGS H, 1987, CARCINOGENESIS, V8, P1343, DOI 10.1093/carcin/8.9.1343; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; Hunn M, 1997, FEBS LETT, V400, P226, DOI 10.1016/S0014-5793(96)01395-6; Hurley JH, 1997, PROTEIN SCI, V6, P477; HYATT SL, 1994, BIOCHEMISTRY-US, V33, P1223, DOI 10.1021/bi00171a023; ICHIKAWA S, 1995, J BIOCHEM-TOKYO, V117, P566, DOI 10.1093/oxfordjournals.jbchem.a124745; Irie K, 1997, BIOORGAN MED CHEM, V5, P1725, DOI 10.1016/S0968-0896(97)00116-8; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P14679, DOI 10.1074/jbc.270.24.14679; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P21852, DOI 10.1074/jbc.270.37.21852; KISHIMOTO A, 1980, J BIOL CHEM, V255, P2273; KRAFT AS, 1986, P NATL ACAD SCI USA, V83, P1334, DOI 10.1073/pnas.83.5.1334; LEVENTHAL PS, 1993, J BIOL CHEM, V268, P13906; MAKOWSKE M, 1989, J BIOL CHEM, V264, P16155; MOCHLYROSEN D, 1991, P NATL ACAD SCI USA, V88, P3997, DOI 10.1073/pnas.88.9.3997; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; MURTI KG, 1992, EXP CELL RES, V202, P36, DOI 10.1016/0014-4827(92)90401-S; NAKADATE T, 1987, J BIOL CHEM, V262, P11507; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; ONO Y, 1989, P NATL ACAD SCI USA, V86, P3099, DOI 10.1073/pnas.86.9.3099; ORR JW, 1992, J BIOL CHEM, V267, P15263; PEARS CJ, 1990, EUR J BIOCHEM, V194, P89, DOI 10.1111/j.1432-1033.1990.tb19431.x; Prekeris R, 1996, J CELL BIOL, V132, P77, DOI 10.1083/jcb.132.1.77; QUEST AFG, 1994, J BIOL CHEM, V269, P2953; QUEST AFG, 1994, J BIOL CHEM, V269, P2961; QUEST AFG, 1994, J BIOL CHEM, V269, P20000; QUEST AFG, 1995, METHOD ENZYMOL, V252, P153; SAKO T, 1987, CANCER RES, V47, P5445; SHARKEY NA, 1985, BIOCHEM BIOPH RES CO, V133, P1051, DOI 10.1016/0006-291X(85)91242-2; SHARKEY NA, 1984, P NATL ACAD SCI-BIOL, V81, P607, DOI 10.1073/pnas.81.2.607; SLATER SJ, 1994, J BIOL CHEM, V269, P17160; Slater SJ, 1997, J BIOL CHEM, V272, P6167, DOI 10.1074/jbc.272.10.6167; Slater SJ, 1996, J BIOL CHEM, V271, P4627; SLATER SJ, 1994, J BIOL CHEM, V269, P4866; SPUDICH A, 1992, CELL MOTIL CYTOSKEL, V22, P250, DOI 10.1002/cm.970220405; STUBBS CD, 1981, BIOCHEMISTRY-US, V20, P4257, DOI 10.1021/bi00518a004; SZALLASI Z, 1994, MOL PHARMACOL, V46, P840; Szallasi Z, 1996, J BIOL CHEM, V271, P18299, DOI 10.1074/jbc.271.31.18299; WAYS DK, 1992, J BIOL CHEM, V267, P4799; WENDER PA, 1995, P NATL ACAD SCI USA, V92, P239, DOI 10.1073/pnas.92.1.239; Yanai Y, 1997, BIOORG MED CHEM LETT, V7, P117, DOI 10.1016/S0960-894X(96)00587-2; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	60	34	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23160	23168		10.1074/jbc.273.36.23160	http://dx.doi.org/10.1074/jbc.273.36.23160			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722545	hybrid			2022-12-27	WOS:000075778100045
J	Ghosh, S; Gachhui, R; Crooks, C; Wu, CQ; Lisanti, MP; Stuehr, DJ				Ghosh, S; Gachhui, R; Crooks, C; Wu, CQ; Lisanti, MP; Stuehr, DJ			Interaction between caveolin-1 and the reductase domain of endothelial nitric-oxide synthase - Consequences for catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSFER; BINDING DOMAIN; L-ARGININE; CALMODULIN; TETRAHYDROBIOPTERIN; EXPRESSION; OXYGENASE; PROTEINS; CELLS; HEME	Endothelial nitric oxide synthase (eNOS) is targeted to caveoli through interaction with caveolin-1 (cav-l), cav-l binding to a consensus site in the eNOS oxygenase domain is proposed to antagonize calmodulin (CaM) binding and thereby inhibit eNOS nitric oxide (NO) synthesis. To study the mechanism, we examined how cav-l scaffolding domain peptide (amino acids 82-101; cav-1P) would affect NO synthesis, NADPH oxidation, cytochrome c reduction, and ferricyanide reduction by full-length eNOS or its isolated oxygenase and reductase domains, Cav-1P equivalently inhibited NO synthesis and NADPH oxidation by full-length eNOS in a manner reversible by CaM but did not affect NADPH-independent NO synthesis by full-length eNOS or its oxygenase domain, indicating inhibition required the reductase domain. Similar concentrations of cav-1P inhibited cytochrome c reduction by full-length eNOS or the reductase domain (amino acids 492-1205) in a CaM-reversible manner, indicating cav-1P interaction with reductase or full-length eNOS are equivalent. Ferricyanide reduction was unaffected by cav-1P in all cases. Immunoblotting showed that full-length eNOS, eNOS oxygenase, and eNOS reductase all bound to an immobilized glutathione S-transferase-cav-l fusion protein. Thus, cav-l interacts independently with both oxygenase and reductase domains of eNOS. The reductase interaction occurs independent of a cav-l binding motif, is CaM-reversible, and is of sufficient affinity to match cav-1P inhibition of NO synthesis by full-length eNOS. We propose that cav-l binding to eNOS reductase compromises its ability to bind CaM and to donate electrons to the eNOS heme, thereby inhibiting NO synthesis.	Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Cleveland Clinic Foundation; Yeshiva University; Albert Einstein College of Medicine	Stuehr, DJ (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, 9500 Euclid Ave, Cleveland, OH 44195 USA.		Lisanti, Michael P/C-6866-2013; Lisanti, Michael/B-6131-2018	Lisanti, Michael/0000-0003-2034-1382; Ghosh, Sanjay/0000-0001-8624-1494	NATIONAL CANCER INSTITUTE [R29CA053914, R01CA053914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491] Funding Source: NIH RePORTER; NCI NIH HHS [CA53914] Funding Source: Medline; NIGMS NIH HHS [GM51491] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AbuSoud HM, 1997, J BIOL CHEM, V272, P17349, DOI 10.1074/jbc.272.28.17349; ABUSOUD HM, 1993, P NATL ACAD SCI USA, V90, P10769, DOI 10.1073/pnas.90.22.10769; ABUSOUD HM, 1994, J BIOL CHEM, V269, P32047; Chen PF, 1996, J BIOL CHEM, V271, P14631, DOI 10.1074/jbc.271.24.14631; CHEN PF, 1994, J BIOL CHEM, V269, P25062; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Feron O, 1996, J BIOL CHEM, V271, P22810, DOI 10.1074/jbc.271.37.22810; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Gachhui R, 1997, BIOCHEMISTRY-US, V36, P5097, DOI 10.1021/bi970331x; Gachhui R, 1998, J BIOL CHEM, V273, P5451, DOI 10.1074/jbc.273.10.5451; Gachhui R, 1996, J BIOL CHEM, V271, P20594, DOI 10.1074/jbc.271.34.20594; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; GHOSH DK, 1995, BIOCHEMISTRY-US, V34, P801, DOI 10.1021/bi00003a013; Harrison DG, 1997, J CLIN INVEST, V100, P2153, DOI 10.1172/JCI119751; IGNARRO L, 1995, ADV PHARM, V34; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; List BM, 1997, BIOCHEM J, V323, P159, DOI 10.1042/bj3230159; Liu JW, 1997, J CELL BIOL, V137, P1525, DOI 10.1083/jcb.137.7.1525; Martasek P, 1996, BIOCHEM BIOPH RES CO, V219, P359, DOI 10.1006/bbrc.1996.0238; Michel JB, 1997, J BIOL CHEM, V272, P25907, DOI 10.1074/jbc.272.41.25907; Michel JB, 1997, J BIOL CHEM, V272, P15583, DOI 10.1074/jbc.272.25.15583; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; Nishida CR, 1998, J BIOL CHEM, V273, P5566, DOI 10.1074/jbc.273.10.5566; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Presta A, 1997, NITRIC OXIDE-BIOL CH, V1, P74, DOI 10.1006/niox.1996.0110; PRESTA A, 1998, IN PRESS J AM CHEM S; PUFAHL RA, 1995, BIOCHEMISTRY-US, V34, P1930, DOI 10.1021/bi00006a014; Ruan J, 1996, J BIOL CHEM, V271, P22679, DOI 10.1074/jbc.271.37.22679; SESSA WC, 1992, J BIOL CHEM, V267, P15274; Shaul PW, 1996, J BIOL CHEM, V271, P6518, DOI 10.1074/jbc.271.11.6518; Wu CQ, 1996, BIOCHEM BIOPH RES CO, V222, P439, DOI 10.1006/bbrc.1996.0763	33	124	127	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22267	22271		10.1074/jbc.273.35.22267	http://dx.doi.org/10.1074/jbc.273.35.22267			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712842	hybrid			2022-12-27	WOS:000075616600018
J	LaVallee, TM; Tarantini, F; Gamble, S; Carreira, CM; Jackson, A; Maciag, T				LaVallee, TM; Tarantini, F; Gamble, S; Carreira, CM; Jackson, A; Maciag, T			Synaptotagmin-1 is required for fibroblast growth factor-1 release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I; C-2-DOMAIN PROTEINS; BINDING; DOMAIN; CELLS; P65; IDENTIFICATION; FAMILY; FORMS	By using p65 synaptotagmin-1 and fibroblast growth factor (FGF)-1:beta-galactosidase (beta-gal) NIH 3T3 cell cotransfectants, we demonstrate that a proteolytic fragment consisting of the extravesicular domain of synaptotagmin-1 is released into the extracellular compartment in response to temperature stress with similar kinetics and pharmacological properties as FGF-1:beta-gal, Using a deletion mutant that lacks 95 amino acids from the extravesicular domain of synaptotagmin-1, neither synaptotagmin-1 nor FGF-1:beta-gal are able to access the stress-induced release pathway. Furthermore, the p40 extravesicular fragment of synaptotagmin-1 is constitutively released in p40 synaptotagmin-1 NIH 3T3 cell transfectants, and this release is potentiated when the cells are subjected to temperature stress. These data demonstrate that the p40 fragment derived from synaptotagmin-1 is able to utilize the FGF-1 non-classical exocytotic pathway and that the release of FGF-1 is dependent on synaptotagmin-1.	Maine Med Ctr, Res Inst, Ctr Mol Med, Portland, ME 04106 USA; Amer Red Cross, Holland Lab, Dept Mol Biol, Rockville, MD 20855 USA	Maine Medical Center; American Red Cross	Maciag, T (corresponding author), Maine Med Ctr, Res Inst, Ctr Mol Med, 125 John Roberts Rd, Portland, ME 04106 USA.	maciat@mail.mmc.org	Tarantini, Francesca/I-6332-2012	TARANTINI, FRANCESCA/0000-0002-1390-2965	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032348, P01HL054710, R01HL035627] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL54710, HL35627, HL32348] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BENNETT MK, 1994, ANNU REV BIOCHEM, V63, P63, DOI 10.1146/annurev.bi.63.070194.000431; BENNETT MK, 1993, J NEUROSCI, V13, P1701; Bergmeyer H.U., 1965, METHODS ENZYMATIC AN, P736, DOI [10.1016/b978-0-12-395630-9.50134-1, DOI 10.1016/B978-0-12-395630-9.50134-1]; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; BURGESS WH, 1985, J BIOL CHEM, V260, P1389; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; Carreira CM, 1998, J BIOL CHEM, V273, P22224, DOI 10.1074/jbc.273.35.22224; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; Chapman ER, 1996, BIOCHEM BIOPH RES CO, V225, P326, DOI 10.1006/bbrc.1996.1174; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; CHRISTMAS P, 1991, J BIOL CHEM, V266, P2499; Cleves AE, 1996, J CELL BIOL, V133, P1017, DOI 10.1083/jcb.133.5.1017; Damer CK, 1996, J NEUROCHEM, V67, P1661; DAVKTOV B, 1993, J BIOL CHEM, V268, P6816; ENGLEKA KA, 1992, J BIOL CHEM, V267, P11307; FOROUGH R, 1993, J BIOL CHEM, V268, P2960; Goldberg AL, 1997, BIOL CHEM, V378, P131; JACKSON A, 1995, J BIOL CHEM, V270, P33, DOI 10.1074/jbc.270.1.33; JACKSON A, 1992, P NATL ACAD SCI USA, V89, P10691, DOI 10.1073/pnas.89.22.10691; KELLY RB, 1995, CURR BIOL, V5, P257, DOI 10.1016/S0960-9822(95)00054-6; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; KOLODZIEJ PA, 1991, METHOD ENZYMOL, V194, P508; KOSTURA MJ, 1989, P NATL ACAD SCI USA, V86, P5227, DOI 10.1073/pnas.86.14.5227; Kwon OJ, 1996, FEBS LETT, V378, P135, DOI 10.1016/0014-5793(95)01430-6; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; MACH H, 1995, BIOCHEMISTRY-US, V34, P9913, DOI 10.1021/bi00031a013; MARTIN GM, 1970, LAB INVEST, V23, P86; Miller D K, 1997, Semin Immunol, V9, P35, DOI 10.1006/smim.1996.0058; NABEL EG, 1993, NATURE, V362, P844, DOI 10.1038/362844a0; Oyama Y, 1997, BIOCHEM BIOPH RES CO, V240, P341, DOI 10.1006/bbrc.1997.7476; PERIN MS, 1991, J BIOL CHEM, V266, P615; PERIN MS, 1991, J BIOL CHEM, V266, P623; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; SANO H, 1990, J CELL BIOL, V110, P1417, DOI 10.1083/jcb.110.4.1417; Shi JP, 1997, J BIOL CHEM, V272, P1142, DOI 10.1074/jbc.272.2.1142; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tarantini F, 1998, J BIOL CHEM, V273, P22209, DOI 10.1074/jbc.273.35.22209; TARANTINI F, 1995, J BIOL CHEM, V270, P29039, DOI 10.1074/jbc.270.49.29039; TUGAL HB, 1991, BIOCHEM J, V279, P699, DOI 10.1042/bj2790699; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0	42	65	67	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22217	22223		10.1074/jbc.273.35.22217	http://dx.doi.org/10.1074/jbc.273.35.22217			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712835	hybrid			2022-12-27	WOS:000075616600011
J	Scaturro, M; Nastasi, T; Raimondi, L; Bellafiore, M; Cestelli, A; Di Liegro, I				Scaturro, M; Nastasi, T; Raimondi, L; Bellafiore, M; Cestelli, A; Di Liegro, I			H1(0) RNA-binding proteins specifically expressed in the rat brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN MESSENGER-RNA; CORTICAL-NEURONS; TRANSLATIONAL REGULATION; INTRACELLULAR-LOCALIZATION; TERMINAL DIFFERENTIATION; 3'-UNTRANSLATED REGION; ERYTHROLEUKEMIA-CELLS; HISTONE H1-DEGREES; FRIEND-CELLS; DROSOPHILA	During brain maturation, histone H1(0) accumulates in both nerve and glial cells. The expression of this "linker" histone, the role of which still remains unclear, is a complex process, having both transcriptional and post-transcriptional regulatory components. In particular, the expression of H1(0) in rat cortical neurons is regulated mainly at the post-transcriptional level, and unknown cellular proteins are likely to affect H1(0) mRNA stability and/or translation. In looking for such factors, we tested the ability of rat brain extracts to protect H1(0) RNA probe from degradation by T1 RNase. The results reported here demonstrate that rat brain contains at least one major (p40) and two minor (p110 and p70) binding factors, specific for H1(0) RNA, all of which are much more or exclusively expressed in adult rat brain, when compared with other tissues. The binding of the factors is confined to a portion of the 3'-untranslated region (3'-UTR), which is highly conserved among murine and human H1(0) mRNAs. These findings suggest that the proteins identified play a critical role in regulating the expression of H1(0) histone in the brain of mammals.	Dipartimento Biol Cellulare & Sviluppo Alberto Mo, I-90128 Palermo, Italy		Di Liegro, I (corresponding author), Dipartimento Biol Cellulare & Sviluppo Alberto Mo, Viale Sci,Parco Orleans, I-90128 Palermo, Italy.	diliegro@mbox.unipa.it	Bellafiore, Marianna/AAN-5526-2021; nastasi, tommaso/AAR-8730-2020; Raimondi, Lavinia/K-4085-2016; Scaturro, Maria/B-5005-2013	Bellafiore, Marianna/0000-0002-3092-1666; Raimondi, Lavinia/0000-0001-9394-2002; Scaturro, Maria/0000-0001-5614-8678				BANCHEV T, 1988, EXP CELL RES, V177, P1, DOI 10.1016/0014-4827(88)90019-5; BASS BL, 1994, CURR BIOL, V4, P301, DOI 10.1016/S0960-9822(00)00069-5; BOIX J, 1992, EXP CELL RES, V201, P531, DOI 10.1016/0014-4827(92)90306-S; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; CASTIGLIA D, 1994, NEUROCHEM RES, V19, P1531, DOI 10.1007/BF00969002; Castiglia D, 1996, BIOCHEM BIOPH RES CO, V218, P390, DOI 10.1006/bbrc.1996.0068; CASTIGLIA D, 1993, NUCLEIC ACIDS RES, V21, P1674, DOI 10.1093/nar/21.7.1674; CASTIGLIA D, 1992, CELL MOL NEUROBIOL, V12, P259, DOI 10.1007/BF00712930; CESTELLI A, 1992, CELL MOL NEUROBIOL, V12, P33, DOI 10.1007/BF00711637; Cuezva JM, 1997, J BIOENERG BIOMEMBR, V29, P365, DOI 10.1023/A:1022450831360; CURTIS D, 1995, CELL, V81, P171, DOI 10.1016/0092-8674(95)90325-9; DILIEGRO I, 1990, CELL MOL NEUROBIOL, V10, P267, DOI 10.1007/BF00734579; DOMINGUEZ V, 1992, DEVELOPMENT, V115, P181; Dubnau J, 1996, NATURE, V379, P694, DOI 10.1038/379694a0; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; GRAY NK, 1994, EMBO J, V13, P3882, DOI 10.1002/j.1460-2075.1994.tb06699.x; GRUNWALD D, 1991, EXP CELL RES, V194, P174, DOI 10.1016/0014-4827(91)90350-4; HENTZE MW, 1995, CURR OPIN CELL BIOL, V7, P393, DOI 10.1016/0955-0674(95)80095-6; Izquierdo JM, 1997, MOL CELL BIOL, V17, P5255, DOI 10.1128/MCB.17.9.5255; KHOCHBIN S, 1991, FEBS LETT, V283, P65, DOI 10.1016/0014-5793(91)80554-G; KHOCHBIN S, 1994, EUR J BIOCHEM, V225, P501, DOI 10.1111/j.1432-1033.1994.00501.x; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LATHAM VM, 1994, J CELL BIOL, V126, P1211, DOI 10.1083/jcb.126.5.1211; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; MARUSICH MF, 1994, J NEUROBIOL, V25, P143, DOI 10.1002/neu.480250206; MATTAJ IW, 1993, CELL, V73, P837, DOI 10.1016/0092-8674(93)90265-R; MCCARTHY JEG, 1995, TRENDS BIOCHEM SCI, V20, P191, DOI 10.1016/S0968-0004(00)89006-4; MOORMAN AFM, 1987, DIFFERENTIATION, V35, P100, DOI 10.1111/j.1432-0436.1987.tb00156.x; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4; NAKAMURA M, 1994, NEURON, V13, P67, DOI 10.1016/0896-6273(94)90460-X; PEHRSON J, 1980, NATURE, V285, P43, DOI 10.1038/285043a0; Pennisi E, 1996, SCIENCE, V274, P503, DOI 10.1126/science.274.5287.503; PINA B, 1987, EUR J BIOCHEM, V164, P71, DOI 10.1111/j.1432-1033.1987.tb10994.x; PINA B, 1987, DEV BIOL, V123, P51, DOI 10.1016/0012-1606(87)90426-X; PINA B, 1984, BIOCHEM BIOPH RES CO, V123, P697, DOI 10.1016/0006-291X(84)90285-7; RiveraPomar R, 1996, NATURE, V379, P746, DOI 10.1038/379746a0; ROBINOW S, 1988, SCIENCE, V242, P1570, DOI 10.1126/science.3144044; ROCHE J, 1985, NATURE, V314, P197, DOI 10.1038/314197a0; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; SALLES FJ, 1994, SCIENCE, V266, P1996, DOI 10.1126/science.7801127; SCATURRO M, 1995, NEUROCHEM RES, V20, P969, DOI 10.1007/BF00970744; Sossin WS, 1996, TRENDS NEUROSCI, V19, P215; Steward Oswald, 1995, Current Opinion in Neurobiology, V5, P55, DOI 10.1016/0959-4388(95)80087-5; STJOHNSTON D, 1992, P NATL ACAD SCI USA, V89, P10979, DOI 10.1073/pnas.89.22.10979; STJOHNSTON D, 1995, CELL, V81, P161, DOI 10.1016/0092-8674(95)90324-0; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; SZABO A, 1991, CELL, V67, P325, DOI 10.1016/0092-8674(91)90184-Z; TAYLOR SJ, 1994, NATURE, V368, P867, DOI 10.1038/368867a0; WILHELM JE, 1993, J CELL BIOL, V123, P269, DOI 10.1083/jcb.123.2.269; WOLFFE A, 1995, CHROMATIN STRUCTURE, P148; ZAIDI SHE, 1994, J BIOL CHEM, V269, P24007; ZLATANOVA JS, 1980, FEBS LETT, V112, P199, DOI 10.1016/0014-5793(80)80179-7	55	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22788	22791		10.1074/jbc.273.35.22788	http://dx.doi.org/10.1074/jbc.273.35.22788			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712912	hybrid			2022-12-27	WOS:000075616600088
J	Collins, M; Rojnuckarin, P; Zhu, YH; Bornstein, P				Collins, M; Rojnuckarin, P; Zhu, YH; Bornstein, P			A far upstream, cell type-specific enhancer of the mouse thrombospondin 3 gene is located within intron 6 of the adjacent metaxin gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SP1; MATRIX PROTEIN COMP; SYNERGISTIC ACTIVATION; RAT CHONDROSARCOMA; GAUCHER-DISEASE; BINDING PROTEIN; RECEPTOR; ELEMENT; EXPRESSION; PSEUDOACHONDROPLASIA	Thrombospondin 3 (TSP3) is a secreted, pentameric glycoprotein whose regulation of expression and function are not well understood. Mouse Thbs3 is located just downstream from the divergently transcribed metaxin gene (Mtx), which encodes an outer mitochondrial membrane import. protein. Although Thbs3 and Mtx share a common promoter region, previous studies showed that Mtx is regulated by proximal elements that had Little effect on Thbs3 expression. In this study, transient transfection. of rat chondrosarcoma cells and NIH-3T3 fibroblasts demonstrated that Thbs3 is regulated in a cell type-specific manner by a position- and orientation-independent far upstream enhancer located within intron 6 of Mtx. Despite its greater proximity to the transcription start site of Mtx, the Thbs3 enhancer did not have a significant effect on Mtx expression. Two DNA-protein complexes, which were both required for activity, were identified when nuclear extracts were assayed with a probe containing the enhancer sequence. The protein ire one of these complexes was identified as Spl, while the other DNA-protein complex remains uncharacterized. A B-kilobase pair promoter containing the enhancer was able to direct specific expression of the E. coli lacZ gene in transgenic mice, whereas a 2-kilobase pair promoter that lacked the enhancer was inactive. Thus, despite their close proximity, the genes of the Mtx/Thbs3 gene cluster are regulated independently.	Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Bornstein, P (corresponding author), Univ Washington, Dept Biochem, J-341-HSB,Box 357350, Seattle, WA 98195 USA.	bornsten@u.washington.edu	Collins, Malcolm/G-4046-2011	Collins, Malcolm/0000-0002-2564-0480	FIC NIH HHS [1 F05 TW05218-01] Funding Source: Medline; NIA NIH HHS [AG 13280] Funding Source: Medline; NIDCR NIH HHS [DE 08229] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [F05TW005218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE008229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013280] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams J. C., 1995, THROMBOSPONDIN GENE; ANDERSON GM, 1991, MOL CELL BIOL, V11, P1935, DOI 10.1128/MCB.11.4.1935; ARBER S, 1995, J CELL BIOL, V131, P1083, DOI 10.1083/jcb.131.4.1083; Armstrong LC, 1997, J BIOL CHEM, V272, P6510, DOI 10.1074/jbc.272.10.6510; BEUTLER E, 1995, ADV GENET, V32, P17; BORNSTEIN P, 1993, GENOMICS, V15, P607, DOI 10.1006/geno.1993.1114; BORNSTEIN P, 1995, P NATL ACAD SCI USA, V92, P4547, DOI 10.1073/pnas.92.10.4547; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; BORNSTEIN P, 1994, METHOD ENZYMOL, V245, P62; BORNSTEIN P, 1991, P NATL ACAD SCI USA, V88, P8636, DOI 10.1073/pnas.88.19.8636; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; Chen SS, 1997, NUCLEIC ACIDS RES, V25, P3261, DOI 10.1093/nar/25.16.3261; CHOI HU, 1971, P NATL ACAD SCI USA, V68, P877, DOI 10.1073/pnas.68.5.877; Collins M, 1996, NUCLEIC ACIDS RES, V24, P3661, DOI 10.1093/nar/24.19.3661; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; DICESARE P, 1994, FEBS LETT, V354, P237, DOI 10.1016/0014-5793(94)01134-6; FRAMSON P, 1993, J BIOL CHEM, V268, P4989; Gao AG, 1996, J BIOL CHEM, V271, P21, DOI 10.1074/jbc.271.1.21; HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325; HOGAN B, 1986, MANIPULATING MOUSE E; IRUELAARISPE ML, 1993, DEV DYNAM, V197, P40, DOI 10.1002/aja.1001970105; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lafeuillade B, 1996, J CELL PHYSIOL, V167, P164, DOI 10.1002/(SICI)1097-4652(199604)167:1<164::AID-JCP19>3.3.CO;2-0; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LAWLER J, 1993, J CELL BIOL, V120, P1059, DOI 10.1083/jcb.120.4.1059; LAWLER J, 1989, BLOOD, V74, P2022; LAWLER J, 1995, J BIOL CHEM, V270, P2809, DOI 10.1074/jbc.270.6.2809; LEE KAW, 1990, METHOD ENZYMOL, V181, P20; LEE YH, 1994, MOL CELL BIOL, V14, P1383, DOI 10.1128/MCB.14.2.1383; Malashkevich VN, 1996, SCIENCE, V274, P761, DOI 10.1126/science.274.5288.761; MERCER EH, 1991, NEURON, V7, P703, DOI 10.1016/0896-6273(91)90274-4; Mikhailenko I, 1997, J BIOL CHEM, V272, P6784, DOI 10.1074/jbc.272.10.6784; MUKHOPADHYAY K, 1995, J BIOL CHEM, V270, P27711, DOI 10.1074/jbc.270.46.27711; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; QABAR A, 1995, J BIOL CHEM, V270, P12725, DOI 10.1074/jbc.270.21.12725; QABAR AN, 1994, J BIOL CHEM, V269, P1262; ROSENTHAL N, 1987, METHOD ENZYMOL, V152, P704; SANCHEZ HB, 1995, J BIOL CHEM, V270, P1161, DOI 10.1074/jbc.270.3.1161; Tucker RP, 1997, DEV DYNAM, V208, P326, DOI 10.1002/(SICI)1097-0177(199703)208:3<326::AID-AJA4>3.0.CO;2-K; TUCKER RP, 1995, DEV DYNAM, V203, P477, DOI 10.1002/aja.1002030410; TYBULEWICZ VLJ, 1992, NATURE, V357, P407, DOI 10.1038/357407a0; Urry LA, 1998, DEV DYNAM, V211, P390, DOI 10.1002/(SICI)1097-0177(199804)211:4<390::AID-AJA10>3.0.CO;2-8; VOS HL, 1995, MAMM GENOME, V6, P820, DOI 10.1007/BF00539013; VOS HL, 1992, J BIOL CHEM, V267, P12192	47	5	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21816	21824		10.1074/jbc.273.34.21816	http://dx.doi.org/10.1074/jbc.273.34.21816			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705320	hybrid			2022-12-27	WOS:000075492600054
J	Ho, PD; Zechner, DK; He, HP; Dillman, WH; Glembotski, CC; McDonough, PM				Ho, PD; Zechner, DK; He, HP; Dillman, WH; Glembotski, CC; McDonough, PM			The Raf-MEK-ERK cascade represents a common pathway for alteration of intracellular calcium by Ras and protein kinase C in cardiac myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; VENTRICULAR MYOCYTES; PHORBOL ESTERS; HYPERTROPHY; HEART; ACTIVATION; CONTRACTION; STIMULATION; CELLS; CARDIOMYOCYTES	Ras and protein kinase C (PKC), which regulate the Raf-MEK-ERK cascade, may participate in the development of cardiac hypertrophy, a condition characterized by diminished and prolonged contractile calcium transients. To directly examine the influence of this pathway on intracellular calcium ([Ca2+](i)), cardiac myocytes were cotransfected with effectors of this pathway and with green fluorescent protein, which allowed the living transfected myocytes to be identified and examined for [Ca2+](i) via indo-1. Transfection with constitutively active Pas (Ha-Ras(V12)) increased cell size, decreased expression of the myofibrils and the calcium-regulatory enzyme SERCA2, and reduced the magnitude and prolonged the decay phase of the contractile [Ca2+](i) transients, Similar effects on [Ca2+](i) were obtained with Ha-Ras(V12S35), a Ras mutant that selectively couples to Raf, and with constitutively active Raf. in contrast, Ha-Ras(V12C40), a Ras mutant that activates the phosphatidylinositol 3-kinase pathway, had a lesser effect. The PKC-activating phorbol ester, phorbol 12-myristate 13-acetate, also prolonged the contractile [Ca2+](i) transients. Cotransfection with dnMEK inhibited the effects of Ha-RasV12, Raf, and phorbol 12-myristate 13-acetate on [Ca2+](i). The effects of Ha-Ras(V12) and Raf on [Ca2+]i were also counteracted by SERCA2 overexpression. Both Ras and PKC may thus regulate cardiac [Ca2+](i) via the Raf-MEK-ERK cascade, and this pathway may represent a critical determinant of cardiac physiological function.	San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; San Diego State Univ, Inst Mol Biol, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University	McDonough, PM (corresponding author), San Diego State Univ, Dept Biol, 5500 Campanile Dr, San Diego, CA 92182 USA.	pmcdonough@biology.sdsu.edu			NHLBI NIH HHS [HL-46345, NL/HL-25073, HL-54030] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046345, R01HL054030] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bailey BA, 1997, J MOL CELL CARDIOL, V29, P1823, DOI 10.1006/jmcc.1997.0422; BASSANI JWM, 1995, BIOPHYS J, V68, P1453, DOI 10.1016/S0006-3495(95)80318-8; Bogoyevitch MA, 1996, INT J BIOCHEM CELL B, V28, P1, DOI 10.1016/1357-2725(95)00142-5; BOGOYEVITCH MA, 1993, FEBS LETT, V317, P271, DOI 10.1016/0014-5793(93)81291-7; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DUNNMON PM, 1990, J MOL CELL CARDIOL, V22, P901, DOI 10.1016/0022-2828(90)90121-H; Giordano FJ, 1997, CIRCULATION, V96, P400; Gomez AM, 1997, SCIENCE, V276, P800, DOI 10.1126/science.276.5313.800; Gotshall KR, 1997, P NATL ACAD SCI USA, V94, P4710, DOI 10.1073/pnas.94.9.4710; GU X, 1994, CIRC RES, V75, P926, DOI 10.1161/01.RES.75.5.926; Hartong R, 1996, J MOL CELL CARDIOL, V28, P2467, DOI 10.1006/jmcc.1996.0239; HUNTER JJ, 1995, J BIOL CHEM, V270, P23173, DOI 10.1074/jbc.270.39.23173; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Launay S, 1997, J BIOL CHEM, V272, P10746; MARON BJ, 1981, AM HEART J, V102, P95, DOI 10.1016/0002-8703(81)90419-1; McDonough PM, 1997, J BIOL CHEM, V272, P24046, DOI 10.1074/jbc.272.38.24046; MCDONOUGH PM, 1992, J BIOL CHEM, V267, P11665; MOSES RL, 1989, J CELL SCI, V93, P95; MURAMATSU MA, 1989, MOL CELL BIOL, V9, P831, DOI 10.1128/MCB.9.2.831; PUCEAT M, 1994, J BIOL CHEM, V269, P16938; Qi M, 1996, AM J PHYSIOL-HEART C, V271, pH1031, DOI 10.1152/ajpheart.1996.271.3.H1031; Qi M, 1997, AM J PHYSIOL-HEART C, V272, pH2416, DOI 10.1152/ajpheart.1997.272.5.H2416; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; SOMMER JR, 1995, J MOL CELL CARDIOL, V27, P19, DOI 10.1016/S0022-2828(08)80004-1; THORBURN A, 1993, J BIOL CHEM, V268, P2244; TROPPMAIR J, 1994, J BIOL CHEM, V269, P7030; WANG JX, 1994, AM J PHYSIOL, V267, pH918, DOI 10.1152/ajpheart.1994.267.3.H918; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Wang YB, 1998, J BIOL CHEM, V273, P5423, DOI 10.1074/jbc.273.10.5423; WANKERL M, 1995, J MOL MED-JMM, V73, P487; WOODROW MA, 1993, J IMMUNOL, V150, P3853; Wu PSC, 1997, ENDOCRINOLOGY, V138, P114, DOI 10.1210/en.138.1.114; Zechner D, 1997, J CELL BIOL, V139, P115, DOI 10.1083/jcb.139.1.115; ZIMMER G, 1992, J AM COLL CARDIOL, V20, P1135, DOI 10.1016/0735-1097(92)90369-X; Zou YZ, 1996, J BIOL CHEM, V271, P33592, DOI 10.1074/jbc.271.52.33592	36	70	71	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21730	21735		10.1074/jbc.273.34.21730	http://dx.doi.org/10.1074/jbc.273.34.21730			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705309	hybrid			2022-12-27	WOS:000075492600043
J	ROISE, D; SCHATZ, G				ROISE, D; SCHATZ, G			MITOCHONDRIAL PRESEQUENCES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review											ROISE, D (corresponding author), UNIV BASEL, BIOCTR, CH-4056 BASEL, SWITZERLAND.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037803] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM37803-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLISON DS, 1986, P NATL ACAD SCI USA, V83, P9011, DOI 10.1073/pnas.83.23.9011; AUSTEN BM, 1984, BIOCHEM J, V224, P317, DOI 10.1042/bj2240317; BRIGGS MS, 1986, ADV PROTEIN CHEM, V38, P109, DOI 10.1016/S0065-3233(08)60527-6; BRIGGS MS, 1984, BIOCHEMISTRY-US, V23, P3111, DOI 10.1021/bi00309a001; CHEN LB, 1981, COLD SPRING HARB SYM, V46, P141, DOI 10.1101/SQB.1982.046.01.018; DIERSTEIN R, 1985, J BIOL CHEM, V260, P5919; DOUGLAS MG, 1986, MICROBIOL REV, V50, P166, DOI 10.1128/MMBR.50.2.166-178.1986; EILERS M, 1988, IN PRESS CELL; EPAND RM, 1986, J BIOL CHEM, V261, P17; GILLESPIE LL, 1985, J BIOL CHEM, V260, P6045; HAY R, 1984, BIOCHIM BIOPHYS ACTA, V779, P65, DOI 10.1016/0304-4157(84)90004-2; HURT EC, 1986, EMBO J, V5, P1343, DOI 10.1002/j.1460-2075.1986.tb04365.x; HURT EC, 1986, TRENDS BIOCHEM SCI, V11, P204, DOI 10.1016/0968-0004(86)90007-1; HURT EC, 1987, NATURE, V325, P499, DOI 10.1038/325499a0; ITO A, 1985, J BIOCHEM-TOKYO, V98, P1571, DOI 10.1093/oxfordjournals.jbchem.a135426; KATAKAI R, 1984, J AM CHEM SOC, V106, P5715, DOI 10.1021/ja00331a049; KELLEMS RE, 1975, J CELL BIOL, V65, P1, DOI 10.1083/jcb.65.1.1; Laxma Reddy G, 1986, FEBS Lett, V202, P349; MACCECCHINI ML, 1979, P NATL ACAD SCI USA, V76, P343, DOI 10.1073/pnas.76.1.343; MAJZOUB JA, 1980, J BIOL CHEM, V255, P1478; MYERS M, 1987, BIOCHEMISTRY-US, V26, P4309, DOI 10.1021/bi00388a019; OHBA M, 1987, EMBO J, V6, P2109, DOI 10.1002/j.1460-2075.1987.tb02477.x; PFANNER N, 1985, EMBO J, V4, P2819, DOI 10.1002/j.1460-2075.1985.tb04009.x; RIEZMAN H, 1983, EMBO J, V2, P1113, DOI 10.1002/j.1460-2075.1983.tb01554.x; ROISE D, 1986, EMBO J, V5, P1327, DOI 10.1002/j.1460-2075.1986.tb04363.x; ROISE D, 1988, IN PRESS EMBO J, V7; ROSENBLATT M, 1980, P NATL ACAD SCI-BIOL, V77, P3983, DOI 10.1073/pnas.77.7.3983; SCHATZ G, 1987, EUR J BIOCHEM, V165, P1, DOI 10.1111/j.1432-1033.1987.tb11186.x; SCHLEYER M, 1985, CELL, V43, P339, DOI 10.1016/0092-8674(85)90039-X; SCHWAIGER M, 1987, J CELL BIOL, V105, P235, DOI 10.1083/jcb.105.1.235; SHINNAR AE, 1984, J AM CHEM SOC, V106, P5006, DOI 10.1021/ja00329a063; SKERJANC IS, 1987, EMBO J, V6, P3117, DOI 10.1002/j.1460-2075.1987.tb02621.x; TAMM LK, 1986, BIOCHEMISTRY-US, V25, P7470, DOI 10.1021/bi00371a032; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; WATSON MEE, 1984, NUCLEIC ACIDS RES, V12, P5145, DOI 10.1093/nar/12.13.5145; YAFFE MP, 1985, EMBO J, V4, P2069, DOI 10.1002/j.1460-2075.1985.tb03893.x; ZWIZINSKI C, 1984, J BIOL CHEM, V259, P7850; ZWIZINSKI C, 1983, J BIOL CHEM, V258, P4071	38	379	383	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	1988	263	10					4509	4511						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	M7886	9729103				2022-12-27	WOS:A1988M788600001
J	Dadgostar, H; Cheng, GH				Dadgostar, H; Cheng, GH			An intact zinc ring finger is required for tumor necrosis factor receptor-associated factor-mediated nuclear factor-kappa B activation but is dispensable for c-Jun N-terminal kinase signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAF-INTERACTING PROTEIN; CYTOPLASMIC DOMAIN; FAMILY; CD40; MEMBER; BINDS; DEATH	The diverse biological effects of the tumor necrosis factor (TNF) receptor superfamily are believed to be mediated in part through TNF receptor-associated factors (TRAFs), a family of cytoplasmic adaptor proteins which can activate intracellular signaling pathways, including the nuclear factor-kappa B (NF-kappa B) and c-Jun N-terminal kinase (JNK) pathways. TRAFs 2, 5, and 6 strongly activate both pathways when overexpressed; however, TRAF 3 (a close homologue of TRAF 5) does not significantly activate either pathway. The current study addresses the structural basis for this difference by substituting corresponding domains of TRAF 5 into TRAF 3 and testing activation of both pathways. A small region of TRAF 5 (the first zinc finger and 10 residues of the second zinc finger) is sufficient to convert TRAF 3 into an activator of both pathways. Also, an intact zinc ring finger is required for NF-kappa B activation but not JNK activation. In agreement with this finding, TRAF 2A, a TRAF 2 splice variant with an altered ring finger, is a specific activator of JNK. These findings suggest that different domains of TRAFs may be involved in NF-kappa B and JNK signaling. Also, alternative splicing of TRAFs may represent a novel mechanism whereby TNF family receptors can mediate distinct downstream effects in different tissues.	Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Microbiol & Mol Genet, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Cheng, GH (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.	genhongc@microbio.ucla.edu			NIGMS NIH HHS [GM 08042] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akiba H, 1998, J BIOL CHEM, V273, P13353, DOI 10.1074/jbc.273.21.13353; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Brink R, 1998, J BIOL CHEM, V273, P4129, DOI 10.1074/jbc.273.7.4129; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; CHENG GH, 1995, SCIENCE, V267, P1494, DOI 10.1126/science.7533327; Cheng GH, 1996, GENE DEV, V10, P963, DOI 10.1101/gad.10.8.963; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; HU HM, 1994, J BIOL CHEM, V269, P30069; Ishida T, 1996, P NATL ACAD SCI USA, V93, P9437, DOI 10.1073/pnas.93.18.9437; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Lee SY, 1997, J EXP MED, V185, P1275, DOI 10.1084/jem.185.7.1275; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; Nakano H, 1996, J BIOL CHEM, V271, P14661, DOI 10.1074/jbc.271.25.14661; REGNIER CH, 1995, J BIOL CHEM, V270, P25715, DOI 10.1074/jbc.270.43.25715; Relaix F, 1998, NAT GENET, V18, P287, DOI 10.1038/ng0398-287; Rothe M, 1996, P NATL ACAD SCI USA, V93, P8241, DOI 10.1073/pnas.93.16.8241; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; SATO T, 1995, FEBS LETT, V358, P113, DOI 10.1016/0014-5793(94)01406-Q; Shi CS, 1997, J BIOL CHEM, V272, P32102, DOI 10.1074/jbc.272.51.32102; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X	31	60	67	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24775	24780		10.1074/jbc.273.38.24775	http://dx.doi.org/10.1074/jbc.273.38.24775			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733779	hybrid			2022-12-27	WOS:000076007300071
J	Le Dantec, L; Castroviejo, M; Bove, JM; Saillard, C				Le Dantec, L; Castroviejo, M; Bove, JM; Saillard, C			Purification, cloning, and preliminary characterization of a Spiroplasma citri ribosomal protein with DNA binding capacity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIUM MYCOPLASMA-PNEUMONIAE; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; PSEUDOMONAS-AERUGINOSA; HYDROXYLAMINE CLEAVAGE; PHYLOGENETIC ANALYSIS; POLYACRYLAMIDE GELS; SEQUENCE-ANALYSIS; GENE-CLUSTER; HISTONE H1	The rpsB-tsf-x operon of Spiroplasma citri encodes ribosomal protein S2 and elongation factor Ts, two components of the translational apparatus, and an unidentified X protein. A potential DNA-binding site (a 20-base pair (bp) inverted repeat sequence) is located at the 3' end of rpsB. Southwestern analysis of S. citri proteins, with a 30-bp double-stranded oligonucleotide probe (IRS), containing the 20-bp inverted repeat sequence and the genomic flanking sequences, detected an IRS-binding protein of 46 kDa (P46). P46 protein, which displays preferential affinity for the IRS, was purified from S. citri by a combination of affinity and gel filtration chromatographies. The native form of P46 seems to be homomultimeric as estimated by SDS-polyacrylamide gel electrophoresis analysis and gel filtration. A 3.5-kilobase pair S. citri DNA fragment comprising the P46 gene and flanking sequences was cloned and sequenced. Sequence analysis of this DNA fragment indicated that the P46 gene is located within the S10-spc operon of S. citri at the position of the gene coding for ribosomal protein L29 in the known S10-spc operons, The similarity between the N-terminal domain of P46 and the L29 ribosomal protein family and the presence of a 46-kDa IRS-binding protein in S. citri ribosomes indicated that P46 is the L29 ribosomal protein of S. citri, We suggest that P46 is a bifunctional protein with an L29 N-terminal domain and a C-terminal domain involved in IRS binding.	INRA, Biol Cellulaire & Mol Lab, F-33883 Villenave Dornon, France; Univ Victor Segalen Bordeaux 2, F-33883 Villenave Dornon, France; Inst Biochim & Genet Cellulaires, F-33077 Bordeaux, France; CNRS, F-33077 Bordeaux, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS)	Saillard, C (corresponding author), INRA, Biol Cellulaire & Mol Lab, BP 81, F-33883 Villenave Dornon, France.	saillard@bordeaux.inra.fr						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AN G, 1981, NUCLEIC ACIDS RES, V9, P4163, DOI 10.1093/nar/9.16.4163; ARNOLDSCHULZGAHMEN B, 1994, J BACTERIOL, V176, P50, DOI 10.1128/JB.176.1.50-60.1994; BENDIAK DS, 1981, MOL GEN GENET, V181, P356, DOI 10.1007/BF00425611; BORNSTEIN P, 1970, J BIOL CHEM, V245, P4854; Bornstein P, 1977, Methods Enzymol, V47, P132; Bove J.M., 1993, CLIN INFECT DIS, V17, P10; BOWEN B, 1980, NUCLEIC ACIDS RES, V8, P1, DOI 10.1093/nar/8.1.1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRICKMAN TJ, 1993, J BACTERIOL, V175, P4274, DOI 10.1128/JB.175.14.4274-4281.1993; Buttner K, 1997, J BASIC MICROB, V37, P3; CERRETTI DP, 1983, NUCLEIC ACIDS RES, V11, P2599, DOI 10.1093/nar/11.9.2599; CHANGCHIEN LM, 1986, NUCLEIC ACIDS RES, V14, P1957, DOI 10.1093/nar/14.5.1957; Cordwell SJ, 1997, GENE, V195, P113, DOI 10.1016/S0378-1119(97)00063-2; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DERETIC V, 1990, J BACTERIOL, V172, P5544, DOI 10.1128/jb.172.10.5544-5554.1990; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Gouzy J, 1996, TRENDS BIOCHEM SCI, V21, P493, DOI 10.1016/S0968-0004(96)30040-6; Gryaznova OI, 1996, BIOCHIMIE, V78, P915, DOI 10.1016/S0300-9084(97)86713-2; GUDKOV AT, 1978, EUR J BIOCHEM, V90, P309, DOI 10.1111/j.1432-1033.1978.tb12605.x; GUDKOV AT, 1977, FEBS LETT, V82, P125, DOI 10.1016/0014-5793(77)80901-0; HARDY SJS, 1975, MOL GEN GENET, V140, P253, DOI 10.1007/BF00334270; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; Hilbert H, 1996, NUCLEIC ACIDS RES, V24, P628, DOI 10.1093/nar/24.4.628; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; KATO J, 1990, P NATL ACAD SCI USA, V87, P2887, DOI 10.1073/pnas.87.8.2887; KONYECSNI WM, 1990, J BACTERIOL, V172, P2511, DOI 10.1128/jb.172.5.2511-2520.1990; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEDANTEC L, 1998, IN PRESS CURR MICROB; Li X, 1997, J BACTERIOL, V179, P7046, DOI 10.1128/jb.179.22.7046-7054.1997; LINDAHL L, 1990, BIOCHIM BIOPHYS ACTA, V1050, P337, DOI 10.1016/0167-4781(90)90191-4; MATTHAEI JH, 1961, P NATL ACAD SCI USA, V47, P1580, DOI 10.1073/pnas.47.10.1580; MICHAEL N, 1988, SCIENCE, V239, P1531, DOI 10.1126/science.2832940; MISKIMINS WK, 1985, P NATL ACAD SCI USA, V82, P6741, DOI 10.1073/pnas.82.20.6741; MOLLER W, 1972, EUR J BIOCHEM, V25, P5, DOI 10.1111/j.1432-1033.1972.tb01660.x; MYERS DA, 1988, J BIOL CHEM, V263, P17122; Oberto J, 1996, MOL MICROBIOL, V19, P1319, DOI 10.1111/j.1365-2958.1996.tb02476.x; OHKUBO S, 1987, MOL GEN GENET, V210, P314, DOI 10.1007/BF00325700; PABO CO, 1984, ANNU REV BIOCHEM, V53, P293, DOI 10.1146/annurev.bi.53.070184.001453; Pedersen LB, 1996, MOL MICROBIOL, V20, P295, DOI 10.1111/j.1365-2958.1996.tb02618.x; PEDERSEN S, 1978, CELL, V14, P179, DOI 10.1016/0092-8674(78)90312-4; PERARA E, 1992, P NATL ACAD SCI USA, V89, P2125, DOI 10.1073/pnas.89.6.2125; POST LE, 1978, CELL, V15, P215, DOI 10.1016/0092-8674(78)90096-X; ROGERS MJ, 1985, P NATL ACAD SCI USA, V82, P1160, DOI 10.1073/pnas.82.4.1160; SAGLIO P, 1973, INT J SYST BACTERIOL, V23, P191, DOI 10.1099/00207713-23-3-191; SALTI V, 1989, BIOCHIM BIOPHYS ACTA, V1009, P161, DOI 10.1016/0167-4781(89)90096-1; Sambrook J., 2002, MOL CLONING LAB MANU; SARIS CJM, 1983, ANAL BIOCHEM, V132, P54, DOI 10.1016/0003-2697(83)90425-6; SCARLATO V, 1995, MOL MICROBIOL, V15, P871, DOI 10.1111/j.1365-2958.1995.tb02357.x; SONNHAMMER ELL, 1994, PROTEIN SCI, V3, P482; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STADEN R, 1982, NUCLEIC ACIDS RES, V10, P141, DOI 10.1093/nar/10.1.141; SUBRAMANIAN AR, 1975, J MOL BIOL, V95, P1, DOI 10.1016/0022-2836(75)90330-7; TISSIERES A, 1959, J MOL BIOL, V1, P221, DOI 10.1016/S0022-2836(59)80029-2; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TULLY JG, 1977, SCIENCE, V195, P892, DOI 10.1126/science.841314; WAGAR EA, 1988, INFECT IMMUN, V56, P1678, DOI 10.1128/IAI.56.7.1678-1684.1988; WEISBURG WG, 1989, J BACTERIOL, V171, P6455, DOI 10.1128/jb.171.12.6455-6467.1989; WILSON CM, 1979, ANAL BIOCHEM, V96, P263, DOI 10.1016/0003-2697(79)90581-5; WOESE CR, 1980, P NATL ACAD SCI-BIOL, V77, P494, DOI 10.1073/pnas.77.1.494; WOOL IG, 1993, TRANSLATIONAL APPARATUS, P727; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; WOOL IG, 1996, RIBOSOMAL RNA GROUP, P153; YOSHIKAWA H, 1990, NUCLEIC ACIDS RES, V18, P1647, DOI 10.1093/nar/18.6.1647; ZENGEL JM, 1994, PROG NUCLEIC ACID RE, V47, P331, DOI 10.1016/S0079-6603(08)60256-1; Zouine M, 1996, FEMS MICROBIOL LETT, V145, P41; ZURAWSKI G, 1985, NUCLEIC ACIDS RES, V13, P4521, DOI 10.1093/nar/13.12.4521	69	5	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24379	24386		10.1074/jbc.273.38.24379	http://dx.doi.org/10.1074/jbc.273.38.24379			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733727	Green Published, hybrid			2022-12-27	WOS:000076007300019
J	Luttik, MAH; Overkamp, KM; Kotter, P; de Vries, S; van Dijken, JP; Pronk, JT				Luttik, MAH; Overkamp, KM; Kotter, P; de Vries, S; van Dijken, JP; Pronk, JT			The Saccharomyces cerevisiae NDE1 and NDE2 genes encode separate mitochondrial NADH dehydrogenases catalyzing the oxidation of cytosolic NADH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIMITED CHEMOSTAT CULTURES; ROTENONE-INSENSITIVE NADH; UBIQUINONE OXIDOREDUCTASE; METABOLIC RESPONSES; RESPIRATORY-CHAIN; CANDIDA-UTILIS; GLUCOSE EXCESS; YEAST; PURIFICATION; CELLS	In Saccharomyces cerevisiae, the NDI1 gene encodes a mitochondrial NADH dehydrogenase, the catalytic side of which projects to the matrix side of the inner mitochondrial membrane, In addition to this NADH dehydrogenase, S. cerevisiae exhibits another mitochondrial NADH-dehydrogenase activity, which oxidizes NADH at the cytosolic side of the inner membrane. To investigate whether open reading frames YMR145c/NDE1 and YDL 085w/NDE2, which exhibit sequence similarity with NDI1, encode the latter enzyme, NADH-dependent mitochondrial respiration was assayed in wild-type S. cerevisiae and nde deletion mutants. Mitochondria were isolated from aerobic, glucose-limited chemostat cultures grown at a dilution rate (D) of 0.10 h(-1), in which reoxidation of cytosolic NADH by wild-type cells occurred exclusively by respiration. Compared with the wild type, rates of mitochondrial NADH oxidation were about 3-fold reduced in an nde1 Delta mutant and unaffected in an nde2 mutant. NADH-dependent mitochondrial respiration was completely abolished in an nde1 Delta nde2 Delta double mutant. Mitochondrial respiration of substrates other than NADH was not affected in nde mutants, In shake flasks, an nde1 Delta nde2 Delta mutant exhibited reduced specific growth rates on ethanol and galactose but not on glucose, Glucose metabolism in aerobic, glucose-limited chemostat cultures (D = 0.10 h(-1)) of an nde1 Delta nde2 Delta mutant was essentially respiratory. Apparently, under these conditions alternative systems for reoxidation of cytosolic NADH could replace the role of Nde1p and Nde2p in S. cerevisiae,	Delft Univ Technol, Kluyver Inst Biotechnol, Dept Microbiol & Enzymol, NL-2628 BC Delft, Netherlands; Goethe Univ Frankfurt, Inst Mikrobiol, Biozentrum N250, D-60439 Frankfurt, Germany	Delft University of Technology; Goethe University Frankfurt	Pronk, JT (corresponding author), Delft Univ Technol, Kluyver Inst Biotechnol, Dept Microbiol & Enzymol, Julianalaan 67, NL-2628 BC Delft, Netherlands.	j.t.pronk@stm.tudelft.nl		Pronk, Jack/0000-0002-5617-4611; Luttik, Marijke/0000-0002-9798-8072				AINSWORTH PJ, 1980, ARCH BIOCHEM BIOPHYS, V202, P172, DOI 10.1016/0003-9861(80)90420-8; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ausubel FM, 1988, MOL REPROD DEV; Beudecher R.F., 1990, YEAST BIOTECHNOLOGY, P103; Bjorkqvist S, 1997, APPL ENVIRON MICROB, V63, P128; BRUINENBERG PM, 1985, J GEN MICROBIOL, V131, P1043; CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65; DAWSON AG, 1979, TRENDS BIOCHEM SCI, V4, P171, DOI 10.1016/0968-0004(79)90417-1; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DEVRIES S, 1988, EUR J BIOCHEM, V176, P377; DEVRIES S, 1992, EUR J BIOCHEM, V203, P587; DEVRIES S, 1987, BIOCHIM BIOPHYS ACTA, V895, P205, DOI 10.1016/S0304-4173(87)80003-4; DOUCE R, 1989, ANNU REV PLANT PHYS, V40, P371, DOI 10.1146/annurev.pp.40.060189.002103; Flikweert MT, 1997, APPL ENVIRON MICROB, V63, P3399, DOI 10.1128/AEM.63.9.3399-3404.1997; GANCEDO JM, 1992, EUR J BIOCHEM, V206, P297, DOI 10.1111/j.1432-1033.1992.tb16928.x; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; HENSING MCM, 1995, ANTON LEEUW INT J G, V67, P261, DOI 10.1007/BF00873690; HOLLENBERG CP, 1970, BIOCHIM BIOPHYS ACTA, V201, P13, DOI 10.1016/0304-4165(70)90004-8; HUXLEY C, 1990, TRENDS GENET, V6, P236, DOI 10.1016/0168-9525(90)90190-H; KAPPELI O, 1986, ADV MICROB PHYSIOL, V28, P181; LAGUNAS R, 1986, YEAST, V2, P221, DOI 10.1002/yea.320020403; Larsson C, 1998, YEAST, V14, P347, DOI 10.1002/(SICI)1097-0061(19980315)14:4<347::AID-YEA226>3.0.CO;2-9; LEHNINGER AL, 1955, HARVEY LECT, P176; MARRES CAM, 1991, EUR J BIOCHEM, V195, P857, DOI 10.1111/j.1432-1033.1991.tb15775.x; MOLLER IM, 1986, ANNU REV PLANT PHYS, V37, P309, DOI 10.1146/annurev.arplant.37.1.309; NOORMAN HJ, 1991, J GEN MICROBIOL, V137, P2171, DOI 10.1099/00221287-137-9-2171; Norbeck J, 1996, J BIOL CHEM, V271, P13875, DOI 10.1074/jbc.271.23.13875; OHNISHI T, 1973, BIOCHIM BIOPHYS ACTA, V301, P105, DOI 10.1016/0304-4173(73)90001-3; OHNISHI T, 1966, J BIOL CHEM, V241, P1797; PATCHETT RA, 1986, A VAN LEEUW J MICROB, V52, P387, DOI 10.1007/BF00393466; PETRIK M, 1983, J GEN MICROBIOL, V129, P43; PLUTHERO FG, 1993, NUCLEIC ACIDS RES, V21, P4850, DOI 10.1093/nar/21.20.4850; POSTMA E, 1989, APPL ENVIRON MICROB, V55, P468, DOI 10.1128/AEM.55.2.468-477.1989; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; RONNOW B, 1993, YEAST, V9, P1121, DOI 10.1002/yea.320091013; VANDIJKEN JP, 1986, FEMS MICROBIOL LETT, V32, P199, DOI 10.1016/0378-1097(86)90291-0; VANURK H, 1988, YEAST, V4, P283, DOI 10.1002/yea.320040406; VERDUYN C, 1991, ANTON LEEUW INT J G, V60, P325, DOI 10.1007/BF00430373; VERDUYN C, 1990, J GEN MICROBIOL, V136, P395, DOI 10.1099/00221287-136-3-395; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; von Jagow G, 1970, Eur J Biochem, V12, P583; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang XP, 1998, J BACTERIOL, V180, P822, DOI 10.1128/JB.180.4.822-830.1998; WEUSTHUIS RA, 1994, MICROBIOL-SGM, V140, P703, DOI 10.1099/00221287-140-4-703	46	217	227	6	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24529	24534		10.1074/jbc.273.38.24529	http://dx.doi.org/10.1074/jbc.273.38.24529			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733747	hybrid			2022-12-27	WOS:000076007300039
J	Park, K; Mukhopadhyay, S; Chattoraj, DK				Park, K; Mukhopadhyay, S; Chattoraj, DK			Requirements for and regulation of origin opening of plasmid P1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPY-NUMBER CONTROL; ESCHERICHIA-COLI; DNA-REPLICATION; INITIATOR PROTEIN; NEGATIVE CONTROL; REPA GENE; BINDING; INCOMPATIBILITY; SEQUESTRATION; MAINTENANCE	Origin opening is essential for the initiation of DNA replication in the theta mode and requires binding of initiator proteins. Using reactivity to KMnO4 in vivo as an assay, we find that, like initiation, origin opening of the Escherichia coli plasmid P1 requires the host initiators DnaA and HU and the plasmid-encoded initiator RepA. The ability to detect opening at the P1ori in vivo allowed us to study this activity at various copy numbers in chimeric replicons, The opening was prevented when the P1ori was cloned in high copy vectors or when excess RepA binding sites (iterons) mere provided in trans. However, when RepA supply was also increased, the opening was efficient. A further increase in RepA prevented opening. Replication of an incoming pi under these conditions correlated with opening. These results demonstrate that initiation is possible even at abnormally high origin concentrations and that oversupply of RepA, relative to iterons, can prevent replication by blocking origin opening. It appears that plasmid overreplication can be prevented either by limiting RepA or by accumulating RepA at a rate higher than that of the origin.	NCI, Biochem Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chattoraj, DK (corresponding author), NCI, Biochem Lab, NIH, 37-4D-18, Bethesda, MD 20892 USA.							ABELES AL, 1990, J BACTERIOL, V172, P4386, DOI 10.1128/jb.172.8.4386-4391.1990; ABELES AL, 1991, P NATL ACAD SCI USA, V88, P9011, DOI 10.1073/pnas.88.20.9011; Abeles AL, 1995, MOL MICROBIOL, V18, P903, DOI 10.1111/j.1365-2958.1995.18050903.x; AUSTIN SJ, 1985, J MOL BIOL, V183, P195, DOI 10.1016/0022-2836(85)90212-8; BRAMHILL D, 1988, CELL, V54, P915, DOI 10.1016/0092-8674(88)90102-X; BRAUN RE, 1985, CELL, V40, P159, DOI 10.1016/0092-8674(85)90319-8; CARL PL, 1970, MOL GEN GENET, V109, P107, DOI 10.1007/BF00269647; CHATTORAJ D, 1984, P NATL ACAD SCI-BIOL, V81, P6456, DOI 10.1073/pnas.81.20.6456; Chattoraj D K, 1995, Genet Eng (N Y), V17, P81; Chattoraj DK, 1997, PROG NUCLEIC ACID RE, V57, P145, DOI 10.1016/S0079-6603(08)60280-9; CHATTORAJ DK, 1988, CELL, V52, P551, DOI 10.1016/0092-8674(88)90468-0; CHURCHWARD G, 1984, GENE, V31, P165, DOI 10.1016/0378-1119(84)90207-5; DURLAND RH, 1990, J BACTERIOL, V172, P3849, DOI 10.1128/jb.172.7.3849-3858.1990; FILUTOWICZ M, 1986, P NATL ACAD SCI USA, V83, P9645, DOI 10.1073/pnas.83.24.9645; HANSEN EB, 1986, P NATL ACAD SCI USA, V83, P4423, DOI 10.1073/pnas.83.12.4423; INGMER H, 1993, J BACTERIOL, V175, P7834, DOI 10.1128/JB.175.24.7834-7841.1993; Kawasaki Y, 1996, MOL GEN GENET, V253, P42, DOI 10.1007/s004380050294; KIM K, 1985, J MOL BIOL, V185, P755, DOI 10.1016/0022-2836(85)90060-9; Konieczny I, 1997, J BIOL CHEM, V272, P20173, DOI 10.1074/jbc.272.32.20173; LIN LS, 1986, PLASMID, V15, P35, DOI 10.1016/0147-619X(86)90012-0; MALLORY JB, 1990, J BIOL CHEM, V265, P13297; MCEACHERN MJ, 1989, P NATL ACAD SCI USA, V86, P7942, DOI 10.1073/pnas.86.20.7942; MUKHOPADHYAY G, 1993, EMBO J, V12, P4547, DOI 10.1002/j.1460-2075.1993.tb06143.x; MURAISO K, 1990, J BACTERIOL, V172, P4441, DOI 10.1128/jb.172.8.4441-4447.1990; OGURA T, 1990, MOL GEN GENET, V220, P197; PAL SK, 1986, J MOL BIOL, V192, P275, DOI 10.1016/0022-2836(86)90364-5; PAL SK, 1988, J BACTERIOL, V170, P3554, DOI 10.1128/jb.170.8.3554-3560.1988; PAPP PP, 1994, J BIOL CHEM, V269, P23563; Sambrook J., 2002, MOL CLONING LAB MANU; SOM T, 1982, MOL GEN GENET, V187, P375, DOI 10.1007/BF00332615; SOZHAMANNAN S, 1993, J BACTERIOL, V175, P3546, DOI 10.1128/jb.175.11.3546-3555.1993; SUTTON MD, 1995, J BACTERIOL, V177, P6657, DOI 10.1128/jb.177.22.6657-6665.1995; SWACK JA, 1987, J BACTERIOL, V169, P3737, DOI 10.1128/jb.169.8.3737-3742.1987; TERAWAKI Y, 1990, J BACTERIOL, V172, P786, DOI 10.1128/jb.172.2.786-792.1990; TSUTSUI H, 1983, J BACTERIOL, V155, P337, DOI 10.1128/JB.155.1.337-344.1983; WADA M, 1988, J MOL BIOL, V204, P581, DOI 10.1016/0022-2836(88)90357-9; WICKNER SH, 1987, P NATL ACAD SCI USA, V84, P3668, DOI 10.1073/pnas.84.11.3668	37	33	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24906	24911		10.1074/jbc.273.38.24906	http://dx.doi.org/10.1074/jbc.273.38.24906			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733797	hybrid			2022-12-27	WOS:000076007300089
J	Schwartzbauer, G; Yu, JH; Cheng, H; Menon, RK				Schwartzbauer, G; Yu, JH; Cheng, H; Menon, RK			Transcription factor MSY-1 regulates expression of the murine growth hormone receptor gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-SPECIFIC PROMOTER; BOX-BINDING PROTEINS; NF-Y; MESSENGER-RNA; DNA-BINDING; IDENTIFICATION; INVITRO; CLONING; FAMILY; SEQUENCE	Previous studies identified and partially characterized a 42-base pair regulatory element in the 5'-flanking region of the L1 transcript of the murine growth hormone (GH) receptor gene that interacted with both double- and single-stranded DNA-binding proteins. We present evidence that the double-stranded DNA-binding protein is NF-Y, a CCAAT box-binding protein. Experiments with a dominant negative form of NF-Y indicate that NF-Y does not play a direct role in regulating the activity of the FP42 element. A cDNA clone that specifically interacts with the upper (coding) strand of the regulatory element was isolated by screening a cDNA expression library using the Southwestern technique, DNA sequencing, electrophoretic mobility shift assay, Southwestern blot analysis, and supershift EMSA confirm the identity of the single-stranded binding protein to be MSY-1, a DNA-binding protein that is evolutionary conserved from prokaryotes to eukaryote, Mapping of single-stranded DNA configurations reveals that MSY-1 can facilitate the formation of single-stranded DNA regions in the GH receptor 5'-flanking region, Transient transfection experiments support the role of MSY-1 as a repressor of GH receptor gene activation. Southwestern blot analysis indicates that the levels of nuclear MSY-1 are decreased in the livers of pregnant mice, suggesting a role for MSY-1 in the increased expression of the GH receptor during pregnancy.	Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Menon, RK (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat, 3705 5th Ave, Pittsburgh, PA 15213 USA.	menon@chplink.chp.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007729, R29DK049845] Funding Source: NIH RePORTER; NIDDK NIH HHS [R29-DK49845, 5T32DK07729] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADAMS TE, 1995, MOL CELL ENDOCRINOL, V108, P23, DOI 10.1016/0303-7207(95)92575-9; Bargou RC, 1997, NAT MED, V3, P447, DOI 10.1038/nm0497-447; BOUCHER PD, 1995, MOL CELL BIOL, V15, P5144; Currie RA, 1998, J BIOL CHEM, V273, P1430, DOI 10.1074/jbc.273.3.1430; DORN A, 1987, CELL, V50, P863, DOI 10.1016/0092-8674(87)90513-7; FRAMSON P, 1993, J BIOL CHEM, V268, P4989; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Harvey S., 1995, GROWTH HORMONE; JOHNSON PF, 1994, LIVER GENE EXPRESSIO, P231; Koike K, 1997, FEBS LETT, V417, P390, DOI 10.1016/S0014-5793(97)01296-9; LIM LC, 1993, J BIOL CHEM, V268, P18008; LIWEBER M, 1994, J IMMUNOL, V153, P4122; LLOBERAS J, 1995, MOL CELL BIOL, V15, P5092; MACDONALD GH, 1995, J BIOL CHEM, V270, P3527, DOI 10.1074/jbc.270.8.3527; MANTOVANI R, 1994, J BIOL CHEM, V269, P20340; Maxam A M, 1980, Methods Enzymol, V65, P499; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MENON RK, 1995, J BIOL CHEM, V270, P8851, DOI 10.1074/jbc.270.15.8851; Menon RK, 1997, MOL ENDOCRINOL, V11, P1291, DOI 10.1210/me.11.9.1291; Mertens PR, 1997, J BIOL CHEM, V272, P22905, DOI 10.1074/jbc.272.36.22905; OMAHONEY JV, 1994, MOL CELL ENDOCRINOL, V101, P129, DOI 10.1016/0303-7207(94)90227-5; Orita T, 1997, J BIOL CHEM, V272, P23216, DOI 10.1074/jbc.272.37.23216; RONCHI A, 1995, NUCLEIC ACIDS RES, V23, P4565, DOI 10.1093/nar/23.22.4565; SAMBROOK J, 1969, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; SHERRIE R, 1990, P NATL ACAD SCI USA, V87, P9028; SIMON M, 1995, J BIOL CHEM, V270, P21445; SINGH H, 1988, CELL, V52, P415, DOI 10.1016/S0092-8674(88)80034-5; Sommerville J, 1996, FASEB J, V10, P435, DOI 10.1096/fasebj.10.4.8647342; SOUTHARD JN, 1995, ENDOCRINOLOGY, V136, P2913, DOI 10.1210/en.136.7.2913; TAFURI SR, 1993, J BIOL CHEM, V268, P12213; TAFURI SR, 1992, NEW BIOL, V4, P349; TORCZYNSKI R, 1983, MOL GEN GENET, V191, P427, DOI 10.1007/BF00425758; WOLFFE AP, 1992, NEW BIOL, V4, P290; WRIGHT KL, 1995, J BIOL CHEM, V270, P20978, DOI 10.1074/jbc.270.36.20978; ZOU LL, 1995, ENDOCRINOLOGY, V136, P5236, DOI 10.1210/en.136.11.5236; Zou LL, 1997, ENDOCRINOLOGY, V138, P1771, DOI 10.1210/en.138.4.1771	39	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24760	24769		10.1074/jbc.273.38.24760	http://dx.doi.org/10.1074/jbc.273.38.24760			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733777	hybrid			2022-12-27	WOS:000076007300069
J	Gatsios, P; Terstegen, L; Schliess, F; Haussinger, D; Kerr, IM; Heinrich, PC; Graeve, L				Gatsios, P; Terstegen, L; Schliess, F; Haussinger, D; Kerr, IM; Heinrich, PC; Graeve, L			Activation of the Janus kinase signal transducer and activator of transcription pathway by osmotic shock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; DNA-BINDING; MAMMALIAN-CELLS; GENE-EXPRESSION; STAT PROTEINS; KAPPA-B; HEPATOMA-CELLS; RAT-LIVER; INTERLEUKIN-6	Numerous cytokines, growth, and differentiation factors elicit their intracellular responses via Janus tyrosine kinases (Jaks) and transcription factors of the STAT (signal transducer and activator of transcription) family. Additionally, environmental stress (UV light, heat, aniso-osmolarity, and radicals) has recently been shown to activate intracellular signaling cascades such as the stress-activated protein kinases and nuclear factor-kappa B. In this study, we demonstrate that in different cell lines a particular stress, namely hyperosmolarity, results in tyrosine phosphorylation of the Janus kinases Jak1, Jak2, and Tyk2 and in the activation of STAT1 and/or STAT3. Both transcription factors are phosphorylated at a specific tyrosine residue and translocation to the nucleus was demonstrated by the use of a STAT3/green fluorescent protein fusion protein. A prominent role for Jak1 in the activation of STATs by hypertonicity was demonstrated by the use of Jak-deficient cell lines. Stress-activated STAT1 and STAT3 transactivate a reporter gene containing the acute-phase response element of the rat alpha(2)-macroglobulin promoter. Experiments using a diffusible solute suggest that not the increase in intracellular osmolarity but the resultant cell shrinkage is the trigger for Jak/STAT activation.	Rhein Westfal TH Aachen, Inst Biochem, D-52057 Aachen, Germany; Univ Dusseldorf, Med Klin, D-40225 Dusseldorf, Germany; Rhein Westfal TH Aachen, Interdisziplinares Zentrum Klin Forsch, BIOMAT, D-52057 Aachen, Germany; Imperial Canc Res Fund, London WC2A 3PX, England	RWTH Aachen University; Heinrich Heine University Dusseldorf; RWTH Aachen University; Cancer Research UK	Graeve, L (corresponding author), Rhein Westfal TH Aachen, Inst Biochem, Pauwelsstr 30, D-52057 Aachen, Germany.							ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; ARCONE R, 1991, EUR J BIOCHEM, V198, P541, DOI 10.1111/j.1432-1033.1991.tb16048.x; BACON CM, 1995, FEBS LETT, V370, P63, DOI 10.1016/0014-5793(95)00796-C; Batiza AF, 1996, J BIOL CHEM, V271, P23357, DOI 10.1074/jbc.271.38.23357; Briscoe J, 1996, EMBO J, V15, P799, DOI 10.1002/j.1460-2075.1996.tb00415.x; Bugno M, 1995, NUCLEIC ACIDS RES, V23, P5041, DOI 10.1093/nar/23.24.5041; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; DEVARY Y, 1993, SCIENCE, V261, P1442, DOI 10.1126/science.8367725; DEVARY Y, 1992, CELL, V71, P1081, DOI 10.1016/S0092-8674(05)80058-3; Fischer R, 1997, GLIA, V20, P51; FU XY, 1993, CELL, V74, P1135, DOI 10.1016/0092-8674(93)90734-8; GALCHEVAGARGOVA Z, 1994, SCIENCE, V265, P806, DOI 10.1126/science.8047888; Gerhartz C, 1996, J BIOL CHEM, V271, P12991, DOI 10.1074/jbc.271.22.12991; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; GOUILLEUX F, 1995, EMBO J, V14, P2005, DOI 10.1002/j.1460-2075.1995.tb07192.x; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; HALLBRUCKER C, 1994, PFLUG ARCH EUR J PHY, V428, P552, DOI 10.1007/BF00374577; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Kirito K, 1997, J BIOL CHEM, V272, P16507, DOI 10.1074/jbc.272.26.16507; KOONG AC, 1994, CANCER RES, V54, P5273; Krump E, 1997, J BIOL CHEM, V272, P17303, DOI 10.1074/jbc.272.28.17303; Leaman DW, 1996, MOL CELL BIOL, V16, P369; LORD KA, 1991, MOL CELL BIOL, V11, P4371, DOI 10.1128/MCB.11.9.4371; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; Mertens PR, 1997, J BIOL CHEM, V272, P22905, DOI 10.1074/jbc.272.36.22905; MEYER DJ, 1994, J BIOL CHEM, V269, P4701; NAKAJIMA K, 1991, MOL CELL BIOL, V11, P1409, DOI 10.1128/MCB.11.3.1409; NARAZAKI M, 1994, P NATL ACAD SCI USA, V91, P2285, DOI 10.1073/pnas.91.6.2285; Noe B, 1996, GASTROENTEROLOGY, V110, P858, DOI 10.1053/gast.1996.v110.pm8608896; Pellegrini S, 1997, EUR J BIOCHEM, V248, P615, DOI 10.1111/j.1432-1033.1997.00615.x; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; RUFFJAMISON S, 1994, J BIOL CHEM, V269, P21933; Schaper F, 1997, FEBS LETT, V405, P99, DOI 10.1016/S0014-5793(97)00167-1; Schliess F, 1996, BIOCHEM J, V320, P167, DOI 10.1042/bj3200167; SCHLIESS F, 1995, BIOCHEM J, V309, P13, DOI 10.1042/bj3090013; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; SHUAL K, 1993, NATURE, V366, P580, DOI 10.1038/366580a0; SILVENNOINEN O, 1993, SCIENCE, V261, P1736, DOI 10.1126/science.8378775; Sinning R, 1997, FEBS LETT, V400, P163, DOI 10.1016/S0014-5793(96)01376-2; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; Szaszi K, 1997, J BIOL CHEM, V272, P16670, DOI 10.1074/jbc.272.26.16670; TORTOLANI PJ, 1995, BLOOD, V85, P3444, DOI 10.1182/blood.V85.12.3444.bloodjournal85123444; Vignais ML, 1996, MOL CELL BIOL, V16, P1759; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; WEIERGRABER O, 1995, EUR J BIOCHEM, V234, P661, DOI 10.1111/j.1432-1033.1995.661_b.x; YUAN JP, 1994, MOL CELL BIOL, V14, P1657, DOI 10.1128/MCB.14.3.1657; Zhang Z, 1996, AM J PHYSIOL-RENAL, V271, pF1234, DOI 10.1152/ajprenal.1996.271.6.F1234; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	53	78	78	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					22962	22968		10.1074/jbc.273.36.22962	http://dx.doi.org/10.1074/jbc.273.36.22962			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722518	hybrid			2022-12-27	WOS:000075778100018
J	Unzai, S; Eich, R; Shibayama, N; Olson, JS; Morimoto, H				Unzai, S; Eich, R; Shibayama, N; Olson, JS; Morimoto, H			Rate constants for O-2 and CO binding to the alpha and beta subunits within the R and T states of human hemoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NI(II)-FE(II) HYBRID HEMOGLOBINS; CARBON-MONOXIDE BINDING; OXYGEN EQUILIBRIUM PROPERTIES; LIGAND-BINDING; CRYSTAL-STRUCTURE; THERMODYNAMIC STABILITY; QUATERNARY STRUCTURE; PROTOPORPHYRIN-IX; VALENCY HYBRIDS; DISTAL RESIDUES	Despite a large amount of work over the past 30 years, there is still no universal agreement on the differential reactivities of the individual alpha and beta subunits in human hemoglobin. To address this question systematically, we prepared a series of hybrid hemoglobins in which heme was replaced by chromium(III), manganese(III), nickel(II), and magnesium(II) protoporphyrin IXs in either the alpha or beta subunits to produce alpha(2)(M)beta(2)(Fe)(1) and alpha(2)(Fe)beta(2)(M) tetramers. None of the abnormal metal complexes react with dioxygen or carbon monoxide. The O-2 affinities of the resultant hemoglobins vary from 3 mu M-1 (Cr(III)/Fe(II) hybrids) to 0.003 mu M-1 (Mg(II)/Fe(II) hybrids), covering the full range expected for the various high (R) and low (T) affinity quaternary conformations, respectively, of human hemoglobin A(0). The alpha and beta subunits in hemoglobin have similar O-2 affinities in both quaternary states, despite the fact that the R to T transition causes significantly different structural changes in the alpha and beta heme pockets, This functional equivalence almost certainly evolved to maintain high n values for efficient O-2 transport.	Osaka Univ, Fac Engn Sci, Dept Biophys Engn, Osaka 560, Japan; Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; Jichi Med Sch, Dept Phys, Minami Kawachi, Tochigi 32904, Japan	Osaka University; Rice University; Jichi Medical University	Unzai, S (corresponding author), Osaka Univ, Fac Engn Sci, Dept Biophys Engn, Osaka 560, Japan.			Olson, John/0000-0002-0760-5403; Shibayama, Naoya/0000-0002-2208-1126				Ackers GK, 1997, BIOCHEMISTRY-US, V36, P10822, DOI 10.1021/bi971382x; ACKERS GK, 1992, SCIENCE, V255, P54, DOI 10.1126/science.1553532; BALCH AL, 1992, INORG CHEM, V31, P1148, DOI 10.1021/ic00033a007; BLOUGH NV, 1984, BIOCHEMISTRY-US, V23, P2875, DOI 10.1021/bi00308a005; BLOUGH NV, 1982, J AM CHEM SOC, V104, P4247, DOI 10.1021/ja00379a035; BRUNORI M, 1970, J MOL BIOL, V49, P461, DOI 10.1016/0022-2836(70)90257-3; BUCHLER JW, 1975, PORPHYRINS METALLOPO, P191; CASSOLY R, 1972, J BIOL CHEM, V247, P7332; DAUGHERTY MA, 1991, P NATL ACAD SCI USA, V88, P1110, DOI 10.1073/pnas.88.4.1110; EARLEY JE, 1965, TRANSITION METAL CHE, V1, P33; FRONTICELLI C, 1993, BIOCHEMISTRY-US, V32, P1235, DOI 10.1021/bi00056a006; FUJII M, 1993, J BIOL CHEM, V268, P15386; GIBSON QH, 1969, J BIOL CHEM, V244, P4668; GIBSON QH, 1973, P NATL ACAD SCI USA, V70, P1, DOI 10.1073/pnas.70.1.1; HILLE R, 1979, J BIOL CHEM, V254, P2110; HO C, 1992, ADV PROTEIN CHEM, V43, P153, DOI 10.1016/S0065-3233(08)60555-0; HOFFMAN BM, 1975, ANN NY ACAD SCI, V244, P174, DOI 10.1111/j.1749-6632.1975.tb41530.x; IKEDASAITO M, 1980, J MOL BIOL, V138, P845, DOI 10.1016/0022-2836(80)90068-6; IMAI K, 1973, BIOCHEMISTRY-US, V12, P798, DOI 10.1021/bi00729a003; IMAI K, 1982, ALLOSTERIC EFFECTS H, P218; Kroeger KS, 1997, STRUCTURE, V5, P227, DOI 10.1016/S0969-2126(97)00181-0; KUILA D, 1991, J AM CHEM SOC, V113, P6520, DOI 10.1021/ja00017a024; LIDDINGTON R, 1992, J MOL BIOL, V228, P551, DOI 10.1016/0022-2836(92)90842-8; LUISI B, 1990, J MOL BIOL, V214, P7, DOI 10.1016/0022-2836(90)90139-D; LUISI B, 1989, J MOL BIOL, V206, P723, DOI 10.1016/0022-2836(89)90579-2; MATHEWS AJ, 1991, J BIOL CHEM, V266, P21631; MATHEWS AJ, 1989, J BIOL CHEM, V264, P16573; MATHEWS AJ, 1994, METHOD ENZYMOL, V232, P363; NAGAI K, 1987, NATURE, V329, P858, DOI 10.1038/329858a0; Olson J S, 1981, Methods Enzymol, V76, P631; OLSON JS, 1972, J BIOL CHEM, V247, P1713; Olson JS, 1997, ARTIF CELL BLOOD SUB, V25, P227, DOI 10.3109/10731199709118912; OLSON JS, 1971, J BIOL CHEM, V246, P5241; Paoli M, 1997, J MOL BIOL, V271, P161, DOI 10.1006/jmbi.1997.1180; Paoli M, 1996, J MOL BIOL, V256, P775, DOI 10.1006/jmbi.1996.0124; Park SY, 1996, J MOL BIOL, V255, P726, DOI 10.1006/jmbi.1996.0059; PERRELLA M, 1992, J BIOL CHEM, V267, P8744; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; PERUTZ MF, 1989, TRENDS BIOCHEM SCI, V14, P42, DOI 10.1016/0968-0004(89)90039-X; PERUTZ MF, 1987, ACCOUNTS CHEM RES, V20, P309, DOI 10.1021/ar00141a001; PHILO JS, 1990, J BIOL CHEM, V265, P139; Philo JS, 1996, BIOPHYS J, V70, P1949, DOI 10.1016/S0006-3495(96)79760-6; ROHLFS RJ, 1990, J BIOL CHEM, V265, P3168; SAMAJA M, 1987, J BIOL CHEM, V262, P4528; SAWICKI CA, 1977, J BIOL CHEM, V252, P7538; Schumacher MA, 1997, P NATL ACAD SCI USA, V94, P7841, DOI 10.1073/pnas.94.15.7841; SHARMA VS, 1976, J BIOL CHEM, V251, P4267; SHARMA VS, 1991, J BIOL CHEM, V266, P24492; Shibayama N, 1998, BIOCHEMISTRY-US, V37, P6221, DOI 10.1021/bi980134d; Shibayama N, 1997, BIOCHEMISTRY-US, V36, P4375, DOI 10.1021/bi970009m; SHIBAYAMA N, 1986, J MOL BIOL, V192, P331, DOI 10.1016/0022-2836(86)90368-2; SHIBAYAMA N, 1986, J MOL BIOL, V192, P323, DOI 10.1016/0022-2836(86)90367-0; SHIBAYAMA N, 1995, BIOCHEMISTRY-US, V34, P4773, DOI 10.1021/bi00014a035; SHIBAYAMA N, 1995, BIOCHEMISTRY-US, V34, P14658, DOI 10.1021/bi00045a006; SILVA MM, 1992, J BIOL CHEM, V267, P17248; SIMOLO K, 1985, J AM CHEM SOC, V107, P2865, DOI 10.1021/ja00296a006; SUMMERVILLE DA, 1977, J AM CHEM SOC, V99, P8195, DOI 10.1021/ja00467a012; TAME J, 1991, J MOL BIOL, V218, P761, DOI 10.1016/0022-2836(91)90264-7; Unzai S, 1996, J BIOL CHEM, V271, P12451, DOI 10.1074/jbc.271.21.12451; VANDEGRIFF KD, 1991, J BIOL CHEM, V266, P17049; WATERMAN MR, 1970, J BIOL CHEM, V245, P5847	61	68	70	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23150	23159		10.1074/jbc.273.36.23150	http://dx.doi.org/10.1074/jbc.273.36.23150			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722544	hybrid			2022-12-27	WOS:000075778100044
J	Bartoli, M; Monneron, A; Ladant, D				Bartoli, M; Monneron, A; Ladant, D			Interaction of calmodulin with striatin, a WD-repeat protein present in neuronal dendritic spines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTSYNAPTIC DENSITIES; NMDA RECEPTOR; KINASE-II; BINDING; SUBUNIT; IDENTIFICATION; MUTAGENESIS; EXPRESSION; FAMILY	Rat striatin, a quantitatively minor protein belonging to the WD-repeat family of proteins, is a Ca2+/calmodulin-binding protein mostly expressed in the striatum and in the motor and olfactory systems (Castets, F., Bartoli, M., Barnier, J. V., Baillat, G., Salin, P., Moqrich, A., Bourgeois, J. P., Denizot, F., Rougon, G., Calothy, G., and Monneron, A. (1996) J. Cell Biol. 134, 1051-1062). Generally associated with membranes, striatin is mostly found in dendritic spines where it is likely to play a role in Ca2+-signaling events. In this paper, we characterize its calmodulin-binding properties. By using deletion mapping and site-directed mutagenesis, we identified the sequence located between amino acids 149 and 166 as the main calmodulin-binding site. The predicted corresponding peptide is potentially able to form a basic amphiphilic helix, as is often the case for many known calmodulin-binding sites. Calmodulin binding to striatin is Ca2+-dependent, with half-maximal binding occurring around 0.5 mu M free Ca2+. In the presence of Ca2+, the equilibrium dissociation constant of calmodulin/striatin fusion protein complex is 40 +/- 5 nM. me also show that brain striatin subcellular localization, as studied by tissue fractionation, is Ca2+-dependent, this effect being probably mediated by calmodulin. Our results are in agreement with the hypothesis that striatin is a transducer involved in Ca2+ signaling or an adapter protein involved in regulating macromolecular assemblies within dendritic spines.	CNRS, UPR 9013, Lab Neurobiol Cellulaire & Fonct, F-13402 Marseille 20, France; Inst Pasteur, CNRS, URA 1129, Unite Biochim Cellulaire, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Monneron, A (corresponding author), CNRS, UPR 9013, Lab Neurobiol Cellulaire & Fonct, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	monneron@lnf.cnrs-mrs.fr	Bartoli, Marc/Q-5979-2017; Bartoli, Marc/O-8893-2016	Bartoli, Marc/0000-0003-3339-9858; Bartoli, Marc/0000-0003-3339-9858; LADANT, Daniel/0000-0003-1955-548X				Ansaldi M, 1996, ANAL BIOCHEM, V234, P110, DOI 10.1006/abio.1996.0060; Castets F, 1996, J CELL BIOL, V134, P1051, DOI 10.1083/jcb.134.4.1051; Denk W, 1996, CURR OPIN NEUROBIOL, V6, P372, DOI 10.1016/S0959-4388(96)80122-X; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; GLENNEY JR, 1984, EUR J BIOCHEM, V144, P529, DOI 10.1111/j.1432-1033.1984.tb08498.x; GNEGY ME, 1993, ANNU REV PHARMACOL, V33, P45, DOI 10.1146/annurev.pa.33.040193.000401; GRAB DJ, 1979, J BIOL CHEM, V254, P8690; HAKES DJ, 1992, ANAL BIOCHEM, V202, P293, DOI 10.1016/0003-2697(92)90108-J; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; LADANT D, 1992, J BIOL CHEM, V267, P2244; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Liu MY, 1997, J BIOL CHEM, V272, P18801, DOI 10.1074/jbc.272.30.18801; MOQRICH A, 1998, IN PRESS GENOMICS; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Newbell BJ, 1997, BIOCHEMISTRY-US, V36, P1295, DOI 10.1021/bi962452n; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; PATEL SN, 1988, BRAIN RES, V449, P34, DOI 10.1016/0006-8993(88)91021-9; Salin P, 1998, J COMP NEUROL, V397, P41; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SEGAL M, 1995, TRENDS NEUROSCI, V18, P468, DOI 10.1016/0166-2236(95)92765-I; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Sonnenburg WK, 1995, J BIOL CHEM, V270, P30989, DOI 10.1074/jbc.270.52.30989; Strack S, 1997, J BIOL CHEM, V272, P13467, DOI 10.1074/jbc.272.21.13467; Suzuki T, 1997, J NEUROCHEM, V69, P436; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Warr CG, 1996, BIOCHEM J, V314, P497, DOI 10.1042/bj3140497; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; YAMAZAKI M, 1992, FEBS LETT, V300, P39, DOI 10.1016/0014-5793(92)80160-I; Yoshimura Y, 1997, J BIOL CHEM, V272, P26354, DOI 10.1074/jbc.272.42.26354; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	35	49	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22248	22253		10.1074/jbc.273.35.22248	http://dx.doi.org/10.1074/jbc.273.35.22248			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712839	hybrid			2022-12-27	WOS:000075616600015
J	Riches, DWH; Chan, ED; Zahradka, EA; Winston, BW; Remigio, LK; Lake, FR				Riches, DWH; Chan, ED; Zahradka, EA; Winston, BW; Remigio, LK; Lake, FR			Cooperative signaling by tumor necrosis factor receptors CD120a (p55) and CD120b (p75) in the expression of nitric oxide and inducible nitric oxide synthase by mouse macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ARGININE; TNF-ALPHA; MURINE MACROPHAGES; LISTERIA-MONOCYTOGENES; ACTIVATED MACROPHAGES; PROTEIN-KINASE; PATHWAY; CLONING; DOMAIN; IDENTIFICATION	Tumor necrosis factor-alpha (TNF alpha) is recognized by the cell-surface receptors CD120a (p55) and CD120b (p75). In the present study, we have investigated the role of these receptors in the expression of NO2- a stable metabolite of nitric oxide, and inducible nitric oxide synthase (iNOS) by mouse macrophages. Specific antibody-mediated aggregation of CD120a (p55) induced NO2- accumulation in culture supernatants and iNOS mRNA expression in macrophage lysates, whereas cross-linking of CD120b (p75) had a minimal effect. In contrast, simultaneous cross-linking of both receptors led to a marked augmentation in NO2- and iNOS mRNA expression. Antibody-mediated blockade of CD120a (p55) completely inhibited NO2- expression in response to TNF alpha, whereas blockade of CD120b (p75) reduced NO2- accumulation by similar to 50%. Specific Ligation of CD120a (p55) with either (i) human TNF alpha or (ii) by incubation with mouse TNF alpha following pretreatment of macrophages with blocking concentrations of anti-CD120b (p75) antibody resulted in a similar reduction in NO2- production in response to TNF alpha. Quantification of iNOS mRNA, protein, and NO2- expression during independent and coligation of CD120a (p55) and CD120b (p75) indicated that iNOS mRNA and protein expression was transient in nature when CD120a (p55) was cross-linked alone but was prolonged when both receptors were simultaneously cross-linked. In addition, cross-linking both receptors also led to a potentiation of NO2- accumulation in culture supernatants that was more pronounced at later time points. These findings suggest that while cross-linking of CD120a (p55) is necessary and sufficient for iNOS mRNA and NO(2)(-)expression, CD120b (p75) participates by (i) increasing the sensitivity of the cells to TNF alpha, probably by "passing" ligand to CD120a (p55), and (ii) initiating a signaling event that results in a more sustained induction of iNOS mRNA and protein and thereby augments the production of nitric oxide.	Natl Jewish Med & Res Ctr, Dept Pediat, Div Basic Sci, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Biochem Biophys & Genet, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Div Pulm Sci, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA; Univ Calgary, Dept Med, Div Crit Care Med, Calgary, AB T2N 4N1, Canada; Univ Calgary, Dept Biochem, Div Crit Care Med, Calgary, AB T2N 4N1, Canada; Univ Calgary, Dept Mol Biol, Div Crit Care Med, Calgary, AB T2N 4N1, Canada	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Calgary; University of Calgary; University of Calgary	Riches, DWH (corresponding author), Natl Jewish Med & Res Ctr, Dept Pediat, Div Basic Sci, Neustadt Rm D405,1400 Jackson St, Denver, CO 80206 USA.				NHLBI NIH HHS [HL55549, HL56556] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056556, R01HL055549] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMS LB, 1991, J IMMUNOL, V147, P1642; ADAMS LB, 1990, J IMMUNOL, V144, P2725; BAUMANN H, 1993, J IMMUNOL, V151, P4248; BECKERMAN KP, 1993, J IMMUNOL, V150, P888; BERMUDEZ LE, 1993, CLIN EXP IMMUNOL, V91, P277; BROCKHAUS M, 1990, P NATL ACAD SCI USA, V87, P3127, DOI 10.1073/pnas.87.8.3127; Chan ED, 1997, P NATL ACAD SCI USA, V94, P13169, DOI 10.1073/pnas.94.24.13169; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DING AH, 1988, J IMMUNOL, V141, P2407; GREEN SJ, 1990, J IMMUNOL, V144, P278; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HOHMANN HP, 1989, J BIOL CHEM, V264, P14927; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Kalb A, 1996, J BIOL CHEM, V271, P28097, DOI 10.1074/jbc.271.45.28097; KWON NS, 1990, J BIOL CHEM, V265, P13442; LAKE FR, 1994, J CLIN INVEST, V93, P1661, DOI 10.1172/JCI117148; LEWIS M, 1991, P NATL ACAD SCI USA, V88, P2830, DOI 10.1073/pnas.88.7.2830; LIEW FY, 1991, EUR J IMMUNOL, V21, P3009, DOI 10.1002/eji.1830211216; LORSBACH RB, 1993, J BIOL CHEM, V268, P1908; LOWENSTEIN CJ, 1992, P NATL ACAD SCI USA, V89, P6711, DOI 10.1073/pnas.89.15.6711; LYONS CR, 1992, J BIOL CHEM, V267, P6370; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; NOBLE PW, 1993, J CLIN INVEST, V91, P2368, DOI 10.1172/JCI116469; Pinckard JK, 1997, J BIOL CHEM, V272, P10784; Reinhard C, 1997, EMBO J, V16, P1080, DOI 10.1093/emboj/16.5.1080; RICHES DWH, 1991, J BIOL CHEM, V266, P24785; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; TARTAGLIA LA, 1992, J BIOL CHEM, V267, P4304; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; TARTAGLIA LA, 1993, J BIOL CHEM, V268, P18542; VANDENABEELE P, 1992, J EXP MED, V176, P1015, DOI 10.1084/jem.176.4.1015; Weiss T, 1997, J IMMUNOL, V158, P2398; Winston BW, 1997, J IMMUNOL, V159, P4491; WINSTON BW, 1995, J IMMUNOL, V155, P1525; XIE QW, 1994, J BIOL CHEM, V269, P4705; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522	39	36	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22800	22806		10.1074/jbc.273.35.22800	http://dx.doi.org/10.1074/jbc.273.35.22800			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712914	hybrid			2022-12-27	WOS:000075616600090
J	Stuible, HP; Meier, S; Wagner, C; Hannappel, E; Schweizer, E				Stuible, HP; Meier, S; Wagner, C; Hannappel, E; Schweizer, E			A novel phosphopantetheine : protein transferase activating yeast mitochondrial acyl carrier protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHETASE; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; BIOCHEMICAL-CHARACTERIZATION; TRANSFORMATION; BIOSYNTHESIS; SYNTHASE; PEPTIDE; GENES; EXPRESSION	In Saccharomyces cerevisiae, the low molecular weight acyl carrier protein (ACP) of mitochondrial type ZI fatty acid synthase (FAS) and the cytoplasmic type I FAS multienzyme contain 4'-phosphopantetheine as a prosthetic group. Sequence alignment studies with the recently isolated phosphopantetheine:protein transferase (PPTase), Ppt1p, from Brevibacterium ammoniagenes revealed the yeast open reading frame, YPL148C, as a potential PPTase gene (25% identical and 43% conserved amino acids). In accordance with this similarity, pantetheinylation of mitochondrial ACP was lost upon disruption of YPL148C. In contrast, biosynthesis of cytoplasmic holo-FAS remained unaffected by this mutation. According to these characteristics, the newly identified gene was designated as PPT2. Similar to ACP null mutants, cellular lipoic acid synthesis and, hence, respiration were abolished in PPT2 deletants. ACP pantetheinylation, Lipoic acid synthesis, and respiratory competence were restored upon transformation of PPT2 mutants with cloned PPT2 DNA, In vitro, holo-ACP synthesis was achieved by incubating apo-ACP with coenzyme A in the presence of purified Ppt2p. The homologous yeast enzyme could be replaced, in this assay, by the ACP synthase (EC 2.7.8.7) of Escherichia coli but not by the type I FAS-specific PPTase of B. ammoniagenes, Ppt1p. These results conform with the inability of Ppt2p to activate the cytoplasmic type I FAS complex of yeast.	Univ Erlangen Nurnberg, Lehrstuhl Biochem, Fak Med, Inst Mikrobiol Biochem & Genet, D-91058 Erlangen, Germany; Univ Erlangen Nurnberg, Fak Med, Inst Biochem, D-91058 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Schweizer, E (corresponding author), Univ Erlangen Nurnberg, Lehrstuhl Biochem, Fak Med, Inst Mikrobiol Biochem & Genet, Staudtstr 5, D-91058 Erlangen, Germany.							Bollag D.M., 1996, PROTEIN METHODS; BORELL CW, 1988, CURR GENET, V13, P299, DOI 10.1007/BF00424423; Brody S, 1997, FEBS LETT, V408, P217, DOI 10.1016/S0014-5793(97)00428-6; CHUMAN L, 1989, EUR J BIOCHEM, V184, P643, DOI 10.1111/j.1432-1033.1989.tb15061.x; FERNANDEZ MD, 1990, PLANT CELL, V2, P195, DOI 10.1105/tpc.2.3.195; Gehring AM, 1997, BIOCHEMISTRY-US, V36, P8495, DOI 10.1021/bi970453p; GUERRA DJ, 1988, J BIOL CHEM, V263, P4386; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HANNAPPEL E, 1988, ARCH BIOCHEM BIOPHYS, V260, P546, DOI 10.1016/0003-9861(88)90480-8; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V779, P65; HENSCHEN A, 1986, ADV METHODS PROTEIN, P244; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; HOPWOOD DA, 1990, ANNU REV GENET, V24, P37, DOI 10.1146/annurev.ge.24.120190.000345; Huang ME, 1997, YEAST, V13, P1181, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1181::AID-YEA169>3.3.CO;2-F; KEATING DH, 1995, J BIOL CHEM, V270, P22229, DOI 10.1074/jbc.270.38.22229; Kleinkauf H, 1996, EUR J BIOCHEM, V236, P335, DOI 10.1111/j.1432-1033.1996.00335.x; Ku J, 1997, CHEM BIOL, V4, P203, DOI 10.1016/S1074-5521(97)90289-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; LAMBALOT RH, 1995, J BIOL CHEM, V270, P24658, DOI 10.1074/jbc.270.42.24658; LYNEN F, 1980, EUR J BIOCHEM, V112, P431; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; PRESCOTT DJ, 1975, METHOD ENZYMOL, V25, P95; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; REED KE, 1993, J BACTERIOL, V175, P1325, DOI 10.1128/JB.175.5.1325-1336.1993; ROCK CO, 1979, J BIOL CHEM, V254, P9778; ROISE D, 1988, J BIOL CHEM, V263, P4509; RUNSWICK MJ, 1991, FEBS LETT, V286, P121, DOI 10.1016/0014-5793(91)80955-3; SCHATZ G, 1987, EUR J BIOCHEM, V165, P1, DOI 10.1111/j.1432-1033.1987.tb11186.x; Schneider R, 1997, FEBS LETT, V407, P249, DOI 10.1016/S0014-5793(97)00360-8; Schneider R, 1995, CURR GENET, V29, P10, DOI 10.1007/BF00313188; SCHORR R, 1994, J PLANT PHYSIOL, V143, P407, DOI 10.1016/S0176-1617(11)81800-6; SCHULLER HJ, 1992, EUR J BIOCHEM, V203, P607, DOI 10.1111/j.1432-1033.1992.tb16590.x; Schwank S, 1997, CURR GENET, V31, P462, DOI 10.1007/s002940050231; SONI R, 1993, CURR GENET, V24, P455, DOI 10.1007/BF00351857; Stuible HP, 1997, EUR J BIOCHEM, V248, P481, DOI 10.1111/j.1432-1033.1997.00481.x; SULO P, 1993, J BIOL CHEM, V268, P17634; TEICHERT U, 1989, J BIOL CHEM, V264, P16037; Wada H, 1997, P NATL ACAD SCI USA, V94, P1591, DOI 10.1073/pnas.94.4.1591	39	48	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22334	22339		10.1074/jbc.273.35.22334	http://dx.doi.org/10.1074/jbc.273.35.22334			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712852	hybrid			2022-12-27	WOS:000075616600028
J	van de Wal, M; D'Hulst, C; Vincken, JP; Buleon, A; Visser, R; Ball, S				van de Wal, M; D'Hulst, C; Vincken, JP; Buleon, A; Visser, R; Ball, S			Amylose is synthesized in vitro by extension of and cleavage from amylopectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALGA CHLAMYDOMONAS-REINHARDTII; STARCH SYNTHASE ACTIVITY; BRANCHING ENZYME; GRANULE; WAXY; BIOSYNTHESIS; BIOGENESIS; STORAGE; MUTANT	Amylose synthesis was obtained in vitro from purified Chlamydomonas reinhardtii starch granules. Labeling experiments clearly indicate that initially the major granule-bound starch synthase extends glucans available on amylopectin, Amylose synthesis occurs thereafter at rates approaching or exceeding those of net polysaccharide synthesis. Although these results suggested that amylose originates from cleavage of a pre-existing external amylopectin chain, such transfer of chains from amylopectin to amylose was directly evidenced from pulse-chase experiments. The structure of the in vitro synthesized amylose could not be distinguished from in vivo synthesized amylose by a variety of methods. Moreover high molecular mass branched amylose synthesis preceded that of the low molecular mass, suggesting that chain termination occurs consequently to glucan cleavage. Short pulses of synthesis followed by incubation in buffer with or without ADP-Glc prove that transfer requires the presence of the glucosyl-nucleotide. Taken together, these observations make a compelling case for amylopectin acting as the in vivo primer for amylose synthesis. They further prove that extension is followed by cleavage. A model is presented that can explain the major features of amylose synthesis in plants. The consequences of intensive amylose synthesis on the crystal organization of amylopectin are reported through wide angle x-ray analysis of the in vitro synthesized polysaccharides.	Univ Sci & Technol Lille, Chim Biol Lab, CNRS, UMR 111, F-59655 Villeneuve Dascq, France; INRA, Ctr Rech Agroalimentaires, F-44316 Nantes 03, France; Agr Univ Wageningen, Grad Sch Expt Plant Sci, Dept Plant Breeding, NL-6700 AJ Wageningen, Netherlands	Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; INRAE; Wageningen University & Research	Ball, S (corresponding author), Univ Sci & Technol Lille, Chim Biol Lab, CNRS, UMR 111, F-59655 Villeneuve Dascq, France.	steven.ball@univ-lille1.fr	Visser, Richard GF/B-3423-2012; D'HULST, Christophe/B-2072-2012; Vincken, Jean-Paul/A-1778-2009; D'Hulst, Christophe/AAX-2809-2020	Visser, Richard GF/0000-0002-0213-4016; D'HULST, Christophe/0000-0002-5556-9099; D'Hulst, Christophe/0000-0002-5556-9099; Ball, Steven/0000-0003-1629-1650				BABA T, 1987, STARCH-STARKE, V39, P52, DOI 10.1002/star.19870390207; BALL S, 1991, PLANTA, V185, P17, DOI 10.1007/BF00194509; BALL SG, 1990, PLANT SCI, V66, P1, DOI 10.1016/0168-9452(90)90162-H; BLANCO L, 1991, GENE, V100, P27, DOI 10.1016/0378-1119(91)90346-D; BULEON A, 1982, STARKE, V34, P361, DOI 10.1002/star.19820341102; Buleon A, 1997, PLANT PHYSIOL, V115, P949, DOI 10.1104/pp.115.3.949; BULEON A, 1998, IN PRESS INT J BIOL; DEFEKETE MAR, 1960, NATURE, V187, P918, DOI 10.1038/187918a0; DELRUE B, 1992, J BACTERIOL, V174, P3612, DOI 10.1128/JB.174.11.3612-3620.1992; DENYER K, 1993, PLANT J, V4, P191, DOI 10.1046/j.1365-313X.1993.04010191.x; DENYER K, 1995, PLANT CELL ENVIRON, V18, P1019, DOI 10.1111/j.1365-3040.1995.tb00612.x; Denyer K, 1996, PLANT J, V10, P1135, DOI 10.1046/j.1365-313X.1996.10061135.x; ERIKSSON G, 1969, HEREDITAS-GENETISK A, V63, P180; FONTAINE T, 1993, J BIOL CHEM, V268, P16223; Harris EH, 1989, CHLAMYDOMONAS SOURCE, P25, DOI [DOI 10.1016/B978-0-12-326880-8.50007-9, DOI 10.1126/SCIENCE.246.4936.1503-A]; HOVENKAMPHERMELINK JHM, 1987, THEOR APPL GENET, V75, P217, DOI 10.1007/BF00249167; IMBERTY A, 1991, STARCH-STARKE, V43, P375, DOI 10.1002/star.19910431002; JANE JL, 1993, CARBOHYD RES, V247, P279, DOI 10.1016/0008-6215(93)84260-D; KONISHI Y, 1985, AGR BIOL CHEM TOKYO, V49, P1965, DOI 10.1080/00021369.1985.10867018; LELOIR LF, 1961, J BIOL CHEM, V236, P636; LIBESSART N, 1995, PLANT CELL, V7, P1117; MACDONALD FD, 1985, PLANT PHYSIOL, V78, P849, DOI 10.1104/pp.78.4.849; MADDELEIN ML, 1994, J BIOL CHEM, V269, P25150; MURATA T, 1965, BIOCHEM BIOPH RES CO, V18, P371, DOI 10.1016/0006-291X(65)90716-3; NAKAMURA T, 1995, MOL GEN GENET, V248, P253, DOI 10.1007/BF02191591; NELSON OE, 1962, BIOCHEM BIOPH RES CO, V9, P297, DOI 10.1016/0006-291X(62)90043-8; Planchot V, 1997, CARBOHYD RES, V298, P319, DOI 10.1016/S0008-6215(96)00317-5; PONSTEIN AS, 1991, STARCH-STARKE, V43, P208, DOI 10.1002/star.19910430603; Preiss J., 1996, PHOTOASSIMILATE DIST, V3, p63?96; RECONDO E, 1961, BIOCHEM BIOPH RES CO, V6, P85, DOI 10.1016/0006-291X(61)90389-8; Takata H, 1996, CARBOHYD RES, V295, P91, DOI 10.1016/S0008-6215(96)00217-0; Takata H, 1996, J BACTERIOL, V178, P1600, DOI 10.1128/jb.178.6.1600-1606.1996; VandenKoornhuyse N, 1996, J BIOL CHEM, V271, P16281, DOI 10.1074/jbc.271.27.16281; WAKELIN JH, 1959, J APPL PHYS, V30, P1654, DOI 10.1063/1.1735031; Weatherwax P, 1922, GENETICS, V7, P568	35	94	97	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22232	22240		10.1074/jbc.273.35.22232	http://dx.doi.org/10.1074/jbc.273.35.22232			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712837	Green Published, hybrid			2022-12-27	WOS:000075616600013
J	Xia, Y; Roman, LJ; Masters, BSS; Zweier, JL				Xia, Y; Roman, LJ; Masters, BSS; Zweier, JL			Inducible nitric-oxide synthase generates superoxide from the reductase domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; POSTISCHEMIC HEART; NADPH OXIDASE; PEROXYNITRITE; EXPRESSION; MECHANISM; INJURY; MACROPHAGES; CALMODULIN; INHIBITION	In the absence of L-arginine, the heme center of the oxygenase domain of neuronal nitric-oxide synthase reduces molecular oxygen to superoxide (OX). Our recent work has provided evidence that inducible NOS (iNOS) may also catalyze O-2(radical anion) formation in macrophages. However, there has been a lack of direct evidence of superoxide generation from the purified iNOS, and it was previously hypothesized that significant O-2(radical anion) production does not occur. Moreover, the mechanism and enzyme site responsible for OX generation is unknown. To determine whether iNOS produces O-2(radical anion) and to identify the mechanism of this process, we performed electron paramagnetic resonance measurements on purified iNOS using the spin trap 5,5-dimethyl-1-pyrroline N-oxide. In the presence of NADPH, prominent O-2(radical anion) adduct signals were detected from NOS. These signals were totally abolished by superoxide dismutase but not affected by catalase. High concentrations of L-arginine decreased this OX formation, whereas its enantiomer D-arginine did not. Pre-incubation of iNOS with the flavoprotein inhibitor diphenyleneiodonium totally blocked these O-2(radical anion) signals. Conversely, pretreatment of the enzyme with the heme blocker cyanide had no effect on OX generation. Furthermore, strong O-2(radical anion) generation was directly detected from the isolated iNOS reductase domain. Together, these data demonstrate that iNOS does generate O-2(radical anion), and this mainly occurs at the flavin-binding sites of the reductase domain.	Johns Hopkins Univ, Sch Med, Johns Hopkins Bayview Med Ctr, Dept Med,Div Cardiol,Mol & Cellular Biophys Labs, Baltimore, MD 21224 USA; Johns Hopkins Univ, Sch Med, Johns Hopkins Bayview Med Ctr, Electron Paramagnet Resonance Ctr, Baltimore, MD 21224 USA; Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78284 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of Texas System; University of Texas Health San Antonio	Zweier, JL (corresponding author), Johns Hopkins Asthma & Allergy Ctr, LA-14,5501 Hopkins Bayview Circle, Baltimore, MD 21224 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL038324, R01HL038324, P50HL052315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052419] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-38324, HL-52315] Funding Source: Medline; NIGMS NIH HHS [GM-52419] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABU SH, 1993, P NATL ACAD SCI USA, V90, P10769; ABUSOUD HM, 1994, J BIOL CHEM, V269, P32047; BASTIAN NR, 1994, CURR OPIN IMMUNOL, V6, P131, DOI 10.1016/0952-7915(94)90044-2; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; CHO HJ, 1992, J EXP MED, V176, P599, DOI 10.1084/jem.176.2.599; FINKELSTEIN E, 1982, MOL PHARMACOL, V21, P262; Fossetta JD, 1996, FEBS LETT, V379, P135, DOI 10.1016/0014-5793(95)01496-9; FREJAVILLE C, 1995, J MED CHEM, V38, P258, DOI 10.1021/jm00002a007; GERBER NC, 1995, J BIOL CHEM, V270, P17791, DOI 10.1074/jbc.270.30.17791; Giraldez RR, 1997, J BIOL CHEM, V272, P21420, DOI 10.1074/jbc.272.34.21420; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; HEINZEL B, 1992, BIOCHEM J, V281, P627, DOI 10.1042/bj2810627; MARLETTA MA, 1993, J BIOL CHEM, V268, P12231; Martasek P, 1996, BIOCHEM BIOPH RES CO, V219, P359, DOI 10.1006/bbrc.1996.0238; MASTERS BSS, 1965, J BIOL CHEM, V240, P4081; Masters BSS, 1996, FASEB J, V10, P552, DOI 10.1096/fasebj.10.5.8621055; MONCADA S, 1991, PHARMACOL REV, V43, P109; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; NISHIBAYASHI H, 1963, BIOCHIM BIOPHYS ACTA, V67, P520; POU S, 1992, J BIOL CHEM, V267, P24173; PROUGH RA, 1973, ANN NY ACAD SCI, V212, P89, DOI 10.1111/j.1749-6632.1973.tb47588.x; ROMAN LJ, 1995, P NATL ACAD SCI USA, V92, P8428, DOI 10.1073/pnas.92.18.8428; Roubaud V, 1997, ANAL BIOCHEM, V247, P404, DOI 10.1006/abio.1997.2067; VasquezVivar J, 1997, BIOCHEMISTRY-US, V36, P11293, DOI 10.1021/bi971475e; Xia Y, 1996, J BIOL CHEM, V271, P10096, DOI 10.1074/jbc.271.17.10096; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770; Xia Y, 1997, P NATL ACAD SCI USA, V94, P6954, DOI 10.1073/pnas.94.13.6954	29	312	321	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22635	22639		10.1074/jbc.273.35.22635	http://dx.doi.org/10.1074/jbc.273.35.22635			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712892	hybrid			2022-12-27	WOS:000075616600068
J	DeWitt, ND; dos Santos, CFT; Allen, KE; Slayman, CW				DeWitt, ND; dos Santos, CFT; Allen, KE; Slayman, CW			Phosphorylation region of the yeast plasma-membrane H+-ATPase - Role in protein folding and biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; DOMINANT LETHAL MUTATIONS; CYSTEINE-RICH REPEAT; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; CYSTIC-FIBROSIS; FAMILIAL HYPERCHOLESTEROLEMIA; DIRECTED MUTAGENESIS; SECRETORY VESICLES; GENE	Mutations at the phosphorylation site (Asp-378) of the yeast plasma-membrane H+-ATPase have been shown previously to cause misfolding of the ATPase, preventing normal movement along the secretory pathway; Asp-378 mutations also block the biogenesis of co-expressed wild-type ATPase and lead to a dominant lethal phenotype. To ask whether these defects are specific for Asp-378 or whether the phosphorylation region as a whole is involved, alanine-scanning mutagenesis has been carried out to examine the role of 11 conserved residues flanking Asp-378, In the sec6-4 expression system (Nakamoto, R.K., Rao, R., and Slayman, C. W. (1991) J. Biol. Chem. 266, 7940-7949), the mutant ATPases displayed varying abilities to reach the secretory vesicles that deliver plasma-membrane proteins to the cell surface. Indirect immunofluorescence of intact cells also gave evidence for a spectrum of behavior, ranging from mutant ATPases completely arrested (D378A, K379A, T380A, and T384A) or partially arrested in the endoplasmic reticulum to those that reached the plasma membrane in normal amounts (C376A, S377A, and G381A). Although the extent of ER retention varied among the mutants, the endoplasmic reticulum appeared to be the only secretory compartment in which the mutant ATPases accumulated. All of the mutant proteins that localized either partially or fully to the ER were also malfolded based ore their abnormal sensitivity to trypsin. Among them, the severely affected mutants had a dominant lethal phenotype, and even the intermediate mutants caused a visible slowing of growth when co-expressed with wild-type ATPase. The effects on growth could be traced to the trapping of the wild-type enzyme with the mutant enzyme in the ER, as visualized by double label immunofluorescence, Taken together, the results indicate that the residues surrounding Asp-378 are critically important for ATPase maturation and transport to the cell surface.	Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Yale University; Yale University	DeWitt, ND (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06510 USA.				NIGMS NIH HHS [GM15761, GM18623] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015761, R37GM015761] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambesi A, 1997, ANAL BIOCHEM, V251, P127, DOI 10.1006/abio.1997.2257; Ambesi A, 1996, J BIOL CHEM, V271, P22999, DOI 10.1074/jbc.271.38.22999; Brooks DA, 1997, FEBS LETT, V409, P115, DOI 10.1016/S0014-5793(97)00423-7; CHANG A, 1995, J CELL BIOL, V128, P39, DOI 10.1083/jcb.128.1.39; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; dExaerde AD, 1996, YEAST, V12, P907; Djordjevic JT, 1996, EUR J BIOCHEM, V239, P214, DOI 10.1111/j.1432-1033.1996.0214u.x; FRANZUSOFF A, 1991, J CELL BIOL, V112, P27, DOI 10.1083/jcb.112.1.27; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GOFF CG, 1984, GENE, V27, P35, DOI 10.1016/0378-1119(84)90236-1; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; HARRIS SL, 1994, P NATL ACAD SCI USA, V91, P10531, DOI 10.1073/pnas.91.22.10531; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jensen HK, 1997, ATHEROSCLEROSIS, V131, P67, DOI 10.1016/S0021-9150(96)06059-5; Kolling R, 1996, EUR J BIOCHEM, V239, P356, DOI 10.1111/j.1432-1033.1996.0356u.x; LEITERSDORF E, 1988, P NATL ACAD SCI USA, V85, P7912, DOI 10.1073/pnas.85.21.7912; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Luo WJ, 1997, J CELL BIOL, V138, P731, DOI 10.1083/jcb.138.4.731; MANDALA SM, 1989, J BIOL CHEM, V264, P16276; MARQUARDT T, 1992, J CELL BIOL, V117, P505, DOI 10.1083/jcb.117.3.505; Nakamoto RK, 1998, J BIOL CHEM, V273, P7338, DOI 10.1074/jbc.273.13.7338; NAKAMOTO RK, 1991, J BIOL CHEM, V266, P7940; NAO SQ, 1995, J BIOL CHEM, V270, P6815, DOI 10.1074/jbc.270.12.6815; PETROV VV, 1995, J BIOL CHEM, V270, P28535, DOI 10.1074/jbc.270.48.28535; Portillo F, 1997, FEBS LETT, V402, P136, DOI 10.1016/S0014-5793(96)01515-3; PREUSS D, 1991, YEAST, V7, P891, DOI 10.1002/yea.320070902; RAO R, 1993, J BIOL CHEM, V268, P6708; RAO R, 1992, ANN NY ACAD SCI, V671, P195, DOI 10.1111/j.1749-6632.1992.tb43796.x; RAO R, 1996, MYCOTA, V3, P29; REDDING K, 1991, J CELL BIOL, V113, P527, DOI 10.1083/jcb.113.3.527; RIORDAN JR, 1993, ANNU REV PHYSIOL, V55, P609, DOI 10.1146/annurev.ph.55.030193.003141; ROSE GD, 1985, ADV PROTEIN CHEM, V37, P1, DOI 10.1016/S0065-3233(08)60063-7; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; Rose MD., 1990, METHODS YEAST GENETI; SCHEKMAN R, 1992, Current Opinion in Cell Biology, V4, P587, DOI 10.1016/0955-0674(92)90076-O; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; SUPPLY P, 1993, J BIOL CHEM, V268, P19744; VERGERES G, 1993, J CELL SCI, V106, P249; VILLAFANE R, 1988, J MOL BIOL, V204, P607, DOI 10.1016/0022-2836(88)90359-2; VILLALBA JM, 1992, J BIOL CHEM, V267, P12341; WEIDMANN B, 1993, BIOCHIM BIOPHYS ACTA, V1153, P267, DOI 10.1016/0005-2736(93)90415-V; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; WRIGHT R, 1988, J CELL BIOL, V130, P29; YU MH, 1988, J BIOL CHEM, V263, P1424	47	46	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21744	21751		10.1074/jbc.273.34.21744	http://dx.doi.org/10.1074/jbc.273.34.21744			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705311	hybrid			2022-12-27	WOS:000075492600045
J	Knudsen, BR; Lee, J; Lisby, M; Westergaard, O; Jayaram, M				Knudsen, BR; Lee, J; Lisby, M; Westergaard, O; Jayaram, M			Alcoholysis and strand joining by the Flp site-specific recombinase - Mechanistically equivalent reactions mediated by distinct catalytic configurations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEP-ARREST MUTANTS; DNA RECOMBINATION; TOPOISOMERASE-I; HALF-SITE; CLEAVAGE; PROTEIN; LIGATION; HOMOLOGY; MUTATIONS; TRANS	The strand joining step of recombination mediated by the Flp site-specific recombinase involves the attack of a 3'-phosphotyrosyl bond by a 5'-hydroxyl group from DNA, The nucleophile in this reaction, the 5'-OH, can be substituted by glycerol or other polyhydric alcohols, The strand joining and glycerolysis reactions are mechanistically equivalent and are competitive to each other. The target diester in strand joining can be a 3'-phosphate covalently linked either to a short tyrosyl peptide or to the whole Flp protein via Tyr-343. By contrast, only the latter type of 3'-phosphotyrosyl linkage is a substrate for glycerolysis. As a result, in activated DNA substrates (containing the scissile phosphate linked to a short Flp peptide), Flp(Y343F) can mediate the joining reaction utilizing the 5'-hydroxyl attack but fails to promote glycerolysis, Wild type Flp promotes both reactions in these substrates. The strand joining and glycerolysis reactions are absolutely dependent on the catalytic histidine sat position 305 of Flp. Our results fit into a model in which a Flp dimer, with one monomer covalently attached to the 3'-phosphate, is essential for orienting the target diester or the nucleophile (or both) during glycerolysis, The requirement for this dimeric complex is relaxed in the strand joining reaction because of the ability of DNA to orient the nucleophile (5'-OH) by complementary base pairing, The experimental outcomes described here have parallels to the "cleavage-dependent ligation" carried out by a catalytic variant of Flp, Flp(R308K) (Zhu, X.-D., and Sadowski, P.D. (1995) J. Biol. Chem. 270, 23044-23054).	Univ Texas, Dept Microbiol, Austin, TX 78712 USA; Univ Texas, Inst Mol & Cell Biol, Austin, TX 78712 USA; Aarhus Univ, Dept Mol & Struct Biol, DK-8000 Aarhus, Denmark; Cheju Univ, Fac Appl Marine Sci, Cheju 690756, South Korea	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Aarhus University; Jeju National University	Jayaram, M (corresponding author), Univ Texas, Dept Microbiol, Austin, TX 78712 USA.		Lisby, Michael/K-9814-2014; Lee, Jehee/AAS-3229-2021	Lisby, Michael/0000-0002-4830-5247; Lee, Jehee/0000-0001-9144-3648; Knudsen, Birgitta Ruth/0000-0002-3484-3802				Azam N, 1997, J BIOL CHEM, V272, P8731, DOI 10.1074/jbc.272.13.8731; BEAUCAGE SL, 1981, TETRAHEDRON LETT, V22, P1859, DOI 10.1016/S0040-4039(01)90461-7; CHEN JW, 1993, J BIOL CHEM, V268, P14417; CHEN JW, 1992, CELL, V69, P647, DOI 10.1016/0092-8674(92)90228-5; CHRISTIANSEN K, 1993, J BIOL CHEM, V268, P9690; GOU F, 1997, NATURE, V389, P40; JAYARAM M, 1994, NUCLEIC ACIDS MOL BI, V8, P268; KIMBALL AS, 1993, BIOCHEMISTRY-US, V32, P4698, DOI 10.1021/bi00069a002; Knudsen BR, 1997, J MOL BIOL, V266, P93, DOI 10.1006/jmbi.1996.0767; LANDY A, 1993, CURR OPIN GENET DEV, V3, P699, DOI 10.1016/S0959-437X(05)80086-3; LEE J, 1993, J BIOL CHEM, V268, P17564; LEE J, 1994, EMBO J, V13, P5346, DOI 10.1002/j.1460-2075.1994.tb06869.x; LEE J, 1995, J BIOL CHEM, V270, P4042, DOI 10.1074/jbc.270.8.4042; LEE J, 1995, J BIOL CHEM, V270, P23203, DOI 10.1074/jbc.270.39.23203; NUNESDUBY SE, 1987, CELL, V50, P779, DOI 10.1016/0092-8674(87)90336-9; PAN GH, 1993, MOL CELL BIOL, V13, P3167, DOI 10.1128/MCB.13.6.3167; PAN GH, 1992, J BIOL CHEM, V267, P12397; PAN GH, 1993, J BIOL CHEM, V268, P3683; PARSONS RL, 1988, MOL CELL BIOL, V8, P3303, DOI 10.1128/MCB.8.8.3303; PRASAD PV, 1987, P NATL ACAD SCI USA, V84, P2189, DOI 10.1073/pnas.84.8.2189; PRASAD PV, 1988, P NATL ACAD SCI USA, V85, P1497; QIAN XH, 1992, J BIOL CHEM, V267, P7794; SADOWSKI PD, 1995, PROG NUCLEIC ACID RE, V51, P53, DOI 10.1016/S0079-6603(08)60876-4; SERRE MC, 1992, J MOL BIOL, V225, P643, DOI 10.1016/0022-2836(92)90391-V; SORRE MC, 1992, J MOL BIOL, V225, P621; Voziyanov Y, 1996, J MOL BIOL, V256, P720, DOI 10.1006/jmbi.1996.0120; Xu CJ, 1998, MOL CELL, V1, P729, DOI 10.1016/S1097-2765(00)80072-6; Yang SW, 1996, P NATL ACAD SCI USA, V93, P11534, DOI 10.1073/pnas.93.21.11534; ZHU XD, 1995, J BIOL CHEM, V270, P11646, DOI 10.1074/jbc.270.19.11646; ZHU XD, 1995, J BIOL CHEM, V270, P23044, DOI 10.1074/jbc.270.39.23044	30	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					22028	22036		10.1074/jbc.273.34.22028	http://dx.doi.org/10.1074/jbc.273.34.22028			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705345	hybrid			2022-12-27	WOS:000075492600079
J	Zakharova, N; Bass, I; Arsenieva, E; Nikiforov, V; Severinov, K				Zakharova, N; Bass, I; Arsenieva, E; Nikiforov, V; Severinov, K			Mutations in and monoclonal antibody binding to evolutionary hypervariable region of Escherichia coli RNA polymerase beta ' subunit inhibit transcript cleavage and transcript elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO CHARACTERIZATION; AMINO-ACID SUBSTITUTIONS; CONSERVED REGIONS; ACTIVE-CENTER; FACTOR TFIIS; TERMINATION; ARCHAEBACTERIAL; BETA'-SUBUNIT; PURIFICATION; LETHAL	A 190 amino acid-long region centered around position 1050 of the 1407-amino acid-long beta' subunit of Escherichia coli RNA polymerase (RNAP) is absent from homologues in eukaryotes, archaea and many bacteria. In chloroplasts, the corresponding region can be more than 900 amino acids long. The role of this hypervariable region was studied by deletion mutagenesis of the cloned E. coli rpoC, encoding beta', Long deletions mimicking beta' from Gram-positive bacteria failed to assemble into RNAP, Mutants with short, 40-60-amino acid-long deletions spanning beta' residues 941-1130 assembled into active RNAP in vitro. These mutant enzymes were defective in the transcript cleavage reaction and had dramatically reduced transcription elongation rates at subsaturating substrate concentrations due to prolonged pausing at sites of transcriptional arrest. Binding of a monoclonal antibody, Pyn1, to the hypervariable region inhibited transcription elongation and intrinsic transcript cleavage and, to a lesser degree, GreB-induced transcript cleavage, but did not interfere with GreB binding to RNAP, We propose that mutations in and antibody binding to the hypervariable, functionally dispensable region of beta' inhibit transcript cleavage and elongation by distorting the flanking conserved segment G in the active center.	Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Russian Academy of Sciences	Severinov, K (corresponding author), Rutgers State Univ, Waksman Inst, POB 759, Piscataway, NJ 08854 USA.	severik@waksman.rutgers.edu	Grivennikov, IGOR/ABA-6403-2020; Severinov, Konstantin/C-8545-2016					ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; ARCHAMBAULT J, 1992, MOL CELL BIOL, V12, P4142, DOI 10.1128/MCB.12.9.4142; ARCHAMBAULT J, 1992, MOL GEN GENET, V232, P408, DOI 10.1007/BF00266244; BORUKHOV S, 1993, PROTEIN EXPRES PURIF, V4, P503, DOI 10.1006/prep.1993.1066; BORUKHOV S, 1991, J BIOL CHEM, V266, P23932; GRAGEROV AI, 1980, FEBS LETT, V122, P17, DOI 10.1016/0014-5793(80)80391-7; GROSS CA, 1992, TRANSCRIPTIONAL REGU, P129; HONORE N, 1993, MOL MICROBIOL, V7, P207, DOI 10.1111/j.1365-2958.1993.tb01112.x; IGARASHI K, 1991, CELL, V65, P1015, DOI 10.1016/0092-8674(91)90553-B; Ito K, 1996, MOL GEN GENET, V251, P699, DOI 10.1007/BF02174119; KASHLEV M, 1993, GENE, V130, P9, DOI 10.1016/0378-1119(93)90340-9; KEANA JFW, 1990, J ORG CHEM, V55, P3640, DOI 10.1021/jo00298a048; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Koulich D, 1997, J BIOL CHEM, V272, P7201, DOI 10.1074/jbc.272.11.7201; KRUMMEL B, 1992, J MOL BIOL, V225, P221, DOI 10.1016/0022-2836(92)90917-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDICK R, 1990, J BACTERIOL, V172, P2844, DOI 10.1128/jb.172.6.2844-2854.1990; LANDICK R, 1990, GENE DEV, V4, P1623, DOI 10.1101/gad.4.9.1623; LUO JY, 1992, J BIOL CHEM, V267, P18175; Markovtsov V, 1996, P NATL ACAD SCI USA, V93, P3221, DOI 10.1073/pnas.93.8.3221; Mollet C, 1998, GENE, V207, P97, DOI 10.1016/S0378-1119(97)00618-5; MUSTAEV A, 1991, J BIOL CHEM, V266, P23927; NUDLER E, 1995, CELL, V81, P351, DOI 10.1016/0092-8674(95)90388-7; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; NUDLER E, 1994, SCIENCE, V265, P793, DOI 10.1126/science.8047884; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; PETERSEN SK, 1991, J BACTERIOL, V173, P5200, DOI 10.1128/jb.173.16.5200-5206.1991; PUHLER G, 1989, P NATL ACAD SCI USA, V86, P4569, DOI 10.1073/pnas.86.12.4569; SEVERINOV K, 1994, J BIOL CHEM, V269, P14254; SEVERINOV K, 1995, P NATL ACAD SCI USA, V92, P4591, DOI 10.1073/pnas.92.10.4591; SEVERINOV K, 1995, J BIOL CHEM, V270, P23926, DOI 10.1074/jbc.270.41.23926; Severinov K, 1996, J BIOL CHEM, V271, P27969, DOI 10.1074/jbc.271.44.27969; Severinov K, 1997, J BIOL CHEM, V272, P24137, DOI 10.1074/jbc.272.39.24137; STEBBINS CE, 1995, NATURE, V373, P636, DOI 10.1038/373636a0; SWEETSER D, 1987, P NATL ACAD SCI USA, V84, P1192, DOI 10.1073/pnas.84.5.1192; TANG H, 1995, P NATL ACAD SCI USA, V92, P4902, DOI 10.1073/pnas.92.11.4902; Tavormina PL, 1996, J BACTERIOL, V178, P5263, DOI 10.1128/jb.178.17.5263-5271.1996; WEILBAECHER R, 1994, GENE DEV, V8, P2913, DOI 10.1101/gad.8.23.2913; Wu JS, 1996, P NATL ACAD SCI USA, V93, P11552, DOI 10.1073/pnas.93.21.11552; Zaychikov E, 1996, SCIENCE, V273, P107, DOI 10.1126/science.273.5271.107; ZILLIG W, 1986, RNA POLYMERASE REGUL, P17	42	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24912	24920		10.1074/jbc.273.38.24912	http://dx.doi.org/10.1074/jbc.273.38.24912			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733798	hybrid			2022-12-27	WOS:000076007300090
J	Combadiere, C; Salzwedel, K; Smith, ED; Tiffany, HL; Berger, EA; Murphy, PM				Combadiere, C; Salzwedel, K; Smith, ED; Tiffany, HL; Berger, EA; Murphy, PM			Identification of CX(3)CR1 - A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; FUNCTIONAL EXPRESSION; HUMAN MONOCYTE; TROPIC HIV-1; CDNA CLONING; COFACTOR; ENTRY; GENE; 7-TRANSMEMBRANE; MIP-1-ALPHA	Fractalkine is a multimodular human leukocyte chemoattractant protein and a member of the chemokine superfamily. Unlike other human chemokines, the chemokine domain of fractalkine has three amino acids between two conserved cysteines, referred to as the CX3C motif. Both plasma membrane-associated and shed forms of fractalkine have been identified. Here, we show that the recombinant 76-amino acid chemokine domain of fractalkine is a potent and highly specific chemotactic agonist at a human orphan receptor previously named V28 or alternatively CMKBRL1 (chemokine beta receptor-like 1), which was shown previously to be expressed in neutrophils, monocytes, T lymphocytes, and several solid organs, including brain. CMKBRL1/V28 also functioned with CD4 as a coreceptor for the envelope protein from a primary isolate of HIV-1 in a cell-cell fusion assay, and fusion was potently and specifically inhibited by fractalkine. Thus CMKBRL1/V28 is a specific receptor for fractalkine, and we propose to rename it CX(3)CR1 (CX3C chemokine receptor 1), according to an accepted nomenclature system.	NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA; NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA; CHU X Bichat, INSERM U479, F-75877 Paris, France	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Murphy, PM (corresponding author), NIAID, Host Def Lab, NIH, Bldg 10,Rm 11N113, Bethesda, MD 20892 USA.		Combadiere, Christophe/I-5639-2013	Combadiere, Christophe/0000-0002-1755-4531				Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Alkhatib G, 1997, VIROLOGY, V234, P340, DOI 10.1006/viro.1997.8673; Baba M, 1997, J BIOL CHEM, V272, P14893, DOI 10.1074/jbc.272.23.14893; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; COMBADIERE C, 1995, DNA CELL BIOL, V14, P673, DOI 10.1089/dna.1995.14.673; COMBADIERE C, 1995, J BIOL CHEM, V270, P30235; COMBADIERE C, 1995, J BIOL CHEM, V270, P16491, DOI 10.1074/jbc.270.28.16491; Combadiere C, 1996, J LEUKOCYTE BIOL, V60, P147, DOI 10.1002/jlb.60.1.147; Doms RW, 1997, VIROLOGY, V235, P179, DOI 10.1006/viro.1997.8703; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; HARRISON JK, 1994, NEUROSCI LETT, V169, P85, DOI 10.1016/0304-3940(94)90362-X; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; KELNER GS, 1994, SCIENCE, V266, P1395, DOI 10.1126/science.7973732; Liao F, 1997, BIOCHEM BIOPH RES CO, V236, P212, DOI 10.1006/bbrc.1997.6936; Liao F, 1997, J EXP MED, V185, P2015, DOI 10.1084/jem.185.11.2015; Murphy Philip M., 1996, Cytokine and Growth Factor Reviews, V7, P47, DOI 10.1016/1359-6101(96)00009-3; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; NUSSBAUM O, 1994, J VIROL, V68, P5411, DOI 10.1128/JVI.68.9.5411-5422.1994; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; RAPORT CJ, 1995, GENE, V163, P295, DOI 10.1016/0378-1119(95)00336-5; Reeves JD, 1997, VIROLOGY, V231, P130, DOI 10.1006/viro.1997.8508; Roos RS, 1997, J BIOL CHEM, V272, P17251, DOI 10.1074/jbc.272.28.17251; Rucker J, 1997, J VIROL, V71, P8999, DOI 10.1128/JVI.71.12.8999-9007.1997; Samson M, 1996, GENOMICS, V36, P522, DOI 10.1006/geno.1996.0498; Tiffany HL, 1997, J EXP MED, V186, P165, DOI 10.1084/jem.186.1.165; Yoshida R, 1997, J BIOL CHEM, V272, P13803, DOI 10.1074/jbc.272.21.13803	28	238	262	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23799	23804		10.1074/jbc.273.37.23799	http://dx.doi.org/10.1074/jbc.273.37.23799			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726990	hybrid			2022-12-27	WOS:000075893100031
J	Okino, ST; Chichester, CH; Whitlock, JP				Okino, ST; Chichester, CH; Whitlock, JP			Hypoxia-inducible mammalian gene expression analyzed in vivo at a TATA-driven promoter and at an initiator-driven promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AH RECEPTOR; DNA-BINDING; FACTOR-I; PHOSPHOGLYCERATE KINASE-1; CRYSTAL-STRUCTURE; PAS DOMAIN; TRANSCRIPTION; PROTEIN; DIOXIN; COMPLEX	We have analyzed protein-DNA interactions in vivo at transcriptional control elements for two hypoxia-inducible genes in mouse hepatoma cells. The promoter for the phosphoglycerate kinase 1 (PGK1) gene contains an initiator element, but no TATA sequence, whereas the promoter for the glucose transporter 1 (Glut1) gene contains a TATA element but no initiator sequence. Our findings reveal hypoxia-inducible, Arnt-dependent occupancy of DNA recognition sites for hypoxia-inducible factor 1 (HIF-1) upstream of both target genes. The conserved recognition motif among the five recognition sites is 5'-CGTG-3'. The PGK1 promoter exhibits constitutive occupancy of a binding site for an unknown protein(s); however, we detect no protein-DNA interaction at the initiator element, in either uninduced or induced cells. The Glut1 promoter also exhibits constitutive protein binding; in addition, the TATA element exhibits partial occupancy in uninduced cells and increased occupancy under hypoxic conditions. We find no evidence for hypoxia-induced changes in chromatin structure of either gene. Time-course analyses of the Glut1 gene reveal a temporal relationship between occupancy of HIF-1 sites and TATA element occupancy. Our findings suggest that the promoters for both hypoxia-responsive genes constitutively maintain an accessible chromatin configuration and that HIF-1 facilitates transcription by recruiting and/or stabilizing a transcription factor(s), such as TFIID, at both promoters.	Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA	Stanford University	Whitlock, JP (corresponding author), Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA.				NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES005677, R01ES008655] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES 05677, ES 08655] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; BACSI SG, 1995, MOL PHARMACOL, V47, P432; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; DENISON MS, 1995, J BIOL CHEM, V270, P18175, DOI 10.1074/jbc.270.31.18175; EBERT BL, 1995, J BIOL CHEM, V270, P29083, DOI 10.1074/jbc.270.49.29083; FIRTH JD, 1994, P NATL ACAD SCI USA, V91, P6496, DOI 10.1073/pnas.91.14.6496; Garraway IP, 1996, P NATL ACAD SCI USA, V93, P4336, DOI 10.1073/pnas.93.9.4336; Guillemin K, 1997, CELL, V89, P9, DOI 10.1016/S0092-8674(00)80176-2; Hahn ME, 1997, P NATL ACAD SCI USA, V94, P13743, DOI 10.1073/pnas.94.25.13743; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Hitoshi Y, 1998, IMMUNITY, V8, P461, DOI 10.1016/S1074-7613(00)80551-8; HUANG ZJ, 1993, NATURE, V364, P259, DOI 10.1038/364259a0; ISSAC DD, 1997, GENE DEV, V10, P103; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Kay SA, 1997, SCIENCE, V276, P753, DOI 10.1126/science.276.5313.753; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; Ko HP, 1997, MOL CELL BIOL, V17, P3497, DOI 10.1128/MCB.17.7.3497; Ko HSP, 1996, MOL CELL BIOL, V16, P430; Li H, 1996, J BIOL CHEM, V271, P21262, DOI 10.1074/jbc.271.35.21262; LINDEBRO MC, 1995, EMBO J, V14, P3528, DOI 10.1002/j.1460-2075.1995.tb07359.x; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; MARTINEZ E, 1994, EMBO J, V13, P3115, DOI 10.1002/j.1460-2075.1994.tb06610.x; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; MCBURNEY MW, 1991, NUCLEIC ACIDS RES, V19, P5755, DOI 10.1093/nar/19.20.5755; MILLER AG, 1983, J BIOL CHEM, V258, P3523; MORGAN JE, 1992, P NATL ACAD SCI USA, V89, P11622, DOI 10.1073/pnas.89.23.11622; MULLER PR, 1989, SCIENCE, V246, P780; MURAKAMI T, 1992, J BIOL CHEM, V267, P9300; NAMBU JR, 1991, CELL, V67, P1157, DOI 10.1016/0092-8674(91)90292-7; Oelgeschlager T, 1996, NATURE, V382, P735, DOI 10.1038/382735a0; OKEY AB, 1994, TRENDS PHARMACOL SCI, V15, P226, DOI 10.1016/0165-6147(94)90316-6; OKINO ST, 1995, MOL CELL BIOL, V15, P3714; PFEIFER GP, 1990, GENE DEV, V4, P1277, DOI 10.1101/gad.4.8.1277; PFEIFER GP, 1991, GENE DEV, V5, P1102, DOI 10.1101/gad.5.6.1102; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Salceda S, 1996, ARCH BIOCHEM BIOPHYS, V334, P389, DOI 10.1006/abbi.1996.0469; Sambrook J., 2002, MOL CLONING LAB MANU; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; SHEN ES, 1992, J BIOL CHEM, V267, P6815; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; Sun WM, 1997, J BIOL CHEM, V272, P31845, DOI 10.1074/jbc.272.50.31845; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; Wang G L, 1996, Curr Opin Hematol, V3, P156; WANG GL, 1993, J BIOL CHEM, V268, P21513; Wenger RH, 1997, BIOL CHEM, V378, P609; Whitlock JP, 1996, FASEB J, V10, P809, DOI 10.1096/fasebj.10.8.8666157; Wilk R, 1996, GENE DEV, V10, P93, DOI 10.1101/gad.10.1.93; Wood SM, 1998, J BIOL CHEM, V273, P8360, DOI 10.1074/jbc.273.14.8360; Wood SM, 1996, J BIOL CHEM, V271, P15117, DOI 10.1074/jbc.271.25.15117; ZAWAL L, 1995, ANNU REV BIOCHEM, V64, P533; Zelzer E, 1997, GENE DEV, V11, P2079, DOI 10.1101/gad.11.16.2079	57	46	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23837	23843		10.1074/jbc.273.37.23837	http://dx.doi.org/10.1074/jbc.273.37.23837			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726995	hybrid			2022-12-27	WOS:000075893100036
J	Vanderstraeten, S; Van den Brule, S; Hu, JP; Foury, F				Vanderstraeten, S; Van den Brule, S; Hu, JP; Foury, F			The role of 3 '-5 ' exonucleolytic proofreading and mismatch repair in yeast mitochondrial DNA error avoidance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXONUCLEASE ACTIVE-SITE; LARGE RIBOSOMAL-RNA; ENCODING MIP1 GENE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; POLYMERASE-GAMMA; 3'->5' EXONUCLEASE; REPLICATION ERRORS; RIB2 LOCUS; MUTAGENESIS	In the D171G/D2SOA mutant generated at conserved aspartate residues in the Exo1 and Exo2 sites of the 3'-5' exonuclease domain of the yeast mitochondrial DNA (mtDNA) polymerase (pol-gamma), the mitochondrial genome is unstable and the frequency of mtDNA point mutations is 1500 times higher than in the wild-type strain and 10 times higher than in single substitution mutants. The 10(4)-fold decrease in the 3'-5' exonuclease activity of the purified mtDNA polymerase is associated with mismatch extension and high rates of base misincorporation. Processivity of the purified polymerase on primed single-stranded DNA is decreased and the K-m for dNTP is increased. The sequencing of mtDNA point mutations in the wild-type strain and in proofreading and mismatch-repair deficient mutants shows that mismatch repair contributes to elimination of the transitions while exonucleolytic proofreading preferentially repairs transversions, and more specifically A to T (or T to A) transversions. However, even in the wild-type strain, A to T (or T to A) transversions are the most frequent substitutions, suggesting that they are imperfectly repaired. The combination of both mismatch repair and proofreading deficiencies elicits a mitochondrial error catastrophe. These data show that the faithful replication of yeast mtDNA requires both exonucleolytic proofreading and mismatch repair.	Unite Biochim Physiol, B-1348 Louvain, Belgium		Foury, F (corresponding author), Unite Biochim Physiol, Pl Croix du Sud,2-20, B-1348 Louvain, Belgium.							AQUADRO CF, 1983, GENETICS, V103, P287; AVISE JC, 1991, ANNU REV GENET, V25, P45, DOI 10.1146/annurev.ge.25.120191.000401; BACKER J, 1985, CURR GENET, V10, P7, DOI 10.1007/BF00418487; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; CHI NW, 1994, J BIOL CHEM, V269, P29984; CLARKWALKER GD, 1991, CURR GENET, V20, P195, DOI 10.1007/BF00326232; COLSON AM, 1993, J BIOENERG BIOMEMBR, V25, P211, DOI 10.1007/BF00762583; CUI Z, 1989, CURR GENET, V16, P273, DOI 10.1007/BF00422114; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; ELLEDGE SJ, 1990, GENE DEV, V4, P740, DOI 10.1101/gad.4.5.740; ERIKSSON S, 1995, J BIOL CHEM, V270, P18929, DOI 10.1074/jbc.270.32.18929; ESTEBAN JA, 1994, J BIOL CHEM, V269, P31946; Fijalkowska IJ, 1996, P NATL ACAD SCI USA, V93, P2856, DOI 10.1073/pnas.93.7.2856; FOURY F, 1979, P NATL ACAD SCI USA, V76, P6529, DOI 10.1073/pnas.76.12.6529; FOURY F, 1992, EMBO J, V11, P2717, DOI 10.1002/j.1460-2075.1992.tb05337.x; FOURY F, 1989, J BIOL CHEM, V264, P20552; GRAY H, 1992, J BIOL CHEM, V267, P5835; HU JP, 1995, GENE, V160, P105, DOI 10.1016/0378-1119(95)00215-R; INSDORF NF, 1989, J BIOL CHEM, V264, P21498; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; KAGUNI LS, 1989, P NATL ACAD SCI USA, V86, P6469, DOI 10.1073/pnas.86.17.6469; Kogelnik AM, 1996, NUCLEIC ACIDS RES, V24, P177, DOI 10.1093/nar/24.1.177; Kuhn FJP, 1996, J BIOL CHEM, V271, P29245; KUNKEL TA, 1988, J BIOL CHEM, V263, P4450; KUNKEL TA, 1988, J BIOL CHEM, V263, P14784; KUNKEL TA, 1989, BIOCHEMISTRY-US, V28, P988, DOI 10.1021/bi00429a011; KUNKEL TA, 1981, SCIENCE, V213, P765, DOI 10.1126/science.6454965; Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4; LECRENIER N, 1995, MOL GEN GENET, V249, P1, DOI 10.1007/BF00290229; LONGLEY MJ, 1991, J BIOL CHEM, V266, P24702; MACINO G, 1979, P NATL ACAD SCI USA, V76, P131, DOI 10.1073/pnas.76.1.131; MORRISON A, 1994, MOL GEN GENET, V242, P289, DOI 10.1007/BF00280418; MORRISON A, 1993, EMBO J, V12, P1467, DOI 10.1002/j.1460-2075.1993.tb05790.x; PONTKINGDON GA, 1995, NATURE, V375, P109, DOI 10.1038/375109b0; REENAN RAG, 1992, GENETICS, V132, P975; Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490; SCHAAPER RM, 1987, P NATL ACAD SCI USA, V84, P6220, DOI 10.1073/pnas.84.17.6220; SCHAAPER RM, 1988, P NATL ACAD SCI USA, V85, P8126, DOI 10.1073/pnas.85.21.8126; SCHAAPER RM, 1993, J BIOL CHEM, V268, P23762; SCHAAPER RM, 1989, EMBO J, V8, P3511, DOI 10.1002/j.1460-2075.1989.tb08516.x; SOENGAS MS, 1992, EMBO J, V11, P4227, DOI 10.1002/j.1460-2075.1992.tb05517.x; SOR F, 1983, NUCLEIC ACIDS RES, V11, P339, DOI 10.1093/nar/11.2.339; SOR F, 1984, NUCLEIC ACIDS RES, V12, P8313, DOI 10.1093/nar/12.22.8313	44	69	72	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23690	23697		10.1074/jbc.273.37.23690	http://dx.doi.org/10.1074/jbc.273.37.23690			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726974	hybrid			2022-12-27	WOS:000075893100015
J	Chien, AJ; Gao, TY; Perez-Reyes, E; Hosey, MM				Chien, AJ; Gao, TY; Perez-Reyes, E; Hosey, MM			Membrane targeting of L-type calcium channels - Role of palmitoylation in the subcellular localization of the beta(2a) subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ CHANNELS; FUNCTIONAL EXPRESSION; CHARGE MOVEMENTS; SH3 DOMAIN; CLONING; ALPHA(1)-SUBUNIT; DIHYDROPYRIDINE; IDENTIFICATION; DIVERSITY; INCREASES	In this study, we report that palmitoylation was a critical determinant of the subcellular localization of the rat beta(2a) subunit of voltage-dependent calcium channels. Immunohistochemical staining of transfected cells revealed that a palmitoylation-deficient beta(2a) subunit exhibited a diffuse intracellular staining pattern, in contrast to the plasma membrane distribution seen with the wild-type beta(2a) subunit. Unexpectedly, mutations in regions distal to the palmitoylation sites at Cys(3) and Cys(4) affected palmitoylation of the beta(2a) protein. Mutations in an src homology 3 motif of the beta(2a) subunit affected both palmitoylation and subcellular localization of the beta(2a) protein, A mutation in the beta interaction domain, which disrupted interactions between the expressed alpha(1) and beta subunits, also resulted in a decreased palmitoylation and diffuse intracellular localization of the beta(2a) protein. Studies of chimeric proteins revealed that the 16-amino acid N terminus of the beta(2a) subunit was sufficient to confer palmitoylation to the nonpalmitoylated beta(1b) and beta(3) isoforms. However, palmitoylation of chimeric beta subunits was by itself insufficient to restore the plasma membrane localization observed with the wild-type beta(2a) protein. Treatment of transfected cells with brefeldin A increased the amount of palmitic acid incorporated in the beta(2a) protein, suggesting that palmitoylation of beta(2a) occurs during or shortly after protein synthesis. Two other beta(2) variants, the rabbit beta(2a) and beta(2b), which lack the palmitoylation sties at Cys(3) and Cys(4), exhibited a diffuse intracellular staining pattern and were not palmitoylated.	Northwestern Univ, Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; Loyola Univ, Med Ctr, Dept Physiol, Maywood, IL 60153 USA; Loyola Univ, Med Ctr, Cardiovasc Inst, Maywood, IL 60153 USA	Northwestern University; Loyola University Chicago; Loyola University Chicago	Hosey, MM (corresponding author), Northwestern Univ, Sch Med, Dept Mol Pharmacol & Biol Chem, 303 E Chicago Ave,S215, Chicago, IL 60611 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL023306, R29HL046702, R55HL046702, R37HL023306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH010770] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL46702, HL23306] Funding Source: Medline; NIMH NIH HHS [MH10770] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BERTHIAUME L, 1995, J BIOL CHEM, V270, P22399, DOI 10.1074/jbc.270.38.22399; Beurg M, 1997, BIOPHYS J, V73, P807, DOI 10.1016/S0006-3495(97)78113-X; Brice NL, 1997, EUR J NEUROSCI, V9, P749, DOI 10.1111/j.1460-9568.1997.tb01423.x; CAMP LA, 1994, J BIOL CHEM, V269, P23212; CASTELLANO A, 1994, BIOCHEM SOC T, V22, P483, DOI 10.1042/bst0220483; CASTELLANO A, 1993, J BIOL CHEM, V268, P12359; CASTELLANO A, 1993, J BIOL CHEM, V268, P3450; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; CHIEN AJ, 1995, J BIOL CHEM, V270, P30036; De Waard M, 1996, Ion Channels, V4, P41; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; DEWAARD M, 1995, J BIOL CHEM, V270, P12056, DOI 10.1074/jbc.270.20.12056; ERPEL T, 1995, EMBO J, V14, P963, DOI 10.1002/j.1460-2075.1995.tb07077.x; Gonzalo S, 1998, MOL BIOL CELL, V9, P585, DOI 10.1091/mbc.9.3.585; Hosey MM, 1996, TRENDS CARDIOVAS MED, V6, P265, DOI 10.1016/S1050-1738(96)00109-0; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; Josephson IR, 1996, BIOPHYS J, V70, P1285, DOI 10.1016/S0006-3495(96)79685-6; Kamp TJ, 1996, J PHYSIOL-LONDON, V492, P89, DOI 10.1113/jphysiol.1996.sp021291; MITTERDORFER J, 1994, FEBS LETT, V352, P141, DOI 10.1016/0014-5793(94)00938-4; Mumby SM, 1997, CURR OPIN CELL BIOL, V9, P148, DOI 10.1016/S0955-0674(97)80056-7; MUNDY DI, 1995, BIOCHEM SOC T, V23, P572, DOI 10.1042/bst0230572; NISHIMURA S, 1993, FEBS LETT, V324, P283, DOI 10.1016/0014-5793(93)80135-H; NOBLE MEM, 1993, EMBO J, V12, P2617, DOI 10.1002/j.1460-2075.1993.tb05922.x; PEREZGARCIA MT, 1995, J GEN PHYSIOL, V105, P289, DOI 10.1085/jgp.105.2.289; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Qin N, 1998, P NATL ACAD SCI USA, V95, P4690, DOI 10.1073/pnas.95.8.4690; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; ROBINSON LJ, 1995, J BIOL CHEM, V270, P985; SCHWEIZER A, 1995, J BIOL CHEM, V270, P9638, DOI 10.1074/jbc.270.16.9638; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q	33	86	88	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23590	23597		10.1074/jbc.273.36.23590	http://dx.doi.org/10.1074/jbc.273.36.23590			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722599	hybrid			2022-12-27	WOS:000075778100099
J	Erhardt, JA; Pittman, RN				Erhardt, JA; Pittman, RN			Ectopic p21(WAF1) expression induces differentiation-specific cell cycle changes in PC12 cells characteristic of nerve growth factor treatment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE INHIBITOR P21; DEPENDENT KINASES; NEURONAL DIFFERENTIATION; PHEOCHROMOCYTOMA CELLS; ANTIPROLIFERATIVE ACTIVITY; TERMINAL DIFFERENTIATION; NEURITE OUTGROWTH; IN-VIVO; INDUCTION; PROTEIN	Nerve growth factor treatment of PC12 cells results in neuronal differentiation, a process accompanied by induction of the Cdk inhibitor p21(WAF1). To determine the role of p21 in differentiation, PC12 clones containing an inducible p21 construct were utilized to induce growth arrest. Expression of p21 led to accumulation of cyclins D1 and E and to a decrease in cyclins A and B. Levels of Cdc2 and Cdk4 also decreased after p21 induction. Initially, thymidine incorporation into DNA was dramatically inhibited; however, low levels of incorporation were observed during prolonged p21 expression. Fluorescence-activated cell, sorter analysis revealed that this low level of DNA synthesis resulted in the generation of polyploid cells. Results from Western blots were consistent with phosphorylation of p21 protein coincident with the resumption of DNA synthesis. Finally, treatment of p21-arrested populations with epidermal growth factor, a known PC12 mitogen, resulted in neurite extension, a key feature of neuronal differentiation. Overall, cell cycle changes following p21 overexpression in PC12 cells closely mimic distinctive events previously shown to occur during differentiation. These results suggest that the mechanism by which nerve growth factor induces the many cellular changes associated with growth arrest during differentiation is through p21(WAF1) induction.	Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania	Erhardt, JA (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 155 John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.				NINDS NIH HHS [NS32465] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032465] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BLUMBERG D, 1995, J NEUROSCI RES, V41, P628, DOI 10.1002/jnr.490410509; BUCHKOVICH KJ, 1994, MOL BIOL CELL, V5, P1225, DOI 10.1091/mbc.5.11.1225; DOBASHI Y, 1995, J BIOL CHEM, V270, P23031, DOI 10.1074/jbc.270.39.23031; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Erhardt JA, 1998, ONCOGENE, V16, P443, DOI 10.1038/sj.onc.1201577; Gartel AL, 1996, P SOC EXP BIOL MED, V213, P138; Gollapudi L, 1997, J NEUROSCI RES, V49, P461, DOI 10.1002/(SICI)1097-4547(19970815)49:4<461::AID-JNR7>3.3.CO;2-6; GRANA X, 1995, ONCOGENE, V11, P211; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; GUO K, 1995, MOL CELL BIOL, V15, P3823; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Harper JW, 1996, CURR OPIN GENET DEV, V6, P56; HARPER JW, 1993, CELL, V75, P805; HONDERMARCK H, 1994, P NATL ACAD SCI USA, V91, P9377, DOI 10.1073/pnas.91.20.9377; HUPPI K, 1994, ONCOGENE, V9, P3017; IGNATIUS MJ, 1985, J NEUROSCI, V5, P343; IONOSO F, 1994, J NEUROCHEM, V63, P1235; Jiang Hongping, 1993, Molecular and Cellular Differentiation, V1, P285; JIANG HP, 1994, ONCOGENE, V9, P3397; KALMAN D, 1993, MOL BIOL CELL, V4, P353, DOI 10.1091/mbc.4.4.353; Kikuchi J, 1997, BLOOD, V89, P3980, DOI 10.1182/blood.V89.11.3980; LAPHAM LW, 1968, SCIENCE, V159, P310, DOI 10.1126/science.159.3812.310; Lazarovici P, 1997, J BIOL CHEM, V272, P11026, DOI 10.1074/jbc.272.17.11026; LENTZ RD, 1970, J NEUROPATH EXP NEUR, V29, P43, DOI 10.1097/00005072-197001000-00004; MACLACHLAN TK, 1995, CRIT REV EUKAR GENE, V5, P127, DOI 10.1615/CritRevEukarGeneExpr.v5.i2.20; Mark MD, 1997, NEUROSCI LETT, V230, P73, DOI 10.1016/S0304-3940(97)00491-6; Mark MD, 1997, J BIOL CHEM, V272, P17238, DOI 10.1074/jbc.272.27.17238; MISSERO C, 1995, P NATL ACAD SCI USA, V92, P5451, DOI 10.1073/pnas.92.12.5451; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; PINES J, 1995, BIOCHEM J, V308, P697, DOI 10.1042/bj3080697; PITTMAN RN, 1993, J NEUROSCI, V13, P3669; Poluha W, 1997, J BIOL CHEM, V272, P24002, DOI 10.1074/jbc.272.38.24002; Poluha W, 1996, MOL CELL BIOL, V16, P1335; RAFFIONI S, 1995, J BIOL CHEM, V270, P7568, DOI 10.1074/jbc.270.13.7568; RUDKIN BB, 1989, EMBO J, V8, P3319, DOI 10.1002/j.1460-2075.1989.tb08493.x; SHEIKH MS, 1995, ONCOGENE, V11, P1899; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; STEINMAN RA, 1994, ONCOGENE, V9, P3389; Tchou WW, 1996, J BIOL CHEM, V271, P29556, DOI 10.1074/jbc.271.47.29556; vanGrunsven LA, 1996, ONCOGENE, V12, P1347; Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245; Wu YY, 1996, J BIOL CHEM, V271, P13033, DOI 10.1074/jbc.271.22.13033; XIONG Y, 1992, CELL, V71, P505, DOI 10.1016/0092-8674(92)90518-H; Yan GZ, 1997, J NEUROSCI, V17, P6122; YAN GZ, 1995, J NEUROSCI, V15, P6200; ZHANG H, 1994, GENE DEV, V8, P1750, DOI 10.1101/gad.8.15.1750	50	72	72	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23517	23523		10.1074/jbc.273.36.23517	http://dx.doi.org/10.1074/jbc.273.36.23517			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722590	hybrid			2022-12-27	WOS:000075778100090
J	Kuhlbrodt, K; Schmidt, C; Sock, E; Pingault, V; Bondurand, N; Goossens, M; Wegner, M				Kuhlbrodt, K; Schmidt, C; Sock, E; Pingault, V; Bondurand, N; Goossens, M; Wegner, M			Functional analysis of Sox10 mutations found in human Waardenburg-Hirschsprung patients	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; ARCHITECTURAL TRANSCRIPTION FACTORS; CAMPOMELIC DYSPLASIA; NUCLEAR-LOCALIZATION; BETA-CATENIN; JC VIRUS; DNA; PROTEIN; DOMAIN	The Sry-related protein Sox10 is selectively expressed in neural crest cells during early stages of development and in glial cells of the peripheral and central nervous systems during late development and in the adult. Mutation of the Sox10 gene leads to neural crest defects in the Dominant megacolon mouse mutant and to combined Waardenburg-Hirschsprung syndrome in humans. Here, we have studied the four Sox10 mutations found to date in Waardenburg-Hirschsprung patients both in the context of the rat and the human cDNA. Unlike the rat Sox10 protein, which failed to show transcriptional activity on its own, human Sox10 displayed a weak, but reproducible, activity as a transcriptional activator, All mutant Sox10 proteins, including the one that only lacked the 106 last amino acids were deficient in this capacity, indicating that the carboxyl terminus of human Sox10 carries a transactivation domain. Whereas all four mutants failed to transactivate, only two failed to synergistically enhance the activity of other transcription factors. Synergy required both the ability to bind to DNA and a region in the amino-terminal part of Sox10, Those mutants that failed to synergize were unable to bind to DNA, Analysis of the naturally occurring Sox10 mutations not only helps to dissect Sox10 structure, but also allows limited predictions on the severity of the disease.	Univ Hamburg, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; Hop Henri Mondor, INSERM, U468, F-94010 Creteil, France	University of Hamburg; University Medical Center Hamburg-Eppendorf; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Wegner, M (corresponding author), ZMNH, Martinistr 52, D-20246 Hamburg, Germany.		Bondurand, Nadege/H-4737-2017	Bondurand, Nadege/0000-0002-1531-1544; Wegner, Michael/0000-0002-4586-3294; Sock, Elisabeth/0000-0001-9925-3136; Pingault, Veronique/0000-0001-7064-0765				BADNER JA, 1990, AM J HUM GENET, V46, P568; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; DUBIN RA, 1994, MOL ENDOCRINOL, V8, P1182, DOI 10.1210/me.8.9.1182; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; HARLEY VR, 1994, NUCLEIC ACIDS RES, V22, P1500, DOI 10.1093/nar/22.8.1500; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; HOSKING BM, 1995, NUCLEIC ACIDS RES, V23, P2626, DOI 10.1093/nar/23.14.2626; JAGER RJ, 1990, NATURE, V348, P452, DOI 10.1038/348452a0; KAMACHI Y, 1995, EMBO J, V14, P3510, DOI 10.1002/j.1460-2075.1995.tb07357.x; Kanai Y, 1996, J CELL BIOL, V133, P667, DOI 10.1083/jcb.133.3.667; Kent J, 1996, DEVELOPMENT, V122, P2813; Kuhlbrodt K, 1998, J BIOL CHEM, V273, P16050, DOI 10.1074/jbc.273.26.16050; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; LAUDET V, 1993, NUCLEIC ACIDS RES, V21, P2493, DOI 10.1093/nar/21.10.2493; Meyer J, 1997, HUM MOL GENET, V6, P91, DOI 10.1093/hmg/6.1.91; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Nambu PA, 1996, DEVELOPMENT, V122, P3467; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Pevny LH, 1997, CURR OPIN GENET DEV, V7, P338, DOI 10.1016/S0959-437X(97)80147-5; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; POULAT F, 1995, J CELL BIOL, V128, P737, DOI 10.1083/jcb.128.5.737; Read AP, 1997, J MED GENET, V34, P656, DOI 10.1136/jmg.34.8.656; RENNER K, 1994, P NATL ACAD SCI USA, V91, P6433, DOI 10.1073/pnas.91.14.6433; Roose J, 1998, NUCLEIC ACIDS RES, V26, P469, DOI 10.1093/nar/26.2.469; Russell SRH, 1996, DEVELOPMENT, V122, P3669; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Schreiber J, 1997, P NATL ACAD SCI USA, V94, P4739, DOI 10.1073/pnas.94.9.4739; Sock E, 1996, J VIROL, V70, P1512, DOI 10.1128/JVI.70.3.1512-1520.1996; Sock E, 1996, J BIOL CHEM, V271, P17512, DOI 10.1074/jbc.271.29.17512; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Sudbeck P, 1996, NAT GENET, V13, P230, DOI 10.1038/ng0696-230; Sudbeck P, 1997, J BIOL CHEM, V272, P27848, DOI 10.1074/jbc.272.44.27848; TAKAMATSU N, 1995, MOL CELL BIOL, V15, P3759; VANDEWETERING M, 1993, EMBO J, V12, P3847, DOI 10.1002/j.1460-2075.1993.tb06063.x; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WERNER MH, 1995, CELL, V81, P705, DOI 10.1016/0092-8674(95)90532-4; Werner MH, 1997, CELL, V88, P733, DOI 10.1016/S0092-8674(00)81917-0; WOLFFE AP, 1994, SCIENCE, V264, P1100, DOI 10.1126/science.8178167; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635	42	104	109	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23033	23038		10.1074/jbc.273.36.23033	http://dx.doi.org/10.1074/jbc.273.36.23033			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722528	hybrid			2022-12-27	WOS:000075778100028
J	Stella, L; Caccuri, AM; Rosato, N; Nicotra, M; Lo Bello, M; De Matteis, F; Mazzetti, AP; Federici, G; Ricci, G				Stella, L; Caccuri, AM; Rosato, N; Nicotra, M; Lo Bello, M; De Matteis, F; Mazzetti, AP; Federici, G; Ricci, G			Flexibility of helix 2 in the human glutathione transferase P1-1 - Time-resolved fluorescence spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; 3-DIMENSIONAL STRUCTURE; S-TRANSFERASE; LIFETIME DISTRIBUTIONS; HUMAN PLACENTA; RESOLUTION; PROTEINS; COMPLEX; RAT; MECHANISM	Time-resolved fluorescence spectroscopy and site-directed mutagenesis have been used to probe the flexibility of alpha-helix 2 (residues 35-46) in the apo structure of the human glutathione transferase P1-1 (EC 2.5.1.18) as well as in the binary complex with the natural substrate glutathione. Trp-38, which resides on helix 2, has been exploited as an intrinsic fluorescent probe of the dynamics of this region. A Trp-28 mutant enzyme was studied in which the second tryptophan of glutathione transferase P1-1 is replaced by histidine. Time-resolved fluorescence data indicate that, in the absence of glutathione, the apoenzyme exists in at least two different families of conformational states. The first one (38% of the total population) corresponds to a number of slightly different conformations of helix 2, in which Trp-38 resides in a polar environment showing an average emission wavelength of 350 nm. The second one (62% of the total population) displays an emission centered at 320 nm, thus suggesting a quite apolar environment near Trp-38. The interconversion between these two conformations is much slower than 1 ns. In the presence of saturating glutathione concentrations, the equilibrium is shifted toward the apolar component, which is now 83% of the total population. The polar conformers, on the other hand, do not change their average decay lifetime, but the distribution becomes wider, indicating a slightly increased rigidity. These data suggest a central role of conformational transitions in the binding mechanism, and are consistent with NMR data (Nicotra, M., Paci, M., Sette, M., Oakley, A. J., Parker, M. W., Lo Bello, M., Caccuri, A. M., Federici, G., and Ricci, G. (1998) Biochemistry 37, 3020-3027) and pre-steady state kinetic experiments (Caccuri, A. M., Lo Bello, M., Nuccetelli, M., Nicotra, M., Rossi, P., Antonini, G., Federici, G., and Ricci, G. (1998) Biochemistry 37, 3028-3034) indicating the existence of a pre-complex in which GSH is not firmly bound to the active site.	Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; Univ Roma Tor Vergata, Dept Chem Sci & Technol, I-00133 Rome, Italy; Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy; Univ Roma Tor Vergata, Dept Phys, I-00133 Rome, Italy; Ist Nazl Fis Mat, I-00133 Rome, Italy; Osped Pediat IRCCS Bambin Gesu, I-00165 Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); IRCCS Bambino Gesu	Ricci, G (corresponding author), Univ Roma Tor Vergata, Dept Biol, Viale Ric Sci, I-00133 Rome, Italy.	RICCIG@UNIROMA2.IT	CACCURI, ANNA MARIA/AFU-2643-2022; De Matteis, Fabio/ABG-1923-2020; Stella, Lorenzo/A-7996-2010	Stella, Lorenzo/0000-0002-5489-7381; Ricci, Giorgio/0000-0002-7108-2846; CACCURI, ANNA MARIA/0000-0002-3756-4163; De Matteis, Fabio/0000-0001-7860-9754				ALCALA JR, 1987, BIOPHYS J, V51, P925, DOI 10.1016/S0006-3495(87)83420-3; ALCALA JR, 1987, BIOPHYS J, V51, P597, DOI 10.1016/S0006-3495(87)83384-2; ALCALA JR, 1987, BIOPHYS J, V51, P587, DOI 10.1016/S0006-3495(87)83383-0; ARMSTRONG RN, 1991, CHEM RES TOXICOL, V4, P131, DOI 10.1021/tx00020a001; ARMSTRONG RN, 1994, ADV ENZYMOL RELAT A, V10, P1; BATTISTONI A, 1995, PROTEIN EXPRES PURIF, V6, P579, DOI 10.1006/prep.1995.1076; BEECHEM JM, 1988, P SPIE INT SOC OPT E, V909, P70; Beechem JM., 2002, TOPICS FLUORESCENCE, P241, DOI DOI 10.1007/0-306-47058-6_5; BISMUTO E, 1989, PHOTOCHEM PHOTOBIOL, V50, P165, DOI 10.1111/j.1751-1097.1989.tb04143.x; BUETLER TM, 1992, J ENVIRON SCI HEAL C, V10, P181; Caccuri AM, 1998, BIOCHEMISTRY-US, V37, P3028, DOI 10.1021/bi971903g; Caccuri AM, 1996, J BIOL CHEM, V271, P16193, DOI 10.1074/jbc.271.27.16193; Dietze EC, 1996, BIOCHEMISTRY-US, V35, P6745, DOI 10.1021/bi9530346; EFTINK MR, 1991, METHOD BIOCHEM ANAL, V35, P127; FERREIRA ST, 1994, BIOPHYS J, V66, P1185, DOI 10.1016/S0006-3495(94)80901-4; GRATTON E, 1989, FLUORESCENT BIOMOLEC, P17; JAKOBY WB, 1980, ENZYMATIC BASIS DETO, V2, P63; JI X, 1993, BIOCHEMISTRY-US, V32, P12949, DOI 10.1021/bi00211a001; JI XH, 1995, BIOCHEMISTRY-US, V34, P5317, DOI 10.1021/bi00016a003; JI XH, 1992, BIOCHEMISTRY-US, V31, P10169, DOI 10.1021/bi00157a004; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LANDAW EM, 1984, AM J PHYSIOL, V246, pR665, DOI 10.1152/ajpregu.1984.246.5.R665; LOBELLO M, 1995, J BIOL CHEM, V270, P1249; MANNERVIK B, 1985, P NATL ACAD SCI USA, V82, P7202, DOI 10.1073/pnas.82.21.7202; McMahon LP, 1997, J PHYS CHEM B, V101, P3269, DOI 10.1021/jp963273i; MEYER DJ, 1995, BIOCHEM J, V311, P739, DOI 10.1042/bj3110739; MEYER DJ, 1991, BIOCHEM J, V274, P409, DOI 10.1042/bj2740409; Nicotra M, 1998, BIOCHEMISTRY-US, V37, P3020, DOI 10.1021/bi971902o; REINEMER P, 1992, J MOL BIOL, V227, P214, DOI 10.1016/0022-2836(92)90692-D; REINEMER P, 1991, EMBO J, V10, P1997, DOI 10.1002/j.1460-2075.1991.tb07729.x; RICCI G, 1991, J BIOL CHEM, V266, P21409; RICCI G, 1995, J BIOL CHEM, V270, P1243, DOI 10.1074/jbc.270.3.1243; Ricci G, 1996, J BIOL CHEM, V271, P16187, DOI 10.1074/jbc.271.27.16187; Simons P C, 1981, Methods Enzymol, V77, P235; SINNING I, 1993, J MOL BIOL, V232, P192, DOI 10.1006/jmbi.1993.1376; WANG RW, 1993, PROTEIN SCI, V2, P2085, DOI 10.1002/pro.5560021209; WILCE MCJ, 1995, EMBO J, V14, P2133, DOI 10.1002/j.1460-2075.1995.tb07207.x	37	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23267	23273		10.1074/jbc.273.36.23267	http://dx.doi.org/10.1074/jbc.273.36.23267			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722558	hybrid			2022-12-27	WOS:000075778100058
J	Abe, T; Kakyo, M; Sakagami, H; Tokui, T; Nishio, T; Tanemoto, M; Nomura, H; Hebert, SC; Matsuno, S; Kondo, H; Yawo, H				Abe, T; Kakyo, M; Sakagami, H; Tokui, T; Nishio, T; Tanemoto, M; Nomura, H; Hebert, SC; Matsuno, S; Kondo, H; Yawo, H			Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARRIER-MEDIATED TRANSPORT; PRIMARY CULTURE; CHOROID-PLEXUS; FUNCTIONAL-CHARACTERIZATION; RAT HEPATOCYTES; BRAIN; PROTEIN; LIVER; 3,5,3'-TRIIODOTHYRONINE; SYSTEM	Two complementary DNAs for the organic anion transporter subtypes oatp2 and oatp3, which transport thyroid hormones as well as taurocholate, were isolated from a rat retina cDNA library. The sequence of oatp2 is identical to that recently reported (Noe, B,, Hagenbuch, B,, Stieger, B,, and Meier, P, J, (1997) Proc. Natl, Acad, Sci, U.S.A. 94, 10346-10350), whereas the sequence of oatp3 is novel. oatp3 consists of 670 amino acid residues and exhibits a structural architecture common to the organic anion transporter family, possessing the 12 putative membrane-spanning segments. Oocytes injected with oatp2 and oatp3 cRNAs showed taurocholate uptake in a saturable manner. The oatp2 and oatp3 cRNA-injected oocytes also showed significant uptake of both thyroxine and triiodothyronine. Northern blot and in situ analyses showed that the oatp2 mRNA was widely expressed in neuronal cells of the central nervous system, especially in the hippocampus, cerebellum, and choroid plexus as well as in the retina and liver. The oatp3 mRNA was highly expressed in the kidney and moderately abundant in the retina. This suggests that oatp2 and oatp3 are multifunctional transporters involved in the transport of thyroid hormones in the brain, retina, liver, and kidney.	Tohoku Univ, Sch Med, Dept Neurophysiol, Aoba Ku, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Sch Med, Dept Histol, Aoba Ku, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Sch Med, Dept Surg 1, Aoba Ku, Sendai, Miyagi 9808575, Japan; Sankyo Co Ltd, Analyt & Metab Res Labs, Tokyo 1408710, Japan; Vanderbilt Univ, Div Nephrol, Nashville, TN 37232 USA	Tohoku University; Tohoku University; Tohoku University; Daiichi Sankyo Company Limited; Vanderbilt University	Abe, T (corresponding author), Tohoku Univ, Sch Med, Dept Neurophysiol, Aoba Ku, 2-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan.	takaabe@mail.cc.tohoku.ac.jp	Yawo, Hiromu/I-4871-2015	Yawo, Hiromu/0000-0002-4299-3288				ABE T, 1992, J BIOL CHEM, V267, P13361; Angeletti RH, 1997, P NATL ACAD SCI USA, V94, P283, DOI 10.1073/pnas.94.1.283; BERRY MJ, 1991, NATURE, V349, P438, DOI 10.1038/349438a0; BESLIN A, 1995, ENDOCRINOLOGY, V136, P5385, DOI 10.1210/en.136.12.5385; BLONDEAU JP, 1988, J BIOL CHEM, V263, P2685; Bossuyt X, 1996, J PHARMACOL EXP THER, V276, P891; BRIGHTMA.MW, 1969, J CELL BIOL, V40, P648, DOI 10.1083/jcb.40.3.648; CAVALLARO T, 1990, INVEST OPHTH VIS SCI, V31, P497; CENTANNI M, 1987, J CLIN INVEST, V80, P1068, DOI 10.1172/JCI113162; CHANTOUX F, 1995, J NEUROCHEM, V65, P2549; CRANTZ FR, 1982, ENDOCRINOLOGY, V110, P367, DOI 10.1210/endo-110-2-367; CSERR HF, 1971, PHYSIOL REV, V51, P273, DOI 10.1152/physrev.1971.51.2.273; Docter R, 1997, ENDOCRINOLOGY, V138, P1841, DOI 10.1210/en.138.5.1841; DUSSAULT JH, 1987, ANNU REV PHYSIOL, V49, P321, DOI 10.1146/annurev.ph.49.030187.001541; FRANCON J, 1989, J NEUROCHEM, V53, P1456, DOI 10.1111/j.1471-4159.1989.tb08538.x; GINGRICH SA, 1985, ENDOCRINOLOGY, V116, P2306, DOI 10.1210/endo-116-6-2306; HORTZ JA, 1996, BIOCH BIOPHYS ACAT, V1300, P114; JACQUEMIN E, 1994, P NATL ACAD SCI USA, V91, P133, DOI 10.1073/pnas.91.1.133; Kanai N, 1996, AM J PHYSIOL-RENAL, V270, pF319, DOI 10.1152/ajprenal.1996.270.2.F319; KANAI N, 1995, SCIENCE, V268, P866, DOI 10.1126/science.7754369; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KRENNING E, 1981, BIOCHIM BIOPHYS ACTA, V676, P314, DOI 10.1016/0304-4165(81)90165-3; KRENNING EP, 1982, FEBS LETT, V140, P229, DOI 10.1016/0014-5793(82)80900-9; KULLAKUBLICK GA, 1994, HEPATOLOGY, V20, P411; Noe B, 1997, P NATL ACAD SCI USA, V94, P10346, DOI 10.1073/pnas.94.19.10346; OSTY J, 1988, ENDOCRINOLOGY, V123, P2303, DOI 10.1210/endo-123-5-2303; PARDRIDGE WM, 1979, ENDOCRINOLOGY, V105, P605, DOI 10.1210/endo-105-3-605; PORTERFIELD SP, 1993, ENDOCR REV, V14, P94, DOI 10.1210/er.14.1.94; REFETOFF S, 1993, ENDOCR REV, V14, P348, DOI 10.1210/er.14.3.348; Saito H, 1996, J BIOL CHEM, V271, P20719, DOI 10.1074/jbc.271.34.20719; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SOUTHWELL BR, 1993, ENDOCRINOLOGY, V133, P2116, DOI 10.1210/en.133.5.2116; TOPLISS DJ, 1989, ENDOCRINOLOGY, V124, P980, DOI 10.1210/endo-124-2-980; VANDOORN J, 1983, J CLIN INVEST, V72, P1778, DOI 10.1172/JCI111138; VINCENT J, 1983, J PHYSIOL-PARIS, V78, P729	36	285	291	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22395	22401		10.1074/jbc.273.35.22395	http://dx.doi.org/10.1074/jbc.273.35.22395			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712861	hybrid			2022-12-27	WOS:000075616600037
J	Guerrin, M; Simon, M; Montezin, M; Haftek, M; Vincent, C; Serre, G				Guerrin, M; Simon, M; Montezin, M; Haftek, M; Vincent, C; Serre, G			Expression cloning of human corneodesmosin proves its identity with the product of the S gene and allows improved characterization of its processing during keratinocyte differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORNEUM CHYMOTRYPTIC ENZYME; PROTEIN DESMOGLEIN-I; STRATUM-CORNEUM; ENDOGENOUS PROTEOLYSIS; CORNIFIED EPITHELIA; HUMAN-EPIDERMIS; PIG EPIDERMIS; DESQUAMATION; PSORIASIS; IDENTIFICATION	In human epidermis and other cornified squamous epithelia, corneodesmosin is located in the desmosomes of the upper living layers, and in related structures of the cornified layers, the corneodesmosomes. During maturation of the cornified layers, the protein undergoes a series of cleavages, thought to be a prerequisite of desquamation. Partial amino acid sequencing of corneodesmosin fragments suggested that it is related to the product of the S gene, previously identified in the human major histocompatibility complex. We report the expression cloning of corneodesmosin cDNA from a human epidermis library screened with monoclonal antibodies. Sequencing demonstrated that corneodesmosin is really the product of the S gene. However, analysis of 20 alleles of the gene revealed that its product is 27 amino acids longer than initially reported. Two additional polymorphic sites were described, and the position of the unique intron was ascertained. Corneodesmosin cDNA expression in COS-7 cells led to secretion of the protein. Precise epitope mapping allowed further characterization of the molecular forms of corneodesmosin present in the most superficial cornified layers, where fragments corresponding to the central region of the protein were detected. This indicated a cleavage of the N- and C-terminal domains of corneodesmosin before desquamation, These serine- and glycine-rich domains are proposed to mediate an adhesive function.	CHU Toulouse, UPS,Dept Biol & Pathol Cell, CNRS,Toulouse Purpan Sch Med, INSERM,IFR30,Univ Toulouse 3,CJF 96 02, F-31073 Toulouse, France; CNRS, INSERM U346, F-69437 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); VetAgro Sup	Serre, G (corresponding author), CHU Purpan, Lab Biol Cellulaire & Cytol, Pl Dr Baylac, F-31059 Toulouse, France.	serre@cict.fr	Simon, Michel/B-7308-2011	Simon, Michel/0000-0003-3655-6329				ALLEN TD, 1975, J ULTRA MOL STRUCT R, V51, P94, DOI 10.1016/S0022-5320(75)80011-6; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BRYSK MM, 1989, EXP CELL BIOL, V57, P60; CHAPMAN SJ, 1990, ARCH DERMATOL RES, V282, P304, DOI 10.1007/BF00375724; CHAPMAN SJ, 1991, ARCH DERMATOL RES, V283, P167, DOI 10.1007/BF00372057; EGELRUD T, 1993, J INVEST DERMATOL, V101, P200, DOI 10.1111/1523-1747.ep12363804; EGELRUD T, 1990, J INVEST DERMATOL, V95, P456, DOI 10.1111/1523-1747.ep12555620; EGELRUD T, 1989, ACTA DERM-VENEREOL, V69, P470; Ghadially R, 1996, J INVEST DERMATOL, V107, P558, DOI 10.1111/1523-1747.ep12582813; GHADIALLY R, 1992, J INVEST DERMATOL, V99, P755, DOI 10.1111/1523-1747.ep12614489; HAFTEK M, 1991, J HISTOCHEM CYTOCHEM, V39, P1531, DOI 10.1177/39.11.1717544; HANSSON L, 1994, J BIOL CHEM, V269, P19420; Holbrook K., 1994, KERATINOCYTE HDB, P3; Ishihara M, 1996, TISSUE ANTIGENS, V48, P182, DOI 10.1111/j.1399-0039.1996.tb02626.x; KING IA, 1987, J CELL BIOL, V105, P3053, DOI 10.1083/jcb.105.6.3053; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LUNDSTROM A, 1994, ARCH DERMATOL RES, V286, P369, DOI 10.1007/BF00371795; LUNDSTROM A, 1990, J INVEST DERMATOL, V94, P216, DOI 10.1111/1523-1747.ep12874531; Mallon E, 1997, J INVEST DERMATOL, V109, P183, DOI 10.1111/1523-1747.ep12319304; MENTON DN, 1971, J ULTRA MOL STRUCT R, V35, P247, DOI 10.1016/S0022-5320(71)80155-7; Montezin M, 1997, EXP CELL RES, V231, P132, DOI 10.1006/excr.1996.3452; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Reichert Uwe, 1993, P107; ROOP D, 1995, SCIENCE, V267, P474, DOI 10.1126/science.7529942; SERRE G, 1991, J INVEST DERMATOL, V97, P1061, DOI 10.1111/1523-1747.ep12492589; Simon M, 1997, J BIOL CHEM, V272, P31770, DOI 10.1074/jbc.272.50.31770; SIMON M, 1994, KERATINOCYTE HDB, P275; SKERROW CJ, 1989, J CELL SCI, V92, P667; SOMMER SS, 1992, BIOTECHNIQUES, V12, P82; STEINERT PM, 1991, INT J BIOL MACROMOL, V13, P130, DOI 10.1016/0141-8130(91)90037-U; SUZUKI Y, 1994, ARCH DERMATOL RES, V286, P249, DOI 10.1007/BF00387596; TIILIKAINEN A, 1980, BRIT J DERMATOL, V102, P179, DOI 10.1111/j.1365-2133.1980.tb05690.x; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813; Velten F, 1998, TISSUE ANTIGENS, V51, P183, DOI 10.1111/j.1399-0039.1998.tb02963.x; Vicanova J, 1996, CELL TISSUE RES, V286, P115, DOI 10.1007/s004410050680; WALSH A, 1991, ARCH DERMATOL RES, V283, P174, DOI 10.1007/BF00372058; ZHOU YQ, 1993, P NATL ACAD SCI USA, V90, P9470, DOI 10.1073/pnas.90.20.9470	37	56	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22640	22647		10.1074/jbc.273.35.22640	http://dx.doi.org/10.1074/jbc.273.35.22640			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712893	hybrid			2022-12-27	WOS:000075616600069
J	Toma, L; Berninsone, P; Hirschberg, CB				Toma, L; Berninsone, P; Hirschberg, CB			The putative heparin-specific N-acetylglucosaminyl N-deacetylase/N-sulfotransferase also occurs in non-heparin-producing cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST GROWTH-FACTOR; SACCHAROMYCES-CEREVISIAE; SULFATE SULFOTRANSFERASE; GUANOSINE DIPHOSPHATASE; MOLECULAR-CLONING; GOLGI LUMEN; EXPRESSION; BINDING; PROTEOGLYCANS; PURIFICATION	N-Deacetylation and N-sulfation of N-acetylglucosamine of heparin and heparan sulfate are hypothesized to be mediated by different tissue-specific N-acetylglucosaminyl N-deacetylases/N-sulfotransferases, which in turn lead to the higher L-iduronic acid and sulfate content of heparin versus heparan sulfate. Furthermore, the putative heparin-specific N-acetylglucosaminyl N-deacetylase/N-sulfotransferase has been reported to require auxiliary proteins for its N-acetylglucosaminyl N-deacetylase activity in vivo based on its requirement of polycations in vitro, me have now found that cells derived from embryonic bovine trachea, a tissue that does not synthesize heparin, has a N-acetylglucosaminyl N-deacetylase/N-sulfotransferase, which has 95% amino acid sequence identity to the above enzyme postulated to be involved in the biosynthesis of heparin. Both enzymes also have very similar affinity for their substrates, The trachea enzyme does not require additional effecters for its N-acetylglucosaminyl N-deacetylase activity in vitro even though its biochemical characteristics are virtually the same as the enzyme previously isolated from cells of a heparin-producing mastocytoma tumor. The trachea enzyme, which is encoded by an abundant 4.6-kilobase mRNA, like mastocytoma cells, has 70% amino acid sequence identity with the corresponding enzyme from rat liver postulated to participate in the biosynthesis of heparan sulfate. Heparan sulfate synthesized by trachea cells has a higher content of sulfated iduronic acid than from other tissues, Together, the above results strongly suggest that the above enzymes from mastocytoma, liver, and trachea, per se, are not solely responsible for the selective tissue-specific synthesis of heparin or heparan sulfate; more likely cellular factors, additional enzymes, and availability of substrates in the Golgi lumen also play important roles in the differential synthesis of the above proteoglycans.	Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA	Boston University	Hirschberg, CB (corresponding author), Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA.			Hirschberg, Carlos/0000-0003-2299-7721	NIGMS NIH HHS [GM34396] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABEIJON C, 1993, J CELL BIOL, V122, P307, DOI 10.1083/jcb.122.2.307; Abeijon C, 1997, TRENDS BIOCHEM SCI, V22, P203, DOI 10.1016/S0968-0004(97)01053-0; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; BAME KJ, 1991, J BIOL CHEM, V266, P12461; BERNINSONE P, 1994, J BIOL CHEM, V269, P207; BRANDAN E, 1988, J BIOL CHEM, V263, P2417; Cheung WF, 1996, BIOCHEMISTRY-US, V35, P5250, DOI 10.1021/bi952325b; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CONRAD HE, 1998, HEPARIN BINDING PROT, P175; DISCHE Z, 1947, J BIOL CHEM, V167, P189; ERIKSSON I, 1994, J BIOL CHEM, V269, P10438; GROSS-BELLARD MM, 1973, EUR J BIOCHEM, V36, P32, DOI 10.1111/j.1432-1033.1973.tb02881.x; HASHIMOTO Y, 1992, J BIOL CHEM, V267, P15744; KJELLEN L, 1992, ADV EXP MED BIOL, V313, P107; KLAGSBRUN M, 1991, CELL, V67, P229, DOI 10.1016/0092-8674(91)90173-V; LEBARON RG, 1989, J BIOL CHEM, V264, P7950; LEBARON RG, 1988, J CELL BIOL, V106, P945, DOI 10.1083/jcb.106.3.945; LINDAHL U, 1984, J BIOL CHEM, V259, P2368; LINDAHL U, 1994, THROMB RES, V75, P1, DOI 10.1016/0049-3848(94)90136-8; LUPA MT, 1990, DEV BIOL, V142, P31, DOI 10.1016/0012-1606(90)90148-C; MANDON E, 1994, J BIOL CHEM, V269, P11729; Nader H. B., 1989, HEPARIN CHEM BIOL PR, P81; NADER HB, 1987, P NATL ACAD SCI USA, V84, P3565, DOI 10.1073/pnas.84.11.3565; NADER HB, 1990, J BIOL CHEM, V265, P16807; NURCOMBE V, 1993, SCIENCE, V260, P103, DOI 10.1126/science.7682010; ORELLANA A, 1994, J BIOL CHEM, V269, P2270; PETTERSSON I, 1991, J BIOL CHEM, V266, P8044; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TERSARIOL ILS, 1994, BRAZ J MED BIOL RES, V27, P2097; Toma L, 1996, J BIOL CHEM, V271, P3897; WEI Z, 1993, P NATL ACAD SCI USA, V90, P3885, DOI 10.1073/pnas.90.9.3885; WUDUNN D, 1989, J VIROL, V63, P52, DOI 10.1128/JVI.63.1.52-58.1989; YANAGISHITA M, 1984, J BIOL CHEM, V259, P270; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	37	22	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22458	22465		10.1074/jbc.273.35.22458	http://dx.doi.org/10.1074/jbc.273.35.22458			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712870	hybrid			2022-12-27	WOS:000075616600046
J	Lee, MJ; Thangada, S; Liu, CH; Thompson, BD; Hla, T				Lee, MJ; Thangada, S; Liu, CH; Thompson, BD; Hla, T			Lysophosphatidic acid stimulates the G-protein-coupled receptor EDG-1 as a low affinity agonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOSINE 1-PHOSPHATE; NEURITE RETRACTION; ADP-RIBOSYLATION; SURFACE-RECEPTOR; KINASE PATHWAY; CDC42 GTPASES; RHO; SPHINGOSINE-1-PHOSPHATE; CELLS; INHIBITION	EDG-1, an inducible G-protein-coupled receptor from vascular endothelial cells, is a high affinity receptor for sphingosine I-phosphate (SPP) (Lee, M-J., van Brocklyn, J. R., Thangada, S., Liu, C. H., Hand, A. R., Menzeleev, R., Spiegel, S., and Hla, T. (1998) Science 279, 1552-1555). In this study, we show that lysophosphatidic acid (LPA), a platelet-derived bioactive lipid structurally related to SPP, is an agonist for EDG-1. LPA binds to EDG-1 receptor with an apparent K-d of 2.3 mu M. In addition, LPA binding to EDG-1 induces receptor phosphorylation, mitogen-activated protein kinase activation, as well as Rho-dependent morphogenesis and P-cadherin expression. These data suggest that LPA is a low-affinity agonist for EDG-1. Activation of the endothelial receptor EDG-1 by platelet-derived lipids LPA and SPP may be important in thrombosis and angiogenesis, conditions in which critical platelet-endothelial interactions occur.	Univ Connecticut, Sch Med, Dept Physiol, Farmington, CT 06030 USA	University of Connecticut	Hla, T (corresponding author), Univ Connecticut, Sch Med, Dept Physiol, MC3505,263 Farmington Ave, Farmington, CT 06030 USA.		Hla, Timothy/G-5873-2012	Hla, Timothy/0000-0001-8355-4065	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045659] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL49094] Funding Source: Medline; NIDDK NIH HHS [DK45659] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alexander JS, 1998, AM J PHYSIOL-HEART C, V274, pH115, DOI 10.1152/ajpheart.1998.274.1.H115; An SZ, 1997, BIOCHEM BIOPH RES CO, V231, P619, DOI 10.1006/bbrc.1997.6150; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; DURIEUX ME, 1993, TRENDS PHARMACOL SCI, V14, P249, DOI 10.1016/0165-6147(93)90021-B; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; Erickson JP, 1998, J BIOL CHEM, V273, P1506, DOI 10.1074/jbc.273.3.1506; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Gohla A, 1998, J BIOL CHEM, V273, P4653, DOI 10.1074/jbc.273.8.4653; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; HLA T, 1990, J BIOL CHEM, V265, P9308; Hung WC, 1996, BIOCHEM BIOPH RES CO, V229, P11, DOI 10.1006/bbrc.1996.1750; IMAMURA F, 1993, BIOCHEM BIOPH RES CO, V193, P497, DOI 10.1006/bbrc.1993.1651; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; JALINK K, 1993, CELL GROWTH DIFFER, V4, P247; JALINK K, 1994, BBA-REV CANCER, V1198, P185, DOI 10.1016/0304-419X(94)90013-2; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee MJ, 1996, J BIOL CHEM, V271, P11272, DOI 10.1074/jbc.271.19.11272; Moolenaar WH, 1997, CURR OPIN CELL BIOL, V9, P168, DOI 10.1016/S0955-0674(97)80059-2; MOOLENAAR WH, 1994, TRENDS CELL BIOL, V4, P249; MURAYAMA T, 1983, J BIOL CHEM, V258, P3319; NAGY JA, 1989, BIOCHIM BIOPHYS ACTA, V948, P305, DOI 10.1016/0304-419X(89)90004-8; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Postma FR, 1996, EMBO J, V15, P2388, DOI 10.1002/j.1460-2075.1996.tb00595.x; RESHKIN SJ, 1992, AM J PHYSIOL, V262, pF572, DOI 10.1152/ajprenal.1992.262.4.F572; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; SADAHIRA Y, 1992, P NATL ACAD SCI USA, V89, P9686, DOI 10.1073/pnas.89.20.9686; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Wang F, 1997, BIOCHEM J, V324, P481, DOI 10.1042/bj3240481; WU J, 1995, J BIOL CHEM, V270, P11484, DOI 10.1074/jbc.270.19.11484; Yatomi Y, 1997, J BIOCHEM, V121, P969; Yatomi Y, 1997, J BIOL CHEM, V272, P5291, DOI 10.1074/jbc.272.8.5291; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155	36	112	117	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					22105	22112		10.1074/jbc.273.34.22105	http://dx.doi.org/10.1074/jbc.273.34.22105			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705355	hybrid			2022-12-27	WOS:000075492600089
J	Cho, YK; Northrop, DB				Cho, YK; Northrop, DB			Transpeptidation by porcine pepsin catalyzed by a noncovalent intermediate unique to its iso-mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITION; SUBSTRATE; ENZYMES	Porcine pepsin proteolysis of the hexapeptide Leu-Ser-p-nitro-Phe-Me-Ala Leu-OMe (where OMe = methoxy and Nle = norleucine) in the presence of dipeptide Leu-Leu synthesizes a new hexapeptide Leu-Ser-p-nitro-Phe-Leu-Leu. Contrary to transpeptidation kinetics of other proteases, which depend upon an acyl-enzyme intermediate, the time course for pepsin-catalyzed transpeptidation displays a distinct lag before reaching a steady-state reaction velocity. Moreover, this lag is coupled to burst kinetics for the formation of proteolytic products, Leu-Ser-p-nitro-Phe and Nle-Ala-Leu-OMe. The lag requires that free Leu-Ser-p-nitro-Phe accumulate in the reaction medium during the lag phase and subsequently rebind for transpeptidation, Consistent with this dissociative kinetic mechanism are normal solvent isotope effects on formation of the proteolytic products Leu-Ser-p-nitro-Phe (v(H)/v(D), = 2.2 +/- 0.2) and Nle-Ala-Leu-OMe (v(H)/v(D) = 1.8 +/- 0.1) as opposed to an inverse effect on the formation of the transpeptidation product Leu-Ser-p-nitro-Phe-Leu-Leu (v(H)/v(D) = 0.40 +/- 0.09), Because proteolysis is slower in D2O but transpeptidation is faster, the isotopically sensitive step must occur after release of both products of proteolysis, which precludes putative acyl-enzyme covalent intermediates. Isotopically enhanced transpeptidation is a new type of isotope effect but one that is consistent with the Uni Bi iso-mechanism previously postulated on the basis of solvent isotope effects on V-max but not on V-max/K-m (Rebholz, K. L., and Northrop, D, B, (1991) Biochem. Biophys Res. Commun, 179, 65-69) and confirmed by solvent isotope effects on the onset of inhibition by pepstatin (Cho, Y, a, Rebholz, a, L,, and Northrop, D, B, (1994) Biochemistry 33, 9637-9642). As a new biochemical mechanism for peptide bond synthesis that has a potential for applications in biotechnology, it is here proposed that the energy necessary to drive peptide synthesis from free peptides comes from the sizable free energy drop associated with rehydration of the active site of pepsin in 55 M water.	Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, Madison, WI 53706 USA; Changwon Natl Univ, Dept Biochem, Chang Won 641773, Kyungnam, South Korea	University of Wisconsin System; University of Wisconsin Madison; Changwon National University	Northrop, DB (corresponding author), Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, 425 N Charter St, Madison, WI 53706 USA.	dbn@pharmacy.wisc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046695] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM46695] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANTONOV VK, 1981, EUR J BIOCHEM, V117, P195; BRITTON HG, 1973, BIOCHEM J, V133, P255, DOI 10.1042/bj1330255; CHO YK, 1994, BIOCHEMISTRY-US, V33, P9637, DOI 10.1021/bi00198a032; CLEMENT GE, 1973, PROG BIOORG CHEM, V2, P676; DUGGLEBY RG, 1984, COMPUT BIOL MED, V14, P447, DOI 10.1016/0010-4825(84)90045-3; DUNN BM, 1984, BIOCHEMISTRY-US, V23, P5241, DOI 10.1021/bi00317a023; FISHER LM, 1986, BIOCHEMISTRY-US, V25, P2529, DOI 10.1021/bi00357a037; FRIEDEN C, 1979, ANNU REV BIOCHEM, V48, P471, DOI 10.1146/annurev.bi.48.070179.002351; FRUTON JS, 1980, MOL CELL BIOCHEM, V32, P105; HUNKAPILLER MW, 1972, BIOCHEMISTRY-US, V11, P2829, DOI 10.1021/bi00765a015; HYLAND LJ, 1991, BIOCHEMISTRY-US, V30, P8454, DOI 10.1021/bi00098a024; JAMES MNG, 1983, J MOL BIOL, V163, P299, DOI 10.1016/0022-2836(83)90008-6; KASCHE V, 1989, PROTEOLYTIC ENZYMES, P125; KNOWLES JR, 1970, PHILOS T R SOC B, V257, P135, DOI 10.1098/rstb.1970.0016; KRESGE AJ, 1973, J AM CHEM SOC, V95, P3065, DOI 10.1021/ja00790a082; Northrop DB, 1998, ARCH BIOCHEM BIOPHYS, V352, P288, DOI 10.1006/abbi.1997.0589; REBHOLZ KL, 1991, BIOCHEM BIOPH RES CO, V176, P65, DOI 10.1016/0006-291X(91)90890-J	17	6	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24305	24308		10.1074/jbc.273.38.24305	http://dx.doi.org/10.1074/jbc.273.38.24305			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733715	hybrid			2022-12-27	WOS:000076007300007
J	Keilhack, H; Tenev, T; Nyakatura, E; Godovac-Zimmermann, J; Nielsen, L; Seedorf, K; Bohmer, FD				Keilhack, H; Tenev, T; Nyakatura, E; Godovac-Zimmermann, J; Nielsen, L; Seedorf, K; Bohmer, FD			Phosphotyrosine 1173 mediates binding of the protein-tyrosine phosphatase SHP-1 to the epidermal growth factor receptor and attenuation of receptor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC-CELL PHOSPHATASE; ADHESION MOLECULE-1 PECAM-1; SRC HOMOLOGY-2 DOMAINS; SH2 DOMAIN; DIFFERENTIAL REGULATION; INTACT-CELLS; C-KIT; KINASE; DEPHOSPHORYLATION; ASSOCIATION	The protein-tyrosine phosphatase SHP-1 binds to and dephosphorylates the epidermal growth factor receptor (EGFR), and both SH2 domains of SHP-1 are important for this interaction (Tenev, T., Keilhack, H., Tomic, S., Stoyanov, B., Stein-Gerlach, M., Lammers, R., Krivtsov, A. V., Ullrich, A., and Bohmer, F. D. (1997) J. Biol, Chem. 272, 5966-5973). We mapped the EGFR phosphotyrosine 1173 as the major binding site for SHP-1 by a combination of phosphopeptide activation, phosphopeptide competition, and receptor YF mutant analysis. Mutational conversion of the EGFR sequence 1171-1176 AEY-LRV into the high affinity SHP-1 binding sequence LEY-LYL of the erythropoietin receptor (EpoR) led to a highly elevated SHP-1 binding to the mutant EGFR (EGFR(1171-1176EpoR)) and in torn to an enhanced dephosphorylation of the receptor. SHP-1 expression interfered with EGF-dependent mitogen-activated protein kinase stimulation, and this effect was more pronounced in case of EGFR(1171-1176EpoR). Reduced SHP-1 binding to the EGFR Y1173F mutant resulted in a reduced receptor dephosphorylation by coexpressed SHP-1 and less interference with EGF-dependent mitogen-activated protein kinase stimulation. The effects of receptor mutations on SHP-1 binding were, however, stronger than those on receptor dephosphorylation by SHP-1. Therefore, receptor dephosphorylation may be the result of the combined activity of receptor-bound SHP-1 and SHP-1 bound to an auxiliary docking protein.	Univ Jena, Fac Med, Res Unit Mol Cell Biol, D-07747 Jena, Germany; Inst Mol Biotechnol eV, D-07745 Jena, Germany; Hagedorn Res Lab, DK-2820 Gentofte, Denmark	Friedrich Schiller University of Jena; Novo Nordisk; Hagedorn Research Institute	Bohmer, FD (corresponding author), Univ Jena, Fac Med, Res Unit Mol Cell Biol, Drackendorfer Str 1, D-07747 Jena, Germany.	i5frbo@rz.uni-jena.de	Zimmermann, Jasminka Godovac/E-6863-2010	Tenev, Tencho/0000-0001-8762-1069				Adachi M, 1996, CELL, V85, P15; Atherton E., 1990, SOLID PHASE PEPTIDE; BANVILLE D, 1995, GENOMICS, V27, P165, DOI 10.1006/geno.1995.1020; BATZER AG, 1995, MOL CELL BIOL, V15, P4403; BATZER AG, 1994, MOL CELL BIOL, V14, P5192, DOI 10.1128/MCB.14.8.5192; BOHMER FD, 1993, FEBS LETT, V331, P276, DOI 10.1016/0014-5793(93)80352-U; BOHMER FD, 1995, ANAL BIOCHEM, V228, P267, DOI 10.1006/abio.1995.1349; Burshtyn DN, 1997, J BIOL CHEM, V272, P13066, DOI 10.1074/jbc.272.20.13066; CANTLEY LC, 1994, J CELL SCI, P121; CASE RD, 1994, J BIOL CHEM, V269, P10467; Chen HE, 1996, MOL CELL BIOL, V16, P3685, DOI 10.1128/mcb.16.7.3685; Cossette LJ, 1996, EXP CELL RES, V223, P459, DOI 10.1006/excr.1996.0102; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; DAVID M, 1995, MOL CELL BIOL, V15, P7050; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; FAURE R, 1992, J BIOL CHEM, V267, P11215; FENG GS, 1994, TRENDS GENET, V10, P54, DOI 10.1016/0168-9525(94)90149-X; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; Frearson JA, 1997, BIOESSAYS, V19, P417, DOI 10.1002/bies.950190509; HEINONEN JK, 1981, ANAL BIOCHEM, V113, P313, DOI 10.1016/0003-2697(81)90082-8; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Jackson DE, 1997, J BIOL CHEM, V272, P24868, DOI 10.1074/jbc.272.40.24868; Jackson DE, 1997, J BIOL CHEM, V272, P6986, DOI 10.1074/jbc.272.11.6986; Jiao HY, 1996, MOL CELL BIOL, V16, P6985; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; Krautwald S, 1996, MOL CELL BIOL, V16, P5955; Kulas DT, 1996, J BIOL CHEM, V271, P748, DOI 10.1074/jbc.271.2.748; LAMMERS R, 1993, J BIOL CHEM, V268, P22456; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Lorenz U, 1996, J EXP MED, V184, P1111, DOI 10.1084/jem.184.3.1111; Lorenz U, 1996, P NATL ACAD SCI USA, V93, P9624, DOI 10.1073/pnas.93.18.9624; MOONEY RA, 1989, J BIOL CHEM, V264, P6850; Neel B G, 1993, Semin Cell Biol, V4, P419, DOI 10.1006/scel.1993.1050; Ottinger EA, 1998, J BIOL CHEM, V273, P729, DOI 10.1074/jbc.273.2.729; PANI G, 1995, J EXP MED, V181, P2077, DOI 10.1084/jem.181.6.2077; Paulson RF, 1996, NAT GENET, V13, P309, DOI 10.1038/ng0796-309; Pei DH, 1996, P NATL ACAD SCI USA, V93, P1141, DOI 10.1073/pnas.93.3.1141; PEI DH, 1994, BIOCHEMISTRY-US, V33, P15483, DOI 10.1021/bi00255a030; Perkins LA, 1996, DEV BIOL, V180, P63, DOI 10.1006/dbio.1996.0285; PLUSKEY S, 1995, J BIOL CHEM, V270, P2897, DOI 10.1074/jbc.270.7.2897; SEEDORF K, 1995, PROTEIN TYROSINE KIN, V2, P123; SHEN SH, 1991, NATURE, V352, P736, DOI 10.1038/352736a0; SOLER C, 1994, J BIOL CHEM, V269, P12320; Somani AK, 1997, J BIOL CHEM, V272, P21113, DOI 10.1074/jbc.272.34.21113; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Stewart JM, 1984, SOLID PHASE PEPTIDE; Su L, 1996, J BIOL CHEM, V271, P10385, DOI 10.1074/jbc.271.17.10385; SWARUP G, 1982, BIOCHEM BIOPH RES CO, V107, P1104, DOI 10.1016/0006-291X(82)90635-0; Symes A, 1997, CURR BIOL, V7, P697, DOI 10.1016/S0960-9822(06)00298-3; Tenev T, 1997, J BIOL CHEM, V272, P5966, DOI 10.1074/jbc.272.9.5966; TOMIC S, 1995, J BIOL CHEM, V270, P21277, DOI 10.1074/jbc.270.36.21277; VOGEL W, 1993, SCIENCE, V259, P1611, DOI 10.1126/science.7681217; Wright JH, 1997, MOL BIOL CELL, V8, P1575, DOI 10.1091/mbc.8.8.1575; YI TL, 1995, BLOOD, V85, P87, DOI 10.1182/blood.V85.1.87.bloodjournal85187; YI TL, 1993, MOL CELL BIOL, V13, P7577, DOI 10.1128/MCB.13.12.7577; YI TL, 1993, MOL CELL BIOL, V13, P3350, DOI 10.1128/MCB.13.6.3350; You M, 1997, J BIOL CHEM, V272, P23376, DOI 10.1074/jbc.272.37.23376; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	59	120	121	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24839	24846		10.1074/jbc.273.38.24839	http://dx.doi.org/10.1074/jbc.273.38.24839			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733788	hybrid			2022-12-27	WOS:000076007300080
J	Seger, D; Gechtman, Z; Shaltiel, S				Seger, D; Gechtman, Z; Shaltiel, S			Phosphorylation of vitronectin by casein kinase II - Identification of the sites and their promotion of cell adhesion and spreading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PROTEIN VITRONECTIN; PLASMINOGEN-ACTIVATOR INHIBITOR-1; HEPARIN-BINDING DOMAIN; ARG-GLY-ASP; ENDOTHELIAL-CELLS; INTEGRIN ALPHA(V)BETA(3); EXTRACELLULAR-MATRIX; INVITRO PHOSPHORYLATION; FIBRINOGEN BEHAVIOR; FACTOR-VA	The cell adhesion protein vitronectin (Vn) was previously shown to be the major target in human blood for an extracellular protein kinase A, which is released from platelets upon their physiological stimulation with thrombin and also prevails as an ectoenzyme in several other types of blood cells. Because plasma Vn was shown to have only one protein kinase A phosphorylation site (Ser(378)) but to contain similar to 3 mol of covalently bound phosphate, and because human serum and blood cells were shown to contain also a casein kinase II (CKII) on their surface, we studied the phosphorylation of Vn by CKII attempting to find out whether such phosphorylation modulates Vn function, an acid test for its having a physiological, relevance. Here we show (i) that the CKII phosphorylation of Vn has a K-m of 0.5-2 mu M (lower than the Vn concentration in blood, 3-6 mu M), (ii) that it is targeted to Thr(50) and Thr(57), which are vicinal to the RGD site of Vn, and (iii) that the phosphorylation of Thr(57) facilitates the phosphorylation of Thr(50). The maximal stoichiometry of the CKII phosphorylation of plasma Vn was found to be low, which, in principle, could be due to its partial prephosphorylation in vivo. However, for the detection of a functional modulation, we needed a comparison between a fully phosphorylated Vn (at Thr(57) and Thr(50)) and a nonphosphorylated Vn, Therefore, we expressed Vn in a baculovirus system and show (i) that the CKII phosphorylation of wt-Vn enhances the adhesion of bovine aorta endothelial cells; (ii) that the double mutant T50E/T57E (in which the neutral Thr residues are replaced by the negatively charged Glu residues considered analogs of Thr-P) has a significantly enhanced capacity to promote cell adhesion and to accelerate cell spreading when compared with either wild-type Vn or to the neutral T50A/T57A mutant; and (iii) that, at least in the case of bovine aorta endothelial cells, the T50E/T57E mutant exhibits an enhanced adhesion, which seems to be due to an increased affinity toward the alpha(v)beta(3) Vn receptors.	Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Shaltiel, S (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	lishalt@wiccmail.weizmann.ac.il						AUSUBEL FM, 1994, CURRENT PROTOCOLS MO, V3; Beavo J A, 1974, Methods Enzymol, V38, P299; BHAKDI S, 1988, CLIN EXP IMMUNOL, V74, P459; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; BROWN C, 1991, J INVEST DERMATOL, V96, P724, DOI 10.1111/1523-1747.ep12470960; CHAIN D, 1990, FEBS LETT, V269, P221, DOI 10.1016/0014-5793(90)81159-L; CHAIN D, 1991, BIOCHEM J, V274, P387, DOI 10.1042/bj2740387; CHAIN D, 1991, FEBS LETT, V285, P251, DOI 10.1016/0014-5793(91)80810-P; CHERESH DA, 1987, J BIOL CHEM, V262, P17703; DAHLBACK B, 1985, BIOCHEMISTRY-US, V24, P2368, DOI 10.1021/bi00330a036; DANO K, 1985, ADV CANC RES; DUSENBERY KE, 1988, BIOCHEM BIOPH RES CO, V153, P7, DOI 10.1016/S0006-291X(88)81182-3; EL MC, 1992, BIOCHIM BIOPHYS ACTA, V1134, P31; ERIKSSON S, 1993, THROMB RES, V72, P315, DOI 10.1016/0049-3848(93)90140-J; FELDING HB, 1998, CURR OPIN CELL BIOL, V5, P864; Gechtman Z, 1997, BIOCHEM J, V325, P339, DOI 10.1042/bj3250339; Gechtman Z, 1997, EUR J BIOCHEM, V243, P493, DOI 10.1111/j.1432-1033.1997.0493a.x; HARTMANN M, 1992, BIOCHIM BIOPHYS ACTA, V1136, P189, DOI 10.1016/0167-4889(92)90256-B; HAYMAN EG, 1985, EXP CELL RES, V160, P245, DOI 10.1016/0014-4827(85)90173-9; HAYMAN EG, 1983, P NATL ACAD SCI-BIOL, V80, P4003, DOI 10.1073/pnas.80.13.4003; HOLMES R, 1967, J CELL BIOL, V32, P297, DOI 10.1083/jcb.32.2.297; Horwitz AF, 1997, SCI AM, V276, P68, DOI 10.1038/scientificamerican0597-68; Juliano RL, 1993, CURR OPIN CELL BIOL, V5, P812, DOI 10.1016/0955-0674(93)90030-T; KALAFATIS M, 1993, BLOOD, V81, P704; KORCGRODZICKI B, 1988, BIOCHEM BIOPH RES CO, V157, P1131; KORCGRODZICKI B, 1988, P NATL ACAD SCI USA, V85, P7541, DOI 10.1073/pnas.85.20.7541; KORCGRODZICKI B, 1990, ANAL BIOCHEM, V188, P288, DOI 10.1016/0003-2697(90)90608-C; KORCGRODZICKI B, 1990, THESIS WEIZMANN I SC; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KUBLER D, 1983, P NATL ACAD SCI-BIOL, V80, P4021, DOI 10.1073/pnas.80.13.4021; LINDAHL TL, 1989, THROMB HAEMOSTASIS, V62, P748; MARIN O, 1994, BIOCHEM BIOPH RES CO, V198, P898, DOI 10.1006/bbrc.1994.1128; MARTIN SC, 1991, THROMB RES, V61, P243, DOI 10.1016/0049-3848(91)90100-B; MARTIN SC, 1992, THROMB RES, V68, P467, DOI 10.1016/0049-3848(92)90059-J; MARTIN SC, 1990, FEBS LETT, V272, P103, DOI 10.1016/0014-5793(90)80458-U; MCGUIRE EA, 1988, J BIOL CHEM, V263, P1942; MEGGIO F, 1994, BIOCHEMISTRY-US, V33, P4336, DOI 10.1021/bi00180a030; MEGGIO F, 1994, CELL MOL BIOL RES, V40, P401; MEHRINGER JH, 1991, BIOCHEM BIOPH RES CO, V179, P655, DOI 10.1016/0006-291X(91)91422-9; MIMURO J, 1989, J BIOL CHEM, V264, P5058; OWENSBY DA, 1991, J BIOL CHEM, V266, P4334; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; PLANTEFABER LC, 1989, CELL, V56, P281, DOI 10.1016/0092-8674(89)90902-1; PODACK ER, 1984, ACTA PATH MICRO IM C, V92, P89; PREISSNER KP, 1989, EUR J IMMUNOL, V19, P69, DOI 10.1002/eji.1830190112; PREISSNER KT, 1991, THROMB HAEMOSTASIS, V66, P123; PREISSNER KT, 1990, BIOCHEM BIOPH RES CO, V168, P966, DOI 10.1016/0006-291X(90)91123-A; PREISSNER KT, 1988, BLOOD, V71, P1581; PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cellbio.7.1.275; PYERIN W, 1987, BIOL CHEM H-S, V368, P215, DOI 10.1515/bchm3.1987.368.1.215; PYTELA R, 1985, P NATL ACAD SCI USA, V82, P5766, DOI 10.1073/pnas.82.17.5766; RAND MD, 1994, BLOOD, V83, P2180; RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X; RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957; SEGER R, 1994, J BIOL CHEM, V269, P25699; SEIFFERT D, 1990, CELL DIFFER DEV, V32, P287, DOI 10.1016/0922-3371(90)90041-T; SHALTIEL S, 1993, MOL CELL BIOCHEM, V128, P283, DOI 10.1007/BF01076778; SHALTIEL S, 1993, INT CONGR SER, V1042, P311; SIGURDARDOTTIR O, 1990, BIOCHIM BIOPHYS ACTA, V1035, P56, DOI 10.1016/0304-4165(90)90173-T; SKUBITZ KM, 1992, CELL MOL BIOL, V38, P543; SKUBITZ KM, 1991, J IMMUNOL, V147, P638; STOCKMANN A, 1993, J BIOL CHEM, V268, P22874; SUZUKI S, 1985, EMBO J, V4, P2519, DOI 10.1002/j.1460-2075.1985.tb03965.x; SUZUKI S, 1984, J BIOL CHEM, V259, P5307; Tomasini B R, 1991, Prog Hemost Thromb, V10, P269; TSCHOPP J, 1988, BIOCHEMISTRY-US, V27, P4103, DOI 10.1021/bi00411a029; Varner JA, 1995, CELL ADHES COMMUN, V3, P367, DOI 10.3109/15419069509081020	71	49	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24805	24813		10.1074/jbc.273.38.24805	http://dx.doi.org/10.1074/jbc.273.38.24805			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733784	hybrid			2022-12-27	WOS:000076007300076
J	Tsuda, T; Kaya, S; Yokoyama, T; Hayashi, Y; Taniguchi, K				Tsuda, T; Kaya, S; Yokoyama, T; Hayashi, Y; Taniguchi, K			ATP and acetyl phosphate induces molecular events near the ATP binding site and the membrane domain of Na+,K+-ATPase - The tetrameric nature of the enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-SENSITIVE PHOSPHOENZYME; ADENOSINE-TRIPHOSPHATASE; TRYPTOPHAN FLUORESCENCE; CONFORMATIONAL CHANGE; PHOSPHORYLATION; N-<PARA-(2-BENZIMIDAZOLYL)PHENYL>MALEIMIDE; NA,K-ATPASE; MECHANISM; PROBES; SODIUM	The addition of ATP to Mg2+-Na+-bound-probe labeled Na+,K+-ATPase preparations containing similar to 0.5 mol of pyridoxal 5'-diphospho-5'-adenosine (AP(2)PL) probe at Lys-480 and similar to 0.9 mol of fluorescein 5'-isothiocyanate (FITC) probe at Lys-501 showed a decrease and an increase in the AP(2)PL fluorescence intensity with neither significant ATP-dependent phosphorylation nor FITC fluorescence change. The rate constants for the fluorescence change increased nearly linearly with increasing ATP concentrations, The substitution of AcP for ATP decreased the FITC fluorescence rather monophasically, 8.5/s, which was followed by the half-site phosphorylation with same amount of components with different rate constant, 7.2 and 4.6/s, followed by a much slower increase in the two components of AP(2)PL fluorescence, 1.4 and 0.2/s. The addition of Na+ with increasing concentrations of ATP to the K+-bound AP(2)PL-FITC enzymes induced accelerations in the decrease and an increase in the AP(2)PL fluorescence intensity with two different increases in the FITC fluorescence intensity, showing that the same concentration of ATP is capable of inducing four different fluorescence changes. The addition of ATP to the Mg2+-Na+-bound enzymes modified with N-[p-(2-benzimidazolyl)phenyl] -maleimide (BIPM) at Cys-964 and retaining full Na+,K+-ATPase activity induced two different increases in BIPM fluorescence intensity. Each rate constant for the BIPM fluorescence change versus concentrations of ATP gave two intersecting straight lines. These data and the stoichiometries of fluorescence probe bindings and ATP- and AcP-dependent phosphorylation provide strong support for the conclusion that the functional membrane-bound Na+,K+ -ATPase is a tetramer.	Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 060, Japan; Kyorin Univ, Sch Med, Dept Biochem, Tokyo 181, Japan	Hokkaido University; Kyorin University	Taniguchi, K (corresponding author), Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 060, Japan.							ALBERS RW, 1976, ENZYMES BIOLOGICAL M, V3, P283; EGUCHI H, 1993, BIOCHEM BIOPH RES CO, V196, P294, DOI 10.1006/bbrc.1993.2248; Gatto C, 1997, ARCH BIOCHEM BIOPHYS, V340, P90, DOI 10.1006/abbi.1997.9879; GLYNN IM, 1985, SODIUM PUMP, P589; JORGENSEN PL, 1991, SOC GEN PHY, V46, P189; KARLISH SJD, 1978, BIOCHIM BIOPHYS ACTA, V525, P252, DOI 10.1016/0005-2744(78)90219-X; KARLISH SJD, 1978, BIOCHIM BIOPHYS ACTA, V527, P115, DOI 10.1016/0005-2744(78)90261-9; KAYA SJ, 1994, J BIOL CHEM, V269, P7419; Lutsenko S, 1997, J BIOL CHEM, V272, P5249, DOI 10.1074/jbc.272.8.5249; NAKAMURA Y, 1989, J BIOCHEM-TOKYO, V115, P454; POST RL, 1969, J GEN PHYSIOL, V54, pS306, DOI 10.1085/jgp.54.1.306; POST RL, 1972, J BIOL CHEM, V247, P6530; REPKE KRH, 1986, BIOCHIM BIOPHYS ACTA, V864, P195, DOI 10.1016/0304-4157(86)90011-0; ROBINSON JD, 1993, BIOCHIM BIOPHYS ACTA, V1154, P83, DOI 10.1016/0304-4157(93)90018-J; TANIGUCHI K, 1986, J BIOL CHEM, V261, P3272; TANIGUCHI K, 1993, J BIOL CHEM, V268, P15588; TANIGUCHI K, 1984, J BIOL CHEM, V259, P5228; TANIGUCHI K, 1986, J BIOCHEM-TOKYO, V100, P1231, DOI 10.1093/oxfordjournals.jbchem.a121828; TANIGUCHI K, 1982, J BIOL CHEM, V257, P659; TANIGUCHI K, 1988, J BIOL CHEM, V263, P12943; TANIGUCHI K, 1994, SODIUM PUMP, P581; Taniguchi K, 1988, Prog Clin Biol Res, V268A, P369; Tsuda T, 1998, J BIOCHEM, V123, P169; Tsuda T, 1997, ANN NY ACAD SCI, V834, P186, DOI 10.1111/j.1749-6632.1997.tb52250.x; Tsuda T, 1998, J BIOL CHEM, V273, P24334, DOI 10.1074/jbc.273.38.24334; YAMAZAKI A, 1994, J BIOCHEM, V116, P1360, DOI 10.1093/oxfordjournals.jbchem.a124688	26	25	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24339	24345		10.1074/jbc.273.38.24339	http://dx.doi.org/10.1074/jbc.273.38.24339			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733721	hybrid			2022-12-27	WOS:000076007300013
J	Drmota, T; Gould, GW; Milligan, G				Drmota, T; Gould, GW; Milligan, G			Real time visualization of agonist-mediated redistribution and internalization of a green fluorescent protein-tagged form of the thyrotropin-releasing hormone receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED RECEPTOR; BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTOR; PHOSPHOLIPASE-C; STIMULATED INTERNALIZATION; CHOLECYSTOKININ RECEPTOR; THROMBIN RECEPTORS; ENDOCYTIC PATHWAY; FUSION PROTEIN; DESENSITIZATION	The long isoform of the rat thyrotropin-releasing hormone receptor (TRHR) was modified by the addition of a vesicular stomatitis virus (VSV) epitope tag and green fluorescent protein (GFP), VSV-TPHR-GFP hound TRH with affinity similar to that of the unmodified receptor and stimulated [H-3]inositol phosphate production. A clone stably expressing VSV-TRHR-GFP at some 120,000 copies/cell was selected to visualize this receptor during cellular exposure to TRH. internalization was detected within 3-5 mile after treatment with 1 x 10(-7) M TRH, with dramatic reductions in plasma membrane localization achieved within 10-15 min. The TRHR antagonist/inverse agonist chlordiazepoxide competitively inhibited internalization Hyperosmotic sucrose inhibited internalization of VSV-TRHR-GFP, measured both by intact cell [H-3]TRH binding studies and by confocal microscopy. Now TRH caused a redistribution of VSV-TRHR-GFP to highly punctate but plasma membrane-delineated foci. Pretreatment with the microtubule-disrupting agent nocodazole allowed internalization of the VSV-TRHR-GFP construct but only into vesicles that remained in close apposition to the plasma membrane, Covisualization of VSV-TRHR-GFP and Texas Red transferrin initially indicated entirely separate localizations. After exposure to TRH substantial amounts of VSV-TRHR-GFP were present in vesicles overlapping those containing Texas Red transferrin. Such results demonstrate the G protein-coupling capacity and provide real time visualization of the processes of internalization of a TRH-receptor-GFP construct in response to agonist.	Univ Glasgow, Mol Pharmacol Grp, Div Biochem & Mol Biol, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Milligan, G (corresponding author), Univ Glasgow, Mol Pharmacol Grp, Div Biochem & Mol Biol, Inst Biomed & Life Sci, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.		Gould, Gwyn/AAF-6721-2019; Milligan, Graeme/F-9426-2011	Gould, Gwyn/0000-0001-6571-2875; Milligan, Graeme/0000-0002-6946-3519				ANDERSON L, 1995, BIOCHEM J, V311, P385, DOI 10.1042/bj3110385; ARAGAY AM, 1992, J BIOL CHEM, V267, P24983; ASHWORTH R, 1995, P NATL ACAD SCI USA, V92, P512, DOI 10.1073/pnas.92.2.512; Barak LS, 1997, MOL PHARMACOL, V51, P177, DOI 10.1124/mol.51.2.177; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; BERTIN B, 1994, P NATL ACAD SCI USA, V91, P8827, DOI 10.1073/pnas.91.19.8827; Burt AR, 1998, J BIOL CHEM, V273, P10367, DOI 10.1074/jbc.273.17.10367; CONKLIN BR, 1992, J BIOL CHEM, V267, P31; DAUKAS G, 1985, J CELL BIOL, V101, P1673, DOI 10.1083/jcb.101.5.1673; DEBLASI A, 1989, TRENDS PHARMACOL SCI, V10, P227, DOI 10.1016/0165-6147(89)90266-6; DEBRABANDER M, 1988, CELL MOTIL CYTOSKEL, V9, P30, DOI 10.1002/cm.970090105; Drmota T, 1998, J BIOL CHEM, V273, P21699, DOI 10.1074/jbc.273.34.21699; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; Gaudriault G, 1997, J BIOL CHEM, V272, P2880, DOI 10.1074/jbc.272.5.2880; Gershengorn MC, 1996, PHYSIOL REV, V76, P175, DOI 10.1152/physrev.1996.76.1.175; GHOSH RN, 1994, J CELL SCI, V107, P2177; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; HEIN L, 1994, J BIOL CHEM, V269, P27719; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; HINKLE PM, 1989, MOL ENDOCRINOL, V3, P1337, DOI 10.1210/mend-3-9-1337; Holtmann MH, 1996, J BIOL CHEM, V271, P23566, DOI 10.1074/jbc.271.38.23566; HSIEH KP, 1992, MOL ENDOCRINOL, V6, P1673, DOI 10.1210/me.6.10.1673; JAHRAUS A, 1994, J CELL SCI, V107, P145; Kakinoki Y, 1997, J BIOL CHEM, V272, P32308, DOI 10.1074/jbc.272.51.32308; Kallal L, 1998, J BIOL CHEM, V273, P322, DOI 10.1074/jbc.273.1.322; KIM GD, 1994, J BIOL CHEM, V269, P19933; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; Milligan G, 1998, TRENDS ENDOCRIN MET, V9, P13, DOI 10.1016/S1043-2760(98)00004-6; Molino M, 1997, J BIOL CHEM, V272, P6011, DOI 10.1074/jbc.272.9.6011; MOORE RH, 1995, J CELL SCI, V108, P2983; Mukhopadhyay A, 1997, J BIOL CHEM, V272, P13055, DOI 10.1074/jbc.272.20.13055; NUSSENZVEIG DR, 1993, J BIOL CHEM, V268, P2389; Petrou C, 1997, J BIOL CHEM, V272, P2326; Roettger BF, 1997, MOL PHARMACOL, V51, P357; RuizGomez A, 1997, J BIOL CHEM, V272, P9601; Seifert R, 1998, J BIOL CHEM, V273, P5109, DOI 10.1074/jbc.273.9.5109; Svoboda P, 1996, MOL PHARMACOL, V49, P646; Tarasova NI, 1997, J BIOL CHEM, V272, P14817, DOI 10.1074/jbc.272.23.14817; Tolbert LM, 1996, J BIOL CHEM, V271, P17335, DOI 10.1074/jbc.271.29.17335; VONZASTROW M, 1994, J BIOL CHEM, V269, P18448; Wise A, 1997, J BIOL CHEM, V272, P24673, DOI 10.1074/jbc.272.39.24673; Wise A, 1997, BIOCHEM J, V325, P17, DOI 10.1042/bj3250017; Yu R, 1997, J BIOL CHEM, V272, P28301, DOI 10.1074/jbc.272.45.28301; Yu R, 1997, MOL PHARMACOL, V51, P785, DOI 10.1124/mol.51.5.785; ZernickaGoetz M, 1997, DEVELOPMENT, V124, P1133; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	48	55	56	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24000	24008		10.1074/jbc.273.37.24000	http://dx.doi.org/10.1074/jbc.273.37.24000			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727016	hybrid			2022-12-27	WOS:000075893100057
J	Jeannin, E; Robyr, D; Desvergne, B				Jeannin, E; Robyr, D; Desvergne, B			Transcriptional regulatory patterns of the myelin basic protein and malic enzyme genes by the thyroid hormone receptors alpha 1 and beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOID-X-RECEPTOR; PROLIFERATOR-ACTIVATED RECEPTOR; LIGAND-BINDING DOMAIN; RESPONSE ELEMENT; DNA-BINDING; NUCLEAR RECEPTORS; DIFFERENTIAL EXPRESSION; FUNCTIONAL-ANALYSIS; BRAIN-DEVELOPMENT; ORPHAN RECEPTORS	While there is evidence that the two ubiquitously expressed thyroid hormone (T3) receptors, TR alpha 1 and TR beta 1, have distinct functional specificities, the mechanism by which they discriminate potential target genes remains largely unexplained. In this study, we demonstrate that the thyroid hormone response elements (TRE) from the malic enzyme and myelin basic protein genes (METRE and MBPTRE) respectively, are not functionally equivalent. The METRE which is a direct repeat motif with a 4-base pair gap between the two half-site hexamers binds thyroid hormone receptor as a heterodimer with 9-cis-retinoic acid receptor (RXR) and mediates a high T3-dependent activation in response to TR alpha 1 or TR beta 1 in NIH3T3 cells. In contrast, the MBPTRE, which consists of an inverted palindrome formed by two hexamers spaced by 6 base pairs, confers an efficient transactivation by TR beta 1 but a poor transactivation by TR alpha 1, While both receptors form heterodimers with RXR on MBPTRE the poor transactivation by TR alpha 1 correlates also with its ability to bind efficiently as a monomer, This monomer, which is only observed with TR alpha 1 bound to MBPTRE, interacts neither with N-CoR nor with SEC-I, explaining its functional inefficacy, However, in Xenopus oocytes, in which RXR proteins are not detectable, the transactivation mediated by TR alpha 1 and TR beta 1 is equivalent and independent of a RXR supply, raising the question of the identity of the thyroid hormone receptor partner in these cells. Thus, in mammalian cells, the binding characteristics of TR alpha 1 to MBPTRE (i.e. high monomer binding efficiency and low transactivation activity) might explain the particular pattern of T3 responsiveness of MBP gene expression during central nervous system development.	Univ Lausanne, Inst Biol Anim, CH-1015 Lausanne, Switzerland	University of Lausanne	Desvergne, B (corresponding author), Univ Lausanne, Inst Biol Anim, Batiment Biol, CH-1015 Lausanne, Switzerland.	beatrice.desvergne@iba.unil.ch	Desvergne, Beatrice/C-8892-2016	Desvergne, Beatrice/0000-0001-5483-288X				ANDERSSON ML, 1992, NUCLEIC ACIDS RES, V20, P4803, DOI 10.1093/nar/20.18.4803; BHAT MK, 1994, P NATL ACAD SCI USA, V91, P7927, DOI 10.1073/pnas.91.17.7927; BRADLEY DJ, 1989, P NATL ACAD SCI USA, V86, P7250, DOI 10.1073/pnas.86.18.7250; BRADLEY DJ, 1994, P NATL ACAD SCI USA, V91, P439, DOI 10.1073/pnas.91.2.439; BRADLEY DJ, 1992, J NEUROSCI, V12, P2288; BRENT GA, 1992, MOL ENDOCRINOL, V6, P502, DOI 10.1210/me.6.4.502; BUGGE TH, 1992, EMBO J, V11, P1409, DOI 10.1002/j.1460-2075.1992.tb05186.x; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; DARLING DS, 1993, J BIOL CHEM, V268, P10221; DESVERGNE B, 1991, J BIOL CHEM, V266, P1008; DESVERGNE B, 1994, MOL CELL ENDOCRINOL, V100, P125, DOI 10.1016/0303-7207(94)90291-7; DOLLE P, 1994, MECH DEVELOP, V45, P91, DOI 10.1016/0925-4773(94)90023-X; FARSETTI A, 1991, J BIOL CHEM, V266, P23226; FARSETTI A, 1992, J BIOL CHEM, V267, P15784; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; FORREST D, 1991, EMBO J, V10, P269, DOI 10.1002/j.1460-2075.1991.tb07947.x; FORREST D, 1990, EMBO J, V9, P1519, DOI 10.1002/j.1460-2075.1990.tb08270.x; Gronemeyer H, 1995, PROTEIN PROFILE, V2, P1173; Henttu PMA, 1997, MOL CELL BIOL, V17, P1832, DOI 10.1128/MCB.17.4.1832; Higuchi R., 1989, PCR TECHNOLOGY, P61; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Horwitz KB, 1996, MOL ENDOCRINOL, V10, P1167, DOI 10.1210/me.10.10.1167; HSU JH, 1995, ENDOCRINOLOGY, V136, P421, DOI 10.1210/en.136.2.421; Ijpenberg A, 1997, J BIOL CHEM, V272, P20108, DOI 10.1074/jbc.272.32.20108; KAMEI Y, 1996, CELL, V85, P1; KATZ D, 1995, MOL CELL BIOL, V15, P2341; KATZ RW, 1993, J BIOL CHEM, V268, P19392; KATZ RW, 1994, J BIOL CHEM, V269, P18915; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; KIM HS, 1992, MOL ENDOCRINOL, V6, P1489, DOI 10.1210/me.6.9.1489; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; KREY G, 1995, MOL ENDOCRINOL, V9, P219, DOI 10.1210/me.9.2.219; KUROKAWA R, 1993, GENE DEV, V7, P1423, DOI 10.1101/gad.7.7b.1423; KUROKAWA R, 1995, NATURE, V377, P451, DOI 10.1038/377451a0; LAZAR MA, 1991, MOL CELL BIOL, V11, P5005, DOI 10.1128/MCB.11.10.5005; LEE IJ, 1994, P NATL ACAD SCI USA, V91, P1647, DOI 10.1073/pnas.91.5.1647; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; LeRicousse S, 1996, P NATL ACAD SCI USA, V93, P5072, DOI 10.1073/pnas.93.10.5072; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; MARKS MS, 1992, EMBO J, V11, P1419, DOI 10.1002/j.1460-2075.1992.tb05187.x; MEDIN JA, 1994, MOL CELL ENDOCRINOL, V105, P27, DOI 10.1016/0303-7207(94)90032-9; MELLSTROM B, 1991, MOL ENDOCRINOL, V5, P1339, DOI 10.1210/mend-5-9-1339; MIYAMOTO T, 1993, MOL ENDOCRINOL, V7, P224, DOI 10.1210/me.7.2.224; MODAK SP, 1993, ONCOGENE, V8, P645; MORIOKA H, 1988, MOL CELL BIOL, V8, P3542, DOI 10.1128/MCB.8.8.3542; NAWAZ Z, 1995, P NATL ACAD SCI USA, V92, P11691, DOI 10.1073/pnas.92.25.11691; ONATE SA, 1995, SCIENCE, V270, P1354; PARK HY, 1993, MOL ENDOCRINOL, V7, P319, DOI 10.1210/me.7.3.319; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; RIBEIRO RC, 1992, MOL ENDOCRINOL, V6, P1142, DOI 10.1210/me.6.7.1142; SCHRADER M, 1994, J BIOL CHEM, V269, P6444; STRAIT KA, 1990, J BIOL CHEM, V265, P10514; STRAIT KA, 1991, P NATL ACAD SCI USA, V88, P3887, DOI 10.1073/pnas.88.9.3887; STRAIT KA, 1992, MOL ENDOCRINOL, V6, P1874, DOI 10.1210/me.6.11.1874; Strait KA, 1997, ENDOCRINOLOGY, V138, P635, DOI 10.1210/en.138.2.635; SUGAWARA A, 1993, ENDOCRINOLOGY, V133, P965, DOI 10.1210/en.133.3.965; Tong GX, 1996, MOL CELL BIOL, V16, P1909; TOYODA N, 1995, MOL CELL BIOL, V15, P5100; WAHLSTROM GM, 1992, MOL ENDOCRINOL, V6, P1013, DOI 10.1210/me.6.7.1013; WILLIAMS GR, 1991, J BIOL CHEM, V266, P19636; WILSON TE, 1992, SCIENCE, V256, P107, DOI 10.1126/science.1314418; WONG J, 1995, GENE DEV, P2696; YARWOOD NJ, 1993, J BIOL CHEM, V268, P21984; YEN PM, 1994, J BIOL CHEM, V269, P12704; YEN PM, 1992, J BIOL CHEM, V267, P3565; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E; Zamir I, 1997, GENE DEV, V11, P835, DOI 10.1101/gad.11.7.835; ZHANG XK, 1992, NATURE, V355, P442	72	44	44	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24239	24248		10.1074/jbc.273.37.24239	http://dx.doi.org/10.1074/jbc.273.37.24239			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727048	hybrid			2022-12-27	WOS:000075893100089
J	Oda, Y; Tu, CL; Pillai, S; Bikle, DD				Oda, Y; Tu, CL; Pillai, S; Bikle, DD			The calcium sensing receptor and its alternatively spliced form in keratinocyte differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-SENSING RECEPTOR; CELL-SURFACE; HYPOCALCIURIC HYPERCALCEMIA; TERMINAL DIFFERENTIATION; EXTRACELLULAR CALCIUM; MOLECULAR-CLONING; EPIDERMAL-CELLS; VITAMIN-D; EXPRESSION; MUTATIONS	We have recently reported the presence of the calcium sensing receptor (CaR) in keratinocytes and suggested that it signaled calcium-induced differentiation of these cells. cDNA clones encoding the full-length CaR were isolated from human keratinocytes. In addition, an alternatively spliced form that lacks exon 5, encoding a portion of the extracellular domain, also was found. The in frame deletion of 231 nucleotides of exon 5 resulted in the loss of function of the CaR as measured by calcium-stimulated production of inositol phosphates when transfected into HEK293 cells or keratinocytes. This variant produced a smaller CaR protein with an altered glycosylation pattern compared with the full-length CaR. Coexpression of the spliced variant with the full-length CaR reduced the function of the full-length CaR. The full-length CaR was expressed in undifferentiated keratinocytes consistent with their greater response to elevated extracellular calcium in terms of increased intracellular free calcium and production of inositol phosphates. The full-length CaR decreased as the keratinocytes differentiated with an increase in the ratio of the spliced variant to the full-length form. The relative proportions of these two forms of CaR may regulate the calcium responsiveness of keratinocytes during their differentiation.	Univ Calif San Francisco, Vet Adm Med Ctr, Dept Med & Dermatol, San Francisco, CA 94121 USA; Univ Calif San Francisco, Vet Adm Med Ctr, Dept Endocrinol, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Oda, Y (corresponding author), Vet Adm Med Ctr, Dept Dermatol 190, 4150 Clement St, San Francisco, CA 94121 USA.	y2073@itsa.ucsf.edu		Tu, Chia-Ling/0000-0002-7323-7733	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR039448, R01AR038386] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01-AR38386, P01-AR39448] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AIDA K, 1995, BIOCHEM BIOPH RES CO, V214, P524, DOI 10.1006/bbrc.1995.2318; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Bai M, 1996, J BIOL CHEM, V271, P19537, DOI 10.1074/jbc.271.32.19537; Bikle DD, 1996, J CLIN INVEST, V97, P1085, DOI 10.1172/JCI118501; BIKLE DD, 1993, ENDOCR REV, V14, P3, DOI 10.1210/er.14.1.3; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Chang WH, 1998, J BONE MINER RES, V13, P570, DOI 10.1359/jbmr.1998.13.4.570; Chattopadhyay N, 1996, ENDOCR REV, V17, P289, DOI 10.1210/er.17.4.289; Fan GF, 1997, ENDOCRINOLOGY, V138, P1916, DOI 10.1210/en.138.5.1916; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GALIETTA LJV, 1991, PFLUG ARCH EUR J PHY, V418, P18, DOI 10.1007/BF00370447; GARRETT JE, 1995, J BIOL CHEM, V270, P12919, DOI 10.1074/jbc.270.21.12919; Gibson DFC, 1996, J INVEST DERMATOL, V106, P154, DOI 10.1111/1523-1747.ep12329856; GREEN H, 1977, CELL, V11, P405, DOI 10.1016/0092-8674(77)90058-7; Heath H, 1996, J CLIN ENDOCR METAB, V81, P1312, DOI 10.1210/jcem.81.4.8636323; HEBERT SC, 1995, CURR OPIN CELL BIOL, V7, P484, DOI 10.1016/0955-0674(95)80004-2; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; LI LW, 1995, J CELL PHYSIOL, V163, P105, DOI 10.1002/jcp.1041630112; MAURO TM, 1993, J MEMBRANE BIOL, V132, P201; NEMETH EF, 1987, J BIOL CHEM, V262, P5188; Oda Y, 1997, FEBS LETT, V414, P140, DOI 10.1016/S0014-5793(97)00927-7; Pearce SHS, 1995, J CLIN INVEST, V96, P2683, DOI 10.1172/JCI118335; PILLAI S, 1992, J CLIN INVEST, V90, P42, DOI 10.1172/JCI115854; PILLAI S, 1990, J CELL PHYSIOL, V143, P294, DOI 10.1002/jcp.1041430213; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; Ray K, 1997, J BIOL CHEM, V272, P31355, DOI 10.1074/jbc.272.50.31355; SEUWEN K, 1990, J BIOL CHEM, V265, P22292; Xie ZJ, 1997, J BIOL CHEM, V272, P6573, DOI 10.1074/jbc.272.10.6573	29	132	136	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23344	23352		10.1074/jbc.273.36.23344	http://dx.doi.org/10.1074/jbc.273.36.23344			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722568	hybrid			2022-12-27	WOS:000075778100068
J	Seah, SYK; Terracina, G; Bolin, JT; Riebel, P; Snieckus, V; Eltis, LD				Seah, SYK; Terracina, G; Bolin, JT; Riebel, P; Snieckus, V; Eltis, LD			Purification and preliminary characterization of a serine hydrolase involved in the microbial degradation of polychlorinated biphenyls	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-HYDROXY-6-KETO-NONA-2,4-DIENE-1,9-DIOIC ACID 5,6-HYDROLASE; 2-HYDROXYMUCONIC SEMIALDEHYDE HYDROLASE; BACTERIOPHAGE-T7 RNA-POLYMERASE; PSEUDOMONAS-PUTIDA F1; 2-HYDROXY-6-OXOHEPTA-2,4-DIENOATE HYDROLASE; CHLORINE SUBSTITUTION; ENCODING BIPHENYL; ESCHERICHIA-COLI; META-CLEAVAGE; STRAIN RHA1	2-Hydroxy-6-oxo-6-phenylhexa-2,4-dienoate (6-phenyl-HODA) hydrolase (BphD), an enzyme of the biphenyl biodegradation pathway encoded by the bphD gene of Burkholderia cepacia LB400, was hyperexpressed and purified to apparent homogeneity, SDS-polyacrylamide gel electrophoresis confirmed that BphD has a subunit molecular mass of 32 kDa, while gel filtration demonstrated that it is a homotetramer of molecular weight 122,000, The enzyme hydrolyzed 6-phenyl-HODA with a k(cat) of 5.0 (+/- 0.07) s(-1) and a k(cat)/K-m of 2.0 (+/- 0.08) x 10(7) M-1 s(-1) (100 mM phosphate, pH 7.5, 25 degrees C). The specificity of BphD for other 2-hydroxy-6-oxohexa-2,4-dienoates (HODAs) decreased markedly with the size of the C6 substituent; 6-methyl-HODA, the meta cleavage product of 3-methylcatechol, was hydrolyzed approximately 2300 times less specifically than 6-phenyl-HODA, By comparison, the homologous hydrolase from the toluene degradation pathway, TodF, showed highest specificity for 6-methyl- and 6-ethyl-HODA (k(cat)/K-m of 2.0 (+/- 0.05) x 10(6) M-1 s(-1) and 9.0 (+/- 0.5) x 10(6) M-1 s(-1), respectively). TodF showed no detectable activity toward 6-phenyl-HODA and 6-tert-butyl-HODA, Neither BphD nor TodF hydrolyzed 5-methyl-HODA efficiently. The k(cat) of BphD determined by monitoring product formation was about half that determined by monitoring substrate disappearance, suggesting that some uncoupling of substrate utilization and product formation occurs during the enzyme catalyzed reaction. Crystals of BphD were obtained using ammonium sulfate combined with polyethylene glycol 400 as the precipitant. Diffraction was observed to a resolution of at least 1.9 Angstrom and the evaluation of self-rotation functions confirmed 222 (D2) molecular symmetry.	Univ Laval, Dept Biochem, Quebec City, PQ G1K 7P4, Canada; Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Univ Waterloo, Guelph Waterloo Ctr Grad Work Chem, Waterloo, ON N2L 3G1, Canada	Laval University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Guelph; University of Waterloo	Eltis, LD (corresponding author), Univ Laval, Dept Biochem, Quebec City, PQ G1K 7P4, Canada.		Eltis, Lindsay D/J-8272-2015	Eltis, Lindsay D/0000-0002-6774-8158	NIGMS NIH HHS [GM-52381] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHMAD D, 1995, GENE, V156, P69, DOI 10.1016/0378-1119(95)00073-F; Barnes MR, 1997, J BACTERIOL, V179, P6145, DOI 10.1128/jb.179.19.6145-6153.1997; BAYLY RC, 1978, J BACTERIOL, V134, P30, DOI 10.1128/JB.134.1.30-37.1978; BEDARD DL, 1990, MICROBIAL ECOL, V20, P87, DOI 10.1007/BF02543870; BOPP LH, 1986, J IND MICROBIOL, V1, P23, DOI 10.1007/BF01569413; BORCK K, 1976, MOL GEN GENET, V146, P199, DOI 10.1007/BF00268089; Bunz P V, 1993, Biodegradation, V4, P171, DOI 10.1007/BF00695119; Cornish-Bowden A., 1995, ANAL ENZYME KINETIC; Dagley S., 1986, BACTERIA, V10, P527; DENTE L, 1987, METHOD ENZYMOL, V155, P111; DIAZ E, 1995, J BIOL CHEM, V270, P6403, DOI 10.1074/jbc.270.11.6403; DOWLING DN, 1993, FEMS MICROBIOL LETT, V113, P149, DOI 10.1111/j.1574-6968.1993.tb06506.x; DUGGLEBY CJ, 1986, J GEN MICROBIOL, V132, P717; FOCHT DD, 1995, CURR OPIN BIOTECH, V6, P341, DOI 10.1016/0958-1669(95)80057-3; FURUKAWA K, 1986, J BACTERIOL, V166, P392, DOI 10.1128/jb.166.2.392-398.1986; FURUKAWA K, 1993, J BACTERIOL, V175, P5224, DOI 10.1128/JB.175.16.5224-5232.1993; FURUKAWA K, 1979, APPL ENVIRON MICROB, V38, P301, DOI 10.1128/AEM.38.2.301-310.1979; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hatta T, 1998, J FERMENT BIOENG, V85, P174, DOI 10.1016/S0922-338X(97)86763-3; HAYASE N, 1990, J BACTERIOL, V172, P1160, DOI 10.1128/jb.172.2.1160-1164.1990; HECHT HJ, 1994, NAT STRUCT BIOL, V1, P532, DOI 10.1038/nsb0894-532; Henderson IMJ, 1997, BIOCHEMISTRY-US, V36, P12252, DOI 10.1021/bi971116j; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; HOFER B, 1993, GENE, V130, P47, DOI 10.1016/0378-1119(93)90345-4; HORN JM, 1991, MOL MICROBIOL, V5, P2459, DOI 10.1111/j.1365-2958.1991.tb02091.x; Kim E, 1996, APPL ENVIRON MICROB, V62, P262, DOI 10.1128/AEM.62.1.262-265.1996; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lam WWY, 1997, BIOCHEMISTRY-US, V36, P12242, DOI 10.1021/bi971115r; Lau PCK, 1996, GENE, V171, P53, DOI 10.1016/0378-1119(96)00025-X; LORENZO V, 1993, GENE, V123, P17, DOI DOI 10.1016/0378-1119(93)90533-9; Masai E, 1997, GENE, V187, P141, DOI 10.1016/S0378-1119(96)00748-2; McPherson A, 1982, PREPARATION ANAL PRO; MENN FM, 1991, GENE, V104, P91, DOI 10.1016/0378-1119(91)90470-V; Nandhagopal N, 1997, P JPN ACAD B-PHYS, V73, P154, DOI 10.2183/pjab.73.154; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; OMORI T, 1986, AGR BIOL CHEM TOKYO, V50, P931, DOI 10.1080/00021369.1986.10867489; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pokorny D, 1997, TRENDS BIOTECHNOL, V15, P291, DOI 10.1016/S0167-7799(97)01055-X; SALATREPAT JM, 1972, EUR J BIOCHEM, V28, P347, DOI 10.1111/j.1432-1033.1972.tb01920.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TIMMIS KN, 1994, ANNU REV MICROBIOL, V48, P525, DOI 10.1146/annurev.mi.48.100194.002521; Tong L, 1997, METHOD ENZYMOL, V276, P594, DOI 10.1016/S0076-6879(97)76080-4; WASSERFALLEN A, 1989, THESIS U GENEVA; ZYLSTRA GJ, 1989, J BIOL CHEM, V264, P14940	47	66	67	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					22943	22949		10.1074/jbc.273.36.22943	http://dx.doi.org/10.1074/jbc.273.36.22943			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722515	hybrid			2022-12-27	WOS:000075778100015
J	Thannickal, VJ; Aldweib, KDL; Fanburg, BL				Thannickal, VJ; Aldweib, KDL; Fanburg, BL			Tyrosine phosphorylation regulates H2O2 production in lung fibroblasts stimulated by transforming growth factor beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENERATING NADPH OXIDASE; SIGNAL-TRANSDUCTION; ACTIVATION; OXYGEN; CELLS; PROLIFERATION; NEUTROPHILS; RECEPTORS; PROTEINS; KINASE	Transforming growth factor beta 1 (TGF-beta 1) is a multifunctional, profibrotic cytokine involved in cellular growth and differentiation. We have previously described a cell surface-associated H2O2-generating NADH:flavin:O-2 oxidoreductase (referred to as NADIR oxidase) activity in human lung fibroblasts induced by TGF-beta 1 (Thannickal, V. J., and Fanburg, B. L. (1995) J. Biol. Chem. 270, 30334-30338). In this study, the potential for regulation of this novel TGF-beta 1-activated oxidase in fibroblasts by protein tyrosine phosphorylation was examined. Immunoblots using anti-phosphotyrosine antibody demonstrated a time-dependent but delayed phosphorylation of two proteins of 115 and 103 kDa in cells stimulated with TGF-beta 1 (2 ng/ml), Similar to the effect on TGF-beta 1-induced H2O2 production, phosphorylation of these proteins was blocked by the addition of actinomycin D. The protein-tyrosine kinase inhibitors genistein and herbimycin A inhibited TGF-beta 1-induced protein tyrosine phosphorylation, NADH oxidase activation, and H2O2 production in a dose-dependent manner. Catalase, diphenyliodonium (an inhibitor of flavoenzymes), and suramin (an inhibitor of receptor activation, added 4 h after TGF-beta 1) had no effect on the induction of protein tyrosine phosphorylation, Phosphorylation of the 115- and 103-kDa proteins preceded the generation of H2O2 production and returned to control levels when H2O2 was undetectable at 48 h after TGF-beta 1 exposure, These results suggest that protein tyrosine phosphorylation by a nonreceptor protein-tyrosine kinase(s) regulates the activity of the TGF-beta 1-responsive H2O2-generating NADH oxidase in human lung fibroblasts, Additionally, this study demonstrates that TGF-beta 1, which binds to a serine-threonine kinase receptor, is able to induce protein tyrosine phosphorylation in a delayed manner via a signaling pathway that requires transcriptional activation.	New England Med Ctr, Tupper Res Inst, Dept Med, Div Pulm & Crit Care, Boston, MA 02111 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Thannickal, VJ (corresponding author), New England Med Ctr, Tupper Res Inst, Dept Med, Div Pulm & Crit Care, 750 Washington St,NEMC 369, Boston, MA 02111 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003552, R01HL042376] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08 HL-03552, HL-42376] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; BATTEGAY EJ, 1990, CELL, V63, P515, DOI 10.1016/0092-8674(90)90448-N; BAUSKIN AR, 1991, CELL, V66, P685, DOI 10.1016/0092-8674(91)90114-E; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; FIALKOW L, 1993, J BIOL CHEM, V268, P17131; KUSUNOKI T, 1992, BIOCHEM BIOPH RES CO, V183, P789, DOI 10.1016/0006-291X(92)90552-V; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEOF EB, 1986, P NATL ACAD SCI USA, V83, P2453, DOI 10.1073/pnas.83.8.2453; LIBBY J, 1986, J CELL PHYSIOL, V129, P159, DOI 10.1002/jcp.1041290206; LO YYC, 1995, J BIOL CHEM, V270, P11727, DOI 10.1074/jbc.270.20.11727; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; MASSEY V, 1994, J BIOL CHEM, V269, P22459; MEIER B, 1993, BIOCHEM J, V289, P481, DOI 10.1042/bj2890481; MIZUNO T, 1992, J BIOL CHEM, V267, P10215; OBHA M, 1994, J CELL BIOL, V126, P1079; ODONNELL VB, 1993, BIOCHEM J, V290, P41, DOI 10.1042/bj2900041; Reimann T, 1997, FEBS LETT, V403, P57, DOI 10.1016/S0014-5793(97)00024-0; ROBERTS AB, 1990, PEPTIDE GROWTH FACTO, P421; ROTROSEN D, 1990, J BIOL CHEM, V265, P19910; RUCH W, 1983, J IMMUNOL METHODS, V63, P347, DOI 10.1016/S0022-1759(83)80008-8; SACHSENMAIER C, 1994, CELL, V78, P963, DOI 10.1016/0092-8674(94)90272-0; Savage C, 1996, P NATL ACAD SCI USA, V93, P790, DOI 10.1073/pnas.93.2.790; SEKELSKY JJ, 1995, GENETICS, V139, P1347; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; STOUFFER GA, 1994, J CLIN INVEST, V93, P2048, DOI 10.1172/JCI117199; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; TAKEHARA K, 1987, CELL, V49, P415, DOI 10.1016/0092-8674(87)90294-7; Thannickal VJ, 1995, J BIOL CHEM, V270, P30334, DOI 10.1074/jbc.270.51.30334; TUCKER RF, 1984, SCIENCE, V226, P705, DOI 10.1126/science.6093254; WEI HC, 1995, P SOC EXP BIOL MED, V208, P124	34	68	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23611	23615		10.1074/jbc.273.36.23611	http://dx.doi.org/10.1074/jbc.273.36.23611			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722602	hybrid			2022-12-27	WOS:000075778100102
J	Van Eyk, JE; Arrell, DK; Foster, DB; Strauss, JD; Heinonen, TYK; Furmaniak-Kazmierczak, E; Cote, GP; Mak, AS				Van Eyk, JE; Arrell, DK; Foster, DB; Strauss, JD; Heinonen, TYK; Furmaniak-Kazmierczak, E; Cote, GP; Mak, AS			Different molecular mechanisms for Rho family GTPase-dependent, Ca2+-independent contraction of smooth muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; CA2+ SENSITIZATION; KINASE; PHOSPHORYLATION; CALDESMON; MYOSIN; PROTEIN; PURIFICATION; PHOSPHATASE; ACTIVATION	Abnormal smooth muscle contraction may contribute to diseases such as asthma and hypertension. Alterations to myosin light chain kinase or phosphatase change the phosphorylation level of the 20-kDa myosin regulatory light chain (MRLC), increasing Ca2+ sensitivity and basal tone. One Rho family GTPase-dependent kinase, Rho-associated kinase (ROR or p160(ROCK)) can induce Ca2+-independent contraction of Triton-skinned smooth muscle by phosphorylating MRLC and/or myosin light chain phosphatase. We show that another Rho family GTPase-dependent kinase, p21-activated protein kinase (PAK), induces Triton-skinned smooth muscle contracts independently of calcium to 62 +/- 12% (n = 10) of the value observed in presence of calcium, Remarkably, PAK. and ROK use different molecular mechanisms to achieve the Ca2+-independent contraction. Like ROM and myosin light chain kinase, PAK phosphorylates MRLC at serine 19 in vitro, However, PAK-induced contraction correlates with enhanced phosphorylation of caldesmon and desmin but not MRLC, The level of MRLC phosphorylation remains similar to that in relaxed muscle fibers (absence of GST-mPAK3 and calcium) even as the force induced by GST-mPAK3 increases from 26 to 70%. Thus, PAK uncouples force generation from MRLC phosphorylation, These data support a model of PAK-induced contraction in which myosin phosphorylation is at least complemented through regulation of thin filament proteins. Because ROK and PAK homologues are present in smooth muscle, they may work in parallel to regulate smooth muscle contraction.	Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Physiol, Kingston, ON K7L 3N6, Canada; New York Inst Technol, New York Coll Osteopath Med, Old Westbury, NY 11542 USA	Queens University - Canada; Queens University - Canada; New York Institute Technology	Van Eyk, JE (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	JVEl@post.queensu.ca	Foster, D. Brian/S-9108-2019; Foster, D. Brian/C-6350-2009	Foster, D. Brian/0000-0002-9290-9590; Foster, D. Brian/0000-0002-9290-9590				Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; BRETSCHER A, 1984, J BIOL CHEM, V259, P2873; CHALOVICH JM, 1992, PHARMACOL THERAPEUT, V55, P95, DOI 10.1016/0163-7258(92)90013-P; CHILDS TJ, 1992, J BIOL CHEM, V267, P22853; Gong MC, 1996, P NATL ACAD SCI USA, V93, P1340, DOI 10.1073/pnas.93.3.1340; Gong MC, 1997, J BIOL CHEM, V272, P10704; HATHAWAY DR, 1983, ANAL BIOCHEM, V135, P37, DOI 10.1016/0003-2697(83)90726-1; HIRATA K, 1992, J BIOL CHEM, V267, P8719; IKEBE M, 1985, J BIOL CHEM, V260, P27; Jakobi R, 1996, J BIOL CHEM, V271, P6206, DOI 10.1074/jbc.271.11.6206; KATSUYAMA H, 1992, J BIOL CHEM, V267, P14555; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kureishi Y, 1997, J BIOL CHEM, V272, P12257, DOI 10.1074/jbc.272.19.12257; LEBERER E, 1992, EMBO J, V11, P4805, DOI 10.1002/j.1460-2075.1992.tb05586.x; MAK AS, 1991, J BIOL CHEM, V266, P19971; MAK AS, 1991, J BIOL CHEM, V266, P6678; Malmquist U, 1996, PFLUG ARCH EUR J PHY, V432, P241, DOI 10.1007/s004240050130; MANSER E, 1995, J BIOL CHEM, V270, P25070, DOI 10.1074/jbc.270.42.25070; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MANSER E, 1996, METHOD ENZYMOL, V256, P215; MARTIN GA, 1995, EMBO J, V14, P1970, DOI 10.1002/j.1460-2075.1995.tb07189.x; NOVY RE, 1993, CELL MOTIL CYTOSKEL, V26, P248, DOI 10.1002/cm.970260308; Otto B, 1996, J PHYSIOL-LONDON, V496, P317, DOI 10.1113/jphysiol.1996.sp021687; Paul R J, 1987, Prog Clin Biol Res, V245, P319; PFITZER G, 1993, P NATL ACAD SCI USA, V90, P5904, DOI 10.1073/pnas.90.13.5904; Ridley AJ, 1996, CURR BIOL, V6, P1256, DOI 10.1016/S0960-9822(02)70711-2; SATOH S, 1994, J CLIN INVEST, V94, P1397, DOI 10.1172/JCI117475; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; STRAUSS JD, 1992, AM J PHYSIOL, V262, pC1437, DOI 10.1152/ajpcell.1992.262.6.C1437; Strauss John D., 1993, Methods (Orlando), V5, P281, DOI 10.1006/meth.1993.1034; STULL JT, 1991, HYPERTENSION, V17, P723, DOI 10.1161/01.HYP.17.6.723; TRINKLEMULCAHY L, 1995, J BIOL CHEM, V270, P18191, DOI 10.1074/jbc.270.31.18191; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Van Eyk JE, 1998, CIRC RES, V82, P261; Wu CL, 1996, J BIOL CHEM, V271, P31787, DOI 10.1074/jbc.271.50.31787; Zigmond SH, 1996, CURR OPIN CELL BIOL, V8, P66, DOI 10.1016/S0955-0674(96)80050-0	37	119	123	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23433	23439		10.1074/jbc.273.36.23433	http://dx.doi.org/10.1074/jbc.273.36.23433			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722579	hybrid			2022-12-27	WOS:000075778100079
J	Zhang, JH; Ding, XX				Zhang, JH; Ding, XX			Identification and characterization of a novel tissue-specific transcriptional activating element in the 5 '-flanking region of the CYP2A3 gene predominantly expressed in rat olfactory mucosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR FACTOR-I; RABBIT NASAL MICROSOMES; DNA-BINDING PROTEIN; MOLECULAR-CLONING; CYTOCHROMES P450; CDNA CLONING; STEROID 15-ALPHA-HYDROXYLASE; HETEROLOGOUS EXPRESSION; MARKER PROTEIN; PROMOTER	CYP2A3 is expressed preferentially in rat olfactory mucosa and is believed to play important roles in maintaining cellular homeostasis in the chemosensory tissue. DNase I footprinting analysis revealed a single protected region in the proximal promoter of the CYP2A3 gene with nuclear extracts from olfactory mucosa, but not from liver, lung, kidney, or brain. The core sequence of the binding site, named the nasal predominant transcriptional activating (NPTA) element, is similar to that of nuclear factor 1, but it interacted with unique proteins detected only in the olfactory mucosa in electrophoretic mobility shift assays or on Southwestern blots. The NPTA element is conserved in rat CYP2A3, mouse Cyp2a5, and human CYP2A6 genes and was found to be essential for transcriptional activity of the CYP2A3 promoter in in vitro transcription assays. NPTA-binding proteins were detectable at day 1 and were much more abundant at day 8 than at day 60 after birth. Furthermore, their levels decreased dramatically during chemically induced degeneration of the olfactory epithelium, paralleling the disappearance of CYP2A3 protein, and rebounded to higher than pretreatment levels during recovery. Thus, we have identified a novel transcriptional activation element potentially responsible for the olfactory mucosa-predominant expression of the CYP2A3 gene in rats and orthologous genes in mice and humans.	New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; SUNY Albany, Sch Publ Hlth, Dept Environm Hlth & Toxicol, Albany, NY 12201 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Ding, XX (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Empire State Plaza,Box 509, Albany, NY 12201 USA.	xding@wadsworth.org			NIDCD NIH HHS [DC-02640] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002640] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ABE M, 1993, P NATL ACAD SCI USA, V90, P282, DOI 10.1073/pnas.90.1.282; ADAMS AD, 1995, J BIOL CHEM, V270, P6975, DOI 10.1074/jbc.270.12.6975; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; BUIAKOVA OI, 1994, GENOMICS, V20, P452, DOI 10.1006/geno.1994.1200; CHEN Y, 1992, NEUROREPORT, V3, P749, DOI 10.1097/00001756-199209000-00007; DAHL AR, 1991, CRIT REV TOXICOL, V21, P345, DOI 10.3109/10408449109019571; DANCIGER E, 1989, P NATL ACAD SCI USA, V86, P8565, DOI 10.1073/pnas.86.21.8565; Davis JA, 1996, J NEUROSCI, V16, P5082; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DING X, 1988, BIOCHEMISTRY-US, V27, P8330, DOI 10.1021/bi00422a007; DING X, 1993, CYTOCHROME P450 HDB, V105, P351; DING XX, 1990, MOL PHARMACOL, V37, P489; DING XX, 1994, ARCH BIOCHEM BIOPHYS, V315, P454, DOI 10.1006/abbi.1994.1524; DING XX, 1992, MOL PHARMACOL, V42, P1027; Gao B, 1996, MOL CELL BIOL, V16, P5997; GETCHELL ML, 1993, ANN OTO RHINOL LARYN, V102, P368, DOI 10.1177/000348949310200509; GIL G, 1988, P NATL ACAD SCI USA, V85, P8963, DOI 10.1073/pnas.85.23.8963; Gonzalez FJ, 1996, FASEB J, V10, P1112, DOI 10.1096/fasebj.10.10.8751713; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; Gu J, 1997, TOXICOL APPL PHARM, V146, P134, DOI 10.1006/taap.1997.8238; HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777; Honkakoski P, 1997, J BIOL CHEM, V272, P14943, DOI 10.1074/jbc.272.23.14943; IBEANU GC, 1995, BIOCHEMISTRY-US, V34, P8028, DOI 10.1021/bi00025a008; ISHIJI T, 1992, EMBO J, V11, P2271, DOI 10.1002/j.1460-2075.1992.tb05286.x; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; Kim J, 1997, J BIOL CHEM, V272, P29423, DOI 10.1074/jbc.272.47.29423; KIMURA S, 1989, BIOCHEMISTRY-US, V28, P3798, DOI 10.1021/bi00435a026; KUDRYCKI K, 1993, MOL CELL BIOL, V13, P3002, DOI 10.1128/MCB.13.5.3002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZARD D, 1990, BIOCHEMISTRY-US, V29, P7433, DOI 10.1021/bi00484a012; Liu C, 1996, MOL PHARMACOL, V50, P781; LO K, 1991, MOL CELL BIOL, V11, P5229, DOI 10.1128/MCB.11.10.5229; Longo V, 1997, BIOCHEM J, V323, P65, DOI 10.1042/bj3230065; Maxam A M, 1980, Methods Enzymol, V65, P499; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; NEF P, 1989, J BIOL CHEM, V264, P6780, DOI 10.1016/S0021-9258(18)83497-4; NEHLS MC, 1991, MOL CELL BIOL, V11, P4065, DOI 10.1128/MCB.11.8.4065; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; PAONESSA G, 1988, EMBO J, V7, P3115, DOI 10.1002/j.1460-2075.1988.tb03178.x; PENG HM, 1993, J BIOL CHEM, V268, P17253; PEVSNER J, 1988, P NATL ACAD SCI USA, V85, P2383, DOI 10.1073/pnas.85.7.2383; ROGERS KE, 1987, P NATL ACAD SCI USA, V84, P1704, DOI 10.1073/pnas.84.6.1704; ROUSSEL F, 1995, DNA CELL BIOL, V14, P777, DOI 10.1089/dna.1995.14.777; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; SCHWOB JE, 1995, J COMP NEUROL, V359, P15, DOI 10.1002/cne.903590103; Su T, 1996, DRUG METAB DISPOS, V24, P884; Sumner C, 1996, J NEUROVIROL, V2, P87, DOI 10.3109/13550289609146542; SZABO P, 1995, J BIOL CHEM, V270, P10212, DOI 10.1074/jbc.270.17.10212; Tamura Taka-Aki, 1996, Methods (Orlando), V10, P312, DOI 10.1006/meth.1996.0108; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UENO T, 1990, MOL CELL BIOL, V10, P4495, DOI 10.1128/MCB.10.9.4495; UENO T, 1990, NUCLEIC ACIDS RES, V18, P4623, DOI 10.1093/nar/18.15.4623; VENEPALLY P, 1992, J BIOL CHEM, V267, P17333; WALTERS E, 1992, J NEUROSCI RES, V33, P103, DOI 10.1002/jnr.490330113; WALTERS E, 1993, TOXICOLOGY, V81, P113, DOI 10.1016/0300-483X(93)90003-B; WANG MM, 1993, MOL CELL BIOL, V13, P5805, DOI 10.1128/MCB.13.9.5805; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; Wang SS, 1997, J NEUROSCI, V17, P4149; Wingender E, 1997, NUCLEIC ACIDS RES, V25, P265, DOI 10.1093/nar/25.1.265; YANG BS, 1993, MOL CELL BIOL, V13, P3093, DOI 10.1128/MCB.13.5.3093; YOKOE H, 1993, P NATL ACAD SCI USA, V90, P4655, DOI 10.1073/pnas.90.10.4655; Yokomori N, 1997, J STEROID BIOCHEM, V62, P307, DOI 10.1016/S0960-0760(97)00048-4; Zhang QY, 1997, ARCH BIOCHEM BIOPHYS, V340, P270, DOI 10.1006/abbi.1997.9922	68	24	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23454	23462		10.1074/jbc.273.36.23454	http://dx.doi.org/10.1074/jbc.273.36.23454			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722582	hybrid			2022-12-27	WOS:000075778100082
J	Lee, NH; Malek, RL				Lee, NH; Malek, RL			Nerve growth factor regulation of m4 muscarinic receptor mRNA stability but not gene transcription requires mitogen-activated protein kinase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; INDUCED DOWN-REGULATION; 3' UNTRANSLATED REGION; ACETYLCHOLINE-RECEPTOR; PC12 CELLS; PC-12 CELLS; POSTTRANSCRIPTIONAL REGULATION; NEURONAL DIFFERENTIATION; 3'-UNTRANSLATED REGION; INDUCED STABILIZATION	Nerve growth factor (NGF) up-regulated steady-state levels of m4 muscarinic acetylcholine receptor (mAChR) mRNA in PC12 cells. Up-regulation of mRNA levels was associated with a corresponding increase in mAChR binding sites. Two other growth factors, basic fibroblast growth factor (bFGP) and epidermal growth factor (EGF), up regulated m4 mRNA and mAChR binding sites. Treatment of PC12 cells with NGF and bFGF, but not EGF, has previously been demonstrated to result in sustained activation of mitogen activated protein kinase (MAPK), Analogously, NGF and bFGF, but not EGF, increased the stability of m4 mRNA in PC12 cells. In HER-PC12 cells, a clonal PC12 cell transfectant overexpressing EGF receptors and displaying sustained MAPK activation upon receptor stimulation, EGF treatment stabilized the m4 transcript, A synthetic inhibitor of MAPK kinase, PD98059, inhibited growth factor-induced stabilization of the m4 transcript in both PC12 and HER-PC12 cells. These findings demonstrate that the MAPK pathway is involved in transcript stabilization. Cycloheximide pretreatment abolished the posttranscriptional effect of NGF, indicating that de novo protein synthesis was required for the observed increase in m4 mRNA stability, By contrast, cycloheximide had no discernible post-transcriptional effect if added after NGF treatment, suggesting that an inducible yet stable protein factor was involved in m4 mRNA decay, An unusually well conserved 137 nucleotides of m4 3'-untranslated region has been identified by sequence comparison with other mRNAs that are post-transcriptionally regulated by NGF. In PC12 cells that heterologously overexpress this region, we demonstrate that NGF no longer stabilizes endogenous m4 mRNA This conserved region probably represents an NGF-responsive element involved in mRNA stability regulation, Finally, transcription of the m4 gene can be induced by all three growth factors but is not dependent on MAPK activity, unlike growth factor-induced m4 mRNA stabilization.	Inst Genom Res, Dept Mol & Cellular Biol, Rockville, MD 20850 USA	J. Craig Venter Institute	Lee, NH (corresponding author), Inst Genom Res, Dept Mol & Cellular Biol, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	nhlee@tigr.org			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS035231] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35231] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ATWATER JA, 1994, ANNU REV GENET, V24, P519; BASI GS, 1987, CELL, V49, P785, DOI 10.1016/0092-8674(87)90616-7; BOHJANEN PR, 1991, MOL CELL BIOL, V11, P3288, DOI 10.1128/MCB.11.6.3288; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; BONNER TI, 1988, NEURON, V1, P403, DOI 10.1016/0896-6273(88)90190-0; CAVALLARO S, 1995, MOL PHARMACOL, V48, P56; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chung SM, 1997, J BIOL CHEM, V272, P6593, DOI 10.1074/jbc.272.10.6593; DIKIC I, 1994, CURR BIOL, V4, P702, DOI 10.1016/S0960-9822(00)00155-X; DURET L, 1993, NUCLEIC ACIDS RES, V21, P2315, DOI 10.1093/nar/21.10.2315; EVA C, 1992, MOL BRAIN RES, V14, P344, DOI 10.1016/0169-328X(92)90102-H; FRASER CM, 1994, PROG NUCLEIC ACID RE, V49, P113; FRASER CM, 1995, LIFE SCI, V56, P899, DOI 10.1016/0024-3205(95)00026-3; FUKAMAUCHI F, 1993, MOL PHARMACOL, V44, P940; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; HABECKER BA, 1992, P NATL ACAD SCI USA, V89, P5035, DOI 10.1073/pnas.89.11.5035; HADCOCK JR, 1993, J NEUROCHEM, V60, P1, DOI 10.1111/j.1471-4159.1993.tb05816.x; Haddad EB, 1996, MOL PHARMACOL, V49, P781; HALEGOUA S, 1991, CURR TOP MICROBIOL, V165, P119; HEASLEY LE, 1992, MOL BIOL CELL, V3, P545, DOI 10.1091/mbc.3.5.545; Irwin N, 1997, NUCLEIC ACIDS RES, V25, P1281, DOI 10.1093/nar/25.6.1281; JUMBLATT JE, 1982, NATURE, V297, P152, DOI 10.1038/297152a0; KIJIMA K, 1995, BIOCHEM BIOPH RES CO, V216, P359, DOI 10.1006/bbrc.1995.2632; KUBO T, 1986, NATURE, V323, P411, DOI 10.1038/323411a0; LEE NH, 1995, P NATL ACAD SCI USA, V92, P8303, DOI 10.1073/pnas.92.18.8303; Lee NH, 1996, MOL PHARMACOL, V50, P140; LEE NH, 1994, J BIOL CHEM, V269, P4291; LEE NH, 1995, MOL B INT U, P247; LEE NH, 1996, PHOSPHOINOSITIDASE C, P133; LENZ W, 1994, N-S ARCH PHARMACOL, V350, P507, DOI 10.1007/BF00173020; LINDENBAUM MH, 1988, J BIOL CHEM, V263, P5662; LUDLAM WH, 1994, DEV BIOL, V164, P528, DOI 10.1006/dbio.1994.1221; MALTER JS, 1991, J BIOL CHEM, V266, P3167; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mieda M, 1996, J BIOL CHEM, V271, P5177; NARAYANAN CS, 1992, J BIOL CHEM, V267, P17296; NISHIZAWA K, 1994, BIOCHEM BIOPH RES CO, V200, P789, DOI 10.1006/bbrc.1994.1520; NISHIZAWA K, 1994, BIOCHEM BIOPH RES CO, V205, P1380, DOI 10.1006/bbrc.1994.2818; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Pepitoni S, 1997, J BIOL CHEM, V272, P17112, DOI 10.1074/jbc.272.27.17112; PERALTA EG, 1987, EMBO J, V6, P3923, DOI 10.1002/j.1460-2075.1987.tb02733.x; PERRONEBIZZOZERO NI, 1993, J CELL BIOL, V120, P1263, DOI 10.1083/jcb.120.5.1263; Rosoff ML, 1996, P NATL ACAD SCI USA, V93, P14889, DOI 10.1073/pnas.93.25.14889; ROUSELL J, 1995, J BIOL CHEM, V270, P7213, DOI 10.1074/jbc.270.13.7213; Smith MA, 1997, J BIOL CHEM, V272, P15675, DOI 10.1074/jbc.272.25.15675; STEEL MC, 1993, MOL PHARMACOL, V43, P694; Szeberenyi J., 1996, Neurobiology (Budapest), V4, P1; Tholanikunnel BG, 1997, J BIOL CHEM, V272, P11471; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; Tsai KC, 1997, J NEUROSCI, V17, P1950; TWISS JL, 1995, J NEUROCHEM, V64, P550; WANG SZ, 1990, FEBS LETT, V276, P185, DOI 10.1016/0014-5793(90)80538-T; Wood IC, 1995, J BIOL CHEM, V270, P30933, DOI 10.1074/jbc.270.52.30933; Wood IC, 1996, J BIOL CHEM, V271, P14221, DOI 10.1074/jbc.271.24.14221; Yan GZ, 1997, J NEUROSCI, V17, P6122	55	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22317	22325		10.1074/jbc.273.35.22317	http://dx.doi.org/10.1074/jbc.273.35.22317			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712850	hybrid			2022-12-27	WOS:000075616600026
J	Marks-Konczalik, J; Chu, SC; Moss, J				Marks-Konczalik, J; Chu, SC; Moss, J			Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kappa B-binding sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; PROTEOLYTIC DEGRADATION; SIGNAL-TRANSDUCTION; MOUSE MACROPHAGES; INTERFERON-GAMMA; P50 SUBUNIT; JUN-D; PROMOTER; FOS; CELLS	The involvement of AP-1 and NF-kappa B transcription factors in cytokine-mediated induction of human inducible nitric oxide synthase (hiNOS) promoter activity was examined. Luciferase reporter plasmids, containing mutations in AP-1 and NF-kappa B sites, in a hiNOS promoter extending from -8.3 kilobase pairs (kb) to +168, were transiently expressed in A549 cells, and promoter activity was determined after treatment with a cytokine mixture (CM) containing interleukin 1-beta, interferon-gamma, and tumor necrosis factor-alpha. Mutation of the AP-1 heptad located -5301 base pairs upstream decreased gene activation by 90% in a -8.3-kb promoter and a shorter -5.574-kb promoter. Disruption of AP-1 (at -5115) or NF-kappa B (at -115 and -8283) sites reduced promoter activity by 45, 67, and 52%, respectively. Responsiveness to CM was decreased by 85% in constructs mutated in both NF-kappa B sites. By gel retardation analyses, CM increased AP-1- and NF-kappa B binding. Supershift analysis identified Jun D and Fra-2 as components of AP-1 complexes. Each kappa B Site bound different complements of NF-kappa B/Rel family members (downstream site, Rel A/p50; upstream site, Rel A/Rel A). Rel A was maximally, whereas I kappa B-alpha was minimally, expressed in nuclei after 1 h of CM treatment, corresponding with the peak in NF-kappa B inding activity. Thus, AP-1 and NF-kappa B are important cis-elements for induction of hiNOS gene transcription.	NHLBI, Pulm Crit Care Med Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Marks-Konczalik, J (corresponding author), NHLBI, Pulm Crit Care Med Branch, NIH, Bldg 10,Rm 6D03,10 Ctr Dr,MSC 1590, Bethesda, MD 20892 USA.	markrsj@gwgate.nhlbi.nih.gov						ADDOCK IM, 1994, BIOCHEM SOC T, V22, P186; AMOAHAPRAKU B, 1995, KIDNEY INT, V48, P674, DOI 10.1038/ki.1995.337; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; AUBLE DT, 1991, BIOCHEMISTRY-US, V30, P4629, DOI 10.1021/bi00232a039; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BEDOYA FJ, 1995, BIOCHEM BIOPH RES CO, V210, P816, DOI 10.1006/bbrc.1995.1731; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Blackwell TS, 1997, AM J RESP CELL MOL, V17, P3, DOI 10.1165/ajrcmb.17.1.f132; CHO HJ, 1992, J EXP MED, V176, P599, DOI 10.1084/jem.176.2.599; CHU SC, 1995, J BIOL CHEM, V270, P10625, DOI 10.1074/jbc.270.18.10625; Chu SC, 1998, BIOCHEM BIOPH RES CO, V248, P871, DOI 10.1006/bbrc.1998.9062; CORBETT JA, 1991, J BIOL CHEM, V266, P21351; deVera ME, 1996, P NATL ACAD SCI USA, V93, P1054, DOI 10.1073/pnas.93.3.1054; EBERHARDT W, 1994, BIOCHEM BIOPH RES CO, V200, P163, DOI 10.1006/bbrc.1994.1429; Eissa NT, 1996, J BIOL CHEM, V271, P27184, DOI 10.1074/jbc.271.43.27184; FAN CM, 1991, NATURE, V354, P395, DOI 10.1038/354395a0; Farivar RS, 1996, J BIOL CHEM, V271, P31585, DOI 10.1074/jbc.271.49.31585; Foletta VC, 1996, IMMUNOL CELL BIOL, V74, P121, DOI 10.1038/icb.1996.17; FORSTERMANN U, 1995, N-S ARCH PHARMACOL, V352, P351; GARDNER K, 1994, J BIOL CHEM, V269, P32963; GENTZ R, 1989, SCIENCE, V243, P1695, DOI 10.1126/science.2494702; HIRAI SI, 1989, EMBO J, V8, P1433, DOI 10.1002/j.1460-2075.1989.tb03525.x; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; KERR LD, 1993, NATURE, V365, P412, DOI 10.1038/365412a0; KLEEMANN R, 1993, FEBS LETT, V328, P9, DOI 10.1016/0014-5793(93)80954-S; KONE BC, 1995, AM J PHYSIOL-RENAL, V269, pF718, DOI 10.1152/ajprenal.1995.269.5.F718; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; LAMAS S, 1992, P NATL ACAD SCI USA, V89, P6348, DOI 10.1073/pnas.89.14.6348; LECLAIR KP, 1992, P NATL ACAD SCI USA, V89, P8145, DOI 10.1073/pnas.89.17.8145; LIN RT, 1995, J BIOL CHEM, V270, P3123, DOI 10.1074/jbc.270.7.3123; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; MCCARTNEYFRANCIS N, 1993, J EXP MED, V178, P749, DOI 10.1084/jem.178.2.749; MELLITS KH, 1993, NUCLEIC ACIDS RES, V21, P5059, DOI 10.1093/nar/21.22.5059; MERCURIO F, 1993, GENE DEV, V7, P705, DOI 10.1101/gad.7.4.705; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Nunokawa Y, 1996, BIOCHEM BIOPH RES CO, V223, P347, DOI 10.1006/bbrc.1996.0897; NUSSLER AK, 1993, J LEUKOCYTE BIOL, V54, P171, DOI 10.1002/jlb.54.2.171; PANKOV R, 1994, P NATL ACAD SCI USA, V91, P873, DOI 10.1073/pnas.91.3.873; PEARSE RN, 1991, P NATL ACAD SCI USA, V88, P11305, DOI 10.1073/pnas.88.24.11305; PERKINS ND, 1992, P NATL ACAD SCI USA, V89, P1529, DOI 10.1073/pnas.89.5.1529; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; PETROS A, 1991, LANCET, V338, P1557, DOI 10.1016/0140-6736(91)92376-D; POLI V, 1989, P NATL ACAD SCI USA, V86, P8202, DOI 10.1073/pnas.86.21.8202; Rahmsdorf HJ, 1996, J MOL MED, V74, P725, DOI 10.1007/s001090050077; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; RYSECK RP, 1991, ONCOGENE, V6, P533; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Spitsin SV, 1996, MOL MED, V2, P226, DOI 10.1007/BF03401619; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; SUZUKI T, 1991, NUCLEIC ACIDS RES, V19, P5537, DOI 10.1093/nar/19.20.5537; Suzuki T, 1996, J BIOL CHEM, V271, P1626, DOI 10.1074/jbc.271.3.1626; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; VODOVOTZ Y, 1994, J IMMUNOL, V152, P4110; WEINBERG JB, 1994, J EXP MED, V179, P651, DOI 10.1084/jem.179.2.651; WELTER JF, 1995, J BIOL CHEM, V270, P12614, DOI 10.1074/jbc.270.21.12614; XIE QW, 1994, J BIOL CHEM, V269, P4705; XIE QW, 1994, J LEUKOCYTE BIOL, V56, P576, DOI 10.1002/jlb.56.5.576; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; YANG Z, 1990, P NATL ACAD SCI USA, V87, P9226, DOI 10.1073/pnas.87.23.9226; YOON JK, 1994, MOL CELL BIOL, V14, P7731, DOI 10.1128/MCB.14.12.7731; YOSHIDA T, 1991, BIOCHEM BIOPH RES CO, V174, P934, DOI 10.1016/0006-291X(91)91508-A	65	264	273	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22201	22208		10.1074/jbc.273.35.22201	http://dx.doi.org/10.1074/jbc.273.35.22201			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712833	hybrid			2022-12-27	WOS:000075616600009
J	Brewster, NK; Johnston, GC; Singer, RA				Brewster, NK; Johnston, GC; Singer, RA			Characterization of the CP complex, an abundant dimer of Cdc68 and Pob3 proteins that regulates yeast transcriptional activation and chromatin repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; SHUTTLE VECTORS; NUCLEAR-PROTEIN; ESSENTIAL GENE; EXPRESSION; MUTATIONS; SUPPRESS; ENCODES; SPT5	The Cdc68 protein of the yeast Saccharomyces cerevisiae is an essential nuclear protein that has been shown to be necessary for the tl-ans-activation of many genes as well as for the maintenance of chromatin-mediated repression in the absence of trans-activation, These activities implicate, the Cdc68 protein in the regulation of chromatin structure and/or function, Here we report that Cdc68 is found in association with another essential nuclear protein, Pob3, in what we term the CP complex. This dimer of Cdc68 with Pob3 is stable to partial purification, so that the functions of gene activation and repression that are assigned to Cdc68 are likely to be properties of the CP complex. The CP complex is highly abundant, suggesting that it may be widespread throughout chromatin.	Dalhousie Univ, Dept Biochem, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Dept Med, Halifax, NS B3H 4H7, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Singer, RA (corresponding author), Dalhousie Univ, Dept Biochem, Halifax, NS B3H 4H7, Canada.	rasinger@is.dal.ca						BECKER DM, 1991, METHOD ENZYMOL, V194, P182; Bortvin A, 1996, SCIENCE, V272, P1473, DOI 10.1126/science.272.5267.1473; Chiang PW, 1996, GENOMICS, V38, P421, DOI 10.1006/geno.1996.0646; Chiang PW, 1996, GENOMICS, V34, P328, DOI 10.1006/geno.1996.0294; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; CLARKADAMS CD, 1988, GENE DEV, V2, P150, DOI 10.1101/gad.2.2.150; CLARKADAMS CD, 1987, MOL CELL BIOL, V7, P679, DOI 10.1128/MCB.7.2.679; DING HF, 1994, SCIENCE, V265, P796, DOI 10.1126/science.8047885; DRAPER MP, 1994, MOL CELL BIOL, V14, P4522, DOI 10.1128/MCB.14.7.4522; FASSLER JS, 1988, GENETICS, V118, P203; HAPPEL AM, 1991, GENETICS, V128, P69; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HIRSCHHORN JN, 1992, GENE DEV, V6, P2288, DOI 10.1101/gad.6.12a.2288; JIANG YW, 1995, GENETICS, V140, P103; Kingston RE, 1996, GENE DEV, V10, P905, DOI 10.1101/gad.10.8.905; KOERNER TJ, 1991, METHOD ENZYMOL, V194, P477; KOLODZIEJ PA, 1991, METHOD ENZYMOL, V194, P508; LYCAN D, 1994, MOL CELL BIOL, V14, P7455, DOI 10.1128/MCB.14.11.7455; MALONE EA, 1991, MOL CELL BIOL, V11, P5710, DOI 10.1128/MCB.11.11.5710; NEIGEBORN L, 1986, GENETICS, V112, P741; NEIGEBORN L, 1984, GENETICS, V108, P845; NEIGEBORN L, 1987, MOL CELL BIOL, V7, P672, DOI 10.1128/MCB.7.2.672; NISHIWAKI K, 1993, MOL GEN GENET, V239, P313, DOI 10.1007/BF00276929; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; PETERSON CL, 1991, CELL, V64, P1135, DOI 10.1016/0092-8674(91)90268-4; PETERSON CL, 1995, TRENDS BIOCHEM SCI, V20, P143, DOI 10.1016/S0968-0004(00)88990-2; PRELICH G, 1993, GENETICS, V135, P665; PTASHNE M, 1990, NATURE, V346, P329, DOI 10.1038/346329a0; ROWLEY A, 1991, MOL CELL BIOL, V11, P5718, DOI 10.1128/MCB.11.11.5718; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SIKORSKI RS, 1989, GENETICS, V122, P19; SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302; Stachora AA, 1997, FEBS LETT, V409, P74, DOI 10.1016/S0014-5793(97)00486-9; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SWANSON MS, 1991, MOL CELL BIOL, V11, P4286, DOI 10.1128/MCB.11.8.4286; SWANSON MS, 1991, MOL CELL BIOL, V11, P3009, DOI 10.1128/MCB.11.6.3009; SWANSON MS, 1992, GENETICS, V132, P325; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Winston, 1992, TRANSCRIPTIONAL REGU, P1271; WINSTON F, 1984, GENETICS, V107, P179; WINSTON F, 1992, TRENDS GENET, V8, P387, DOI 10.1016/0168-9525(92)90167-3; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; XU QL, 1995, MOL CELL BIOL, V15, P6025; XU QL, 1993, MOL CELL BIOL, V13, P7553, DOI 10.1128/MCB.13.12.7553	46	73	76	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21972	21979		10.1074/jbc.273.34.21972	http://dx.doi.org/10.1074/jbc.273.34.21972			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705338	hybrid			2022-12-27	WOS:000075492600072
J	Tabor, DE; Kim, JB; Spiegelman, BM; Edwards, PA				Tabor, DE; Kim, JB; Spiegelman, BM; Edwards, PA			Transcriptional activation of the stearoyl-CoA desaturase 2 gene by sterol regulatory element-binding protein/adipocyte determination and differentiation factor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FARNESYL DIPHOSPHATE SYNTHASE; MUTANT HAMSTER-CELLS; 3T3-L1 PREADIPOCYTES; FATTY-ACIDS; EXPRESSION; CHOLESTEROL; PROMOTER; PROTEIN; METABOLISM; MYC	To identify genes that are transcriptionally activated by sterol regulatory element-binding proteins (SREBPs), we utilized mRNA differential display and mutant cells that express either high car low levels of transcriptionally active SREBP. This approach identified stearoyl-CoA desaturase 2 (SCD2) as a new SREBP-regulated gene. Cells were transiently transfected with reporter genes blinder the control of different fragments of the mouse SCD2 promoter. Constructs containing >199 base pairs of the SCD2 proximal promoter were activated following incubation of cells in sterol-depleted medium or as a result of co-expression of SREBP-1a, SREBP-2, or rat adipocyte determination and differentiation factor 1 (ADD1). Electromobility shift assays and DNase I footprint analysis demonstrated that recombinant SREBP-1a hound to a novel cis element (5'-AGCAGATTGTG-3') in the proximal promoter of the SCD2 gene. The finding that the endogenous SCD2 mRNA Bevels were induced when wild-type Chinese hamster ovary fibroblasts were incubated in sterol-deficient medium is consistent with a role for SREBP in regulating transcription of the gene. These studies identify SCD2 as a new member of the family of genes that are transcriptionally regulated in response to changing levels of nuclear SREBP/ADD1. In addition, the sterol regulatory element in the SCD2 promoter is distinct from all previously characterized motifs that confer SREBP- and ADD1-dependent transcriptional activation.	Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Edwards, PA (corresponding author), Univ Calif Los Angeles, Dept Biol Chem, CHS 33-257, Los Angeles, CA 90095 USA.	pedwards@medicine.medsch.ucla.edu		KIM, Jae Bum/0000-0003-2337-6935	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 30568] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Athanikar JN, 1998, P NATL ACAD SCI USA, V95, P4935, DOI 10.1073/pnas.95.9.4935; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; CHIN J, 1982, BIOCHEMISTRY-US, V21, P3196, DOI 10.1021/bi00256a025; Ericsson J, 1996, P NATL ACAD SCI USA, V93, P945, DOI 10.1073/pnas.93.2.945; EVANS MJ, 1993, MOL CELL BIOL, V13, P5175, DOI 10.1128/MCB.13.9.5175; Guan GM, 1997, J BIOL CHEM, V272, P10295; HASAN MT, 1994, SOMAT CELL MOLEC GEN, V20, P183, DOI 10.1007/BF02254759; Jackson SM, 1996, J LIPID RES, V37, P1712; KAESTNER KH, 1989, J BIOL CHEM, V264, P14755; KIM JB, 1995, MOL CELL BIOL, V15, P2582; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Liang P, 1997, Methods Mol Biol, V85, P3; Magana MM, 1996, J BIOL CHEM, V271, P32689, DOI 10.1074/jbc.271.51.32689; Maniatis T., 1989, MOL CLONING LAB MANU; METHERALL JE, 1989, J BIOL CHEM, V264, P15634; MURRE C, 1994, BBA-GENE STRUCT EXPR, V1218, P129, DOI 10.1016/0167-4781(94)90001-9; NTAMBI JM, 1988, J BIOL CHEM, V263, P17291; NTAMBI JM, 1995, PROG LIPID RES, V34, P139, DOI 10.1016/0163-7827(94)00010-J; PANINI SR, 1990, J BIOL CHEM, V265, P14118; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; SCHNITZERPOLOKOFF R, 1983, ARCH BIOCHEM BIOPHYS, V227, P71, DOI 10.1016/0003-9861(83)90348-X; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; SPEAR DH, 1992, J BIOL CHEM, V267, P14462; Tabor DE, 1998, MAMM GENOME, V9, P341, DOI 10.1007/s003359900765; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; YANG JX, 1995, J BIOL CHEM, V270, P12152, DOI 10.1074/jbc.270.20.12152	32	93	94	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					22052	22058		10.1074/jbc.273.34.22052	http://dx.doi.org/10.1074/jbc.273.34.22052			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705348	hybrid, Green Published			2022-12-27	WOS:000075492600082
J	Ferreira, PA; Cai, YF; Schick, D; Roepman, R				Ferreira, PA; Cai, YF; Schick, D; Roepman, R			The cyclophilin-like domain mediates the association of ran-binding protein 2 with subunits of the 19 S regulatory complex of the proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; FUNCTIONAL-ANALYSIS; COUPLED RECEPTORS; VISUAL PIGMENTS; 26S PROTEASOME; HOMOLOG NINAA; CDNA CLONING; DROSOPHILA; TRANSPORT; RHODOPSIN	The combination of the Ran-binding domain 4 and cyclophilin domains of Ran-binding protein 2 selectively associate with a subset of G protein-coupled receptors, red/green opsins, upon cis-trans prolyl isomerase-dependent and direct modification of opsin followed by association of the modified opsin isoform to Ran-binding domain 4. This effect enhances in vivo the production of functional receptor and generates an opsin isoform with no propensity to self-aggregate in vitro. We now show that another domain of Ran-binding protein 2, cyclophilin-like domain, specifically associates with the 112-kDa subunit, P112, and other subunits of the 19 S regulatory complex of the 26 S proteasome in the neuroretina. This association possibly mediates Ran-binding protein 2 limited proteolysis into a smaller and stable isoform. Also, the interaction of Ran-binding protein 2 with P112 regulatory subunit of the 26 S proteasome involves still another protein, a putative kinesin-like protein. Our results indicate that Ran-binding protein 2 is a key component of a macro-assembly complex selectively linking protein biogenesis with the proteasome pathway and, thus, with potential implications for the presentation of misfolded and ubiquitin-like modified proteins to this proteolytic machinery.	Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Ferreira, PA (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	ferreira@post.its.mcw.edu	Roepman, Ronald/B-1339-2014; Ferreira, Paulo A/S-4209-2016; Ferreira, Paulo/A-3893-2008	Roepman, Ronald/0000-0002-5178-8163; Ferreira, Paulo A/0000-0003-4585-1717; 	NEI NIH HHS [R01 EY011993] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011993] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		APPLEBURY ML, 1994, SOC GEN PHY, V49, P235; Arbour NC, 1997, HUM MOL GENET, V6, P689, DOI 10.1093/hmg/6.5.689; Bargmann CI, 1997, CELL, V90, P585, DOI 10.1016/S0092-8674(00)80518-8; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; CHENG Y, 1995, SCIENCE, V267, P1807, DOI 10.1126/science.7534442; CLAPHAM DE, 1993, CELL, V75, P1237, DOI 10.1016/0092-8674(93)90609-T; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; COLLEY NJ, 1995, P NATL ACAD SCI USA, V92, P3070, DOI 10.1073/pnas.92.7.3070; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; DEMARTINO GN, 1994, J BIOL CHEM, V269, P20878; FERREIRA PA, 1995, J BIOL CHEM, V270, P23179, DOI 10.1074/jbc.270.39.23179; Ferreira PA, 1996, NATURE, V383, P637, DOI 10.1038/383637a0; Ferreira PA, 1997, P NATL ACAD SCI USA, V94, P1556, DOI 10.1073/pnas.94.4.1556; FUCHS S, 1995, NAT GENET, V10, P360, DOI 10.1038/ng0795-360; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; GUDERMANN T, 1995, J MOL MED, V73, P51, DOI 10.1007/BF00270578; HARGRAVE PA, 1993, BIOESSAYS, V15, P43, DOI 10.1002/bies.950150107; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; KADOWAKI T, 1993, EMBO J, V12, P2929, DOI 10.1002/j.1460-2075.1993.tb05955.x; LARRIVEE DC, 1981, J GEN PHYSIOL, V78, P521, DOI 10.1085/jgp.78.5.521; Leverson JD, 1998, MOL CELL, V1, P203, DOI 10.1016/S1097-2765(00)80021-0; Li TS, 1996, P NATL ACAD SCI USA, V93, P14176, DOI 10.1073/pnas.93.24.14176; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; MANUTIS M, 1997, J CELL BIOL, V135, P1457; MOLDAY RS, 1987, J CELL BIOL, V105, P2589, DOI 10.1083/jcb.105.6.2589; Nehrbass U, 1996, SCIENCE, V272, P120, DOI 10.1126/science.272.5258.120; Nothwang HG, 1998, GENOMICS, V47, P383, DOI 10.1006/geno.1997.5119; Ohno M, 1998, CELL, V92, P327, DOI 10.1016/S0092-8674(00)80926-5; OKANO T, 1992, P NATL ACAD SCI USA, V89, P5932, DOI 10.1073/pnas.89.13.5932; PAK WL, 1986, PHOTOBIOCH PHOTOBIOP, V13, P229; PAK WL, 1995, INVEST OPHTH VIS SCI, V36, P2340; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; REN MD, 1995, MOL CELL BIOL, V15, P2117; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rush MG, 1996, BIOESSAYS, V18, P103, DOI 10.1002/bies.950180206; Saitoh H, 1997, P NATL ACAD SCI USA, V94, P3736, DOI 10.1073/pnas.94.8.3736; SAVARESE TM, 1992, BIOCHEM J, V283, P1; SCHLENSTEDT G, 1995, P NATL ACAD SCI USA, V92, P225, DOI 10.1073/pnas.92.1.225; SCHNEUWLY S, 1989, P NATL ACAD SCI USA, V86, P5390, DOI 10.1073/pnas.86.14.5390; SHIEH BH, 1989, NATURE, V338, P67, DOI 10.1038/338067a0; STAMNES MA, 1991, CELL, V65, P219, DOI 10.1016/0092-8674(91)90156-S; STEPHENSON RS, 1983, BIOL PHOTORECEPTION, P447; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Tsurumi C, 1996, EUR J BIOCHEM, V239, P912, DOI 10.1111/j.1432-1033.1996.0912u.x; Vallee RB, 1996, SCIENCE, V271, P1539, DOI 10.1126/science.271.5255.1539; WILKEN N, 1995, EUR J CELL BIOL, V68, P211; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yamamoto S, 1997, NAT GENET, V15, P175, DOI 10.1038/ng0297-175; Yokota K, 1996, MOL BIOL CELL, V7, P853, DOI 10.1091/mbc.7.6.853; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0; 1996, NATURE S, V384, P5	56	19	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24676	24682		10.1074/jbc.273.38.24676	http://dx.doi.org/10.1074/jbc.273.38.24676			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733766	Green Published, hybrid			2022-12-27	WOS:000076007300058
J	Wang, PY; Kitchens, RL; Munford, RS				Wang, PY; Kitchens, RL; Munford, RS			Phosphatidylinositides bind to plasma membrane CD14 and can prevent monocyte activation by bacterial lipopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID-COMPOSITION; FATTY-ACID; PROTEIN; RECEPTOR; LPS; LIPOPROTEIN; MACROPHAGES; METABOLISM; LIPOSOMES	Although bacterial lipopolysaccharides (LPS) and several other microbial agonists can bind to mCD14 (membrane CD14), a cell-surface receptor found principally on monocytes and neutrophils, host-derived mCD14 ligands are poorly defined. We report here that phosphatidylinositol (PtdIns), phosphatidylinositol-4-phosphate, and other phosphatidylinositides can bind to mCD14. Phosphatidylserine (PS), another anionic glycerophospholipid, binds to mCD14 with lower apparent affinity than does PtdIns. LPS-binding protein, a lipid transfer protein found in serum, facilitates both PS- and PtdIns-mCD14 binding. PtdIns binding to mCD14 can be blocked by anti-CD14 monoclonal antibodies that inhibit LPS-mCD14 binding, and PtdIns can inhibit both LPS-mCD14 binding and LPS-induced responses in monocytes. Serum-equilibrated PtdIns also binds to mCD14-expressing cells, raising the possibility that endogenous PtdIns may modulate cellular responses to LPS and other mCD14 ligands in vivo.	Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Microbiol, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Cell Regulat Grad Program, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Munford, RS (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.	rmunf1@mednet.swmed.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018188, R37AI018188, R56AI018188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR041940] Funding Source: NIH RePORTER; NIAID NIH HHS [AI18188] Funding Source: Medline; NIAMS NIH HHS [AR41940] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BAGDADE JD, 1995, ATHEROSCLEROSIS, V117, P209, DOI 10.1016/0021-9150(95)05573-F; BRADAMANTE S, 1990, ANAL BIOCHEM, V185, P299, DOI 10.1016/0003-2697(90)90297-M; BRECKENRIDGE WC, 1982, BIOCHIM BIOPHYS ACTA, V712, P707, DOI 10.1016/0005-2760(82)90302-2; CUNNANE SC, 1989, AM J CLIN NUTR, V50, P801, DOI 10.1093/ajcn/50.4.801; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; Dziarski R, 1998, J BIOL CHEM, V273, P8680, DOI 10.1074/jbc.273.15.8680; KIRKLAND TN, 1993, J BIOL CHEM, V268, P24818; Kitchens RL, 1998, J IMMUNOL, V160, P1920; KITCHENS RL, 1995, J BIOL CHEM, V270, P9904, DOI 10.1074/jbc.270.17.9904; KITCHENS RL, 1992, J EXP MED, V176, P485, DOI 10.1084/jem.176.2.485; KITCHENS RL, 1998, ENDOTOXIN HLTH DIS; MUNFORD RS, 1992, J IMMUNOL METHODS, V148, P115, DOI 10.1016/0022-1759(92)90164-O; Murao K, 1997, J BIOL CHEM, V272, P17551, DOI 10.1074/jbc.272.28.17551; NISHIKAWA K, 1990, J BIOL CHEM, V265, P5226; OTTERLEI M, 1993, INFECT IMMUN, V61, P1917, DOI 10.1128/IAI.61.5.1917-1925.1993; Pradhan D, 1997, MOL BIOL CELL, V8, P767, DOI 10.1091/mbc.8.5.767; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; SATTA N, 1994, J IMMUNOL, V153, P3245; Savedra R, 1996, J IMMUNOL, V157, P2549; Savill J, 1998, NATURE, V392, P442, DOI 10.1038/33025; Schromm AB, 1996, FEBS LETT, V399, P267, DOI 10.1016/S0014-5793(96)01338-5; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; SCHWENDENER RA, 1984, BIOCHIM BIOPHYS ACTA, V772, P93, DOI 10.1016/0005-2736(84)90521-2; Sellati TJ, 1998, J IMMUNOL, V160, P5455; TOBIAS PS, 1993, J IMMUNOL, V150, P3011; Tobias PS, 1992, J CELL BIOCHEM, V16C, P151; WADEE AA, 1983, J IMMUNOL, V130, P2271; WASSEF NM, 1984, P NATL ACAD SCI-BIOL, V81, P2655, DOI 10.1073/pnas.81.9.2655; WATALA C, 1990, CLIN CHIM ACTA, V188, P211, DOI 10.1016/0009-8981(90)90202-4; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wurfel MM, 1997, J EXP MED, V186, P2051, DOI 10.1084/jem.186.12.2051; Wurfel MM, 1997, J IMMUNOL, V158, P3925; WURFEL MM, 1994, J EXP MED, V180, P1025, DOI 10.1084/jem.180.3.1025; Yu B, 1997, J CLIN INVEST, V99, P315, DOI 10.1172/JCI119160; Yu WG, 1998, AM J PATHOL, V152, P759; ZOELLER RA, 1987, J BIOL CHEM, V262, P17212	36	75	79	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24309	24313		10.1074/jbc.273.38.24309	http://dx.doi.org/10.1074/jbc.273.38.24309			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733716	hybrid			2022-12-27	WOS:000076007300008
J	Patrick, GN; Zhou, PB; Kwon, YT; Howley, PM; Tsai, LH				Patrick, GN; Zhou, PB; Kwon, YT; Howley, PM; Tsai, LH			p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRAIN-SPECIFIC ACTIVATOR; PROTEIN-KINASE; REGULATORY SUBUNIT; MICROBIAL METABOLITE; NEUROBLASTOMA-CELLS; CRYSTAL-STRUCTURE; NERVOUS-SYSTEM; INHIBITION; EXPRESSION; DIFFERENTIATION	Cyclin-dependent kinase 5 (Cdk5) was originally isolated by its close homology to the human CDC2 gene, which is a key regulator of cell cycle progression. However, unlike other Cdks, the activity of Cdk5 is required in post-mitotic neurons. The neuronal-specific p35 protein, which shares no homology to cyclins, was identified by virtue of its association and activation of Cdk5, Gene targeting studies in mice have shown that the p35/Cdk5 kinase is required for the proper neuronal migration and development of the mammalian cortex, We have investigated the regulation of the p35/Cdk5 kinase, Here we show that p35, the activator of Cdk5, is a short-lived protein with a half-life (t(1/2)) of 20 to 30 min. Specific proteasome inhibitors such as lactacystin greatly stabilize p35 in vivo, Ubiquitination of p35 can be readily demonstrated in vitro and in vivo. Inhibition of Cdk5 activity by a specific Cdk inhibitor, roscovitine, or by overexpression of a dominant negative mutant of Cdk5 increases the stability of p35 by 2- to 3-fold. Furthermore, phosphorylation mutants of p35 also stabilize p35 2- to 3-fold. Together, these observations demonstrate that the p35/Cdk5 kinase can be subject to rapid turnover in vivo and suggest that phosphorylation of p35 upon Cdk5 kinase activation plays a autoregulatory role in p35 degradation mediated by ubiquitin-mediated proteolysis.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Patrick, GN (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol, 200 Longwood Ave, Boston, MA 02115 USA.	gpatrick@fas.harvard.edu		Howley, Peter/0000-0002-8668-9579	NCI NIH HHS [R01-CA 64888-3] Funding Source: Medline; NIGMS NIH HHS [GM53049] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA064888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053049] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; BEAUDETTE KN, 1993, J BIOL CHEM, V268, P20825; Bogyo M, 1997, P NATL ACAD SCI USA, V94, P6629, DOI 10.1073/pnas.94.13.6629; BROWN NR, 1995, STRUCTURE, V3, P1235, DOI 10.1016/S0969-2126(01)00259-3; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; Delalle I, 1997, J NEUROCYTOL, V26, P283, DOI 10.1023/A:1018500617374; ELLISON MJ, 1991, J BIOL CHEM, V266, P21150; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; HELLMICH MR, 1992, P NATL ACAD SCI USA, V89, P10867, DOI 10.1073/pnas.89.22.10867; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; ISHIGURO K, 1994, FEBS LETT, V342, P203, DOI 10.1016/0014-5793(94)80501-6; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; Kwon YT, 1998, J COMP NEUROL, V395, P510, DOI 10.1002/(SICI)1096-9861(19980615)395:4<510::AID-CNE7>3.0.CO;2-4; Lee KY, 1997, INT J BIOCHEM CELL B, V29, P951, DOI 10.1016/S1357-2725(97)00048-4; Lee MH, 1996, P NATL ACAD SCI USA, V93, P3259, DOI 10.1073/pnas.93.8.3259; LEW J, 1992, J BIOL CHEM, V267, P25922; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; LUSKIN MB, 1985, J COMP NEUROL, V242, P611, DOI 10.1002/cne.902420409; Maki CG, 1996, CANCER RES, V56, P2649; Maki CG, 1997, MOL CELL BIOL, V17, P355, DOI 10.1128/MCB.17.1.355; Matsubara M, 1996, J BIOL CHEM, V271, P21108, DOI 10.1074/jbc.271.35.21108; MEHDI S, 1991, TRENDS BIOCHEM SCI, V16, P150, DOI 10.1016/0968-0004(91)90058-4; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; OMURA S, 1991, J ANTIBIOT, V44, P117, DOI 10.7164/antibiotics.44.117; OMURA S, 1991, J ANTIBIOT, V44, P113, DOI 10.7164/antibiotics.44.113; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Philpott A, 1997, GENE DEV, V11, P1409, DOI 10.1101/gad.11.11.1409; Poon RYC, 1997, J BIOL CHEM, V272, P5703, DOI 10.1074/jbc.272.9.5703; Sheaff RJ, 1996, CHEM BIOL, V3, P869, DOI 10.1016/S1074-5521(96)90174-X; Shuang RQ, 1998, J BIOL CHEM, V273, P4957, DOI 10.1074/jbc.273.9.4957; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Tang DM, 1997, J BIOL CHEM, V272, P12318, DOI 10.1074/jbc.272.19.12318; Tomizawa K, 1996, NEUROSCIENCE, V74, P519, DOI 10.1016/0306-4522(96)00136-4; TSAI LH, 1993, DEVELOPMENT, V119, P1029; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; XIONG Y, 1992, CELL, V71, P505, DOI 10.1016/0092-8674(92)90518-H	45	253	262	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24057	24064		10.1074/jbc.273.37.24057	http://dx.doi.org/10.1074/jbc.273.37.24057			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727024	hybrid			2022-12-27	WOS:000075893100065
J	Greenberg, JR; Phan, L; Gu, ZY; deSilva, A; Apolito, C; Sherman, F; Hinnebusch, AG; Goldfarb, DS				Greenberg, JR; Phan, L; Gu, ZY; deSilva, A; Apolito, C; Sherman, F; Hinnebusch, AG; Goldfarb, DS			Nip1p associates with 40 S ribosomes and the Prt1p subunit of eukaryotic initiation factor 3 and is required for efficient translation initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SYNTHESIS INITIATION; INTACT YEAST-CELLS; STEM-LOOP MUTATION; SACCHAROMYCES-CEREVISIAE; BINDING-PROTEIN; RNA-BINDING; AMINOGLYCOSIDE ANTIBIOTICS; INTERNAL INITIATION; COMPLEX-FORMATION; SHUTTLE VECTORS	Nip1p is an essential Saccharomyces cerevisiae protein that was identified in a screen for temperature conditional (ts) mutants exhibiting defects in nuclear transport. New results indicate that Nip1p has a primary role in translation initiation. Polysome profiles indicate that cells depleted of Nip1p and nip1-1 cells are defective in translation initiation, a conclusion that is supported by a reduced rate of protein synthesis in Nip1p-depleted cells. Nip1p cosediments with free 40 S ribosomal subunits and polysomal preinitiation complexes, but not with free or elongating 80 S ribosomes or 60 S subunits. Nip1p can be isolated in an about 670-kDa complex containing polyhistidine-tagged Prt1p, a subunit of translation initiation factor 3, by binding to Ni2+-NTA-agarose beads in a manner completely dependent on the tagged form of Prt1p. The nip1-1 ts growth defect was suppressed by the deletion of the ribosomal protein, RPL46. Also, nip1-1 mutant cells are hypersensitive to paromomycin. These results suggest that Nip1p is a subunit of eukaryotic initiation factor 3 required for efficient translation initiation.	Univ Rochester, Dept Biol, Rochester, NY 14627 USA; NICHD, Lab Eukaryot Gene Regulat, NIH, Bethesda, MD 20892 USA; Univ Rochester, Sch Med, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Rochester	Goldfarb, DS (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	dasg@uhura.cc.rochester.edu			NIGMS NIH HHS [R01 GM12702] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM012702] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLROBYN JA, 1990, MOL CELL BIOL, V10, P6544, DOI 10.1128/MCB.10.12.6544; Asano K, 1998, J BIOL CHEM, V273, P18573, DOI 10.1074/jbc.273.29.18573; Asano K, 1997, J BIOL CHEM, V272, P1101, DOI 10.1074/jbc.272.2.1101; Asano K, 1997, J BIOL CHEM, V272, P23477, DOI 10.1074/jbc.272.38.23477; Asano K, 1997, J BIOL CHEM, V272, P27042, DOI 10.1074/jbc.272.43.27042; BENNE R, 1978, J BIOL CHEM, V253, P3078; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAKRABARTI A, 1991, J BIOL CHEM, V266, P14039; CHERNOFF YO, 1994, EMBO J, V13, P906, DOI 10.1002/j.1460-2075.1994.tb06334.x; CIGAN AM, 1991, MOL CELL BIOL, V11, P3217, DOI 10.1128/MCB.11.6.3217; CIGAN AM, 1989, P NATL ACAD SCI USA, V86, P2784, DOI 10.1073/pnas.86.8.2784; DANAIE P, 1995, J BIOL CHEM, V270, P4288, DOI 10.1074/jbc.270.9.4288; DEVER TE, 1995, MOL CELL BIOL, V15, P6351; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DONAHUE TF, 1988, CELL, V54, P621, DOI 10.1016/S0092-8674(88)80006-0; FOIANI M, 1991, MOL CELL BIOL, V11, P3203, DOI 10.1128/MCB.11.6.3203; FROLOVA L, 1994, NATURE, V372, P701, DOI 10.1038/372701a0; Gale E.F., 1981, MOL BASIS ANTIBIOTIC, Vsecond; GARCIABARRIO MT, 1995, GENE DEV, V9, P1781, DOI 10.1101/gad.9.14.1781; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GU Z, 1995, THESIS U ROCHESTER R; GU ZY, 1992, P NATL ACAD SCI USA, V89, P10355, DOI 10.1073/pnas.89.21.10355; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; GULYAS KD, 1992, CELL, V69, P1031, DOI 10.1016/0092-8674(92)90621-I; HANICJOYCE PJ, 1987, J BIOL CHEM, V262, P2845; HERSHEY JWB, 1996, POSTTRANSCRIPTIONAL; Huang HK, 1997, GENE DEV, V11, P2396, DOI 10.1101/gad.11.18.2396; IIZUKA N, 1994, MOL CELL BIOL, V14, P7322, DOI 10.1128/MCB.14.11.7322; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JACKSON RJ, 1994, MOL BIOL REP, V19, P147, DOI 10.1007/BF00986957; KANG HA, 1994, J BIOL CHEM, V269, P3934; KASPERAITIS MAM, 1995, FEBS LETT, V365, P47, DOI 10.1016/0014-5793(95)00427-B; LEE WC, 1989, P NATL ACAD SCI USA, V86, P8808, DOI 10.1073/pnas.86.22.8808; LEE WC, 1991, J CELL BIOL, V113, P1, DOI 10.1083/jcb.113.1.1; LEER RJ, 1985, NUCLEIC ACIDS RES, V13, P701, DOI 10.1093/nar/13.3.701; Merrick WC., 1996, TRANSLATION CONTROL, P31; Methot N, 1997, J BIOL CHEM, V272, P1110, DOI 10.1074/jbc.272.2.1110; NARANDA T, 1994, J BIOL CHEM, V269, P32286; Naranda T, 1996, MOL CELL BIOL, V16, P2307; Naranda T, 1997, MOL CELL BIOL, V17, P145, DOI 10.1128/MCB.17.1.145; PALMER E, 1979, NATURE, V277, P148, DOI 10.1038/277148a0; PARK EC, 1992, P NATL ACAD SCI USA, V89, P1249, DOI 10.1073/pnas.89.4.1249; PETERSON DT, 1979, J BIOL CHEM, V254, P7730; PHAN L, 1998, IN PRESS MOL CELL BI, V18; PUROHIT P, 1994, NATURE, V370, P659, DOI 10.1038/370659a0; RAYCHAUDHURI P, 1985, J BIOL CHEM, V260, P2140; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; SACHS AB, 1990, SCIENCE, V247, P1077, DOI 10.1126/science.2408148; SACHS AB, 1989, CELL, V58, P857, DOI 10.1016/0092-8674(89)90938-0; SHERMAN F, 1987, METHODS YEAST GENETI; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SHIINA N, 1994, SCIENCE, V266, P282, DOI 10.1126/science.7939665; SIKORSKI RS, 1989, GENETICS, V122, P19; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; TRACHSEL H, 1978, P NATL ACAD SCI USA, V75, P204, DOI 10.1073/pnas.75.1.204; Verlhac MH, 1997, EMBO J, V16, P6812, DOI 10.1093/emboj/16.22.6812; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WAKEM LP, 1990, GENETICS, V124, P515; YANG F, 1990, NATURE, V347, P494, DOI 10.1038/347494a0; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; YOON H, 1992, GENE DEV, V6, P2463, DOI 10.1101/gad.6.12b.2463; YOON HJ, 1992, MOL CELL BIOL, V12, P248, DOI 10.1128/MCB.12.1.248; Zanchin NIT, 1997, MOL CELL BIOL, V17, P5001, DOI 10.1128/MCB.17.9.5001; ZHONG T, 1993, CELL, V73, P1175, DOI 10.1016/0092-8674(93)90646-8; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	67	17	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23485	23494		10.1074/jbc.273.36.23485	http://dx.doi.org/10.1074/jbc.273.36.23485			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722586	Green Submitted, hybrid			2022-12-27	WOS:000075778100086
J	Juckett, M; Zheng, YH; Yuan, H; Pastor, T; Antholine, W; Weber, M; Vercellotti, G				Juckett, M; Zheng, YH; Yuan, H; Pastor, T; Antholine, W; Weber, M; Vercellotti, G			Heme and the endothelium - Effects of nitric oxide on catalytic iron and heme degradation by heme oxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPEROXIDE-DEPENDENT FORMATION; ELEMENT-BINDING PROTEIN; FERRITIN MESSENGER-RNA; HUMAN SKIN FIBROBLASTS; RESPONSIVE-ELEMENT; OXIDATIVE STRESS; ACTIVATED MACROPHAGES; HYDROXYL RADICALS; REGULATORY FACTOR; CYTO-TOXICITY	We studied the effects of nitric oxide (NO) on the control of excess cellular heme and release of catalytically active iron. Endothelial cells (ECs) exposed to hemin followed by a NO donor have a ferritin content that is 16% that of cells exposed to hemin alone. Hemin-treated ECs experience a 3.5-fold rise in non-heme, catalytic iron 2 h later, but a hemin rechallenge 20 h later results in only a 24% increase. The addition of a NO donor after the first hemin exposure prevents this adaptive response, presumably due to effects on ferritin synthesis. NO donors were found to reduce iron release from hemin, while hemin accumulated in cells. A NO donor, in a dose-dependent fashion, inhibited heme oxygenase activity, measured by bilirubin production. Using low temperature EPR spectroscopy, heme oxygenase inhibition correlated with nitrosylation of free heme in microsomes, Nitrosylation of cellular heme prevented iron release, for while there was heme oxygenase-dependent release of iron in cells incubated with hemin for 24 h, the addition of a NO donor blocked iron release. This indicates that NO readily nitrosylates intracellular free heme and prevents its degradation by heme oxygenase. Nitrosylation of heme was found to reduce sensitization of cells to oxidative injury.	Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Biophys Res Inst, Milwaukee, WI 53226 USA; Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	Medical College of Wisconsin; Medical College of Wisconsin; University of Minnesota System; University of Minnesota Twin Cities	Juckett, M (corresponding author), Froedtert E, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.				NATIONAL CANCER INSTITUTE [K08CA068102] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001008] Funding Source: NIH RePORTER; NCI NIH HHS [CA68102] Funding Source: Medline; NCRR NIH HHS [RR01008] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ABRAHAM NG, 1995, P NATL ACAD SCI USA, V92, P6798, DOI 10.1073/pnas.92.15.6798; BALLA G, 1991, ARTERIOSCLER THROMB, V11, P1700, DOI 10.1161/01.ATV.11.6.1700; BALLA G, 1991, LAB INVEST, V64, P648; BALLA G, 1992, J BIOL CHEM, V267, P18148; BALLA J, 1995, AM J PHYSIOL-LUNG C, V268, pL321, DOI 10.1152/ajplung.1995.268.2.L321; BALLA J, 1993, P NATL ACAD SCI USA, V90, P9285, DOI 10.1073/pnas.90.20.9285; BASTIAN NR, 1994, J BIOL CHEM, V269, P5127; Berger TM, 1997, J BIOL CHEM, V272, P15656, DOI 10.1074/jbc.272.25.15656; CANTONI L, 1981, INT J BIOCHEM, V13, P823, DOI 10.1016/0020-711X(81)90102-6; DOCHERTY JC, 1984, ARCH BIOCHEM BIOPHYS, V235, P657, DOI 10.1016/0003-9861(84)90241-8; DRAPIER JC, 1993, EMBO J, V12, P3643, DOI 10.1002/j.1460-2075.1993.tb06038.x; DRAPIER JC, 1988, J IMMUNOL, V140, P2829; DRAPIER JC, 1986, J CLIN INVEST, V78, P790, DOI 10.1172/JCI112642; EISENSTEIN RS, 1991, P NATL ACAD SCI USA, V88, P688, DOI 10.1073/pnas.88.3.688; GORBUNOV NV, 1995, BIOCHEMISTRY-US, V34, P6689, DOI 10.1021/bi00020a014; Gorbunov NV, 1997, J BIOL CHEM, V272, P12328, DOI 10.1074/jbc.272.19.12328; GRAY NK, 1993, EUR J BIOCHEM, V218, P657, DOI 10.1111/j.1432-1033.1993.tb18420.x; GUTTERIDGE JMC, 1982, BIOCHEM J, V206, P605, DOI 10.1042/bj2060605; GUTTERIDGE JMC, 1981, BIOCHEM J, V199, P263, DOI 10.1042/bj1990263; Gutteridge JMC, 1996, BIOCHEM BIOPH RES CO, V229, P806, DOI 10.1006/bbrc.1996.1884; HAILE DJ, 1990, J BIOL CHEM, V265, P12786; HENRY Y, 1991, EUR BIOPHYS J, V20, P1; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; HIBBS JB, 1984, BIOCHEM BIOPH RES CO, V123, P716, DOI 10.1016/0006-291X(84)90288-2; JUCKETT MB, 1995, AM J PATHOL, V147, P782; Juckett MB, 1996, FREE RADICAL BIO MED, V20, P63, DOI 10.1016/0891-5849(95)02024-1; KANNER J, 1991, ARCH BIOCHEM BIOPHYS, V289, P130, DOI 10.1016/0003-9861(91)90452-O; Keefer LK, 1996, METHOD ENZYMOL, V268, P281; KENNEDY MC, 1993, BIOCHEM BIOPH RES CO, V196, P632, DOI 10.1006/bbrc.1993.2296; Kharitonov VG, 1997, BIOCHEMISTRY-US, V36, P6814, DOI 10.1021/bi970201o; KHATSENKO OG, 1993, P NATL ACAD SCI USA, V90, P11147, DOI 10.1073/pnas.90.23.11147; KIM YM, 1995, J BIOL CHEM, V270, P5710, DOI 10.1074/jbc.270.11.5710; Kurata S, 1996, J BIOCHEM-TOKYO, V120, P49; KUROSS SA, 1988, BLOOD, V71, P876; Liu XP, 1998, P NATL ACAD SCI USA, V95, P2175, DOI 10.1073/pnas.95.5.2175; MOORADIAN DL, 1995, J CARDIOVASC PHARM, V25, P674, DOI 10.1097/00005344-199504000-00023; Motterlini R, 1996, AM J PHYSIOL-HEART C, V270, pH107, DOI 10.1152/ajpheart.1996.270.1.H107; MULSCH A, 1993, BIOCHEM BIOPH RES CO, V196, P1303, DOI 10.1006/bbrc.1993.2394; Mumby S, 1997, INTENS CARE MED, V23, P635, DOI 10.1007/s001340050386; Nakano R, 1996, J BIOL CHEM, V271, P8570, DOI 10.1074/jbc.271.15.8570; PALLER MS, 1994, P NATL ACAD SCI USA, V91, P7002, DOI 10.1073/pnas.91.15.7002; PANTOPOULOS K, 1995, P NATL ACAD SCI USA, V92, P1267, DOI 10.1073/pnas.92.5.1267; PHILPOTT CC, 1994, P NATL ACAD SCI USA, V91, P7321, DOI 10.1073/pnas.91.15.7321; Ponka P, 1997, BLOOD, V89, P1; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; ROUAULT TA, 1988, SCIENCE, V241, P1207, DOI 10.1126/science.3413484; SCHAEFER WH, 1985, BIOCHEMISTRY-US, V24, P3254, DOI 10.1021/bi00334a027; Sergent O, 1997, HEPATOLOGY, V25, P122, DOI 10.1002/hep.510250123; SUN J, 1993, BIOCHEMISTRY-US, V32, P14151, DOI 10.1021/bi00214a012; Takahashi K, 1996, J NEUROCHEM, V67, P482; VILE GF, 1994, P NATL ACAD SCI USA, V91, P2607, DOI 10.1073/pnas.91.7.2607; VILE GF, 1993, J BIOL CHEM, V268, P14678; WEISS G, 1993, EMBO J, V12, P3651, DOI 10.1002/j.1460-2075.1993.tb06039.x; WHARTON M, 1988, J IMMUNOL, V141, P1311; WILLIS D, 1995, BIOCHEM BIOPH RES CO, V214, P1152, DOI 10.1006/bbrc.1995.2406; Yee EL, 1996, AM J PHYSIOL-LUNG C, V271, pL512, DOI 10.1152/ajplung.1996.271.4.L512	56	67	69	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23388	23397		10.1074/jbc.273.36.23388	http://dx.doi.org/10.1074/jbc.273.36.23388			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722574	hybrid			2022-12-27	WOS:000075778100074
J	Kachel, K; Ren, JH; Collier, RJ; London, E				Kachel, K; Ren, JH; Collier, RJ; London, E			Identifying transmembrane states and defining the membrane insertion boundaries of hydrophobic helices in membrane-inserted diphtheria toxin T domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER DISTANCE MEASUREMENTS; CRYSTAL-STRUCTURE; REFINED STRUCTURE; COLICIN-A; FLUORESCENCE; CHANNELS; VESICLES; RESOLUTION; DEPENDENCE; RESIDUE	The membrane topography of proteins that convert between soluble and membrane-inserted states has proven a challenging problem. In particular, it has been difficult to define both whether a transmembrane orientation is achieved and what are the boundaries of membrane-inserted segments. In this report the fluorescence of bimane-labeled Cys residues and the binding of antibodies antibodies to BODIPY-labeled Cys residues are combined to define these features for helices THS and TH9 of the T domain of diphtheria toxin, Using a series of labeled residues the topography of these helices was examined in both conformations of membrane-inserted T domain identified previously (Wang, Y., Malenbaum, S. E., Kachel, K., Zhan, H., Collier, R. J., and London, E. (1997) J. Biol Chem, 272, 25091-25098). In the shallowly inserted conformation these helices are found to be aligned close to the cis surface of the bilayer all along their sequences. In contrast, in the more deeply inserted conformation most TH8 and TH9 residues examined located in a non-polar environment, with the boundaries of the membrane-inserted sequences close to residues 324 and 372-374 on the cia (insertion) side of the bilayer, It was also found that residues 348 and 349, which are in the loop connecting TH8 and TH9, reached the opposite trans side of the bilayer, but did not protrude fully into the aqueous environment. These boundaries suggest the membrane-inserted segments of TH8 and TH9 form transmembrane helices about 25 residues in length, and suggest that they are connected by a tight turn. It is concluded that this combination of fluorescent techniques can be combined to obtain transmembrane helix topography.	SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Harvard University; Harvard Medical School	London, E (corresponding author), SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA.				NIAID NIH HHS [AI22021] Funding Source: Medline; NIGMS NIH HHS [GM31986] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022021, R37AI022021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031986] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bell CE, 1997, BIOCHEMISTRY-US, V36, P481, DOI 10.1021/bi962214s; BENNETT MJ, 1994, PROTEIN SCI, V3, P1464, DOI 10.1002/pro.5560030912; BENNETT MJ, 1994, PROTEIN SCI, V3, P1444, DOI 10.1002/pro.5560030911; Benson EL, 1998, BIOCHEMISTRY-US, V37, P3941, DOI 10.1021/bi972657b; CABIAUX V, 1994, MOL MICROBIOL, V11, P43, DOI 10.1111/j.1365-2958.1994.tb00288.x; CHATTOPADHYAY A, 1987, BIOCHEMISTRY-US, V26, P39, DOI 10.1021/bi00375a006; CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; CHUNG LA, 1992, BIOCHEMISTRY-US, V31, P6608, DOI 10.1021/bi00143a035; COLLIER RJ, 1982, ADP RIBOSYLATION REA, P573; GREENFIELD L, 1983, P NATL ACAD SCI-BIOL, V80, P6853, DOI 10.1073/pnas.80.22.6853; Huynh PD, 1997, J GEN PHYSIOL, V110, P229, DOI 10.1085/jgp.110.3.229; KAISER R, 1998, IN PRESS BIOCH BIOPH; LADOKHIN AS, 1993, BIOCHEMISTRY-US, V32, P6951, DOI 10.1021/bi00078a020; LAKEY JH, 1993, J MOL BIOL, V230, P1055, DOI 10.1006/jmbi.1993.1218; LAKEY JH, 1991, J MOL BIOL, V218, P639, DOI 10.1016/0022-2836(91)90707-D; LONDON E, 1992, BIOCHIM BIOPHYS ACTA, V1113, P25, DOI 10.1016/0304-4157(92)90033-7; LONDON E, 1998, MEMBRANE PROTEIN TRA, P201; MALENBAUM SE, 1998, IN PRESS J NATURAL T; MINDELL JA, 1994, J MEMBRANE BIOL, V137, P45; MINDELL JA, 1994, J MEMBRANE BIOL, V137, P29; MINDELL JA, 1994, P NATL ACAD SCI USA, V91, P5272, DOI 10.1073/pnas.91.12.5272; MINDELL JA, 1992, BIOPHYS J, V62, P41, DOI 10.1016/S0006-3495(92)81772-1; Oh KJ, 1996, SCIENCE, V273, P810, DOI 10.1126/science.273.5276.810; SILVERMAN JA, 1994, J MEMBRANE BIOL, V137, P17; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Taylor KMP, 1996, BBA-BIOMEMBRANES, V1278, P35, DOI 10.1016/0005-2736(95)00195-6; TORTORELLA D, 1995, J BIOL CHEM, V270, P27446, DOI 10.1074/jbc.270.46.27446; Wang Y, 1997, J BIOL CHEM, V272, P25091, DOI 10.1074/jbc.272.40.25091; WEINER M, 1992, BIOPHYS J, V61, P437; ZHAN HJ, 1994, BIOCHEMISTRY-US, V33, P11254, DOI 10.1021/bi00203a022; ZHAN HJ, 1995, BIOCHEMISTRY-US, V34, P4856, DOI 10.1021/bi00014a043	31	49	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					22950	22956		10.1074/jbc.273.36.22950	http://dx.doi.org/10.1074/jbc.273.36.22950			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722516	hybrid			2022-12-27	WOS:000075778100016
J	Pham, PT; Olson, MW; McHenry, CS; Schaaper, RM				Pham, PT; Olson, MW; McHenry, CS; Schaaper, RM			The base substitution and frameshift fidelity of Escherichia coli DNA polymerase III holoenzyme in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COORDINATED LEADING-STRAND; SPONTANEOUS MUTATION; MISMATCH REPAIR; NUCLEOTIDE MISINCORPORATION; REPLICATION FORK; EPSILON-SUBUNIT; BETA-SUBUNIT; MUTAGENESIS; EXONUCLEASE; COMPLEX	We have investigated the in vitro fidelity of Escherichia coli DNA polymerase III holoenzyme from a wildtype and a proofreading-impaired mutD5 strain. Exonuclease assays showed the mutD5 holoenzyme to have a 30-50-fold reduced 3'-->5'-exonuclease activity. Fidelity was assayed during gap-filling synthesis across the lacI(d) forward mutational target. The error rate for both enzymes was lowest at low dNTP concentrations (10-50 mu M) and highest at high dNTP concentration (1000 mu M) The mutD5 proofreading defect increased the error rate by only 3-5-fold. Both enzymes produced a high level of (-1)-frameshift mutations in addition to base substitutions. The base substitutions were mainly C-->T, G-->T, and G-->C, but cNTP pool imbalances suggested that these may reflect misincorporations opposite damaged template bases and that, instead, T-->C, G-->A, and C-->T transitions represent the normal polymerase III-mediated base base mispairs. The frequent (-1)-frameshift mutations do not result from direct slippage but may be generated via a mechanism involving "misincorporation plus slippage." Measurements of the fidelity of wild-type and mutD5 holoenzyme during M13 in vivo replication revealed significant differences between the in vivo and in vitro fidelity with regard to both the frequency of frameshift errors and the extent of proofreading.	NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA; Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Denver, CO 80262 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Schaaper, RM (corresponding author), NIEHS, Mol Genet Lab, NIH, E3-01,POB 12233,111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	schaaper@niehs.nih.gov	Schaaper, Roel M/E-6680-2019	Schaaper, Roel M/0000-0003-1344-3196				BEBENEK K, 1990, P NATL ACAD SCI USA, V87, P4946, DOI 10.1073/pnas.87.13.4946; BEBENEK K, 1990, J BIOL CHEM, V265, P13878; Bloom LB, 1997, J BIOL CHEM, V272, P27919, DOI 10.1074/jbc.272.44.27919; CLAYTON LK, 1979, J BIOL CHEM, V254, P1902; COX EC, 1982, GENETICS, V100, P7; DALLMANN HG, 1995, J BIOL CHEM, V270, P29555, DOI 10.1074/jbc.270.49.29555; DALLMANN HG, 1995, J BIOL CHEM, V270, P29563, DOI 10.1074/jbc.270.49.29563; DIFRANCESCO R, 1984, J BIOL CHEM, V259, P5567; DONLIN MJ, 1991, BIOCHEMISTRY-US, V30, P538, DOI 10.1021/bi00216a031; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; ECHOLS H, 1983, P NATL ACAD SCI-BIOL, V80, P2189, DOI 10.1073/pnas.80.8.2189; FERSHT AR, 1982, J MOL BIOL, V156, P37, DOI 10.1016/0022-2836(82)90457-0; FERSHT AR, 1981, P NATL ACAD SCI-BIOL, V78, P4251, DOI 10.1073/pnas.78.7.4251; FERSHT AR, 1979, P NATL ACAD SCI USA, V76, P4946, DOI 10.1073/pnas.76.10.4946; FERSHT AR, 1983, J MOL BIOL, V165, P633, DOI 10.1016/S0022-2836(83)80271-X; Fijalkowska IJ, 1996, P NATL ACAD SCI USA, V93, P2856, DOI 10.1073/pnas.93.7.2856; FOWLER RG, 1992, MUTAT RES, V284, P307, DOI 10.1016/0027-5107(92)90015-T; Jonczyk P, 1998, J BACTERIOL, V180, P1563, DOI 10.1128/JB.180.6.1563-1566.1998; JOYCE CM, 1992, J BIOL CHEM, V267, P24485; KELMAN Z, 1995, ANNU REV BIOCHEM, V64, P171, DOI 10.1146/annurev.bi.64.070195.001131; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; KUNKEL TA, 1985, J BIOL CHEM, V260, P5787; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KUNKEL TA, 1988, J BIOL CHEM, V263, P4450; KUNKEL TA, 1981, J BIOL CHEM, V256, P9883; KUNKEL TA, 1988, J BIOL CHEM, V263, P14784; KUNKEL TA, 1986, J BIOL CHEM, V261, P160; KUNKEL TA, 1990, BIOCHEMISTRY-US, V29, P8003, DOI 10.1021/bi00487a001; KUNKEL TA, 1994, P NATL ACAD SCI USA, V91, P6830, DOI 10.1073/pnas.91.15.6830; LADUCA RJ, 1986, J BIOL CHEM, V261, P7550; LU Q, 1995, J MOL BIOL, V254, P337, DOI 10.1006/jmbi.1995.0620; Malia SA, 1996, BIOCHEMISTRY-US, V35, P4568, DOI 10.1021/bi9525132; MARUYAMA M, 1983, J MOL BIOL, V167, P757, DOI 10.1016/S0022-2836(83)80109-0; MCHENRY CS, 1991, J BIOL CHEM, V266, P19127; MENDELMAN LV, 1989, J BIOL CHEM, V264, P14415; Mo JY, 1996, J BIOL CHEM, V271, P18947, DOI 10.1074/jbc.271.31.18947; Mozzherin DJ, 1996, J BIOL CHEM, V271, P31711, DOI 10.1074/jbc.271.49.31711; OBERFELDER R, 1987, J BIOL CHEM, V262, P4190; ONRUST R, 1995, J BIOL CHEM, V270, P13348, DOI 10.1074/jbc.270.22.13348; Pavlov YI, 1996, MUTAT RES-FUND MOL M, V357, P1, DOI 10.1016/0027-5107(96)00060-7; PAVLOV YI, 1994, BIOCHEMISTRY-US, V33, P4695, DOI 10.1021/bi00181a029; QUE BG, 1978, BIOCHEMISTRY-US, V17, P1603, DOI 10.1021/bi00602a004; Sambrook J., 2002, MOL CLONING LAB MANU; SCHAAPER RM, 1991, GENETICS, V129, P317; SCHAAPER RM, 1987, P NATL ACAD SCI USA, V84, P6220, DOI 10.1073/pnas.84.17.6220; SCHAAPER RM, 1985, GENE, V39, P181, DOI 10.1016/0378-1119(85)90312-9; SCHAAPER RM, 1988, P NATL ACAD SCI USA, V85, P8126, DOI 10.1073/pnas.85.21.8126; SCHAAPER RM, 1993, J BIOL CHEM, V268, P23762; SCHAAPER RM, 1992, J BACTERIOL, V174, P1974, DOI 10.1128/jb.174.6.1974-1982.1992; SCHEUERMANN R, 1983, P NATL ACAD SCI-BIOL, V80, P7085, DOI 10.1073/pnas.80.23.7085; SCHEUERMANN RH, 1984, P NATL ACAD SCI-BIOL, V81, P7747, DOI 10.1073/pnas.81.24.7747; SHIBUTANI S, 1993, CHEM RES TOXICOL, V6, P625, DOI 10.1021/tx00035a006; STREISINGER G, 1985, GENETICS, V109, P633; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; WU CA, 1992, J BIOL CHEM, V267, P4064; WU CA, 1992, J BIOL CHEM, V267, P4074; Yuzhakov A, 1996, CELL, V86, P877, DOI 10.1016/S0092-8674(00)80163-4	59	54	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23575	23584		10.1074/jbc.273.36.23575	http://dx.doi.org/10.1074/jbc.273.36.23575			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722597	hybrid			2022-12-27	WOS:000075778100097
J	Rafiq, I; Kennedy, HJ; Rutter, GA				Rafiq, I; Kennedy, HJ; Rutter, GA			Glucose-dependent translocation of insulin promoter factor-1 (IPF-1) between the nuclear periphery and the nucleoplasm of single MIN6 beta-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; KINASE; TRANSCRIPTION; ACTIVATION; INVOLVEMENT; BINDING	Using laser-scanning confocal microscopy, we have monitored glucose-induced changes in the subcellular localization of insulin promoter factor-1 (IPF-1) labeled with a c-myc epitope tag. This construct trans-activated the insulin promoter in single living MIN6-beta-cells as assessed by luciferase-based promoter analysis. IPF-1.c-myc expression also enhanced the response of the insulin promoter to elevations in extracellular glucose concentration. In the majority (148/235, 63%) of cells maintained at low (3 mM) extracellular glucose concentration, IPF-1.c-myc immunoreactivity was confined to the nuclear periphery. Incubation of cells at stimulatory (30 mM) glucose concentrations caused a rapid redistribution of the chimera to the nucleoplasm (775/958, 81% of cells). By contrast, the irrelevant transcription factor c-Fos, tagged with either c-myc or as a chimera with luciferase, was localized exclusively to the nucleoplasm irrespective of the glucose concentration. Furthermore, IPF-1 extended with the bulky (27 kDa) enhanced green fluorescent protein (EGFP) group was confined largely to the nucleoplasm at all glucose concentrations tested and did not support trans-activation of the insulin promoter by glucose. Movement of endogenous IPF-1 from the nuclear periphery to the nucleoplasm may therefore increase the trans-activational capacity of this factor in native beta-cells exposed to high extracellular glucose concentrations.	Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England	University of Bristol	Rutter, GA (corresponding author), Univ Bristol, Sch Med Sci, Dept Biochem, Univ Walk, Bristol BS8 1TD, Avon, England.			Rutter, Guy/0000-0001-6360-0343	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BELL GI, 1990, DIABETES CARE, V13, P198, DOI 10.2337/diacare.13.3.198; BOAM DSW, 1990, J BIOL CHEM, V265, P8285; Bonny C, 1998, J BIOL CHEM, V273, P1843, DOI 10.1074/jbc.273.4.1843; Darnell JE, 1996, RECENT PROG HORM RES, V51, P391; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; DOCHERTY K, 1994, FASEB J, V8, P20, DOI 10.1096/fasebj.8.1.8299887; Dutta S, 1998, NATURE, V392, P560, DOI 10.1038/33311; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; HELM R, 1995, NATURE, V373, P663; JENSEN EV, 1991, NUCLEAR HORMONE RECE, P1; Kennedy HJ, 1997, J BIOL CHEM, V272, P20636, DOI 10.1074/jbc.272.33.20636; KENNEDY HJ, 1998, DIABETIC MED, V15, pS21; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; MACFARLANE WM, 1994, BIOCHEM J, V303, P625, DOI 10.1042/bj3030625; Macfarlane WM, 1997, J BIOL CHEM, V272, P20936, DOI 10.1074/jbc.272.33.20936; MARIE S, 1993, J BIOL CHEM, V268, P23881; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Roder K, 1997, J BIOL CHEM, V272, P21616, DOI 10.1074/jbc.272.34.21616; RUTTER GA, 1995, CURR BIOL, V5, P890, DOI 10.1016/S0960-9822(95)00179-5; Rutter GA, 1996, P NATL ACAD SCI USA, V93, P5489, DOI 10.1073/pnas.93.11.5489; Sambrook J., 2002, MOL CLONING LAB MANU; Sherf BA, 1994, PROMEGA NOTES, V49, P14; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Waeber G, 1996, MOL ENDOCRINOL, V10, P1327, DOI 10.1210/me.10.11.1327; Watada H, 1996, BIOCHEM BIOPH RES CO, V229, P746, DOI 10.1006/bbrc.1996.1875; Watada H, 1996, DIABETES, V45, P1478, DOI 10.2337/diabetes.45.11.1478	28	82	83	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23241	23247		10.1074/jbc.273.36.23241	http://dx.doi.org/10.1074/jbc.273.36.23241			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722555	hybrid			2022-12-27	WOS:000075778100055
J	Fomitcheva, J; Baker, ME; Anderson, E; Lee, GY; Aziz, N				Fomitcheva, J; Baker, ME; Anderson, E; Lee, GY; Aziz, N			Characterization of Ke 6, a new 17 beta-hydroxysteroid dehydrogenase, and its expression in gonadal tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYSTIC KIDNEY-DISEASE; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; CYSTIC-DISEASE; CELLS; SEQUENCE; ENZYME; MOUSE; GENE; OXIDOREDUCTASE; CLONING	The abnormal regulation of the Ke 6 gene has been linked to the development of recessive polycystic kidney disease in the mouse. In this report, we have shown that Ke 6 is a 17 beta-hydroxysteroid dehydrogenase and can regulate the concentration of biologically active estrogens and androgens. The Ke 6 enzyme is preferentially an oxidative enzyme and inactivates estradiol, testosterone, and dihydrotestosterone. However, the enzyme has some reductive activity and can synthesize estradiol from estrone. We find that the Ke 6 gene is expressed within the ovaries and testes. The presence of Ke 6 protein within the cumulus cells surrounding the oocyte places it in a strategic location to control the level of steroids to which the egg is exposed. Previously, it had been shown that glucocorticoids can induce renal cysts in the neonatal rodent, only when given at a narrow time window of postnatal kidney development. We propose that the reduction in the level of Ke 6 enzyme, which occurs in the cpk, jck, and pcy mice, may lead to abnormal elevations in local level of sex steroids, which either directly or indirectly via abnormal glucocorticoid metabolism result in recessive renal cystic disease, a developmental disorder of the kidney.	Childrens Hosp, Div Nephrol, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of California System; University of California San Diego	Aziz, N (corresponding author), Childrens Hosp, Div Nephrol, Dept Med, 300 Longwood Ave,Enders 1251, Boston, MA 02115 USA.	naziz@alum.mit.edu	Baker, Michael/ABB-8508-2020	Baker, Michael/0000-0003-4387-3269				Andersson S, 1997, STEROIDS, V62, P143, DOI 10.1016/S0039-128X(96)00173-0; AVNER ED, 1984, EXPERIENTIA, V40, P489, DOI 10.1007/BF01952400; AZIZ N, 1993, MOL CELL BIOL, V13, P1847, DOI 10.1128/MCB.13.3.1847; AZIZ N, 1994, AM J PHYSIOL-RENAL, V267, pF791, DOI 10.1152/ajprenal.1994.267.5.F791; AZIZ N, 1995, J AM SOC NEPHROL, V6, P690; Aziz N, 1996, ENDOCRINOLOGY, V137, P5581, DOI 10.1210/en.137.12.5581; AZIZ N, 1996, J AM SOC NEPHROL, V7, P1743; Baker ME, 1996, BIOESSAYS, V18, P63, DOI 10.1002/bies.950180112; Biswas MG, 1997, J BIOL CHEM, V272, P15959, DOI 10.1074/jbc.272.25.15959; BLOMQUIST CH, 1987, J CLIN ENDOCR METAB, V65, P647, DOI 10.1210/jcem-65-4-647; CROCKER JFS, 1976, AM J PATHOL, V82, P373; EDWARDS C, 1988, LANCET, P986; ERICKSON GF, 1985, ENDOCR REV, V6, P371, DOI 10.1210/edrv-6-3-371; FENG DF, 1990, METHOD ENZYMOL, V183, P375; FILMER RB, 1973, AM J PATHOL, V72, P461; FITCH WM, 1967, SCIENCE, V214, P149; GEISSLER WM, 1994, NAT GENET, V7, P34, DOI 10.1038/ng0594-34; Janaswami PM, 1997, GENOMICS, V40, P101, DOI 10.1006/geno.1996.4567; Kikuti YY, 1997, GENOMICS, V42, P422, DOI 10.1006/geno.1997.4745; Labrie F, 1997, STEROIDS, V62, P148, DOI 10.1016/S0039-128X(96)00174-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee GY, 1998, BIOL REPROD, V58, P330, DOI 10.1095/biolreprod58.2.330; Leenders F, 1996, J BIOL CHEM, V271, P5438, DOI 10.1074/jbc.271.10.5438; LEENDERS F, 1994, EUR J BIOCHEM, V222, P221, DOI 10.1111/j.1432-1033.1994.tb18860.x; Li JM, 1997, P NATL ACAD SCI USA, V94, P3554, DOI 10.1073/pnas.94.8.3554; LOW SC, 1993, J ENDOCRINOL, V139, P27, DOI 10.1677/joe.0.1390027; LuuThe V, 1995, J STEROID BIOCHEM, V55, P581, DOI 10.1016/0960-0760(95)00209-X; MAXWELL MM, 1995, J BIOL CHEM, V270, P25213, DOI 10.1074/jbc.270.42.25213; MCDONALD ATJ, 1990, KIDNEY INT, V37, P901, DOI 10.1038/ki.1990.64; MOORE JB, 1992, EMBO J, V11, P1973, DOI 10.1002/j.1460-2075.1992.tb05251.x; OJEDA JL, 1986, NEPHRON, V42, P240, DOI 10.1159/000183674; OJEDA JL, 1981, EXPERIENTIA, V37, P894, DOI 10.1007/BF01985700; PEREY DYE, 1967, SCIENCE, V158, P494, DOI 10.1126/science.158.3800.494; Poutanen M, 1995, J STEROID BIOCHEM, V55, P525, DOI 10.1016/0960-0760(95)00201-4; POUTANEN M, 1993, ENDOCRINOLOGY, V133, P2639, DOI 10.1210/en.133.6.2639; PREMINGER GM, 1982, J UROLOGY, V127, P556, DOI 10.1016/S0022-5347(17)53911-7; RUSVAI E, 1993, J BIOL CHEM, V268, P10717; SAWETAWAN C, 1994, MOL CELL ENDOCRINOL, V99, P161, DOI 10.1016/0303-7207(94)90004-3; VOUTILAINEN R, 1986, J CLIN ENDOCR METAB, V63, P202, DOI 10.1210/jcem-63-1-202; WELLING L, 1991, KIDNEY, V2, P1657; WHITEHOUSE RW, 1980, EXPERIENTIA, V36, P244, DOI 10.1007/BF01953758; WOO D, 1997, J AM SOC NEPHROL, V8, P385; WU L, 1993, J BIOL CHEM, V268, P12964; ZERRES K, 1994, NAT GENET, V7, P429, DOI 10.1038/ng0794-429; Zhang Y, 1996, J CLIN ENDOCR METAB, V81, P3594, DOI 10.1210/jc.81.10.3594	45	68	76	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22664	22671		10.1074/jbc.273.35.22664	http://dx.doi.org/10.1074/jbc.273.35.22664			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712896	hybrid			2022-12-27	WOS:000075616600072
J	Kampranis, SC; Maxwell, A				Kampranis, SC; Maxwell, A			The DNA gyrase-quinolone complex - ATP hydrolysis and the mechanism of DNA cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-PROTEIN; TOPOISOMERASE-II; NALIDIXIC-ACID; BINDING; INHIBITION; DRUGS; FRAGMENTS; ANTIBACTERIALS; RESISTANCE; MUTATIONS	Quinolone binding to the gyrase-DNA complex induces a conformational change that results in the blocking of supercoiling, Under these conditions gyrase is still capable of ATP hydrolysis which now proceeds through an alternative pathway involving two different conformations of the enzyme (Kampranis, S. C., and Maxwell, A. (1998) J. Biol. Chem, 269, 22606-22614), The kinetics of ATP hydrolysis via this pathway have been studied and found to differ from those of the reaction of the drug-free enzyme. The quinolone-characteristic ATPase rate is DNA-dependent and can be induced in the presence of DNA fragments as small as 20 base pairs. By observing the conversion of the ATPase rate to the quinolone characteristic rate, the formation and dissociation of the gyrase-DNA-quinolone complex can be monitored. Comparison of the time dependence of the conversion of the gyrase ATPase with that of DNA cleavage reveals that formation of the gyrase-DNA-quinolone complex does not correspond to the formation of cleaved DNA. Quinolone-induced DNA cleavage proceeds via a mechanism consisting of two cleavage events that is modulated in the presence of a nucleotide cofactor. We demonstrate that quinolone binding and drug-induced DNA cleavage are separate processes constituting two sequential steps in the mechanism of action of quinolones on DNA gyrase.	Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England	University of Leicester	Maxwell, A (corresponding author), Univ Leicester, Dept Biochem, Univ Rd, Leicester LE1 7RH, Leics, England.		Kampranis, Sotirios C/G-8374-2016	Kampranis, Sotirios C/0000-0001-6208-1684; Maxwell, Anthony/0000-0002-5756-6430				ALI JA, 1993, BIOCHEMISTRY-US, V32, P2717, DOI 10.1021/bi00061a033; CABRAL MJH, 1997, NATURE, V388, P903; Cove ME, 1997, NUCLEIC ACIDS RES, V25, P2716, DOI 10.1093/nar/25.14.2716; Critchlow SE, 1996, BIOCHEMISTRY-US, V35, P7387, DOI 10.1021/bi9603175; DOBBS ST, 1992, NUCLEIC ACIDS RES, V20, P3567, DOI 10.1093/nar/20.14.3567; FREUDENREICH CH, 1993, EMBO J, V12, P2085, DOI 10.1002/j.1460-2075.1993.tb05857.x; GELLERT M, 1977, P NATL ACAD SCI USA, V74, P4772, DOI 10.1073/pnas.74.11.4772; Gmunder H, 1997, NUCLEIC ACIDS RES, V25, P604, DOI 10.1093/nar/25.3.604; HALLETT P, 1991, ANTIMICROB AGENTS CH, V35, P335, DOI 10.1128/AAC.35.2.335; Hammonds TR, 1997, J BIOL CHEM, V272, P32696, DOI 10.1074/jbc.272.51.32696; Kampranis SC, 1996, P NATL ACAD SCI USA, V93, P14416, DOI 10.1073/pnas.93.25.14416; KIRKEGAARD K, 1981, CELL, V23, P721, DOI 10.1016/0092-8674(81)90435-9; LINDSLEY JE, 1993, J BIOL CHEM, V268, P8096; Marians KJ, 1997, J BIOL CHEM, V272, P9401; MAXWELL A, 1984, J BIOL CHEM, V259, P4472; MAXWELL A, 1999, PROTOCOLS DNA TOPOIS, V1, P135; MAXWELL A, 1986, BIOMOLECULAR STEREOD, P137; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; MORRISON A, 1980, J BIOL CHEM, V255, P2211; ODea MH, 1996, J BIOL CHEM, V271, P9723, DOI 10.1074/jbc.271.16.9723; ORPHANIDES G, 1994, NUCLEIC ACIDS RES, V22, P1567, DOI 10.1093/nar/22.9.1567; POMMIER Y, 1991, NUCLEIC ACIDS RES, V19, P5973, DOI 10.1093/nar/19.21.5973; REECE RJ, 1989, J BIOL CHEM, V264, P19648; REECE RJ, 1991, J BIOL CHEM, V266, P3540; Scheirer KE, 1997, J BIOL CHEM, V272, P27202, DOI 10.1074/jbc.272.43.27202; SHEN LL, 1989, J BIOL CHEM, V264, P2973; SHEN LL, 1985, P NATL ACAD SCI USA, V82, P307, DOI 10.1073/pnas.82.2.307; SHEN LL, 1989, BIOCHEMISTRY-US, V28, P3886, DOI 10.1021/bi00435a039; SHEN LL, 1989, BIOCHEMISTRY-US, V28, P3879, DOI 10.1021/bi00435a038; SUGINO A, 1978, P NATL ACAD SCI USA, V75, P4838, DOI 10.1073/pnas.75.10.4838; TORNALETTI S, 1988, BIOCHIM BIOPHYS ACTA, V949, P279, DOI 10.1016/0167-4781(88)90153-4; TSE YC, 1980, J BIOL CHEM, V255, P5560; WILLMOTT CJR, 1993, ANTIMICROB AGENTS CH, V37, P126, DOI 10.1128/AAC.37.1.126; YOSHIDA H, 1993, ANTIMICROB AGENTS CH, V37, P839, DOI 10.1128/AAC.37.4.839; ZECHIEDRICH EL, 1989, BIOCHEMISTRY-US, V28, P6229, DOI 10.1021/bi00441a014	35	90	92	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22615	22626		10.1074/jbc.273.35.22615	http://dx.doi.org/10.1074/jbc.273.35.22615			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712890	hybrid			2022-12-27	WOS:000075616600066
J	Olmsted, VK; Awrey, DE; Koth, C; Shan, X; Morin, PE; Kazanis, S; Edwards, AM; Arrowsmith, CH				Olmsted, VK; Awrey, DE; Koth, C; Shan, X; Morin, PE; Kazanis, S; Edwards, AM; Arrowsmith, CH			Yeast transcript elongation factor (TFIIS), structure and function - I: NMR structural analysis of the minimal transcriptionally active region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; NUCLEAR MAGNETIC-RESONANCE; BACKBONE DYNAMICS; CORRELATION SPECTROSCOPY; C-13-ENRICHED PROTEINS; ZINC-FINGER; N-15 NMR; DOMAIN; CLEAVAGE; SPECTRA	TFIIS is a general transcription elongation factor that helps arrested RNA polymerase II elongation complexes resume transcription. We have previously shown that yeast TFIIS (yTFIIS) comprises three structural domains (I-III). The three-dimensional structures of domain II and part of domain III have been previously reported, but neither domain can autonomously stimulate transcription elongation. Here we report the NMR structural analysis of residues 131-309 of yTPIIS which retains full activity and contains all of domains II and III. We confirm that the structure of domain II in the context of fully active yTFIIS is the same as that determined previously for a shorter construct. We have determined the structure of the C-terminal zinc ribbon domain of active yTFIIS and shown that it is similar to that reported for a shorter construct of human TFIIS, The region linking domain II with the zinc ribbon of domain III appears to be conformationally flexible and does not adopt a single defined tertiary structure. NMR analysis of inactive mutants of yTFIIS support a role for the linker region in interactions with the transcription elongation complex.	Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; Univ Toronto, Banting & Best Dept Med Res, CH Best Inst, Toronto, ON M5G 1L6, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Arrowsmith, CH (corresponding author), Univ Toronto, Ontario Canc Inst, 500 Sherbourne St, Toronto, ON M5G 2M9, Canada.	carrow@oci.utoronto.ca		Koth, Christopher/0000-0003-3939-8856; Edwards, Aled/0000-0002-4782-6016; Arrowsmith, Cheryl/0000-0002-4971-3250				AGARWAL K, 1991, BIOCHEMISTRY-US, V30, P7842, DOI 10.1021/bi00245a026; Awrey DE, 1998, J BIOL CHEM, V273, P22595, DOI 10.1074/jbc.273.35.22595; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; BAX A, 1990, J MAGN RESON, V88, P425, DOI 10.1016/0022-2364(90)90202-K; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; CHRISTIE KR, 1994, J BIOL CHEM, V269, P936; CIPRESPALACIN G, 1995, BIOCHEMISTRY-US, V34, P15375, DOI 10.1021/bi00046a046; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; IKURA M, 1990, J AM CHEM SOC, V112, P90020; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; JEON CJ, 1994, P NATL ACAD SCI USA, V91, P9106, DOI 10.1073/pnas.91.19.9106; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KAY LE, 1993, J MAGN RESON SER B, V101, P133; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; MARION D, 1989, J MAGN RESON, V84, P425, DOI 10.1016/0022-2364(89)90391-0; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; MONTELIONE GT, 1992, J AM CHEM SOC, V114, P10974, DOI 10.1021/ja00053a051; Morin PE, 1996, P NATL ACAD SCI USA, V93, P10604, DOI 10.1073/pnas.93.20.10604; Palmer Arthur G. Iii, 1993, Current Opinion in Biotechnology, V4, P385, DOI 10.1016/0958-1669(93)90002-E; PASCAL S, 1994, J MAGN RESON, V101, P197; PETERSON MG, 1991, NATURE, V354, P369; PLEVANI P, 1988, BIOCHIM BIOPHYS ACTA, V951, P268, DOI 10.1016/0167-4781(88)90096-6; QIAN XQ, 1993, NATURE, V365, P277, DOI 10.1038/365277a0; QIAN XQ, 1993, BIOCHEMISTRY-US, V32, P9944, DOI 10.1021/bi00089a010; REINES D, 1994, RAV S MOL C, V3, P263; STEBBINS CE, 1995, NATURE, V373, P636, DOI 10.1038/373636a0; VUISTER GW, 1992, J MAGN RESON, V98, P428, DOI 10.1016/0022-2364(92)90144-V; WAGNER G, 1987, J MOL BIOL, V196, P611, DOI 10.1016/0022-2836(87)90037-4; WOYCHIK NA, 1991, J BIOL CHEM, V266, P19053; WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2; Zhu WL, 1996, NAT STRUCT BIOL, V3, P122, DOI 10.1038/nsb0296-122; ZUIDERWEG ERP, 1985, BIOPOLYMERS, V24, P601, DOI 10.1002/bip.360240402	40	42	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22589	22594		10.1074/jbc.273.35.22589	http://dx.doi.org/10.1074/jbc.273.35.22589			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712887	hybrid			2022-12-27	WOS:000075616600063
J	Hendzel, MJ; Nishioka, WK; Raymond, Y; Allis, CD; Bazett-Jones, DP; Th'ng, JPH				Hendzel, MJ; Nishioka, WK; Raymond, Y; Allis, CD; Bazett-Jones, DP; Th'ng, JPH			Chromatin condensation is not associated with apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PC12 PHEOCHROMOCYTOMA CELLS; HISTONE ACETYLATION; IN-VITRO; PROTEIN-SYNTHESIS; NUCLEAR MATRIX; DNA-DAMAGE; ACTIVATION; TRANSCRIPTION; CYCLE; PHOSPHORYLATION	Apoptosis plays an important role in the survival of an organism, and substantial work has been done to understand the signaling pathways that regulate this process. Characteristic changes in chromatin organization accompany apoptosis and are routinely used as markers for cell death. We have examined the organization of chromatin in apoptotic PC12 and HeLa cells by indirect immunofluorescence and electron spectroscopic imaging. Our results indicate that de novo chromatin condensation normally seen during mitosis does not occur when cells undergo apoptosis. Instead, the condensed chromatin typically observed results from aggregation of the heterochromatin. We present evidence that, early in apoptosis, there is a rapid degradation of the nuclease-hypersensitive euchromatin that contains hyperacetylated histones. This occurs coincident with the loss of nuclear integrity due to degradation of lamins and reorganization of intranuclear protein matrix. These events lead to collapse of the nucleus and aggregation of heterochromatin to produce the appearance of condensed apoptotic chromatin. This heterochromatin aggregate is then digested by nucleases to produce the oligonucleosomal DNA ladder that is a hallmark of late apoptosis. Unlike mitosis, we have not seen any evidence for the requirement of phosphorylated histones H1 and H3 to maintain the chromatin in the condensed state.	McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ H3T 1E2, Canada; Univ Calgary, Dept Anat, Calgary, AB T2N 4N1, Canada; Univ Calgary, Dept Med Biochem, Calgary, AB T2N 4N1, Canada; Vical Inc, San Diego, CA 92121 USA; Ctr Hosp Univ Montreal, Lab Rech Autoimmun, Montreal, PQ H2L 4M1, Canada; Univ Rochester, Dept Biol, Rochester, NY 14627 USA	Lady Davis Institute; McGill University; University of Calgary; University of Calgary; Universite de Montreal; University of Rochester	Th'ng, JPH (corresponding author), McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, 3755 Cote Ste Catherine Rd, Montreal, PQ H3T 1E2, Canada.	mdjt@musica.mcgill.ca	Hendzel, Michael/C-3391-2009	Hendzel, Michael/0000-0002-9603-7945				ABOLHASSANIDADRAS S, 1994, J MICROSC-OXFORD, V174, P233, DOI 10.1111/j.1365-2818.1994.tb03470.x; Allera C, 1997, J BIOL CHEM, V272, P10817; Bartsch J, 1996, P NATL ACAD SCI USA, V93, P10741, DOI 10.1073/pnas.93.20.10741; BazettJones DP, 1996, NUCLEIC ACIDS RES, V24, P321, DOI 10.1093/nar/24.2.321; BAZETTJONES DP, 1992, ELECTRON MICROSC REV, V5, P37, DOI 10.1016/0892-0354(92)90004-A; Boggs BA, 1996, CHROMOSOMA, V105, P303, DOI 10.1007/BF02524648; BRADBURY EM, 1992, BIOESSAYS, V14, P9; BRENEMAN JW, 1993, EXP CELL RES, V206, P16, DOI 10.1006/excr.1993.1115; BUCHKOVICH KJ, 1994, MOL BIOL CELL, V5, P1225, DOI 10.1091/mbc.5.11.1225; CARMICHAEL J, 1987, CANCER RES, V47, P936; CHIANG JL, 1995, SCIENCE, V268, P429; Cidlowski JA, 1996, RECENT PROG HORM RES, V51, P457; COMPTON MM, 1992, CANCER METAST REV, V11, P105, DOI 10.1007/BF00048058; Davie JR, 1996, J CELL BIOCHEM, V62, P149, DOI 10.1002/(SICI)1097-4644(199608)62:2<149::AID-JCB2>3.0.CO;2-S; DONALDSON KL, 1994, CELL GROWTH DIFFER, V5, P1041; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Furukawa Y, 1996, J BIOL CHEM, V271, P28469, DOI 10.1074/jbc.271.45.28469; GAO CY, 1995, EXP CELL RES, V219, P612, DOI 10.1006/excr.1995.1271; Geier A, 1996, CANCER INVEST, V14, P435, DOI 10.3109/07357909609018901; GREENE LA, 1987, METHOD ENZYMOL, V147, P207; GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747; GURLEY LR, 1975, J BIOL CHEM, V250, P3936; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; HEBBES TR, 1992, NUCLEIC ACIDS RES, V20, P1017, DOI 10.1093/nar/20.5.1017; Hendzel MJ, 1996, J MICROSC-OXFORD, V182, P1, DOI 10.1046/j.1365-2818.1996.123403.x; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; JARVIS WD, 1994, P NATL ACAD SCI USA, V91, P73, DOI 10.1073/pnas.91.1.73; Kew JNC, 1996, NEUROSCIENCE, V70, P329, DOI 10.1016/0306-4522(95)00365-7; KRUH J, 1982, MOL CELL BIOCHEM, V42, P65; LAZEBNIK YA, 1993, J CELL BIOL, V123, P7, DOI 10.1083/jcb.123.1.7; LIN R, 1989, J CELL BIOL, V108, P1577, DOI 10.1083/jcb.108.5.1577; LINDENBOIM L, 1995, CANCER RES, V55, P1242; LU MJ, 1994, CHROMOSOMA, V103, P111; MARTIN SJ, 1995, SCIENCE, V269, P106, DOI 10.1126/science.7604270; MARUSHIGE Y, 1995, ANTICANCER RES, V15, P267; Medina V, 1997, CANCER RES, V57, P3697; MEIKRANTZ W, 1994, P NATL ACAD SCI USA, V91, P3754, DOI 10.1073/pnas.91.9.3754; Nasmyth K, 1996, SCIENCE, V274, P1643, DOI 10.1126/science.274.5293.1643; NISHIOKA WK, 1993, NAT IMMUN, V12, P113; NORBURY C, 1994, BIOCHEM BIOPH RES CO, V202, P1400, DOI 10.1006/bbrc.1994.2086; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; NORTON VG, 1989, CELL, V57, P449, DOI 10.1016/0092-8674(89)90920-3; OBEID LM, 1995, J CELL BIOCHEM, V58, P191, DOI 10.1002/jcb.240580208; OBERHAMMER FA, 1994, J CELL BIOL, V126, P827, DOI 10.1083/jcb.126.4.827; ONEILL LP, 1995, EMBO J, V14, P3946, DOI 10.1002/j.1460-2075.1995.tb00066.x; ONGKEKO W, 1995, J CELL SCI, V108, P2897; PANDEY S, 1995, J CELL BIOCHEM, V56, P1; Pazin MJ, 1997, CELL, V89, P325, DOI 10.1016/S0092-8674(00)80211-1; Rao L, 1996, J CELL BIOL, V135, P1441, DOI 10.1083/jcb.135.6.1441; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; SHI L, 1994, SCIENCE, V263, P1143, DOI 10.1126/science.8108732; THNG JPH, 1994, J BIOL CHEM, V269, P9568; TURNER BM, 1991, J CELL SCI, V99, P13; UCKER DS, 1991, NEW BIOL, V3, P103; VetteseDadey M, 1996, EMBO J, V15, P2508, DOI 10.1002/j.1460-2075.1996.tb00608.x; WALKER PR, 1994, BIOCHEM CELL BIOL, V72, P615, DOI 10.1139/o94-081; Waring P, 1997, J BIOL CHEM, V272, P17929, DOI 10.1074/jbc.272.29.17929; Weaver VM, 1996, J CELL SCI, V109, P45; WOLFFE AP, 1994, CELL, V77, P13, DOI 10.1016/0092-8674(94)90229-1	59	115	117	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24470	24478		10.1074/jbc.273.38.24470	http://dx.doi.org/10.1074/jbc.273.38.24470			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733739	hybrid			2022-12-27	WOS:000076007300031
J	Parkkila, AK; Scarim, AL; Parkkila, S; Waheed, A; Corbett, JA; Sly, WS				Parkkila, AK; Scarim, AL; Parkkila, S; Waheed, A; Corbett, JA; Sly, WS			Expression of carbonic anhydrase V in pancreatic beta cells suggests role for mitochondrial carbonic anhydrase in insulin secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; SUBCELLULAR-LOCALIZATION; LIPID-PEROXIDATION; NITRIC-OXIDE; CDNA CLONING; REDOX STATE; ISLETS; GLUCOSE; METABOLISM; PURIFICATION	Carbonic anhydrase V (CA-V) is a mitochondrial enzyme that provides bicarbonate for pyruvate carboxylase in liver and kidney. In the course of a survey of the tissue distribution of CA-V, we detected intense immunostaining in pancreatic islets when sections from rat and mouse pancreases were reacted with a polyclonal antibody to recombinant mouse CA-V, The distribution and large number of CA-V-positive cells in each islet suggested that they represented beta cells. Double immunofluorescence staining of tissue sections and isolated islet cells showed cellular colocalization of CA-V and insulin, confirming that beta cells contain CA-V, Western blotting of rat islets of Langerhans and primary beta cells showed 33- and 30-kDa polypeptides of precursor and mature CA-V, respectively. The CA-V expression was beta cell-specific since no CA-V immunoreaction was detected in the primary alpha cells. Immunohistochemical staining for CA-I, CA-II, CA-TV, CA-VI, and CA-M was negative in beta cells, and Western blotting of beta cells also failed to identify any CA in beta cells except CA-V, The specific localization of CA-V in beta cells led us to hypothesize that CA-V may be functionally linked to the regulation of insulin secretion. Consistent with this hypothesis, the CA inhibitor acetazolamide was found to be a strong inhibitor of glucose-stimulated insulin secretion by isolated rat pancreatic islets.	St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Sly, WS (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, 1402 S Grand Blvd, St Louis, MO 63104 USA.		Wahhed, Abdul/AAA-3099-2020	Parkkila, Seppo/0000-0001-7323-8536	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040163, R01DK052194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034182, R01GM034182] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK40163, DK52194] Funding Source: Medline; NIGMS NIH HHS [GM34182] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASHCROFT SJ, 1970, BIOCHEM J, V119, P5, DOI 10.1042/bj1190005; ASHCROFT SJH, 1979, BIOCHEM J, V184, P697, DOI 10.1042/bj1840697; BALBONI E, 1986, J BIOL CHEM, V261, P3563; BROLIN SE, 1981, ACTA ENDOCRINOL-COP, V96, P93, DOI 10.1530/acta.0.0960093; CORBETT JA, 1995, DIABET ANN, V9, P265; DODGSON SJ, 1984, ANN NY ACAD SCI, V429, P516, DOI 10.1111/j.1749-6632.1984.tb12380.x; DODGSON SJ, 1991, CARBONIC ANHYDRASES, P297; ELDER JA, 1973, BIOCHEMISTRY-US, V12, P976, DOI 10.1021/bi00729a029; Hazen SA, 1996, FASEB J, V10, P481, DOI 10.1096/fasebj.10.4.8647347; HEDESKOV CJ, 1980, PHYSIOL REV, V60, P442, DOI 10.1152/physrev.1980.60.2.442; Heitmeier MR, 1997, J BIOL CHEM, V272, P13697, DOI 10.1074/jbc.272.21.13697; Kennedy ED, 1996, J CLIN INVEST, V98, P2524, DOI 10.1172/JCI119071; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MACDONALD MJ, 1995, ARCH BIOCHEM BIOPHYS, V319, P128, DOI 10.1006/abbi.1995.1274; MACDONALD MJ, 1985, DIABETES, V34, P246, DOI 10.2337/diabetes.34.3.246; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; NAGAO Y, 1993, P NATL ACAD SCI USA, V90, P7623, DOI 10.1073/pnas.90.16.7623; NAGAO Y, 1994, P NATL ACAD SCI USA, V91, P10330, DOI 10.1073/pnas.91.22.10330; NIEMELA O, 1995, HEPATOLOGY, V22, P1208, DOI 10.1016/0270-9139(95)90630-4; NIEMELA O, 1994, LAB INVEST, V70, P537; PANTEN U, 1975, DIABETOLOGIA, V11, P569, DOI 10.1007/BF01222108; Parkkila AK, 1996, J HISTOCHEM CYTOCHEM, V44, P245, DOI 10.1177/44.3.8648084; Parkkila S, 1996, HEPATOLOGY, V24, P1104; Parkkila S, 1996, SCAND J GASTROENTERO, V31, P305, DOI 10.3109/00365529609006403; Saarnio J, 1998, J HISTOCHEM CYTOCHEM, V46, P497, DOI 10.1177/002215549804600409; SENER A, 1984, BIOCHEM J, V220, P433, DOI 10.1042/bj2200433; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; VANDEWINKEL M, 1983, BIOCHEM BIOPH RES CO, V114, P835, DOI 10.1016/0006-291X(83)90857-4; WRIGHT PH, 1971, DIABETES, V20, P33, DOI 10.2337/diab.20.1.33; ZHU XL, 1990, J BIOL CHEM, V265, P8795	30	53	56	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24620	24623		10.1074/jbc.273.38.24620	http://dx.doi.org/10.1074/jbc.273.38.24620			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733757	hybrid			2022-12-27	WOS:000076007300049
J	Bennett, MK; Van Leeuwen, JEM; Kearse, KP				Bennett, MK; Van Leeuwen, JEM; Kearse, KP			Calnexin association is not sufficient to protect T cell receptor alpha proteins from rapid degradation in CD4(+)CD8(+) thymocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; TCR-BETA PROTEINS; ENDOPLASMIC-RETICULUM; ANTIGEN RECEPTOR; MOLECULAR CHAPERONE; DEVELOPMENTAL REGULATION; MONOCLONAL-ANTIBODY; TRANSGENIC MICE; QUALITY-CONTROL; INITIAL STEP	During T cell development, assembly of the mutisubunit T cell receptor (TCR) complex is regulated by the differential stability of newly synthesized TCR alpha molecules, having a half-life of approximately 20 min in immature CD4(+)CD8(+) thymocytes compared with >75 min in mature T cells. The molecular basis for TCRa instability in CD4(+)CD8(+) thymocytes is unknown but has been postulated to involve abnormalities in N-glycan processing and calnexin assembly as perturbation of these pathways markedly destabilizes TCR alpha proteins in all other T cell types examined. Here, we compared the processing of TCR alpha glycoproteins and their assembly with calnexin and calreticulin chaperones in CD4(+)CD8(+) thymocytes and splenic T cells, These studies show that TCR alpha glycoproteins synthesized in CD4(+)CD8(+) thymocytes were processed in a similar manner as those made in splenic T cells and that TCR alpha proteins stably associated with calnexin in both cell types. Interestingly, however, TCR alpha association with the calnexin-related molecule calreticulin was decreased in CD4(+)CD8(+) thymocytes compared with splenic T cells. Finally, TCR alpha degradation in CD4(+)CD8(+) thymocytes was impaired by inhibitors of proteasome activity, which was correlated with stabilization of calnexin TCR alpha complexes. These data demonstrate that calnexin association is not sufficient to protect TCR alpha proteins from rapid degradation in CD4(+)CD8(+) thymocytes, suggesting that additional components of the quality control system of the endoplasmic reticulum operate to ensure the proper folding of nascent TCR alpha glycoproteins.	E Carolina Univ, Sch Med, Dept Microbiol & Immunol, Greenville, NC 27858 USA; NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	University of North Carolina; East Carolina University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kearse, KP (corresponding author), E Carolina Univ, Sch Med, Dept Microbiol & Immunol, Greenville, NC 27858 USA.	kearse@brody.med.ecu.edu	van Leeuwen, Jeroen/G-3555-2010		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI042104] Funding Source: NIH RePORTER; NIAID NIH HHS [R29 AI42104] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BECKER MLB, 1989, CELL, V58, P911, DOI 10.1016/0092-8674(89)90943-4; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; ELBEIN AD, 1991, FASEB J, V5, P3055, DOI 10.1096/fasebj.5.15.1743438; Halaban R, 1997, P NATL ACAD SCI USA, V94, P6210, DOI 10.1073/pnas.94.12.6210; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; INOUE S, 1992, J BIOL CHEM, V267, P9080; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KEARSE KP, 1995, J EXP MED, V181, P193, DOI 10.1084/jem.181.1.193; KEARSE KP, 1995, BIOESSAYS, V17, P1049, DOI 10.1002/bies.950171209; KEARSE KP, 1994, EMBO J, V13, P3678, DOI 10.1002/j.1460-2075.1994.tb06677.x; KEARSE KP, 1994, EMBO J, V13, P4504, DOI 10.1002/j.1460-2075.1994.tb06772.x; KEARSE KP, 1995, IMMUNITY, V2, P391; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KUBO RT, 1989, J IMMUNOL, V142, P2736; LE AQ, 1994, J BIOL CHEM, V269, P7514; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; Liu Y, 1997, J BIOL CHEM, V272, P7946, DOI 10.1074/jbc.272.12.7946; MOORE SEH, 1992, J BIOL CHEM, V267, P8443; MOREMEN KW, 1994, GLYCOBIOLOGY, V4, P113, DOI 10.1093/glycob/4.2.113; NAUSEEF WM, 1995, J BIOL CHEM, V270, P4741, DOI 10.1074/jbc.270.9.4741; Otteken A, 1996, J BIOL CHEM, V271, P97, DOI 10.1074/jbc.271.1.97; PETERSON JR, 1995, MOL BIOL CELL, V6, P1173, DOI 10.1091/mbc.6.9.1173; PIND S, 1994, J BIOL CHEM, V269, P12784; Rodan AR, 1996, EMBO J, V15, P6921, DOI 10.1002/j.1460-2075.1996.tb01084.x; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Spiro RG, 1996, J BIOL CHEM, V271, P11588, DOI 10.1074/jbc.271.19.11588; TARENTINO AL, 1974, J BIOL CHEM, V249, P811; THOMAS PJ, 1995, TRENDS BIOCHEM SCI, V20, P456, DOI 10.1016/S0968-0004(00)89100-8; VanLeeuwen JEM, 1997, J BIOL CHEM, V272, P4179, DOI 10.1074/jbc.272.7.4179; VanLeeuwen JEM, 1996, J BIOL CHEM, V271, P25345, DOI 10.1074/jbc.271.41.25345; VanLeeuwen JEM, 1996, P NATL ACAD SCI USA, V93, P13997, DOI 10.1073/pnas.93.24.13997; vanLeeuwen JEM, 1996, J BIOL CHEM, V271, P9660, DOI 10.1074/jbc.271.16.9660; Vassilakos A, 1996, EMBO J, V15, P1495, DOI 10.1002/j.1460-2075.1996.tb00493.x; WADA I, 1994, J BIOL CHEM, V269, P7464; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; Zapun A, 1997, CELL, V88, P29, DOI 10.1016/S0092-8674(00)81855-3	42	14	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23674	23680		10.1074/jbc.273.37.23674	http://dx.doi.org/10.1074/jbc.273.37.23674			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726972	hybrid			2022-12-27	WOS:000075893100013
J	Dey, BR; Spence, SL; Nissley, P; Furlanetto, RW				Dey, BR; Spence, SL; Nissley, P; Furlanetto, RW			Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED STAT INHIBITOR; PROTEIN; FAMILY; ACTIVATION; CIS; SUBSTRATE; KINASES; CLONING; DOMAIN; SHC	SOCS (suppressor of cytokine signaling) proteins have been shown to be negative regulators of cytokine receptor signaling via the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway. We have cloned a member of this family (hSOCS-2) by utilizing the insulin-like growth factor I receptor (IGF-IR) cytoplasmic domain as bait in a yeast two-hybrid screen of a human fetal brain library. The hSOCS-2 protein interacted strongly with the activated IGF-IR and not with a kinase negative mutant receptor in the two-hybrid assay. Mutation of receptor tyrosines 950, 1250, 1251, and 1316 to phenylalanine or deletion of the COOH-terminal 93 amino acids did not result in decreased interaction of the receptor with hSOCS-2 protein. hSOCS-1 protein also interacted strongly with IGF-IR in the two-hybrid assay. Glutathione S-transferase-hSOCS-2 associated with activated IGF-IR in lysates of mouse fibroblasts overexpressing IGF-IR, Human embryonic kidney cells (293) were transiently transfected with vectors containing IGF-IR and FLAG epitope-tagged hSOCS-2, After IGF-I stimulation, activated IGF-IR was found in anti-FLAG immunoprecipitates and, conversely, FLAG-hSOCS-2 was found in anti IGF-IR immunoprecipitates. Thus, hSOCS-2 interacted with IGF-IR both in vitro and in vivo. HSOCS-2 mRNA was expressed in many human fetal and adult tissues with particularly high abundance in fetal kidney and adult heart, skeletal muscle, pancreas, and liver, These results raise the possibility that SOCS proteins may also play a regulatory role in IGF-I receptor signaling.	NCI, Metab Branch, NIH, Bethesda, MD 20892 USA; Univ Rochester, Sch Med & Dent, Dept Pediat, Strong Childrens Res Ctr, Rochester, NY 14642 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Rochester	Nissley, P (corresponding author), NCI, Metab Branch, NIH, Bldg 10,Rm 4N115, Bethesda, MD 20892 USA.	spniss@box-s.nih.gov			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051657] Funding Source: NIH RePORTER; NIDDK NIH HHS [1RO1 DK51657] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams TE, 1998, J BIOL CHEM, V273, P1285, DOI 10.1074/jbc.273.3.1285; Aman NJ, 1997, CURR BIOL, V7, pR784, DOI 10.1016/S0960-9822(06)00405-2; Ausbel FM, 1994, CURRENT PROTOCOLS MO; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117; Chen J, 1997, P NATL ACAD SCI USA, V94, P2295, DOI 10.1073/pnas.94.6.2295; Dey BR, 1996, MOL ENDOCRINOL, V10, P631, DOI 10.1210/me.10.6.631; Dey BR, 1998, GENE, V209, P175, DOI 10.1016/S0378-1119(98)00045-6; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; FU XY, 1993, CELL, V74, P1135, DOI 10.1016/0092-8674(93)90734-8; Furlanetto RW, 1997, BIOCHEM J, V327, P765; Gual P, 1998, ENDOCRINOLOGY, V139, P884, DOI 10.1210/en.139.3.884; GUSTAFSON TA, 1995, MOL CELL BIOL, V15, P2500; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kozak M, 1997, EMBO J, V16, P2482, DOI 10.1093/emboj/16.9.2482; Leaman DW, 1996, MOL CELL BIOL, V16, P369; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; Masuhara M, 1997, BIOCHEM BIOPH RES CO, V239, P439, DOI 10.1006/bbrc.1997.7484; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Minamoto S, 1997, BIOCHEM BIOPH RES CO, V237, P79, DOI 10.1006/bbrc.1997.7080; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Ohya K, 1997, J BIOL CHEM, V272, P27178, DOI 10.1074/jbc.272.43.27178; SawkaVerhelle D, 1997, EUR J BIOCHEM, V250, P411, DOI 10.1111/j.1432-1033.1997.0411a.x; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Vignais ML, 1996, MOL CELL BIOL, V16, P1759; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x	26	167	176	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24095	24101		10.1074/jbc.273.37.24095	http://dx.doi.org/10.1074/jbc.273.37.24095			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727029	hybrid			2022-12-27	WOS:000075893100070
J	Saunders, C; Keefer, JR; Bonner, CA; Limbird, LE				Saunders, C; Keefer, JR; Bonner, CA; Limbird, LE			Targeting of G protein-coupled receptors to the basolateral surface of polarized renal epithelial cells involves multiple, non-contiguous structural signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANINE KIDNEY-CELLS; NEPHROGENIC DIABETES-INSIPIDUS; MDCK CELLS; ALPHA(2A)-ADRENERGIC RECEPTOR; ADRENERGIC-RECEPTORS; CYTOPLASMIC DOMAIN; LIGAND-BINDING; MEMBRANE; LOCALIZATION; TYROSINE	Truncations and chimeras of the alpha(2A)-adrenergic receptor (alpha(2A)AR) were evaluated to identify membrane domains responsible for its direct basolateral targeting in Madin-Darby canine kidney cells. An alpha(2A)AR truncation, encoding transmembrane (TM) regions 1-5, was first delivered basolaterally, but within minutes appeared apically, and at steady-state was primarily lateral ire its immunocytochemical localization. A TM 1-5 truncation with the third intracellular loop revealed more intense lateral localization than for the TRI 1-5 structure, consistent with the role of the third intracellular loop in alpha(2A)AR stabilization Addition of TM 6-7 of A(1) adenosine receptor (A(1)AdoR) to alpha(2A)ARTM1-5 creates a chimera, alpha(2A)ARTM1-5/A(1)AdoRTM6-7, which was first delivered apically, resulting either from loss of alpha(2A)AR sorting information in TM 6-7 or acquisition of apical trafficking signals within A(1)AdoRTM6-7. Evidence that alpha(2A)ARTM6-7 imparts basolateral targeting information is revealed by the significant basolateral localization of the A(1)AdoRTM1-5/alpha(2A)ARTM6-7 and A(1)AdoRTM1-5/alpha(2A)ARTM6-7 + i3 chimeras, in contrast to the dominant apical localization of A(1)AdoR. These results reveal that sequences within TM 1-5 and within TM 6-7 of the alpha(2A)AR confer basolateral targeting, providing the first evidence that alpha(2A)AR basolateral localization is not conferred by a single region but by non-contiguous membrane-embedded or proximal sequences.	Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University	Limbird, LE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, MRB 464, Nashville, TN 37232 USA.				NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043879] Funding Source: NIH RePORTER; NCI NIH HHS [CA68485] Funding Source: Medline; NHLBI NIH HHS [TG HL07323] Funding Source: Medline; NIDDK NIH HHS [DK 43879] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alonso MA, 1997, J BIOL CHEM, V272, P30748, DOI 10.1074/jbc.272.49.30748; COTECCHIA S, 1992, J BIOL CHEM, V267, P1633; Eason MG, 1996, J BIOL CHEM, V271, P12826, DOI 10.1074/jbc.271.22.12826; EATON S, 1995, CELL, V82, P5, DOI 10.1016/0092-8674(95)90045-4; FISH EM, 1994, NEW ENGL J MED, V330, P1580; FOLETTI D, 1995, FASEB J, V9, P670, DOI 10.1096/fasebj.9.8.7768360; GUYER CA, 1990, J BIOL CHEM, V265, P17307; HUNZIKER W, 1994, EMBO J, V13, P2963, DOI 10.1002/j.1460-2075.1994.tb06594.x; Inukai K, 1997, MOL ENDOCRINOL, V11, P442, DOI 10.1210/me.11.4.442; KEEFER JR, 1993, J BIOL CHEM, V268, P11340; KEEFER JR, 1994, J BIOL CHEM, V269, P16425; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; LIGGETT SB, 1993, P NATL ACAD SCI USA, V90, P3665, DOI 10.1073/pnas.90.8.3665; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; Maggio R, 1996, J BIOL CHEM, V271, P31055, DOI 10.1074/jbc.271.49.31055; MAGGIO R, 1993, P NATL ACAD SCI USA, V90, P3103, DOI 10.1073/pnas.90.7.3103; Marks MS, 1996, J CELL BIOL, V135, P341, DOI 10.1083/jcb.135.2.341; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; MATTER K, 1994, CURR OPIN CELL BIOL, V6, P545, DOI 10.1016/0955-0674(94)90075-2; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; Monnot C, 1996, J BIOL CHEM, V271, P1507, DOI 10.1074/jbc.271.3.1507; MOSTOV K, 1992, J CELL BIOL, V116, P577, DOI 10.1083/jcb.116.3.577; Nasman J, 1997, J BIOL CHEM, V272, P9703; NEAME SJ, 1993, J CELL BIOL, V121, P1299, DOI 10.1083/jcb.121.6.1299; Odorizzi G, 1997, J BIOL CHEM, V272, P11757, DOI 10.1074/jbc.272.18.11757; Odorizzi G, 1996, J CELL BIOL, V135, P139, DOI 10.1083/jcb.135.1.139; Oksche A, 1996, MOL PHARMACOL, V50, P820; Perego C, 1997, J BIOL CHEM, V272, P6584, DOI 10.1074/jbc.272.10.6584; ROBINSON SW, 1994, MOL PHARMACOL, V46, P352; Saunders C, 1996, J BIOL CHEM, V271, P995, DOI 10.1074/jbc.271.2.995; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; Schoneberg T, 1996, EMBO J, V15, P1283, DOI 10.1002/j.1460-2075.1996.tb00470.x; THOMAS DC, 1994, J BIOL CHEM, V269, P15732; THOMAS DC, 1993, J BIOL CHEM, V268, P3313; VERHEY KJ, 1993, J CELL BIOL, V123, P137, DOI 10.1083/jcb.123.1.137; WANG CD, 1991, MOL PHARMACOL, V40, P168; WONG SKF, 1990, J BIOL CHEM, V265, P6219; Wozniak M, 1996, J BIOL CHEM, V271, P5017; Yeaman C, 1996, AM J PHYSIOL-CELL PH, V270, pC753, DOI 10.1152/ajpcell.1996.270.3.C753	39	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24196	24206		10.1074/jbc.273.37.24196	http://dx.doi.org/10.1074/jbc.273.37.24196			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727043	hybrid			2022-12-27	WOS:000075893100084
J	Li, XY; McClure, WR				Li, XY; McClure, WR			Characterization of the closed complex intermediate formed during transcription initiation by Escherichia coli RNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNASE-I; PROMOTER RECOGNITION; BACTERIOPHAGE-LAMBDA; SIGMA-70 SUBUNIT; WILD-TYPE; HOLOENZYME; PROTEIN; ACTIVATION; REPRESSOR; MECHANISM	We have carried out detailed DNase I footprinting studies of the closed complex formed on the phage lambda prmup-1 Delta 265 promoter under reaction conditions such that the contribution of the open complex to the footprint was negligible. Detailed quantification shows that the closed complex detected has the same binding constant as that determined in kinetic studies. The footprinting pattern of the closed complex shows major differences from that of the open complex. Not only is it about 20 base pairs shorter, there are also many fewer positions being protected around and upstream of the -35 region. We have derived potential contact regions in the closed and open complexes based on the DNase I footprinting patterns, and confirmed the contact region for the open complex by hydroxyl radical footprinting. One important finding is that most of the essential contacts with the phosphate groups in the -35 region are formed during the isomerization step, a conclusion consistent with our kinetic data showing that this step is salt dependent on this promoter. In addition, we found that the derived contact regions for the closed and open complexes are offset by about three base pairs in the -35 region, which suggests a shift of the contact during isomerization. Finally, we found that the footprintimg pattern of the complex formed at 4 degrees C has some similarities to as well as differences from the closed complex formed under standard transcription conditions.	Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University	McClure, WR (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.				NIGMS NIH HHS [GM 30375] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030375] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMOUYAL M, 1987, J MOL BIOL, V195, P795, DOI 10.1016/0022-2836(87)90485-2; AUBLE DT, 1988, J MOL BIOL, V202, P471, DOI 10.1016/0022-2836(88)90279-3; BOROWIEC JA, 1986, BIOCHEMISTRY-US, V25, P5051, DOI 10.1021/bi00366a012; BRENOWITZ M, 1986, P NATL ACAD SCI USA, V83, P8462, DOI 10.1073/pnas.83.22.8462; BURGESS RR, 1975, BIOCHEMISTRY-US, V14, P4634, DOI 10.1021/bi00692a011; CHOY HA, 1986, J MOL BIOL, V191, P59, DOI 10.1016/0022-2836(86)90422-5; COWING DW, 1989, J MOL BIOL, V210, P521, DOI 10.1016/0022-2836(89)90128-9; COWING DW, 1989, J MOL BIOL, V210, P513, DOI 10.1016/0022-2836(89)90127-7; CRAIG ML, 1995, BIOCHEMISTRY-US, V34, P15624, DOI 10.1021/bi00048a004; DARST SA, 1989, NATURE, V340, P730, DOI 10.1038/340730a0; DEHASETH P L, 1978, Biochemistry, V17, P1612, DOI 10.1021/bi00602a006; DUVALVALENTIN G, 1986, NUCLEIC ACIDS RES, V14, P1967, DOI 10.1093/nar/14.5.1967; GARDELLA T, 1989, J MOL BIOL, V206, P579, DOI 10.1016/0022-2836(89)90567-6; HAWLEY DK, 1980, P NATL ACAD SCI-BIOL, V77, P6381, DOI 10.1073/pnas.77.11.6381; HAWLEY DK, 1982, J MOL BIOL, V157, P493, DOI 10.1016/0022-2836(82)90473-9; HEUMANN H, 1988, J MOL BIOL, V201, P115, DOI 10.1016/0022-2836(88)90443-3; HOFER B, 1985, NUCLEIC ACIDS RES, V13, P5995, DOI 10.1093/nar/13.16.5995; JOHNSON AD, 1979, P NATL ACAD SCI USA, V76, P5061, DOI 10.1073/pnas.76.10.5061; KADESCH TR, 1982, J MOL BIOL, V155, P1, DOI 10.1016/0022-2836(82)90489-2; KOVACIC RT, 1987, J BIOL CHEM, V262, P13654; LEIRMO S, 1987, BIOCHEMISTRY-US, V26, P2095, DOI 10.1021/bi00382a006; Li M, 1997, P NATL ACAD SCI USA, V94, P3691, DOI 10.1073/pnas.94.8.3691; LI M, 1994, SCIENCE, V263, P75, DOI 10.1126/science.8272867; LI XY, 1989, DNA PROTEIN INTERACT, P63; LOWE PA, 1979, BIOCHEMISTRY-US, V18, P1344, DOI 10.1021/bi00574a034; MCCLURE WR, 1985, ANNU REV BIOCHEM, V54, P171, DOI 10.1146/annurev.bi.54.070185.001131; MEYER BJ, 1980, J MOL BIOL, V139, P163, DOI 10.1016/0022-2836(80)90303-4; OHALLORAN TV, 1989, CELL, V56, P119, DOI 10.1016/0092-8674(89)90990-2; OZOLINE ON, 1995, NUCLEIC ACIDS RES, V23, P4533, DOI 10.1093/nar/23.22.4533; POPHAM DL, 1989, SCIENCE, V243, P629, DOI 10.1126/science.2563595; Record Jr MT, 1996, ESCHERICHIA COLI SAL, P792; ROE JH, 1985, J MOL BIOL, V184, P441, DOI 10.1016/0022-2836(85)90293-1; SCHICKOR P, 1990, EMBO J, V9, P2215, DOI 10.1002/j.1460-2075.1990.tb07391.x; SIEBENLIST U, 1980, CELL, V20, P269, DOI 10.1016/0092-8674(80)90613-3; SIEBENLIST U, 1980, P NATL ACAD SCI-BIOL, V77, P122, DOI 10.1073/pnas.77.1.122; SIEGELE DA, 1989, J MOL BIOL, V206, P591, DOI 10.1016/0022-2836(89)90568-8; SIMPSON RB, 1979, P NATL ACAD SCI USA, V76, P3233, DOI 10.1073/pnas.76.7.3233; SPASSKY A, 1985, BIOCHEMISTRY-US, V24, P2723, DOI 10.1021/bi00332a019; SUCK D, 1988, NATURE, V332, P464, DOI 10.1038/332464a0; TRAVERS AA, 1987, PHILOS T ROY SOC B, V317, P537, DOI 10.1098/rstb.1987.0080; TULLIUS TD, 1986, P NATL ACAD SCI USA, V83, P5469, DOI 10.1073/pnas.83.15.5469; WILLIAMS RC, 1977, P NATL ACAD SCI USA, V74, P3740, DOI 10.1073/pnas.74.9.3740; Zaychikov E, 1997, J BIOL CHEM, V272, P2259	43	29	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23549	23557		10.1074/jbc.273.36.23549	http://dx.doi.org/10.1074/jbc.273.36.23549			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722594	hybrid			2022-12-27	WOS:000075778100094
J	Yoo, SJ; Kim, HH; Shin, DH; Lee, CS; Seong, IS; Seol, JH; Shimbara, N; Tanaka, K; Chung, CH				Yoo, SJ; Kim, HH; Shin, DH; Lee, CS; Seong, IS; Seol, JH; Shimbara, N; Tanaka, K; Chung, CH			Effects of the Cys mutations on structure and function of the ATP-dependent HslVU protease in Escherichia coli - The Cys(287) to Val mutation in HslU uncouples the ATP-dependent proteolysis by HslVU from ATP hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE BINDING; ACTIVATED ATPASE; 26S PROTEASOMES; HS1VU PROTEASE; CLP PROTEASE; PROTEINS; COMPONENT; DEGRADATION; SUBUNIT; UBIQUITIN	To define the role of the Cys residues in the ATP-dependent HslVU protease, mutagenesis was performed to replace either Cys(261) Or Cys(287) in HslU with Val and Cys(159) in HslV with Ser or Ala. Whereas HslU/C261V could hydrolyze ATP and support the ATP-dependent proteolytic activity of HslV as well as the wild-type HslU, HslU/C287V could not hydrolyze ATP, Nevertheless, HslU/C287V could support the HslV-mediated proteolysis by forming the HslVU complex in the presence of ATP but not its absence, indicating that ATP binding but not its hydrolysis is essential for proteolysis. Whereas treatment of N-ethylmaleimide (NEM) resulted in dissociation of the oligomeric HslU into monomers, the C261V mutation, but not C287V, prevented the NEM effect. These results suggest that Cys261 is involved in oligomerization and that Cys(287) is related to the ATPase function of HslU, NEM also dissociated the dodecameric HslV into monomers, and this effect could be prevented by either the C159S or C159A mutation, suggesting the involvement of Cys(159) in oligomerization of HslV. Moreover, either mutation abolished both the basal and HslU-activated proteolytic activity of HslV and its ability to activate the HslU ATPase and to form the HslVU complex, indicating that Cys(159) is essential for the proteolytic activity of HslV and its interaction with HslU. These results suggest that the Cys residues play an important role in maintaining the structure and function of the HslUV protease.	Seoul Natl Univ, Coll Nat Sci, Dept Mol Biol, Seoul 151742, South Korea; Seoul Natl Univ, Coll Nat Sci, Res Ctr Cell Differentiat, Seoul 151742, South Korea; Sumitomo Elect Ind Ltd, Dept Biomed R&D, Yokohama, Kanagawa 244, Japan; Japan Sci & Technol Corp, CREST, Tokyo Metropolitan Inst Med Sci, Tokyo 113, Japan	Seoul National University (SNU); Seoul National University (SNU); Sumitomo Electric Industries; Japan Science & Technology Agency (JST); Tokyo Metropolitan Institute of Medical Science	Chung, CH (corresponding author), Seoul Natl Univ, Coll Nat Sci, Dept Mol Biol, Seoul 151742, South Korea.	chchung@plaza.snu.ac.kr	Shin, Donghun/A-2092-2012					Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; ARMON T, 1990, J BIOL CHEM, V265, P20723; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bochtler M, 1997, P NATL ACAD SCI USA, V94, P6070, DOI 10.1073/pnas.94.12.6070; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHUANG SE, 1993, GENE, V134, P1, DOI 10.1016/0378-1119(93)90167-2; Chung CH, 1996, BIOL CHEM, V377, P549; CHUNG CH, 1993, SCIENCE, V262, P372, DOI 10.1126/science.8211156; Chung CH, 1997, BIOCHEM BIOPH RES CO, V241, P613, DOI 10.1006/bbrc.1997.7735; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; GOLDBERG AL, 1992, EUR J BIOCHEM, V203, P9, DOI 10.1111/j.1432-1033.1992.tb19822.x; Gottesman S, 1997, CELL, V91, P435, DOI 10.1016/S0092-8674(00)80428-6; GOTTESMAN S, 1990, P NATL ACAD SCI USA, V87, P3513, DOI 10.1073/pnas.87.9.3513; GOTTESMAN S, 1993, J BIOL CHEM, V268, P22618; GOTTESMAN S, 1992, MICROBIOL REV, V56, P592, DOI 10.1128/MMBR.56.4.592-621.1992; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Huang HC, 1997, J BIOL CHEM, V272, P21364, DOI 10.1074/jbc.272.34.21364; HWANG BJ, 1988, J BIOL CHEM, V263, P8727; KATAYAMAFUJIMURA Y, 1987, J BIOL CHEM, V262, P4477; Kessel M, 1996, FEBS LETT, V398, P274, DOI 10.1016/S0014-5793(96)01261-6; KIMS KI, 1995, J BIOL CHEM, V270, P29799; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsen CN, 1997, CELL, V91, P431, DOI 10.1016/S0092-8674(00)80427-4; LEHNHERR H, 1995, P NATL ACAD SCI USA, V92, P3274, DOI 10.1073/pnas.92.8.3274; LEVCHENKO I, 1995, GENE DEV, V9, P2399, DOI 10.1101/gad.9.19.2399; MARKWELL MAK, 1982, ANAL BIOCHEM, V125, P427, DOI 10.1016/0003-2697(82)90025-2; MAURIZI MR, 1992, EXPERIENTIA, V48, P178, DOI 10.1007/BF01923511; MENON AS, 1987, J BIOL CHEM, V262, P14929; MHAMMEDIALAOUI A, 1994, MOL MICROBIOL, V11, P1109, DOI 10.1111/j.1365-2958.1994.tb00387.x; Missiakas D, 1996, EMBO J, V15, P6899, DOI 10.1002/j.1460-2075.1996.tb01082.x; PETERS JM, 1994, J BIOL CHEM, V269, P7709; RECHSTEINER M, 1993, J BIOL CHEM, V268, P6065; Rep M, 1996, SCIENCE, V274, P103, DOI 10.1126/science.274.5284.103; Rohrwild M, 1996, P NATL ACAD SCI USA, V93, P5808, DOI 10.1073/pnas.93.12.5808; Rohrwild M, 1997, NAT STRUCT BIOL, V4, P133, DOI 10.1038/nsb0297-133; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; SEEMULLER E, 1995, SCIENCE, V268, P579, DOI 10.1126/science.7725107; Seol JH, 1997, EUR J BIOCHEM, V247, P1143, DOI 10.1111/j.1432-1033.1997.01143.x; Shin DH, 1996, FEBS LETT, V398, P151, DOI 10.1016/S0014-5793(96)01223-9; TANAHASHI N, 1993, ENZYME PROTEIN, V47, P241, DOI 10.1159/000468683; TOMOYASU T, 1995, EMBO J, V14, P2551, DOI 10.1002/j.1460-2075.1995.tb07253.x; VanMelderen L, 1996, J BIOL CHEM, V271, P27730, DOI 10.1074/jbc.271.44.27730; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WAXMAN L, 1982, P NATL ACAD SCI-BIOL, V79, P4883, DOI 10.1073/pnas.79.16.4883; WICKNER S, 1994, P NATL ACAD SCI USA, V91, P12218, DOI 10.1073/pnas.91.25.12218; Yoo SJ, 1997, FEBS LETT, V412, P57, DOI 10.1016/S0014-5793(97)00742-4; Yoo SJ, 1997, BIOCHEM BIOPH RES CO, V238, P581, DOI 10.1006/bbrc.1997.7341; Yoo SJ, 1996, J BIOL CHEM, V271, P14035, DOI 10.1074/jbc.271.24.14035	52	12	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					22929	22935		10.1074/jbc.273.36.22929	http://dx.doi.org/10.1074/jbc.273.36.22929			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722513	hybrid			2022-12-27	WOS:000075778100013
J	Hammacher, A; Richardson, RT; Layton, JE; Smith, DK; Angus, LJL; Hilton, DJ; Nicola, NA; Wijdenes, J; Simpson, RJ				Hammacher, A; Richardson, RT; Layton, JE; Smith, DK; Angus, LJL; Hilton, DJ; Nicola, NA; Wijdenes, J; Simpson, RJ			The immunoglobulin-like module of gp130 is required for signaling by interleukin-6, but not by leukemia inhibitory factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATING FACTOR-RECEPTOR; IL-6 RECEPTOR; HIGH-AFFINITY; MONOCLONAL-ANTIBODIES; HEXAMERIC COMPLEX; BINDING-SITES; 2 DISTINCT; TRANSDUCER; EXPRESSION; MURINE	The transmembrane protein gp130 is a shared component of the receptor complexes for the interleukin-6 (IL-6)-type cytokines, which include IL-6, leukemia inhibitory factor (LIF) and oncostatin M (OSM). In addition to its role in the generation of high affinity receptors, gp130 is required for signal transduction by these cytokines. In the present study we have examined the role of the N-terminal located, extracellular immunoglobulin (Ig)-like module of gp130 in signal transduction by IL-6 and LIF. We have expressed wild-type human gp130 or three mutants in murine myeloid M1-UR21 cells that lack functional endogenous gp130 but express the IL-6 receptor (IL-GR) and the LIF receptor (LIFR). By measuring cellular responses, such as morphological changes upon differentiation, soft agar colony formation, and induction of tyrosine phosphorylation of the signal transducer and activator of transcription, STAT3, we show that signaling by IL-6, but not LIF, is significantly reduced by mutations in the Ig-like module of gp130. However, the binding of I-125-labeled IL-6 or LIF is not affected by these mutations. We also present evidence that the Ig-like module forms part of the epitope of an anti-gp130 monoclonal antibody that neutralizes the bioactivity of IL-6, but not of LIF or OSM. The data suggest that gp130-activation by IL-6 and LIF requires different regions of gp130, that the Ig-like module of gp130 may be required for IL B-induced gp130 dimerization, and that the stoichiometry of the high affinity IL-6 receptor-complex differs from those of the receptor-complexes for LIF and OSM.	Ludwig Inst Canc Res, Melbourne Tumour Biol Branch, Joint Prot Struct Lab, Parkville, Vic 3050, Australia; Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Cooperat Res Ctr Cellular Growth Factors, Parkville, Vic 3050, Australia; DIACLONE, F-25020 Besancon, France	Ludwig Institute for Cancer Research; Walter & Eliza Hall Institute	Hammacher, A (corresponding author), Royal Melbourne Hosp, Ludwig Inst Canc Res, POB 2008, Melbourne, Vic 3050, Australia.	annet.hammacher@udwig.edu.au	Nicola, Nicos/D-2989-2011; Hilton, Douglas J/C-7250-2013	Nicola, Nicos/0000-0003-1054-7889; Hilton, Douglas J/0000-0002-7698-2392; Simpson, Richard/0000-0002-9834-0796; Smith, David/0000-0003-3608-0586; Richardson, Rachael/0000-0002-2412-8354				AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BRAKENHOFF JPJ, 1994, J BIOL CHEM, V269, P86; CALVO JC, 1983, BIOCHEM J, V212, P259, DOI 10.1042/bj2120259; Chevalier S, 1996, J BIOL CHEM, V271, P14764, DOI 10.1074/jbc.271.25.14764; COULIE PG, 1989, EUR J IMMUNOL, V19, P2107, DOI 10.1002/eji.1830191121; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DESERIO A, 1995, J MOL BIOL, V254, P795, DOI 10.1006/jmbi.1995.0655; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; FUKUNAGA R, 1991, EMBO J, V10, P2855, DOI 10.1002/j.1460-2075.1991.tb07835.x; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; Grotzinger J, 1997, PROTEINS, V27, P96; Hammacher A, 1996, J BIOL CHEM, V271, P5464, DOI 10.1074/jbc.271.10.5464; HAMMACHER A, 1994, PROTEIN SCI, V3, P2280, DOI 10.1002/pro.5560031213; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HILTON DJ, 1992, J BIOL CHEM, V267, P10238; HIRAOKA O, 1995, J BIOL CHEM, V270, P25928, DOI 10.1074/jbc.270.43.25928; Horsten U, 1997, J BIOL CHEM, V272, P23748, DOI 10.1074/jbc.272.38.23748; HORSTEN U, 1995, FEBS LETT, V360, P43, DOI 10.1016/0014-5793(95)00053-C; Hudson KR, 1996, J BIOL CHEM, V271, P11971, DOI 10.1074/jbc.271.20.11971; Kalai M, 1997, BLOOD, V89, P1319, DOI 10.1182/blood.V89.4.1319; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LARSEN A, 1990, J EXP MED, V172, P1559, DOI 10.1084/jem.172.6.1559; LAYTON JE, 1991, J BIOL CHEM, V266, P23815; Layton JE, 1997, GROWTH FACTORS, V14, P117, DOI 10.3109/08977199709021515; LAYTON MJ, 1994, J BIOL CHEM, V269, P29891; METCALF D, 1989, LEUKEMIA, V3, P349; Minami M, 1996, P NATL ACAD SCI USA, V93, P3963, DOI 10.1073/pnas.93.9.3963; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P307; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Neddermann P, 1996, J BIOL CHEM, V271, P30986, DOI 10.1074/jbc.271.48.30986; OWCZAREK CM, 1993, EMBO J, V12, P3487, DOI 10.1002/j.1460-2075.1993.tb06023.x; PAONESSA G, 1995, EMBO J, V14, P1942, DOI 10.1002/j.1460-2075.1995.tb07186.x; SALVATI AL, 1995, J BIOL CHEM, V270, P12242, DOI 10.1074/jbc.270.20.12242; Simpson RJ, 1997, PROTEIN SCI, V6, P929, DOI 10.1002/pro.5560060501; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; Taga T, 1996, J NEUROCHEM, V67, P1; WARD LD, 1994, J BIOL CHEM, V269, P23286; Ward LD, 1996, J BIOL CHEM, V271, P20138, DOI 10.1074/jbc.271.33.20138; Wijdenes J, 1995, EUR J IMMUNOL, V25, P3474, DOI 10.1002/eji.1830251240; Zhang JG, 1997, BIOCHEM J, V325, P693, DOI 10.1042/bj3250693; ZHANG JG, 1992, EUR J BIOCHEM, V207, P903, DOI 10.1111/j.1432-1033.1992.tb17123.x	46	60	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22701	22707		10.1074/jbc.273.35.22701	http://dx.doi.org/10.1074/jbc.273.35.22701			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712900	hybrid			2022-12-27	WOS:000075616600076
J	Stevenson, JM; Perera, IY; Boss, WF				Stevenson, JM; Perera, IY; Boss, WF			A phosphatidylinositol 4-kinase pleckstrin homology domain that binds phosphatidylinositol 4-monophosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; SUSPENSION-CULTURE; PH DOMAIN; PHOSPHOLIPASE-C; MESSENGER-RNA; PROTEIN; KINASE; CELLS; ARABIDOPSIS; ASSOCIATION	Pleckstrin homology (PH) domains are found in many proteins involved in signal transduction, including the family of large molecular mass phosphatidylinositol (PI) 4-kinases. Although the exact function of these newly discovered domains is unknown, it is recognized that they may influence enzyme regulation by binding different ligands. In this study, the recombinant PI 4-kinase PH domain was explored for its ability to bind to different phospholipids. First, we isolated partial cDNAs of the >7-kilobase transcripts of PI 4-kinases from carrot (DcPI4K alpha) and Arabidopsis (AtPI4K alpha). The deduced primary sequences were 41% identical and 68% similar to rat and human PI 4-kinases and contained the telltale lipid kinase unique domain, PH domain, and catalytic domain. Antibodies raised against the expressed lipid kinase unique, PH, and catalytic domains identified a polypeptide of 205 kDa in Arabidopsis microsomes and an F-actin-enriched fraction from carrot cells. The 205-kDa immunoaffinity-purified Arabidopsis protein had PI 4-kinase activity. We have used the expressed PH domain to characterize lipid binding properties. The recombinant PH domain selectively bound to phosphatidylinositol 4-monophosphate (PI-4-P), phosphatidylinositol 4,5-bisphosphate (PI-4,5-P(2)), and phosphatidic acid and did not bind to the S-phosphoinositides. The PH domain had the highest affinity for PI-4-P, the product of the reaction. Consideration is given to the potential impact that this has on cytoskeletal organization and the PI signaling pathway in cells that have a high PI-4-P/PI-4,5-P(2), ratio.	N Carolina State Univ, Dept Bot, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Boss, WF (corresponding author), N Carolina State Univ, Dept Bot, Box 7612, Raleigh, NC 27695 USA.	wendy_boss@ncsu.edu		Perera, Imara/0000-0001-9421-1420				Balla T, 1997, J BIOL CHEM, V272, P18358, DOI 10.1074/jbc.272.29.18358; Bjerrum OJ, 1986, ANAL ELECTROPHORESIS, P315; BOSS WF, 1989, 2ND MESSENGERS PLANT, P29; CARRAWAY KL, 1992, CYTOSKELETON PRACTIC; CHEN QY, 1990, PLANT PHYSIOL, V94, P1820, DOI 10.1104/pp.94.4.1820; CHO MH, 1993, PLANT PHYSIOL, V103, P637, DOI 10.1104/pp.103.2.637; COTE GG, 1994, BIOESSAYS, V16, P39, DOI 10.1002/bies.950160106; CUNNINGHAM E, 1995, CURR BIOL, V5, P775, DOI 10.1016/S0960-9822(95)00154-0; DROBAK BK, 1992, BIOCHEM J, V288, P697, DOI 10.1042/bj2880697; FLANAGAN CA, 1993, SCIENCE, V262, P1444, DOI 10.1126/science.8248783; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; GARCIABUSTOS JF, 1994, EMBO J, V13, P2352, DOI 10.1002/j.1460-2075.1994.tb06519.x; Gehrmann T, 1996, BBA-MOL CELL RES, V1311, P53, DOI 10.1016/0167-4889(95)00180-8; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; GROSS W, 1992, BIOCHIM BIOPHYS ACTA, V1134, P73, DOI 10.1016/0167-4889(92)90029-B; HALL TC, 1978, P NATL ACAD SCI USA, V75, P3196, DOI 10.1073/pnas.75.7.3196; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; Harlow E., 1988, ANTIBODIES LAB MANUA; HIRAYAMA T, 1995, P NATL ACAD SCI USA, V92, P3903, DOI 10.1073/pnas.92.9.3903; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; INGLEY E, 1994, J CELL BIOCHEM, V56, P436, DOI 10.1002/jcb.240560403; JANMEY PA, 1992, J BIOL CHEM, V267, P11818; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Lemmon MA, 1996, CELL, V85, P621, DOI 10.1016/S0092-8674(00)81022-3; Lomasney JW, 1996, J BIOL CHEM, V271, P25316, DOI 10.1074/jbc.271.41.25316; MORSE MJ, 1987, P NATL ACAD SCI USA, V84, P7075, DOI 10.1073/pnas.84.20.7075; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; OKPODU CM, 1995, PLANT PHYSIOL, V107, P491, DOI 10.1104/pp.107.2.491; PERERA IY, 1992, PLANT PHYSIOL, V100, P812, DOI 10.1104/pp.100.2.812; Perera IY, 1996, CUR TOP PL, V17, P114; PITCHER JA, 1995, J BIOL CHEM, V270, P11707, DOI 10.1074/jbc.270.20.11707; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Sambrook J., 2002, MOL CLONING LAB MANU; SANDELIUS AS, 1990, PLANT BIOL, V9, P139; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATTERLEE JS, 1997, PLANT PHYSIOL, V115, P864; Shaw G, 1996, BIOESSAYS, V18, P35, DOI 10.1002/bies.950180109; SOMMARIN M, 1988, BIOCHIM BIOPHYS ACTA, V958, P268, DOI 10.1016/0005-2760(88)90185-3; TAN Z, 1992, PLANT PHYSIOL, V100, P2116, DOI 10.1104/pp.100.4.2116; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; TSUKADA S, 1994, P NATL ACAD SCI USA, V91, P11256, DOI 10.1073/pnas.91.23.11256; WALSH JP, 1991, P NATL ACAD SCI USA, V88, P9184, DOI 10.1073/pnas.88.20.9184; Wong K, 1997, J BIOL CHEM, V272, P13236, DOI 10.1074/jbc.272.20.13236; WONG K, 1994, J BIOL CHEM, V269, P28878; XU P, 1992, PLANT CELL, V4, P941, DOI 10.1105/tpc.4.8.941; YAMAMOTO YT, 1995, PLANT PHYSIOL, V107, P1029, DOI 10.1104/pp.107.3.1029; YOSHIDA S, 1994, J BIOL CHEM, V269, P1166; YU FX, 1992, J BIOL CHEM, V267, P14616; ZIELINSKI RE, 1987, PLANT PHYSIOL, V84, P937, DOI 10.1104/pp.84.3.937	50	124	126	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22761	22767		10.1074/jbc.273.35.22761	http://dx.doi.org/10.1074/jbc.273.35.22761			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712908	hybrid			2022-12-27	WOS:000075616600084
J	Whittaker, MM; Whittaker, JW				Whittaker, MM; Whittaker, JW			A glutamate bridge is essential for dimer stability and metal selectivity in manganese superoxide dismutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ANION BINDING-PROPERTIES; ESCHERICHIA-COLI-B; X-RAY STRUCTURE; PROPIONIBACTERIUM-SHERMANII; THERMUS-THERMOPHILUS; PSEUDOMONAS-OVALIS; CRYSTAL-STRUCTURES; PH-DEPENDENCE; IRON	In Escherichia coli manganese superoxide dismutase (MnSOD), the absolutely conserved Glu(170) Of one monomer is hydrogen-bonded to the Mn Ligand His(171) Of th, other monomer, forming a double bridge at the dimer interface. Point mutation of Glu(170) --> Ala destabilizes the dimer structure, and the mutant protein occurs as a mixture of dimer and monomer species, The purified E170A MnSOD contains exclusively Fe and is devoid of superoxide dismutase activity. E170A Fe-2-MnSOD closely resembles authentic FeSOD in terms of spectroscopic properties, anion interactions and pH titration behavior. Reconstitution of E170A Fe2-MnSOD with Mn(II) salts does not restore superoxide dismutase activity despite the spectroscopic similarity between E170A Mn-2-MnSOD and wild type Mn-2-MnSOD. Growth of sodA(+) and sodA(-) E. coli containing the mutant plasmid pDT1-5(E170A) is impaired, suggesting that expression of mutant protein is toxic to the host cells.	Oregon Grad Inst Sci & Technol, Dept Biochem & Mol Biol, Portland, OR 97291 USA		Whittaker, JW (corresponding author), Oregon Grad Inst Sci & Technol, Dept Biochem & Mol Biol, POB 91000, Portland, OR 97291 USA.	jim@bmb.ogi.edu			NIGMS NIH HHS [GM 42680] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042680] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEYER WF, 1991, J BIOL CHEM, V266, P303; BEYER WF, 1989, BIOCHEMISTRY-US, V28, P4403, DOI 10.1021/bi00436a042; BORGSTAHL GEO, 1992, CELL, V71, P107, DOI 10.1016/0092-8674(92)90270-M; BULL C, 1985, J AM CHEM SOC, V107, P3295, DOI 10.1021/ja00297a040; Bunting K, 1998, EUR J BIOCHEM, V251, P795, DOI 10.1046/j.1432-1327.1998.2510795.x; CARLIOZ A, 1988, J BIOL CHEM, V263, P1555; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; COOPER JB, 1995, J MOL BIOL, V246, P531, DOI 10.1006/jmbi.1994.0105; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Edwards RA, 1998, J BIOL INORG CHEM, V3, P161, DOI 10.1007/s007750050217; FARR SB, 1986, P NATL ACAD SCI USA, V83, P8268, DOI 10.1073/pnas.83.21.8268; FEE JA, 1981, ISRAEL J CHEM, V21, P54, DOI 10.1002/ijch.198100014; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; Griffith J.S., 1964, THEORY TRANSITION ME; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; Huggett ASG, 1957, BIOCHEM J, V66, P12; Hunter T, 1997, BIOCHEMISTRY-US, V36, P4925, DOI 10.1021/bi9629541; Lim JH, 1997, J MOL BIOL, V270, P259, DOI 10.1006/jmbi.1997.1105; Liochev SI, 1997, ARCH BIOCHEM BIOPHYS, V346, P263, DOI 10.1006/abbi.1997.0298; LUDWIG ML, 1991, J MOL BIOL, V219, P335, DOI 10.1016/0022-2836(91)90569-R; MARTIN ME, 1986, J BIOL CHEM, V261, P9361; McCord J M, 1976, Adv Exp Med Biol, V74, P540; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MCCORD JM, 1988, FREE RADICAL BIO MED, V5, P363, DOI 10.1016/0891-5849(88)90109-8; MEIER B, 1995, BIOCHEM J, V310, P945, DOI 10.1042/bj3100945; Meier B, 1997, FEBS LETT, V414, P122, DOI 10.1016/S0014-5793(97)00960-5; OSE DE, 1979, ARCH BIOCHEM BIOPHYS, V194, P360, DOI 10.1016/0003-9861(79)90628-3; PARBOOSINGH JS, 1995, NEUROMUSCULAR DISORD, V5, P7, DOI 10.1016/0960-8966(94)E0022-Z; PARKER MW, 1987, PROTEIN ENG, V1, P393, DOI 10.1093/protein/1.5.393; PARKER MW, 1988, FEBS LETT, V229, P377, DOI 10.1016/0014-5793(88)81160-8; PARKER MW, 1988, J MOL BIOL, V199, P649, DOI 10.1016/0022-2836(88)90308-7; RABIZADEH S, 1995, P NATL ACAD SCI USA, V92, P3024, DOI 10.1073/pnas.92.7.3024; Schmidt M, 1996, J BIOL INORG CHEM, V1, P532, DOI 10.1007/s007750050089; SLYKHOUSE TO, 1976, J BIOL CHEM, V251, P5472; STALLINGS WC, 1983, P NATL ACAD SCI-BIOL, V80, P3884, DOI 10.1073/pnas.80.13.3884; STODDARD BL, 1990, PROTEIN ENG, V4, P113, DOI 10.1093/protein/4.2.113; STODDARD BL, 1990, BIOCHEMISTRY-US, V29, P8885, DOI 10.1021/bi00490a002; TOUATI D, 1983, J BACTERIOL, V155, P1078, DOI 10.1128/JB.155.3.1078-1087.1983; Vance CK, 1998, J AM CHEM SOC, V120, P461, DOI 10.1021/ja972060j; WAGNER UG, 1993, PROTEIN SCI, V2, P814, DOI 10.1002/pro.5560020511; WEISIGER RA, 1973, J BIOL CHEM, V248, P4793; WERBER MM, 1991, FREE RADICAL RES COM, V12-3, P335, DOI 10.3109/10715769109145803; WHITTAKER JW, 1991, J AM CHEM SOC, V113, P5528, DOI 10.1021/ja00015a003; Whittaker MM, 1997, BIOCHEMISTRY-US, V36, P8923, DOI 10.1021/bi9704212; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; YAMAKURA F, 1995, EUR J BIOCHEM, V227, P700, DOI 10.1111/j.1432-1033.1995.tb20191.x; YAMAKURA F, 1994, INT CONGR SER, V1058, P115; YOST FJ, 1973, J BIOL CHEM, V248, P4905; Youn HD, 1996, BIOCHEM J, V318, P889, DOI 10.1042/bj3180889	50	52	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22188	22193		10.1074/jbc.273.35.22188	http://dx.doi.org/10.1074/jbc.273.35.22188			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712831	hybrid			2022-12-27	WOS:000075616600007
J	Gotoh, K; Yokota, H; Kikuya, E; Watanabe, T; Oishi, M				Gotoh, K; Yokota, H; Kikuya, E; Watanabe, T; Oishi, M			Genomic structure of MUNC18-1 protein, which is involved in docking and fusion of synaptic vesicles in brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING SITES; CAENORHABDITIS-ELEGANS; ROP; YEAST; GENE; SECRETION; INTERACTS; SELECTION; REGULATOR; SYNTAXIN	MUNC18-1 (n-Sec1) is a brain-specific protein and is known to play a role in neurotransmitter release by mediating docking and fusion of synaptic vesicles to presynaptic membranes. The protein is also implicated in the cellular excretion process of hormones and other biological substances in other mammalian tissues and yeasts. We have studied the structure of mouse munc18-1 gene by sequencing the genomic munc18-1 gene and its 5'-flanking region, munc18-1 gene comprises 19 exons whose size ranges from 50 base pairs (2nd exon) to 1676 base pairs (19th exon) with a total gene size of approximately 56 kilobases. In the 5'-flanking region, there are several transcription factor binding sites such as for HSF2, Lyf-1, and Spl but no TATA or CAAT sequences, munc18-1 gene was mapped on mouse chromosome 2 between two anchor markers D2Mit152 and D2Mit242. Transfection experiments employing these and upstream sequences suggest the presence of a sequence(s) that negatively regulates the expression of munc18-1 gene.	Kazusa DNA Res Inst, Chiba, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 113, Japan; Daiichi Pharmaceut Co Ltd, Tokyo 134, Japan; Tohoku Univ, Inst Dev Aging & Canc, Aoba Ku, Sendai, Miyagi 980, Japan	Kazusa DNA Research Institute; University of Tokyo; Daiichi Sankyo Company Limited; Tohoku University	Oishi, M (corresponding author), Kazusa DNA Res Inst, 1532-3 Yana, Chiba, Japan.							BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BRENNER S, 1974, GENETICS, V77, P71; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; GREEN MR, 1980, CELL, V22, P231, DOI 10.1016/0092-8674(80)90171-3; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; HOSONO R, 1992, J NEUROCHEM, V58, P1517, DOI 10.1111/j.1471-4159.1992.tb11373.x; JACOBSSON G, 1994, P NATL ACAD SCI USA, V91, P12487, DOI 10.1073/pnas.91.26.12487; KATOHSEMBA R, 1987, J NEUROSCI RES, V17, P36, DOI 10.1002/jnr.490170106; KROEGER PE, 1994, MOL CELL BIOL, V14, P7592, DOI 10.1128/MCB.14.11.7592; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; LO K, 1991, MOL CELL BIOL, V11, P5229, DOI 10.1128/MCB.11.10.5229; MORRIS JF, 1994, MOL CELL BIOL, V14, P1786, DOI 10.1128/MCB.14.3.1786; Mount SM, 1996, SCIENCE, V271, P1690, DOI 10.1126/science.271.5256.1690; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; SALZBERG A, 1993, DEVELOPMENT, V117, P1309; Sambrook J., 2002, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; SCHULZE KL, 1994, NEURON, V13, P1099, DOI 10.1016/0896-6273(94)90048-5; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; THIESEN HJ, 1990, NUCLEIC ACIDS RES, V18, P3203, DOI 10.1093/nar/18.11.3203	22	4	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21642	21647		10.1074/jbc.273.34.21642	http://dx.doi.org/10.1074/jbc.273.34.21642			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705297	hybrid			2022-12-27	WOS:000075492600031
J	Guittet, O; Ducastel, B; Salem, JS; Henry, Y; Rubin, H; Lemaire, G; Lepoivre, M				Guittet, O; Ducastel, B; Salem, JS; Henry, Y; Rubin, H; Lemaire, G; Lepoivre, M			Differential sensitivity of the tyrosyl radical of mouse ribonucleotide reductase to nitric oxide and peroxynitrite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; R2 PROTEIN; ADENOCARCINOMA CELLS; PHOTOSYSTEM-II; IRON CENTER; SUPEROXIDE; MACROPHAGES; SUBUNIT; INHIBITION; SITE	Ribonucleotide reductase is essential for DNA synthesis in cycling cells. It has been previously shown that the catalytically competent tyrosyl free radical of its small R2 subunit (R2-Y-.) is scavenged in tumor cells co-cultured with macrophages expressing a nitric oxide synthase II activity. We now demonstrate a loss of R2-Y-. induced either by (NO)-N-. or peroxynitrite in vitro. The (NO)-N-. effect is reversible and followed by an increase in ferric iron release from mouse protein R2. A similar increased iron lability in radical-free, diferric metR2 protein suggests reciprocal stabilizing interactions between R2-Y-. and the diiron center in the mouse protein. Scavenging of R2-Y-. by peroxynitrite is irreversible and paralleled to an irreversible loss of R2 activity. Formation of nitrotyrosine and dihydroxyphenylalanine was also detected in peroxynitrite-modified protein R2. In R2-overexpressing tumor cells co-cultured with activated murine macrophages, scavenging of R2-Y-. following NO synthase II induction was fully reversible, even when endogenous production of peroxynitrite was induced by triggering NADPH oxidase activity with a phorbol ester. Our results did not support the involvement of peroxynitrite in R2-Y-. scavenging by macrophage (NO)-N-. synthase II activity. They confirmed the preponderant physiological role of (NO)-N-. in the process.	Univ Paris Sud, CNRS, U571, F-91405 Orsay, France; Inst Curie, INSERM, U350, Orsay, France; Univ Penn, Dept Med, Philadelphia, PA 19104 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Pennsylvania	Guittet, O (corresponding author), Univ Paris Sud, CNRS, U571, ERS 571,Bat 430, F-91405 Orsay, France.	michel.lepoivre@bbmpc.u-psud.fr	Lepoivre, Michel/J-8578-2013; Guittet, Olivier/J-8642-2013					Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bouton C, 1996, J BIOL CHEM, V271, P2300, DOI 10.1074/jbc.271.4.2300; Bouton C, 1997, J BIOL CHEM, V272, P19969, DOI 10.1074/jbc.272.32.19969; Cassina A, 1996, ARCH BIOCHEM BIOPHYS, V328, P309, DOI 10.1006/abbi.1996.0178; CROW JP, 1995, BIOCHEMISTRY-US, V34, P3544, DOI 10.1021/bi00011a008; Davydov A, 1996, BIOCHEM BIOPH RES CO, V219, P213, DOI 10.1006/bbrc.1996.0207; Davydov R, 1996, BIOCHEMISTRY-US, V35, P5571, DOI 10.1021/bi952836y; EISERICH JP, 1995, BIOCHEM J, V310, P745, DOI 10.1042/bj3100745; ERIKSSON S, 1984, J BIOL CHEM, V259, P1695; Fan HZ, 1996, FEBS LETT, V382, P145, DOI 10.1016/0014-5793(96)00143-3; FEELISCH M, 1987, EUR J PHARMACOL, V139, P19, DOI 10.1016/0014-2999(87)90493-6; Gaudu P, 1996, FEBS LETT, V387, P137, DOI 10.1016/0014-5793(96)00480-2; Gerez C, 1997, EUR J BIOCHEM, V249, P401, DOI 10.1111/j.1432-1033.1997.t01-2-00401.x; GRANDPERRET T, 1986, EUR J IMMUNOL, V16, P332, DOI 10.1002/eji.1830160403; GRASLUND A, 1982, J BIOL CHEM, V257, P5711; Gunther MR, 1997, J BIOL CHEM, V272, P17086, DOI 10.1074/jbc.272.27.17086; Han JY, 1997, J BIOL INORG CHEM, V2, P287, DOI 10.1007/s007750050134; HASKIN CJ, 1995, BIOCHEMISTRY-US, V34, P11090, DOI 10.1021/bi00035a014; HENRIKSEN MA, 1994, J AM CHEM SOC, V116, P9773, DOI 10.1021/ja00100a062; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W; JANZEN EG, 1993, J ORG CHEM, V58, P3597, DOI 10.1021/jo00066a001; Kauppi B, 1996, J MOL BIOL, V262, P706, DOI 10.1006/jmbi.1996.0546; KWON NS, 1991, J EXP MED, V174, P761, DOI 10.1084/jem.174.4.761; LARSSON A, 1986, EMBO J, V5, P2037, DOI 10.1002/j.1460-2075.1986.tb04461.x; LEPOIVRE M, 1990, J BIOL CHEM, V265, P14143; LEPOIVRE M, 1992, J BIOL CHEM, V267, P22994; LEPOIVRE M, 1991, BIOCHEM BIOPH RES CO, V179, P442, DOI 10.1016/0006-291X(91)91390-X; LEPOIVRE M, 1982, J IMMUNOL, V129, P860; LEPOIVRE M, 1994, J BIOL CHEM, V269, P21891; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MANN GJ, 1991, BIOCHEMISTRY-US, V30, P1939, DOI 10.1021/bi00221a030; Miles AM, 1996, J BIOL CHEM, V271, P40, DOI 10.1074/jbc.271.1.40; MONCADA S, 1991, PHARMACOL REV, V43, P109; NOCEK JM, 1988, BIOCHEMISTRY-US, V27, P1014, DOI 10.1021/bi00403a026; NORDLUND P, 1993, J MOL BIOL, V232, P123, DOI 10.1006/jmbi.1993.1374; NYHOLM S, 1993, BIOCHEMISTRY-US, V32, P11569, DOI 10.1021/bi00094a013; NYHOLM S, 1993, J BIOL CHEM, V268, P26200; ORMO M, 1995, J BIOL CHEM, V270, P6570, DOI 10.1074/jbc.270.12.6570; PAZ MA, 1991, J BIOL CHEM, V266, P689; Pfeiffer S, 1997, J BIOL CHEM, V272, P3465, DOI 10.1074/jbc.272.6.3465; REICHARD P, 1993, SCIENCE, V260, P1773, DOI 10.1126/science.8511586; ROY B, 1995, BIOCHEMISTRY-US, V34, P5411, DOI 10.1021/bi00016a012; RUBBO H, 1994, J BIOL CHEM, V269, P26066; SAHLIN M, 1987, BIOCHEMISTRY-US, V26, P5541, DOI 10.1021/bi00391a049; SALEM JS, 1993, FEBS LETT, V323, P93, DOI 10.1016/0014-5793(93)81455-9; Sanakis Y, 1997, BIOCHEMISTRY-US, V36, P1411, DOI 10.1021/bi9622074; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; SJOBERG BM, 1986, J BIOL CHEM, V261, P5658; Stubbe JA, 1995, CHEM BIOL, V2, P793, DOI 10.1016/1074-5521(95)90084-5; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Szabo C, 1996, FEBS LETT, V381, P82, DOI 10.1016/0014-5793(96)00087-7; Szalai VA, 1996, BIOCHEMISTRY-US, V35, P15080, DOI 10.1021/bi961117w; THELANDER L, 1983, BIOCHEM BIOPH RES CO, V110, P859, DOI 10.1016/0006-291X(83)91040-9; WINK DA, 1994, CHEM RES TOXICOL, V7, P519, DOI 10.1021/tx00040a007; Xia Y, 1997, P NATL ACAD SCI USA, V94, P6954, DOI 10.1073/pnas.94.13.6954	58	34	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					22136	22144		10.1074/jbc.273.34.22136	http://dx.doi.org/10.1074/jbc.273.34.22136			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705359	hybrid			2022-12-27	WOS:000075492600093
J	Posner, BA; Mixon, MB; Wall, MA; Sprang, SR; Gilman, AG				Posner, BA; Mixon, MB; Wall, MA; Sprang, SR; Gilman, AG			The A326S mutant of G(i alpha 1) as an approximation of the receptor-bound state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN ALPHA-SUBUNITS; BETA-GAMMA; MOLECULAR REPLACEMENT; ADENYLATE-CYCLASE; BINDING; GTP; MECHANISM; MG-2+	Agonist-bound heptahelical receptors activate heterotrimeric G proteins by catalyzing exchange of GDP for GTP on their alpha subunits. In search of an approximation of the receptor-alpha subunit complex, we have considered the properties of A326S G(i alpha 1), a mutation discovered originally in G(s alpha) (Iiri, T., Herzmark, P., Nakamoto, J. M., Van Dop, C., and Bourne, H. R. (1994) Nature 371, 164-168) that mimics the effect of receptor on nucleotide exchange. The mutation accelerates dissociation of GDP from the alpha(i1)beta(1)gamma(2) heterotrimer by 250-fold. Nevertheless, affinity of mutant G(i alpha 1) for GTP gamma S is high in the presence of Mg2+, and the mutation has no effect on the intrinsic GTPase activity of the alpha subunit. The mutation also uncouples two activities of beta gamma stabilization of the GDP-bound alpha subunit (which is retained) and retardation of GDP dissociation from the heterotrimer (which is lost). For wild-type and mutant G(i alpha 1), beta gamma prevents irreversible inactivation of the alpha subunit at 30 degrees C. However, the mutation accelerates irreversible inactivation of alpha at 37 degrees C despite the presence of beta gamma, Structurally, the mutation weakens affinity for GTP gamma S by steric crowding: a 2-fold increase in the number of close contacts between the protein and the purine ring of the nucleotide, By contrast, we observe no differences in structure at the GDP binding site between wild-type heterotrimers and those containing A326S G(i alpha 1). However, the GDP binding site is only partially occupied ill crystals of G protein heterotrimers containing A326S G(i alpha 1). In contrast to original speculations about the structural correlates of receptor-catalyzed nucleotide exchange, rapid dissociation of GDP can be observed in the absence of substantial structural alteration of a G(alpha) subunit in the GDP-bound state.	Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Gilman, AG (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046371, R01DK046371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034497, R37GM034497, F32GM017530] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK46371] Funding Source: Medline; NIGMS NIH HHS [GM34497, GM17530] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASANO T, 1984, BIOCHEMISTRY-US, V23, P5467, DOI 10.1021/bi00318a014; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; BRANDT DR, 1983, BIOCHEMISTRY-US, V22, P4357, DOI 10.1021/bi00288a002; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P46, DOI 10.1107/S0108767389009633; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HIGASHIJIMA T, 1991, J BIOL CHEM, V266, P3396; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P757; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; Johnson R A, 1979, Adv Cyclic Nucleotide Res, V10, P135; JONES TA, 1996, O VERSION 5 1; KATADA T, 1986, J BIOL CHEM, V261, P8182; LEE E, 1994, METHOD ENZYMOL, V237, P146; MUMBY SM, 1994, METHOD ENZYMOL, V237, P254; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NORTHUP JK, 1982, J BIOL CHEM, V257, P1416; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Sambrook J., 2002, MOL CLONING LAB MANU; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; THOMAS TC, 1993, P NATL ACAD SCI USA, V90, P10295, DOI 10.1073/pnas.90.21.10295; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1	25	67	70	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21752	21758		10.1074/jbc.273.34.21752	http://dx.doi.org/10.1074/jbc.273.34.21752			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705312	hybrid			2022-12-27	WOS:000075492600046
J	Sheng, HM; Williams, CS; Shao, JY; Liang, P; DuBois, RN; Beauchamp, RD				Sheng, HM; Williams, CS; Shao, JY; Liang, P; DuBois, RN; Beauchamp, RD			Induction of cyclooxygenase-2 by activated Ha-ras oncogene in rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL EPITHELIAL-CELLS; SYNTHASE-2 GENE-EXPRESSION; GROWTH-FACTOR; MESSENGER-RNA; POSTTRANSCRIPTIONAL REGULATION; SIGNAL-TRANSDUCTION; TRANSCRIPTION FACTOR; PLASMA-MEMBRANE; PC12 CELLS; C-JUN	Elevated cyclooxygenase-2 (COX-2) expression and activity have been observed in several different transformed cell types that express mutated ras genes. To investigate the mechanism of increased COX-2 expression following Ras-mediated transformation, Rat-1:iRas cell line was transfected with an Ha-Ras(Val-12) cDNA expressions vector that is under the transcriptional control of the lac operon and is inducible with isopropyl-1-thio-beta-D-galactopyranoside (IPTG). IPTG treatment caused parallel increases in the levels of Ha-Ras and COX-2 proteins in Rat-1:iRas cells. The increased expression of COX-2 was accompanied by increased prostaglandin E-2 production. Selective inhibition of COX-2 activity suppressed the production of prostaglandin E-2 by >90% but did not alter the progress of the morphological transformation. The Bevel of COX-2 mRNA was up-regulated by activated Ha-Ras. Induction of Ras increased the transcription of COX-2 by 44.3 +/- 10.1% and increased the half-life of COX-2 mRNA by similar to 3.5-fold. A specific mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) inhibitor (PD 98059) caused a delay in both the activation of ERK1/2 and the induction of COX-2 in IPTG-induced Rat-1:iRas cells. Inhibition of ERK activity by PD 98059 also suppressed the induction of COX-2 by epidermal growth factor in intestinal epithelial cells and significantly reduced the expression of COX-2 in Ha-Ras-transformed rat intestinal epithelial cells. ERK activity appears to be required for induction of COX-2 by Ras.	Vanderbilt Univ, Ctr Med, Ctr Canc, Dept Surg, Nashville, TN 37232 USA; Vanderbilt Univ, Ctr Med, Ctr Canc, Dept Med, Nashville, TN 37232 USA; Vanderbilt Univ, Ctr Med, Ctr Canc, Dept Cell Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Beauchamp, RD (corresponding author), Vanderbilt Univ, Ctr Med, Ctr Canc, Dept Surg, CC-2306,Med Ctr N,1161 21st Ave S, Nashville, TN 37232 USA.		Williams, christopher S/A-1186-2009; DuBois, Raymond N./AAX-8869-2020	Beauchamp, Robert Daniel/0000-0002-8446-4114	NATIONAL CANCER INSTITUTE [R01CA069457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047297, R01DK052334, R37DK047297] Funding Source: NIH RePORTER; NCI NIH HHS [CA-69457] Funding Source: Medline; NIDDK NIH HHS [DK-47297, DK-52334] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Barrie AP, 1997, J BIOL CHEM, V272, P19666, DOI 10.1074/jbc.272.32.19666; BEAUCHAMP RD, 1992, MOL ENDOCRINOL, V6, P1789, DOI 10.1210/me.6.11.1789; BOS JL, 1989, CANCER RES, V49, P4682; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5291; Coffey RJ, 1997, P NATL ACAD SCI USA, V94, P657, DOI 10.1073/pnas.94.2.657; COLEMAN WB, 1994, CARCINOGENESIS, V15, P1005, DOI 10.1093/carcin/15.5.1005; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DuBois RN, 1996, GASTROENTEROLOGY, V110, P1259, DOI 10.1053/gast.1996.v110.pm8613017; DUBOIS RN, 1994, J CLIN INVEST, V93, P493, DOI 10.1172/JCI116998; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; FILMUS J, 1992, ONCOGENE, V7, P521; HALL A, 1994, SCIENCE, V264, P1413, DOI 10.1126/science.8197454; Heasley LE, 1997, J BIOL CHEM, V272, P14501, DOI 10.1074/jbc.272.23.14501; KARIN M, 1994, CURR OPIN CELL BIOL, V6, P415, DOI 10.1016/0955-0674(94)90035-3; Katz ME, 1997, CURR OPIN GENET DEV, V7, P75, DOI 10.1016/S0959-437X(97)80112-8; KHOSRAVIFAR R, 1994, CANCER METAST REV, V13, P67, DOI 10.1007/BF00690419; KHOSRAVIFAR R, 1995, MOL CELL BIOL, V15, P6443; KO TC, 1995, ONCOGENE, V10, P177; LANGECARTER CA, 1994, SCIENCE, V265, P1458, DOI 10.1126/science.8073291; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Masferrer JL, 1996, GASTROENTEROL CLIN N, V25, P363, DOI 10.1016/S0889-8553(05)70252-1; MCCARTHY SA, 1995, GENE DEV, V9, P1953, DOI 10.1101/gad.9.16.1953; MCCORMICK F, 1994, CURR OPIN GENET DEV, V4, P71, DOI 10.1016/0959-437X(94)90093-0; Mestre JR, 1997, CANCER RES, V57, P2890; Oldham SM, 1996, P NATL ACAD SCI USA, V93, P6924, DOI 10.1073/pnas.93.14.6924; ONEILL GP, 1993, FEBS LETT, V330, P156, DOI 10.1016/0014-5793(93)80263-T; PRENDERGAST GC, 1995, ONCOGENE, V10, P2289; PRENDERGAST GC, 1993, ADV CANCER RES, V62, P19, DOI 10.1016/S0065-230X(08)60314-0; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; QUILLIAM LA, 1995, BIOESSAYS, V17, P395, DOI 10.1002/bies.950170507; RISTIMAKI A, 1994, J BIOL CHEM, V269, P11769; Ristimaki A, 1996, BIOCHEM J, V318, P325, DOI 10.1042/bj3180325; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; RUSSELL M, 1995, J BIOL CHEM, V270, P11757, DOI 10.1074/jbc.270.20.11757; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; SCHWARZ LC, 1988, CANCER RES, V48, P6999; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; Sheng GG, 1997, GASTROENTEROLOGY, V113, P1883, DOI 10.1016/S0016-5085(97)70007-6; Sheng HM, 1998, CANCER RES, V58, P362; Sheng HM, 1997, CELL GROWTH DIFFER, V8, P463; Sheng HM, 1997, J CLIN INVEST, V99, P2254, DOI 10.1172/JCI119400; Sirenko OI, 1997, MOL CELL BIOL, V17, P3898, DOI 10.1128/MCB.17.7.3898; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; Subbaramaiah K, 1996, CANCER RES, V56, P4424; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; Williams CS, 1996, AM J PHYSIOL-GASTR L, V270, pG393; XIE WL, 1995, J BIOL CHEM, V270, P27622, DOI 10.1074/jbc.270.46.27622; Xie WL, 1996, J BIOL CHEM, V271, P31742, DOI 10.1074/jbc.271.49.31742; YAN MH, 1994, NATURE, V372, P798; Zhang R, 1997, ONCOGENE, V14, P1607, DOI 10.1038/sj.onc.1200957; ZHAO JM, 1993, EXP CELL RES, V204, P82, DOI 10.1006/excr.1993.1011	58	170	174	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					22120	22127		10.1074/jbc.273.34.22120	http://dx.doi.org/10.1074/jbc.273.34.22120			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705357	hybrid			2022-12-27	WOS:000075492600091
J	Sanderson, RJ; Mosbaugh, DW				Sanderson, RJ; Mosbaugh, DW			Fidelity and mutational specificity of uracil-initiated base excision DNA repair synthesis in human glioblastoma cell extracts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLASE INHIBITOR PROTEIN; HUMAN APURINIC ENDONUCLEASE; POLYMERASE-BETA; ESCHERICHIA-COLI; HELA-CELLS; PURIFIED PROTEINS; MAMMALIAN-CELLS; BOVINE TESTIS; UNG GENE; NUCLEAR	The fidelity of DNA synthesis associated with uracil-initiated base excision repair was measured in human whole cell extracts. An M13mp2 lacZ alpha DNA-based reversion assay was developed to assess the error frequency of DNA repair synthesis at a site-specific uracil residue. All three possible base substitution errors were detected at the uracil target causing reversion of opal codon 14 in the Escherichia coli lacZ alpha gene. Using human glioblastoma U251 whole cell extracts, approximately 50% of the heteroduplex uracil-containing DNA substrate was completely repaired, as determined by the insensitivity of form I DNA reaction products to cleavage by a combined treatment of E. coli uracil-DNA glycosylase and endonuclease IV. The majority of repair occurred by the uracil-initiated base excision repair pathway, since the addition of the bacteriophage PBS2 uracil-DNA glycosylase inhibitor protein to extracts significantly blocked this process. In addition, the formation of repaired form I DNA molecules occurred concurrently with limited DNA synthesis, which was largely restricted to the HinfI DNA fragment initially containing the uracil residue and specific to the uracil-containing DNA strand. Based on the reversion frequency of repaired M13mp2 DNA, the fidelity of DNA repair synthesis at the target was determined to be about one misincorporated nucleotide per 1900 repaired uracil residues. The major class of base substitutions propagated transversion mutations, which were distributed almost equally between T to G and T to A changes in the template. A similar mutation frequency was also observed using whole cell extracts from human colon adenocarcinoma LoVo cells, suggesting that mismatch repair did not interfere with the fidelity measurements.	Oregon State Univ, Dept Agr Chem, Corvallis, OR 97331 USA; Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; Oregon State Univ, Environm Hlth Sci Ctr, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University	Mosbaugh, DW (corresponding author), Oregon State Univ, Dept Agr Chem, Corvallis, OR 97331 USA.				NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032823] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES00210] Funding Source: Medline; NIGMS NIH HHS [GM32823] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn J, 1997, BIOCHEMISTRY-US, V36, P1100, DOI 10.1021/bi961653o; Barrett TE, 1998, CELL, V92, P117, DOI 10.1016/S0092-8674(00)80904-6; Beard WA, 1996, J BIOL CHEM, V271, P12141, DOI 10.1074/jbc.271.21.12141; Bennett RAO, 1997, P NATL ACAD SCI USA, V94, P7166, DOI 10.1073/pnas.94.14.7166; BENNETT SE, 1993, J BIOL CHEM, V268, P26879; BENNETT SE, 1995, BIOCHEMISTRY-US, V34, P6109, DOI 10.1021/bi00018a014; Biade S, 1998, J BIOL CHEM, V273, P898, DOI 10.1074/jbc.273.2.898; BOOSALIS MS, 1989, J BIOL CHEM, V264, P11360; BRANCH P, 1995, CANCER RES, V55, P2304; Caradonna S, 1996, EXP CELL RES, V222, P345, DOI 10.1006/excr.1996.0044; Chagovetz AM, 1997, J BIOL CHEM, V272, P27501, DOI 10.1074/jbc.272.44.27501; DIANOV G, 1992, MOL CELL BIOL, V12, P1605, DOI 10.1128/MCB.12.4.1605; DIANOV G, 1994, CURR BIOL, V4, P1069, DOI 10.1016/S0960-9822(00)00245-1; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; Fortini P, 1998, BIOCHEMISTRY-US, V37, P3575, DOI 10.1021/bi972999h; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Gallinari P, 1996, NATURE, V383, P735, DOI 10.1038/383735a0; HUSAIN I, 1995, J BIOL CHEM, V270, P9683, DOI 10.1074/jbc.270.16.9683; IZUTA S, 1995, J BIOL CHEM, V270, P2595, DOI 10.1074/jbc.270.6.2595; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; KOETSIER PA, 1993, BIOTECHNIQUES, V15, P260; Krokan HE, 1997, BIOCHEM J, V325, P1; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KUNKEL TA, 1986, J BIOL CHEM, V261, P160; LINDAHL T, 1977, J BIOL CHEM, V252, P3286; Lindahl T, 1997, CURR OPIN GENET DEV, V7, P158, DOI 10.1016/S0959-437X(97)80124-4; LONGLEY MJ, 1993, METHOD ENZYMOL, V218, P587; Lundquist AJ, 1997, J BIOL CHEM, V272, P21408, DOI 10.1074/jbc.272.34.21408; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; MATSUMOTO Y, 1994, MOL CELL BIOL, V14, P6187, DOI 10.1128/MCB.14.9.6187; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; MOL CD, 1995, CELL, V82, P701, DOI 10.1016/0092-8674(95)90467-0; MOSBAUGH DW, 1980, J BIOL CHEM, V255, P1743; MOSBAUGH DW, 1994, PROG NUCLEIC ACID RE, V48, P315, DOI 10.1016/S0079-6603(08)60859-4; MOSBAUGH DW, 1983, J BIOL CHEM, V258, P108; MULLER SJ, 1993, J BIOL CHEM, V268, P1310; Nealon K, 1996, NUCLEIC ACIDS RES, V24, P3763, DOI 10.1093/nar/24.19.3763; NEDDERMANN P, 1993, J BIOL CHEM, V268, P21218; NEDDERMANN P, 1994, P NATL ACAD SCI USA, V91, P1642, DOI 10.1073/pnas.91.5.1642; Nicholl ID, 1997, BIOCHEMISTRY-US, V36, P7557, DOI 10.1021/bi962950w; Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; Prasad R, 1996, J BIOL CHEM, V271, P16000, DOI 10.1074/jbc.271.27.16000; Roberts J.D., 1996, DNA REPLICATION EUKA, P217; ROBERTS JD, 1993, BIOCHEMISTRY-US, V32, P4083, DOI 10.1021/bi00066a033; RUSH J, 1989, PREP BIOCHEM, V19, P329, DOI 10.1080/10826068908544921; Sambrook J., 2002, MOL CLONING LAB MANU; SANCAR A, 1995, J BIOL CHEM, V270, P15915, DOI 10.1074/jbc.270.27.15915; SINGHAL RK, 1993, J BIOL CHEM, V268, P15906; SINGHAL RK, 1995, J BIOL CHEM, V270, P949, DOI 10.1074/jbc.270.2.949; SLUPPHAUG G, 1993, NUCLEIC ACIDS RES, V21, P2579, DOI 10.1093/nar/21.11.2579; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; THOMAS DC, 1991, J BIOL CHEM, V266, P3744; UMAR A, 1994, J BIOL CHEM, V269, P14367; WANG Z, 1989, J BIOL CHEM, V264, P1163; Wang ZG, 1997, J BIOL CHEM, V272, P24064, DOI 10.1074/jbc.272.38.24064; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002; Wood Richard D., 1995, Methods (Orlando), V7, P163, DOI 10.1006/meth.1995.1022	60	34	35	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24822	24831		10.1074/jbc.273.38.24822	http://dx.doi.org/10.1074/jbc.273.38.24822			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733786	hybrid			2022-12-27	WOS:000076007300078
J	Tsuda, T; Kaya, S; Yokoyama, T; Hayashi, Y; Taniguchi, K				Tsuda, T; Kaya, S; Yokoyama, T; Hayashi, Y; Taniguchi, K			Half-site modification of Lys-480 of the Na+,K+-ATPase alpha-chain with pyridoxal 5 '-diphospho-5 '-adenosine reduces ATP-dependent phosphorylation stoichiometry from half to a quarter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE-TRIPHOSPHATASE; NA+/K+-ATPASE; CONFORMATIONAL-CHANGES; NA,K-ATPASE; BINDING; SODIUM; K+; IDENTIFICATION; ENZYME; ADP	Pig and dog kidney Na+,K+-ATPase preparations, irrespective of specific activity, showed similar to 0.5 mol of maximum phosphorylation/mol alpha-chain for ATP or acetyl phosphate (AcP) at steady state conditions. Pyridoxal 5'-diphospho-5'-adenosine (AP(2)PL)-treated pig kidney enzymes containing similar to 0.5 mol of AP(2)PL probe at Lys-480/ mol (Tsuda, T., Kaya, S., Funatsu, H., Hayashi, Y., and Taniguchi, K. (1998) J. Biochem. (Tokyo) 123, 169-174) showed a quarter-site phosphorylation by ATP and half-site phosphorylation from AcP. The addition of 10 mu M ATP to the Mg2+-Na+-bound AP(2)PL enzyme induced rapid quarter-site phosphorylation (47/s), followed by two different AP(2)PL fluorescence changes, a rapid decrease (29/s) and a slow increase (1.1/s). The addition of 1 mM AcP to the Mg2+-Na+-bound AP(2)PL enzyme induced a slow half-site phosphorylation (3/s), followed by a monophasic AP(2)PL fluorescence increase (1.2/s). After treatment of the AP(2)PL enzyme with fluorescein 5'-isothiocyanate to modify Lys-501 fully, the Mg2+-Na+-dependent phosphorylation capacity from ATP of the resulting AP(2)PL-fluorescein 5'-isothiocyanate enzyme was reduced to similar to 6% without significant changes in half-site phosphorylation capacity with respect to AcP, dynamic AP(2)PL fluorescence change by ATP and change by AcP. These data and others support the hypothesis that the functional membrane-bound Na+,K+-ATPase has tetrameric properties.	Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 060, Japan; Kyorin Univ, Sch Med, Dept Biochem, Mitaka, Tokyo 181, Japan	Hokkaido University; Kyorin University	Taniguchi, K (corresponding author), Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 060, Japan.							ALBERS RW, 1976, ENZYMES BIOLOGICAL M, V3, P283; ASKARI A, 1987, J BIOENERG BIOMEMBR, V19, P359, DOI 10.1007/BF00768539; BARRABIN H, 1984, BIOCHEMISTRY-US, V23, P1542, DOI 10.1021/bi00302a031; BLOSTEIN R, 1988, METHOD ENZYMOL, V156, P171; DZHANDZHUGAZYAN KN, 1985, SODIUM PUMP, P129; FROEHLICH JP, 1994, SODIUM PUMP, P441; Froehlich JP, 1997, ANN NY ACAD SCI, V834, P280, DOI 10.1111/j.1749-6632.1997.tb52259.x; GLYNN IM, 1985, SODIUM PUMP, P589; HAYASHI Y, 1989, BIOCHIM BIOPHYS ACTA, V983, P217, DOI 10.1016/0005-2736(89)90237-X; Hayashi Y, 1997, ANN NY ACAD SCI, V834, P19, DOI 10.1111/j.1749-6632.1997.tb52222.x; HINZ HR, 1990, J BIOL CHEM, V265, P10260; JENSEN J, 1992, BIOCHIM BIOPHYS ACTA, V1110, P81, DOI 10.1016/0005-2736(92)90297-Y; JORGENSEN PL, 1986, BIOCHEMISTRY-US, V25, P2889; KARLISH SJD, 1980, J BIOENERG BIOMEMBR, V12, P111, DOI 10.1007/BF00744678; KAYA SJ, 1994, J BIOL CHEM, V269, P7419; Liu GQ, 1996, FEBS LETT, V390, P323, DOI 10.1016/0014-5793(96)00687-4; Lutsenko S, 1997, J BIOL CHEM, V272, P5249, DOI 10.1074/jbc.272.8.5249; MATSUI H, 1983, CURR TOP MEMBR TRANS, V19, P141; NAGAI M, 1986, J BIOL CHEM, V261, P3197; NAKAMURA Y, 1989, J BIOCHEM-TOKYO, V115, P454; NORBY JG, 1983, J GEN PHYSIOL, V82, P725, DOI 10.1085/jgp.82.6.725; NORBY JG, 1991, SOC GEN PHY, V46, P173; OTTOLENGHI P, 1985, SODIUM PUMP, P219; PEDEMONTE CH, 1990, AM J PHYSIOL, V258, pC1, DOI 10.1152/ajpcell.1990.258.1.C1; PELUFFO RD, 1994, J BIOL CHEM, V269, P1051; Plesner IW, 1997, ANN NY ACAD SCI, V834, P412, DOI 10.1111/j.1749-6632.1997.tb52286.x; POST RL, 1969, J GEN PHYSIOL, V54, pS306, DOI 10.1085/jgp.54.1.306; POST RL, 1972, J BIOL CHEM, V247, P6530; REPKE KRH, 1986, BIOCHIM BIOPHYS ACTA, V864, P195, DOI 10.1016/0304-4157(86)90011-0; ROBINSON JD, 1993, BIOCHIM BIOPHYS ACTA, V1154, P83, DOI 10.1016/0304-4157(93)90018-J; SARVAZYAN NA, 1995, J BIOL CHEM, V270, P26528, DOI 10.1074/jbc.270.44.26528; SCHEINERBOBIS G, 1993, BIOCHEMISTRY-US, V32, P9592, DOI 10.1021/bi00088a011; SCHONER W, 1994, SODIUM PUMP, P332; TANIGUCHI K, 1993, J BIOL CHEM, V268, P15588; TANIGUCHI K, 1984, J BIOL CHEM, V259, P5228; TANIGUCHI K, 1982, J BIOL CHEM, V257, P659; TANIGUCHI K, 1988, J BIOL CHEM, V263, P12943; TANIMURA A, 1986, Journal of Experimental Pathology (New York), V2, P261; Thoenges D, 1997, J BIOL CHEM, V272, P16315, DOI 10.1074/jbc.272.26.16315; Tsuda T, 1998, J BIOCHEM, V123, P169; Tsuda T, 1998, J BIOL CHEM, V273, P24339, DOI 10.1074/jbc.273.38.24339; Tsuda T, 1997, ANN NY ACAD SCI, V834, P186, DOI 10.1111/j.1749-6632.1997.tb52250.x; Ward DG, 1996, J BIOL CHEM, V271, P12317, DOI 10.1074/jbc.271.21.12317; XU KY, 1989, BIOCHEMISTRY-US, V28, P5764, DOI 10.1021/bi00440a010; YAMAZAKI A, 1994, J BIOCHEM, V116, P1360, DOI 10.1093/oxfordjournals.jbchem.a124688	45	22	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24334	24338		10.1074/jbc.273.38.24334	http://dx.doi.org/10.1074/jbc.273.38.24334			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733720	hybrid			2022-12-27	WOS:000076007300012
J	Mandrup, S; Sorensen, RV; Helledie, T; Nohr, J; Baldursson, T; Gram, C; Knudsen, J; Kristiansen, K				Mandrup, S; Sorensen, RV; Helledie, T; Nohr, J; Baldursson, T; Gram, C; Knudsen, J; Kristiansen, K			Inhibition of 3T3-L1 adipocyte differentiation by expression of acyl-CoA-binding protein antisense RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-ALPHA; PEROXISOME PROLIFERATOR; FATTY-ACIDS; ADIPOSE CONVERSION; PPAR-GAMMA; CELLS; ADIPOGENESIS; METABOLISM; INDUCTION; INVOLVEMENT	Several lines of evidence have recently underscored the significance of fatty acids or fatty acid-derived metabolites as signaling molecules in adipocyte differentiation. The acyl-CoA-binding protein (ACBP), which functions as an intracellular acyl-CoA pool former and transporter, is induced during adipocyte differentiation. in this report we describe the effects of expression of high levels of ACBP antisense RNA on the differentiation of 3T3-L1 cells. Pools of 3T3-L1 cells transfected with vectors expressing ACBP antisense RNA showed significantly less Lipid accumulation as compared with cells transfected with the control vector. When individual clones were analyzed the degree of differentiation at day 10 was inversely correlated with the level of ACBP antisense RNA expression at day 0, Furthermore, in the clones with the highest levels of ACBP antisense expression, the induction of expression of the adipogenic transcription factors peroxisome proliferator-activated receptor gamma and CCAAT/enhancer-binding protein alpha as well as several adipocyte-specific genes was significantly delayed and reduced. The adipogenic potential of antisense-expressing cells was partially restored by transfection with a vector expressing high levels of ACBP. Taken together, these results are strong evidence that inhibition of differentiation is causally related to the decreased expression of ACBP, indicating that ACBP plays an important role during adipocyte differentiation.	Odense Univ, Dept Mol Biol, DK-5230 Odense M, Denmark; Odense Univ, Inst Biochem, DK-5230 Odense, Denmark	University of Southern Denmark; University of Southern Denmark	Mandrup, S (corresponding author), Odense Univ, Dept Mol Biol, Campusvej 55, DK-5230 Odense M, Denmark.		Kristiansen, Karsten/J-5148-2014; Mandrup, Susanne/B-6693-2008	Kristiansen, Karsten/0000-0002-6024-0917; Mandrup, Susanne/0000-0002-0961-5787				Adams M, 1997, J CLIN INVEST, V100, P3149, DOI 10.1172/JCI119870; AMRI EZ, 1994, J LIPID RES, V35, P930; AMRI EZ, 1995, J BIOL CHEM, V270, P2367, DOI 10.1074/jbc.270.5.2367; BASS NM, 1993, MOL CELL BIOCHEM, V123, P191, DOI 10.1007/BF01076492; Brandes R, 1995, BIOCHEM PHARMACOL, V50, P1949, DOI 10.1016/0006-2952(95)02082-9; Brun RP, 1996, GENE DEV, V10, P974, DOI 10.1101/gad.10.8.974; CHAWLA A, 1994, P NATL ACAD SCI USA, V91, P1786, DOI 10.1073/pnas.91.5.1786; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DIRUSSO CC, 1992, J BIOL CHEM, V267, P8685; Faergeman NJ, 1997, BIOCHEM J, V323, P1; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; GAILLARD D, 1989, BIOCHEM J, V257, P389, DOI 10.1042/bj2570389; Glatz JFC, 1996, PROG LIPID RES, V35, P243, DOI 10.1016/S0163-7827(96)00006-9; HANSEN HO, 1991, BIOCHEM J, V277, P341, DOI 10.1042/bj2770341; HAUNER H, 1990, ENDOCRINOLOGY, V127, P865, DOI 10.1210/endo-127-2-865; HERTZ R, 1994, EUR J BIOCHEM, V221, P611, DOI 10.1111/j.1432-1033.1994.tb18773.x; JENSEN TG, 1992, BIOCHIM BIOPHYS ACTA, V1180, P65, DOI 10.1016/0925-4439(92)90028-L; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; KLYDE BJ, 1979, J LIPID RES, V20, P705; KNUDSEN J, 1994, BIOCHEM J, V302, P479, DOI 10.1042/bj3020479; KNUDSEN J, 1993, MOL CELL BIOCHEM, V123, P129, DOI 10.1007/BF01076484; KURIHARCUCH W, 1983, J CELL PHYSIOL, V114, P39, DOI 10.1002/jcp.1041140107; KURIHARCUCH W, 1978, P NATL ACAD SCI USA, V75, P6107, DOI 10.1073/pnas.75.12.6107; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; MACDOUGALD OA, 1994, J BIOL CHEM, V269, P19041; MANDRUP S, 1993, BIOCHEM J, V290, P369, DOI 10.1042/bj2900369; Mandrup S, 1997, J BIOL CHEM, V272, P5367, DOI 10.1074/jbc.272.9.5367; OWENS GP, 1989, MOL BRAIN RES, V6, P101, DOI 10.1016/0169-328X(89)90043-0; PAIRAULT J, 1979, P NATL ACAD SCI USA, V76, P5138, DOI 10.1073/pnas.76.10.5138; RASMUSSEN JT, 1994, BIOCHEM J, V299, P165, DOI 10.1042/bj2990165; RASMUSSEN JT, 1993, BIOCHEM J, V292, P907, DOI 10.1042/bj2920907; Sambrook J., 2002, MOL CLONING LAB MANU; SAMUELSSON L, 1991, EMBO J, V10, P3787, DOI 10.1002/j.1460-2075.1991.tb04948.x; SANDOUK T, 1993, AM J PHYSIOL, V264, pC1600, DOI 10.1152/ajpcell.1993.264.6.C1600; Schjerling CK, 1996, J BIOL CHEM, V271, P22514, DOI 10.1074/jbc.271.37.22514; SCHMIDT W, 1990, J BIOL CHEM, V265, P15489; SHILLABEER G, 1994, J LIPID RES, V35, P592; SHILLABEER G, 1989, J CLIN INVEST, V84, P381, DOI 10.1172/JCI114177; TEBOUL L, 1995, J BIOL CHEM, V270, P28183, DOI 10.1074/jbc.270.47.28183; WIBORG O, 1985, EMBO J, V4, P755, DOI 10.1002/j.1460-2075.1985.tb03693.x; Xue JC, 1996, MOL CELL BIOL, V16, P1567	44	51	52	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23897	23903		10.1074/jbc.273.37.23897	http://dx.doi.org/10.1074/jbc.273.37.23897			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727003	hybrid			2022-12-27	WOS:000075893100044
J	McCarthy, JV; Dixit, VM				McCarthy, JV; Dixit, VM			Apoptosis induced by Drosophila Reaper and Grim in a human system - Attenuation by inhibitor of apoptosis proteins (cIAPs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; CAENORHABDITIS-ELEGANS; SIGNAL-TRANSDUCTION; BACULOVIRUS IAP; MAMMALIAN-CELLS; GENE; PROTEASES; FAMILY; P35; EXPRESSION	Previous genetic studies have established Reaper and Grim as central regulators of apoptosis in Drosophila melanogaster. Reaper and Grim induce extensive apoptosis in Drosophila, yet share no homology to known vertebrate proteins. In this study, we show for the first time that ectopic expression of Reaper or Grim induced substantial apoptosis in mammalian cells. Reaper- or Grim-induced apoptosis was inhibited by a broad range of caspase inhibitors and by human inhibitor of apoptosis proteins cIAP1 and cIAP2. Additionally, in vivo binding studies demonstrated that both Reaper and Grim physically interacted with human IAPs through a homologous 15-amino acid N-terminal segment. Deletion of this segment from either Reaper or Grim abolished binding to cIAPs. In vitro binding experiments indicated that Reaper and Grim bound specifically to the BIR domain-containing region of cIAPs as deletion of this region resulted in loss of binding, The physical interaction was further confirmed by immunolocalization. When co-expressed, Reaper or Grim co-localized with cIAP1. However, deletion of the N-terminal 15 amino acids of Reaper or Grim abolished co-localization with cIAP1, suggesting that this homologous region can serve as a protein-protein interacting domain in regulating cell death, Moreover, by virtue of this interaction, we demonstrate that cIAPs can regulate Reaper and Grim by abrogating their ability to activate caspases and thereby inhibit apoptosis. This is the first function attributed to this 15-amino acid N-terminal domain that is the only region having significant homology between these Drosophila death inducers.	Genentech Inc, Dept Mol Oncol, S San Francisco, CA 94080 USA	Roche Holding; Genentech	Dixit, VM (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way,Bldg 10,Room 290, S San Francisco, CA 94080 USA.		dixit, vishva m/A-4496-2012; mccarthy, justin/AAG-7550-2019	dixit, vishva m/0000-0001-6983-0326; mccarthy, justin/0000-0002-2667-7365				ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; BIRNBAUM MJ, 1994, J VIROL, V68, P2521, DOI 10.1128/JVI.68.4.2521-2528.1994; BUMP NJ, 1995, SCIENCE, V269, P1885, DOI 10.1126/science.7569933; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4573; Chinnaiyan AM, 1997, SCIENCE, V275, P1122, DOI 10.1126/science.275.5303.1122; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; CLEM RJ, 1994, MOL CELL BIOL, V14, P5212, DOI 10.1128/MCB.14.8.5212; CLEM RJ, 1994, APOPTOSIS, V2, P89; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Hawkins CJ, 1996, P NATL ACAD SCI USA, V93, P13786, DOI 10.1073/pnas.93.24.13786; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; HAY BA, 1994, DEVELOPMENT, V120, P2121; HENGARTNER MO, 1994, CURR OPIN GENET DEV, V4, P581, DOI 10.1016/0959-437X(94)90076-F; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Hu SM, 1997, J BIOL CHEM, V272, P9621; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Pronk GJ, 1996, SCIENCE, V271, P808, DOI 10.1126/science.271.5250.808; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974; VAUX DL, 1992, SCIENCE, V258, P1955, DOI 10.1126/science.1470921; VUICI D, 1997, P NATL ACAD SCI USA, V94, P10183; White E, 1996, GENE DEV, V10, P1, DOI 10.1101/gad.10.1.1; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Wyllie A H, 1980, Int Rev Cytol, V68, P251	35	86	96	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24009	24015		10.1074/jbc.273.37.24009	http://dx.doi.org/10.1074/jbc.273.37.24009			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727017	hybrid			2022-12-27	WOS:000075893100058
J	Raventos, D; Skriver, K; Schlein, M; Karnahl, K; Rogers, SW; Rogers, JC; Mundy, J				Raventos, D; Skriver, K; Schlein, M; Karnahl, K; Rogers, SW; Rogers, JC; Mundy, J			HRT, a novel zinc finger, transcriptional repressor from barley	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMYLASE GENE; GIBBERELLIN RESPONSE COMPLEX; ALEURONE CELLS; SIGNAL-TRANSDUCTION; ABSCISIC-ACID; PROTEINS BIND; PROMOTER; ARABIDOPSIS; ELEMENTS; DNA	A barley gene encoding a novel DNA-binding protein (HRT) was identified by southwestern screening with baits containing a gibberellin phytohormone response element from an alpha-amylase promoter. The HRT gene contains two introns, the larger of which (5722 base pairs (bp)) contains a 3094-bp LINE-like element with homology to maize Colonist1. In vitro mutagenesis and zinc- and DNA-binding assays demonstrate that HRT contains three unusual zinc fingers with a CX8-9CX10CX2H consensus sequence. HRT is targeted to nuclei, and homologues are expressed in other plants. In vivo, functional tests in plant cells indicate that full-length HRT can repress expression from certain promoters including the Amy1/6-4 and Amy2/32 alpha-amylase promoters. In contrast, truncated forms of HRT containing DNA-binding domains can activate, or derepress, transcription from these promoters. Northern hybridizations indicate that HRT mRNA accumulates to low levels in various tissues. Roles for HRT in mediating developmental and phytohormone-responsive gene expression are discussed.	Univ Copenhagen, Inst Mol Biol, DK-1353 Copenhagen K, Denmark; Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	University of Copenhagen; Washington State University	Mundy, J (corresponding author), Univ Copenhagen, Inst Mol Biol, Oster Farimagsgade 2A, DK-1353 Copenhagen K, Denmark.		mundy, john/A-2361-2013; Skriver, Karen/K-9860-2014	mundy, john/0000-0001-7490-4588; Skriver, Karen/0000-0003-2225-4012	NIGMS NIH HHS [GM52427] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052427] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; BRUCE WB, 1990, PLANT CELL, V2, P1081, DOI 10.1105/tpc.2.11.1081; BRUCE WB, 1989, P NATL ACAD SCI USA, V86, P9692, DOI 10.1073/pnas.86.24.9692; CAROL P, 1995, PLANTA, V197, P414, DOI 10.1007/BF00202665; Chen XF, 1997, PLANT J, V11, P363, DOI 10.1046/j.1365-313X.1997.11030363.x; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FROMM ME, 1990, BIO-TECHNOL, V8, P833, DOI 10.1038/nbt0990-833; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; GRANDBASTIEN MA, 1992, TRENDS GENET, V8, P103, DOI 10.1016/0168-9525(92)90198-D; GUBLER F, 1992, PLANT CELL, V4, P1435; GUBLER F, 1995, PLANT CELL, V7, P1879, DOI 10.1105/tpc.7.11.1879; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HOECKER U, 1995, GENE DEV, V9, P2459, DOI 10.1101/gad.9.20.2459; HOOLEY R, 1994, PLANT MOL BIOL, V26, P1529, DOI 10.1007/BF00016489; Jacobsen SE, 1996, P NATL ACAD SCI USA, V93, P9292, DOI 10.1073/pnas.93.17.9292; Jones HD, 1998, PLANT CELL, V10, P245, DOI 10.1105/tpc.10.2.245; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Kuo AL, 1996, PLANT CELL, V8, P259, DOI 10.1105/tpc.8.2.259; LANAHAN MB, 1992, PLANT CELL, V4, P203, DOI 10.1105/tpc.4.2.203; LUTZ S, 1996, MAIZE GENET COOP NEW, V70, P59; Meshi T, 1995, PLANT CELL PHYSIOL, V36, P1405; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; MUNDY J, 1986, PLANT PHYSIOL, V81, P630, DOI 10.1104/pp.81.2.630; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nagy F., 1988, PLANT MOL BIOL MAN B, VB4, P1; Ogas J, 1997, SCIENCE, V277, P91, DOI 10.1126/science.277.5322.91; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Penson SP, 1996, PLANT CELL, V8, P2325, DOI 10.1105/tpc.8.12.2325; ROGERS JC, 1995, PLANT J, V7, P221, DOI 10.1046/j.1365-313X.1995.7020221.x; ROGERS JC, 1985, J BIOL CHEM, V260, P3731; ROGERS JC, 1992, PLANT CELL, V4, P1443, DOI 10.1105/tpc.4.11.1443; ROGERS JC, 1994, PLANT PHYSIOL, V105, P151, DOI 10.1104/pp.105.1.151; Rushton PJ, 1995, PLANT MOL BIOL, V29, P691, DOI 10.1007/BF00041160; RUSHTON PJ, 1992, PLANT MOL BIOL, V19, P891, DOI 10.1007/BF00040522; SCHIFF LA, 1988, P NATL ACAD SCI USA, V85, P4195, DOI 10.1073/pnas.85.12.4195; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; SINGH H, 1989, BIOTECHNIQUES, V7, P252; SKRIVER K, 1991, P NATL ACAD SCI USA, V88, P7266, DOI 10.1073/pnas.88.16.7266; SUTLIFF TD, 1993, PLANT CELL, V5, P1681, DOI 10.1105/tpc.5.11.1681; Swain SM, 1996, PLANT PHYSIOL, V112, P11, DOI 10.1104/pp.112.1.11; Takatsuji H, 1996, J BIOL CHEM, V271, P23368, DOI 10.1074/jbc.271.38.23368; VANDERKROL AR, 1991, PLANT CELL, V3, P667, DOI 10.1105/tpc.3.7.667; VARAGONA MJ, 1992, PLANT CELL, V4, P1213, DOI 10.1105/tpc.4.10.1213; VONARNIM AG, 1994, CELL, V79, P1035, DOI 10.1016/0092-8674(94)90034-5; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x	47	58	70	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23313	23320		10.1074/jbc.273.36.23313	http://dx.doi.org/10.1074/jbc.273.36.23313			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722564	hybrid			2022-12-27	WOS:000075778100064
J	Askwith, CC; Kaplan, J				Askwith, CC; Kaplan, J			Site-directed mutagenesis of the yeast multicopper oxidase Fet3p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON UPTAKE; SACCHAROMYCES-CEREVISIAE; FERRIC REDUCTASE; CERULOPLASMIN; GENE; FERROXIDASE; TRANSPORT; HOMOLOG	High affinity iron transport in yeast is mediated by two proteins, Fet3p and Ftr1p. The multicopper oxidase Fet3p is thought to convert extracellular ferrous iron to ferric iron, which then crosses the plasma membrane through the permease Ftr1p, Fet3p is capable of oxidizing other substrates, such as p-phenylenediamine, and there is still a question of whether it is the ferroxidase activity that is essential for iron transport. Fet3p is also required for Ftr1p localization to the cell surface, making it difficult to prove a direct role for Fet3p oxidase in high affinity iron transport. In an attempt to generate Fet3p specifically lacking ferroxidase activity, we used site-directed mutagenesis to alter residues within Fet3p that had been suggested to impart iron oxidase activity. These substitutions resulted in either a loss or retention of both p-phenylenediamine and ferroxidase activities, indicating that the ability of Fet3p to act as a ferroxidase involves other amino acids. Inactive Fet3p, however, did mediate Ftr1p localization to the cell surface but did not mediate high affinity iron transport. These observations indicate that the ferroxidase activity of Fet3p is intrinsically required for high affinity iron transport.	Univ Utah, Sch Med, Dept Pathol, Div Cell Biol & Immunol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Kaplan, J (corresponding author), Univ Utah, Sch Med, Dept Pathol, Div Cell Biol & Immunol, 50 N Med Dr, Salt Lake City, UT 84132 USA.				NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030534, R01DK030534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007464] Funding Source: NIH RePORTER; NCI NIH HHS [CA 42014] Funding Source: Medline; NIDDK NIH HHS [DK30534] Funding Source: Medline; NIGMS NIH HHS [T32 GM07464] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Askwith C, 1997, J BIOL CHEM, V272, P401; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; DANCIS A, 1992, P NATL ACAD SCI USA, V89, P3869, DOI 10.1073/pnas.89.9.3869; DANCIS A, 1990, MOL CELL BIOL, V10, P2294, DOI 10.1128/MCB.10.5.2294; deSilva D, 1997, J BIOL CHEM, V272, P14208, DOI 10.1074/jbc.272.22.14208; DESILVA DM, 1995, J BIOL CHEM, V270, P1098, DOI 10.1074/jbc.270.3.1098; EIDE D, 1992, J BIOL CHEM, V267, P20774; FRIEDEN B, 1976, EXP BIOL MED, V74, P505; MESSERSCHMIDT A, 1990, EUR J BIOCHEM, V187, P341, DOI 10.1111/j.1432-1033.1990.tb15311.x; Murphy MEP, 1997, PROTEIN SCI, V6, P761; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; WILLIAMS DM, 1974, AM J PHYSIOL, V227, P1094, DOI 10.1152/ajplegacy.1974.227.5.1094; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632	13	53	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22415	22419		10.1074/jbc.273.35.22415	http://dx.doi.org/10.1074/jbc.273.35.22415			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712864	hybrid			2022-12-27	WOS:000075616600040
J	Li, LT; Kaplan, J				Li, LT; Kaplan, J			Defects in the yeast high affinity iron transport system result in increased metal sensitivity because of the increased expression of transporters with a broad transition metal specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE ENCODES; COPPER DETOXIFICATION; VACUOLAR FUNCTION; GENE; PROTEIN; MUTANTS; RESISTANCE; NRAMP2	Yeast with defects in vacuolar pH show increased sensitivity to high concentrations of transition metals. This sensitivity has been presumed to result from defective metal storage. We demonstrate that mutations that result in a defective high affinity iron transport system, such as a deletion in the surface ferroxidase FET3, also result in increased metal sensitivity independent of vacuolar function. Multiple copies of transition metal transporter resistance genes, such as COTI or ZRC1, do not reduce the metal sensitivity of fet3 mutations. Increased metal sensitivity is because of an increased cellular accumulation of transition metals resulting from the increased activity of low affinity iron transporters, such as FET4, that mediates the transport of other transition metals. In cells lacking a high affinity iron transport system, the increased transition metal uptake can be prevented by increased extracellular iron. These results suggest that vacuolar function may not be required for transition metal sequestration.	Univ Utah, Sch Med, Dept Pathol, Div Cell Biol & Immunol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Kaplan, J (corresponding author), Univ Utah, Sch Med, Dept Pathol, Div Cell Biol & Immunol, Salt Lake City, UT 84132 USA.				NCI NIH HHS [CA 42014] Funding Source: Medline; NIDDK NIH HHS [DK-30534] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030534, R01DK030534] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMBERG DC, 1995, YEAST, V11, P1275, DOI 10.1002/yea.320111307; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; BODE HP, 1995, EUR J BIOCHEM, V228, P337; CONKLIN DS, 1992, MOL CELL BIOL, V12, P3678, DOI 10.1128/MCB.12.9.3678; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; Dix D, 1997, J BIOL CHEM, V272, P11770, DOI 10.1074/jbc.272.18.11770; DIX DR, 1994, J BIOL CHEM, V269, P26092; EIDE DJ, 1993, MOL GEN GENET, V241, P447, DOI 10.1007/BF00284699; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Gaxiola RA, 1998, P NATL ACAD SCI USA, V95, P4046, DOI 10.1073/pnas.95.7.4046; GREENE JR, 1993, MOL GEN GENET, V241, P542, DOI 10.1007/BF00279896; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Huang LP, 1997, NAT GENET, V17, P292, DOI 10.1038/ng1197-292; Iyer V, 1996, P NATL ACAD SCI USA, V93, P5208, DOI 10.1073/pnas.93.11.5208; KAMIZONO A, 1989, MOL GEN GENET, V219, P161, DOI 10.1007/BF00261172; KITAMOTO K, 1988, J BACTERIOL, V170, P2687, DOI 10.1128/jb.170.6.2687-2691.1988; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; Li ZS, 1996, J BIOL CHEM, V271, P6509, DOI 10.1074/jbc.271.11.6509; Liu XF, 1997, J BIOL CHEM, V272, P11763, DOI 10.1074/jbc.272.18.11763; Pinner E, 1997, J BIOL CHEM, V272, P28933, DOI 10.1074/jbc.272.46.28933; Radisky DC, 1997, P NATL ACAD SCI USA, V94, P5662, DOI 10.1073/pnas.94.11.5662; Ramsay LM, 1997, FEMS MICROBIOL LETT, V152, P293, DOI 10.1016/S0378-1097(97)00213-9; Sambrook J., 2002, MOL CLONING LAB MANU; SHERMAN F, 1989, METHODS YEAST GENETI; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; Szczypka MS, 1997, YEAST, V13, P1423, DOI 10.1002/(SICI)1097-0061(199712)13:15<1423::AID-YEA190>3.3.CO;2-3; Yuan DS, 1997, J BIOL CHEM, V272, P25787, DOI 10.1074/jbc.272.41.25787; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632	30	132	139	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22181	22187		10.1074/jbc.273.35.22181	http://dx.doi.org/10.1074/jbc.273.35.22181			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712830	hybrid			2022-12-27	WOS:000075616600006
J	Sastre, M; Turner, RS; Levy, E				Sastre, M; Turner, RS; Levy, E			X11 interaction with beta-amyloid precursor protein modulates its cellular stabilization and reduces amyloid beta-protein secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE-BINDING DOMAIN; ALZHEIMERS-DISEASE; HIPPOCAMPAL-NEURONS; CYTOPLASMIC DOMAIN; NEURITE OUTGROWTH; TRANSGENIC MICE; DISTINCT SITES; GROWTH-FACTOR; FE65 PROTEIN; PC12 CELLS	The protein interaction domain of the neuronal protein X11 binds to the YENPTY motif within the cytoplasmic domain of beta-amyloid precursor protein (beta APP). Amyloid-beta protein (A beta), the major constituent of the amyloid deposited in brain of Alzheimer's disease patients, is generated by proteolytic processing of beta APP, which occurs in part following beta APP internalization. Because the YENPTY motif has a role in the internalization of beta APP, the effect of X11 binding on beta APP processing was studied in mouse neuroblastoma N2a, human embryonic kidney 293, monkey kidney COS-1, and human glial U251 cell lines transfected with wild type or mutated beta APP cDNAs. Secretion of soluble beta APP via alpha-secretase activity increased significantly in cells transfected with beta APP variants containing mutations that impair interaction with X11 when compared with cells transfected with wild type cDNA Cotransfection of beta APP and X11 caused retention of cellular beta APP, decreased secretion of s beta APP alpha, and decreased AP secretion. Thus, beta APP interaction with the protein interaction domain of X11 stabilizes cellular beta APP and thereby participates in the regulation of beta APP processing pathways.	NYU, Med Ctr, Dept Pharmacol, New York, NY 10016 USA; NYU, Med Ctr, Dept Pathol, New York, NY 10016 USA; Univ Michigan, Med Ctr, Dept Neurol, Ann Arbor, MI 48109 USA	New York University; New York University; University of Michigan System; University of Michigan	Levy, E (corresponding author), NYU, Med Ctr, Dept Pharmacol, 550 1st Ave, New York, NY 10016 USA.		Turner, Raymond Scott/G-2263-2011	Turner, Raymond Scott/0000-0001-7534-2935	NATIONAL INSTITUTE ON AGING [P50AG008671, R01AG013705] Funding Source: NIH RePORTER; NIA NIH HHS [P50 AG008671, AG13705] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BLAIKIE P, 1994, J BIOL CHEM, V269, P32031; Borg JP, 1996, MOL CELL BIOL, V16, P6229; BORK P, 1995, CELL, V80, P693, DOI 10.1016/0092-8674(95)90347-X; BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Bressler SL, 1996, HUM MOL GENET, V5, P1589, DOI 10.1093/hmg/5.10.1589; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; DESTROOPER B, 1993, J CELL BIOL, V121, P295, DOI 10.1083/jcb.121.2.295; DUCLOS F, 1993, P NATL ACAD SCI USA, V90, P109, DOI 10.1073/pnas.90.1.109; DUILIO A, 1991, NUCLEIC ACIDS RES, V19, P5269, DOI 10.1093/nar/19.19.5269; DYRKS T, 1994, FEBS LETT, V349, P210, DOI 10.1016/0014-5793(94)00671-7; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; FARAONIO R, 1994, NUCLEIC ACIDS RES, V22, P4876, DOI 10.1093/nar/22.23.4876; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; GABUZDA D, 1993, J NEUROCHEM, V61, P2326, DOI 10.1111/j.1471-4159.1993.tb07479.x; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Guenette SY, 1996, P NATL ACAD SCI USA, V93, P10832, DOI 10.1073/pnas.93.20.10832; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1991, J NEUROSCI, V11, P3783; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KAVANAUGH WM, 1994, SCIENCE, V266, P1862, DOI 10.1126/science.7527937; Koo EH, 1997, MOL MED, V3, P204, DOI 10.1007/BF03401673; KOO EH, 1994, J BIOL CHEM, V269, P17386; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; KUENTZEL SL, 1993, BIOCHEM J, V295, P367, DOI 10.1042/bj2950367; LAI A, 1995, J BIOL CHEM, V270, P3565, DOI 10.1074/jbc.270.8.3565; LARNER AJ, 1995, BIOESSAYS, V17, P819, DOI 10.1002/bies.950170912; LEBLANC AC, 1994, BIOCHEM BIOPH RES CO, V204, P1371, DOI 10.1006/bbrc.1994.2615; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MATTSON MP, 1994, J NEUROBIOL, V25, P439, DOI 10.1002/neu.480250409; McLoughlin DM, 1996, FEBS LETT, V397, P197; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; NINOMIYA H, 1993, J CELL BIOL, V121, P879, DOI 10.1083/jcb.121.4.879; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; Peraus GC, 1997, J NEUROSCI, V17, P7714; QIU WQ, 1995, J NEUROSCI, V15, P2157, DOI 10.1523/JNEUROSCI.15-03-02157.1995; SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2; SAMBAMURTI K, 1992, J NEUROSCI RES, V33, P319, DOI 10.1002/jnr.490330216; SATO T, 1995, SCIENCE, V268, P411, DOI 10.1126/science.7536343; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHDOJI M, 1992, SCIENCE, V258, P126; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Tienari PJ, 1997, P NATL ACAD SCI USA, V94, P4125, DOI 10.1073/pnas.94.8.4125; Turner RS, 1996, J BIOL CHEM, V271, P8966, DOI 10.1074/jbc.271.15.8966; VASILAKOS JP, 1994, FEBS LETT, V354, P289, DOI 10.1016/0014-5793(94)01142-7; Wei LH, 1998, J BIOL CHEM, V273, P11806, DOI 10.1074/jbc.273.19.11806; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; XU HX, 1995, J BIOL CHEM, V270, P23243, DOI 10.1074/jbc.270.40.23243; Yamazaki T, 1996, J CELL SCI, V109, P999; Zambrano N, 1997, J BIOL CHEM, V272, P6399, DOI 10.1074/jbc.272.10.6399; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141	62	127	130	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22351	22357		10.1074/jbc.273.35.22351	http://dx.doi.org/10.1074/jbc.273.35.22351			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712855	hybrid			2022-12-27	WOS:000075616600031
J	Berg, TO; Fengsrud, M; Stromhaug, PE; Berg, T; Seglen, PO				Berg, TO; Fengsrud, M; Stromhaug, PE; Berg, T; Seglen, PO			Isolation and characterization of rat liver amphisomes - Evidence for fusion of autophagosomes with both early and late endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VINBLASTINE-INDUCED AUTOPHAGOCYTOSIS; LYSOSOMAL ACID-PHOSPHATASE; CATHEPSIN-C SUBSTRATE; PROTEIN-DEGRADATION; ENDOCYTIC PATHWAYS; MOUSE-LIVER; ASIALOGLYCOPROTEIN ENDOCYTOSIS; PRELYSOSOMAL COMPARTMENT; HEPATOCYTIC AUTOPHAGY; LEUPEPTIN TREATMENT	Amphisomes, the autophagic vacuoles (AVs) formed upon fusion between autophagosomes and endosomes, have so far only been characterized in indirect, functional terms. To enable a physical distinction between autophagosomes and amphisomes, the latter were selectively density-shifted in sucrose gradients following fusion with AOM-gold-loaded endosomes (endosomes made dense by asialoorosomucoid-conjugated gold particles, endocytosed by isolated rat hepatocytes prier to subcellular fractionation). Whereas amphisomes, by this criterion, accounted for only a minor fraction of the AVs in control hepatocytes, treatment of the cells with leupeptin (an inhibitor of lysosomal protein degradation) caused an accumulation of amphisomes to about one-half of the AV population. A quantitative electron microscopic study confirmed that leupeptin induced a severalfold increase in the number of hepatocytic amphi somes (recognized by their gold particle contents; otherwise, their ultrastructure was quite similar to autophagosomes), Leupeptin caused, furthermore, a selective retention of endocytosed AOM-gold in the amphisomes at the expense of the lysosomes, consistent with an inhibition of amphisome-lysosome fusion. The electron micrographs suggested that autophagosomes could undergo multiple independent fusions, with multivesicular (late) endosomes to form amphisomes and with small lysosomes to form large autolysosomes. A biochemical comparison between autophagosomes and amphisomes, purified by a novel procedure, showed that the amphisomes were enriched in early endosome markers (the asialoglycoprotein receptor and the early endosome-associated protein I) as well as in a late endosome marker (the cation-independent mannose 6-phosphate receptor). Amphisomes would thus seem to be capable of receiving inputs both from early and late endosomes.	Norwegian Radium Hosp, Dept Cell Biol, Inst Canc Res, N-0310 Oslo, Norway; Univ Oslo, Dept Biol, Div Mol Cell Biol, N-0316 Oslo, Norway	University of Oslo; University of Oslo	Seglen, PO (corresponding author), Norwegian Radium Hosp, Dept Cell Biol, Inst Canc Res, N-0310 Oslo, Norway.		Brinchmann, Monica Fengsrud/C-2916-2012	Brinchmann, Monica Fengsrud/0000-0002-1222-0743				Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; ARSTILA AU, 1968, AM J PATHOL, V53, P687; BERG T, 1985, EXP CELL RES, V161, P285, DOI 10.1016/0014-4827(85)90086-2; BERG TO, 1994, BIOCHEM J, V300, P229, DOI 10.1042/bj3000229; BERG TO, 1994, EUR J BIOCHEM, V221, P595, DOI 10.1111/j.1432-1033.1994.tb18771.x; Bergmeyer HU, 1974, METHODEN ENZYMATISCH; BERTHIAUME EP, 1995, J CELL BIOL, V129, P989, DOI 10.1083/jcb.129.4.989; BOHLEY P, 1992, EXPERIENTIA, V48, P151, DOI 10.1007/BF01923508; BOLENDER RP, 1973, J CELL BIOL, V56, P746, DOI 10.1083/jcb.56.3.746; COURTOY PJ, 1984, J CELL BIOL, V98, P870, DOI 10.1083/jcb.98.3.870; DAHMS NM, 1989, J BIOL CHEM, V264, P12115; DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923; DUNN WA, 1979, J BIOL CHEM, V254, P4191; DUNN WA, 1990, J CELL BIOL, V110, P1935, DOI 10.1083/jcb.110.6.1935; ERICSSON JL, 1969, EXP CELL RES, V56, P393, DOI 10.1016/0014-4827(69)90030-5; FENGSRUD M, 1995, EXP CELL RES, V221, P504, DOI 10.1006/excr.1995.1402; FERRIS AL, 1987, J CELL BIOL, V105, P2703, DOI 10.1083/jcb.105.6.2703; FURUNO K, 1982, J BIOCHEM-TOKYO, V91, P1485, DOI 10.1093/oxfordjournals.jbchem.a133840; FURUNO K, 1990, EXP CELL RES, V189, P261, DOI 10.1016/0014-4827(90)90245-6; FUTTER CE, 1989, J CELL SCI, V94, P685; GORDON PB, 1992, BIOCHEM J, V283, P361, DOI 10.1042/bj2830361; GORDON PB, 1987, BIOCHEM J, V243, P655, DOI 10.1042/bj2430655; GORDON PB, 1988, BIOCHEM BIOPH RES CO, V151, P40, DOI 10.1016/0006-291X(88)90556-6; GORDON PB, 1982, EXP CELL RES, V142, P1, DOI 10.1016/0014-4827(82)90402-5; GRIFFITHS G, 1990, J CELL SCI, V95, P441; GRINDE B, 1981, H-S Z PHYSIOL CHEM, V362, P549, DOI 10.1515/bchm2.1981.362.1.549; HIMENO M, 1991, BIOCHEM BIOPH RES CO, V180, P1483, DOI 10.1016/S0006-291X(05)81363-4; HOLEN I, 1995, J BIOL CHEM, V270, P12823, DOI 10.1074/jbc.270.21.12823; HOLEN I, 1995, BIOCHEM J, V311, P317, DOI 10.1042/bj3110317; HOPKINS CR, 1990, NATURE, V346, P335, DOI 10.1038/346335a0; HOYVIK H, 1991, J CELL BIOL, V113, P1305, DOI 10.1083/jcb.113.6.1305; HOYVIK H, 1986, EXP CELL RES, V166, P1, DOI 10.1016/0014-4827(86)90503-3; HOYVIK H, 1987, BIOCHEM SOC T, V15, P964, DOI 10.1042/bst0150964; ISHIKAWA T, 1983, EXP CELL RES, V144, P15, DOI 10.1016/0014-4827(83)90436-6; KOLSET SO, 1979, EXP CELL RES, V122, P159, DOI 10.1016/0014-4827(79)90570-6; KOPITZ J, 1990, J CELL BIOL, V111, P941, DOI 10.1083/jcb.111.3.941; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; KOVACS AL, 1982, EXP CELL RES, V137, P191, DOI 10.1016/0014-4827(82)90020-9; LAWRENCE BP, 1992, J CELL SCI, V102, P515; LEHMANN LE, 1992, EMBO J, V11, P4391, DOI 10.1002/j.1460-2075.1992.tb05539.x; Liou W, 1997, J CELL BIOL, V136, P61, DOI 10.1083/jcb.136.1.61; LUIKEN JJFP, 1992, FEBS LETT, V304, P93, DOI 10.1016/0014-5793(92)80596-9; MARZELLA L, 1908, LYSOSOMES THEIR ROLE, P319; MAXFIELD FR, 1982, J CELL BIOL, V95, P676, DOI 10.1083/jcb.95.2.676; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; MULLOCK BM, 1994, J CELL BIOL, V126, P1173, DOI 10.1083/jcb.126.5.1173; PFEIFER U, 1978, J CELL BIOL, V78, P152, DOI 10.1083/jcb.78.1.152; Pfeifer U., 1987, LYSOSOMES THEIR ROLE, P3; PUNNONEN EL, 1993, EUR J CELL BIOL, V61, P54; PUNNONEN EL, 1989, CELL TISSUE RES, V258, P269; RABOUILLE C, 1993, J CELL BIOL, V120, P897, DOI 10.1083/jcb.120.4.897; REUNANEN H, 1985, HISTOCHEMISTRY, V83, P513, DOI 10.1007/BF00492453; REUNANEN H, 1983, HISTOCHEMISTRY, V79, P59, DOI 10.1007/BF00494342; ROTH J, 1978, J HISTOCHEM CYTOCHEM, V26, P1074, DOI 10.1177/26.12.366014; SEGLEN O, 1975, BIOCHEM BIOPH RES CO, V66, P44, DOI 10.1016/S0006-291X(75)80292-0; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; SEGLEN PO, 1985, EXP CELL RES, V157, P550, DOI 10.1016/0014-4827(85)90141-7; SEGLEN PO, 1977, EXP CELL RES, V107, P207, DOI 10.1016/0014-4827(77)90402-5; SEGLEN PO, 1986, BIOMED BIOCHIM ACTA, V45, P1647; SEGLEN PO, 1980, MOL PHARMACOL, V18, P468; SEGLEN PO, 1979, EUR J BIOCHEM, V95, P215, DOI 10.1111/j.1432-1033.1979.tb12956.x; SEGLEN PO, 1976, EXP CELL RES, V100, P276, DOI 10.1016/0014-4827(76)90148-8; SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509; Seglen PO, 1987, LYSOSOMES THEIR ROLE, P369; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; STOORVOGEL W, 1991, CELL, V65, P417, DOI 10.1016/0092-8674(91)90459-C; STROMHAUG PE, 1993, BIOCHEM J, V291, P115, DOI 10.1042/bj2910115; TOLLESHAUG H, 1979, BIOCHIM BIOPHYS ACTA, V585, P71, DOI 10.1016/0304-4165(79)90326-X; TOLLESHAUG H, 1981, EXP CELL RES, V134, P207, DOI 10.1016/0014-4827(81)90478-X; TOOZE J, 1990, J CELL BIOL, V111, P329, DOI 10.1083/jcb.111.2.329; VANDYKE RW, 1993, AM J PHYSIOL, V265, pC901, DOI 10.1152/ajpcell.1993.265.4.C901; YOKOTA S, 1995, EUR J CELL BIOL, V66, P15; ZACHGO S, 1992, J CELL SCI, V103, P811	74	287	295	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21883	21892		10.1074/jbc.273.34.21883	http://dx.doi.org/10.1074/jbc.273.34.21883			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705327	hybrid			2022-12-27	WOS:000075492600061
J	Nickel, V; Prehm, S; Lansing, M; Mausolf, A; Podbielski, A; Deutscher, J; Prehm, P				Nickel, V; Prehm, S; Lansing, M; Mausolf, A; Podbielski, A; Deutscher, J; Prehm, P			An ectoprotein kinase of group C streptococci binds hyaluronan and regulates capsule formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; EXTRACELLULAR ATP; ACID CAPSULE; M-PROTEIN; SYNTHASE; CELL; PYOGENES; SURFACE; PHOSPHORYLATION; GENE	A 56-kDa protein had been isolated and cloned from protoplast membranes of group C streptococci that had erroneously been identified as hyaluronan synthase, The function of this protein was reexamined. When streptococcal membranes were separated on an SDS-polyacrylamide,bel and renatured, a 56-kDa protein was detected that had kinase activity for a casein substrate. When this recombinant protein was expressed in Escherichia coli and incubated in the presence of [P-32]ATP, it was responsible for phosphorylation of two proteins with 30 and 56 kDa that were not present in the control lysate, The 56-kDa protein was specifically phosphorylated in an immunoprecipitate of a detergent extract of the recombinant E. coli lysate with antibodies against the 56-kDa protein, indicating that it was autophosphorylated. The E. coli lysate containing the recombinant protein could bind hyaluronan, and hyaluronan binding was abolished by the addition of ATP, Kinetic analysis of hyaluronan synthesis and release from isolated protoplast membranes indicated that phosphorylation by ATP stimulated hyaluronan release and synthesis. Incubation of membranes with antibodies to the 56-kDa protein increased hyaluronan release. The addition of [P-32]ATP to intact streptococci led to rapid phosphorylation of two proteins, 56 and 75 Ir;Da each at threonine residues. This phosphorylation was neither observed with [P-32]phosphate nor in the presence of trypsin, indicating that the kinase was localized extracellularly. The addition of ATP to growing group C streptococci led to increased hyaluronan synthesis and release,However marl;ed differences were found between group A and group C streptococci, Antibodies against the 56-kDa protein from group C streptococci did not recognize proteins from group A strains, and a homologous DNA sequence could not be detected by polymerase chain reaction or Southern blotting, in addition, Group A streptococci did not retain a large hyaluronan capsule like group C strains. These results indicated that the 56-kDa protein is an ectoprotein kinase specific for group C streptococci that regulates hyaluronan capsule shedding by phosphorylation.	Inst Physiol Chem & Pathobiochem, D-48129 Munster, Germany; Inst Med Mikrobiol & Immunol, D-89081 Ulm, Germany; Inst Biol & Chim Prot, CNRS, F-9367 Lyon, France	Centre National de la Recherche Scientifique (CNRS)	Prehm, P (corresponding author), Inst Physiol Chem & Pathobiochem, Waldeyerstr 15, D-48129 Munster, Germany.	prehm@uni-muenster.de		Prehm, Peter/0000-0002-8063-311X				Apasov SG, 1996, J BIOL CHEM, V271, P25677, DOI 10.1074/jbc.271.41.25677; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; Dale JB, 1996, INFECT IMMUN, V64, P1495, DOI 10.1128/IAI.64.5.1495-1501.1996; DEANGELIS PL, 1994, BIOCHEMISTRY-US, V33, P9033, DOI 10.1021/bi00197a001; DEANGELIS PL, 1993, J BIOL CHEM, V268, P19181; DEANGELIS PL, 1993, J BIOL CHEM, V268, P14568; DEUTSCHER J, 1983, P NATL ACAD SCI-BIOL, V80, P6790, DOI 10.1073/pnas.80.22.6790; DOUGHERTY BA, 1994, J BIOL CHEM, V269, P169; EHRLICH YH, 1990, ANN NY ACAD SCI, V603, P401; ELMOATASSIM C, 1992, BIOCHIM BIOPHYS ACTA, V1134, P31, DOI 10.1016/0167-4889(92)90025-7; FRIEDBERG I, 1995, J BIOL CHEM, V270, P20560, DOI 10.1074/jbc.270.35.20560; GEAHLEN RL, 1986, ANAL BIOCHEM, V153, P151, DOI 10.1016/0003-2697(86)90074-6; GORDON JL, 1986, BIOCHEM J, V233, P309, DOI 10.1042/bj2330309; Kass EH, 1944, J EXP MED, V79, P319, DOI 10.1084/jem.79.3.319; KLEWES L, 1993, BIOCHEM J, V290, P791, DOI 10.1042/bj2900791; KUBLER D, 1982, J BIOL CHEM, V257, P322; LANSING M, 1993, BIOCHEM J, V289, P179, DOI 10.1042/bj2890179; Lukomski S, 1997, J CLIN INVEST, V99, P2574, DOI 10.1172/JCI119445; MAUSOLF A, 1990, BIOCHEM J, V267, P191, DOI 10.1042/bj2670191; Moses AE, 1997, INFECT IMMUN, V65, P64, DOI 10.1128/IAI.65.1.64-71.1997; PREHM P, 1986, BIOCHEM J, V235, P887, DOI 10.1042/bj2350887; PREHM S, 1995, J ANAT, V187, P271; Prehm S, 1996, PROTEIN EXPRES PURIF, V7, P343, DOI 10.1006/prep.1996.0051; Schrager HM, 1996, J CLIN INVEST, V98, P1954, DOI 10.1172/JCI118998; SKUBITZ KM, 1991, J IMMUNOL, V147, P638; SRIVASTAVA DK, 1987, ANNU REV BIOPHYS BIO, V16, P175; VANDERIJN I, 1983, J BACTERIOL, V156, P1059, DOI 10.1128/JB.156.3.1059-1065.1983; Walter J, 1996, J BIOL CHEM, V271, P111, DOI 10.1074/jbc.271.1.111; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WESSELS MR, 1994, P NATL ACAD SCI USA, V91, P12238, DOI 10.1073/pnas.91.25.12238; YANG BH, 1994, EMBO J, V13, P286, DOI 10.1002/j.1460-2075.1994.tb06261.x	33	24	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23668	23673		10.1074/jbc.273.37.23668	http://dx.doi.org/10.1074/jbc.273.37.23668			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726971	hybrid			2022-12-27	WOS:000075893100012
J	Opitz, OG; Jenkins, TD; Rustgi, AK				Opitz, OG; Jenkins, TD; Rustgi, AK			Transcriptional regulation of the differentiation-linked human K4 promoter is dependent upon esophageal-specific nuclear factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K3 KERATIN GENE; TRANSGENIC MICE; EPIDERMOLYTIC HYPERKERATOSIS; INTERMEDIATE FILAMENTS; EPITHELIAL-CELLS; EXPRESSION; ELEMENT; PROTEIN; AP-1; MUTAGENESIS	The stratified squamous epithelium comprises actively proliferating basal cells that undergo a program of differentiation accompanied by morphological, biochemical, and genetic changes. The transcriptional regulatory signals and the genes that orchestrate this snitch from proliferation to differentiation can he studied through the keratin gene family. Givers the localization of keratin 4 (K4) to the early differentiated suprabasal compartment sand leaving previously demonstrated that targeted disruption of this gene in murine embryonic stem cells results in impairment of the normal differentiation program in esophageal and corneal epithelial cells, we studied the transcriptional regulation of the human K4 promoter. A panel of K4 promoter deletions were found in transient transfection assays to be predominantly active in esophageal and corneal cell lines. A critical cis-regulatory element resides between -163 and -140 bp and contains an inverted CACACCT motif. A site-directed mutated version of this motif within the K4 promoter renders it inactive, whereas the wild-type version is active in a heterologous promoter system. It specifically binds esophageal-specific zinc-dependent transcriptional factors. Our studies demonstrate that regulation of the human K4 promoter is in part mediated through tissue-specific transcriptional factors.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Hematol Oncol Unit, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Rustgi, AK (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Jackson 904,50 Blossom St, Boston, MA 02114 USA.	rustgi@helix.mgh.harvard.edu			NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE012467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053377] Funding Source: NIH RePORTER; NIDCR NIH HHS [1P01 DE12467-01A1] Funding Source: Medline; NIDDK NIH HHS [R01-DK53377, 5P30DK43357-08] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andersen B, 1997, GENE DEV, V11, P1873, DOI 10.1101/gad.11.14.1873; Bex F, 1998, MOL CELL BIOL, V18, P2392, DOI 10.1128/MCB.18.4.2392; BLESSING M, 1987, EMBO J, V6, P567, DOI 10.1002/j.1460-2075.1987.tb04792.x; Blobel GA, 1998, P NATL ACAD SCI USA, V95, P2061, DOI 10.1073/pnas.95.5.2061; BONIFAS JM, 1991, SCIENCE, V254, P1202, DOI 10.1126/science.1720261; BYRNE C, 1993, MOL CELL BIOL, V13, P3176, DOI 10.1128/MCB.13.6.3176; BYRNE C, 1994, DEVELOPMENT, V120, P2369; CASATORRES J, 1994, J BIOL CHEM, V269, P20489; CHAN Y, 1994, GENE DEV, V8, P2563; Chen TT, 1997, MOL CELL BIOL, V17, P3056, DOI 10.1128/MCB.17.6.3056; CHENG J, 1992, CELL, V70, P811, DOI 10.1016/0092-8674(92)90314-3; CHUNG DC, 1995, J BIOL CHEM, V270, P8829, DOI 10.1074/jbc.270.15.8829; Eckner R, 1996, GENE DEV, V10, P2478, DOI 10.1101/gad.10.19.2478; FUCHS E, 1994, J CELL BIOL, V125, P511, DOI 10.1083/jcb.125.3.511; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; FUCHS E, 1992, P NATL ACAD SCI USA, V89, P6906, DOI 10.1073/pnas.89.15.6906; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; HATZFELD M, 1990, J CELL BIOL, V110, P1199, DOI 10.1083/jcb.110.4.1199; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jenkins TD, 1997, J BIOL CHEM, V272, P24433, DOI 10.1074/jbc.272.39.24433; Jenkins TD, 1998, J BIOL CHEM, V273, P10747, DOI 10.1074/jbc.273.17.10747; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; LEASK A, 1991, P NATL ACAD SCI USA, V88, P7948, DOI 10.1073/pnas.88.18.7948; LEASK A, 1990, GENE DEV, V4, P1985, DOI 10.1101/gad.4.11.1985; LU B, 1994, J BIOL CHEM, V269, P7443; MACK DH, 1991, P NATL ACAD SCI USA, V88, P9102, DOI 10.1073/pnas.88.20.9102; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Nakagawa H, 1997, ONCOGENE, V14, P1185, DOI 10.1038/sj.onc.1200937; Nakagawa H, 1997, J BIOL CHEM, V272, P16688, DOI 10.1074/jbc.272.26.16688; Ness SL, 1998, J BIOL CHEM, V273, P23904, DOI 10.1074/jbc.273.37.23904; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; Oettgen P, 1997, MOL CELL BIOL, V17, P4419, DOI 10.1128/MCB.17.8.4419; ROTHNAGEL JA, 1992, SCIENCE, V257, P1128, DOI 10.1126/science.257.5073.1128; RUGG EL, 1995, NAT GENET, V11, P450, DOI 10.1038/ng1295-450; RUGG EL, 1994, GENE DEV, V8, P1563; SNAPE AM, 1991, DEVELOPMENT, V113, P283; SNAPE AM, 1990, DEVELOPMENT, V109, P157; TAKAHASHI H, 1995, HISTOPATHOLOGY, V26, P45, DOI 10.1111/j.1365-2559.1995.tb00619.x; TSENG H, 1994, J CELL BIOL, V126, P495, DOI 10.1083/jcb.126.2.495; TSENG H, 1992, P NATL ACAD SCI USA, V89, P10311, DOI 10.1073/pnas.89.21.10311; VANMUIJEN GNP, 1986, EXP CELL RES, V162, P97, DOI 10.1016/0014-4827(86)90429-5; VASSAR R, 1989, P NATL ACAD SCI USA, V86, P1563, DOI 10.1073/pnas.86.5.1563; Wanner R, 1997, ARCH DERMATOL RES, V289, P705, DOI 10.1007/s004030050265; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670; WU RL, 1994, J BIOL CHEM, V269, P28450; WU RL, 1993, J CELL SCI, V105, P303	47	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23912	23921		10.1074/jbc.273.37.23912	http://dx.doi.org/10.1074/jbc.273.37.23912			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727005	hybrid			2022-12-27	WOS:000075893100046
J	Rehm, BHA; Kruger, N; Steinbuchel, A				Rehm, BHA; Kruger, N; Steinbuchel, A			A new metabolic link between fatty acid de novo synthesis and polyhydroxyalkanoic acid synthesis - The phaG gene from Pseudomonas putida KT2440 encodes a 3-hydroxyacyl-acyl carrier protein coenzyme A transferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; POLY(3-HYDROXYALKANOATE) SYNTHESIS; BIODEGRADABLE POLYESTERS; FLUORESCENT PSEUDOMONADS; AERUGINOSA; PLASMID; DNA; BACTERIA; CLONING; IDENTIFICATION	To investigate the metabolic link between fatty acid de novo synthesis and polyhydroxyalkanoic acid (PHA) synthesis, we isolated mutants of Pseudomonas putida KT2440 deficient in this metabolic route. The gene phaG was cloned by phenotypic complementation of these mutants; it encoded a protein of 295 amino acids with a molecular mass of 33,876 Da, and the amino acid sequence exhibited 44% amino acid identity to the primary structure of the rhlA gene product, which is involved in the rhamnolipid biosynthesis in Pseudomonas aeruginosa PG201. S-1 nuclease protection assay identified the transcriptional start site 239 base pairs upstream of the putative translational start codon, Transcriptional induction of phaG was observed when gluconate was provided, and PHA synthesis occurred from this carbon source. No complementation of the rhlA mutant P. aeruginosa UO299-harboring plasmid pBHR81, expressing phaG gene under lac promoter control, was obtained. Heterologous expression of phaG in Pseudomonas oleovorans, which is not capable of PHA synthesis from gluconate, enabled PHA synthesis on gluconate as the carbon source, Native recombinant PhaG was purified by native polyacrylamide gel electrophoresis from P. oleovorans-harborinag plasmid pBHR81. It catalyzes the transfer of the acyl moiety from in vitro synthesized 3-hydroxydecanoyl-CoA to acyl carrier protein, indicating that PhaG exhibits a 3-hydroxyacyl-CoA-acyl carrier protein transferase activity.	Univ Munster, Inst Mikrobiol, D-48149 Munster, Germany	University of Munster	Steinbuchel, A (corresponding author), Univ Munster, Inst Mikrobiol, Corrensstr 3, D-48149 Munster, Germany.		Rehm, Bernd HA/B-3675-2011	Rehm, Bernd/0000-0003-3908-8903				ALDEA M, 1988, GENE, V65, P101, DOI 10.1016/0378-1119(88)90421-0; ANDERSON AJ, 1990, MICROBIOL REV, V54, P450, DOI 10.1128/MMBR.54.4.450-472.1990; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BERK AJ, 1977, CELL, V12, P721, DOI 10.1016/0092-8674(77)90272-0; BIBB MJ, 1984, GENE, V30, P157, DOI 10.1016/0378-1119(84)90116-1; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Boulton C.A., 1987, BIOSURFACTANTS BIOTE, P47; BRANDL H, 1988, APPL ENVIRON MICROB, V54, P1977, DOI 10.1128/AEM.54.8.1977-1982.1988; Burger M, 1966, METHODS ENZYMOLOGY, V588, P441; BURGER MM, 1963, J BIOL CHEM, V238, P2595; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Dotson GD, 1998, J BACTERIOL, V180, P330, DOI 10.1128/JB.180.2.330-337.1998; Eggink G.W., 1992, FEMS MICROBIOL REV, V105, P759; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Heath RJ, 1998, J BACTERIOL, V180, P1425, DOI 10.1128/JB.180.6.1425-1430.1998; HUIJBERTS GNM, 1992, APPL ENVIRON MICROB, V58, P536, DOI 10.1128/AEM.58.2.536-544.1992; HUIJBERTS GNM, 1994, J BACTERIOL, V176, P1661, DOI 10.1128/jb.176.6.1661-1666.1994; HUISMAN GW, 1989, APPL ENVIRON MICROB, V55, P1949, DOI 10.1128/AEM.55.8.1949-1954.1989; KNAUF VC, 1982, PLASMID, V8, P45, DOI 10.1016/0147-619X(82)90040-3; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kraak MN, 1997, J BACTERIOL, V179, P4985, DOI 10.1128/jb.179.16.4985-4991.1997; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langenbach S, 1997, FEMS MICROBIOL LETT, V150, P303, DOI 10.1016/S0378-1097(97)00142-0; LENZ RW, 1990, NATO ADV SCI I E-APP, V186, P23; MILLER JH, 1972, EXPT MOL GENETICS, P125; MIZUSAWA S, 1986, NUCLEIC ACIDS RES, V14, P1319, DOI 10.1093/nar/14.3.1319; OCHSNER UA, 1994, J BIOL CHEM, V269, P19787; OELMULLER U, 1990, J MICROBIOL METH, V11, P73, DOI 10.1016/0167-7012(90)90050-G; Qi QS, 1997, FEMS MICROBIOL LETT, V157, P155, DOI 10.1111/j.1574-6968.1997.tb12767.x; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; Rock C O, 1981, Methods Enzymol, V71 Pt C, P163; ROTHMEL RK, 1991, METHOD ENZYMOL, V204, P485; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHLEGEL HG, 1961, ARCH MIKROBIOL, V38, P209, DOI 10.1007/BF00422356; SCHWEIZER HP, 1991, GENE, V97, P109, DOI 10.1016/0378-1119(91)90016-5; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; STEINBUCHEL A, 1992, FEMS MICROBIOL LETT, V103, P217, DOI 10.1016/0378-1097(92)90313-D; STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O; STRAUSS EC, 1986, ANAL BIOCHEM, V154, P353, DOI 10.1016/0003-2697(86)90536-1; TIMM A, 1990, APPL ENVIRON MICROB, V56, P3360, DOI 10.1128/AEM.56.11.3360-3367.1990; TIMM A, 1992, EUR J BIOCHEM, V209, P15, DOI 10.1111/j.1432-1033.1992.tb17256.x; VANDERLEIJ FR, 1995, CAN J MICROBIOL, V41, P222, DOI 10.1139/m95-191; VERWOERT IIGS, 1994, FEBS LETT, V348, P311, DOI 10.1016/0014-5793(94)00630-X; VUORIO R, 1994, FEBS LETT, V337, P289, DOI 10.1016/0014-5793(94)80211-4; WEBER K, 1969, J BIOL CHEM, V244, P4406; WORSEY MJ, 1975, J BACTERIOL, V124, P7, DOI 10.1128/JB.124.1.7-13.1975	48	204	221	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24044	24051		10.1074/jbc.273.37.24044	http://dx.doi.org/10.1074/jbc.273.37.24044			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727022	hybrid, Green Published			2022-12-27	WOS:000075893100063
J	Warner, DR; Weng, GZ; Yu, SH; Matalon, R; Weinstein, LS				Warner, DR; Weng, GZ; Yu, SH; Matalon, R; Weinstein, LS			A novel mutation in the switch 3 region of G(s)alpha in a patient with Albright hereditary osteodystrophy impairs GDP binding and receptor activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRADIENT GEL-ELECTROPHORESIS; PROTEIN ALPHA-SUBUNITS; GTP-GAMMA-S; ADENYLATE-CYCLASE; ESCHERICHIA-COLI; GS-ALPHA; CRYSTAL-STRUCTURE; G(S-ALPHA); PSEUDOHYPOPARATHYROIDISM; TRANSDUCIN	Albright hereditary osteodystrophy (AHO), a disorder characterized by skeletal abnormalities and obesity, is associated with heterozygous inactivating mutations in the gene for G(s)alpha. A novel G(s)alpha mutation encoding the substitution of tryptophan for a nonconserved arginine within the switch 3 region (G(s)alpha R258W) was identified in an AHO patient. Although reverse transcription-polymerase chain reaction studies demonstrated that mRNA expression from wild type and mutant alleles was similar, G(s)alpha expression in erythrocyte membranes from the affected patient was reduced by 50%. A G(s)alpha R258W cDNA, as well as one with arginine replaced by alanine (G(s)alpha R258A), was generated, and the biochemical properties of lit vitro transcription/translation products were examined, When reconstituted with cyc(-) membranes, both mutant proteins were able to stimulate adenylyl cyclase normally in the presence of guanosine-5'-O-(3-thiotriphosphate) (GTP gamma S) but had decreased ability in the presence of isoproterenol or AlF4- (a mixture of 10 mu M AlCl3 and 10 mM NaF). The ability of each mutant to bind and be activated by GTP gamma S or AlF4- was assessed by trypsin protection assays. Both mutants were protected normally by GTP gamma S but showed reduced protection in the presence of AlF4-. The addition of excess GDP (2 mM) was able to rescue the ability of AlF4- to protect the mutants, suggesting that they might have reduced affinity for GDP. A G(s)alpha R258A mutant purified from Escherichia coli had decreased affinity for GDP and an apparent rate of GDP release that was 10-fold greater than that of wild type G(s)alpha. Sucrose density gradient analysis demonstrated that both G(s)alpha R258W and G(s)alpha R258A were thermolabile at higher temperatures and that denaturation of both mutants was prevented by the presence of 0.1 mM GTP gamma S or 2 mM GDP. The crystal structure of G(s)alpha demonstrates that Arg(258) interacts with a conserved residue in the helical domain (Gln(170)). Arg(258) substitutions would be predicted to open the cleft between the GTPase and helical domains, allowing for increased GDP release in the inactive state, resulting in enhanced thermolability and reduced AlF4--induced adenylyl cyclase stimulation and trypsin protection, since activation by AlF4- requires bound GDP.	NINDS, Membrane Biochem Sect, Mol & Cellular Neurobiol Lab, NIH, Bethesda, MD 20892 USA; NIDDK, Metab Dis Branch, NIH, Bethesda, MD 20892 USA; CUNY Mt Sinai Sch Med, Dept Pharmacol, New York, NY 10029 USA; Univ Texas, Med Branch, Dept Pediat, Galveston, TX 77555 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Medical Branch Galveston	Warner, DR (corresponding author), NINDS, Membrane Biochem Sect, Mol & Cellular Neurobiol Lab, NIH, Bldg 49,Rm 2A28, Bethesda, MD 20892 USA.		Weinstein, Lee S/I-5575-2015	Weinstein, Lee/0000-0002-1899-5152				BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; CARTY DJ, 1994, METHOD ENZYMOL, V237, P38; CODINA J, 1994, J BIOL CHEM, V269, P29339; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; CRAIG D, 1992, NUCLEIC ACIDS RES, V20, P4987, DOI 10.1093/nar/20.19.4987; Farfel Z, 1996, J BIOL CHEM, V271, P19653, DOI 10.1074/jbc.271.33.19653; FERGUSON KM, 1986, J BIOL CHEM, V261, P7393; GEJMAN PV, 1994, METHOD ENZYMOL, V237, P308; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRAZIANO MP, 1989, J BIOL CHEM, V264, P15475; GRAZIANO MP, 1989, J BIOL CHEM, V264, P409; Grishina G, 1998, J BIOL CHEM, V273, P15053, DOI 10.1074/jbc.273.24.15053; Iiri T, 1997, P NATL ACAD SCI USA, V94, P5656, DOI 10.1073/pnas.94.11.5656; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; LAMBRIGHT DG, 1996, NATURE, V379, P297; LEE E, 1994, METHOD ENZYMOL, V237, P146; LEVINE MA, 1980, BIOCHEM BIOPH RES CO, V94, P1319, DOI 10.1016/0006-291X(80)90563-X; Li QB, 1997, J BIOL CHEM, V272, P21673, DOI 10.1074/jbc.272.35.21673; MARKBY DW, 1993, SCIENCE, V262, P1895, DOI 10.1126/science.8266082; MILLER RT, 1988, NATURE, V334, P712, DOI 10.1038/334712a0; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; PATTEN JL, 1990, NEW ENGL J MED, V322, P1412, DOI 10.1056/NEJM199005173222002; ROOF DJ, 1985, J BIOL CHEM, V260, P6242; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Schreibmayer W, 1996, NATURE, V380, P624, DOI 10.1038/380624a0; SCHWINDINGER WF, 1994, J BIOL CHEM, V269, P25387; SIMONDS WF, 1989, FEBS LETT, V249, P189, DOI 10.1016/0014-5793(89)80622-2; SPIEGEL AM, 1992, ENDOCR REV, V13, P536, DOI 10.1210/er.13.3.536; STERNWEIS PC, 1981, J BIOL CHEM, V256, P1517; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Warner DR, 1997, MOL ENDOCRINOL, V11, P1718, DOI 10.1210/me.11.11.1718; WEINSTEIN LS, 1990, P NATL ACAD SCI USA, V87, P8287, DOI 10.1073/pnas.87.21.8287; YATANI A, 1987, SCIENCE, V238, P1288, DOI 10.1126/science.2446390	38	55	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23976	23983		10.1074/jbc.273.37.23976	http://dx.doi.org/10.1074/jbc.273.37.23976			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727013	hybrid			2022-12-27	WOS:000075893100054
J	Blackman, MJ; Fujioka, H; Stafford, WHL; Sajid, M; Clough, B; Fleck, SL; Aikawa, M; Grainger, M; Hackett, F				Blackman, MJ; Fujioka, H; Stafford, WHL; Sajid, M; Clough, B; Fleck, SL; Aikawa, M; Grainger, M; Hackett, F			A subtilisin-like protein in secretory organelles of Plasmodium falciparum merozoites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXOPLASMA-GONDII; SURFACE PROTEIN-1; DENSE GRANULES; ERYTHROCYTE INVASION; SERINE PROTEASES; PARASITOPHOROUS VACUOLE; PROHORMONE CONVERTASES; MALARIAL PARASITES; CELL INVASION; KNOWLESI	In the vertebrate host, the malaria parasite invades and replicates asexually within circulating erythrocytes. Parasite proteolytic enzymes play an essential but poorly understood role in erythrocyte invasion. We have identified a Plasmodium falciparum gene, denoted pf-sub-1, encoding a member of the subtilisin-like serine protease family (subtilases). The pfsub-1 gene is ex pressed in asexual blood stages of P. falciparum, and the primary gene product (PfSUB-1) undergoes post-translational processing during secretory transport in a manner consistent with its being converted to a mature, enzymatically active form, as documented for other subtilases. In the invasive merozoite, the putative mature protease (p47) is concentrated in dense granules, which are secretory organelles located toward the apical end of the merozoite. At some point following merozoite release and completion of erythrocyte invasion, p47 is secreted from the parasite in a truncated, soluble form. The subcellular location and timing of secretion of p47 suggest that it is likely to play a role in erythrocyte invasion. PfSUB-1 is a new potential target for antimalarial drug development.	Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA; Tokai Univ, Inst Med Sci, Isehara, Kanagawa 25911, Japan	MRC National Institute for Medical Research; Case Western Reserve University; Tokai University	Blackman, MJ (corresponding author), Natl Inst Med Res, Div Parasitol, Mill Hill, London NW7 1AA, England.	mblackm@nimr.mrc.ac.uk		Clough, Barbara/0000-0002-3235-6170				ACHBAROU A, 1991, MOL BIOCHEM PARASIT, V47, P223, DOI 10.1016/0166-6851(91)90182-6; AIKAWA M, 1990, ADV PARASIT, V29, P151, DOI 10.1016/S0065-308X(08)60106-2; AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; AIKAWA M, 1990, EXP PARASITOL, V71, P326, DOI 10.1016/0014-4894(90)90037-D; ALLEN G, 1981, LAB TECHNIQUES BIOCH; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anderson ED, 1997, EMBO J, V16, P1508, DOI 10.1093/emboj/16.7.1508; Baker D, 1993, CURR OPIN CELL BIOL, V5, P966, DOI 10.1016/0955-0674(93)90078-5; BANNISTER LH, 1975, PARASITOLOGY, V71, P483, DOI 10.1017/S0031182000047247; BANNISTER LH, 1986, PARASITOLOGY, V92, P291, DOI 10.1017/S0031182000064064; BANYAL HS, 1981, J PARASITOL, V67, P623, DOI 10.2307/3280435; BLACKMAN MJ, 1992, MOL BIOCHEM PARASIT, V50, P307, DOI 10.1016/0166-6851(92)90228-C; BLACKMAN MJ, 1993, MOL BIOCHEM PARASIT, V62, P103, DOI 10.1016/0166-6851(93)90182-W; BLACKMAN MJ, 1994, METHOD CELL BIOL, V45, P213; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P35, DOI 10.1016/0166-6851(91)90128-S; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; BLACKMAN MJ, 1994, J EXP MED, V180, P389, DOI 10.1084/jem.180.1.389; Blackman MJ, 1996, EXP PARASITOL, V83, P229, DOI 10.1006/expr.1996.0069; BONNIN A, 1995, J EUKARYOT MICROBIOL, V42, P395, DOI 10.1111/j.1550-7408.1995.tb01601.x; BRAUNBRETON C, 1988, NATURE, V332, P457, DOI 10.1038/332457a0; BRAUNBRETON C, 1992, P NATIONAL ACADEMY S, V89, P9647; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; COWAN DA, 1987, FEMS MICROBIOL LETT, V43, P155; CULVENOR JG, 1991, INFECT IMMUN, V59, P1183, DOI 10.1128/IAI.59.3.1183-1187.1991; DEJKRIENGKRAIKHUL PN, 1983, Z PARASITENKD, V69, P313, DOI 10.1007/BF00927873; DLUZEWSKI AR, 1986, EXP PARASITOL, V62, P416, DOI 10.1016/0014-4894(86)90050-0; DUBREMETZ JF, 1993, PARASITOL RES, V79, P402, DOI 10.1007/BF00931830; DUTTA GP, 1981, INDIAN J EXP BIOL, V19, P9; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; ENTZEROTH R, 1986, EUR J CELL BIOL, V41, P182; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HADLEY T, 1983, EXP PARASITOL, V55, P306, DOI 10.1016/0014-4894(83)90027-9; HARLOW E, 1988, ANTIBODIES LAB MANUA, P53; HARPER JW, 1985, BIOCHEMISTRY-US, V24, P1831, DOI 10.1021/bi00329a005; HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3; Howard RF, 1995, MOL BIOCHEM PARASIT, V74, P43, DOI 10.1016/0166-6851(95)02481-6; IKEMURA H, 1988, J BIOL CHEM, V263, P12959; MCPHERSON RA, 1993, MOL BIOCHEM PARASIT, V62, P233, DOI 10.1016/0166-6851(93)90112-B; MEANS GE, 1979, ARCH BIOCHEM BIOPHYS, V194, P526, DOI 10.1016/0003-9861(79)90647-7; MILLER LH, 1979, J EXP MED, V149, P172, DOI 10.1084/jem.149.1.172; OGUN SA, 1994, EXP PARASITOL, V79, P270, DOI 10.1006/expr.1994.1090; Powner D, 1997, BIOCHEM SOC T, V25, pS230, DOI 10.1042/bst025230s; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; ROSENTHAL PJ, 1987, J EXP MED, V166, P816, DOI 10.1084/jem.166.3.816; SADAK A, 1988, MOL BIOCHEM PARASIT, V29, P203, DOI 10.1016/0166-6851(88)90075-8; SAKANARI JA, 1989, P NATL ACAD SCI USA, V86, P4863, DOI 10.1073/pnas.86.13.4863; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SamYellowe TY, 1996, PARASITOL TODAY, V12, P308, DOI 10.1016/0169-4758(96)10030-2; Sarath G., 1996, PROTEOLYTIC ENZYMES, P25; SCHREVEL J, 1990, BLOOD CELLS, V16, P563; SHENNAN KIJ, 1995, J BIOL CHEM, V270, P1402, DOI 10.1074/jbc.270.3.1402; SHINDE U, 1993, TRENDS BIOCHEM SCI, V18, P442, DOI 10.1016/0968-0004(93)90146-E; SIBLEY LD, 1994, EXP PARASITOL, V79, P301, DOI 10.1006/expr.1994.1093; Siezen RJ, 1997, PROTEIN SCI, V6, P501; SIEZEN RJ, 1991, PROTEIN ENG, V4, P719, DOI 10.1093/protein/4.7.719; SIEZEN RJ, 1994, EUR J BIOCHEM, V222, P255, DOI 10.1111/j.1432-1033.1994.tb18864.x; SNOUNOU G, 1988, MOL BIOCHEM PARASIT, V28, P153, DOI 10.1016/0166-6851(88)90063-1; TORII M, 1989, INFECT IMMUN, V57, P3230, DOI 10.1128/IAI.57.10.3230-3233.1989; TRAGER W, 1992, INFECT IMMUN, V60, P4656, DOI 10.1128/IAI.60.11.4656-4661.1992; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; UDENFRIEND S, 1995, ANNU REV BIOCHEM, V64, P563, DOI 10.1146/annurev.bi.64.070195.003023; VALLS LA, 1990, J CELL BIOL, V111, P361, DOI 10.1083/jcb.111.2.361; Volkov A, 1996, J MOL BIOL, V262, P595, DOI 10.1006/jmbi.1996.0538; ZHOU A, 1995, J BIOL CHEM, V270, P21509, DOI 10.1074/jbc.270.37.21509; 1997, NATURE S, V387, P1	66	101	106	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23398	23409		10.1074/jbc.273.36.23398	http://dx.doi.org/10.1074/jbc.273.36.23398			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722575	hybrid			2022-12-27	WOS:000075778100075
J	Daniels, MJ; Turner-Cavet, JS; Selkirk, R; Sun, HZ; Parkinson, JA; Sadler, PJ; Robinson, NJ				Daniels, MJ; Turner-Cavet, JS; Selkirk, R; Sun, HZ; Parkinson, JA; Sadler, PJ; Robinson, NJ			Coordination of Zn2+ (and Cd2+) by prokaryotic metallothionein - Involvement of His-imidazole	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-BINDING PROPERTIES; ESCHERICHIA-COLI; EXPRESSED PROTEIN; ZINC-FINGER; DNA-BINDING; RECEPTOR; METALLOPROTEINS; SENSITIVITY; CADMIUM; DOMAIN	In mammalian metallothionein Zn2+ is exclusively coordinated to Cys-thiolate to form clusters in which the metal is thermodynamically stable but also kinetically labile, By contrast, little is known about coordination to prokaryotic metallothionein, SmtA, 3 nmol of Zn2+ nmol(-1) SmtA were displaced by 8 nmol of p-(hydroxymercuri)phenylsulfonate implicating eight of the nine Cys in the coordination of three metal ions. None of the Zn2+ associated with SmtA was accessible to 4-(2-pyridylazo)resorcinol prior to the addition of p-(hydroxymercuri)phenylsulfonate. An unusual feature of SmtA is the presence of three His residues, and we have investigated whether these contribute to metal coordination. Less Zn2+ was associated with purified SmtA(H40R/H49R/H55R), in which all three His residues were substituted with Arg, and approximately one equivalent of Zn2+ was immediately accessible to 4-(2-pyridylazo)resorcinol. Following incubation of SmtA with Cd-111, three Cd-111 resonances were detected, two in a range expected for CdS4 and the third indicative of either CdNS3 or CdN2S2 coordination. Two-dimensional TOCSY H-1 NMR and Cd-111-edited H-1 NMR showed two His residues bound to Cd-111, confirming CdN2S2 coordination. The pH of half-dissociation of Zn2+ increased from 4.05 for SmtA to 5.37 for SmtA(H40R/H49R/H55R), Equivalent values for single His mutants SmtA(H40R), SmtA(H49R), and SmtA(H55R) were 4.62, 4.48, and 3.81, respectively, revealing that conversion of His(40) or His(49) to Arg impairs Zn2+ binding at the CdN2S2 and CdS4 sites. Only approximately two equivalents of Zn2+ were associated with purified SmtA(H49R), The appearance of a fourth Cd-111 resonance at lower pH suggests that an alternative CdN2S2 site also exists.	Newcastle Univ, Sch Med, Dept Biochem & Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Edinburgh, Dept Chem, Edinburgh EH9 3JJ, Midlothian, Scotland	Newcastle University - UK; University of Edinburgh	Robinson, NJ (corresponding author), Newcastle Univ, Sch Med, Dept Biochem & Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	n.j.robinson@newcastle.ac.uk	Robinson, Nigel J/J-6363-2012	Robinson, Nigel J/0000-0001-5586-1092; Cavet, Jennifer/0000-0001-5913-7157; Parkinson, John Andrew/0000-0003-4270-6135				BAX A, 1983, J MAGN RESON, V55, P301, DOI 10.1016/0022-2364(83)90241-X; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Bird AJ, 1998, J BIOL CHEM, V273, P21246, DOI 10.1074/jbc.273.33.21246; BOBSEIN BR, 1980, J AM CHEM SOC, V102, P2454, DOI 10.1021/ja00527a053; CanoGauci DF, 1996, FEBS LETT, V386, P1, DOI 10.1016/0014-5793(96)00356-0; COLEMAN JE, 1993, METHOD ENZYMOL, V227, P16; GAN T, 1995, J BIOL CHEM, V270, P5339, DOI 10.1074/jbc.270.10.5339; GIEDROC DP, 1989, BIOCHEMISTRY-US, V28, P2410, DOI 10.1021/bi00432a011; HIGHAM DP, 1984, SCIENCE, V225, P1043, DOI 10.1126/science.225.4666.1043; HUNT JB, 1984, J BIOL CHEM, V259, P4793; KAGI JHR, 1991, METHOD ENZYMOL, V205, P613; KAGI JHR, 1960, J BIOL CHEM, V235, P3460; KAGI JHR, 1961, J BIOL CHEM, V236, P2535; Li H, 1996, BIOCHEMISTRY-US, V35, P13929, DOI 10.1021/bi961401n; Maret W, 1998, P NATL ACAD SCI USA, V95, P3478, DOI 10.1073/pnas.95.7.3478; MASTERS BA, 1994, P NATL ACAD SCI USA, V91, P584, DOI 10.1073/pnas.91.2.584; OLAFSON RW, 1988, BIOCHEM J, V251, P691, DOI 10.1042/bj2510691; PAN T, 1990, BIOCHEMISTRY-US, V29, P9218, DOI 10.1021/bi00491a016; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; SHAKA AJ, 1985, J MAGN RESON, V64, P547, DOI 10.1016/0022-2364(85)90122-2; SHI JG, 1992, FEBS LETT, V303, P159, DOI 10.1016/0014-5793(92)80509-F; SOUTH TL, 1989, J AM CHEM SOC, V111, P395, DOI 10.1021/ja00183a074; STONEHOUSE J, 1994, J MAGN RESON SER A, V107, P178, DOI 10.1006/jmra.1994.1066; THIELE DJ, 1987, METALLOTHIONEIN, V2, P423; TOMMEY AM, 1991, FEBS LETT, V292, P48, DOI 10.1016/0014-5793(91)80831-M; TSUJIKAWA K, 1991, FEBS LETT, V283, P239, DOI 10.1016/0014-5793(91)80597-V; TURNER JS, 1993, J BIOL CHEM, V268, P4494; YU W, 1994, J BIOL CHEM, V269, P21010; ZENG J, 1991, FEBS LETT, V279, P310, DOI 10.1016/0014-5793(91)80175-3; ZENG J, 1991, P NATL ACAD SCI USA, V88, P9984, DOI 10.1073/pnas.88.22.9984; ZERBE O, 1994, J AM CHEM SOC, V116, P377, DOI 10.1021/ja00080a046	31	61	62	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					22957	22961		10.1074/jbc.273.36.22957	http://dx.doi.org/10.1074/jbc.273.36.22957			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722517	hybrid			2022-12-27	WOS:000075778100017
J	Kim, L; Wong, TW				Kim, L; Wong, TW			Growth factor-dependent phosphorylation of the actin-binding protein cortactin is mediated by the cytoplasmic tyrosine kinase FER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAY; PP60SRC SUBSTRATE; TRANSGENIC MICE; FOCAL ADHESIONS; FACTOR RECEPTOR; FPS/FES; IDENTIFICATION; CELLS; CATENIN; TRANSFORMATION	Previous characterization of the nonreceptor tyrosine kinase FER identified a tight physical association with the catenin pp120 and led to the suggestion that FER may be involved in cell-cell signaling. To further understand the function of FER, we have continued our analyses of the interaction of FER with pp120 and other proteins. The majority of FER is localized to the cytoplasmic fraction where it forms a complex with the actin-binding protein cortactin, The Src homology 2 sequence of FER. is required for directly binding cortactin, and phosphorylation of the FER-cortactin complex is up-regulated in cells treated with peptide growth factors. Using a dominant-negative mutant of FER, we provided evidence that FER kinase activity is required for the growth factor-dependent phosphorylation of cortactin. These data suggest that cortactin is likely to be a direct substrate of FER. Our observations provide additional support for a role of FER in mediating signaling from the cell surface, via growth factor receptors, to the cytoskeleton. The nature of the FER-cortactin interaction, and their putative enzyme-substrate relationship, support the previous proposal that one of the functions of the Src homology 2 sequences of nonreceptor tyrosine kinases is to provide a binding site for their preferred substrates.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Wong, TW (corresponding author), Bristol Myers Squibb Pharmaceut Res Inst, Dept Oncol, POB 4000, Princeton, NJ 08543 USA.							ARECES LB, 1994, MOL CELL BIOL, V14, P4606, DOI 10.1128/MCB.14.7.4606; CALAUTTI E, 1995, GENE DEV, V9, P2279, DOI 10.1101/gad.9.18.2279; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Daniel JM, 1997, BIOESSAYS, V19, P883, DOI 10.1002/bies.950191008; DEHIO C, 1995, EMBO J, V14, P2471, DOI 10.1002/j.1460-2075.1995.tb07244.x; DOWNING JR, 1991, ONCOGENE, V6, P607; FELDMAN RA, 1985, P NATL ACAD SCI USA, V82, P2397; GREER P, 1990, MOL CELL BIOL, V10, P2521, DOI 10.1128/MCB.10.6.2521; GREER P, 1994, MOL CELL BIOL, V14, P6755, DOI 10.1128/MCB.14.10.6755; Guan JL, 1997, MATRIX BIOL, V16, P195, DOI 10.1016/S0945-053X(97)90008-1; HANAZONO Y, 1993, EMBO J, V12, P1641, DOI 10.1002/j.1460-2075.1993.tb05809.x; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; HOSCHUETZKY H, 1994, J CELL BIOL, V127, P1375, DOI 10.1083/jcb.127.5.1375; Huang C, 1997, J BIOL CHEM, V272, P13911, DOI 10.1074/jbc.272.21.13911; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; IZUHARA K, 1994, J BIOL CHEM, V269, P18623; KANNER SB, 1991, MOL CELL BIOL, V11, P713, DOI 10.1128/MCB.11.2.713; KAPLAN KB, 1992, J CELL BIOL, V118, P321, DOI 10.1083/jcb.118.2.321; KIM L, 1995, MOL CELL BIOL, V15, P4553; LETWIN K, 1988, ONCOGENE, V3, P621; MACDONALD I, 1985, MOL CELL BIOL, V5, P2543, DOI 10.1128/MCB.5.10.2543; Nakamoto T, 1997, MOL CELL BIOL, V17, P3884, DOI 10.1128/MCB.17.7.3884; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; SCHECTER D, 1993, J OPER RES SOC, V44, P205; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; VOLBERG T, 1992, EMBO J, V11, P1733, DOI 10.1002/j.1460-2075.1992.tb05225.x; VUORI K, 1995, J BIOL CHEM, V270, P22259, DOI 10.1074/jbc.270.38.22259; WELSH JB, 1991, J CELL BIOL, V114, P533, DOI 10.1083/jcb.114.3.533; WU H, 1991, MOL CELL BIOL, V11, P5113, DOI 10.1128/MCB.11.10.5113; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417	31	89	91	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23542	23548		10.1074/jbc.273.36.23542	http://dx.doi.org/10.1074/jbc.273.36.23542			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722593	hybrid			2022-12-27	WOS:000075778100093
J	Nagao, M; Yamauchi, J; Kaziro, Y; Itoh, H				Nagao, M; Yamauchi, J; Kaziro, Y; Itoh, H			Involvement of protein kinase C and Src family tyrosine kinase in G alpha(q/11)-induced activation of c-jun N-terminal kinase and p38 mitogen-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; FOCAL ADHESION KINASE; G-BETA-GAMMA; MAP KINASE; COUPLED RECEPTORS; ALPHA-SUBUNIT; DEPENDENT ACTIVATION; NH2-TERMINAL KINASE; SIGNALING PATHWAYS; REGULATED KINASE	Mitogen-activated protein kinases (MAPKs) are activated by various extracellular stimuli. The signaling pathways from G protein-coupled receptors to extracellular signal-regulated kinase have been partially elucidated, whereas the mechanisms by which G protein-coupled receptors stimulate c-Jun N-terminal kinase (JNK) and p38 MAPK activities remain largely unknown. We have recently demonstrated that the signal from G(q/11)-coupled mi muscarinic acetylcholine receptor to p38 MAPK is mediated by both G alpha(q/11) and G beta gamma in HEK-293 cells (Yamauchi, J., Nagao, M., Kaziro, Y., and Itoh, H. (1997) J. Biol. Chem. 272, 27771-27777). In the present study, we report that a constitutively activated mutant of G alpha(11) (G alpha(11) Q209L) activated not only p38 MAPK but also JNK, and the activation of JNK and p38 MAPK by Ga-11 Q209L was partially inhibited by prolonged treatment with phorbol 12-myristate 13-acetate and calphostin C. In addition, the G alpha(11) Q209L-stimulated activation of both kinases was blocked by a specific inhibitor of protein tyrosine kinases (PP2) and Csk ((C) under bar-terminal (S) under bar rc (k) under bar inase). Furthermore, we demonstrated that Gall Q209L stimulated Src family kinase activity and induced tyrosine phosphorylation of several proteins in HEK-293 cells. These results suggest that G alpha(q/11) stimulates JNK and p38 MAPK activities through protein kinase C- and Src family kinase-dependent signaling pathways.	Tokyo Inst Technol, Fac Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Itoh, H (corresponding author), Tokyo Inst Technol, Fac Biosci & Biotechnol, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.							Althoefer H, 1997, J BIOL CHEM, V272, P24380, DOI 10.1074/jbc.272.39.24380; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; AVRAHAM S, 1995, J BIOL CHEM, V270, P27742, DOI 10.1074/jbc.270.46.27742; Bence K, 1997, NATURE, V389, P296, DOI 10.1038/38520; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Blank JL, 1996, J BIOL CHEM, V271, P5361, DOI 10.1074/jbc.271.10.5361; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Collins LR, 1996, J BIOL CHEM, V271, P17349, DOI 10.1074/jbc.271.29.17349; COSO OA, 1995, J BIOL CHEM, V270, P5620, DOI 10.1074/jbc.270.10.5620; Coso OA, 1996, J BIOL CHEM, V271, P3963; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V19, P470, DOI 10.1016/0968-0004(94)90132-5; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; DEVIVO M, 1992, J BIOL CHEM, V267, P18263; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; EARP HS, 1995, J BIOL CHEM, V270, P28440; Gerwins P, 1997, J BIOL CHEM, V272, P8288, DOI 10.1074/jbc.272.13.8288; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Heasley LE, 1996, MOL CELL BIOL, V16, P648; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; KALINEC G, 1992, MOL CELL BIOL, V12, P4687, DOI 10.1128/MCB.12.10.4687; KAZIRO Y, 1991, ANNU REV BIOCHEM, V60, P349, DOI 10.1146/annurev.bi.60.070191.002025; KRAMER RM, 1995, J BIOL CHEM, V270, P27395, DOI 10.1074/jbc.270.46.27395; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; McLaughlin MM, 1996, J BIOL CHEM, V271, P8488, DOI 10.1074/jbc.271.14.8488; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; MITCHELL FM, 1995, BIOCHEM J, V309, P381, DOI 10.1042/bj3090381; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; OSHEROV N, 1994, EUR J BIOCHEM, V225, P1047, DOI 10.1111/j.1432-1033.1994.1047b.x; Post GR, 1996, FASEB J, V10, P741, DOI 10.1096/fasebj.10.7.8635691; PRASAD MVVSV, 1995, J BIOL CHEM, V270, P18655, DOI 10.1074/jbc.270.31.18655; RodriguezFernandez JL, 1996, J BIOL CHEM, V271, P27895, DOI 10.1074/jbc.271.44.27895; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; Shapiro PS, 1996, J BIOL CHEM, V271, P5750, DOI 10.1074/jbc.271.10.5750; Siow YL, 1997, J BIOL CHEM, V272, P7586, DOI 10.1074/jbc.272.12.7586; Umemori H, 1997, SCIENCE, V276, P1878, DOI 10.1126/science.276.5320.1878; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamauchi J, 1997, J BIOL CHEM, V272, P7602, DOI 10.1074/jbc.272.12.7602; Yamauchi JJ, 1997, J BIOL CHEM, V272, P27771, DOI 10.1074/jbc.272.44.27771; YAN MH, 1994, NATURE, V372, P798; Yu H, 1996, J BIOL CHEM, V271, P29993, DOI 10.1074/jbc.271.47.29993; ZOHN IE, 1995, MOL CELL BIOL, V15, P6160	50	113	116	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					22892	22898		10.1074/jbc.273.36.22892	http://dx.doi.org/10.1074/jbc.273.36.22892			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722508	hybrid			2022-12-27	WOS:000075778100008
J	Crump, MP; Rajarathnam, K; Kim, KS; Clark-Lewis, I; Sykes, BD				Crump, MP; Rajarathnam, K; Kim, KS; Clark-Lewis, I; Sykes, BD			Solution structure of eotaxin, a chemokine that selectively recruits eosinophils in allergic inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; CC-CHEMOKINE; NEUTROPHIL ACTIVATION; MOLECULAR-CLONING; NMR ASSIGNMENTS; RECEPTOR; IDENTIFICATION; INTERLEUKIN-8; EXPRESSION; RANTES	The solution structure of the CCR3-specific chemokine, eotaxin, has been determined by NMR spectroscopy. The quaternary structure of eotaxin was investigated by ultracentrifugation and NMR, and it was found to be in equilibrium between monomer and dimer under a wide range of conditions. At pH less than or equal to 5 and low ionic strength, eotaxin was found to be predominantly a monomer, The three dimensional structure of the eotaxin monomer solved at pH 5.0 revealed that it has a typical chemokine fold, which includes a 3-stranded beta-sheet and an overlying alpha-helix, Except for the N-terminal residues (residues 1-8), the core of the protein is well defined. The eotaxin structure is compared with the chemokines regulated upon activation, normal T-cell expressed and secreted (RANTES) and monocyte chemoattractant protein-1 (MCP-1); eotaxin binds only CC chemokine receptor CCR3, whereas RANTES binds many receptors including CCR3, and MCP-1 binds a distinct receptor, CCR2. The RMSD of the eotaxin ensemble of structures with the RANTES average minimized monomeric subunit is 5.52 +/- 0.87 Angstrom over all backbone atoms and 1.14 +/- 0.09 Angstrom over backbone atoms of residues 11-28 and 34-65, The most important difference between the structures is in the N-terminal residues that are unstructured in eotaxin but structured in RANTES and MCP-1, Several residues in the loop region of RANTES show similar packing in eotaxin (residues 11-17), As the N-terminal and loop regions have been shown to be critical for receptor binding and signaling, this structure will be useful for determining the basis for CCR3 selectivity of the eotaxin.	Univ Alberta, Prot Engn Network Ctr Excellence, Edmonton, AB T6G 2S2, Canada; Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada; Korea Inst Sci & Technol, Struct Biol Ctr, Seoul 130650, South Korea; Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of Alberta; University of Alberta; Korea Institute of Science & Technology (KIST); University of British Columbia; University of British Columbia	Sykes, BD (corresponding author), Univ Alberta, Prot Engn Network Ctr Excellence, Edmonton, AB T6G 2S2, Canada.	bds@polaris.biochem.ualberta.ca		Crump, Matthew/0000-0002-7868-5818				Baba M, 1997, J BIOL CHEM, V272, P14893, DOI 10.1074/jbc.272.23.14893; BAGGIOLINI M, 1994, IMMUNOL TODAY, V15, P127, DOI 10.1016/0167-5699(94)90156-2; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Beall CJ, 1996, BIOCHEM J, V313, P633, DOI 10.1042/bj3130633; Brunger A. T, 1993, XPLOR MANUAL VERSION; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; CHUNG CW, 1995, BIOCHEMISTRY-US, V34, P9307, DOI 10.1021/bi00029a005; CLARKLEWIS I, 1995, J LEUKOCYTE BIOL, V57, P703, DOI 10.1002/jlb.57.5.703; ClarkLewis I, 1997, METHOD ENZYMOL, V287, P233; COMBADIERE C, 1995, J BIOL CHEM, V270, P16491, DOI 10.1074/jbc.270.28.16491; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Forssmann U, 1997, J EXP MED, V185, P2171, DOI 10.1084/jem.185.12.2171; GarciaZepeda EA, 1996, NAT MED, V2, P449, DOI 10.1038/nm0496-449; GLEICH GJ, 1986, ADV IMMUNOL, V39, P177; Gong JH, 1996, J BIOL CHEM, V271, P10521, DOI 10.1074/jbc.271.18.10521; Handel TM, 1996, BIOCHEMISTRY-US, V35, P6569, DOI 10.1021/bi9602270; HYBERTS SG, 1992, PROTEIN SCI, V1, P736, DOI 10.1002/pro.5560010606; Kim KS, 1996, FEBS LETT, V395, P277, DOI 10.1016/0014-5793(96)01024-1; Kitaura M, 1996, J BIOL CHEM, V271, P7725, DOI 10.1074/jbc.271.13.7725; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUBONIWA H, 1994, J BIOMOL NMR, V4, P871, DOI 10.1007/BF00398416; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LODI PJ, 1994, SCIENCE, V263, P1762, DOI 10.1126/science.8134838; Lubkowski J, 1997, NAT STRUCT BIOL, V4, P64, DOI 10.1038/nsb0197-64; Mattoli S, 1997, BIOCHEM BIOPH RES CO, V236, P299, DOI 10.1006/bbrc.1997.6958; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Pakianathan DR, 1997, BIOCHEMISTRY-US, V36, P9642, DOI 10.1021/bi970593z; PAOLINI JF, 1994, J IMMUNOL, V153, P2704; Ponath PD, 1996, J CLIN INVEST, V97, P604, DOI 10.1172/JCI118456; Rajarathnam K, 1997, J BIOL CHEM, V272, P1725, DOI 10.1074/jbc.272.3.1725; Rajarathnam K, 1997, METHOD ENZYMOL, V287, P89; RAJARATHNAM K, 1994, SCIENCE, V264, P90, DOI 10.1126/science.8140420; RAJARATHNAM K, 1994, BIOCHEMISTRY-US, V33, P6623, DOI 10.1021/bi00187a032; Roos RS, 1997, J BIOL CHEM, V272, P17251, DOI 10.1074/jbc.272.28.17251; SKELTON NJ, 1995, BIOCHEMISTRY-US, V34, P5329, DOI 10.1021/bi00016a004; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Yoshida R, 1997, J BIOL CHEM, V272, P13803, DOI 10.1074/jbc.272.21.13803; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413; ZHANG YJ, 1994, J BIOL CHEM, V269, P15918	40	88	95	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22471	22479		10.1074/jbc.273.35.22471	http://dx.doi.org/10.1074/jbc.273.35.22471			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712872	hybrid			2022-12-27	WOS:000075616600048
J	Dimon-Gadal, S; Gerbaud, P; Keryer, G; Anderson, W; Evain-Brion, D; Raynaud, F				Dimon-Gadal, S; Gerbaud, P; Keryer, G; Anderson, W; Evain-Brion, D; Raynaud, F			In vitro effects of oxygen-derived free radicals on type I and type II cAMP-dependent protein kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE 3'-5'-CYCLIC MONOPHOSPHATE; CULTURED HUMAN KERATINOCYTES; REGULATORY SUBUNIT; HYDROGEN-PEROXIDE; HUMAN-FIBROBLASTS; BINDING-SITES; MESSENGER-RNA; AMINO-ACIDS; OXIDATION; EXPRESSION	Oxygen free radicals may act as second messengers in signal transduction pathways and contribute to inflammatory diseases. We studied the action in vitro of radiolytically generated hydroxyl radicals ((OH)-O-.) and superoxide radicals (O(2)radical anion) on the cAMP-dependent protein kinases, I and II (PKAI and -II, respectively). The effects of the gasses O-2, and N2O used to produce O(2)radical anion or (OH)-O-. radicals by gamma-radiolysis of the water were also studied. PKAI is more sensitive than PKAII to oxygen gas (10 mM sodium formate) and to hydroxyl and superoxide radicals. Hydroxyl radicals decreased the kinase phosphotransferase activities stimulated either by cAMP or its site-specific analogs for both PKAI and PKAII; however, PKAI was more affected. The binding of [H-3]cAMP and of 8-N-3-[P-32]cAMP to RI regulatory subunits was decreased. (OH)-O-. caused a loss of tryptophan 260 fluorescence at site A of PKAI and of bityrosine production. Superoxide radicals affected only PKAI. O(2)radical anion modified both cAMP-binding sites A and B of the regulatory subunit but had a smaller effect on the catalytic subunit, The catalytic subunit was more sensitive to radicals when free than when part of the holoenzymes during exposure to the oxygen free radicals. These results suggest that oxygen free radicals alter the structure of PKA enzymes. Thus, oxidative modifications may alter key enzymes, including cAMP-dependent protein kinases, in certain pathological states.	Univ Paris 05, Fac Sci Pharmaceut & Biol Paris, INSERM, U427, F-75270 Paris 06, France; NCI, Cellular Oncol Lab, NIH, Bethesda, MD 20892 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Raynaud, F (corresponding author), Univ Paris 05, Fac Sci Pharmaceut & Biol Paris, INSERM, U427, 4 Ave Observ, F-75270 Paris 06, France.			Gerbaud, Pascale/0000-0001-5579-1979				ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; BUBIS J, 1987, BIOCHEMISTRY-US, V26, P3478, DOI 10.1021/bi00386a035; BUBIS J, 1987, J BIOL CHEM, V262, P14961; CARMICHAEL DF, 1982, J BIOL CHEM, V257, P440; CHEVALIER M, 1990, J BIOL CHEM, V265, P42; CORBIN JD, 1978, J BIOL CHEM, V253, P3997; DAVIES KJA, 1987, J BIOL CHEM, V262, P9895; DAVIES KJA, 1987, J BIOL CHEM, V262, P9902; Dean RT, 1997, BIOCHEM J, V324, P1; DellAcqua ML, 1997, J BIOL CHEM, V272, P12881, DOI 10.1074/jbc.272.20.12881; DOSKELAND SO, 1978, BIOCHEM BIOPH RES CO, V83, P542, DOI 10.1016/0006-291X(78)91024-0; ERLICHMAN J, 1983, METHOD ENZYMOL, V99, P76; Evain-Brion D., 1986, P NATL ACAD SCI USA, V83, P5272, DOI [10.1073/pnas.83.14.5272, DOI 10.1073/PNAS.83.14.5272]; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Fricke H., 1966, RADIATION DOSIMETRY, V2, P167; GARETT IR, 1990, J CLIN INVEST, V85, P632, DOI DOI 10.1172/JCI114485; Gibson RM, 1997, J BIOL CHEM, V272, P16343, DOI 10.1074/jbc.272.26.16343; GILL GN, 1970, BIOCHEM BIOPH RES CO, V39, P335, DOI 10.1016/0006-291X(70)90581-4; GILMAN AG, 1970, P NATL ACAD SCI USA, V67, P305, DOI 10.1073/pnas.67.1.305; GOPALAKRISHNA R, 1991, ARCH BIOCHEM BIOPHYS, V285, P382, DOI 10.1016/0003-9861(91)90377-U; GOPALAKRISHNA R, 1989, P NATL ACAD SCI USA, V86, P6758, DOI 10.1073/pnas.86.17.6758; GROSSMAN RM, 1989, P NATL ACAD SCI USA, V86, P6367, DOI 10.1073/pnas.86.16.6367; Halliwell B., 1989, FREE RADICAL BIO MED, P86; HEMMINGS BA, 1982, EUR J BIOCHEM, V127, P473; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; KERYER G, 1991, J CELL BIOL, V115, P284; LANDGRAF W, 1991, J BIOL CHEM, V266, P16305; LOFFNER F, 1986, BRAIN RES, V363, P205, DOI 10.1016/0006-8993(86)91006-1; LONTZ W, 1995, FREE RADICAL BIO MED, V18, P349, DOI 10.1016/0891-5849(94)E0124-2; MATSUBARA T, 1986, J IMMUNOL, V137, P3295; MEIER B, 1989, BIOCHEM J, V263, P539, DOI 10.1042/bj2630539; OGREID D, 1980, FEBS LETT, V121, P340, DOI 10.1016/0014-5793(80)80376-0; OHTA Y, 1991, ARCH DERMATOL RES, V283, P351, DOI 10.1007/BF00371814; PARISET C, 1989, J CELL BIOL, V109, P1195, DOI 10.1083/jcb.109.3.1195; Rao GN, 1996, ONCOGENE, V13, P713; RAYNAUD F, 1987, J INVEST DERMATOL, V89, P105, DOI 10.1111/1523-1747.ep12580448; Raynaud F, 1997, FREE RADICAL BIO MED, V22, P623, DOI 10.1016/S0891-5849(96)00353-X; RAYNAUD F, 1989, LANCET, P1158; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; Schreck R, 1991, Trends Cell Biol, V1, P39, DOI 10.1016/0962-8924(91)90072-H; STADTMAN ER, 1986, TRENDS BIOCHEM SCI, V11, P11, DOI 10.1016/0968-0004(86)90221-5; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; STEVENSON MA, 1994, CANCER RES, V54, P12; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; TASKEN K, 1995, PROTEIN KINASE FACTS, P58; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; TAYLOR SS, 1992, ANNU REV CELL BIOL, V8, P429, DOI 10.1146/annurev.cb.08.110192.002241; THOMAS G, 1986, BIOCHEM BIOPH RES CO, V139, P102, DOI 10.1016/S0006-291X(86)80085-7; UEDA M, 1984, J BIOL CHEM, V259, P9520; WALTER U, 1977, J BIOL CHEM, V252, P6494; ZOCCARATO F, 1989, EUR J BIOCHEM, V180, P473, DOI 10.1111/j.1432-1033.1989.tb14670.x	51	21	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22833	22840		10.1074/jbc.273.35.22833	http://dx.doi.org/10.1074/jbc.273.35.22833			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712918	hybrid			2022-12-27	WOS:000075616600094
J	Kampranis, SC; Maxwell, A				Kampranis, SC; Maxwell, A			Conformational changes in DNA gyrase revealed by limited proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; BREAKAGE-REUNION DOMAIN; N-TERMINAL FRAGMENT; ESCHERICHIA-COLI; TOPOISOMERASE-II; NALIDIXIC-ACID; A-PROTEIN; CRYSTAL-STRUCTURE; B-PROTEIN; MECHANISM	We have used Limited proteolysis to identify conformational changes in DNA gyrase. Gyrase exhibits a proteolytic fingerprint dominated by two fragments, one of similar to 62 kDa, deriving hom the A protein, and another of similar to 25 kDa from the B protein. Quinolone binding to the enzyme-DNA complex induces a conformational change which is reflected in the protection of the C-terminal 47-kDa domain of the B protein. An active site mutant (Tyr(122) to Ser in the A protein) that binds quinolones but cannot cleave DNA still gives the quinolone proteolytic pattern, while stabilization of a cleaved-DNA intermediate by calcium ions does not reveal any protection, suggesting that the quinolone-induced conformational change is different from an "open-gate" state of the enzyme, A quinolone-resistant mutant of gyrase fails to give the characteristic quinolone-associated proteolytic signature. The ATP-induced dimerization of the B subunits is a key step of the gyrase mechanism. The proteolytic fingerprint of this conformation (stabilized by the non-hydrolyzable ATP analog 5'-adenylyl-beta,gamma-imidodiphosphate (ADPNP) shows a protection of the 43-kDa N-terminal domain of the B subunit, The presence of quinolones does not prevent dimerization since incubation of the enzyme-DNA complex with both ADPNP and quinolones gives rise to a complex whose proteolytic pattern retains the characteristic signature of dimerization but has lost the quinolone-induced protection. As a result, the quinolone-gyrase complex can still hydrolyze ATP, albeit with different kinetic characteristics. We interpret the proteolytic signatures observed in terms of four complexes of gyrase, each representing a particular conformational state.	Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England	University of Leicester	Maxwell, A (corresponding author), Univ Leicester, Dept Biochem, Univ Rd, Leicester LE1 7RH, Leics, England.		Kampranis, Sotirios C/G-8374-2016	Kampranis, Sotirios C/0000-0001-6208-1684; Maxwell, Anthony/0000-0002-5756-6430				ABDELMEGUID SS, 1984, P NATL ACAD SCI-BIOL, V81, P2001, DOI 10.1073/pnas.81.7.2001; ALI JA, 1993, BIOCHEMISTRY-US, V32, P2717, DOI 10.1021/bi00061a033; ALI JA, 1995, TRENDS MICROBIOL, V5, P102; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Caron P R, 1994, Adv Pharmacol, V29B, P271; Critchlow SE, 1996, BIOCHEMISTRY-US, V35, P7387, DOI 10.1021/bi9603175; DOBBS ST, 1992, NUCLEIC ACIDS RES, V20, P3567, DOI 10.1093/nar/20.14.3567; GELLERT M, 1979, P NATL ACAD SCI USA, V76, P6289, DOI 10.1073/pnas.76.12.6289; GELLERT M, 1977, P NATL ACAD SCI USA, V74, P4772, DOI 10.1073/pnas.74.11.4772; Hammonds TR, 1997, J BIOL CHEM, V272, P32696, DOI 10.1074/jbc.272.51.32696; Kampranis SC, 1996, P NATL ACAD SCI USA, V93, P14416, DOI 10.1073/pnas.93.25.14416; Kampranis SC, 1998, J BIOL CHEM, V273, P22615, DOI 10.1074/jbc.273.35.22615; KIRKEGAARD K, 1981, CELL, V23, P721, DOI 10.1016/0092-8674(81)90435-9; LINDSLEY JE, 1993, NATURE, V361, P749, DOI 10.1038/361749a0; LINDSLEY JE, 1991, P NATL ACAD SCI USA, V88, P10485, DOI 10.1073/pnas.88.23.10485; LIU LF, 1978, P NATL ACAD SCI USA, V75, P2098, DOI 10.1073/pnas.75.5.2098; MAXWELL A, 1998, PROTOCOLS DNA TOPOIS, V1; MORRISON A, 1980, J BIOL CHEM, V255, P2211; ORPHANIDES G, 1994, NUCLEIC ACIDS RES, V22, P1567, DOI 10.1093/nar/22.9.1567; REECE RJ, 1989, J BIOL CHEM, V264, P19648; REECE RJ, 1991, CRIT REV BIOCHEM MOL, V26, P335, DOI 10.3109/10409239109114072; REECE RJ, 1991, NUCLEIC ACIDS RES, V19, P1399, DOI 10.1093/nar/19.7.1399; REECE RJ, 1991, J BIOL CHEM, V266, P3540; ROBINSON MJ, 1991, J BIOL CHEM, V266, P14585; Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; SHEN LL, 1989, J BIOL CHEM, V264, P2973; SHIOZAKI K, 1991, MOL CELL BIOL, V11, P6093, DOI 10.1128/MCB.11.12.6093; Stewart L, 1996, J BIOL CHEM, V271, P7602, DOI 10.1074/jbc.271.13.7602; SUGINO A, 1978, P NATL ACAD SCI USA, V75, P4838, DOI 10.1073/pnas.75.10.4838; SUGINO A, 1977, P NATL ACAD SCI USA, V74, P4767, DOI 10.1073/pnas.74.11.4767; TAMURA JK, 1992, J BIOL CHEM, V267, P9214; TSE YC, 1980, J BIOL CHEM, V255, P5560; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; WILLMOTT CJR, 1993, ANTIMICROB AGENTS CH, V37, P126, DOI 10.1128/AAC.37.1.126; YAMAGISHI J, 1986, MOL GEN GENET, V204, P367, DOI 10.1007/BF00331012; YOSHIDA H, 1993, ANTIMICROB AGENTS CH, V37, P839, DOI 10.1128/AAC.37.4.839	40	52	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22606	22614		10.1074/jbc.273.35.22606	http://dx.doi.org/10.1074/jbc.273.35.22606			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712889	hybrid			2022-12-27	WOS:000075616600065
J	Pawate, S; Schey, KL; Meier, GP; Ullian, ME; Mais, DE; Halushka, PV				Pawate, S; Schey, KL; Meier, GP; Ullian, ME; Mais, DE; Halushka, PV			Expression, characterization, and purification of C-terminally hexahistidine-tagged thromboxane A(2) receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONIZATION MASS-SPECTROMETRY; LIGAND-BINDING; AFFINITY-CHROMATOGRAPHY; STEP PURIFICATION; HUMAN PLATELETS; PROTEINS; CLONING; ANTAGONIST; SUBTYPE; AGONIST	Thromboxane A(2) (TxA(2)) receptors belong to the class of G-protein-coupled receptors. Knowledge of the relationship of structure to function for TxA(2) receptors is limited because of their low levels of expression, lengthy purification procedures and poor recoveries. A C-terminal hexahistidine-tag (C-His) was ligated to the a-isoform of TxA(2), receptors and expressed in COS-7 and Chinese hamster ovary cells. The C-His-TxA(2), receptors bound the radioligands I-125-7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4-benzenesulfonylamino)bicyclo[3.1.1]hept-2-y]-5(Z)-heptenoic acid, an antagonist, and I-125-[1S-1 alpha,2 beta-(5Z),3 alpha(1E,3S*),4 alpha]-7-[3[(3-hydroxy-4-(4'-phenoxy)-1-butenyl)-7-oxabicyclo-[2.2.1]heptan-2-yl]-heptanoic acid, an agonist, with affinities not significantly different from those of the wild type (wt)-TxA(2), receptors. LipofectAMINE transfection of the cDNAs resulted in high levels of expression (B-max = 95 +/- 6 pmol/mg) of the C-His-TxA(2), receptors. In competition binding studies the IC50 values of five different ligands were not significantly different between C-His-TxA(2), and wt-TxA(2), receptors. Agonist-induced stimulation of cAMP and total inositol phosphate formation were not significantly different between the two receptors. Purification on a Ni2+-NTA column resulted in a rapid (within 4 h) purification with a 36 +/- 2% recovery and a 30 +/- 6-fold purification (n = 5). The partially purified receptors were resolved on SDS-polyacrylamide gel electrophoresis, transferred to a nitrocellulose membrane, dissolved in acetone/trifluoroacetic acid/hexafluoroisopropanol/sinapinic acid, and successfully subjected to matrix-assisted laser desorption ionization-time of flight mass spectrometry analysis. The results suggest that the combination of a high level of expression of C-His-TxA(2), receptors and a rapid purification procedure followed by SDS- polyacrylamide gel electrophoresis may provide a useful approach for mass-spectrometry based structure-function and other studies of TxA(2), receptors.	Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Div Clin Pharmacol, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Pharmaceut Sci, Charleston, SC 29425 USA; Ligand Pharmaceut Inc, San Diego, CA 92121 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Ligand Pharmaceuticals	Halushka, PV (corresponding author), Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Div Clin Pharmacol, 171 Ashley Ave, Charleston, SC 29425 USA.				NHLBI NIH HHS [HL36838] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036838] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allan CJ, 1996, J PHARMACOL EXP THER, V277, P1132; ARITA H, 1989, PROG LIPID RES, V28, P273, DOI 10.1016/0163-7827(89)90002-7; BEAVIS RC, 1990, P NATL ACAD SCI USA, V87, P6873, DOI 10.1073/pnas.87.17.6873; Becker KP, 1998, BBA-MOL CELL RES, V1403, P109, DOI 10.1016/S0167-4889(98)00019-6; Chiang N, 1996, ARCH BIOCHEM BIOPHYS, V334, P9, DOI 10.1006/abbi.1996.0423; Courchesne PL, 1997, ELECTROPHORESIS, V18, P369, DOI 10.1002/elps.1150180311; DAngelo DD, 1996, J BIOL CHEM, V271, P6233, DOI 10.1074/jbc.271.11.6233; DANGELO DD, 1994, J PHARMACOL EXP THER, V271, P1034; DOBELI H, 1990, MOL BIOCHEM PARASIT, V41, P259, DOI 10.1016/0166-6851(90)90189-S; Eckerskorn C, 1997, ANAL CHEM, V69, P2888, DOI 10.1021/ac970077e; Enguita FJ, 1996, FEMS MICROBIOL LETT, V137, P135; FONG TM, 1994, MED RES REV, V14, P387, DOI 10.1002/med.2610140402; Gao MH, 1998, P NATL ACAD SCI USA, V95, P1038, DOI 10.1073/pnas.95.3.1038; GRISSHAMMER R, 1995, Q REV BIOPHYS, V28, P315, DOI 10.1017/S0033583500003504; HALUSHKA PV, 1995, J LIPID MEDIAT CELL, V12, P361, DOI 10.1016/0929-7855(95)00023-J; Halushka PV, 1997, HANDB EXP PHARM, V126, P459; HAMBERG M, 1975, P NATL ACAD SCI USA, V72, P2994, DOI 10.1073/pnas.72.8.2994; Hayashi MK, 1996, J BIOCHEM, V120, P1232; HIRATA M, 1991, NATURE, V349, P617, DOI 10.1038/349617a0; Hirata T, 1996, J CLIN INVEST, V97, P949, DOI 10.1172/JCI118518; HONDA A, 1993, J BIOL CHEM, V268, P7759; JANSSEN JJM, 1995, J BIOL CHEM, V270, P11222, DOI 10.1074/jbc.270.19.11222; JIN H, 1992, J BIOL CHEM, V267, P5735; KAPLAN RS, 1985, ANAL BIOCHEM, V150, P97, DOI 10.1016/0003-2697(85)90445-2; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; KOJRO E, 1993, BIOCHEMISTRY-US, V32, P13537, DOI 10.1021/bi00212a020; Kosugi S, 1996, J BIOL CHEM, V271, P31813, DOI 10.1074/jbc.271.50.31813; Liang XL, 1996, ANAL CHEM, V68, P1012, DOI 10.1021/ac950685z; Lima JJ, 1996, J RECEPT SIGNAL TR R, V16, P357, DOI 10.3109/10799899609039956; MAYEUX PR, 1991, J BIOL CHEM, V266, P13752; MCALLISTER G, 1992, P NATL ACAD SCI USA, V89, P5517, DOI 10.1073/pnas.89.12.5517; MORINELLI TA, 1989, J PHARMACOL EXP THER, V251, P557; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NAKA M, 1992, J PHARMACOL EXP THER, V262, P632; PONG AS, 1994, ANAL BIOCHEM, V217, P165; PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0; QIAGEN, 1992, QIAEXPRESSIONIST; RAYCHOWDHURY MK, 1994, J BIOL CHEM, V269, P19256; Robeva AS, 1996, BIOCHEM PHARMACOL, V51, P545, DOI 10.1016/0006-2952(95)02235-X; SAUDOU F, 1992, EMBO J, V11, P7, DOI 10.1002/j.1460-2075.1992.tb05021.x; Schey K L, 1996, Methods Mol Biol, V61, P227; SIMMONS TR, 1993, J LEUKOCYTE BIOL, V53, P173, DOI 10.1002/jlb.53.2.173; USHIKUBI F, 1989, J BIOL CHEM, V264, P16496; Wu CQ, 1996, BIOCHEM BIOPH RES CO, V222, P439, DOI 10.1006/bbrc.1996.0763; YAMASHITA M, 1991, P NATL ACAD SCI USA, V88, P11515, DOI 10.1073/pnas.88.24.11515	45	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22753	22760		10.1074/jbc.273.35.22753	http://dx.doi.org/10.1074/jbc.273.35.22753			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712907	hybrid			2022-12-27	WOS:000075616600083
J	Tretiakova, A; Gallia, GL; Shcherbik, N; Jameson, B; Johnson, EM; Amini, S; Khalili, K				Tretiakova, A; Gallia, GL; Shcherbik, N; Jameson, B; Johnson, EM; Amini, S; Khalili, K			Association of Pur alpha with RNAs homologous to 7 SL determines its binding ability to the myelin basic protein promoter DNA sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; DYSMYELINATING MUTANT MICE; MOUSE-BRAIN; INSITU HYBRIDIZATION; ALU REPEAT; DEVELOPMENTAL EXPRESSION; INDUCED TRANSFORMATION; GENE-TRANSCRIPTION; RECEPTOR COMPLEXES; ESTROGEN-RECEPTOR	Cell type and developmental stage expression of the myelin basic protein (MBP) gene in mouse brain is regulated at the transcriptional level. Earlier studies from our laboratory have led to the identification of a DNA binding protein from mouse brain, named Pur alpha, which interacts with the MB1 regulatory motif of the MBP and stimulates its transcription in glial cells. In this report, we demonstrate that a cellular RNA, with significant homology to 7 SL RNA is associated with Pur alpha, Results from band shift competition studies indicate that Pur alpha-associated RNA (PU-RNA), inhibits the interaction of immunopurified Pur alpha with the MB1 DNA sequence, Re suits from Northern blot studies indicated that PU-RNA is expressed during various stages of brain development. Of interest, this RNA was found in association with Pur alpha that was produced in the mouse brain at the early stage of brain development. Results from Northwestern analysis using a PU-RNA probe identified the regions within Pur alpha that are important for Pur alpha/PU-RNA association. Production of Purer at the early stage of brain development and its association with PU-RNA at this stage, when Pur alpha exhibits poor binding ability to the MB1 DNA sequence, suggests that PU-RNA may function as a co-factor that negatively regulates Pur alpha interaction with the MBP promoter sequence.	Allegheny Univ Hlth Sci, Ctr Neurovirol & Neurooncol, Philadelphia, PA 19102 USA; CUNY Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA	Drexel University; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Khalili, K (corresponding author), Allegheny Univ Hlth Sci, Ctr Neurovirol & Neurooncol, Broad & Vine,MS 406, Philadelphia, PA 19102 USA.							ALMENOFF JS, 1994, J BIOL CHEM, V269, P16610; Ausubel FM, 1988, MOL REPROD DEV; BERGEMANN AD, 1992, MOL CELL BIOL, V12, P5673, DOI 10.1128/MCB.12.12.5673; Bovia F, 1996, J CELL SCI, V109, P2601; BRITTEN RJ, 1994, P NATL ACAD SCI USA, V91, P5992, DOI 10.1073/pnas.91.13.5992; CAMPAGNONI AT, 1988, MOL NEUROBIOL, V2, P41, DOI 10.1007/BF02935632; CARSON JH, 1983, DEV BIOL, V96, P485, DOI 10.1016/0012-1606(83)90185-9; Chang DY, 1996, NUCLEIC ACIDS RES, V24, P4165, DOI 10.1093/nar/24.21.4165; CHEN NN, 1995, J VIROL, V69, P5843, DOI 10.1128/JVI.69.9.5843-5848.1995; Cheng JG, 1996, DNA CELL BIOL, V15, P549, DOI 10.1089/dna.1996.15.549; CHUANG LM, 1988, BIOCHEM BIOPH RES CO, V156, P1287, DOI 10.1016/S0006-291X(88)80772-1; Clawson GA, 1996, CELL GROWTH DIFFER, V7, P635; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dubnau J, 1996, NATURE, V379, P694, DOI 10.1038/379694a0; FRENCH BT, 1984, CANCER LETT, V23, P45, DOI 10.1016/0304-3835(84)90060-0; GIAMBIAGI N, 1989, LIFE SCI, V44, P2067, DOI 10.1016/0024-3205(89)90353-6; GIORDANO T, 1992, MECH AGEING DEV, V64, P13, DOI 10.1016/0047-6374(92)90092-R; HAAS S, 1993, MOL CELL BIOL, V13, P3103, DOI 10.1128/MCB.13.5.3103; HAAS S, 1995, J CELL BIOL, V130, P1171, DOI 10.1083/jcb.130.5.1171; Herault Yann, 1995, Gene Expression, V4, P85; Ishizaki J, 1996, NAT MED, V2, P1386, DOI 10.1038/nm1296-1386; JANG KL, 1992, J ACQ IMMUN DEF SYND, V5, P1142; KOHNOE S, 1987, BIOCHIM BIOPHYS ACTA, V909, P107, DOI 10.1016/0167-4781(87)90032-7; Krachmarov CP, 1996, P NATL ACAD SCI USA, V93, P14112, DOI 10.1073/pnas.93.24.14112; KRAUSE MO, 1986, CANCER RES, V46, P1990; KRISTENSSON K, 1986, J HISTOCHEM CYTOCHEM, V34, P467, DOI 10.1177/34.4.2419396; KURZ J, 1988, BIOCHEM BIOPH RES CO, V152, P753, DOI 10.1016/S0006-291X(88)80102-5; LASHGARI MS, 1990, J CLIN INVEST, V86, P1671, DOI 10.1172/JCI114890; LIU WM, 1995, NUCLEIC ACIDS RES, V23, P1758, DOI 10.1093/nar/23.10.1758; LUKIW WJ, 1992, NEUROCHEM RES, V17, P591, DOI 10.1007/BF00968788; LUTCKE H, 1995, EUR J BIOCHEM, V228, P531, DOI 10.1111/j.1432-1033.1995.0531m.x; MA ZW, 1994, GENE, V149, P311, DOI 10.1016/0378-1119(94)90167-8; MARTIGNETTI JA, 1993, P NATL ACAD SCI USA, V90, P11563, DOI 10.1073/pnas.90.24.11563; QUENTIN Y, 1994, GENETICA, V93, P203, DOI 10.1007/BF01435252; RiveraPomar R, 1996, NATURE, V379, P746, DOI 10.1038/379746a0; ROSSINI GP, 1990, LIFE SCI, V47, P743, DOI 10.1016/0024-3205(90)90630-A; ROSSINI GP, 1989, J STEROID BIOCHEM, V32, P633, DOI 10.1016/0022-4731(89)90507-4; SAKAMOTO K, 1991, J BIOL CHEM, V266, P3031; SHARP PA, 1983, NATURE, V301, P471, DOI 10.1038/301471a0; SHIOTA C, 1991, J NEUROCHEM, V56, P818, DOI 10.1111/j.1471-4159.1991.tb01997.x; SORG BA, 1987, J NEUROCHEM, V49, P1146, DOI 10.1111/j.1471-4159.1987.tb10005.x; STRUB K, 1991, MOL CELL BIOL, V11, P3949, DOI 10.1128/MCB.11.8.3949; THOMAS T, 1985, J STEROID BIOCHEM, V23, P19, DOI 10.1016/0022-4731(85)90255-9; THOMAS T, 1986, J STEROID BIOCHEM, V24, P505, DOI 10.1016/0022-4731(86)90112-3; TIERCY JM, 1985, EXPERIENTIA, V41, P82, DOI 10.1007/BF02005887; VERITY AN, 1988, J NEUROSCI RES, V21, P238, DOI 10.1002/jnr.490210216; WATSON JB, 1987, MOL CELL BIOL, V7, P3324, DOI 10.1128/MCB.7.9.3324; WIKTOROWICZ M, 1991, DEV NEUROSCI-BASEL, V13, P143, DOI 10.1159/000112152; Zamore PD, 1996, CURR BIOL, V6, P773, DOI 10.1016/S0960-9822(02)00591-2; ZELLER NK, 1984, P NATL ACAD SCI-BIOL, V81, P18, DOI 10.1073/pnas.81.1.18	50	38	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22241	22247		10.1074/jbc.273.35.22241	http://dx.doi.org/10.1074/jbc.273.35.22241			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712838	hybrid			2022-12-27	WOS:000075616600014
J	Megidish, T; Cooper, J; Zhang, LX; Fu, HA; Hakomori, S				Megidish, T; Cooper, J; Zhang, LX; Fu, HA; Hakomori, S			A novel sphingosine-dependent protein kinase (SDK1) specifically phosphorylates certain isoforms of 14-3-3 protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SIGNALING PATHWAYS; TYROSINE PHOSPHORYLATION; SPHINGOLIPID METABOLITES; CELLULAR PROLIFERATION; LIPID 2ND-MESSENGERS; MOLECULAR-CLONING; HUMAN-PLATELETS; T-CELLS; BRAIN; INHIBITION	Protein kinases activated by sphingosine or N,N'-di-methylsphingosine, but not by other lipids, have been detected and are termed sphingosine-dependent protein kinases (SDKs), These SDKs were previously shown to phosphorylate endogenous 14-3-3 proteins (Megidish, T., White, T., Takio, K., Titani, K., Igarashi, Y., and Hakomori, S. (1995) Biochem. Biophys. Res. Commun. 216, 739-747). We have now partially purified one SDK, termed SDK1, from cytosol of mouse Balb/c 3T3(A31) fibroblasts. SDK1 is a serine kinase with molecular mass 50-60 kDa that is strongly activated by N,N'-dimethylsphingosine and sphingosine, but not by ceramide, sphingosine 1-phosphate, or other sphingo-, phospho-, or glycerolipids tested. Its activity is inhibited by the protein kinase C activator phosphatidylserine. Activity of SDK1 is clearly distinct from other types of serine kinases tested, including casein kinase II, the alpha and zeta isoforms of protein kinase C, extracellular signal-regulated mitogene-activated protein kinase 1 (Erk-1), Erk-2, and Raf-1. SDK1 specifically phosphorylates certain isoforms of 14-3-3 (eta, beta, zeta) but not others (sigma, tau). The phosphorylation site was identified as Ser* in the sequence Arg-Arg-Ser-Ser*-Trp-Arg in 14-3-3 beta. The sigma and tau isoforms of 14-3-3 lack serine at this position, potentially explaining their lack of phosphorylation by SDK1. Interestingly, the phosphorylation site is located on the dimes interface of 14-3-3. Phosphorylation of this site by SDK1 was studied in 14-3-3 mutants. Mutation Of a lysine residue, located 9 amino acids N-terminal to the phosphorylation site, abolished 14-3-3 phosphorylation. Furthermore, co-immunoprecipitation experiments demonstrate an association between ate SDK and 14-3-3 in sifts. Exogenous N,N'-dimethylsphingosine stimulates 14-3-3 phosphorylation in Balb/c 3T3 fibroblasts, suggesting that SDK1 may phosphorylate 14-3-3 in situ. These data support a biological sole of SDK1 activation and consequent phosphorylation of specific 14-3-3 isoforms that regulate signal transduction. In view of the three-dimensional structure of 14-3-3, it is likely that phosphorylation by SDK1 would alter dimerization of 14-3-3, and/or induce conformational changes that alter 14-3-3 association with other kinases involved in signal transduction.	Pacific NW Res Inst, Seattle, WA 98122 USA; Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Emory University	Hakomori, S (corresponding author), Pacific NW Res Inst, Seattle, WA 98122 USA.	hakomori@u.washington.edu		Zhang, Lixin/0000-0003-0894-9520	NATIONAL CANCER INSTITUTE [R01CA054786, R35CA042505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053165, R29GM053165] Funding Source: NIH RePORTER; NCI NIH HHS [CA42505, CA54786] Funding Source: Medline; NIGMS NIH HHS [GM53165] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABDELGHANY M, 1992, BIOCHIM BIOPHYS ACTA, V1137, P349, DOI 10.1016/0167-4889(92)90156-6; AITKEN A, 1995, MOL CELL BIOCHEM, V149, P41, DOI 10.1007/BF01076562; AITKEN A, 1995, J BIOL CHEM, V270, P5706, DOI 10.1074/jbc.270.11.5706; Aitken A, 1996, TRENDS CELL BIOL, V6, P341, DOI 10.1016/0962-8924(96)10029-5; ARNOLD RS, 1991, BIOCHEMISTRY-US, V30, P7747, DOI 10.1021/bi00245a011; Blakesley VA, 1997, J BIOL CHEM, V272, P16211, DOI 10.1074/jbc.272.26.16211; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; CORONEOS E, 1995, J BIOL CHEM, V270, P23305, DOI 10.1074/jbc.270.40.23305; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dubois T, 1997, J BIOL CHEM, V272, P28882, DOI 10.1074/jbc.272.46.28882; HAKOMORI SI, 1990, J BIOL CHEM, V265, P18713; HANNUN YA, 1986, J BIOL CHEM, V261, P2604; HANNUN YA, 1993, BIOCHIM BIOPHYS ACTA, V1154, P223, DOI 10.1016/0304-4157(93)90001-5; HANNUN YA, 1985, J BIOL CHEM, V260, P39; HUNTER T, 1995, CELL, V83, P1, DOI 10.1016/0092-8674(95)90225-2; IGARASHI Y, 1990, J BIOL CHEM, V265, P5385; IGARASHI Y, 1989, BIOCHEMISTRY-US, V28, P6796, DOI 10.1021/bi00443a002; IGARASHI Y, 1989, BIOCHEM BIOPH RES CO, V164, P1411, DOI 10.1016/0006-291X(89)91827-5; JEFFERSON AB, 1988, J BIOL CHEM, V263, P15241; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KOBAYASHI T, 1988, EUR J BIOCHEM, V172, P747, DOI 10.1111/j.1432-1033.1988.tb13952.x; LAVIE Y, 1994, BBA-MOL CELL RES, V1220, P323, DOI 10.1016/0167-4889(94)90156-2; LITCHFIELD DW, 1990, J BIOL CHEM, V265, P7638; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; LUO ZJ, 1995, J BIOL CHEM, V270, P23681, DOI 10.1074/jbc.270.40.23681; Mano N, 1997, ANAL BIOCHEM, V244, P291, DOI 10.1006/abio.1996.9891; MARTIN H, 1994, J NEUROCHEM, V63, P2259; MCDONALD OB, 1991, J BIOL CHEM, V266, P21773; MEGIDISH T, 1995, BIOCHEM BIOPH RES CO, V216, P739, DOI 10.1006/bbrc.1995.2684; Meller N, 1996, MOL CELL BIOL, V16, P5782; MERRILL AH, 1989, BIOCHIM BIOPHYS ACTA, V1010, P131, DOI 10.1016/0167-4889(89)90152-3; MORRISON D, 1994, SCIENCE, V266, P56, DOI 10.1126/science.7939645; MORRISON DK, 1995, MOL REPROD DEV, V42, P507, DOI 10.1002/mrd.1080420420; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; OHTA H, 1995, CANCER RES, V55, P691; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Perego L, 1997, MOL REPROD DEV, V47, P370, DOI 10.1002/(SICI)1098-2795(199708)47:4&lt;370::AID-MRD3&gt;3.0.CO;2-H; PUSHKAREVA MY, 1992, J BIOL CHEM, V267, P15246; RADUNZ HE, 1988, LIEBIGS ANN CHEM, P1103; REUTHER GW, 1994, SCIENCE, V266, P129, DOI 10.1126/science.7939633; RODRIGUEZPENA A, 1984, BIOCHEM BIOPH RES CO, V120, P1053, DOI 10.1016/S0006-291X(84)80213-2; Rommel C, 1996, ONCOGENE, V12, P609; SEUFFERLEIN T, 1994, J BIOL CHEM, V269, P27610; SPIEGEL S, 1995, J MEMBRANE BIOL, V146, P225; Spiegel S, 1996, CURR OPIN CELL BIOL, V8, P159, DOI 10.1016/S0955-0674(96)80061-5; TAYLOR SS, 1995, FASEB J, V9, P1255, DOI 10.1096/fasebj.9.13.7557015; TOKER A, 1992, EUR J BIOCHEM, V206, P453, DOI 10.1111/j.1432-1033.1992.tb16946.x; Vincenz C, 1996, J BIOL CHEM, V271, P20029, DOI 10.1074/jbc.271.33.20029; WATANABE M, 1994, MOL BRAIN RES, V25, P113, DOI 10.1016/0169-328X(94)90285-2; Xiao Bing, 1995, Nature (London), V376, P188, DOI 10.1038/376188a0; Xing HM, 1997, CURR BIOL, V7, P294, DOI 10.1016/S0960-9822(06)00152-7; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yatomi Y, 1997, BIOCHEM BIOPH RES CO, V231, P848, DOI 10.1006/bbrc.1997.6207; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; ZHANG H, 1990, J BIOL CHEM, V265, P76; Zhang LX, 1997, J BIOL CHEM, V272, P13717, DOI 10.1074/jbc.272.21.13717	56	111	124	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21834	21845		10.1074/jbc.273.34.21834	http://dx.doi.org/10.1074/jbc.273.34.21834			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705322	hybrid			2022-12-27	WOS:000075492600056
J	Amino, R; Porto, RM; Chammas, R; Egami, MI; Schenkman, S				Amino, R; Porto, RM; Chammas, R; Egami, MI; Schenkman, S			Identification and characterization of a sialidase released by the salivary gland of the hematophagous insect Triatoma infestans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPANOSOMA-CRUZI; TRANS-SIALIDASE; SALMONELLA-TYPHIMURIUM; MAST-CELLS; ACID; PROTEIN; NEURAMINIDASE; PURIFICATION; SELECTIN; REPEATS	Sialidases (EC 3.2.1.18) are commonly found in viruses, bacteria, fungi, protozoa, and vertebrates, but not in invertebrates. We have previously reported the presence of a new siaIidase activity in the gut of exclusively hematophagous insects of the Triatoma genus, which transmit Chagas' disease (Amino, R., Acosta, A, Morita, O. M., Chioccola, V. L. P., and Schenkman, S. (1995) Glycobiology 5, 625-631). Here we show that this sialidase is present in the salivary gland of Triatoma infestans, and it is released with the saliva during the insect bite. The sialidase was purified to homogeneity (>5000 times) to a specific activity of more than 20 units/mg. It elutes from a gel filtration column with a volume corresponding to the size of 33 kDa, and it migrates as a single 26-kDa band in SDS-polyacrylamide gel electrophoresis, which is unusually smaller when compared with other known sialidases. T. infestans sialidase hydrolyzes preferentially alpha 2-->3-linked sialic acids at pH 4-8, with maximaI activity between pH 5.5 and 6.5, which is compatible with the optimal pH of secreted sialidases. The sialidase is competitively inhibited by 2-deoxy-2,3-dehydro-N-acetyl-neuraminic acid (K-i = 0.075 mM) and differently from many sialidases, with exception of Salmonella typhimurium sialidase, it is inhibited competitively by HEPES (K-i = 15 mM). The fact that T. infestans sialidase is released with the saliva and can hydrolyze sialyl-Lewis(x) blood groups, which are the ligands for selectins, suggests that it might have a role in the blood feeding.	Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, BR-04023062 Sao Paulo, Brazil; Univ Fed Sao Paulo, Escola Paulista Med, Dept Histol, BR-04023062 Sao Paulo, Brazil; Ludwig Inst Canc Res, BR-01509010 Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Ludwig Institute for Cancer Research	Schenkman, S (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, R Botucatu 862-8, BR-04023062 Sao Paulo, Brazil.	Sergio.dmip@Epm.br	Marques-Porto, Rafael/H-3533-2016; Schenkman, Sergio/A-9227-2013; Chammas, Roger/A-8004-2011	Schenkman, Sergio/0000-0001-9353-8480; Chammas, Roger/0000-0003-0342-8726; Amino, Rogerio/0000-0002-8086-2932				AMINO R, 1995, GLYCOBIOLOGY, V5, P625, DOI 10.1093/glycob/5.6.625; ANSORGE W, 1983, ELECTROPHORESIS, V82, P235; BEVILACQUA MP, 1993, J CLIN INVEST, V91, P379, DOI 10.1172/JCI116210; BRIONES MRS, 1994, EXP PARASITOL, V79, P211, DOI 10.1006/expr.1994.1083; BRIONES MRS, 1995, J MOL EVOL, V41, P120, DOI 10.1007/BF00170663; BRIONES MRS, 1995, MOL BIOCHEM PARASIT, V70, P9, DOI 10.1016/0166-6851(95)00004-K; CHOU MY, 1994, J BIOL CHEM, V269, P18821; CHUANG NN, 1990, COMP BIOCHEM PHYS C, V97, P353, DOI 10.1016/0742-8413(90)90153-Z; Cocchiara R, 1997, J NEUROIMMUNOL, V75, P9, DOI 10.1016/S0165-5728(96)00229-9; CORFIELD T, 1992, GLYCOBIOLOGY, V2, P509, DOI 10.1093/glycob/2.6.509; COSTELLO M, 1979, NATURE, V281, P677, DOI 10.1038/281677a0; Crennell SJ, 1996, J MOL BIOL, V259, P264, DOI 10.1006/jmbi.1996.0318; CROSS GAM, 1993, ANNU REV MICROBIOL, V47, P385, DOI 10.1146/annurev.mi.47.100193.002125; DANG CV, 1989, J BIOL CHEM, V264, P15104; EMADIKHIAV B, 1995, EUR J PHARMACOL, V272, P97, DOI 10.1016/0014-2999(94)00628-K; ENGSTLER M, 1993, PARASITOL TODAY, V9, P222, DOI 10.1016/0169-4758(93)90018-B; Feizi Ten, 1993, Current Opinion in Structural Biology, V3, P701, DOI 10.1016/0959-440X(93)90053-N; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; GOSSRAU R, 1977, HISTOCHEMISTRY, V53, P189, DOI 10.1007/BF00498493; GUO XM, 1994, J AM CHEM SOC, V116, P5572, DOI 10.1021/ja00092a007; HARRIS JG, 1995, EUR J PHARMACOL, V279, P149, DOI 10.1016/0014-2999(95)00145-B; HOYER LL, 1991, J BIOCHEM-TOKYO, V110, P462, DOI 10.1093/oxfordjournals.jbchem.a123603; NOESKEJUNGBLUT C, 1995, J BIOL CHEM, V270, P28629, DOI 10.1074/jbc.270.48.28629; OConnell D, 1996, P NATL ACAD SCI USA, V93, P5883, DOI 10.1073/pnas.93.12.5883; Otsu K, 1995, EXP PARASITOL, V81, P529, DOI 10.1006/expr.1995.1146; PIRIESHEPHERD SR, 1995, J BIOL CHEM, V270, P5877, DOI 10.1074/jbc.270.11.5877; POWELL LD, 1986, ANAL BIOCHEM, V157, P179, DOI 10.1016/0003-2697(86)90211-3; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; ROGGENTIN P, 1993, MOL MICROBIOL, V9, P915, DOI 10.1111/j.1365-2958.1993.tb01221.x; Rosenberg A, 1976, BIOL ROLES SIALIC AC, P295; Saito M, 1995, BIOL SIALIC ACIDS, P261, DOI [10.1007/978-1-4757-9504-2_8, DOI 10.1007/978-1-4757-9504-2_8]; SCHAUB GA, 1992, ADV PARASIT, V31, P255, DOI 10.1016/S0065-308X(08)60023-8; SCHAUER R, 1989, BIOL CHEM H-S, V370, P183, DOI 10.1515/bchm3.1989.370.1.183; SCHENKMAN S, 1994, ANNU REV MICROBIOL, V48, P499, DOI 10.1146/annurev.mi.48.100194.002435; SILVA CP, 1994, INSECT BIOCHEM MOLEC, V24, P493, DOI 10.1016/0965-1748(94)90044-2; STACK MS, 1992, BIOCHEM J, V284, P81, DOI 10.1042/bj2840081; TERRA WR, 1990, ANNU REV ENTOMOL, V35, P181, DOI 10.1146/annurev.en.35.010190.001145; VARKI A, 1994, P NATL ACAD SCI USA, V91, P7390, DOI 10.1073/pnas.91.16.7390; Vimr Eric R., 1994, Trends in Microbiology, V2, P271, DOI 10.1016/0966-842X(94)90003-5; WARE JA, 1995, HEMATOLOGY, P1161	40	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24575	24582		10.1074/jbc.273.38.24575	http://dx.doi.org/10.1074/jbc.273.38.24575			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733752	hybrid			2022-12-27	WOS:000076007300044
J	Pyrowolakis, G; Hofmann, D; Herrmann, R				Pyrowolakis, G; Hofmann, D; Herrmann, R			The subunit b of the F0F1-type ATPase of the bacterium Mycoplasma pneumoniae is a lipoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEINS; SEQUENCE-ANALYSIS; DNA-SEQUENCE; OPERON; GENITALIUM; ACYLATION; GENOME; GENES; ACID	The DNA sequence analysis of the F0F1-ATPase operon of the bacterium Mycoplasma pneumoniae predicted that the subunit b, encoded by the gene afpF, is a lipoprotein of the murein lipoprotein type of Escherichia coli, Here we experimentally verify this prediction by metabolic labeling of subunit b with [C-14]palmitic acid and by in vivo interfering with the processing of the prolipoprotein form of subunit b by the antibiotic globomycin, a specific inhibitor of the signal peptidase II, Our results suggest that the subunit b of the F0F1-ATPase of M. pneumoniae is anchored at the cytoplasmic membrane by an N-terminal lipid modification in addition to its transmembrane domain, The lipoprotein nature of subunit b and its proposed membrane topology seems to be characteristic for mycoplasmas, since among all sequenced bacterial atpF genes, only those from Mycoplasma gallisepticum and Mycoplasma genitalium code for a conserved lipoprotein consensus sequence.	Heidelberg Univ, Zentrum Mol Biol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Herrmann, R (corresponding author), Heidelberg Univ, Zentrum Mol Biol, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	r.herrmann@mail.zmbh.uni-heidelberg.de						BORDIER C, 1981, J BIOL CHEM, V256, P1604; Braun V., 1994, BACTERIAL CELL WALL, P319, DOI 10.1016/S0167-7306(08)60417-2; DeckersHebestreit G, 1996, ANNU REV MICROBIOL, V50, P791, DOI 10.1146/annurev.micro.50.1.791; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; HANTKE K, 1973, EUR J BIOCHEM, V34, P284, DOI 10.1111/j.1432-1033.1973.tb02757.x; Hilbert H, 1996, NUCLEIC ACIDS RES, V24, P628, DOI 10.1093/nar/24.4.628; Himmelreich R, 1997, NUCLEIC ACIDS RES, V25, P701, DOI 10.1093/nar/25.4.701; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; HU PC, 1977, J EXP MED, V145, P1328, DOI 10.1084/jem.145.5.1328; INUKAI M, 1978, J ANTIBIOT, V31, P1203, DOI 10.7164/antibiotics.31.1203; Jan G, 1995, RES MICROBIOL, V146, P739, DOI 10.1016/0923-2508(96)81070-9; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAYHSCHMITT G, 1992, INFECT IMMUN, V60, P2906, DOI 10.1128/IAI.60.7.2906-2913.1992; Muhlradt PF, 1997, J EXP MED, V185, P1951, DOI 10.1084/jem.185.11.1951; NYSTROM S, 1992, EUR J BIOCHEM, V204, P231, DOI 10.1111/j.1432-1033.1992.tb16629.x; Pollack JD, 1997, CRIT REV MICROBIOL, V23, P269, DOI 10.3109/10408419709115140; PROFT T, 1994, MOL MICROBIOL, V13, P337, DOI 10.1111/j.1365-2958.1994.tb00427.x; PROFT T, 1995, J BACTERIOL, V177, P3370, DOI 10.1128/jb.177.12.3370-3378.1995; RASMUSSEN OF, 1992, BIOCHEM J, V285, P881, DOI 10.1042/bj2850881; RAZIN S, 1992, FEMS MICROBIOL LETT, V100, P423, DOI 10.1016/0378-1097(92)90241-F; RIEHTMAN HC, 1987, INFECT IMMUN, V55, P1094; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; SANTANA M, 1994, J BACTERIOL, V176, P6802, DOI 10.1128/JB.176.22.6802-6811.1994; Smith Paul F., 1992, P79; SUTCLIFFE IC, 1995, J BACTERIOL, V177, P1123, DOI 10.1128/jb.177.5.1123-1128.1995; TOKUNAGA M, 1982, P NATL ACAD SCI-BIOL, V79, P2255, DOI 10.1073/pnas.79.7.2255; WALKER JE, 1984, BIOCHEM J, V224, P799, DOI 10.1042/bj2240799; Wieslander Ake, 1992, P93; WOESE CR, 1980, P NATL ACAD SCI-BIOL, V77, P494, DOI 10.1073/pnas.77.1.494	30	18	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24792	24796		10.1074/jbc.273.38.24792	http://dx.doi.org/10.1074/jbc.273.38.24792			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733782	hybrid			2022-12-27	WOS:000076007300074
J	Skinner, KA; White, CR; Patel, R; Tan, S; Barnes, S; Kirk, M; Darley-Usmar, V; Parks, DA				Skinner, KA; White, CR; Patel, R; Tan, S; Barnes, S; Kirk, M; Darley-Usmar, V; Parks, DA			Nitrosation of uric acid by peroxynitrite - Formation of a vasoactive nitric oxide donor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROXYL RADICAL PRODUCTION; HUMAN-BLOOD PLASMA; ORGANIC NITRATES; TYROSINE NITRATION; CARBON-DIOXIDE; PROTEIN MODIFICATIONS; S-NITROSOGLUTATHIONE; LIPID-PEROXIDATION; LUNG INJURY; SUPEROXIDE	Peroxynitrite (ONOO-), formed by the reaction between nitric oxide (. NO) and superoxide, has been implicated in the etiology of numerous disease processes. Low molecular weight antioxidants, including uric acid, may minimize ONOO--mediated damage to tissues. The tissue-sparing effects of uric acid are typically attributed to oxidant scavenging; however, little attention has been paid to the biology of the reaction products. In this study, a previously unidentified uric acid derivative was detected in ONOO--treated human plasma. The product of the uric acid/ONOO- reaction resulted in endothelium-independent vasorelaxation of rat thoracic aorta, with an EC50 value in the range of 0.03-0.3 mu M. Oxyhemoglobin, a . NO scavenger, completely attenuated detectable . NO release and vascular relaxation. Uric acid plus decomposed ONOO- neither released . NO nor altered vascular reactivity. Electrochemical quantification of . NO confirmed that the uric acid/ONOO- reaction resulted in spontaneous (thiol-independent) and protracted (t(1/2) similar to 125 min) release of . NO. Mass spectroscopic analysis indicated that the product was a nitrated uric acid derivative. The uric acid nitration/nitrosation product may play a pivotal role in human pathophysiology by releasing . NO, which could decrease vascular tone, increase tissue blood flow, and thereby constitute a role for uric acid not previously described.	Univ Alabama, Dept Anesthesiol, Birmingham, AL 35233 USA; Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35233 USA; Univ Alabama, Dept Med, Birmingham, AL 35233 USA; Univ Alabama, Dept Mol & Cellular Pathol, Birmingham, AL 35233 USA; Univ Alabama, Dept Pediat, Birmingham, AL 35233 USA; Univ Alabama, Dept Pharmacol & Toxicol, Birmingham, AL 35233 USA; Univ Alabama, Ctr Free Rad Biol, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Parks, DA (corresponding author), Univ Alabama, Dept Anesthesiol, 619 S 19th St, Birmingham, AL 35233 USA.		Darley-Usmar, Victor/F-7656-2010	Darley-Usmar, Victor/0000-0001-8921-7086; Patel, Rakesh/0000-0002-1526-4303	NCRR NIH HHS [S10RR06487] Funding Source: Medline; NHLBI NIH HHS [HL 54815, HL 48676] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR006487] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048676, R29HL054815] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; ANTONINI E, 1971, HAEMOGLOBIN MYOGLOBI, P12; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; BECKER BF, 1991, CHEST, V100, pS176, DOI 10.1378/chest.100.3_Supplement.176S; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BECKMAN JS, 1994, METHOD ENZYMOL, V233, P229; BECKMANN JS, 1994, BIOL CHEM H-S, V375, P81, DOI 10.1515/bchm3.1994.375.2.81; BENNETT BM, 1994, TRENDS PHARMACOL SCI, V15, P245, DOI 10.1016/0165-6147(94)90319-0; Berlett BS, 1996, P NATL ACAD SCI USA, V93, P1776, DOI 10.1073/pnas.93.5.1776; Caulfield JL, 1996, J BIOL CHEM, V271, P25859, DOI 10.1074/jbc.271.42.25859; Chang J, 1996, AM J PHYSIOL-LUNG C, V270, pL931, DOI 10.1152/ajplung.1996.270.6.L931; CholletMartin S, 1996, AM J RESP CRIT CARE, V153, P985, DOI 10.1164/ajrccm.153.3.8630584; CHONG S, 1991, BIOCHEM PHARMACOL, V42, P1433; Crow JP, 1996, ADV EXP MED BIOL, V387, P147; Denicola A, 1996, ARCH BIOCHEM BIOPHYS, V333, P49, DOI 10.1006/abbi.1996.0363; Evans TJ, 1996, P NATL ACAD SCI USA, V93, P9553, DOI 10.1073/pnas.93.18.9553; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748; FUNG HL, 1993, AM J CARDIOL, V72, pC9, DOI 10.1016/0002-9149(93)90249-C; GIACOIA GP, 1995, SOUTH MED J, V88, P33, DOI 10.1097/00007611-199501000-00004; Gow A, 1996, ARCH BIOCHEM BIOPHYS, V333, P42, DOI 10.1006/abbi.1996.0362; Gow AJ, 1996, FEBS LETT, V385, P63, DOI 10.1016/0014-5793(96)00347-X; GRANGER DN, 1994, J LEUKOCYTE BIOL, V55, P662, DOI 10.1002/jlb.55.5.662; GROOTVELD M, 1987, BIOCHEM J, V243, P803, DOI 10.1042/bj2430803; GUTTERIDGE JMC, 1994, CHEM-BIOL INTERACT, V91, P133, DOI 10.1016/0009-2797(94)90033-7; HADDAD IY, 1994, J CLIN INVEST, V94, P2407, DOI 10.1172/JCI117607; HADDAD IY, 1994, CHEST, V105, pS84, DOI 10.1378/chest.105.3_Supplement.84S; HADDAD IY, 1993, AM J PHYSIOL, V265, P555; HU P, 1994, AM J PHYSIOL, V266, pL628, DOI 10.1152/ajplung.1994.266.6.L628; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; IGNARRO LJ, 1980, BIOCHIM BIOPHYS ACTA, V631, P221, DOI 10.1016/0304-4165(80)90297-4; IGNARRO LJ, 1981, J PHARMACOL EXP THER, V218, P739; ISCHIROPOULOS H, 1995, FEBS LETT, V364, P279, DOI 10.1016/0014-5793(95)00307-U; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U; Ji YB, 1996, BIOCHEM J, V313, P377, DOI 10.1042/bj3130377; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Kengatharan KM, 1996, BRIT J PHARMACOL, V119, P1411, DOI 10.1111/j.1476-5381.1996.tb16053.x; Kong SK, 1996, P NATL ACAD SCI USA, V93, P3377, DOI 10.1073/pnas.93.8.3377; Konorev EA, 1996, BRIT J PHARMACOL, V119, P511, DOI 10.1111/j.1476-5381.1996.tb15701.x; KOWALUK EA, 1991, J PHARMACOL EXP THER, V259, P519; Langford EJ, 1996, ARTERIOSCL THROM VAS, V16, P51, DOI 10.1161/01.ATV.16.1.51; LIU S, 1994, J PHARMACOL EXP THER, V268, P1114; Lymar SV, 1996, BIOCHEMISTRY-US, V35, P7855, DOI 10.1021/bi960331h; Mayer B, 1998, J BIOL CHEM, V273, P3264, DOI 10.1074/jbc.273.6.3264; Mellander S, 1997, ACTA PHYSIOL SCAND, V160, P57, DOI 10.1046/j.1365-201X.1997.00117.x; Moncada S, 1997, ANN NY ACAD SCI, V811, P60, DOI 10.1111/j.1749-6632.1997.tb51989.x; MORENO JJ, 1992, CHEM RES TOXICOL, V5, P425, DOI 10.1021/tx00027a017; MORO MA, 1995, BRIT J PHARMACOL, V116, P1999, DOI 10.1111/j.1476-5381.1995.tb16404.x; PRYOR WA, 1995, AM J PHYSIOL-LUNG C, V268, pL699, DOI 10.1152/ajplung.1995.268.5.L699; Quinlan GJ, 1997, AM J RESP CRIT CARE, V155, P479, DOI 10.1164/ajrccm.155.2.9032182; RADOMSKI MW, 1993, CARDIOVASC RES, V27, P1380, DOI 10.1093/cvr/27.7.1380; Royall J A, 1995, New Horiz, V3, P113; RUBBO H, 1994, J BIOL CHEM, V269, P26066; SALGO MG, 1995, ARCH BIOCHEM BIOPHYS, V322, P500, DOI 10.1006/abbi.1995.1493; Shigenaga MK, 1997, P NATL ACAD SCI USA, V94, P3211, DOI 10.1073/pnas.94.7.3211; Skinner KA, 1997, ARCH BIOCHEM BIOPHYS, V342, P282, DOI 10.1006/abbi.1997.0114; SOKOLOVS.M, 1966, BIOCHEMISTRY-US, V5, P3582, DOI 10.1021/bi00875a029; Terada LS, 1996, J APPL PHYSIOL, V81, P2456, DOI 10.1152/jappl.1996.81.6.2456; Uppu RM, 1996, ARCH BIOCHEM BIOPHYS, V327, P335, DOI 10.1006/abbi.1996.0131; VANDERVLIET A, 1994, BIOCHEM J, V303, P295, DOI 10.1042/bj3030295; VANDERVLIET A, 1995, ARCH BIOCHEM BIOPHYS, V319, P341, DOI 10.1006/abbi.1995.1303; VANDERVLIET A, 1994, FEBS LETT, V339, P89, DOI 10.1016/0014-5793(94)80391-9; WAYNER DDM, 1985, FEBS LETT, V187, P33, DOI 10.1016/0014-5793(85)81208-4; White CR, 1997, BIOCHEM J, V328, P517, DOI 10.1042/bj3280517; Whiteman M, 1996, FEBS LETT, V379, P74, DOI 10.1016/0014-5793(95)01489-6; WU MD, 1994, AM J PHYSIOL, V266, pH2108, DOI 10.1152/ajpheart.1994.266.5.H2108; WU XW, 1989, P NATL ACAD SCI USA, V86, P9412, DOI 10.1073/pnas.86.23.9412; Zapol W M, 1996, Acta Anaesthesiol Scand Suppl, V109, P81	68	111	116	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24491	24497		10.1074/jbc.273.38.24491	http://dx.doi.org/10.1074/jbc.273.38.24491			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733742	hybrid			2022-12-27	WOS:000076007300034
J	Katz, RA; Gravuer, K; Skalka, AM				Katz, RA; Gravuer, K; Skalka, AM			A preferred target DNA structure for retroviral integrase in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL-DNA; IN-VITRO; CRUCIFORM STRUCTURES; DIRECTS INTEGRATION; V(D)J RECOMBINATION; SUPERCOILED DNA; SITE SELECTION; HIV INTEGRASE; PROTEIN; INVITRO	The retroviral integrase protein catalyzes the insertion of linear viral DNA ends into the host cell DNA. Although integration in vivo is not site-specific, the detection of local and regional preferences within cellular DNA suggests that the integration reaction can be influenced by specific features of host DNA or chromatin. Here we describe highly preferred in vivo integration sites for avian sarcoma virus and human immunodeficiency virus-1 integrases within the stems of plasmid DNA cruciform structures, The preferred sites are adjacent to the loops ire the cruciform and are strand-specific. We suggest that the observed preference is due to the end-like character of the stem loop structure that allows DNA unpairing. From these results we propose that such unpairing may enhance both the processing and the joining steps in the integration reaction, and perhaps other cellular recombination reactions as men.	Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Katz, RA (corresponding author), Fox Chase Canc Ctr, Inst Canc Res, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	r_katz@fccc.edu	Gravuer, Kelly/AAJ-4802-2020	Gravuer, Kelly/0000-0002-2567-658X	NATIONAL CANCER INSTITUTE [R01CA071515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R41AI040721, R01AI040385] Funding Source: NIH RePORTER; NCI NIH HHS [CA71515] Funding Source: Medline; NIAID NIH HHS [AI40721, AI40385] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andrake MD, 1996, J BIOL CHEM, V271, P19633, DOI 10.1074/jbc.271.33.19633; Asante-Appiah E, 1997, ANTIVIR RES, V36, P139, DOI 10.1016/S0166-3542(97)00046-6; BOR YC, 1995, P NATL ACAD SCI USA, V92, P10334, DOI 10.1073/pnas.92.22.10334; BUSHMAN FD, 1994, P NATL ACAD SCI USA, V91, P9233, DOI 10.1073/pnas.91.20.9233; CAIN RJ, 1995, NUCLEIC ACIDS RES, V23, P2153, DOI 10.1093/nar/23.12.2153; CRAIGIE R, 1990, CELL, V62, P829, DOI 10.1016/0092-8674(90)90126-Y; CRAIGIE R, 1992, TRENDS GENET, V8, P187, DOI 10.1016/0168-9525(92)90223-Q; Curcio MJ, 1996, TRENDS GENET, V12, P436; ENGELMAN A, 1992, J VIROL, V66, P6361, DOI 10.1128/JVI.66.11.6361-6369.1992; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; FITZGERALD ML, 1994, J VIROL, V68, P4314, DOI 10.1128/JVI.68.7.4314-4321.1994; FURLONG JC, 1986, NUCLEIC ACIDS RES, V14, P3995, DOI 10.1093/nar/14.10.3995; Goulaouic H, 1996, J VIROL, V70, P37, DOI 10.1128/JVI.70.1.37-46.1996; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Katz RA, 1996, VIROLOGY, V217, P178, DOI 10.1006/viro.1996.0105; KATZ RA, 1994, ANNU REV BIOCHEM, V63, P133, DOI 10.1146/annurev.bi.63.070194.001025; KATZ RA, 1990, CELL, V63, P87, DOI 10.1016/0092-8674(90)90290-U; KATZMAN M, 1989, J VIROL, V63, P5319, DOI 10.1128/JVI.63.12.5319-5327.1989; KIRCHNER J, 1995, SCIENCE, V267, P1488, DOI 10.1126/science.7878467; KITAMURA Y, 1992, P NATL ACAD SCI USA, V89, P5532, DOI 10.1073/pnas.89.12.5532; KUKOLJ G, 1995, GENE DEV, V9, P2556, DOI 10.1101/gad.9.20.2556; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331; MULLER HP, 1994, EMBO J, V13, P4704, DOI 10.1002/j.1460-2075.1994.tb06794.x; MURCHIE AIH, 1992, METHOD ENZYMOL, V211, P158; PANAYOTATOS N, 1981, NATURE, V289, P466, DOI 10.1038/289466a0; Pearson CE, 1996, J CELL BIOCHEM, V63, P1; PRUSS D, 1994, J BIOL CHEM, V269, P25031; PRUSS D, 1994, P NATL ACAD SCI USA, V91, P5913, DOI 10.1073/pnas.91.13.5913; PRYCIAK PM, 1992, EMBO J, V11, P291, DOI 10.1002/j.1460-2075.1992.tb05052.x; PRYCIAK PM, 1992, CELL, V69, P769, DOI 10.1016/0092-8674(92)90289-O; Ramsden DA, 1996, EMBO J, V15, P3197, DOI 10.1002/j.1460-2075.1996.tb00682.x; SANDMEYER SB, 1990, ANNU REV GENET, V24, P491; Scottoline BP, 1997, GENE DEV, V11, P371, DOI 10.1101/gad.11.3.371; vanGent DC, 1996, SCIENCE, V271, P1592, DOI 10.1126/science.271.5255.1592; VINK C, 1991, J VIROL, V65, P4636, DOI 10.1128/JVI.65.9.4636-4644.1991; WITHERSWARD ES, 1994, GENE DEV, V8, P1473, DOI 10.1101/gad.8.12.1473; YANG W, 1995, STRUCTURE, V3, P131, DOI 10.1016/S0969-2126(01)00142-3	37	57	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24190	24195		10.1074/jbc.273.37.24190	http://dx.doi.org/10.1074/jbc.273.37.24190			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727042	hybrid			2022-12-27	WOS:000075893100083
J	Krause, A; Holtmann, H; Eickemeier, S; Winzen, R; Szamel, M; Resch, K; Saklatvala, J; Kracht, M				Krause, A; Holtmann, H; Eickemeier, S; Winzen, R; Szamel, M; Resch, K; Saklatvala, J; Kracht, M			Stress-activated protein kinase Jun N-terminal kinase is required for interleukin (IL)-1-induced IL-6 and IL-8 gene expression in the human epidermal carcinoma cell line KB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; SIGNAL-TRANSDUCTION PATHWAY; KAPPA-B KINASE; C-JUN; MAP KINASE; TRANSCRIPTION FACTOR; INFLAMMATORY CYTOKINES; NH2-TERMINAL KINASE; NUCLEAR FACTOR; MESSENGER-RNA	The cytokine interleukin-l (IL-1) is a major inflammatory hormone which activates a broad range of genes during inflammation. The signaling mechanisms triggered by IL-1 include activation of several distinct protein kinase systems. The stress-activated protein kinase (SAPK), also termed Jun N-terminal kinase (JNK), is activated particularly strongly by the cytokine. In an attempt to delineate its role in activation of gene expression by IL-1, we inhibited the IL-l-induced SAPK/JNK activity by stable overexpression of either a catalytically inactive mutant of SAPK beta (SAPK beta(K-R)) or antisense RNA to SAPK beta in human epidermal carcinoma cells. A detailed analysis of signal transduction in those cells showed that activation of neither NF kappa B nor p38 mitogen-activated protein kinase was affected, suggesting that we achieved specific blockade of the SAPK/JNK. In untransfected and vector-transfected KB cells, IL-1 induced a strong increase in expression of IL-6 and IL-8 mRNA, along with the synthesis of high amounts of the proteins. In two KB cell clones stably overexpressing the mutant SAPK beta(K-R), and three clones stably overexpressing antisense RNA to SAPK beta, expression of IL-6 and IL-8 in response to IL-1 was strongly reduced at both the mRNA and protein level. These data indicate that the SAPK/JNK pathway provides an indispensable signal for IL-l-induced expression of IL-6 and IL-8.	Hannover Med Sch, Inst Mol Pharmacol, D-30625 Hannover, Germany; Kennedy Inst Rheumatol, London W6 8LH, England	Hannover Medical School; University of Oxford	Kracht, M (corresponding author), Hannover Med Sch, Inst Mol Pharmacol, Carl Neuberg Str 1, D-30625 Hannover, Germany.			Kracht, Michael/0000-0002-8501-043X				AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; BRIGELIUSFLOHE R, 1996, BIOFACTORS, V9, P1; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; CAO Z, 1996, SCIENCE, V383, P443; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; ELIAS JA, 1990, J IMMUNOL, V145, P161; Finch A, 1997, FEBS LETT, V418, P144, DOI 10.1016/S0014-5793(97)01364-1; Force T, 1996, CIRC RES, V78, P947, DOI 10.1161/01.RES.78.6.947; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; GUESDON F, 1993, J BIOL CHEM, V268, P14343; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HAWLER S, 1997, FEBS LETT, V414, P153; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HIRANO T, 1990, IMMUNOL TODAY, V11, P443, DOI 10.1016/0167-5699(90)90173-7; Hirsch DD, 1997, J BIOL CHEM, V272, P4568, DOI 10.1074/jbc.272.7.4568; Holland PM, 1997, J BIOL CHEM, V272, P24994, DOI 10.1074/jbc.272.40.24994; Janknecht R, 1997, J BIOL CHEM, V272, P4219, DOI 10.1074/jbc.272.7.4219; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; Kannabiran C, 1997, MOL CELL BIOL, V17, P1, DOI 10.1128/MCB.17.1.1; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; KASAHARA T, 1991, IMMUNOLOGY, V74, P60; KRACHT M, 1994, BIOCHEM J, V302, P897, DOI 10.1042/bj3020897; KRACHT M, 1994, J EXP MED, V180, P2017, DOI 10.1084/jem.180.6.2017; KUNSCH C, 1994, J IMMUNOL, V153, P153; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Martin MU, 1997, EUR CYTOKINE NETW, V8, P5; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; MATTHIAS P, 1989, NUCLEIC ACIDS RES, V17, P6418, DOI 10.1093/nar/17.15.6418; MUKAIDA N, 1994, J BIOL CHEM, V269, P13289; MUKAIDA N, 1994, J LEUKOCYTE BIOL, V56, P554, DOI 10.1002/jlb.56.5.554; NG SB, 1994, J BIOL CHEM, V269, P19021; Nishina H, 1997, NATURE, V385, P350, DOI 10.1038/385350a0; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Price MA, 1996, EMBO J, V15, P6552, DOI 10.1002/j.1460-2075.1996.tb01046.x; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Ridley SH, 1997, J IMMUNOL, V158, P3165; SAKLATVALA J, 1993, FEBS LETT, V334, P189, DOI 10.1016/0014-5793(93)81709-9; SALE EM, 1995, EMBO J, V14, P674, DOI 10.1002/j.1460-2075.1995.tb07046.x; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; SEGER R, 1994, J BIOL CHEM, V269, P25699; Shapiro L, 1995, P NATL ACAD SCI USA, V92, P12230, DOI 10.1073/pnas.92.26.12230; STOECKLE MY, 1991, NUCLEIC ACIDS RES, V19, P917, DOI 10.1093/nar/19.4.917; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Uciechowski P, 1996, FEBS LETT, V394, P273, DOI 10.1016/0014-5793(96)00967-2; Wesche H, 1997, J BIOL CHEM, V272, P7727, DOI 10.1074/jbc.272.12.7727; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Wu GD, 1997, J BIOL CHEM, V272, P2396; Yang D, 1997, P NATL ACAD SCI USA, V94, P3004, DOI 10.1073/pnas.94.7.3004; Zanke BW, 1996, CURR BIOL, V6, P606, DOI 10.1016/S0960-9822(02)00547-X; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0; ZINCK R, 1995, MOL CELL BIOL, V15, P4930	66	86	87	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23681	23689		10.1074/jbc.273.37.23681	http://dx.doi.org/10.1074/jbc.273.37.23681			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726973	hybrid			2022-12-27	WOS:000075893100014
J	McCartney, RG; Rice, JE; Sanderson, SJ; Bunik, V; Lindsay, H; Lindsay, JG				McCartney, RG; Rice, JE; Sanderson, SJ; Bunik, V; Lindsay, H; Lindsay, JG			Subunit interactions in the mammalian alpha-ketoglutarate dehydrogenase complex - Evidence for direct association of the alpha-ketoglutarate dehydrogenase and dihydrolipoamide dehydrogenase components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-DEHYDROGENASE; 2-OXOGLUTARATE DEHYDROGENASE; PROTEIN-X; SACCHAROMYCES-CEREVISIAE; MULTIENZYME COMPLEXES; MOLECULAR-CLONING; SUCCINYLTRANSFERASE COMPONENT; STRUCTURAL ORGANIZATION; BOVINE HEART; GENE	Selective tryptic proteolysis of the mammalian alpha-ketoglutarate dehydrogenase complex (OGDC) leads to its rapid inactivation as a result of a single cleavage within the N-terminal region of its alpha-ketoglutarate dehydrogenase (E1) component, which promotes the dissociation of the dihydrolipoamide dehydrogenase (E3) enzyme smd also a fully active E1' fragment. Similarities between the N-terminal region of E1 and the dihydrolipoamide acetyltransferase (E2) and E2-binding components (E3BP) of the pyruvate dehydrogenase complex are highlighted by the specific cross-reactivities of subunit-specific antisera. Analysis of the pattern of release of E1 and E1' polypeptides from the OGDC during tryptic inactivation suggests that both polypeptide chains of individual E1 homodimers must be cleaved to permit the dissociation of the E1 and E3 components. A new protocol has been devised that promotes E1 dissociation from the oligomeric dihydrolipoamide succinyltransferase (E2) core in an active state. Significant Bevels of overall OGDC reconstitution could also be achieved by re-mixing the constituent enzymes in stoichiometric amounts. Moreover, a high affinity interaction has been demonstrated between the homodimeric E1 and E3 components, which form a stable subcomplex comprising single copies of these two enzymes.	Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland; Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119899, Russia	University of Glasgow; Lomonosov Moscow State University	Lindsay, JG (corresponding author), Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	G.Lindsay@bio.gla.ac.uk	Bunik, Victoria/E-3427-2012	Bunik, Victoria/0000-0002-2552-8560	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BEHAL RH, 1993, ANNU REV NUTR, V13, P497, DOI 10.1146/annurev.nu.13.070193.002433; BROWN JP, 1976, BIOCHEM J, V155, P419, DOI 10.1042/bj1550419; DEMARCUCCI O, 1985, EUR J BIOCHEM, V149, P641, DOI 10.1111/j.1432-1033.1985.tb08972.x; DEMARCUCCI OL, 1985, BIOCHEM J, V226, P509, DOI 10.1042/bj2260509; JACKMAN SA, 1990, EUR J BIOCHEM, V193, P91, DOI 10.1111/j.1432-1033.1990.tb19308.x; JILKA JM, 1986, J BIOL CHEM, V261, P1858; Khailova L S, 1977, Biokhimiia, V42, P113; LAU KS, 1992, J BIOL CHEM, V267, P24090; LAWSON JE, 1991, BIOCHEMISTRY-US, V30, P11249, DOI 10.1021/bi00111a009; LAWSON JE, 1991, BIOCHEMISTRY-US, V30, P2834, DOI 10.1021/bi00225a015; MAENG CY, 1994, BIOCHEMISTRY-US, V33, P13801, DOI 10.1021/bi00250a034; Mande SS, 1996, STRUCTURE, V4, P277, DOI 10.1016/S0969-2126(96)00032-9; Mattevi A., 1992, CURR OPIN STRUC BIOL, V2, P877, DOI [10.1016/0959-440X(92)90114-M, DOI 10.1016/0959-440X(92)90114-M]; McCartney RG, 1997, BIOCHEMISTRY-US, V36, P6819, DOI 10.1021/bi9630016; NAKANO K, 1994, EUR J BIOCHEM, V224, P179, DOI 10.1111/j.1432-1033.1994.tb20010.x; NAKANO K, 1991, J BIOL CHEM, V266, P19013; NEAGLE JC, 1991, BIOCHEM J, V278, P423, DOI 10.1042/bj2780423; ODonohue J, 1996, QJM-MON J ASSOC PHYS, V89, P5, DOI 10.1093/oxfordjournals.qjmed.a030137; PATEL MS, 1995, FASEB J, V9, P1164, DOI 10.1096/fasebj.9.12.7672509; POWERSGREENWOOD SL, 1989, J BIOL CHEM, V264, P3655; REED LJ, 1990, J BIOL CHEM, V265, P8971; REED LJ, 1974, ACCOUNTS CHEM RES, V7, P40, DOI 10.1021/ar50074a002; RICE JE, 1992, EMBO J, V11, P3229, DOI 10.1002/j.1460-2075.1992.tb05400.x; Sanderson SJ, 1996, BIOCHEM J, V319, P109, DOI 10.1042/bj3190109; Sanderson SJ, 1996, EUR J BIOCHEM, V236, P68, DOI 10.1111/j.1432-1033.1996.00068.x; SPENCER ME, 1984, EUR J BIOCHEM, V141, P361, DOI 10.1111/j.1432-1033.1984.tb08200.x; STANLEY C, 1980, BIOCHEM J, V257, P625; Stoops JK, 1997, J BIOL CHEM, V272, P5757, DOI 10.1074/jbc.272.9.5757; Usuda Y, 1996, MICROBIOL-UK, V142, P3347, DOI 10.1099/13500872-142-12-3347; WESTPHAL AH, 1990, EUR J BIOCHEM, V187, P235, DOI 10.1111/j.1432-1033.1990.tb15300.x	30	37	40	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24158	24164		10.1074/jbc.273.37.24158	http://dx.doi.org/10.1074/jbc.273.37.24158			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727038	hybrid			2022-12-27	WOS:000075893100079
J	Ness, SL; Edelmann, W; Jenkins, TD; Liedtke, W; Rustgi, AK; Kucherlapati, R				Ness, SL; Edelmann, W; Jenkins, TD; Liedtke, W; Rustgi, AK; Kucherlapati, R			Mouse keratin 4 is necessary for internal epithelial integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WHITE SPONGE NEVUS; EPIDERMOLYSIS-BULLOSA SIMPLEX; INTERMEDIATE FILAMENTS; MESSENGER-RNAS; CELL TYPE; EXPRESSION; MUTATION; DIFFERENTIATION; HYPERKERATOSIS; GENES	Keratins are intermediate filaments ts of epithelial cells. Mutations in keratin genes expressed in skis lead to human disorders, including epidermolysis bullosa simplex and epidermolytic hyperkeratosis. We examined the role of keratin 4 (K4) in maintaining the integrity of internal epithelial linings by using gene targeting to generate mice containing a null mutation in the epithelial K4 gene. Homozygous mice that do not express K4 develop a spectrum of phenotypes that affect several organs which express K4 including the esophagus, tongue, and cornea. The cellular phenotypes include basal hyperplasia, Hack of maturation, hyperkeratosis, atypical nuclei, perinuclear clearing, and cell degeneration. These results are consistent with the notion that K4 is required for internal epithelial cell integrity. As mutations in K4 in humans lead to a disorder called white sponge nevus, the K4-deficient mice may serve as models Tor white sponge nevus and for understanding the role of K4 in cellular proliferation and differentiation.	Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Hematol Oncol Unit, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Div Neuropathol, Bronx, NY 10461 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10023 USA	Yeshiva University; Albert Einstein College of Medicine; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; Rockefeller University	Kucherlapati, R (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	kucherla@aecom.yu.edu	Liedtke, Wolfgang B/G-4633-2011; Kucherlapati, Raju/ABC-8807-2021; Liedtke, Wolfgang/GNH-1878-2022		NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER; NCI NIH HHS [CA 13330] Funding Source: Medline; NIDDK NIH HHS [DK40561] Funding Source: Medline; NIGMS NIH HHS [T32GM07288] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BONIFAS JM, 1991, SCIENCE, V254, P1202, DOI 10.1126/science.1720261; CHAN YM, 1994, GENE DEV, V8, P2574, DOI 10.1101/gad.8.21.2574; CHENG J, 1992, CELL, V70, P811, DOI 10.1016/0092-8674(92)90314-3; CHIPEV CC, 1992, CELL, V70, P821, DOI 10.1016/0092-8674(92)90315-4; COMPTON JG, 1991, ANN NY ACAD SCI, V642, P32; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; FRITHIOF L, 1976, ORAL SURG ORAL MED O, V41, P607, DOI 10.1016/0030-4220(76)90313-3; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; KLYMKOWSKY MW, 1983, J CELL BIOL, V96, P494, DOI 10.1083/jcb.96.2.494; KNAPP B, 1986, NUCLEIC ACIDS RES, V14, P751, DOI 10.1093/nar/14.2.751; KRAJEWSKA IA, 1992, PATHOLOGY, V24, P112, DOI 10.3109/00313029209063635; KULESH DA, 1988, MOL CELL BIOL, V8, P1540, DOI 10.1128/MCB.8.4.1540; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; LAUWERYNS B, 1993, INVEST OPHTH VIS SCI, V34, P1983; LERSCH R, 1989, MOL CELL BIOL, V9, P3685, DOI 10.1128/MCB.9.9.3685; LLOYD C, 1995, J CELL BIOL, V129, P1329, DOI 10.1083/jcb.129.5.1329; MCGINNIS JP, 1975, ORAL SURG ORAL MED O, V40, P644, DOI 10.1016/0030-4220(75)90374-6; MOLL R, 1982, DIFFERENTIATION, V23, P170, DOI 10.1111/j.1432-0436.1982.tb01280.x; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Moore K.L., 1988, DEV HUMAN; MORRIS R, 1988, ACTA CYTOL, V32, P357; Nakagawa H, 1997, ONCOGENE, V14, P1185, DOI 10.1038/sj.onc.1200937; NISCHT R, 1988, MOL CARCINOGEN, V1, P96, DOI 10.1002/mc.2940010205; RICHARD G, 1995, NAT GENET, V11, P453, DOI 10.1038/ng1295-453; ROTHNAGEL JA, 1992, SCIENCE, V257, P1128, DOI 10.1126/science.257.5073.1128; RUGG EL, 1995, NAT GENET, V11, P450, DOI 10.1038/ng1295-450; RUGG EL, 1994, GENE DEV, V8, P2563, DOI 10.1101/gad.8.21.2563; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SAWAF MH, 1992, PATHOL BIOL, V40, P655; SAYAG J, 1985, ANN DERMATOL VENER, V112, P759; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; VANMUIJEN GNP, 1986, EXP CELL RES, V162, P97, DOI 10.1016/0014-4827(86)90429-5; VIAENE AI, 1995, ANAT REC, V241, P88, DOI 10.1002/ar.1092410112; WILEY L, 1991, INVEST OPHTH VIS SCI, V32, P594; WOLFE HG, 1966, BIOL LAB MOUSE; WURST W, 1995, GENE TARGETING PRACT, P234	37	56	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23904	23911		10.1074/jbc.273.37.23904	http://dx.doi.org/10.1074/jbc.273.37.23904			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727004	hybrid			2022-12-27	WOS:000075893100045
J	Belkner, J; Stender, H; Kuhn, H				Belkner, J; Stender, H; Kuhn, H			The rabbit 15-lipoxygenase preferentially oxygenates LDL cholesterol esters, and this reaction does not require vitamin E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; TOCOPHEROL-MEDIATED PEROXIDATION; HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; ATHEROSCLEROTIC LESIONS; RETICULOCYTE LIPOXYGENASE; OXIDATIVE MODIFICATION; INITIATED OXIDATION; MESSENGER-RNA; PROTEIN; ATHEROGENESIS	The oxidation of low density lipoprotein (LDL) by mammalian 15-lipoxygenases (15-LOX) was implicated in early atherogenesis, We investigated the molecular mechanism of 15-LOX/LDL interaction and found that during short term incubations, LDL cholesterol esters are oxygenated preferentially by the enzyme. Even when the LDL particle was loaded with free linoleic acid, cholesteryl linoleate constituted the major LOX substrate. In contrast, only small amounts of free oxygenated fatty acid isomers were detected, and re-esterification of oxidized fatty acids into the LDL ester lipid fraction was ruled out. When LDL was depleted from alpha-tocopherol, specific oxygenation of the cholesterol esters was not prevented, and the product pattern was not altered. Similar results were obtained at low (LDL/LOX ratio of 1:1) and high LOX loading (LDL/LOX ratio of 1:10) of the LDL particle. During long term incubations (up to 24 h), a less specific product pattern was observed. However, when the hydroperoxy lipids formed by the 15-LOX were immediately reduced by the phospholipid hydroperoxide glutathione peroxidase, when the reaction was carried out with vitamin E-depleted LDL, or when the assay sample was diluted, the specific pattern of oxygenation products was retained over a long period of time. These data suggest that mammalian 15-LOX preferentially oxidize LDL cholesterol esters, forming a specific pattern of oxygenation products. During long term incubations, free radical-mediated secondary reactions, which lead to a more unspecific product pattern, may become increasingly important. These secondary reactions appear to be suppressed when the hydroperoxy lipids formed are immediately reduced, when alpha-tocopherol-depleted LDL was used, or when the incubation sample was diluted. It may be concluded that 15-LOX-initiated LDL oxidation constitutes a dual-type oxygenase reaction with an initial enzymatic and a subsequent nonenzymatic phase. The biological relevance of this dual-type reaction for atherogenesis will be discussed.	Humboldt Univ, Univ Clin Charite, Inst Biochem, D-10115 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kuhn, H (corresponding author), Humboldt Univ, Univ Clin Charite, Inst Biochem, Hess Str 3-4, D-10115 Berlin, Germany.	hartmut.kuehn@rz.hu-berlin.de						BELKNER J, 1993, EUR J BIOCHEM, V213, P251, DOI 10.1111/j.1432-1033.1993.tb17755.x; BELKNER J, 1991, FEBS LETT, V279, P110, DOI 10.1016/0014-5793(91)80263-3; BENZ DJ, 1995, J BIOL CHEM, V270, P5191, DOI 10.1074/jbc.270.10.5191; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOWRY VW, 1993, J AM CHEM SOC, V115, P6029, DOI 10.1021/ja00067a019; BOWRY VW, 1995, J BIOL CHEM, V270, P5756, DOI 10.1074/jbc.270.11.5756; BURK RF, 1993, ANNU REV NUTR, V13, P65, DOI 10.1146/annurev.nu.13.070193.000433; FOLCIK VA, 1995, J CLIN INVEST, V96, P504, DOI 10.1172/JCI118062; Harats D, 1997, ATHEROSCLEROSIS, V134, P279, DOI 10.1016/S0021-9150(97)89459-2; HARLAND WA, 1973, BIOCHIM BIOPHYS ACTA, V316, P378, DOI 10.1016/0005-2760(73)90076-3; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HILTUNEN T, 1995, CIRCULATION, V92, P3297, DOI 10.1161/01.CIR.92.11.3297; HOLVOET P, 1994, FASEB J, V8, P1279, DOI 10.1096/fasebj.8.15.8001740; KHOO JC, 1981, J BIOL CHEM, V256, P2659; KUHN H, 1990, J BIOL CHEM, V265, P18351; KUHN H, 1992, EICOSANOIDS, V5, P17; KUHN H, 1994, J LIPID RES, V35, P1749; KUHN H, 1994, J EXP MED, V179, P1903, DOI 10.1084/jem.179.6.1903; Kuhn H, 1997, J CLIN INVEST, V99, P888, DOI 10.1172/JCI119253; Kuhn H, 1997, CURR OPIN LIPIDOL, V8, P111; KUHN H, 1993, BIOCHIM BIOPHYS ACTA, V1169, P80, DOI 10.1016/0005-2760(93)90085-N; Lass A, 1996, BIOCHEM J, V314, P577, DOI 10.1042/bj3140577; MIDDLETON B, 1992, BIOCHEM BIOPH RES CO, V182, P830, DOI 10.1016/0006-291X(92)91807-3; MURRAY JJ, 1988, ARCH BIOCHEM BIOPHYS, V265, P514, DOI 10.1016/0003-9861(88)90156-7; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; OLEARY VJ, 1992, BIOCHEM J, V282, P631, DOI 10.1042/bj2820631; PORTER N, 1985, J CHEM SOC CHEM COMM, P1472, DOI 10.1039/c39850001472; Resnick D, 1996, J BIOL CHEM, V271, P26924, DOI 10.1074/jbc.271.43.26924; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; SATTLER W, 1994, ARCH BIOCHEM BIOPHYS, V309, P214, DOI 10.1006/abbi.1994.1105; SCHEWE T, 1975, FEBS LETT, V60, P149, DOI 10.1016/0014-5793(75)80439-X; Schnurr K, 1996, J BIOL CHEM, V271, P4653; Sendobry SM, 1997, BRIT J PHARMACOL, V120, P1199, DOI 10.1038/sj.bjp.0701007; Shen JH, 1996, J CLIN INVEST, V98, P2201, DOI 10.1172/JCI119029; Shen JH, 1995, FASEB J, V9, P1623, DOI 10.1096/fasebj.9.15.8529842; SPARROW CP, 1988, J LIPID RES, V29, P745; TAKANO T, 1990, J PHARMACOBIO-DYNAM, V13, P385, DOI 10.1248/bpb1978.13.385; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Upston JM, 1996, J LIPID RES, V37, P2650; Upston JM, 1997, J BIOL CHEM, V272, P30067, DOI 10.1074/jbc.272.48.30067; URSINI F, 1995, METHOD ENZYMOL, V252, P38; YLAHERTTUALA S, 1990, P NATL ACAD SCI USA, V87, P6959, DOI 10.1073/pnas.87.18.6959; YLAHERTTUALA S, 1995, J CLIN INVEST, V95, P2692, DOI 10.1172/JCI117971	43	98	98	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23225	23232		10.1074/jbc.273.36.23225	http://dx.doi.org/10.1074/jbc.273.36.23225			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722553	hybrid			2022-12-27	WOS:000075778100053
J	Loo, DT; Kanner, SB; Aruffo, A				Loo, DT; Kanner, SB; Aruffo, A			Filamin binds to the cytoplasmic domain of the beta(1)-integrin - Identification of amino acids responsible for this interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE-1; LATE ACTIVATION ANTIGEN-4; BETA-1 INTEGRIN SUBUNIT; LYMPHOCYTE MIGRATION; TRANSENDOTHELIAL MIGRATION; MONOCLONAL-ANTIBODIES; EXTRACELLULAR-MATRIX; PLASMA FIBRONECTIN; HUMAN-PLATELETS; VLA-4 INTEGRIN	Integrins play an important role in regulating cell adhesion, motility, and activation. In an effort to identify intracellular proteins expressed by activated T cells that interact with the cytoplasmic domain of beta(1)-integrin (CD29), we used the beta(1)-integrin cytoplasmic domain as bait in the yeast two-hybrid system. Here we report that the cytoplasmic domain of beta(1)-integrin specifically interacts with the cytoskeletal protein filamin. This interaction required all but the most carboxyl-terminal three residues of the cytoplasmic domain of beta(1), and the carboxyl-terminal 477 residues of filamin containing the terminal 4.5 similar to 96-residue tandem repeats of filamin. To verify this interaction in vivo, we showed that filamin specifically coprecipitated with beta(1) in mammalian cells. We also showed that recombinant filamin chimeric proteins were able to bind to the beta(1) cytoplasmic domain in vitro. We observed that a subset of single point mutations in the cytoplasmic domain of beta(1), which had been previously reported to impair its function, disrupt the interaction between beta(1) and filamin, Taken together, these findings suggest that the interaction between beta(1) and filamin, which in turn can bind actin, provides a mechanism for the interaction of this cell surface receptor with cytoskeletal proteins and that this interaction plays a role in normal receptor function.	Bristol Myers Squibb Pharmaceut Res Inst, Princeton, NJ 08543 USA	Bristol-Myers Squibb	Loo, DT (corresponding author), Bristol Myers Squibb Pharmaceut Res Inst, POB 4000, Princeton, NJ 08543 USA.	lood@bms.com						ALTRUDA F, 1990, GENE, V95, P261, DOI 10.1016/0378-1119(90)90369-3; BALZAC F, 1993, J CELL BIOL, V121, P171, DOI 10.1083/jcb.121.1.171; BARON JL, 1994, J CLIN INVEST, V93, P1700, DOI 10.1172/JCI117153; Belkin AM, 1996, J CELL BIOL, V132, P211, DOI 10.1083/jcb.132.1.211; CARLOS TM, 1990, BLOOD, V76, P965; Carr MW, 1996, IMMUNITY, V4, P179, DOI 10.1016/S1074-7613(00)80682-2; CHAN PY, 1993, J BIOL CHEM, V268, P24655; CHISHOLM PL, 1993, EUR J IMMUNOL, V23, P682, DOI 10.1002/eji.1830230317; CHULUYAN HE, 1993, J CLIN INVEST, V92, P2768, DOI 10.1172/JCI116895; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; EZZELL RM, 1988, J BIOL CHEM, V263, P13303; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; FERGUSON TA, 1993, J IMMUNOL, V150, P1172; FOX JEB, 1985, J BIOL CHEM, V260, P1970; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; GUAN JL, 1990, CELL, V60, P53, DOI 10.1016/0092-8674(90)90715-Q; GURTNER GC, 1995, GENE DEV, V9, P1, DOI 10.1101/gad.9.1.1; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; HAUZENBERGER D, 1994, J IMMUNOL, V153, P960; HAYASHI Y, 1990, J CELL BIOL, V110, P175, DOI 10.1083/jcb.110.1.175; Hirsch E, 1996, NATURE, V380, P171, DOI 10.1038/380171a0; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JAKUBOWSKI A, 1995, J IMMUNOL, V155, P938; KANNER SB, 1992, J IMMUNOL, V148, P2023; KANNER SB, 1993, P NATL ACAD SCI USA, V90, P7099, DOI 10.1073/pnas.90.15.7099; KANNER SB, 1990, P NATL ACAD SCI USA, V87, P3328, DOI 10.1073/pnas.87.9.3328; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; KWEE L, 1995, DEVELOPMENT, V121, P489; LANGUINO LR, 1992, J BIOL CHEM, V267, P7116; LEWIS JM, 1995, MOL BIOL CELL, V6, P151, DOI 10.1091/mbc.6.2.151; MARCANTONIO EE, 1990, CELL REGUL, V1, P597, DOI 10.1091/mbc.1.8.597; MASELLISSMITH A, 1994, J IMMUNOL, V152, P2768; MASSIA SP, 1992, J BIOL CHEM, V267, P14019; MEREDITH J, 1995, SCIENCE, V269, P1570, DOI 10.1126/science.7545312; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; MOLOSSI S, 1995, J CELL PHYSIOL, V164, P620, DOI 10.1002/jcp.1041640321; MOULD AP, 1990, J BIOL CHEM, V265, P4020; MOULD AP, 1991, EMBO J, V10, P4089, DOI 10.1002/j.1460-2075.1991.tb04985.x; NAKAJIMA H, 1994, J EXP MED, V179, P1145, DOI 10.1084/jem.179.4.1145; OKITA JR, 1985, J CELL BIOL, V100, P317, DOI 10.1083/jcb.100.1.317; OTEY CA, 1993, J BIOL CHEM, V268, P21193; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; PRETOLANI M, 1994, J EXP MED, V180, P795, DOI 10.1084/jem.180.3.795; RATNER S, 1992, INVAS METAST, V12, P82; RESZKA AA, 1992, J CELL BIOL, V117, P1321, DOI 10.1083/jcb.117.6.1321; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SCHWARTZ BR, 1990, J CLIN INVEST, V85, P2019, DOI 10.1172/JCI114668; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; SHARMA CP, 1995, J IMMUNOL, V154, P3461; SHATTIL SJ, 1995, J CELL BIOL, V131, P807, DOI 10.1083/jcb.131.3.807; SHIMIZU Y, 1992, J EXP MED, V175, P577, DOI 10.1084/jem.175.2.577; SHIMIZU Y, 1990, NATURE, V345, P250, DOI 10.1038/345250a0; VanNhieu GT, 1996, J BIOL CHEM, V271, P7665, DOI 10.1074/jbc.271.13.7665; WAYNER EA, 1989, J CELL BIOL, V109, P1321, DOI 10.1083/jcb.109.3.1321; Weber C, 1996, J CELL BIOL, V134, P1063, DOI 10.1083/jcb.134.4.1063; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	58	158	160	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23304	23312		10.1074/jbc.273.36.23304	http://dx.doi.org/10.1074/jbc.273.36.23304			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722563	hybrid			2022-12-27	WOS:000075778100063
J	de Haan, JB; Bladier, C; Griffiths, P; Kelner, M; O'Shea, RD; Cheung, NS; Bronson, RT; Silvestro, MJ; Wild, S; Zheng, SS; Beart, PM; Hertzog, PJ; Kola, I				de Haan, JB; Bladier, C; Griffiths, P; Kelner, M; O'Shea, RD; Cheung, NS; Bronson, RT; Silvestro, MJ; Wild, S; Zheng, SS; Beart, PM; Hertzog, PJ; Kola, I			Mice with a homozygous null mutation for the most abundant glutathione peroxidase, Gpx1, show increased susceptibility to the oxidative stress-inducing agents paraquat and hydrogen peroxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CU/ZN-SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; ENZYME-ACTIVITY; KNOCKOUT MICE; FREE-RADICALS; GSHPX-GI; SELENIUM; GENE; EXPRESSION; CELLS	Glutathione peroxidases have been thought to function in cellular antioxidant defense. However, some recent studies on Gpx1 knockout (-/-) mice have failed to show a role for Gpx1 under conditions of oxidative stress such as hyperbaric oxygen and the exposure of eye lenses to high levels of H2O2. These findings have, unexpectedly, raised the issue of the role of Gpx1, especially under conditions of oxidative stress. Here we demonstrate a role for Gpx1 in protection against oxidative stress by showing that Gpx1 (-/-) mice are highly sensitive to the oxidant paraquat. Lethality was already detected within 24 h in mice exposed to paraquat at 10 mg . kg(-1) (approximately 1/7 the LD50 of wild-type controls). The effects of paraquat were dose-related. In the 30 mg . kg(-1)-treated group, 100% of mice died within 5 h, whereas the controls showed no evidence of toxicity. me further demonstrate that paraquat transcriptionally upregulates Gpx1 in normal cells, reinforcing a role for Gpzl in protection against paraquat toxicity. Finally, we show that cortical neurons from Gpx1 (-/-) mice are more susceptible to H2O2; 30% of neurons from Gpx1 (-/-) mice were killed when exposed to 65 mu M H2O2, whereas the wild-type controls were unaffected. These data establish a function for Gpx1 in protection against some oxidative stressors and in protection of neurons against H2O2. Further, they emphasize the need to elucidate the role of Gpx1 in protection against different oxidative stressors and in different disease states and suggest that Gpx1 (-/-) mice may be valuable for studying the role of H2O2 in neurodegenerative disorders.	Monash Med Ctr, Inst Reprod & Dev, Mol Genet & Dev Grp, Clayton, Vic 3168, Australia; Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; Monash Univ, Dept Pharmacol, Clayton, Vic 3168, Australia; Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA	Monash University; University of California System; University of California San Diego; Monash University; Tufts University	Kola, I (corresponding author), Monash Med Ctr, Inst Reprod & Dev, Mol Genet & Dev Grp, 246 Clayton Rd, Clayton, Vic 3168, Australia.		O'Shea, Ross D/B-5426-2012; Hertzog, Paul J/I-7053-2013; Kola, Ismail/C-5254-2013; de Haan, Judy/E-8778-2010	O'Shea, Ross D/0000-0002-8178-8797; Hertzog, Paul J/0000-0002-1373-8472; de Haan, Judy B./0000-0002-2749-7833	NIEHS NIH HHS [R01ES04989] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004989] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BALDIER C, 1997, CELL GROWTH DIFFER, V8, P589; BarPeled O, 1996, P NATL ACAD SCI USA, V93, P8530, DOI 10.1073/pnas.93.16.8530; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; BUS JS, 1976, TOXICOL APPL PHARM, V35, P501, DOI 10.1016/0041-008X(76)90073-9; BUS JS, 1974, BIOCHEM BIOPH RES CO, V58, P749, DOI 10.1016/S0006-291X(74)80481-X; BUSCIGLIO J, 1995, NATURE, V378, P777; CHAMBERS I, 1986, EMBO J, V5, P1221, DOI 10.1002/j.1460-2075.1986.tb04350.x; Cheng WH, 1997, J NUTR, V127, P1445, DOI 10.1093/jn/127.8.1445; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHU FF, 1992, BLOOD, V79, P3233; CHU FF, 1990, NUCLEIC ACIDS RES, V18, P1531, DOI 10.1093/nar/18.6.1531; CHU FF, 1993, J BIOL CHEM, V268, P2571; CHU FF, 1995, ARCH BIOCHEM BIOPHYS, V323, P288, DOI 10.1006/abbi.1995.9962; DAWSON VL, 1993, J NEUROSCI, V13, P2651; DE R, 1979, TOXICOL APPL PHARM, V48, P479; DEHAAN JB, 1995, BIOCHEM MOL BIOL INT, V35, P1281; deHaan JB, 1996, HUM MOL GENET, V5, P283, DOI 10.1093/hmg/5.2.283; DEHAAN JB, 1992, MOL BRAIN RES, V13, P179, DOI 10.1016/0169-328X(92)90025-7; Esworthy RS, 1997, ARCH BIOCHEM BIOPHYS, V340, P59, DOI 10.1006/abbi.1997.9901; FREEMAN BA, 1982, LAB INVEST, V47, P412; Fuchs O, 1997, NEOPLASMA, V44, P184; GHYSELINCK NB, 1993, MOL ENDOCRINOL, V7, P258, DOI 10.1210/me.7.2.258; GIRI SN, 1983, TOXICOL APPL PHARM, V71, P132, DOI 10.1016/0041-008X(83)90052-2; Halliwel B, 1989, FREE RADICALS BIOL M; HALLIWELL B, 1992, J LAB CLIN MED, V119, P598; HASSAN HM, 1979, ARCH BIOCHEM BIOPHYS, V196, P385, DOI 10.1016/0003-9861(79)90289-3; Ho YS, 1997, J BIOL CHEM, V272, P16644, DOI 10.1074/jbc.272.26.16644; HORNSBY PJ, 1985, J CELL PHYSIOL, V123, P33, DOI 10.1002/jcp.1041230106; Hussain S, 1995, INT J DEV NEUROSCI, V13, P811, DOI 10.1016/0736-5748(95)00071-2; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; JONES DP, 1981, ARCH BIOCHEM BIOPHYS, V210, P505, DOI 10.1016/0003-9861(81)90215-0; Jornot L, 1997, BIOCHEM J, V326, P117, DOI 10.1042/bj3260117; KEELING PL, 1982, BIOCHIM BIOPHYS ACTA, V716, P249, DOI 10.1016/0304-4165(82)90275-6; KELNER MJ, 1990, FREE RADICAL BIO MED, V9, P149, DOI 10.1016/0891-5849(90)90118-3; KELNER MJ, 1990, J BIOL CHEM, V265, P10872; KHAN AU, 1995, CHEM BIOL, V2, P437; Kola I, 1997, HUM MOL GENET, V6, P1713, DOI 10.1093/hmg/6.10.1713; Larm JA, 1997, J NEUROCHEM, V69, P617; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; MAIORINO M, 1991, FREE RADICAL RES COM, V12-3, P131, DOI 10.3109/10715769109145777; MAKINO N, 1994, J BIOL CHEM, V269, P1020; MARTINDALE, 1978, EXTRA PHARMACOPOEIA, P794; MOSCOW JA, 1992, J BIOL CHEM, V267, P5949; NICHOLLS P, 1972, BIOCHIM BIOPHYS ACTA, V279, P306, DOI 10.1016/0304-4165(72)90147-X; POOT M, 1991, MUTAT RES, V256, P117; RAHMAN IU, 1992, FREE RADICAL BIO MED, V12, P323, DOI 10.1016/0891-5849(92)90119-2; Reddy VN, 1997, OPHTHALMOLOGICA, V211, P192, DOI 10.1159/000310788; Sagara Y, 1996, J NEUROSCI, V16, P497; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHUCKELT R, 1991, FREE RADICAL RES COM, V14, P343, DOI 10.3109/10715769109093424; Sies H., 1991, OXIDATIVE STRESS OXI; SOHAL RS, 1990, MECH AGEING DEV, V53, P217, DOI 10.1016/0047-6374(90)90040-M; Spector A, 1996, EXP EYE RES, V62, P521, DOI 10.1006/exer.1996.0063; Spector A, 1997, EXP EYE RES, V64, P477, DOI 10.1006/exer.1996.0250; TAKAHASHI K, 1987, ARCH BIOCHEM BIOPHYS, V256, P677, DOI 10.1016/0003-9861(87)90624-2; TUCKER RP, 1990, BRAIN RES REV, V15, P101, DOI 10.1016/0165-0173(90)90013-E; URSINI F, 1987, CHEM PHYS LIPIDS, V44, P255, DOI 10.1016/0009-3084(87)90053-3; VERNET P, 1996, CELL BIOL, V74, P125; Yoshida T, 1997, CIRCULATION, V96, P216; YOSHIMURA S, 1991, J BIOCHEM-TOKYO, V109, P918, DOI 10.1093/oxfordjournals.jbchem.a123480	62	354	361	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22528	22536		10.1074/jbc.273.35.22528	http://dx.doi.org/10.1074/jbc.273.35.22528			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712879	hybrid, Green Published			2022-12-27	WOS:000075616600055
J	Kurdi-Haidar, B; Heath, D; Aebi, S; Howell, SB				Kurdi-Haidar, B; Heath, D; Aebi, S; Howell, SB			Biochemical characterization of the human arsenite-stimulated ATPase (hASNA-I)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ARS OPERON; RESISTANCE; BINDING; PURIFICATION; SUBUNITS; HOMOLOG	Arsenic is a potent toxin and carcinogen. In pro karyotes, arsenic detoxification is accomplished by chromosomal and plasmid-borne operon-encoded efflux systems. We have previously reported the cloning of hASNA-I, a human homologue of arsA encoding the ATPase component of the Escherichia coli arsenite transporter. Purified glutathione S-transferase (GST)hASNA-I fusion protein was biochemically characterized, and its properties were compared with those of ArsA. The GST-hASNA-I exhibited a basal level of ATPase activity of 18.5 +/- 8 nmol/min/mg in the absence of arsenite. Arsenite produced a 1.6 +/- 0.1-fold stimulation of activity (p = 0.0044), which was related to an increase in V-max; antimonite did not stimulate activity. Two lines of evidence suggest that an oligomer is the most likely native form of hASNA-I, First, lysates of human embryo kidney 293 cells overproducing recombinant hASNA-I produced a single monomeric 37-kDa band on SDS-polyacrylamide gel electrophoresis (PAGE) and two distinct species when analyzed using nondenaturing PAGE. Second, chemical cross-linking of the 63-kDa GST-hASNA-I resulted in the formation of dimeric and tetrameric protein forms, The results indicate that hASNA-I is a distinct human arsenite-stimulated ATPase belonging to the same superfamily of ATPases represented by the E. coli ArsA protein.	Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Bern, Dept Med Oncol, CH-3010 Bern, Switzerland	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Bern	Kurdi-Haidar, B (corresponding author), Univ Calif San Diego, Ctr Canc, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Aebi, Stefan/F-2004-2010	Aebi, Stefan/0000-0002-3383-9449	NATIONAL CANCER INSTITUTE [R01CA069004] Funding Source: NIH RePORTER; NCI NIH HHS [CA69004] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARLIN A, 1995, J BACTERIOL, V177, P981, DOI 10.1128/jb.177.4.981-986.1995; DIORIO C, 1995, J BACTERIOL, V177, P2050, DOI 10.1128/jb.177.8.2050-2056.1995; DUPUIS A, 1985, BIOCHEMISTRY-US, V24, P734, DOI 10.1021/bi00324a030; GLADYSHEVA TB, 1994, BIOCHEMISTRY-US, V33, P7288, DOI 10.1021/bi00189a033; HEDGES RW, 1973, J BACTERIOL, V115, P459, DOI 10.1128/JB.115.1.459-460.1973; HSU CM, 1989, J BIOL CHEM, V264, P17349; HSU CM, 1991, J BIOL CHEM, V266, P2327; JI GY, 1992, J BACTERIOL, V174, P3684, DOI 10.1128/JB.174.11.3684-3694.1992; KOONIN EV, 1993, J MOL BIOL, V229, P1165, DOI 10.1006/jmbi.1993.1115; KurdiHaidar B, 1996, GENOMICS, V36, P486, DOI 10.1006/geno.1996.0494; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leatherbarrow R. J., 1992, GRAFIT VERSION 3 0; NAKATSUJI T, 1981, ANAL BIOCHEM, V112, P52, DOI 10.1016/0003-2697(81)90258-X; NOVICK RP, 1968, J BACTERIOL, V95, P1335, DOI 10.1128/JB.95.4.1335-1342.1968; OLEARY KA, 1988, ARCH BIOCHEM BIOPHYS, V264, P1, DOI 10.1016/0003-9861(88)90563-2; ROSEN BP, 1990, BIOCHIM BIOPHYS ACTA, V1018, P203, DOI 10.1016/0005-2728(90)90249-4; ROSENSTEIN R, 1992, J BACTERIOL, V174, P3676, DOI 10.1128/JB.174.11.3676-3683.1992; SMITH DB, 1992, CURRENT PROTOCOLS MO, V2; VOGEL G, 1976, BIOCHEMISTRY-US, V15, P208, DOI 10.1021/bi00646a032; Wang ZL, 1996, TOXICOL APPL PHARM, V137, P112, DOI 10.1006/taap.1996.0062	21	28	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22173	22176		10.1074/jbc.273.35.22173	http://dx.doi.org/10.1074/jbc.273.35.22173			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712828	hybrid, Green Published			2022-12-27	WOS:000075616600004
J	Rivera, I; Harhaj, EW; Sun, SC				Rivera, I; Harhaj, EW; Sun, SC			Involvement of NF-AT in type I human T-cell leukemia virus tax-mediated Fas ligand promoter transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATIVE CALCIUM-ENTRY; TRANSCRIPTION FACTOR NFAT1; RECEPTOR GENE-EXPRESSION; KAPPA-B-ALPHA; HTLV-I; C-REL; INTERLEUKIN-2 PROMOTER; NUCLEAR-LOCALIZATION; RESPONSE ELEMENT; ACTIVATOR TAX	Human T-cell leukemia virus type I (HTLV-I)-infected T-cells constitutively express surface Fas ligand (FasL), which may serve as a mechanism of viral pathogenesis. HTLV-I induces transcription of FasL gene through the viral transactivator Tax, although the underlying molecular mechanism remains unclear. In the present study, we have analyzed both the cis-activating element and transactivating factors involved in Tax activation of the Fast promoter. We show that the 486-base pair upstream region of the human Fast gene is sufficient for Tax-mediated transactivation in Jurkat T-cells. Interestingly, a palindromic DNA sequence (GGAAACTTCC) covering the consensus NF-ATp binding site (GGAAA), is required for Tax activation of Fast promoter. The involvement of NF-AT in this transactivation event is suggested by the finding that Tax fails to activate the Fast promoter in a Jurkat T-cell line defective in capacitative calcium entry, a signaling mechanism involved in NF-AT activation. Furthermore, activation of Fast promoter by Tax is largely attenuated in the nonlymphoid F9 embryonal and COS kidney cells deficient in NF-ATE, expression. DNA-protein interaction assays reveal that the NF-AT-like motif in the Fast promoter is bound by both NF-ATp and NF-AT4 in Jurkat T-cells expressing Tax. The binding of NF-ATp, although not NF-AT4, to this enhancer also occurs along with HTLV-I-mediated infection of human peripheral blood T-cells. Furthermore, exogenously transfected NF-ATp binds to the NF-AT-like enhancer and participates in Tax-mediated Fast promoter transactivation. These results suggest an important role for proteins of the NF-AT family in HTLV-1 Tax-mediated Fast gene transactivation.	Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Sun, SC (corresponding author), Penn State Univ, Coll Med, Dept Microbiol & Immunol, 500 Univ Dr, Hershey, PA 17033 USA.	sxs70@psu.edu			NCI NIH HHS [1 R01 CA68471-03] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA068471] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADYA N, 1995, J VIROL, V69, P1834, DOI 10.1128/JVI.69.3.1834-1841.1995; ADYA N, 1994, P NATL ACAD SCI USA, V91, P5642, DOI 10.1073/pnas.91.12.5642; BALLARD D W, 1989, New Biologist, V1, P83; BALLARD DW, 1988, SCIENCE, V241, P1652, DOI 10.1126/science.2843985; BELLGRAU D, 1995, NATURE, V377, P630, DOI 10.1038/377630a0; Chen XL, 1997, J GEN VIROL, V78, P3277, DOI 10.1099/0022-1317-78-12-3277; CHLICHLIA K, 1995, ONCOGENE, V10, P269; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1054; CRENON I, 1993, ONCOGENE, V8, P867; CROSS SL, 1987, CELL, V49, P47, DOI 10.1016/0092-8674(87)90754-9; Curtiss VE, 1996, MOL CELL BIOL, V16, P3567; FANGER CM, 1995, J CELL BIOL, V131, P655, DOI 10.1083/jcb.131.3.655; FEUER G, 1992, BIOCHIM BIOPHYS ACTA, V1114, P223, DOI 10.1016/0304-419X(92)90017-S; GANCHI PA, 1992, MOL BIOL CELL, V3, P1339, DOI 10.1091/mbc.3.12.1339; GESSAIN A, 1985, LANCET, V2, P407; GHOSH P, 1993, P NATL ACAD SCI USA, V90, P1696, DOI 10.1073/pnas.90.5.1696; Good LF, 1996, J VIROL, V70, P2730, DOI 10.1128/JVI.70.5.2730-2735.1996; Good LF, 1996, EMBO J, V15, P3744, DOI 10.1002/j.1460-2075.1996.tb00744.x; GRASSMANN R, 1992, J VIROL, V66, P4570, DOI 10.1128/JVI.66.7.4570-4575.1992; Green DR, 1997, P NATL ACAD SCI USA, V94, P5986, DOI 10.1073/pnas.94.12.5986; GREENE WC, 1989, IMMUNOL TODAY, V10, P272, DOI 10.1016/0167-5699(89)90141-2; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; Hahne M, 1996, SCIENCE, V274, P1363, DOI 10.1126/science.274.5291.1363; Himes SR, 1996, J VIROL, V70, P4001, DOI 10.1128/JVI.70.6.4001-4008.1996; HINRICHS SH, 1987, SCIENCE, V237, P1340, DOI 10.1126/science.2888191; HO SN, 1995, J BIOL CHEM, V270, P19898, DOI 10.1074/jbc.270.34.19898; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; HOLBROOK NJ, 1987, VIROLOGY, V157, P211, DOI 10.1016/0042-6822(87)90330-8; INOUE J, 1986, EMBO J, V5, P2883, DOI 10.1002/j.1460-2075.1986.tb04583.x; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Latinis KM, 1997, J IMMUNOL, V158, P4602; LI M, 1993, MOL CELL BIOL, V13, P6490, DOI 10.1128/MCB.13.10.6490; Loh C, 1996, MOL CELL BIOL, V16, P3945; Lyakh L, 1997, MOL CELL BIOL, V17, P2475, DOI 10.1128/MCB.17.5.2475; LYNCH DH, 1995, IMMUNOL TODAY, V16, P569, DOI 10.1016/0167-5699(95)80079-4; Maggirwar SB, 1997, MOL CELL BIOL, V17, P2605, DOI 10.1128/MCB.17.5.2605; MARUYAMA M, 1987, CELL, V48, P343, DOI 10.1016/0092-8674(87)90437-5; MASUDA ES, 1995, MOL CELL BIOL, V15, P2697; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; MERL S, 1984, BLOOD, V64, P967; MIYATAKE S, 1988, NUCLEIC ACIDS RES, V16, P6547, DOI 10.1093/nar/16.14.6547; MIYOSHI I, 1981, GANN, V72, P978; NERENBERG M, 1987, SCIENCE, V237, P1324, DOI 10.1126/science.2888190; NISHIOKA K, 1993, RHEUM DIS CLIN N AM, V19, P489; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; OConnell J, 1996, J EXP MED, V184, P1075, DOI 10.1084/jem.184.3.1075; OSAME M, 1986, LANCET, V1, P1031; PARK JC, 1995, J BIOL CHEM, V270, P20653, DOI 10.1074/jbc.270.35.20653; PERSAUD D, 1995, J VIROL, V69, P6297, DOI 10.1128/JVI.69.10.6297-6303.1995; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; POZZATTI R, 1990, MOL CELL BIOL, V10, P413, DOI 10.1128/MCB.10.1.413; RAO A, 1994, IMMUNOL TODAY, V15, P274, DOI 10.1016/0167-5699(94)90007-8; ROONEY JW, 1995, MOL CELL BIOL, V15, P6299; RUBEN S, 1988, SCIENCE, V241, P89, DOI 10.1126/science.2838905; RUFF VA, 1995, J BIOL CHEM, V270, P22602, DOI 10.1074/jbc.270.38.22602; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SEMMES OJ, 1992, J VIROL, V66, P7183, DOI 10.1128/JVI.66.12.7183-7192.1992; SERAFINI AT, 1995, IMMUNITY, V3, P239, DOI 10.1016/1074-7613(95)90093-4; SHAW KTY, 1995, P NATL ACAD SCI USA, V92, P11205, DOI 10.1073/pnas.92.24.11205; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; SIEKEVITZ M, 1987, P NATL ACAD SCI USA, V84, P5389, DOI 10.1073/pnas.84.15.5389; SMITH MR, 1991, J CLIN INVEST, V88, P1038, DOI 10.1172/JCI115364; SMITH MR, 1991, J CLIN INVEST, V87, P761, DOI 10.1172/JCI115078; SMITH MR, 1990, GENE DEV, V4, P1875, DOI 10.1101/gad.4.11.1875; SODROSKI J, 1992, BIOCHIM BIOPHYS ACTA, V1114, P19, DOI 10.1016/0304-419X(92)90003-H; SUDA T, 1995, J IMMUNOL, V154, P3806; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; SUN SC, 1994, MOL CELL BIOL, V14, P7377, DOI 10.1128/MCB.14.11.7377; Sun SC, 1996, MOL CELL BIOL, V16, P1058; SUZUKI T, 1993, P NATL ACAD SCI USA, V90, P610, DOI 10.1073/pnas.90.2.610; TAKAHASHI T, 1994, INT IMMUNOL, V6, P1567, DOI 10.1093/intimm/6.10.1567; TANAKA A, 1990, P NATL ACAD SCI USA, V87, P1071, DOI 10.1073/pnas.87.3.1071; Uchiyama T, 1997, ANNU REV IMMUNOL, V15, P15, DOI 10.1146/annurev.immunol.15.1.15; VERWEIJ CL, 1991, J BIOL CHEM, V266, P14179; WANO Y, 1988, P NATL ACAD SCI USA, V85, P9733, DOI 10.1073/pnas.85.24.9733; WATANABEFUKUNAGA R, 1992, J IMMUNOL, V148, P1274; Xu XN, 1997, J EXP MED, V186, P7, DOI 10.1084/jem.186.1.7; YAMADA T, 1994, J VIROL, V68, P3374, DOI 10.1128/JVI.68.5.3374-3379.1994; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; ZHAO LJ, 1991, P NATL ACAD SCI USA, V88, P11445, DOI 10.1073/pnas.88.24.11445	83	32	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22382	22388		10.1074/jbc.273.35.22382	http://dx.doi.org/10.1074/jbc.273.35.22382			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712859	hybrid			2022-12-27	WOS:000075616600035
J	Schimmoller, F; Simon, I; Pfeffer, SR				Schimmoller, F; Simon, I; Pfeffer, SR			Rab GTPases, directors of vesicle docking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NUCLEOTIDE EXCHANGE; MEMBRANE-FUSION; SACCHAROMYCES-CEREVISIAE; GDP/GTP EXCHANGE; SNARE ACTIVATION; TRANSPORT; EFFECTOR; SPECIFICITY; PROTEINS; BINDING		Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Stanford University	Pfeffer, SR (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.	pfeffer@cmgm.stanford.edu						Ayad N, 1997, EMBO J, V16, P4497, DOI 10.1093/emboj/16.15.4497; Benli M, 1996, EMBO J, V15, P6460, DOI 10.1002/j.1460-2075.1996.tb01037.x; BRENNER M, 1994, BRAIN PATHOL, V4, P245, DOI 10.1111/j.1750-3639.1994.tb00840.x; BRENNWALD P, 1993, NATURE, V362, P560, DOI 10.1038/362560a0; CHAVRIER P, 1991, NATURE, V353, P769, DOI 10.1038/353769a0; DASCHER C, 1991, MOL CELL BIOL, V11, P872, DOI 10.1128/MCB.11.2.872; Diaz E, 1997, J CELL BIOL, V138, P283, DOI 10.1083/jcb.138.2.283; DiracSvejstrup AB, 1997, EMBO J, V16, P465, DOI 10.1093/emboj/16.3.465; Du LL, 1998, J BIOL CHEM, V273, P3253, DOI 10.1074/jbc.273.6.3253; DUNN B, 1993, NATURE, V362, P563, DOI 10.1038/362563a0; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Finger FP, 1998, CELL, V92, P559, DOI 10.1016/S0092-8674(00)80948-4; Hay JC, 1997, CURR OPIN CELL BIOL, V9, P505, DOI 10.1016/S0955-0674(97)80026-9; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Jedd G, 1997, J CELL BIOL, V137, P563, DOI 10.1083/jcb.137.3.563; Kato M, 1996, J BIOL CHEM, V271, P31775, DOI 10.1074/jbc.271.50.31775; LIAN JP, 1994, NATURE, V372, P698, DOI 10.1038/372698a0; Lupashin VV, 1997, SCIENCE, V276, P1255, DOI 10.1126/science.276.5316.1255; McLauchlan H, 1998, CURR BIOL, V8, P34, DOI 10.1016/S0960-9822(98)70018-1; NOVICK P, 1993, CELL, V75, P597, DOI 10.1016/0092-8674(93)90478-9; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; NUOFFER C, 1994, J CELL BIOL, V125, P225, DOI 10.1083/jcb.125.2.225; NUOFFER C, 1994, ANNU REV BIOCHEM, V63, P949, DOI 10.1146/annurev.bi.63.070194.004505; Peranen J, 1996, J CELL BIOL, V135, P153, DOI 10.1083/jcb.135.1.153; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; PFEFFER SR, 1994, CURR OPIN CELL BIOL, V6, P522, DOI 10.1016/0955-0674(94)90071-X; Pfeffer SR, 1996, ANNU REV CELL DEV BI, V12, P441, DOI 10.1146/annurev.cellbio.12.1.441; RIEDERER MA, 1994, J CELL BIOL, V125, P573, DOI 10.1083/jcb.125.3.573; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; SOGAARD M, 1994, CELL, V78, P937, DOI 10.1016/0092-8674(94)90270-4; SOLDATI T, 1994, NATURE, V369, P76, DOI 10.1038/369076a0; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; STENMARK H, 1994, EMBO J, V13, P575, DOI 10.1002/j.1460-2075.1994.tb06295.x; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; TERBUSH DR, 1995, J CELL BIOL, V130, P299, DOI 10.1083/jcb.130.2.299; ULLRICH O, 1994, NATURE, V368, P157, DOI 10.1038/368157a0; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580	41	268	276	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22161	22164		10.1074/jbc.273.35.22161	http://dx.doi.org/10.1074/jbc.273.35.22161			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712825	hybrid			2022-12-27	WOS:000075616600001
J	Moyer, BD; Loffing, J; Schwiebert, EM; Loffing-Cueni, D; Halpin, PA; Karlson, KH; Ismailov, II; Guggino, WB; Langford, GM; Stanton, BA				Moyer, BD; Loffing, J; Schwiebert, EM; Loffing-Cueni, D; Halpin, PA; Karlson, KH; Ismailov, II; Guggino, WB; Langford, GM; Stanton, BA			Membrane trafficking of the cystic fibrosis gene product, cystic fibrosis transmembrane conductance regulator, tagged with green fluorescent protein in Madin-Darby canine kidney cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFYING CHLORIDE CHANNELS; EPITHELIAL-CELLS; PLASMA-MEMBRANE; VIRAL GLYCOPROTEINS; COLLECTING DUCT; XENOPUS-OOCYTES; LIPID BILAYERS; MDCK CELLS; 2 STRAINS; CFTR	The mechanism by which cAMP stimulates cystic fibrosis transmembrane conductance regulator (CFTR)-mediated chloride (Cl-) secretion is cell type-specific. By using Madin-Darby canine kidney (MDCK) type I epithelial cells as a model, we tested the hypothesis that cAMP stimulates Cl- secretion by stimulating CFTR Cl- channel trafficking from an intracellular pool to the apical plasma membrane. To this end, we generated a green fluorescent protein (GFP)-CFTR expression vector in which GFP was linked to the N terminus of CFTR, GFP did not alter CFTR function in whole cell patch-clamp or planar lipid bilayer experiments. In stably transfected MDCK type I cells, GFP-CFTR localization was substratum dependent. In cells grown on glass coverslips, GFP-CFTR was polarized to the basolateral membrane, whereas in cells grown on permeable supports, GFP-CFTR was polarized to the apical membrane. Quantitative confocal fluorescence microscopy and surface biotinylation experiments demonstrated that cAMP did not stimulate detectable GFP-CFTR translocation from an intracellular pool to the apical membrane or regulate GFP-CFTR endocytosis. Disruption of the microtubular cytoskeleton with colchicine did not affect cAMP-stimulated Cl- secretion or GFP-CFTR expression in the apical membrane. We conclude that cAMP stimulates CFTR-mediated Cl- secretion in MDCK type I cells by activating channels resident in the apical plasma membrane.	Dartmouth Med Sch, Dept Physiol, Hanover, NH 03755 USA; Dartmouth Med Sch, Dept Biol, Hanover, NH 03755 USA; Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA	Dartmouth College; Dartmouth College; Johns Hopkins University; University of Alabama System; University of Alabama Birmingham	Stanton, BA (corresponding author), Dartmouth Med Sch, Dept Physiol, Hanover, NH 03755 USA.	Bruce.A.Stanton@Dartmouth.edu	Loffing, Johannes/ABG-9973-2020	Langford, George/0000-0001-9737-2182; Loffing, Johannes/0000-0002-9415-6588	NCI NIH HHS [CA 23108] Funding Source: Medline; NIDDK NIH HHS [DK-45881, DK-51067] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045881, R01DK051067] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; BERGER HA, 1991, J CLIN INVEST, V88, P1422, DOI 10.1172/JCI115450; BRADBURY NA, 1994, AM J PHYSIOL, V267, pC1, DOI 10.1152/ajpcell.1994.267.1.C1; BREITFELD PP, 1990, J CELL BIOL, V111, P2365, DOI 10.1083/jcb.111.6.2365; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; CLIFF WH, 1992, AM J PHYSIOL, V262, pC1154, DOI 10.1152/ajpcell.1992.262.5.C1154; CRAWFORD I, 1991, P NATL ACAD SCI USA, V88, P9262, DOI 10.1073/pnas.88.20.9262; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; DAndrea L, 1996, J BIOL CHEM, V271, P28969, DOI 10.1074/jbc.271.46.28969; DENNING GM, 1992, J CLIN INVEST, V89, P339, DOI 10.1172/JCI115582; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; GEKLE M, 1994, PFLUG ARCH EUR J PHY, V428, P157, DOI 10.1007/BF00374853; Gerdes HH, 1996, FEBS LETT, V389, P44, DOI 10.1016/0014-5793(96)00586-8; GOLDIN AL, 1992, METHOD ENZYMOL, V207, P266; GOTTLIEB TA, 1986, J CELL BIOL, V102, P1242, DOI 10.1083/jcb.102.4.1242; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; Hanaoka K, 1996, AM J PHYSIOL-CELL PH, V270, pC389, DOI 10.1152/ajpcell.1996.270.1.C389; HANSSON GC, 1986, EMBO J, V5, P483, DOI 10.1002/j.1460-2075.1986.tb04237.x; Howard M, 1996, KIDNEY INT, V49, P1642, DOI 10.1038/ki.1996.239; HOWARD MB, 1996, PED PULMONOL S, V13, P231; Hug MJ, 1997, PFLUG ARCH EUR J PHY, V434, P779, DOI 10.1007/s004240050465; HUSTED RF, 1995, J CLIN INVEST, V95, P644, DOI 10.1172/JCI117709; JILING T, 1997, INT REV CYTOL, V172, P193; JOVOV B, 1995, J BIOL CHEM, V270, P1521, DOI 10.1074/jbc.270.4.1521; JOVOV B, 1995, J BIOL CHEM, V270, P29194, DOI 10.1074/jbc.270.49.29194; KAETHER C, 1995, FEBS LETT, V369, P267, DOI 10.1016/0014-5793(95)00765-2; Kunzelmann K, 1997, FEBS LETT, V400, P341, DOI 10.1016/S0014-5793(96)01414-7; KUWAHARA M, 1995, J BIOL CHEM, V270, P10384, DOI 10.1074/jbc.270.18.10384; Lehrich RW, 1998, J CLIN INVEST, V101, P737, DOI 10.1172/JCI803; LIM CR, 1995, J BIOCHEM-TOKYO, V118, P13, DOI 10.1093/oxfordjournals.jbchem.a124868; Ling BN, 1997, J BIOL CHEM, V272, P594; LippincottSchwartz J, 1997, CURR OPIN NEUROBIOL, V7, P631, DOI 10.1016/S0959-4388(97)80082-7; LISANTI MP, 1989, J CELL BIOL, V109, P2117, DOI 10.1083/jcb.109.5.2117; Lukacs GL, 1997, BIOCHEM J, V328, P353; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Makhina EN, 1998, J BIOL CHEM, V273, P3369, DOI 10.1074/jbc.273.6.3369; Maples CJ, 1997, J BIOL CHEM, V272, P6741, DOI 10.1074/jbc.272.10.6741; MARPLES D, 1995, AM J PHYSIOL-CELL PH, V269, pC655, DOI 10.1152/ajpcell.1995.269.3.C655; MARSHALL J, 1994, J BIOL CHEM, V269, P2987; MARSHALL J, 1995, NEURON, V14, P211, DOI 10.1016/0896-6273(95)90279-1; McNicholas CM, 1996, P NATL ACAD SCI USA, V93, P8083, DOI 10.1073/pnas.93.15.8083; Mohamed A, 1997, BIOCHEM J, V322, P259, DOI 10.1042/bj3220259; Morris RG, 1998, AM J PHYSIOL-RENAL, V274, pF300, DOI 10.1152/ajprenal.1998.274.2.F300; MOYER BD, 1997, EXPRESSIONS, V4, P6; NICHOLS GE, 1986, BIOCHIM BIOPHYS ACTA, V887, P1, DOI 10.1016/0167-4889(86)90115-1; OSTEDGAARD LS, 1992, J BIOL CHEM, V267, P26142; PEREZ G, 1994, BIOPHYS J, V66, P1022, DOI 10.1016/S0006-3495(94)80883-5; PRINCE LS, 1993, AM J PHYSIOL, V264, pC491, DOI 10.1152/ajpcell.1993.264.2.C491; PRINCE LS, 1994, P NATL ACAD SCI USA, V91, P5192, DOI 10.1073/pnas.91.11.5192; Rice JE, 1996, BIOCHEM SOC T, V24, P540, DOI 10.1042/bst0240540; RICHARDSON JCW, 1981, BIOCHIM BIOPHYS ACTA, V673, P26, DOI 10.1016/0304-4165(81)90307-X; RINDLER MJ, 1984, J CELL BIOL, V98, P1304, DOI 10.1083/jcb.98.4.1304; RIORDAN JR, 1989, SCIENCE, V245, P1066; Schwiebert EM, 1998, P NATL ACAD SCI USA, V95, P2674, DOI 10.1073/pnas.95.5.2674; SCHWIEBERT EM, 1994, AM J PHYSIOL, V266, pC1464, DOI 10.1152/ajpcell.1994.266.5.C1464; SCHWIEBERT EM, 1995, CELL, V81, P1063, DOI 10.1016/S0092-8674(05)80011-X; Stanton BA, 1997, WIEN KLIN WOCHENSCHR, V109, P457; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; TILLY BC, 1992, J BIOL CHEM, V267, P9470; Torres RJ, 1996, AM J PHYSIOL-CELL PH, V271, pC1574, DOI 10.1152/ajpcell.1996.271.5.C1574; Tousson A, 1996, J CELL SCI, V109, P1325; Valentich J D, 1981, Ann N Y Acad Sci, V372, P384, DOI 10.1111/j.1749-6632.1981.tb15490.x; VANDORPE D, 1995, AM J PHYSIOL-CELL PH, V269, pC683, DOI 10.1152/ajpcell.1995.269.3.C683; WARD CL, 1994, J BIOL CHEM, V269, P25710; WESTERMEIER R, 1993, ELECTROPHORESIS PRAC, P167; Zhang GH, 1996, BIOCHEM BIOPH RES CO, V227, P707, DOI 10.1006/bbrc.1996.1573	68	143	145	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21759	21768		10.1074/jbc.273.34.21759	http://dx.doi.org/10.1074/jbc.273.34.21759			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705313	hybrid			2022-12-27	WOS:000075492600047
J	Fiermonte, G; Palmieri, L; Dolce, V; Lasorsa, FM; Palmieri, F; Runswick, MJ; Walker, JE				Fiermonte, G; Palmieri, L; Dolce, V; Lasorsa, FM; Palmieri, F; Runswick, MJ; Walker, JE			The sequence, bacterial expression, and functional reconstitution of the rat mitochondrial dicarboxylate transporter cloned via distant homologs in yeast and Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP ATP TRANSLOCASE; TISSUE-SPECIFIC EXPRESSION; LIVER MITOCHONDRIA; CARRIER PROTEINS; SACCHAROMYCES-CEREVISIAE; UNCOUPLING PROTEIN-3; OXOGLUTARATE CARRIER; SUBSTRATE-BINDING; PHOSPHATE CARRIER; GENES ENCODE	The dicarboxylate carrier (DIC) belongs to a family of transport proteins found in the inner mitochondrial membranes. The. biochemical properties of the mammalian protein have been characterized, but the protein is not abundant. It is difficult to purify and had not been sequenced. We have used the sequence of the distantly related yeast DIC to identify a related protein encoded in the genome of Caenorhabditis elegans, Then, related murine expressed sequence tags were identified with the worm sequence, and the murine sequence was used to isolate the cDNA for the rat homolog, The sequences of the worm and rat proteins have features characteristic of the family of mitochondrial transport proteins. Both proteins were expressed in bacteria and reconstituted into phospholipid vesicles where their transport characteristics closely resembled those of whole rat mitochondria and of the rat DIC reconstituted into vesicles. As expected from the role of the DIC in gluconeogenesis and ureogenesis, its transcripts were detected in rat liver and kidney, but unexpectedly, they were also detected in rat heart and brain tissues where the protein may fulfill other roles, possibly in supplying substrates to the Krebs cycle.	Univ Bari, Dept Phamacobiol, Biochem & Mol Biol Lab, I-70125 Bari, Italy; MRC, Mol Biol Lab, Cambridge CB2 2QH, England	Universita degli Studi di Bari Aldo Moro; MRC Laboratory Molecular Biology	Walker, JE (corresponding author), Univ Bari, Dept Phamacobiol, Biochem & Mol Biol Lab, Via Orabona 4, I-70125 Bari, Italy.		Fiermonte, Giuseppe/D-3680-2018; lasorsa, francesco massimo m/B-7931-2008	Fiermonte, Giuseppe/0000-0002-6764-9395; lasorsa, francesco massimo m/0000-0001-8418-5222; Dolce, Vincenza/0000-0003-2966-4866; Walker, John/0000-0001-7929-2162				BATHGATE B, 1989, EUR J BIOCHEM, V183, P303, DOI 10.1111/j.1432-1033.1989.tb14929.x; BISACCIA F, 1988, BIOCHIM BIOPHYS ACTA, V933, P229, DOI 10.1016/0005-2728(88)90030-8; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; Capobianco L, 1996, BIOCHEMISTRY-US, V35, P8974, DOI 10.1021/bi960258v; Chappell J.B., 1967, BIOCH MITOCHONDRIA, P75; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COZENS AL, 1989, J MOL BIOL, V206, P261, DOI 10.1016/0022-2836(89)90477-4; CROMPTON M, 1974, FEBS LETT, V46, P247, DOI 10.1016/0014-5793(74)80379-0; CROMPTON M, 1974, BIOCHEM J, V142, P127, DOI 10.1042/bj1420127; DOLCE V, 1994, J BIOL CHEM, V269, P10451; Dolce V, 1996, FEBS LETT, V399, P95, DOI 10.1016/S0014-5793(96)01294-X; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; FIERMONTE G, 1993, BIOCHEM J, V294, P293, DOI 10.1042/bj2940293; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; IAOBAZZI V, 1996, PLANT PHYSIOL, V110, P1435; INDIVERI C, 1993, BIOCHIM BIOPHYS ACTA, V1143, P310, DOI 10.1016/0005-2728(93)90202-Q; INDIVERI C, 1989, BIOCHIM BIOPHYS ACTA, V977, P187, DOI 10.1016/S0005-2728(89)80070-2; INDIVERI C, 1989, BIOCHIM BIOPHYS ACTA, V977, P194, DOI 10.1016/S0005-2728(89)80071-4; JOHNSON RN, 1973, BIOCHEM J, V134, P769, DOI 10.1042/bj1340769; Kakhniashvili D, 1997, J BIOL CHEM, V272, P4516, DOI 10.1074/jbc.272.7.4516; KAPLAN RS, 1985, J BIOL CHEM, V260, P293; KOLAROV J, 1990, J BIOL CHEM, V265, P12711; KUAN J, 1993, CRIT REV BIOCHEM MOL, V28, P209, DOI 10.3109/10409239309086795; LancarBenba J, 1996, BIOCHIMIE, V78, P195, DOI 10.1016/0300-9084(96)89505-8; LANCARBENBA J, 1994, BBA-BIOMEMBRANES, V1190, P213, DOI 10.1016/0005-2736(94)90076-0; LAWSON JE, 1988, J BIOL CHEM, V263, P14812; MEIJER AJ, 1970, FEBS LETT, V8, P41, DOI 10.1016/0014-5793(70)80220-4; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; NESS GC, 1991, FEBS LETT, V288, P21, DOI 10.1016/0014-5793(91)80993-D; PALMIERI F, 1974, BIOCHIM BIOPHYS ACTA, V333, P195, DOI 10.1016/0005-2728(74)90004-8; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; PALMIERI F, 1971, EUR J BIOCHEM, V22, P66, DOI 10.1111/j.1432-1033.1971.tb01515.x; PALMIERI F, 1972, EUR J BIOCHEM, V29, P408, DOI 10.1111/j.1432-1033.1972.tb02003.x; PALMIERI F, 1994, FEBS LETT, V346, P48, DOI 10.1016/0014-5793(94)00329-7; PALMIERI F, 1998, IN PRESS FRONTIERS C; Palmieri L, 1996, FEBS LETT, V399, P299, DOI 10.1016/S0014-5793(96)01350-6; PASSARELLA S, 1973, FEBS LETT, V38, P91, DOI 10.1016/0014-5793(73)80521-6; POWELL SJ, 1989, BIOCHEMISTRY-US, V28, P866, DOI 10.1021/bi00428a069; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; ROBINSON BH, 1972, J MEMBRANE BIOL, V7, P391, DOI 10.1007/BF01867928; RUNSWICK MJ, 1994, DNA SEQUENCE, V4, P281, DOI 10.3109/10425179409020854; RUNSWICK MJ, 1990, BIOCHEMISTRY-US, V29, P11033, DOI 10.1021/bi00502a004; SARASTE M, 1982, FEBS LETT, V144, P250, DOI 10.1016/0014-5793(82)80648-0; Solanes G, 1997, J BIOL CHEM, V272, P25433, DOI 10.1074/jbc.272.41.25433; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WALKER JE, 1993, J BIOENERG BIOMEMBR, V25, P435, DOI 10.1007/BF01108401; WALKER JE, 1987, CHEM SCRIPTA, V27B, P97	47	110	116	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24754	24759		10.1074/jbc.273.38.24754	http://dx.doi.org/10.1074/jbc.273.38.24754			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733776	hybrid			2022-12-27	WOS:000076007300068
J	Jimenez-Garcia, E; Vaquero, A; Espinas, ML; Soliva, R; Orozco, M; Bernues, J; Azorin, F				Jimenez-Garcia, E; Vaquero, A; Espinas, ML; Soliva, R; Orozco, M; Bernues, J; Azorin, F			The GAGA factor of Drosophila binds triple-stranded DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PROTEIN BINDING; HEAT-SHOCK PROMOTER; ASTERISK-H-DNA; TRANSCRIPTION FACTOR; NUCLEOSOME DISRUPTION; RAS PROMOTER; SP1 BINDING; HUMAN-CELLS; SEQUENCE; GENE	The Drosophila GAGA factor binds specifically to simple repeating d(GA.TC)(n) DNA sequences. These sequences are known to be capable of forming triple-stranded DNA as well as other non-B-DNA conformations. Here, it is shown that GAGA binds to a d[CT(GA.TC)](22) intermolecular tripler with similar specificity and affinity as to a regular double-stranded B form d[AG(GA.TC)](22) sequence. The interaction of GAGA with tripler DNA cannot, however, stimulate transcription in vitro. The affinity of GAGA for triplexes of the purine motif, such as a d[AG(GA.TC)](22) intermolecular tripler, is significantly lower. The DNA binding domain of GAGA is sufficient for efficient binding to tripler DNA. Eased on the reported solution structure of the complex of GAGA-DNA binding domain with double-stranded DNA, a model for its interaction with tripler DNA is proposed in which most of the protein-DNA contacts observed in duplex DNA are maintained, especially those occurring through the minor groove. The higher negative charge of the tripler is likely to have also an important contribution to both the specificity and affinity of the interaction.	CSIC, Ctr Invest Desenvolupament, Dept Mol & Cellular Biol, ES-08034 Barcelona, Spain; Univ Barcelona, Fac Quim, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Barcelona	Azorin, F (corresponding author), CSIC, Ctr Invest Desenvolupament, Dept Mol & Cellular Biol, Jordi Girona Salgado 18-26, ES-08034 Barcelona, Spain.		Azorin, Fernando/N-4388-2014; Bernues, Jordi/ABE-8360-2021	Azorin, Fernando/0000-0002-8426-7858; Bernues, Jordi/0000-0001-6218-8254; Espinas, M Lluisa/0000-0003-3914-2228; Orozco Lopez, Modesto/0000-0002-8608-3278				BELTRAN R, 1993, J MOL BIOL, V230, P966, DOI 10.1006/jmbi.1993.1213; BERNUES J, 1993, EMBO J, V12, P3573, DOI 10.1002/j.1460-2075.1993.tb06031.x; Bernues J., 1995, NUCL ACIDS MOL BIOL, V9, P1; Bhat KM, 1996, DEVELOPMENT, V122, P1113; BIGGIN MD, 1988, CELL, V53, P699, DOI 10.1016/0092-8674(88)90088-8; CASASNOVAS JM, 1987, EUR J BIOCHEM, V167, P489, DOI 10.1111/j.1432-1033.1987.tb13363.x; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; CROSTON GE, 1991, SCIENCE, V251, P643, DOI 10.1126/science.1899487; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Espinas ML, 1996, J BIOL CHEM, V271, P31807, DOI 10.1074/jbc.271.50.31807; FARKAS G, 1994, NATURE, V371, P806, DOI 10.1038/371806a0; GEE JE, 1992, J BIOL CHEM, V267, P11163; GILMOUR DS, 1989, SCIENCE, V245, P1487, DOI 10.1126/science.2781290; GLASER RL, 1990, J MOL BIOL, V211, P751, DOI 10.1016/0022-2836(90)90075-W; GRANOK H, 1995, CURR BIOL, V5, P238, DOI 10.1016/S0960-9822(95)00048-0; GRIGORIEV M, 1992, J BIOL CHEM, V267, P3389; Guieysse AL, 1997, J MOL BIOL, V267, P289, DOI 10.1006/jmbi.1997.0884; KERRIGAN LA, 1991, J BIOL CHEM, V266, P574; KIYAMA R, 1991, P NATL ACAD SCI USA, V88, P10450, DOI 10.1073/pnas.88.23.10450; KOWHI Y, 1993, GENE DEV, V7, P1766; LIS J, 1993, CELL, V74, P1, DOI 10.1016/0092-8674(93)90286-Y; MAHER LJ, 1989, SCIENCE, V245, P725, DOI 10.1126/science.2549631; MARTINEZBALBAS A, 1993, NUCLEIC ACIDS RES, V21, P2557, DOI 10.1093/nar/21.11.2557; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; MAYFIELD C, 1994, J BIOL CHEM, V269, P18232; MAYFIELD C, 1994, BIOCHEMISTRY-US, V33, P3358, DOI 10.1021/bi00177a029; OBRIEN T, 1995, GENE DEV, V9, P1098, DOI 10.1101/gad.9.9.1098; Omichinski JG, 1997, NAT STRUCT BIOL, V4, P122, DOI 10.1038/nsb0297-122; Pedone PV, 1996, P NATL ACAD SCI USA, V93, P2822, DOI 10.1073/pnas.93.7.2822; Platero JS, 1998, J CELL BIOL, V140, P1297; PTASHNE M, 1990, NATURE, V346, P329, DOI 10.1038/346329a0; RADHAKRISHNAN I, 1994, BIOCHEMISTRY-US, V33, P11405, DOI 10.1021/bi00204a001; RAFF JW, 1994, EMBO J, V13, P5977, DOI 10.1002/j.1460-2075.1994.tb06943.x; REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0; REDDOCH JF, 1995, BIOCHEMISTRY-US, V34, P7659, DOI 10.1021/bi00023a012; Shields GC, 1997, J AM CHEM SOC, V119, P7463, DOI 10.1021/ja970601z; SOELLER WC, 1993, MOL CELL BIOL, V13, P7961, DOI 10.1128/MCB.13.12.7961; SOLIVA R, 1998, IN PRESS J AM CHEM S; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; Tsukiyama T, 1996, METHOD ENZYMOL, V274, P291; WESTIN L, 1995, NUCLEIC ACIDS RES, V23, P2184, DOI 10.1093/nar/23.12.2184; Wilkins RC, 1997, NUCLEIC ACIDS RES, V25, P3963, DOI 10.1093/nar/25.20.3963	43	39	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24640	24648		10.1074/jbc.273.38.24640	http://dx.doi.org/10.1074/jbc.273.38.24640			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733760	hybrid			2022-12-27	WOS:000076007300052
J	Laser, M; Kasi, VS; Hamawaki, M; Cooper, G; Kerr, CM; Kuppuswamy, D				Laser, M; Kasi, VS; Hamawaki, M; Cooper, G; Kerr, CM; Kuppuswamy, D			Differential activation of p70 and p85 S6 kinase isoforms during cardiac hypertrophy in the adult mammal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; SIGNAL-TRANSDUCTION; IN-VITRO; PHOSPHATIDYLINOSITOL 3-KINASE; TYROSINE PHOSPHORYLATION; DEPENDENT ACTIVATION; GENE-EXPRESSION; CYCLIC-AMP; PHAS-I; RAPAMYCIN	An adult feline right ventricular pressure overload (RVPO) model was used to examine the two S6 kinase (S6K) isoforms, p70(S6K) and p85(S6K), that are involved in translational and transcriptional activation. Biochemical and confocal microscopy analyses at the level of the cardiocyte revealed that p70(S6K) is present predominantly in the cytosol, substantially activated in 1-h RVPO (>12 fold), and phosphorylated in the pseudosubstrate domain at the Ser-411, Thr-421, and Ser-424 sites. p85(S6K), which was localized exclusively in the nucleus, showed activation subsequent to p70(S6K). With a sustained increase in phosphorylation for up to 48 h of RVPO at equivalent sites of p70(S6K), Thr-421 and Ser-424, but not at Ser-411. Neither isoform translocated between the cytosol and the nucleus. Further studies to determine potential upstream elements of S6K activation revealed: (i) similar time course of activation for protein kinase C isoforms (alpha, gamma, and epsilon) and c-Raf, (ii) absence of accompanying phosphatidylinositol S-kinase activation, (iii) activation of c-Src subsequent to p70(S6K), and (iv) similar changes in adult cardiocytes after treatment with 12-O-tetradecanoylphorbol-13-acetate. Thus, these studies suggest that a protein kinase C-mediated pathway couples pressure overload to growth induction via differential activation of S6K isoforms in cardiac hypertrophy.	Med Univ S Carolina, Dept Med, Div Cardiol, Charleston, SC 29425 USA; Med Univ S Carolina, Gazes Cardiac Res Inst, Dept Physiol, Charleston, SC 29425 USA; Med Univ S Carolina, Gazes Cardiac Res Inst, Dept Cell Biol, Charleston, SC 29425 USA; Ralph H Johnson Dept Vet Affairs Med Ctr, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Kuppuswamy, D (corresponding author), Med Univ S Carolina, Dept Med, Div Cardiol, 171 Ashley Ave, Charleston, SC 29425 USA.				NHLBI NIH HHS [HL-487788] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Angst BD, 1997, CIRC RES, V80, P88, DOI 10.1161/01.RES.80.1.88; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; Boluyt MO, 1997, CIRC RES, V81, P176, DOI 10.1161/01.RES.81.2.176; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; CHOU MM, 1995, CURR OPIN CELL BIOL, V7, P806, DOI 10.1016/0955-0674(95)80064-6; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; Cooper G, 1997, ANNU REV MED, V48, P13, DOI 10.1146/annurev.med.48.1.13; COOPER G, 1974, J APPL PHYSIOL, V37, P762, DOI 10.1152/jappl.1974.37.5.762; COOPER G, 1986, CIRC RES, V58, P692, DOI 10.1161/01.RES.58.5.692; DEGROOT RP, 1994, CELL, V79, P81, DOI 10.1016/0092-8674(94)90402-2; ERIKSON RL, 1991, J BIOL CHEM, V266, P6007; Fadden P, 1997, J BIOL CHEM, V272, P10240; FERRARI S, 1993, J BIOL CHEM, V268, P16091; FOX JEB, 1993, J BIOL CHEM, V268, P25973; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; FROST V, 1995, J BIOL CHEM, V270, P26698, DOI 10.1074/jbc.270.44.26698; FUKUI Y, 1991, MOL CELL BIOL, V11, P1972, DOI 10.1128/MCB.11.4.1972; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GROVE JR, 1991, MOL CELL BIOL, V11, P5541, DOI 10.1128/MCB.11.11.5541; GU X, 1994, CIRC RES, V75, P926, DOI 10.1161/01.RES.75.5.926; HAN JW, 1995, J BIOL CHEM, V270, P21396, DOI 10.1074/jbc.270.36.21396; HERSHEY JWB, 1990, ENZYME, V44, P17, DOI 10.1159/000468744; HOMMA T, 1992, J BIOL CHEM, V267, P23129; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Kuppuswamy D, 1997, J BIOL CHEM, V272, P4500, DOI 10.1074/jbc.272.7.4500; KUPPUSWAMY D, 1993, J BIOL CHEM, V268, P19134; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE HA, 1993, NATURE, V363, P170, DOI 10.1038/363170a0; Lenormand P, 1996, J BIOL CHEM, V271, P15762, DOI 10.1074/jbc.271.26.15762; Mahalingam M, 1996, MOL CELL BIOL, V16, P405; Malik RK, 1996, J BIOL CHEM, V271, P29785, DOI 10.1074/jbc.271.47.29785; MING XF, 1994, NATURE, V371, P426, DOI 10.1038/371426a0; MONFAR M, 1995, MOL CELL BIOL, V15, P326, DOI 10.1128/MCB.15.1.326; Morgan HE, 1997, MOL CELL BIOCHEM, V176, P145, DOI 10.1023/A:1006855818855; Moser BA, 1997, MOL CELL BIOL, V17, P5648, DOI 10.1128/MCB.17.9.5648; Paul K, 1997, CIRC RES, V81, P643; PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x; PRICE DJ, 1991, J BIOL CHEM, V266, P16281; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; Proud CG, 1996, TRENDS BIOCHEM SCI, V21, P181, DOI 10.1016/0968-0004(96)10016-5; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; ROZICH JD, 1995, J MOL CELL CARDIOL, V27, P485, DOI 10.1016/S0022-2828(08)80044-2; SADOSHIMA J, 1995, CIRC RES, V77, P1040, DOI 10.1161/01.RES.77.6.1040; SafiejkoMroczka B, 1996, J HISTOCHEM CYTOCHEM, V44, P641, DOI 10.1177/44.6.8666749; Servillo G, 1997, ONCOGENE, V14, P1601, DOI 10.1038/sj.onc.1200996; Silvennoinen O, 1996, J IMMUNOL, V156, P100; STEWART MJ, 1994, BIOESSAYS, V16, P809, DOI 10.1002/bies.950161107; Stokoe D, 1997, EMBO J, V16, P2384, DOI 10.1093/emboj/16.9.2384; Takano H, 1996, FEBS LETT, V379, P255, DOI 10.1016/0014-5793(95)01523-X; TERADA N, 1993, J BIOL CHEM, V268, P12062; vonManteuffel SR, 1997, MOL CELL BIOL, V17, P5426, DOI 10.1128/MCB.17.9.5426; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0	57	58	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24610	24619		10.1074/jbc.273.38.24610	http://dx.doi.org/10.1074/jbc.273.38.24610			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733756	hybrid			2022-12-27	WOS:000076007300048
J	Morooka, T; Nishida, E				Morooka, T; Nishida, E			Requirement of p38 mitogen-activated protein kinase for neuronal differentiation in PC12 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; MAP KINASE; PC-12 CELLS; RECEPTOR; TYROSINE; THREONINE; INSULIN	Nerve growth factor (NGF) induces sustained activation of classical MAP kinase (MAPK, also known as ERK) and neuronal differentiation in PC12 cells, whereas epidermal growth factor (EGF) induces transient activation of ERK/MAPK and stimulates proliferation of the cells, Although previous studies showed that sustained activation of ERK/MAPK is important for neuronal differentiation of the cells, a recent report revealed that inhibition of the sustained phase of ERK/MAPK activation alone does not block neurite outgrowth caused by NGF. These results suggest requirement for an additional signaling pathway(s) triggered by NGF in neuronal differentiation. Here we show that NGF induces sustained activation of p38, a subfamily member of the MAPK superfamily, and that inhibition of the p38 pathway blocks neurite outgrowth in PC12 cells. Surprisingly, expression of constitutively active MAPK/ERK kinase (MAPKK, also known as MEK) results in p38 activation as well as ERK/MAPK activation, and a p38 inhibitor blocks neurite outgrowth caused by the constitutively active MAPK/MEK, Moreover, constitutive activation of p38 is able to induce neurite outgrowth when combined with EGF treatment. These results reveal an essential role of p38 in neuronal differentiation in PC12 cells.	Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Nishida, E (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.							BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DIKIC I, 1994, CURR BIOL, V4, P702, DOI 10.1016/S0960-9822(00)00155-X; Fukuda M, 1997, J BIOL CHEM, V272, P32642, DOI 10.1074/jbc.272.51.32642; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HEASLEY LE, 1992, MOL BIOL CELL, V3, P545, DOI 10.1091/mbc.3.5.545; Iwasaki S, 1996, J BIOL CHEM, V271, P17360, DOI 10.1074/jbc.271.29.17360; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Ludwig S, 1998, J BIOL CHEM, V273, P1917, DOI 10.1074/jbc.273.4.1917; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Marshall CJ, 1998, NATURE, V392, P553, DOI 10.1038/33293; MIYASAKA T, 1990, J BIOL CHEM, V265, P4730; Moriguchi T, 1997, EMBO J, V16, P7045, DOI 10.1093/emboj/16.23.7045; Moriguchi T, 1996, J BIOL CHEM, V271, P26981, DOI 10.1074/jbc.271.43.26981; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Yao H, 1998, J BIOL CHEM, V273, P8240, DOI 10.1074/jbc.273.14.8240; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	24	303	306	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24285	24288		10.1074/jbc.273.38.24285	http://dx.doi.org/10.1074/jbc.273.38.24285			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733710	hybrid			2022-12-27	WOS:000076007300002
J	Papadimou, E; Georgiou, S; Tsambaos, D; Drainas, D				Papadimou, E; Georgiou, S; Tsambaos, D; Drainas, D			Inhibition of ribonuclease P activity by retinoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNASE-P; DICTYOSTELIUM-DISCOIDEUM; DIFFERENTIATION; APOPTOSIS	The effect of two naturally occurring (retinol and all-trans retinoic acid) and two synthetic (isotretinoin and acitretin) analogs of vitamin A (retinoids) on tRNA biogenesis was investigated employing the RNase P of Dictyostelium discoideum as an in vitro experimental system. RNase P is an ubiquitous and essential enzyme that endonucleolytically cleaves all tRNA precursors to produce the mature 5' end. All retinoids tested revealed a dose-dependent inhibition of RNase P activity, indicating that these compounds may have a direct effect on tRNA biogenesis, Detailed kinetic analysis showed that all retinoids behave as classical competitive inhibitors. The K-i values determined were 1475 mu M for retinol, 15 mu M for ah-trans retinoic acid, 20 mu M for isotretinoin, and 8.0 mu M for acitretin, On the basis of these values acitretin is a 184, 2.5, and 1.9 times more potent inhibitor, as compared with retinol, isotretinoin, and all-trans retinoic acid, respectively. Taking into account that retinoids share no structural similarities to precursor tRNA, it is suggested that their kinetic behavior reflects allosteric interactions of these compounds with hydrophobic site(s) of D, discoideum RNase P.	Univ Patras, Sch Med, Dept Biochem, Patras 26500, Greece; Univ Patras, Sch Med, Dept Dermatol, Patras 26500, Greece	University of Patras; University of Patras	Drainas, D (corresponding author), Univ Patras, Sch Med, Dept Biochem, Patras 26500, Greece.	Drainas@med.upatras.gr						BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Botling J, 1997, J BIOL CHEM, V272, P9443; Chao WR, 1997, CANCER LETT, V115, P1, DOI 10.1016/S0304-3835(97)04598-9; DARR SC, 1992, TRENDS BIOCHEM SCI, V17, P178, DOI 10.1016/0968-0004(92)90262-8; DE LUCA LM, 1991, FASEB J, V5, P2924; Drainas D, 1996, MOL BIOL REP, V22, P135, DOI 10.1007/BF00988718; DRAINAS D, 1989, FEBS LETT, V251, P84, DOI 10.1016/0014-5793(89)81433-4; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Hsu CA, 1997, BLOOD, V89, P4470, DOI 10.1182/blood.V89.12.4470; Lacour M, 1996, BRIT J DERMATOL, V134, P1023, DOI 10.1111/j.1365-2133.1996.tb07936.x; LEID M, 1992, TRENDS BIOCHEM SCI, V17, P427, DOI 10.1016/0968-0004(92)90014-Z; LIPPMAN SM, 1995, J CELL BIOCHEM, P1; Minucci S, 1997, MOL CELL BIOL, V17, P644, DOI 10.1128/MCB.17.2.644; MUINDI JR, 1996, CANC TREAT RES, V870, P305; Plewig G, 1997, HAUTARZT, V48, P881, DOI 10.1007/s001050050679; ROSS AC, 1993, FASEB J, V7, P317, DOI 10.1096/fasebj.7.2.8440409; Sankaranarayanan R, 1996, IARC SCI PUBL, P47; SEGEL IH, 1975, ENZYME KINETICS, P110; STATHOPOULOS C, 1995, EUR J BIOCHEM, V228, P976, DOI 10.1111/j.1432-1033.1995.0976m.x; SYMONS RH, 1994, CURR OPIN STRUC BIOL, V4, P322, DOI 10.1016/S0959-440X(94)90099-X; TSAMBAOS D, 1991, EFFECTS SYNTHETIC RE, P659; vanderSaag PT, 1996, EUR J CLIN NUTR, V50, pS24; WIEDER JM, 1995, DERMATOL CLIN, V13, P891, DOI 10.1016/S0733-8635(18)30051-2	23	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24375	24378		10.1074/jbc.273.38.24375	http://dx.doi.org/10.1074/jbc.273.38.24375			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733726	hybrid			2022-12-27	WOS:000076007300018
J	San Agustin, JT; Leszyk, JD; Nuwaysir, LM; Witman, GB				San Agustin, JT; Leszyk, JD; Nuwaysir, LM; Witman, GB			The catalytic subunit of the cAMP-dependent protein kinase of ovine sperm flagella has a unique amino-terminal sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE CARDIAC-MUSCLE; REGULATORY SUBUNIT; CYCLIC-AMP; C-GAMMA; SPERMATOZOA; MOTILITY; LOCALIZATION; ISOFORM; CALCIUM; CELLS	The basis for the unusual properties of the catalytic subunit (C) of ram sperm cAMP-dependent protein kinase was investigated. Ram sperm C was purified and found by mass spectrometry (MS) to be similar to 890 Da smaller than C alpha, the predominant somatic isoform. Partial internal amino acid sequence from ram sperm C was an exact match to that of bovine C alpha, but differed from the predicted sequences for the C beta and C gamma isoforms. MS analysis of 2-nitro-5-thiocyanatobenzoic acid fragments showed that the mass difference originated in the amino-terminal region. A unique blocked amino-terminal fragment was isolated from sperm C and sequenced by a combination of tandem mass spectrometry and Edman degradation of a subfragment, The results revealed that the amino-terminal myristate and the first 14 amino acids of C alpha are replaced by an amino-terminal acetate and six different amino acids in sperm C. The predicted mass difference due to these changes is 899 Da, The region of homology between sperm C and C alpha begins at the exon 1/exon 2 boundary in C alpha, suggesting that sperm C results from use of an alternate exon 1 in the C alpha gene. The different amino terminus of sperm C may be related to a unique requirement for localization of the "free" C subunit within the sperm flagellum.	Univ Massachusetts, Med Ctr, Dept Cell Biol, Shrewsbury, MA 01545 USA; Univ Massachusetts, Med Ctr, Prot Chem Facil, Shrewsbury, MA 01545 USA; Perkin Elmer Sciex, Appl Biosyst Div, Foster City, CA 94404 USA	University of Massachusetts System; University of Massachusetts System; Thermo Fisher Scientific; Applied Biosystems	San Agustin, JT (corresponding author), Univ Massachusetts, Med Ctr, Dept Cell Biol, Worcester Fdn Campus, Shrewsbury, MA 01545 USA.			Witman, George/0000-0002-9497-9218	NICHD NIH HHS [HD23858] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD023858] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AGUSTIN JTS, 1993, CELL MOTIL CYTOSKEL, V24, P264, DOI 10.1002/cm.970240407; BABCOCK DF, 1975, J BIOL CHEM, V250, P6488; BEEBE SJ, 1992, J BIOL CHEM, V267, P25505; BEEBE SJ, 1990, MOL ENDOCRINOL, V4, P465, DOI 10.1210/mend-4-3-465; BEEBE SJ, 1986, ENZYMES, V17, P43; BEUSHAUSEN S, 1992, P NATL ACAD SCI USA, V89, P1641, DOI 10.1073/pnas.89.5.1641; CARR SA, 1982, P NATL ACAD SCI-BIOL, V79, P6128, DOI 10.1073/pnas.79.20.6128; CHENG HC, 1986, J BIOL CHEM, V261, P989; CHRIVIA JC, 1988, J BIOL CHEM, V263, P5739; CUMMINGS DE, 1994, MAMM GENOME, V5, P701, DOI 10.1007/BF00426076; DACHEUX JL, 1983, BIOL REPROD, V29, P1033, DOI 10.1095/biolreprod29.4.1033; DellAcqua ML, 1997, J BIOL CHEM, V272, P12881, DOI 10.1074/jbc.272.20.12881; DEY CS, 1991, J CELL SCI, V100, P815; DURONIO RJ, 1990, P NATL ACAD SCI USA, V87, P1506, DOI 10.1073/pnas.87.4.1506; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; FERRELL JE, 1991, METHOD ENZYMOL, V200, P430; Garbers D L, 1980, Adv Cyclic Nucleotide Res, V13, P251; Herberg FW, 1997, PROTEIN SCI, V6, P569; HOROWITZ JA, 1984, J BIOL CHEM, V259, P832; ISHIJIMA S, 1985, J EXP BIOL, V114, P463; JEKEL PA, 1983, ANAL BIOCHEM, V134, P347, DOI 10.1016/0003-2697(83)90308-1; Jones R, 1996, J CELL SCI, V109, P2561; LAKOSKI K, 1989, GAMETE RES, V23, P21, DOI 10.1002/mrd.1120230104; LIEBERMAN SJ, 1988, J CELL BIOL, V107, P1809, DOI 10.1083/jcb.107.5.1809; LINDEMANN CB, 1978, CELL, V13, P9, DOI 10.1016/0092-8674(78)90133-2; LOO JA, 1990, SCIENCE, V248, P201, DOI 10.1126/science.2326633; MACLEOD J, 1994, EUR J BIOCHEM, V225, P107, DOI 10.1111/j.1432-1033.1994.00107.x; MALDONADO F, 1988, NUCLEIC ACIDS RES, V16, P8189, DOI 10.1093/nar/16.16.8189; MCILHINNEY RAJ, 1990, TRENDS BIOCHEM SCI, V15, P387; MOHRI H, 1980, EXP CELL RES, V127, P191, DOI 10.1016/0014-4827(80)90426-7; OKUNO S, 1990, BIOCHIM BIOPHYS ACTA, V1038, P204, DOI 10.1016/0167-4838(90)90206-U; OTTER T, 1987, ANAL BIOCHEM, V162, P370, DOI 10.1016/0003-2697(87)90406-4; OYEN O, 1990, BIOL REPROD, V43, P46, DOI 10.1095/biolreprod43.1.46; PARISET C, 1989, J CELL BIOL, V109, P1195, DOI 10.1083/jcb.109.3.1195; Qi M, 1996, P NATL ACAD SCI USA, V93, P1571, DOI 10.1073/pnas.93.4.1571; SANAGUSTIN JT, 1995, METHOD CELL BIOL, V47, P31, DOI 10.1016/S0091-679X(08)60787-6; SANAGUSTIN JT, 1994, CELL MOTIL CYTOSKEL, V27, P206, DOI 10.1002/cm.970270303; SANAGUSTIN JT, 1995, METHOD CELL BIOL, V47, P135, DOI 10.1016/S0091-679X(08)60801-8; SCHAGGER H, 1986, METHOD ENZYMOL, V126, P224; Scott JD, 1997, SOC GEN PHY, V52, P227; SCOTT JD, 1994, MOL ENDOCRINOL, V8, P5, DOI 10.1210/me.8.1.5; SHOJI S, 1979, J BIOL CHEM, V254, P6211; SHOWERS MO, 1986, J BIOL CHEM, V261, P6288; SODERLING TR, 1990, J BIOL CHEM, V265, P1823; TASH JS, 1982, BIOL REPROD, V26, P745, DOI 10.1095/biolreprod26.4.745; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; TAYLOR SS, 1989, J BIOL CHEM, V264, P8443; THOMIS DC, 1992, J BIOL CHEM, V267, P10723; UHLER MD, 1986, J BIOL CHEM, V261, P5360; Vijayaraghavan S, 1997, BIOL REPROD, V56, P1450, DOI 10.1095/biolreprod56.6.1450; WIEMANN S, 1991, J BIOL CHEM, V266, P5140; Yanagimachi R., 1994, Zygote, V2, P371; YEUNG CH, 1984, GAMETE RES, V9, P99, DOI 10.1002/mrd.1120090109; YONEMOTO W, 1993, J BIOL CHEM, V268, P2348; ZHENG JH, 1993, PROTEIN SCI, V2, P1559, DOI 10.1002/pro.5560021003	55	58	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24874	24883		10.1074/jbc.273.38.24874	http://dx.doi.org/10.1074/jbc.273.38.24874			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733793	hybrid			2022-12-27	WOS:000076007300085
J	Luongo, CL; Contreras, CM; Farsetta, DL; Nibert, ML				Luongo, CL; Contreras, CM; Farsetta, DL; Nibert, ML			Binding site for S-adenosyl-L-methionine in a central region of mammalian reovirus lambda 2 protein - Evidence for activities in mRNA CAP methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA CAPPING ENZYME; MESSENGER-RNA; VACCINIA VIRUS; TERMINAL REGION; GUANYLYLTRANSFERASE; PARTICLES; CORES; METHYLTRANSFERASE; IDENTIFICATION; LOCALIZATION	One or more proteins in mammalian reovirus core particles mediate two RNA methylation activities, (guanosine-7-N)-methyltransferase and (guanosine-2'-O)-methyltransferase, that contribute to forming the 5' cap 1 structure on viral mRNA, We used UV irradiation to identify core proteins that bind S-adenosyl-L-methionine (SAM), the methyl-group donor for both methyltransferases. A [methyl-H-3]SAM-binding site was observed among the reovirus lambda proteins; was shown to be specific by competition with low levels of S-adenosyl-L-homocysteine, the product of methyl-group transfer from SAM; and was subsequently localized to protein lambda 2, lambda 2 mediates the guanylyltransferase reaction in cap formation and was previously proposed to mediate one or both methylation reactions as well. SAM binding was demonstrated for both lambda 2 in cores and lambda 2 expressed in insect cells from a recombinant baculovirus. Using three different methods to cleave lambda 2, a binding site for SAM was tentatively localized to a central region of lambda 2, between residues 792 and 1100, which includes a smaller region with sequence similarity to the SAM-binding pocket of other methyltransferases. Alanine substitutions at positions 827 and 829 within this predicted binding region greatly reduced the capacity of baculovirus-expressed lambda 2 protein to undergo UV cross-linking to SARI but had no effects on either the guanylyltransferase activity of this protein or its conformation as judged by partial proteolysis, suggesting that one or both of these residues is essential for SAM binding. Based on these findings, we propose that the two methyltransferase activities involved in mRNA capping by reovirus cores utilize a single SAM-binding pocket within a central region of lambda 2.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA; Univ Wisconsin, Cell & Mol Biol Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Nibert, ML (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53706 USA.	mlnibert@facstaff.wisc.edu	Contreras, Carlos M./AAZ-3345-2020		NCI NIH HHS [T32 CA09075] Funding Source: Medline; NIAID NIH HHS [R29 AI39533] Funding Source: Medline; NIGMS NIH HHS [T32 GM08349] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI039533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008349] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahola T, 1997, J VIROL, V71, P392, DOI 10.1128/JVI.71.1.392-397.1997; ANDERS DG, 1983, J VIROL, V48, P197, DOI 10.1128/JVI.48.1.197-205.1983; BANERJEE AK, 1971, NATURE-NEW BIOL, V230, P169, DOI 10.1038/newbio230169a0; Bisaillon M, 1997, J BIOL CHEM, V272, P18298, DOI 10.1074/jbc.272.29.18298; Bisaillon M, 1997, J BIOL CHEM, V272, P29954, DOI 10.1074/jbc.272.47.29954; CASHDOLLAR LW, 1984, VIROLOGY, V133, P191, DOI 10.1016/0042-6822(84)90438-0; Centonze VE, 1995, J STRUCT BIOL, V115, P215, DOI 10.1006/jsbi.1995.1046; CLEVELAND DR, 1986, J VIROL, V60, P307, DOI 10.1128/JVI.60.1.307-311.1986; Dryden KA, 1998, VIROLOGY, V245, P33, DOI 10.1006/viro.1998.9146; DRYDEN KA, 1993, J CELL BIOL, V122, P1023, DOI 10.1083/jcb.122.5.1023; FAUSNAUGH J, 1990, J BIOL CHEM, V265, P7669; FURLONG DB, 1988, J VIROL, V62, P246, DOI 10.1128/JVI.62.1.246-256.1988; FURUICHI Y, 1976, J BIOL CHEM, V251, P5043; FURUICHI Y, 1975, P NATL ACAD SCI USA, V72, P362, DOI 10.1073/pnas.72.1.362; FURUICHI Y, 1976, P NATL ACAD SCI USA, V73, P3448, DOI 10.1073/pnas.73.10.3448; HIGMAN MA, 1994, J BIOL CHEM, V269, P14982; KOONIN EV, 1993, J GEN VIROL, V74, P733, DOI 10.1099/0022-1317-74-4-733; LANGE C, 1991, NATURE, V352, P645, DOI 10.1038/352645a0; Liao HJ, 1997, VIROLOGY, V228, P19, DOI 10.1006/viro.1996.8365; Luongo CL, 1997, J VIROL, V71, P8035, DOI 10.1128/JVI.71.10.8035-8040.1997; MAO XD, 1995, MOL CELL BIOL, V15, P4167; MAO ZX, 1991, VIROLOGY, V185, P377, DOI 10.1016/0042-6822(91)90785-A; NIBERT ML, 1992, J VIROL, V66, P6408, DOI 10.1128/JVI.66.11.6408-6418.1992; Noble S, 1997, J VIROL, V71, P2182, DOI 10.1128/JVI.71.3.2182-2191.1997; Noble S, 1997, J VIROL, V71, P7728, DOI 10.1128/JVI.71.10.7728-7735.1997; RALPH SJ, 1980, J VIROL, V36, P894, DOI 10.1128/JVI.36.3.894-896.1980; SCHNIERLE BS, 1992, P NATL ACAD SCI USA, V89, P2897, DOI 10.1073/pnas.89.7.2897; SELIGER LS, 1987, J BIOL CHEM, V262, P16289; SHATKIN AJ, 1974, P NATL ACAD SCI USA, V71, P3204, DOI 10.1073/pnas.71.8.3204; SHATKIN AJ, 1983, REOVIRIDAE, P79; SHUMAN S, 1995, MOL MICROBIOL, V17, P405, DOI 10.1111/j.1365-2958.1995.mmi_17030405.x; SHUMAN S, 1990, METHOD ENZYMOL, V181, P170; SMITH RE, 1969, VIROLOGY, V39, P791, DOI 10.1016/0042-6822(69)90017-8; STARNES MC, 1993, VIROLOGY, V193, P356, DOI 10.1006/viro.1993.1132; VIRGIN HW, 1991, J VIROL, V65, P6772, DOI 10.1128/JVI.65.12.6772-6781.1991; WHITE CK, 1976, VIROLOGY, V70, P171, DOI 10.1016/0042-6822(76)90247-6; YAMAKAWA M, 1982, VIROLOGY, V118, P157, DOI 10.1016/0042-6822(82)90329-4	37	46	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23773	23780		10.1074/jbc.273.37.23773	http://dx.doi.org/10.1074/jbc.273.37.23773			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726986	hybrid			2022-12-27	WOS:000075893100027
J	Rameh, LE; Rhee, SG; Spokes, K; Kazlauskas, A; Cantley, LC; Cantley, LG				Rameh, LE; Rhee, SG; Spokes, K; Kazlauskas, A; Cantley, LC; Cantley, LG			Phosphoinositide 3-kinase regulates phospholipase C gamma-mediated calcium signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR-BETA; PROTEIN-KINASE-B; GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; LYSOPHOSPHATIDIC ACID; HOMOLOGY DOMAINS; LIPID PRODUCTS; CROSS-LINKING; ACTIVATION; WORTMANNIN	It has been demonstrated that the lipid products of the phosphoinositide a-kinase (PI3K) can associate with the Src homology 2 (SH2) domains of specific signaling molecules and modify their actions. In the current experiments, phosphatidylinositol 3,4,5-trisphosphate (Pt-dIns-3,4,5-P-3) was found to bind to the C-terminal SH2 domain of phospholipase C gamma (PLC gamma) with an apparent K-d of 2.4 pra and to displace the C-terminal SH2 domain from the activated platelet-derived growth factor receptor (PDGFR). To investigate the in vivo relevance of this observation, intracellular inositol trisphosphate (IP3) generation and calcium release were examined in HepGB cells expressing a series of PDGFR mutants that activate PLC gamma with or without receptor association with PI3K. Coactivation of PLC gamma and PI3K resulted in an similar to 40% increase in both intracellular IF, generation and intracellular calcium release as compared with selective activation of PLC gamma. Similarly, the addition of wortmannin or LY294002 to cells expressing the wild-type PDGFR inhibited the release of intracellular calcium. Thus, generation of PtdIns-3,4,5-P-3 by receptor-associated PI3K causes an increase in IP3 production and intracellular calcium release, potentially via enhanced PtdIns-4,5-P-2 substrate availability due to PtdIns-3,4,5-P-3-mediated recruitment of PLC gamma to the lipid bilayer.	Harvard Univ, Sch Med, Div Nephrol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Div Signal Transduct, Boston, MA 02215 USA; Schepens Eye Res Inst, Boston, MA 02114 USA; NHLBI, Lab Cell Signaling, NIH, Bethesda, MD 20892 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Schepens Eye Research Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Cantley, LG (corresponding author), Harvard Univ, Sch Med, Div Nephrol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.		Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041890, R01GM048339, R37GM041890] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK48871] Funding Source: Medline; NIGMS NIH HHS [GM48339, GM41890, R01 GM041890] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Bae YS, 1998, J BIOL CHEM, V273, P4465, DOI 10.1074/jbc.273.8.4465; BARKER SA, 1995, MOL BIOL CELL, V6, P1145, DOI 10.1091/mbc.6.9.1145; BONSER RW, 1991, BRIT J PHARMACOL, V103, P1237, DOI 10.1111/j.1476-5381.1991.tb12330.x; CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117; Derman MP, 1996, J BIOL CHEM, V271, P4251; Derman MP, 1997, J BIOL CHEM, V272, P6465, DOI 10.1074/jbc.272.10.6465; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; JALINK K, 1990, J BIOL CHEM, V265, P12232; KAZLAUSKAS A, 1993, P NATL ACAD SCI USA, V90, P6939, DOI 10.1073/pnas.90.15.6939; KAZLAUSKAS A, 1992, MOL CELL BIOL, V12, P2534, DOI 10.1128/MCB.12.6.2534; Klarlund JK, 1998, J BIOL CHEM, V273, P1859, DOI 10.1074/jbc.273.4.1859; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; KUNDRA V, 1994, NATURE, V367, P474, DOI 10.1038/367474a0; NAKANISHI S, 1994, J BIOL CHEM, V269, P6528; RAMEH LE, 1995, CELL, V83, P821, DOI 10.1016/0092-8674(95)90195-7; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Sambrook J., 2002, MOL CLONING LAB MANU; SECKL MJ, 1994, CANCER RES, V54, P6143; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; TOKER A, 1994, J BIOL CHEM, V269, P32358; VALIUS M, 1993, MOL CELL BIOL, V13, P133, DOI 10.1128/MCB.13.1.133; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; Vossebeld PJM, 1997, BIOCHEM J, V323, P87, DOI 10.1042/bj3230087; Wang DS, 1996, J ORG CHEM, V61, P5905, DOI 10.1021/jo960602u	28	193	195	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23750	23757		10.1074/jbc.273.37.23750	http://dx.doi.org/10.1074/jbc.273.37.23750			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726983	hybrid			2022-12-27	WOS:000075893100024
J	Vasilyeva, E; Forgac, M				Vasilyeva, E; Forgac, M			Interaction of the clathrin-coated vesicle V-ATPase with ADP and sodium azide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATING ADENOSINE-TRIPHOSPHATASE; VACUOLAR H+-ATPASE; NUCLEOTIDE-BINDING-SITES; PROTON PUMP; SACCHAROMYCES-CEREVISIAE; NONCATALYTIC SITES; STRUCTURAL-CHANGES; NEUROSPORA-CRASSA; MEMBRANE ATPASES; CDNA SEQUENCE	The kinetics of adenosine triphosphate (ATP)-dependent proton transport into clathrin-coated vesicles from bovine brain have been studied. We observe that the vacuolar proton-translocating ATPase (V-ATPase) from clathrin-coated vesicles is subject to two different types of inhibition by ADP. The first is competitive inhibition with respect to ATP, with a K-i for ADP of 11 mu M. The second type of inhibition occurs after preincubation of the V-ATPase in the presence of ADP and Mg2+, which results in inhibition of the initial rate of proton transport followed by reactivation over the course of several minutes. The second effect is observed at ADP concentrations as low as 0.1-0.2 mu M, indicating that a high affinity inhibitory complex is formed between ADP and the V-ATPase and is only slowly dissociated after the addition of ATP. We have further investigated the effect of sodium azide, an inhibitor of the F-ATPases that has been shown to stabilize an inactive complex between ADP and the F-1-F-0-ATP synthase (F-ATPase), We observed that azide inhibited ATP-dependent proton transport by the purified, reconstituted V-ATPase with a K-0.5 of 0.2-0.4 mw but had no effect on ATP hydrolysis. Azide was shown not to increase the passive proton permeability of reconstituted vesicles and did not stimulate ATP hydrolysis by the reconstituted enzyme, in contrast with CCCP, which both abolished the proton gradient and stimulated hydrolysis, Thus, azide does not appear to act as a simple uncoupler of proton transport and ATP hydrolysis. Rather, azide may have some more direct effect on V-ATPase activity. Possible mechanisms by which azide could exert this effect on the V-ATPase and the contrasting effects of azide on the F- and V-ATPases are discussed.	Tufts Univ, Sch Med, Dept Cellular & Mol Physiol, Boston, MA 02111 USA	Tufts University	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Cellular & Mol Physiol, 136 Harrison Ave, Boston, MA 02111 USA.	mforgac@opal.tufts.edu			NIGMS NIH HHS [GM 34478, R01 GM034478] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034478, R37GM034478] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADACHI I, 1990, J BIOL CHEM, V265, P960; ANRAKU Y, 1992, J BIOENERG BIOMEMBR, V24, P395, DOI 10.1007/BF00762532; ARAI H, 1987, J BIOL CHEM, V262, P11006; ARAI H, 1987, BIOCHEMISTRY-US, V26, P6632, DOI 10.1021/bi00395a011; ARAI H, 1989, BIOCHEMISTRY-US, V28, P3075, DOI 10.1021/bi00433a051; BOWMAN BJ, 1992, J BIOENERG BIOMEMBR, V24, P361, DOI 10.1007/BF00762529; BOWMAN EJ, 1983, J BIOL CHEM, V258, P5238; BOWMAN EJ, 1988, J BIOL CHEM, V263, P13994; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; Capaldi RA, 1996, J BIOENERG BIOMEMBR, V28, P397, DOI 10.1007/BF02113980; Cross RL, 1996, J BIOENERG BIOMEMBR, V28, P403, DOI 10.1007/BF02113981; DAVID P, 1994, J BIOL CHEM, V269, P30158; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; FELDMAN RI, 1985, J BIOL CHEM, V260, P3088; Fillingame RH, 1997, J EXP BIOL, V200, P217; FORGAC M, 1983, P NATL ACAD SCI-BIOL, V80, P1300, DOI 10.1073/pnas.80.5.1300; FORGAC M, 1986, BIOCHEMISTRY-US, V25, P4275, DOI 10.1021/bi00363a015; FORGAC M, 1982, J BIOL CHEM, V257, P5652; Futai M, 1996, J BIOENERG BIOMEMBR, V28, P409, DOI 10.1007/BF02113982; GLUCK SL, 1992, J BIOENERG BIOMEMBR, V24, P351, DOI 10.1007/BF00762528; HUANG CS, 1983, BIOCHIM BIOPHYS ACTA, V722, P107, DOI 10.1016/0005-2728(83)90163-9; HYNDMAN DJ, 1994, J BIOL CHEM, V269, P28871; JAULT JM, 1994, J BIOL CHEM, V269, P319; KAKINUMA Y, 1981, J BIOL CHEM, V256, P859; KANE PM, 1992, J BIOENERG BIOMEMBR, V24, P383, DOI 10.1007/BF00762531; KASHO VN, 1989, P NATL ACAD SCI USA, V86, P8708, DOI 10.1073/pnas.86.22.8708; KIBAK H, 1992, J BIOENERG BIOMEMBR, V24, P415, DOI 10.1007/BF00762534; KIBAK H, 1993, J BIOL CHEM, V268, P23325; KOBAYASHI H, 1977, J BIOCHEM-TOKYO, V81, P1071, DOI 10.1093/oxfordjournals.jbchem.a131530; MANDEL M, 1988, P NATL ACAD SCI USA, V85, P5521, DOI 10.1073/pnas.85.15.5521; MILGROM YM, 1993, J BIOL CHEM, V268, P23179; MORIYAMA Y, 1987, J BIOL CHEM, V262, P14723; MUNEYUKI E, 1993, BIOCHIM BIOPHYS ACTA, V1144, P62, DOI 10.1016/0005-2728(93)90031-A; MURATALIEV MB, 1991, BIOCHEMISTRY-US, V30, P8305, DOI 10.1021/bi00098a004; NELSON N, 1992, J BIOENERG BIOMEMBR, V24, P407, DOI 10.1007/BF00762533; Pedersen PL, 1996, J BIOENERG BIOMEMBR, V28, P389, DOI 10.1007/BF02113979; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; ROBERTSON H. E., 1955, JOUR BIOL CHEM, V214, P295; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; STONE DK, 1982, J BIOL CHEM, V258, P4059; SZE H, 1992, J BIOENERG BIOMEMBR, V24, P371, DOI 10.1007/BF00762530; UCHIDA E, 1988, J BIOL CHEM, V263, P45; UCHIDA E, 1988, METHOD ENZYMOL, V157, P544; Vasilyeva E, 1996, J BIOL CHEM, V271, P12775, DOI 10.1074/jbc.271.22.12775; VASILYEVA EA, 1982, BIOCHEM J, V202, P15, DOI 10.1042/bj2020015; VASILYEVA EA, 1982, BIOCHEM J, V202, P1; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; WEBSTER LC, 1995, EUR J BIOCHEM, V232, P586; Webster LC, 1996, EUR J BIOCHEM, V240, P156, DOI 10.1111/j.1432-1033.1996.0156h.x; XIE XS, 1988, J BIOL CHEM, V263, P9859; XIE XS, 1988, METHOD ENZYMOL, V157, P634; ZHANG JM, 1995, J BIOL CHEM, V270, P15494, DOI 10.1074/jbc.270.26.15494; ZHANG JM, 1992, J BIOL CHEM, V267, P9773; ZIMNIAK L, 1988, J BIOL CHEM, V263, P9102	55	28	31	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23823	23829		10.1074/jbc.273.37.23823	http://dx.doi.org/10.1074/jbc.273.37.23823			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726993	hybrid			2022-12-27	WOS:000075893100034
J	Anders, RA; Dore, JE; Arline, SL; Garamszegi, N; Leof, EB				Anders, RA; Dore, JE; Arline, SL; Garamszegi, N; Leof, EB			Differential requirement for type I and type II transforming growth factor beta receptor kinase activity in ligand-mediated receptor endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE THREONINE KINASE; TGF-BETA; HETEROOLIGOMERIC COMPLEXES; SIGNAL-TRANSDUCTION; INSULIN-RECEPTOR; TYROSINE KINASE; INDUCED INTERNALIZATION; HOMOMERIC INTERACTIONS; SMAD PROTEINS; GS DOMAIN	Transforming growth factor beta (TGF beta) superfamily polypeptides regulate cell growth and differentiation by binding to single pass serine/threonine kinases referred to as TGF beta type I and type II receptors, Signal propagation is dependent upon heteromeric (type I-type II) complex formation and transphosphorylation of the type I receptor by the type II receptor. While many of the phosphorylation events necessary for receptor signaling have recently been characterized, the role of TGF beta receptor kinase activity in modulating receptor endocytosis has not been addressed. To that end, we have used chimeric receptors consisting of the extracellular domain of the granulocyte/macrophage colony-stimulating factor alpha and beta receptors spliced to the TGF beta type I and type II transmembrane and cytoplasmic domains to address the specific role of type I and/or type II receptor kinase activity in TGF beta receptor internalization, downregulation, and signaling. To inactivate chimeric receptor kinase activity, point mutations in the ATP binding site were made at amino acids 232 and 277 in the type I and type II receptor, respectively. Either of these mutations abolished plasminogen activator inhibitor 1 protein expression stimulated by granulocyte/macrophage colony-stimulating factor activation of chimeric heteromeric type I-type II TGF beta receptors, They did not, how ever, modulate TGF beta signaling stimulated through the endogenous TGF beta receptor. Although TGF beta receptor signaling was dependent upon the kinase activity of both chimeric receptors, the initial endocytic response was distinctly regulated by type I and/or type II receptor kinase activity. For instance, while heteromeric receptor complexes containing a kinase-inactive type I receptor were endocytosed similarly to wild type complexes, the kinase activity of the type II TGF beta receptor was necessary for optimal internalization and receptor down-regulation. Furthermore, these responses were shown to occur independently of type II receptor autophosphorylation but require a type II receptor capable of transphosphorylation.	Mayo Clin & Mayo Fdn, Thorac Res Unit, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Leof, EB (corresponding author), Mayo Clin & Mayo Fdn, Thorac Res Unit, Guggenheim 642C, Rochester, MN 55905 USA.				NIGMS NIH HHS [GM 54200, GM 55816] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM055816, R01GM055816, R01GM054200] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anders RA, 1997, MOL BIOL CELL, V8, P2133, DOI 10.1091/mbc.8.11.2133; Anders RA, 1996, J BIOL CHEM, V271, P21758, DOI 10.1074/jbc.271.36.21758; Bottinger EP, 1997, EMBO J, V16, P2621, DOI 10.1093/emboj/16.10.2621; BRAND T, 1993, J BIOL CHEM, V268, P11500; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; CARCAMO J, 1995, MOL CELL BIOL, V15, P1573; CARPENTIER JL, 1995, J BIOL CHEM, V270, P5001, DOI 10.1074/jbc.270.10.5001; CHANG CP, 1993, J BIOL CHEM, V268, P19312; CHEN RH, 1995, J BIOL CHEM, V270, P12235, DOI 10.1074/jbc.270.20.12235; CHEN RH, 1994, J BIOL CHEM, V269, P22868; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; CHOI ME, 1995, J BIOL CHEM, V270, P21144, DOI 10.1074/jbc.270.36.21144; deCaestecker MP, 1997, J BIOL CHEM, V272, P13690, DOI 10.1074/jbc.272.21.13690; FRANZEN P, 1995, BIOCHEM BIOPH RES CO, V207, P682, DOI 10.1006/bbrc.1995.1241; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; FROLIK CA, 1984, J BIOL CHEM, V259, P995; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; HENIS YI, 1994, J CELL BIOL, V126, P139, DOI 10.1083/jcb.126.1.139; KAWABATA M, 1995, J BIOL CHEM, V270, P5625, DOI 10.1074/jbc.270.10.5625; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; LAMAZE C, 1995, CURR OPIN CELL BIOL, V7, P573, DOI 10.1016/0955-0674(95)80015-8; LAMAZE C, 1995, J CELL BIOL, V129, P47, DOI 10.1083/jcb.129.1.47; LARKIN JM, 1983, CELL, V33, P273, DOI 10.1016/0092-8674(83)90356-2; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; Luo KX, 1996, EMBO J, V15, P4485, DOI 10.1002/j.1460-2075.1996.tb00826.x; Luo KX, 1997, EMBO J, V16, P1970, DOI 10.1093/emboj/16.8.1970; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; Massague J, 1997, TRENDS CELL BIOL, V7, P187, DOI 10.1016/S0962-8924(97)01036-2; MASSAGUE J, 1985, CANCER CELL, V3, P73; Moses HL, 1996, CURR OPIN GENET DEV, V6, P581, DOI 10.1016/S0959-437X(96)80087-6; MOUSTAKAS A, 1993, J BIOL CHEM, V268, P22215; Muramatsu M, 1997, MOL BIOL CELL, V8, P469, DOI 10.1091/mbc.8.3.469; Nakao A, 1997, J BIOL CHEM, V272, P2896, DOI 10.1074/jbc.272.5.2896; NESTEROV A, 1995, P NATL ACAD SCI USA, V92, P8719, DOI 10.1073/pnas.92.19.8719; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; RAJAGOPALAN M, 1995, BIOCHEM BIOPH RES CO, V211, P714, DOI 10.1006/bbrc.1995.1871; RAJAGOPALAN M, 1991, J BIOL CHEM, V266, P23068; Saitoh M, 1996, J BIOL CHEM, V271, P2769, DOI 10.1074/jbc.271.5.2769; SCHMID SL, 1992, BIOESSAYS, V14, P589, DOI 10.1002/bies.950140903; SORKIN A, 1995, J BIOL CHEM, V270, P619, DOI 10.1074/jbc.270.2.619; SORKIN A, 1993, BIOESSAYS, V15, P375, DOI 10.1002/bies.950150603; Souchelnytskyi S, 1996, EMBO J, V15, P6231, DOI 10.1002/j.1460-2075.1996.tb01013.x; tenDijke P, 1996, CURR OPIN CELL BIOL, V8, P139; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; WeisGarcia F, 1996, EMBO J, V15, P276, DOI 10.1002/j.1460-2075.1996.tb00358.x; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; WILEY HS, 1991, J BIOL CHEM, V266, P11083; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wu RY, 1997, MOL CELL BIOL, V17, P2521, DOI 10.1128/MCB.17.5.2521; YAMASHITA H, 1994, J BIOL CHEM, V269, P20172; Yingling JM, 1996, P NATL ACAD SCI USA, V93, P8940, DOI 10.1073/pnas.93.17.8940; ZHAO J, 1995, CANCER RES, V55, P6181; Zhao Y, 1996, J BIOL CHEM, V271, P2369, DOI 10.1074/jbc.271.5.2369	56	48	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23118	23125		10.1074/jbc.273.36.23118	http://dx.doi.org/10.1074/jbc.273.36.23118			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722540	hybrid			2022-12-27	WOS:000075778100040
J	Hoshi, N; Takahashi, H; Shahidullah, M; Yokoyama, S; Higashida, H				Hoshi, N; Takahashi, H; Shahidullah, M; Yokoyama, S; Higashida, H			KCR1, a membrane protein that facilitates functional expression of non-inactivating K+ currents associates with rat EAG voltage-dependent K+ channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBELLAR GRANULE NEURONS; CARDIAC POTASSIUM CURRENT; ACTIVATION; PATTERNS; RECEPTOR; BRAIN; GENE; SUBFAMILIES; K(V)LQT1; CLONING	Cerebellar granule neurons possess a non-inactivating K+ current, which controls resting membrane potentials and modulates the firing rate by means of muscarinic agonists. kcr1 was cloned from the cerebellar cDNA library by suppression cloning. KCR1 is a novel protein with 12 putative transmembrane domains and enhances the functional expression of the cerebellar non-inactivating K+ current in Xenopus oocytes, KCR1 also accelerates the activation of rat EAG K+ channels expressed in Xenopus oocytes or in COS-7 cells. Far-Western blotting revealed that KCR1 and EAG proteins interacted with each other by means of their C-terminal regions. These results suggest that KCR1 is the regulatory component of non-inactivating K+ channels.	Kanazawa Univ, Grad Sch Med, Dept Biophys Genet, Kanazawa, Ishikawa 9208640, Japan	Kanazawa University	Hoshi, N (corresponding author), Kanazawa Univ, Grad Sch Med, Dept Biophys Genet, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	biophys@med.kanazawa-u.ac.jp	higashida, haruhiro/L-3773-2015	higashida, haruhiro/0000-0002-1779-0606				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; BROWN D, 1988, TRENDS NEUROSCI, V11, P294, DOI 10.1016/0166-2236(88)90089-6; CULLCANDY SG, 1989, J PHYSIOL-LONDON, V414, P179, DOI 10.1113/jphysiol.1989.sp017683; DREWE JA, 1992, J NEUROSCI, V12, P538; FLORMAN HM, 1985, CELL, V41, P313, DOI 10.1016/0092-8674(85)90084-4; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GUNDERSEN CB, 1992, NEURON, V9, P527, DOI 10.1016/0896-6273(92)90190-O; HANSEN JE, 1995, BIOCHEM J, V308, P801, DOI 10.1042/bj3080801; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HIGASHIDA H, 1986, NATURE, V323, P333, DOI 10.1038/323333a0; Hille B., 1992, IONIC CHANNELS EXCIT, V2 ed, P115; HOGER JH, 1991, MOL BRAIN RES, V10, P1, DOI 10.1016/0169-328X(91)90050-8; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LUDWIG J, 1994, EMBO J, V13, P4451, DOI 10.1002/j.1460-2075.1994.tb06767.x; Marrion NV, 1997, TRENDS NEUROSCI, V20, P243; MASTROGIACOMO A, 1994, SCIENCE, V263, P981, DOI 10.1126/science.7906056; Mathie A, 1997, TRENDS NEUROSCI, V20, P14, DOI 10.1016/S0166-2236(96)20057-8; McDonald TV, 1997, NATURE, V388, P289, DOI 10.1038/40882; MCKINNON D, 1989, J BIOL CHEM, V264, P8230; NIKAWA J, 1995, MOL MICROBIOL, V16, P301, DOI 10.1111/j.1365-2958.1995.tb02302.x; PETERSON GL, 1986, BIOCHEMISTRY-US, V25, P3189, DOI 10.1021/bi00359a017; ROSENBERG RL, 1992, NATURE, V360, P166, DOI 10.1038/360166a0; RUDY B, 1992, P NATL ACAD SCI USA, V89, P4603, DOI 10.1073/pnas.89.10.4603; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SHAHIDULLAH M, 1995, P ROY SOC B-BIOL SCI, V261, P309, DOI 10.1098/rspb.1995.0152; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; SIEGELBAUM SA, 1982, NATURE, V299, P413, DOI 10.1038/299413a0; Stansfeld C, 1997, TRENDS NEUROSCI, V20, P13, DOI 10.1016/S0166-2236(96)20058-X; STORM JF, 1990, PROG BRAIN RES, V83, P161; Terlau H, 1996, PFLUG ARCH EUR J PHY, V432, P301, DOI 10.1007/s004240050137; WARMKE J, 1991, SCIENCE, V252, P1560, DOI 10.1126/science.1840699; Watkins CS, 1996, J PHYSIOL-LONDON, V491, P401, DOI 10.1113/jphysiol.1996.sp021224; WOLD F, 1981, ANNU REV BIOCHEM, V50, P783, DOI 10.1146/annurev.bi.50.070181.004031; YOKOYAMA S, 1989, FEBS LETT, V259, P37, DOI 10.1016/0014-5793(89)81488-7; ZHAO B, 1994, NEURON, V13, P1205, DOI 10.1016/0896-6273(94)90058-2	37	40	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23080	23085		10.1074/jbc.273.36.23080	http://dx.doi.org/10.1074/jbc.273.36.23080			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722534	hybrid			2022-12-27	WOS:000075778100034
J	Kolhekar, AS; Quon, ASW; Berard, CA; Mains, RE; Eipper, BA				Kolhekar, AS; Quon, ASW; Berard, CA; Mains, RE; Eipper, BA			Post-translational N-glycosylation of a truncated form of a peptide processing enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMIDATING MONOOXYGENASE; INTEGRAL MEMBRANE-PROTEIN; LINKED OLIGOSACCHARIDES; ENDOPLASMIC-RETICULUM; HYDROXYLATING MONOOXYGENASE; SECRETORY GRANULES; CATALYTIC CORE; ATT-20 CELLS; ACTIVE-SITE; PROHORMONE	Peptidylglycine alpha-amidating monooxygenase (PAM) catalyzes the carboxyl-terminal amidation of bioactive peptides through a two-step reaction involving the monooxygenase and lyase domains. PAM undergoes endoproteolytic cleavage in neuroendocrine cells in the lyase domain. To determine which of the two possible paired basic sites is utilized, truncated PAM proteins ending at these sites were stably expressed in Chinese hamster ovary cells. While characterizing the truncation mutants, it became apparent that N-glycosylation occurred post-translationally at the single site localized near the carboxyl terminus of the lyase domain. The post-translational N-glycosylation of this site does not require the newly synthesized protein to remain tightly bound to membranes. Both malfolded, secretion incompetent proteins and fully active, secreted proteins were subject to post-translational N-glycosylation.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Eipper, BA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 907 WBSB,725 N Wolfe St, Baltimore, MD 21205 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK032949, R56DK032949, R01DK032949] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK32949] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; BLOOMQUIST BT, 1993, CELL PHYSIOL BIOCHEM, V3, P197, DOI 10.1159/000154684; BRADBURY AF, 1991, TRENDS BIOCHEM SCI, V16, P112, DOI 10.1016/0968-0004(91)90044-V; BULLEID NJ, 1992, BIOCHEM J, V286, P275, DOI 10.1042/bj2860275; EIPPER BA, 1995, BIOCHEMISTRY-US, V34, P2857, DOI 10.1021/bi00009a016; EIPPER BA, 1992, J BIOL CHEM, V267, P4008; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; EIPPER BA, 1991, J BIOL CHEM, V266, P7827; EIPPER BA, 1993, PROTEIN SCI, V2, P489; FENG W, 1995, J BIOL CHEM, V270, P11851, DOI 10.1074/jbc.270.20.11851; FIEDLER K, 1995, CELL, V81, P309, DOI 10.1016/0092-8674(95)90380-1; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; GEETHAHABIB M, 1990, J BIOL CHEM, V265, P13655; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GILMORE R, 1985, CELL, V42, P497, DOI 10.1016/0092-8674(85)90107-2; GLABE CG, 1980, J BIOL CHEM, V255, P9236; GUAN JL, 1985, CELL, V42, P489, DOI 10.1016/0092-8674(85)90106-0; Hauser F, 1997, BIOCHEM BIOPH RES CO, V241, P509, DOI 10.1006/bbrc.1997.7854; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; HUSTEN EJ, 1993, J BIOL CHEM, V268, P9709; HUSTEN EJ, 1994, ARCH BIOCHEM BIOPHYS, V312, P487, DOI 10.1006/abbi.1994.1336; JETHMALANI SM, 1994, J BIOL CHEM, V269, P23603; KAPLAN HA, 1987, BIOCHIM BIOPHYS ACTA, V906, P161, DOI 10.1016/0304-4157(87)90010-4; KATOPODIS AG, 1990, BIOCHEMISTRY-US, V29, P6115, DOI 10.1021/bi00478a001; Kolhekar AS, 1997, BIOCHEMISTRY-US, V36, P10901, DOI 10.1021/bi9708747; Kolhekar AS, 1997, J NEUROSCI, V17, P1363, DOI 10.1523/jneurosci.17-04-01363.1997; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Lehmann S, 1997, J BIOL CHEM, V272, P21479, DOI 10.1074/jbc.272.34.21479; Lindberg I., 1995, METH NEUROSCI, V23, P94; MALTESE JY, 1993, ENDOCRINOLOGY, V133, P2579, DOI 10.1210/en.133.6.2579; MATHIS JP, 1992, ENDOCRINOLOGY, V131, P2287, DOI 10.1210/en.131.5.2287; Milgram SL, 1996, J BIOL CHEM, V271, P17526, DOI 10.1074/jbc.271.29.17526; MILGRAM SL, 1994, J CELL BIOL, V124, P33, DOI 10.1083/jcb.124.1.33; MILGRAM SL, 1992, J CELL BIOL, V117, P717, DOI 10.1083/jcb.117.4.717; MILLER DA, 1992, ARCH BIOCHEM BIOPHYS, V298, P380, DOI 10.1016/0003-9861(92)90425-V; NILSSON I, 1993, J BIOL CHEM, V268, P5798; NOGUCHI M, 1992, BIOCHEM J, V283, P883, DOI 10.1042/bj2830883; Prigge ST, 1997, SCIENCE, V278, P1300, DOI 10.1126/science.278.5341.1300; RONNETT GV, 1981, J BIOL CHEM, V256, P4704; ROUILLE Y, 1995, FRONT NEUROENDOCRIN, V16, P322, DOI 10.1006/frne.1995.1012; SCHULKE N, 1988, J BIOL CHEM, V263, P8832; SEIDAH NG, 1993, BIOCHEM SOC T, V21, P685, DOI 10.1042/bst0210685; Silberstein S, 1996, FASEB J, V10, P849, DOI 10.1096/fasebj.10.8.8666161; TIKKANEN R, 1995, DNA CELL BIOL, V14, P305, DOI 10.1089/dna.1995.14.305; Whitley P, 1996, J BIOL CHEM, V271, P6241, DOI 10.1074/jbc.271.11.6241; YUN HY, 1993, ARCH BIOCHEM BIOPHYS, V301, P77, DOI 10.1006/abbi.1993.1117; YUN HY, 1995, J BIOL CHEM, V270, P15412, DOI 10.1074/jbc.270.25.15412; ZHOU A, 1994, J BIOL CHEM, V269, P17440	48	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23012	23018		10.1074/jbc.273.36.23012	http://dx.doi.org/10.1074/jbc.273.36.23012			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722525	hybrid			2022-12-27	WOS:000075778100025
J	May, JM; Cobb, CE; Mendiratta, S; Hill, KE; Burk, RF				May, JM; Cobb, CE; Mendiratta, S; Hill, KE; Burk, RF			Reduction of the ascorbyl free radical to ascorbate by thioredoxin reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT DEHYDROASCORBATE REDUCTASE; RAT-LIVER; HUMAN-ERYTHROCYTES; OXIDATIVE STRESS; SELENIUM DEFICIENCY; LIPID-PEROXIDATION; SELENOPROTEIN-W; VITAMIN-C; PURIFICATION; GLUTATHIONE	Recycling of ascorbic acid from its oxidized forms is required to maintain intracellular stores of the vitamin in most cells. Since the ubiquitous selenoenzyme thioredoxin reductase can recycle dehydroascorbic acid to ascorbate, we investigated the possibility that the enzyme can also reduce the one-electron-oxidized ascorbyl free radical to ascorbate, Purified rat liver thioredoxin reductase catalyzed the disappearance of NADPH in the presence of low micromolar concentrations of the ascorbyl free radical that were generated from ascorbate by ascorbate oxidase, and this effect was markedly stimulated by selenocystine, Dehydroascorbic acid is generated by dismutation of the ascorbyl free radical, and thioredoxin reductase can reduce dehydroascorbic acid to ascorbate. However, control studies showed that the amounts of dehydroascorbic acid generated under the assay conditions used were too low to account for the observed loss of NADPH. Electron paramagnetic resonance spectroscopy directly confirmed that the reductase decreased steady-state ascorbyl free radical concentrations, as expected if thioredoxin reductase reduces the ascorbyl free radical, Dialyzed cytosol from rat liver homogenates also catalyzed NADPH-dependent reduction of the ascorbyl free radical. Specificity for thioredoxin reductase was indicated by loss of activity in dialyzed cytosol prepared from livers of selenium-deficient rats, by inhibition with aurothioglucose at concentrations selective for thioredoxin reductase, and by stimulation with selenocystine. Microsomal fractions prepared from rat liver showed substantial NADH-dependent ascorbyl free radical reduction that was not sensitive to selenium depletion. These results suggest that thioredoxin reductase can function as a cytosolic ascorbyl free radical reductase that may complement cellular ascorbate recycling by membrane-bound NADH-dependent reductases.	Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Physiol & Mol Biophys, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	May, JM (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, 751 Med Res Bldg 2, Nashville, TN 37232 USA.				NIDDK NIH HHS [DK 50435, DK 26657] Funding Source: Medline; NIEHS NIH HHS [ES02497] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026657, R01DK050435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002497, R37ES002497] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BANDO M, 1994, JPN J OPHTHALMOL, V38, P1; BANDO M, 1988, JPN J OPHTHALMOL, V32, P176; BEHRENS WA, 1989, INT J VITAM NUTR RES, V59, P360; BIELSKI BHJ, 1975, ANN NY ACAD SCI, V258, P231, DOI 10.1111/j.1749-6632.1975.tb29283.x; BIELSKI BHJ, 1982, AM CHEM SOC ADV CHEM, V200, P81; BJORNSTEDT M, 1995, J BIOL CHEM, V270, P11761, DOI 10.1074/jbc.270.20.11761; BUETTNER GR, 1993, FREE RADICAL BIO MED, V14, P49, DOI 10.1016/0891-5849(93)90508-R; BURK RF, 1993, ANNU REV NUTR, V13, P65, DOI 10.1146/annurev.nu.13.070193.000433; BURK RF, 1975, ARCH BIOCHEM BIOPHYS, V170, P124, DOI 10.1016/0003-9861(75)90103-4; BURK RF, 1987, METHOD ENZYMOL, V143, P307; CLARK WM, 1960, OXIDATION REDUCTION, P467; DELBELLO B, 1994, BIOCHEM J, V304, P385, DOI 10.1042/bj3040385; ESAKI N, 1982, J BIOL CHEM, V257, P4386; Gladyshev VN, 1996, P NATL ACAD SCI USA, V93, P6146, DOI 10.1073/pnas.93.12.6146; Glinn MA, 1997, BBA-BIOENERGETICS, V1318, P246, DOI 10.1016/S0005-2728(96)00142-9; Guaiquil VH, 1997, J BIOL CHEM, V272, P9915; HARA T, 1971, J BIOCHEM-TOKYO, V69, P825; Hill KE, 1997, BIOCHEM BIOPH RES CO, V234, P293, DOI 10.1006/bbrc.1997.6618; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; Hou WC, 1997, PLANT SCI, V128, P151, DOI 10.1016/S0168-9452(97)00153-2; ITO A, 1981, BIOCHEM BIOPH RES CO, V101, P591, DOI 10.1016/0006-291X(81)91300-0; IYANAGI T, 1969, BIOCHIM BIOPHYS ACTA, V172, P370, DOI 10.1016/0005-2728(69)90133-9; KOBAYASHI K, 1991, BIOCHEMISTRY-US, V30, P8310, DOI 10.1021/bi00098a005; LUMPER L, 1967, H-S Z PHYSIOL CHEM, V348, P323, DOI 10.1515/bchm2.1967.348.1.323; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; MAELLARO E, 1994, BIOCHEM J, V301, P471, DOI 10.1042/bj3010471; May JM, 1997, J BIOL CHEM, V272, P22607, DOI 10.1074/jbc.272.36.22607; May JM, 1996, FREE RADICAL BIO MED, V20, P543, DOI 10.1016/0891-5849(95)02130-2; Morell S, 1997, FEBS LETT, V414, P567, DOI 10.1016/S0014-5793(97)01074-0; MUNDAY R, 1989, FREE RADICAL BIO MED, V7, P659, DOI 10.1016/0891-5849(89)90147-0; NIKI E, 1987, CHEM PHYS LIPIDS, V44, P227, DOI 10.1016/0009-3084(87)90052-1; NJUS D, 1991, FEBS LETT, V284, P147, DOI 10.1016/0014-5793(91)80672-P; Nordberg J, 1998, J BIOL CHEM, V273, P10835, DOI 10.1074/jbc.273.18.10835; OKAMURA M, 1979, J NUTR SCI VITAMINOL, V25, P269, DOI 10.3177/jnsv.25.269; PIETRI S, 1990, EUR J BIOCHEM, V193, P845, DOI 10.1111/j.1432-1033.1990.tb19408.x; ROGINSKY VA, 1994, FREE RADICAL BIO MED, V17, P93, DOI 10.1016/0891-5849(94)90107-4; ROSE RC, 1988, BIOCHIM BIOPHYS ACTA, V947, P335, DOI 10.1016/0304-4157(88)90014-7; SCHULER RH, 1977, RADIAT RES, V69, P417, DOI 10.2307/3574655; SCHULZ GE, 1978, NATURE, V273, P120, DOI 10.1038/273120a0; SCHULZE HU, 1970, H-S Z PHYSIOL CHEM, V351, P809, DOI 10.1515/bchm2.1970.351.2.809; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; VanDyke BR, 1996, FREE RADICAL BIO MED, V20, P985, DOI 10.1016/0891-5849(95)02186-8; VENDELAND SC, 1993, J BIOL CHEM, V268, P17103; WAGNER ES, 1987, BIOCHIM BIOPHYS ACTA, V902, P133, DOI 10.1016/0005-2736(87)90143-X; WELLS WW, 1995, METHOD ENZYMOL, V252, P30; WELLS WW, 1990, J BIOL CHEM, V265, P15361; WINKLER BS, 1994, FREE RADICAL BIO MED, V17, P333, DOI 10.1016/0891-5849(94)90019-1; Xu DP, 1996, BIOCHEM BIOPH RES CO, V221, P117, DOI 10.1006/bbrc.1996.0555; YAMAZAKI I, 1961, BIOCHIM BIOPHYS ACTA, V50, P62, DOI 10.1016/0006-3002(61)91060-5; YEH JY, 1995, FASEB J, V9, P392, DOI 10.1096/fasebj.9.5.7896009; YEW MS, 1983, HORM METAB RES, V15, P158, DOI 10.1055/s-2007-1018657; Zhon LW, 1998, J BIOL CHEM, V273, P8581, DOI 10.1074/jbc.273.15.8581	52	137	142	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23039	23045		10.1074/jbc.273.36.23039	http://dx.doi.org/10.1074/jbc.273.36.23039			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722529	hybrid			2022-12-27	WOS:000075778100029
J	Paik, SH; Chakicherla, A; Hansen, JN				Paik, SH; Chakicherla, A; Hansen, JN			Identification and characterization of the structural and transporter genes for, and the chemical and biological properties of, sublancin 168, a novel lantibiotic produced by Bacillus subtilis 168	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL MODIFICATION; ANTIMICROBIAL PROPERTIES; NISIN; SEQUENCE; ANTIBIOTICS; PEPTIDES; BIOSYNTHESIS; EXPRESSION; PRECURSOR; BACTERIA	An antimicrobial peptide produced by Bacillus subtilis 168 was isolated and characterized. It was named sublancin 168, and its behavior during Edman sequence analysis and its NMR spectrum suggested that sublancin is a dehydroalanine-containing lantibiotic, A hybridization probe based on the peptide sequence was used to clone the presublancin gene, which encoded a 56-residue polypeptide consisting of a 19-residue leader segment and a 37-residue mature segment. The mature segment contained one serine, one threonine, and five cysteine residues. Alkylation of mature sublancin showed no free sulfhydryl groups, suggesting that one sulfydryl had formed a beta-methyllanthionine bridge with a dehydrobutyrine derived by posttranslational modification of threonine; with the other four cysteines forming two disulfide bridges. It is unprecedented for a lantibiotic to contain a disulfide bridge. The sublancin leader was similar to known type AII lantibiotics, containing a double-glycine motif that is typically recognized by dual-function transporters. A protein encoded immediately downstream from the sublancin gene possessed features of a dual-function ABC transporter with a proteolytic domain and an ATP-binding domain. The antimicrobial activity spectrum of sublancin was like other lantibiotics, inhibiting Gram-positive bacteria but not Gram-negative bacteria; and like the lantibiotics nisin and subtilin in its ability to inhibit both bacterial spore outgrowth and vegetative growth. Sublancin is an extraordinarily stable lantibiotic, showing no degradation or inactivation after being stored in aqueous solution at room temperature for 2 years. The fact that sublancin is a natural product of B. subtilis 168, for which a great deal of genetic information is available, including the entire sequence of its genome, suggests that sublancin will be an especially good model for studying the potential of lantibiotics as sources of novel biomaterials.	Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Hansen, JN (corresponding author), Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.				NIAID NIH HHS [AI24454] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024454, R55AI024454] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASQUITH RS, 1972, TETRAHEDRON, V28, P4769, DOI 10.1016/0040-4020(72)88085-2; BANERJEE S, 1988, J BIOL CHEM, V263, P9508; BUCHMAN GW, 1988, J BIOL CHEM, V263, P16260; BUCHMAN GW, 1988, THESIS U MARYLAND CO; CHAKICHERLA A, 1995, J BIOL CHEM, V270, P23533, DOI 10.1074/jbc.270.40.23533; Chan WC, 1996, APPL ENVIRON MICROB, V62, P2966, DOI 10.1128/AEM.62.8.2966-2969.1996; CHAN WC, 1993, BIOCHEM J, V291, P23, DOI 10.1042/bj2910023; DEVOS WM, 1995, MOL MICROBIOL, V17, P427, DOI 10.1111/j.1365-2958.1995.mmi_17030427.x; FEENEY RE, 1948, ARCH BIOCHEM, V17, P435; FISK CL, 1975, THESIS GEORGETOWN U; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; HANCOCK REW, 1997, BIOTECHNOLOGY ANTIBI, P471; HANSEN JN, 1993, ANNU REV MICROBIOL, V47, P535, DOI 10.1146/annurev.micro.47.1.535; HANSEN JN, 1997, BIOTECHNOLOGY ANTIBI, P437; HAVARSTEIN LS, 1995, MOL MICROBIOL, V16, P229, DOI 10.1111/j.1365-2958.1995.tb02295.x; JONES AJ, 1983, BIOCHEM J, V211, P499, DOI 10.1042/bj2110499; KOZAK M, 1983, MICROBIOL REV, V47, P1; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; KUPKE T, 1992, J BACTERIOL, V174, P5354, DOI 10.1128/JB.174.16.5354-5361.1992; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; LIU W, 1992, J BIOL CHEM, V267, P25078; LIU W, 1991, J BACTERIOL, V173, P7387, DOI 10.1128/jb.173.22.7387-7390.1991; LIU W, 1990, APPL ENVIRON MICROB, V56, P2551, DOI 10.1128/AEM.56.8.2551-2558.1990; LIU W, 1993, APPL ENVIRON MICROB, V59, P648, DOI 10.1128/AEM.59.2.648-651.1993; Maniatis T., 1982, MOL CLONING LAB MANU; MEYER C, 1995, EUR J BIOCHEM, V232, P478, DOI 10.1111/j.1432-1033.1995.tb20834.x; MEYER HE, 1994, ANAL BIOCHEM, V223, P185, DOI 10.1006/abio.1994.1571; MORRIS SL, 1984, J BIOL CHEM, V259, P3590; Nes IF, 1996, ANTON LEEUW INT J G, V69, P89, DOI 10.1007/BF00399414; ROSENBERG M, 1979, ANNU REV GENET, V13, P319, DOI 10.1146/annurev.ge.13.120179.001535; Roy C., 1991, EVALUATION NEW ANTIM, P739; SAHL HG, 1994, CIBA F SYMP, V186, P27; SAHL HG, 1995, EUR J BIOCHEM, V230, P827, DOI 10.1111/j.1432-1033.1995.tb20627.x; VARY JC, 1965, J BACTERIOL, V89, P1340, DOI 10.1128/JB.89.5.1340-1347.1965; WAKAMIYA T, 1985, TETRAHEDRON LETT, V26, P665, DOI 10.1016/S0040-4039(00)89174-1	35	189	215	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23134	23142		10.1074/jbc.273.36.23134	http://dx.doi.org/10.1074/jbc.273.36.23134			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722542	hybrid			2022-12-27	WOS:000075778100042
J	Cheong, J; Coligan, JE; Shuman, JD				Cheong, J; Coligan, JE; Shuman, JD			Activating transcription factor-2 regulates phosphoenolpyruvate carboxykinase transcription through a stress-inducible mitogen-activated protein kinase pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BINDING-PROTEIN; GROWTH-HORMONE GENE; TRANSGENIC MICE; C/EBP-ALPHA; GTP GENE; DIETARY-REGULATION; HEPATOMA-CELLS; RAT-LIVER; EXPRESSION; PHOSPHORYLATION	Several protein-nucleic acid complexes are observed when nuclear extracts from hepatoma cells are assayed for binding to the cAMP response element found in the phosphoenolpyruvate carboxykinase-cytosolic (PEPCK-C) promoter. Although cAMP response element-binding protein and CCAAT/enhancer binding proteins alpha and beta have been identified as Liver factors that bind this motif, an uncharacterized, slower migrating complex was also observed. We identify activating transcription factor-2 (ATF-2) as the factor in this complex and show that ATF-S stimulates expression from the PEPCK-C promoter. ATF-2 is a basic-leucine zipper transcription factor and a target for stress-activated protein kinases. We demonstrate that p38 beta mitogen-activated protein (MAP) kinase augments ATF-S transactivation activity on the PEPCK-C promoter, which is consistent with the interpretation that PEPCK-C promoter activity is maintained under stress through a p38 MAP kinase dependent pathway. In this regard, we show that treatment with sodium arsenite, a known activator of p38 MAP kinases, also stimulates expression from the PEPCK promoter. These results show that ATF-2 can stimulate transcription of the PEPCK-C promoter and support a role for stress inducible kinases in the maintenance of PEPCK-C expression.	NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Shuman, JD (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.			Shuman, Jon/0000-0001-8412-9087				ALAM T, 1992, J BIOL CHEM, V267, P5021; BENBROOK DM, 1994, NUCLEIC ACIDS RES, V22, P1463, DOI 10.1093/nar/22.8.1463; Cuenda A, 1997, EMBO J, V16, P295, DOI 10.1093/emboj/16.2.295; DESCHATRETTE J, 1974, BIOCHIMIE, V56, P1603; DIEHL AM, 1995, HEPATOLOGY, V22, P252, DOI 10.1016/0270-9139(95)90379-8; EISENBERGER CL, 1992, MOL CELL BIOL, V12, P1396, DOI 10.1128/MCB.12.3.1396; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; FREYTAG SO, 1992, SCIENCE, V256, P379, DOI 10.1126/science.256.5055.379; GUNN JM, 1975, BIOCHEM J, V150, P195, DOI 10.1042/bj1500195; GURNEY AL, 1992, J BIOL CHEM, V267, P18133; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; KIOUSSIS D, 1978, J BIOL CHEM, V253, P4327; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; LOOSE DS, 1985, BIOCHEMISTRY-US, V24, P4509, DOI 10.1021/bi00338a004; MCGRANE MM, 1990, J BIOL CHEM, V265, P22371; MCGRANE MM, 1988, J BIOL CHEM, V263, P11443; MISCHOULON D, 1992, MOL CELL BIOL, V12, P2553, DOI 10.1128/MCB.12.6.2553; Nizielski SE, 1996, J NUTR, V126, P2697; Nizielski SE, 1996, AM J PHYSIOL-REG I, V270, pR1005, DOI 10.1152/ajpregu.1996.270.5.R1005; PARK EA, 1990, MOL CELL BIOL, V10, P6264, DOI 10.1128/MCB.10.12.6264; PARK EA, 1993, J BIOL CHEM, V268, P613; QUINN PG, 1988, MOL CELL BIOL, V8, P3467, DOI 10.1128/MCB.8.8.3467; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; ROESLER WJ, 1989, J BIOL CHEM, V264, P9657; ROESLER WJ, 1992, J BIOL CHEM, V267, P21235; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Sambrook J., 2002, MOL CLONING LAB MANU; SHORT MK, 1992, MOL CELL BIOL, V12, P1007, DOI 10.1128/MCB.12.3.1007; Shuman JD, 1997, J BIOL CHEM, V272, P12793, DOI 10.1074/jbc.272.19.12793; Sutherland C, 1997, DIABETES, V46, P17, DOI 10.2337/diabetes.46.1.17; TILGHMAN S M, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1304, DOI 10.1073/pnas.71.4.1304; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; VIDNES J, 1976, ACTA PAEDIATR SCAND, V65, P297, DOI 10.1111/j.1651-2227.1976.tb04889.x; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557	39	42	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22714	22718		10.1074/jbc.273.35.22714	http://dx.doi.org/10.1074/jbc.273.35.22714			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712902	hybrid			2022-12-27	WOS:000075616600078
J	Liu, W; Litwack, ED; Stanley, MJ; Langford, JK; Lander, AD; Sanderson, RD				Liu, W; Litwack, ED; Stanley, MJ; Langford, JK; Lander, AD; Sanderson, RD			Heparan sulfate proteoglycans as adhesive and anti-invasive molecules - Syndecans and glypican have distinct functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE PROTEOGLYCAN; MAMMARY EPITHELIAL-CELLS; INTEGRAL MEMBRANE PROTEOGLYCAN; FIBROBLAST GROWTH-FACTOR; PROTEIN-KINASE-C; MESENCHYMAL INTERACTIONS; CHONDROITIN SULFATE; NERVOUS-SYSTEM; CORE PROTEINS; EXPRESSION	ARH-77 cells do not adhere to type I collagen and readily invade into collagen gels, but following expression of the transmembrane heparan sulfate proteoglycan syndecan-1, they bind collagen and fail to invade. We now show that cells transfected with syndecan-2 or syndecan-4 also bind collagen and are non-invasive. In contrast, cells transfected with the glycosylphosphatidylinositol-anchored proteoglycan glypican-1 do not bind to collagen and remain invasive, even though glypican- and syndecan-expressing cells have similar surface levels of heparan sulfate, and their proteoglycans have similar affinities for collagen. Analysis of cells expressing syndecan-1-glypican-1 chimeric proteoglycans reveals that inhibition of invasion requires the extracellular domain of syndecan but not its transmembrane or cytoplasmic domain. Surprisingly, cells bearing a chimera composed of the glypican extracellular domain fused to the syndecan transmembrane and cytoplasmic domains bind to collagen but remain invasive, implying that adhesion to collagen is not by itself sufficient to inhibit invasion. Apparently, the extracellular domain of syndecan-1, presumably by interacting with cell-surface signal transducing molecules, directly regulates complex cell behaviors such as motility and invasiveness. These results also show for the first time that syndecans and glypicans can have distinct functions, even when expressed by the same cell type.	Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Dept Anat, Little Rock, AR 72205 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; Massachusetts Institute of Technology (MIT); University of California System; University of California Irvine	Sanderson, RD (corresponding author), Univ Arkansas Med Sci, Dept Pathol, Slot 517,4301 W Markham, Little Rock, AR 72205 USA.		Lander, Arthur/L-2827-2019; Lander, Arthur D/C-9008-2011	Lander, Arthur/0000-0002-4380-5525; Lander, Arthur D/0000-0002-4380-5525	NATIONAL CANCER INSTITUTE [R29CA055879, R01CA068494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026862] Funding Source: NIH RePORTER; NCI NIH HHS [CA 55879, CA 68494] Funding Source: Medline; NINDS NIH HHS [NS 26862] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBELDA SM, 1993, LAB INVEST, V68, P4; ASUNDI VK, 1995, J BIOL CHEM, V270, P26404, DOI 10.1074/jbc.270.44.26404; BACIU PC, 1995, MOL BIOL CELL, V6, P1503, DOI 10.1091/mbc.6.11.1503; BERNFIELD M, 1993, DEVELOPMENT, P205; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; BOUTIN EL, 1991, DEV BIOL, V148, P63, DOI 10.1016/0012-1606(91)90317-V; Carey DJ, 1996, J BIOL CHEM, V271, P15253, DOI 10.1074/jbc.271.25.15253; Carey DJ, 1997, BIOCHEM J, V327, P1; CHERNOUSOV MA, 1993, J BIOL CHEM, V268, P16810; Couchman JR, 1996, J CELL BIOCHEM, V61, P578, DOI 10.1002/(SICI)1097-4644(19960616)61:4<578::AID-JCB11>3.0.CO;2-C; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; DAVID G, 1993, FASEB J, V7, P1023, DOI 10.1096/fasebj.7.11.8370471; Dhodapkar MV, 1998, BLOOD, V91, P2679, DOI 10.1182/blood.V91.8.2679.2679_2679_2688; ELENIUS K, 1991, J CELL BIOL, V114, P585, DOI 10.1083/jcb.114.3.585; Fuki IV, 1997, J CLIN INVEST, V100, P1611, DOI 10.1172/JCI119685; Gallo R, 1996, J INVEST DERMATOL, V107, P676, DOI 10.1111/1523-1747.ep12365571; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; INKI P, 1994, BRIT J CANCER, V70, P319, DOI 10.1038/bjc.1994.300; Inki P, 1996, ANN MED, V28, P63, DOI 10.3109/07853899608999076; JALKANEN M, 1985, J CELL BIOL, V101, P976, DOI 10.1083/jcb.101.3.976; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; KATO M, 1995, MOL BIOL CELL, V6, P559, DOI 10.1091/mbc.6.5.559; KIM CW, 1994, MOL BIOL CELL, V5, P797, DOI 10.1091/mbc.5.7.797; KODA JE, 1985, J BIOL CHEM, V260, P8157; KOJIMA T, 1992, J BIOL CHEM, V267, P4870; KOKENYESI R, 1994, J BIOL CHEM, V269, P12304; Lander AD, 1996, PERSPECT DEV NEUROBI, V3, P347; Lebakken CS, 1996, J CELL BIOL, V132, P1209, DOI 10.1083/jcb.132.6.1209; LEE MK, 1991, P NATL ACAD SCI USA, V88, P2768, DOI 10.1073/pnas.88.7.2768; LEPPA S, 1992, P NATL ACAD SCI USA, V89, P932, DOI 10.1073/pnas.89.3.932; LIEBERSBACH BF, 1994, J BIOL CHEM, V269, P20013; LITWACK ED, 1994, J NEUROSCI, V14, P3713; Litwack ED, 1998, DEV DYNAM, V211, P72, DOI 10.1002/(SICI)1097-0177(199801)211:1<72::AID-AJA7>3.3.CO;2-8; LOTZ MM, 1989, J CELL BIOL, V109, P1795, DOI 10.1083/jcb.109.4.1795; MARYNEN P, 1989, J BIOL CHEM, V264, P7017; McFall AJ, 1997, J BIOL CHEM, V272, P12901, DOI 10.1074/jbc.272.20.12901; Mertens G, 1996, J CELL BIOL, V132, P487, DOI 10.1083/jcb.132.3.487; Oh ES, 1997, J BIOL CHEM, V272, P8133, DOI 10.1074/jbc.272.13.8133; PIERCE A, 1992, J BIOL CHEM, V267, P3894; Pulkkinen JO, 1997, ACTA OTO-LARYNGOL, V117, P312, DOI 10.3109/00016489709117794; RAPRAEGER A, 1985, J BIOL CHEM, V260, P1046; RAPRAEGER A, 1985, J BIOL CHEM, V260, P4103; Reiland J, 1996, BIOCHEM J, V319, P39, DOI 10.1042/bj3190039; ROSKELLEY CD, 1995, CURR OPIN CELL BIOL, V7, P736, DOI 10.1016/0955-0674(95)80117-0; Ruoslahti E, 1996, TUMOR BIOL, V17, P117, DOI 10.1159/000217975; SANDERSON RD, 1992, J INVEST DERMATOL, V99, P390, DOI 10.1111/1523-1747.ep12616103; SANDERSON RD, 1994, J BIOL CHEM, V269, P13100; Saunders S, 1997, DEV BIOL, V190, P78, DOI 10.1006/dbio.1997.8690; SAUNDERS S, 1989, J CELL BIOL, V108, P1547, DOI 10.1083/jcb.108.4.1547; STANLEY MJ, 1995, J BIOL CHEM, V270, P5077, DOI 10.1074/jbc.270.10.5077; Steinfeld R, 1996, J CELL BIOL, V133, P405, DOI 10.1083/jcb.133.2.405; THESLEFF I, 1988, DEV BIOL, V129, P565, DOI 10.1016/0012-1606(88)90401-0; TRAUTMAN MS, 1991, DEVELOPMENT, V111, P213; VAINIO S, 1989, DEV BIOL, V134, P382, DOI 10.1016/0012-1606(89)90110-3; Wahl SM, 1996, J LEUKOCYTE BIOL, V59, P789, DOI 10.1002/jlb.59.6.789; WOODS A, 1994, MOL BIOL CELL, V5, P183, DOI 10.1091/mbc.5.2.183; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0	57	144	156	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22825	22832		10.1074/jbc.273.35.22825	http://dx.doi.org/10.1074/jbc.273.35.22825			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712917	hybrid			2022-12-27	WOS:000075616600093
J	Uchimura, K; Muramatsu, H; Kadomatsu, K; Fan, QW; Kurosawa, N; Mitsuoka, C; Kannagi, R; Habuchi, O; Muramatsu, T				Uchimura, K; Muramatsu, H; Kadomatsu, K; Fan, QW; Kurosawa, N; Mitsuoka, C; Kannagi, R; Habuchi, O; Muramatsu, T			Molecular cloning and characterization of an N-acetylglucosamine-6-O-sulfotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIALYL-LEWIS-X; N-LINKED OLIGOSACCHARIDES; FUCOSYL-TRANSFERASE GENE; L-SELECTIN; CHONDROITIN 6-SULFOTRANSFERASE; CARBOHYDRATE CHAINS; ACETYLGLUCOSAMINE RESIDUES; EXPRESSION; SULFATE; LIGAND	We isolated a cDNA clone encoding mouse N-acetyl-glucosamine-6-O-sulfotransferase based on sequence homology to the previously cloned mouse chondroitin B-sulfotransferase. The cDNA clone contained an open reading frame that predicts a type II transmembrane protein composed of 483 amino acid residues. The expressed enzyme transferred sulfate to the 6 position of nonreducing GlcNAc in GlcNAc beta 1-3Gal beta 1-4GlcNAc. Gal beta 1-4GlcNAc beta 1-3Gal beta 1-4GlcNAc and various glycosaminoglycans did not serve as accepters. Expression of the cDNA in COS-7 cells resulted in production of a cell-surface antigen, the epitope of which was NeuAc alpha 2-3Gal beta 1-4(SO4-6)GlcNAc; double transfection with fucosyltransferase IV yielded Gal beta 1-4(Fuc alpha 1-3) (SO4-6)Glc-NAc antigen. The sulfotransferase mRNA was strongly expressed in the cerebrum, cerebellum, eye, pancreas, and lung of adult mice. In situ hybridization revealed that the mRNA was localized in high endothelial venules of mesenteric lymph nodes. The sulfotransferase was concluded to be involved in biosynthesis of glycoconjugates bearing the 6-sulfo N-acetyllactosamine structure such as 6-sulfo sialyl Lewis X. The products of the sulfo transferase probably include glycoconjugates with intercellular recognition signals; one candidate of such a glycoconjugate is an L-selectin ligand.	Nagoya Univ, Sch Med, Dept Biochem, Nagoya, Aichi 466, Japan; Aichi Canc Ctr, Res Inst, Program Expt Pathol, Nagoya, Aichi 464, Japan; Aichi Univ Educ, Dept Life Sci, Kariya, Aichi 448, Japan	Nagoya University; Aichi Cancer Center; Aichi University Education	Muramatsu, T (corresponding author), Nagoya Univ, Sch Med, Dept Biochem, Nagoya, Aichi 466, Japan.	tmurama@tsuru.med.nagoya-u.ac.jp	Uchimura, Kenji/C-9635-2014; Muramatsu, Hideki/ABA-3376-2021; Muramatsu, Hideki/I-3763-2012; Kannagi, Reiji/Q-6459-2018; Kadomatsu, Kenji/G-8083-2012; Uchimura, Kenji/AFV-1802-2022	Uchimura, Kenji/0000-0003-3009-248X; Muramatsu, Hideki/0000-0002-8801-0021; Kannagi, Reiji/0000-0003-4202-2921; Uchimura, Kenji/0000-0003-3009-248X; Kurosawa, Nobuyuki/0000-0002-1548-4541				ARUFFO A, 1991, CURRENT PROTOCOL S14, V14; Bakker H, 1997, J BIOL CHEM, V272, P29942, DOI 10.1074/jbc.272.47.29942; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DEWAARD P, 1991, J BIOL CHEM, V266, P4237; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; EDGE ASB, 1984, J BIOL CHEM, V259, P4710; Fan QW, 1998, NEUROSCI RES, V30, P53, DOI 10.1016/S0168-0102(97)00119-3; FUKUTA M, 1995, J BIOL CHEM, V270, P18575, DOI 10.1074/jbc.270.31.18575; Fukuta M, 1997, J BIOL CHEM, V272, P32321, DOI 10.1074/jbc.272.51.32321; GOELZ SE, 1990, CELL, V63, P1349, DOI 10.1016/0092-8674(90)90430-M; GREEN ED, 1986, MOL CELL BIOCHEM, V72, P81; GUO Y, 1989, ANAL BIOCHEM, V176, P96, DOI 10.1016/0003-2697(89)90278-9; HABUCHI H, 1995, J BIOL CHEM, V270, P4172, DOI 10.1074/jbc.270.8.4172; Habuchi O, 1996, GLYCOBIOLOGY, V6, P51, DOI 10.1093/glycob/6.1.51; HABUCHI O, 1993, J BIOL CHEM, V268, P21968; HASHIMOTO Y, 1992, J BIOL CHEM, V267, P15744; HEMMERICH S, 1994, BIOCHEMISTRY-US, V33, P4830, DOI 10.1021/bi00182a011; HEMMERICH S, 1994, BIOCHEMISTRY-US, V33, P4820, DOI 10.1021/bi00182a010; Honke K, 1997, J BIOL CHEM, V272, P4864, DOI 10.1074/jbc.272.8.4864; IMAI Y, 1993, NATURE, V361, P555; IMAI Y, 1991, J CELL BIOL, V113, P1213, DOI 10.1083/jcb.113.5.1213; KAMEYAMA A, 1991, CARBOHYD RES, V209, pC1, DOI 10.1016/0008-6215(91)80171-I; KIYOHARA T, 1976, J BIOCHEM, V80, P9, DOI 10.1093/oxfordjournals.jbchem.a131263; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kobayashi M, 1997, J BIOL CHEM, V272, P13980, DOI 10.1074/jbc.272.21.13980; Komba S, 1996, CARBOHYD RES, V285, pC1, DOI 10.1016/S0008-6215(96)90188-3; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LOGUIDICE JM, 1994, J BIOL CHEM, V269, P18794; LOWE JB, 1991, J BIOL CHEM, V266, P17467; MAKITA A, 1985, NEW COMPREHENSIVE BI, V10, P1; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Mitsuoka C, 1997, BIOCHEM BIOPH RES CO, V230, P546, DOI 10.1006/bbrc.1996.6012; Mitsuoka C, 1998, J BIOL CHEM, V273, P11225, DOI 10.1074/jbc.273.18.11225; NOGUCHI S, 1992, EUR J BIOCHEM, V209, P883, DOI 10.1111/j.1432-1033.1992.tb17361.x; Ohmoto H, 1996, J MED CHEM, V39, P1339, DOI 10.1021/jm9506478; OHOMORI K, 1993, BLOOD, V82, P2797; OSHINO K, 1997, J MED CHEM, V40, P455; Ozawa M, 1996, J BIOCHEM-TOKYO, V119, P302; ROUX L, 1988, J BIOL CHEM, V263, P8879; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHILATIFARD A, 1993, J VIROL, V67, P943, DOI 10.1128/JVI.67.2.943-952.1993; Shworak NW, 1997, J BIOL CHEM, V272, P28008, DOI 10.1074/jbc.272.44.28008; Spiro RG, 1996, BIOCHEM J, V319, P209, DOI 10.1042/bj3190209; STRECKER G, 1989, CARBOHYD RES, V185, P1, DOI 10.1016/0008-6215(89)84016-9; Tsuboi S, 1996, J BIOL CHEM, V271, P27213, DOI 10.1074/jbc.271.44.27213; Uchimura K, 1998, GLYCOBIOLOGY, V8, P489, DOI 10.1093/glycob/8.5.489	48	138	143	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22577	22583		10.1074/jbc.273.35.22577	http://dx.doi.org/10.1074/jbc.273.35.22577			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712885	hybrid			2022-12-27	WOS:000075616600061
J	Valenti, G; Procino, G; Liebenhoff, U; Frigeri, A; Benedetti, PA; Ahnert-Hilger, G; Nurnberg, B; Svelto, M; Rosenthal, W				Valenti, G; Procino, G; Liebenhoff, U; Frigeri, A; Benedetti, PA; Ahnert-Hilger, G; Nurnberg, B; Svelto, M; Rosenthal, W			A heterotrimeric G protein of the G(i) family is required for cAMP-triggered trafficking of aquaporin 2 in kidney epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLECTING DUCT; WATER CHANNEL; PLASMA-MEMBRANE; VASOPRESSIN; MICROSCOPY; TOXIN; PERMEABILITY; EXOCYTOSIS; EXPRESSION; TRANSPORT	Vasopressin is the key regulator of water homeostasis in vertebrates. Central to its antidiuretic action in mammals is the redistribution of the water channel aquaporin 2 (AQP2) from intracellular vesicles to the apical membrane of kidney epithelial cells, an event initiated by an increase in cAMP and activation of protein kinase A. The subsequent steps of the signaling cascade are not known. To identify proteins involved in the AQP2 shuttle we exploited a recently developed cell line (CD8) derived from the rabbit cortical collecting duct and stably transfected with rat AQP2 cDNA, Treatment of CD8 cells with pertussis toxin (PTX) inhibited both the vasopressin-induced increase in water permeability and the redistribution of AQP2 from an intracellular compartment to the apical membrane. ADP-ribosylation studies revealed the presence of at least two major PTX substrates, Correspondingly, two a: subunits of PTX-sensitive G proteins, G alpha(i2), and G alpha(i3), were identified by Western blotting. Introduction of a synthetic peptide corresponding to the C terminus of the G(i3) alpha subunit into permeabilized CD8 cells efficiently inhibited the cAMP-induced AQP2 translocation; a peptide corresponding to the a subunits of G(i1/2) was much less potent. Thus a member of the G(i) family, most likely G(i3), is involved in the cAMP-triggered targeting of AQP2-bearing vesicles to the apical membrane of kidney epithelial cells.	Forschungsinst Mol Pharmakol, D-10315 Berlin, Germany; Univ Bari, Dipartimento Fisiol Gen & Ambientale, I-70126 Bari, Italy; Justus Liebig Univ, Rudolf Buchheim Inst Pharmakol, D-35392 Giessen, Germany; CNR, Ist Biofis, I-56127 Pisa, Italy; Humboldt Universitat Berlin, Inst Anat, D-10115 Berlin, Germany; Free Univ Berlin, Inst Pharmakol, D-14195 Berlin, Germany	Universita degli Studi di Bari Aldo Moro; Justus Liebig University Giessen; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Humboldt University of Berlin; Free University of Berlin	Rosenthal, W (corresponding author), Forschungsinst Mol Pharmakol, D-10315 Berlin, Germany.	rosenthal@fmp-berlin.de	frigeri, Antonio/AAC-6336-2022; Svelto, Maria/P-6186-2014	Nurnberg, Bernd/0000-0002-5995-6555; Procino, Giuseppe/0000-0002-0043-7523; Frigeri, Antonio/0000-0002-5284-2934; VALENTI, GIOVANNA/0000-0003-0233-0778; Svelto, Maria/0000-0002-5584-9541				AHNERTHILGER G, 1989, METHOD CELL BIOL, V31, P63; ARIDOR M, 1993, SCIENCE, V262, P1569, DOI 10.1126/science.7504324; BENEDETTI PA, 1995, P SOC PHOTO-OPT INS, V2412, P56, DOI 10.1117/12.205348; BENEDETTI PA, 1995, ZOOL STUD, V34, P186; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; ERCOLANI L, 1990, P NATL ACAD SCI USA, V87, P4635, DOI 10.1073/pnas.87.12.4635; FARINAS J, 1995, BIOPHYS J, V68, P1613, DOI 10.1016/S0006-3495(95)80335-8; Fushimi K, 1997, J BIOL CHEM, V272, P14800, DOI 10.1074/jbc.272.23.14800; HELMS JB, 1995, FEBS LETT, V369, P84, DOI 10.1016/0014-5793(95)00620-O; Jena BP, 1997, P NATL ACAD SCI USA, V94, P13317, DOI 10.1073/pnas.94.24.13317; JO IH, 1995, P NATL ACAD SCI USA, V92, P1876, DOI 10.1073/pnas.92.6.1876; Katsura T, 1997, AM J PHYSIOL-RENAL, V272, pF816; Knepper MA, 1997, CURR OPIN CELL BIOL, V9, P560, DOI 10.1016/S0955-0674(97)80034-8; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Leopoldt D, 1997, N-S ARCH PHARMACOL, V356, P216, DOI 10.1007/PL00005044; LIEBENHOFF U, 1995, FEBS LETT, V365, P209, DOI 10.1016/0014-5793(95)00476-P; Mandon B, 1996, J CLIN INVEST, V98, P906, DOI 10.1172/JCI118873; NIELSEN S, 1993, AM J PHYSIOL, V265, pF225, DOI 10.1152/ajprenal.1993.265.2.F225; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; NOVICK P, 1993, CELL, V75, P597, DOI 10.1016/0092-8674(93)90478-9; NUOFFER C, 1994, ANNU REV BIOCHEM, V63, P949, DOI 10.1146/annurev.bi.63.070194.004505; Nurnberg B, 1996, FEBS LETT, V389, P61, DOI 10.1016/0014-5793(96)00584-4; RUDOLPH U, 1989, MOL CELL ENDOCRINOL, V63, P143, DOI 10.1016/0303-7207(89)90090-7; SABOLIC I, 1992, J CELL BIOL, V119, P111, DOI 10.1083/jcb.119.1.111; Sands JM, 1997, J CLIN INVEST, V99, P1399, DOI 10.1172/JCI119299; SCHMIDT A, 1991, J BIOL CHEM, V266, P18025; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; Valenti G, 1996, J BIOL CHEM, V271, P24365, DOI 10.1074/jbc.271.40.24365; VANDEWALLE A, 1989, J CELL PHYSIOL, V141, P203, DOI 10.1002/jcp.1041410128; WADE JB, 1994, SEMIN NEPHROL, V14, P322; WOLLHEIM CB, 1996, DIABETES REV, V4, P276	31	60	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22627	22634		10.1074/jbc.273.35.22627	http://dx.doi.org/10.1074/jbc.273.35.22627			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712891	hybrid, Green Published			2022-12-27	WOS:000075616600067
J	Brown, GW; Kelly, TJ				Brown, GW; Kelly, TJ			Purification of Hsk1, a minichromosome maintenance protein kinase from fission yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE CDC7; DNA-POLYMERASE-ALPHA; CELL-CYCLE CONTROL; S-PHASE; SCHIZOSACCHAROMYCES-POMBE; MCM PROTEINS; REPLICATION ORIGINS; BUDDING YEAST; COMPLEX; GENE	Members of the Cdc7 family of protein kinases are essential for the initiation of DNA replication in all eukaryotes, but their precise biochemical function is unclear. We have purified the fission yeast Cdc7 homologue Hsk1 approximately 30,000-fold, to near homogeneity. Purified Hsk1 has protein kinase activity on several substrates and is capable of autophosphorylation, Point mutations in highly conserved regions of Hsk1 inactivate the kinase in vitro and in vivo, Overproduction of two of the mutant hsk1 alleles blocks initiation of DNA replication and deranges the mitotic checkpoint, a phenotype consistent with a role for Hsk1 in the early stages of initiation. The purified Hsk1 kinase can be separated into two active forms, a Hsk1 monomer and a heterodimer consisting of Hsk1 complexed with a copurifying polypeptide, Dfp1. Association with Dfp1 stimulates phosphorylation of exogenous substrates but has little effect on autokinase activity. We have identified Dfp1 as the fission yeast homologue of budding yeast Dbf4. Purified Hsk1 phosphorylates the Cdc19 (Mcm2) subunit of the six-member minichromosome maintenance protein complex purified from fission yeast, Since minichromosome maintenance proteins have been implicated in the initiation of DNA replication, the essential function of Hsk1 at the G(1)/S transition may be mediated by phosphorylation of Cdc19. Furthermore, the phosphorylation of critical substrates by Hsk1 kinase is likely regulated by association with a Dbf4-like co-factor.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Johns Hopkins University	Kelly, TJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, 725 N Wolfe St, Baltimore, MD 21205 USA.	tom_kelly@qmail.bs.jhu.edu		Brown, Grant/0000-0002-9002-5003	NATIONAL CANCER INSTITUTE [T32CA009139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050806] Funding Source: NIH RePORTER; NCI NIH HHS [CA09139] Funding Source: Medline; NIGMS NIH HHS [GM50806] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adachi Y, 1997, GENES CELLS, V2, P467, DOI 10.1046/j.1365-2443.1997.1350333.x; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Brown GW, 1997, P NATL ACAD SCI USA, V94, P6142, DOI 10.1073/pnas.94.12.6142; BUCK V, 1991, MOL GEN GENET, V227, P452, DOI 10.1007/BF00273937; CHAPMAN JW, 1989, EXP CELL RES, V180, P419, DOI 10.1016/0014-4827(89)90068-2; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; DIFFLEY JFX, 1992, NATURE, V357, P169, DOI 10.1038/357169a0; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; DOWELL SJ, 1994, SCIENCE, V265, P1243, DOI 10.1126/science.8066465; DURSO G, 1995, J CELL SCI, V108, P3109; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FERGUSON KA, 1964, METABOLISM, V13, P985, DOI 10.1016/S0026-0495(64)80018-4; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; Forsburg SL, 1997, GENE, V191, P191, DOI 10.1016/S0378-1119(97)00058-9; Grallert B, 1996, GENE DEV, V10, P2644, DOI 10.1101/gad.10.20.2644; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; HARTWELL LH, 1973, J BACTERIOL, V115, P966, DOI 10.1128/JB.115.3.966-974.1973; HEDRICK JL, 1968, ARCH BIOCHEM BIOPHYS, V126, P155, DOI 10.1016/0003-9861(68)90569-9; Hess GF, 1998, GENE, V211, P133, DOI 10.1016/S0378-1119(98)00094-8; HOLLINGSWORTH RE, 1990, P NATL ACAD SCI USA, V87, P6272, DOI 10.1073/pnas.87.16.6272; Ishimi Y, 1998, J BIOL CHEM, V273, P8369, DOI 10.1074/jbc.273.14.8369; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; JACKSON AL, 1993, MOL CELL BIOL, V13, P2899, DOI 10.1128/MCB.13.5.2899; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jiang W, 1997, P NATL ACAD SCI USA, V94, P14320, DOI 10.1073/pnas.94.26.14320; JOHNSTON LH, 1982, MOL GEN GENET, V186, P445, DOI 10.1007/BF00729467; Kearsey SE, 1996, BIOESSAYS, V18, P183, DOI 10.1002/bies.950180305; KEENEY JB, 1994, GENETICS, V136, P849; KELLY TJ, 1993, CELL, V74, P371, DOI 10.1016/0092-8674(93)90427-R; KIMURA H, 1994, EMBO J, V13, P4311, DOI 10.1002/j.1460-2075.1994.tb06751.x; KITADA K, 1992, GENETICS, V131, P21; KUBOTA Y, 1995, CELL, V81, P601, DOI 10.1016/0092-8674(95)90081-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; MASAI H, 1995, EMBO J, V14, P3094, DOI 10.1002/j.1460-2075.1995.tb07312.x; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MuziFalconi F, 1996, CURR BIOL, V6, P229, DOI 10.1016/S0960-9822(02)00464-5; Ohtoshi A, 1997, MOL GEN GENET, V254, P562, DOI 10.1007/s004380050452; Romanowski P, 1996, CURR BIOL, V6, P1416, DOI 10.1016/S0960-9822(96)00746-4; Sato N, 1997, EMBO J, V16, P4340, DOI 10.1093/emboj/16.14.4340; SCLAFANI RA, 1994, MOL MICROBIOL, V11, P805, DOI 10.1111/j.1365-2958.1994.tb00358.x; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TODOROV IT, 1995, J CELL BIOL, V129, P1433, DOI 10.1083/jcb.129.6.1433; YOON HJ, 1991, P NATL ACAD SCI USA, V88, P3574, DOI 10.1073/pnas.88.9.3574; YOON HJ, 1993, MOL BIOL CELL, V4, P195, DOI 10.1091/mbc.4.2.195	48	102	104	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					22083	22090		10.1074/jbc.273.34.22083	http://dx.doi.org/10.1074/jbc.273.34.22083			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705352	hybrid			2022-12-27	WOS:000075492600086
J	Callebaut, C; Blanco, J; Benkirane, N; Krust, B; Jacotot, E; Guichard, G; Seddiki, N; Svab, J; Dam, E; Muller, S; Briand, JP; Hovanessian, AG				Callebaut, C; Blanco, J; Benkirane, N; Krust, B; Jacotot, E; Guichard, G; Seddiki, N; Svab, J; Dam, E; Muller, S; Briand, JP; Hovanessian, AG			Identification of V3 loop-binding proteins as potential receptors implicated in the binding of HIV particles to CD4(+) cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LINE-ADAPTED HIV-1; ENVELOPE GLYCOPROTEIN; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; TYPE-1 GP120; PHOSPHATASE 2A; AMINO-ACIDS; HISTONE H3; T-CELLS	The binding of human immunodeficiency virus (HIV) type 1 particles to CD4(+) cells could be blocked either by antibodies against the V3 loop domain of the viral external envelope glycoprotein gp120, or by the V3 loop mimicking pseudopeptide 5[K psi(CH2N)PR]-TASP, which forms a stable complier with a cell-surface-expressed 95-kDa protein, Here, by using an affinity matrix containing 5[K psi(CH2N)PR]-TASP and cytoplasmic extracts from human CEM cells, we purified three V3 loop-binding proteins of 95, 40, and 30 kDa, which after microsequencing were revealed to be as nucleolin, putative HLA class II-associated protein (PHAP) II, and PHAP I, respectively. The 95-kDa cell-surface protein was also isolated and found to be nucleolin, We show that recombinant preparations of gp120 bind the purified preparations containing the V3 loop-binding proteins with a high affinity, comparable to the binding of gp120 to soluble CD4, Such binding is inhibited either by 5[K psi(CH2N)PR]-TASP or antibodies against the V3 loop. Moreover, these purified preparations inhibit HIV entry into CD4+ cells as efficiently as soluble CD4, Taken together, our results suggest that nucleolin, PHAP II, and PHAP I appear to be functional as potential receptors in the HIV binding process by virtue of their capacity to interact with the V3 loop of gp120.	Inst Pasteur, Unite Virol & Immunol Cellulaire, ERS 572 CNRS, F-75724 Paris 15, France; Inst Biol Mol & Cellulaire, UPR 9021 CNRS, F-67084 Strasbourg, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Hovanessian, AG (corresponding author), Inst Pasteur, Unite Virol & Immunol Cellulaire, ERS 572 CNRS, 28 Rue Dr Roux, F-75724 Paris 15, France.	arahovan@pasteur.fr	Blanco, Julià/A-5347-2008; Benkirane-Jessel, Nadia/H-6438-2016; GUICHARD, Gilles/I-3858-2016; Muller, Sylviane/J-5319-2014	Blanco, Julià/0000-0002-2225-0217; GUICHARD, Gilles/0000-0002-2584-7502; /0000-0002-5301-1569; Benkirane-Jessel, Nadia/0000-0003-3059-3559; Seddiki, Nabila/0000-0002-0379-8527				ADACHI Y, 1994, J BIOL CHEM, V269, P2258; AVRIL LE, 1994, FEBS LETT, V345, P81, DOI 10.1016/0014-5793(94)00410-2; Battini JL, 1996, J VIROL, V70, P4387, DOI 10.1128/JVI.70.7.4387-4393.1996; BENKIRANE N, 1995, J BIOL CHEM, V270, P11921, DOI 10.1074/jbc.270.20.11921; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; BORMAN AM, 1995, J VIROL, V69, P2058, DOI 10.1128/JVI.69.4.2058-2067.1995; BOUR S, 1995, MICROBIOL REV, V59, P63, DOI 10.1128/MMBR.59.1.63-93.1995; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; Callebaut C, 1996, VIROLOGY, V218, P181, DOI 10.1006/viro.1996.0178; Callebaut C, 1998, EXP CELL RES, V241, P352, DOI 10.1006/excr.1998.4063; Callebaut C, 1997, J BIOL CHEM, V272, P7159, DOI 10.1074/jbc.272.11.7159; Callebaut C, 1996, RES VIROLOGY, V147, P67, DOI 10.1016/0923-2516(96)80241-X; CALLEBAUT C, 1994, RETROVIRUSES HUMAN A, V237, P141; CHIN LT, 1995, IMMUNOL LETT, V44, P25, DOI 10.1016/0165-2478(94)00192-T; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; CLAPHAM PR, 1989, NATURE, V337, P368, DOI 10.1038/337368a0; Cocchi F, 1996, NAT MED, V2, P1244, DOI 10.1038/nm1196-1244; DEEN KC, 1988, NATURE, V331, P82, DOI 10.1038/331082a0; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Deng JS, 1996, MOL BIOL REP, V23, P191, DOI 10.1007/BF00351168; DEVERDUGO UR, 1995, J VIROL, V69, P6751, DOI 10.1128/JVI.69.11.6751-6757.1995; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; DRAGIC T, 1992, J VIROL, V66, P4794, DOI 10.1128/JVI.66.8.4794-4802.1992; DSouza MP, 1996, NAT MED, V2, P1293, DOI 10.1038/nm1296-1293; FANG SH, 1993, EXP CELL RES, V208, P48, DOI 10.1006/excr.1993.1221; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; HOOK WA, 1991, J IMMUNOL, V147, P2670; Jacotot E, 1996, VIROLOGY, V223, P318, DOI 10.1006/viro.1996.0483; JAVAHERIAN K, 1995, AIDS RES HUM RETROV, V11, P1163, DOI 10.1089/aid.1995.11.1163; Jordan P, 1996, MOL BIOL REP, V22, P63, DOI 10.1007/BF00996307; KINNEYTHOMAS E, 1988, AIDS, V2, P25; LAMAN JD, 1992, J VIROL, V66, P1823, DOI 10.1128/JVI.66.3.1823-1831.1992; Lapham CK, 1996, SCIENCE, V274, P602, DOI 10.1126/science.274.5287.602; LASKY LA, 1987, CELL, V50, P975, DOI 10.1016/0092-8674(87)90524-1; Leydet A, 1996, J MED CHEM, V39, P1626, DOI 10.1021/jm950358j; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; LINSLEY PS, 1988, J VIROL, V62, P3695, DOI 10.1128/JVI.62.10.3695-3702.1988; MATSUOKA K, 1994, P NATL ACAD SCI USA, V91, P9670, DOI 10.1073/pnas.91.21.9670; MCKEATING JA, 1992, VIROLOGY, V190, P134, DOI 10.1016/0042-6822(92)91199-5; Mebatsion T, 1997, CELL, V90, P841, DOI 10.1016/S0092-8674(00)80349-9; MOORE JP, 1991, AIDS, V5, P455, DOI 10.1097/00002030-199104000-00017; MOORE JP, 1993, VIRAL FUSION MECHANI, P233; Niwa Y, 1996, EUR J BIOCHEM, V237, P64, DOI 10.1111/j.1432-1033.1996.0064n.x; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Oravecz T, 1996, J IMMUNOL, V157, P1329; ORAVECZ T, 1995, NAT MED, V1, P919, DOI 10.1038/nm0995-919; PATEL M, 1993, AIDS RES HUM RETROV, V9, P167, DOI 10.1089/aid.1993.9.167; RODERIQUEZ G, 1995, J VIROL, V69, P2233, DOI 10.1128/JVI.69.4.2233-2239.1995; Schnell MJ, 1997, CELL, V90, P849, DOI 10.1016/S0092-8674(00)80350-5; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; SRIVASTAVA M, 1989, FEBS LETT, V250, P99, DOI 10.1016/0014-5793(89)80692-1; Stemmer C, 1996, J BIOL CHEM, V271, P21257, DOI 10.1074/jbc.271.35.21257; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; UGEN KE, 1993, VACCINES, V93, P215; Ugolini S, 1997, J EXP MED, V186, P1287, DOI 10.1084/jem.186.8.1287; VAESEN M, 1994, BIOL CHEM H-S, V375, P113, DOI 10.1515/bchm3.1994.375.2.113; Valenzuela A, 1997, J VIROL, V71, P8289, DOI 10.1128/JVI.71.11.8289-8298.1997; Valenzuela A, 1997, J IMMUNOL, V158, P3721; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; YU Y, 1995, AIDS RES HUM RETROV, V11, P563	63	65	74	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21988	21997		10.1074/jbc.273.34.21988	http://dx.doi.org/10.1074/jbc.273.34.21988			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705340	hybrid			2022-12-27	WOS:000075492600074
J	Kifor, O; Diaz, R; Butters, R; Kifor, I; Brown, EM				Kifor, O; Diaz, R; Butters, R; Kifor, I; Brown, EM			The calcium-sensing receptor is localized in caveolin-rich plasma membrane domains of bovine parathyroid cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; EXTRACELLULAR CA2+-SENSING RECEPTOR; SIGNAL-TRANSDUCTION; CARDIAC MYOCYTES; ALPHA-SUBUNITS; EXPRESSION; PROTEIN; INTERNALIZATION; SURFACE; HYPERPARATHYROIDISM	Parathyroid cells have an intracellular machinery for parathyroid hormone (PTH) secretion that is inversely regulated by the extracellular calcium concentration (Ca-0(2+)). The recently characterized Ca-0(2+)-semsing receptor (CaR) is a G protein-coupled, seven-transmembrane receptor mediating the inhibitory effects of high Ca-0(2+) on PTH secretion. The CaR's precise cell surface localization and the signal transducation pathway(s) mediating its inhibitory effects on PTH secretion have not been characterized fully. Here, we demonstrate that the CaR resides within caveolin-rich membrane domains in bovine parathyroid cells. Chief cells within bovine parathyroid glands exhibit a similar pattern of staining for caveolin-1 and for alkaline phosphatase, a glucosylphosphatidylinositol-anchored protein often enriched in caveolae. Purified caveolin-enriched membrane fractions (CEMF) from bovine parathyroid cells are highly enriched in the CaR. and alkaline phosphatase. Other signaling proteins, including G(q/11), eNOS, and several protein kinase C isoforms (i.e. alpha, delta, and zeta, are also present in CEMF, Activation of the CaR by high Ca-0(2+) increases tyrosine phosphorylation of caveolin-1 in CEMF, suggesting that CaR-mediated signal transduction potentially involved in Ca-0(2+)-regulated processes in parathyroid cells occur in caveolae-like domains.	Brigham & Womens Hosp, Div Endocrine Hypertens, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Childrens Hosp, Div Endocrine, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital	Kifor, O (corresponding author), Brigham & Womens Hosp, Div Endocrine Hypertens, 221 Longwood Ave, Boston, MA 02115 USA.		Vehi, Josep/D-6602-2013	Vehi, Josep/0000-0001-6884-9789	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044588, K08DK002530, R01DK052005] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK44588, DK02530, DK52005] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson RGW, 1993, CURR OPIN CELL BIOL, V5, P647, DOI 10.1016/0955-0674(93)90135-D; Bai M, 1996, J BIOL CHEM, V271, P19537, DOI 10.1074/jbc.271.32.19537; Brown Edward M., 1994, P15; BROWN EM, 1976, ENDOCRINOLOGY, V99, P1582, DOI 10.1210/endo-99-6-1582; BROWN EM, 1995, NEW ENGL J MED, V333, P234, DOI 10.1056/NEJM199507273330407; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; BROWN EM, 1991, PHYSIOL REV, V71, P371, DOI 10.1152/physrev.1991.71.2.371; Chattopadhyay N, 1996, ENDOCR REV, V17, P289, DOI 10.1210/er.17.4.289; CHUN MY, 1994, P NATL ACAD SCI USA, V91, P11728, DOI 10.1073/pnas.91.24.11728; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; deWeerd WFC, 1997, J BIOL CHEM, V272, P17858, DOI 10.1074/jbc.272.28.17858; Feron O, 1997, J BIOL CHEM, V272, P17744, DOI 10.1074/jbc.272.28.17744; Feron O, 1996, J BIOL CHEM, V271, P22810, DOI 10.1074/jbc.271.37.22810; FOX J, 1993, J BONE MINER RES, V8, pS181; GARDNER DG, 1979, ENDOCRINOLOGY, V105, P360, DOI 10.1210/endo-105-2-360; GARRETT JE, 1995, ENDOCRINOLOGY, V136, P5202, DOI 10.1210/en.136.11.5202; Gogusev J, 1997, KIDNEY INT, V51, P328, DOI 10.1038/ki.1997.41; HEIDIN CH, 1995, CELL, V80, P213; Huang CF, 1997, MOL BIOL CELL, V8, P2365, DOI 10.1091/mbc.8.12.2365; Isshiki M, 1998, P NATL ACAD SCI USA, V95, P5009, DOI 10.1073/pnas.95.9.5009; Kifor O, 1997, J BONE MINER RES, V12, P715, DOI 10.1359/jbmr.1997.12.5.715; Kifor O, 1996, J CLIN ENDOCR METAB, V81, P1598, DOI 10.1210/jc.81.4.1598; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; Liu J, 1997, J BIOL CHEM, V272, P7211, DOI 10.1074/jbc.272.11.7211; LIU PS, 1995, J BIOL CHEM, V270, P27179, DOI 10.1074/jbc.270.45.27179; Liu PS, 1996, J BIOL CHEM, V271, P10299, DOI 10.1074/jbc.271.17.10299; Mastick CC, 1997, J BIOL CHEM, V272, P20706, DOI 10.1074/jbc.272.33.20706; McNeil SE, 1998, J BIOL CHEM, V273, P1114, DOI 10.1074/jbc.273.2.1114; Michel JB, 1997, J BIOL CHEM, V272, P15583, DOI 10.1074/jbc.272.25.15583; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; Mineo C, 1996, J BIOL CHEM, V271, P11930, DOI 10.1074/jbc.271.20.11930; Mineo C, 1996, MOL BIOL CELL, V7, P1604; MITHAL A, 1995, ENDOCRINOLOGY, V136, P3087, DOI 10.1210/en.136.7.3087; Oka N, 1997, J BIOL CHEM, V272, P33416, DOI 10.1074/jbc.272.52.33416; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; PARTON RG, 1995, SCIENCE, V269, P1398, DOI 10.1126/science.7660120; PEARCE S, 1995, J CLIN INVEST, V52, P736; RICCARDI D, 1995, P NATL ACAD SCI USA, V92, P131, DOI 10.1073/pnas.92.1.131; Ross ME, 1996, METHOD ENZYMOL, V269, P408; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; SCHNITZER JE, 1995, J BIOL CHEM, V270, P14399, DOI 10.1074/jbc.270.24.14399; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; SMART EJ, 1995, J CELL BIOL, V131, P929, DOI 10.1083/jcb.131.4.929; Smart EJ, 1996, J BIOL CHEM, V271, P29427, DOI 10.1074/jbc.271.46.29427; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Tang ZL, 1997, J BIOL CHEM, V272, P2437, DOI 10.1074/jbc.272.4.2437; TSUCHIYA T, 1980, HISTOCHEMISTRY, V65, P321, DOI 10.1007/BF00493182; VARRAULT A, 1995, ENDOCRINOLOGY, V136, P4390, DOI 10.1210/en.136.10.4390; WILD P, 1995, MICROSC RES TECHNIQ, V32, P120, DOI 10.1002/jemt.1070320207; WILD P, 1990, HISTOCHEMISTRY, V94, P409	53	112	115	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21708	21713		10.1074/jbc.273.34.21708	http://dx.doi.org/10.1074/jbc.273.34.21708			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705306	hybrid			2022-12-27	WOS:000075492600040
J	Song, CS; Jung, MH; Kim, SC; Hassan, T; Roy, AK; Chatterjee, B				Song, CS; Jung, MH; Kim, SC; Hassan, T; Roy, AK; Chatterjee, B			Tissue-specific and androgen-repressible regulation of the rat dehydroepiandrosterone sulfotransferase gene promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENRICHED TRANSCRIPTION FACTOR; NF-KAPPA-B; DNA-BINDING; HYDROXYSTEROID SULFOTRANSFERASE; MOLECULAR-CLONING; MESSENGER-RNA; RECEPTOR GENE; LIVER; PROTEIN; HORMONE	Dehydroepiandrosterone sulfotransferase (Std) catalyzes sulfonation of androgenic steroids and certain aromatic procarcinogens, In rats, this enzyme is selectively expressed in the fiver, and its expression is strongly repressed by androgens, DNase I footprinting and electrophoretic mobility shift analyses revealed two hepatocyte nuclear factor-1 (HNF1), three CCAAT/enhancer-binding protein (C/EBP), and one consensus palindromic thyroid hormone response elements within the first 215 base pairs (bp) of the promoter sequence of sat Std. This promoter is normally inactive in fibroblast-derived NIH 3T3 cells. However, overexpression of HNF1 and C/EBP resulted in synergistic activation of the Std promoter in this cell type, indicating essential roles of these two trans-regulators in liver-selective expression of the rat Std gene. On the other hand, point mutations at any one of five cis elements proximal to the -215 bp region markedly reduced reporter gene expression, suggesting that all of these sites are important for overall promoter function. Androgenic repression of the Std gene in rat liver can be recapitulated in androgen receptor (AR)-negative HepG2 hepatoma cells after co-transfection with an AR expression plasmid. Functional assay of a nested set of 5'-deleted promoters mapped the negative androgen response region between positions -235 and -310, Antibody supershift and oligonucleotide competition identified three OCT-1 and two C/EBP elements between bp -231 and -292, An additional OCT-1 site was found to overlap with a C/EBP element at the -262/-252 position. Mutational inactivation of any one of five cis elements within the -231/-292 region abolished negative androgen response, However, none of these cis elements showed DNase I protection by recombinant AR in footprinting assay, suggesting the absence of a direct AR-DNA interaction. Thus, these studies on rat Std promoter function indicate that (i) HNF1 and C/EBP are responsible for Liver specificity of the rat Std gene; (ii) androgenic repression of the gene requires the presence of all of the OCT-1 and C/EBP elements between positions -231 and -292; and (iii) AR may exert its negative regulatory effect indirectly through transcriptional interference of OCT-1 and C/EBP rather than through a direct DNA-AR interaction.	Univ Texas, Hlth Sci Ctr, Dept Struct & Cellular Biol, San Antonio, TX 78284 USA; Audie L Murphy Mem Vet Hosp, San Antonio, TX 78284 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Chatterjee, B (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Struct & Cellular Biol, San Antonio, TX 78284 USA.				NATIONAL INSTITUTE ON AGING [R01AG003527] Funding Source: NIH RePORTER; NIA NIH HHS [AG-03527] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan J, 1998, CHEM-BIOL INTERACT, V109, P267, DOI 10.1016/S0009-2797(97)00138-5; Chatterjee B, 1996, P NATL ACAD SCI USA, V93, P728, DOI 10.1073/pnas.93.2.728; CHATTERJEE B, 1987, J BIOL CHEM, V262, P822; CHEN C, 1987, MOL CELL BIOL, V7, P2031; Compagnone NA, 1998, P NATL ACAD SCI USA, V95, P4678, DOI 10.1073/pnas.95.8.4678; DEMYAN WF, 1992, MOL ENDOCRINOL, V6, P589, DOI 10.1210/me.6.4.589; Flesher JW, 1997, BIOCHEM BIOPH RES CO, V234, P554, DOI 10.1006/bbrc.1997.6679; Glatt H, 1997, FASEB J, V11, P314, DOI 10.1096/fasebj.11.5.9141497; GonzalezCouto E, 1997, P NATL ACAD SCI USA, V94, P8036, DOI 10.1073/pnas.94.15.8036; HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777; Heckert LL, 1997, MOL ENDOCRINOL, V11, P1497, DOI 10.1210/me.11.10.1497; HO AN, 1989, GENE, V77, P51; HOBKIRK R, 1993, TRENDS ENDOCRIN MET, V4, P69, DOI 10.1016/S1043-2760(05)80018-9; HOMMA H, 1994, CHEM-BIOL INTERACT, V92, P15, DOI 10.1016/0009-2797(94)90049-3; Ikonen T, 1997, J BIOL CHEM, V272, P29821, DOI 10.1074/jbc.272.47.29821; JOHNSON PF, 1987, GENE DEV, V1, P133, DOI 10.1101/gad.1.2.133; KALLIO PJ, 1995, MOL ENDOCRINOL, V9, P1017, DOI 10.1210/me.9.8.1017; LABRIE Y, 1994, ENDOCRINOLOGY, V134, P1693, DOI 10.1210/en.134.4.1693; LAI E, 1990, GENE DEV, V4, P1427, DOI 10.1101/gad.4.8.1427; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MENDEL DB, 1991, J BIOL CHEM, V266, P677; MUELLER CR, 1990, CELL, V61, P279, DOI 10.1016/0092-8674(90)90808-R; OGURA K, 1990, BIOCHEM BIOPH RES CO, V166, P1494, DOI 10.1016/0006-291X(90)91036-R; Osada S, 1996, J BIOL CHEM, V271, P3891; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; OTTERNESS DM, 1995, DNA CELL BIOL, V14, P331, DOI 10.1089/dna.1995.14.331; Palvimo JJ, 1996, J BIOL CHEM, V271, P24151, DOI 10.1074/jbc.271.39.24151; PASQUALINI JR, 1992, EUR J CANCER, V28A, P758, DOI 10.1016/0959-8049(92)90110-N; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; RENNIE PS, 1993, MOL ENDOCRINOL, V7, P23, DOI 10.1210/me.7.1.23; ROCHE PJ, 1992, MOL ENDOCRINOL, V6, P2229, DOI 10.1210/me.6.12.2229; Roy AK, 1999, VITAM HORM, V55, P309; ROY AK, 1992, P SOC EXP BIOL MED, V199, P265; Samadani U, 1996, MOL CELL BIOL, V16, P6273; Schneikert J, 1996, J BIOL CHEM, V271, P23907, DOI 10.1074/jbc.271.39.23907; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; SONG CS, 1993, BIOCHEM J, V294, P779, DOI 10.1042/bj2940779; SONG CS, 1990, BIOCHEMISTRY-US, V29, P542, DOI 10.1021/bi00454a031; Sourla A, 1998, ENDOCRINOLOGY, V139, P753, DOI 10.1210/en.139.2.753; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Strott CA, 1996, ENDOCR REV, V17, P670, DOI 10.1210/er.17.6.670; Suh DS, 1997, MOL ENDOCRINOL, V11, P1822, DOI 10.1210/me.11.12.1822; SUPAKAR PC, 1995, J BIOL CHEM, V270, P837, DOI 10.1074/jbc.270.2.837; Weinshilboum RM, 1997, FASEB J, V11, P3, DOI 10.1096/fasebj.11.1.9034160; WILSON JD, 1993, ENDOCR REV, V14, P577, DOI 10.1210/er.14.5.577; XIE YB, 1992, J BIOL CHEM, V267, P4939; YAMAZOE Y, 1989, MOL PHARMACOL, V35, P707; YANUKAKASHLES O, 1994, MOL CELL BIOL, V14, P7124, DOI 10.1128/MCB.14.11.7124	49	58	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21856	21866		10.1074/jbc.273.34.21856	http://dx.doi.org/10.1074/jbc.273.34.21856			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705324	hybrid			2022-12-27	WOS:000075492600058
J	Xu, Y; Wong, SH; Tang, BL; Subramaniam, VN; Zhang, T; Hong, WJ				Xu, Y; Wong, SH; Tang, BL; Subramaniam, VN; Zhang, T; Hong, WJ			A 29-kilodalton Golgi soluble N-ethylmaleimide-sensitive factor attachment protein receptor (Vti1-rp2) implicated in protein trafficking in the secretory pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRAL MEMBRANE-PROTEIN; ENDOPLASMIC-RETICULUM; VESICULAR TRANSPORT; SYNTAXIN FAMILY; CIS-GOLGI; SNARE; COMPLEX; YEAST; VESICLES; FUSION	Expressed sequence tags coding for a potential SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) were revealed during data base searches. The deduced amino acid sequence of the complete coding region predicts a 217-residue protein with a COOH-terminal hydrophobic membrane anchor. Affinity-purified antibodies raised against the cytoplasmic region of this protein specifically detect a 29-kilo-dalton integral membrane protein enriched in the Golgi membrane. Indirect immunofluorescence microscopy reveals that this protein is mainly associated with the Golgi apparatus. When detergent extracts of the Golgi membrane are incubated with immobilized glutathione S-transferase a soluble N-ethylmaleimide-sensitive factor attachment protein (GST-alpha-SNAP), this protein was specifically retained. This protein has been independently identified and termed Vtil-rp2, and it is homologous to Vti1p, a yeast Golgi SNARE. We further show that Vti1-rp2 can be qualitatively coimmunoprecipitated with Golgi syntaxin 5 and syntaxin 6, suggesting that Vti1-rp2 exists in at least two distinct Golgi SNARE complexes. In cells microinjected with antibodies against Vti1-rp2, transport of the envelope protein (G-protein) of vesicular stomatitis virus from the endoplasmic reticulum to the plasma membrane was specifically arrested at the Golgi apparatus, providing further evidence for functional importance of Vtil-rpa in protein trafficking in the secretory pathway.	Inst Mol & Cell Biol, Membrane Biol Lab, Singapore 117609, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Hong, WJ (corresponding author), Inst Mol & Cell Biol, Membrane Biol Lab, 30 Med Dr, Singapore 117609, Singapore.	mcbhwj@imcb.nus.edu.sg	HONG, Wanjin/E-9927-2010; Subramaniam, V. Nathan/A-1901-2010; Tang, Bor Luen/E-4548-2012	Subramaniam, V. Nathan/0000-0002-4583-7790; Tang, Bor Luen/0000-0002-1925-636X				Advani RJ, 1998, J BIOL CHEM, V273, P10317, DOI 10.1074/jbc.273.17.10317; BANFIELD DK, 1994, J CELL BIOL, V127, P357, DOI 10.1083/jcb.127.2.357; Becherer KA, 1996, MOL BIOL CELL, V7, P579, DOI 10.1091/mbc.7.4.579; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; Bock JB, 1996, J BIOL CHEM, V271, P17961, DOI 10.1074/jbc.271.30.17961; DASCHER C, 1994, J BIOL CHEM, V269, P29363; Davanger S, 1997, MOL BIOL CELL, V8, P1261, DOI 10.1091/mbc.8.7.1261; FERRONOVICK S, 1994, NATURE, V370, P191, DOI 10.1038/370191a0; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HARDWICK KG, 1992, J CELL BIOL, V119, P513, DOI 10.1083/jcb.119.3.513; HAY JC, 1997, CELL, V89, P147; Holthuis JCM, 1998, EMBO J, V17, P113, DOI 10.1093/emboj/17.1.113; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; LOUVARD D, 1982, J CELL BIOL, V92, P92, DOI 10.1083/jcb.92.1.92; Lowe SL, 1996, J CELL SCI, V109, P209; Lowe SL, 1997, NATURE, V389, P881, DOI 10.1038/39923; Lupashin VV, 1997, MOL BIOL CELL, V8, P2659, DOI 10.1091/mbc.8.12.2659; MOREMEN KW, 1991, J CELL BIOL, V115, P1521, DOI 10.1083/jcb.115.6.1521; Nagahama M, 1996, J CELL BIOL, V133, P507, DOI 10.1083/jcb.133.3.507; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2; Pfeffer SR, 1996, ANNU REV CELL DEV BI, V12, P441, DOI 10.1146/annurev.cellbio.12.1.441; PRYER NK, 1992, ANNU REV BIOCHEM, V61, P471; ROTHMAN JE, 1994, CURR BIOL, V4, P220, DOI 10.1016/S0960-9822(00)00051-8; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; SCHELLER RH, 1995, NEURON, V14, P893; SOGAARD M, 1994, CELL, V78, P937, DOI 10.1016/0092-8674(94)90270-4; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Subramaniam VN, 1997, J BIOL CHEM, V272, P25441, DOI 10.1074/jbc.272.41.25441; Subramaniam VN, 1996, SCIENCE, V272, P1161, DOI 10.1126/science.272.5265.1161; SUBRAMANIAM VN, 1995, J CELL SCI, V108, P2405; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; von Mollard GF, 1998, J BIOL CHEM, V273, P2624, DOI 10.1074/jbc.273.5.2624; vonMollard GF, 1997, J CELL BIOL, V137, P1511, DOI 10.1083/jcb.137.7.1511; WHITEHEART SW, 1995, TRENDS CELL BIOL, V5, P84; Wong SH, 1998, J BIOL CHEM, V273, P375, DOI 10.1074/jbc.273.1.375; Xu Y, 1997, J BIOL CHEM, V272, P20162, DOI 10.1074/jbc.272.32.20162; Zhang T, 1997, J CELL BIOL, V139, P1157, DOI 10.1083/jcb.139.5.1157	40	52	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21783	21789		10.1074/jbc.273.34.21783	http://dx.doi.org/10.1074/jbc.273.34.21783			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705316	hybrid			2022-12-27	WOS:000075492600050
J	Jansson, M; Andersson, G; Uhlen, M; Nilsson, B; Kordel, J				Jansson, M; Andersson, G; Uhlen, M; Nilsson, B; Kordel, J			The insulin-like growth factor (IGF)binding protein 1 binding epitope on IGF-I probed by heteronuclear NMB spectroscopy and mutational analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOTOPICALLY-ENRICHED PROTEINS; NUCLEAR-MAGNETIC-RESONANCE; ESCHERICHIA-COLI; SIDE-CHAIN; LIGAND INTERACTIONS; RECEPTOR-BINDING; FUSION PROTEINS; ASSIGNMENT; SPECTRA; DOMAIN	NMR spectroscopy studies and biosensor interaction analysis of native and site-directed mutants of insulinlike growth factor I (IGF-I) was applied to identify the involvement of individual residues in IGF-I binding to IGF-binding protein 1 (IGFBP-1). Backbone NMR chemical shifts were found to be affected by IGFBP-1 binding in the following residues: Pro(2), Glu(3), Cys(6), Gly(7), Gly(19), Pro(28)-Gly(30), Gly(32), Arg(36), Arg(37), Gln(40)-Gly(42), Pro(63), Lys(65), Pro(66), and Lys(68)-Ala(70). Three IGF-I arginine side chains were identified by NMR to participate in IGFBP-1 binding. All IGF-I arginine residues were replaced by alanines, using site-directed mutagenesis, in four single substituted variants, IGF-I(R21A), IGF-I(R50A), IGF-I(R55A), and IGF-I(R56A), and one double replacement mutant, IGF-I(R36A/R37A), Biosensor interaction analysis binding studies demonstrate the involvement of Arg(36)-Arg(37) and Arg(50) in IGFBP-1 binding, while experiments with the IGF-I receptor implicate Arg(21), Arg(36)-Arg(37), and Arg(56) as part of the receptor binding epitope, These overlapping binding surfaces explain why IGF-I receptor and IGFBP-1 binding to IGF-I is competitive, The C terminus of free, but not IGFBP-1-bound, IGF-I is found to exist in two distinct, NMR-detectable conformations at 30 degrees C, One possible explanation for this structural heterogeneity could be cis-trans isomerization of the Cys(6)-Cys(48) disulfide bond.	Pharmacia & Upjohn Inc, Dept Struct Chem, SE-11237 Stockholm, Sweden; Royal Inst Technol, Dept Biochem & Biotechnol, SE-10044 Stockholm, Sweden	Pfizer; Pharmacia Corporation; Royal Institute of Technology	Kordel, J (corresponding author), Pharmacia & Upjohn Inc, Dept Struct Chem, SE-11237 Stockholm, Sweden.	johan.kordel@eu.pnu.com	Uhlen, Mathias/B-3262-2016; Uhlen, Mathias/AAV-8746-2021	Uhlen, Mathias/0000-0002-4858-8056; 				ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; BACH LA, 1993, J BIOL CHEM, V268, P9246; BAGLEY CJ, 1989, BIOCHEM J, V259, P665, DOI 10.1042/bj2590665; BALLARD FJ, 1987, BIOCHEM BIOPH RES CO, V149, P398, DOI 10.1016/0006-291X(87)90380-9; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; CLEMMONS DR, 1992, ENDOCRINOLOGY, V131, P890, DOI 10.1210/en.131.2.890; COOKE RM, 1991, BIOCHEMISTRY-US, V30, P5484, DOI 10.1021/bi00236a022; Craven CJ, 1996, BIOCHEMISTRY-US, V35, P10287, DOI 10.1021/bi9605043; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FORSBERG G, 1990, BIOCHEM J, V271, P357, DOI 10.1042/bj2710357; Gargaro AR, 1996, EUR J BIOCHEM, V238, P435, DOI 10.1111/j.1432-1033.1996.0435z.x; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; HOBER S, 1994, BIOCHEMISTRY-US, V33, P6758, DOI 10.1021/bi00188a003; HUA QX, 1993, P NATL ACAD SCI USA, V90, P582, DOI 10.1073/pnas.90.2.582; Hua QX, 1996, J MOL BIOL, V259, P297, DOI 10.1006/jmbi.1996.0320; Jansson M, 1997, J BIOL CHEM, V272, P8189, DOI 10.1074/jbc.272.13.8189; Jansson M, 1996, J BIOMOL NMR, V7, P131; Jansson M, 1997, FEBS LETT, V416, P259, DOI 10.1016/S0014-5793(97)01149-6; Jansson M, 1997, BIOCHEMISTRY-US, V36, P4108, DOI 10.1021/bi961553i; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; KOBAYASHI Y, 1991, PEPTIDES 1990, P565; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRAULIS PJ, 1989, J MAGN RESON, V84, P627, DOI 10.1016/0022-2364(89)90130-3; KRAULIS PJ, 1994, BIOCHEMISTRY-US, V33, P3515, DOI 10.1021/bi00178a008; LOFAS S, 1990, J CHEM SOC CHEM COMM, P1526, DOI 10.1039/c39900001526; LOGAN TM, 1992, FEBS LETT, V314, P413, DOI 10.1016/0014-5793(92)81517-P; McAlister MSB, 1996, BIOCHEMISTRY-US, V35, P5982, DOI 10.1021/bi952756u; MOHAN S, 1995, J BIOL CHEM, V270, P20424, DOI 10.1074/jbc.270.35.20424; MONTELIONE GT, 1992, J AM CHEM SOC, V114, P10974, DOI 10.1021/ja00053a051; Moore DD, 1995, GLOB MOB SURV; MUHANDIRAM DR, 1993, J MAGN RESON SER B, V102, P317, DOI 10.1006/jmrb.1993.1102; NILSSON B, 1987, PROTEIN ENG, V1, P107, DOI 10.1093/protein/1.2.107; NILSSON B, 1991, METHOD ENZYMOL, V198, P3; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; OMICHINSKI JG, 1993, SCIENCE, V261, P438, DOI 10.1126/science.8332909; OTTING G, 1993, BIOCHEMISTRY-US, V32, P3571, DOI 10.1021/bi00065a008; OTTING G, 1993, CURR OPIN STRUC BIOL, V3, P760, DOI 10.1016/0959-440X(93)90061-O; PASCAL SM, 1994, J MAGN RESON SER B, V103, P197, DOI 10.1006/jmrb.1994.1031; PASCAL SM, 1994, CELL, V77, P461, DOI 10.1016/0092-8674(94)90160-0; SANTORO J, 1992, J MAGN RESON, V97, P202, DOI 10.1016/0022-2364(92)90250-B; SATO A, 1992, J BIOCHEM-TOKYO, V111, P529, DOI 10.1093/oxfordjournals.jbchem.a123791; SATO A, 1993, INT J PEPT PROT RES, V41, P433; SWISSHELM K, 1995, P NATL ACAD SCI USA, V92, P4472, DOI 10.1073/pnas.92.10.4472; TERASAWA H, 1994, EMBO J, V13, P5590, DOI 10.1002/j.1460-2075.1994.tb06896.x; TORRES AM, 1995, J MOL BIOL, V248, P385, DOI 10.1006/jmbi.1995.0229; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; YAMAZAKI T, 1995, J AM CHEM SOC, V117, P3556, DOI 10.1021/ja00117a025; ZHANG WG, 1994, J BIOL CHEM, V269, P10609	50	37	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24701	24707		10.1074/jbc.273.38.24701	http://dx.doi.org/10.1074/jbc.273.38.24701			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733769	hybrid			2022-12-27	WOS:000076007300061
J	Katan-Khaykovich, Y; Shaul, Y				Katan-Khaykovich, Y; Shaul, Y			RFX1, a single DNA-binding protein with a split dimerization domain, generates alternative complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B VIRUS ENHANCER; II GENE-REGULATION; FACTOR EF-C; NUCLEAR FACTOR; NF-X; TRANSCRIPTION; PROMOTER; ELEMENT; REGION; FAMILY	The transcription of various viral and cellular genes is regulated by palindromic and nonpalindromic DNA sites resembling the EP element of the hepatitis B virus enhancer, which generate similar DNA-protein complexes. The upper EP complex contains homodimers of the transcription regulator RFX1. We show that RFX1 possesses a split, extended dimerization domain composed of several evolutionarily conserved boxes, one of which was previously shown to mediate dimerization. Such an unusually long and complex dimerization domain could potentially serve for generating multiple complexes. In addition to the previously characterized complex, RFX1 generated a novel DNA-protein complex of extremely low mobility, formed only with palindromic DNA sites. Different deletions within the dimerization domain altered the relative abundance of the two complexes, suggesting an interplay between them. Formation of the low mobility complex correlated with transcriptional repression, in that both activities were mediated by several portions of the conserved region. Our results propose a mechanism by which the extended dimerization domain mediates the formation of alternative homodimeric complexes, which differ in the nature of the intersubunit interaction. By participating in different types of interactions, this domain may regulate the relative abundance of the different complexes, thus affecting transcriptional activity.	Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Shaul, Y (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	lvshaul@weizmann.weizmann.ac.il						Agami R, 1998, ONCOGENE, V16, P1779, DOI 10.1038/sj.onc.1201708; BENLEVY R, 1989, MOL CELL BIOL, V9, P1804, DOI 10.1128/MCB.9.4.1804; Blake M, 1996, J VIROL, V70, P6060, DOI 10.1128/JVI.70.9.6060-6066.1996; BOLWIG GM, 1991, J VIROL, V65, P1884, DOI 10.1128/JVI.65.4.1884-1892.1991; Buckwold VE, 1997, VIROLOGY, V227, P515, DOI 10.1006/viro.1996.8360; DAVID E, 1995, J BIOL CHEM, V270, P8353, DOI 10.1074/jbc.270.14.8353; DIKSTEIN R, 1992, CELL, V69, P751, DOI 10.1016/0092-8674(92)90287-M; DIKSTEIN R, 1990, MOL CELL BIOL, V10, P3683, DOI 10.1128/MCB.10.7.3683; Emery P, 1996, MOL CELL BIOL, V16, P4486; Emery P, 1996, NUCLEIC ACIDS RES, V24, P803, DOI 10.1093/nar/24.5.803; GARCIA AD, 1991, VIROLOGY, V182, P857, DOI 10.1016/0042-6822(91)90629-P; GARCIA AD, 1993, J VIROL, V67, P3940, DOI 10.1128/JVI.67.7.3940-3950.1993; Katan Y, 1997, NUCLEIC ACIDS RES, V25, P3621, DOI 10.1093/nar/25.18.3621; KOUSKOFF V, 1991, J IMMUNOL, V146, P3197; Lee BH, 1998, J VIROL, V72, P1138, DOI 10.1128/JVI.72.2.1138-1145.1998; Ori A, 1998, EMBO J, V17, P544, DOI 10.1093/emboj/17.2.544; OSTAPCHUK P, 1989, MOL CELL BIOL, V9, P2787, DOI 10.1128/MCB.9.7.2787; OSTAPCHUK P, 1986, P NATL ACAD SCI USA, V83, P8550, DOI 10.1073/pnas.83.22.8550; REINHOLD W, 1995, MOL CELL BIOL, V15, P3041; REITH W, 1994, MOL CELL BIOL, V14, P1230, DOI 10.1128/MCB.14.2.1230; REITH W, 1990, GENE DEV, V4, P1528, DOI 10.1101/gad.4.9.1528; REITH W, 1989, P NATL ACAD SCI USA, V86, P4200, DOI 10.1073/pnas.86.11.4200; SAFRANY G, 1993, GENE, V132, P279, DOI 10.1016/0378-1119(93)90208-K; SANCHEZ CH, 1992, MOL CELL BIOL, V12, P4076, DOI 10.1128/MCB.12.9.4076; SAUER F, 1993, NATURE, V364, P454, DOI 10.1038/364454a0; SAUER F, 1995, NATURE, V375, P162, DOI 10.1038/375162a0; SIEGRIST CA, 1993, EUR J IMMUNOL, V23, P2903, DOI 10.1002/eji.1830231126; SIEGRIST CA, 1993, MOL CELL BIOL, V13, P6375, DOI 10.1128/MCB.13.10.6375; STEIMLE V, 1995, GENE DEV, V9, P1021, DOI 10.1101/gad.9.9.1021; SUPAKAR PC, 1989, NUCLEIC ACIDS RES, V17, P8611, DOI 10.1093/nar/17.21.8611; TSANG SY, 1990, MOL CELL BIOL, V10, P711, DOI 10.1128/MCB.10.2.711; TSANG SY, 1988, P NATL ACAD SCI USA, V85, P8598, DOI 10.1073/pnas.85.22.8598; WU SY, 1995, MOL CELL BIOL, V15, P1479; ZAJAC-KAYE M, 1990, J BIOL CHEM, V265, P4547; ZAJAC-KAYE M, 1988, SCIENCE, V240, P1776, DOI 10.1126/science.2454510; ZECHEL C, 1994, EMBO J, V13, P1425, DOI 10.1002/j.1460-2075.1994.tb06396.x; ZECHEL C, 1994, EMBO J, V13, P1414, DOI 10.1002/j.1460-2075.1994.tb06395.x; ZHANG XY, 1993, MOL CELL BIOL, V13, P6810, DOI 10.1128/MCB.13.11.6810; ZHANG XY, 1990, NUCLEIC ACIDS RES, V18, P6253, DOI 10.1093/nar/18.21.6253	39	24	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24504	24512		10.1074/jbc.273.38.24504	http://dx.doi.org/10.1074/jbc.273.38.24504			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733744	hybrid			2022-12-27	WOS:000076007300036
J	Orozco, BM; Hanley-Bowdoin, L				Orozco, BM; Hanley-Bowdoin, L			Conserved sequence and structural motifs contribute to the DNA binding and cleavage activities of a geminivirus replication protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLDEN MOSAIC-VIRUS; WHEAT DWARF VIRUS; REP PROTEIN; VIRAL-DNA; TRANSCRIPTIONAL REGULATION; INITIATOR PROTEINS; GENETIC-ANALYSIS; PLANT-CELLS; IDENTIFICATION; EXPRESSION	Tomato golden mosaic virus (TGMV), a member of the geminivirus family, has a single-stranded DNA genome that replicates through a rolling circle mechanism in nuclei of infected plant cells. TGMV encodes one essential replication protein, AL1, and recruits the rest of the DNA replication apparatus from its host. AL1 is a multifunctional protein that binds double-stranded DNA, catalyzes cleavage and ligation of single-stranded DNA, and forms oligomers, Earlier experiments showed that the region of TG:MV AL1 necessary for DNA binding maps to the N-terminal 181 amino acids of the protein and overlaps the DNA cleavage (amino acids 1-120) and oligomerization (amino acids 134-181) domains. In this study, we generated a series of site-directed mutations in conserved sequence and structural motifs in the overlapping DNA binding and cleavage domains and analyzed their impact on AL1 function in vivo and in vitro. Only two of the fifteen mutant proteins were capable of supporting viral DNA synthesis in tobacco protoplasts. In vitro experiments demonstrated that a pair of predicted alpha-helices with highly conserved charged residues are essential for DNA binding and cleavage. Three sequence motifs conserved among geminivirus AL1 proteins and initiator proteins from other rolling circle systems are also required for both activities. We used truncated AL1 proteins fused to a heterologous dimerization domain to show that the DNA binding domain is located between amino acids 1 and 130 and that binding is dependent on protein dimerization, In contrast, AL1 monomers were sufficient for DNA cleavage and ligation, Together, these results established that the conserved motifs in the AL1 N terminus contribute to DNA binding and cleavage with both activities displaying nearly identical amino acid requirements. However, DNA binding was readily distinguished from cleavage and ligation by its dependence on AL1/AL1 interactions.	N Carolina State Univ, Dept Biochem, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Orozco, BM (corresponding author), N Carolina State Univ, Dept Biochem, Box 7622, Raleigh, NC 27695 USA.	orozco@bchserver.bch.ncsu.edu		Hanley-Bowdoin, Linda/0000-0001-7999-8595				Ach RA, 1997, MOL CELL BIOL, V17, P5077, DOI 10.1128/MCB.17.9.5077; ARGUELLOASTORGA GR, 1994, VIROLOGY, V203, P90, DOI 10.1006/viro.1994.1458; BISARO DM, 1982, NUCLEIC ACIDS RES, V10, P4913, DOI 10.1093/nar/10.16.4913; CHOI IR, 1995, VIROLOGY, V206, P904, DOI 10.1006/viro.1995.1013; Collin S, 1996, VIROLOGY, V219, P324, DOI 10.1006/viro.1996.0256; CORUZZI G, 1984, EMBO J, V3, P1671, DOI 10.1002/j.1460-2075.1984.tb02031.x; DELSOLAR G, 1993, MOL MICROBIOL, V8, P789; DESBIEZ C, 1995, P NATL ACAD SCI USA, V92, P5640, DOI 10.1073/pnas.92.12.5640; EAGLE PA, 1994, PLANT CELL, V6, P1157, DOI 10.1105/tpc.6.8.1157; Eagle PA, 1997, J VIROL, V71, P6947, DOI 10.1128/JVI.71.9.6947-6955.1997; ELMER JS, 1988, NUCLEIC ACIDS RES, V16, P7043, DOI 10.1093/nar/16.14.7043; FONTES EPB, 1992, PLANT CELL, V4, P597, DOI 10.1105/tpc.4.5.597; FONTES EPB, 1994, J BIOL CHEM, V269, P8459; FONTES EPB, 1994, PLANT CELL, V6, P405, DOI 10.1105/tpc.6.3.405; Gladfelter HJ, 1997, VIROLOGY, V239, P186, DOI 10.1006/viro.1997.8869; HAMILTON WDO, 1983, NUCLEIC ACIDS RES, V11, P7387, DOI 10.1093/nar/11.21.7387; HANLEYBOWDOIN L, 1998, IN PRESS CRIT REV PL; HEYRAUD F, 1993, EMBO J, V12, P4445, DOI 10.1002/j.1460-2075.1993.tb06130.x; HEYRAUDNITSCHKE F, 1995, NUCLEIC ACIDS RES, V23, P910, DOI 10.1093/nar/23.6.910; Hoogstraten RA, 1996, MOL PLANT MICROBE IN, V9, P594, DOI 10.1094/MPMI-9-0594; ILYINA TV, 1992, NUCLEIC ACIDS RES, V20, P3279, DOI 10.1093/nar/20.13.3279; JUPIN I, 1995, FEBS LETT, V362, P116, DOI 10.1016/0014-5793(95)00221-T; KAY R, 1987, SCIENCE, V236, P1299, DOI 10.1126/science.236.4806.1299; KOONIN EV, 1992, J GEN VIROL, V73, P2763, DOI 10.1099/0022-1317-73-10-2763; KORNBERG A, 1992, DNA REPLICATION; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P482; LAUFS J, 1995, P NATL ACAD SCI USA, V92, P3879, DOI 10.1073/pnas.92.9.3879; Laufs J, 1995, FEBS LETT, V377, P258, DOI 10.1016/0014-5793(95)01355-5; LUCKOW VA, 1993, J VIROL, V67, P4566, DOI 10.1128/JVI.67.8.4566-4579.1993; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; NAGAR S, 1995, PLANT CELL, V7, P705, DOI 10.1105/tpc.7.6.705; NI TH, 1994, J VIROL, V68, P1128, DOI 10.1128/JVI.68.2.1128-1138.1994; NOIROTGROS MF, 1994, EMBO J, V13, P4412, DOI 10.1002/j.1460-2075.1994.tb06761.x; NUESCH JPF, 1995, VIROLOGY, V209, P122, DOI 10.1006/viro.1995.1236; Orozco BM, 1998, VIROLOGY, V242, P346, DOI 10.1006/viro.1997.9013; Orozco BM, 1996, J VIROL, V70, P148, DOI 10.1128/JVI.70.1.148-158.1996; Orozco BM, 1997, J BIOL CHEM, V272, P9840; SAUNDERS K, 1991, NUCLEIC ACIDS RES, V19, P2325, DOI 10.1093/nar/19.9.2325; Settlage SB, 1996, J VIROL, V70, P6790, DOI 10.1128/JVI.70.10.6790-6795.1996; SNYDER RO, 1990, CELL, V60, P105, DOI 10.1016/0092-8674(90)90720-Y; SOENGAS MS, 1992, EMBO J, V11, P4227, DOI 10.1002/j.1460-2075.1992.tb05517.x; STANLEY J, 1995, VIROLOGY, V206, P707, DOI 10.1016/S0042-6822(95)80093-X; STENGER DC, 1991, P NATL ACAD SCI USA, V88, P8029, DOI 10.1073/pnas.88.18.8029; SUNTER G, 1990, VIROLOGY, V179, P69, DOI 10.1016/0042-6822(90)90275-V; SUNTER G, 1993, VIROLOGY, V195, P275, DOI 10.1006/viro.1993.1374; SUNTER G, 1989, VIROLOGY, V170, P243, DOI 10.1016/0042-6822(89)90372-3; TIMMERMANS MCP, 1994, ANNU REV PLANT PHYS, V45, P79, DOI 10.1146/annurev.pp.45.060194.000455; XIE Q, 1995, EMBO J, V14, P4073, DOI 10.1002/j.1460-2075.1995.tb00079.x; Xie Q, 1996, EMBO J, V15, P4900, DOI 10.1002/j.1460-2075.1996.tb00870.x	49	74	77	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24448	24456		10.1074/jbc.273.38.24448	http://dx.doi.org/10.1074/jbc.273.38.24448			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733736	hybrid			2022-12-27	WOS:000076007300028
J	Lam, LT; Bresnick, EH				Lam, LT; Bresnick, EH			Identity of the beta-globin locus control region binding protein HS2NF5 as the mammalian homolog of the notch-regulated transcription factor suppressor of hairless	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARR-VIRUS EBNA2; ERYTHROID-DIFFERENTIATION; HYPERSENSITIVE SITES; TRANSGENIC MICE; GAMMA-GLOBIN; FACTOR NF-E2; CHROMATIN STRUCTURE; DROSOPHILA HOMOLOG; ACTIVATION REGION; GENE-CLUSTER	Previously, we characterized a DNA-binding protein, HS2NF5, that bound tightly to a conserved region within hypersensitive site 2 (HS2) of the human beta-globin locus control region (LCR) (Lam, L, T., and Bresnick, E. H. (1996) J. Biol. Chem. 271, 32421-32429). The beta-globin LCR controls the chromatin structure, transcription, and replication of the beta-globin genes. We have now purified HS2NF5 to near-homogeneity from fetal bovine thymus, Two polypeptides of 56 and 61 kDa copurified with the DNA binding activity. The two proteins bound to the LCR recognition site with an affinity (3.1 nM) and specificity similar to mouse erythroleukemia cell HS2NF5. The amino acid sequences of tryptic peptides of purified HS2NF5 revealed it to be identical to the murine homolog of the suppressor of hairless transcription factor, also known as recombination signal binding protein J(K) or C promoter binding factor 1 (CBF1). The CBF1 site within HS2 resides near sites for hematopoietic regulators such as GATA-1, NF-ES, and TAL1. An additional conserved, high affinity CBF1 site was localized within HS4 of the LCR, As CBF1 is a downstream target of the Notch signaling pathway, we propose that Notch may modulate LCR activity during hematopoiesis.	Univ Wisconsin, Sch Med, Dept Pharmacol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Bresnick, EH (corresponding author), Univ Wisconsin, Sch Med, Dept Pharmacol, 387 Med Sci Bldg,1300 Univ Ave, Madison, WI 53706 USA.	ehbresni@facstaff.wisc.edu			NIDDK NIH HHS [DK50107] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050107, R37DK050107] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Bray S, 1998, CELL, V93, P499, DOI 10.1016/S0092-8674(00)81180-0; BRESNICK EH, 1993, J BIOL CHEM, V268, P18824; BRESNICK EH, 1994, P NATL ACAD SCI USA, V91, P1314, DOI 10.1073/pnas.91.4.1314; Bresnick EH, 1997, P NATL ACAD SCI USA, V94, P4566, DOI 10.1073/pnas.94.9.4566; BRESNICK EH, 1997, CHEMTRACTS BIOCH MOL, V10, P1001; CATERINA JJ, 1994, NUCLEIC ACIDS RES, V22, P1006, DOI 10.1093/nar/22.6.1006; Christensen S, 1996, DEVELOPMENT, V122, P1373; Clark BR, 1995, ANN NY ACAD SCI, V770, P70, DOI 10.1111/j.1749-6632.1995.tb31044.x; DOU SB, 1994, MOL CELL BIOL, V14, P3310, DOI 10.1128/MCB.14.5.3310; ELLIS J, 1993, EMBO J, V12, P127, DOI 10.1002/j.1460-2075.1993.tb05638.x; Elnitski L, 1997, J BIOL CHEM, V272, P369; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; ENGEL JD, 1993, TRENDS GENET, V9, P304, DOI 10.1016/0168-9525(93)90248-G; ENVER T, 1994, DEV BIOL, V165, P574, DOI 10.1006/dbio.1994.1277; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; FIERING S, 1995, GENE DEV, V9, P2203, DOI 10.1101/gad.9.18.2203; FORRESTER WC, 1987, NUCLEIC ACIDS RES, V15, P10159, DOI 10.1093/nar/15.24.10159; FORRESTER WC, 1986, P NATL ACAD SCI USA, V83, P1359, DOI 10.1073/pnas.83.5.1359; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X; FURUKAWA T, 1994, BLOOD, V83, P1412; FURUKAWA T, 1991, J BIOL CHEM, V266, P23334; Gould KA, 1998, GENE EXPRESSION, V7, P87; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; HANSCOMBE O, 1991, GENE DEV, V5, P1387, DOI 10.1101/gad.5.8.1387; Hanspal M, 1997, Curr Opin Hematol, V4, P142; HARDISON R, 1993, NUCLEIC ACIDS RES, V21, P1265, DOI 10.1093/nar/21.5.1265; Hardison R, 1997, GENE, V205, P73, DOI 10.1016/S0378-1119(97)00474-5; HENKEL T, 1994, SCIENCE, V265, P92, DOI 10.1126/science.8016657; HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; KAWAICHI M, 1992, J BIOL CHEM, V267, P4016; Kimble J, 1997, ANNU REV CELL DEV BI, V13, P333, DOI 10.1146/annurev.cellbio.13.1.333; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Lam LT, 1996, J BIOL CHEM, V271, P32421, DOI 10.1074/jbc.271.50.32421; Lam LT, 1995, BIOCHEMISTRY-US, V34, P16347, DOI 10.1021/bi00050a015; LING PD, 1994, J VIROL, V68, P5375, DOI 10.1128/JVI.68.9.5375-5383.1994; LING PD, 1993, P NATL ACAD SCI USA, V90, P9237, DOI 10.1073/pnas.90.20.9237; LLOYD JA, 1992, MOL CELL BIOL, V12, P1561, DOI 10.1128/MCB.12.4.1561; MATSUNAMI N, 1989, NATURE, V342, P934, DOI 10.1038/342934a0; Milner LA, 1996, P NATL ACAD SCI USA, V93, P13014, DOI 10.1073/pnas.93.23.13014; MILNER LA, 1994, BLOOD, V83, P2057; MOI P, 1990, P NATL ACAD SCI USA, V87, P9000, DOI 10.1073/pnas.87.22.9000; Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3; NEY PA, 1993, MOL CELL BIOL, V13, P5604, DOI 10.1128/MCB.13.9.5604; OKA C, 1995, DEVELOPMENT, V121, P3291; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; PRUZINA S, 1991, NUCLEIC ACIDS RES, V19, P1413, DOI 10.1093/nar/19.7.1413; REDDY PMS, 1994, J BIOL CHEM, V269, P8287; Robb L, 1996, EMBO J, V15, P4123, DOI 10.1002/j.1460-2075.1996.tb00787.x; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; Ryan J A, 1989, Arch Psychiatr Nurs, V3, P323; SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O; SHIVDASANI RA, 1995, CELL, V81, P695, DOI 10.1016/0092-8674(95)90531-6; SORRENTINO B, 1990, NUCLEIC ACIDS RES, V18, P2721, DOI 10.1093/nar/18.9.2721; STAMATOYANNOPOULOS JA, 1995, EMBO J, V14, P106, DOI 10.1002/j.1460-2075.1995.tb06980.x; TALBOT D, 1990, EMBO J, V9, P2169, DOI 10.1002/j.1460-2075.1990.tb07386.x; TALBOT D, 1991, EMBO J, V10, P1391, DOI 10.1002/j.1460-2075.1991.tb07659.x; Taniguchi Y, 1998, MOL CELL BIOL, V18, P644, DOI 10.1128/MCB.18.1.644; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; TUAN D, 1984, P NATL ACAD SCI-BIOL, V81, P2718, DOI 10.1073/pnas.81.9.2718; TUAN DYH, 1989, P NATL ACAD SCI USA, V86, P2554, DOI 10.1073/pnas.86.8.2554; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Visvader JE, 1997, P NATL ACAD SCI USA, V94, P13707, DOI 10.1073/pnas.94.25.13707; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Wettstein DA, 1997, DEVELOPMENT, V124, P693; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353	71	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24223	24231		10.1074/jbc.273.37.24223	http://dx.doi.org/10.1074/jbc.273.37.24223			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727046	hybrid			2022-12-27	WOS:000075893100087
J	Mahmood, R; Ray, DS				Mahmood, R; Ray, DS			Nuclear extracts of Crithidia fasciculata contain a factor(s) that binds to the 5 '-untranslated regions of TOP2 and RPA1 mRNAs containing sequences required for their cell cycle regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; RNA-POLYMERASE-II; TRYPANOSOMA-BRUCEI; KINETOPLAST DNA; 3'-UNTRANSLATED REGION; GENE-EXPRESSION; MESSENGER-RNAS; TRANSCRIPTION; TOPOISOMERASE; LEISHMANIA	The Crithidia fasciculata replication protein A gene, RPA1, and topoisomerase II gene, TOP2, encode proteins involved in the replication of nuclear and mitochondrial DNA, respectively. Transcripts of both genes accumulate periodically during the cell cycle and attain their maximum levels just before S phase. Octamer consensus sequences within the 5'-untranslated region (UTR) of both genes have been shown to be necessary for cycling of these transcripts. Using a gel retardation assay, we show here that nuclear extracts of C. fasciculata contain a protein factor(s) that binds specifically to RNA from 5'-UTRs of TOP2 and RPA1 genes. In addition, mutations in the consensus octamer sequence abolish binding to the RNA in both cases. Ultraviolet cross-linking using a radiolabeled TOP2 5'-UTR probe identified proteins with apparent molecular masses of 74 and 37 kDa in the RNA-protein complex. Nuclear extracts prepared from synchronized cells show that the binding activity varies during the cell cycle in parallel with TOP2 and RPA1 mRNA levels. These results suggest that the cell cycle regulation of the mRNA levels of trypanosomatid DNA replication genes may be mediated by binding of specific proteins to conserved sequences in the 5'-UTR of their transcripts.	Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Ray, DS (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, 611 Circle Dr E, Los Angeles, CA 90095 USA.	danray@mbi.ucla.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053254, R56GM053254] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53254] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGABIAN N, 1990, CELL, V61, P1157, DOI 10.1016/0092-8674(90)90674-4; BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0; BONEN L, 1993, FASEB J, V7, P40, DOI 10.1096/fasebj.7.1.8422973; BROWN GW, 1994, MOL BIOCHEM PARASIT, V63, P135, DOI 10.1016/0166-6851(94)90016-7; BROWN GW, 1992, P NATL ACAD SCI USA, V89, P10227, DOI 10.1073/pnas.89.21.10227; Brown LM, 1997, NUCLEIC ACIDS RES, V25, P3281, DOI 10.1093/nar/25.16.3281; Charest H, 1996, J BIOL CHEM, V271, P17081, DOI 10.1074/jbc.271.29.17081; CLAYTON C, 1992, PROG NUCLEIC ACID RE, V43, P37, DOI 10.1016/S0079-6603(08)61043-0; DELAFAILLE MAC, 1992, P NATL ACAD SCI USA, V89, P2703, DOI 10.1073/pnas.89.7.2703; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Furger A, 1997, MOL CELL BIOL, V17, P4372, DOI 10.1128/MCB.17.8.4372; Graham SV, 1996, NUCLEIC ACIDS RES, V24, P272, DOI 10.1093/nar/24.2.272; GUTTES EW, 1967, BIOCHIM BIOPHYS ACTA, V142, P181, DOI 10.1016/0005-2787(67)90526-6; KONARSKA MM, 1986, CELL, V46, P845, DOI 10.1016/0092-8674(86)90066-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee MGS, 1996, MOL CELL BIOL, V16, P1220; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; PASION SG, 1992, MOL BIOCHEM PARASIT, V50, P57, DOI 10.1016/0166-6851(92)90244-E; PASION SG, 1994, J CELL SCI, V107, P3515; Pasion SG, 1996, MOL CELL BIOL, V16, P6724; Pays Etienne, 1993, Symposium of the Society for General Microbiology, V50, P127; SHAPIRO TA, 1995, ANNU REV MICROBIOL, V49, P117, DOI 10.1146/annurev.mi.49.100195.001001; SIMPSON L, 1986, INT REV CYTOL, V99, P119; WOODWARD R, 1990, J CELL SCI, V95, P49	24	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23729	23734		10.1074/jbc.273.37.23729	http://dx.doi.org/10.1074/jbc.273.37.23729			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726980	hybrid			2022-12-27	WOS:000075893100021
J	Feliciello, A; Rubin, CS; Avvedimento, EV; Gottesman, ME				Feliciello, A; Rubin, CS; Avvedimento, EV; Gottesman, ME			Expression of a kinase anchor protein 121 is regulated by hormones in thyroid and testicular germ cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-KINASE; II-BETA; CYCLIC-AMP; SUBUNITS; LOCALIZATION; CYTOSKELETON; CLONING; RAS; RII; BINDING	Distinct A Kinase Anchor Proteins (AKAPs) immobilize and concentrate protein kinase A II (PKAII) isoforms at specific intracellular locations. AKAP121 binds and targets PKAII alpha to the cytoplasmic surface of mitochondria. Mechanisms that control expression of this mitochondrial AKAP are unknown. We have cloned cDNA for rat AKAP-121 and show that AKAP121 protein expression is regulated by thyroid stimulating hormone (TSH) and cAMP. Differentiated thyroid cells (TL5) accumulate AKAP121 upon incubation with TSH or a cAMP analog. Levels of total and newly synthesized AKAP121 mRNA also increased after treatment. AKAP121 mRNA accumulated in the presence of cycloheximide, suggesting that transcription of the anchor protein gene is directly controlled by cAMP and PKA. AKAP121 is induced with similar kinetics when an unrelated, spermatocyte-derived cell line (GC-2) is incubated with 8-chlorophenylthio-cAMP. Thus, AKAP121 concentration may be controlled by hormones that activate adenylate cyclase. This mode of regulation could provide a general mechanism for (a) enhancing the sensitivity of distal organelles to cAMP and (b) shifting the focus of cAMP-mediated signaling from cytoplasm to organelles.	Columbia Univ, Inst Canc Res, New York, NY 10032 USA; Univ Naples Federico II, Fac Med, CNR,Ctr Endocrinol & Oncol Sperimentale, Dipartimento Biol & Patol Mol & Cellulare, I-80131 Naples, Italy; Fac Med, Dipartimento Med Sperimentale & Clin, Catanzaro, Italy; Albert Einstein Coll Med, Atran Labs, Dept Mol Pharmacol, Bronx, NY 10461 USA	Columbia University; Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II; Yeshiva University; Albert Einstein College of Medicine	Gottesman, ME (corresponding author), Columbia Univ, Inst Canc Res, HHSC Rm 914,701 W 168th, New York, NY 10031 USA.			Feliciello, Antonio/0000-0002-7932-2170	NIDDK NIH HHS [DK50702] Funding Source: Medline; NIGMS NIH HHS [GM 22792] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022792] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMBESIIMPIOMBATO FS, 1980, P NATL ACAD SCI-BIOL, V77, P3455, DOI 10.1073/pnas.77.6.3455; AVVEDIMENTO VE, 1991, GENE DEV, V5, P22, DOI 10.1101/gad.5.1.22; BREGMAN DB, 1989, J BIOL CHEM, V264, P4648; CARR DW, 1992, J BIOL CHEM, V267, P16816; CARR DW, 1993, J BIOL CHEM, V268, P20729; Cassano S, 1996, J BIOL CHEM, V271, P29870, DOI 10.1074/jbc.271.47.29870; Chen Q, 1997, J BIOL CHEM, V272, P15247, DOI 10.1074/jbc.272.24.15247; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Dong F, 1998, J BIOL CHEM, V273, P6533, DOI 10.1074/jbc.273.11.6533; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; Feliciello A, 1997, CURR BIOL, V7, P1011, DOI 10.1016/S0960-9822(06)00424-6; Feliciello A, 1996, J BIOL CHEM, V271, P25350, DOI 10.1074/jbc.271.41.25350; GALLO A, 1992, GENE DEV, V6, P1621, DOI 10.1101/gad.6.9.1621; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; GLANTZ SB, 1993, J BIOL CHEM, V268, P12796; HIRSCH AH, 1992, J BIOL CHEM, V267, P2131; HOFMANN MC, 1994, P NATL ACAD SCI USA, V91, P5533, DOI 10.1073/pnas.91.12.5533; Huang LJS, 1997, J BIOL CHEM, V272, P8057, DOI 10.1074/jbc.272.12.8057; Huang LJS, 1997, P NATL ACAD SCI USA, V94, P11184, DOI 10.1073/pnas.94.21.11184; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; LEISER M, 1986, J BIOL CHEM, V261, P1904; Lester LB, 1997, P NATL ACAD SCI USA, V94, P14942, DOI 10.1073/pnas.94.26.14942; LI Y, 1995, J BIOL CHEM, V270, P1935, DOI 10.1074/jbc.270.4.1935; Li Y, 1996, J BIOL CHEM, V271, P16862, DOI 10.1074/jbc.271.28.16862; LIN RY, 1995, J BIOL CHEM, V270, P27804, DOI 10.1074/jbc.270.46.27804; McKnight GS, 1991, CURR OPIN CELL BIOL, V3, P213; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; NDUBUKA C, 1993, J BIOL CHEM, V268, P7621; QUINN CO, 1990, J BIOL CHEM, V265, P22342; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; RUBIN CS, 1994, BBA-MOL CELL RES, V1224, P467; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCOTT JD, 1994, MOL ENDOCRINOL, V8, P5, DOI 10.1210/me.8.1.5; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; TRAMONTANO D, 1988, ENDOCRINOLOGY, V122, P127, DOI 10.1210/endo-122-1-127; Trendelenburg G, 1996, BIOCHEM BIOPH RES CO, V225, P313, DOI 10.1006/bbrc.1996.1172; Vijayaraghavan S, 1997, J BIOL CHEM, V272, P4747, DOI 10.1074/jbc.272.8.4747	39	52	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23361	23366		10.1074/jbc.273.36.23361	http://dx.doi.org/10.1074/jbc.273.36.23361			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722570	hybrid			2022-12-27	WOS:000075778100070
J	Guilherme, A; Torres, K; Czeck, MP				Guilherme, A; Torres, K; Czeck, MP			Cross-talk between insulin receptor and integrin alpha(5)beta(1) signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; MEDIATED CELL-ADHESION; PHOSPHATIDYLINOSITOL 3-KINASE; TYROSINE DEPHOSPHORYLATION; PHOSPHOINOSITIDE 3-KINASE; PHOSPHOTYROSINE PROTEIN; EXTRACELLULAR-MATRIX; SUBSTRATE FAMILY; TRANSDUCTION; ACTIVATION	The ligation and clustering of cell surface crp heterodimeric integrins enhances cell adhesion and initiates signaling pathways that regulate such processes as cell spreading, migration, differentiation, proliferation and apoptosis, Here we show that insulin treatment of Chinese hamster ovary cells expressing insulin receptors (CHO-T) markedly promotes cell adhesion onto a fibronectin matrix, but not onto bovine serum albumin or poly-lysine. Incubation of cells with a GRGDSP peptide that specifically binds integrins (but not the nonspecific GRADSP peptide) abolishes this insulin effect, as does the potent phosphoinositide 3-kinase (PI 3-kinase) inhibitor wortmannin. Moreover, a specific blocking monoclonal anti-alpha(5)beta(1) integrin antibody, PB-1, blocks insulin-stimulated cell adhesion onto fibronectin. Conversely, activating alpha(5)beta(1) integrins on CHO-T cells by adherence onto fibronectin markedly potentiates the action of insulin to enhance insulin receptor and insulin receptor substrate (IRS)-1 tyrosine phosphorylation, Activation of alpha(5)beta(1) integrin also markedly potentiates the recruitment of p85-associated PI 3-kinase activity to IRS-1 in response to submaximal levels of insulin in CHO-T cells. These data indicate that insulin potently activates integrin alpha(5)beta(1) mediated CHO-T cell adhesion, while integrin alpha(5)beta(1) signaling in turn enhances insulin receptor kinase activity and formation of complexes containing IRS-1 and PI 3-kinase, These findings raise the hypothesis that insulin receptor and alpha(5)beta(1) integrin signaling act synergistically to enhance cell adhesion.	Univ Massachusetts, Med Ctr, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Med Ctr, Dept Biochem & Mol Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Czeck, MP (corresponding author), Univ Massachusetts, Med Ctr, Program Mol Med, Worcester, MA 01605 USA.	Michael.Czech@ummed.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030648] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 30648] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BROWN PJ, 1988, BIOCHEM BIOPH RES CO, V155, P603, DOI 10.1016/S0006-291X(88)80537-0; BROWN PJ, 1985, SCIENCE, V228, P1448, DOI 10.1126/science.4012302; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; CHEN QM, 1994, J BIOL CHEM, V269, P26602; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; CROSS DAE, 1994, BIOCHEM J, V303, P21, DOI 10.1042/bj3030021; CYBULSKY AV, 1994, J CLIN INVEST, V94, P68, DOI 10.1172/JCI117350; DANILOV YN, 1989, J CELL BIOL, V108, P1925, DOI 10.1083/jcb.108.5.1925; Dedhar S, 1996, CURR OPIN CELL BIOL, V8, P657, DOI 10.1016/S0955-0674(96)80107-4; Guan JL, 1997, INT J BIOCHEM CELL B, V29, P1085, DOI 10.1016/S1357-2725(97)00051-4; Guilherme A, 1996, J BIOL CHEM, V271, P29533, DOI 10.1074/jbc.271.47.29533; KAPELLER R, 1994, BIOESSAYS, V16, P565, DOI 10.1002/bies.950160810; KINASHI T, 1995, BLOOD, V86, P2086, DOI 10.1182/blood.V86.6.2086.bloodjournal8662086; King WG, 1997, MOL CELL BIOL, V17, P4406, DOI 10.1128/MCB.17.8.4406; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; KNIGHT JB, 1995, J BIOL CHEM, V270, P10199, DOI 10.1074/jbc.270.17.10199; KOTANI K, 1994, EMBO J, V13, P2313, DOI 10.1002/j.1460-2075.1994.tb06515.x; Lavan BE, 1997, J BIOL CHEM, V272, P11439; Lavan BE, 1997, J BIOL CHEM, V272, P21403, DOI 10.1074/jbc.272.34.21403; Martin SS, 1996, ENDOCRINOLOGY, V137, P5045, DOI 10.1210/en.137.11.5045; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; MYERS MG, 1994, TRENDS BIOCHEM SCI, V19, P289, DOI 10.1016/0968-0004(94)90007-8; OKADA T, 1994, J BIOL CHEM, V269, P3568; Ouwens DM, 1996, BIOCHEM J, V318, P609, DOI 10.1042/bj3180609; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; PILLAY TS, 1995, J BIOL CHEM, V270, P991, DOI 10.1074/jbc.270.3.991; QUON MJ, 1995, MOL CELL BIOL, V15, P5403; RICHARDSON A, 1995, BIOESSAYS, V17, P229, DOI 10.1002/bies.950170309; Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; SERVE H, 1995, EMBO J, V14, P473, DOI 10.1002/j.1460-2075.1995.tb07023.x; SHEPHERD PR, 1995, BIOCHEM J, V305, P25, DOI 10.1042/bj3050025; Shimizu Y, 1996, IMMUNOL TODAY, V17, P565, DOI 10.1016/S0167-5699(96)10061-X; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; VUORI K, 1994, SCIENCE, V266, P1576, DOI 10.1126/science.7527156; WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354; WHITE MF, 1994, J BIOL CHEM, V269, P1; YAMADA KM, 1991, J BIOL CHEM, V266, P12809; YUROCHKO AD, 1992, P NATL ACAD SCI USA, V89, P9034, DOI 10.1073/pnas.89.19.9034	40	72	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					22899	22903		10.1074/jbc.273.36.22899	http://dx.doi.org/10.1074/jbc.273.36.22899			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722509	hybrid			2022-12-27	WOS:000075778100009
J	Ge, NL; Elferink, CJ				Ge, NL; Elferink, CJ			A direct interaction between the aryl hydrocarbon receptor and retinoblastoma protein - Linking dioxin signaling to the cell cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AH-RECEPTOR; NUCLEAR TRANSLOCATOR; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; TRANSCRIPTIONAL ACTIVATION; EXPRESSION; DROSOPHILA; CLONING; BINDING; DOMAINS; GENE	The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor in eukaryotic cells that alters gene expression in response to the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), In 5L hepatoma cells, TCDD induces a G(1), cell cycle arrest through a mechanism that involves the AhR. The retinoblastoma tumor suppressor protein (pRb) controls cell cycle progression through G(1), in addition to promoting differentiation, We examined whether the human AhR or its dimerization partner, the AhR nuclear translocator, interacts with pRb as a basis of the TCDD-induced cell cycle arrest. In vivo and in vitro assays reveal a direct interaction between pRb and the AhR but not the AhR nuclear translocator protein. Binding between the AhR and pRb occurs through two distinct regions in the AhR. A high affinity site lies within the N-terminal 364 amino acids of the AhR, whereas a lower affinity binding region colocalizes with the glutamine-rich transactivation domain of the receptor. AhR ligand binding is not required for the pRb interaction per se, although immunoprecipitation experiments in 5L cells reveal that pRb associates preferentially with the liganded AhR, consistent with a requirement for ligand-induced nuclear translocation. These observations provide a mechanistic insight into AhR-mediated cell cycle arrest and a new perspective on TCDD-induced toxicity.	Wayne State Univ, Inst Chem Toxicol, Detroit, MI 48201 USA	Wayne State University	Elferink, CJ (corresponding author), NCI, Genet Lab, NIH, Bethesda, MD 20892 USA.	Cornelis_Elferink@wayne.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006639, R29ES007800] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES06639, R29ES07800] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BERTAZZI PA, 1993, EPIDEMIOLOGY, V4, P398, DOI 10.1097/00001648-199309000-00004; BJELDANES LF, 1991, P NATL ACAD SCI USA, V88, P9543, DOI 10.1073/pnas.88.21.9543; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; BURBACH KM, 1992, P NATL ACAD SCI USA, V89, P8185, DOI 10.1073/pnas.89.17.8185; CHAN WK, 1994, J BIOL CHEM, V269, P26464; Cover CM, 1998, J BIOL CHEM, V273, P3838, DOI 10.1074/jbc.273.7.3838; DOLWICK KM, 1993, MOL PHARMACOL, V44, P911; Du W, 1996, GENE DEV, V10, P1206, DOI 10.1101/gad.10.10.1206; ELFERINK CJ, 1994, RECEPTOR, V4, P157; ELFERINK CJ, 1990, J BIOL CHEM, V265, P20708; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; FUKUNAGA BN, 1995, J BIOL CHEM, V270, P29270, DOI 10.1074/jbc.270.49.29270; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HANKINSON O, 1995, ARCH BIOCHEM BIOPHYS, V300, P1; HATAKEYAMA M, 1994, GENE DEV, V8, P1759, DOI 10.1101/gad.8.15.1759; HENRY EC, 1994, MOL PHARMACOL, V46, P1022; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; HUANG ZJ, 1993, NATURE, V364, P259, DOI 10.1038/364259a0; Ikuta T, 1998, J BIOL CHEM, V273, P2895, DOI 10.1074/jbc.273.5.2895; JAIN S, 1994, J BIOL CHEM, V269, P31518; Ko HSP, 1996, MOL CELL BIOL, V16, P430; Kobayashi A, 1997, J BIOCHEM, V122, P703; Lavender P, 1997, ONCOGENE, V14, P2721, DOI 10.1038/sj.onc.1201243; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Ma Q, 1996, MOL CELL BIOL, V16, P2144; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; NAMBU JR, 1991, CELL, V67, P1157, DOI 10.1016/0092-8674(91)90292-7; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; PETERSON CL, 1992, CELL, V68, P573, DOI 10.1016/0092-8674(92)90192-F; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; Pollenz RS, 1996, J BIOL CHEM, V271, P30886, DOI 10.1074/jbc.271.48.30886; Reiners JJ, 1997, MOL CARCINOGEN, V19, P91, DOI 10.1002/(SICI)1098-2744(199707)19:2<91::AID-MC4>3.0.CO;2-O; Rininger JA, 1997, CHEMOSPHERE, V34, P1557, DOI 10.1016/S0045-6535(96)00451-1; SAFE SH, 1986, ANN REV PHARM TOXICO, V26, P517; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; SCHOLLER A, 1994, MOL PHARMACOL, V45, P944; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SINGH P, 1995, NATURE, V374, P562, DOI 10.1038/374562a0; SOGAWA K, 1995, J CANCER RES CLIN, V121, P612, DOI 10.1007/BF01197779; TIAN Y, 1997, TOXICOLOGIST, V37, P129; Vaziri C, 1997, J BIOL CHEM, V272, P2762, DOI 10.1074/jbc.272.5.2762; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Weiss C, 1996, EXP CELL RES, V226, P154, DOI 10.1006/excr.1996.0214; WHITLOCK JP, 1993, CHEM RES TOXICOL, V6, P754, DOI 10.1021/tx00036a003; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; Xie Q, 1996, EMBO J, V15, P4900, DOI 10.1002/j.1460-2075.1996.tb00870.x	47	213	219	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22708	22713		10.1074/jbc.273.35.22708	http://dx.doi.org/10.1074/jbc.273.35.22708			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712901	hybrid			2022-12-27	WOS:000075616600077
J	Kundu, GC; Mandal, AK; Zhang, ZJ; Mantile-Selvaggi, G; Mukherjee, AB				Kundu, GC; Mandal, AK; Zhang, ZJ; Mantile-Selvaggi, G; Mukherjee, AB			Uteroglobin (UG) suppresses extracellular matrix invasion by normal and cancer cells that express the high affinity UG-binding proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; RECOMBINANT HUMAN UTEROGLOBIN; TISSUE-SPECIFIC EXPRESSION; RABBIT UTEROGLOBIN; PROGESTERONE-BINDING; GENE-EXPRESSION; 10-KDA PROTEIN; PHOSPHOLIPASE-A2 ACTIVITY; QUATERNARY STRUCTURE; POSSIBLE MECHANISM	Uteroglobin (UG) is a steroid-inducible, multifunctional, secreted protein with antiinflammatory and antichemotactic properties. Recently, we have reported a high affinity UG-binding protein (putative receptor), on several cell types, with an apparent molecular mass of 190 kDa (Kundu, G. C., Mantile, G., Miele, L., Cordella-Miele, E., and Mukherjee, A. B. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 2915-2919). Since UG is a homodimer in which the 70 amino acid subunits are connected by two disulfide bonds, we sought to determine whether UG monomers also interact with the 190-kDa UG-binding protein and if so, whether it has the same biological activity as the dimer. Surprisingly, we discovered that in addition to the 190-kDa species, another protein, with an apparent molecular mass of 49 kDa, binds reduced UG with high affinity and specificity. Both 49- and 190-kDa proteins are readily detectable on nontransformed NIH 3T3 and some murine cancer cells (e.g. mastocytoma, sarcoma, and lymphoma), while lacking on others (e.g. fibrosarcoma). Most interestingly, pretreatment of the cells, which express the binding proteins, with reduced UG dramatically suppresses extracellular matrix (ECM) invasion, when such treatment had no effect on fibrosarcoma cells that lack the UG-binding proteins. Tissue-specific expression studies confirmed that while both 190- and 49-kDa UG-binding proteins are present in bovine heart, spleen, and the liver, only the 190-kDa protein is detectable in the trachea and in the lung. Neither the 190-kDa nor the 49-kDa protein was detectable in the aorta. Purification of these binding proteins from bovine spleen by UG-affinity chromatography and analysis by SDS-polyacrylamide gel electrophoresis followed by silver staining identified two protein bands with apparent molecular masses of 40 and 180 kDa, respectively. Treatment of the NIH 3T3 cells with specific cytokines (i.e. interleukin-6) and other agonists (i.e. lipopolysaccharide) caused a substantially increased level of I-125-UG binding but the same cells, when treated with platelet-derived growth factor, tumor necrosis factor-alpha, interferon-gamma, and phorbol 12-myristate 13-acetate, did not alter the UG binding. Taken together, these findings raise the possibility that UG, through its binding proteins, plays critical roles in the regulation of cellular motility and ECM invasion.	NICHD, Sect Dev Genet, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Mukherjee, AB (corresponding author), NICHD, Sect Dev Genet, Heritable Disorders Branch, NIH, Bldg 10,Rm 9S241, Bethesda, MD 20892 USA.	mukherja@cc1.nichd.nih.gov	Kundu, Gopal C./ABA-9897-2020					Aoki A, 1996, MOL HUM REPROD, V2, P489, DOI 10.1093/molehr/2.7.489; ATGER M, 1979, BIOCHEM J, V177, P985, DOI 10.1042/bj1770985; BAKER ME, 1983, BIOCHEM BIOPH RES CO, V114, P325, DOI 10.1016/0006-291X(83)91631-5; BEATO M, 1976, J STEROID BIOCHEM, V7, P327, DOI 10.1016/0022-4731(76)90091-1; BEIER HM, 1968, BIOCHIM BIOPHYS ACTA, V160, P289, DOI 10.1016/0005-2795(68)90108-6; BERNARD A, 1991, CLIN CHIM ACTA, V201, P231, DOI 10.1016/0009-8981(91)90374-L; BERNARD AM, 1989, CLIN CHEM, V35, P2141; BORDER WA, 1992, J CLIN INVEST, V90, P1, DOI 10.1172/JCI115821; BUEHNER M, 1978, J MOL BIOL, V120, P337, DOI 10.1016/0022-2836(78)90072-4; BUEHNER M, 1982, J MOL BIOL, V159, P353, DOI 10.1016/0022-2836(82)90499-5; CABRE F, 1992, BIOCHEM PHARMACOL, V44, P519, DOI 10.1016/0006-2952(92)90444-N; Carlomagno T, 1997, J BIOMOL NMR, V9, P35, DOI 10.1023/A:1018619501038; CHILTON BS, 1987, J REPROD FERTIL, V79, P581, DOI 10.1530/jrf.0.0790581; CHILTON BS, 1988, MOL ENDOCRINOL, V2, P1169, DOI 10.1210/mend-2-12-1169; CHILTON BS, 1998, ENDOMETRIUM; DANIEL JC, 1984, J REPROD FERTIL, V72, P443, DOI 10.1530/jrf.0.0720443; DEHARO MSL, 1994, FEBS LETT, V349, P249, DOI 10.1016/0014-5793(94)00678-4; DelaCruz X, 1996, PROTEIN SCI, V5, P857; DOMINGUEZ P, 1995, FEBS LETT, V376, P257, DOI 10.1016/0014-5793(95)01294-4; FACCHIANO A, 1991, LIFE SCI, V48, P453, DOI 10.1016/0024-3205(91)90501-2; GILLNER M, 1988, J STEROID BIOCHEM, V31, P27, DOI 10.1016/0022-4731(88)90201-4; HAGEN G, 1990, NUCLEIC ACIDS RES, V18, P2939, DOI 10.1093/nar/18.10.2939; HAY JG, 1995, AM J PHYSIOL-LUNG C, V268, pL565, DOI 10.1152/ajplung.1995.268.4.L565; HaywardLester A, 1996, MOL ENDOCRINOL, V10, P1335, DOI 10.1210/me.10.11.1335; Hewetson A, 1997, MOL CELL ENDOCRINOL, V136, P1, DOI 10.1016/S0303-7207(97)00203-7; Hynes RO, 1990, FIBRONECTINS; JACKSON PJ, 1988, J CHROMATOGR, V452, P359, DOI 10.1016/S0021-9673(01)81460-6; Kieber-Emmons T, 1998, DNA CELL BIOL, V17, P133, DOI 10.1089/dna.1998.17.133; KIKUKAWA T, 1989, MOL CELL ENDOCRINOL, V62, P177, DOI 10.1016/0303-7207(89)90004-X; KLEISSANFRANCISCO S, 1993, MOL ENDOCRINOL, V7, P214, DOI 10.1210/me.7.2.214; KRISHNAN RS, 1967, SCIENCE, V158, P490, DOI 10.1126/science.158.3800.490; Kundu GC, 1996, P NATL ACAD SCI USA, V93, P2915, DOI 10.1073/pnas.93.7.2915; LEVIN SW, 1986, LIFE SCI, V38, P1813, DOI 10.1016/0024-3205(86)90135-9; Magdaleno SM, 1997, AM J PHYSIOL-LUNG C, V272, pL1142, DOI 10.1152/ajplung.1997.272.6.L1142; MANTILE G, 1993, J BIOL CHEM, V268, P20343; MATTHEWS JH, 1994, PROTEINS, V20, P191, DOI 10.1002/prot.340200209; MELCHIORI A, 1990, ANTICANCER RES, V10, P37; METAFORA S, 1987, GAMETE RES, V16, P229, DOI 10.1002/mrd.1120160305; MIELE L, 1987, ENDOCR REV, V8, P474, DOI 10.1210/edrv-8-4-474; MIELE L, 1994, J ENDOCRINOL INVEST, V17, P679, DOI 10.1007/BF03349687; MIELE L, 1990, J BIOL CHEM, V265, P6427; MIELE L, 1988, NATURE, V335, P726, DOI 10.1038/335726a0; MORGENSTERN JP, 1991, P NATL ACAD SCI USA, V88, P9690, DOI 10.1073/pnas.88.21.9690; MORIZE I, 1987, J MOL BIOL, V194, P725, DOI 10.1016/0022-2836(87)90250-6; MORNON JP, 1978, J MOL BIOL, V122, P237, DOI 10.1016/0022-2836(78)90038-4; MORNON JP, 1979, J MOL BIOL, V127, P237, DOI 10.1016/0022-2836(79)90245-6; Mukherjee A B, 1988, Adv Exp Med Biol, V231, P135; MUKHERJEE AB, 1998, IN PRESS AM J KIDNEY; NIETO A, 1977, ARCH BIOCHEM BIOPHYS, V180, P82, DOI 10.1016/0003-9861(77)90011-X; OKUTANI R, 1992, J CHROMATOGR-BIOMED, V577, P25, DOI 10.1016/0378-4347(92)80595-H; PERI A, 1993, J CLIN INVEST, V92, P2099, DOI 10.1172/JCI116810; PONSTINGL H, 1978, BIOCHEMISTRY-US, V17, P3908, DOI 10.1021/bi00612a003; POPP RA, 1978, P NATL ACAD SCI USA, V75, P5516, DOI 10.1073/pnas.75.11.5516; RANDALL GW, 1991, J REPROD FERTIL, V91, P249, DOI 10.1530/jrf.0.0910249; RAY MK, 1993, BIOCHEM BIOPH RES CO, V197, P163, DOI 10.1006/bbrc.1993.2455; Robinson CA, 1997, GENE, V198, P1, DOI 10.1016/S0378-1119(97)00305-3; ROBINSON DH, 1989, MOL CELL ENDOCRINOL, V63, P227, DOI 10.1016/0303-7207(89)90099-3; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; Russell RB, 1997, PROTEIN ENG, V10, P333, DOI 10.1093/protein/10.4.333; SINGH G, 1988, BIOCHIM BIOPHYS ACTA, V950, P329, DOI 10.1016/0167-4781(88)90129-7; SINGH G, 1988, J HISTOCHEM CYTOCHEM, V36, P73, DOI 10.1177/36.1.3275712; Singh G, 1997, AM J RESP CELL MOL, V17, P141, DOI 10.1165/ajrcmb.17.2.f138; SINGH G, 1993, EXP LUNG RES, V19, P67, DOI 10.3109/01902149309071081; Watson MA, 1996, CANCER RES, V56, P860; WU CY, 1995, CELL, V83, P715, DOI 10.1016/0092-8674(95)90184-1; YAO XL, 1998, AM J PHYSIOL, V18, pL864; Zhang QH, 1996, J BIOL CHEM, V271, P33284, DOI 10.1074/jbc.271.52.33284; Zhang ZJ, 1997, DNA CELL BIOL, V16, P73, DOI 10.1089/dna.1997.16.73; Zhang ZJ, 1997, SCIENCE, V276, P1408, DOI 10.1126/science.276.5317.1408	69	41	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22819	22824		10.1074/jbc.273.35.22819	http://dx.doi.org/10.1074/jbc.273.35.22819			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712916	hybrid			2022-12-27	WOS:000075616600092
J	Stachelhaus, T; Mootz, HD; Bergendahl, V; Marahiel, MA				Stachelhaus, T; Mootz, HD; Bergendahl, V; Marahiel, MA			Peptide bond formation in nonribosomal peptide biosynthesis - Catalytic role of the condensation domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEHYDROGENASE MULTIENZYME COMPLEX; COMPLETE NUCLEOTIDE-SEQUENCE; GRAMICIDIN-S SYNTHETASE-2; BACILLUS-BREVIS; CHLORAMPHENICOL ACETYLTRANSFERASE; TYROCIDINE BIOSYNTHESIS; MULTIFUNCTIONAL ENZYME; ESCHERICHIA-COLI; BIOCHEMICAL-CHARACTERIZATION; ACTIVATING DOMAIN	Recently, considerable insight has been gained into the modular organization and catalytic properties of nonribosomal peptide synthetases. However, molecular and biochemical aspects of the condensation of two aminoacyl substrates or a peptidyl and an aminoacyl substrate, leading to the formation of a peptide bond, have remained essentially impenetrable. To investigate this crucial part of nonribosomal peptide synthesis, an in vitro assay for a dipeptide formation was developed. Two recombinant holomodules, GrsA (PheATE), providing D-Phe, and a C-terminally truncated TycB, corresponding to the first, L-Pro-incorporating module (ProCAT), were investigated. Upon combination of the two aminoacylated modules, a fast reaction is observed, due to the formation of the linear dipeptide D-Phe-L-Pro-S-enzyme on ProCAT, followed by a noncatalyzed release of the dipeptide from the enzyme. The liberated product was identified by TLC, high pressure liquid chromatography-mass spectrometry, H-1 and C-13 NMR, and comparison with a chemically synthesized standard to be the expected D-Phe-L-Pro diketopiperazine. Further minimization of the two modules was not possible without a loss of transfer activity. Likewise, a mutation in a proposed active-site motif (HHXXXDG) of the condensation domain giving ProCAT(H147V), abolished the condensation reaction. These results strongly suggest the condensation domain to be involved in the catalysis of nonribosomal peptide bond formation with the histidine 147 playing a catalytic role.	Univ Marburg, Biochem Fachbereich Chem, D-35032 Marburg, Germany	Philipps University Marburg	Marahiel, MA (corresponding author), Univ Marburg, Biochem Fachbereich Chem, Hans Meerwein Str, D-35032 Marburg, Germany.	marahiel@ps1515.chemie.uni-marburg.de						BORCHERT S, 1994, J BACTERIOL, V176, P2458, DOI 10.1128/JB.176.8.2458-2462.1994; BULLOCK WO, 1987, BIOTECHNIQUES, V5, P376; Byford MF, 1997, CHEM REV, V97, P2631, DOI 10.1021/cr960018l; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; DECRECYLAGARD V, 1995, CR ACAD SCI III-VIE, V318, P927; deCrecyLagard V, 1997, ANTIMICROB AGENTS CH, V41, P1904, DOI 10.1128/AAC.41.9.1904; deFerra F, 1997, J BIOL CHEM, V272, P25304, DOI 10.1074/jbc.272.40.25304; DIECKMANN R, 1995, FEBS LETT, V357, P212, DOI 10.1016/0014-5793(94)01342-X; FUJIKAWA K, 1971, J BIOCHEM, V69, P869, DOI 10.1093/oxfordjournals.jbchem.a129538; GAIDENKO TA, 1992, BIOTECHNOLOGIA, V3, P13; GEVERS W, 1968, P NATL ACAD SCI USA, V60, P269, DOI 10.1073/pnas.60.1.269; GEVERS W, 1969, P NATL ACAD SCI USA, V63, P1335, DOI 10.1073/pnas.63.4.1335; GOCHT M, 1994, J BACTERIOL, V176, P2654, DOI 10.1128/JB.176.9.2654-2662.1994; HAESE A, 1994, J MOL BIOL, V243, P116, DOI 10.1006/jmbi.1994.1634; HORI K, 1983, J BIOCHEM-TOKYO, V93, P177, DOI 10.1093/oxfordjournals.jbchem.a134152; HORI K, 1991, J BIOCHEM-TOKYO, V110, P111, DOI 10.1093/oxfordjournals.jbchem.a123528; Konz D, 1997, CHEM BIOL, V4, P927, DOI 10.1016/S1074-5521(97)90301-X; KRATZSCHMAR J, 1989, J BACTERIOL, V171, P5422; Ku J, 1997, CHEM BIOL, V4, P203, DOI 10.1016/S1074-5521(97)90289-1; KUROTSU T, 1991, J BIOCHEM-TOKYO, V109, P763, DOI 10.1093/oxfordjournals.jbchem.a123454; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; LEE SG, 1977, P NATL ACAD SCI USA, V74, P2343, DOI 10.1073/pnas.74.6.2343; LESLIE AGW, 1990, J MOL BIOL, V213, P167, DOI 10.1016/S0022-2836(05)80129-9; LEWENDON A, 1993, J BIOL CHEM, V268, P20997; LIPMANN F, 1971, ADV ENZYMOL RAMB, V35, P1; Marahiel MA, 1997, CHEM BIOL, V4, P561, DOI 10.1016/S1074-5521(97)90242-8; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; MATHUR M, 1992, J BIOL CHEM, V267, P19388; MATTEVI A, 1992, SCIENCE, V255, P1544, DOI 10.1126/science.1549782; Mootz HD, 1997, J BACTERIOL, V179, P6843, DOI 10.1128/jb.179.21.6843-6850.1997; Mootz HD, 1997, CURR OPIN CHEM BIOL, V1, P543, DOI 10.1016/S1367-5931(97)80051-8; PFEIFER E, 1995, BIOCHEMISTRY-US, V34, P7450, DOI 10.1021/bi00022a019; ROSKOSKI R, 1970, BIOCHEMISTRY-US, V9, P4839; ROSKOSKI R, 1970, BIOCHEMISTRY-US, V9, P4846; RUSSELL GC, 1992, BIOCHEM J, V287, P611, DOI 10.1042/bj2870611; RYDON HN, 1956, J CHEM SOC, P3642, DOI 10.1039/jr9560003642; Sambrook J., 2002, MOL CLONING LAB MANU; SCHLUMBOHM W, 1991, J BIOL CHEM, V266, P23135; Schneider A, 1998, MOL GEN GENET, V257, P308, DOI 10.1007/s004380050652; SHAW WV, 1983, CRC CR REV BIOCH MOL, V14, P1, DOI 10.3109/10409238309102789; SHAW WV, 1992, SCI PROGRESS-UK, V76, P565; Shiau CY, 1997, BIOCHEMISTRY-US, V36, P8798, DOI 10.1021/bi962932e; Stachelhaus T, 1996, BIOCHEM PHARMACOL, V52, P177, DOI 10.1016/0006-2952(96)00111-6; STACHELHAUS T, 1995, J BIOL CHEM, V270, P6163, DOI 10.1074/jbc.270.11.6163; Stachelhaus T, 1996, CHEM BIOL, V3, P913, DOI 10.1016/S1074-5521(96)90180-5; STACHELHAUS T, 1995, SCIENCE, V269, P69, DOI 10.1126/science.7604280; Stein T, 1996, J BIOL CHEM, V271, P15428, DOI 10.1074/jbc.271.26.15428; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TURGAY K, 1992, MOL MICROBIOL, V6, P529, DOI 10.1111/j.1365-2958.1992.tb01498.x; VATER J, 1989, BIOL CHEM H-S, V370, P1013, DOI 10.1515/bchm3.1989.370.2.1013; Vater J, 1997, J PROTEIN CHEM, V16, P557, DOI 10.1023/A:1026386100259; VERCELLONE A, 1989, J BIOL CHEM, V264, P7447; VICAR J, 1973, COLLECT CZECH CHEM C, V38, P1940; VOLLENBROICH D, 1994, J BACTERIOL, V176, P395, DOI 10.1128/JB.176.2.395-400.1994; vonDohren H, 1997, CHEM REV, V97, P2675, DOI 10.1021/cr9600262; Walsh CT, 1997, CURR OPIN CHEM BIOL, V1, P309, DOI 10.1016/S1367-5931(97)80067-1; WECKERMANN R, 1988, NUCLEIC ACIDS RES, V16, P11841, DOI 10.1093/nar/16.24.11841; Weinreb PH, 1998, BIOCHEMISTRY-US, V37, P1575, DOI 10.1021/bi9719859; YOUNG PE, 1976, J AM CHEM SOC, V98, P5365, DOI 10.1021/ja00433a051	60	258	276	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22773	22781		10.1074/jbc.273.35.22773	http://dx.doi.org/10.1074/jbc.273.35.22773			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712910	hybrid			2022-12-27	WOS:000075616600086
J	Tarantini, F; LaVallee, T; Jackson, A; Gamble, S; Carreira, CM; Garfinkel, S; Burgess, WH; Maciag, T				Tarantini, F; LaVallee, T; Jackson, A; Gamble, S; Carreira, CM; Garfinkel, S; Burgess, WH; Maciag, T			The extravesicular domain of synaptotagmin-1 is released with the latent fibroblast growth factor-1 homodimer in response to neat shock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2 C2 DOMAINS; FACTOR-I; PROTEIN-KINASE; RAT-BRAIN; CELLS; BINDING; IDENTIFICATION; MEMBRANES; RECEPTOR; FORMS	The heparin-binding fibroblast growth factor (FGF) prototypes lack a classical signal sequence, yet their presence is required in the extracellular compartment for the activation of cell-surface receptor-dependent signaling. Early studies with FGF-1 demonstrated its presence in bovine brain as a novel high molecular weight complex, and subsequent studies identified a second heparin-binding protein that co-purified with FGF-1. Polypeptide sequence analysis revealed that this heparin-binding protein corresponded to the extravesicular domain of bovine synaptotagmin (Syn)-1, a transmembrane component of synaptic vesicles involved in the regulation of organelle traffic. Since FGF-1 is released in response to heat shock as a mitogenically inactive Cys-SO homodimer, we sought to determine whether this heparin-binding protein was involved in the release of FGF-1. We report that a proteolytic fragment of the extravesicular domain of Syn-1 is associated with FGF-1 in the extracellular compartment of FGF-l-transfected NIH 3T3 cells following temperature stress. By using heparin-Sepharose affinity to discriminate between the monomer and homodimer forms of FGF-1 and resolution by conventional and limited denaturant gel shift immunoblot analysis, it was possible to identify FGF-1 and Syn-1 as potential components of a denaturant- and reducing agent-sensitive extracellular complex. It was also possible to demonstrate that the expression of an antisense-Syn-l gene represses the release of FGF-1 in response to heat shock. These data indicate that FGF-1 may be able to utilize the cytosolic face of conventional exocytotic vesicles to traffic to the inner surface of the plasma membrane where it may gain access to the extracellular compartment as a complex with Syn-1.	Maine Med Ctr, Res Inst, Ctr Mol Med, S Portland, ME 04106 USA; Amer Red Cross, Holland Lab, Dept Mol Biol, Rockville, MD 20855 USA	Maine Medical Center; American Red Cross	Maciag, T (corresponding author), Maine Med Ctr, Res Inst, Ctr Mol Med, 125 John Roberts Rd, S Portland, ME 04106 USA.		Tarantini, Francesca/I-6332-2012	TARANTINI, FRANCESCA/0000-0002-1390-2965	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035627, R01HL032348, P01HL054710] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL54710, HL35627, HL32348] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BENNETT MK, 1993, J NEUROSCI, V13, P1701; BURGESS WH, 1985, J BIOL CHEM, V260, P1389; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; DAMER CK, 1994, J BIOL CHEM, V269, P31115; ENGLEKA KA, 1992, J BIOL CHEM, V267, P11307; FOROUGH R, 1993, J BIOL CHEM, V268, P2960; GARFINKEL S, 1992, J BIOL CHEM, V267, P24375; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; JACKSON A, 1995, J BIOL CHEM, V270, P33, DOI 10.1074/jbc.270.1.33; JACKSON A, 1992, P NATL ACAD SCI USA, V89, P10691, DOI 10.1073/pnas.89.22.10691; JACOBSSON G, 1994, P NATL ACAD SCI USA, V91, P12487, DOI 10.1073/pnas.91.26.12487; Kwon OJ, 1996, FEBS LETT, V378, P135, DOI 10.1016/0014-5793(95)01430-6; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; MACH H, 1995, BIOCHEMISTRY-US, V34, P9913, DOI 10.1021/bi00031a013; NISHIKI T, 1994, J BIOL CHEM, V269, P10498; PERIN MS, 1991, J BIOL CHEM, V266, P623; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; SAMUEL CE, 1992, PHARMACOL THERAPEUT, V54, P307, DOI 10.1016/0163-7258(92)90005-K; SANO H, 1990, J CELL BIOL, V110, P1417, DOI 10.1083/jcb.110.4.1417; Shi JP, 1997, J BIOL CHEM, V272, P1142, DOI 10.1074/jbc.272.2.1142; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; TARANTINI F, 1995, J BIOL CHEM, V270, P29039, DOI 10.1074/jbc.270.49.29039; TUGAL HB, 1991, BIOCHEM J, V279, P699, DOI 10.1042/bj2790699; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1; Zimrin AB, 1996, J BIOL CHEM, V271, P32499, DOI 10.1074/jbc.271.51.32499	27	64	65	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22209	22216		10.1074/jbc.273.35.22209	http://dx.doi.org/10.1074/jbc.273.35.22209			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712834	hybrid, Green Published			2022-12-27	WOS:000075616600010
J	Gross, CN; Irrinki, A; Feder, JN; Enns, CA				Gross, CN; Irrinki, A; Feder, JN; Enns, CA			Co-trafficking of HFE, a nonclassical major histocompatibility complex class I protein, with the transferrin receptor implies a role in intracellular iron regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED GLYCOSYLATION SITE; HEREDITARY HEMOCHROMATOSIS; INSULIN-RECEPTORS; HLA-H; ANTIGENS; ASSOCIATION; EXPRESSION; CELLS; GENE; TETRACYCLINE	The mechanism by which a novel major histocompatibility compiler class I protein, HFE, regulates iron uptake into the body is not known. HFE is the product of the gene that is mutated in >80% of hereditary hemochromatosis patients. It was recently found to coprecipitate with the transferrin receptor (Feder, J. N., Penny, D. M., Irrinki, A., Lee, V. K., Lebron, J. A., Watson, N., Tsuchihashi, Z., Sigal, E., Bjorkman, P. J., and Schatzman, R. C. (1998) Proc. Natl. Acad. Sci. U.S.A. 95, 1472-1477; Parkkila, S., Waheed, A., Britton, R. S., Bacon, B. R., Zhou, X. Y., Tomatsu, S., Fleming, R.E., and Sly, W. S. (1997) Proc. Natl. Acad Sci. U.S.A. 94, 13198-13202) and to decrease the affinity of transferrin for the transferrin receptor (Feder et al.). In this study, HeLa cells were transfected with HFE: under the control of the tetracycline-repressible promoter. We demonstrate that HFE: and the transferrin receptor are capable of associating with each other within 30 min of their synthesis with pulse-chase experiments. HFE and the transferrin receptor co-immunoprecipitate throughout the biosynthetic pathway. Excess HFE is rapidly degraded, whereas the HFE-transferrin receptor complex is stable. Immunofluorescence experiments indicate that they salse endocytose into transferrin-positive compartments. Combined, these results suggest a role for the transferrin receptor in HFE trafficking, Cells expressing HFE have modestly increased levels of transferrin receptor and drastically reduced levels of ferritin. These results implicate HFE further in the modulation of iron levels in the cell.	Oregon Hlth Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA; Progenitor Inc, Menlo Park, CA 94025 USA	Oregon Health & Science University	Enns, CA (corresponding author), Oregon Hlth Sci Univ, Dept Cell & Dev Biol, L215, Portland, OR 97201 USA.				NHLBI NIH HHS [T32-HL00781] Funding Source: Medline; NIDDK NIH HHS [DK 40608] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040608] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON GJ, 1990, GASTROENTEROLOGY, V98, P576, DOI 10.1016/0016-5085(90)90276-7; BARON U, 1995, NUCLEIC ACIDS RES, V23, P3605, DOI 10.1093/nar/23.17.3605; Bonkovsky HL, 1996, HEPATOLOGY, V24, P718, DOI 10.1053/jhep.1996.v24.ajhep0240718; BOTHWELL TH, 1995, METABOLIC MOL BASIS, V2, P1433; DUE C, 1986, P NATL ACAD SCI USA, V83, P6007, DOI 10.1073/pnas.83.16.6007; Enns C.A., 1996, BIOMEMBRANE, V4, P255, DOI [10.1016/S1874-5342(96)80012-2, DOI 10.1016/S1874-5342(96)80012-2]; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Feder JN, 1997, J BIOL CHEM, V272, P14025, DOI 10.1074/jbc.272.22.14025; FEHLMANN M, 1985, P NATL ACAD SCI USA, V82, P8634, DOI 10.1073/pnas.82.24.8634; Ghetie V, 1997, IMMUNOL TODAY, V18, P592, DOI 10.1016/S0167-5699(97)01172-9; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; Parkkila S, 1997, P NATL ACAD SCI USA, V94, P2534, DOI 10.1073/pnas.94.6.2534; Parkkila S, 1997, P NATL ACAD SCI USA, V94, P13198, DOI 10.1073/pnas.94.24.13198; PHILLIPS ML, 1986, P NATL ACAD SCI USA, V83, P3474, DOI 10.1073/pnas.83.10.3474; POWELL LW, 1970, GUT, V11, P727, DOI 10.1136/gut.11.9.727; RECKHOW CL, 1988, J BIOL CHEM, V263, P7297; RUTLEDGE EA, 1991, J BIOL CHEM, V266, P21125; RUTLEDGE EA, 1994, BLOOD, V83, P580; SCHREIBER AB, 1984, J CELL BIOL, V98, P725, DOI 10.1083/jcb.98.2.725; VERLAND S, 1989, J IMMUNOL, V143, P945; Warren RA, 1997, J BIOL CHEM, V272, P2116; WILLIAMS AM, 1991, J BIOL CHEM, V266, P17648; WILLIAMS AM, 1993, J BIOL CHEM, V268, P12780; YANG B, 1993, J BIOL CHEM, V268, P7435	28	193	195	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					22068	22074		10.1074/jbc.273.34.22068	http://dx.doi.org/10.1074/jbc.273.34.22068			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705350	hybrid			2022-12-27	WOS:000075492600084
J	Haeseleer, F; Huang, J; Lebioda, L; Saari, JC; Palczewski, K				Haeseleer, F; Huang, J; Lebioda, L; Saari, JC; Palczewski, K			Molecular characterization of a novel short-chain dehydrogenase/reductase that reduces all-trans-retinal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-ALPHA-HYDROXYSTEROID DEHYDROGENASES; ALCOHOL DEHYDROGENASES; BIOCHEMICAL ASPECTS; PIGMENT EPITHELIUM; VISUAL PROCESS; BOVINE RETINA; PROTEINS; RHODOPSIN; RAT; IDENTIFICATION	The reduction of all-trans-retinal in photoreceptor outer segments is the first step in the regeneration of bleached visual pigments. We report here the cloning of a dehydrogenase, retSDR1, that belongs to the short-chain dehydrogenase/reductase superfamily and localizes predominantly in cone photoreceptors. retSDR1 expressed in insect cells displayed substrate specificities of the photoreceptor all-trans-retinol dehydrogenase. Homology modeling of retSDR1 using the carbonyl reductase structure as a scaffold predicted a classical Rossmann fold for the nucleotide binding and an N-terminal extension that could facilitate binding of the enzyme to the cell membranes. The presence of retSDR1 in a subset of inner retinal neurons and in other tissues suggests that the enzyme may also be involved in retinol metabolism outside of photoreceptors.	Univ Washington, Dept Ophthalmol, Sch Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA; Univ S Carolina, Dept Biochem & Chem, Columbia, SC 29208 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Palczewski, K (corresponding author), Univ Washington, Dept Ophthalmol, Sch Med, Box 356485, Seattle, WA 98195 USA.	palczews@u.washington.edu			NATIONAL EYE INSTITUTE [R01EY009339, P30EY001730] Funding Source: NIH RePORTER; NEI NIH HHS [EY09339, EY02317, EY01730] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALPERN M, 1971, J PHYSIOL-LONDON, V217, P447, DOI 10.1113/jphysiol.1971.sp009580; ALPERN M, 1971, VISION RES, V11, P539, DOI 10.1016/0042-6989(71)90075-7; Biswas MG, 1997, J BIOL CHEM, V272, P15959, DOI 10.1074/jbc.272.25.15959; BOERMAN MHE, 1995, BIOCHEMISTRY-US, V34, P1027; Boll F., 1876, MONATSBERICHTE KONIG, P783; Breton R, 1996, STRUCTURE, V4, P905, DOI 10.1016/S0969-2126(96)00098-6; CHAI XY, 1995, J BIOL CHEM, V270, P3900, DOI 10.1074/jbc.270.8.3900; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; CHAYKIN S, 1966, BIOCHIM BIOPHYS ACTA, V124, P1, DOI 10.1016/0304-4165(66)90307-2; DAVIS JT, 1995, BIOL REPROD, V52, P356, DOI 10.1095/biolreprod52.2.356; Dowling J. E., 1987, RETINA APPROACHABLE; DOWLING JE, 1960, NATURE, V188, P114, DOI 10.1038/188114a0; EDELHOFF S, 1994, ONCOGENE, V9, P665; FUTTERMAN SIDNEY, 1963, JOUR BIOL CHEM, V238, P1145; Harlow E, 1988, ANTIBODIES LAB MANUA, P139; HOFMANN KP, 1992, J BIOL CHEM, V267, P15701; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; KROZOWSKI Z, 1994, J STEROID BIOCHEM, V51, P125, DOI 10.1016/0960-0760(94)90084-1; KUHNE W, 1877, UNTERS PHYSL I U HEI, V1, P1; LAW WC, 1989, J AM CHEM SOC, V111, P793, DOI 10.1021/ja00184a090; Mertz JR, 1997, J BIOL CHEM, V272, P11744, DOI 10.1074/jbc.272.18.11744; Milam AH, 1997, VISUAL NEUROSCI, V14, P601, DOI 10.1017/S0952523800012256; NAKAJIMA N, 1989, J BIOCHEM-TOKYO, V106, P515, DOI 10.1093/oxfordjournals.jbchem.a122884; OttoBruc A, 1997, P NATL ACAD SCI USA, V94, P4727, DOI 10.1073/pnas.94.9.4727; PALCZEWSKI K, 1994, BIOCHEMISTRY-US, V33, P13741, DOI 10.1021/bi00250a027; Palczewski K, 1997, CURR OPIN NEUROBIOL, V7, P500, DOI 10.1016/S0959-4388(97)80029-3; Penning TM, 1996, STEROIDS, V61, P508, DOI 10.1016/S0039-128X(96)00093-1; PERSSON B, 1991, EUR J BIOCHEM, V200, P537, DOI 10.1111/j.1432-1033.1991.tb16215.x; Polans A, 1996, TRENDS NEUROSCI, V19, P547, DOI 10.1016/S0166-2236(96)10059-X; Rando RR, 1996, CHEM BIOL, V3, P255, DOI 10.1016/S1074-5521(96)90105-2; REES DC, 1994, MEMBRANE PROTEIN STR, P1; ROSSMANN MG, 1978, MOL CELL BIOCHEM, V21, P161; SAARI JC, 1982, J BIOL CHEM, V257, P13329; Saari JC, 1997, GLIA, V21, P259; SAARI JC, 1993, ANAL BIOCHEM, V213, P128, DOI 10.1006/abio.1993.1395; SAARI JC, 1998, VISION RES, V44, P17; Saari John C., 1994, P351; Sakai N, 1996, J AM CHEM SOC, V118, P1559, DOI 10.1021/ja953480g; SIMON A, 1995, J BIOL CHEM, V270, P1107, DOI 10.1074/jbc.270.34.19979; TANAKA N, 1995, J BIOCHEM-TOKYO, V118, P871, DOI 10.1093/jb/118.5.871; Tsigelny I, 1996, BIOCHEM BIOPH RES CO, V226, P118, DOI 10.1006/bbrc.1996.1320; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; Zhao XY, 1998, J BIOL CHEM, V273, P5124, DOI 10.1074/jbc.273.9.5124; ZIMMERMAN WF, 1974, NATURE, V250, P66, DOI 10.1038/250066a0; ZIMMERMAN WF, 1975, EXP EYE RES, V21, P325, DOI 10.1016/0014-4835(75)90043-3	49	143	148	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21790	21799		10.1074/jbc.273.34.21790	http://dx.doi.org/10.1074/jbc.273.34.21790			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705317	hybrid			2022-12-27	WOS:000075492600051
J	Hamza, I; Chauhan, S; Hassett, R; O'Brian, MR				Hamza, I; Chauhan, S; Hassett, R; O'Brian, MR			The bacterial Irr protein is required for coordination of heme biosynthesis with iron availability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOLEVULINIC-ACID DEHYDRATASE; SYNTHASE MESSENGER-RNA; SOYBEAN ROOT-NODULES; BRADYRHIZOBIUM-JAPONICUM; ESCHERICHIA-COLI; TETRAPYRROLE SYNTHESIS; TRANSLATIONAL CONTROL; REGULATORY PROTEIN-2; NITRIC-OXIDE; GENE	Heme is a ubiquitous macromolecule that serves as the active group of proteins involved in many cellular processes. The multienzyme pathway for heme formation culminates with the insertion of iron into a protoporphyrin ring. The cytotoxicity of porphyrins suggests the need for coordination of its biosynthesis with iron availability. We isolated a mutant strain of the bacterium Bradyrhizobium japonicum that, under iron limitation, accumulated protoporphyrin and showed aberrantly high expression of hemB, an iron-regulated gene encoding the heme synthesis enzyme delta-aminolevulinic acid dehydratase. The strain carries a loss of function mutation in irr, a newly described gene that encodes a putative member of the GntR family of bacterial transcriptional regulators. Irr accumulated only under iron limitation, and turned over rapidly upon an increase in iron availability. A separate role for Irr in controlling the cellular iron level was inferred based on a deficiency in high affinity iron transport activity in the irr strain, and suggests that regulation of the heme pathway is coordinated with iron homeostasis. A high level of protoporphyrin accumulation is not a normal consequence of nutritional iron deprivation, thus a mechanism for iron-dependent control of heme biosynthesis may be present in other organisms.	SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	O'Brian, MR (corresponding author), SUNY Buffalo, Dept Biochem, 140 Farber Hall, Buffalo, NY 14214 USA.			Hamza, Iqbal/0000-0003-0045-0610				BHASKER CR, 1993, J BIOL CHEM, V268, P12699; Braun V., 1991, HDB MICROBIAL IRON C, P107; Camilli A, 1995, MOL MICROBIOL, V18, P671, DOI 10.1111/j.1365-2958.1995.mmi_18040671.x; Chauhan S, 1997, J BACTERIOL, V179, P3706, DOI 10.1128/jb.179.11.3706-3710.1997; Chauhan S, 1997, J BACTERIOL, V179, P5516, DOI 10.1128/jb.179.17.5516-5520.1997; CHAUHAN S, 1995, J BIOL CHEM, V270, P19823, DOI 10.1074/jbc.270.34.19823; DELORENZO V, 1987, J BACTERIOL, V169, P2624, DOI 10.1128/jb.169.6.2624-2630.1987; FRUSTACI JM, 1991, J BACTERIOL, V173, P1145, DOI 10.1128/jb.173.3.1145-1150.1991; FRUSTACI JM, 1995, J BIOL CHEM, V270, P7387, DOI 10.1074/jbc.270.13.7387; FRUSTACI JM, 1992, J BACTERIOL, V174, P4223, DOI 10.1128/JB.174.13.4223-4229.1992; GARRET S, 1994, ACTA HAEMATOL-BASEL, V91, P21; GILLESGONZALEZ MA, 1991, NATURE, V350, P170, DOI 10.1038/350170a0; GOTTESMAN S, 1992, MICROBIOL REV, V56, P592, DOI 10.1128/MMBR.56.4.592-621.1992; GUO B, 1995, J BIOL CHEM, V270, P16529, DOI 10.1074/jbc.270.28.16529; HAMILTON JW, 1991, ARCH BIOCHEM BIOPHYS, V289, P387, DOI 10.1016/0003-9861(91)90428-L; HANTKE K, 1987, MOL GEN GENET, V210, P135, DOI 10.1007/BF00337769; HENIKOFF S, 1994, GENOMICS, V19, P97, DOI 10.1006/geno.1994.1018; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; IWAI K, 1995, EMBO J, V14, P5350, DOI 10.1002/j.1460-2075.1995.tb00219.x; KAPPAS A, 1995, METABOLIC MOL BASES, V3, P2103; LATHROP JT, 1993, SCIENCE, V259, P522, DOI 10.1126/science.8424176; LOWENSTEIN CJ, 1992, CELL, V70, P705, DOI 10.1016/0092-8674(92)90301-R; MELEFORS O, 1993, J BIOL CHEM, V268, P5974; MENDEZ R, 1992, J BIOL CHEM, V267, P11500; Mock HP, 1997, PLANT PHYSIOL, V113, P1101, DOI 10.1104/pp.113.4.1101; MOSTELLER RD, 1980, J BIOL CHEM, V255, P2524; NAKAHIGASHI K, 1991, P NATL ACAD SCI USA, V88, P10520, DOI 10.1073/pnas.88.23.10520; OBrian MR, 1996, J BACTERIOL, V178, P2471, DOI 10.1128/jb.178.9.2471-2478.1996; PAGE KM, 1994, J BACTERIOL, V176, P1535, DOI 10.1128/jb.176.5.1535-1538.1994; PAGE KM, 1995, J BACTERIOL, V177, P3979, DOI 10.1128/jb.177.14.3979-3984.1995; REIZER A, 1991, MOL MICROBIOL, V5, P1081, DOI 10.1111/j.1365-2958.1991.tb01880.x; Rouault TA, 1996, TRENDS BIOCHEM SCI, V21, P174, DOI 10.1016/0968-0004(96)10024-4; SANGWAN I, 1991, SCIENCE, V251, P1220, DOI 10.1126/science.251.4998.1220; SCHILKE BA, 1995, J BACTERIOL, V177, P1929, DOI 10.1128/jb.177.8.1929-1937.1995; Schweder T, 1996, J BACTERIOL, V178, P470, DOI 10.1128/jb.178.2.470-476.1996; Smith K. M., 1975, PORPHYRINS METALLOPO; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; Wang JY, 1996, P NATL ACAD SCI USA, V93, P10434, DOI 10.1073/pnas.93.19.10434; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x; YURA T, 1993, ANNU REV MICROBIOL, V47, P321, DOI 10.1146/annurev.mi.47.100193.001541; ZHANG L, 1994, GENE DEV, V8, P2110, DOI 10.1101/gad.8.17.2110	41	129	134	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21669	21674		10.1074/jbc.273.34.21669	http://dx.doi.org/10.1074/jbc.273.34.21669			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705301	hybrid			2022-12-27	WOS:000075492600035
J	Govindan, MV; Warriar, N				Govindan, MV; Warriar, N			Reconstitution of the N-terminal transcription activation function of human mineralocorticoid receptor in a defective human glucocorticoid receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ANDROGEN RECEPTOR; HORMONE-BINDING DOMAIN; MAJOR TRANSACTIVATION DOMAIN; HUMAN ESTROGEN-RECEPTOR; PROGESTERONE-RECEPTOR; CHLORAMPHENICOL ACETYLTRANSFERASE; NUCLEAR RECEPTORS; GENE-EXPRESSION; STEROID-BINDING; DNA-BINDING	N-terminal sequences involved in transcription activation by the human mineralocorticoid receptor (hMR) have yet to be defined, We have addressed this issue and generated overlapping internal deletion mutants hMR Delta(59-162), hMR Delta(59-247), hMR Delta(59-328), hMR Delta(162-247), hMR Delta(247-328), hMR Delta(247-382), and hMR Delta(328-382), with intact DNA-binding and hormone-binding domains. A second set of mutant receptors with unique BglII sites was generated to facilitate the isolations of fragments. Immunodetection with anti-hMR peptide antibodies and hormone-binding assays showed that the mutations did not affect the expression of the receptors or ability to bind aldosterone, Distribution of aldosterone binding activity of wild type and deletion mutants expressed in HeLa cells was predominantly nuclear, Furthermore, deletion of sequences between 59 and 390 did not affect DNA binding activity. Transfection studies with HeLa cells revealed a region around residue 247 that was crucial for normal receptor function. Deletion of amino acids 59-162 did not affect the transcriptional activity of the hMR. However, deletion of sequences 247-382 and 328-382 markedly decreased the transcription activation function. The induction of the reporter gene by the chimera hGR Delta(71-262)/hMR(328-382) was 2-fold higher than with the wild type hGrR, but 200-fold when compared with hGR Delta(71-262), indicating that the AF-1 domain is located between positions 328 and 382 in the hMR.	Hop Hotel Dieu, Ctr Rech, Quebec City, PQ G1R 2J6, Canada; Univ Laval, Quebec City, PQ G1R 2J6, Canada	Laval University	Govindan, MV (corresponding author), Hop Hotel Dieu, Ctr Rech, Cote Palais, Quebec City, PQ G1R 2J6, Canada.	manjapra.govindan@crhdq.ulaval.ca						ALNEMRI ES, 1991, J BIOL CHEM, V266, P18072; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; ARRIZA JL, 1988, NEURON, V1, P887, DOI 10.1016/0896-6273(88)90136-5; Baur EV, 1996, EMBO J, V15, P110, DOI 10.1002/j.1460-2075.1996.tb00339.x; BOHEN SP, 1993, P NATL ACAD SCI USA, V90, P11424, DOI 10.1073/pnas.90.23.11424; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; CIDLOWSKI JA, 1981, ENDOCRINOLOGY, V109, P1975; DAHLMANWRIGHT K, 1994, P NATL ACAD SCI USA, V91, P1619, DOI 10.1073/pnas.91.5.1619; Fang YF, 1996, J BIOL CHEM, V271, P28697, DOI 10.1074/jbc.271.45.28697; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; GOVINDAN MV, 1990, MOL ENDOCRINOL, V4, P417, DOI 10.1210/mend-4-3-417; GOVINDAN MV, 1991, J STEROID BIOCHEM, V39, P91, DOI 10.1016/0960-0760(91)90017-Y; GRONEMEYER H, 1987, EMBO J, V6, P3985, DOI 10.1002/j.1460-2075.1987.tb02741.x; Henttu PMA, 1997, MOL CELL BIOL, V17, P1832, DOI 10.1128/MCB.17.4.1832; HOLLENBERG SM, 1987, CELL, V49, P39, DOI 10.1016/0092-8674(87)90753-7; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; MCDONNELL DP, 1992, P NATL ACAD SCI USA, V89, P10563, DOI 10.1073/pnas.89.22.10563; MCEWAN IJ, 1993, MOL CELL BIOL, V13, P399, DOI 10.1128/MCB.13.1.399; MEYER ME, 1992, J BIOL CHEM, V267, P10882; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; NEMOTO T, 1990, BIOCHEMISTRY-US, V29, P1880, DOI 10.1021/bi00459a031; Norris JD, 1997, MOL ENDOCRINOL, V11, P747, DOI 10.1210/me.11.6.747; PAGE N, 1994, AM J PHYSIOL-LUNG C, V267, pL464, DOI 10.1152/ajplung.1994.267.4.L464; PEARCE D, 1993, SCIENCE, V259, P1161, DOI 10.1126/science.8382376; Rogatsky I, 1998, P NATL ACAD SCI USA, V95, P2050, DOI 10.1073/pnas.95.5.2050; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; SCHWERK C, 1995, J BIOL CHEM, V270, P21331, DOI 10.1074/jbc.270.36.21331; SHEMSHEDINI L, 1992, J BIOL CHEM, V267, P1834; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Smith CL, 1997, MOL ENDOCRINOL, V11, P657, DOI 10.1210/me.11.6.657; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; WARRIAR N, 1994, J BIOL CHEM, V269, P29016; WARRIAR N, 1994, BIOCHEMISTRY-US, V33, P12837, DOI 10.1021/bi00209a015; WARRIAR N, 1994, J BIOL CHEM, V269, P29010; WRIGHT APH, 1991, MOL ENDOCRINOL, V5, P1366, DOI 10.1210/mend-5-10-1366; YU CY, 1995, BIOCHEMISTRY-US, V34, P14163, DOI 10.1021/bi00043a022	39	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24439	24447		10.1074/jbc.273.38.24439	http://dx.doi.org/10.1074/jbc.273.38.24439			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733735	hybrid			2022-12-27	WOS:000076007300027
J	Syntichaki, P; Thireos, G				Syntichaki, P; Thireos, G			The Gcn5 Ada complex potentiates the histone acetyltransferase activity of Gcn5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; PUTATIVE TRANSCRIPTIONAL ADAPTER; ACIDIC ACTIVATION DOMAINS; TATA-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; CHROMATIN STRUCTURE; REMODELING FACTOR; NUCLEOSOMAL DNA; SWI/SNF COMPLEX; IN-VIVO	The Gcn5 histone acetyltransferase (HAT) is part of a large multimeric complex that is required for transcriptional activation in yeast. This complex can acetylate in vitro and in a Gcn5-dependent manner both nucleosomal and free core histones. For this reason it is believed that part of the function of the GcnF5.Ada complex is chromatin remodeling effected by histone acetylation. The roles of the other subunits of this complex are not yet known. We have generated mutated Gcn5 proteins with severely attenuated in vitro HAT activities. Despite their apparent loss in HAT activity, these GCN5 derivatives complemented all the defects of a gcn5 strain. We have shown that when these mutated proteins were produced in yeast cells in the absence of another component of the complex, Ada2, their activity was still compromised. By contrast, when produced in the wild type context, they were partially capable of acetylating free histones and were even more active when nucleosomal arrays were used as substrates. Kinetic enzymatic analyses showed that the rate of catalysis by Gcn5 was enhanced when the mutated proteins were produced in yeast in the presence of Ada2. Because Ada2 is required for the assembly of Gcn5, we conclude that one role for components of the Gcn5 Ada complex is the potentiation of its HAT activity.	Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion 71110, Greece; Univ Crete, Dept Biol, Iraklion 71110, Greece	University of Crete	Thireos, G (corresponding author), Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion 71110, Greece.	Thireos@imbb.forth.gr	Syntichaki, Popi/ABA-7218-2020	Syntichaki, Popi/0000-0001-9536-8905				BARLEV NA, 1995, J BIOL CHEM, V270, P19337, DOI 10.1074/jbc.270.33.19337; BERGER SL, 1992, CELL, V70, P251, DOI 10.1016/0092-8674(92)90100-Q; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; BROWNELL JE, 1995, P NATL ACAD SCI USA, V92, P6364, DOI 10.1073/pnas.92.14.6364; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; CAIRNS BR, 1994, P NATL ACAD SCI USA, V91, P1950, DOI 10.1073/pnas.91.5.1950; Candau R, 1997, EMBO J, V16, P555, DOI 10.1093/emboj/16.3.555; Candau R, 1996, J BIOL CHEM, V271, P5237; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; EISENMANN DM, 1992, GENE DEV, V6, P1319, DOI 10.1101/gad.6.7.1319; GARCIARAMIREZ M, 1995, J BIOL CHEM, V270, P17923, DOI 10.1074/jbc.270.30.17923; GEORGAKOPOULOS T, 1995, MOL GEN GENET, V246, P723, DOI 10.1007/BF00290718; GEORGAKOPOULOS T, 1992, EMBO J, V11, P4145, DOI 10.1002/j.1460-2075.1992.tb05507.x; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Habraken Y, 1997, CURR BIOL, V7, P790, DOI 10.1016/S0960-9822(06)00337-X; HIRSCHHORN JN, 1992, GENE DEV, V6, P2288, DOI 10.1101/gad.6.12a.2288; Horiuchi J, 1997, MOL CELL BIOL, V17, P3220, DOI 10.1128/MCB.17.6.3220; HORIUCHI J, 1995, MOL CELL BIOL, V15, P1203; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; KOLESKE A, 1994, NATURE, V368, P4663; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Marcus GA, 1996, MOL CELL BIOL, V16, P3197; MARCUS GA, 1994, EMBO J, V13, P4807, DOI 10.1002/j.1460-2075.1994.tb06806.x; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nikolov DB, 1997, P NATL ACAD SCI USA, V94, P15, DOI 10.1073/pnas.94.1.15; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; OwenHughes T, 1996, SCIENCE, V273, P513, DOI 10.1126/science.273.5274.513; Parthun MR, 1996, CELL, V87, P85, DOI 10.1016/S0092-8674(00)81325-2; Pollard KJ, 1997, MOL CELL BIOL, V17, P6212, DOI 10.1128/MCB.17.11.6212; Roberts SM, 1996, MOL CELL BIOL, V16, P3206; Saleh A, 1997, J BIOL CHEM, V272, P5571, DOI 10.1074/jbc.272.9.5571; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SILVERMAN N, 1994, P NATL ACAD SCI USA, V91, P11665, DOI 10.1073/pnas.91.24.11665; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; VARGAWEISZ PD, 1995, EMBO J, V14, P2209, DOI 10.1002/j.1460-2075.1995.tb07215.x; Wang L, 1998, GENE DEV, V12, P640, DOI 10.1101/gad.12.5.640; WORKMAN JL, 1992, SCIENCE, V258, P1780, DOI 10.1126/science.1465613; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0	42	28	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24414	24419		10.1074/jbc.273.38.24414	http://dx.doi.org/10.1074/jbc.273.38.24414			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733731	hybrid			2022-12-27	WOS:000076007300023
J	Xu, J; Koudelka, GB				Xu, J; Koudelka, GB			DNA-based positive control mutants in the binding site sequence of 434 repressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAMBDA-PRM PROMOTER; COLI RNA-POLYMERASE; BACTERIOPHAGE-434 REPRESSOR; TRANSCRIPTION ACTIVATION; NONCONTACTED BASES; OPERATOR; RECOGNITION; AFFINITY; O(R)3; RESOLUTION	As detected by chemical nuclease treatments, the conformation of the 434 repressor-DNA complex depends on the sequence of the bound DNA (Bell, A. C., and Koudelka, G. B. (1993) J, Mel. Biol. 234, 542-553). We show here that these DNA sequence-dependent conformational changes alter the efficiency with which the repressor activates transcription from 434 P-RM. Several lines of evidence suggest that binding site sequence affects the repressor's ability to activate transcription by altering the accessibility of the activation surface on the repressor to RNA polymerase, The results presented here show that in addition to affecting transcription by altering the overall binding affinity of protein for DNA, DNA sequence may also modulate the activity of the DNA-bound protein.	SUNY Buffalo, Dept Sci Biol, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Koudelka, GB (corresponding author), SUNY Buffalo, Dept Sci Biol, Buffalo, NY 14260 USA.	koudelka@acsu.buffalo.edu	Koudelka, Gerald B./AAI-3738-2020	Koudelka, Gerald B./0000-0001-6280-0837				AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; BELL AC, 1993, J MOL BIOL, V234, P542, DOI 10.1006/jmbi.1993.1610; BELL AC, 1995, J BIOL CHEM, V270, P1205, DOI 10.1074/jbc.270.3.1205; BUSBY S, 1994, CELL, V79, P743, DOI 10.1016/0092-8674(94)90063-9; BUSHMAN FD, 1993, J MOL BIOL, V230, P28, DOI 10.1006/jmbi.1993.1123; BUSHMAN FD, 1986, P NATL ACAD SCI USA, V83, P9353, DOI 10.1073/pnas.83.24.9353; BUSHMAN FD, 1988, CELL, V54, P191, DOI 10.1016/0092-8674(88)90551-X; BUSHMAN FD, 1985, NATURE, V316, P651, DOI 10.1038/316651a0; DENTE L, 1983, NUCLEIC ACIDS RES, V11, P1645, DOI 10.1093/nar/11.6.1645; DOMBROSKI AJ, 1992, CELL, V70, P501, DOI 10.1016/0092-8674(92)90174-B; GARDELLA T, 1989, J MOL BIOL, V206, P579, DOI 10.1016/0022-2836(89)90567-6; GARTENBERG MR, 1988, NATURE, V333, P824, DOI 10.1038/333824a0; GUSSIN GN, 1992, J BACTERIOL, V174, P5156, DOI 10.1128/JB.174.15.5156-5160.1992; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; HAWLEY DK, 1983, CELL, V32, P327, DOI 10.1016/0092-8674(83)90452-X; HAWLEY DK, 1982, J MOL BIOL, V157, P493, DOI 10.1016/0022-2836(82)90473-9; HOCHSCHILD A, 1983, CELL, V32, P319, DOI 10.1016/0092-8674(83)90451-8; JORDAN SR, 1988, SCIENCE, V242, P893, DOI 10.1126/science.3187530; KOUDELKA GB, 1987, NATURE, V326, P886, DOI 10.1038/326886a0; KOUDELKA GB, 1991, NUCLEIC ACIDS RES, V19, P4115, DOI 10.1093/nar/19.15.4115; KOUDELKA GB, 1993, J BIOL CHEM, V268, P23812; KOUDELKA GB, 1992, NATURE, V355, P89, DOI 10.1038/355089a0; KOUDELKA GB, 1988, P NATL ACAD SCI USA, V85, P4633, DOI 10.1073/pnas.85.13.4633; KULDELL N, 1994, J BACTERIOL, V176, P2291; KUMAR A, 1994, J MOL BIOL, V235, P405, DOI 10.1006/jmbi.1994.1001; LAUER G, 1981, Journal of Molecular and Applied Genetics, V1, P139; LAVIGNE M, 1992, BIOCHEMISTRY-US, V31, P9647, DOI 10.1021/bi00155a018; LI M, 1994, SCIENCE, V263, P75, DOI 10.1126/science.8272867; MIKAELIAN I, 1992, NUCLEIC ACIDS RES, V20, P376, DOI 10.1093/nar/20.2.376; Monsalve M, 1996, EMBO J, V15, P383, DOI 10.1002/j.1460-2075.1996.tb00368.x; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; Ptashne M, 1986, GENETIC SWITCH; RODGERS DW, 1993, STRUCTURE, V1, P227, DOI 10.1016/0969-2126(93)90012-6; SHIMON LJW, 1993, J MOL BIOL, V232, P826, DOI 10.1006/jmbi.1993.1434; Starr DB, 1996, GENE DEV, V10, P1271, DOI 10.1101/gad.10.10.1271; Tang H, 1996, METHOD ENZYMOL, V273, P130; Tang Y, 1996, J BACTERIOL, V178, P6945, DOI 10.1128/jb.178.23.6945-6951.1996; WHARTON RR, 1986, THESIS HARVARD U CAM; WU L, 1993, J BIOL CHEM, V268, P18975; WU L, 1992, J BIOL CHEM, V267, P9134	40	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24165	24172		10.1074/jbc.273.37.24165	http://dx.doi.org/10.1074/jbc.273.37.24165			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727039	hybrid			2022-12-27	WOS:000075893100080
J	Zheng, XL; Guo, JH; Wang, H; Malbon, CC				Zheng, XL; Guo, JH; Wang, H; Malbon, CC			Expression of constitutively activated G(i alpha 2) in vivo ameliorates Streptozotocin-induced diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN ACTION; GLUCOSE-TRANSPORT; GLYCOGEN-SYNTHASE; MECHANISM	Streptozotocin treatment in vivo generates a model of insulin-dependent diabetes mellitus via destruction of the pancreatic beta-cells responsible for insulin secretion. Tissue-specific expression of the Q205L constitutively activated mutant form of the G-protein G(i alpha 2) in vivo ameliorates streptozotocin-induced insulin-dependent diabetes mellitus in transgenic mice. Conditional expression of Q205L G(i alpha 2) in vivo in liver, skeletal muscle, and adipose tissue markedly rectifies glucose tolerance, fasting glucose levels, and glycogen synthase activation in the mice with insulin-dependent diabetes mellitus, providing a novel therapeutic target for diabetes.	SUNY Stony Brook, Med Ctr, Dept Mol Pharmacol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Med Ctr, Dept Physiol & Biophys, Diabet & Metab Dis Res Program, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Malbon, CC (corresponding author), SUNY Stony Brook, Hlth Sci Ctr, Dept Pharmacol, Stony Brook, NY 11794 USA.		malbon, craig/ABF-3604-2020	Zheng, Xi-Long/0000-0002-0889-1827				Chen JF, 1997, J MOL MED, V75, P283, DOI 10.1007/s001090050113; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; KARNIELI E, 1981, J CLIN INVEST, V68, P811, DOI 10.1172/JCI110318; KOBAYASHI M, 1979, DIABETES, V28, P87, DOI 10.2337/diab.28.2.87; Lawrence JC, 1997, DIABETES, V46, P541, DOI 10.2337/diabetes.46.4.541; LIKE AA, 1978, LAB INVEST, V38, P470; Moxham CM, 1996, NATURE, V379, P840, DOI 10.1038/379840a0; NISHIMURA H, 1989, AM J PHYSIOL, V256, pE624, DOI 10.1152/ajpendo.1989.256.5.E624; RAKIETEN N, 1976, P SOC EXP BIOL MED, V151, P632; VillarPalasi C, 1997, FASEB J, V11, P544, DOI 10.1096/fasebj.11.7.9212078; WHITE MF, 1994, J BIOL CHEM, V269, P1; YAMAMOTO H, 1981, NATURE, V294, P284, DOI 10.1038/294284a0	12	19	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23649	23651		10.1074/jbc.273.37.23649	http://dx.doi.org/10.1074/jbc.273.37.23649			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726968	hybrid			2022-12-27	WOS:000075893100009
J	Barnett, P; Hemrika, W; Dekker, HL; Muijsers, AO; Renirie, R; Wever, R				Barnett, P; Hemrika, W; Dekker, HL; Muijsers, AO; Renirie, R; Wever, R			Isolation, characterization, and primary structure of the vanadium chloroperoxidase from the fungus Embellisia didymospora	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CURVULARIA-INAEQUALIS; ASCOPHYLLUM-NODOSUM; PROSTHETIC GROUP; BROMOPEROXIDASE; ENZYME; SIGNAL; PURIFICATION; PEROXIDASES; STABILITY; SEQUENCES	Here we describe the isolation, purification, and basic kinetic parameters of a vanadium type chloroperoxidase from the hyphomycete fungus Embellisia didymospora. The enzyme proved to possess similar high substrate affinities, a K-m of 5 mu M for a bromide, 1.2 mM for a chloride, and 60 mu M for a hydrogen peroxide, as those of the vanadium chloroperoxidase from Curvularia inaequalis, although with lower turnover rates for both Cl- and Br-. Substrate bromide was also found to inhibit the enzyme, a feature subsequently also noted for the chloroperoxidase from C, inaequalis, The gene encoding this enzyme was identified using DNA Southern blotting techniques and subsequently isolated and sequenced. A comparison is made between this vanadium chloroperoxidase and that of the fungus C, inaequalis both kinetically and at the sequence level. At the primary structural level the two chloroperoxidases share 68% identity, with conservation of all active site residues.	Univ Amsterdam, EC Slater Inst Biochem Res, Dept Biochem, NL-1018 TV Amsterdam, Netherlands	University of Amsterdam	Wever, R (corresponding author), Univ Amsterdam, EC Slater Inst Biochem Res, Dept Biochem, Plantage Muidergracht 12, NL-1018 TV Amsterdam, Netherlands.		Barnett, Phil/F-6153-2011; Wever, Ron/AAM-4520-2020	Barnett, Phil/0000-0001-7420-6106				Barnett P, 1997, BBA-GENE STRUCT EXPR, V1352, P73, DOI 10.1016/S0167-4781(96)00238-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DEBOER E, 1988, J BIOL CHEM, V263, P12326; DEBOER E, 1986, BIOCHIM BIOPHYS ACTA, V872, P104, DOI 10.1016/0167-4838(86)90153-6; DEBOER E, 1987, BIOTECHNOL BIOENG, V30, P607, DOI 10.1002/bit.260300504; DEBOER E, 1986, BIOCHIM BIOPHYS ACTA, V869, P48, DOI 10.1016/0167-4838(86)90308-0; GHIGO JM, 1992, MOL GEN GENET, V236, P135, DOI 10.1007/BF00279652; GRIBBLE GW, 1994, ENVIRON SCI TECHNOL, V28, P310; Hemrika W, 1997, P NATL ACAD SCI USA, V94, P2145, DOI 10.1073/pnas.94.6.2145; HEWSON WD, 1980, J PHYCOL, V16, P340; HUNTERCEVERA JC, 1986, MICROBIAL ECOL, V12, P121, DOI 10.1007/BF02153227; KRENN BE, 1989, BIOCHIM BIOPHYS ACTA, V998, P63, DOI 10.1016/0167-4838(89)90119-2; KRENN BE, 1987, BIOCHIM BIOPHYS ACTA, V912, P287, DOI 10.1016/0167-4838(87)90100-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIU TNE, 1987, BIOCHEM BIOPH RES CO, V142, P329; MESSERSCHMIDT A, 1996, P NATL ACAD SCI USA, V93, P393; MUNTANJOLACVETKOVIC M, 1976, MYCOLOGIA, V68, P47, DOI 10.2307/3758896; PERLMAN D, 1983, J MOL BIOL, V167, P391, DOI 10.1016/S0022-2836(83)80341-6; PLAT H, 1987, BIOCHEM J, V248, P277, DOI 10.1042/bj2480277; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; Sambrook J., 2002, MOL CLONING LAB MANU; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHEFFIELD DJ, 1993, PHYTOCHEMISTRY, V32, P21; SIMONS BH, 1995, EUR J BIOCHEM, V229, P566, DOI 10.1111/j.1432-1033.1995.tb20499.x; THORNTON JM, 1995, PROTEIN FOLDING, P71; vanPee KH, 1996, ANNU REV MICROBIOL, V50, P375, DOI 10.1146/annurev.micro.50.1.375; VANSCHIJNDEL JWPM, 1993, BIOCHIM BIOPHYS ACTA, V1161, P249, DOI 10.1016/0167-4838(93)90221-C; VANSCHIJNDEL JWPM, 1994, EUR J BIOCHEM, V225, P151; VILTER H, 1984, PHYTOCHEMISTRY, V23, P1387, DOI 10.1016/S0031-9422(00)80471-9; VOLLENBROEK EGM, 1995, BIOCHEM SOC T, V23, P267, DOI 10.1042/bst0230267; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WEVER R, 1985, BIOCHIM BIOPHYS ACTA, V830, P181, DOI 10.1016/0167-4838(85)90026-3; WEVER R, 1991, BIOCH GLOBAL CHANGE, P811; Wever R, 1991, MICROBIAL PRODUCTION, P277	34	37	38	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23381	23387		10.1074/jbc.273.36.23381	http://dx.doi.org/10.1074/jbc.273.36.23381			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722573	hybrid			2022-12-27	WOS:000075778100073
J	Kim, JM; Sato, N; Yamada, M; Arai, K; Masai, H				Kim, JM; Sato, N; Yamada, M; Arai, K; Masai, H			Growth regulation of the expression of mouse cDNA and gene encoding a serine/threonine kinase related to Saccharomyces cerevisiae CDC7 essential for G(1)/S transition - Structure, chromosomal localization, and expression of mouse gene for S-cerevisiae CDC7-related kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIGIN RECOGNITION COMPLEX; TRANSCRIPTION FACTOR; PROTEIN-KINASE; DNA-REPLICATION; BUDDING YEAST; CYCLE; HOMOLOG; FAMILY; E2F1; MITOSIS	Saccharomyces cerevisiae CDC7 encodes a serine/threonine kinase required for G(1)/S transition of the yeast cells. We previously reported human and Xenopus cDNAs encoding CDC7-related kinases and suggested the possibility that chromosomal replication of higher eukaryotes may be regulated through conserved mechanisms involving Cdc7-related kinases. Here we report a murine cDNA and gene (muCdc7) encoding a serine/threonine kinase related to CDC7. The predicted coding frame for the longest cDNA for muCdc7 consists of 564 amino acids, which shares 46, 77, and 93% identity, respectively, with those of budding yeast, Xenopus, and human in kinase conserved domains. The chromosomal gene for muCdc7, located at the band 5E5 on the mouse chromosome 5, consists of 12 exons, and its exon/intron organization shares some similarity with that of other protein kinases including Cdk and cAMP-dependent kinase. Transcription of muCdc7, initiated at multiple sites over the 370-base pair promoter region, is repressed in the resting state and is induced at the G(1)/S boundary after growth factor stimulation in a growth factor-dependent cell line. Transient transfection assays indicated that a 231-base pair segment of the muCdc7 promoter containing three putative E2F binding sites and one Sp1 site but lacking TATA sequence is sufficient for response to growth stimulation.	Univ Tokyo, Inst Med Sci, Dept Mol & Dev Biol, Minato Ku, Tokyo 1088639, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Masai, H (corresponding author), Univ Tokyo, Inst Med Sci, Dept Mol & Dev Biol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	hisao@ims.u-tokyo.ac.jp	Sato, Noriko/Y-7693-2019					BELL DW, 1995, CYTOGENET CELL GENET, V70, P263, DOI 10.1159/000134048; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; BUCK V, 1991, MOL GEN GENET, V227, P452, DOI 10.1007/BF00273937; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Donaldson AD, 1998, GENE DEV, V12, P491, DOI 10.1101/gad.12.4.491; GAVIN KA, 1995, SCIENCE, V270, P1667, DOI 10.1126/science.270.5242.1667; GOSSEN M, 1995, SCIENCE, V270, P1674, DOI 10.1126/science.270.5242.1674; GROSS RE, 1990, J BIOL CHEM, V265, P6896; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HARTWELL LH, 1971, J MOL BIOL, V59, P183, DOI 10.1016/0022-2836(71)90420-7; HARTWELL LH, 1973, J BACTERIOL, V115, P966, DOI 10.1128/JB.115.3.966-974.1973; IMAJUKU Y, 1992, FEBS LETT, V304, P73, DOI 10.1016/0014-5793(92)80592-5; Karlseder J, 1996, MOL CELL BIOL, V16, P1659; Lin SY, 1996, MOL CELL BIOL, V16, P1668; LOWNDES NF, 1991, NATURE, V350, P247, DOI 10.1038/350247a0; MASAI H, 1995, EMBO J, V14, P3094, DOI 10.1002/j.1460-2075.1995.tb07312.x; MuziFalconi M, 1995, P NATL ACAD SCI USA, V92, P12475, DOI 10.1073/pnas.92.26.12475; NEVINS JR, 1992, SCIENCE, V258, P424; OHSHIMA J, 1995, GENOMICS, V28, P585, DOI 10.1006/geno.1995.1194; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Ohtani K, 1996, MOL CELL BIOL, V16, P6977; Sato N, 1997, EMBO J, V16, P4340, DOI 10.1093/emboj/16.14.4340; SCLAFANI RA, 1988, MOL CELL BIOL, V8, P293, DOI 10.1128/MCB.8.1.293; SETO E, 1991, NATURE, V354, P241, DOI 10.1038/354241a0; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; SUGINO A, 1995, TRENDS BIOCHEM SCI, V20, P319, DOI 10.1016/S0968-0004(00)89059-3; TODOROV IT, 1995, J CELL BIOL, V129, P1433, DOI 10.1083/jcb.129.6.1433; Williams RS, 1997, P NATL ACAD SCI USA, V94, P142, DOI 10.1073/pnas.94.1.142	28	43	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23248	23257		10.1074/jbc.273.36.23248	http://dx.doi.org/10.1074/jbc.273.36.23248			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722556	hybrid			2022-12-27	WOS:000075778100056
J	Lorenzo, P; Bayliss, MT; Heinegard, D				Lorenzo, P; Bayliss, MT; Heinegard, D			A novel cartilage protein (CILP) present in the mid-zone of human articular cartilage increases with age	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN; IX	A novel, somewhat basic noncollagenous protein was purified from guanidine hydrochloride extracts of human articular cartilage using cesium chloride density gradient centrifugation, followed by ion-exchange chromatography at pH 5, and gel filtration on two serially coupled columns of Superose 6 and Superdex 200. The protein of 91.5 kDa contains a single polypeptide chain substituted with N-linked oligosaccharides. It appeared unique to cartilage as studied by enzyme-linked immunosorbent assay and immunoblots of various tissue extracts. Its concentration in articular cartilages showed some variability with age being lower in young individuals. It represents a chondrocyte product, since it is synthesized by articular chondrocytes in explant cultures. Interestingly, the distribution of the protein in the articular cartilage provides important information on the nature of chondrocytes at different compartments in the tissue. Thus, chondrocytes in the middle/ deeper layers of the tissue in particular, appeared to have produced the protein and deposited it in the interterritorial matrix. The protein was neither seen in the superficial nor in the deepest regions of the articular cartilage. Based on its immunolocalization we have named this protein CILP (cartilage intermediate layer protein).	Univ Lund, Dept Cell & Mol Biol, S-22100 Lund, Sweden; Univ London Royal Vet Coll, London NW1 0TU, England	Lund University; University of London; University of London Royal Veterinary College	Heinegard, D (corresponding author), Univ Lund, Dept Cell & Mol Biol, POB 94, S-22100 Lund, Sweden.	Dick.Heinegard@medkem.lu.se						BANKER GA, 1972, J BIOL CHEM, V247, P5856; BAYLISS MT, 1983, BIOCHEM J, V209, P387, DOI 10.1042/bj2090387; BOWEN B, 1980, NUCLEIC ACIDS RES, V8, P1, DOI 10.1093/nar/8.1.1; DEBLAS AL, 1983, ANAL BIOCHEM, V133, P214, DOI 10.1016/0003-2697(83)90245-2; EYRE DR, 1987, FEBS LETT, V220, P337, DOI 10.1016/0014-5793(87)80842-6; FERGUSON KA, 1964, METABOLISM, V13, P985, DOI 10.1016/S0026-0495(64)80018-4; HEINEGARD D, 1987, METHOD ENZYMOL, V144, P319; HEINEGARD D, 1993, CONNECTIVE TISSUE IT, P103; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSSON T, 1991, J BIOL CHEM, V266, P20428; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; PAULSSON M, 1983, BIOCHEM J, V212, P659, DOI 10.1042/bj2120659; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105	13	132	144	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23463	23468		10.1074/jbc.273.36.23463	http://dx.doi.org/10.1074/jbc.273.36.23463			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722583	hybrid			2022-12-27	WOS:000075778100083
J	Low, WK; Miao, M; Ewart, KV; Yang, DSC; Fletcher, GL; Hew, CL				Low, WK; Miao, M; Ewart, KV; Yang, DSC; Fletcher, GL; Hew, CL			Skin-type antifreeze protein from the shorthorn sculpin, Myoxocephalus scorpius - Expression and characterization of a M-r 9,700 recombinant protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; WINTER FLOUNDER; POLAR FISHES; ICE; MECHANISM; POLYPEPTIDES; ADSORPTION; PEPTIDES; BINDING; INHIBITION	A cDNA clone encoding a presumptive antifreeze protein was isolated from a skin library from shorthorn sculpin, Myoxocephalus scorpius. The alone encodes a 92-residue mature polypeptide (sssAFP-2) without any signal and prosequence, which suggests an intracellular localization. It is the largest alanine-rich, alpha-helical type I antifreeze protein known. A recombinant fusion protein containing an N-terminal-linked His-tag was produced and purified from Escherichia coli. This protein is alpha-helical at 0 degrees C and exhibits significant antifreeze activity. Northern blot and reverse transcription-polymerase chain reaction analyses indicate that sssAFP-2 mRNA has limited tissue distribution and is present in peripheral tissues such as skin and dorsal fin, but is notably absent in the liver. These studies reinforce recent evidence that indicate that the external tissues of cold water marine fishes are major organs for antifreeze protein synthesis and are likely the first line of defense against the threat of freezing.	Univ Toronto, Banting Inst, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L5, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5G 1L5, Canada; Hosp Sick Children, Struct Biol & Biochem Div, Toronto, ON M5G 1L5, Canada; McMaster Univ, Dept Biochem, Hamilton, ON L8N 3Z5, Canada; Mem Univ Newfoundland, Ctr Ocean Sci, St John, NF A1C 5S7, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; Memorial University Newfoundland	Hew, CL (corresponding author), Univ Toronto, Banting Inst, Dept Lab Med & Pathobiol, 100 Coll St,Rm 351, Toronto, ON M5G 1L5, Canada.	choy.hew@utoronto.ca	Hew, Choy Leong/I-1501-2012	Hew, Choy Leong/0000-0002-9441-0064				BOORSTEIN WR, 1989, METHOD ENZYMOL, V180, P347; CHAKRABARTTY A, 1989, J BIOL CHEM, V264, P11313; Chao HM, 1997, BIOCHEMISTRY-US, V36, P14652, DOI 10.1021/bi970817d; Cheng AL, 1997, BIOPHYS J, V73, P2851, DOI 10.1016/S0006-3495(97)78315-2; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Davies PL, 1997, CURR OPIN STRUC BIOL, V7, P828, DOI 10.1016/S0959-440X(97)80154-6; DAVIES PL, 1988, CAN J ZOOL, V66, P2611, DOI 10.1139/z88-385; DAVIES PL, 1990, FASEB J, V4, P2460, DOI 10.1096/fasebj.4.8.2185972; Deng GJ, 1997, FEBS LETT, V402, P17, DOI 10.1016/S0014-5793(96)01466-4; DEVRIES AL, 1977, BIOCHIM BIOPHYS ACTA, V495, P388, DOI 10.1016/0005-2795(77)90395-6; DEVRIES AL, 1984, PHILOS T R SOC B, V304, P575; FLETCHER GL, 1982, ARCTIC, V35, P302; FLETCHER GL, 1998, COLD OCEAN PHYSL, P239; GONG ZY, 1992, CAN J ZOOL, V70, P810, DOI 10.1139/z92-114; Gong ZY, 1996, J BIOL CHEM, V271, P4106, DOI 10.1074/jbc.271.8.4106; GONG ZY, 1995, BIOCHEM BIOPH RES CO, V206, P387, DOI 10.1006/bbrc.1995.1053; Gronwald W, 1996, BIOCHEMISTRY-US, V35, P16698, DOI 10.1021/bi961934w; HEW CL, 1980, CAN J BIOCHEM CELL B, V58, P377, DOI 10.1139/o80-049; HEW CL, 1985, EUR J BIOCHEM, V151, P167, DOI 10.1111/j.1432-1033.1985.tb09081.x; HEW CL, 1992, EUR J BIOCHEM, V203, P33, DOI 10.1111/j.1432-1033.1992.tb19824.x; KNIGHT CA, 1984, NATURE, V308, P295, DOI 10.1038/308295a0; KNIGHT CA, 1991, BIOPHYS J, V59, P409, DOI 10.1016/S0006-3495(91)82234-2; RAYMOND JA, 1977, P NATL ACAD SCI USA, V74, P2589, DOI 10.1073/pnas.74.6.2589; SCHNEPPENHEIM R, 1982, POLAR BIOL, V1, P115; Shears Margaret A., 1993, Molecular Marine Biology and Biotechnology, V2, P104; SICHERI F, 1995, NATURE, V375, P427, DOI 10.1038/375427a0; VALERIO PF, 1992, J EXP BIOL, V164, P135; WEN DY, 1992, BIOPHYS J, V63, P1659, DOI 10.1016/S0006-3495(92)81750-2; WEN DY, 1992, J BIOL CHEM, V267, P14102; Wierzbicki A, 1996, BIOPHYS J, V71, P8, DOI 10.1016/S0006-3495(96)79204-4	30	28	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23098	23103		10.1074/jbc.273.36.23098	http://dx.doi.org/10.1074/jbc.273.36.23098			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722537	hybrid			2022-12-27	WOS:000075778100037
J	Smith, KE; Walker, MW; Artymyshyn, R; Bard, J; Borowsky, B; Tamm, JA; Yao, WJ; Vaysse, PJJ; Branchek, TA; Gerald, C; Jones, KA				Smith, KE; Walker, MW; Artymyshyn, R; Bard, J; Borowsky, B; Tamm, JA; Yao, WJ; Vaysse, PJJ; Branchek, TA; Gerald, C; Jones, KA			Cloned human and rat galanin GALR3 receptors - Pharmacology and activation of G-protein inwardly rectifying K+ channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; GUINEA-PIG STOMACH; MOLECULAR-CLONING; FUNCTIONAL EXPRESSION; ALZHEIMERS-DISEASE; HORMONE SECRETION; NEUROPEPTIDE-Y; PEPTIDE; ANTAGONISTS; BINDING	The neuropeptide galanin has been implicated in the regulation of processes such as nociception, cognition, feeding behavior, and hormone secretion. Multiple galanin receptors are predicted to mediate its effects, but only two functionally coupled receptors have been reported. We now report the cloning of a third galanin receptor distinct from GALR1 and GALR2. The receptor, termed GALR3, was isolated from a rat hypothalamus cDNA library by both expression and homology cloning approaches. The rat GALR3 receptor cDNA can encode a protein of 370 amino acids with 35% and 52% identity to GALR1 and GALR2, respectively. Localization of mRNA, by solution hybridization/RNase protection demonstrates that the GALR3 transcript is widely distributed, but expressed at low abundance, with the highest levels in the hypothalamus and pituitary. We also isolated the gene encoding the human homologue of GALR3. The human GALR3 receptor is 90% identical to rat GALR3 and contains 368 amino acids. Binding of porcine I-125-galanin to stably expressed rat and human GALR3 receptors is saturable (rat K-D = 0.98 nM and human K-D = 2.23 nM) and displaceable by galanin peptides and analogues in the following rank, order: rat galanin, porcine galanin similar or equal to M32, M35 similar or equal to porcine galanin-(-7 to +29), galantide, human galanin > M40, galanin-(1-16) > [D-Trp(2)]galanin-(1-29), galanin-(3-29). This profile resembles that of the rat GALR1 and GALR2 receptors with the notable exception that human galanin, galanin-(1-16), and M40 show lower affinity at GALR3. In Xenopus oocytes, activation of rat and human GALR3 receptors co-expressed with potassium channel subunits GIRK1 and GIRK4 resulted in inward K+ currents characteristic of G(i)/G(o)-coupled receptors, These data confirm the functional efficacy of GALR3 receptors and further suggest that GALR3 signaling pathways resemble those of GALR1 in that both can activate potassium channels linked to the regulation of neurotransmitter release.	Synapt Pharmaceut Corp, Dept Mol Biol, Paramus, NJ 07652 USA; Synapt Pharmaceut Corp, Dept Pharmacol, Paramus, NJ 07652 USA		Smith, KE (corresponding author), Synapt Pharmaceut Corp, Dept Mol Biol, 215 Coll Rd, Paramus, NJ 07652 USA.							ARTYMYSHYN RP, 1992, NEUROCHEM INT, V20, pS189; BARD JA, 1995, J BIOL CHEM, V270, P26762, DOI 10.1074/jbc.270.45.26762; BARTFAI T, 1992, TRENDS PHARMACOL SCI, V13, P312, DOI 10.1016/0165-6147(92)90098-Q; BARTFAI T, 1993, P NATL ACAD SCI USA, V90, P11287, DOI 10.1073/pnas.90.23.11287; BEDECS K, 1994, EUR J PHARMACOL, V259, P151, DOI 10.1016/0014-2999(94)90504-5; BERSANI M, 1991, ENDOCRINOLOGY, V129, P2693, DOI 10.1210/endo-129-5-2693; BOROWSKY B, 1997, SOC NEUR ABSTR, V22, P393; CHAKDER S, 1991, GASTROENTEROLOGY, V100, P711, DOI 10.1016/0016-5085(91)80015-2; Chan YY, 1996, ENDOCRINOLOGY, V137, P5303, DOI 10.1210/en.137.12.5303; Chan-Palay V, 1990, Adv Neurol, V51, P253; Cimini V, 1996, EXP CELL RES, V228, P212, DOI 10.1006/excr.1996.0319; CORWIN RL, 1993, EUR J NEUROSCI, V5, P1528, DOI 10.1111/j.1460-9568.1993.tb00221.x; Crawley JN, 1996, LIFE SCI, V58, P2185, DOI 10.1016/0024-3205(96)00093-8; CRAWLEY JN, 1993, BRAIN RES, V600, P268, DOI 10.1016/0006-8993(93)91382-3; CRAWLEY JN, 1990, J NEUROSCI, V10, P3695; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; Diaz Z, 1996, BRAIN RES, V741, P32, DOI 10.1016/S0006-8993(96)00883-9; EVANS HF, 1991, ENDOCRINOLOGY, V129, P1682, DOI 10.1210/endo-129-3-1682; Fathi Z, 1997, MOL BRAIN RES, V51, P49, DOI 10.1016/S0169-328X(97)00210-6; Forray C., 1996, Society for Neuroscience Abstracts, V22, P1304; Grottoli S, 1996, J ENDOCRINOL INVEST, V19, P739, DOI 10.1007/BF03347877; GU ZF, 1994, AM J PHYSIOL, V266, pG839, DOI 10.1152/ajpgi.1994.266.5.G839; GU ZF, 1995, J PHARMACOL EXP THER, V272, P371; Gustafson EL, 1996, NEUROREPORT, V7, P953, DOI 10.1097/00001756-199603220-00025; HABERTORTOLI E, 1994, P NATL ACAD SCI USA, V91, P9780, DOI 10.1073/pnas.91.21.9780; HEDLUND PB, 1994, BRAIN RES, V634, P163, DOI 10.1016/0006-8993(94)90271-2; Howard AD, 1997, FEBS LETT, V405, P285, DOI 10.1016/S0014-5793(97)00196-8; JI RR, 1995, NEUROSCIENCE, V68, P563, DOI 10.1016/0306-4522(95)94333-T; KALKBRENNER F, 1995, EMBO J, V14, P4728, DOI 10.1002/j.1460-2075.1995.tb00154.x; Kask K, 1995, CELL MOL NEUROBIOL, V15, P653, DOI 10.1007/BF02071130; Kask K, 1997, LIFE SCI, V60, P1523, DOI 10.1016/S0024-3205(96)00624-8; Kinney GA, 1998, J NEUROSCI, V18, P3489; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; McCormick M, 1987, Methods Enzymol, V151, P445, DOI 10.1016/S0076-6879(87)51036-9; NOWAK MW, 1995, SCIENCE, V268, P439, DOI 10.1126/science.7716551; Parker EM, 1995, MOL BRAIN RES, V34, P179, DOI 10.1016/0169-328X(95)00159-P; REIMANN W, 1993, LIFE SCI, V52, P251; Renstrom E, 1996, NEURON, V17, P513, DOI 10.1016/S0896-6273(00)80183-X; SAHU A, 1994, ENDOCRINOLOGY, V134, P529, DOI 10.1210/en.134.2.529; SCHREIBER RC, 1994, NEUROSCIENCE, V60, P17, DOI 10.1016/0306-4522(94)90200-3; Shi TJS, 1997, NEUROSCI LETT, V237, P57, DOI 10.1016/S0304-3940(97)00805-7; Smith KE, 1997, J BIOL CHEM, V272, P24612, DOI 10.1074/jbc.272.39.24612; TSUDA K, 1989, HYPERTENSION, V14, P81, DOI 10.1161/01.HYP.14.1.81; Wang SK, 1997, J BIOL CHEM, V272, P31949, DOI 10.1074/jbc.272.51.31949; Wang ZL, 1997, J CLIN INVEST, V100, P189, DOI 10.1172/JCI119512; WYNICK D, 1993, P NATL ACAD SCI USA, V90, P4231, DOI 10.1073/pnas.90.9.4231; XU XJ, 1995, BRIT J PHARMACOL, V116, P2076, DOI 10.1111/j.1476-5381.1995.tb16414.x; Xu ZQ, 1996, NEUROREPORT, V8, P237, DOI 10.1097/00001756-199612200-00048; Xu ZQD, 1997, P NATL ACAD SCI USA, V94, P13262, DOI 10.1073/pnas.94.24.13262	51	223	233	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23321	23326		10.1074/jbc.273.36.23321	http://dx.doi.org/10.1074/jbc.273.36.23321			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722565	hybrid			2022-12-27	WOS:000075778100065
J	Tarcsa, E; Candi, E; Kartasova, T; Idler, WW; Marekov, LN; Steinert, PM				Tarcsa, E; Candi, E; Kartasova, T; Idler, WW; Marekov, LN; Steinert, PM			Structural and transglutaminase substrate properties of the small proline-rich 2 family of cornified cell envelope proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN EPIDERMAL-KERATINOCYTES; DIFFERENTIATION-SPECIFIC GENES; INTERMEDIATE FILAMENTS; EPITHELIAL-CELLS; HUMAN LORICRIN; BOND FORMATION; CROSS-LINKING; RETINOIC ACID; SPR1 GENE; EXPRESSION	The small proline-rich (SPR) proteins are components of the cornified cell envelope of stratified squamous epithelia and become cross-linked to other proteins by transglutaminases (TGases). The SIPR2 family is the most complex, as it consists of several differentially expressed members of the same size. To explore their physical and cross-linking properties, we have expressed in bacteria a human SPR2 family member, and purified it to homogeneity. By circular dichroism, it possesses no alpha or beta structure but has some organized structure associated with the central peptide repeat domain. The TGase 1, 2, and 3 enzymes expressed in epithelia use the recombinant SPR2 protein as a complete substrate in vitro, but with widely differing kinetic efficiencies, and in different ways. With TGase 1, only one glutamine on the head domain and one lysine on the tail domain were used for limited interchain cross-linking. With TGase 3, multiple head and tail domain residues were used for extensive interchain cross-linking. The total usage of glutamine and lysine residues in vitro by TGase 3 was similar to that seen in earlier in vivo studies. We conclude that SPR2 proteins are cross-linked in epithelia primarily by the TGase 3 enzyme, a minor extent by TGase 1, and probably not by TGase 2.	NIAMS, Skin Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Steinert, PM (corresponding author), NIAMS, Skin Biol Lab, NIH, Bldg 6,Room 425,9000 Rockville Pike, Bethesda, MD 20892 USA.	pemast@helix.nih.gov						AESCHLIMANN D, 1991, J BIOL CHEM, V266, P15308; AN G, 1993, J CELL PHYSIOL, V157, P562, DOI 10.1002/jcp.1041570316; AN G, 1993, J BIOL CHEM, V268, P10977; Austin SJ, 1996, J BIOL CHEM, V271, P3737, DOI 10.1074/jbc.271.7.3737; BACKENDORF C, 1992, NAT GENET, V2, P91, DOI 10.1038/ng1092-91; BARRY ELR, 1990, J BIOL CHEM, V265, P9302; BIRCKBICHLER PJ, 1977, BIOCHEM BIOPH RES CO, V78, P1, DOI 10.1016/0006-291X(77)91213-X; Candi E, 1998, J BIOL CHEM, V273, P13693, DOI 10.1074/jbc.273.22.13693; CANDI E, 1995, J BIOL CHEM, V270, P26382, DOI 10.1074/jbc.270.44.26382; FOLK JE, 1985, METHOD ENZYMOL, V113, P358; FOLK JE, 1983, ADV ENZYMOL RAMB, V54, P1; Fujimoto W, 1997, J INVEST DERMATOL, V108, P200, DOI 10.1111/1523-1747.ep12334240; GANG A, 1992, AM J RESP CELL MOL, V7, P104, DOI 10.1165/ajrcmb/7.1.104; GIBBS S, 1990, NUCLEIC ACIDS RES, V18, P4401, DOI 10.1093/nar/18.15.4401; GIBBS S, 1993, GENOMICS, V16, P630, DOI 10.1006/geno.1993.1240; GILCHREST BA, 1994, ARCH DERMATOL, V130, P82, DOI 10.1001/archderm.130.1.82; GRECO MA, 1995, J INVEST DERMATOL, V104, P204, DOI 10.1111/1523-1747.ep12612759; HOHL D, 1990, DERMATOLOGICA, V180, P201, DOI 10.1159/000248031; HOHL D, 1995, J INVEST DERMATOL, V104, P902, DOI 10.1111/1523-1747.ep12606176; HOHL D, 1991, J BIOL CHEM, V266, P6626; Jarnik M, 1998, J CELL SCI, V111, P1051; Jarnik M, 1996, J CELL SCI, V109, P1381; Kartasova T, 1996, J INVEST DERMATOL, V106, P294, DOI 10.1111/1523-1747.ep12340741; KARTASOVA T, 1988, MOL CELL BIOL, V8, P2195, DOI 10.1128/MCB.8.5.2195; KARTASOVA T, 1988, MOL CELL BIOL, V8, P2204, DOI 10.1128/MCB.8.5.2204; KARTASOVA T, 1995, J INVEST DERMATOL, V104, P611; KIM HC, 1990, J BIOL CHEM, V265, P21971; KIM SY, 1994, J BIOL CHEM, V269, P27979; Koizumi H, 1996, BRIT J DERMATOL, V134, P686, DOI 10.1111/j.1365-2133.1996.tb06971.x; LORAND L, 1984, MOL CELL BIOCHEM, V58, P9, DOI 10.1007/BF00240602; MARTINET N, 1988, BIOCHEM J, V271, P305; MARVIN KW, 1992, P NATL ACAD SCI USA, V89, P11026, DOI 10.1073/pnas.89.22.11026; Owens DM, 1996, J INVEST DERMATOL, V106, P647, DOI 10.1111/1523-1747.ep12345463; PHILLIPS SB, 1990, COMP BIOCHEM PHYS B, V95, P781, DOI 10.1016/0305-0491(90)90317-M; Reichert Uwe, 1993, P107; Robinson NA, 1997, J BIOL CHEM, V272, P12035, DOI 10.1074/jbc.272.18.12035; SAUNDERS NA, 1994, J BIOL CHEM, V269, P2016; SAUNDERS NA, 1993, BIOCHEM BIOPH RES CO, V197, P46, DOI 10.1006/bbrc.1993.2439; SIMON M, 1988, J BIOL CHEM, V263, P18093; SIMON M, 1994, KERATINOCYTE HDB, P275; Steinert P M, 1995, Cell Death Differ, V2, P33; STEINERT PM, 1976, J MOL BIOL, V108, P547, DOI 10.1016/S0022-2836(76)80136-2; STEINERT PM, 1981, P NATL ACAD SCI-BIOL, V78, P4097, DOI 10.1073/pnas.78.7.4097; Steinert PM, 1998, J BIOL CHEM, V273, P11758, DOI 10.1074/jbc.273.19.11758; STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702; Steinert PM, 1997, J BIOL CHEM, V272, P2021, DOI 10.1074/jbc.272.3.2021; STEINERT PM, 1998, IN PRESS J STRUCT BI; Tarcsa E, 1997, J BIOL CHEM, V272, P27893, DOI 10.1074/jbc.272.44.27893; TESFAIGZI J, 1993, AM J RESP CELL MOL, V9, P434, DOI 10.1165/ajrcmb/9.4.434; YAAR M, 1995, EXP CELL RES, V217, P217, DOI 10.1006/excr.1995.1081	50	52	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23297	23303		10.1074/jbc.273.36.23297	http://dx.doi.org/10.1074/jbc.273.36.23297			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722562	hybrid			2022-12-27	WOS:000075778100062
J	Awrey, DE; Shimasaki, N; Koth, C; Weilbaecher, R; Olmsted, V; Kazanis, S; Shan, X; Arellano, J; Arrowsmith, CH; Kane, CM; Edwards, AM				Awrey, DE; Shimasaki, N; Koth, C; Weilbaecher, R; Olmsted, V; Kazanis, S; Shan, X; Arellano, J; Arrowsmith, CH; Kane, CM; Edwards, AM			Yeast transcript elongation factor (TFIIS), structure and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; BINDING DOMAIN; INTRINSIC BLOCKS; S-II; CLEAVAGE; DNA; STIMULATION; MUTAGENESIS; SITE; COMPLEXES	The transcriptionally active fragment of the yeast RNA polymerase II transcription elongation factor, TFIIS, comprises a three-helix bundle and a zinc ribbon motif joined by a linker region. We have probed the function of this fragment of TFIIS using structure-guided mutagenesis. The helix bundle domain binds RNA polymerase II with the same affinity as does the full-length TFIIS, and this interaction is mediated by a basic patch on the outer face of the third helix. TFIIS mutants that were unable to bind RNA polymerase II were inactive for transcription activity, confirming the central role of polymerase binding in the TFIIS mechanism of action. The linker and zinc ribbon regions play roles in promoting cleavage of the nascent transcript and read-through past the block to elongation. Mutation of three aromatic residues in the zinc ribbon domain (Phe(269), Phe(296), and Phe(308)) impaired both transcript cleavage and read-through. Mutations introduced in the linker region between residues 240 and 245 and between 250 and 255 also severely impaired both transcript cleavage and read-through activities. Our analysis suggests that the linker region of TFIIS probably adopts a critical structure in the context of the elongation complex.	Univ Toronto, Banting & Best Dept Med Res, CH Best Inst, Toronto, ON M5G 1L6, Canada; Univ Calif Berkeley, Div Mol & Cellular Biol, Berkeley, CA 94720 USA; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; Ontario Canc Inst, Toronto, ON M5G 2M9, Canada	University of Toronto; University of California System; University of California Berkeley; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Edwards, AM (corresponding author), Univ Toronto, Banting & Best Dept Med Res, CH Best Inst, 112 Coll St, Toronto, ON M5G 1L6, Canada.	aled.edwards@utoronto.ca		Edwards, Aled/0000-0002-4782-6016; Arrowsmith, Cheryl/0000-0002-4971-3250; Koth, Christopher/0000-0003-3939-8856	NIGMS NIH HHS [GM54012] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054012] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGARWAL K, 1991, BIOCHEMISTRY-US, V30, P7842, DOI 10.1021/bi00245a026; ARCHAMBAULT J, 1992, MOL CELL BIOL, V12, P4142, DOI 10.1128/MCB.12.9.4142; Awrey DE, 1997, J BIOL CHEM, V272, P14747, DOI 10.1074/jbc.272.23.14747; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bycroft M, 1997, CELL, V88, P235, DOI 10.1016/S0092-8674(00)81844-9; CHAMBERLIN MJ, 1995, HARVEY LECT, V88, P1; CHRISTIE KR, 1994, J BIOL CHEM, V269, P936; CIPRESPALACIN G, 1994, P NATL ACAD SCI USA, V91, P8087, DOI 10.1073/pnas.91.17.8087; CIPRESPALACIN G, 1995, BIOCHEMISTRY-US, V34, P15375, DOI 10.1021/bi00046a046; EDWARDS AM, 1990, P NATL ACAD SCI USA, V87, P2122, DOI 10.1073/pnas.87.6.2122; Gu WG, 1995, J BIOL CHEM, V270, P30441, DOI 10.1074/jbc.270.51.30441; GU WG, 1995, J BIOL CHEM, V270, P11238, DOI 10.1074/jbc.270.19.11238; GU WG, 1993, J BIOL CHEM, V268, P25604; HORIKOSHI N, 1990, J BIOL CHEM, V265, P11854; JEON CJ, 1994, P NATL ACAD SCI USA, V91, P9106, DOI 10.1073/pnas.91.19.9106; Kane C. M., 1994, TRANSCRIPTION MECH R, P279; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Morin PE, 1996, P NATL ACAD SCI USA, V93, P10604, DOI 10.1073/pnas.93.20.10604; NAKANISHI T, 1995, J BIOL CHEM, V270, P8991, DOI 10.1074/jbc.270.15.8991; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Olmsted VK, 1998, J BIOL CHEM, V273, P22589, DOI 10.1074/jbc.273.35.22589; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; Powell W, 1996, J BIOL CHEM, V271, P22301, DOI 10.1074/jbc.271.37.22301; QIAN XQ, 1993, NATURE, V365, P277, DOI 10.1038/365277a0; REINES D, 1992, J BIOL CHEM, V267, P3795; REINES D, 1989, J BIOL CHEM, V264, P10799; REINES D, 1994, RAV S MOL C, V3, P263; RIVA M, 1990, J BIOL CHEM, V265, P16498; RIVA M, 1987, J BIOL CHEM, V262, P14377; Rudd MD, 1996, J BIOL CHEM, V271, P21549, DOI 10.1074/jbc.271.35.21549; SOPTA M, 1985, J BIOL CHEM, V260, P353; Wu JS, 1996, P NATL ACAD SCI USA, V93, P11552, DOI 10.1073/pnas.93.21.11552	33	64	64	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22595	22605		10.1074/jbc.273.35.22595	http://dx.doi.org/10.1074/jbc.273.35.22595			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712888	hybrid			2022-12-27	WOS:000075616600064
J	Liu, CY; Shiraishi, A; Kao, CWC; Converse, RL; Funderburgh, JL; Corpuz, LM; Conrad, GW; Kao, WWY				Liu, CY; Shiraishi, A; Kao, CWC; Converse, RL; Funderburgh, JL; Corpuz, LM; Conrad, GW; Kao, WWY			The cloning of mouse keratocan cDNA and genomic DNA and the characterization of its expression during eye development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KERATAN SULFATE PROTEOGLYCAN; LUMICAN; GENE; CORNEA; SEQUENCE; MATRIX; UNIQUE	Keratan sulfate proteoglycans (KSPGs) play a pivotal role in the development and maintenance of corneal transparency. Keratocan, lumican, and mimecan (osteoglycin) are the major KSPGs in vertebrate corneas. To provide a better understanding of the structure/function relationship of keratocan, we have cloned both the mouse keratocan gene and its cDNA. We have also examined its expression during embryonic development. The mouse keratocan gene spans approximately 6.5 kilobases of the mouse genome and contains three exons and two introns. Northern blotting and in situ hybridization were employed to examine keratocan gene expression during mouse development. Unlike lumican gene, which is expressed by many tissues other than cornea, keratocan mRNA is more selectively expressed in the corneal tissue of the adult mouse. During embryonic development, keratocan mRNA was first detected in periocular mesenchymal cells migrating toward developing corneas on embryonic day 13.5 (E13.5). Its expression was gradually restricted to corneal stromal cells on E14.5 similar to E18.5. Interestingly, keratocan mRNA can be detected in scleral cells of E15.5 embryos, but not in E18.5 embryos. In adult eyes, keratocan mRNA can be detected in corneal keratocytes, but not in scleral cells.	Univ Cincinnati, Dept Ophthalmol, Cincinnati, OH 45267 USA; Kansas State Univ, Div Biol, Manhattan, KS 66506 USA	University System of Ohio; University of Cincinnati; Kansas State University	Liu, CY (corresponding author), Univ Cincinnati, Dept Ophthalmol, Eden & Bethesda Ave,ML 0527, Cincinnati, OH 45267 USA.			Liu, Chia-yang/0000-0002-8398-5516	NEI NIH HHS [EY10556, EY09368, EY00952] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY000952, R01EY009368, R01EY010556] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANTONSSON P, 1991, J BIOL CHEM, V266, P16859; AXELSSON I, 1984, ACTA OPHTHALMOL, V62, P25; Corpuz LM, 1996, J BIOL CHEM, V271, P9759, DOI 10.1074/jbc.271.16.9759; Doane KJ, 1996, EXP EYE RES, V62, P271; FUNDERBURGH JL, 1991, J BIOL CHEM, V266, P14226; FUNDERBURGH JL, 1993, J BIOL CHEM, V268, P11874; Funderburgh JL, 1997, J BIOL CHEM, V272, P28089, DOI 10.1074/jbc.272.44.28089; FUNDERBURGH JL, 1995, INVEST OPHTH VIS SCI, V36, P2296; HASSELL JR, 1980, P NATL ACAD SCI-BIOL, V77, P3705, DOI 10.1073/pnas.77.6.3705; HASSELL JR, 1983, ARCH BIOCHEM BIOPHYS, V222, P362, DOI 10.1016/0003-9861(83)90532-5; Hay E.D., 1980, International Review of Cytology, V63, P263, DOI 10.1016/S0074-7696(08)61760-X; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; LIU CY, 1994, J BIOL CHEM, V269, P24627; LIU CY, 1993, CURR EYE RES, V12, P963, DOI 10.3109/02713689309029222; Liu CY, 1996, GENE DEV, V10, P1835, DOI 10.1101/gad.10.14.1835; MAURICE DM, 1984, VEGETATIVE PHYSL BIO, P49; Meier S., 1982, Progress in Clinical and Biological Research, V82, P1; POOLE AR, 1986, BIOCHEM J, V236, P1; RADA JA, 1993, EXP EYE RES, V56, P635, DOI 10.1006/exer.1993.1081; TASHEVA ES, 1998, IN PRESS GENE AMST; Ying SX, 1997, J BIOL CHEM, V272, P30306, DOI 10.1074/jbc.272.48.30306	21	75	78	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22584	22588		10.1074/jbc.273.35.22584	http://dx.doi.org/10.1074/jbc.273.35.22584			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712886	hybrid			2022-12-27	WOS:000075616600062
J	Marzesco, AM; Galli, T; Louvard, D; Zahraoui, A				Marzesco, AM; Galli, T; Louvard, D; Zahraoui, A			The rod cGMP phosphodiesterase delta subunit dissociates the small GTPase Rab13 from membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP/GTP EXCHANGE PROTEIN; EPITHELIAL-CELLS; BINDING PROTEINS; SNARE ACTIVATION; DOMAIN; INHIBITOR; TRANSPORT; EFFECTOR; RABAPTIN-5; COMPLEXES	Small Rab GTPases are involved in the regulation of membrane trafficking. They cycle between cytosolic and membrane-bound forms. These membrane association/dissociation are tightly controlled by regulatory proteins. To search for proteins interacting with Rab13, a small GTPase associated with vesicles in fibroblasts and predominantly with tight junctions in epithelial cells, we screened a HeLa two-hybrid cDNA Library and isolated a clone encoding a protein of 17.4 kDa. This protein, almost identical to the bovine rod cGMP phosphodiesterase delta subunit, was named human delta-PDE. The delta-PDE binds specifically to Rab13. It exhibits two putative C-terminal sequences necessary for the interaction with PDZ (PSD95, Dig, ZO-1) domains contained in many proteins localized to specific plasma membrane microdomains. Immunofluorescence microscopic studies revealed that the vesicular stomatitis virus (VSV)tagged F-PDE is localized in vesicular structures accumulated near the plasma membrane in epithelial cells. Deletion of the PDZ binding motifs impair VSV-S-PDE subcellular distribution. Purified recombinant S-PDE had the capacity to dissociate Rab13 from cellular membranes. Our data support the proposal that S-PDE, but not GDP dissociation inhibitor, may serve to control the dynamic of the association of Rab13 with cellular membranes.	Inst Curie, CNRS, UMR 144, F-75248 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Zahraoui, A (corresponding author), Inst Curie, CNRS, UMR 144, 26 Rue Ulm, F-75248 Paris 05, France.		Galli, Thierry/G-8842-2011; Galli, Thierry/Q-2249-2019	Galli, Thierry/0000-0001-8514-7455; Galli, Thierry/0000-0001-8514-7455				ARAKI S, 1991, MOL CELL BIOL, V11, P1438, DOI 10.1128/MCB.11.3.1438; Ayad N, 1997, EMBO J, V16, P4497, DOI 10.1093/emboj/16.15.4497; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; DIRAC SA, 1997, EMBO J, V16, P465; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Fanning AS, 1996, CURR BIOL, V6, P1385, DOI 10.1016/S0960-9822(96)00737-3; Florio SK, 1996, J BIOL CHEM, V271, P24036, DOI 10.1074/jbc.271.39.24036; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; JANOUEIXLEROSEY I, 1995, J BIOL CHEM, V270, P14801, DOI 10.1074/jbc.270.24.14801; JOBERTY G, 1993, FEBS LETT, V330, P323, DOI 10.1016/0014-5793(93)80897-4; JULLIENFLORES V, 1995, J BIOL CHEM, V270, P22473, DOI 10.1074/jbc.270.38.22473; Kato M, 1996, J BIOL CHEM, V271, P31775, DOI 10.1074/jbc.271.50.31775; KINSELLA BT, 1992, J BIOL CHEM, V267, P3940; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; KREIS TE, 1986, EMBO J, V5, P931, DOI 10.1002/j.1460-2075.1986.tb04306.x; LIAN JP, 1994, NATURE, V372, P698, DOI 10.1038/372698a0; LOUVARD D, 1980, P NATL ACAD SCI-BIOL, V77, P4132, DOI 10.1073/pnas.77.7.4132; Lupashin VV, 1997, SCIENCE, V276, P1255, DOI 10.1126/science.276.5316.1255; Mayer A, 1997, J CELL BIOL, V136, P307, DOI 10.1083/jcb.136.2.307; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; REGAZZI R, 1992, J BIOL CHEM, V267, P17512; Ren MD, 1996, P NATL ACAD SCI USA, V93, P5151, DOI 10.1073/pnas.93.10.5151; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SOGAARD M, 1994, CELL, V78, P937, DOI 10.1016/0092-8674(94)90270-4; SOLDATI T, 1993, MOL BIOL CELL, V4, P425, DOI 10.1091/mbc.4.4.425; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; ULLRICH O, 1993, J BIOL CHEM, V268, P18143; Wada M, 1997, J BIOL CHEM, V272, P3875, DOI 10.1074/jbc.272.7.3875; WEBER E, 1994, J CELL BIOL, V125, P583, DOI 10.1083/jcb.125.3.583; ZAHRAOUI A, 1994, J CELL BIOL, V124, P101, DOI 10.1083/jcb.124.1.101	34	54	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22340	22345		10.1074/jbc.273.35.22340	http://dx.doi.org/10.1074/jbc.273.35.22340			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712853	hybrid			2022-12-27	WOS:000075616600029
J	Bresnahan, WA; Albrecht, T; Thompson, EA				Bresnahan, WA; Albrecht, T; Thompson, EA			The cyclin E promoter is activated by human cytomegalovirus 86-kDa immediate early protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IE2 86-KILODALTON PROTEIN; BOX-BINDING-PROTEIN; CELL-CYCLE; TATA-BOX; RETINOBLASTOMA PROTEIN; TRANSCRIPTIONAL ACTIVATION; CDK2 ACTIVITY; GENE-PRODUCT; IE86 PROTEIN; INTERACTS	Human cytomegalovirus (HCMV) activates cyclin E/Cdk2, which regulates cell cycle progression in G(1) and S phase of the cell cycle. HCMV activation of cyclin E/Cdk2 can be demonstrated in cells that are refractory to normal mitotic stimuli. This observation suggests that the virus has some means to overcome the stringent control on expression of cell cycle progression factors that is characteristic of cells in the G(0) state. One of the mechanisms involved in activation of cyclin E/Cdk2 is the induction of cyclin E expression. We report here that HCMV induces cyclin E expression through a transcriptional mechanism. The cyclin E gene is activated by the HCMV 86-kDa immediate early gene product (IE86), which directly binds to nucleotide sequences within the cyclin E promoter. An IE86 DNA-binding mutant neither binds nor activates the cyclin E promoter. IE86-binding sites within the cyclin E promoter are required for IE86-mediated activation, and deletion of the IE86-binding site inhibits IE86 activation of the cyclin E promoter. We also demonstrate that mutation of the known E2F-binding sites in the cyclin E promoter does not block activation by HCMV or IE86. These data provide a molecular mechanism for HCMV induction of cyclin E and represent the first report of IE86 directly binding to a cellular promoter.	Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Thompson, EA (corresponding author), Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA.	athompso@utmb.edu			NCI NIH HHS [CA24347] Funding Source: Medline; NIDCR NIH HHS [DE11389] Funding Source: Medline; NIEHS NIH HHS [ES06676] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA024347, R01CA024347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ARLT H, 1994, J VIROL, V68, P4117, DOI 10.1128/JVI.68.7.4117-4125.1994; BOLDOGH I, 1990, SCIENCE, V247, P961; Botz J, 1996, MOL CELL BIOL, V16, P3401; Bresnahan WA, 1997, J GEN VIROL, V78, P1993, DOI 10.1099/0022-1317-78-8-1993; Bresnahan WA, 1997, VIROLOGY, V231, P239, DOI 10.1006/viro.1997.8489; Bresnahan WA, 1996, VIROLOGY, V224, P150, DOI 10.1006/viro.1996.0516; Bresnahan WA, 1996, CELL GROWTH DIFFER, V7, P1283; CASWELL R, 1993, J GEN VIROL, V74, P2691, DOI 10.1099/0022-1317-74-12-2691; CHOI KS, 1995, VIROLOGY, V208, P450, DOI 10.1006/viro.1995.1175; Dittmer D, 1997, J VIROL, V71, P1629, DOI 10.1128/JVI.71.2.1629-1634.1997; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; FURNARI BA, 1993, J VIROL, V67, P4981, DOI 10.1128/JVI.67.8.4981-4991.1993; GENG Y, 1993, P NATL ACAD SCI USA, V90, P10315, DOI 10.1073/pnas.90.21.10315; Geng Y, 1996, ONCOGENE, V12, P1173; HAGEMEIER C, 1994, EMBO J, V13, P2897, DOI 10.1002/j.1460-2075.1994.tb06584.x; HAGEMEIER C, 1992, J GEN VIROL, V73, P2385, DOI 10.1099/0022-1317-73-9-2385; HAGEMEIER C, 1992, J VIROL, V66, P4452, DOI 10.1128/JVI.66.7.4452-4456.1992; JAULT FM, 1995, J VIROL, V69, P6697, DOI 10.1128/JVI.69.11.6697-6704.1995; JUPP R, 1993, J VIROL, V67, P5595, DOI 10.1128/JVI.67.9.5595-5604.1993; JUPP R, 1993, J VIROL, V67, P7539, DOI 10.1128/JVI.67.12.7539-7546.1993; KINGSTON RE, 1996, INTRO DNA MAMMALIAN; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; LANG D, 1993, J VIROL, V67, P323, DOI 10.1128/JVI.67.1.323-331.1993; LANG D, 1994, NUCLEIC ACIDS RES, V22, P3331, DOI 10.1093/nar/22.16.3331; LEW DJ, 1991, CELL, V66, P1197, DOI 10.1016/0092-8674(91)90042-W; Lu MS, 1996, J VIROL, V70, P8850, DOI 10.1128/JVI.70.12.8850-8857.1996; LUKAC DM, 1994, J VIROL, V68, P5184, DOI 10.1128/JVI.68.8.5184-5193.1994; MARGOLIS MJ, 1995, J VIROL, V69, P7759, DOI 10.1128/JVI.69.12.7759-7767.1995; MONICK MM, 1992, AM J RESP CELL MOL, V7, P251, DOI 10.1165/ajrcmb/7.3.251; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; OHTSUBO M, 1995, P NATL ACAD SCI USA, V92, P12146; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; RESNITZKY D, 1995, MOL CELL BIOL, V15, P3463; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; SANTOMENNA LD, 1988, J VIROL, V166, P217; SCHWARTZ R, 1994, J VIROL, V68, P5613, DOI 10.1128/JVI.68.9.5613-5622.1994; SLINGERLAND JM, 1994, MOL CELL BIOL, V14, P3683, DOI 10.1128/MCB.14.6.3683; SOMMER MH, 1994, J VIROL, V68, P6223, DOI 10.1128/JVI.68.10.6223-6231.1994; Spector DH, 1996, INTERVIROLOGY, V39, P361, DOI 10.1159/000150507; Stenberg RM, 1996, INTERVIROLOGY, V39, P343, DOI 10.1159/000150505; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; WATHEN MW, 1982, J VIROL, V41, P462, DOI 10.1128/JVI.41.2.462-477.1982; Yoo YD, 1996, J VIROL, V70, P7062, DOI 10.1128/JVI.70.10.7062-7070.1996	45	78	79	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					22075	22082		10.1074/jbc.273.34.22075	http://dx.doi.org/10.1074/jbc.273.34.22075			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705351	hybrid			2022-12-27	WOS:000075492600085
J	Bajorath, J				Bajorath, J			Detailed comparison of two molecular models of the human CD40 ligand with an x-ray structure and critical assessment of model-based mutagenesis and residue mapping studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN SUPERFAMILY PROTEINS; HYPER-IGM SYNDROME; B-CELL ACTIVATION; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; RECEPTOR-BINDING; CTLA-4 CD152; GP39; RESOLUTION; CLASSIFICATION	The interactions between the B cell receptor CD40 and its ligand on T cells are critical for the integrity of immune responses. The human CD40 ligand gp39, a tumor necrosis factor-like protein, has been the subject of intense efforts to identify the receptor-binding site and to analyze naturally occurring mutations that compromise gp39 function in vivo. These investigations relied heavily on molecular models of gp39, built in the presence of only similar to 25% sequence identity to tumor necrosis factor. The x-ray structure of gp39 has made it possible to assess modeling accuracy and to evaluate the results of model-based mutagenesis analyses. Although the models display local errors, their accuracy was sufficient to predict the CD40-binding site, to map natural mutations, and to rationalize their effects. One of five gp39 residues critical for CD40 binding was displaced in the models, and 1 of 21 point mutants was incorrectly classified. Factors most important for the reliability of the molecular models and their successful applications were valid sequence alignments and the focus of experimental studies on regions of high prediction confidence. Analysis of mutagenesis experiments correlated with anti-gp39 monoclonal antibody binding studies to assess the conformational integrity of mutant proteins.	MDS Panlabs, Computat Chem & Informat, Bothell, WA 98011 USA; Univ Washington, Dept Biol Struct, Seattle, WA 98194 USA	University of Washington; University of Washington Seattle	Bajorath, J (corresponding author), MDS Panlabs, Computat Chem & Informat, 11804 N Creek Pkwy S, Bothell, WA 98011 USA.	jbajorath@panlabs.com	Bajorath, Jürgen/F-7493-2014					ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; Aruffo A, 1994, Curr Opin Hematol, V1, P12; ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; BAJORATH J, 1993, PROTEIN SCI, V2, P1798, DOI 10.1002/pro.5560021103; Bajorath J, 1997, PROTEINS, V27, P59; BAJORATH J, 1995, BIOCHEMISTRY-US, V34, P9884, DOI 10.1021/bi00031a009; BAJORATH J, 1995, BIOCHEMISTRY-US, V34, P1833, DOI 10.1021/bi00006a003; Bajorath J, 1996, PROTEIN SCI, V5, P531; Bajorath J, 1998, J MOL MODEL, V4, P1, DOI 10.1007/s008940050066; Bajorath J, 1997, J MOL MODEL, V3, P117, DOI 10.1007/s008940050025; Bajorath J, 1997, J MOL MODEL, V3, P287, DOI 10.1007/s008940050039; BAJORATH J, 1995, J BIOL CHEM, V270, P22081, DOI 10.1074/jbc.270.38.22081; Bajorath J, 1997, J MOL MODEL, V3, P216, DOI 10.1007/s008940050033; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BEUTLER B, 1994, SCIENCE, V264, P667, DOI 10.1126/science.8171316; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; BRUCCOLERI RE, 1988, NATURE, V335, P564, DOI 10.1038/335564a0; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; CLARK EA, 1991, ANNU REV IMMUNOL, V9, P97; CLARK EA, 1986, P NATL ACAD SCI USA, V83, P4494, DOI 10.1073/pnas.83.12.4494; DUNBRACK RL, 1994, NAT STRUCT BIOL, V1, P334, DOI 10.1038/nsb0594-334; ECK MJ, 1992, J BIOL CHEM, V267, P2119; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; GREER J, 1990, PROTEINS, V7, P317, DOI 10.1002/prot.340070404; HOLLENBAUGH D, 1992, EMBO J, V11, P4313, DOI 10.1002/j.1460-2075.1992.tb05530.x; KARPUSAS M, 1995, STRUCTURE, V3, P1031, DOI 10.1016/S0969-2126(01)00239-8; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Martin ACR, 1997, PROTEINS, P14; MOSIMANN S, 1995, PROTEINS, V23, P301, DOI 10.1002/prot.340230305; NOELLE RJ, 1992, IMMUNOL TODAY, V13, P431, DOI 10.1016/0167-5699(92)90068-I; PEITSCH MC, 1993, INT IMMUNOL, V5, P233, DOI 10.1093/intimm/5.2.233; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; Sanchez R, 1997, PROTEINS, P50; Sanchez R, 1997, CURR OPIN STRUC BIOL, V7, P206, DOI 10.1016/S0959-440X(97)80027-9; SATOW Y, 1986, J MOL BIOL, V190, P593, DOI 10.1016/0022-2836(86)90245-7; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7	39	28	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24603	24609		10.1074/jbc.273.38.24603	http://dx.doi.org/10.1074/jbc.273.38.24603			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733755	hybrid			2022-12-27	WOS:000076007300047
J	Burritt, JB; Busse, SC; Gizachew, D; Siemsen, DW; Quinn, MT; Bond, CW; Dratz, EA; Jesaitis, AJ				Burritt, JB; Busse, SC; Gizachew, D; Siemsen, DW; Quinn, MT; Bond, CW; Dratz, EA; Jesaitis, AJ			Antibody imprint of a membrane protein surface - Phagocyte flavocytochrome b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; PHAGE-DISPLAY LIBRARIES; SUPEROXIDE PRODUCTION; FILAMENTOUS PHAGE; TRANSFERRED NOESY; PLASMA-MEMBRANE; MOLECULAR-BASIS; MATRIX ANALYSIS; CYTOCHROME-B; EXCHANGE	Structural features of the integral membrane protein flavocytochrome b (Cyt b) were discovered using an antibody "imprint" of the Cyt b surface. Amino acid sequences were selected from a random nonapeptide phage-display library by their affinity for the monoclonal antibody 44.1 binding site, which recognizes the native conformation of the p22(phox) subunit of Cyt b, Transferred nuclear Overhauser effect spectroscopy and rotating frame Overhauser effect spectroscopy NMR were used to study the antibody-bound conformation of a synthetic peptide derived from phage-displayed sequences. The NMR data supported the phage-display analysis suggesting the existence of a complex epitope and allowed the modeling of the close spatial proximity of the epitope components (29)TAGRF(33) and (183)PQVNPI(188) from discontinuous regions of p22(phox). Although these regions are separated by two putative membrane-spanning domains and are 150 residues apart in the sequence, they appear to combine to form a complex epitope on the cytosolic surface of the transmembrane protein. NMR constraints, measured from the antibody-bound conformation of a composite peptide mimetic of the Cyt b epitope, and one constraint inferred from the phage-display results, were used to demonstrate the close proximity of these two regions. This information provides a low resolution view of the tertiary structure of the native discontinuous epitope on the Cyt b surface. Given additional antibodies, such imprint analysis has the potential for producing structural constraints to help support molecular modeling of this and other low abundance or noncrystallizable proteins.	Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA; Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; Montana State Univ, Lab Vet Mol Biol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Jesaitis, AJ (corresponding author), Montana State Univ, Dept Microbiol, 109 Lewis Hall, Bozeman, MT 59717 USA.			Quinn, Mark/0000-0001-8114-5073; Jesaitis, Algirdas/0000-0001-9001-5617	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI022735, R01AI026711, R01AI022735] Funding Source: NIH RePORTER; NCRR NIH HHS [2 P41 RR06009] Funding Source: Medline; NIAID NIH HHS [AI 22735, AI 26711] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AREPALLI SR, 1995, J MAGN RESON SER B, V106, P195, DOI 10.1006/jmrb.1995.1033; BROMBERG Y, 1985, J BIOL CHEM, V260, P3539; Burritt JB, 1996, ANAL BIOCHEM, V238, P1, DOI 10.1006/abio.1996.0241; BURRITT JB, 1995, J BIOL CHEM, V270, P16974, DOI 10.1074/jbc.270.28.16974; CAMPBELL AP, 1991, J MOL BIOL, V222, P405, DOI 10.1016/0022-2836(91)90219-V; CAMPBELL AP, 1993, ANNU REV BIOPH BIOM, V22, P99, DOI 10.1146/annurev.bb.22.060193.000531; CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378; DAVIS DG, 1994, J MAGN RESON SER B, V104, P266, DOI 10.1006/jmrb.1994.1084; DELEO FR, 1995, P NATL ACAD SCI USA, V92, P7110, DOI 10.1073/pnas.92.15.7110; DINAUER MC, 1993, CRIT REV CL LAB SCI, V30, P329, DOI 10.3109/10408369309082591; DRATZ EA, 1993, NATURE, V363, P267; FEJZO J, 1989, J MAGN RESON, V82, P518, DOI 10.1016/0022-2364(89)90215-1; GIZACHEW D, 1998, BIOPHYS J, V74, pA74; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; JACKSON PL, 1995, J MAGN RESON SER B, V107, P289, DOI 10.1006/jmrb.1995.1092; Janeway CA., 2001, IMMUNOBIOLOGY IMMUNE, V5th edition; JESAITIS AJ, 1991, NEW BIOL, V3, P651; KOSHKIN V, 1994, FEBS LETT, V338, P285, DOI 10.1016/0014-5793(94)80285-8; LANDY SB, 1989, J MAGN RESON, V81, P371, DOI 10.1016/0022-2364(89)90068-1; LONDON RE, 1992, J MAGN RESON, V97, P79, DOI 10.1016/0022-2364(92)90238-3; MEEKER AK, 1993, BIOTECHNIQUES, V15, P370; Moore DD, 1995, GLOB MOB SURV; NI F, 1994, PROG NUCL MAG RES SP, V26, P517, DOI 10.1016/0079-6565(94)90000-0; PARKOS CA, 1987, J CLIN INVEST, V80, P732, DOI 10.1172/JCI113128; PARKOS CA, 1988, BIOCHIM BIOPHYS ACTA, V932, P71, DOI 10.1016/0005-2728(88)90140-5; Roos D, 1996, BLOOD, V87, P1663; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; SMITH GP, 1993, METHOD ENZYMOL, V217, P228; SMITH RM, 1991, BLOOD, V77, P673; ZHENG J, 1993, J MAGN RESON SER B, V101, P262, DOI 10.1006/jmrb.1993.1042; [No title captured]	31	48	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24847	24852		10.1074/jbc.273.38.24847	http://dx.doi.org/10.1074/jbc.273.38.24847			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733789	hybrid			2022-12-27	WOS:000076007300081
J	Grawunder, U; Zimmer, D; Kulesza, P; Lieber, MR				Grawunder, U; Zimmer, D; Kulesza, P; Lieber, MR			Requirement for an interaction of XRCC4 with DNA ligase IV for wild-type V(D)J recombination and DNA double-strand break repair in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; SEVERE COMBINED IMMUNODEFICIENCY; ACTIVATING GENE; EXPRESSION; MUTATION; RAG-1; IDENTIFICATION; DIVERSITY; DEFECTS; SUBUNIT	The XRCC4 gene is required for the repair of DNA double-strand breaks in mammalian cells. Without XRCC4, cells are hypersensitive to ionizing radiation and deficient for V(D)J recombination. It has been demonstrated that XRCC4 binds and stimulates DNA ligase IV, which has led to the hypothesis that DNA ligase IV is essential for both of these processes. In this study deletion mutants of XRCC4 were tested for their ability to associate with DNA ligase IV in vitro and for their ability to reconstitute XRCC4-deficient cells in vivo. We find that a central region of XRCC4 from amino acids 100-250 is necessary for DNA ligase IV binding and that deletions within this region functionally inactivates XRCC4. Deletions within the C-terminal 84 amino acids neither affect DNA ligase IV binding nor the in vivo function of XRCC4. The correlation between the ability or inability of XRCC4 to bind DNA ligase IV and its ability or failure to reconstitute wild-type DNA repair in vivo, respectively, demonstrates for the first time that the physical interaction with DNA ligase IV is crucial for the in vivo function of XRCC4, Deletions within the N-terminal 100 amino acids inactivate XRCC4 in vivo but leave DNA ligase IV binding unaffected. This indicates further DNA ligase IV-independent functions of XRCC4.	Univ So Calif, Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90033 USA	University of Southern California	Lieber, MR (corresponding author), Univ So Calif, Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Pathol, 1441 Eastlake Ave,Mailstop 73, Los Angeles, CA 90033 USA.			Lieber, Michael/0000-0001-8809-0909; Lieber, Michael/0000-0003-3700-6345				BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; Blunt T, 1996, P NATL ACAD SCI USA, V93, P10285, DOI 10.1073/pnas.93.19.10285; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Critchlow SE, 1997, CURR BIOL, V7, P588, DOI 10.1016/S0960-9822(06)00258-2; Danska JS, 1996, MOL CELL BIOL, V16, P5507; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Gauss GH, 1996, MOL CELL BIOL, V16, P258; Gauss GH, 1998, EUR J IMMUNOL, V28, P351, DOI 10.1002/(SICI)1521-4141(199801)28:01<351::AID-IMMU351>3.0.CO;2-#; Grawunder U, 1996, CURR TOP MICROBIOL, V217, P31; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; Grawunder U, 1998, CURR OPIN IMMUNOL, V10, P172, DOI 10.1016/S0952-7915(98)80246-X; Grawunder U, 1996, EUR J BIOCHEM, V241, P931, DOI 10.1111/j.1432-1033.1996.00931.x; Grawunder U, 1996, J EXP MED, V183, P1731, DOI 10.1084/jem.183.4.1731; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; HSIEH CL, 1993, J BIOL CHEM, V268, P20105; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; Leber R, 1998, J BIOL CHEM, V273, P1794, DOI 10.1074/jbc.273.3.1794; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; MIMORI T, 1990, P NATL ACAD SCI USA, V87, P1777, DOI 10.1073/pnas.87.5.1777; Mizuta R, 1997, INT IMMUNOL, V9, P1607, DOI 10.1093/intimm/9.10.1607; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Ouyang H, 1997, J EXP MED, V186, P921, DOI 10.1084/jem.186.6.921; PETRINI JHJ, 1994, J IMMUNOL, V152, P176; Ramsden DA, 1997, NATURE, V388, P488, DOI 10.1038/41351; REEVES WH, 1989, J BIOL CHEM, V264, P5047; Schar P, 1997, GENE DEV, V11, P1912, DOI 10.1101/gad.11.15.1912; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Teo SH, 1997, EMBO J, V16, P4788, DOI 10.1093/emboj/16.15.4788; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Wilson TE, 1997, NATURE, V388, P495, DOI 10.1038/41365; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7	34	128	130	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24708	24714		10.1074/jbc.273.38.24708	http://dx.doi.org/10.1074/jbc.273.38.24708			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733770	hybrid			2022-12-27	WOS:000076007300062
J	Saito, J; Kon, T; Nagasaki, A; Adachi, H; Sutoh, K				Saito, J; Kon, T; Nagasaki, A; Adachi, H; Sutoh, K			Dictyostelium TRFA homologous to yeast Ssn6 is required for normal growth and early development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; GLUCOSE REPRESSION; REPEAT MOTIF; SNAP HELIX; TPR MOTIFS; PROTEIN; DISCOIDEUM; GENE; TRANSCRIPTION; COMPLEX	The TPR (tetratricopeptide repeat) family became widespread during evolution, having been found from bacteria to mammals. By means of restriction enzyme-mediated integration, we have identified a Dictyostelium gene (trfA) highly homologous to a Saccharomyces cerevisiae gene encoding a TPR protein, Ssn6 (Cyc8), which functions as a global transcriptional repressor for diverse genes. The deduced amino acid sequence of the Dictyostelium gene product, TRFA, contains 10 consecutive TPR units as well as Gin repeats, Asn repeats, and a region rich in Glu, Lys, Ser, and Thr, The sequences of some of the 10 TPR units in TRFA are more than 70% identical to the corresponding units in Ssn6. The trfA(-) cells produced smooth plaques on a bacterial lawn and failed to aggregate normally when stirred on a plain agar plate, Individual trfA(-) cells also failed to correctly respond to cAMP, although the adenylyl cyclase of trfA(-) cells was expressed upon starvation and activated by stimulation with cAMP as in the wild-type cells. When cultured in a rich medium in suspension, they grew more slowly and stopped growing at a lower density than the wild-type cells. Furthermore, they divided into cells of various sizes and tended to be much smaller than the wild-type cells, These pleiotropic defects of the trfA(-) cells suggest the possibility that Dictyostelium TRFA may regulate the transcription of diverse genes required for normal growth and early development.	Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 153, Japan	University of Tokyo	Sutoh, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 153, Japan.		Nagasaki, Akira/M-4892-2018; Kon, Takahide/AAG-6975-2021	Nagasaki, Akira/0000-0002-1468-4592; Kon, Takahide/0000-0002-1231-7609				Adachi H, 1997, J CELL BIOL, V137, P891, DOI 10.1083/jcb.137.4.891; ADACHI H, 1994, BIOCHEM BIOPH RES CO, V205, P1808, DOI 10.1006/bbrc.1994.2880; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BAIN G, 1991, J GEN MICROBIOL, V137, P501, DOI 10.1099/00221287-137-3-501; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; FIRTEL RA, 1995, GENE DEV, V9, P1427, DOI 10.1101/gad.9.12.1427; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; Haucke V, 1996, EMBO J, V15, P1231, DOI 10.1002/j.1460-2075.1996.tb00464.x; HIRANO T, 1990, CELL, V60, P319, DOI 10.1016/0092-8674(90)90746-2; Insall RH, 1996, CURR BIOL, V6, P719, DOI 10.1016/S0960-9822(09)00453-9; Kawata T, 1997, CELL, V89, P909, DOI 10.1016/S0092-8674(00)80276-7; KELEHER CA, 1992, CELL, V68, P709, DOI 10.1016/0092-8674(92)90146-4; KIMMEL AR, 1985, MOL CELL BIOL, V5, P2123, DOI 10.1128/MCB.5.8.2123; KLEIN PS, 1988, SCIENCE, V241, P1467, DOI 10.1126/science.3047871; KONIJN TM, 1987, METHOD CELL BIOL, V28, P283; KUWAYAMA H, 1993, J CELL BIOL, V123, P1453, DOI 10.1083/jcb.123.6.1453; LAMB JR, 1994, EMBO J, V13, P4321, DOI 10.1002/j.1460-2075.1994.tb06752.x; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Liu YZ, 1996, J BIOL CHEM, V271, P20853, DOI 10.1074/jbc.271.34.20853; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MORIO T, 1995, J PLANT RES, V108, P111, DOI 10.1007/BF02344314; PITT GS, 1992, CELL, V69, P305, DOI 10.1016/0092-8674(92)90411-5; ROTH SY, 1990, MOL CELL BIOL, V10, P2247, DOI 10.1128/MCB.10.5.2247; Sambrook J., 1989, MOL CLONING, pA1; SCHNITZLER GR, 1994, GENE DEV, V8, P502, DOI 10.1101/gad.8.4.502; SCHULTZ J, 1990, MOL CELL BIOL, V10, P4744, DOI 10.1128/MCB.10.9.4744; SCHULTZ J, 1987, MOL CELL BIOL, V7, P3637, DOI 10.1128/MCB.7.10.3637; SHAW DR, 1989, MOL GEN GENET, V218, P453, DOI 10.1007/BF00332409; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; STROEHER VL, 1986, MOL CELL BIOL, V6, P4667, DOI 10.1128/MCB.6.12.4667; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; SUTOH K, 1993, PLASMID, V30, P150, DOI 10.1006/plas.1993.1042; TRUMBLY RJ, 1988, GENE, V73, P97, DOI 10.1016/0378-1119(88)90316-2; TRUMBLY RJ, 1986, J BACTERIOL, V166, P1123, DOI 10.1128/jb.166.3.1123-1127.1986; TUGENDREICH S, 1995, CELL, V81, P261, DOI 10.1016/0092-8674(95)90336-4; TZAMARIAS D, 1995, GENE DEV, V9, P821, DOI 10.1101/gad.9.7.821; TZAMARIAS D, 1994, NATURE, V369, P758, DOI 10.1038/369758a0; Urushiyama S, 1997, GENETICS, V147, P101; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; Wang Lee-Ho, 1991, Gene Expression, V1, P207; Wang YW, 1998, J CELL SCI, V111, P373; WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171; WILLIAMS FE, 1991, MOL CELL BIOL, V11, P3307, DOI 10.1128/MCB.11.6.3307; Yip MLR, 1997, DEVELOPMENT, V124, P2129	45	4	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24654	24659		10.1074/jbc.273.38.24654	http://dx.doi.org/10.1074/jbc.273.38.24654			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733762	hybrid			2022-12-27	WOS:000076007300054
J	Souza, SC; de Vargas, LM; Yamamoto, MT; Lien, P; Franciosa, MD; Moss, LG; Greenberg, AS				Souza, SC; de Vargas, LM; Yamamoto, MT; Lien, P; Franciosa, MD; Moss, LG; Greenberg, AS			Overexpression of perilipin A and B blocks the ability of tumor necrosis factor alpha to increase lipolysis in 3T3-L1 adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; HUMAN ADENOVIRUS TYPE-5; PROTEIN-KINASE; ADIPOSE-TISSUE; IN-VIVO; EXPRESSION; OBESITY; PHOSPHORYLATION; STIMULATION; INHIBITION	Perilipins, a family of phosphoproteins, are specifically located at the surface of intracellular lipid (triacylglycerol) droplets, the site of lipolysis. Stimulation of lipolysis in 3T3-L1 adipocytes by tumor necrosis factor alpha (TNF-alpha) is associated with a decrease in total cellular expression of perilipin A and B, consistent with the hypothesis that a decrease in perilipin protein expression is required for TNF-alpha-induced lipolysis. Adenovirus-mediated overexpression of perilipin A or B maintains perilipin protein levels on the lipid droplet and blocks TNF alpha-induced lipolysis. In contrast, overexpression of perilipin A or perilipin B does not inhibit isoproterenol-stimulated lipolysis and does not alter the isoproterenol-induced migration of perilipins from the lipid droplet. These results provide the first evidence of how perilipin functions and suggest that TNF-alpha regulates lipolysis, in part, by decreasing perilipin protein levels at the lipid droplet surface.	Tufts Univ, USDA, Jean Mayer Human Nutr Res Ctr, Boston, MA 02111 USA; New England Med Ctr, Tupper Res Inst, Div Endocrinol, Boston, MA 02111 USA; New England Med Ctr, Dept Med, Boston, MA 02111 USA; New England Med Ctr, Dept Physiol, Boston, MA 02111 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA	Tufts University; United States Department of Agriculture (USDA); Tufts Medical Center; Tufts Medical Center; Tufts Medical Center; Tufts University	Greenberg, AS (corresponding author), Tufts Univ, USDA, Jean Mayer Human Nutr Res Ctr, 711 Washington St, Boston, MA 02111 USA.							ARNER P, 1996, DIABETES REV, V4, P450; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bruening W, 1998, NUCLEIC ACIDS RES, V26, P486, DOI 10.1093/nar/26.2.486; COPPACK SW, 1994, J LIPID RES, V35, P177; EGAN JJ, 1990, J BIOL CHEM, V265, P18769; EGAN JJ, 1992, P NATL ACAD SCI USA, V89, P8537, DOI 10.1073/pnas.89.18.8537; FEINGOLD KR, 1992, ENDOCRINOLOGY, V130, P10, DOI 10.1210/en.130.1.10; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; GREENBERG AS, 1993, P NATL ACAD SCI USA, V90, P12035, DOI 10.1073/pnas.90.24.12035; HERZ J, 1993, P NATL ACAD SCI USA, V90, P2812, DOI 10.1073/pnas.90.7.2812; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; KERN PA, 1995, J CLIN INVEST, V95, P2111, DOI 10.1172/JCI117899; KOHANSKI RA, 1986, J BIOL CHEM, V261, P2272; MCGRORY WJ, 1988, VIROLOGY, V163, P614, DOI 10.1016/0042-6822(88)90302-9; Miles PDG, 1997, DIABETES, V46, P1678, DOI 10.2337/diabetes.46.11.1678; OKUDA H, 1994, J LIPID RES, V35, P36; Peraldi P, 1997, J CLIN INVEST, V100, P1863, DOI 10.1172/JCI119715; RAINES M, 1993, J BIOL CHEM, V278, P14572; Souza SC, 1998, DIABETES, V47, P691, DOI 10.2337/diabetes.47.4.691; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; VIETOR I, 1993, J BIOL CHEM, V268, P18994	24	236	243	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24665	24669		10.1074/jbc.273.38.24665	http://dx.doi.org/10.1074/jbc.273.38.24665			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733764	hybrid			2022-12-27	WOS:000076007300056
J	Cheng, HC; Abdel-Ghany, M; Elble, RC; Pauli, BU				Cheng, HC; Abdel-Ghany, M; Elble, RC; Pauli, BU			Lung endothelial dipeptidyl peptidase IV promotes adhesion and metastasis of rat breast cancer cells via tumor cell surface-associated fibronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA FIBRONECTIN; BINDING; MOLECULE; MATRIX; CD26; HEPATOCYTES; EXPRESSION; INTEGRIN; DOMAIN; GLYCOPROTEIN	Endothelial cell adhesion molecules are partly responsible for the distinct organ distribution of cancer metastases. Dipeptidyl peptidase IV (DPP nr) expressed on rat lung capillary endothelia is shown here to be an adhesion receptor for rat breast cancer cells and to mediate lung colonization by these tumor cells. Fibronectin (FN) assembled on breast cancer cell surfaces into multiple, randomly dispersed globules from cellular and plasma FN is identified as the principal ligand for DPP IV. Ligand expression correlates quantitatively with the tumor cells' capabilities to bind to DPP IV and to metastasize to the lungs. DPP IV/FN-mediated adhesion and metastasis are blocked when tumor cells are incubated with soluble DPP TV prior to conducting adhesion and lung colony assays. Adhesion is also blocked by anti-DPP IV monoclonal antibody 6A3 and anti-FN antiserum. However, adhesion to immobilized FN is unaffected by soluble plasma FN and, thus, can happen during hematogenous spread of cancer cells at high plasma FN concentrations. The ability of many cancer cells to capture FN molecules on their surface and to augment such deposits by FN self-association during passage in the blood suggests that DPP IV/FN binding may be a relatively common mechanism for lung metastasis.	Cornell Univ, Coll Vet Med, Dept Mol Med, Canc Biol Labs, Ithaca, NY 14853 USA	Cornell University	Pauli, BU (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Canc Biol Labs, Ithaca, NY 14853 USA.	bup1@cornell.edu			NATIONAL CANCER INSTITUTE [R01CA047668, R01CA071626] Funding Source: NIH RePORTER; NCI NIH HHS [CA47668, CA71626] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABBOTT CA, 1994, IMMUNOGENETICS, V40, P331, DOI 10.1007/BF01246674; AGUIRRE KM, 1994, J BIOL CHEM, V269, P27863; ALBELDA SM, 1993, LAB INVEST, V68, P4; BAUVOIS B, 1988, BIOCHEM J, V252, P723, DOI 10.1042/bj2520723; CALLEBAUT C, 1993, SCIENCE, V262, P2045, DOI 10.1126/science.7903479; CHERNOUSOV MA, 1991, J BIOL CHEM, V266, P10851; Elble RC, 1997, J BIOL CHEM, V272, P27853, DOI 10.1074/jbc.272.44.27853; ELSABBAN ME, 1991, J CELL BIOL, V115, P1375, DOI 10.1083/jcb.115.5.1375; FELLIN FM, 1988, J BIOL CHEM, V263, P1791; Fidler Isaiah J., 1997, P135; FLEISCHER B, 1994, IMMUNOL TODAY, V15, P180, DOI 10.1016/0167-5699(94)90316-6; GARDNER HA, 1988, CANCER INVEST, V6, P161, DOI 10.3109/07357908809077044; GOEBEL HW, 1992, VIRCHOWS ARCH B, V62, P9, DOI 10.1007/BF02899660; GUAN JL, 1990, J CELL BIOL, V110, P833, DOI 10.1083/jcb.110.3.833; HAREL S, 1988, HISTOCHEMISTRY, V89, P151; Hocking DC, 1996, J CELL BIOL, V133, P431, DOI 10.1083/jcb.133.2.431; HOMANDBERG GA, 1987, THROMB RES, V48, P321, DOI 10.1016/0049-3848(87)90444-0; HONG WJ, 1987, P NATL ACAD SCI USA, V84, P7962, DOI 10.1073/pnas.84.22.7962; HORMANN H, 1986, BIOPOLYMERS, V25, P947, DOI 10.1002/bip.360250513; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; HYNES RO, 1973, P NATL ACAD SCI USA, V70, P3170, DOI 10.1073/pnas.70.11.3170; Hynes RO, 1990, FIBRONECTIN; ISAACS JT, 1986, PROSTATE, V9, P261, DOI 10.1002/pros.2990090306; IwakiEgawa S, 1997, CELL IMMUNOL, V178, P180, DOI 10.1006/cimm.1997.1123; JOHNSON RC, 1991, CANCER RES, V51, P394; JOHNSON RC, 1993, J CELL BIOL, V121, P1423, DOI 10.1083/jcb.121.6.1423; KORACH S, 1986, CANCER RES, V46, P3624; Lafrenie R M, 1993, Cell Biophys, V23, P3; LOSTER K, 1995, BIOCHEM BIOPH RES CO, V217, P341, DOI 10.1006/bbrc.1995.2782; MCCAUGHAN GW, 1990, HEPATOLOGY, V11, P534, DOI 10.1002/hep.1840110403; MCKEOWNLONGO PJ, 1983, J CELL BIOL, V97, P466, DOI 10.1083/jcb.97.2.466; MOORE KA, 1990, BLOOD, V75, P2085; MORLA A, 1992, J CELL BIOL, V118, P421, DOI 10.1083/jcb.118.2.421; NERI A, 1982, J NATL CANCER I, V68, P507; ODERMATT E, 1982, J MOL BIOL, V159, P109, DOI 10.1016/0022-2836(82)90034-1; PAULI BU, 1997, ENCY CANC, V1, P464; PIAZZA GA, 1989, BIOCHEM J, V262, P327, DOI 10.1042/bj2620327; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; RUOSLAHTI E, 1994, B I PASTEUR, V92, P242; Sakai K, 1996, J BIOCHEM-TOKYO, V119, P58; SCHARPE S, 1988, CLIN CHEM, V34, P2299; Sechler JL, 1996, J CELL BIOL, V134, P573, DOI 10.1083/jcb.134.2.573; SUGARBAKER EV, 1981, CANCER BIOL REV, V2, P235; UGAROVA TP, 1995, BIOCHEMISTRY-US, V34, P4457, DOI 10.1021/bi00013a039; WEISS L, 1986, J THEOR BIOL, V121, P307, DOI 10.1016/S0022-5193(86)80110-2; WU CY, 1993, J BIOL CHEM, V268, P21883; Yamaguchi N, 1996, TRANSPLANTATION, V62, P973, DOI 10.1097/00007890-199610150-00017; YEATMAN TJ, 1993, SEMIN SURG ONCOL, V9, P256; ZHU DZ, 1993, INT J CANCER, V53, P628; ZHU DZ, 1992, J CLIN INVEST, V89, P1718, DOI 10.1172/JCI115773; ZHU DZ, 1991, P NATL ACAD SCI USA, V88, P9568, DOI 10.1073/pnas.88.21.9568	51	145	153	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24207	24215		10.1074/jbc.273.37.24207	http://dx.doi.org/10.1074/jbc.273.37.24207			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727044	hybrid			2022-12-27	WOS:000075893100085
J	Jensen, LT; Posewitz, MC; Srinivasan, C; Winge, DR				Jensen, LT; Posewitz, MC; Srinivasan, C; Winge, DR			Mapping of the DNA binding domain of the copper-responsive transcription factor Mac1 from Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION DOMAIN; GAL4 DERIVATIVES; CANDIDA-GLABRATA; YEAST; TRANSPORT; PROTEIN; GENE; EXPRESSION; REPRESSION; SEQUENCE	Mad from Saccharomyces cerevisiae activates transcription of genes, including CTR1 in copper-deficient cells. N-terminal fusions of Mad with the herpes simplex VP16 activation domain were used to show that residues 1-159 in Mac1 constitute the minimal DNA binding domain. Mac1-(1-159) purified from Escherichia coli contains two bound Zn(II) ions. Electrophoretic mobility shift assays showed direct and specific binding by Mac1-(1-159) to a DNA duplex containing the copper-responsive element TTTGCTCA, The DNA binding affinity of Mac1-(1-159) for a duplex containing a single promoter element or an inverted repeat was 5 nM for the 1:1 complex. The N-terminal 40-residue segment of Mad is homologous to the DNA binding zinc module found in the copper-activated transcription factors Ace1 and Amt1. A MAC1 mutation yielding a Cys(11) --> Tyr substitution at the first candidate zinc ligand position relative to Ace1 resulted in a loss of in vivo function, Two TTTGCTCA promoter elements are necessary for efficient Mad-mediated transcriptional activation. The elements appear to function synergistically. Increasing the number of elements yields more than additive enhancements in CTR1 expression.	Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA; Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Winge, DR (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA.	dennis.winge@hsc.utah.edu	Winge, Dennis/G-3611-2010	Jensen, Laran/0000-0003-3199-1743	NATIONAL CANCER INSTITUTE [R01CA061286] Funding Source: NIH RePORTER; NCI NIH HHS [CA 61286] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADMAN ET, 1991, ADV PROTEIN CHEM, V42, P145; ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; BACHHAWAT N, 1995, J BIOL CHEM, V270, P25087, DOI 10.1074/jbc.270.42.25087; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUCHMAN C, 1990, MOL CELL BIOL, V10, P4778, DOI 10.1128/MCB.10.9.4778; CAREY M, 1990, NATURE, V345, P361, DOI 10.1038/345361a0; DANCIS A, 1992, P NATL ACAD SCI USA, V89, P3869, DOI 10.1073/pnas.89.9.3869; DANCIS A, 1994, J BIOL CHEM, V269, P25660; DANCIS A, 1994, CELL, V76, P893; DOBI A, 1995, J BIOL CHEM, V270, P10171, DOI 10.1074/jbc.270.17.10171; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Farrell RA, 1996, BIOCHEMISTRY-US, V35, P1571, DOI 10.1021/bi9517087; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Georgatsou E, 1997, J BIOL CHEM, V272, P13786, DOI 10.1074/jbc.272.21.13786; Graden JA, 1997, P NATL ACAD SCI USA, V94, P5550, DOI 10.1073/pnas.94.11.5550; Graden JA, 1996, BIOCHEMISTRY-US, V35, P14583, DOI 10.1021/bi961642v; HAHN S, 1993, CELL, V72, P481, DOI 10.1016/0092-8674(93)90064-W; HASSETT R, 1995, J BIOL CHEM, V270, P128, DOI 10.1074/jbc.270.1.128; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; JUNGMANN J, 1993, EMBO J, V12, P5061; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; Koch KA, 1996, MOL CELL BIOL, V16, P724; Labbe S, 1997, J BIOL CHEM, V272, P15951, DOI 10.1074/jbc.272.25.15951; LEFSTIN JA, 1994, GENE DEV, V8, P2842, DOI 10.1101/gad.8.23.2842; LIN YS, 1990, NATURE, V345, P359, DOI 10.1038/345359a0; LIN YS, 1988, CELL, V54, P659, DOI 10.1016/S0092-8674(88)80010-2; Linder Maria C., 1996, American Journal of Clinical Nutrition, V63, p797S; Martins LJ, 1998, J BIOL CHEM, V273, P23716, DOI 10.1074/jbc.273.37.23716; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Shatwell KP, 1996, J BIOL CHEM, V271, P14240, DOI 10.1074/jbc.271.24.14240; SILVERMAN N, 1994, P NATL ACAD SCI USA, V91, P11665, DOI 10.1073/pnas.91.24.11665; TRIEZENBERG SJ, 1988, GENE DEV, V2, P718, DOI 10.1101/gad.2.6.718; TURNER RB, 1998, NAT STRUCT BIOL, V7, P9; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; VULPE CD, 1995, ANNU REV NUTR, V15, P293, DOI 10.1146/annurev.nu.15.070195.001453; Wang D, 1997, J BIOL CHEM, V272, P19383, DOI 10.1074/jbc.272.31.19383; YamaguchiIwai Y, 1997, J BIOL CHEM, V272, P17711, DOI 10.1074/jbc.272.28.17711; ZHOU PB, 1991, P NATL ACAD SCI USA, V88, P6112, DOI 10.1073/pnas.88.14.6112	41	43	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23805	23811		10.1074/jbc.273.37.23805	http://dx.doi.org/10.1074/jbc.273.37.23805			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726991	hybrid			2022-12-27	WOS:000075893100032
J	Jiang, CJ; Imamoto, N; Matsuki, R; Yoneda, Y; Yamamoto, N				Jiang, CJ; Imamoto, N; Matsuki, R; Yoneda, Y; Yamamoto, N			Functional characterization of a plant importin alpha homologue - Nuclear localization signal (NLS)-selective binding and mediation of nuclear import of NLS proteins in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-TARGETING COMPLEX; PERMEABILIZED MAMMALIAN-CELLS; GUANINE-NUCLEOTIDE EXCHANGE; TRANSPORT SUBSTRATE; CYTOSOLIC FACTORS; RAN; GTP; IDENTIFICATION; ARABIDOPSIS; RANGAP1	Nuclear import of most nuclear proteins is initiated by recognition of the nuclear localization signal (NLS) by importin alpha. We recently isolated an importin alpha homologue from rice (rice importin alpha 1) and demonstrated that transcription of the gene is down-regulated by light in rice leaves. To address the function of rice importin alpha 1 in the process of nuclear import of proteins, we performed in vitro binding and nuclear import assays. The rice importin alpha 1 showed specific binding to fusion proteins containing either monopartite or bipartite NLSs, but not to a fusion protein containing a Mat alpha-2-type NLS, suggesting that there exists selective binding of rice importin alpha 1 to different plant NLSs. The rice importin alpha 1 is also capable of forming a complex with mouse importin beta and NLS protein in vitro. An in vitro nuclear import assay using permeabilized HeLa cells revealed that rice importin alpha 1, in conjunction with other vertebrate transport factors, mediates the nuclear envelope docking of NLS proteins and their subsequent translocation into the nucleus. These data provide strong, direct evidence suggesting that rice importin alpha 1 functions as a component of the NLS receptor in plant cells.	Natl Inst Agrobiol Resources, Dept Plant Physiol, Photosynthesis Lab, Tsuchiura, Ibaraki 3058602, Japan; Osaka Univ, Sch Med, Dept Anat & Cell Biol, Suita, Osaka 5650871, Japan; Cent Res Inst Elect Power Ind, Abiko, Chiba 2701194, Japan	National Institute of Agrobiological Sciences - Japan; Osaka University; Central Research Institute of Electric Power Industry - Japan	Yamamoto, N (corresponding author), Natl Inst Agrobiol Resources, Dept Plant Physiol, Photosynthesis Lab, 2-1-2 Kannondai, Tsuchiura, Ibaraki 3058602, Japan.	naoyam@abr.affrc.go.jp	Imamoto, Naoko/A-7458-2015	Imamoto, Naoko/0000-0002-2886-3022; Jiang, Chang-Jie/0000-0003-1845-541X				ACH RA, 1994, P NATL ACAD SCI USA, V91, P5863, DOI 10.1073/pnas.91.13.5863; ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Ballas N, 1997, P NATL ACAD SCI USA, V94, P10723, DOI 10.1073/pnas.94.20.10723; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FR, 1995, METHOD ENZYMOL, V257, P135; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broder YC, 1997, FEBS LETT, V412, P535, DOI 10.1016/S0014-5793(97)00855-7; Chi NC, 1997, J BIOL CHEM, V272, P6818, DOI 10.1074/jbc.272.10.6818; Doye V, 1997, CURR OPIN CELL BIOL, V9, P401, DOI 10.1016/S0955-0674(97)80014-2; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Gorlich D, 1997, CURR OPIN CELL BIOL, V9, P412, DOI 10.1016/S0955-0674(97)80015-4; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Haizel T, 1997, PLANT J, V11, P93, DOI 10.1046/j.1365-313X.1997.11010093.x; Hicks GR, 1996, PLANT CELL, V8, P1337, DOI 10.1105/tpc.8.8.1337; HOPPER AK, 1990, J CELL BIOL, V111, P309, DOI 10.1083/jcb.111.2.309; Imamoto N, 1998, EUR J HISTOCHEM, V42, P9; IMAMOTO N, 1995, J BIOL CHEM, V270, P8559, DOI 10.1074/jbc.270.15.8559; IMAMOTO N, 1995, EMBO J, V14, P3617, DOI 10.1002/j.1460-2075.1995.tb00031.x; IMAMOTO N, 1995, FEBS LETT, V368, P415; Iovine MK, 1995, J CELL BIOL, V131, P1699, DOI 10.1083/jcb.131.6.1699; KRAEMER DM, 1995, J BIOL CHEM, V270, P19017, DOI 10.1074/jbc.270.32.19017; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; MELCHIOR F, 1993, J CELL BIOL, V123, P1649, DOI 10.1083/jcb.123.6.1649; MELCHIOR F, 1995, METHOD ENZYMOL, V257, P279; Merkle T, 1996, PLANT J, V10, P1177, DOI 10.1046/j.1365-313X.1996.10061177.x; MERKLE T, 1994, PLANT J, V6, P555, DOI 10.1046/j.1365-313X.1994.6040555.x; Merkle T, 1997, TRENDS PLANT SCI, V2, P458, DOI 10.1016/S1360-1385(97)01140-0; Miyamoto Y, 1997, J BIOL CHEM, V272, P26375, DOI 10.1074/jbc.272.42.26375; MOORE MS, 1993, NATURE, V365, P661, DOI 10.1038/365661a0; MOORE MS, 1994, P NATL ACAD SCI USA, V91, P10212, DOI 10.1073/pnas.91.21.10212; Nadler SG, 1997, J BIOL CHEM, V272, P4310, DOI 10.1074/jbc.272.7.4310; OHTSUBO M, 1989, J CELL BIOL, V109, P1389, DOI 10.1083/jcb.109.4.1389; PASCHAL BM, 1995, J CELL BIOL, V129, P925, DOI 10.1083/jcb.129.4.925; Pemberton LF, 1997, J CELL BIOL, V139, P1645, DOI 10.1083/jcb.139.7.1645; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; POWERS MA, 1994, CELL, V79, P931, DOI 10.1016/0092-8674(94)90024-8; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; RAIKHEL N, 1992, PLANT PHYSIOL, V100, P1627, DOI 10.1104/pp.100.4.1627; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Rosenblum JS, 1997, J CELL BIOL, V139, P1655, DOI 10.1083/jcb.139.7.1655; SAALBACH G, 1994, PLANT MOL BIOL, V24, P969, DOI 10.1007/BF00014451; SAFER D, 1989, ANAL BIOCHEM, V178, P32, DOI 10.1016/0003-2697(89)90351-5; Sekimoto T, 1997, EMBO J, V16, P7067, DOI 10.1093/emboj/16.23.7067; Shoji K, 1998, GENE, V212, P279, DOI 10.1016/S0378-1119(98)00175-9; Smith HMS, 1997, PLANT PHYSIOL, V114, P411, DOI 10.1104/pp.114.2.411; Sweitzer TD, 1996, P NATL ACAD SCI USA, V93, P14574, DOI 10.1073/pnas.93.25.14574; Tsuji L, 1997, FEBS LETT, V416, P30, DOI 10.1016/S0014-5793(97)01092-2; Ullman KS, 1997, CELL, V90, P967, DOI 10.1016/S0092-8674(00)80361-X; Yoneda Y, 1996, TRENDS MICROBIOL, V4, P1, DOI 10.1016/0966-842X(96)81494-6	53	30	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24083	24087		10.1074/jbc.273.37.24083	http://dx.doi.org/10.1074/jbc.273.37.24083			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727027	hybrid			2022-12-27	WOS:000075893100068
J	Kohama, T; Olivera, A; Edsall, L; Nagiec, MM; Dickson, R; Spiegel, S				Kohama, T; Olivera, A; Edsall, L; Nagiec, MM; Dickson, R; Spiegel, S			Molecular cloning and functional characterization of murine sphinogosine kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; RECEPTOR SUBSTRATE FAMILY; SPHINGOSINE KINASE; DIACYLGLYCEROL-KINASE; PHOSPHOTYROSINE PROTEIN; 3T3 FIBROBLASTS; SPHINGOSINE-1-PHOSPHATE; 1-PHOSPHATE; SEQUENCE; CELLS	Sphingosine-l-phosphate (SPP) is a novel lipid messenger that has dual function. Intracellularly it regulates proliferation and survival, and extracellularly, it is a ligand for the G protein-coupled receptor Edp-1. Based on peptide sequences obtained from purified rat kidney sphingosine kinase, the enzyme that regulates SPP levels, we report here the cloning, identification, and characterization of the first mammalian sphingosine kinases (murine SPHK1a and SPHK1b), Sequence analysis indicates that these are novel kinases, which are not similar to other known kinases, and that they are evolutionarily conserved, Comparison with Saccharomyces cerevisiae and Caenorhabditis elegans sphingosine kinase sequences shows that several blocks are highly conserved in all of these sequences. One of these blocks contains an invariant, positively charged motif, GGHGK, which may be part of the ATP binding site. From Northern blot analysis of multiple mouse tissues, we observed that expression was highest in adult lung and spleen, with barely detectable levels in skeletal muscle and Liver. Human embryonic kidney cells and NIH 3T3 fibroblasts transiently transfected with either sphingosine kinase expression vectors had marked increases (more than 100-fold) in sphingosine kinase activity. The enzyme specifically phosphorylated D-erythro-sphingosine and did not catalyze the phosphorylation of phosphatidylinositol, diacylglycerol, ceramide, D,L-threo-dihydrosphingosine or N,N-dimethylsphingosine. The latter two sphingolipids were competitive inhibitors of sphingosine kinase in the transfected cells as was previously found with the purified rat kidney enzyme. Transfected cells also had a marked increase in mass levels of SPP with a concomitant decrease in levels of sphingosine and, to a lesser extent, in ceramide levels, Our data suggest that sphingosine kinase is a prototypical member of a new class of lipid kinases. Cloning of sphingosine kinase is an important step in corroborating the intracellular role of SPP as a second messenger.	Georgetown Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20007 USA; Univ Kentucky, Med Ctr, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA; Univ Kentucky, Med Ctr, Dept Biochem, Lexington, KY 40536 USA	Georgetown University; University of Kentucky; University of Kentucky	Spiegel, S (corresponding author), Georgetown Univ, Med Ctr, Dept Biochem & Mol Biol, 353 Basic Sci Bldg,3900 Reservoir Rd NW, Washington, DC 20007 USA.	spiegel@biochem1.basic-sci.georgetown.edu		Kohama, Takafumi/0000-0002-6822-8170	NATIONAL CANCER INSTITUTE [R01CA061774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043880, R37GM043880] Funding Source: NIH RePORTER; NCI NIH HHS [CA61774] Funding Source: Medline; NIGMS NIH HHS [GM43880] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BORNFELDT KE, 1995, J CELL BIOL, V130, P193, DOI 10.1083/jcb.130.1.193; BUEHRER BM, 1992, J BIOL CHEM, V267, P3154; Buehrer BM, 1996, BBA-LIPID LIPID MET, V1303, P233, DOI 10.1016/0005-2760(96)00092-6; Bunting M, 1996, J BIOL CHEM, V271, P10230, DOI 10.1074/jbc.271.17.10230; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Dickson RC, 1997, J BIOL CHEM, V272, P30196, DOI 10.1074/jbc.272.48.30196; Ding L, 1997, P NATL ACAD SCI USA, V94, P5519, DOI 10.1073/pnas.94.11.5519; Edsall LC, 1997, J NEUROSCI, V17, P6952; GHOSH TK, 1994, J BIOL CHEM, V269, P22628; Jenkins GM, 1997, J BIOL CHEM, V272, P32566, DOI 10.1074/jbc.272.51.32566; Klauck TM, 1996, J BIOL CHEM, V271, P19781, DOI 10.1074/jbc.271.33.19781; LANE WS, 1991, J PROTEIN CHEM, V10, P151, DOI 10.1007/BF01024778; Lavan BE, 1997, J BIOL CHEM, V272, P11439; Lavan BE, 1997, J BIOL CHEM, V272, P21403, DOI 10.1074/jbc.272.34.21403; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Mandala SM, 1998, P NATL ACAD SCI USA, V95, P150, DOI 10.1073/pnas.95.1.150; MAZUREK N, 1994, BIOCHEM BIOPH RES CO, V198, P1, DOI 10.1006/bbrc.1994.1001; Melendez A, 1998, J BIOL CHEM, V273, P9393, DOI 10.1074/jbc.273.16.9393; Nagiec MM, 1998, J BIOL CHEM, V273, P19437, DOI 10.1074/jbc.273.31.19437; Olivera A, 1998, J BIOL CHEM, V273, P12576, DOI 10.1074/jbc.273.20.12576; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; OLIVERA A, 1994, ANAL BIOCHEM, V223, P306, DOI 10.1006/abio.1994.1589; Perez GI, 1997, NAT MED, V3, P1228, DOI 10.1038/nm1197-1228; Rani CSS, 1997, J BIOL CHEM, V272, P10777; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rius RA, 1997, FEBS LETT, V417, P173, DOI 10.1016/S0014-5793(97)01277-5; SAKANE F, 1990, NATURE, V344, P345, DOI 10.1038/344345a0; SCHAAP D, 1994, BIOCHEM J, V304, P661, DOI 10.1042/bj3040661; Spiegel S, 1996, CURR OPIN CELL BIOL, V8, P159, DOI 10.1016/S0955-0674(96)80061-5; STOFFEL W, 1973, H-S Z PHYSIOL CHEM, V354, P1311, DOI 10.1515/bchm2.1973.354.2.1311; STOFFEL W, 1973, H-S Z PHYSIOL CHEM, V354, P562, DOI 10.1515/bchm2.1973.354.1.562; Tang W, 1996, J BIOL CHEM, V271, P10237, DOI 10.1074/jbc.271.17.10237; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155	35	446	506	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23722	23728		10.1074/jbc.273.37.23722	http://dx.doi.org/10.1074/jbc.273.37.23722			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726979	hybrid			2022-12-27	WOS:000075893100020
J	Lacour, T; Achstetter, T; Dumas, B				Lacour, T; Achstetter, T; Dumas, B			Characterization of recombinant adrenodoxin reductase homologue (Arh1p) from yeast - Implication in in vitro cytochrome P45011 beta monooxygenase system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSFER FUNCTION; ESCHERICHIA-COLI; BOVINE ADRENODOXIN; SACCHAROMYCES-CEREVISIAE; DIRECT EXPRESSION; PROTEIN IMPORT; C REDUCTASE; GENE; MITOCHONDRIA; BINDING	The mammalian electron transfer chain of mitochondrial cytochrome P450 forms involved in steroidogenesis includes very specific proteins, namely adrenodoxin reductase and adrenodoxin. Adrenodoxin reductase transfers electrons from NADPH to adrenodoxin, which subsequently donates them to the cytochrome P450 forms. The Saccharomyces cerevisiae ARH1 gene product (Arh1p) presents homology to mammalian adreanodoxin reductase. We demonstrate the capacity of recombinant Arh1p, made in Escherichia coli, to substitute for its mammalian homologue in ferricyanide, cytochrome b: reduction, and, more importantly, in vitro 11 beta-hydroxylase assays. Electrons could be transfer-red from NADPH and NADH as measured in the cytochrome c reduction assay. Apparent K-m values were determined tea be 0.5, 0.6, and 0.1 mu M for NADPH, NADH, and bovine adrenodoxin, respectively, These values differ slightly from those of mammalian adrenodoxin reductase, except for NADH, which is a very poor electron donor to the mammalian protein. Subcellular fractionation studies have localized Arh1p to the inner membrane of yeast mitochondria. The biological function of Arh1p remains unknown, and to date, no mitochondrial cytochrome P450 has been identified. ARH1 is, however, essential for yeast viability because ale ARH1 gene disruption is lethal not only in aerobic growth conditions but also, surprisingly enough, during fermentation.	Hoechst Marion Roussel, Dept Biotechnol, F-93230 Romainville, France; Transgene SA, F-67000 Strasbourg, France	Sanofi-Aventis; Sanofi France; Transgene SA	Dumas, B (corresponding author), Hoechst Marion Roussel, Dept Biotechnol, 102 Route Noisy, F-93230 Romainville, France.							ACHSTETTER T, 1992, GENE, V110, P25, DOI 10.1016/0378-1119(92)90440-Z; Addya S, 1997, J CELL BIOL, V139, P589, DOI 10.1083/jcb.139.3.589; BAKER KP, 1991, NATURE, V349, P205, DOI 10.1038/349205a0; BECKERT V, 1994, J BIOL CHEM, V269, P2568; BLACKES WL, 1993, HDB EXPT PHARM, V105, P15; BRANDT ME, 1992, ARCH BIOCHEM BIOPHYS, V294, P735, DOI 10.1016/0003-9861(92)90749-M; CHU JW, 1973, J BIOL CHEM, V248, P5183; DEGRYSE E, 1995, YEAST, V11, P629, DOI 10.1002/yea.320110704; DEGTYARENKO KN, 1995, PROTEIN ENG, V8, P737, DOI 10.1093/protein/8.8.737; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DUGGLEBY RG, 1981, ANAL BIOCHEM, V110, P9, DOI 10.1016/0003-2697(81)90104-4; Dumas B, 1996, EUR J BIOCHEM, V238, P495, DOI 10.1111/j.1432-1033.1996.0495z.x; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GUARENTE L, 1982, P NATL ACAD SCI-BIOL, V79, P7410, DOI 10.1073/pnas.79.23.7410; Hannavy K, 1993, CURR OPIN CELL BIOL, V5, P694, DOI 10.1016/0955-0674(93)90142-D; HANUKOGLU I, 1989, EUR J BIOCHEM, V180, P479, DOI 10.1111/j.1432-1033.1989.tb14671.x; IYANAGI T, 1973, BIOCHEMISTRY-US, V12, P2297, DOI 10.1021/bi00736a018; Kagawa Norio, 1995, P419; KARPLUS PA, 1991, SCIENCE, V251, P60, DOI 10.1126/science.1986412; Lacour T, 1996, GENE, V174, P289, DOI 10.1016/0378-1119(96)00041-8; LAMBETH JD, 1977, J BIOL CHEM, V252, P2908; LAMBETH JD, 1979, J BIOL CHEM, V254, P2766; LATHE R, 1987, GENE, V57, P193, DOI 10.1016/0378-1119(87)90122-3; LITHGOW T, 1994, P NATL ACAD SCI USA, V91, P11973, DOI 10.1073/pnas.91.25.11973; Manzella L, 1998, YEAST, V14, P839, DOI 10.1002/(SICI)1097-0061(19980630)14:9<839::AID-YEA283>3.0.CO;2-A; Moore DD, 1995, GLOB MOB SURV; NOBREGA FG, 1992, EMBO J, V11, P3821, DOI 10.1002/j.1460-2075.1992.tb05474.x; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; ROSPERT S, 1993, FEBS LETT, V335, P358, DOI 10.1016/0014-5793(93)80419-U; SAGARA Y, 1993, BIOL PHARM BULL, V16, P627; SERRA EC, 1995, J BIOL CHEM, V270, P19930, DOI 10.1074/jbc.270.34.19930; Sirrenberg C, 1996, NATURE, V384, P582, DOI 10.1038/384582a0; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TAKEMORI S, 1993, CYTOCHROME P450, P44; Thain A, 1996, TRENDS GENET, V12, P209, DOI 10.1016/S0168-9525(96)90022-0; THIERRY A, 1990, YEAST, V6, P521, DOI 10.1002/yea.320060609; TULS J, 1987, J BIOL CHEM, V262, P10020; UHLMANN H, 1994, J BIOL CHEM, V269, P22557; UHLMANN H, 1995, J BIOL CHEM, V270, P29959; UHLMANN H, 1992, BIOCHEM BIOPH RES CO, V188, P1131, DOI 10.1016/0006-291X(92)91349-U; Vickery LE, 1997, STEROIDS, V62, P124, DOI 10.1016/S0039-128X(96)00170-5; WADA A, 1985, J BIOCHEM-TOKYO, V98, P245, DOI 10.1093/oxfordjournals.jbchem.a135264; WADA A, 1984, BIOCHEM BIOPH RES CO, V119, P365, DOI 10.1016/0006-291X(84)91660-7; WARBURTON RJ, 1995, BBA-PROTEIN STRUCT M, V1246, P39, DOI 10.1016/0167-4838(94)00178-J; WATENPAUGH KD, 1973, P NATL ACAD SCI USA, V70, P3857, DOI 10.1073/pnas.70.12.3857; YASUKOCHI Y, 1976, J BIOL CHEM, V251, P5337; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	48	43	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23984	23992		10.1074/jbc.273.37.23984	http://dx.doi.org/10.1074/jbc.273.37.23984			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727014	hybrid			2022-12-27	WOS:000075893100055
J	Pukatzki, S; Tordilla, N; Franke, J; Kessin, RH				Pukatzki, S; Tordilla, N; Franke, J; Kessin, RH			A novel component involved in ubiquitination is required for development of Dictyostelium discoideum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED PROTEOLYTIC PATHWAY; PROTEASOME PATHWAY; SIGNALING PATHWAYS; RIBOSOMAL-SUBUNIT; GENE; PROTEIN; DEGRADATION; SEQUENCE; ENZYME; DNA	A novel component of the ubiquitination system, called NOSA, is essential for cellular differentiation in Dictyostelium discoideum, Disruption of nosA does not affect the growth rate but causes an arrest in development after the cells have aggregated. nosA contains seven exons and codes for a developmentally regulated 3.5-kb mRNA, The 125-kDa NOSA protein is present in the cytosol at constant levels during growth and development. The C-terminal region of NOSA has homology with ubiquitin fusion degradation protein-2 (UFD2) of Saccharomyces cerevisiae and putative homologs in Caenorhabditis elegans and humans. UFD2 is involved in the ubiquitin-mediated degradation of model substrates in which ubiquitin forms part of the translation product, but ufd2 mutants have no detected phenotype, In accord with the homology to UFD2, we found differences in the ubiquitination patterns between nosA mutants and their parental cell line, While general in vivo and in vitro ubiquitination is minimally affected, ubiquitination of individual proteins is altered throughout growth and development in nosA mutants. These findings suggest that events involving ubiquitination are critical for progression through the aggregate stage of the Dictyostelium life cycle.	Columbia Univ Coll Phys & Surg, Dept Anat & Cell Biol, New York, NY 10032 USA	Columbia University	Kessin, RH (corresponding author), Columbia Univ Coll Phys & Surg, Dept Anat & Cell Biol, 630 W 168th St, New York, NY 10032 USA.				NIGMS NIH HHS [GM33136] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033136] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Altschul Stephen F., J MOL BIOL, V215, P403, DOI [10.1016/S0022-2836(05)80360-2, DOI 10.1016/S0022-2836(05)80360-2]; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P217, DOI 10.1093/nar/25.1.217; BAIROCH A, 1991, NUCLEIC ACIDS RES, V19, P2241, DOI 10.1093/nar/19.suppl.2241; BOYMARCOTTE E, 1984, MOL GEN GENET, V193, P406, DOI 10.1007/BF00382076; CATERINA MJ, 1994, J BIOL CHEM, V269, P1523; CECCARELLI A, 1987, NUCLEIC ACIDS RES, V15, P7463, DOI 10.1093/nar/15.18.7463; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CIECHANOVER A, 1994, BIOL CHEM H-S, V375, P565; CIECHANOVER A, 1994, FASEB J, V8, P182, DOI 10.1096/fasebj.8.2.8119489; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Clark A, 1997, MOL BIOL CELL, V8, P1989, DOI 10.1091/mbc.8.10.1989; EARLY A, 1988, DEV GENET, V9, P383, DOI 10.1002/dvg.1020090419; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; HADWIGER JA, 1992, GENE DEV, V6, P38, DOI 10.1101/gad.6.1.38; Hershko A, 1997, CURR OPIN CELL BIOL, V9, P788, DOI 10.1016/S0955-0674(97)80079-8; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; HOPPER NA, 1993, EMBO J, V12, P2459, DOI 10.1002/j.1460-2075.1993.tb05900.x; HUANG YZ, 1995, SCIENCE, V270, P1828, DOI 10.1126/science.270.5243.1828; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; INSALL RH, 1994, MOL BIOL CELL, V5, P703, DOI 10.1091/mbc.5.6.703; JACQUET M, 1988, MOL GEN GENET, V211, P441, DOI 10.1007/BF00425698; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; KITAGAWA T, 1976, J BIOCHEM-TOKYO, V79, P233, DOI 10.1093/oxfordjournals.jbchem.a131053; Kuspa A, 1996, P NATL ACAD SCI USA, V93, P5562, DOI 10.1073/pnas.93.11.5562; KUSPA A, 1992, P NATL ACAD SCI USA, V89, P8803, DOI 10.1073/pnas.89.18.8803; LOOMIS WF, 1997, DICTYOSTELIUM MODEL, P15; MANSTEIN DJ, 1995, GENE, V162, P129, DOI 10.1016/0378-1119(95)00351-6; MULLERTAUBENBERGER A, 1988, FEBS LETT, V229, P273, DOI 10.1016/0014-5793(88)81139-6; MULLERTAUBENBERGER A, 1988, J CELL SCI, V90, P51; MULLERTAUBENBERGER A, 1989, J BIOL CHEM, V264, P5319; OHMACHI T, 1989, BIOCHEMISTRY-US, V28, P5226, DOI 10.1021/bi00438a046; Pagano M, 1997, FASEB J, V11, P1067, DOI 10.1096/fasebj.11.13.9367342; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; PODGORSKI GJ, 1989, MOL CELL BIOL, V9, P3938, DOI 10.1128/MCB.9.9.3938; Ramos PCR, 1996, J EXP BOT, V47, P569, DOI 10.1093/jxb/47.4.569; REDMAN KL, 1994, INSECT BIOCHEM MOLEC, V24, P191, DOI 10.1016/0965-1748(94)90085-X; RICHARDSON DL, 1994, DEVELOPMENT, V120, P2891; Scheirton L S, 1993, Camb Q Healthc Ethics, V2, P495; Shaulsky G, 1996, P NATL ACAD SCI USA, V93, P15260, DOI 10.1073/pnas.93.26.15260; SHAULSKY G, 1995, GENE DEV, V9, P1111, DOI 10.1101/gad.9.9.1111; SHAW DR, 1989, MOL GEN GENET, V218, P453, DOI 10.1007/BF00332409; SMITH DF, 1983, BIOCHEM BIOPH RES CO, V115, P360, DOI 10.1016/0006-291X(83)91012-4; SUTOH K, 1993, PLASMID, V30, P150, DOI 10.1006/plas.1993.1042; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Wang N, 1996, EMBO J, V15, P3890, DOI 10.1002/j.1460-2075.1996.tb00763.x; WESTPHAL M, 1986, FEBS LETT, V209, P92, DOI 10.1016/0014-5793(86)81090-0; WU L, 1995, DEV BIOL, V167, P1, DOI 10.1006/dbio.1995.1001; WU L, 1990, GENE, V91, P51, DOI 10.1016/0378-1119(90)90161-J	50	24	28	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24131	24138		10.1074/jbc.273.37.24131	http://dx.doi.org/10.1074/jbc.273.37.24131			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727034	hybrid			2022-12-27	WOS:000075893100075
J	Samari, HR; Seglen, PO				Samari, HR; Seglen, PO			Inhibition of hepatocytic autophagy by adenosine, aminoimidazole-4-carboxamide riboside, and N-6-mercaptopurine riboside - Evidence for involvement of AMP-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLATED RAT HEPATOCYTES; 5-AMINO-4-IMIDAZOLECARBOXAMIDE RIBOSIDE; ENERGY-DEPENDENCE; LYSOSOMAL PATHWAY; ATP DEPLETION; INTACT-CELLS; OKADAIC ACID; AMINO-ACIDS; DEGRADATION; LIVER	To examine the role of AMP-activated protein kinase (AMPK; EC 2.7.1.109) in the regulation of autophagy, rat hepatocytes were incubated with the AMPK proactivators, adenosine, 5-amino-4-imidazole carboxamide riboside (AICAR), or N-G-mercaptopurine riboside. Autophagic activity was inhibited by all three nucleosides, AICAR and N6-mercaptopurine riboside being more potent (IC50 = 0.3 mM) than adenosine (IC50 = 1 mM), 2'-Deoxycoformycin, an adenosine deaminase (EC 3.5.4.4) inhibitor, increased the potency of adenosine B-fold, suggesting that the effectiveness of adenosine as an autophagy inhibitor was curtailed by its intracellular deamination. 5-Iodotubercidin, an adenosine kinase (EC 2.7.1.20) inhibitor, abolished the effects of all three nucleosides, indicating that they needed to be phosphorylated to inhibit autophagy. A S-iodotubercidin-suppressible phosphorylation of AICAR to 4-aminoimidazole-4-carboxamide riboside monophosphate was confirmed by chromatographic analysis, AICAR, up to 0.4 mM, had no significant effect on intracellular ATP concentrations. Because activated AMPK phosphorylates and inactivates 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase (EC 1.1,1.88), the rate-limiting enzyme in cholesterol synthesis, the strong inhibition of hepatocytic cholesterol synthesis by all three nucleosides confirmed their ability to activate AMPK under the conditions used. Lovastatin and simvastatin, inhibitors of HMG-CoA reductase, strongly suppressed cholesterol synthesis while having no effect on autophagic activity, suggesting that AMPK inhibits autophagy independently of its effects on HMG-CoA reductase and cholesterol metabolism.	Norwegian Radium Hosp, Dept Cell Biol, Canc Res Inst, N-0310 Oslo, Norway	University of Oslo	Seglen, PO (corresponding author), Norwegian Radium Hosp, Dept Cell Biol, Canc Res Inst, N-0310 Oslo, Norway.							ALBERTS AW, 1990, CARDIOLOGY, V77, P14, DOI 10.1159/000174688; ATKINSON DE, 1971, METABOLIC REGULATION, V5, P1; AW TY, 1989, AM J PHYSIOL, V257, pC435, DOI 10.1152/ajpcell.1989.257.3.C435; BONTEMPS F, 1983, P NATL ACAD SCI-BIOL, V80, P2829, DOI 10.1073/pnas.80.10.2829; BONTEMPS F, 1993, BIOCHEM J, V290, P671, DOI 10.1042/bj2900671; CARABAZA A, 1990, J BIOL CHEM, V265, P2724; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; CARO LHP, 1988, EUR J BIOCHEM, V175, P325, DOI 10.1111/j.1432-1033.1988.tb14200.x; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; CORTON JM, 1994, CURR BIOL, V4, P315, DOI 10.1016/S0960-9822(00)00070-1; Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8; GORDON PB, 1982, ARCH BIOCHEM BIOPHYS, V217, P282, DOI 10.1016/0003-9861(82)90504-5; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; HARDIE DG, 1989, TRENDS BIOCHEM SCI, V14, P20; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; HELLAND S, 1982, CANCER RES, V42, P1130; HENDERSON JF, 1977, BIOCHEM PHARMACOL, V26, P1967, DOI 10.1016/0006-2952(77)90003-X; HENDERSON JF, 1972, CANCER CHEMOTH REP 2, V3, P71; HENIN N, 1995, FASEB J, V9, P541, DOI 10.1096/fasebj.9.7.7737463; Henin N, 1996, BBA-GEN SUBJECTS, V1290, P197, DOI 10.1016/0304-4165(96)00021-9; HOFFMAN DR, 1980, J BIOL CHEM, V255, P822; HOLEN I, 1995, J BIOL CHEM, V270, P12823, DOI 10.1074/jbc.270.21.12823; HOLEN I, 1992, BIOCHEM J, V284, P633, DOI 10.1042/bj2840633; HOLEN I, 1993, EUR J BIOCHEM, V215, P113, DOI 10.1111/j.1432-1033.1993.tb18013.x; Holen I, 1996, EUR J BIOCHEM, V236, P163, DOI 10.1111/j.1432-1033.1996.00163.x; Holtzman E, 1989, LYSOSOMES; HUE L, 1982, BIOCHEM J, V206, P359, DOI 10.1042/bj2060359; KOPITZ J, 1990, J CELL BIOL, V111, P941, DOI 10.1083/jcb.111.3.941; KOVACS AL, 1981, EXP CELL RES, V133, P431, DOI 10.1016/0014-4827(81)90336-0; MOORE F, 1991, EUR J BIOCHEM, V199, P691, DOI 10.1111/j.1432-1033.1991.tb16172.x; MORTIMORE GE, 1990, INT J BIOCHEM, V22, P1075, DOI 10.1016/0020-711X(90)90104-B; OKAJIMA F, 1987, J BIOL CHEM, V262, P13483; OLAH ME, 1995, ANNU REV PHARMACOL, V35, P581, DOI 10.1146/annurev.pa.35.040195.003053; PLOMP PJAM, 1987, EUR J BIOCHEM, V164, P197, DOI 10.1111/j.1432-1033.1987.tb11011.x; PLOMP PJAM, 1989, J BIOL CHEM, V264, P6699; RUSTAN AC, 1988, J BIOL CHEM, V263, P8126; SABINA RL, 1985, J BIOL CHEM, V260, P6107; SATO R, 1993, P NATL ACAD SCI USA, V90, P9261, DOI 10.1073/pnas.90.20.9261; SCHELLENS JPM, 1988, EXP CELL RES, V177, P103, DOI 10.1016/0014-4827(88)90028-6; SCHWORER CM, 1979, P NATL ACAD SCI USA, V76, P3169, DOI 10.1073/pnas.76.7.3169; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; SEGLEN PO, 1979, EUR J BIOCHEM, V95, P215, DOI 10.1111/j.1432-1033.1979.tb12956.x; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509; Seglen PO, 1992, ENDOCYTOSIS, P247; Shevchuk I, 1996, INT J CANCER, V67, P791; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; VINCENT MF, 1992, BIOCHEM J, V281, P267, DOI 10.1042/bj2810267; WEEKES J, 1994, EUR J BIOCHEM, V219, P751, DOI 10.1111/j.1432-1033.1994.tb18554.x	49	126	134	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23758	23763		10.1074/jbc.273.37.23758	http://dx.doi.org/10.1074/jbc.273.37.23758			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726984	hybrid			2022-12-27	WOS:000075893100025
J	Smalheiser, NR; Haslam, SM; Sutton-Smith, M; Morris, HR; Dell, A				Smalheiser, NR; Haslam, SM; Sutton-Smith, M; Morris, HR; Dell, A			Structural analysis of sequences O-linked to mannose reveals a novel Lewis X structure in cranin (Dystroglycan) purified from sheep brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE ALPHA-DYSTROGLYCAN; CHONDROITIN SULFATE PROTEOGLYCAN; CENTRAL-NERVOUS-SYSTEM; EXTRACELLULAR-MATRIX; LE(X) CARBOHYDRATE; PERIPHERAL-NERVE; LAMININ; OLIGOSACCHARIDES; BINDING; CELLS	The Lewis X epitope, Gal beta 1-4(Fuc alpha 1-3)GlcNAc-R, has been implicated in cell-cell recognition events in a number of systems including the central nervous system and is expressed on diverse glycoconjugates including cell adhesion molecules, glycolipids, and the proteoglycan phosphacan, Although Lewis X sequences 3-Linked to mannose have been described within proteoglycan fractions of mammalian brain, these have not been reported in other contexts and have been widely believed to be peculiar constituents of brain proteoglycans. in the present paper, we confirm the existence of Lewis X structures O-linked to mannose within the mammalian br ain, demonstrate that these structures are present on a well defined mucin-like glycoprotein, cranin (dystroglycan), and report studies suggesting that the linkages involved may be predominantly 8-linked to mannose, Mannose-linked Lewis X is the latest in an increasing List of oligosaccharide recognition "tags" that have been shown to be expressed on cranin (dystroglycan) purified from brain.	Univ Illinois, Dept Psychiat & Anat Cell Biol, Chicago, IL 60612 USA; Univ Illinois, Inst Psychiat, Chicago, IL 60612 USA; Univ London Imperial Coll Sci Technol & Med, Dept Biochem, London SW7 2AY, England	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Imperial College London	Smalheiser, NR (corresponding author), Univ Illinois, Dept Psychiat & Anat Cell Biol, 1601 W Taylor St, Chicago, IL 60612 USA.	smalheiser@psych.uic.edu		Smalheiser, Neil/0000-0003-1079-3406	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALLENDOERFER KL, 1995, MOL CELL NEUROSCI, V6, P381, DOI 10.1006/mcne.1995.1029; Apperson ML, 1996, J NEUROSCI, V16, P6839; Belkin AM, 1996, CELL ADHES COMMUN, V4, P281, DOI 10.3109/15419069609010772; BRANCACCIO A, 1995, FEBS LETT, V368, P139, DOI 10.1016/0014-5793(95)00628-M; Brancaccio A, 1997, EUR J BIOCHEM, V246, P166, DOI 10.1111/j.1432-1033.1997.00166.x; Chiba A, 1997, J BIOL CHEM, V272, P2156; DELL A, 1994, METHOD ENZYMOL, V230, P108; DOWBENKO D, 1993, J BIOL CHEM, V268, P14399; DURBEEJ M, 1995, J CELL BIOL, V130, P79, DOI 10.1083/jcb.130.1.79; EGGENS I, 1989, J BIOL CHEM, V264, P9476; Ervasti JM, 1997, J BIOL CHEM, V272, P22315, DOI 10.1074/jbc.272.35.22315; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FINNE J, 1979, J BIOL CHEM, V254, P295; Gesemann M, 1998, J BIOL CHEM, V273, P600, DOI 10.1074/jbc.273.1.600; Gotz M, 1996, NEURON, V16, P551, DOI 10.1016/S0896-6273(00)80074-4; Haslam SM, 1996, J BIOL CHEM, V271, P30561, DOI 10.1074/jbc.271.48.30561; Henry MD, 1996, CURR OPIN CELL BIOL, V8, P625, DOI 10.1016/S0955-0674(96)80103-7; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; KHOO KH, 1995, J BIOL CHEM, V270, P17114, DOI 10.1074/jbc.270.29.17114; KRUSIUS T, 1986, J BIOL CHEM, V261, P8237; Matsumura K, 1997, J BIOL CHEM, V272, P13904, DOI 10.1074/jbc.272.21.13904; Pall EA, 1996, J BIOL CHEM, V271, P3817; PENG HB, 1998, IN PRESS CELL ADHES; ROBERTS C, 1991, DEVELOPMENT, V112, P959; SMALHEISER NR, 1995, J BIOL CHEM, V270, P15425, DOI 10.1074/jbc.270.25.15425; SMALHEISER NR, 1993, J NEUROSCI RES, V36, P528, DOI 10.1002/jnr.490360505; SMALHEISER NR, 1998, IN PRESS CELL ADHES; Streit A, 1996, J NEUROCHEM, V66, P834; SUGIYAMA J, 1994, NEURON, V13, P103, DOI 10.1016/0896-6273(94)90462-6; TOLE S, 1995, J NEUROSCI, V15, P957; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831; Yamada H, 1996, J NEUROCHEM, V66, P1518; Yuen CT, 1997, J BIOL CHEM, V272, P8924	33	111	113	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23698	23703		10.1074/jbc.273.37.23698	http://dx.doi.org/10.1074/jbc.273.37.23698			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726975	hybrid			2022-12-27	WOS:000075893100016
J	Ziogas, A; Lorenz, IC; Moelling, K; Radziwill, G				Ziogas, A; Lorenz, IC; Moelling, K; Radziwill, G			Mitotic Raf-1 is stimulated independently of Ras and is active in the cytoplasm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE KINASE; CELL-CYCLE ARREST; PROTEIN-KINASE; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; PLASMA-MEMBRANE; AMINO-TERMINUS; IN-VIVO; C-JUN; ACTIVATION	Raf-1 is a Ser/Thr protein kinase that is involved in regulation of proliferation, differentiation, and apoptosis, Recently, we and others showed that Raf-1 is mot only activated in mitogenic pathways leading to cell cycle entry but also during mitosis, Transient expression studies in COS cells now demonstrate that, in contrast to growth factor-dependent activation of Raf-1, mitotic activation of Raf-1 is Ras-independent, Dominant negative RasS17N does not interfere with mitotic activation of Raf-1, whereas epidermal growth factor-dependent stimulation of Raf-1 is inhibited, In addition, the Raf-1 mutant RafR89L, which cannot bind to activated Ras, is still stimulated in mitotic cells, Mitotic activation of Raf-1 seems to be partially dependent on tyrosine phosphorylation since the kinase activity of the Raf mutant RafYY340/341FF, which can no longer be activated by Src, is reduced in mitotic cells. Surprisingly, cell fractionation experiments showed that mitotic-activated Raf-1 is predominantly located in the cytoplasm in contrast to the mitogen-activated Raf-1 that is hound to the plasma membrane, In addition, mitotic activation of Raf-1 does not lead to stimulation of the mitogen-activated protein kinase kinase (MAPKK or MEK) and the extracellular signal-regulated protein kinase (ERK). These data demonstrate that in mitotic cells a Ras-independent mechanism results in a cytoplasmic active Raf-1 kinase which does not signal via the MEW ERK pathway,These data demonstrate that in mitotic cells a Ras-independent mechanism results in a cytoplasmic active Raf-1 kinase which does not signal via the MEK/ERK pathway.	Univ Zurich, Inst Med Virol, CH-8028 Zurich, Switzerland	University of Zurich	Radziwill, G (corresponding author), Univ Zurich, Inst Med Virol, Gloriastr 30, CH-8028 Zurich, Switzerland.							Aitken A, 1996, TRENDS CELL BIOL, V6, P341, DOI 10.1016/0962-8924(96)10029-5; ALESSI DR, 1995, METHOD ENZYMOL, V255, P279; AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; BRTVA TR, 1995, J BIOL CHEM, V270, P9809, DOI 10.1074/jbc.270.17.9809; CHERNIACK AD, 1995, J BIOL CHEM, V270, P1485, DOI 10.1074/jbc.270.4.1485; CLEGHON V, 1994, J BIOL CHEM, V269, P17749; CONKLIN DS, 1995, P NATL ACAD SCI USA, V92, P7892, DOI 10.1073/pnas.92.17.7892; DENHERTOG J, 1994, EMBO J, V13, P3020, DOI 10.1002/j.1460-2075.1994.tb06601.x; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; Drugan JK, 1996, J BIOL CHEM, V271, P233, DOI 10.1074/jbc.271.1.233; Edelmann HML, 1996, J BIOL CHEM, V271, P963, DOI 10.1074/jbc.271.2.963; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; FANTL WJ, 1994, NATURE, V371, P612, DOI 10.1038/371612a0; FEIG LA, 1986, P NATL ACAD SCI USA, V83, P4607, DOI 10.1073/pnas.83.13.4607; GALAKTIONOV K, 1995, GENE DEV, V9, P1046, DOI 10.1101/gad.9.9.1046; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; Jelinek T, 1996, MOL CELL BIOL, V16, P1027; JOHN J, 1988, J BIOL CHEM, V263, P11792; LAIRD AD, 1995, J BIOL CHEM, V270, P26742, DOI 10.1074/jbc.270.45.26742; Laird AD, 1997, CELL SIGNAL, V9, P249, DOI 10.1016/S0898-6568(96)00176-3; Larsson N, 1997, MOL CELL BIOL, V17, P5530, DOI 10.1128/MCB.17.9.5530; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Lloyd AC, 1997, GENE DEV, V11, P663, DOI 10.1101/gad.11.5.663; Lovric J, 1996, ONCOGENE, V12, P1109; MAMON H, 1991, COLD SPRING HARB SYM, V56, P251; Marais R, 1996, CANCER SURV, V27, P101; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; MOELLING K, 1984, NATURE, V312, P558, DOI 10.1038/312558a0; MORRISON DK, 1995, MOL REPROD DEV, V42, P507, DOI 10.1002/mrd.1080420420; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Pathan NI, 1996, J BIOL CHEM, V271, P30315, DOI 10.1074/jbc.271.48.30315; Popik W, 1996, MOL CELL BIOL, V16, P6532; RADZIWILL G, 1995, P NATL ACAD SCI USA, V92, P1421, DOI 10.1073/pnas.92.5.1421; Renshaw MW, 1997, EMBO J, V16, P5592, DOI 10.1093/emboj/16.18.5592; Rommel C, 1997, MECH DEVELOP, V64, P95, DOI 10.1016/S0925-4773(97)00052-X; Rommel C, 1996, ONCOGENE, V12, P609; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; TRAVERSE S, 1993, ONCOGENE, V8, P3175; TURNER BC, 1993, P NATL ACAD SCI USA, V90, P5544, DOI 10.1073/pnas.90.12.5544; Wartmann M, 1997, J BIOL CHEM, V272, P3915, DOI 10.1074/jbc.272.7.3915; WATERS SB, 1995, MOL CELL BIOL, V15, P2791; WESTWICK JK, 1994, P NATL ACAD SCI USA, V91, P6030, DOI 10.1073/pnas.91.13.6030; WILLIAMS NG, 1992, P NATL ACAD SCI USA, V89, P2922, DOI 10.1073/pnas.89.7.2922; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Xia K, 1996, P NATL ACAD SCI USA, V93, P11681, DOI 10.1073/pnas.93.21.11681; Zimmermann S, 1997, ONCOGENE, V15, P1503, DOI 10.1038/sj.onc.1201322	50	37	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24108	24114		10.1074/jbc.273.37.24108	http://dx.doi.org/10.1074/jbc.273.37.24108			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727031	hybrid			2022-12-27	WOS:000075893100072
J	Davies, BJ; Pickard, BS; Steel, R; Morris, RGM; Lathe, R				Davies, BJ; Pickard, BS; Steel, R; Morris, RGM; Lathe, R			Serine proteases in rodent hippocampus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; LONG-TERM POTENTIATION; HEPATOCYTE GROWTH-FACTOR; AMYLOID-BETA-PEPTIDE; NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; MESSENGER-RNA; RAT-BRAIN; NEURONAL DEGENERATION; EXPRESSION	Brain serine proteases are implicated in developmental processes, synaptic plasticity, and in disorders including Alzheimer's disease. The spectrum of the major enzymes expressed in brain has not been established previously. We now present a systematic study of the serine proteases expressed in adult rat and mouse hippocampus. Using a combination of techniques including polymerase chain reaction amplification and Northern blotting we show that tissue-type plasminogen activator (t-PA) is the major species represented. Unexpectedly, the next most abundant species were RNK-Met-1, a lymphocyte protease not reported previously in brain, and two new family members, BSP1 (brain serine protease 1) and BSP2. We report full-length sequences of the two new proteases; homologies indicate that these are of tryptic specificity, Although BSP2 is expressed in several brain regions, BSP1 expression is strikingly restricted to hippocampus, Other enzymes represented, but at lower levels, included elastase IV, proteinase 3, complement C2, chymotrypsin B, chymotrypsin-like protein, and Hageman factor. Although thrombin and urokinase-type plasminogen activator were not detected in the primary screen, low level expression was confirmed using specific polymerase chain reaction primers. In contrast, and despite robust expression of t-PA, the usual t-PA substrate plasminogen was not expressed at detectable levels.	Univ Edinburgh, Ctr Neurosci, Edinburgh EH9 3JQ, Midlothian, Scotland; Univ Edinburgh, Ctr Genome Res, Edinburgh EH9 3JQ, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Lathe, R (corresponding author), Univ Edinburgh, Ctr Neurosci, Kings Bldg,W Mains Rd, Edinburgh EH9 3JQ, Midlothian, Scotland.	rlathe@ed.ac.uk	Davies, Ben/GYD-9163-2022; Pickard, Benjamin S/K-3923-2014; Morris, Richard G M/C-9982-2013	Davies, Ben/0000-0003-3405-507X; Pickard, Benjamin S/0000-0002-2374-6329; Davies, Benjamin/0000-0003-3623-600X; Lathe, Richard/0000-0001-9698-9834				BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; CAVANAUGH KP, 1990, J NEUROCHEM, V54, P1735, DOI 10.1111/j.1471-4159.1990.tb01228.x; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; CHEN ZL, 1995, J NEUROSCI, V15, P5088; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DENT MAR, 1993, EUR J NEUROSCI, V5, P633, DOI 10.1111/j.1460-9568.1993.tb00529.x; DIHANICH M, 1991, NEURON, V6, P575, DOI 10.1016/0896-6273(91)90060-D; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; EVIN G, 1995, BIOCHEMISTRY-US, V34, P14185, DOI 10.1021/bi00043a024; Frey U, 1996, J NEUROSCI, V16, P2057; FRIEDMAN GC, 1994, DEV BRAIN RES, V81, P41, DOI 10.1016/0165-3806(94)90066-3; GEINISMAN Y, 1991, BRAIN RES, V566, P77, DOI 10.1016/0006-8993(91)91683-R; Gschwend TP, 1997, MOL CELL NEUROSCI, V9, P207, DOI 10.1006/mcne.1997.0616; GURWITZ D, 1988, P NATL ACAD SCI USA, V85, P3440, DOI 10.1073/pnas.85.10.3440; HARTLEY BS, 1964, NATURE, V201, P1284, DOI 10.1038/2011284a0; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KITAGUCHI N, 1990, BIOCHIM BIOPHYS ACTA, V1038, P105, DOI 10.1016/0167-4838(90)90017-A; Krueger SR, 1997, J NEUROSCI, V17, P8984; KRYSTOSEK A, 1981, P NATL ACAD SCI-BIOL, V78, P7810, DOI 10.1073/pnas.78.12.7810; KRYSTOSEK A, 1981, SCIENCE, V213, P1532, DOI 10.1126/science.7197054; LATHE R, 1994, NEUROPATH APPL NEURO, V20, P350, DOI 10.1111/j.1365-2990.1994.tb00980.x; Luthi A, 1997, J NEUROSCI, V17, P4688; MARS WM, 1993, AM J PATHOL, V143, P949; Masos T, 1996, MOL BRAIN RES, V35, P139, DOI 10.1016/0169-328X(95)00199-3; MAYFORD M, 1995, CURR OPIN NEUROBIOL, V5, P141, DOI 10.1016/0959-4388(95)80019-0; NAKAJIMA K, 1992, J NEUROCHEM, V58, P1401, DOI 10.1111/j.1471-4159.1992.tb11356.x; NELSON RB, 1993, J NEUROCHEM, V61, P567; NICK H, 1990, BIOCHEMISTRY-US, V29, P2417, DOI 10.1021/bi00461a027; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Pasinetti GM, 1996, NEUROBIOL DIS, V3, P197, DOI 10.1006/nbdi.1996.0020; PERONA JJ, 1995, BIOCHEMISTRY-US, V34, P1489, DOI 10.1021/bi00005a004; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; RAO NV, 1991, ANN NY ACAD SCI, V624, P60, DOI 10.1111/j.1749-6632.1991.tb17006.x; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P19; RUTKA JT, 1988, J NEUROSURG, V69, P155, DOI 10.3171/jns.1988.69.2.0155; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; SAPPINO AP, 1993, J CLIN INVEST, V92, P679, DOI 10.1172/JCI116637; Scarisbrick IA, 1997, J NEUROSCI, V17, P8156; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SEEDS NW, 1995, SCIENCE, V270, P1992, DOI 10.1126/science.270.5244.1992; SHIMOMURA T, 1995, EUR J BIOCHEM, V229, P257, DOI 10.1111/j.1432-1033.1995.0257l.x; SMITHSWINTOSKY VL, 1995, J NEUROSCI, V15, P5840; SMITHSWINTOSKY VL, 1995, J NEUROCHEM, V65, P1415; SMYTH MJ, 1992, J BIOL CHEM, V267, P24418; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; STAPLETON G, 1995, J BIOL CHEM, V270, P29739, DOI 10.1074/jbc.270.50.29739; Thewke DP, 1996, J NEUROSCI, V16, P6933; TSIRKA SE, 1995, NATURE, V377, P340, DOI 10.1038/377340a0; Tsirka SE, 1996, NATURE, V384, P123, DOI 10.1038/384123b0; Tsirka SE, 1997, J NEUROSCI, V17, P543; VALINSKY JE, 1985, EMBO J, V4, P1403, DOI 10.1002/j.1460-2075.1985.tb03793.x; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; VENSTROM KA, 1993, FASEB J, V7, P996, DOI 10.1096/fasebj.7.11.8370483; VINCENT S, 1993, NUCLEIC ACIDS RES, V21, P1498, DOI 10.1093/nar/21.6.1498; WARE JH, 1995, BRAIN RES BULL, V37, P275, DOI 10.1016/0361-9230(95)00008-3; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Yamashiro K, 1997, BBA-GENE STRUCT EXPR, V1350, P11, DOI 10.1016/S0167-4781(96)00187-X; YASUHARA O, 1994, BRAIN RES, V654, P234, DOI 10.1016/0006-8993(94)90484-7; Yong VW, 1998, TRENDS NEUROSCI, V21, P75; [No title captured]	65	68	74	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23004	23011		10.1074/jbc.273.36.23004	http://dx.doi.org/10.1074/jbc.273.36.23004			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722524	hybrid			2022-12-27	WOS:000075778100024
J	Soltoff, SP				Soltoff, SP			Related adhesion focal tyrosine kinase and the epidermal growth factor receptor mediate the stimulation of mitogen-activated protein kinase by the G-protein-coupled P-2Y2 receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; MAP KINASE; EGF RECEPTOR; PC12 CELLS; PHOSPHOLIPASE-C; DEPENDENT PHOSPHORYLATION; MEMBRANE DEPOLARIZATION; SIGNAL-TRANSDUCTION; ATP; RAS	The activation of growth factor receptors and receptors coupled to heterotrimeric guanine nucleotide-binding proteins (G-proteins) can increase mitogen-activated protein (MAP) kinase activity in many cells. Previously, we demonstrated that the activation of G-protein-coupled P-2Y2 receptors by extracellular ATP and UTP stimulated MAP (p42 ERK2) kinase by a mechanism that was dependent on the elevation of [Ca2+](i) and the activation of related adhesion focal tyrosine kinase (RAFTK) (also called PYK2, CAK beta, and CADTK) and protein kinase C (PKC). Here, we examine further the signaling cascade between the P-2Y2 receptor and MAP kinase, MAP kinase was transiently activated by exposure of PC12 cells to UTP, UTP, ionomycin, and phorbol ester (phorbol 12-myristate 13-acetate) increased MAP kinase activity and also promoted the tyrosine phosphorylation of RAFTK, the epidermal growth factor (EGF) receptor, SHC, and p120(cbl). Down-regulation of PKC and inhibition of the elevation of [Ca2+](i), conditions that block the activation of MAP kinase, also blocked the increases in the tyrosine phosphorylation of RAFTK and the EGF receptor. AG1478, a tyrphostin selective for the EGF receptor, reduced the activation of MAP kinase, the tyrosine phosphorylation of SHC, the association of Grb2 with SRC, and the tyrosine phosphorylation of the EGF receptor and p120(cbl) but did not block the tyrosine phosphorylation of RAFTK. The similar effects of UTP, ionomycin, and phorbol 12-myristate 13-acetate (PMA) on these signaling proteins demonstrate that the two signaling molecules from phosphatidylinositol 4,5-bisphosphate hydrolysis ([Ca2+](i), from inositol 1,4,5-trisphosphate production, and diacylglycerol) can individually initiate the activation of MAP kinase in an EGF receptor-dependent manner. These results demonstrate that the P-2Y2 receptor-mediated transactivation of the EGF receptor occurs at a point downstream of RAFTK and indicate that the EGF receptor is required for P-2Y2 receptor-mediated MAP kinase activation. Although P-2Y2 and EGF receptors may both activate a similar multiprotein signaling cascade immediately upstream of MAP kinase, the P-2Y2 receptor appears to uniquely utilize [Ca2+](i), PKC, and, subsequently, RAFTK.	Harvard Univ, Inst Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Signal Transduct, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Soltoff, SP (corresponding author), Harvard Univ, Inst Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Signal Transduct, 330 Brookline Ave, Boston, MA 02215 USA.	ssoltoff@bidmc.harvard.edu			NIDCR NIH HHS [DE10877] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010877] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BARRY VA, 1994, J CELL SCI, V107, P451; Burnstock G, 1996, CIBA F SYMP, V198, P1; Burnstock G., 1978, CELL MEMBRANE RECEPT, Vpp, P107; Chen P, 1996, MOL BIOL CELL, V7, P871, DOI 10.1091/mbc.7.6.871; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; EDWARDS FA, 1992, NATURE, V359, P144, DOI 10.1038/359144a0; Eguchi S, 1998, J BIOL CHEM, V273, P8890, DOI 10.1074/jbc.273.15.8890; Emkey R, 1997, J BIOL CHEM, V272, P31172, DOI 10.1074/jbc.272.49.31172; EVANS RJ, 1992, NATURE, V357, P503, DOI 10.1038/357503a0; Gelderloos JA, 1998, J BIOL CHEM, V273, P5908, DOI 10.1074/jbc.273.10.5908; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; Habib AA, 1998, J BIOL CHEM, V273, P6885, DOI 10.1074/jbc.273.12.6885; HUNTER T, 1984, NATURE, V311, P480, DOI 10.1038/311480a0; Hwang TH, 1996, AM J PHYSIOL-CELL PH, V270, pC1611, DOI 10.1152/ajpcell.1996.270.6.C1611; KENNEDY C, 1995, TRENDS PHARMACOL SCI, V16, P168, DOI 10.1016/S0165-6147(00)89010-0; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; LANGGUT W, 1995, FEBS LETT, V372, P173, DOI 10.1016/0014-5793(95)00971-B; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Li JZ, 1996, BLOOD, V88, P417, DOI 10.1182/blood.V88.2.417.bloodjournal882417; LINSEMAN DA, 1995, J BIOL CHEM, V270, P12563, DOI 10.1074/jbc.270.21.12563; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; MORRISON P, 1993, J BIOL CHEM, V268, P15536; MURRIN RJA, 1992, MOL PHARMACOL, V41, P561; Neary JT, 1996, NEUROREPORT, V7, P2893, DOI 10.1097/00001756-199611250-00017; OHMICHI M, 1992, J BIOL CHEM, V267, P14604; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Rosen LB, 1996, P NATL ACAD SCI USA, V93, P1113, DOI 10.1073/pnas.93.3.1113; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Rusanescu G, 1995, NEURON, V15, P1415, DOI 10.1016/0896-6273(95)90019-5; SCHWIEBERT EM, 1995, CELL, V81, P1063, DOI 10.1016/S0092-8674(05)80011-X; Soltoff SP, 1996, J BIOL CHEM, V271, P563, DOI 10.1074/jbc.271.1.563; Soltoff SP, 1998, J BIOL CHEM, V273, P2653, DOI 10.1074/jbc.273.5.2653; Swanson KD, 1998, J BIOL CHEM, V273, P19965, DOI 10.1074/jbc.273.32.19965; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VANBIESEN T, 1995, NATURE, V376, P781, DOI 10.1038/376781a0; Wan Y, 1996, NATURE, V380, P541, DOI 10.1038/380541a0; XIAN WJ, 1995, CELL GROWTH DIFFER, V6, P1447; Yamauchi T, 1997, NATURE, V390, P91, DOI 10.1038/36369; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; Zwick E, 1997, J BIOL CHEM, V272, P24767, DOI 10.1074/jbc.272.40.24767	46	129	132	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23110	23117		10.1074/jbc.273.36.23110	http://dx.doi.org/10.1074/jbc.273.36.23110			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722539	hybrid			2022-12-27	WOS:000075778100039
J	Xiao, H; Jeang, KT				Xiao, H; Jeang, KT			Glutamine-rich domains activate transcription in yeast Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; GENE-EXPRESSION; FUNCTIONAL DISSECTION; UPSTREAM ACTIVATOR; MAMMALIAN-CELLS; PHO5 PROMOTER; IN-VIVO; SP1; SEQUENCE; RECRUITMENT	Activation domains of eukaryotic transcription factors can be classified into at least three distinct types based on their amino acid composition: acidic, proline-rich, and glutamine-rich, Acidic activators, such as yeast GAL4 and GCN4 and herpes simplex virus VP16, have been shown to stimulate transcription in various higher and lower eukaryotic cells. Similarly, proline-rich activators also function in both mammalian and yeast cells. These activators are regarded to possess "universal" activating potentials. By contrast, several studies have suggested that glutamine-rich activators such as human Spl are active in higher (mammalian) but not lower (yeast) eukaryotic cells. One interpretation is that lower eukaryotic cells lack a critical cofactor necessary for a glutamine-rich domain. This reasoning is counter-intuitive because many native yeast activator proteins contain glutamine-rich domains. Here, we have investigated the activity of a glutamine-rich GAL4-Sp1 domain A (Sp1A) hybrid protein in yeast Saccharomyces cerevisiae. We show that GAL4-Sp1A activated a GAL1-lacZ reporter by more than 200-fold over basal when the reporter was carried on a 2 mu vector. The generality of the Sp1A results is supported by our finding that yeast glutamine-rich domains from HAP2 and MCM1 are also transcriptionally active in S. cerevisiae, Interestingly, we found that glutamine-rich domains are considerably less potent when responsive promoters (i.e. GAL1-lacZ) are integrated into yeast chromosome. Thus our results segregate the inherent transcriptional activity of a glutamine-rich domain in yeast S, cerevisiae from its apparent lack of activity when assayed on chromosomally embedded promoters.	NIAID, Mol Virol Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Xiao, H (corresponding author), NIAID, Mol Virol Sect, Mol Microbiol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	hxiao@atlas.niaid.nih.gov	Jeang, Kuan-Teh/A-2424-2008					Ausubel FM, 1994, CURRENT PROTOCOLS MO; BECKER DM, 1991, P NATL ACAD SCI USA, V88, P1968, DOI 10.1073/pnas.88.5.1968; Blau J, 1996, MOL CELL BIOL, V16, P2044; CHOY B, 1993, NATURE, V366, P531, DOI 10.1038/366531a0; Chun RF, 1998, J VIROL, V72, P2615, DOI 10.1128/JVI.72.4.2615-2629.1998; EMILI A, 1994, MOL CELL BIOL, V14, P1582, DOI 10.1128/MCB.14.3.1582; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; GILL G, 1987, CELL, V51, P121, DOI 10.1016/0092-8674(87)90016-X; HILL J, 1991, NUCLEIC ACIDS RES, V19, P5791, DOI 10.1093/nar/19.20.5791; JEANG KT, 1993, J VIROL, V67, P6224, DOI 10.1128/JVI.67.10.6224-6233.1993; KAKIDANI H, 1988, CELL, V52, P161, DOI 10.1016/0092-8674(88)90504-1; KIM TK, 1993, J BIOL CHEM, V268, P20866; KINGSTON RE, 1994, CURR BIOL, V4, P325, DOI 10.1016/S0960-9822(00)00071-3; KUNZLER M, 1994, EMBO J, V13, P641, DOI 10.1002/j.1460-2075.1994.tb06302.x; MA J, 1988, NATURE, V334, P631, DOI 10.1038/334631a0; Majello B, 1998, J BIOL CHEM, V273, P16509, DOI 10.1074/jbc.273.26.16509; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Moqtaderi Z, 1996, NATURE, V383, P188, DOI 10.1038/383188a0; NAKAO J, 1986, MOL CELL BIOL, V6, P2613, DOI 10.1128/MCB.6.7.2613; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; PASSMORE S, 1988, J MOL BIOL, V204, P593, DOI 10.1016/0022-2836(88)90358-0; PFEIFER K, 1989, CELL, V56, P291, DOI 10.1016/0092-8674(89)90903-3; PINKHAM JL, 1987, MOL CELL BIOL, V7, P578, DOI 10.1128/MCB.7.2.578; PONTICELLI AS, 1995, MOL CELL BIOL, V15, P983; PTASHNE M, 1990, NATURE, V346, P329, DOI 10.1038/346329a0; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; RUDOLPH H, 1987, P NATL ACAD SCI USA, V84, P1340, DOI 10.1073/pnas.84.5.1340; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCAFE C, 1990, NATURE, V347, P491, DOI 10.1038/347491a0; SENGSTAG C, 1987, NUCLEIC ACIDS RES, V15, P233, DOI 10.1093/nar/15.1.233; STRUHL K, 1989, ANNU REV BIOCHEM, V58, P1051, DOI 10.1146/annurev.bi.58.070189.005155; STRUHL K, 1981, J MOL BIOL, V152, P569, DOI 10.1016/0022-2836(81)90269-2; STRUHL K, 1982, COLD SPRING HARB SYM, V47, P901, DOI 10.1101/SQB.1983.047.01.104; SUZUKI Y, 1988, MOL CELL BIOL, V8, P4991, DOI 10.1128/MCB.8.11.4991; TANSEY WP, 1994, GENE DEV, V8, P2756, DOI 10.1101/gad.8.22.2756; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; TRIEZENBERG SJ, 1988, GENE DEV, V2, P718, DOI 10.1101/gad.2.6.718; Walker SS, 1996, NATURE, V383, P185, DOI 10.1038/383185a0; XIAO H, 1994, NUCLEIC ACIDS RES, V22, P1966, DOI 10.1093/nar/22.11.1966; XIAO H, 1995, MOL CELL BIOL, V15, P5757; Xiao H, 1997, MOL CELL BIOL, V17, P6898, DOI 10.1128/MCB.17.12.6898; XIAO H, 1989, NATURE HEAT SHOCK RE	45	41	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					22873	22876		10.1074/jbc.273.36.22873	http://dx.doi.org/10.1074/jbc.273.36.22873			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722505	hybrid			2022-12-27	WOS:000075778100005
J	Ketchum, CJ; Nakamoto, RK				Ketchum, CJ; Nakamoto, RK			A mutation in the Escherichia coli F0F1-ATP synthase rotor, gamma E208K, perturbs conformational coupling between transport and catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F1F0 ATP SYNTHASE; TRANSLOCATING ADENOSINE-TRIPHOSPHATASE; POLAR LOOP REGION; SUBUNIT-C; EPSILON-SUBUNIT; GAMMA-SUBUNIT; H+-ATPASE; BETA-SUBUNIT; F-0 PARTS; F1-ATPASE	Cross-Linking studies on the Escherichia coli F0F1-ATP synthase indicated a site of interaction involving gamma and epsilon subunits in F-1 and subunit c in F-0 (Watts, S. D., Tang, C., and Capaldi, R. A. (1996) J. Biol. Chem. 271, 28341-28347), To assess the function of these interactions, we introduced random mutations in this region of the gamma subunit (gamma 194-213). One mutation, gamma Glu-208 to Lys (gamma E208K), caused a temperature-sensitive defect in oxidative phosphorylation-dependent growth. ATP hydrolytic rates of the gamma E208K F0F1 enzyme became increasingly uncoupled from H+ pumping above 28 degrees C. In contrast, Arrhenius plot of steady-state ATP hydrolysis of the mutant enzyme was Linear from 20 to 50 degrees C, Analysis of this plot revealed a significant increase in the activation energy of the catalytic transition state to a value very similar to soluble, epsilon subunit-inhibited F-1 and suggested that the mutation blocked normal release of epsilon inhibition of ATP hydrolytic activity upon binding of F-1 to F-0. The difference in temperature dependence suggested that the gamma E208K mutation perturbed release of inhibition via a different mechanism than it did energy coupling. Suppressor mutations in the polar loop of subunit c restored ATP-dependent H+ pumping and transition state thermodynamic parameters close to wild-type values indicating that interactions between gamma and c subunits mediate release of epsilon inhibition and communication of coupling information.	Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22906 USA	University of Virginia	Nakamoto, RK (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, POB 10011, Charlottesville, VA 22906 USA.				NIGMS NIH HHS [R01-GM50957, R01 GM050957] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050957] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; AlShawi MK, 1997, J BIOL CHEM, V272, P2300; ALSHAWI MK, 1992, BIOCHEMISTRY-US, V31, P878, DOI 10.1021/bi00118a033; AlShawi MK, 1997, BIOCHEMISTRY-US, V36, P12961, DOI 10.1021/bi971478r; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Cross RL, 1996, J BIOENERG BIOMEMBR, V28, P403, DOI 10.1007/BF02113981; DeckersHebestreit G, 1996, ANNU REV MICROBIOL, V50, P791, DOI 10.1146/annurev.micro.50.1.791; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DUNCAN TM, 1985, J BIOL CHEM, V260, P4901; DUNN SD, 1987, BIOCHEMISTRY-US, V26, P4488, DOI 10.1021/bi00388a047; Elston T, 1998, NATURE, V391, P510, DOI 10.1038/35185; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; FRAGA D, 1991, J BACTERIOL, V173, P2639, DOI 10.1128/jb.173.8.2639-2643.1991; FRAGA D, 1989, J BIOL CHEM, V264, P6797; FRAGA D, 1994, J BIOL CHEM, V269, P7532; FUTAI M, 1974, P NATL ACAD SCI USA, V71, P2725, DOI 10.1073/pnas.71.7.2725; GIRVIN ME, 1993, BIOCHEMISTRY-US, V32, P12167, DOI 10.1021/bi00096a029; GIRVIN ME, 1995, BIOCHEMISTRY-US, V34, P1635, DOI 10.1021/bi00005a020; GIRVIN ME, 1994, BIOCHEMISTRY-US, V33, P665, DOI 10.1021/bi00169a006; HERMOLIN J, 1989, J BIOL CHEM, V264, P3896; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; Kaibara C, 1996, J BIOL CHEM, V271, P2433, DOI 10.1074/jbc.271.5.2433; Ketchum CJ, 1998, BIOCHEM J, V330, P707; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; KUKI M, 1988, J BIOL CHEM, V263, P17437; Kuo PH, 1998, FEBS LETT, V426, P217, DOI 10.1016/S0014-5793(98)00337-8; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MILLER MJ, 1989, J BIOL CHEM, V264, P305; MORIYAMA Y, 1991, J BIOL CHEM, V266, P22141; NAKAMOTO RK, 1995, J BIOL CHEM, V270, P14042, DOI 10.1074/jbc.270.23.14042; Nakamoto RK, 1996, J MEMBRANE BIOL, V151, P101, DOI 10.1007/s002329900061; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SENIOR AE, 1990, ANNU REV BIOPHYS BIO, V19, P7; Shirakihara Y, 1997, STRUCTURE, V5, P825, DOI 10.1016/S0969-2126(97)00236-0; SMITH JB, 1977, BIOCHEMISTRY-US, V16, P306, DOI 10.1021/bi00621a023; STERNWEIS PC, 1980, BIOCHEMISTRY-US, V19, P526, DOI 10.1021/bi00544a021; TAKEYAMA M, 1990, J BIOL CHEM, V265, P21279; VIK SB, 1994, J BIOL CHEM, V269, P30364; Watts SD, 1997, J BIOL CHEM, V272, P15065, DOI 10.1074/jbc.272.24.15065; WATTS SD, 1995, FEBS LETT, V368, P235, DOI 10.1016/0014-5793(95)00658-V; Watts SD, 1996, J BIOL CHEM, V271, P28341, DOI 10.1074/jbc.271.45.28341; WILKENS S, 1995, NAT STRUCT BIOL, V2, P961, DOI 10.1038/nsb1195-961; XIONG H, 1995, J BIOL CHEM, V270, P23300, DOI 10.1074/jbc.270.40.23300; ZHANG Y, 1995, J BIOL CHEM, V270, P24609, DOI 10.1074/jbc.270.41.24609; ZHANG Y, 1994, J BIOL CHEM, V269, P10221; [No title captured]	48	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22292	22297		10.1074/jbc.273.35.22292	http://dx.doi.org/10.1074/jbc.273.35.22292			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712846	hybrid			2022-12-27	WOS:000075616600022
J	Pohl, E; Holmes, RK; Hol, WGJ				Pohl, E; Holmes, RK; Hol, WGJ			Motion of the DNA-binding domain with respect to the core of the diphtheria toxin repressor (DtxR) revealed in the crystal structures of apo- and holo-DtxR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE R-VALUE; CORYNEBACTERIUM-DIPHTHERIAE; SEQUENCE-ANALYSIS; MET REPRESSOR; IRON; PROTEIN; IDENTIFICATION; ACTIVATION; CLONING; HOMOLOG	The diphtheria toxin repressor (DtxR) from Corynebacterium diphtheriae is a divalent metal-activated repressor of chromosomal genes that encode proteins responsible for siderophore-mediated iron uptake and also of the gene of certain corynebacteriophages that encodes diphtheria toxin. DtxR consists of two 25.3-kDa three-domain subunits and is a member of a family of related repressor proteins in several Gram-positive bacterial species, some of which are important human pathogens. In this paper, we report on the first high resolution crystal structures of apo-DtxR in two related space groups. In addition, crystal structures of Zn-DtxR were determined in the same two space groups. The resolutions of the structures range from 2.2 to 2.4 Angstrom. The four refined models of the apo- and the hoIo-repressor exhibit quite similar metal binding centers, which do, however, show higher thermal motion in the ape-structures. All four structures reported differ from each other in one important aspect. The N-terminal DNA-binding domain and the last 20 residues of the dimerization domain of each subunit move significantly with respect to the core of the DtxR dimer, which consists of residues 74-120 from both subunits. These results provide the first indication of a conformational change that may occur upon binding of the hole-repressor to DNA.	Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Biomol Struct Ctr, Seattle, WA 98195 USA; Univ Colorado, Hlth Sci Ctr, Dept Microbiol, Denver, CO 80262 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Hol, WGJ (corresponding author), Univ Washington, Howard Hughes Med Inst, Hlth Sci Bldg,Rm K-428,Box 357742, Seattle, WA 98195 USA.		Pohl, Ehmke/I-2408-2012	Pohl, Ehmke/0000-0002-9949-4471	NCI NIH HHS [R01CA65656] Funding Source: Medline; NIAID NIH HHS [R01AI4107] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA065656] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Ding X, 1996, NAT STRUCT BIOL, V3, P382, DOI 10.1038/nsb0496-382; DOUKHAN L, 1995, GENE, V165, P67, DOI 10.1016/0378-1119(95)00427-8; GUNTERSEEBOTH K, 1995, GENE, V166, P117, DOI 10.1016/0378-1119(95)00628-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lee JH, 1997, INFECT IMMUN, V65, P4273, DOI 10.1128/IAI.65.10.4273-4280.1997; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; OGUIZA JA, 1995, J BACTERIOL, V177, P465, DOI 10.1128/jb.177.2.465-467.1995; OTWINOWSKI Z, 1993, P CCP4 STUD WEEK COL; PAPPENHEIMER AM, 1977, ANNU REV BIOCHEM, V46, P69, DOI 10.1146/annurev.bi.46.070177.000441; PHILLIPS K, 1994, STRUCTURE, V2, P309, DOI 10.1016/S0969-2126(00)00032-0; Pohl E, 1997, PROTEIN SCI, V6, P1114, DOI 10.1002/pro.5560060519; Qiu XY, 1996, BIOCHEMISTRY-US, V35, P12292, DOI 10.1021/bi960861d; QIU XY, 1995, STRUCTURE, V3, P87, DOI 10.1016/S0969-2126(01)00137-X; RAFFERTY JB, 1989, NATURE, V341, P705, DOI 10.1038/341705a0; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; SCHIERING N, 1995, P NATL ACAD SCI USA, V92, P9843, DOI 10.1073/pnas.92.21.9843; Schmidt F.L., 1992, CURRENT DIRECTIONS P, V1, P89, DOI [DOI 10.1111/1467-8721.EP10768758, 10.1111/1467-8721.ep10768758]; SCHMITT MP, 1993, MOL MICROBIOL, V9, P173, DOI 10.1111/j.1365-2958.1993.tb01679.x; SCHMITT MP, 1991, INFECT IMMUN, V59, P1899, DOI 10.1128/IAI.59.6.1899-1904.1991; Schmitt MP, 1997, INFECT IMMUN, V65, P4634, DOI 10.1128/IAI.65.11.4634-4641.1997; Schmitt MP, 1997, INFECT IMMUN, V65, P5364, DOI 10.1128/IAI.65.12.5364-5367.1997; SCHMITT MP, 1995, INFECT IMMUN, V63, P4284, DOI 10.1128/IAI.63.11.4284-4289.1995; SCHMITT MP, 1994, J BACTERIOL, V176, P1141, DOI 10.1128/JB.176.4.1141-1149.1994; SOMERS WS, 1992, NATURE, V359, P387, DOI 10.1038/359387a0; STOJILJKOVIC I, 1994, J MOL BIOL, V236, P531, DOI 10.1006/jmbi.1994.1163; TAO X, 1993, P NATL ACAD SCI USA, V90, P8524, DOI 10.1073/pnas.90.18.8524; TENG TY, 1990, J APPL CRYSTALLOGR, V23, P387, DOI 10.1107/S0021889890005568; WEINBERG ED, 1993, PERSPECT BIOL MED, V36, P215; XU T, 1992, J BIOL CHEM, V267, P21761; ZHANG XJ, 1995, J APPL CRYSTALLOGR, V28, P624, DOI 10.1107/S0021889895001063; 1994, ACTA CRYSTALLOGR, V50, P760	37	49	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22420	22427		10.1074/jbc.273.35.22420	http://dx.doi.org/10.1074/jbc.273.35.22420			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712865	hybrid			2022-12-27	WOS:000075616600041
J	Ugarova, TP; Solovjov, DAS; Zhang, L; Loukinov, DI; Yee, VC; Medved, LV; Plow, EF				Ugarova, TP; Solovjov, DAS; Zhang, L; Loukinov, DI; Yee, VC; Medved, LV; Plow, EF			Identification of a novel recognition sequence for integrin alpha(M)beta(2) within the gamma-chain of fibrinogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL INHIBITORY FACTOR; MAC-1 CD11B CD18; MONOCLONAL-ANTIBODIES; I-DOMAIN; LEUKOCYTE ADHESION; PLASMA FIBRONECTIN; BINDING-SITE; RECEPTOR; FIBRIN(OGEN); GLYCOPROTEIN	The interaction of leukocyte integrin alpha(M)beta(2) (CD11b/CD18, Mac-1) with fibrinogen has been implicated in the inflammatory response by contributing to leukocyte adhesion to the endothelium and subsequent transmigration. Previously, it has been demonstrated that a peptide, P1, corresponding to residues 190-202 in the gamma-chain of fibrinogen, binds to alpha(M)beta(2) and blocks the interaction of fibrinogen with the receptor and that Asp(199) within P1 is important to activity. We have demonstrated, however, that a double mutation of Asp(199)-Gly(200) to Gly-Ala in the recombinant gamma-module of fibrinogen, spanning region 148-411, did not abrogate alpha(M)beta(2) recognition and considered that other binding sites in the gamma-module may participate in the receptor recognition. We have found that synthetic peptide P2, duplicating gamma 377-395, inhibited adhesion of alpha(M)beta(2)-transfected cells to immobilized D-100 fragment of fibrinogen in a dose-dependent manner. In addition, immobilized Pa directly supported efficient adhesion of the alpha(M)beta(2)-expressing cells, including activated and non-activated monocytoid cells. The I domain of alpha(M)beta(2) was implicated in recognition of P2, as the biotinylated recombinant alpha(M)I domain specifically bound to both P2 and P1 peptides, Analysis of overlapping peptides spanning P2 demonstrated that it may contain two functional sequences: gamma 377-386 (P2-N) and gamma 383-395 (P2-C), with the latter sequence being more active. In the three-dimensional structure of the gamma-module, gamma 190-202 and gamma 377-395 reside in close proximity, forming two antiparallel beta strands. The juxtapositioning of these two sequences may form an unique and complex binding site for alpha(M)beta(2).	Cleveland Clin Fdn, Dept Mol Cardiol, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Cleveland, OH 44195 USA; Amer Red Cross, Jerome H Holland Lab, Rockville, MD 20855 USA	Cleveland Clinic Foundation; American Red Cross	Ugarova, TP (corresponding author), Cleveland Clin Fdn, Dept Mol Cardiol, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Cleveland, OH 44195 USA.			Medved, Leonid/0000-0002-3665-9849	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054924, R01HL056051] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-54924, HL-56051, R01 HL056051] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTIERI DC, 1993, J BIOL CHEM, V268, P1847; ALTIERI DC, 1988, J CELL BIOL, V107, P1893, DOI 10.1083/jcb.107.5.1893; ALTIERI DC, 1990, J BIOL CHEM, V265, P12119; AMAOUT MA, 1990, BLOOD, V75, P1037; AOTA S, 1994, J BIOL CHEM, V269, P24756; BINI A, 1989, ARTERIOSCLEROSIS, V9, P109, DOI 10.1161/01.ATV.9.1.109; DANA N, 1986, J IMMUNOL, V137, P3259; DIAMOND MS, 1993, J CELL BIOL, V120, P1031, DOI 10.1083/jcb.120.4.1031; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; GRESHAM HD, 1989, J CELL BIOL, V108, P1935, DOI 10.1083/jcb.108.5.1935; GUSTAFSON EJ, 1989, J CELL BIOL, V109, P377, DOI 10.1083/jcb.109.1.377; HUMPHRIES MJ, 1987, J BIOL CHEM, V262, P6886; IIDA J, 1992, J CELL BIOL, V118, P431, DOI 10.1083/jcb.118.2.431; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LANGUINO LR, 1995, P NATL ACAD SCI USA, V92, P1505, DOI 10.1073/pnas.92.5.1505; LANGUINO LR, 1993, CELL, V73, P1423, DOI 10.1016/0092-8674(93)90367-Y; LOIKE JD, 1991, P NATL ACAD SCI USA, V88, P1044, DOI 10.1073/pnas.88.3.1044; Medved L, 1997, BIOCHEMISTRY-US, V36, P4685, DOI 10.1021/bi962795l; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MOULD AP, 1991, EMBO J, V10, P4089, DOI 10.1002/j.1460-2075.1991.tb04985.x; MOYLE M, 1994, J BIOL CHEM, V269, P10008; MUCHOWSKI PJ, 1994, J BIOL CHEM, V269, P26419; PLOW EF, 1987, BIOCHEM PHARMACOL, V36, P4035, DOI 10.1016/0006-2952(87)90558-2; PLOW EF, 1981, J BIOL CHEM, V256, P9477; PROCYK R, 1991, BLOOD, V77, P1469; SHATTIL SJ, 1987, BLOOD, V70, P307; SIMON DI, 1993, BLOOD, V82, P2414; Spraggon G, 1997, NATURE, V389, P455, DOI 10.1038/38947; Sriramarao P, 1996, BLOOD, V88, P3416, DOI 10.1182/blood.V88.9.3416.bloodjournal8893416; TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147; Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549; UGAROVA TP, 1992, J BIOL CHEM, V267, P13687; VALENZUELA R, 1992, AM J PATHOL, V141, P861; WRIGHT SD, 1983, P NATL ACAD SCI-BIOL, V80, P5699, DOI 10.1073/pnas.80.18.5699; Yee VC, 1997, STRUCTURE, V5, P125, DOI 10.1016/S0969-2126(97)00171-8; ZAMARRON C, 1991, J BIOL CHEM, V266, P16193; Zhang L, 1997, J BIOL CHEM, V272, P17558, DOI 10.1074/jbc.272.28.17558; Zhang L, 1996, J BIOL CHEM, V271, P18211, DOI 10.1074/jbc.271.30.18211; ZHOU LB, 1994, J BIOL CHEM, V269, P17075	39	134	138	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22519	22527		10.1074/jbc.273.35.22519	http://dx.doi.org/10.1074/jbc.273.35.22519			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712878	hybrid			2022-12-27	WOS:000075616600054
J	Contreres, JO; Faure, R; Baquiran, G; Bergeron, JJ; Posner, BI				Contreres, JO; Faure, R; Baquiran, G; Bergeron, JJ; Posner, BI			ATP-dependent desensitization of insulin binding and tyrosine kinase activity of the insulin receptor kinase - The role of endosomal acidification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER; DIABETES-MELLITUS; SIGNAL-TRANSDUCTION; AFRICAN CHILDREN; CHLOROQUINE; DEGRADATION; ACTIVATION; INVIVO; INTERNALIZATION; PROTEIN	Incubating endosomes with ATP decreased binding of I-125-insulin but not I-125-labeled human growth hormone. Increasing ATP concentrations from 0.1 to 1 mM increased P-subunit tyrosine phosphorylation and insulin receptor kinase (IRK) activity assayed after partial purification. At higher (5 mM) ATP concentrations P-subunit tyrosine phosphorylation and IRK activity were markedly decreased. This was not observed with nonhydrolyzable analogs of ATP, nor with plasma membrane IRK, nor with endosomal epidermal growth factor receptor kinase autophosphorylation. The inhibition of endosomal IRK tyrosine phosphorylation and activity was completely reversed by bafilomycin A(1), indicating a role for endosomal proton pump(s), The inhibition of IRK was not due to serine/threonine phosphorylation nor was it influenced by the inhibition of phosphotyrosyl phosphatase using bisperoxo(1,10-phenanthroline)oxovanadate anion, Prior phosphorylation of the beta-subunit with 1 mM ATP did not prevent the inhibition of IRK activity on incubating with 5 mM ATP, To evaluate conformational change we incubated endosomes with dithiothreitol (DTT) followed by SDS-polyacrylamide gel electrophoresis under nonreducing conditions. Without DTT the predominant species of IRK observed was alpha(2)beta(2). With DTT the alpha beta dimer predominated but on co-incubation with 5 mM ATP the alpha(2)beta(2) form predominated. Thus, ATP-dependent endosomal acidification contributes to the termination of transmembrane signaling by, among other processes, effecting a deactivating conformational change of the IRK.	McGill Univ, Polypeptide Hormone Lab, Montreal, PQ, Canada; McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada; Univ Laval, CHUL, Dept Med, Quebec City, PQ G1V 4G2, Canada; Univ Laval, CHUL, Ctr Rech, Quebec City, PQ G1V 4G2, Canada	McGill University; McGill University; Laval University; Laval University	Posner, BI (corresponding author), McGill Univ, Polypeptide Hormone Lab, Strathcona Anat & Dent Bdg,3640 Univ St,Rm W315, Montreal, PQ, Canada.	mc85@musica.mcgill.ca	Posner, Barry/B-6733-2008; Bergeron, John/AAW-1893-2021					ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; AUTHIER F, 1994, J BIOL CHEM, V269, P3010; AUTHIER F, 1994, CELLULAR PROTEOLYTIC, P89; BAASS PC, 1995, TRENDS CELL BIOL, V5, P465, DOI 10.1016/S0962-8924(00)89116-3; BACKER JM, 1990, J BIOL CHEM, V265, P14828; BERGERON JJM, 1986, BIOCHEMISTRY-US, V25, P1756, DOI 10.1021/bi00355a046; BERGERON JJM, 1982, J CELL BIOL, V92, P139, DOI 10.1083/jcb.92.1.139; Bevan AP, 1996, TRENDS ENDOCRIN MET, V7, P13, DOI 10.1016/1043-2760(95)00179-4; Bevan AP, 1997, J BIOL CHEM, V272, P26833, DOI 10.1074/jbc.272.43.26833; BEVAN AP, 1995, J BIOL CHEM, V270, P10784, DOI 10.1074/jbc.270.18.10784; BLAZAR BR, 1984, DIABETES, V33, P1133, DOI 10.2337/diabetes.33.12.1133; BONISCHNETZLER M, 1988, J BIOL CHEM, V263, P6822; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BURGESS JW, 1992, J BIOL CHEM, V267, P10077; BURGESS JW, 1992, EXP CLIN ENDOCRINOL, V11, P67; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; Courtoy P J, 1993, Subcell Biochem, V19, P29; DESBUQUOIS B, 1990, EUR J BIOCHEM, V193, P501, DOI 10.1111/j.1432-1033.1990.tb19365.x; DOHERTY JJ, 1990, J CELL BIOL, V110, P35, DOI 10.1083/jcb.110.1.35; DURRER P, 1995, J BIOL CHEM, V270, P17575, DOI 10.1074/jbc.270.29.17575; FUCHS R, 1989, P NATL ACAD SCI USA, V86, P539, DOI 10.1073/pnas.86.2.539; GALLOWAY CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3334, DOI 10.1073/pnas.80.11.3334; GAUDIN Y, 1993, J VIROL, V67, P1365, DOI 10.1128/JVI.67.3.1365-1372.1993; HAMEL FG, 1988, J BIOL CHEM, V263, P6703; HOPKINS CR, 1990, NATURE, V346, P335, DOI 10.1038/346335a0; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; ILARDE A, 1994, DRUG AGING, V4, P470, DOI 10.2165/00002512-199404060-00004; KAY DG, 1986, J BIOL CHEM, V261, P8473; KHAN MN, 1986, J BIOL CHEM, V261, P8462; KHAN MN, 1989, J BIOL CHEM, V264, P12931; KHAN MN, 1985, DIABETES, V34, P1025, DOI 10.2337/diabetes.34.10.1025; Krueger KM, 1997, J BIOL CHEM, V272, P5; KUBLAOUI B, 1995, J BIOL CHEM, V270, P59, DOI 10.1074/jbc.270.1.59; LAI WH, 1989, J CELL BIOL, V109, P2741, DOI 10.1083/jcb.109.6.2741; LEE JS, 1994, AM J PHYSIOL, V266, pC319, DOI 10.1152/ajpcell.1994.266.2.C319; LEVY JR, 1988, J BIOL CHEM, V263, P6101; LEWIS RE, 1994, J BIOL CHEM, V269, P26259; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; MEYER RA, 1982, AM J PHYSIOL, V242, pC1, DOI 10.1152/ajpcell.1982.242.1.C1; MILLER DS, 1986, J BIOL CHEM, V261, P13911; MYERS MG, 1993, DIABETES, V42, P643, DOI 10.2337/diabetes.42.5.643; PAPINI E, 1993, J BIOL CHEM, V268, P1567; PASVOL G, 1991, AM J TROP MED HYG, V45, P702, DOI 10.4269/ajtmh.1991.45.702; POSNER BI, 1980, J BIOL CHEM, V255, P735; POSNER BI, 1994, J BIOL CHEM, V269, P4596; POSNER BI, 1982, J BIOL CHEM, V257, P5789; POWRIE JK, 1991, AM J PHYSIOL, V260, pE897, DOI 10.1152/ajpendo.1991.260.6.E897; QUATRARO A, 1988, DIABETES METAB, V14, P666; ROSEN OM, 1987, SCIENCE, V237, P1452, DOI 10.1126/science.2442814; SASAOKA T, 1994, J BIOL CHEM, V269, P10734; SMITH GD, 1987, BRIT MED J, V294, P465, DOI 10.1136/bmj.294.6570.465; STADTMAUER L, 1986, J BIOL CHEM, V261, P3402; SUSSMAN I, 1980, BIOCHIM BIOPHYS ACTA, V591, P209, DOI 10.1016/0005-2728(80)90153-X; TAKAYAMA S, 1988, J BIOL CHEM, V263, P3440; TOBE K, 1995, J BIOL CHEM, V270, P5698, DOI 10.1074/jbc.270.11.5698; TRISCHITTA V, 1984, METABOLISM, V33, P577, DOI 10.1016/0026-0495(84)90015-5; WEI L, 1995, J BIOL CHEM, V270, P8122, DOI 10.1074/jbc.270.14.8122; WHITE NJ, 1987, LANCET, V1, P708	58	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					22007	22013		10.1074/jbc.273.34.22007	http://dx.doi.org/10.1074/jbc.273.34.22007			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705342	hybrid			2022-12-27	WOS:000075492600076
J	Bertram, JG; Bloom, LB; Turner, J; O'Donnell, M; Beechem, JM; Goodman, MF				Bertram, JG; Bloom, LB; Turner, J; O'Donnell, M; Beechem, JM; Goodman, MF			Pre-steady state analysis of the assembly of wild type and mutant circular clamps of Escherichia coli DNA polymerase III onto DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACCESSORY PROTEINS; FLUORESCENCE ANISOTROPY; REPLICATION MACHINE; INITIATION COMPLEX; ATP ACTIVATION; HOLOENZYME; SUBUNIT; IDENTIFICATION; PURIFICATION; MECHANISM	The beta protein, a dimeric ring-shaped clamp essential for processive DNA replication by Escherichia coli DNA polymerase III holoenzyme, is assembled onto DNA by the gamma complex. This study examines the clamp loading pathway in real time, using pre-steady state fluorescent depolarization measurements to investigate the loading reaction and ATP requirements for the assembly of beta onto DNA. Two beta dimer interface mutants, L273A and L108A, and a nonhydrolyzable ATP analog, adenosine 5'-O-(3-thiotriphosphate) (ATP gamma S), have been used to show that ATP binding is required for gamma complex and beta to associate with DNA, but that a gamma complex-catalyzed ATP hydrolysis is required for gamma complex to release the beta DNA complex and complete the reaction. In the presence of ATP and gamma complex, the beta mutants associate with DNA as efficiently as wild type beta. However, completion of the reaction is much slower with the beta mutants because of decreased ATP hydrolysis by the gamma complex, resulting in a much slower release of the mutants onto DNA. The effects of mutations in the dimer interface were similar to the effects of replacing ATP with ATP gamma S in reactions using wild type beta. Thus, the assembly of beta around DNA is coupled tightly to the ATPase activity of the gamma complex, and completion of the assembly process requires ATP hydrolysis for turnover of the catalytic clamp loader.	Univ So Calif, Dept Biol Sci, Hedco Mol Biol Labs, Los Angeles, CA 90089 USA; Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; Rockefeller Univ, New York, NY 10021 USA; Howard Hughes Med Inst, New York, NY 10021 USA; Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	University of Southern California; Arizona State University; Arizona State University-Tempe; Rockefeller University; Howard Hughes Medical Institute; Vanderbilt University	Goodman, MF (corresponding author), Univ So Calif, Dept Biol Sci, Hedco Mol Biol Labs, Los Angeles, CA 90089 USA.		Bloom, Linda B/F-3684-2014		NIGMS NIH HHS [GM38839, GM21422, GM42554] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038839, R37GM021422, R01GM021422, R37GM038839, R01GM042554] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bloom LB, 1996, J BIOL CHEM, V271, P30699, DOI 10.1074/jbc.271.48.30699; BURGERS PMJ, 1982, J BIOL CHEM, V257, P1474; BURGERS PMJ, 1982, J BIOL CHEM, V257, P1468; DIFRANCESCO R, 1984, J BIOL CHEM, V259, P5567; DONG ZM, 1993, J BIOL CHEM, V268, P11758; FAY PJ, 1981, J BIOL CHEM, V256, P976; Heyduk T, 1996, METHOD ENZYMOL, V274, P492; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; KELMAN Z, 1995, ANNU REV BIOCHEM, V64, P171, DOI 10.1146/annurev.bi.64.070195.001131; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Lakowicz J.R., 1983, PRINCIPLES FLUORESCE, P145; LETILLY V, 1993, BIOCHEMISTRY-US, V32, P7753, DOI 10.1021/bi00081a021; MAKI H, 1985, J BIOL CHEM, V260, P2987; MAKI S, 1988, J BIOL CHEM, V263, P6555; MCHENRY CS, 1991, J BIOL CHEM, V266, P19127; MCHENRY CS, 1979, J BIOL CHEM, V254, P1748; Naktinis V, 1996, CELL, V84, P137, DOI 10.1016/S0092-8674(00)81000-4; ONRUST R, 1993, J BIOL CHEM, V268, P11766; ONRUST R, 1991, J BIOL CHEM, V266, P21681; ONRUST R, 1995, J BIOL CHEM, V270, P13348, DOI 10.1074/jbc.270.22.13348; OTTO MR, 1994, BIOPHYS J, V67, P2511, DOI 10.1016/S0006-3495(94)80741-6; PEREZHOWARD GM, 1995, BIOCHEMISTRY-US, V34, P8005, DOI 10.1021/bi00025a006; SCHEUERMANN R, 1983, P NATL ACAD SCI-BIOL, V80, P7085, DOI 10.1073/pnas.80.23.7085; STUDWELL PS, 1990, J BIOL CHEM, V265, P1171; STUDWELLVAUGHAN PS, 1993, J BIOL CHEM, V268, P11785; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; XIAO H, 1993, J BIOL CHEM, V268, P11773	27	47	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24564	24574		10.1074/jbc.273.38.24564	http://dx.doi.org/10.1074/jbc.273.38.24564			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733751	hybrid			2022-12-27	WOS:000076007300043
J	Cheng, ZJ; Yu, QM; Wu, YL; Ma, L; Pei, G				Cheng, ZJ; Yu, QM; Wu, YL; Ma, L; Pei, G			Selective interference of beta-arrestin 1 with kappa and delta but not mu opioid receptor G protein coupling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGONIST-INDUCED DESENSITIZATION; KINASE-C; HOMOLOGOUS DESENSITIZATION; BETA(2)-ADRENERGIC RECEPTOR; SYNERGISTIC REGULATION; CARBOXYL-TERMINUS; XENOPUS OOCYTES; PHOSPHORYLATION; INVOLVEMENT; MORPHINE	The role of beta-arrestin 1 (beta-arr1) in regulation of responsiveness of kappa, delta, and mu opioid receptors has been investigated in human embryonic kidney 293 cells cotransfected with opioid receptor and beta-arr1. Expression of human beta-arr1 attenuated kappa and delta opioid receptor subtype-mediated inhibition of cAMP production and resulted in a 100-fold increase of EC50 values for kappa-agonist U69593 and delta-agonist [D-Pen(2),D-Pen(5)]enkephalin and 30-40% reduction of their maximal responses. In contrast, coexpression of beta-arr1 with mu opioid receptor did not affect the concentration-effect relationship of mu-agonist [D-Ala(2),N-Me-Phe(4),Gly(5)-ol]enkephalin. In parallel, kappa and delta receptor-mediated G protein activation was also remarkably attenuated by overexpression of beta-arr1, while the mu-agonist-stimulated response remained intact. These results indicate that beta-arr1 interferes receptor/G protein coupling and differentially regulates the responsiveness of opioid receptors, Truncation of kappa and delta opioid receptors at carboxyl termini abolished inhibition of beta-arr1 on the responsiveness of both receptors. Furthermore, mu opioid receptor became sensitive to beta-arr1 regulation following replacement of its carboxyl terminus with the corresponding portion of the delta receptor, Removal of potential phosphorylation sites on the carboxyl terminus of kappa opioid receptor led to reduced effect of beta-arr1 on the receptor-mediated response, These results suggest that receptor carboxyl terminus and its phosphorylation play an important role in the interaction of beta-arr1 and opioid receptors.	Chinese Acad Sci, Shanghai Inst Cell Biol, Shanghai 200031, Peoples R China; Shanghai Med Univ, Natl Lab Med Neurobiol, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University	Ma, L (corresponding author), Chinese Acad Sci, Shanghai Inst Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	gangpei@sunm.shcnc.ac.cn	Ma, Lan/B-9295-2009	Ma, Lan/0000-0001-9034-5472				Appleyard SM, 1997, J NEUROCHEM, V69, P2405; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Cai YC, 1996, BIOCHEM BIOPH RES CO, V219, P342, DOI 10.1006/bbrc.1996.0235; CHAKRABARTI S, 1995, MOL BRAIN RES, V30, P269, DOI 10.1016/0169-328X(95)00014-J; CHEN Y, 1994, J BIOL CHEM, V269, P7839; Cheng ZJ, 1997, NEUROREPORT, V8, P1913, DOI 10.1097/00001756-199705260-00024; CRAFT CM, 1994, J BIOL CHEM, V269, P4613; DIDSBURY JR, 1991, P NATL ACAD SCI USA, V88, P11564, DOI 10.1073/pnas.88.24.11564; Diviani D, 1996, J BIOL CHEM, V271, P5049; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; FREEDMAN NJ, 1995, J BIOL CHEM, V270, P17953, DOI 10.1074/jbc.270.30.17953; FUKUSHIMA N, 1994, NEUROSCI LETT, V176, P55, DOI 10.1016/0304-3940(94)90870-2; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147; Kovoor A, 1997, J BIOL CHEM, V272, P27605, DOI 10.1074/jbc.272.44.27605; KUHN H, 1978, BIOCHEMISTRY-US, V17, P4389; LOHSE MJ, 1992, J BIOL CHEM, V267, P8558; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Menard L, 1997, MOL PHARMACOL, V51, P800, DOI 10.1124/mol.51.5.800; MURAKAMI A, 1993, FEBS LETT, V334, P203, DOI 10.1016/0014-5793(93)81712-9; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; Noble F, 1996, BRIT J PHARMACOL, V117, P161, DOI 10.1111/j.1476-5381.1996.tb15169.x; Pak Y, 1997, J BIOL CHEM, V272, P24961, DOI 10.1074/jbc.272.40.24961; PEI G, 1995, MOL PHARMACOL, V48, P173; PIPPIG S, 1993, J BIOL CHEM, V268, P3201; PREMONT RT, 1995, FASEB J, V9, P175, DOI 10.1096/fasebj.9.2.7781920; RAPOPORT B, 1992, MOL CELL ENDOCRINOL, V84, pR39, DOI 10.1016/0303-7207(92)90038-8; RAYNOR K, 1994, J PHARMACOL EXP THER, V270, P1381; Schlador ML, 1997, J BIOL CHEM, V272, P18882, DOI 10.1074/jbc.272.30.18882; Schulz S, 1998, NEUROSCIENCE, V82, P613; SHINOHARA T, 1987, P NATL ACAD SCI USA, V84, P6975, DOI 10.1073/pnas.84.20.6975; Sim LJ, 1996, NEUROREPORT, V7, P729, DOI 10.1097/00001756-199602290-00012; SterneMarr R, 1995, VITAM HORM, V51, P193, DOI 10.1016/S0083-6729(08)61039-0; TERWILLIGER RZ, 1994, J NEUROCHEM, V63, P1983; Trapaidze N, 1996, J BIOL CHEM, V271, P29279, DOI 10.1074/jbc.271.46.29279; UEDA H, 1995, J NEUROSCI, V15, P7485; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; Zhang L, 1996, J BIOL CHEM, V271, P11449, DOI 10.1074/jbc.271.19.11449; Zhao J, 1997, BIOCHEM BIOPH RES CO, V238, P71, DOI 10.1006/bbrc.1997.7242; Zhu X, 1997, BIOCHEM BIOPH RES CO, V232, P513, DOI 10.1006/bbrc.1997.6324	43	64	64	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24328	24333		10.1074/jbc.273.38.24328	http://dx.doi.org/10.1074/jbc.273.38.24328			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733719	hybrid			2022-12-27	WOS:000076007300011
J	Gratacap, MP; Payrastre, B; Viala, C; Mauco, G; Plantavid, M; Chap, H				Gratacap, MP; Payrastre, B; Viala, C; Mauco, G; Plantavid, M; Chap, H			Phosphatidylinositol 3,4,5-trisphosphate-dependent stimulation of phospholipase C-gamma 2 is an early key event in Fc gamma RIIA-mediated activation of human platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHORYLATED PROTEINS; HUMAN BLOOD-PLATELETS; PHOSPHOINOSITIDE 3-KINASE; SIGNAL-TRANSDUCTION; CROSS-LINKING; C ISOZYMES; RECEPTOR; KINASE; THROMBIN; TRANSLOCATION	Platelets express a single class of Fc gamma receptor (Fc gamma RIIA), which is involved in heparin-associated thrombocytopenia and possibly in inflammation. Fc gamma RIIA cross-linking induces platelet secretion and aggregation, together with a number of cellular events such as tyrosine phosphorylation, activation of phospholipase C-gamma 2 (PLC-gamma 2), and calcium signaling. Here, we show that in response to Fc gamma RIIA cross-linking, phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)P-3) is rapidly produced, whereas phosphatidylinositol (3,4)bisphosphate accumulates more slowly, demonstrating a marked activation of phosphoinositide 3-kinase (PI 3-kinase). Inhibition of PI 3-kinase by wortmannin or LY294002 abolished platelet secretion and aggregation, as well as phospholipase C (PLC) activation, indicating a role of this lipid kinase in the early phase of platelet activation. Inhibition of PLC gamma 2 was not related to its tyrosine phosphorylation state, since wortmannin actually suppressed its dephosphorylation, which requires platelet aggregation and integrin alpha(IIb)/beta(3) engagement. In contrast, the stable association of PLC gamma 2 to the membrane/cytoskeleton interface observed at early stage of platelet activation was fully abolished upon inhibition of PI 3-kinase. In addition, PLC gamma 2 was able to preferentially interact in vitro with PtdIns(3,4,5)P-3. Finally, exogenous PtdIns(3,4,5)P-3 restored PLC activation in permeabilized platelets treated with wortmannin. We propose that PI 3-kinase and its product PtdIns(3,4,5)P-3 play a key role in the activation and adequate location of PLC gamma 2 induced by Fc gamma RIIA cross-linking.	Hop Purpan, Ctr Hosp Univ Toulouse, INSERM, U326, F-31059 Toulouse, France; Univ Toulouse 3, Inst Federat Rech Immunol Cellulaire & Mol, F-31059 Toulouse, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Payrastre, B (corresponding author), Hop Purpan, Ctr Hosp Univ Toulouse, INSERM, U326, F-31059 Toulouse, France.		Mauco, Gerard/A-3164-2016	Mauco, Gerard/0000-0003-2998-2397; , Bernard/0000-0002-8693-0190; Gratacap, Marie-Pierre/0000-0003-4362-6401				Agullo G, 1997, BIOCHEM PHARMACOL, V53, P1649, DOI 10.1016/S0006-2952(97)82453-7; ANDERSON CL, 1995, SEMIN THROMB HEMOST, V21, P1, DOI 10.1055/s-2007-1000374; ANDERSON GP, 1990, BLOOD, V76, P1165; Bae YS, 1998, J BIOL CHEM, V273, P4465, DOI 10.1074/jbc.273.8.4465; Balla T, 1997, J BIOL CHEM, V272, P18358, DOI 10.1074/jbc.272.29.18358; Banno Y, 1996, J BIOL CHEM, V271, P14989, DOI 10.1074/jbc.271.25.14989; Barker SA, 1998, MOL BIOL CELL, V9, P483, DOI 10.1091/mbc.9.2.483; BLAKE RA, 1994, FEBS LETT, V342, P15, DOI 10.1016/0014-5793(94)80575-X; BLAKE RA, 1994, FEBS LETT, V353, P212, DOI 10.1016/0014-5793(94)01037-4; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRISTOL JA, 1994, TRENDS ENDOCRIN MET, V5, P402, DOI 10.1016/1043-2760(95)92522-K; Buhl AM, 1997, J EXP MED, V186, P1897, DOI 10.1084/jem.186.11.1897; CAZENAVE JP, 1983, ANN BIOL CLIN-PARIS, V41, P167; CHACKO GW, 1994, J BIOL CHEM, V269, P32435; Chacko GW, 1996, J BIOL CHEM, V271, P10775, DOI 10.1074/jbc.271.18.10775; Chan AC, 1996, CURR OPIN IMMUNOL, V8, P394, DOI 10.1016/S0952-7915(96)80130-0; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; COHEN P, 1971, J CLIN INVEST, V50, P762, DOI 10.1172/JCI106547; Domin J, 1997, FEBS LETT, V410, P91, DOI 10.1016/S0014-5793(97)00617-0; EZUMI Y, 1995, J BIOL CHEM, V270, P11927, DOI 10.1074/jbc.270.20.11927; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Fluckiger AC, 1998, EMBO J, V17, P1973, DOI 10.1093/emboj/17.7.1973; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; Gibbins J, 1996, J BIOL CHEM, V271, P18095, DOI 10.1074/jbc.271.30.18095; Giuriato S, 1997, J BIOL CHEM, V272, P26857, DOI 10.1074/jbc.272.43.26857; GRONDIN P, 1991, J BIOL CHEM, V266, P15705; GUINEBAULT C, 1995, J CELL BIOL, V129, P831, DOI 10.1083/jcb.129.3.831; Hackam DJ, 1997, J EXP MED, V186, P955, DOI 10.1084/jem.186.6.955; HOLMSEN H, 1970, J LAB CLIN MED, V75, P840; HUANG MM, 1992, J BIOL CHEM, V267, P5467; HUANG R, 1991, J BIOL CHEM, V266, P1652; KUCERA GL, 1990, J BIOL CHEM, V265, P5345; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE SB, 1995, CURR OPIN CELL BIOL, V7, P183, DOI 10.1016/0955-0674(95)80026-3; LI RY, 1994, FEBS LETT, V343, P89, DOI 10.1016/0014-5793(94)80613-6; LI RY, 1995, EMBO J, V14, P219; Li ZM, 1997, P NATL ACAD SCI USA, V94, P13820, DOI 10.1073/pnas.94.25.13820; Matsuo T, 1996, BIOCHEM J, V315, P505, DOI 10.1042/bj3150505; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; PAYRASTRE B, 1994, FEBS LETT, V341, P113, DOI 10.1016/0014-5793(94)80251-3; Polgar J, 1998, BLOOD, V91, P549, DOI 10.1182/blood.V91.2.549.549_549_554; RAMEH LE, 1995, CELL, V83, P821, DOI 10.1016/0092-8674(95)90195-7; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; RAVETCH JV, 1994, CELL, V78, P553, DOI 10.1016/0092-8674(94)90521-5; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; RIDLEY AJ, 1994, EMBO J, V13, P2600, DOI 10.1002/j.1460-2075.1994.tb06550.x; Rittenhouse SE, 1996, BLOOD, V88, P4401, DOI 10.1182/blood.V88.12.4401.bloodjournal88124401; Robinson A, 1996, BLOOD, V88, P522, DOI 10.1182/blood.V88.2.522.bloodjournal882522; Scharenberg AM, 1998, EMBO J, V17, P1961, DOI 10.1093/emboj/17.7.1961; SULTAN C, 1990, BIOCHEM J, V269, P831, DOI 10.1042/bj2690831; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Tilton B, 1997, J BIOL CHEM, V272, P28096, DOI 10.1074/jbc.272.44.28096; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; VANDERMEULEN J, 1990, BIOCHEM J, V271, P693, DOI 10.1042/bj2710693; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Vossebeld PJM, 1997, BIOCHEM J, V323, P87, DOI 10.1042/bj3230087; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; YANAGA F, 1995, BIOCHEM J, V311, P471, DOI 10.1042/bj3110471; YANO H, 1993, J BIOL CHEM, V268, P25846; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	63	148	150	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24314	24321		10.1074/jbc.273.38.24314	http://dx.doi.org/10.1074/jbc.273.38.24314			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733717	hybrid			2022-12-27	WOS:000076007300009
J	Ishisaki, A; Yamato, K; Nakao, A; Nonaka, K; Ohguchi, M; ten Dijke, P; Nishihara, T				Ishisaki, A; Yamato, K; Nakao, A; Nonaka, K; Ohguchi, M; ten Dijke, P; Nishihara, T			Smad7 is an activin-inducible inhibitor of activin-induced growth arrest and apoptosis in mouse B cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE SERINE KINASE; TGF-BETA RECEPTOR; CYCLE CONTROL; I RECEPTORS; EXPRESSION; INDUCTION; PROTEINS; CLONING; IDENTIFICATION; ANTAGONIST	Members of the transforming growth factor-p (TGF-P) family, which includes the activins, relay signals from serine/threonine kinase receptors in membrane to nucleus via intracellular Sma- and Mad-related (Smad) proteins. Inhibitory Smad proteins were found to prevent the interaction between the serine/threonine kinase receptors and pathway-restricted Smad proteins. Smad7 was identified as a TGF-beta-inducible antagonist of TGF-beta signaling, and it may participate in a negative feedback loop to control TGF-beta signaling. Here we demonstrate that the mRNA expression of Smad7 is induced by activin A in mouse B cell hybridoma HS-72 cells, which undergo growth arrest and apoptosis upon exposure to activin A. The ectopic expression of mouse Smad7 in HS-72 cells suppressed the activin A-induced cell cycle arrest in the G(1) phase by abolishing the activin A-induced expression of p21(CIP1/WAF1) and hypophosphorylation of retinoblastoma protein. Furthermore, Smad7 expression suppressed activin A-induced apoptosis in HS-72 cells. Thus, our data indicate that Smad7 is an activin A-inducible antagonist of activin A-induced growth arrest and apoptosis of B lineage cells.	Natl Inst Infect Dis, Dept Oral Sci, Shinjuku Ku, Tokyo 1628640, Japan; Tokyo Med & Dent Univ, Fac Dent, Dept Mol Cellular Oncol Microbiol, Bunkyo Ku, Tokyo 1138549, Japan; Chiba Univ, Sch Med, Dept Med, Chuo Ku, Chiba 2600856, Japan; Biomed Ctr, Ludwig Inst Canc Res, S-75124 Uppsala, Sweden	National Institute of Infectious Diseases (NIID); Tokyo Medical & Dental University (TMDU); Chiba University; Ludwig Institute for Cancer Research	Nishihara, T (corresponding author), Natl Inst Infect Dis, Dept Oral Sci, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.		Dijke, Peter ten/AAG-4660-2021	Dijke, Peter ten/0000-0002-7234-342X; Ishisaki, Akira/0000-0001-6704-4436				Akifusa S, 1998, EXP CELL RES, V238, P82, DOI 10.1006/excr.1997.3848; ATTISANO L, 1992, CELL, V68, P97, DOI 10.1016/0092-8674(92)90209-U; Attisano Liliana, 1996, Cytokine and Growth Factor Reviews, V7, P327, DOI 10.1016/S1359-6101(96)00042-1; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; Derynck R, 1997, BBA-REV CANCER, V1333, pF105, DOI 10.1016/S0304-419X(97)00017-6; EBNER R, 1993, SCIENCE, V262, P900, DOI 10.1126/science.8235612; ETO Y, 1987, BIOCHEM BIOPH RES CO, V142, P1095, DOI 10.1016/0006-291X(87)91528-2; GONZALEZMANCHON C, 1989, ENDOCRINOLOGY, V125, P1666, DOI 10.1210/endo-125-3-1666; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; HASHIMOTO O, 1998, IN PRESS CELL SIGNAL; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; KOJIMA I, 1989, BIOCHEM BIOPH RES CO, V159, P1107, DOI 10.1016/0006-291X(89)92223-7; KOSEKI T, 1995, FEBS LETT, V376, P247, DOI 10.1016/0014-5793(95)01290-7; LATHANGUE NB, 1994, CURR OPIN CELL BIOL, V6, P443, DOI 10.1016/0955-0674(94)90038-8; LING N, 1986, NATURE, V321, P779, DOI 10.1038/321779a0; LMACCARTHY S, 1993, J BIOL CHEM, V268, P23066; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; MATHEWS LS, 1994, ENDOCR REV, V15, P310, DOI 10.1210/er.15.3.310; MATHEWS LS, 1992, SCIENCE, V255, P1702, DOI 10.1126/science.1313188; MATHEWS LS, 1991, CELL, V65, P973, DOI 10.1016/0092-8674(91)90549-E; MOORE KJ, 1994, J IMMUNOL, V152, P2930; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; NISHIHARA T, 1995, BIOCHEM BIOPH RES CO, V212, P255, DOI 10.1006/bbrc.1995.1964; NISHIHARA T, 1993, BIOCHEM BIOPH RES CO, V197, P985, DOI 10.1006/bbrc.1993.2576; NISHIHARA T, 1995, J INTERF CYTOK RES, V15, P509, DOI 10.1089/jir.1995.15.509; PERANDONES CE, 1993, J IMMUNOL, V151, P3521; Roberts AB, 1990, HDB EXPT PHARM, V95, P419; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SMITH JC, 1993, EMBO J, V12, P4463, DOI 10.1002/j.1460-2075.1993.tb06135.x; SMITH JC, 1990, NATURE, V345, P729, DOI 10.1038/345729a0; SOKOL S, 1991, NATURE, V351, P409, DOI 10.1038/351409a0; SPENCER SJ, 1990, J CLIN ENDOCR METAB, V71, P1678, DOI 10.1210/jcem-71-6-1678; SUGITO S, 1991, INT J CANCER, V49, P880, DOI 10.1002/ijc.2910490614; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; TOKUNAGA K, 1987, CANCER RES, V47, P5616; TSUCHIDA K, 1993, P NATL ACAD SCI USA, V90, P11242, DOI 10.1073/pnas.90.23.11242; VALE W, 1986, NATURE, V321, P732; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Willis SA, 1996, MOL ENDOCRINOL, V10, P367, DOI 10.1210/me.10.4.367; Yamato K, 1997, MOL ENDOCRINOL, V11, P1044, DOI 10.1210/me.11.8.1044	43	111	117	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24293	24296		10.1074/jbc.273.38.24293	http://dx.doi.org/10.1074/jbc.273.38.24293			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733712	hybrid			2022-12-27	WOS:000076007300004
J	Kiyokawa, E; Hashimoto, Y; Kurata, T; Sugimura, H; Matsuda, M				Kiyokawa, E; Hashimoto, Y; Kurata, T; Sugimura, H; Matsuda, M			Evidence that DOCK180 up-regulates signals from the CrkII-p130(Cas) complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-RECEPTOR; PHOSPHORYLATION-DEPENDENT MANNER; SRC HOMOLOGY-3 DOMAINS; MEDIATED CELL-ADHESION; TYROSINE PHOSPHORYLATION; EXTRACELLULAR-MATRIX; SH3 DOMAINS; IN-VIVO; V-CRK; PROTEIN	DOCR180 is one of the two principal proteins bound to the SH3 domain of the adaptor protein CrkII. Here, we have studied the involvement of DOCR180 in integrin signaling. DOCR180 was neither phosphorylated nor bound to CrkII in quiescent NIH 3T3 cells and 3Y1 cells. We found that DOCR180 was phosphorylated and bound to CrkII in MH 3T3 cells stimulated with integrin and also in 3Y1 cells transformed by v-src or v-crk. The binding of DOCK180 to CrkII correlated with the binding of CrkII to p130(Cas), which is a major CrkII SH2 domain-binding protein at focal adhesions. In a reconstitution experiment, expression of DOCK180 induced hyperphosphorylation of p130(Cas) and a concomitant increase in the amount of CrkII bound to p130(Cas). Similarly, binding of DOCK180 to CrkII was also enhanced by the coexpression of p130(Cas). Finally, we found that coexpression of p130(Cas) and CrkII with DOCR180 induced local membrane spreading and accumulation of DOCK180-CrkII-p130(Cas) complexes at focal adhesions. These findings suggest that DOCK180 positively regulates signaling from integrins to CrkII-p130(Cas) complexes at focal adhesions.	Int Med Ctr Japan, Inst Res, Dept Pathol, Shinjuku Ku, Tokyo 1628655, Japan; Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628840, Japan; Hamamatsu Univ Sch Med, Dept Pathol, Hamamatsu, Shizuoka 4313192, Japan	National Center for Global Health & Medicine - Japan; National Institute of Infectious Diseases (NIID); Hamamatsu University School of Medicine	Matsuda, M (corresponding author), Int Med Ctr Japan, Inst Res, Dept Pathol, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	mmatsuda@ri.imcj.go.jp		Matsuda, Michiyuki/0000-0002-5876-9969				BIRGE RB, 1992, J BIOL CHEM, V267, P10588; Buday L, 1996, J BIOL CHEM, V271, P6159, DOI 10.1074/jbc.271.11.6159; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Chen D, 1996, J BIOL CHEM, V271, P6328, DOI 10.1074/jbc.271.11.6328; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; COOK TA, 1994, P NATL ACAD SCI USA, V91, P644, DOI 10.1073/pnas.91.2.644; DEJONG R, 1995, J BIOL CHEM, V270, P21468, DOI 10.1074/jbc.270.37.21468; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; GOTOH N, 1994, P NATL ACAD SCI USA, V91, P167, DOI 10.1073/pnas.91.1.167; GOTOH T, 1995, MOL CELL BIOL, V15, P6746; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; KANNER SB, 1991, EMBO J, V10, P1689, DOI 10.1002/j.1460-2075.1991.tb07693.x; KANNER SB, 1990, P NATL ACAD SCI USA, V87, P3328, DOI 10.1073/pnas.87.9.3328; KAWAI S, 1980, J VIROL, V34, P772, DOI 10.1128/JVI.34.3.772-776.1980; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; KizakaKondoh S, 1996, P NATL ACAD SCI USA, V93, P12177, DOI 10.1073/pnas.93.22.12177; MATSUDA M, 1990, SCIENCE, V248, P1537, DOI 10.1126/science.1694307; Matsuda M, 1996, CELL SIGNAL, V8, P335, DOI 10.1016/0898-6568(96)00067-8; MATSUDA M, 1992, MOL CELL BIOL, V12, P3482, DOI 10.1128/MCB.12.8.3482; MAYER BJ, 1995, CURR BIOL, V5, P296, DOI 10.1016/S0960-9822(95)00060-1; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; Nakamoto T, 1997, MOL CELL BIOL, V17, P3884, DOI 10.1128/MCB.17.7.3884; Nakamoto T, 1996, J BIOL CHEM, V271, P8959, DOI 10.1074/jbc.271.15.8959; Nievers MG, 1997, J CELL SCI, V110, P389; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ota S, 1998, CELL SIGNAL, V10, P283, DOI 10.1016/S0898-6568(97)00130-7; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; QUILLIAM LA, 1994, P NATL ACAD SCI USA, V91, P8512, DOI 10.1073/pnas.91.18.8512; Reedquist KA, 1996, J BIOL CHEM, V271, P8435, DOI 10.1074/jbc.271.14.8435; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Ribon V, 1996, MOL CELL BIOL, V16, P45; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Sawasdikosol S, 1996, J IMMUNOL, V157, P110; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; Schwartz MA, 1997, J CELL BIOL, V139, P575, DOI 10.1083/jcb.139.3.575; Schwartz MA, 1996, EMBO J, V15, P6525, DOI 10.1002/j.1460-2075.1996.tb01043.x; SUMIMOTO H, 1994, P NATL ACAD SCI USA, V91, P5345, DOI 10.1073/pnas.91.12.5345; TANAKA S, 1994, P NATL ACAD SCI USA, V91, P3443, DOI 10.1073/pnas.91.8.3443; Vuori K, 1996, MOL CELL BIOL, V16, P2606; VUORI K, 1995, J BIOL CHEM, V270, P22259, DOI 10.1074/jbc.270.38.22259; WATERS SB, 1995, MOL CELL BIOL, V15, P2791; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; YAMAGUCHI R, 1994, FEBS LETT, V356, P114, DOI 10.1016/0014-5793(94)01246-6	43	171	173	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24479	24484		10.1074/jbc.273.38.24479	http://dx.doi.org/10.1074/jbc.273.38.24479			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733740	hybrid			2022-12-27	WOS:000076007300032
J	Lowry, MB; Duchemin, AM; Coggeshall, KM; Robinson, JM; Anderson, CL				Lowry, MB; Duchemin, AM; Coggeshall, KM; Robinson, JM; Anderson, CL			Chimeric receptors composed of phosphoinositide 3-kinase domains and Fc gamma receptor ligand-binding domains mediate phagocytosis in COS fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; NATURAL-KILLER-CELLS; SYK TYROSINE KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; HIGH-AFFINITY; GROWTH-FACTOR; SIGNAL-TRANSDUCTION; LIPID PRODUCTS; MACROPHAGES; ASSOCIATION	Receptors for the Fc portion of IgG (Fc gamma R) initiate phagocytosis of IgG-opsonized particles by a process involving the assembly of a multi-molecular signaling complex. Several members of this complex have been identified, including Src family kinases, Syk/ZAP 70 family kinases, and phosphoinositide S-kinase (PIS-K). To test directly the role of PB-K in mediating phagocytosis, we assessed the phagocytic ability of chimeric receptors composed of Fc gamma R extracellular and transmembrane domains fused to regions of the p85 subunit of PI3-K. We found that chimeric receptors with cytoplasmic tails composed of the entire p85 subunit of PI3-K or the inter-Src homology 2 portion of p85 triggered phagocytosis in transfected COS fibroblasts, These two chimeras also showed phosphoinositide kinase activity in vitro when immunoadsorbed. In contrast, a chimera containing only the carboxyl-terminal Src homology 2 domain of p85 that does not interact with the catalytic p110 subunit of PI3-K did not trigger phagocytosis, nor did it show kinase activity in vitro. These data suggest that localization and direct activation of PI3-K at the site of particle attachment is sufficient to trigger the process of phagocytosis.	Ohio State Univ, Coll Med, Davis Res Ctr 1054, Dept Internal Med, Columbus, OH 43210 USA; Ohio State Univ, Coll Med, Dept Psychiat, Columbus, OH 43210 USA; Ohio State Univ, Coll Med, Dept Microbiol, Columbus, OH 43210 USA; Ohio State Univ, Coll Med, Dept Cell Biol Neurobiol & Anat, Columbus, OH 43210 USA	Ohio State University; Ohio State University; Ohio State University; Ohio State University	Anderson, CL (corresponding author), Ohio State Univ, Coll Med, Davis Res Ctr 1054, Dept Internal Med, 480 W 9th Ave, Columbus, OH 43210 USA.				NCI NIH HHS [R01-CA44983] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA044983] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akimoto K, 1996, EMBO J, V15, P788, DOI 10.1002/j.1460-2075.1996.tb00414.x; Allen LAH, 1996, J EXP MED, V184, P627, DOI 10.1084/jem.184.2.627; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; BONNEMA JD, 1994, J EXP MED, V180, P1427, DOI 10.1084/jem.180.4.1427; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; CHACKO GW, 1994, J BIOL CHEM, V269, P32435; Cox D, 1996, J BIOL CHEM, V271, P16597, DOI 10.1074/jbc.271.28.16597; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; Derman MP, 1997, J BIOL CHEM, V272, P6465, DOI 10.1074/jbc.272.10.6465; DIEKMANN D, 1995, EMBO J, V14, P5297, DOI 10.1002/j.1460-2075.1995.tb00214.x; Duchemin AM, 1997, J IMMUNOL, V158, P865; DURDEN DL, 1995, J IMMUNOL, V154, P4039; ERNST LK, 1992, J BIOL CHEM, V267, P15692; ERNST LK, 1993, P NATL ACAD SCI USA, V90, P6023, DOI 10.1073/pnas.90.13.6023; GHAZIZADEH S, 1995, BIOCHEM J, V305, P669, DOI 10.1042/bj3050669; GREENBERG S, 1993, J EXP MED, V177, P529, DOI 10.1084/jem.177.2.529; Greenberg S, 1996, P NATL ACAD SCI USA, V93, P1103, DOI 10.1073/pnas.93.3.1103; GRIFFIN FM, 1976, J EXP MED, V144, P788, DOI 10.1084/jem.144.3.788; Hartwig JH, 1996, J BIOL CHEM, V271, P32986, DOI 10.1074/jbc.271.51.32986; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; HU P, 1992, MOL CELL BIOL, V12, P981, DOI 10.1128/MCB.12.3.981; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; HUTCHINSON MJ, 1995, EUR J IMMUNOL, V25, P481, DOI 10.1002/eji.1830250226; INDIK Z, 1991, J CLIN INVEST, V88, P1766, DOI 10.1172/JCI115496; JONES AT, 1995, BIOCHEM J, V311, P31, DOI 10.1042/bj3110031; JOUVIN MHE, 1994, J BIOL CHEM, V269, P5918; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; KLIPPEL A, 1992, MOL CELL BIOL, V12, P1451, DOI 10.1128/MCB.12.4.1451; KLIPPEL A, 1993, MOL CELL BIOL, V13, P5560, DOI 10.1128/MCB.13.9.5560; KLIPPEL A, 1994, MOL CELL BIOL, V14, P2675, DOI 10.1128/MCB.14.4.2675; Lowry MB, 1998, J EXP MED, V187, P161, DOI 10.1084/jem.187.2.161; Lu PJ, 1996, BIOCHEMISTRY-US, V35, P14027, DOI 10.1021/bi961878z; Martin SS, 1996, J BIOL CHEM, V271, P17605, DOI 10.1074/jbc.271.30.17605; Martin SS, 1996, ENDOCRINOLOGY, V137, P5045, DOI 10.1210/en.137.11.5045; Moriya S, 1996, P NATL ACAD SCI USA, V93, P151, DOI 10.1073/pnas.93.1.151; NINOMIYA N, 1994, J BIOL CHEM, V269, P22732; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; SALCEDO TW, 1993, J EXP MED, V177, P1475, DOI 10.1084/jem.177.5.1475; TOKER A, 1994, J BIOL CHEM, V269, P32358; WALSH JP, 1991, P NATL ACAD SCI USA, V88, P9184, DOI 10.1073/pnas.88.20.9184; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; ZHELEZNYAK A, 1992, J BIOL CHEM, V267, P12042; ZIGMOND SH, 1972, EXP CELL RES, V73, P383, DOI 10.1016/0014-4827(72)90062-6	46	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24513	24520		10.1074/jbc.273.38.24513	http://dx.doi.org/10.1074/jbc.273.38.24513			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733745	hybrid			2022-12-27	WOS:000076007300037
J	Schulz, JR; Sasaki, JD; Vacquier, VD				Schulz, JR; Sasaki, JD; Vacquier, VD			Increased association of synaptosome-associated protein of 25 kDa with syntaxin and vesicle-associated membrane protein following acrosomal exocytosis of sea urchin sperm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLES; FUSION COMPLEX; CDNA CLONES; IN-VITRO; SNAP-25; EGG; IDENTIFICATION; SPERMATOZOA; ACTIVATION; TRANSPORT	Synaptosomal-associated protein of 25 kDa (SNAP-25) is a palmitoylated integral membrane protein expressed almost exclusively in neuronal and neuroendocrine tissues. This protein forms a ternary complex with vesicle-associated membrane protein (VAMP) and syntaxin, which is thought to regulate the fusion of plasma and vesicle membranes during exocytosis, We report the identification of SNAP-25 expressed in sea urchin sperm. Sea urchin SNAP-25 shares greater identity with mammalian SNAP-25 than with mammalian SNAP-23, a ubiquitously expressed homologue believed to regulate membrane fusion in non-neuronal tissues. Sea urchin sperm contain a single exocytotic vesicle, the acrosomal vesicle, whose contents are exposed during the acrosome reaction. Fusion of the plasma membrane with the acrosomal vesicle membrane at multiple points (vesiculation) results in the release of SNAP-25 with the shed acrosome reaction vesicles. A complex containing SNAP-25, syntaxin, and VAMP is present in sperm, as detected by affinity chromatography and immunoprecipitation. Although this complex is present prior to the acrosome reaction, the amount of complex increases over 4-fold following acrosomal exocytosis, These findings support the involvement of SNAP-25 in the invertebrate sperm acrosome reaction, possibly through increased association with VAMP and syntaxin driving the fusion of plasma and acrosomal membranes.	Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Schulz, JR (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD012986, R01HD012986] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-12986] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARK IC, 1994, GENE, V139, P291, DOI 10.1016/0378-1119(94)90773-0; BARK IC, 1993, J MOL BIOL, V233, P67, DOI 10.1006/jmbi.1993.1485; BARROS C, 1967, J CELL BIOL, V34, P1; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bruns D, 1997, J NEUROSCI, V17, P1898; CASTELLANO LE, 1995, EUR J CELL BIOL, V67, P23; Conner S, 1997, MOL REPROD DEV, V48, P106; Darszon A, 1996, CURR TOP DEV BIOL, V34, P117, DOI 10.1016/S0070-2153(08)60710-3; EPEL D, 1978, MEMBRANE FUSION, P1; FOLTZ KR, 1993, DEV BIOL, V158, P46, DOI 10.1006/dbio.1993.1167; Garbers D L, 1980, Adv Cyclic Nucleotide Res, V13, P251; GASSMANN M, 1990, FASEB J, V4, P2528, DOI 10.1096/fasebj.4.8.1970792; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; HESS DT, 1992, J NEUROSCI, V12, P4634; KUMAR S, 1993, MEGA; LOEWY A, 1991, J NEUROSCI, V11, P3412; Nicholas HBJ, 1997, GENEDOC; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; PODELL SB, 1984, J CELL BIOL, V99, P1598, DOI 10.1083/jcb.99.5.1598; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; RISINGER C, 1993, J BIOL CHEM, V268, P24408; Rothman JE, 1996, PROTEIN SCI, V5, P185; Schulz JR, 1997, DEV BIOL, V191, P80, DOI 10.1006/dbio.1997.8712; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; Vacquier VD, 1997, DEV BIOL, V192, P125, DOI 10.1006/dbio.1997.8729; VACQUIER VD, 1986, METHOD CELL BIOL, V27, P15, DOI 10.1016/S0091-679X(08)60340-4; Wang GY, 1997, J CELL SCI, V110, P505; WARD CR, 1993, DEV BIOL, V158, P9, DOI 10.1006/dbio.1993.1165	33	37	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24355	24359		10.1074/jbc.273.38.24355	http://dx.doi.org/10.1074/jbc.273.38.24355			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733723	hybrid			2022-12-27	WOS:000076007300015
J	Simonsson, S; Samuelsson, T; Elias, P				Simonsson, S; Samuelsson, T; Elias, P			The herpes simplex virus type 1 origin binding protein - Specific recognition of phosphates and methyl groups defines the interacting surface for a monomeric DNA binding domain in the major groove of DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; UL9 GENE; VIRAL ORIGIN; REPLICATION; HELICASE; ORIS; COMPLEX; ORI(S); ICP8	The UL9 gene of herpes simplex virus type I (HSV-1) encodes an origin binding protein (OBP), It is an ATP-dependent DNA helicase and a sequence-specific DNA-binding protein, The latter function is carried out by the C-terminal domain of OBP (Delta OBP). We have now performed a quantitative analysis of the interaction between Delta OBP and its recognition sequence, GTTCGCAC, in oris, Initially optimal conditions for binding were carefully determined. We observed that complexes with different electrophoretic mobilities were formed, A cross-linking experiment demonstrated that nonspecific complexes containing 2 or more protein monomers per DNA molecule were formed at high protein concentrations. The specific complex formed at low concentrations of Delta OBP had an electrophoretic mobility corresponding to a 1:1 complex. We then demonstrated that the methyl groups of thymine in the major groove were essential for high affinity binding. Changes in the minor groove had considerably smaller effects. Ethylation interference experiments indicated that specific contacts were made between OBP and three phosphates in the recognition sequence. Finally, these observations were used to present a model of the surface of DNA that interacts with Delta OBP in a sequence-specific manner.	Univ Gothenburg, Dept Biochem Med, SE-40530 Gothenburg, Sweden	University of Gothenburg	Elias, P (corresponding author), Univ Gothenburg, Dept Biochem Med, Box 440, SE-40530 Gothenburg, Sweden.	per.elias@medkem.gu.se	Samuelsson, Tore/B-3548-2008; Simonsson, Stina/R-2699-2016; Samuelsson, Tore/X-7335-2019	Simonsson, Stina/0000-0001-9020-3714; 				ABBOTTS AP, 1995, J GEN VIROL, V76, P3125, DOI 10.1099/0022-1317-76-12-3125; Ausubel FM, CURRENT PROTOCOLS MO; BOEHMER PE, 1994, J BIOL CHEM, V269, P29329; BOEHMER PE, 1993, P NATL ACAD SCI USA, V90, P8444, DOI 10.1073/pnas.90.18.8444; Boehmer PE, 1997, ANNU REV BIOCHEM, V66, P347, DOI 10.1146/annurev.biochem.66.1.347; ELIAS P, 1986, P NATL ACAD SCI USA, V83, P6322, DOI 10.1073/pnas.83.17.6322; ELIAS P, 1992, J BIOL CHEM, V267, P17424; ELIAS P, 1990, J BIOL CHEM, V265, P17167; ELIAS P, 1988, P NATL ACAD SCI USA, V85, P2959, DOI 10.1073/pnas.85.9.2959; FIERER DS, 1995, J BIOL CHEM, V270, P7330, DOI 10.1074/jbc.270.13.7330; FOCHER F, 1992, CHROMOSOMA, V102, pS67, DOI 10.1007/BF02451788; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; GUSTAFSSON CM, 1994, P NATL ACAD SCI USA, V91, P4629, DOI 10.1073/pnas.91.11.4629; GUSTAFSSON CM, 1995, J BIOL CHEM, V270, P19028, DOI 10.1074/jbc.270.32.19028; Hammarsten O, 1996, J GEN VIROL, V77, P969, DOI 10.1099/0022-1317-77-5-969; HAZUDA DJ, 1991, J BIOL CHEM, V266, P24621; KOFF A, 1988, J VIROL, V62, P4096, DOI 10.1128/JVI.62.11.4096-4103.1988; Kornberg A., 1992, DNA REPLICATION; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Lee SSK, 1997, P NATL ACAD SCI USA, V94, P2838, DOI 10.1073/pnas.94.7.2838; Lundback T, 1996, P NATL ACAD SCI USA, V93, P4754, DOI 10.1073/pnas.93.10.4754; MARTINEZ R, 1992, J VIROL, V66, P6735, DOI 10.1128/JVI.66.11.6735-6746.1992; OLIVO PD, 1988, P NATL ACAD SCI USA, V85, P5414, DOI 10.1073/pnas.85.15.5414; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; STABELL EC, 1993, NUCLEIC ACIDS RES, V21, P5203, DOI 10.1093/nar/21.22.5203; Stow ND, 1998, VIROLOGY, V240, P183, DOI 10.1006/viro.1997.8910; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; WEIR HM, 1989, NUCLEIC ACIDS RES, V17, P1409, DOI 10.1093/nar/17.4.1409; WISSMANN A, 1991, METHOD ENZYMOL, V208, P365	30	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24633	24639		10.1074/jbc.273.38.24633	http://dx.doi.org/10.1074/jbc.273.38.24633			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733759	hybrid			2022-12-27	WOS:000076007300051
J	Bagrodia, S; Taylor, SJ; Jordon, KA; Van Aelst, L; Cerione, RA				Bagrodia, S; Taylor, SJ; Jordon, KA; Van Aelst, L; Cerione, RA			A novel regulator of p21-activated kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; ACTIN STRESS FIBERS; RAS TRANSFORMATION; DEPENDENT ACTIVATION; FOCAL COMPLEXES; CDC42 GTPASES; RHO; RAC1; MEMBRANE; FAMILY	Proteins of the pal-activated kinase (Pak) family have been implicated in the regulation of gene expression, cytoskeletal architecture, and apoptosis, Although the ability of Cdc42 and Pac GTPases to activate Pak is well established, relatively little else is known about Pak regulation or the identity of Pak cellular targets. Here we report the identification of two closely related Pak3-binding proteins, possibly arising from alternative splicing, designated p50 and p85(Cool-1) (cloned out of library), Both isoforms of Cool contain a Src homology 3 domain that directly mediates interaction with Pak3 and tandem Dbl homology and pleckstrin homology domains. Despite the presence of the Dbl homology-pleckstrin homology motif, a characteristic of Rho family activators, activation of Cdc42 or Rac by Cool is not detectable. Instead binding of p50(Cool-1), but not p85(Cool-1), to Pak3 represses its activation by upstream activators such as the Dbl oncoprotein, indicating a novel mechanism of regulation of Pak signaling.	Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; Cornell Univ, Biochem Mol & Cell Biol Sect, Ithaca, NY 14853 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cornell University; Cornell University; Cold Spring Harbor Laboratory	Cerione, RA (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.				NIGMS NIH HHS [GM40654, GM47458] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040654, R01GM047458] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Brown JL, 1996, CURR BIOL, V6, P598, DOI 10.1016/S0960-9822(02)00546-8; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; KHOSRAVIFAR R, 1995, MOL CELL BIOL, V15, P6443; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Lee N, 1997, P NATL ACAD SCI USA, V94, P13642, DOI 10.1073/pnas.94.25.13642; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; MARTIN GA, 1995, EMBO J, V14, P1970, DOI 10.1002/j.1460-2075.1995.tb07189.x; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Oh WK, 1997, BIOCHEM BIOPH RES CO, V235, P794, DOI 10.1006/bbrc.1997.6875; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Olson MF, 1996, CURR BIOL, V6, P1628, DOI 10.1016/S0960-9822(02)70786-0; Qiu RG, 1997, MOL CELL BIOL, V17, P3449, DOI 10.1128/MCB.17.6.3449; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Tang Y, 1997, MOL CELL BIOL, V17, P4454, DOI 10.1128/MCB.17.8.4454; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; VanAelst L, 1996, EMBO J, V15, P3778, DOI 10.1002/j.1460-2075.1996.tb00751.x; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934	32	262	268	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23633	23636		10.1074/jbc.273.37.23633	http://dx.doi.org/10.1074/jbc.273.37.23633			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726964	hybrid			2022-12-27	WOS:000075893100005
J	DeLange, F; Klaassen, CHW; Wallace-Williams, SE; Bovee-Geurts, PHM; Liu, XM; DeGrip, WJ; Rothschild, KJ				DeLange, F; Klaassen, CHW; Wallace-Williams, SE; Bovee-Geurts, PHM; Liu, XM; DeGrip, WJ; Rothschild, KJ			Tyrosine structural changes detected during the photoactivation of rhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFRARED DIFFERENCE SPECTROSCOPY; DRIVEN PROTON TRANSPORT; AMINO-ACID-SEQUENCE; BOVINE RHODOPSIN; METARHODOPSIN-II; RESONANCE RAMAN; FTIR SPECTROSCOPY; LOW-TEMPERATURE; F-HELIX; BACTERIORHODOPSIN PHOTOCYCLE	We present the first Fourier transform infrared (FTIR) analysis of an isotope-labeled eukaryotic membrane protein. A combination of isotope labeling and FTIR difference spectroscopy was used to investigate the possible involvement of tyrosines in the photoactivation of rhodopsin (Rho), Rho --> MII difference spectra were obtained at 10 degrees C for unlabeled recombinant Rho and isotope-labeled L-[ring-(2)H(4)]Tyr-Rho expressed in Spodoptera frugiperda cells grown on a stringent culture medium containing enriched L-[ring-(2)H(4)]Tyr and isolated using a His, tag, A comparison of these difference spectra revealed reproducible changes in bands that correspond to tyrosine and tyrosinate vibrational modes. A similar pattern of tyrosine/tyrosinate bands has also been observed in the bR --> M transition in bacteriorhodopsin, although the sign of the bands is reversed. In bacteriorhodopsin, these bands were assigned to Tyr-185, which along with Pro-186 in the F-helix, may form a hinge that facilitates alpha-helix movement.	Boston Univ, Dept Phys, Boston, MA 02215 USA; Boston Univ, Lab Mol Biophys, Boston, MA 02215 USA; Univ Nijmegen, Dept Biochem, Inst Cellular Signalling, NL-6500 HB Nijmegen, Netherlands	Boston University; Boston University; Radboud University Nijmegen	Rothschild, KJ (corresponding author), Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA.	kjr@bu.edu	de Grip, W.J./L-4335-2015; Rothschild, Kenneth/P-6177-2018	Rothschild, Kenneth/0000-0002-2847-6671	NEI NIH HHS [EY05499] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY005499] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AHL PL, 1989, BIOCHEMISTRY-US, V28, P10028, DOI 10.1021/bi00452a022; AHL PL, 1988, J BIOL CHEM, V263, P13594; BAENZIGER JE, 1992, BIOPHYS J, V62, P64, DOI 10.1016/S0006-3495(92)81780-0; BAGLEY KA, 1985, BIOCHEMISTRY-US, V24, P6055, DOI 10.1021/bi00343a006; BENDIT EG, 1967, BIOPOLYMERS, V5, P525, DOI 10.1002/bip.1967.360050607; BRAIMAN MS, 1988, BIOCHEMISTRY-US, V27, P8516, DOI 10.1021/bi00423a002; BRAIMAN MS, 1988, ANNU REV BIOPHYS BIO, V17, P541; BRAIMAN MS, 1988, PROTEINS, V3, P219, DOI 10.1002/prot.340030403; BREER H, 1993, CIBA F SYMP, V179, P97; CHANG SH, 1981, P NATL ACAD SCI-BIOL, V78, P3398, DOI 10.1073/pnas.78.6.3398; CLARK NA, 1980, BIOPHYS J, V31, P65, DOI 10.1016/S0006-3495(80)85041-7; DECALUWE GLJ, 1995, BIOPHYS CHEM, V56, P79, DOI 10.1016/0301-4622(95)00018-S; DEGRIP WJ, 1988, PHOTOCHEM PHOTOBIOL, V48, P497, DOI 10.1111/j.1751-1097.1988.tb02852.x; DeLange F, 1997, EUR J BIOCHEM, V243, P174, DOI 10.1111/j.1432-1033.1997.0174a.x; DOHLMAN HG, 1987, KIDNEY INT, V32, pS2; DOUKAS AG, 1978, BIOCHEMISTRY-US, V17, P2430, DOI 10.1021/bi00605a028; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; FRANKE RR, 1992, J BIOL CHEM, V267, P14767; GREEN BH, 1977, NATURE, V269, P179, DOI 10.1038/269179a0; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; Han M, 1996, J BIOL CHEM, V271, P32337, DOI 10.1074/jbc.271.50.32337; Han M, 1997, J BIOL CHEM, V272, P23081, DOI 10.1074/jbc.272.37.23081; HARGRAVE PA, 1992, FASEB J, V6, P2323, DOI 10.1096/fasebj.6.6.1544542; Hienerwadel R, 1997, BIOCHEMISTRY-US, V36, P14712, DOI 10.1021/bi971521a; JANSSEN JJM, 1995, J BIOL CHEM, V270, P11222, DOI 10.1074/jbc.270.19.11222; KANDORI H, 1995, BIOCHEMISTRY-US, V34, P14220, DOI 10.1021/bi00043a029; KHORANA HG, 1992, J BIOL CHEM, V267, P1; KIBELBEK J, 1991, BIOCHEMISTRY-US, V30, P6761, DOI 10.1021/bi00241a019; KLINGER AL, 1992, BIOPHYS J, V63, P1244, DOI 10.1016/S0006-3495(92)81700-9; LEFKOWITZ RJ, 1986, TRENDS PHARMACOL SCI, V7, P444, DOI 10.1016/0165-6147(86)90417-7; Lin SW, 1996, BIOCHEMISTRY-US, V35, P11149, DOI 10.1021/bi960858u; LIU XM, 1995, BIOPHYS CHEM, V56, P63, DOI 10.1016/0301-4622(95)00016-Q; LUDLAM CFC, 1995, BIOCHEMISTRY-US, V34, P2, DOI 10.1021/bi00001a001; Ludlam GJ, 1997, FEBS LETT, V407, P285, DOI 10.1016/S0014-5793(97)00351-7; MAEDA A, 1993, BIOCHEMISTRY-US, V32, P12033, DOI 10.1021/bi00096a013; MATHIES R, 1977, J MOL BIOL, V109, P367, DOI 10.1016/S0022-2836(77)80040-5; NAKAYAMA TA, 1991, J BIOL CHEM, V266, P4269; Nishimura S, 1996, BIOCHEMISTRY-US, V35, P13267, DOI 10.1021/bi960911e; OSEROFF AR, 1974, BIOCHEMISTRY-US, V13, P4243, DOI 10.1021/bi00717a027; OVCHINNIKOV YA, 1982, BIOORG KHIM+, V8, P1424; PALINGS I, 1987, BIOCHEMISTRY-US, V26, P2544, DOI 10.1021/bi00383a021; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; RAFFERTY CN, 1979, PHOTOCHEM PHOTOBIOL, V29, P109, DOI 10.1111/j.1751-1097.1979.tb09268.x; Rath P, 1998, BIOCHEM J, V329, P713, DOI 10.1042/bj3290713; RATH P, 1993, BIOCHEMISTRY-US, V32, P10277, DOI 10.1021/bi00090a001; RATH P, 1994, BIOPHYS J, V66, P2085, DOI 10.1016/S0006-3495(94)81003-3; RIDGE KD, 1992, J BIOL CHEM, V267, P6770; ROEPE P, 1987, BIOCHEMISTRY-US, V26, P6696, DOI 10.1021/bi00395a020; ROTHSCHILD KJ, 1986, PHOTOBIOCH PHOTOBIOP, V13, P245; ROTHSCHILD KJ, 1987, BIOPHYS J, V51, P345, DOI 10.1016/S0006-3495(87)83341-6; ROTHSCHILD KJ, 1980, BIOPHYS J, V31, P53, DOI 10.1016/S0006-3495(80)85040-5; ROTHSCHILD KJ, 1981, BIOCHEM BIOPH RES CO, V103, P483, DOI 10.1016/0006-291X(81)90478-2; ROTHSCHILD KJ, 1986, P NATL ACAD SCI USA, V83, P347, DOI 10.1073/pnas.83.2.347; ROTHSCHILD KJ, 1989, FEBS LETT, V250, P448, DOI 10.1016/0014-5793(89)80774-4; ROTHSCHILD KJ, 1976, SCIENCE, V191, P1176, DOI 10.1126/science.1257742; ROTHSCHILD KJ, 1983, SCIENCE, V219, P1333, DOI 10.1126/science.6828860; SCHOENLEIN RW, 1991, SCIENCE, V254, P412, DOI 10.1126/science.1925597; Shieh T, 1997, J MOL BIOL, V269, P373, DOI 10.1006/jmbi.1997.1035; SIEBERT F, 1983, EUR J BIOCHEM, V136, P119, DOI 10.1111/j.1432-1033.1983.tb07714.x; SUBRAMANIAM S, 1993, EMBO J, V12, P1; Tang L, 1995, ISRAEL J CHEM, V35, P193; Vonck J, 1996, BIOCHEMISTRY-US, V35, P5870, DOI 10.1021/bi952663c; VUONG TM, 1984, NATURE, V311, P659, DOI 10.1038/311659a0; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; Yang K, 1996, BIOCHEMISTRY-US, V35, P12464, DOI 10.1021/bi960848t; YOSHIZAWA T, 1963, NATURE, V197, P1279, DOI 10.1038/1971279a0	68	34	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23735	23739		10.1074/jbc.273.37.23735	http://dx.doi.org/10.1074/jbc.273.37.23735			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726981	Green Published, hybrid			2022-12-27	WOS:000075893100022
J	Wenzel-Seifert, K; Hurt, CM; Seifert, R				Wenzel-Seifert, K; Hurt, CM; Seifert, R			High constitutive activity of the human formyl peptide receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BINDING REGULATORY PROTEINS; INFECTED INSECT CELLS; LEUKEMIA HL-60 CELLS; PERTUSSIS-TOXIN; SIGNAL-TRANSDUCTION; HUMAN-NEUTROPHILS; ADENYLYL-CYCLASE; INVERSE AGONISM; CYCLOSPORINE-H	The formyl peptide receptor (FPR) couples to pertussis toxin (PTX)-sensitive Gi-proteins to activate chemotaxis and exocytosis in neutrophils. PTX reduces not only formyl peptide-stimulated but also agonist-independent ("basal") G(i)-protein activity, suggesting that the FPR is constitutively active. We aimed at identifying an inverse FPR agonist, i.e. a compound that suppresses constitutive FPR activity. In Sf9 insect cell membranes, the G-protein heterotrimer G(i)alpha(2)beta(1)gamma(2) reconstituted N-formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP)stimulated guanosine 5'-O-(3-thiotriphosphate) (GTP gamma S) binding and GTP gamma S-sensitive high affinity [H-3]FMLP binding. The FPR "antagonist" cyclosporin H (CsH) potently and efficiently reduced basal GTP gamma S binding in Sf9 membranes. Another FPR antagonist, N-t-butoxycarbonyl-L-phenylalanyl-L-leucyl-L-phenylalanyl-L-leucyl-L-phenylalanine did not inhibit basal GTP gamma S binding but blocked the inhibitory effect of CsH on GTP gamma S binding. Na+ reduced basal GTP gamma S binding and eliminated the inhibitory effect of CsH. Similar effects of FMLP, CsH, and Na+ as in Sf9 membranes were observed with FPR expressed in the mammalian cell line HEK293. Our data show that the human FPR possesses high constitutive activity. CsH is an inverse FPR agonist and stabilizes the FPR in an inactive state. Na+ also stabilizes the FPR in an inactive state and, thereby, diminishes inverse agonist efficacy.	Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Wenzel-Seifert, K (corresponding author), Univ Kansas, Dept Pharmacol & Toxicol, 5064 Malott Hall, Lawrence, KS 66045 USA.		Seifert, Roland/G-3189-2013		NIGMS NIH HHS [GM 07365] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMATRUDA TT, 1995, J BIOL CHEM, V270, P28010; BARKER EL, 1994, J BIOL CHEM, V269, P11687; Barr AJ, 1997, J BIOL CHEM, V272, P32979, DOI 10.1074/jbc.272.52.32979; BOMMAKANTI RK, 1995, BIOCHEMISTRY-US, V34, P6720, DOI 10.1021/bi00020a017; BOND RA, 1995, NATURE, V374, P272, DOI 10.1038/374272a0; BOULAY F, 1990, BIOCHEMISTRY-US, V29, P11123, DOI 10.1021/bi00502a016; BRANDT SJ, 1985, P NATL ACAD SCI USA, V82, P3277, DOI 10.1073/pnas.82.10.3277; BUHL AM, 1995, J BIOL CHEM, V270, P19828, DOI 10.1074/jbc.270.34.19828; Burstein ES, 1997, MOL PHARMACOL, V51, P312, DOI 10.1124/mol.51.2.312; Campbell JJ, 1996, J CELL BIOL, V134, P255, DOI 10.1083/jcb.134.1.255; CERESA BP, 1994, J BIOL CHEM, V269, P29557; Cetani F, 1996, FEBS LETT, V378, P27, DOI 10.1016/0014-5793(95)01384-9; COSTA T, 1989, P NATL ACAD SCI USA, V86, P7321, DOI 10.1073/pnas.86.19.7321; COSTA T, 1990, MOL PHARMACOL, V37, P383; CUPO JF, 1989, BIOCHIM BIOPHYS ACTA, V982, P31, DOI 10.1016/0005-2736(89)90170-3; dePaulis A, 1996, J ALLERGY CLIN IMMUN, V98, P152, DOI 10.1016/S0091-6749(96)70237-3; DIETRICH A, 1992, FEBS LETT, V313, P220, DOI 10.1016/0014-5793(92)81195-R; DILLON SB, 1988, VIRCHOWS ARCH B, V55, P65; GERARD C, 1994, ANNU REV IMMUNOL, V12, P775, DOI 10.1146/annurev.iy.12.040194.004015; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; GETHER U, 1995, J BIOL CHEM, V270, P28268; GIERSCHIK P, 1991, EUR J BIOCHEM, V197, P725, DOI 10.1111/j.1432-1033.1991.tb15964.x; GIERSCHIK P, 1989, EUR J PHARM-MOLEC PH, V172, P481, DOI 10.1016/0922-4106(89)90031-X; GIERSCHIK P, 1989, J BIOL CHEM, V264, P21470; GIERSCHIK P, 1989, EUR J BIOCHEM, V183, P97, DOI 10.1111/j.1432-1033.1989.tb14901.x; Gimpl G, 1996, EUR J BIOCHEM, V237, P768, DOI 10.1111/j.1432-1033.1996.0768p.x; GOTZE K, 1994, EUR J PHARM-MOLEC PH, V268, P151, DOI 10.1016/0922-4106(94)90184-8; Grunewald S, 1996, BIOCHEMISTRY-US, V35, P15162, DOI 10.1021/bi960757w; GUAN XM, 1992, J BIOL CHEM, V267, P21995; HANF R, 1993, J PHYSIOL-LONDON, V461, P743, DOI 10.1113/jphysiol.1993.sp019539; Hartman JL, 1996, J BIOL CHEM, V271, P22591, DOI 10.1074/jbc.271.37.22591; HILF G, 1992, EUR J PHARM-MOLEC PH, V225, P245, DOI 10.1016/0922-4106(92)90026-R; HINSCH KD, 1989, BIOCHIM BIOPHYS ACTA, V1013, P60, DOI 10.1016/0167-4889(89)90128-6; JACOBS AA, 1995, J LEUKOCYTE BIOL, V57, P679, DOI 10.1002/jlb.57.4.679; Jakubik J, 1995, FEBS LETT, V377, P275, DOI 10.1016/0014-5793(95)01360-1; KANAHO Y, 1990, J LEUKOCYTE BIOL, V47, P420, DOI 10.1002/jlb.47.5.420; Kenakin T, 1997, TRENDS PHARMACOL SCI, V18, P456, DOI 10.1016/S0165-6147(97)90683-0; KLEIN JB, 1992, J IMMUNOL, V148, P2483; KLINKER JF, 1994, BIOCHEM PHARMACOL, V48, P1857, DOI 10.1016/0006-2952(94)90583-5; KLINKER JF, 1994, BIOCHEM J, V304, P377, DOI 10.1042/bj3040377; Klinker JF, 1996, GEN PHARMACOL, V27, P33, DOI 10.1016/0306-3623(95)00107-7; KOBILKA B, 1992, ANNU REV NEUROSCI, V15, P87, DOI 10.1146/annurev.ne.15.030192.000511; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; KRAUSE KH, 1985, J CLIN INVEST, V76, P1348, DOI 10.1172/JCI112109; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEEBLUNDBERG LMF, 1994, J BIOL CHEM, V269, P25970; LEFF P, 1995, TRENDS PHARMACOL SCI, V16, P89, DOI 10.1016/S0165-6147(00)88989-0; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; Leopoldt D, 1997, N-S ARCH PHARMACOL, V356, P216, DOI 10.1007/PL00005044; MCLEISH KR, 1991, BIOCHEM J, V279, P455, DOI 10.1042/bj2790455; MEWES T, 1993, CIRCULATION, V88, P2916, DOI 10.1161/01.CIR.88.6.2916; MUKAI H, 1992, J BIOL CHEM, V267, P16237; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; NACCACHE PH, 1991, BLOOD, V78, P2534; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; NEVE KA, 1991, MOL PHARMACOL, V39, P733; NG GYK, 1993, BIOCHEMISTRY-US, V32, P11727, DOI 10.1021/bi00094a032; Noguera MA, 1996, BRIT J PHARMACOL, V119, P158, DOI 10.1111/j.1476-5381.1996.tb15689.x; PROSSNITZ ER, 1995, J BIOL CHEM, V270, P10686, DOI 10.1074/jbc.270.18.10686; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Robeva AS, 1996, BIOCHEM PHARMACOL, V51, P545, DOI 10.1016/0006-2952(95)02235-X; ROSSI F, 1986, BIOCHIM BIOPHYS ACTA, V853, P65, DOI 10.1016/0304-4173(86)90005-4; Scheer A, 1997, J RECEPT SIGNAL TR R, V17, P57, DOI 10.3109/10799899709036594; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; SCHUTZ W, 1992, TRENDS PHARMACOL SCI, V13, P376, DOI 10.1016/0165-6147(92)90116-N; Seifert R, 1998, EUR J BIOCHEM, V255, P369, DOI 10.1046/j.1432-1327.1998.2550369.x; Seifert R, 1998, J BIOL CHEM, V273, P5109, DOI 10.1074/jbc.273.9.5109; SINGER SJ, 1990, ANNU REV CELL BIOL, V6, P247, DOI 10.1146/annurev.cb.06.110190.001335; Smit MJ, 1996, P NATL ACAD SCI USA, V93, P6802, DOI 10.1073/pnas.93.13.6802; SOKOLOSKI JA, 1991, BIOCHEM J, V280, P515, DOI 10.1042/bj2800515; TIAN WN, 1994, MOL PHARMACOL, V45, P524; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRABER R, 1982, HELV CHIM ACTA, V65, P1655, DOI 10.1002/hlca.19820650538; vanKoppen CJ, 1996, MOL PHARMACOL, V49, P956; VOLPI M, 1985, P NATL ACAD SCI USA, V82, P2708, DOI 10.1073/pnas.82.9.2708; VONWARTBURG A, 1986, PROG ALLERGY, V38, P28; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; Weill C, 1997, EUR J PHARMACOL, V333, P269, DOI 10.1016/S0014-2999(97)01139-4; WENZELSEIFERT K, 1993, J IMMUNOL, V150, P4591; WenzelSeifert K, 1996, BIOCHEM J, V314, P679, DOI 10.1042/bj3140679; WENZELSEIFERT K, 1991, J IMMUNOL, V147, P1940; YE RD, 1991, BIOCHEM BIOPH RES CO, V180, P105, DOI 10.1016/S0006-291X(05)81261-6; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506	83	91	97	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24181	24189		10.1074/jbc.273.37.24181	http://dx.doi.org/10.1074/jbc.273.37.24181			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727041	hybrid			2022-12-27	WOS:000075893100082
J	Glover, BP; McHenry, CS				Glover, BP; McHenry, CS			The chi psi subunits of DNA polymerase III holoenzyme bind to single-stranded DNA-binding protein (SSB) and facilitate replication of an SSB-coated template	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; GAMMA-SUBUNIT; SLIDING CLAMPS; SIZE CLASSES; TAU-SUBUNIT; GENE 32; COMPLEX; MACHINE; BACTERIOPHAGE-T7; IDENTIFICATION	A complex of the chi and psi proteins is required to confer resistance to high levels of glutamate on the DNA polymerase III holoenzyme-catalyzed reaction (Olson, M., Dallmann, H. G., and McHenry, C. (1995) J. Biol Chem. 270, 29570-29577), We demonstrate that this salt resistance also requires templates to be coated with the Escherichia coli single-stranded DNA-binding protein (SSB). We show that this is the result of a direct chi psi-SSB interaction that is strengthened approximately 1000-fold when SSB is bound to DNA. On model oligonucleotide templates, DNA polymerase III core is inhibited by SSB. We show that the minimal polymerase assembly that will synthesize DNA on SSB-coated templates is polymerase III-tau-psi chi. gamma, the alternative product of the dnaX gene, will not replace tau in this reaction, indicating that tau's unique ability to bind to DNA polymerase III holding chi psi in the same complex is essential. All of our findings are consistent with chi psi strengthening DNA polymerase III holoenzyme interactions with the SSB-coated lagging strand at the replication fork, facilitating complex assembly and elongation.	Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet B121, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	McHenry, CS (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet B121, 4200 E 9th Ave, Denver, CO 80262 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035695] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM035695] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLINKOWA AL, 1990, NUCLEIC ACIDS RES, V18, P1725, DOI 10.1093/nar/18.7.1725; CHA TA, 1988, CANCER CELL, V6, P1; DALLMANN HG, 1995, J BIOL CHEM, V270, P29555, DOI 10.1074/jbc.270.49.29555; DALLMANN HG, 1995, J BIOL CHEM, V270, P29563, DOI 10.1074/jbc.270.49.29563; DORNREITER I, 1992, EMBO J, V11, P769, DOI 10.1002/j.1460-2075.1992.tb05110.x; FAY PJ, 1981, J BIOL CHEM, V256, P976; FAY PJ, 1982, J BIOL CHEM, V257, P5692; FLOWER AM, 1990, P NATL ACAD SCI USA, V87, P3713, DOI 10.1073/pnas.87.10.3713; FRADKIN LG, 1992, J BIOL CHEM, V267, P10318; GRIEP MA, 1990, BIOCHEMISTRY-US, V29, P9006, DOI 10.1021/bi00490a018; GRIEP MA, 1989, J BIOL CHEM, V264, P11294; HUBERMAN JA, 1971, J MOL BIOL, V62, P39, DOI 10.1016/0022-2836(71)90129-X; HURLEY JM, 1993, J MOL BIOL, V229, P398, DOI 10.1006/jmbi.1993.1042; JOHANSON KO, 1986, J BIOL CHEM, V261, P1460; KELMAN Z, 1995, ANNU REV BIOCHEM, V64, P171, DOI 10.1146/annurev.bi.64.070195.001131; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; KIM YT, 1994, J BIOL CHEM, V269, P5270; KIM YT, 1992, J BIOL CHEM, V267, P15032; KODAIRA M, 1983, MOL GEN GENET, V192, P80, DOI 10.1007/BF00327650; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE SH, 1987, P NATL ACAD SCI USA, V84, P2713, DOI 10.1073/pnas.84.9.2713; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; MAKI S, 1988, J BIOL CHEM, V263, P6555; MCHENRY CS, 1990, UCLA SYM BI, V127, P115; MCHENRY CS, 1982, J BIOL CHEM, V257, P2657; MCHENRY CS, 1979, J BIOL CHEM, V254, P1748; MOK M, 1987, J BIOL CHEM, V262, P16644; MOLINEUX IJ, 1974, P NATL ACAD SCI USA, V71, P3858, DOI 10.1073/pnas.71.10.3858; MULLIN DA, 1983, MOL GEN GENET, V192, P73, DOI 10.1007/BF00327649; NAKAI H, 1988, J BIOL CHEM, V263, P9831; NAKTINIS V, 1995, J BIOL CHEM, V270, P13358, DOI 10.1074/jbc.270.22.13358; OLSON MW, 1995, J BIOL CHEM, V270, P29570, DOI 10.1074/jbc.270.49.29570; ONRUST R, 1995, J BIOL CHEM, V270, P13366, DOI 10.1074/jbc.270.22.13366; ONRUST R, 1995, J BIOL CHEM, V270, P13348, DOI 10.1074/jbc.270.22.13348; REEMS JA, 1994, J BIOL CHEM, V269, P33091; TSUCHIHASHI Z, 1990, P NATL ACAD SCI USA, V87, P2516, DOI 10.1073/pnas.87.7.2516; WICKNER S, 1976, P NATL ACAD SCI USA, V73, P3511, DOI 10.1073/pnas.73.10.3511; XIAO H, 1993, J BIOL CHEM, V268, P11779	38	126	127	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23476	23484		10.1074/jbc.273.36.23476	http://dx.doi.org/10.1074/jbc.273.36.23476			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722585	hybrid			2022-12-27	WOS:000075778100085
J	Hood, J; Granger, HJ				Hood, J; Granger, HJ			Protein kinase G mediates vascular endothelial growth factor-induced Raf-1 activation and proliferation in human endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; NITRIC-OXIDE; SIGNAL-TRANSDUCTION; PERMEABILITY FACTOR; GENE-EXPRESSION; TYROSINE KINASE; PHORBOL ESTER; ANGIOGENESIS; RECEPTOR; RAS	Vascular endothelial growth factor (VEGF) is an endothelium-specific, secreted protein that acts as a vasodilator, angiogenic peptide, and hyperpermeability factor. Recent reports have shown that nitric oxide synthase inhibitors block proliferation and microvascular hyperpermeability induced by VEGF. This study examined the mechanisms by which nitric oxide and its downstream signals mediate the VEGF-induced proliferative response in human umbilical vein endothelial cells (HUVECs), Nitric oxide synthase blockade by N-G-nitro-L-arginine methyl ester prevented both the proliferative effect of VEGF and Raf-1 activation by VEGF as measured by cell counting and the capacity of immunoprecipitated Raf-1 to phosphorylate syntide 2, a Raf-1-specific synthetic substrate. VEGF-induced proliferation and Raf-1 kinase activity were also inhibited by Rp-8-pCPT-cGMPs and KT5823, inhibitors of the regulatory and catalytic subunits of cGMP-dependent protein kinase (PKG), respectively. The ability of PKG to stimulate proliferation was verified by the observation that the PKG activator, 8-pCPT-cGMPs, stimulated both Raf-1 kinase activity and endothelial proliferation in a dose-dependent manner. Furthermore, recombinant catalytically active PKG phosphorylated and activated Raf-1 in a reconstituted system. Finally, Raf-1 immunoprecipitated from VEGF-stimulated endothelial cells coprecipitated with PKG, indicating a direct protein-protein interaction in activated cells. We conclude that VEGF induces increases in both proliferation and Raf-1 kinase activity in HUVECs and these activities are dependent on NO and its downstream effector, PKG.	Texas A&M Univ Syst, Hlth Sci Ctr, Microcirculat Res Inst, College Stn, TX 77843 USA; Texas A&M Univ Syst, Hlth Sci Ctr, Dept Med Physiol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Granger, HJ (corresponding author), Texas A&M Univ Syst, Hlth Sci Ctr, Microcirculat Res Inst, College Stn, TX 77843 USA.	granger@tamu.edu						BANAI S, 1994, CARDIOVASC RES, V28, P1176, DOI 10.1093/cvr/28.8.1176; Beasley D, 1997, J CARDIOVASC PHARM, V29, P323, DOI 10.1097/00005344-199703000-00004; BROCK TA, 1991, AM J PATHOL, V138, P213; CONNOLLY DT, 1986, ANAL BIOCHEM, V152, P136, DOI 10.1016/0003-2697(86)90131-4; CONNOLLY DT, 1989, J BIOL CHEM, V264, P20017; CORNWELL TL, 1994, AM J PHYSIOL-CELL PH, V267, pC1405, DOI 10.1152/ajpcell.1994.267.5.C1405; DEJONGE HW, 1995, J MOL CELL CARDIOL, V27, P93, DOI 10.1016/S0022-2828(08)80010-7; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; EGAN SE, 1993, NATURE, V365, P781, DOI 10.1038/365781a0; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; FORTE LR, 1992, AM J PHYSIOL, V263, pC607, DOI 10.1152/ajpcell.1992.263.3.C607; GOPALAKRISHNA R, 1993, J BIOL CHEM, V268, P27180; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Gudi T, 1996, J BIOL CHEM, V271, P4597; HAFNER S, 1994, MOL CELL BIOL, V14, P6696; HIRATA K, 1995, HYPERTENSION, V25, P180, DOI 10.1161/01.HYP.25.2.180; Hofmann J, 1997, FASEB J, V11, P649, DOI 10.1096/fasebj.11.8.9240967; Hood JD, 1998, AM J PHYSIOL-HEART C, V274, pH1054; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; LANDER HM, 1995, J BIOL CHEM, V270, P7017, DOI 10.1074/jbc.270.13.7017; Lander HM, 1996, J BIOL CHEM, V271, P19705, DOI 10.1074/jbc.271.33.19705; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Lincoln TM, 1996, METHOD ENZYMOL, V269, P149; LINCOLN TM, 1993, FASEB J, V7, P328, DOI 10.1096/fasebj.7.2.7680013; Lohmann SM, 1997, TRENDS BIOCHEM SCI, V22, P307, DOI 10.1016/S0968-0004(97)01086-4; MARSHALL MS, 1995, FASEB J, V9, P1311, DOI 10.1096/fasebj.9.13.7557021; MOLLOY CJ, 1993, J BIOL CHEM, V268, P7338; Morbidelli L, 1996, AM J PHYSIOL-HEART C, V270, pH411, DOI 10.1152/ajpheart.1996.270.1.H411; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; OBRIAN CA, 1989, CANCER METAST REV, V8, P199, DOI 10.1007/BF00047337; Parenti A, 1998, J BIOL CHEM, V273, P4220, DOI 10.1074/jbc.273.7.4220; PILZ RB, 1995, FASEB J, V9, P552, DOI 10.1096/fasebj.9.7.7737465; Quest AFG, 1996, ENZYME PROTEIN, V49, P231, DOI 10.1159/000468635; SEETHARAM L, 1995, ONCOGENE, V10, P135; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SHIMA DT, 1995, MOL MED, V2, P64; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Thomas KA, 1996, J BIOL CHEM, V271, P603, DOI 10.1074/jbc.271.2.603; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; vanderZee R, 1997, CIRCULATION, V95, P1030; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Yamazaki T, 1997, J MOL CELL CARDIOL, V29, P2491, DOI 10.1006/jmcc.1997.0488; ZICHE M, 1994, J CLIN INVEST, V94, P2036, DOI 10.1172/JCI117557; ZICHE M, 1993, BIOCHEM BIOPH RES CO, V192, P1198, DOI 10.1006/bbrc.1993.1543	45	133	139	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23504	23508		10.1074/jbc.273.36.23504	http://dx.doi.org/10.1074/jbc.273.36.23504			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722588	hybrid			2022-12-27	WOS:000075778100088
J	Smyth, EM; Li, WH; Fitzgerald, GA				Smyth, EM; Li, WH; Fitzgerald, GA			Phosphorylation of the prostacyclin receptor during homologous desensitization - A critical role for protein kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGONIST-DEPENDENT PHOSPHORYLATION; ANGIOTENSIN-II RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; COUPLED RECEPTORS; EXPRESSION; CDNA; INVOLVEMENT; SUBTYPE; CLONING; 1A	Agonist-induced phosphorylation of an epitope-tagged prostacyclin receptor (HAhIP) is mediated primarily by PRC (Smyth, E. M., Nestor, P. V., and FitzGerald G. A. (1996) J. Biol. Chem. 271, 33698-33704). Based on the two consensus sites for protein kinase C (PKC) phosphorylation in the C-terminal region mutant HAhIPs were generated: S328A and S374A, in which an alanine replaced Ser-328 or Ser-374, respectively, S328A/S374A and C-DEL, in which the C-terminal portion was truncated at amino acid 313. Mutant receptors, stably expressed in HEK293 cells, coupled normally to cAMP production. Substantially less coupling to inositol phosphate was apparent with S328A, S328A/S374A, and C-DEL compared with HAhIP or S374A. Point mutants resolved by SDS-polyacrylamide gel electrophoresis as a broad band with a molecular mass of 44-62, indicating that the receptors are glycosylated, and immunofluoresence staining demonstrated their membrane localization. C-DEL demonstrated a substantial reduction in glycosylation; bands with molecular masses of 38-54 (glycosylated), 30, and 27 kDa (unglycosylated) were apparent. Although membrane localization was evident, cellular localization was more diffuse. HAhIP and S374A underwent iloprost- and PMA-induced phosphorylation (1 and 5 mu M, respectively, for 10 min). S328A and S328A/S374A showed a markedly less iloprost- and no PMA-induced phosphorylation. Phosphorylation of C-DEL was completely absent with either agonist. Electrospray mass spectrometry indicated that a peptide, including Ser-328, was phosphorylated in vitro by PKC, whereas one including Ser-374 was not. Iloprost (1 mu M, 10 min) desensitized HAhIP- and S374A-mediated adenylyl cyclase activation. A less impressive desensitization was evident with S328A and S328A/S374A, and no desensitization of C-DEL coupling was apparent. Exposure of transfected cells to iloprost (1 mu M) for increasing times induced a rapid desensitization of subsequent iloprost-induced (1 mu M) HAhIP and S374A adenylyl cyclase coupling. In contrast, no significant time-dependent desensitization of S328A, S328A/S374A, or C-DEL coupling was evident. These results indicate that PKC-dependent phosphorylation is of critical importance to homologous regulation of hIP. Ser-328 is a primary site for PKC phosphorylation of hIP.	Univ Penn, Ctr Expt Therapeut, Stellar Chance Labs 905, Philadelphia, PA 19104 USA	University of Pennsylvania	Fitzgerald, GA (corresponding author), Univ Penn, Ctr Expt Therapeut, Stellar Chance Labs 905, 422 Curie Blvd, Philadelphia, PA 19104 USA.	garret@spirit.gcrc.upenn.edu	FitzGerald, Garret A/A-4222-2010		NHLBI NIH HHS [HL-57847, HL-0945502] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057847] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bastepe M, 1997, MOL PHARMACOL, V51, P343, DOI 10.1124/mol.51.2.343; BOIE Y, 1994, J BIOL CHEM, V269, P12173; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; FISCH A, 1997, CIRCULATION, V96, P765; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; FREEDMAN NJ, 1995, J BIOL CHEM, V270, P17953, DOI 10.1074/jbc.270.30.17953; Giovanazzi S, 1997, BIOCHEM J, V325, P71, DOI 10.1042/bj3250071; Gros R, 1997, J CLIN INVEST, V99, P2087, DOI 10.1172/JCI119381; Habib A, 1997, J BIOL CHEM, V272, P7191, DOI 10.1074/jbc.272.11.7191; HAUSDORFF WP, 1990, SYM SOC EXP BIOL, V44, P225; ISHII K, 1994, J BIOL CHEM, V269, P1125; KATOH H, 1995, BBA-GEN SUBJECTS, V1244, P41, DOI 10.1016/0304-4165(94)00182-W; KINSELLA BT, 1994, J BIOL CHEM, V269, P29914; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; Koenig JA, 1997, TRENDS PHARMACOL SCI, V18, P276, DOI 10.1016/S0165-6147(97)01091-2; MILANO CA, 1994, SCIENCE, V264, P582, DOI 10.1126/science.8160017; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; NAKADATE T, 1987, J BIOL CHEM, V262, P11507; NAMBA T, 1994, J BIOL CHEM, V269, P9986; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; NISHIZUKA Y, 1992, NEUROSCI RES, V15, P3, DOI 10.1016/0168-0102(92)90013-3; Oppermann M, 1996, J BIOL CHEM, V271, P13266, DOI 10.1074/jbc.271.22.13266; Sano T, 1997, J BIOL CHEM, V272, P23631, DOI 10.1074/jbc.272.38.23631; SEUWEN K, 1988, EMBO J, V7, P161, DOI 10.1002/j.1460-2075.1988.tb02796.x; Smyth EM, 1996, J BIOL CHEM, V271, P33698, DOI 10.1074/jbc.271.52.33698; SOLOMON T, 1994, ANAL BIOCHEM, V58, P541; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; Vezza R, 1996, J BIOL CHEM, V271, P30028, DOI 10.1074/jbc.271.47.30028	28	57	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23258	23266		10.1074/jbc.273.36.23258	http://dx.doi.org/10.1074/jbc.273.36.23258			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722557	hybrid			2022-12-27	WOS:000075778100057
J	Briggs, LJ; Stein, D; Goltz, J; Corrigan, VC; Efthymiadis, A; Hubner, S; Jans, DA				Briggs, LJ; Stein, D; Goltz, J; Corrigan, VC; Efthymiadis, A; Hubner, S; Jans, DA			The cAMP-dependent protein kinase site (Ser(312)) enhances dorsal nuclear import through facilitating nuclear localization sequence/importin interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; LARGE T-ANTIGEN; DROSOPHILA MORPHOGEN DORSAL; II SITE; TYROSINE PHOSPHORYLATION; DEGRADATION ESTABLISHES; DORSOVENTRAL PATTERN; TRANSCRIPTION FACTOR; TRANSPORT; EMBRYO	Control over the nuclear import of transcription factors (TFs) represents a level of gene regulation integral to cellular processes such as differentiation and transformation. The Drosophila TF Dorsal shares with other rel TF family members the fact that it contains a phosphorylation site for the cAMP-dependent protein kinase (PKA) 22 amino acids N-terminal to the nuclear localization signal (NLS) at amino acids 335-340. This study examines for the first time the nuclear import kinetics of Dorsal fusion proteins in rat hepatoma cells in vivo and in vitro. Nuclear uptake was found to be not only NLS-dependent, but also strongly dependent on the PKA site, whereby substitution of Ser(312) by either Ala or Glu using site-directed mutagenesis severely reduced nuclear accumulation. Exogenous cAMP or PKA catalytic subunit significantly enhanced the nuclear import of wild-type proteins both in vivo and in vitro. Using a direct binding assay, the molecular basis of PKA site enhancement of Dorsal fusion protein nuclear import was determined to be PKA site-mediated modulation of NLS recognition by the importin 58/97 complex. The physiological relevance of these results is supported by the observation that Drosophila embryos expressing PKA site Dorsal mutant variants were impaired in development. We conclude that the Dorsal NLS and PKA site constitute a phosphorylation-regulated NLS essential to Dorsal function and able to function in heterologous mammalian cell systems, where phosphorylation modulates the affinity of NLS recognition by importin.	Australian Natl Univ, John Curtin Sch Med Res, Div Biochem & Mol Biol, Nucl Signaling Lab, Canberra, ACT 2601, Australia; Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA	Australian National University; John Curtin School of Medical Research; Yeshiva University; Albert Einstein College of Medicine	Jans, DA (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Biochem & Mol Biol, Nucl Signaling Lab, POB 334, Canberra, ACT 2601, Australia.	David.Jans@anu.edu.au	Briggs, Lyndall J/A-7549-2011					BEG AA, 1992, GENE DEV, V6, P1899, DOI 10.1101/gad.6.10.1899; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Bergmann A, 1996, MECH DEVELOP, V60, P109, DOI 10.1016/S0925-4773(96)00607-7; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DRIEVER W, 1990, DEVELOPMENT, V109, P811; Efthymiadis A, 1997, J BIOL CHEM, V272, P22134, DOI 10.1074/jbc.272.35.22134; FINLAY DR, 1987, J CELL BIOL, V104, P189, DOI 10.1083/jcb.104.2.189; GILLESPIE SKH, 1994, MOL CELL BIOL, V14, P3559, DOI 10.1128/MCB.14.6.3559; GOVIND S, 1991, TRENDS GENET, V7, P119, DOI 10.1016/0168-9525(91)90456-Z; Govind S, 1996, MOL CELL BIOL, V16, P1103; HENKEL T, 1992, CELL, V68, P1121, DOI 10.1016/0092-8674(92)90083-O; HENNEKES H, 1993, J CELL BIOL, V120, P1293, DOI 10.1083/jcb.120.6.1293; Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191; ISODA K, 1994, P NATL ACAD SCI USA, V91, P5350, DOI 10.1073/pnas.91.12.5350; JANS DA, 1995, J BIOL CHEM, V270, P17064, DOI 10.1074/jbc.270.29.17064; JANS DA, 1995, BIOCHEM J, V311, P705, DOI 10.1042/bj3110705; JANS DA, 1994, ONCOGENE, V9, P2961; JANS DA, 1991, J CELL BIOL, V115, P1203, DOI 10.1083/jcb.115.5.1203; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; KIDD S, 1992, CELL, V71, P623, DOI 10.1016/0092-8674(92)90596-5; KUBOTA K, 1993, BIOCHEM J, V296, P497, DOI 10.1042/bj2960497; LANE ME, 1993, GENE DEV, V7, P1229, DOI 10.1101/gad.7.7a.1229; LEHMING N, 1995, P NATL ACAD SCI USA, V92, P10242, DOI 10.1073/pnas.92.22.10242; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; MELENDEZ A, 1995, GENETICS, V141, P1507; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; NOLAN GP, 1994, CELL, V77, P795, DOI 10.1016/0092-8674(94)90126-0; NORRIS JL, 1992, GENE DEV, V6, P1654, DOI 10.1101/gad.6.9.1654; NORRIS JL, 1995, GENE DEV, V9, P358, DOI 10.1101/gad.9.3.358; Reach M, 1996, DEV BIOL, V180, P353, DOI 10.1006/dbio.1996.0308; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; RIHS HP, 1991, EMBO J, V10, P633, DOI 10.1002/j.1460-2075.1991.tb07991.x; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; Schmitz M L, 1991, Trends Cell Biol, V1, P130, DOI 10.1016/0962-8924(91)90118-S; SHIRAKAWA F, 1989, MOL CELL BIOL, V9, P2424, DOI 10.1128/MCB.9.6.2424; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; STJOHNSTON D, 1992, CELL, V68, P201; Van der Meer JM., 1977, DROS INFORM SERV, V52, P160; VANCUROVA I, 1995, J CELL SCI, V108, P779; WHALEN AM, 1993, J CELL BIOL, V123, P523, DOI 10.1083/jcb.123.3.523; Xiao CY, 1996, J BIOL CHEM, V271, P6451, DOI 10.1074/jbc.271.11.6451; ZABEL U, 1993, EMBO J, V12, P201, DOI 10.1002/j.1460-2075.1993.tb05646.x	47	86	86	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22745	22752		10.1074/jbc.273.35.22745	http://dx.doi.org/10.1074/jbc.273.35.22745			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712906	hybrid			2022-12-27	WOS:000075616600082
J	Groblewski, GE; Yoshida, M; Bragado, MJ; Ernst, SA; Leykam, J; Williams, JA				Groblewski, GE; Yoshida, M; Bragado, MJ; Ernst, SA; Leykam, J; Williams, JA			Purification and characterization of a novel physiological substrate for calcineurin in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOSPORINE-A; REGULATED PHOSPHOPROTEIN; PROTEIN PHOSPHATASES; SIGNAL TRANSDUCTION; PHOSPHORYLATION; KINASE; DEPHOSPHORYLATION; IDENTIFICATION; TRANSCRIPTION; ACTIVATION	Although the calcium/calmodulin-regulated protein phosphatase calcineurin has been shown to play a role in a number of intracellular processes, relatively few of the downstream phosphoproteins that are dephosphorylated by this enzyme in cells have been described. Calcineurin was previously shown to play a role in amylase secretion by rat pancreatic acinar cells and to specifically dephosphorylate a 24-kDa cytosolic protein. The present study describes the purification and characterization of this novel phosphoprotein, termed CRHSP-24 (calcium-regulated heat-stable protein with a molecular mass of 24 kDa), Microgram quantities of CRHSP-24 were purified from a large-scale rat pancreas preparation in a procedure involving heat and acid precipitation, anion exchange chromatography, preparative electrophoresis, electroelution, and two-dimensional electrophoresis. Internal amino acid sequence was obtained from two peptides following trypsin digestion and high pressure liquid chromatography, Both sequences matched with 100% identity nucleotide sequences of expressed sequence tags from human placenta and rat PC-12 cells. Two CRHSP-24 transcripts of 0.7 and 2.9 kilobases were detected in multiple rat tissues by Northern analysis, whereas a single 24-kDa protein was observed by Western blotting. The CRHSP-24 protein is 147 amino acids in length, is composed of nearly 14% proline, and is phosphorylated entirely on serine residues. Western analysis and P-32 metabolic labeling of acini revealed CRHSP-24 to be maximally phosphorylated in control cells and to undergo a rapid sustained dephosphorylation on at least 3 serine residues in response to calcium-mobilizing stimuli. Dephosphorylation of CRHSP-24 was completely inhibited by pretreatment of acini with cyclosporin A or FK506. Furthermore, the inhibitory effects of FK506 were blocked by excess rapamycin. The ubiquitous expression of CRHSP-24 in rat tissues suggests that this novel calcineurin substrate plays a common role in calcium-mediated signal transduction.	Univ Michigan, Sch Med, Dept Physiol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Anat & Cell Biol, Ann Arbor, MI 48109 USA; Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Michigan State University	Williams, JA (corresponding author), Univ Michigan, Sch Med, Dept Physiol, 7737 Med Sci II, Ann Arbor, MI 48109 USA.	jawillms@umich.edu	Bragado, M Julia/L-6988-2014	Bragado, M Julia/0000-0001-7770-0775; Williams, John/0000-0002-6063-7615	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933, R37DK041122, F32DK008819, R01DK041122] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK34933, DK41122, DK08819] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ankarcrona M, 1996, FEBS LETT, V394, P321, DOI 10.1016/0014-5793(96)00959-3; APERIA A, 1992, P NATL ACAD SCI USA, V89, P7394, DOI 10.1073/pnas.89.16.7394; AUSUBEL FM, 1997, CURRENT PROTOCOLS MO, V1; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501; Bragado MJ, 1997, AM J PHYSIOL-CELL PH, V273, pC101, DOI 10.1152/ajpcell.1997.273.1.C101; BRAUN W, 1995, FASEB J, V9, P63, DOI 10.1096/fasebj.9.1.7529736; BURNHAM DB, 1982, J BIOL CHEM, V257, P523; CAMERON AM, 1995, CELL, V83, P463, DOI 10.1016/0092-8674(95)90124-8; Castiglia D, 1996, BIOCHEM BIOPH RES CO, V218, P390, DOI 10.1006/bbrc.1996.0068; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; DESDOUITS F, 1995, P NATL ACAD SCI USA, V92, P2682, DOI 10.1073/pnas.92.7.2682; FERNANDEZ J, 1992, ANAL BIOCHEM, V201, P255, DOI 10.1016/0003-2697(92)90336-6; FRUMAN DA, 1992, P NATL ACAD SCI USA, V89, P3686, DOI 10.1073/pnas.89.9.3686; GROBLEWSKI GE, 1994, J BIOL CHEM, V269, P15111; Groblewski GE, 1996, J BIOL CHEM, V271, P31502, DOI 10.1074/jbc.271.49.31502; HU CB, 1994, P NATL ACAD SCI USA, V91, P3730, DOI 10.1073/pnas.91.9.3730; HULTSCH T, 1991, P NATL ACAD SCI USA, V88, P6229, DOI 10.1073/pnas.88.14.6229; JONES PG, 1994, MOL MICROBIOL, V11, P811, DOI 10.1111/j.1365-2958.1994.tb00359.x; KINCAID R, 1993, ADV SEC MESS PHOSPH, V27, P1; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Mata M, 1996, J BIOL CHEM, V271, P16888, DOI 10.1074/jbc.271.28.16888; MOMAYEZI M, 1987, J CELL BIOL, V105, P181, DOI 10.1083/jcb.105.1.181; NAIR APK, 1994, NATURE, V369, P239, DOI 10.1038/369239a0; NICHOLS RA, 1994, J BIOL CHEM, V269, P23817; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; ONISHI H, 1996, AM J PHYSIOL, V271, pG531; Quinlan EM, 1996, J NEUROSCI, V16, P7627; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SHENOLIKAR S, 1994, ANNU REV CELL BIOL, V10, P55, DOI 10.1146/annurev.cellbio.10.1.55; SOBEL A, 1991, TRENDS BIOCHEM SCI, V16, P301, DOI 10.1016/0968-0004(91)90123-D; STEMMER PM, 1994, BIOCHEMISTRY-US, V33, P6859, DOI 10.1021/bi00188a015; Sugimoto T, 1997, J BIOL CHEM, V272, P29415, DOI 10.1074/jbc.272.47.29415; Williams John A., 1993, P167; WISHART MJ, 1994, AM J PHYSIOL-GASTR L, V267, pG676, DOI 10.1152/ajpgi.1994.267.4.G676; Yakel JL, 1997, TRENDS PHARMACOL SCI, V18, P124, DOI 10.1016/S0165-6147(97)01046-8	39	50	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22738	22744		10.1074/jbc.273.35.22738	http://dx.doi.org/10.1074/jbc.273.35.22738			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712905	hybrid			2022-12-27	WOS:000075616600081
J	Veillette, A; Thibaudeau, E; Latour, S				Veillette, A; Thibaudeau, E; Latour, S			High expression of inhibitory receptor SHPS-1 and its association with protein-tyrosine phosphatase SHP-1 in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE P50(CSK); CELLS; GLYCOPROTEIN; ADHESION; PRODUCT; CLONING; FAMILY; ZAP-70	SHPS-1 (or SIRP) is a member of the immunoglobulin (Ig) superfamily abundantly expressed in neurons and other cell types, Within its cytoplasmic domain, it possesses at least two immunoreceptor tyrosine-based inhibitory motifs, which are targets for tyrosine phosphorylation and mediate the recruitment of SHP-2, an Src homology 2 (SH2) domain-containing protein-tyrosine phosphatase. Since other immunoreceptor tyrosine based inhibitory motifs-containing receptors have critical roles in the negative regulation of hemopoietic cell functions, we wanted to examine the expression of SHPS-1 in cells of hematological lineages. By analyzing a panel of hemopoietic cell lines, evidence was provided that SHPS-1 is abundantly expressed in macrophages and, to a lesser extent, in myeloid cells. No expression was detected in T-cell or B-cell lines. Expression of SHPS-1 could also be documented in normal ex vivo peritoneal macrophages. Further studies showed that SHPS-1 was an efficient tyrosine phosphorylation substrate in macrophages. However, unlike in non-hemopoietic cells, tyrosine-phosphorylated SHPS-1 in macrophages associated primarily with SHP-1 and not SHP-2, Finally, our analyses allowed us to identify several isoforms of SHPS-1 in mouse cells. In part, this heterogeneity was due to differential glycosylation of SHPS-1, Additionally, it was caused by the production of at least two distinct shps-1 transcripts, coding for SHPS-1 polypeptides having different numbers of Ig-like domains in the extracellular region, Taken together, these findings indicate that SHPS-1 is likely to play a significant role in macrophages, at least partially as a consequence of its capacity to recruit SHP-1.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Oncol, Montreal, PQ H3G 1Y6, Canada; Montreal Gen Hosp, Dept Med, Montreal, PQ H3G 1A4, Canada; Montreal Gen Hosp, Dept Oncol, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University	Veillette, A (corresponding author), McGill Univ, Dept Biochem, Rm 715,McIntyre Med Sci Bldg,3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.		Latour, Sylvain/H-3652-2017	Latour, Sylvain/0000-0001-8238-4391				Beauchemin N, 1997, ONCOGENE, V14, P783, DOI 10.1038/sj.onc.1200888; Brooke GP, 1998, EUR J IMMUNOL, V28, P1, DOI 10.1002/(SICI)1521-4141(199801)28:01&lt;1::AID-IMMU1&gt;3.0.CO;2-V; Cao MY, 1998, J BIOL CHEM, V273, P15765, DOI 10.1074/jbc.273.25.15765; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Chow L M, 1995, Semin Immunol, V7, P207, DOI 10.1006/smim.1995.0026; CHOW LML, 1994, ONCOGENE, V9, P3437; CHUANG W, 1990, DEV BIOL, V137, P219, DOI 10.1016/0012-1606(90)90249-I; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Comu S, 1997, J NEUROSCI, V17, P8702; Cooper J.A, 1990, PEPT PROT PHOSPH, P85; DAMBROSIO D, 1995, SCIENCE, V268, P293, DOI 10.1126/science.7716523; Davidson D, 1997, J BIOL CHEM, V272, P23455, DOI 10.1074/jbc.272.37.23455; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Fournel M, 1996, J EXP MED, V183, P301, DOI 10.1084/jem.183.1.301; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Latour S, 1996, J BIOL CHEM, V271, P22782, DOI 10.1074/jbc.271.37.22782; MUTA T, 1994, NATURE, V368, P70, DOI 10.1038/368070a0; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; SHARENBERG AM, 1996, CELL, V87, P961; Tonks NK, 1996, CELL, V87, P365, DOI 10.1016/S0092-8674(00)81357-4; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Vivier E, 1997, IMMUNOL TODAY, V18, P286, DOI 10.1016/S0167-5699(97)80025-4; Yamao T, 1997, BIOCHEM BIOPH RES CO, V231, P61, DOI 10.1006/bbrc.1996.6047	24	185	206	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22719	22728		10.1074/jbc.273.35.22719	http://dx.doi.org/10.1074/jbc.273.35.22719			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712903	hybrid			2022-12-27	WOS:000075616600079
J	Xu, XM; Ng, S; Wu, ZL; Nguyen, D; Homburger, S; Seidel-Dugan, C; Ebens, A; Luo, YL				Xu, XM; Ng, S; Wu, ZL; Nguyen, D; Homburger, S; Seidel-Dugan, C; Ebens, A; Luo, YL			Human semaphorin K1 is glycosylphosphatidylinositol-linked and defines a new subfamily of viral-related semaphorins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL-NERVE PROJECTION; COLLAPSIN-1 MESSENGER-RNA; GROWTH CONE GUIDANCE; SPINAL-CORD; LUNG-CANCER; MURINE SEMAPHORIN; DEVELOPING CHICK; GENE FAMILY; IN-SITU; EXPRESSION	The semaphorin family contains a large number of secreted and transmembrane proteins, some of which are known to act as repulsive axon guidance cues during development or to be involved in immune function. We report here on the identification of semaphorin K1 (sema K1), the first semaphorin known to be associated with cell surfaces via a glycosylphosphatidylinositol linkage. Sema K1 is highly homologous to a viral semaphorin and can interact with specific immune cells, suggesting that like its viral counterpart, sema K1 could play an important role in regulating immune function. Sema K1 does not bind to neuropilin-1 or neuropilin-2, the two receptors implicated in mediating the repulsive action of several secreted semaphorins, and thus it likely acts through a novel receptor. In contrast to most previously described semaphorins, sema K1 is only weakly expressed during development but is present at high levels in postnatal and adult tissues, particularly brain and spinal cord.	Exelixis Pharmaceut Inc, San Francisco, CA 94080 USA	Exelixis, Inc.	Luo, YL (corresponding author), Exelixis Pharmaceut Inc, 260 Littlefield Ave, San Francisco, CA 94080 USA.	yluo@exelixis.com						Adams RH, 1996, MECH DEVELOP, V57, P33, DOI 10.1016/0925-4773(96)00525-4; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Barron KD, 1995, J NEUROL SCI, V134, P57, DOI 10.1016/0022-510X(95)00209-K; BOUGERET C, 1992, J IMMUNOL, V148, P318; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Eickholt BJ, 1997, MOL CELL NEUROSCI, V9, P358, DOI 10.1006/mcne.1997.0636; ENSSER A, 1995, J GEN VIROL, V76, P1063, DOI 10.1099/0022-1317-76-4-1063; Ensser A, 1997, J VIROL, V71, P6517, DOI 10.1128/JVI.71.9.6517-6525.1997; FAN JH, 1995, NEURON, V14, P263, DOI 10.1016/0896-6273(95)90284-8; Feiner L, 1997, NEURON, V19, P539, DOI 10.1016/S0896-6273(00)80370-0; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; Giger RJ, 1996, J COMP NEUROL, V375, P378, DOI 10.1002/(SICI)1096-9861(19961118)375:3<378::AID-CNE3>3.0.CO;2-#; Hall KT, 1996, P NATL ACAD SCI USA, V93, P11780, DOI 10.1073/pnas.93.21.11780; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; Kikuchi K, 1997, MOL BRAIN RES, V51, P229, DOI 10.1016/S0169-328X(97)00251-9; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kobayashi H, 1997, J NEUROSCI, V17, P8339; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Koppel AM, 1997, NEURON, V19, P531, DOI 10.1016/S0896-6273(00)80369-4; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LazarovSpiegler O, 1996, FASEB J, V10, P1296, DOI 10.1096/fasebj.10.11.8836043; LUO YL, 1995, NEURON, V14, P1131, DOI 10.1016/0896-6273(95)90261-9; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MATTHES DJ, 1995, CELL, V81, P631, DOI 10.1016/0092-8674(95)90084-5; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Puschel AW, 1996, MOL CELL NEUROSCI, V7, P419, DOI 10.1006/mcne.1996.0030; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Roche J, 1996, ONCOGENE, V12, P1289; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sekido Y, 1996, P NATL ACAD SCI USA, V93, P4120, DOI 10.1073/pnas.93.9.4120; Shepherd I, 1996, DEV BIOL, V173, P185, DOI 10.1006/dbio.1996.0016; Shepherd IT, 1997, DEVELOPMENT, V124, P1377; SMITH CA, 1991, BIOCHEM BIOPH RES CO, V176, P335, DOI 10.1016/0006-291X(91)90929-2; Spriggs MK, 1996, ANNU REV IMMUNOL, V14, P101, DOI 10.1146/annurev.immunol.14.1.101; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; UDENFRIEND S, 1995, ANNU REV BIOCHEM, V64, P563, DOI 10.1146/annurev.bi.64.070195.003023; UPTON C, 1991, VIROLOGY, V184, P370, DOI 10.1016/0042-6822(91)90853-4; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Wong JTW, 1997, DEVELOPMENT, V124, P3597; WRIGHT DE, 1995, J COMP NEUROL, V361, P321, DOI 10.1002/cne.903610209; Xiang RH, 1996, GENOMICS, V32, P39, DOI 10.1006/geno.1996.0074; Yamada T, 1997, P NATL ACAD SCI USA, V94, P14713, DOI 10.1073/pnas.94.26.14713; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; Zhou L, 1997, MOL CELL NEUROSCI, V9, P26, DOI 10.1006/mcne.1997.0607	48	98	106	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22428	22434		10.1074/jbc.273.35.22428	http://dx.doi.org/10.1074/jbc.273.35.22428			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712866	hybrid			2022-12-27	WOS:000075616600042
J	Giraudo, E; Primo, L; Audero, E; Gerber, HP; Koolwijk, P; Soker, S; Klagsbrun, M; Ferrara, N; Bussolino, F				Giraudo, E; Primo, L; Audero, E; Gerber, HP; Koolwijk, P; Soker, S; Klagsbrun, M; Ferrara, N; Bussolino, F			Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-ACTIVATING-FACTOR; INDUCED ANGIOGENESIS; TYROSINE KINASE; TNF-ALPHA; IN-VIVO; MOLECULAR MECHANISMS; RHEUMATOID-ARTHRITIS; VEGF RECEPTORS; MESSENGER-RNA; GLIOMA-CELLS	Tumor necrosis factor-alpha (TNF-alpha) modulates gene expression in endothelial cells and is angiogenic in vivo, TNF-alpha does not activate in vitro migration and proliferation of endothelium, and its angiogenic activity is elicited by synthesis of direct angiogenic inducers or of proteases, Here, we show that TNF-alpha up-regulates in a dose- and time-dependent manner the expression and the function of vascular endothelial growth factor receptor-2 (VEGFR-2) as well as the expression of its coreceptor neuropilin-1 in human endothelium, As inferred by nuclear run-on assay and transient expression of VEGFR-2 promoter-based reporter gene construct, the cytokine increased the transcription of the VEGFR-2 gene. Mithramycin, an inhibitor of binding of nuclear transcription factor Spl to the promoter consensus sequence, blocked activation of VEGFR-2, suggesting that the up-regulation of the receptor required Spl binding sites. TNF-alpha increased the cellular amounts of VEGFR-2 protein and tripled the high affinity I-125-VEGF-A(165) capacity without affecting the K-d of ligand-receptor interaction. As a consequence, TNF-alpha enhanced the migration and the wound healing triggered by VEGF-A(165). Since VEGFR-2 mediates angiogenic signals in endothelium, our data indicate that its up-regulation is another mechanism by which TNF-alpha is angiogenic and may provide insight into the mechanism of neovascularization as occurs in TNF-alpha-mediated pathological settings.	Univ Turin, Sch Med, Dept Genet Biol & Biochem, Vasc Biol Lab, I-10126 Turin, Italy; Genentech Inc, Dept Cardiovasc Res, S San Francisco, CA 94080 USA; Lab TNO PG, Dept Vasc & Connect Tissue Res Gaubius, NL-2333 CK Leiden, Netherlands; Harvard Univ, Childrens Hosp, Sch Med, Dept Urol, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Surg, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Surg, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Turin; Roche Holding; Genentech; Netherlands Organization Applied Science Research; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Bussolino, F (corresponding author), Univ Turin, Sch Med, Dept Genet Biol & Biochem, Vasc Biol Lab, I-10126 Turin, Italy.	Bussol@molinette.unito.it	Giraudo, Enrico/K-3192-2016; Giraudo, Enrico/K-6441-2019; Bussolino, Federico/AES-3951-2022; Bussolino, Federico/K-2500-2016	Giraudo, Enrico/0000-0003-4128-4786; Giraudo, Enrico/0000-0003-4128-4786; PRIMO, Luca/0000-0002-1294-0441; Bussolino, Federico/0000-0002-5348-1341; Audero, Enrica/0000-0002-6138-244X	NCI NIH HHS [CA 37392] Funding Source: Medline; PHS HHS [45548] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA037392, R56CA037392, R01CA037392] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albini A, 1996, NAT MED, V2, P1371, DOI 10.1038/nm1296-1371; BACHARACH E, 1992, P NATL ACAD SCI USA, V89, P10686, DOI 10.1073/pnas.89.22.10686; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; BARLEON B, 1994, J CELL BIOCHEM, V54, P56, DOI 10.1002/jcb.240540107; Basile A, 1997, J BIOL CHEM, V272, P8172, DOI 10.1074/jbc.272.13.8172; BIKFALVI A, 1991, J CELL PHYSIOL, V149, P50, DOI 10.1002/jcp.1041490108; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Brogi E, 1996, J CLIN INVEST, V97, P469, DOI 10.1172/JCI118437; BUSSOLINO F, 1988, J BIOL CHEM, V263, P11856; Bussolino F, 1997, TRENDS BIOCHEM SCI, V22, P251, DOI 10.1016/S0968-0004(97)01074-8; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; CAMUSSI G, 1995, J IMMUNOL, V154, P6492; CAMUSSI G, 1991, EUR J BIOCHEM, V202, P3, DOI 10.1111/j.1432-1033.1991.tb16337.x; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; DEFILIPPI P, 1991, J BIOL CHEM, V266, P7638; DEFILIPPI P, 1991, J CELL BIOL, V114, P855, DOI 10.1083/jcb.114.4.855; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; ENSOLI B, 1994, NATURE, V371, P674, DOI 10.1038/371674a0; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277; Gaudry M, 1997, BLOOD, V90, P4153, DOI 10.1182/blood.V90.10.4153; Gerber HP, 1997, J BIOL CHEM, V272, P23659, DOI 10.1074/jbc.272.38.23659; HAMANAKA R, 1992, J BIOL CHEM, V267, P13160; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; HOLZMAN LB, 1990, MOL CELL BIOL, V10, P5830, DOI 10.1128/MCB.10.11.5830; IKEDA E, 1995, J BIOL CHEM, V270, P19761, DOI 10.1074/jbc.270.34.19761; KAIPAINEN A, 1993, J EXP MED, V178, P2077, DOI 10.1084/jem.178.6.2077; KOCH AE, 1995, NATURE, V376, P517, DOI 10.1038/376517a0; KOCH AE, 1994, J IMMUNOL, V152, P4149; Koolwijk P, 1996, J CELL BIOL, V132, P1177, DOI 10.1083/jcb.132.6.1177; LEAVITT J, 1984, MOL CELL BIOL, V4, P1961, DOI 10.1128/MCB.4.10.1961; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; Lupia E, 1996, EUR J IMMUNOL, V26, P1690, DOI 10.1002/eji.1830260804; Mandriota SJ, 1996, J BIOL CHEM, V271, P11500, DOI 10.1074/jbc.271.19.11500; MANTOVANI A, 1992, FASEB J, V6, P2591, DOI 10.1096/fasebj.6.8.1592209; MILES DW, 1994, INT J CANCER, V56, P777, DOI 10.1002/ijc.2910560603; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; MONTRUCCHIO G, 1994, J EXP MED, V180, P377, DOI 10.1084/jem.180.1.377; NAWROTH P, 1986, J EXP MED, V167, P740; OKAMURA K, 1991, J BIOL CHEM, V266, P19162; PANDEY A, 1995, SCIENCE, V268, P567, DOI 10.1126/science.7536959; PATTERSON C, 1995, J BIOL CHEM, V270, P23111, DOI 10.1074/jbc.270.39.23111; Patterson C, 1997, J BIOL CHEM, V272, P8410, DOI 10.1074/jbc.272.13.8410; Patterson C, 1996, J CLIN INVEST, V98, P490, DOI 10.1172/JCI118816; PLATE KH, 1994, INT J CANCER, V59, P520, DOI 10.1002/ijc.2910590415; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; ROESSLER K, 1995, J NEUROSURG, V83, P291, DOI 10.3171/jns.1995.83.2.0291; Ryuto M, 1996, J BIOL CHEM, V271, P28220, DOI 10.1074/jbc.271.45.28220; Sambrook J., 2002, MOL CLONING LAB MANU; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; TERMAN BI, 1991, ONCOGENE, V6, P1677; Thomas KA, 1996, J BIOL CHEM, V271, P603, DOI 10.1074/jbc.271.2.603; TISCHER E, 1991, J BIOL CHEM, V266, P11947; VANHINSBERGH VWM, 1990, BLOOD, V75, P1991; VILCEK J, 1991, J BIOL CHEM, V266, P7313; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Yamamoto S, 1997, BRIT J CANCER, V76, P1221, DOI 10.1038/bjc.1997.537; Yoshida S, 1997, MOL CELL BIOL, V17, P4015, DOI 10.1128/MCB.17.7.4015	59	216	228	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					22128	22135		10.1074/jbc.273.34.22128	http://dx.doi.org/10.1074/jbc.273.34.22128			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705358	Green Published, hybrid			2022-12-27	WOS:000075492600092
J	Griggs, DW; Schmidt, CM; Carron, CP				Griggs, DW; Schmidt, CM; Carron, CP			Characteristics of cation binding to the I domains of LFA-1 and MAC-1 - The LFA-1 I domain contains a Ca2+-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; INTEGRIN ALPHA-2-BETA-1 VLA-2; LIGAND-BINDING; LEUKOCYTE ADHESION; A-DOMAIN; EXTRACELLULAR-MATRIX; REGULATED EXPRESSION; VONWILLEBRAND-FACTOR; CRYSTAL-STRUCTURE; CR3 CD11B/CD18	The crystal structures of the I domains of integrins MAC-1 (alpha(M)beta(2); CD11lb/CD18) and LFA-1 (alpha(L)beta(2); CD11a/CD18) show that a single conserved cation-binding site is present in each protein. Purified recombinant I domains have intrinsic ligand binding activity, and in several systems this interaction has been demonstrated to be cation-dependent, It has been proposed that the I domain cation-binding site represents a general metal ion-dependent adhesion motif utilized for binding protein ligands, Here we show that the purified recombinant I domain of LFA-I (alpha(L)I) binds cations, but with significantly different characteristics compared with the I domain of MAC-1 (alpha(M)I) Both alpha(L)I and alpha(M)I bind Mn-54(2+) in a conformation-dependent manner, and in general, cations with charge and size characteristics similar to Mn2+ most effectively inhibit Mn-54(2+) binding. Surprisingly, however, physiological levels of Ca2+ (1-2 mM) inhibited Mn-54(2+) binding to purified alpha(L)I, but not to alpha(M)I. Using Ca-45(2+) and Mn-54(2+) in direct binding studies, the dissociation constants (K-D) for the interactions between these cations and alpha(L)I were estimated to be 5-6 x 10(-5) and 1-2 x 10(-5) M, respectively. Together with the available structural information, the data suggest differential affinities for Mn2+ and Ca2+ binding to the single conserved site within alpha(L)I. Antagonism of LFA-1, but not MAC-1, -mediated cell adhesion by Ca2+ may be related to the Ca2+ binding activity of the LFA-1 I domain.	Monsanto Co, Searle Res & Dev, Discovery Pharmacol, St Louis, MO 63198 USA	Monsanto; Pfizer	Carron, CP (corresponding author), Monsanto Co, Searle Res & Dev, Discovery Pharmacol, AA3C,700 Chesterfield Village Pkwy, St Louis, MO 63198 USA.							ADAMS DH, 1994, LANCET, V343, P831, DOI 10.1016/S0140-6736(94)92029-X; ALTIERI DC, 1991, J IMMUNOL, V147, P1891; ARNAOUT MA, 1990, BLOOD, V75, P1037; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; CABANAS C, 1993, P NATL ACAD SCI USA, V90, P5838, DOI 10.1073/pnas.90.12.5838; COLOMBATTI A, 1991, BLOOD, V77, P2305; CORBI AL, 1988, J BIOL CHEM, V263, P12403; DIAMOND MS, 1993, J CELL BIOL, V120, P545, DOI 10.1083/jcb.120.2.545; DIAMOND MS, 1993, J CELL BIOL, V120, P1031, DOI 10.1083/jcb.120.4.1031; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; DRANSFIELD I, 1989, EMBO J, V8, P3759, DOI 10.1002/j.1460-2075.1989.tb08552.x; GRAHAM IL, 1991, J IMMUNOL, V146, P685; GRZESIAK JJ, 1995, J CLIN INVEST, V95, P227, DOI 10.1172/JCI117644; Henry J.B, 1996, CLIN DIAGNOSIS MANAG, V9th; JACKSON AM, 1994, IMMUNOLOGY, V81, P120; KAMATA T, 1994, J BIOL CHEM, V269, P26006; KAMATA T, 1994, J BIOL CHEM, V269, P9659; KERN A, 1994, J BIOL CHEM, V269, P22811; LANDIS RC, 1994, J CELL BIOL, V126, P529, DOI 10.1083/jcb.126.2.529; LANDIS RC, 1993, J CELL BIOL, V120, P1519, DOI 10.1083/jcb.120.6.1519; LANGE TS, 1994, EXP CELL RES, V214, P381, DOI 10.1006/excr.1994.1271; LARSON RS, 1989, J CELL BIOL, V108, P703, DOI 10.1083/jcb.108.2.703; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; MICHISHITA M, 1993, CELL, V72, P857, DOI 10.1016/0092-8674(93)90575-B; MILLER LJ, 1986, J IMMUNOL, V137, P2891; MUCHOWSKI PJ, 1994, J BIOL CHEM, V269, P26419; Petruzzelli L, 1998, J IMMUNOL, V160, P4208; QU AD, 1995, P NATL ACAD SCI USA, V92, P10277, DOI 10.1073/pnas.92.22.10277; RANDI AM, 1994, J BIOL CHEM, V269, P12395; ROSS GD, 1983, J EXP MED, V158, P334, DOI 10.1084/jem.158.2.334; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P600; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; SHAW SK, 1994, J BIOL CHEM, V269, P6016; SHIMIZU Y, 1993, J IMMUNOL, V151, P4106; SMITH JW, 1994, J BIOL CHEM, V269, P960; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; Towbin H, 1979, 10 1073 PNAS 76 9 43, V76, P4350, DOI [10.1073/pnas.76.9.4350, DOI 10.1073/PNAS.76.9.4350]; TUCKWELL D, 1995, J CELL SCI, V108, P1629; UEDA T, 1994, P NATL ACAD SCI USA, V91, P10680, DOI 10.1073/pnas.91.22.10680; WRIGHT SD, 1982, J EXP MED, V156, P1149, DOI 10.1084/jem.156.4.1149; ZHOU LB, 1994, J BIOL CHEM, V269, P17075	43	25	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					22113	22119		10.1074/jbc.273.34.22113	http://dx.doi.org/10.1074/jbc.273.34.22113			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705356	hybrid			2022-12-27	WOS:000075492600090
J	Maksymowych, AB; Simpson, LL				Maksymowych, AB; Simpson, LL			Binding and transcytosis of botulinum neurotoxin by polarized human colon carcinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL EPITHELIAL-CELLS; TOXIN TYPE-A; CLOSTRIDIAL NEUROTOXINS; TETANUS TOXIN; CACO-2 CELLS; TRANSPORT; PROTEINS; ANTAGONIZES; MONOLAYERS; INDUCTION	T-84 and Caco-2 human colon carcinoma cells and Madin-Darby canine kidney (MDCK) cells were used to study binding and transcytosis of iodinated. Clostridium botulinum neurotoxin serotypes A, B, and C, as well as tetanus toxin. Specific binding and transcytosis were demonstrated for serotypes A and B in intestinal cells. Using serotype A as an example, the rate of transcytosis by T-84 cells was determined in both apical to basolateral (11.34 fmol/h/cm(2)) as well as basolateral to apical (8.98 fmol/h/cm(2)) directions, and by Caco-2 cells in the apical to basolateral (8.42 fmol/h/cm(2)) direction. Serotype A retained intact di-chain structure during transit through T-84 or Caco-2 cells, and when released on the basolateral side was toxic in vivo to mice and in vitro on mouse phrenic nerve-hemidiaphragm preparations. Serotype C and tetanus toxin did mot bind effectively to T-84 cells, nor were they efficiently transcytosed (8-10% of serotype A). MDCK cells did not bind or efficiently transcytose (0.32 fmol/h/cm(2)) botulinum toxin, Further characterization demonstrated that the rate of transcytosis for serotype A in T-84 cells was increased 66% when vesicle sea-sting was disrupted by 5 mu M brefeldin A, decreased 42% when microtubules were disrupted by 10 mu M nocodazole, and decreased 74% art 18 degrees C. Drugs that antagonize toxin action at the nerve terminal, such as bafilomycin A, (which prevents acidification of endosomes) and methylamine HCl (which neutralizes acidification of endosomes), produced only a modest inhibitory effect on the rate of transcytosis (17-22%). These results may provide an explanation for the mechanism by which botulinum toxin escapes the human gastrointestinal tract, and they may also explain why specific serotypes cause human disease and others do not.	Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Mol Pharmacol & Biochem, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Simpson, LL (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, 1020 Locust St,Rm 314,Jefferson Alumni Hall, Philadelphia, PA 19107 USA.	lance.simpson@mail.tju.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022153] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-22153] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acheson DWK, 1996, INFECT IMMUN, V64, P3294, DOI 10.1128/IAI.64.8.3294-3300.1996; BARROSO M, 1994, J CELL BIOL, V124, P83, DOI 10.1083/jcb.124.1.83; BENLOUNES N, 1995, BIOL NEONATE, V67, P254, DOI 10.1159/000244173; BONVENTRE PF, 1979, REV INFECT DIS, V1, P663; Coffield JA, 1997, J PHARMACOL EXP THER, V280, P1489; DASGUPTA BR, 1968, J BIOL CHEM, V243, P1065; DASGUPTA BR, 1984, TOXICON, V22, P415, DOI 10.1016/0041-0101(84)90085-0; DESHPANDE D, 1994, PHARMACEUT RES, V11, P1121, DOI 10.1023/A:1018980630675; DIX CJ, 1990, GASTROENTEROLOGY, V98, P1272, DOI 10.1016/0016-5085(90)90344-Z; Gebert A, 1996, INT REV CYTOL, V167, P91, DOI 10.1016/S0074-7696(08)61346-7; Hamad ARA, 1997, J EXP MED, V185, P1447, DOI 10.1084/jem.185.8.1447; Hatheway CL, 1995, CURR TOP MICROBIOL, V195, P55; HUNZIKER W, 1990, EMBO J, V9, P3515, DOI 10.1002/j.1460-2075.1990.tb07560.x; Jahn R, 1995, COLD SPRING HARB SYM, V60, P329, DOI 10.1101/SQB.1995.060.01.037; Kiyatkin N, 1997, INFECT IMMUN, V65, P4586, DOI 10.1128/IAI.65.11.4586-4591.1997; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMANNA C, 1967, J INFECT DIS, V117, P327, DOI 10.1093/infdis/117.4.327; LENCER WI, 1993, J CLIN INVEST, V92, P2941, DOI 10.1172/JCI116917; MADARA JL, 1985, J CELL BIOL, V101, P2124, DOI 10.1083/jcb.101.6.2124; MATTER K, 1990, EMBO J, V9, P3163, DOI 10.1002/j.1460-2075.1990.tb07514.x; MIGITA K, 1994, EUR J IMMUNOL, V24, P2081, DOI 10.1002/eji.1830240922; Montecucco C, 1996, ARCH TOX S, V18, P342; MONTECUCCO C, 1994, FEBS LETT, V346, P92, DOI 10.1016/0014-5793(94)00449-8; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; Obiso RJ, 1997, INFECT IMMUN, V65, P1431, DOI 10.1128/IAI.65.4.1431-1439.1997; OBISO RJ, 1995, INFECT IMMUN, V63, P3820, DOI 10.1128/IAI.63.10.3820-3826.1995; OGUMA K, 1995, MICROBIOL IMMUNOL, V39, P161, DOI 10.1111/j.1348-0421.1995.tb02184.x; RAMANUJAM KS, 1991, AM J PHYSIOL, V260, pG416, DOI 10.1152/ajpgi.1991.260.3.G416; RODEWALD R, 1984, J CELL BIOL, V99, pS159, DOI 10.1083/jcb.99.1.159s; ROSSETTO O, 1995, J PHYSIOLOGY-PARIS, V89, P43, DOI 10.1016/0928-4257(96)80550-X; SAKAGUCHI G, 1982, PHARMACOL THERAPEUT, V19, P165, DOI 10.1016/0163-7258(82)90061-4; SANDERS AB, 1983, J FAM PRACTICE, V16, P987; Schiavo G, 1995, CURR TOP MICROBIOL, V195, P257; Shah D, 1996, J PHARM SCI-US, V85, P1306, DOI 10.1021/js9601400; Simpson L.L., 1989, BOTULINUM NEUROTOXIN; SIMPSON LL, 1988, METHOD ENZYMOL, V165, P76; SIMPSON LL, 1993, J PHARMACOL EXP THER, V267, P720; SIMPSON LL, 1988, J PHARMACOL EXP THER, V245, P867; SIMPSON LL, 1981, PHARMACOL REV, V33, P155; SIMPSON LL, 1986, ANNU REV PHARMACOL, V26, P427, DOI 10.1146/annurev.pa.26.040186.002235; SIMPSON LL, 1980, J PHARMACOL EXP THER, V212, P16; SIMPSON LL, 1994, J PHARMACOL EXP THER, V269, P256; SIMPSON LL, 1983, J PHARMACOL EXP THER, V225, P546; SUGII S, 1977, INFECT IMMUN, V17, P491, DOI 10.1128/IAI.17.3.491-496.1977; ZHANG RE, 1995, GENE, V159, P293, DOI 10.1016/0378-1119(95)00152-V	45	95	104	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21950	21957		10.1074/jbc.273.34.21950	http://dx.doi.org/10.1074/jbc.273.34.21950			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705335	hybrid			2022-12-27	WOS:000075492600069
J	Nielsen, LB; Kahn, D; Duell, T; Weier, HUG; Taylor, S; Young, SG				Nielsen, LB; Kahn, D; Duell, T; Weier, HUG; Taylor, S; Young, SG			Apolipoprotein B gene expression in a series of human apolipoprotein B transgenic mice generated with recA-assisted restriction endonuclease cleavage-modified bacterial artificial chromosomes - An intestine-specific enhancer element is located between 54 and 62 kilobases 5 ' to the structural gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCUS-CONTROL REGION; BETA-GLOBIN GENE; RARE CLEAVAGE; TYROSINASE GENE; DNA; PROMOTER; LIVER; LIPOPROTEIN(A); DISEASE; DISTANT	Prior studies have established that the expression of the human apolipoprotein B (apoB) gene in the intestine is dependent on DNA sequences located a great distance from the structural gene. To identify the location of those sequences, we used recA-assisted restriction endonuclease (RARE) cleavage to truncate the 5'- or 3'-flanking sequences from a 145-kilobase (kb) bacterial artificial chromosome spanning the entire human apoB gene. Seven RARE cleavage- modified bacterial artificial chromosomes with different lengths of flanking sequences were used to generate transgenic mice. An analysis of those mice revealed that as little as 1.5 kb of 3' sequences or 5 kb of 5' sequences were sufficient to confer apoB expression in the liver. in contrast, apoB gene expression in the intestine required DNA sequences 54-62 kb 5' to the structural gene. Those sequences retained their ability to direct apoB expression hn the intestine when they were moved closer to the gene. These studies demonstrate that the intestinal expression of the apoB gene is dependent on DNA sequences located an extraordinary distance from the structural gene and that the RARE cleavage/transgenic expression strategy is a powerful approach for analyzing distant gene-regulatory sequences.	Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94143 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Young, SG (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, POB 419100, San Francisco, CA 94141 USA.		Kahn, Daniel/B-9393-2013	Kahn, Daniel/0000-0001-8093-0854; Young, Stephen/0000-0001-7270-3176	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL047660] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL47660] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allan CM, 1997, J BIOL CHEM, V272, P29113, DOI 10.1074/jbc.272.46.29113; Boren J, 1996, GENOME RES, V6, P1123, DOI 10.1101/gr.6.11.1123; CALLOW MJ, 1994, P NATL ACAD SCI USA, V91, P2130, DOI 10.1073/pnas.91.6.2130; CALLOW MJ, 1994, NUCLEIC ACIDS RES, V22, P4348, DOI 10.1093/nar/22.20.4348; CATERINA JJ, 1991, P NATL ACAD SCI USA, V88, P1626, DOI 10.1073/pnas.88.5.1626; Duell T, 1997, CYTOGENET CELL GENET, V79, P64, DOI 10.1159/000134685; ECCLES S, 1990, New Biologist, V2, P801; FAN J, 1995, CIRCULATION, V92, P104; Ferrin L J, 1995, Genet Eng (N Y), V17, P21; FERRIN LJ, 1994, NAT GENET, V6, P379, DOI 10.1038/ng0494-379; FERRIN LJ, 1991, SCIENCE, V254, P1494, DOI 10.1126/science.1962209; FERRIN TE, 1988, J MOL GRAPHICS, V6, P13, DOI 10.1016/0263-7855(88)80054-7; Gregg Richard E., 1994, Current Opinion in Lipidology, V5, P81, DOI 10.1097/00041433-199404000-00003; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; HAMMER RE, 1990, CELL, V63, P1099, DOI 10.1016/0092-8674(90)90512-D; Havel RJ, 1995, METABOLIC MOL BASES, V7th, P1841, DOI [10.1036/ommbid.142, DOI 10.1036/OMMBID.142]; Hug BA, 1996, MOL CELL BIOL, V16, P2906; JONES BK, 1995, MOL CELL BIOL, V15, P7010; LEVYWILSON B, 1989, J BIOL CHEM, V264, P21196; LEVYWILSON B, 1995, PROG NUCLEIC ACID RE, V50, P161, DOI 10.1016/S0079-6603(08)60814-4; LINTON MF, 1993, J CLIN INVEST, V92, P3029, DOI 10.1172/JCI116927; LINTON MF, 1993, J LIPID RES, V34, P521; LOWREY CH, 1992, P NATL ACAD SCI USA, V89, P143; Martin DIK, 1996, CURR OPIN GENET DEV, V6, P488, DOI 10.1016/S0959-437X(96)80072-4; McCormick SPA, 1996, J BIOL CHEM, V271, P11963, DOI 10.1074/jbc.271.20.11963; McCormick SPA, 1996, TRENDS CARDIOVAS MED, V6, P16, DOI 10.1016/1050-1738(95)00125-5; MCCORMICK SPA, 1994, GENET ANAL-BIOMOL E, V11, P158, DOI 10.1016/1050-3862(94)90036-1; MCCORMICK SPA, 1997, TRANSGENIC ANIMALS G, P273; Montoliu L, 1996, EMBO J, V15, P6026, DOI 10.1002/j.1460-2075.1996.tb00991.x; Nielsen LB, 1997, J BIOL CHEM, V272, P29752, DOI 10.1074/jbc.272.47.29752; PAUL M, 1994, ANNU REV PHYSIOL, V56, P811, DOI 10.1146/annurev.ph.56.030194.004115; PAULWEBER B, 1991, J BIOL CHEM, V266, P21956; PAULWEBER B, 1991, J BIOL CHEM, V266, P24161; PURCELLHUYNH DA, 1995, J CLIN INVEST, V95, P2246, DOI 10.1172/JCI117915; SCHEDL A, 1993, NUCLEIC ACIDS RES, V21, P4783, DOI 10.1093/nar/21.20.4783; SCHEDL A, 1993, NATURE, V362, P258, DOI 10.1038/362258a0; SHACHTER NS, 1993, J LIPID RES, V34, P1699; Silver L.M., 1995, MOUSE GENETICS CONCE; SIMONET WS, 1993, J BIOL CHEM, V268, P8221; SIMONET WS, 1990, T ASSOC AM PHYSICIAN, V103, P119; STAMATOYANNOPOULOS JA, 1995, EMBO J, V14, P106, DOI 10.1002/j.1460-2075.1995.tb06980.x; STEINBERG D, 1990, JAMA-J AM MED ASSOC, V264, P3047, DOI 10.1001/jama.264.23.3047; STRICH D, 1993, J PEDIATR GASTR NUTR, V16, P257, DOI 10.1097/00005176-199304000-00006; TAYLOR JM, 1993, CURR OPIN LIPIDOL, V4, P84, DOI 10.1097/00041433-199304000-00002; TOWNES TM, 1990, TRENDS GENET, V6, P219, DOI 10.1016/0168-9525(90)90182-6; WALSH A, 1993, J LIPID RES, V34, P617; WEIER HUG, 1995, HUM MOL GENET, V4, P1903; Young SG, 1995, J CLIN INVEST, V96, P2932, DOI 10.1172/JCI118365; YOUNG SG, 1990, CIRCULATION, V82, P1574, DOI 10.1161/01.CIR.82.5.1574; YOUNG SG, 1994, WESTERN J MED, V160, P153; YOUNG SG, 1998, IN PRESS MOL BASIS H	51	35	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21800	21807		10.1074/jbc.273.34.21800	http://dx.doi.org/10.1074/jbc.273.34.21800			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705318	Green Submitted, hybrid			2022-12-27	WOS:000075492600052
J	Quan, YD; Inouye, P; Liang, C; Rong, LW; Gotte, M; Wainberg, MA				Quan, YD; Inouye, P; Liang, C; Rong, LW; Gotte, M; Wainberg, MA			Dominance of the E89G substitution in HIV-1 reverse transcriptase in regard to increased polymerase processivity and patterns of pausing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIGH-LEVEL RESISTANCE; ANGSTROM RESOLUTION; REDUCED SENSITIVITY; KINETIC-PROPERTIES; INVITRO SELECTION; CRYSTAL-STRUCTURE; CROSS-RESISTANCE; DRUG-RESISTANT; GLU-89 RESIDUE	The substitution of a glycine for glutamic acid at position 89 in human immunodeficiency virus-1 (HIV-1) reverse transcriptase (RT) (E89G) confers resistance to several nucleoside and non-nucleoside inhibitors of RT. As residue 89 contacts the template strand, it has been suggested that this mutation may modulate the conformation of the RT.template/primer complex. in addition, certain mutations in RT that confer resistance to nucleoside analogs, such as M184V, ape located near the polymerase active site. To characterize further these substitutions, we performed processivity assays alongside era analysis of pausing profiles with wild-type (nt) RT and recombinant RTs containing substitutions at E89G, M184V, or both, We now show that E89G RT has higher processivity thats wt enzyme as well as a different pattern of pausing sites. Similar findings were obtained with the doubly mutated RT, although enzyme containing only the M184V mutation had lower processivity thats wt. Consistent with these observations, and from a mechanistic standpoint, both E89G-containing as well as doubly mutated RT had decreased dissociation constants from a complex consisting of RT and template-primer, in comparison with either mt RT or M184V-containing RT. No significant differences were observed among the various enzymes in regard to K-m values for the heteropolymeric RNA template used in these studies. Viruses containing the E89G mutation synthesized longer strand DNA products than either wt viruses or viruses containing only the M184V mutation in endogenous RT assays. Thus, the E89G substitution is a dominant determinant in regard to each of the k(off) values from an RT.template/primer complex, RT processivity, and specific patterns of pausing during DNA polymerization.	McGill Univ, Lady Davis Inst Med Res, McGill AIDS Ctr, Sir Mortimer B Davis Jewish Hosp, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University	Wainberg, MA (corresponding author), McGill Univ, Lady Davis Inst Med Res, McGill AIDS Ctr, Sir Mortimer B Davis Jewish Hosp, 3755 Cote Ste Catherine Rd, Montreal, PQ H3T 1E2, Canada.	mdwa@musica.mcgill.ca						Arion D, 1996, J BIOL CHEM, V271, P19860, DOI 10.1074/jbc.271.33.19860; ARTS EJ, 1994, J BIOL CHEM, V269, P14672; Back NKT, 1996, EMBO J, V15, P4040, DOI 10.1002/j.1460-2075.1996.tb00777.x; BEBENEK K, 1989, J BIOL CHEM, V264, P16948; BOUCHER CAB, 1993, ANTIMICROB AGENTS CH, V37, P2231, DOI 10.1128/AAC.37.10.2231; BOYER JC, 1992, P NATL ACAD SCI USA, V89, P6919, DOI 10.1073/pnas.89.15.6919; BOYER PL, 1992, J VIROL, V66, P1031, DOI 10.1128/JVI.66.2.1031-1039.1992; BOYER PL, 1994, P NATL ACAD SCI USA, V91, P4882, DOI 10.1073/pnas.91.11.4882; BOYER PL, 1995, ANTIMICROB AGENTS CH, V39, P1624, DOI 10.1128/AAC.39.7.1624; Caliendo AM, 1996, J VIROL, V70, P2146, DOI 10.1128/JVI.70.4.2146-2153.1996; CROTHERS DM, 1990, J BIOL CHEM, V265, P7093; DARLIX JL, 1995, J MOL BIOL, V254, P523, DOI 10.1006/jmbi.1995.0635; DEBOUCK C, 1987, P NATL ACAD SCI USA, V84, P8903, DOI 10.1073/pnas.84.24.8903; Drosopoulos WC, 1996, J VIROL, V70, P4834, DOI 10.1128/JVI.70.7.4834-4838.1996; Essink BBO, 1997, NUCLEIC ACIDS RES, V25, P3212, DOI 10.1093/nar/25.16.3212; GAO Q, 1992, J VIROL, V66, P12, DOI 10.1128/JVI.66.1.12-19.1992; GAO Q, 1993, ANTIMICROB AGENTS CH, V37, P1390, DOI 10.1128/AAC.37.6.1390; GU ZX, 1992, J VIROL, V66, P7128, DOI 10.1128/JVI.66.12.7128-7135.1992; GU ZX, 1994, J BIOL CHEM, V269, P28118; GU ZX, 1994, ANTIMICROB AGENTS CH, V38, P275, DOI 10.1128/AAC.38.2.275; Hsu ML, 1997, NUCLEIC ACIDS RES, V25, P4532, DOI 10.1093/nar/25.22.4532; HUBER HE, 1989, J BIOL CHEM, V264, P4669; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; JAPOUR AJ, 1991, P NATL ACAD SCI USA, V88, P3092, DOI 10.1073/pnas.88.8.3092; KELLAM P, 1992, P NATL ACAD SCI USA, V89, P1934, DOI 10.1073/pnas.89.5.1934; KEW Y, 1994, J BIOL CHEM, V269, P15331; Kew Y, 1996, ANTIMICROB AGENTS CH, V40, P1711, DOI 10.1128/AAC.40.7.1711; KLARMANN GJ, 1993, J BIOL CHEM, V268, P9793; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Kornberg A., 1992, DNA REPLICATION; Lanchy JM, 1996, EMBO J, V15, P7178, DOI 10.1002/j.1460-2075.1996.tb01109.x; LARDER BA, 1991, J VIROL, V65, P5232, DOI 10.1128/JVI.65.10.5232-5236.1991; LARDER BA, 1987, NATURE, V327, P716, DOI 10.1038/327716a0; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; LARDER BA, 1989, SCIENCE, V246, P1155, DOI 10.1126/science.2479983; LeGrice SFJ, 1995, METHOD ENZYMOL, V262, P130, DOI 10.1016/0076-6879(95)62015-X; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; MCHENRY CS, 1989, MOL BIOL CHROMOSOME, P97; PATEL PH, 1995, BIOCHEMISTRY-US, V34, P5351, DOI 10.1021/bi00016a006; Perach M, 1997, J MOL BIOL, V268, P648, DOI 10.1006/jmbi.1997.0927; PRASAD VR, 1991, P NATL ACAD SCI USA, V88, P11363, DOI 10.1073/pnas.88.24.11363; Preston BD, 1996, TRENDS MICROBIOL, V4, P16, DOI 10.1016/0966-842X(96)81500-9; Quan YD, 1996, J VIROL, V70, P5642, DOI 10.1128/JVI.70.8.5642-5645.1996; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; SCHINAZI RF, 1993, ANTIMICROB AGENTS CH, V37, P875, DOI 10.1128/AAC.37.4.875; SONG QG, 1992, J VIROL, V66, P7568, DOI 10.1128/JVI.66.12.7568-7571.1992; Sousa R, 1996, TRENDS BIOCHEM SCI, V21, P186, DOI 10.1016/S0968-0004(96)10023-2; STCLAIR MH, 1991, SCIENCE, V253, P1557, DOI 10.1126/science.1716788; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; TANTILLO C, 1994, J MOL BIOL, V243, P369, DOI 10.1006/jmbi.1994.1665; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653; Wainberg MA, 1996, SCIENCE, V271, P1282, DOI 10.1126/science.271.5253.1282; WAKEFIELD JK, 1992, J VIROL, V66, P6806, DOI 10.1128/JVI.66.11.6806-6812.1992; WANG J, 1994, P NATL ACAD SCI USA, V91, P7242, DOI 10.1073/pnas.91.15.7242; WILLIAMS KJ, 1990, J BIOL CHEM, V265, P18682; ZHANG D, 1994, ANTIMICROB AGENTS CH, V38, P282, DOI 10.1128/AAC.38.2.282	56	18	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21918	21925		10.1074/jbc.273.34.21918	http://dx.doi.org/10.1074/jbc.273.34.21918			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705331	hybrid			2022-12-27	WOS:000075492600065
J	Ruckemann, K; Fairbanks, LD; Carrey, EA; Hawrylowicz, CM; Richards, DF; Kirschbaum, B; Simmonds, HA				Ruckemann, K; Fairbanks, LD; Carrey, EA; Hawrylowicz, CM; Richards, DF; Kirschbaum, B; Simmonds, HA			Leflunomide inhibits pyrimidine de Novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOSUPPRESSIVE AGENT LEFLUNOMIDE; DIHYDROOROTIC ACID DEHYDROGENASE; TYROSINE KINASE-ACTIVITY; PROLIFERATION IN-VITRO; DE-NOVO; NUCLEOTIDE BIOSYNTHESIS; BREQUINAR SODIUM; CELLS; TRANSPLANTATION; PHOSPHORYLATION	The mode of action of Leflunomide, an immunomodulatory drug used in rheumatoid arthritis, is debated, This study, using C-14-labeled de novo purine and pyrimidine synthesis precursors, proves conclusively that the prime target in proliferating human T-lymphocytes is pyrimidine biosynthesis at the level of dihydroorotic-acid dehydrogenase. Leflunomide (25 and 50 mu M), like Brequinar (0.5 and 1 mu M), a demonstrated dihydroorotic-acid dehydrogenase inhibitor, was cytostatic, not cytotoxic, with proliferation being halted in the G(1) phase. Both drugs restricted the normal 4-8-fold mitogen-induced expansion of pyrimidine pools over 72 h to concentrations found in nonstimulated T-cells and [C-14]bicarbonate incorporation into UTP, ATP, and GTP. Uridine (50 mu M) restored expansion of all pools, but [C-14]bicarbonate incorporation into ATP and GTP only, not UTP, [C-14]Hypoxanthine salvage was also restricted, indicating that purine salvage pathways are compromised likewise by both inhibitors, [C-14]Glycine studies confirmed that restriction of de novo purine synthesis occurred secondary to inhibition of proliferation since this was reversed by uridine rescue, except at 100 mu M Leflunomide. 100 mu M Leflunomide markedly depleted ATP and GTP pools also, which would have serious consequences for ATP-dependent enzymes essential to the immune response, thereby explaining non-pyrimidine-related effects reported for Leflunomide at 100 mu M and above.	Guys Hosp, UMDS, Purine Res Lab, London SE1 9RT, England; Guys Hosp, UMDS, Dept Allergy & Resp Med, London SE1 9RT, England; St Thomas Hosp, UMDS, Dept Allergy & Resp Med, London SE1 9RT, England; St Thomas Hosp, UMDS, Purine Res Lab, London SE1 9RT, England; Royal Free Hosp, Sch Med, Dept Biochem & Mol Biol, London NW3 2PF, England; Hoechst Marion Roussel, D-65926 Frankfurt, Germany	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Sanofi-Aventis	Simmonds, HA (corresponding author), Guys Hosp, UMDS, Purine Res Lab, 5th Floor Thomas Guy House, London SE1 9RT, England.		Hawrylowicz, Catherine/Q-8483-2017	Hawrylowicz, Catherine/0000-0002-2337-7463; Ruckemann-Dziurdzinska, Katarzyna/0000-0002-5018-0818				Barinaga M, 1997, SCIENCE, V278, P1036, DOI 10.1126/science.278.5340.1036; Bartlett Robert R., 1994, P349; BARTLETT RR, 1991, AGENTS ACTIONS, V32, P10, DOI 10.1007/BF01983301; BOFILL M, 1995, J BIOL CHEM, V270, P29690, DOI 10.1074/jbc.270.50.29682; CHERWINSKI HM, 1995, J PHARMACOL EXP THER, V275, P1043; CHERWINSKI HM, 1995, INFLAMM RES, V44, P317, DOI 10.1007/BF01796261; CHERWINSKI HM, 1995, J PHARMACOL EXP THER, V272, P460; Chong ASF, 1996, TRANSPLANTATION, V61, P140, DOI 10.1097/00007890-199601150-00026; CHRISTOPHERSON RI, 1979, J BIOL CHEM, V254, P2506; CLEAVELAND ES, 1995, BIOCHEM PHARMACOL, V49, P947, DOI 10.1016/0006-2952(95)00009-O; Elder RT, 1997, J IMMUNOL, V159, P22; EUGUI EM, 1991, SCAND J IMMUNOL, V33, P161, DOI 10.1111/j.1365-3083.1991.tb03746.x; FAIRBANKS LD, 1995, J BIOL CHEM, V270, P29682; GREENE S, 1995, BIOCHEM PHARMACOL, V50, P861, DOI 10.1016/0006-2952(95)00255-X; HEMMENS B, 1994, EUR J BIOCHEM, V225, P845, DOI 10.1111/j.1432-1033.1994.0845b.x; KEMP AJ, 1986, J BIOL CHEM, V261, P4891; Knecht W, 1996, EUR J BIOCHEM, V240, P292, DOI 10.1111/j.1432-1033.1996.0292h.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAKOWKA L, 1993, IMMUNOL REV, V136, P51, DOI 10.1111/j.1600-065X.1993.tb00654.x; MARIJNEN YMT, 1989, BIOCHIM BIOPHYS ACTA, V1012, P148, DOI 10.1016/0167-4889(89)90088-8; MATTAR T, 1993, FEBS LETT, V334, P161, DOI 10.1016/0014-5793(93)81704-4; MLADENOVIC V, 1995, ARTHRITIS RHEUM-US, V38, P1595, DOI 10.1002/art.1780381111; NAIR RV, 1995, IMMUNOL LETT, V47, P171, DOI 10.1016/0165-2478(95)00074-5; NIKCEVICH DA, 1994, AGENTS ACTIONS, V41, pC279, DOI 10.1007/BF01987669; PETERS GJ, 1990, CANCER RES, V50, P4644; PETERS GJ, 1987, INVEST NEW DRUGS B, V253, P375; PETERS GJ, 1992, BRIT J CANCER, V365, P229; SAMELSON LE, 1986, NATURE, V324, P674, DOI 10.1038/324674a0; SASVARISZEKELY M, 1993, BIOCHEM BIOPH RES CO, V194, P966, DOI 10.1006/bbrc.1993.1915; SEBESTA I, 1994, CLIN CHIM ACTA, V224, P45, DOI 10.1016/0009-8981(94)90119-8; Siemasko KF, 1996, TRANSPLANTATION, V61, P635, DOI 10.1097/00007890-199602270-00020; Silva H T Jr, 1997, Expert Opin Investig Drugs, V6, P51, DOI 10.1517/13543784.6.1.51; Silva HT, 1997, TRANSPL P, V29, P1292, DOI 10.1016/S0041-1345(96)00523-4; Simmonds H., 1991, TECHNIQUES DIAGNOSTI, P397; Simmonds HA, 1995, BIOCHEM SOC T, V23, P877, DOI 10.1042/bst0230877; SIMON P, 1993, TRANSPLANT P, V25, P77; SOKOLOSKI JA, 1987, INT J CANCER, V39, P764, DOI 10.1002/ijc.2910390618; VANDENBERG AA, 1994, LEUKEMIA, V8, P1375; WEBSTER DR, 1995, METABOLIC MOL BASIS, P1725; WILLIAMSON RA, 1995, J BIOL CHEM, V270, P22467, DOI 10.1074/jbc.270.38.22467; Xu XL, 1997, J IMMUNOL, V159, P167; XU XL, 1995, J BIOL CHEM, V270, P12398, DOI 10.1074/jbc.270.21.12398; Xu XL, 1996, BIOCHEM PHARMACOL, V52, P527, DOI 10.1016/0006-2952(96)00303-6; Zielinski T., 1995, Inflammation Research, V44, pS207, DOI 10.1007/BF01778336; ZIELINSKI T, 1994, AGENTS ACTIONS, V41, P205	45	214	226	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21682	21691		10.1074/jbc.273.34.21682	http://dx.doi.org/10.1074/jbc.273.34.21682			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705303	hybrid			2022-12-27	WOS:000075492600037
J	Singh, U; Rogers, JB				Singh, U; Rogers, JB			The novel core promoter element GAAC in the hgl5 gene of Entamoeba histolytica is able to direct a transcription start site independent of TATA or initiator regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; BINDING PROTEIN; EXPRESSION; DNA; TRANSFECTION; RECOGNITION; COMPLEX; BOX	Entamoeba histolytica, an enteric protozoa, is the third leading parasitic cause of death worldwide. Investigation of the transcriptional machinery of this eukaryotic pathogen has revealed an unusual core promoter structure that consists of nonconsensus TATA and initiator regions and a novel third conserved core promoter sequence, the GAAC element. Mutation of this region in the hgl5 promoter decreases reporter gene expression and alters the transcription start site. Using positional analysis of this element, we have now demonstrated that it is able to direct a new transcription start site, 2-7 bases downstream of itself, independent of TATA and Inr regions. The GAAC region was also shown to control the rate of transcription via nuclear run on analysis and an amebic nuclear protein was demonstrated to specifically interact with this sequence. This is the first description in the eukaryotic literature of a third conserved core promoter element, distinct from TATA or initiator regions, that is able to direct a transcription start site. We have formulated two models for the role of the GAAC region: (i) the GAAC-binding protein is a part of the TFIID complex and (ii) the GAAC-binding protein functions to "tether" TATA-binding protein to the TATA box.	Univ Virginia, Hlth Sci Ctr, Dept Med, Charlottesville, VA 22908 USA	University of Virginia	Singh, U (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Med, Rm 2115,MR 4 Bldg,300 Pk Pl, Charlottesville, VA 22908 USA.			Singh, Upinder/0000-0003-0630-0306	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037941, K08AI001453] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI-37941, K08-AI 01453] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BRUCHHAUS I, 1993, DNA CELL BIOL, V12, P925, DOI 10.1089/dna.1993.12.925; BURATOWSKI S, 1997, CURRENT PROTOCOLS MO; Burke TW, 1996, GENE DEV, V10, P711, DOI 10.1101/gad.10.6.711; CHORY J, 1997, CURRENT PROTOCOLS MO; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; DVORAK JA, 1995, J EUKARYOT MICROBIOL, V42, P610, DOI 10.1111/j.1550-7408.1995.tb05915.x; GELDERMAN AH, 1971, J PARASITOL, V57, P906, DOI 10.2307/3277826; Gilchrist CA, 1998, INFECT IMMUN, V66, P2383, DOI 10.1128/IAI.66.5.2383-2386.1998; Gomez C, 1998, J BIOL CHEM, V273, P7277, DOI 10.1074/jbc.273.13.7277; GREENBERG ME, 1997, CURRENT PROTOCOLS MO; IMBALZANO AN, 1994, J BIOL CHEM, V269, P8280; Jiang JG, 1997, MOL CELL BIOL, V17, P5758, DOI 10.1128/MCB.17.10.5758; KAUFMANN J, 1994, GENE DEV, V8, P821, DOI 10.1101/gad.8.7.821; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; LIOUTAS C, 1995, MOL BIOCHEM PARASIT, V73, P259, DOI 10.1016/0166-6851(95)00101-6; MCANDREW MB, 1993, GENE, V124, P165, DOI 10.1016/0378-1119(93)90390-O; Miglarese MR, 1996, J BIOL CHEM, V271, P22697, DOI 10.1074/jbc.271.37.22697; Nikolov DB, 1997, P NATL ACAD SCI USA, V94, P15, DOI 10.1073/pnas.94.1.15; Perez DG, 1998, J BIOL CHEM, V273, P7285, DOI 10.1074/jbc.273.13.7285; Pugh BF, 1996, CURR OPIN CELL BIOL, V8, P303, DOI 10.1016/S0955-0674(96)80002-0; Purdy JE, 1996, MOL BIOCHEM PARASIT, V78, P91, DOI 10.1016/S0166-6851(96)02614-X; PURDY JE, 1994, P NATL ACAD SCI USA, V91, P7099, DOI 10.1073/pnas.91.15.7099; Ramakrishnan G, 1997, MOL BIOCHEM PARASIT, V84, P93, DOI 10.1016/S0166-6851(96)02784-3; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Singh U, 1997, P NATL ACAD SCI USA, V94, P8812, DOI 10.1073/pnas.94.16.8812; TANNICH E, 1992, J MOL EVOL, V34, P272, DOI 10.1007/BF00162976; TAYLOR ICA, 1990, MOL CELL BIOL, V10, P165, DOI 10.1128/MCB.10.1.165; VINES RR, 1995, MOL BIOCHEM PARASIT, V71, P265, DOI 10.1016/0166-6851(95)00057-8; Yanai K, 1996, J BIOL CHEM, V271, P15981, DOI 10.1074/jbc.271.27.15981; ZENZIEGREGORY B, 1993, MOL CELL BIOL, V13, P3841, DOI 10.1128/MCB.13.7.3841	30	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21663	21668		10.1074/jbc.273.34.21663	http://dx.doi.org/10.1074/jbc.273.34.21663			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705300	hybrid			2022-12-27	WOS:000075492600034
J	Yasuda, H; Lindorfer, MA; Myung, CS; Garrison, JC				Yasuda, H; Lindorfer, MA; Myung, CS; Garrison, JC			Phosphorylation of the G protein gamma(12) subunit regulates effector specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-BETA-GAMMA; BACULOVIRUS EXPRESSION SYSTEM; HETEROTRIMERIC G-PROTEINS; TRIMERIC G-PROTEINS; PHOSPHOLIPASE-C; KINASE-C; ADENOSINE RECEPTORS; ADENYLYL CYCLASES; CRYSTAL-STRUCTURE; ALPHA-SUBUNIT	Although the G protein beta gamma dimer is an important mediator in cell signaling, the mechanisms regulating its activity have not been widely investigated. The gamma(12) subunit is a known substrate for protein kinase C, suggesting phosphorylation as a potential regulatory mechanism. Therefore, recombinant beta(1)gamma(12) dimers were overexpressed using the baculovirus/Sf9 insect cell system,, purified, and phosphorylated stoichiometrically with protein kinase C alpha. Their ability to support coupling of the G(il) alpha subunit to the A1 adenosine receptor and to activate type II adenylyl cyclase or phospholipase C-beta was examined, Phosphorylation of the beta(1)gamma(12) dimer increased its potency in the receptor coupling assay from 6.4 to 1 nM, change the K-act for stimulation of type II adenylyl cyclase from 14 to 37 nM, and decreased its maximal efficacy by 50%. In contrast, phosphorylation of the dimer had no effect on its ability to activate phospholipase C-beta. The native beta(1)gamma(10) dimer, which has 4 similar amino acids in the phosphorylation site at the N terminus, was not phosphorylated by protein kinase C alpha. Creation of a phosphorylation site in the N terminus of the protein (Gly(4) --> Lys) resulted in a beta(1)gamma(10G4K) dimer which could be phosphorylated. The activities of this beta gamma dimer were similar to those of the phosphorylated beta(1)gamma(12) dimer Thus, phosphorylation of the beta(1)gamma(12) dimer ore the gamma subunit with protein kinase C alpha regulates its activity in an effector-specific fashion. Because the gamma(12) subunit is widely expressed, phosphorylation may be an important mechanism for integration of the multiple signals generated by receptor activation.	Univ Virginia, Hlth Sci Ctr, Dept Pharmacol, Charlottesville, VA 22908 USA	University of Virginia	Garrison, JC (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Pharmacol, Box 448, Charlottesville, VA 22908 USA.	jcg8w@virginia.edu		Myung, Chang-Seon/0000-0002-6292-2911	NATIONAL CANCER INSTITUTE [P01CA040042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019952] Funding Source: NIH RePORTER; NCI NIH HHS [P01-CA 40042] Funding Source: Medline; NIDDK NIH HHS [R01-DK-19952] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Asano T, 1998, EUR J BIOCHEM, V251, P314, DOI 10.1046/j.1432-1327.1998.2510314.x; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; BROOKER G, 1976, SCIENCE, V194, P270, DOI 10.1126/science.184530; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; Figler RA, 1996, MOL PHARMACOL, V50, P1587; Fletcher JE, 1998, J BIOL CHEM, V273, P636, DOI 10.1074/jbc.273.1.636; FLORIO VA, 1989, J BIOL CHEM, V264, P3909; FUNG BKK, 1983, J BIOL CHEM, V258, P495; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRABER SG, 1994, METHOD ENZYMOL, V237, P212; GRABER SG, 1992, J BIOL CHEM, V267, P1271; GRABER SG, 1996, METH NEUROSCI, V29, P207; Gudermann T, 1996, ANNU REV PHARMACOL, V36, P429; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; HAWES BE, 1994, J BIOL CHEM, V269, P29825; Hawes BE, 1996, J BIOL CHEM, V271, P12133, DOI 10.1074/jbc.271.21.12133; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; JACOBOWITZ O, 1994, P NATL ACAD SCI USA, V91, P10630, DOI 10.1073/pnas.91.22.10630; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KISSELEV O, 1995, J BIOL CHEM, V270, P25356, DOI 10.1074/jbc.270.43.25356; Kuang YN, 1996, P NATL ACAD SCI USA, V93, P2964, DOI 10.1073/pnas.93.7.2964; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LEE CH, 1995, J BIOL CHEM, V270, P8779, DOI 10.1074/jbc.270.15.8779; LEE RH, 1990, J BIOL CHEM, V265, P15860; Leeuw T, 1998, NATURE, V391, P191, DOI 10.1038/34448; Liu JP, 1996, MOL CELL ENDOCRINOL, V116, P1, DOI 10.1016/0303-7207(95)03706-3; Morishita R, 1997, J NEUROCHEM, V68, P820; MORISHITA R, 1995, J BIOL CHEM, V270, P29469, DOI 10.1074/jbc.270.49.29469; MORRIS AJ, 1990, J BIOL CHEM, V265, P13501; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; MOTULSKY HJ, 1987, FASEB J, V1, P365, DOI 10.1096/fasebj.1.5.3315805; Muller S, 1996, J BIOL CHEM, V271, P11781, DOI 10.1074/jbc.271.20.11781; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; RAY K, 1995, J BIOL CHEM, V270, P21765, DOI 10.1074/jbc.270.37.21765; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Robeva AS, 1996, BIOCHEM PHARMACOL, V51, P545, DOI 10.1016/0006-2952(95)02235-X; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; Sankaran B, 1998, J BIOL CHEM, V273, P7148, DOI 10.1074/jbc.273.12.7148; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; SPRING DJ, 1994, J BIOL CHEM, V269, P22882; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; SUMMERS MD, 1987, TEXAS AGR EXPT STATI, V1555, P1; Sunahara RK, 1996, ANNU REV PHARMACOL, V36, P461, DOI 10.1146/annurev.pa.36.040196.002333; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; TAUSSIG R, 1993, J BIOL CHEM, V268, P9; Ueda H, 1997, J CELL SCI, V110, P1503; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; Yasuda H, 1996, J BIOL CHEM, V271, P18588, DOI 10.1074/jbc.271.31.18588; YOSHIDA T, 1994, J BIOL CHEM, V269, P24050; Zimmermann G, 1996, J BIOL CHEM, V271, P27161, DOI 10.1074/jbc.271.43.27161	69	41	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21958	21965		10.1074/jbc.273.34.21958	http://dx.doi.org/10.1074/jbc.273.34.21958			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705336	hybrid			2022-12-27	WOS:000075492600070
J	Zhang, M; Stauffacher, CV; Lin, DY; Van Etten, RL				Zhang, M; Stauffacher, CV; Lin, DY; Van Etten, RL			Crystal structure of a human low molecular weight phosphotyrosyl phosphatase - Implications for substrate specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; ACID-PHOSPHATASE; BOVINE HEART; ACP1; SEQUENCE; ISOZYMES; EXPRESSION; TUNGSTATE; RESIDUES; CLONING	The low molecular weight phosphotyrosine phosphatases (PTPases) constitute a distinctive class of phosphotyrosine phosphatases that is widely distributed among vertebrate and invertebrate organisms, In vertebrates, two isoenzymes of these low molecular weight PTPases are commonly expressed. The two human isoenzymes, HCPTPA and HCPTPB, differ in an alternatively spliced sequence (residues 40-73) referred to as the variable loop, resulting in isoenzymes that have different substrate specificities and inhibitor/activator responses. We present here the x-ray crystallographic structure of a human low molecular weight PT-Pase solved by molecular replacement to 2.2 Angstrom. The structure of human Bow molecular weight PTPase is compared with a structure representing the other isoenzyme in this PTPase class, in each case with a sulfonate inhibitor bound to the active site. Possible aromatic residue interactions with the phosphotyrosine substrate are proposed from an examination of the binding site of the inhibitors. Differences are observed in the variable loop region, which forms one wall and the floor of a long crevice leading from the active-site loop. A set of residues lying along this crevice (amino acids 49, 50, and 53) is suggested to be responsible for differences in substrate specificity in these two enzymes.	Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Van Etten, RL (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.				NIGMS NIH HHS [GM 27003] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027003] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; BRYSON GLM, 1995, GENOMICS, V30, P133; CAVALLISFORZA L, 1994, HIST GEOGRAPHY HUMAN, P185; Cirri P, 1996, J BIOL CHEM, V271, P2604, DOI 10.1074/jbc.271.5.2604; DISSING J, 1992, BIOCHIM BIOPHYS ACTA, V1121, P261, DOI 10.1016/0167-4838(92)90155-7; DISSING J, 1993, BIOCHIM BIOPHYS ACTA, V1162, P275, DOI 10.1016/0167-4838(93)90291-X; DISSING J, 1991, J BIOL CHEM, V266, P20619; Evans B, 1996, BIOCHEMISTRY-US, V35, P13609, DOI 10.1021/bi9605651; Fauman EB, 1996, J BIOL CHEM, V271, P18780, DOI 10.1074/jbc.271.31.18780; Hoffmann KMV, 1997, J BIOL CHEM, V272, P27505, DOI 10.1074/jbc.272.44.27505; HOPKINSON DA, 1963, NATURE, V199, P969, DOI 10.1038/199969a0; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; LAZARUK KDA, 1993, BIOCHEM BIOPH RES CO, V196, P440, DOI 10.1006/bbrc.1993.2269; LOGAN TM, 1994, BIOCHEMISTRY-US, V33, P11087, DOI 10.1021/bi00203a005; NAVAZA J, 1987, ACTA CRYSTALLOGR A, V43, P645, DOI 10.1107/S0108767387098787; OTWINOWSKI A, 1993, DATA COLLECTION PROC, P66; RAMPONI G, 1994, ADV PROT PHOSPHATASE, V8, P1; SCHUBERT HL, 1995, PROTEIN SCI, V4, P1904, DOI 10.1002/pro.5560040924; SOKAL RR, 1991, NATURE, V351, P143, DOI 10.1038/351143a0; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; STEIN E, 1997, ASBMB SAT M SEATTL W; STUCKEY JA, 1994, NATURE, V370, P571, DOI 10.1038/370571a0; SU XD, 1994, NATURE, V370, P575, DOI 10.1038/370575a0; Tailor P, 1997, J BIOL CHEM, V272, P5371, DOI 10.1074/jbc.272.9.5371; Tishmack PA, 1997, BIOCHEMISTRY-US, V36, P11984, DOI 10.1021/bi9712448; WAHEED A, 1988, BIOCHEMISTRY-US, V27, P4265, DOI 10.1021/bi00412a010; WO WYP, 1992, THESIS PURDUE U; WO YYP, 1992, BIOCHEMISTRY-US, V31, P1712, DOI 10.1021/bi00121a019; WO YYP, 1992, J BIOL CHEM, V267, P10856; YOSHIHARA CM, 1980, AM J HUM GENET, V32, P898; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328; ZHANG M, 1994, BIOCHEMISTRY-US, V33, P11097, DOI 10.1021/bi00203a006; Zhang M, 1997, BIOCHEMISTRY-US, V36, P15, DOI 10.1021/bi961804n; ZHANG M, 1995, ADV PROTEIN PHOSPHAT, V9, P1; ZHANG ZT, 1994, J BIOL CHEM, V269, P25947; ZHOU MM, 1993, BIOCHEMISTRY-US, V32, P8479, DOI 10.1021/bi00084a012	38	73	76	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21714	21720		10.1074/jbc.273.34.21714	http://dx.doi.org/10.1074/jbc.273.34.21714			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705307	hybrid			2022-12-27	WOS:000075492600041
J	Sebastiao, MP; Saraiva, MJ; Damas, AM				Sebastiao, MP; Saraiva, MJ; Damas, AM			The crystal structure of amyloidogenic Leu(55) -> Pro transthyretin variant reveals a possible pathway for transthyretin polymerization into amyloid fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOL-BINDING PROTEIN; REFINEMENT; MUTATION; COMPLEX	The x-ray crystal structure of the amyloidogenic Leu(55) --> Pro transthyretin (TTR) variant, implicated as the causative agent in early-onset familial amyloidotic polyneuropathy (Jacobson, D. R., McFarlin, D. E., Kane, I., and Buxbaum, J. N. (1992) Hum. Genet. 89, 353-356), has been solved by molecular replacement, refined at 2.7 Angstrom to a R-cryst value of 0.190 (F-obs > 2.0 sigma), and compared with wild-type transthyretin to understand the molecular mechanism(s) involved in amyloidogenesis. Leu(55) --> Pro TTR crystallizes in space group C2, with eight monomers in the asymmetric unit, and the observed packing contacts are considerably different from those described for the wild-type protein. Refinement of the crystal structure shows that the proline for leucine substitution disrupts the hydrogen bonds between strands D and A, resulting in different interface contacts. Based on the assumption that the observed packing contacts may be significant for amyloidogenesis, a model for the TTR amyloid is proposed. It consists of a tubular structure with inner and outer diameters approximately of 30 and 100 Angstrom and four monomers per cross-section.	Univ Porto, Inst Ciencias Biomed Abel Salazar, Dept Mol Biol, P-4050 Porto, Portugal; Inst Biol Mol & Celular, P-4150 Porto, Portugal	Universidade do Porto; Universidade do Porto	Damas, AM (corresponding author), Univ Porto, Inst Ciencias Biomed Abel Salazar, Dept Mol Biol, Largo Prof Abel Salazar 2, P-4050 Porto, Portugal.	amdamas@ncc.up.pt	Saraiva, Maria João/K-3907-2013	Saraiva, Maria João/0000-0002-3360-6899				ANDRADE C, 1952, BRAIN, V75, P408, DOI 10.1093/brain/75.3.408; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; Bonifacio MJ, 1996, BBA-MOL BASIS DIS, V1316, P35, DOI 10.1016/0925-4439(96)00014-2; Damas AM, 1996, ACTA CRYSTALLOGR D, V52, P966, DOI 10.1107/S0907444996003307; Goldsteins G, 1997, BIOCHEMISTRY-US, V36, P5346, DOI 10.1021/bi961649c; HAMILTON JA, 1993, J BIOL CHEM, V268, P2416; Hamilton JA, 1996, AMYLOID, V3, P1, DOI 10.3109/13506129609014349; JACOBSON DR, 1992, HUM GENET, V89, P353; Jenne DE, 1996, P NATL ACAD SCI USA, V93, P6302, DOI 10.1073/pnas.93.13.6302; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KANDA Y, 1974, J BIOL CHEM, V249, P6796; KELLY JW, 1994, AMYLOID, V1, P186, DOI 10.3109/13506129409148451; KONNERT JH, 1980, ACTA CRYSTALLOGR A, V36, P344, DOI 10.1107/S0567739480000794; LANS MC, 1993, CHEM-BIOL INTERACT, V88, P7, DOI 10.1016/0009-2797(93)90081-9; MCCUTCHEN SL, 1993, BIOCHEMISTRY-US, V32, P12119, DOI 10.1021/bi00096a024; MONACO HL, 1995, SCIENCE, V268, P1039, DOI 10.1126/science.7754382; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; RICHARDSON SJ, 1994, AM J PHYSIOL, V266, pR1359, DOI 10.1152/ajpregu.1994.266.4.R1359; SARAIVA MJM, 1995, HUM MUTAT, V5, P191; SARAIVA MJM, 1991, AMYLOID AND AMYLOIDOSIS 1990, P569; Saraiva MJM, 1996, CIBA F SYMP, V199, P47; Sebastiao P, 1996, ACTA CRYSTALLOGR D, V52, P566, DOI 10.1107/S0907444995013965; SERPELL LC, 1995, J MOL BIOL, V254, P113, DOI 10.1006/jmbi.1995.0604; SOPRANO DR, 1985, J BIOL CHEM, V260, P1793; TERRY CJ, 1993, EMBO J, V12, P735, DOI 10.1002/j.1460-2075.1993.tb05707.x; VAHLQUIS.A, 1973, EUR J CLIN INVEST, V3, P352, DOI 10.1111/j.1365-2362.1973.tb00362.x	28	109	111	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24715	24722		10.1074/jbc.273.38.24715	http://dx.doi.org/10.1074/jbc.273.38.24715			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733771	hybrid			2022-12-27	WOS:000076007300063
J	Donato, GM; Kawula, TH				Donato, GM; Kawula, TH			Enhanced binding of altered H-NS protein to flagellar rotor protein FliG causes increased flagellar rotational speed and hypermotility in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOID-ASSOCIATED PROTEIN; SALMONELLA-TYPHIMURIUM; BACTERIAL CHEMOTAXIS; MUTATIONAL ANALYSIS; TORQUE GENERATION; GENE-EXPRESSION; DNA INVERSION; MOTA PROTEIN; MOTILITY; SWITCH	H-NS is an Escherichia coli nucleoid protein known only to function as a modulator of gene expression. In this study, we found that specific single amino acid substitutions in H-NS caused are approximately 50% increase in flagellum rotational speed. In fluorescence anisotropy and chemical cross-linking assays, H-NS interacted with the flagellar torque-generating rotor protein FliG to form a complex with a K-d of 2.15 mu M. Furthermore, one of the altered H-NS proteins that exhibited high speed flagellum rotation bound FliG 50% tighter than wild-type H-NS. These results demonstrate the first non-regulatory role for H-NS and provide a direct correlation between H-NS-FliG binding affinities, flagellar rotation, and motor torque generation.	Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Kawula, TH (corresponding author), Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	kawula@med.unc.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034176] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI34176] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMSLER CD, 1993, J BACTERIOL, V175, P6238, DOI 10.1128/JB.175.19.6238-6244.1993; Atlung T, 1997, MOL MICROBIOL, V24, P7, DOI 10.1046/j.1365-2958.1997.3151679.x; BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BERTIN P, 1990, BIOCHIMIE, V72, P889, DOI 10.1016/0300-9084(90)90008-5; BERTIN P, 1994, J BACTERIOL, V176, P5537, DOI 10.1128/JB.176.17.5537-5540.1994; BLAIR DF, 1991, J MOL BIOL, V221, P1433, DOI 10.1016/0022-2836(91)90943-Z; BLAIR DF, 1990, CELL, V60, P439, DOI 10.1016/0092-8674(90)90595-6; BLAIR DF, 1995, ANNU REV MICROBIOL, V49, P489, DOI 10.1146/annurev.mi.49.100195.002421; BRAY D, 1993, MOL BIOL CELL, V4, P469, DOI 10.1091/mbc.4.5.469; CONLEY MP, 1989, J BACTERIOL, V171, P5190, DOI 10.1128/jb.171.9.5190-5193.1989; Donato GM, 1997, J BACTERIOL, V179, P6618, DOI 10.1128/jb.179.21.6618-6625.1997; FALCONI M, 1988, MOL MICROBIOL, V2, P323, DOI 10.1111/j.1365-2958.1988.tb00035.x; FRANCIS NR, 1992, P NATL ACAD SCI USA, V89, P6304, DOI 10.1073/pnas.89.14.6304; GARZA AG, 1995, P NATL ACAD SCI USA, V92, P1970, DOI 10.1073/pnas.92.6.1970; Harshey RM, 1996, TRENDS MICROBIOL, V4, P226, DOI 10.1016/0966-842X(96)10037-8; HINTON JCD, 1992, MOL MICROBIOL, V6, P2327, DOI 10.1111/j.1365-2958.1992.tb01408.x; IRIKURA VM, 1993, J BACTERIOL, V175, P802, DOI 10.1128/JB.175.3.802-810.1993; JONES CJ, 1991, ADV MICROB PHYSIOL, V32, P109, DOI 10.1016/S0065-2911(08)60007-7; KAJITANI M, 1991, NUCLEIC ACIDS RES, V19, P1063, DOI 10.1093/nar/19.5.1063; KAWULA TH, 1994, J BACTERIOL, V176, P610, DOI 10.1128/jb.176.3.610-619.1994; KAWULA TH, 1991, J BACTERIOL, V173, P4116, DOI 10.1128/jb.173.13.4116-4123.1991; KERSTEN S, 1995, P NATL ACAD SCI USA, V92, P8645, DOI 10.1073/pnas.92.19.8645; KHAN S, 1988, J MOL BIOL, V202, P575, DOI 10.1016/0022-2836(88)90287-2; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kutsukake K, 1997, MOL GEN GENET, V254, P440, DOI 10.1007/s004380050437; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; LARSEN SH, 1974, P NATL ACAD SCI USA, V71, P1239, DOI 10.1073/pnas.71.4.1239; LARSEN SH, 1974, NATURE, V249, P74, DOI 10.1038/249074a0; LaurentWinter C, 1997, EUR J BIOCHEM, V244, P767, DOI 10.1111/j.1432-1033.1997.00767.x; LIU JD, 1989, P NATL ACAD SCI USA, V86, P8703, DOI 10.1073/pnas.86.22.8703; LIU QY, 1993, P NATL ACAD SCI USA, V90, P1761, DOI 10.1073/pnas.90.5.1761; Lloyd SA, 1997, J MOL BIOL, V266, P733, DOI 10.1006/jmbi.1996.0836; Lloyd SA, 1996, J BACTERIOL, V178, P223, DOI 10.1128/jb.178.1.223-231.1996; Macnab R., 1996, ESCHERICHIA COLI SAL, V2nd ed, P119; MACNAB RM, 1992, ANNU REV GENET, V26, P131, DOI 10.1146/annurev.ge.26.120192.001023; MACNAB RM, 1984, ANNU REV BIOPHYS BIO, V13, P51; MANSON MD, 1977, P NATL ACAD SCI USA, V74, P3060, DOI 10.1073/pnas.74.7.3060; Marykwas DL, 1996, J MOL BIOL, V256, P564, DOI 10.1006/jmbi.1996.0109; MAY G, 1990, MOL GEN GENET, V224, P81, DOI 10.1007/BF00259454; OOSAWA K, 1994, J BACTERIOL, V176, P3683, DOI 10.1128/JB.176.12.3683-3691.1994; PARKINSON JS, 1978, J BACTERIOL, V135, P45, DOI 10.1128/JB.135.1.45-53.1978; SHINDO H, 1995, FEBS LETT, V360, P125, DOI 10.1016/0014-5793(95)00079-O; SILVERMAN M, 1974, NATURE, V249, P73, DOI 10.1038/249073a0; SPASSKY A, 1984, NUCLEIC ACIDS RES, V12, P5321, DOI 10.1093/nar/12.13.5321; Tang H, 1996, J MOL BIOL, V261, P209, DOI 10.1006/jmbi.1996.0453; TANG H, 1995, J BACTERIOL, V177, P3496, DOI 10.1128/jb.177.12.3496-3503.1995; Togashi F, 1997, J BACTERIOL, V179, P2994, DOI 10.1128/jb.179.9.2994-3003.1997; Toker AS, 1997, J MOL BIOL, V273, P623, DOI 10.1006/jmbi.1997.1335; Ueguchi C, 1996, J MOL BIOL, V263, P149, DOI 10.1006/jmbi.1996.0566; UEGUCHI C, 1993, EMBO J, V12, P1039, DOI 10.1002/j.1460-2075.1993.tb05745.x; USSERY DW, 1994, BIOCHIMIE, V76, P968, DOI 10.1016/0300-9084(94)90022-1; VOGLER AP, 1991, J BACTERIOL, V173, P3564, DOI 10.1128/jb.173.11.3564-3572.1991; WELCH M, 1993, P NATL ACAD SCI USA, V90, P8787, DOI 10.1073/pnas.90.19.8787; YAMADA H, 1991, MOL GEN GENET, V230, P332, DOI 10.1007/BF00290685; YAMAGUCHI S, 1986, J BACTERIOL, V166, P187, DOI 10.1128/jb.166.1.187-193.1986; Zhao RB, 1996, J BACTERIOL, V178, P258, DOI 10.1128/jb.178.1.258-265.1996	57	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24030	24036		10.1074/jbc.273.37.24030	http://dx.doi.org/10.1074/jbc.273.37.24030			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727020	hybrid, Green Published			2022-12-27	WOS:000075893100061
J	McDearmon, EL; Burwell, AL; Combs, AC; Renley, BA; Sdano, MT; Ervasti, JM				McDearmon, EL; Burwell, AL; Combs, AC; Renley, BA; Sdano, MT; Ervasti, JM			Differential heparin sensitivity of alpha-dystroglycan binding to laminins expressed in normal and dy/dy mouse skeletal muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; GLYCOPROTEIN COMPLEX; EXTRACELLULAR-MATRIX; CELL-ADHESION; SHORT ARM; IN-VITRO; G-DOMAIN; CHAIN; MEROSIN; MEMBRANE	The alpha-dystroglycan binding properties of laminins extracted from fully differentiated skeletal muscle were characterized. We observed that the laminins expressed predominantly in normal adult rat or mouse skeletal muscle bound alpha-dystroglycan in a Ca2+-dependent, ionic strength-sensitive, but heparin-insensitive manner as we had observed previously with purified placental merosin (Pall, E. A., Bolton, K, M,, and Ervasti, J. M, 1996 J. Biol, Chem, 271, 3817-3821). Rat skeletal muscle laminins partially purified by heparin-agarose affinity chromatography also bound alpha-dystroglycan without sensitivity to heparin. We also confirm previous studies of dystrophic dy/dy mouse skeletal muscle showing that the alpha 2 chain of merosin is reduced markedly and that the laminin alpha 1 chain is not up-regulated detectably. However, we further observed a quantitative decrease in the expression of laminin beta/gamma chain immunoreactivity in alpha 2 chain-deficient dy/dy skeletal muscle and reduced alpha-dystroglycan binding activity in laminin extracts from dy/dy muscle. Most interestingly, the alpha-dystroglycan binding activity of residual laminins expressed in merosin-deficient dy/dy skeletal muscle was inhibited dramatically (69 +/- 19%) by heparin. These results identify a potentially important biochemical difference between the laminins expressed in normal and dy/dy skeletal muscle which may provide a molecular basis for the inability of other laminin variants to compensate fully for the deficiency of merosin in some forms of muscular dystrophy,	Univ Wisconsin, Dept Physiol, Serv Mem Inst 127, Sch Med, Madison, WI 53706 USA; Univ Wisconsin, Sch Med, Grad Program Mol & Cellular Pharmacol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ervasti, JM (corresponding author), Univ Wisconsin, Dept Physiol, Serv Mem Inst 127, Sch Med, 1300 Univ Ave, Madison, WI 53706 USA.		Ervasti, James/AAZ-4786-2020		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K02AR001985] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR01985] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BEGGS AH, 1991, AM J HUM GENET, V49, P54; BRANCACCIO A, 1995, FEBS LETT, V368, P139, DOI 10.1016/0014-5793(95)00628-M; BRANDENBERGER R, 1995, J CELL SCI, V108, P3099; BROWN JC, 1994, J CELL SCI, V107, P329; Cheng YS, 1997, J BIOL CHEM, V272, P31525, DOI 10.1074/jbc.272.50.31525; Colognato H, 1997, J BIOL CHEM, V272, P29330, DOI 10.1074/jbc.272.46.29330; COLOGNATOPYKE H, 1995, J BIOL CHEM, V270, P9398, DOI 10.1074/jbc.270.16.9398; Crawley S, 1997, EXP CELL RES, V235, P274, DOI 10.1006/excr.1997.3671; DAVID G, 1993, FASEB J, V7, P1023, DOI 10.1096/fasebj.7.11.8370471; Denzer AJ, 1997, J CELL BIOL, V137, P671, DOI 10.1083/jcb.137.3.671; ENGVALL E, 1992, EXP CELL RES, V198, P115, DOI 10.1016/0014-4827(92)90156-3; ENGVALL E, 1990, CELL REGUL, V1, P731, DOI 10.1091/mbc.1.10.731; Ervasti JM, 1997, J BIOL CHEM, V272, P22315, DOI 10.1074/jbc.272.35.22315; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; GEE SH, 1993, J BIOL CHEM, V268, P14972; Henry MD, 1996, CURR OPIN CELL BIOL, V8, P625, DOI 10.1016/S0955-0674(96)80103-7; Herrmann R, 1996, EUR J PEDIATR, V155, P968, DOI 10.1007/BF02282889; Hodges BL, 1997, J CELL SCI, V110, P2873; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Mayer U, 1997, EUR J BIOCHEM, V245, P745, DOI 10.1111/j.1432-1033.1997.t01-1-00745.x; Mayer U, 1997, NAT GENET, V17, P318, DOI 10.1038/ng1197-318; MENKE A, 1995, J CELL SCI, V108, P727; MERCURIO AM, 1995, TRENDS CELL BIOL, V5, P419, DOI 10.1016/S0962-8924(00)89100-X; MINER JH, 1995, J BIOL CHEM, V270, P28523, DOI 10.1074/jbc.270.48.28523; Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7; Mora M, 1996, NEUROMUSCULAR DISORD, V6, P377, DOI 10.1016/0960-8966(96)00359-8; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; Pall EA, 1996, J BIOL CHEM, V271, P3817; PASTERNAK C, 1995, J CELL BIOL, V128, P355, DOI 10.1083/jcb.128.3.355; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; PAULSSON M, 1989, J BIOL CHEM, V264, P18726; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; PICCOLO F, 1995, NAT GENET, V10, P243, DOI 10.1038/ng0695-243; Rambukkana A, 1997, CELL, V88, P811, DOI 10.1016/S0092-8674(00)81927-3; Ryan MC, 1996, MATRIX BIOL, V15, P369, DOI 10.1016/S0945-053X(96)90157-2; Rybakova IN, 1996, J CELL BIOL, V135, P661, DOI 10.1083/jcb.135.3.661; Rybakova IN, 1997, J BIOL CHEM, V272, P28771, DOI 10.1074/jbc.272.45.28771; Sakamoto A, 1997, P NATL ACAD SCI USA, V94, P13873, DOI 10.1073/pnas.94.25.13873; SANES JR, 1990, J CELL BIOL, V111, P1685, DOI 10.1083/jcb.111.4.1685; SCHULER F, 1995, J CELL SCI, V108, P3795; SMALHEISER NR, 1995, J BIOL CHEM, V270, P15425, DOI 10.1074/jbc.270.25.15425; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; SUNADA Y, 1995, NEUROLOGY, V45, P2084, DOI 10.1212/WNL.45.11.2084; SUNADA Y, 1994, J BIOL CHEM, V269, P13729; SUNG U, 1993, J CELL BIOL, V123, P1255, DOI 10.1083/jcb.123.5.1255; Tiger CF, 1997, MUSCLE NERVE, V20, P1515, DOI 10.1002/(SICI)1097-4598(199712)20:12<1515::AID-MUS6>3.0.CO;2-B; Tiger CF, 1997, J BIOL CHEM, V272, P28590, DOI 10.1074/jbc.272.45.28590; UTANI A, 1995, J BIOL CHEM, V270, P3292, DOI 10.1074/jbc.270.7.3292; Vachon PH, 1997, J CLIN INVEST, V100, P1870, DOI 10.1172/JCI119716; Vachon PH, 1996, J CELL BIOL, V134, P1483, DOI 10.1083/jcb.134.6.1483; XU H, 1994, P NATL ACAD SCI USA, V91, P5572, DOI 10.1073/pnas.91.12.5572; Yamada H, 1996, J BIOL CHEM, V271, P23418, DOI 10.1074/jbc.271.38.23418; Yao CC, 1996, J CELL SCI, V109, P3139; YURCHENCO PD, 1993, J BIOL CHEM, V268, P8356; Yurchenco PD, 1997, P NATL ACAD SCI USA, V94, P10189, DOI 10.1073/pnas.94.19.10189; YURCHENCO PD, 1990, J BIOL CHEM, V265, P3981; YURCHENCO PD, 1992, J CELL BIOL, V117, P1119, DOI 10.1083/jcb.117.5.1119	60	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24139	24144		10.1074/jbc.273.37.24139	http://dx.doi.org/10.1074/jbc.273.37.24139			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727035	hybrid			2022-12-27	WOS:000075893100076
J	Tsumaki, N; Kimura, T; Tanaka, K; Kimura, JH; Ochi, T; Yamada, Y				Tsumaki, N; Kimura, T; Tanaka, K; Kimura, JH; Ochi, T; Yamada, Y			Modular arrangement of cartilage- and neural tissue-specific cis-elements in the mouse alpha 2(XI) collagen promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XI COLLAGEN; FIBRILLAR COLLAGEN; GENE; EXPRESSION; ORGANIZATION; CONTRIBUTE; CLONING; REVEALS; COL11A1; CHAINS	Type XI collagen, a heterotrimer specific to cartilage matrix, plays an important role in cartilage morphogenesis. We analyzed various alpha 2(XI) collagen promoter-lacZ reporter gene constructs in transgenic mice to understand tissue-specific transcriptional regulation. The -530 promoter sequence was sufficient to direct reporter gene expression specifically to cartilage. Further deletion to -500 abolished reporter gene expression iu cartilage but activated the expression specific to neural tissues such as brain and neural tube. An additional 47-base pair deletion resulted in random tissue expression patterns. A 24-base pair sequence from -530 to -507 of the alpha 2(XI) promoter was able to switch the activity of the heterologous neurofilament light gene promoter from neural tissues to cartilage. These results suggest that the alpha 2(XI) collagen gene is regulated by at least three modular elements: a basal promoter sequence distal to -453, a neural tissue-specific element (-454 to -500), and a cartilage-specific element (-501 to -530), which inhibits expression in neural tissues and induces expression in cartilage.	Osaka Univ, Sch Med, Dept Orthopaed Surg, Suita, Osaka 5650871, Japan; NIDR, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA; Henry Ford Hosp, Ctr Bone & Joint, Biochem Sect, Detroit, MI 48202 USA	Osaka University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Henry Ford Health System; Henry Ford Hospital	Tsumaki, N (corresponding author), Osaka Univ, Sch Med, Dept Orthopaed Surg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.		Tanaka, Kazuhiro/Q-7387-2019	Tanaka, Kazuhiro/0000-0002-5138-8952; Tsumaki, Noriyuki/0000-0002-0520-3654				Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; BERNARD M, 1988, J BIOL CHEM, V263, P17159; BONNEROT C, 1993, APPL LACZ GENE FUSIO, P451; Charron G, 1995, J BIOL CHEM, V270, P30604, DOI 10.1074/jbc.270.51.30604; CHEAH KSE, 1991, DEVELOPMENT, V111, P945; FURUTO DK, 1983, ARCH BIOCHEM BIOPHYS, V226, P604, DOI 10.1016/0003-9861(83)90329-6; Hogan B, 1994, MANIPULATING MOUSE E; KIMURA T, 1989, J BIOL CHEM, V264, P13910; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; LI Y, 1995, CELL, V80, P423, DOI 10.1016/0092-8674(95)90492-1; LUI VCH, 1995, BIOCHEM J, V311, P511, DOI 10.1042/bj3110511; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; MORRIS NP, 1987, J BIOL CHEM, V262, P11345; PETIT B, 1993, HISTOCHEMISTRY, V100, P231, DOI 10.1007/BF00269096; SAVAGNER P, 1990, J BIOL CHEM, V265, P6669; Sugimoto M, 1998, CELL TISSUE RES, V292, P325, DOI 10.1007/s004410051063; Tsumaki N, 1996, J CELL BIOL, V134, P1573, DOI 10.1083/jcb.134.6.1573; TSUMAKI N, 1995, J BIOL CHEM, V270, P2372, DOI 10.1074/jbc.270.5.2372; VAUGHAN L, 1988, J CELL BIOL, V106, P991, DOI 10.1083/jcb.106.3.991; VIKKULA M, 1995, CELL, V80, P431, DOI 10.1016/0092-8674(95)90493-X; YOSHIOKA H, 1995, DEV DYNAM, V204, P41, DOI 10.1002/aja.1002040106	21	26	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					22861	22864		10.1074/jbc.273.36.22861	http://dx.doi.org/10.1074/jbc.273.36.22861			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722502	hybrid			2022-12-27	WOS:000075778100002
J	van Echten-Deckert, G; Schick, A; Heinemann, T; Schnieders, B				van Echten-Deckert, G; Schick, A; Heinemann, T; Schnieders, B			Phosphorylated cis-4-methylsphingosine mimics the mitogenic effect of sphingosine-1-phosphate in Swiss 3T3 fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN KINASE-C; CELLULAR PROLIFERATION; SPHINGOSINE 1-PHOSPHATE; SIGNAL-TRANSDUCTION; INDEPENDENT PATHWAY; 2ND MESSENGER; SPHINGOLIPIDS; GANGLIOSIDE; ACTIVATION; CALCIUM	The phosphorylated derivative of sphingosine, sphingosine-1-phosphate, is a short-living metabolite of ultimate ceramide degradation and was shown to act as an intracellular signaling molecule, stimulating cell proliferation in quiescent Swiss 3T3 fibroblasts and inducing the release of calcium from intracellular stores (Zhang, H., Desai, N. N., Olivera, A., Seki, T., Brooker, G., and Spiegel, S. (1991) J. Cell. Biol. 114, 155-167). In the present study, 24-h treatment of Swiss 3T3 fibroblasts with the synthetic sphingosine analogue cis-4-methylsphingosine resulted in proliferation of quiescent Swiss 3T3 fibroblasts that was 3-fold stronger than that of equimolar sphingosine-1-phosphate. The phosphorylated derivative of cis-4-methylsphingosine accumulated drastically in the cells. Simultaneous treatment with the sphingosine kinase inhibitor L-threo-sphinganine reduced both the amount of phosphorylated cis-4-methylsphingosine and cell proliferation induced by this compound by about 50%, indicating that the phosphorylated derivative mediated the proliferative stimulus. The mitogenic effect of cis-4-methylsphingosine was associated with a mobilization of intracellular calcium in Swiss 3T3 fibroblasts that was similar to that induced by sphingosine-1-phosphate. The results demonstrate that the phosphorylated derivative of cis-4-methylsphingosine mimics the previously reported mitogenic action of sphingosine-1-phosphate in Swiss 3T3 cells, and the stronger effect most likely corresponds to the unusual accumulation of this compound.	Univ Bonn, Kekule Inst Organ Chem & Biochem, D-53121 Bonn, Germany; Univ Koln, Inst Klin Chem, D-50924 Cologne, Germany	University of Bonn; University of Cologne	van Echten-Deckert, G (corresponding author), Univ Bonn, Kekule Inst Organ Chem & Biochem, Gerhard Domagk Str 1, D-53121 Bonn, Germany.							An SZ, 1997, FEBS LETT, V417, P279, DOI 10.1016/S0014-5793(97)01301-X; BUEHRER BM, 1992, J BIOL CHEM, V267, P3154; BUEHRER BM, 1993, ADV LIPID RES, V26, P59; CLASEN K, 1994, THESIS U BONN GERMAN; DESAI NN, 1992, J BIOL CHEM, V267, P23122; GOSH TK, 1990, SCIENCE, V248, P1653; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hung WC, 1996, BIOCHEM BIOPH RES CO, V229, P11, DOI 10.1006/bbrc.1996.1750; KIM S, 1995, J BIOL CHEM, V270, P5266, DOI 10.1074/jbc.270.10.5266; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; MATTIE M, 1994, J BIOL CHEM, V269, P3181; Merrill AH, 1997, TOXICOL APPL PHARM, V142, P208, DOI 10.1006/taap.1996.8029; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; OLIVERA A, 1994, J BIOL CHEM, V269, P17924; SPIEGEL S, 1988, EXP CELL RES, V177, P414, DOI 10.1016/0014-4827(88)90474-0; Spiegel S, 1996, CURR OPIN CELL BIOL, V8, P159, DOI 10.1016/S0955-0674(96)80061-5; Spiegel S, 1996, FASEB J, V10, P1388, DOI 10.1096/fasebj.10.12.8903509; STOFFEL W, 1973, H-S Z PHYSIOL CHEM, V354, P169, DOI 10.1515/bchm2.1973.354.1.169; STOFFEL W, 1970, H-S Z PHYSIOL CHEM, V351, P1041, DOI 10.1515/bchm2.1970.351.2.1041; SU Y, 1994, J BIOL CHEM, V269, P16512; SVENNERHOLM L, 1994, BIOL FUNCTIONS GANGL, V101, P17; vanEchtenDeckert G, 1997, J BIOL CHEM, V272, P15825, DOI 10.1074/jbc.272.25.15825; vanKoppen CJ, 1996, J BIOL CHEM, V271, P2082, DOI 10.1074/jbc.271.4.2082; VANVELDHOVEN PP, 1993, ADV LIPID RES, V26, P69; Wang F, 1996, GLYCOCONJUGATE J, V13, P937, DOI 10.1007/BF01053189; WU J, 1995, J BIOL CHEM, V270, P11484, DOI 10.1074/jbc.270.19.11484; YATOMI Y, 1995, ANAL BIOCHEM, V230, P315, DOI 10.1006/abio.1995.1480; ZHANG H, 1990, J BIOL CHEM, V265, P76; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155; Zondag GCM, 1998, BIOCHEM J, V330, P605, DOI 10.1042/bj3300605; ZUHERINGDORF DM, 1996, N-S ARCH PHARMACOL, V354, P397	31	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23585	23589		10.1074/jbc.273.36.23585	http://dx.doi.org/10.1074/jbc.273.36.23585			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722598	hybrid			2022-12-27	WOS:000075778100098
J	Yu, Q; Pecchia, DB; Kingsley, SL; Heckman, JE; Burke, JM				Yu, Q; Pecchia, DB; Kingsley, SL; Heckman, JE; Burke, JM			Cleavage of highly structured viral RNA molecules by combinatorial libraries of hairpin ribozymes - The mot effective ribozymes are not predicted by substrate selection rules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOBACCO RINGSPOT VIRUS; HAMMERHEAD RIBOZYME; NUCLEOTIDE-SEQUENCE; INVITRO SELECTION; ACCESSIBLE SITES; IN-VITRO; SATELLITE; OLIGORIBONUCLEOTIDES; OLIGONUCLEOTIDES; IDENTIFICATION	Combinatorial libraries of hairpin ribozymes representing all possible cleavage specificities (>10(5)) were used to evaluate all ribozyme cleavage sites within a large (4.2-kilobase) and highly structured viral mRNA, the 26 S subgenomic RNA of Sindbis virus, The combinatorial approach simultaneously accounts for target site structure and dynamics, together with ribozyme folding, and the sequences that result in a ribozyme-substrate complex with maximal activity. Primer extension was used to map and rank the relative activities of the ribozyme pool against individual sites and revealed two striking findings. First, only a small fraction of potential recognition sites are effectively cleaved (activity-selected sites). Second, nearly all of the most effectively cleaved sites deviated substantially from the established consensus selection rules for the hairpin ribozyme and were not predicted by examining the sequence, or through the use of computer-assisted predictions of RNA secondary structure. In vitro selection methods were used to isolate ribozymes with increased activity against substrates that deviate from the GUC consensus sequence. trans-Acting ribozymes targeting nine of the activity-selected sites were synthesized, together with ribozymes targeting four sites with a perfect match to the cleavage site consensus (sequence-selected sites). Activity-selected ribozymes have much higher cleavage activity against the long, structured RNA molecules than do sequence-selected ribozymes, although the latter are effective in cleaving oligoribonucleotides, as predicted. These results imply that, for Sindbis virus 26 S RNA, designing ribozymes based on matches to the consensus sequence may be an ineffective strategy.	Univ Vermont, Dept Microbiol & Mol Genet, Markey Ctr Mol Genet, Burlington, VT 05405 USA	University of Vermont	Burke, JM (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Markey Ctr Mol Genet, 306 Stafford Hall, Burlington, VT 05405 USA.	jburke@zoo.uvm.edu	, John/AAB-5945-2021		NIAID NIH HHS [AI30534, AI29892] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030534, R01AI029892] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Berkhout B, 1996, PROG NUCLEIC ACID RE, V54, P1, DOI 10.1016/S0079-6603(08)60359-1; BERZALHERRANZ A, 1992, GENE DEV, V6, P129, DOI 10.1101/gad.6.1.129; BERZALHERRANZ A, 1993, EMBO J, V12, P2567, DOI 10.1002/j.1460-2075.1993.tb05912.x; Birikh KR, 1997, RNA, V3, P429; Birikh KR, 1997, EUR J BIOCHEM, V245, P1, DOI 10.1111/j.1432-1033.1997.t01-3-00001.x; Burke JM, 1997, NAT BIOTECHNOL, V15, P414, DOI 10.1038/nbt0597-414; BUTCHER SE, 1994, J MOL BIOL, V244, P52, DOI 10.1006/jmbi.1994.1703; BUTCHER SE, 1995, J BIOL CHEM, V270, P29648; BUTCHER SE, 1994, BIOCHEMISTRY-US, V33, P922; Cai ZP, 1996, BIOCHEMISTRY-US, V35, P6026, DOI 10.1021/bi952985g; CAMPBELL TB, 1995, RNA, V1, P598; CHOWRIRA BM, 1991, BIOCHEMISTRY-US, V30, P8518, DOI 10.1021/bi00099a003; CHOWRIRA BM, 1991, NATURE, V354, P320, DOI 10.1038/354320a0; Couture LA, 1996, TRENDS GENET, V12, P510, DOI 10.1016/S0168-9525(97)81398-4; Esteban JA, 1997, J BIOL CHEM, V272, P13629, DOI 10.1074/jbc.272.21.13629; FELDEN B, 1994, J MOL BIOL, V235, P508, DOI 10.1006/jmbi.1994.1010; FELDSTEIN PA, 1989, GENE, V82, P53, DOI 10.1016/0378-1119(89)90029-2; GOODCHILD J, 1992, NUCLEIC ACIDS RES, V20, P4607, DOI 10.1093/nar/20.17.4607; HAMPEL A, 1990, NUCLEIC ACIDS RES, V18, P299, DOI 10.1093/nar/18.2.299; Hampel A, 1998, PROG NUCLEIC ACID RE, V58, P1; HAMPEL A, 1989, BIOCHEMISTRY-US, V28, P4929, DOI 10.1021/bi00438a002; Hampel A, 1997, Methods Mol Biol, V74, P171; Hertel KJ, 1996, EMBO J, V15, P3751, DOI 10.1002/j.1460-2075.1996.tb00745.x; Ho SP, 1996, NUCLEIC ACIDS RES, V24, P1901, DOI 10.1093/nar/24.10.1901; JAEGER JA, 1989, P NATL ACAD SCI USA, V86, P7706, DOI 10.1073/pnas.86.20.7706; Jarvis TC, 1996, J BIOL CHEM, V271, P29107, DOI 10.1074/jbc.271.46.29107; Jones JT, 1996, NAT MED, V2, P643, DOI 10.1038/nm0696-643; JOSEPH S, 1993, J BIOL CHEM, V268, P24515; JOSEPH S, 1993, GENE DEV, V7, P130, DOI 10.1101/gad.7.1.130; LIEBER A, 1995, MOL CELL BIOL, V15, P540, DOI 10.1128/MCB.15.1.540; Lima WF, 1997, J BIOL CHEM, V272, P626; PRODY GA, 1986, SCIENCE, V231, P1577, DOI 10.1126/science.231.4745.1577; RUBINO L, 1990, J GEN VIROL, V71, P1897, DOI 10.1099/0022-1317-71-9-1897; SARGUEIL B, 1995, BIOCHEMISTRY-US, V34, P7739, DOI 10.1021/bi00023a021; SCARINGE SA, 1990, NUCLEIC ACIDS RES, V18, P5433, DOI 10.1093/nar/18.18.5433; SIMPSON DA, 1996, VIROLOGY, V2, P484; SPROAT B, 1995, NUCLEOS NUCLEOT, V14, P255, DOI 10.1080/15257779508014668; STRAUSS EG, 1984, VIROLOGY, V133, P92, DOI 10.1016/0042-6822(84)90428-8; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; USMAN N, 1996, NUCL ACIDS MOL BIOL, V10, P243; VANTOL H, 1991, VIROLOGY, V180, P23, DOI 10.1016/0042-6822(91)90005-V; Yu Q, 1997, Methods Mol Biol, V74, P161; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181	43	50	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23524	23533		10.1074/jbc.273.36.23524	http://dx.doi.org/10.1074/jbc.273.36.23524			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722591	hybrid			2022-12-27	WOS:000075778100091
J	Fiermonte, G; Dolce, V; Palmieri, F				Fiermonte, G; Dolce, V; Palmieri, F			Expression in Escherichia coli, functional characterization, and tissue distribution of isoforms A and B of the phosphate carrier from bovine mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BEEF-HEART MITOCHONDRIA; RAT-LIVER MITOCHONDRIA; TRANSPORT PROTEIN; N-ETHYLMALEIMIDE; SACCHAROMYCES-CEREVISIAE; OXOGLUTARATE CARRIER; GENES; YEAST; CARDIOLIPIN; SUBUNIT	The two isoforms of the mammalian mitochondrial phosphate carrier (PiC), A and B, differing in the sequence near the N terminus, arise from alternative splicing of a primary transcript of the Pic gene (Dolce, V., Iacobazzi, V., Palmieri, F., and Walker, J. E. (1994) J. Biol. Chem. 269, 10451-10460). To date, the PiC isoforms A and B have not been studied at the protein level. To explore the tissue-distribution and the potential functional differences between the two isoforms, polyclonal site-directed antibodies specific for PiC-A and PiC-B were raised, and the two bovine isoforms were obtained by expression in Escherichia coli and reconstituted into phospholipid vesicles. Western blot analysis demonstrated that isoform A is present in high amounts in heart, skeletal muscle, and diaphragm mitochondria, whereas isoform B is present in the mitochondria of all tissues examined. Heart and liver bovine mitochondria contained 69 and 0 pmol of PiC-A/mg of protein, and 10 and 8 pmol of PiC-B/mg of protein, respectively. In the reconstituted system the pure recombinant isoforms A and B both catalyzed the two known modes of transport (P-i/P-i antiport and P-i/H+ symport) and exhibited similar properties of substrate specificity and inhibitor sensitivity. However, they strongly differed in their kinetic parameters. The transport affinities of isoform B for phosphate and arsenate were found to be 3-fold lower than those of isoform A Furthermore, the maximum transport rate of isoform B is about 3-fold higher than that of isoform A. These results support the hypothesis that the sequence divergence between PiC-A and PiC-B may have functional significance in determining the affinity and the translocation rate of the substrate through the PiC molecule.	Univ Bari, Dept Pharmaco Biol, Biochem & Mol Biol Lab, I-70125 Bari, Italy	Universita degli Studi di Bari Aldo Moro	Palmieri, F (corresponding author), Univ Bari, Dept Pharmaco Biol, Biochem & Mol Biol Lab, Via E Orabona 4, I-70125 Bari, Italy.	fpalm@farmbiol.uniba.it	Fiermonte, Giuseppe/D-3680-2018; Fiermonte, Giuseppe/F-3159-2010	Fiermonte, Giuseppe/0000-0002-6764-9395; Dolce, Vincenza/0000-0003-2966-4866				BATTINI R, 1987, J BIOL CHEM, V262, P4355; BISACCIA F, 1994, BIOCHEMISTRY-US, V33, P3705, DOI 10.1021/bi00178a030; BISACCIA F, 1984, BIOCHIM BIOPHYS ACTA, V766, P386, DOI 10.1016/0005-2728(84)90254-8; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; Capobianco L, 1996, BIOCHEMISTRY-US, V35, P8974, DOI 10.1021/bi960258v; Chappell J.B., 1967, BIOCH MITOCHONDRIA, P75; COTY WA, 1975, J BIOL CHEM, V250, P3515; DESANTIS A, 1976, PLANT CELL PHYSIOL, V17, P1221; DIXON M, 1972, BIOCHEM J, V129, P197, DOI 10.1042/bj1290197; DOLCE V, 1994, J BIOL CHEM, V269, P10451; Dolce V, 1996, FEBS LETT, V399, P95, DOI 10.1016/S0014-5793(96)01294-X; Dyer J, 1997, BIOCHEM BIOPH RES CO, V230, P624, DOI 10.1006/bbrc.1996.6018; FERREIRA GC, 1992, J BIOL CHEM, V267, P5460; FIERMONTE G, 1993, BIOCHEM J, V294, P293, DOI 10.1042/bj2940293; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; FONYO A, 1980, J BIOENERG BIOMEMBR, V12, P137, DOI 10.1007/BF00744679; Fonyo A, 1975, BIOMEMBRANES STRUCTU, P287; GAWAZ M, 1990, J BIOL CHEM, V265, P14202; GAY NJ, 1985, EMBO J, V4, P3519, DOI 10.1002/j.1460-2075.1985.tb04111.x; GENCHI G, 1988, BIOCHIM BIOPHYS ACTA, V936, P413, DOI 10.1016/0005-2728(88)90018-7; GUERIN B, 1990, J BIOL CHEM, V265, P19736; HADVARY P, 1976, EUR J BIOCHEM, V67, P573, DOI 10.1111/j.1432-1033.1976.tb10723.x; HOULDSWORTH J, 1988, P NATL ACAD SCI USA, V85, P377, DOI 10.1073/pnas.85.2.377; KADENBACH B, 1982, FEBS LETT, V139, P109, DOI 10.1016/0014-5793(82)80498-5; KAPLAN RS, 1986, J BIOL CHEM, V261, P2767; KAPLAN RS, 1995, J BIOL CHEM, V270, P4108, DOI 10.1074/jbc.270.8.4108; KOLBE HVJ, 1984, J BIOL CHEM, V259, P9115; KUAN J, 1993, CRIT REV BIOCHEM MOL, V28, P209, DOI 10.3109/10409239309086795; LAVAT A, 1979, ARCH BIOCHEM BIOPHYS, V194, P405, DOI 10.1016/0003-9861(79)90634-9; MARSH S, 1995, GENOMICS, V29, P814, DOI 10.1006/geno.1995.9924; MATSUDA C, 1993, J BIOL CHEM, V268, P24950; MENDE P, 1983, FEBS LETT, V158, P331, DOI 10.1016/0014-5793(83)80607-3; NECKELMANN N, 1987, P NATL ACAD SCI USA, V84, P7580, DOI 10.1073/pnas.84.21.7580; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; PALMIERI F, 1990, BIOCHIM BIOPHYS ACTA, V1018, P147, DOI 10.1016/0005-2728(90)90236-W; PALMIERI F, 1993, J BIOENERG BIOMEMBR, V25, P493, DOI 10.1007/BF01108406; PALMIERI F, 1994, FEBS LETT, V346, P48, DOI 10.1016/0014-5793(94)00329-7; PALMIERI F, 1998, FRONTIERS CELL BIOEN; Palmieri L, 1997, FEBS LETT, V417, P114, DOI 10.1016/S0014-5793(97)01269-6; Palmieri L, 1997, FEBS LETT, V410, P447, DOI 10.1016/S0014-5793(97)00630-3; PARDRIDGE WM, 1990, J BIOL CHEM, V265, P18035; Phelps A, 1996, BIOCHEMISTRY-US, V35, P10757, DOI 10.1021/bi961052x; RUNSWICK MJ, 1987, EMBO J, V6, P1367, DOI 10.1002/j.1460-2075.1987.tb02377.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5163; SCHLERF A, 1988, EMBO J, V7, P2387, DOI 10.1002/j.1460-2075.1988.tb03083.x; Schroers A, 1997, J BIOL CHEM, V272, P10558; SEELAN RS, 1991, J BIOL CHEM, V266, P19752; STAPPEN R, 1993, BIOCHIM BIOPHYS ACTA, V1149, P40, DOI 10.1016/0005-2736(93)90022-R; STAPPEN R, 1994, J BIOL CHEM, V269, P11240; WALKER JE, 1993, J BIOENERG BIOMEMBR, V25, P435, DOI 10.1007/BF01108401; WALKER JE, 1987, CHEM SCRIPTA, V27B, P97; WEHRLE JP, 1989, J MEMBRANE BIOL, V111, P199, DOI 10.1007/BF01871006; WOHLRAB H, 1994, BIOCHEMISTRY-US, V33, P9371, DOI 10.1021/bi00198a001; WOHLRAB H, 1986, BIOCHIM BIOPHYS ACTA, V853, P115, DOI 10.1016/0304-4173(86)90007-8	54	114	115	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22782	22787		10.1074/jbc.273.35.22782	http://dx.doi.org/10.1074/jbc.273.35.22782			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712911	hybrid			2022-12-27	WOS:000075616600087
J	Grant, GA; Xu, XL				Grant, GA; Xu, XL			Probing the regulatory domain interface of D-3-phosphoglycerate dehydrogenase with engineered tryptophan residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODULATED ALLOSTERIC REGULATION; PHOSPHOGLYCERATE DEHYDROGENASE; EFFECTOR-BINDING; MECHANISM; ENZYME; SITE	D-3-Phosphoglycerate dehydrogenase from Escherichia coli is a homotetrameric enzyme which is allosterically regulated by the end product of its pathway, L-serine, The enzyme binds 4 L-serine molecules at two interfaces formed by the noncovalent association of the regulatory domains. The two domains that comprise each interface are related by an approximately 180 degrees axis of symmetry, and two serine molecules bind at each interface by forming a hydrogen bond network between the domains. A model has been proposed that suggests that serine functions by drawing adjacent domains together and that this in turn translates a conformational change to the active site. A tryptophan residue has been engineered into the helices flanking the regulatory interfaces that displays significant quenching in response to serine binding. Residues on the adjacent subunit appear to be primarily responsible for the tryptophan quenching and thus support the hypothesis that serine binding leads to an increase in the proximity between residues on neighboring subunits, Serine binding studies show that this quenching, as well as inhibition of enzymatic activity, are essentially complete when only two of the four serine binding sites are occupied. The requirement for only one serine per interface is consistent with the notion that the interface is formed by relatively rigid domains and that hydrogen bonding at only a single site is all that is required to substantially close the interface. The fluorescence quenching in response to L-serine binding generally correlates with enzymatic inhibition, but there appears to be a slight lag in inhibition relative to quenching at low serine concentrations. The observed fluorescence quenching of residues in the regulatory domains of D-3-phosphoglycerate dehydrogenase provide the first direct evidence for a conformational change in response to effector binding and provide a means to monitor the first step in the allosteric mechanism.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Grant, GA (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, Box 8103,660 S Euclid Ave, St Louis, MO 63110 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056676] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 56676] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AlRabiee R, 1996, J BIOL CHEM, V271, P23235, DOI 10.1074/jbc.271.38.23235; AlRabiee R, 1996, J BIOL CHEM, V271, P13013, DOI 10.1074/jbc.271.22.13013; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CORMACK B, 1991, CURRENT PROTOCOLS MO; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Grant GA, 1996, PROTEIN SCI, V5, P34; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; SCHULLER DJ, 1995, NAT STRUCT BIOL, V2, P69, DOI 10.1038/nsb0195-69; SCHULLER DJ, 1989, J BIOL CHEM, V264, P2645; SUGIMOTO E, 1968, J BIOL CHEM, V243, P2090; SUGIMOTO E, 1968, J BIOL CHEM, V243, P2081; TOBEY KL, 1986, J BIOL CHEM, V261, P2179; Zhao GS, 1996, J BACTERIOL, V178, P232, DOI 10.1128/jb.178.1.232-239.1996	13	16	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22389	22394		10.1074/jbc.273.35.22389	http://dx.doi.org/10.1074/jbc.273.35.22389			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712860	hybrid			2022-12-27	WOS:000075616600036
J	Kametaka, S; Okano, T; Ohsumi, M; Ohsumi, Y				Kametaka, S; Okano, T; Ohsumi, M; Ohsumi, Y			Apg14p and Apg6/Vps30p form a protein complex essential for autophagy in the yeast, Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVITRO MUTAGENESIS; VACUOLAR HYDROLASES; TARGETING PATHWAY; AMINOPEPTIDASE-I; SORTING RECEPTOR; MUTANT YEAST; GENE; TRANSPORT; CYTOPLASM; MEMBRANE	Mutation in the Saccharomyces cerevisiae APG14 gene causes a defect in autophagy, Cloning and structural analysis of the APG14 gene revealed that APG14 encodes a novel hydrophilic protein with a predicted molecular mass of 40.5 kDa, and that Apg14p has a coiled-coil motif at its N terminus region, We found that overproduction of Apg14p partially reversed the defect in autophagy induced by the apg6-1 mutation. The apg6-1 mutant was found to be defective not only in autophagy but also in sorting of carboxypeptidase Y (CPY), a vacuolar-soluble hydrolase, to the vacuole, However, overexpression of APG14 did not alter the CPY sorting defect of the apg6-1 mutant, nor did the apg14 null mutation affect the CPY sorting pathway. Structural analysis of APG6 revealed that APG6 is identical to VPS30, which is involved in a retrieval step of the CPY receptor, Vps10p, to the late-Golgi from the endosome (Seaman, M. N. J., Marcusson, E. G., Cereghino, J. L., and Emr, S. D. (1997) J. Cell Biol. 137, 79-92), Subcellular fractionation indicated that Apg14p and Apg6p peripherally associated with a membrane structure(s), Apg14p was co-immunoprecipitated with Apg6p, suggesting that they form a stable protein complex. These results imply that Apg6/Vps30p has two distinct functions in the autophagic process and the vacuolar protein sorting pathway. Apg14p may be a component specifically required for the function of Apg6/Vps30p through the autophagic pathway.	Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan; Teikyo Univ Sci & Technol, Fac Engn Sci, Dept Biosci, Yamanashi 4090193, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Ohsumi, Y (corresponding author), Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan.	yohsumi@nibb.ac.jp	Kametaka, Satoshi/GVT-6091-2022; Ohsumi, Yoshinori/C-6449-2009	Ohsumi, Yoshinori/0000-0003-2384-2166; Kametaka, Satoshi/0000-0003-0659-6426				Baba M, 1997, J CELL BIOL, V139, P1687, DOI 10.1083/jcb.139.7.1687; Baba M, 1995, CELL STRUCT FUNCT, V20, P465, DOI 10.1247/csf.20.465; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Becherer KA, 1996, MOL BIOL CELL, V7, P579, DOI 10.1091/mbc.7.4.579; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cowles CR, 1997, EMBO J, V16, P2769, DOI 10.1093/emboj/16.10.2769; DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923; DUNN WA, 1990, J CELL BIOL, V110, P1935, DOI 10.1083/jcb.110.6.1935; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Funakoshi T, 1997, GENE, V192, P207, DOI 10.1016/S0378-1119(97)00031-0; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; HARDING TM, 1995, J CELL BIOL, V131, P591, DOI 10.1083/jcb.131.3.591; HENIKOFF S, 1990, NUCLEIC ACIDS RES, V18, P2961, DOI 10.1093/nar/18.10.2961; Horazdovsky BF, 1996, J BIOL CHEM, V271, P33607, DOI 10.1074/jbc.271.52.33607; JONES JS, 1990, YEAST, V6, P363, DOI 10.1002/yea.320060502; Kamada Y, 1996, J BIOL CHEM, V271, P9193, DOI 10.1074/jbc.271.16.9193; Kametaka S, 1996, GENE, V178, P139, DOI 10.1016/0378-1119(96)00354-X; Kim J, 1997, J CELL BIOL, V137, P609, DOI 10.1083/jcb.137.3.609; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; KOPITZ J, 1990, J CELL BIOL, V111, P941, DOI 10.1083/jcb.111.3.941; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Liou W, 1997, J CELL BIOL, V136, P61, DOI 10.1083/jcb.136.1.61; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MARCUSSON EG, 1994, CELL, V77, P579, DOI 10.1016/0092-8674(94)90219-4; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; MORTIMORE GE, 1977, NATURE, V270, P174, DOI 10.1038/270174a0; Nakamura N, 1997, J BIOL CHEM, V272, P11344; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; NOTHWEHR SF, 1995, J CELL BIOL, V129, P35, DOI 10.1083/jcb.129.1.35; PARAVICINI G, 1992, MOL BIOL CELL, V3, P415, DOI 10.1091/mbc.3.4.415; Piper RC, 1997, J CELL BIOL, V138, P531, DOI 10.1083/jcb.138.3.531; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Rose MD., 1990, METHODS YEAST GENETI; SAMBROOK J, 1989, MOL CLINING LAB MANU; Scott SV, 1996, P NATL ACAD SCI USA, V93, P12304, DOI 10.1073/pnas.93.22.12304; Scott SV, 1997, J CELL BIOL, V138, P37, DOI 10.1083/jcb.138.1.37; Seaman MNJ, 1997, J CELL BIOL, V137, P79, DOI 10.1083/jcb.137.1.79; SEGLEN PO, 1987, LYSOSOMES THEIR ROLE, P371; Shirahama K, 1997, CELL STRUCT FUNCT, V22, P501, DOI 10.1247/csf.22.501; SIKORSKI RS, 1989, GENETICS, V122, P19; SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; WADA Y, 1990, MOL CELL BIOL, V10, P2214, DOI 10.1128/MCB.10.5.2214	47	207	220	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22284	22291		10.1074/jbc.273.35.22284	http://dx.doi.org/10.1074/jbc.273.35.22284			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712845	hybrid			2022-12-27	WOS:000075616600021
J	Lepperdinger, G; Strobl, B; Kreil, G				Lepperdinger, G; Strobl, B; Kreil, G			HYAL2, a human gene expressed in many cells, encodes a lysosomal hyaluronidase with a novel type of specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-MICROSCOPY; MURINE MACROPHAGES; MEMBRANE-PROTEIN; PH-20; SPERM; ACID; DEGRADATION; SECONDARY; CLONING; EMBRYOS	Using Expressed Sequence Tags (ESTs) deposited in the data banks, a cDNA has been assembled that encodes a protein related to the hyaluronidases from bee venom and mammalian sperm. Expression of this cDNA yielded a polypeptide termed HYAL2, which is located in lysosomes, The HYAL2 protein was shown to have hyaluronidase activity below pH 4, However, it only hydrolyzed hyaluronan of high molecular mass from umbilical cord, rooster comb, and a Streptococcus strain. The reaction product was a polysaccharide of about 20 kDa, which was further hydrolyzed to small oligosaccharides by the sperm hyaluronidase. Conversely, hyaluronan fragments from vitreous humor, which had a molecular mass of about 20 kDa, were not cleaved by the HYAL2 enzyme to any detectable extent. These results provide evidence for the existence of structural domains in hyaluronan, which are resistant to the action of this enzyme, The structural and functional implications of these findings are discussed.	Austrian Acad Sci, Inst Mol Biol, A-5020 Salzburg, Austria	Austrian Academy of Sciences	Kreil, G (corresponding author), Austrian Acad Sci, Inst Mol Biol, Billrothstr 11, A-5020 Salzburg, Austria.	gkreil@oeaw.ac.at		Lepperdinger, Gunter/0000-0002-4265-4489; Strobl, Birgit/0000-0001-5716-3212				ARNOTT S, 1983, J MOL BIOL, V169, P861, DOI 10.1016/S0022-2836(83)80140-5; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Cherr GN, 1996, DEV BIOL, V175, P142, DOI 10.1006/dbio.1996.0102; DALY MC, 1993, ONCOGENE, V8, P1721; DORFMAN A, 1955, METHOD ENZYMOL, V1, P166, DOI 10.1016/0076-6879(55)01023-9; Frost GI, 1997, BIOCHEM BIOPH RES CO, V236, P10, DOI 10.1006/bbrc.1997.6773; Frost GL, 1996, TRENDS GLYCOSCI GLYC, V8, P419, DOI 10.4052/tigg.8.419; GMACHL M, 1993, P NATL ACAD SCI USA, V90, P3569, DOI 10.1073/pnas.90.8.3569; GMACHL M, 1993, FEBS LETT, V336, P545, DOI 10.1016/0014-5793(93)80873-S; KREIL G, 1995, PROTEIN SCI, V4, P1666, DOI 10.1002/pro.5560040902; LATHROP WF, 1990, J CELL BIOL, V111, P2939, DOI 10.1083/jcb.111.6.2939; Latif F, 1997, HUM GENET, V99, P334, DOI 10.1007/s004390050368; LAURENT T, 1989, CIBA F SYMP, V143, P1; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267; Lepperdinger G, 1996, PROTEIN SCI, V5, P1250, DOI 10.1002/pro.5560050704; LIN Y, 1994, J CELL BIOL, V125, P1157, DOI 10.1083/jcb.125.5.1157; Liu DC, 1996, P NATL ACAD SCI USA, V93, P7832, DOI 10.1073/pnas.93.15.7832; McKee CM, 1997, J BIOL CHEM, V272, P8013, DOI 10.1074/jbc.272.12.8013; MEYER K, 1971, HYALURONIDASES, V5; Meyer MF, 1996, P NATL ACAD SCI USA, V93, P4543, DOI 10.1073/pnas.93.10.4543; MITRA AK, 1983, J MOL BIOL, V169, P813, DOI 10.1016/S0022-2836(83)80138-7; Natowicz MR, 1996, CLIN CHIM ACTA, V245, P1, DOI 10.1016/0009-8981(95)06182-7; Noble PW, 1996, J EXP MED, V183, P2373, DOI 10.1084/jem.183.5.2373; REISSIG JL, 1955, J BIOL CHEM, V217, P959; SAMPSON PM, 1992, J CLIN INVEST, V90, P1492, DOI 10.1172/JCI116017; SCOTT JE, 1990, INT J BIOL MACROMOL, V12, P180, DOI 10.1016/0141-8130(90)90029-A; SCOTT JE, 1991, BIOCHEM J, V274, P699, DOI 10.1042/bj2740699; SCOTT JE, 1989, CIBA F SYMP, V143, P6; STUNNENBERG HG, 1988, NUCLEIC ACIDS RES, V16, P2431, DOI 10.1093/nar/16.6.2431; SZAFARZ BF, 1989, SOMAT CELL MOLEC GEN, V15, P79; VAES G, 1966, METHOD ENZYMOL, V8, P509; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340	33	240	248	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22466	22470		10.1074/jbc.273.35.22466	http://dx.doi.org/10.1074/jbc.273.35.22466			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712871	hybrid			2022-12-27	WOS:000075616600047
J	Oka, T; Yamamoto, R; Futai, M				Oka, T; Yamamoto, R; Futai, M			Multiple genes for vacuolar-type ATPase proteolipids in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE H+-ATPASE; SACCHAROMYCES-CEREVISIAE; SUBUNIT-C; URINARY ACIDIFICATION; B-SUBUNIT; EXPRESSION; CLONING; PROTEIN; CELLS; INACTIVATION	In the vacuolar-type Hf-ATPase (V-ATPase), highly hydrophobic subunits known as the proteolipids are components of the integral membrane V-0 sector. Previously, we described the identification of three different proteolipid genes in Caenorhabditis elegans (Oka, T., Yamamoto, R., and Futai, M. (1997) J. Biol. Chem. 272, 24387-24392): vha-l and vha-2 encoded 16-kDa subunits, and vha-4, a 23-kDa isoform. me report here that a third 16-kDa gene, vha-3, has been identified on chromosome IV. This is the first example in which four proteolipid genes have been found in a single organism, vha-2 and vha-3 exhibited 85% nucleotide identity within the open reading frames which encoded the identical amino acid sequence. Northern blot analysis indicated that all four genes were expressed in a similar pattern during the worm life cycle; however, studies with transgenic worms indicated that the vha-3 gene was expressed differently from other proteolipid genes in a cell-specific manner. These results implied that the isoforms of the proteolipids may be related to functional differences of V-ATPases in various cell types. Another new gene, vha-11, contained seven exons and was found to be located immediately downstream of vha-3. The two genes constitute a single transcriptional unit. The VHA-11 protein had 384 amino acids and shared strong sequence similarities with the C subunit, a component of the peripheral V-1 sector of the V-ATPase, from yeast, bovine, and human. Expression of the Dha-II cDNA complemented a null mutation of VMA5, the yeast C subunit gene, thus demonstrating that vha-11 was the functional C subunit of C. elegans.	Osaka Univ, Japan Sci & Technol Corp, CREST, Inst Sci & Ind Res,Div Biol Sci, Ibaraki, Osaka 5670047, Japan	Japan Science & Technology Agency (JST); Osaka University	Futai, M (corresponding author), Osaka Univ, Japan Sci & Technol Corp, CREST, Inst Sci & Ind Res,Div Biol Sci, Ibaraki, Osaka 5670047, Japan.	m-futai@sanken.osaka-u.ac.jp						ANRAKU Y, 1996, HDB BIOL PHYS, V2, P93; BELTRAN C, 1992, J BIOL CHEM, V267, P774; Breton S, 1996, NAT MED, V2, P470, DOI 10.1038/nm0496-470; CHATTERJEE D, 1992, J EXP BIOL, V172, P193; Davies SA, 1996, J BIOL CHEM, V271, P30677, DOI 10.1074/jbc.271.48.30677; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; FORGAC M, 1989, PHYSIOL REV, V69, P765, DOI 10.1152/physrev.1989.69.3.765; FUTAI M, 1998, IN PRESS J BIOCH; FUTAI M, 1996, HDB BIOL PHYS, V2, P47; GLUCK SL, 1992, J BIOENERG BIOMEMBR, V24, P351, DOI 10.1007/BF00762528; HASEBE M, 1992, BIOCHEM BIOPH RES CO, V183, P856, DOI 10.1016/0006-291X(92)90562-Y; HASENFRATZ MP, 1995, PLANT PHYSIOL, V108, P1395, DOI 10.1104/pp.108.4.1395; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; HO MN, 1993, J BIOL CHEM, V268, P221; KLIONSKY DJ, 1992, J EXP BIOL, V172, P83; KRAUSE M, 1995, CAENORHABDITIS ELEGA, P482; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; MELLMAN I, 1992, J EXP BIOL, V172, P39; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; NELSON FK, 1983, J ULTRA MOL STRUCT R, V82, P156; NELSON H, 1989, FEBS LETT, V247, P147, DOI 10.1016/0014-5793(89)81259-1; NELSON H, 1990, J BIOL CHEM, V265, P20390; NELSON RD, 1992, P NATL ACAD SCI USA, V89, P3541, DOI 10.1073/pnas.89.8.3541; Oka T, 1997, J BIOL CHEM, V272, P24387, DOI 10.1074/jbc.272.39.24387; PUOPOLO K, 1992, J BIOL CHEM, V267, P3696; SPIETH J, 1991, MOL CELL BIOL, V11, P4651, DOI 10.1128/MCB.11.9.4651; SPIETH J, 1993, CELL, V73, P521, DOI 10.1016/0092-8674(93)90139-H; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Sulston J., 1988, NEMATODE CAENORHABDI, P587; TANAKA K, 1990, MOL CELL BIOL, V10, P4303, DOI 10.1128/MCB.10.8.4303; Tomochika K, 1997, FEBS LETT, V404, P61, DOI 10.1016/S0014-5793(97)00090-2; UMEMOTO N, 1991, J BIOL CHEM, V266, P24526; UMEMOTO N, 1990, J BIOL CHEM, V265, P18447; VANHILLE B, 1993, BIOCHEM BIOPH RES CO, V197, P15, DOI 10.1006/bbrc.1993.2434; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; ZORIO DAR, 1994, NATURE, V372, P270, DOI 10.1038/372270a0; ZWAAL RR, 1993, P NATL ACAD SCI USA, V90, P7431, DOI 10.1073/pnas.90.16.7431	37	39	48	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22570	22576		10.1074/jbc.273.35.22570	http://dx.doi.org/10.1074/jbc.273.35.22570			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712884	hybrid			2022-12-27	WOS:000075616600060
J	Kallstrom, H; Islam, MS; Berggren, PO; Jonsson, AB				Kallstrom, H; Islam, MS; Berggren, PO; Jonsson, AB			Cell signaling by the type IV pili of pathogenic Nisseria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN EPITHELIAL-CELLS; NEISSERIA-GONORRHOEAE; ENDOTHELIAL-CELLS; SALMONELLA-TYPHIMURIUM; SELECTIVE INHIBITOR; ESCHERICHIA-COLI; PROTEIN-KINASE; IN-VITRO; ADHERENCE; TRANSDUCTION	Neisseria gonorrhoeae and Neisseria meningitidis are Gram-negative bacterial pathogens that infect human mucosal epithelia. Type TV pilus-mediated adherence of these bacteria is a crucial early event for establishment of infection. In this work, we show that the type IV pill transduce a signal into the eucaryotic host cell. Purified adherent pill, but not pill from a low binding mutant, trigger an increase in the cytosolic free calcium ([Ca2+](i)) in target epithelial cells, a signal known to control many cellular responses. The [Ca2+](i) increase was blocked by antibodies against CD46, a putative pilus receptor, suggesting a role for this protein in signal transduction. Pilus-mediated attachment was inhibited by depletion of host cell intracellular Ca2+ stores but not by removal of extracellular Ca2+. Further, kinase inhibition studies showed that pilus-mediated adherence is dependent on casein kinase II. In summary, these data reveal a novel function of the type IV pill, namely induction of signal transduction pathways in host cells.	Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden; Karolinska Hosp, Karolinska Inst, Dept Mol Med, Rolf Luft Ctr Diabet Res, S-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Jonsson, AB (corresponding author), Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden.	Ann-Beth.Jonsson@mtc.ki.se	Islam, Shahidul/K-3295-2019	Islam, Shahidul/0000-0002-9016-1881; Berggren, Per-Olof/0000-0001-8991-413X				BALDWIN TJ, 1991, INFECT IMMUN, V59, P1599, DOI 10.1128/IAI.59.5.1599-1604.1991; BLISKA JB, 1993, CELL, V73, P903, DOI 10.1016/0092-8674(93)90270-Z; CHEN JCR, 1991, MOL MICROBIOL, V5, P1531, DOI 10.1111/j.1365-2958.1991.tb00800.x; CHEN T, 1995, J EXP MED, V182, P511, DOI 10.1084/jem.182.2.511; Chen T, 1996, P NATL ACAD SCI USA, V93, P14851, DOI 10.1073/pnas.93.25.14851; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; DYTOC M, 1994, GASTROENTEROLOGY, V106, P1150, DOI 10.1016/0016-5085(94)90004-3; GINOCCHIO C, 1992, P NATL ACAD SCI USA, V89, P5976, DOI 10.1073/pnas.89.13.5976; GrayOwen SD, 1997, EMBO J, V16, P3435, DOI 10.1093/emboj/16.12.3435; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; INESI G, 1992, ARCH BIOCHEM BIOPHYS, V298, P313, DOI 10.1016/0003-9861(92)90416-T; ISLAM MS, 1995, BIOCHEM J, V306, P679, DOI 10.1042/bj3060679; JONSSON AB, 1991, EMBO J, V10, P477, DOI 10.1002/j.1460-2075.1991.tb07970.x; JONSSON AB, 1994, MOL MICROBIOL, V13, P403, DOI 10.1111/j.1365-2958.1994.tb00435.x; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; KAO JPY, 1994, METHOD CELL BIOL, V40, P155; KELLOGG DS, 1968, J BACTERIOL, V96, P596, DOI 10.1128/JB.96.3.596-605.1968; LISZEWSKI MK, 1994, J BIOL CHEM, V269, P10776; LISZEWSKI MK, 1991, ANNU REV IMMUNOL, V9, P431, DOI 10.1146/annurev.iy.09.040191.002243; MITTLEMAN B, 1983, J MOL BIOL, V165, P461, DOI 10.1016/S0022-2836(83)80213-7; NASSIF X, 1994, P NATL ACAD SCI USA, V91, P3769, DOI 10.1073/pnas.91.9.3769; NASSIF X, 1993, MOL MICROBIOL, V8, P719, DOI 10.1111/j.1365-2958.1993.tb01615.x; Naumann M, 1997, J EXP MED, V186, P247, DOI 10.1084/jem.186.2.247; OMURA S, 1995, J ANTIBIOT, V48, P535, DOI 10.7164/antibiotics.48.535; PACE J, 1993, CELL, V72, P505, DOI 10.1016/0092-8674(93)90070-7; PATTON C, 1996, MAXCHELATOR; PETERSON G, 1995, J NUTR, V125, pS784, DOI 10.1093/jn/125.suppl_3.784S; Rahman M, 1997, MOL MICROBIOL, V25, P11, DOI 10.1046/j.1365-2958.1997.4601823.x; RODRIGUEZ A, 1995, J CELL BIOL, V129, P1263, DOI 10.1083/jcb.129.5.1263; ROSENSHINE I, 1993, BIOESSAYS, V15, P17, DOI 10.1002/bies.950150104; RUDEL T, 1992, MOL MICROBIOL, V6, P3439, DOI 10.1111/j.1365-2958.1992.tb02211.x; RUDEL T, 1995, NATURE, V373, P357, DOI 10.1038/373357a0; RUDEL T, 1995, MOL MICROBIOL, V17, P1057, DOI 10.1111/j.1365-2958.1995.mmi_17061057.x; RUSCHKOWSKI S, 1992, FEMS MICROBIOL LETT, V95, P121; SCHULZ I, 1990, METHOD ENZYMOL, V192, P280; SWANSON J, 1987, J EXP MED, V165, P1344, DOI 10.1084/jem.165.5.1344; SWANSON J, 1973, J EXP MED, V137, P571, DOI 10.1084/jem.137.3.571; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; VANPUTTEN JPM, 1995, EMBO J, V14, P2144, DOI 10.1002/j.1460-2075.1995.tb07208.x; VANWINKLE WB, 1976, SCIENCE, V193, P1130, DOI 10.1126/science.959824; VIRJI M, 1993, MOL MICROBIOL, V10, P1013, DOI 10.1111/j.1365-2958.1993.tb00972.x; Virji M, 1996, MOL MICROBIOL, V22, P941, DOI 10.1046/j.1365-2958.1996.01551.x; VIRJI M, 1992, MOL MICROBIOL, V6, P1271, DOI 10.1111/j.1365-2958.1992.tb00848.x	43	120	123	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21777	21782		10.1074/jbc.273.34.21777	http://dx.doi.org/10.1074/jbc.273.34.21777			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705315	hybrid			2022-12-27	WOS:000075492600049
J	Pini, A; Viti, F; Santucci, A; Carnemolla, B; Zardi, L; Neri, P; Neri, D				Pini, A; Viti, F; Santucci, A; Carnemolla, B; Zardi, L; Neri, P; Neri, D			Design and use of a phage display library - Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMOBILIZED PH GRADIENTS; BY-PASSING IMMUNIZATION; FIBRONECTIN ISOFORM; MONOCLONAL-ANTIBODIES; SYNTHETIC REPERTOIRES; ESCHERICHIA-COLI; ANTIGEN-BINDING; LIGHT-CHAINS; ELECTROPHORESIS; FRAGMENTS	We report the construction and the use of a phage display human antibody library (>3 x 10(8) clones) based on principles of protein design. A large repertoire of functional antibodies with similar properties was produced by appending short variable complementarity-determining region 3 (CDR3) onto the two antibody germ line segments most frequently found in human antibodies. With this strategy we concentrated sequence diversity in regions of the antibody structure that are centrally located in the antigen binding site, while leaving residues in more peripheral positions available for further mutagenesis aimed at improving the affinity of the selected antibodies. In addition, the library was tested by selecting antibodies against six biologically relevant antigens, Using only 0.3 mu g of antigen eluted from a two-dimensional gel spot, we isolated binders specific for the ED-B domain of fibronectin, a marker of angiogenesis. These antibodies recognize the native antigen with affinities in the 10(7-)10(8) M-1 range, and perform well in immunosorbent assays, in two-dimensional Western blotting and in immunohistochemistry, The affinity of one anti-ED-B antibody was improved by 27-fold by combinatorially mutating six strategically selected residues in the heavy chain variable domain. A further 28-fold affinity improvement could be achieved by mutating residues 32 and 50 of the light chain. The resulting antibody, L19, bound to the ED-B domain of fibronectin with very high affinity (K-d = 54 pM), as determined by real-time interaction analysis with surface plasmon resonance detection, band shift analysis, and by competition experiments with electrochemiluminescent detection.	ETH Honggerberg, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; Univ Siena, Dipartimento Biol Mol, Sez Biochim, I-53100 Siena, Italy; Ist Nazl Ric Canc, I-16132 Genoa, Italy	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Siena; University of Genoa; IRCCS AOU San Martino IST	Neri, D (corresponding author), ETH Honggerberg, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.		Santucci, Annalisa/K-1932-2018; Pini, Alessandro/R-1359-2018; Neri, Dario/P-4368-2016	Santucci, Annalisa/0000-0001-6976-9086; Pini, Alessandro/0000-0002-3832-8349; Neri, Dario/0000-0001-5234-7370				Anderson NG, 1996, ELECTROPHORESIS, V17, P443, DOI 10.1002/elps.1150170303; BALZA E, 1993, FEBS LETT, V332, P39, DOI 10.1016/0014-5793(93)80479-E; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; Borsi L, 1998, EXP CELL RES, V240, P244, DOI 10.1006/excr.1998.3946; Carnemolla B, 1996, INT J CANCER, V68, P397, DOI 10.1002/(SICI)1097-0215(19961104)68:3<397::AID-IJC20>3.3.CO;2-D; CASTELLANI P, 1994, INT J CANCER, V59, P612, DOI 10.1002/ijc.2910590507; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; CLACKSON T, 1991, NATURE, V352, P624, DOI 10.1038/352624a0; COX JPL, 1994, EUR J IMMUNOL, V24, P827, DOI 10.1002/eji.1830240409; DEAVER DR, 1995, NATURE, V377, P758, DOI 10.1038/377758a0; DEKRUIF J, 1995, P NATL ACAD SCI USA, V92, P3938, DOI 10.1073/pnas.92.9.3938; Dunn MJ, 1996, METHOD ENZYMOL, V271, P177; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; GRIFFITHS AD, 1993, EMBO J, V12, P725, DOI 10.1002/j.1460-2075.1993.tb05706.x; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; HELMERCITTERICH M, 1994, J MOL BIOL, V235, P1021, DOI 10.1006/jmbi.1994.1054; HOCHSTRASSER DF, 1988, ANAL BIOCHEM, V173, P424, DOI 10.1016/0003-2697(88)90209-6; HOOGENBOOM HR, 1991, NUCLEIC ACIDS RES, V19, P4133, DOI 10.1093/nar/19.15.4133; HOOGENBOOM HR, 1992, J MOL BIOL, V227, P381, DOI 10.1016/0022-2836(92)90894-P; HUANG H, 1997, SCIENCE, V275, P547; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Ignatovich O, 1997, J MOL BIOL, V268, P69, DOI 10.1006/jmbi.1997.0956; ITO W, 1995, J MOL BIOL, V248, P729, DOI 10.1006/jmbi.1995.0255; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; KAHN P, 1995, SCIENCE, V270, P369, DOI 10.1126/science.270.5235.369; KIRKHAM PM, 1992, EMBO J, V11, P603, DOI 10.1002/j.1460-2075.1992.tb05092.x; LAVOIE TB, 1992, J IMMUNOL, V148, P503; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; MARKS JD, 1993, BIO-TECHNOL, V11, P1145, DOI 10.1038/nbt1093-1145; Neri D, 1996, TRENDS BIOTECHNOL, V14, P465, DOI 10.1016/S0167-7799(96)10067-6; Neri D, 1996, J INVEST DERMATOL, V107, P164, DOI 10.1111/1523-1747.ep12329566; Neri D, 1996, BIOTECHNIQUES, V20, P708; Neri D, 1997, NAT BIOTECHNOL, V15, P1271, DOI 10.1038/nbt1197-1271; NERI D, 1996, NAT BIOTECHNOL, V14, P385; NISSIM A, 1994, EMBO J, V13, P692, DOI 10.1002/j.1460-2075.1994.tb06308.x; OReilly MS, 1996, NAT MED, V2, P689, DOI 10.1038/nm0696-689; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Pasqualini R, 1997, NAT BIOTECHNOL, V15, P542, DOI 10.1038/nbt0697-542; Pereira S, 1997, J IMMUNOL METHODS, V203, P11, DOI 10.1016/S0022-1759(97)00005-7; Pini A, 1997, J IMMUNOL METHODS, V206, P171, DOI 10.1016/S0022-1759(97)00107-5; Righetti PG, 1996, METHOD ENZYMOL, V270, P235; Sanchez JC, 1997, ELECTROPHORESIS, V18, P324, DOI 10.1002/elps.1150180305; Schier R, 1996, GENE, V169, P147, DOI 10.1016/0378-1119(95)00821-7; TOMLINSON IM, 1995, EMBO J, V14, P4628, DOI 10.1002/j.1460-2075.1995.tb00142.x; Tomlinson IM, 1996, J MOL BIOL, V256, P813, DOI 10.1006/jmbi.1996.0127; TOMLINSON IM, 1992, J MOL BIOL, V227, P776, DOI 10.1016/0022-2836(92)90223-7; Vaughan TJ, 1996, NAT BIOTECHNOL, V14, P309, DOI 10.1038/nbt0396-309; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; Watters JM, 1997, IMMUNOTECHNOLOGY, V3, P21, DOI 10.1016/S1380-2933(96)00056-5; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; YANG WP, 1995, J MOL BIOL, V254, P392, DOI 10.1006/jmbi.1995.0626; ZARDI L, 1987, EMBO J, V6, P2337, DOI 10.1002/j.1460-2075.1987.tb02509.x	55	358	480	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21769	21776		10.1074/jbc.273.34.21769	http://dx.doi.org/10.1074/jbc.273.34.21769			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705314	Green Published, hybrid			2022-12-27	WOS:000075492600048
J	Roberts, R; Sciorra, VA; Morris, AJ				Roberts, R; Sciorra, VA; Morris, AJ			Human type 2 phosphatidic acid phosphohydrolases - Substrate specificity of the type 2a, 2b, and 2c enzymes and cell surface activity of the 2a isoform	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; PHOSPHOLIPASE-D; ENDOPLASMIC-RETICULUM; SIGNAL-TRANSDUCTION; SF9 CELLS; RAT-LIVER; IDENTIFICATION; PURIFICATION; PROTEIN; SPHINGOSINE	Phosphatidic acid (PA), lysophosphatidic acid, ceramide l-phosphate (CIP), and sphingosine l-phosphate (S1P) are lipid mediators generated by phospholipases, sphingomyelinases, and lipid kinases, The major pathway for degradation of these lipids is dephosphorylation catalyzed by members of two classes (types 1 and 2) of phosphohydrolase activities (PAPs), cDNAs encoding two type 2 PAPs, PAP-2a and -2b, have been expressed by transient transfection and shown to catalyze hydrolysis of PA, CIP, and SIP (Kai, M., Wada, I., Imai, S., Sakane, F. and Kanoh, H. (1997) J. Biol. Chem. 272, 24572-24578), We report the cloning and expression of a third type 2 PAP enzyme (288 amino acids, predicted molecular mass of 32.6 kDa), PAP-2c, which exhibits 54 and 43% sequence homology to PAPs 2a and 2b. Expression of HA epitope-tagged PAP-2a, -2b, and 2c in HEK293 cells produced immunoreactive proteins and increased membrane-associated PAP activity. Sf9 insect cells contain very low endogenous PAP activity. Recombinant expression of the three PAP enzymes using baculovirus vectors produces dramatic increases in membrane-associated Mg2+-independent, N-ethylmaleimide-insensitive PAP activity, Expression of PAP-2a but not PAP-2b or -2c resulted in high levels of cell surface PAP activity in intact insect cells. Kinetic analysis of PAP-2a, -2b, and -2c activity against PA, lysophosphatidic acid, C1P, and S1P presented in mixed micelles of Triton X-100 revealed differences in substrate specificity and susceptibility to inhibition by sphingosine, Zn2+, and propranol.	SUNY Stony Brook, Hlth Sci Ctr, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; SUNY Stony Brook, Hlth Sci Ctr, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Morris, AJ (corresponding author), SUNY Stony Brook, Hlth Sci Ctr, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.	andrew@pharm.sunysb.edu	Morris, Andrew/B-7869-2010		NIGMS NIH HHS [GM50388] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050388] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barila D, 1996, J BIOL CHEM, V271, P29928, DOI 10.1074/jbc.271.47.29928; Bi K, 1997, CURR BIOL, V7, P301, DOI 10.1016/S0960-9822(06)00153-9; Brindley DN, 1996, CHEM PHYS LIPIDS, V80, P45, DOI 10.1016/0009-3084(96)02545-5; BUTKERAIT P, 1995, J BIOL CHEM, V270, P18691, DOI 10.1074/jbc.270.31.18691; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Chen YG, 1997, J CELL BIOL, V138, P495, DOI 10.1083/jcb.138.3.495; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Exton JH, 1997, J BIOL CHEM, V272, P15579, DOI 10.1074/jbc.272.25.15579; FLEMING IN, 1995, BIOCHEM J, V308, P983, DOI 10.1042/bj3080983; FROHMAN MA, 1994, PCR METH APPL, V4, pS40; GOMEZMUNOZ A, 1992, BIOCHIM BIOPHYS ACTA, V1127, P49, DOI 10.1016/0005-2760(92)90200-F; GOMEZMUNOZ A, 1995, J BIOL CHEM, V270, P26318, DOI 10.1074/jbc.270.44.26318; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; JAIN MK, 1995, METHOD ENZYMOL, V249, P567; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; Kai M, 1997, J BIOL CHEM, V272, P24572, DOI 10.1074/jbc.272.39.24572; Kai M, 1996, J BIOL CHEM, V271, P18931, DOI 10.1074/jbc.271.31.18931; KANOH H, 1992, J BIOL CHEM, V267, P25309; Ktistakis NT, 1996, J CELL BIOL, V134, P295, DOI 10.1083/jcb.134.2.295; LIN YP, 1990, J BIOL CHEM, V265, P166; LINDAU M, 1991, BIOCHIM BIOPHYS ACTA, V1071, P429, DOI 10.1016/0304-4157(91)90006-I; Mandala SM, 1998, P NATL ACAD SCI USA, V95, P150, DOI 10.1073/pnas.95.1.150; Mao CG, 1997, J BIOL CHEM, V272, P28690, DOI 10.1074/jbc.272.45.28690; MARTIN JB, 1949, ANAL CHEM, V21, P965, DOI 10.1021/ac60032a024; Messerschmidt A, 1996, P NATL ACAD SCI USA, V93, P392, DOI 10.1073/pnas.93.1.392; Morris AJ, 1996, TRENDS PHARMACOL SCI, V17, P182, DOI 10.1016/0165-6147(96)10016-X; Neuwald AF, 1997, PROTEIN SCI, V6, P1764, DOI 10.1002/pro.5560060817; OLIVERA A, 1994, ANAL BIOCHEM, V223, P306, DOI 10.1006/abio.1994.1589; OREILLY DR, 1992, BACULOVIRUS EXPRESSI, P107; PAGANO RE, 1985, J BIOL CHEM, V260, P1909; PERRY DK, 1993, J BIOL CHEM, V268, P25302; Spiegel S, 1996, CURR OPIN CELL BIOL, V8, P159, DOI 10.1016/S0955-0674(96)80061-5; Stukey J, 1997, PROTEIN SCI, V6, P469; TAUSSIG R, 1994, METHOD ENZYMOL, V238, P95; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Waggoner DW, 1996, J BIOL CHEM, V271, P16506, DOI 10.1074/jbc.271.28.16506; WAGGONER DW, 1995, J BIOL CHEM, V270, P19422, DOI 10.1074/jbc.270.33.19422; XIE MS, 1994, ARCH BIOCHEM BIOPHYS, V312, P254, DOI 10.1006/abbi.1994.1307; Zhang N, 1997, NATURE, V385, P64, DOI 10.1038/385064a0	39	147	152	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					22059	22067		10.1074/jbc.273.34.22059	http://dx.doi.org/10.1074/jbc.273.34.22059			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705349	hybrid			2022-12-27	WOS:000075492600083
J	Baneres, JL; Roquet, F; Green, M; LeCalvez, H; Parello, J				Baneres, JL; Roquet, F; Green, M; LeCalvez, H; Parello, J			The cation-binding domain from the alpha subunit of integrin alpha(5)beta(1) is a minimal domain for fibronectin recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; DEPENDENT ADHESION SITE; CRYSTAL-STRUCTURE; LIGAND-BINDING; I-DOMAIN; CELL-ADHESION; CRITICAL RESIDUES; DIVALENT-CATIONS	The cation-binding domain from the alpha subunit of human integrin alpha(5)beta(1) was produced as a recombinant protein, alpha(5)-(229-448). This protein displays a well defined fold with a content of 30-35% alpha-helix and 20-25% beta-strand, based on circular dichroism. The binding of Ca2+ or Mg2+ to alpha(5)-(229-448) results in a biphasic conformational rearrangement consistent with the occurrence of two classes of cation-binding sites differing by their affinities. The two classes of sites are located in two conformationally independent lobes, as established by a parallel study of two recombinant half-domains (Nand C-terminal) that also adopt stable folds. Upon saturation with divalent cations, alpha(5)-(229-448) binds an Arg-Gly-Asp (RGD)-containing fibronectin ligand to form a 1:1 complex. Complex formation is associated with a specific conformational adaptation of the Ligand, suggesting an induced fit mechanism. In contrast, neither of the half-domains is competent for ligand binding. The alpha(5)-(229-448)-fibronectin complex is dissociated in the presence of an RGD peptide, as well as of a simple carboxylic acid, suggesting that the RGD aspartyl carboxylate is an essential element that directly interacts with the alpha(5) cation-binding domain.	Fac Pharm Montpellier, CNRS, UMR 9921, F-34060 Montpellier 2, France; Burnham Inst, La Jolla, CA 92037 USA	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Sanford Burnham Prebys Medical Discovery Institute	Parello, J (corresponding author), Fac Pharm Montpellier, CNRS, UMR 9921, 15 Ave Charles Flahault, F-34060 Montpellier 2, France.	joseph@pharma.univ-montpl.fr			NCI NIH HHS [5PO1CA28896-15] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA028896] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alemany M, 1996, BLOOD, V87, P592, DOI 10.1182/blood.V87.2.592.bloodjournal872592; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; [Anonymous], 1996, CIRCULAR DICHROISM C; AOTA S, 1994, J BIOL CHEM, V269, P24756; ARGRAVES WS, 1987, J CELL BIOL, V105, P1183, DOI 10.1083/jcb.105.3.1183; BENZONANA G, 1972, BIOCHIM BIOPHYS ACTA, V278, P110, DOI 10.1016/0005-2795(72)90111-0; BLANCUZZI Y, 1993, BIOCHEMISTRY-US, V32, P1302, DOI 10.1021/bi00056a015; DICKINSON CD, 1994, J MOL BIOL, V236, P1079, DOI 10.1016/0022-2836(94)90013-2; DSOUZA SE, 1994, CELL, V79, P659, DOI 10.1016/0092-8674(94)90551-7; EDWARDS JG, 1988, J CELL SCI, V89, P507; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; GAILIT J, 1988, J BIOL CHEM, V263, P12927; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GLUKHOVA MA, 1993, SEMIN CANCER BIOL, V4, P241; Goodman TG, 1996, J BIOL CHEM, V271, P23729, DOI 10.1074/jbc.271.39.23729; GULINO D, 1992, J BIOL CHEM, V267, P1001; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; IRIE A, 1995, EMBO J, V14, P5550, DOI 10.1002/j.1460-2075.1995.tb00242.x; JONES EY, 1995, NATURE, V373, P539, DOI 10.1038/373539a0; Kamata T, 1996, J BIOL CHEM, V271, P18610, DOI 10.1074/jbc.271.31.18610; KAWASAKI H, 1994, PROTEIN PROFILE, V1, P343; KOIVUNEN E, 1994, J CELL BIOL, V124, P373, DOI 10.1083/jcb.124.3.373; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lin ECK, 1997, J BIOL CHEM, V272, P14236, DOI 10.1074/jbc.272.22.14236; Loftus JC, 1996, J BIOL CHEM, V271, P2033, DOI 10.1074/jbc.271.4.2033; Lombardo A, 1996, PROTEIN SCI, V5, P1934, DOI 10.1002/pro.5560050922; LOSTER K, 1995, J CHROMATOGR A, V711, P187, DOI 10.1016/0021-9673(95)00208-5; MAIN AL, 1992, CELL, V71, P671, DOI 10.1016/0092-8674(92)90600-H; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; MARTIN SR, 1986, BIOCHEM J, V238, P485, DOI 10.1042/bj2380485; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; McKay BS, 1996, J BIOL CHEM, V271, P30544, DOI 10.1074/jbc.271.48.30544; Mould AP, 1997, J BIOL CHEM, V272, P17283, DOI 10.1074/jbc.272.28.17283; PARELLO J, 1971, BIOCHIMIE, V53, P1079, DOI 10.1016/S0300-9084(71)80196-7; PASQUALINI R, 1995, J CELL BIOL, V130, P1189, DOI 10.1083/jcb.130.5.1189; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; PuzonMcLaughlin W, 1996, J BIOL CHEM, V271, P20438, DOI 10.1074/jbc.271.34.20438; QU AD, 1995, P NATL ACAD SCI USA, V92, P10277, DOI 10.1073/pnas.92.22.10277; ROBERTS SGE, 1994, NATURE, V371, P717, DOI 10.1038/371717a0; ROQUET F, 1992, J MOL BIOL, V223, P705, DOI 10.1016/0022-2836(92)90985-S; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SINHA D, 1994, BIOTECHNIQUES, V17, P509; Smith J.W., 1994, INTEGRINS MOL BIOL R, P1; SPEICHER DW, 1989, TECHNIQUES PROTEIN C, V1, P24; Springer TA, 1997, P NATL ACAD SCI USA, V94, P65, DOI 10.1073/pnas.94.1.65; STANLEY P, 1994, EMBO J, V13, P1790, DOI 10.1002/j.1460-2075.1994.tb06447.x; Stempfer G, 1996, NAT BIOTECHNOL, V14, P329, DOI 10.1038/nbt0396-329; Takagi J, 1997, J BIOL CHEM, V272, P19794, DOI 10.1074/jbc.272.32.19794; Tatsumi R, 1997, ANAL BIOCHEM, V254, P126, DOI 10.1006/abio.1997.2369; THOMAS JO, 1989, METHOD ENZYMOL, V170, P549; TUCKWELL DS, 1992, BIOCHEM J, V285, P325, DOI 10.1042/bj2850325; TUCKWELL DS, 1997, INTEGRIN LIGAND INTE, P199; VANDERWE.DR, 1971, FEBS LETT, V14, P333, DOI 10.1016/0014-5793(71)80294-6; WOODY RW, 1994, EUR BIOPHYS J BIOPHY, V23, P253, DOI 10.1007/BF00213575	58	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24744	24753		10.1074/jbc.273.38.24744	http://dx.doi.org/10.1074/jbc.273.38.24744			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733775	hybrid			2022-12-27	WOS:000076007300067
J	Burstein, ES; Spalding, TA; Brann, MR				Burstein, ES; Spalding, TA; Brann, MR			The second intracellular loop of the m5 muscarinic receptor is the switch which enables G-protein coupling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; RANDOM SATURATION MUTAGENESIS; BETA-ADRENERGIC RECEPTORS; INVERSE AGONIST ACTIVITY; HIGH-THROUGHPUT ASSAYS; 3RD CYTOPLASMIC LOOP; CONNECTING HELIX-C; ACETYLCHOLINE-RECEPTOR; CONSTITUTIVE ACTIVATION; AMINO-ACID	We have completed a systematic search of the intracellular loops of a muscarinic acetylcholine receptor for domains that govern G-protein coupling. A unique feature of the second intracellular (i2) loop was an ordered cluster of residues where diverse substitutions cause constitutive activation. A second group of residues in i2 was identified where mutations compromised receptor/ G-protein coupling. The residues of each group alternate and are spaced three to four positions apart, suggesting an cu-helical structure where these groups form opposing faces of the helix. We propose that the constitutively activating face normally constrains the receptor in the "off-state," while the other face couples G-proteins in the "on-state." Therefore, the i2 loop functions as the switch enabling G-protein activation.	ACADIA Pharmaceut Inc, San Diego, CA 92121 USA		Burstein, ES (corresponding author), ACADIA Pharmaceut Inc, 3911 Sorrento Valley, San Diego, CA 92121 USA.							ARDEN JR, 1992, BIOCHEM BIOPH RES CO, V188, P1111, DOI 10.1016/0006-291X(92)91346-R; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; BARKER EL, 1994, J BIOL CHEM, V269, P11687; BLUML K, 1994, J BIOL CHEM, V269, P18870; BLUML K, 1994, P NATL ACAD SCI USA, V91, P7980, DOI 10.1073/pnas.91.17.7980; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; BONNER TI, 1988, NEURON, V1, P403, DOI 10.1016/0896-6273(88)90190-0; Brauner-Osborne H, 1996, EUR J PHARMACOL, V295, P93, DOI 10.1016/0014-2999(95)00639-7; Burstein ES, 1998, BIOCHEMISTRY-US, V37, P4052, DOI 10.1021/bi972132j; Burstein ES, 1996, BIOCHEM PHARMACOL, V51, P539, DOI 10.1016/0006-2952(95)02234-1; Burstein ES, 1996, J BIOL CHEM, V271, P2882, DOI 10.1074/jbc.271.6.2882; BURSTEIN ES, 1995, J BIOL CHEM, V270, P3141, DOI 10.1074/jbc.270.7.3141; Burstein ES, 1997, MOL PHARMACOL, V51, P312, DOI 10.1124/mol.51.2.312; BURSTEIN ES, 1995, FEBS LETT, V363, P261, DOI 10.1016/0014-5793(95)00323-2; Burstein ES, 1997, J NEUROCHEM, V68, P525; CHAHINE M, 1994, PFLUG ARCH EUR J PHY, V427, P136, DOI 10.1007/BF00585952; CHIDIAC P, 1994, MOL PHARMACOL, V45, P490; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; COSTA T, 1989, P NATL ACAD SCI USA, V86, P7321, DOI 10.1073/pnas.86.19.7321; DONNELLY D, 1994, RECEPTOR CHANNEL, V2, P61; DUERSON K, 1993, FEBS LETT, V324, P103, DOI 10.1016/0014-5793(93)81541-7; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P8812, DOI 10.1021/bi00027a033; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; FRASER CM, 1989, MOL PHARMACOL, V36, P840; Gether U, 1997, EMBO J, V16, P6737, DOI 10.1093/emboj/16.22.6737; HILF G, 1992, EUR J PHARM-MOLEC PH, V225, P245, DOI 10.1016/0922-4106(92)90026-R; HillEubanks D, 1996, J BIOL CHEM, V271, P3058, DOI 10.1074/jbc.271.6.3058; HOGGER P, 1995, J BIOL CHEM, V270, P7405; HULME EC, 1990, ANNU REV PHARMACOL, V30, P633, DOI 10.1146/annurev.pa.30.040190.003221; Jakubik J, 1995, FEBS LETT, V377, P275, DOI 10.1016/0014-5793(95)01360-1; JONES PG, 1995, EUR J PHARM-MOLEC PH, V288, P251, DOI 10.1016/0922-4106(95)90036-5; KJELSBERG MA, 1992, J BIOL CHEM, V267, P1430; KUBO T, 1988, FEBS LETT, V241, P119, DOI 10.1016/0014-5793(88)81043-3; KUBO T, 1986, NATURE, V323, P411, DOI 10.1038/323411a0; KUNKEL MT, 1993, EMBO J, V12, P3809, DOI 10.1002/j.1460-2075.1993.tb06059.x; KURTENBACH E, 1990, J BIOL CHEM, V265, P13702; LAMEH J, 1992, J BIOL CHEM, V267, P13406; LECHLEITER J, 1990, EMBO J, V9, P4381, DOI 10.1002/j.1460-2075.1990.tb07888.x; LEEBLUNDBERG LMF, 1994, J BIOL CHEM, V269, P25970; LEFF P, 1995, TRENDS PHARMACOL SCI, V16, P89, DOI 10.1016/S0165-6147(00)88989-0; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; Liu J, 1996, J BIOL CHEM, V271, P6172, DOI 10.1074/jbc.271.11.6172; Lu ZL, 1997, MOL PHARMACOL, V51, P234, DOI 10.1124/mol.51.2.234; MATSUI H, 1995, MOL PHARMACOL, V47, P88; MESSIER TL, 1995, PHARMACOL TOXICOL, V76, P308, DOI 10.1111/j.1600-0773.1995.tb00152.x; MORO O, 1993, J BIOL CHEM, V268, P22273; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; PERALTA EG, 1987, SCIENCE, V236, P600, DOI 10.1126/science.3107123; RESEK JF, 1993, BIOCHEMISTRY-US, V32, P12025, DOI 10.1021/bi00096a012; RIDGE KD, 1995, BIOCHEMISTRY-US, V34, P8804, DOI 10.1021/bi00027a032; Scheer A, 1997, P NATL ACAD SCI USA, V94, P808, DOI 10.1073/pnas.94.3.808; Schwartz Thue W., 1994, Current Opinion in Biotechnology, V5, P434, DOI 10.1016/0958-1669(94)90054-X; SHAPIRO RA, 1989, BIOCHEMISTRY-US, V28, P8946, DOI 10.1021/bi00448a039; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; SPALDING TA, 1994, J BIOL CHEM, V269, P4092; Spalding TA, 1997, BIOCHEMISTRY-US, V36, P10109, DOI 10.1021/bi970565g; Spalding TA, 1998, J BIOL CHEM, V273, P21563, DOI 10.1074/jbc.273.34.21563; Spalding TA, 1995, J PHARMACOL EXP THER, V275, P1274; TIAN WN, 1994, MOL PHARMACOL, V45, P524; Unger VM, 1997, NATURE, V389, P203, DOI 10.1038/38316; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; WESS J, 1989, FEBS LETT, V258, P133, DOI 10.1016/0014-5793(89)81633-3; WESS J, 1990, MOL PHARMACOL, V38, P517; WESS J, 1991, EMBO J, V10, P3729, DOI 10.1002/j.1460-2075.1991.tb04941.x; WESS J, 1993, EMBO J, V12, P331, DOI 10.1002/j.1460-2075.1993.tb05661.x; WONG SKF, 1994, J BIOL CHEM, V269, P18968; WONG SKF, 1990, J BIOL CHEM, V265, P6219	67	105	113	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24322	24327		10.1074/jbc.273.38.24322	http://dx.doi.org/10.1074/jbc.273.38.24322			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733718	hybrid			2022-12-27	WOS:000076007300010
J	Dukes, ID; Sreenan, S; Roe, MW; Levisetti, M; Zhou, YP; Ostrega, D; Bell, GI; Pontoglio, M; Yaniv, M; Philipson, L; Polonsky, KS				Dukes, ID; Sreenan, S; Roe, MW; Levisetti, M; Zhou, YP; Ostrega, D; Bell, GI; Pontoglio, M; Yaniv, M; Philipson, L; Polonsky, KS			Defective pancreatic beta-cell glycolytic signaling in hepatocyte nuclear factor-1 alpha-deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-KINASE GENE; INSULIN-SECRETION; MOUSE ISLETS; B-CELLS; GLUCOSE; EXPRESSION; RELEASE; MODY3; ONSET; RAT	Mutations in the hepatocyte nuclear factor-1 alpha (HNF-1 alpha) gene cause maturity onset diabetes of the young type 3, a form of type 2 diabetes mellitus, In mice lacking the HNF-1 alpha gene, insulin secretion and intracellular calcium ([Ca2+](i)) responses were impaired following stimulation with nutrient secretagogues such as glucose and glyceraldehyde but normal with non-nutrient stimuli such as potassium chloride. Patch clamp recordings revealed ATP-sensitive K+ currents (KATP) in beta-cells that were insensitive to suppression by glucose but normally sensitive to ATP, Exposure to mitochondrial substrates suppressed KATP, elevated [Ca2+](i), and corrected the insulin secretion defect. NAD(P)H responses to glucose were substantially reduced, and inhibitors of glycolytic NADH generation reproduced the mutant phenotype in normal islets. Flux of glucose through glycolysis in islets from mutant mice was reduced, as a result of which ATP generation in response to glucose was impaired. We conclude that hepatocyte nuclear factor-1 alpha diabetes results from defective beta-cell glycolytic signaling, which is potentially correctable using substrates that bypass the defect.	Univ Chicago, Pritzker Sch Med, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Pritzker Sch Med, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Univ Chicago, Pritzker Sch Med, Howard Hughes Med Inst, Chicago, IL 60637 USA; Glaxo Wellcome Inc, Res Inst, Dept Mol Endocrinol, Res Triangle Pk, NC 27709 USA; Inst Pasteur, CNRS, Unite Rech Associee 1644, Dept Biotechnol, F-75015 Paris, France	University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago; GlaxoSmithKline; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Polonsky, KS (corresponding author), Univ Chicago, Pritzker Sch Med, Dept Med, 5841 S Maryland Ave,MC 1027, Chicago, IL 60637 USA.	polonsky@medicine.bsd.uchicago.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK031842, P60DK020595, P01DK044840, R01DK031842, P30DK020595] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK31842, DK44840, DK20595] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; BENZ R, 1983, BIOPHYS J, V41, P381, DOI 10.1016/S0006-3495(83)84449-X; Budinger GRS, 1998, J BIOL CHEM, V273, P3320, DOI 10.1074/jbc.273.6.3320; Byrne MM, 1996, DIABETES, V45, P1503, DOI 10.2337/diabetes.45.11.1503; Cockburn BN, 1997, DIABETES, V46, P1434, DOI 10.2337/diabetes.46.9.1434; COOK DL, 1984, NATURE, V312, P446; DETIMARY P, 1995, J CLIN INVEST, V96, P1738, DOI 10.1172/JCI118219; DUKES ID, 1994, J BIOL CHEM, V269, P10979; EMENS LA, 1992, P NATL ACAD SCI USA, V89, P7300, DOI 10.1073/pnas.89.16.7300; Fajans SS, 1996, DIABETIC MED, V13, pS90; FINDLAY I, 1991, CIRC RES, V69, P623; Froguel P, 1996, DIABETIC MED, V13, pS96; Jijakli H, 1996, ARCH BIOCHEM BIOPHYS, V335, P245, DOI 10.1006/abbi.1996.0505; Lehto M, 1997, J CLIN INVEST, V99, P582, DOI 10.1172/JCI119199; Leyssens A, 1996, J PHYSIOL-LONDON, V496, P111, DOI 10.1113/jphysiol.1996.sp021669; LIU ZR, 1995, BIOCHEM J, V308, P105, DOI 10.1042/bj3080105; MACDONALD MJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P205, DOI 10.1006/abbi.1993.1413; MACDONALD MJ, 1990, DIABETES, V39, P1461, DOI 10.2337/diabetes.39.12.1461; MEGLASSON MD, 1986, DIABETES METAB REV, V2, P215; Mertz RJ, 1996, J BIOL CHEM, V271, P4838, DOI 10.1074/jbc.271.9.4838; MIQUEROL L, 1994, J BIOL CHEM, V269, P8944; MISLER S, 1992, PFLUG ARCH EUR J PHY, V421, P289, DOI 10.1007/BF00374842; Mukai E, 1998, AM J PHYSIOL-ENDOC M, V274, pE38, DOI 10.1152/ajpendo.1998.274.1.E38; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Pontoglio M, 1998, J CLIN INVEST, V101, P2215, DOI 10.1172/JCI2548; ROE MW, 1993, J BIOL CHEM, V268, P9953; SENER A, 1987, DIABETES, V36, P187, DOI 10.2337/diabetes.36.2.187; SENER A, 1978, BIOCHEM J, V176, P217, DOI 10.1042/bj1760217; STURIS J, 1994, AM J PHYSIOL, V267, pE250, DOI 10.1152/ajpendo.1994.267.2.E250; TRENTHAM DR, 1968, BIOCHEM J, V109, P603, DOI 10.1042/bj1090603; TRUBE G, 1986, PFLUG ARCH EUR J PHY, V407, P493, DOI 10.1007/BF00657506; WORLEY JF, 1994, J BIOL CHEM, V269, P14359; Yamada K, 1997, BIOCHEM J, V324, P917, DOI 10.1042/bj3240917; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Zhou YP, 1996, AM J PHYSIOL-ENDOC M, V270, pE988, DOI 10.1152/ajpendo.1996.270.6.E988	35	142	144	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24457	24464		10.1074/jbc.273.38.24457	http://dx.doi.org/10.1074/jbc.273.38.24457			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733737	hybrid			2022-12-27	WOS:000076007300029
J	Frank, P; Hodgson, KO; Kustin, K; Robinson, WE				Frank, P; Hodgson, KO; Kustin, K; Robinson, WE			Vanadium K-edge x-ray absorption spectroscopy reveals species differences within the same ascidian genera - A comparison of whole blood from Ascidia nigra and Ascidia ceratodes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RES; MAGNETIC-PROPERTIES; RESONANCE-SPECTRUM; SYDNEIENSIS-SAMEA; OXIDATION-STATE; CELLS; VANADOCYTES; TUNICHROMES; CHEMISTRY; TUNICATES	Vanadium K-edge x-ray absorption spectroscopy (XAS) was used to examine whole blood preparations from the tunicates Ascidia nigra and Ascidia ceratodes, Each XAS spectrum exhibits a rising edge inflection near 5480 eV characteristic of vanadium(III) and an intensity maximum at 5484.0 eV. In A. ceratodes blood cells, intrinsic aquo-VSO4+ complex ion is indicated by an inflection feature at 5476 eV in the first derivative of the vanadium It-edge XAS spectrum, but this feature is notably absent from the first derivative of the vanadium It-edge spectrum of blood cells from A. nigra. A strong pre-edge feature at 5468.6 eV also uniquely distinguishes the vanadium K-edge XAS spectrum of A.. nigra blood cells, implying that vanadyl ion represents similar to 25% of the endogenous vanadium, However, the energy position of the rising edge inflection of the vanadium It-edge XAS spectrum of A. nigra (5479.5 eV) is 1 eV lower than that of A. ceratodes (5480.5 eV), the reverse of any expected shift arising from the endogenous vanadyl ion. Thus, in contrast to A. ceratodes, a significant fraction of the blood cell vanadium(III) in A. nigra is apparently in a ligation environment substantially different from that provided by water. These novel species-related differences may have taxonomic significance.	Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Stanford Univ, Stanford Linear Accelerator Ctr, Stanford Synchrotron Radiat Lab, Stanford, CA 94309 USA; Brandeis Univ, Dept Chem, Waltham, MA 02254 USA; Univ Massachusetts, Environm Coastal & Ocean Sci Dept, Boston, MA 02125 USA	Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Brandeis University; University of Massachusetts System; University of Massachusetts Boston	Frank, P (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-01209] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abbott D.P., 1980, P177; ANDERSON DH, 1991, COMP BIOCHEM PHYS A, V99, P151, DOI 10.1016/0300-9629(91)90250-G; ANDERSON DH, 1991, COMP BIOCHEM PHYS A, V99, P585, DOI 10.1016/0300-9629(91)90134-X; BENFATTO M, 1986, PHYS REV B, V34, P5774, DOI 10.1103/PhysRevB.34.5774; Bielig H.-J., 1966, PROTIDES BIOL FLUIDS, V14, P197; BIGGS WR, 1979, EXPERIENTIA, V35, P1047, DOI 10.1007/BF01949933; BIGGS WR, 1976, MET IONS BIOL SYST, V6, P141; BOERI E, 1954, ARCH BIOCHEM BIOPHYS, V50, P404, DOI 10.1016/0003-9861(54)90056-9; BOTTE L, 1979, EXPERIENTIA, V35, P1228, DOI 10.1007/BF01963306; BRAND SG, 1989, COMP BIOCHEM PHYS B, V93, P425, DOI 10.1016/0305-0491(89)90103-X; Burojevic S, 1996, INORG CHIM ACTA, V251, P75, DOI 10.1016/S0020-1693(96)05254-1; CARLSON RMK, 1975, P NATL ACAD SCI USA, V72, P2217, DOI 10.1073/pnas.72.6.2217; CASTRO SL, 1995, INORG CHEM, V34, P466, DOI 10.1021/ic00106a008; CIERESZKO LS, 1963, COMP BIOCHEM PHYSIOL, V8, P137, DOI 10.1016/0010-406X(63)90077-X; COOPER SR, 1982, J AM CHEM SOC, V104, P5092, DOI 10.1021/ja00383a016; Cramer S. P., 1979, PROG INORG CHEM, V25, P1, DOI [DOI 10.1002/9780470166260.CH1, 10.1002/9780470166260.ch1]; DANSKIN GP, 1978, CAN J ZOOL, V56, P547, DOI 10.1139/z78-078; DINGLEY AL, 1981, BIOCHIM BIOPHYS ACTA, V649, P493, DOI 10.1016/0005-2736(81)90152-8; FRANCAVILLA J, 1975, INORG CHEM, V14, P2860, DOI 10.1021/ic50153a057; FRANK P, 1986, INORG CHEM, V25, P470, DOI 10.1021/ic00224a016; FRANK P, 1995, INORG CHEM, V34, P5942, DOI 10.1021/ic00128a004; FRANK P, 1994, INORG CHEM, V33, P3794, DOI 10.1021/ic00095a024; FRANK P, 1987, BIOCHEMISTRY-US, V26, P4975, DOI 10.1021/bi00390a014; FRANK P, 1988, INORG CHEM, V27, P118, DOI 10.1021/ic00274a025; Fulton J. F., 1920, Acta Zoologica Stockholm, V1; George WC, 1930, J MORPHOL, V49, P385, DOI 10.1002/jmor.1050490205; George WC, 1939, Q J MICROSC SCI, V81, P391; HAWKINS CJ, 1983, COMP BIOCHEM PHYS B, V76, P555, DOI 10.1016/0305-0491(83)90292-4; HEALD SM, 1990, PHYSICAL METHODS CHE, V5, P189; HIRATA J, 1992, ZOOL SCI, V9, P207; Kanda T, 1997, ZOOL SCI, V14, P37, DOI 10.2108/zsj.14.37; KOMURA A, 1977, B CHEM SOC JPN, V50, P2927, DOI 10.1246/bcsj.50.2927; Kustin K, 1996, J INORG BIOCHEM, V63, P223, DOI 10.1016/0162-0134(95)00238-3; KUSTIN K, 1990, INVERTEBR REPROD DEV, V17, P129, DOI 10.1080/07924259.1990.9672101; KUSTIN K, 1976, BIOL BULL, V150, P426, DOI 10.2307/1540683; KUTZLER FW, 1981, J AM CHEM SOC, V103, P6083, DOI 10.1021/ja00410a016; LEE SH, 1988, J INORG BIOCHEM, V33, P183, DOI 10.1016/0162-0134(88)80048-5; MACARA IG, 1979, COMP BIOCHEM PHYS A, V62, P821, DOI 10.1016/0300-9629(79)90009-4; MICHIBATA H, 1990, J EXP ZOOL, V254, P132, DOI 10.1002/jez.1402540204; Michibata H., 1990, P153; MICHIBATA H, 1991, J EXP ZOOL, V257, P306, DOI 10.1002/jez.1402570304; MICHIBATA H, 1987, J EXP ZOOL, V244, P33, DOI 10.1002/jez.1402440105; MICHIBATA H, 1990, ZOOL SCI, V7, P55; Michibata Hitoshi, 1993, Advances in Biophysics, V29, P105, DOI 10.1016/0065-227X(93)90007-R; OLTZ EM, 1989, EXPERIENTIA, V45, P186, DOI 10.1007/BF01954871; Plass W, 1997, INORG CHEM, V36, P2200, DOI 10.1021/ic9613669; REZAEVA L. T., 1964, ZH OBSHCH BIOL, V25, P347; ROMAN DA, 1988, BIOL BULL, V175, P154, DOI 10.2307/1541903; ROWLEY AF, 1982, J MAR BIOL ASSOC UK, V62, P607, DOI 10.1017/S0025315400019780; Ryan DE, 1996, BIOCHEMISTRY-US, V35, P8651, DOI 10.1021/bi952151y; SAKURAI H, 1987, BIOCHEM BIOPH RES CO, V149, P411, DOI 10.1016/0006-291X(87)90382-2; SHADLE SE, 1995, J AM CHEM SOC, V117, P2259, DOI 10.1021/ja00113a015; SMITH MJ, 1995, MET IONS BIOL SYST, V31, P423; SWINEHAR.JH, 1974, BIOL BULL, V146, P302, DOI 10.2307/1540626; Taylor SW, 1997, ARCH BIOCHEM BIOPHYS, V348, P278, DOI 10.1006/abbi.1997.0371; Taylor SW, 1997, CHEM REV, V97, P333, DOI 10.1021/cr940467q; TAYLOR SW, 1994, J INORG BIOCHEM, V56, P97, DOI 10.1016/0162-0134(94)85041-0; TULLIUS TD, 1980, J AM CHEM SOC, V102, P5670, DOI 10.1021/ja00537a045; Webb DA, 1939, J EXP BIOL, V16, P499; WONG J, 1984, PHYS REV B, V30, P5596, DOI 10.1103/PhysRevB.30.5596; Wright R.K., 1981, INVERTEBR BLOOD CELL, V2, P565; Zhang HH, 1996, INORG CHEM, V35, P4819, DOI 10.1021/ic960021n	62	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24498	24503		10.1074/jbc.273.38.24498	http://dx.doi.org/10.1074/jbc.273.38.24498			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733743	hybrid			2022-12-27	WOS:000076007300035
J	Song, JM; Midson, C; Blachly-Dyson, E; Forte, M; Colombini, M				Song, JM; Midson, C; Blachly-Dyson, E; Forte, M; Colombini, M			The topology of VDAC as probed by biotin modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; PEPTIDE-SPECIFIC ANTIBODIES; ANION-SELECTIVE CHANNEL; VOLTAGE-GATED CHANNEL; MOLECULAR-STRUCTURE; ION CHANNEL; PROTEIN; TOPOGRAPHY; YEAST	The outer membrane of mitochondria contains channels called VDAC (mitochondrial porin), which are formed by a single 30-kDa protein. Cysteine residues introduced by site-directed mutagenesis at sites throughout Neurospora crassa VDAC (naturally devoid of cysteine) were specifically biotinylated prior to reconstitution into planar phospholipid membranes. From previous studies, binding of streptavidin to single biotinylated sites results in one of two effects: reduced single-channel conductance without blockage of voltage gating (type 1) or locking of the channels in a closed conformation (type 2). All sites react with streptavidin only from one side of the membrane, Here, me extend this approach to VDAC molecules containing two cysteines and determine the location of each biotinylated residue with respect to the other within the membrane. When a combination of a type 1 and a type 2 site was used, each site could be observed to react with streptavidin. Two sets of sites located on opposite surfaces of the membrane were identified, thereby establishing the transmembrane topology of VDAC. A revised folding pattern for VDAC, consisting of 1 alpha helix and 13 beta strands, is proposed by combining these results with previously obtained information on which sites are lining the aqueous pore.	Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA	University System of Maryland; University of Maryland College Park; Oregon Health & Science University	Colombini, M (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.		Colombini, Marco/A-1540-2014		NIGMS NIH HHS [GM 35759] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BlachlyDyson E, 1997, MOL CELL BIOL, V17, P5727, DOI 10.1128/MCB.17.10.5727; BLACHLYDYSON E, 1990, SCIENCE, V247, P1233, DOI 10.1126/science.1690454; COLOMBINI M, 1989, J MEMBRANE BIOL, V111, P103, DOI 10.1007/BF01871775; COLOMBINI M, 1987, METHOD ENZYMOL, V148, P465; COLOMBINI M, 1992, METHOD ENZYMOL, V207, P432; COLOMBINI M, 1987, BIOCHIM BIOPHYS ACTA, V905, P297; DEPINTO V, 1991, BIOCHEMISTRY-US, V30, P10191, DOI 10.1021/bi00106a017; FORTE M, 1987, J BIOENERG BIOMEMBR, V19, P341, DOI 10.1007/BF00768537; GUO XW, 1995, J STRUCT BIOL, V114, P41, DOI 10.1006/jsbi.1995.1004; Hodge T, 1997, J MEMBRANE BIOL, V157, P271, DOI 10.1007/s002329900235; Lee AC, 1998, J MEMBRANE BIOL, V161, P173, DOI 10.1007/s002329900324; Mannella CA, 1996, J BIOENERG BIOMEMBR, V28, P163, DOI 10.1007/BF02110647; MANNELLA CA, 1989, FEBS LETT, V253, P231, DOI 10.1016/0014-5793(89)80965-2; MANNELLA CA, 1992, J BIOENERG BIOMEMBR, V24, P7, DOI 10.1007/BF00769525; PENG S, 1992, BIOPHYS J, V62, P123, DOI 10.1016/S0006-3495(92)81799-X; PENG SZ, 1992, J BIOENERG BIOMEMBR, V24, P27, DOI 10.1007/BF00769527; QIU XQ, 1994, J BIOL CHEM, V269, P7483; RAUCH G, 1994, BIOCHEM BIOPH RES CO, V200, P908, DOI 10.1006/bbrc.1994.1536; Rostovtseva T, 1997, BIOPHYS J, V72, P1954, DOI 10.1016/S0006-3495(97)78841-6; Song JM, 1996, J BIOENERG BIOMEMBR, V28, P153, DOI 10.1007/BF02110646; Song JM, 1998, BIOPHYS J, V74, P2926, DOI 10.1016/S0006-3495(98)78000-2; STANLEY S, 1995, J BIOL CHEM, V270, P16694, DOI 10.1074/jbc.270.28.16694; THOMAS L, 1993, P NATL ACAD SCI USA, V90, P5446, DOI 10.1073/pnas.90.12.5446; THOMAS L, 1991, J STRUCT BIOL, V106, P161, DOI 10.1016/1047-8477(91)90085-B	24	93	94	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24406	24413		10.1074/jbc.273.38.24406	http://dx.doi.org/10.1074/jbc.273.38.24406			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733730	hybrid			2022-12-27	WOS:000076007300022
J	Tsukaguchi, H; Shayakul, C; Berger, UV; Mackenzie, B; Devidas, S; Guggino, WB; van Hoek, AN; Hediger, MA				Tsukaguchi, H; Shayakul, C; Berger, UV; Mackenzie, B; Devidas, S; Guggino, WB; van Hoek, AN; Hediger, MA			Molecular characterization of a broad selectivity neutral solute channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY COLLECTING DUCT; WATER CHANNELS; UREA TRANSPORTER; XENOPUS-OOCYTES; RAT-KIDNEY; FUNCTIONAL EXPRESSION; CLONING; MEMBRANE; GLYCEROL; CELLS	In all living cells, coordination of solute and water movement across cell membranes is of critical importance for osmotic balance. The current concept is that these processes are of distinct biophysical nature. Here we report the expression cloning of a Liver cDNA encoding a unique promiscuous solute channel (AQP9) that confers high permeability for both solutes and water. AQP9 mediates passage of a wide variety of non-charged solutes including carbamides, polyols, purines, and pyrimidines in a phloretin- and mercury-sensitive manner, whereas amino acids, cyclic sugars, Na+, K+, Cl-, and deprotonated monocarboxylates are excluded. The properties of AQP9 define a new evolutionary branch of the major intrinsic protein family of aquaporin proteins and describe a previously unknown mechanism by which a large variety of solutes and water can pass through a single pore, enabling rapid cellular uptake or exit of metabolites with minimal osmotic perturbation.	Brigham & Womens Hosp, Div Renal, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; Harvard Univ, Sch Med, Boston, MA 02129 USA; Massachusetts Gen Hosp, Renal Unit, Boston, MA 02129 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Hediger, MA (corresponding author), Brigham & Womens Hosp, Div Renal, Dept Med, 77 Ave Louis Pasteur, Boston, MA 02115 USA.			Mackenzie, Bryan/0000-0002-9661-8838; Hediger, Matthias/0000-0003-1946-027X; Van Hoek, Alfred/0000-0003-2724-6855	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046289, R37DK032753, P01DK038452, R01DK032753] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK46289, DK32753, DK38452] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agre P, 1997, SCIENCE, V275, P1490, DOI 10.1126/science.275.5305.1490; AGRE P, 1995, CURR OPIN CELL BIOL, V7, P472, DOI 10.1016/0955-0674(95)80003-4; Che MX, 1997, FASEB J, V11, P101, DOI 10.1096/fasebj.11.2.9039951; Cheng AC, 1997, NATURE, V387, P627, DOI 10.1038/42517; ECHEVARRIA M, 1994, P NATL ACAD SCI USA, V91, P10997, DOI 10.1073/pnas.91.23.10997; EFFROS RM, 1993, J CLIN INVEST, V91, P2822, DOI 10.1172/JCI116525; Erlinger Serge, 1994, P769; FAIRNESS J, 1995, BIOPSY J, V68, P1613; GARCIA CK, 1995, J BIOL CHEM, V270, P1843, DOI 10.1074/jbc.270.4.1843; HASEGAWA H, 1993, AM J PHYSIOL, V265, pC514, DOI 10.1152/ajpcell.1993.265.2.C514; Ishibashi K, 1997, J BIOL CHEM, V272, P20782, DOI 10.1074/jbc.272.33.20782; Ishibashi K, 1998, BIOCHEM BIOPH RES CO, V244, P268, DOI 10.1006/bbrc.1998.8252; ISHIBASHI K, 1994, P NATL ACAD SCI USA, V91, P6269, DOI 10.1073/pnas.91.14.6269; KEDEM O, 1958, BIOCHIM BIOPHYS ACTA, V27, P229, DOI 10.1016/0006-3002(58)90330-5; Knepper MA, 1996, KIDNEY INT, V49, P1712, DOI 10.1038/ki.1996.253; LIDE DR, 1997, HDB CHEM PHYSICS; MA TH, 1994, J BIOL CHEM, V269, P21845; MANNUZZU LM, 1993, J MEMBRANE BIOL, V133, P85; MAUREL C, 1993, EMBO J, V12, P2241, DOI 10.1002/j.1460-2075.1993.tb05877.x; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; ROMERO MF, 1998, METHODS ENZYMOL, V296; SMITH CP, 1995, J CLIN INVEST, V96, P1556, DOI 10.1172/JCI118194; STRANGE K, 1992, J AM SOC NEPHROL, V3, P12; Tsukaguchi H, 1997, J CLIN INVEST, V99, P1506, DOI 10.1172/JCI119313; VERKMAN AS, 1985, AM J PHYSIOL, V248, pF650, DOI 10.1152/ajprenal.1985.248.5.F650; VERKMAN AS, 1995, KIDNEY INT, V48, P1069, DOI 10.1038/ki.1995.390; VomDahl S, 1996, BIOL CHEM H-S, V377, P25, DOI 10.1515/bchm3.1996.377.1.25; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512; Yool AJ, 1996, SCIENCE, V273, P1216, DOI 10.1126/science.273.5279.1216; YOU GF, 1993, NATURE, V365, P844, DOI 10.1038/365844a0	30	375	386	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24737	24743		10.1074/jbc.273.38.24737	http://dx.doi.org/10.1074/jbc.273.38.24737			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733774	hybrid			2022-12-27	WOS:000076007300066
J	Zhou, MY; Fisher, EA; Ginsberg, HN				Zhou, MY; Fisher, EA; Ginsberg, HN			Regulated co-translational ubiquitination of apolipoprotein - B100 a new paradigm for proteasomal, degradation of a secretory protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; B-CONTAINING LIPOPROTEINS; HEP G2 CELLS; ENDOPLASMIC-RETICULUM; INTRACELLULAR DEGRADATION; QUALITY-CONTROL; TRANSLOCATION; PATHWAY; HEAT-SHOCK-PROTEIN-70; ABETALIPOPROTEINEMIA	Presentation of a wild-type secretory protein, apolipoprotein B100 (apoB), to the cytosol for ubiquitin-proteasome proteolysis has been observed in HepG2 cells. A currently accepted model for proteasomal degradation of secretory proteins is retrograde translocation of the substrate polypeptides from the lumen of endoplasmic reticulum (ER) back to the cytosol. In this report, we present evidence that newly synthesized apoB becomes exposed to the cytosol and targeted to the proteasomes in a co-translational manner. Thus, after protein translation was synchronized with puromycin, partially synthesized apoB polypeptides were found to be conjugated to ubiquitin. The magnitude of co-translational ubiquitination and subsequent degradation of apoB was increased when cells were pretreated with either herbimycin A to induce cytosolic Hsp70 or with an inhibitor of microsomal triglyceride transfer protein; both treatments impede translocation of nascent apoB across the ER membrane. These treatments also decreased secretion of apoB and increased its degradation via the ubiquitin-proteasome pathway. We suggest that translocation arrest with subsequent co-translational exposure to the cytosol provides an alternative model to explain how mammalian secretory proteins can overcome topological segregation by the ER membrane and undergo degradation by the ubiquitin-proteasome pathway.	Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Mt Sinai Sch Med, Cardiovasc Inst, New York, NY 10025 USA	Columbia University; Icahn School of Medicine at Mount Sinai	Ginsberg, HN (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, P&S 9-510,630 W 168th St, New York, NY 10032 USA.	ginsbhe@cudept.cis.columbia.edu		Fisher, Edward/0000-0001-9802-143X				Benoist F, 1997, J BIOL CHEM, V272, P20435, DOI 10.1074/jbc.272.33.20435; Bercovich B, 1997, J BIOL CHEM, V272, P9002; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; BONIFACINO JS, 1994, CELLULAR PROTEOLYTIC, P135; BONIFACINO JS, 1996, NATURE, V384, P399; Brodsky JL, 1997, TRENDS CELL BIOL, V7, P151, DOI 10.1016/S0962-8924(97)01020-9; Corsi AK, 1996, J BIOL CHEM, V271, P30299, DOI 10.1074/jbc.271.48.30299; Davis R A, 1993, Subcell Biochem, V21, P169; DIXON JL, 1991, J BIOL CHEM, V266, P5080; DU EZ, 1994, J BIOL CHEM, V269, P24169; Du EZ, 1996, J LIPID RES, V37, P1309; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; Fisher EA, 1997, J BIOL CHEM, V272, P20427, DOI 10.1074/jbc.272.33.20427; FURUKAWA S, 1992, J BIOL CHEM, V267, P22630; GINSBERG HN, 1995, CURR OPIN LIPIDOL, V6, P275, DOI 10.1097/00041433-199510000-00006; Haghpassand M, 1996, J LIPID RES, V37, P1468; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; Hayes SA, 1996, J CELL BIOL, V132, P255, DOI 10.1083/jcb.132.3.255; Hegde RS, 1996, CELL, V85, P217, DOI 10.1016/S0092-8674(00)81098-3; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; Lord JM, 1996, CURR BIOL, V6, P1067, DOI 10.1016/S0960-9822(02)70666-0; MARBER MS, 1995, J CLIN INVEST, V95, P1446, DOI 10.1172/JCI117815; MCCRACKEN AA, 1996, J CELL BIOL, V132, P292; OMURA S, 1991, J ANTIBIOT, V44, P113, DOI 10.7164/antibiotics.44.113; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; RIVETT AJ, 1993, BIOCHEM J, V291, P1; SAKATA N, 1993, J BIOL CHEM, V268, P22967; SEGREST JP, 1994, ARTERIOSCLER THROMB, V14, P1674, DOI 10.1161/01.ATV.14.10.1674; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WETTERAU JR, 1992, SCIENCE, V258, P999; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wu XJ, 1996, J BIOL CHEM, V271, P10277, DOI 10.1074/jbc.271.17.10277; Yeung SJ, 1996, BIOCHEMISTRY-US, V35, P13843, DOI 10.1021/bi9618777; ZHOU MY, 1995, J BIOL CHEM, V270, P25220, DOI 10.1074/jbc.270.42.25220	37	135	138	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24649	24653		10.1074/jbc.273.38.24649	http://dx.doi.org/10.1074/jbc.273.38.24649			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733761	hybrid			2022-12-27	WOS:000076007300053
J	Baker, RO; Hall, JD				Baker, RO; Hall, JD			Impaired mismatch extension by a herpes simplex DNA polymerase mutant with an editing nuclease defect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							5' EXONUCLEASE ACTIVITY; EXO-III MOTIF; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; REPLICATION FIDELITY; 3'-5' EXONUCLEASE; 3'-5'-EXONUCLEASE DOMAIN; AMINO-ACID; WILD-TYPE; VIRUS	The D368A mutation within the 3'-5'-exonuclease domain of the herpes simplex type 1 DNA polymerase inactivates this nuclease and severely interferes with virus viability. Compared with the wild type enzyme, the D368A mutant exhibits substantially elevated rates of incorrect nucleotide incorporation, as measured in a LacZ reversion assay. This high rate occurs in the presence of high levels of dNTPs, a condition that forces the enzyme to extend mismatched primers. Hence, the mutant fails to correct many misincorporations that are removed in the wild type. In addition, the mutant shows a much reduced ability to replicate DNA templates primed with a 3'-mismatch as compared with wild type. This extension defect also appears more severe than observed for replicases which naturally lack editing nucleases. Based on these findings, we suggest that the inability of the D368A herpes simplex mutant polymerase to replicate beyond a mismatched base pair severely inhibits viral replication.	Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	University of Arizona	Hall, JD (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Life Sci S 444,POB 210106, Tucson, AZ 85721 USA.							ALLAUDEEN HS, 1982, ANTIVIR RES, V2, P123, DOI 10.1016/0166-3542(82)90014-6; Bebenek K, 1995, METHOD ENZYMOL, V262, P217; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAI H, 1995, J BIOL CHEM, V270, P15327, DOI 10.1074/jbc.270.25.15327; DERBYSHIRE V, 1991, EMBO J, V10, P17, DOI 10.1002/j.1460-2075.1991.tb07916.x; DERBYSHIRE V, 1988, SCIENCE, V240, P199, DOI 10.1126/science.2832946; DERSE D, 1981, J BIOL CHEM, V256, P1447; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; Fijalkowska IJ, 1996, P NATL ACAD SCI USA, V93, P2856, DOI 10.1073/pnas.93.7.2856; FOSTER PL, 1995, P NATL ACAD SCI USA, V92, P7951, DOI 10.1073/pnas.92.17.7951; FOURY F, 1992, EMBO J, V11, P2717, DOI 10.1002/j.1460-2075.1992.tb05337.x; HALL JD, 1985, P NATL ACAD SCI USA, V82, P3889, DOI 10.1073/pnas.82.11.3889; Hall JD, 1996, J VIROL, V70, P4816, DOI 10.1128/JVI.70.7.4816-4818.1996; HALL JD, 1984, VIROLOGY, V132, P26, DOI 10.1016/0042-6822(84)90088-6; HALL JD, 1995, J GEN VIROL, V76, P2999, DOI 10.1099/0022-1317-76-12-2999; Hwang YT, 1997, J VIROL, V71, P7791, DOI 10.1128/JVI.71.10.7791-7798.1997; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; JOYCE CM, 1987, TRENDS BIOCHEM SCI, V12, P288, DOI 10.1016/0968-0004(87)90143-5; KNOPF KW, 1979, EUR J BIOCHEM, V98, P231, DOI 10.1111/j.1432-1033.1979.tb13181.x; Kuhn FJP, 1996, J BIOL CHEM, V271, P29245; KUNKEL TA, 1987, P NATL ACAD SCI USA, V84, P4865, DOI 10.1073/pnas.84.14.4865; KUNKEL TA, 1988, J BIOL CHEM, V263, P4450; KUNKEL TA, 1981, J BIOL CHEM, V256, P9883; KUNKEL TA, 1992, J BIOL CHEM, V267, P18251; MENDELMAN LV, 1990, J BIOL CHEM, V265, P2338; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; MORRISON A, 1994, MOL GEN GENET, V242, P289, DOI 10.1007/BF00280418; MORRISON A, 1993, EMBO J, V12, P1467, DOI 10.1002/j.1460-2075.1993.tb05790.x; MORRISON A, 1991, P NATL ACAD SCI USA, V88, P9473, DOI 10.1073/pnas.88.21.9473; MUZYCZKA N, 1972, J BIOL CHEM, V247, P7116; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; REHAKRANTZ LJ, 1993, J BIOL CHEM, V268, P27100; ROBERTS JD, 1989, MOL CELL BIOL, V9, P469, DOI 10.1128/MCB.9.2.469; ROBERTS JD, 1988, P NATL ACAD SCI USA, V85, P7064, DOI 10.1073/pnas.85.19.7064; Sambrook J., 2002, MOL CLONING LAB MANU; SIMON M, 1991, EMBO J, V10, P2165, DOI 10.1002/j.1460-2075.1991.tb07751.x; SOENGAS MS, 1992, EMBO J, V11, P4227, DOI 10.1002/j.1460-2075.1992.tb05517.x; STCLAIR MH, 1984, ANTIMICROB AGENTS CH, V25, P191, DOI 10.1128/AAC.25.2.191; STUDWELL PS, 1990, J BIOL CHEM, V265, P1171; WEISSHART K, 1994, J BIOL CHEM, V269, P22788; ZHU WG, 1994, BBA-GENE STRUCT EXPR, V1219, P267, DOI 10.1016/0167-4781(94)90048-5	43	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24075	24082		10.1074/jbc.273.37.24075	http://dx.doi.org/10.1074/jbc.273.37.24075			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727026	hybrid			2022-12-27	WOS:000075893100067
J	Dierks, EA; Zhang, ZP; Johnson, EF; de Montellano, PRO				Dierks, EA; Zhang, ZP; Johnson, EF; de Montellano, PRO			The catalytic site of cytochrome P4504A11 (CYP4A11) and its L131F mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID OMEGA-HYDROXYLASE; CDNA-DIRECTED EXPRESSION; LAURIC ACID; HUMAN LIVER; 20-HYDROXYEICOSATETRAENOIC ACID; BACILLUS-MEGATERIUM; SEQUENCE ALIGNMENT; CODING NUCLEOTIDE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI	CYP4A11, the principal known human fatty acid omega-hydroxylase, has been expressed as a polyhistidine-tagged protein and purified to homogeneity, Based on an alignment with P450(BM-3), the CYP4A11 L131F mutant has been constructed and similarly expressed. The two proteins are spectroscopically indistinguishable, but wildtype CYP4A11 primarily catalyzes omega-hydroxylation, and the L131F mutant only omega-1 hydroxylation, of lauric acid. The L131F mutant is highly uncoupled in that it slowly (omega-1)-hydroxylates lauric acid yet consumes NADPH at approximately the same rate as the wild-type enzyme. Wild-type CYP4A11 is inactivated by 1-aminobenzotriazole under turnover conditions but the L131F mutant is not. This observation, in conjunction with the binding affinities of substituted imidazoles for the two proteins, indicates that the L131F mutation decreases access of exogenous substrates to the heme site. Leu-131 thus plays a key role in controlling the regioselectivity of substrate hydroxylation and the extent of coupled versus uncoupled enzyme turnover. A further important finding is that the substituted imidazoles bind more weakly to CYP4A11 and its L131F mutant when these proteins are reduced by NADPH-cytochrome P450 reductase than by dithionite. This finding suggests that the ferric enzyme undergoes a conformational change that depends on both reduction of the iron and the presence of cytochrome P450 reductase and NADPH.	Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	University of California System; University of California San Francisco; Scripps Research Institute	de Montellano, PRO (corresponding author), Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD004445] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD004445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025515, R01GM025515] Funding Source: NIH RePORTER; NICHD NIH HHS [HD04445] Funding Source: Medline; NIDDK NIH HHS [5 P30 DK26743] Funding Source: Medline; NIGMS NIH HHS [GM25515] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTERMAN MA, 1995, ARCH BIOCHEM BIOPHYS, V320, P289, DOI 10.1016/0003-9861(95)90012-8; AMET Y, 1994, BIOCHEM BIOPH RES CO, V203, P1168, DOI 10.1006/bbrc.1994.2305; Bambal RB, 1996, ARCH BIOCHEM BIOPHYS, V334, P59, DOI 10.1006/abbi.1996.0429; CAJACOB CA, 1988, J BIOL CHEM, V263, P18640; CASTLE PJ, 1995, DRUG METAB DISPOS, V23, P1037; CUPPVICKERY JR, 1995, NAT STRUCT BIOL, V2, P144, DOI 10.1038/nsb0295-144; DEMONTELLANO PRO, 1984, TETRAHEDRON, V40, P511; DEMONTELLANO PRO, 1981, BIOCHEM J, V195, P761, DOI 10.1042/bj1950761; DEMONTELLANO PRO, 1986, ARCH BIOCHEM BIOPHYS, V251, P514, DOI 10.1016/0003-9861(86)90359-0; DEMONTELLANO PRO, 1995, BIOCHIMIE, V77, P581, DOI 10.1016/0300-9084(96)88174-0; Dierks EA, 1998, BIOCHEMISTRY-US, V37, P1839, DOI 10.1021/bi972458s; ESCALANTE B, 1993, EUR J PHARMACOL, V235, P1, DOI 10.1016/0014-2999(93)90812-V; FUKUDA T, 1994, J BIOCHEM-TOKYO, V115, P338, DOI 10.1093/oxfordjournals.jbchem.a124339; GOTOH O, 1992, J BIOL CHEM, V267, P83; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; HOLMANS PL, 1994, ARCH BIOCHEM BIOPHYS, V312, P554, DOI 10.1006/abbi.1994.1345; IMAOKA S, 1993, DNA CELL BIOL, V12, P893, DOI 10.1089/dna.1993.12.893; KAIKAUS RM, 1993, J BIOL CHEM, V268, P9593; KAWASHIMA H, 1994, J BIOCHEM, V116, P74, DOI 10.1093/oxfordjournals.jbchem.a124506; KIKUTA Y, 1994, FEBS LETT, V348, P70, DOI 10.1016/0014-5793(94)00587-7; KNICKLE LC, 1991, FASEB J, V5, pA479; Li HY, 1997, NAT STRUCT BIOL, V4, P140, DOI 10.1038/nsb0297-140; Lu P, 1997, ARCH BIOCHEM BIOPHYS, V337, P1, DOI 10.1006/abbi.1996.9768; MA YH, 1993, CIRC RES, V72, P126, DOI 10.1161/01.RES.72.1.126; MIURA Y, 1975, BIOCHIM BIOPHYS ACTA, V388, P305, DOI 10.1016/0005-2760(75)90089-2; Modi S, 1996, NAT STRUCT BIOL, V3, P414, DOI 10.1038/nsb0596-414; Mueller Ernest J., 1995, P83; NHAMBURO PT, 1989, BIOCHEMISTRY-US, V28, P8060, DOI 10.1021/bi00446a014; Oliver CF, 1997, BIOCHEMISTRY-US, V36, P1567, DOI 10.1021/bi962826c; OMURA T, 1964, J BIOL CHEM, V239, P2370; PALMER CNA, 1993, BIOCHIM BIOPHYS ACTA, V1172, P161, DOI 10.1016/0167-4781(93)90285-L; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; Powell PK, 1996, ARCH BIOCHEM BIOPHYS, V335, P219, DOI 10.1006/abbi.1996.0501; RAVICHANDRAN KG, 1993, SCIENCE, V261, P731, DOI 10.1126/science.8342039; REICH NO, 1986, BIOCHEM PHARMACOL, V35, P1227, DOI 10.1016/0006-2952(86)90264-9; ROMANO MC, 1988, ANAL BIOCHEM, V170, P83, DOI 10.1016/0003-2697(88)90093-0; RUETTINGER RT, 1989, J BIOL CHEM, V264, P10987; Schwartzman ML, 1996, NEPHRON, V73, P652; SMITH RF, 1992, PROTEIN ENG, V5, P35, DOI 10.1093/protein/5.1.35; ZOU AP, 1994, J PHARMACOL EXP THER, V268, P474	40	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23055	23061		10.1074/jbc.273.36.23055	http://dx.doi.org/10.1074/jbc.273.36.23055			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722531	hybrid			2022-12-27	WOS:000075778100031
J	Subramaniam, N; Cairns, W; Okret, S				Subramaniam, N; Cairns, W; Okret, S			Glucocorticoids repress transcription from a negative glucocorticoid response element recognized by two homeodomain-containing proteins, Pbx and Oct-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLACTIN GENE-EXPRESSION; COOPERATIVE DNA-BINDING; POU-DOMAIN; HOX PROTEINS; COORDINATE REGULATION; MEDIATED REPRESSION; CELL-LINE; RECEPTOR; COMPLEX; PROMOTER	Several studies have established that the prolactin (PRL) gene is expressed not only in lactotrophs and somatotrophs of the anterior pituitary but, albeit to a lesser extent, in non-pituitary cells like human thymocytes, decidualized endometrium, mammary glands during lactation, and some human non-pituitary cell lines. Despite the requirement in the pituitary for the pituitary-specific transcription factor Pit-1/GHF-1 for PRL expression, the expression in non-pituitary cells occurs in the absence of Pit-1/GHF-1 and can be repressed by glucocorticoids. This prompted us to investigate the transcription factors in non-pituitary cells which are involved in controlling expression and glucocorticoid repression of a previously characterized negative glucocorticoid response element from the bovine prolactin gene (PRL3 nGRE). Here we have demonstrated that non-pituitary cells (COS-7 and mouse hepatoma Hepa1c1c7 cells) conferred increased expression via the PRL3 nGRE mainly because of the binding of the ubiquitously expressed POU-homeodomain-containing octamer transcription factor-1 (Oct-1), to an AT-rich sequence present in the PRL3 sequence. However, full transcriptional activity required the binding of a second ubiquitously expressed homeodomain-containing protein, Pbx, previously shown to bind cooperatively with several homeotic selector proteins. The Pbx binding site in the PRL3 nGRE, located just upstream of the Oct-1 binding site, showed a strong sequence similarity with known Pbx binding sites and bound Pbx with an affinity similar to that of other established Pbx target sequences. Interestingly, both Oct-1 and Pbx binding to the PRL3 nGRE were found to be required for glucocorticoid repression. Addition of in vitro translated glucocorticoid receptor DNA binding domain to the nuclear extract prevented Oct-1 and Pbx from binding to the PRL element. The involvement of the homeobox protein Pbx in glucocorticoid repression via an nGRE identifies a new role for this protein.	Huddinge Univ Hosp, Karolinska Inst, Dept Med Nutr, S-14186 Huddinge, Sweden	Karolinska Institutet	Okret, S (corresponding author), Huddinge Univ Hosp, Karolinska Inst, Dept Med Nutr, F60 Novum, S-14186 Huddinge, Sweden.	Sam.Okret@mednut.ki.se						ADLER S, 1988, CELL, V52, P685, DOI 10.1016/0092-8674(88)90406-0; AKERBLOM IW, 1991, REPRESSION GENE EXPR, P175; BenJonathan N, 1996, ENDOCR REV, V17, P639, DOI 10.1210/er.17.6.639; BERWAER M, 1991, MOL CELL ENDOCRINOL, V80, P53, DOI 10.1016/0303-7207(91)90142-F; CAIRNS C, 1993, DNA CELL BIOL, V12, P695, DOI 10.1089/dna.1993.12.695; CALDENHOVEN E, 1995, MOL ENDOCRINOL, V9, P401, DOI 10.1210/me.9.4.401; CAMPER SA, 1985, J BIOL CHEM, V260, P2246; Chan SK, 1996, P NATL ACAD SCI USA, V93, P5223, DOI 10.1073/pnas.93.11.5223; Chang CP, 1997, MOL CELL BIOL, V17, P81, DOI 10.1128/MCB.17.1.81; CHANG CP, 1995, GENE DEV, V9, P663, DOI 10.1101/gad.9.6.663; Chang CP, 1996, MOL CELL BIOL, V16, P1734; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CLEARY MA, 1995, MOL CELL BIOL, V15, P2090; DAY RN, 1990, MOL ENDOCRINOL, V4, P1964, DOI 10.1210/mend-4-12-1964; DIMATTIA GE, 1990, J BIOL CHEM, V265, P16412; DROUIN J, 1993, EMBO J, V12, P145, DOI 10.1002/j.1460-2075.1993.tb05640.x; DROUIN J, 1993, REPRESSION TRANSCRIP, P118; GELLERSEN B, 1989, ENDOCRINOLOGY, V125, P2853, DOI 10.1210/endo-125-6-2853; GELLERSEN B, 1995, MOL ENDOCRINOL, V9, P887, DOI 10.1210/me.9.7.887; Goodman PA, 1996, MOL CELL ENDOCRINOL, V120, P139, DOI 10.1016/0303-7207(96)03830-0; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GOUGH NM, 1988, ANAL BIOCHEM, V173, P93, DOI 10.1016/0003-2697(88)90164-9; HORSEMAN ND, 1995, ENDOCRINOLOGY, V136, P5249, DOI 10.1210/en.136.12.5249; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; JACOB KK, 1995, MOL CELL ENDOCRINOL, V109, P175, DOI 10.1016/0303-7207(95)03500-7; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; KAGAWA N, 1994, J BIOL CHEM, V269, P18716; KAMPS MP, 1993, MOL CELL BIOL, V13, P351, DOI 10.1128/MCB.13.1.351; KAUSHANSKY K, 1994, J IMMUNOL, V152, P1812; Knoepfler PS, 1996, NUCLEIC ACIDS RES, V24, P2288, DOI 10.1093/nar/24.12.2288; Knoepfler PS, 1997, ONCOGENE, V14, P2521, DOI 10.1038/sj.onc.1201097; Knoepfler PS, 1997, MECH DEVELOP, V63, P5, DOI 10.1016/S0925-4773(97)00669-2; KNOEPFLER PS, 1995, MOL CELL BIOL, V15, P5811; KUTOH E, 1992, MOL CELL BIOL, V12, P4960, DOI 10.1128/MCB.12.11.4960; LINDEBRO MC, 1995, EMBO J, V14, P3528, DOI 10.1002/j.1460-2075.1995.tb07359.x; LIPKIN SM, 1993, GENE DEV, V7, P1674, DOI 10.1101/gad.7.9.1674; LU Q, 1994, MOL CELL BIOL, V14, P3938, DOI 10.1128/MCB.14.6.3938; Maconochie MK, 1997, GENE DEV, V11, P1885, DOI 10.1101/gad.11.14.1885; Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3; Meyer T, 1997, J BIOL CHEM, V272, P21090, DOI 10.1074/jbc.272.34.21090; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; MIESFELD R, 1988, UCLA S MOL CELL BIOL, V75, P193; MONICA K, 1991, MOL CELL BIOL, V11, P6149, DOI 10.1128/MCB.11.12.6149; ONEAL KD, 1992, MOL CELL ENDOCRINOL, V87, pR19, DOI 10.1016/0303-7207(92)90251-Z; Ouyang LH, 1996, J BIOL CHEM, V271, P10425, DOI 10.1074/jbc.271.18.10425; PEERS B, 1995, MOL CELL BIOL, V15, P7091; Pei L, 1996, J BIOL CHEM, V271, P20879; PEIFER M, 1990, GENE DEV, V4, P1209, DOI 10.1101/gad.4.7.1209; PFAHL M, 1993, ENDOCR REV, V14, P651, DOI 10.1210/er.14.5.651; POELLINGER L, 1989, NATURE, V337, P573, DOI 10.1038/337573a0; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; RAUSKOLB C, 1994, EMBO J, V13, P3561, DOI 10.1002/j.1460-2075.1994.tb06663.x; RENKAWITZ R, 1993, ANN NY ACAD SCI, V684, P1, DOI 10.1111/j.1749-6632.1993.tb32266.x; SAKAI DD, 1988, GENE DEV, V2, P1144, DOI 10.1101/gad.2.9.1144; STERN S, 1989, NATURE, V341, P624, DOI 10.1038/341624a0; STURM RA, 1988, NATURE, V336, P601, DOI 10.1038/336601a0; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; Subramaniam N, 1997, DNA CELL BIOL, V16, P153, DOI 10.1089/dna.1997.16.153; TANAKA H, 1991, P NATL ACAD SCI USA, V88, P5393, DOI 10.1073/pnas.88.12.5393; ULLMAN KS, 1993, GENE DEV, V7, P188, DOI 10.1101/gad.7.2.188; VOSS JW, 1991, GENE DEV, V5, P1309, DOI 10.1101/gad.5.7.1309; VOSS JW, 1992, CELL, V70, P527, DOI 10.1016/0092-8674(92)90422-9; WIELAND S, 1991, EMBO J, V10, P2513, DOI 10.1002/j.1460-2075.1991.tb07791.x; YAN GZ, 1994, MOL CELL ENDOCRINOL, V101, pR25, DOI 10.1016/0303-7207(94)90255-0	64	62	62	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23567	23574		10.1074/jbc.273.36.23567	http://dx.doi.org/10.1074/jbc.273.36.23567			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722596	hybrid			2022-12-27	WOS:000075778100096
J	Langen, R; Isas, JM; Luecke, H; Haigler, HT; Hubbell, WL				Langen, R; Isas, JM; Luecke, H; Haigler, HT; Hubbell, WL			Membrane-mediated assembly of annexins studied by site-directed spin labeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; T4 LYSOZYME; MOTION; RESOLUTION; DYNAMICS	Annexins are soluble proteins that bind to membranes in the presence of Ca2+. Crystal structures have been determined for some soluble forms, but little is known about the important membrane-bound state. We employed site-directed spin labeling to demonstrate that 1) annexin XII assumes a trimer configuration similar to the crystal structure when bound to bilayers under physiological conditions; 2) trimer assembly on bilayers is remarkably rapid, occurring on a millisecond time scale, whereas subunit exchange requires hours; and 3) different annexins can mix to form heterotrimers. The rapid assembly and heterotrimer formation have important implications concerning the cellular functions of annexins.	Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Haigler, HT (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.		Luecke, Hartmut/F-4712-2012; Haigler, Harry/C-3788-2011	Luecke, Hartmut/0000-0002-4938-0775; 	NATIONAL EYE INSTITUTE [R01EY005216, R37EY005216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055651, R01GM056445] Funding Source: NIH RePORTER; NEI NIH HHS [EY05216] Funding Source: Medline; NIGMS NIH HHS [GM55651, GM56445] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CONCHA NO, 1992, FEBS LETT, V314, P159, DOI 10.1016/0014-5793(92)80964-I; CONCHA NO, 1993, SCIENCE, V261, P1321, DOI 10.1126/science.8362244; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; HUBBELL WL, 1987, REV SCI INSTRUM, V58, P1879, DOI 10.1063/1.1139536; HUBBELL WL, 1994, CURR OPIN STRUC BIOL, V4, P566, DOI 10.1016/S0959-440X(94)90219-4; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; Hustedt EJ, 1997, BIOPHYS J, V72, P1861, DOI 10.1016/S0006-3495(97)78832-5; Liemann S, 1997, J MOL BIOL, V270, P79, DOI 10.1006/jmbi.1997.1091; LUECKE H, 1995, NATURE, V378, P512, DOI 10.1038/378512a0; Mailliard WS, 1997, BIOCHEMISTRY-US, V36, P9045, DOI 10.1021/bi970749v; Mchaourab HS, 1997, BIOCHEMISTRY-US, V36, P307, DOI 10.1021/bi962114m; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; MEHAOURAB HS, 1997, BIOCHEMISTRY-US, V36, P307; OLOFSSON A, 1994, J STRUCT BIOL, V113, P199, DOI 10.1006/jsbi.1994.1054; RABENSTEIN MD, 1995, P NATL ACAD SCI USA, V92, P8239, DOI 10.1073/pnas.92.18.8239; REEVES JP, 1969, J CELL PHYSIOL, V73, P49, DOI 10.1002/jcp.1040730108; Seaton B. A., 1996, ANNEXINS MOL STRUCTU; SOPKOVA J, 1993, J MOL BIOL, V234, P816, DOI 10.1006/jmbi.1993.1627; VOGES D, 1994, J MOL BIOL, V238, P199, DOI 10.1006/jmbi.1994.1281; WENG XW, 1993, PROTEIN SCI, V2, P448	20	80	81	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22453	22457		10.1074/jbc.273.35.22453	http://dx.doi.org/10.1074/jbc.273.35.22453			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712869	hybrid			2022-12-27	WOS:000075616600045
J	Tang, XB; Fujinaga, J; Kopito, R; Casey, JR				Tang, XB; Fujinaga, J; Kopito, R; Casey, JR			Topology of the region surrounding Glu(681) of human AE1 protein, the erythrocyte anion exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-TETRACYCLINE/H+ ANTIPORTER; PROTEOLYTIC CLEAVAGE SITES; BAND-3 PROTEIN; DIRECTED MUTAGENESIS; MEMBRANE TOPOLOGY; TRANSPORT PROTEIN; LOCALIZATION; RESIDUES; GLYCOPROTEIN; ORIENTATION	AE1 protein transports Cl- and HCO3- across the erythrocyte membrane by an electroneutral exchange mechanism, Glu(681) Of human AE1 may form part of the anion translocation apparatus and the permeability barrier. We have therefore studied the structure of the sequence surrounding Glu(681), using scanning cysteine mutagenesis, Residues of the Ser(643) (adjacent to the glycosylation site) to Ser(690) region of cysteineless mutant (AE1C(-)) were replaced individually with cysteine, The ability of mutants to mediate Cl-/HCO3- exchange in transfected HEK293 cells revealed that extracellular mutants, W648C, I650C, P652C, L655C, and F659C have an important role in transport. By contrast, only transmembrane mutation E681C fully blocked anion exchange activity, The topology of the region was investigated by comparing cysteine labeling with the membrane-permeant cysteine-directed reagent 3-(N-maleimidylpropionyl)biocytin, with or without prior labeling with membrane-impermeant lucifer yellow iodoacetamide (LYIA), Two regions readily label with 3-(N-maleimidylpropionyl)biocytin (Ser(643)-Met(663) and Ile(684)-Ser(690)), We propose that poorly labeled Met(664)-Gln(683) corresponds to transmembrane segment 8 of AE1, Regions Ser(643)-Met(663) and Ile(684)-Ser(690) localize, respectively, to extracellular and intracellular sites on the basis of accessibility to LYIA. On the basis of LYIA accessibility, we propose that the Arg(656)-Met(663) region forms a "vestibule" that leads anions to the transport channel, Glu(681) is located 3 amino acids from the C terminus of transmembrane segment 8, which places the membrane permeability barrier within 5 Angstrom of the intracellular surface of the membrane.	Univ Alberta, Dept Physiol, Edmonton, AB T6G 2H7, Canada; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	University of Alberta; Stanford University	Casey, JR (corresponding author), Univ Alberta, Dept Physiol, Edmonton, AB T6G 2H7, Canada.	joe.casey@ualberta.ca	Casey, Joseph/A-8888-2013	Casey, Joseph/0000-0002-9890-5056				CABANTCHIK ZI, 1992, AM J PHYSIOL, V262, pC803, DOI 10.1152/ajpcell.1992.262.4.C803; CASEY JR, 1995, J BIOL CHEM, V270, P8521, DOI 10.1074/jbc.270.15.8521; Catizone A, 1996, CELL MOL BIOL, V42, P1229; COYLE DA, 1998, SCIENCE, V280, P69; CREIGHTON TE, 1983, PROTEINS STRUCTURES, P171; EIDELMAN O, 1991, AM J PHYSIOL, V260, pC1094, DOI 10.1152/ajpcell.1991.260.5.C1094; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; GERSHONI JM, 1985, ANAL BIOCHEM, V146, P59, DOI 10.1016/0003-2697(85)90395-1; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hamasaki N, 1997, J BIOCHEM-TOKYO, V122, P577; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JENNINGS ML, 1990, J GEN PHYSIOL, V96, P991, DOI 10.1085/jgp.96.5.991; JENNINGS ML, 1986, J BIOL CHEM, V261, P9002; JENNINGS ML, 1987, J BIOL CHEM, V262, P1691; JENNINGS ML, 1989, ANION TRANSPORT PROT, P59; Kimura T, 1997, J BIOL CHEM, V272, P580; Kimura T, 1998, J BIOL CHEM, V273, P5243, DOI 10.1074/jbc.273.9.5243; Kimura T, 1996, BIOCHEMISTRY-US, V35, P15896, DOI 10.1021/bi961568g; Kopito R R, 1990, Int Rev Cytol, V123, P177, DOI 10.1016/S0074-7696(08)60674-9; KOPITO RR, 1985, NATURE, V316, P234, DOI 10.1038/316234a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE BS, 1991, J BIOL CHEM, V266, P11448; LIEBERMAN DM, 1988, J BIOL CHEM, V263, P10022; LINDSEY AE, 1990, P NATL ACAD SCI USA, V87, P5278, DOI 10.1073/pnas.87.14.5278; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; Popov M, 1997, J BIOL CHEM, V272, P18325, DOI 10.1074/jbc.272.29.18325; REITHMEIER RAF, 1993, CURR OPIN STRUC BIOL, V3, P515, DOI 10.1016/0959-440X(93)90077-X; REITHMEIER RAF, 1996, TRANSPORT PROCESSES, V2, P281; RUETZ S, 1993, J CELL BIOL, V121, P37, DOI 10.1083/jcb.121.1.37; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; SEKLER I, 1995, J BIOL CHEM, V270, P28751, DOI 10.1074/jbc.270.48.28751; TANNER MJA, 1988, BIOCHEM J, V256, P703, DOI 10.1042/bj2560703; TANNER MJA, 1989, METHOD ENZYMOL, V173, P423; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WAINWRIGHT SD, 1990, BIOCHEM J, V272, P265, DOI 10.1042/bj2720265; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053	38	86	87	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22545	22553		10.1074/jbc.273.35.22545	http://dx.doi.org/10.1074/jbc.273.35.22545			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712881	hybrid			2022-12-27	WOS:000075616600057
J	Ahn, T; Kim, H				Ahn, T; Kim, H			Effects of nonlamellar-prone lipids on the ATPase activity of SecA bound to model membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHASE-TRANSITION TEMPERATURE; ESCHERICHIA-COLI; ACIDIC PHOSPHOLIPIDS; PROTEIN TRANSLOCATION; DIGLYCERIDE KINASE; PLASMA-MEMBRANE; BILAYER; BINDING; PHOSPHATIDYLETHANOLAMINES; PENETRATION	The effect of nonlamellar-prone lipids, diacylglycerol (DG) and phosphatidylethanolamine (PE), on the ATPase activity of SecA was examined. When Escherichia coli PE of the standard vesicles composed of 60 mol% of this lipid and 40 mol% of dioleoylphosphatidylglycerol (DOPG) is gradually replaced with either dioleoylglycerol (DOG) or dioeloyl PE (DOPE), the ATPase activity of SecA present together increased appreciably. On the other hand, when E. coli PE of the standard vesicles was replaced with DOG analogs, the SecA ATPase activity decreased slightly, and when replaced activity was more appreciable. When DOPE or E. coli PE was added to PC vesicles, the SecA ATPase activity was enhanced only slightly, suggesting that the hexagonal II structure per se is not important for the ATPase activity increase. It was observed that DOG induced phase separation of PG, and the lamellar-hexagonal II (L-H-II) 10 degrees C. The DOG analogs had no effect on these properties, suggesting the importance of the phase separation of PG and the decrease of L-H-II transition temperature of lipid bilayers to the SecA ATPase activity. The phase separation of PG by Ca2+ also brought about increased ATPase activity of SecA, underlining the importance of phase separation of PG for the enzyme activity. The incorporation of DOG or DOPE in the vesicle also increased the amount of SecA penetration into the membrane. Studies with vesicles without SecA showed increased exposure of hydrophobic acyl chains when the DOG was present. Taken together, these observations suggest that the phase separation of PG and/or the bilayer penetration of SecA are mainly responsible for the enhanced SecA-vesicle interaction with concomitant increase in SecA ATPase activity.	Korea Adv Inst Sci & Technol, Dept Biol Sci, Yusong Gu, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Kim, H (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Yusong Gu, 373-1 Kusong Dong, Taejon 305701, South Korea.							Ahn T, 1996, J BIOL CHEM, V271, P12372, DOI 10.1074/jbc.271.21.12372; AHN T, 1994, BIOCHEM BIOPH RES CO, V203, P326, DOI 10.1006/bbrc.1994.2185; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREUKINK E, 1992, BIOCHEMISTRY-US, V31, P1119, DOI 10.1021/bi00119a021; BROWN MF, 1994, CHEM PHYS LIPIDS, V73, P159, DOI 10.1016/0009-3084(94)90180-5; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; CABELLI RJ, 1991, J BIOL CHEM, V266, P24420; CHONG PLG, 1985, BIOPHYS J, V47, P613, DOI 10.1016/S0006-3495(85)83957-6; DAS S, 1986, BIOCHEMISTRY-US, V25, P2882, DOI 10.1021/bi00358a022; ELLENS H, 1986, BIOCHEMISTRY-US, V25, P285, DOI 10.1021/bi00350a001; EPAND RM, 1985, BIOCHEMISTRY-US, V24, P7092, DOI 10.1021/bi00346a011; EPAND RM, 1988, BIOCHIM BIOPHYS ACTA, V944, P144, DOI 10.1016/0005-2736(88)90427-0; GALLA HJ, 1980, CHEM PHYS LIPIDS, V27, P199, DOI 10.1016/0009-3084(80)90036-5; GRAHAM I, 1985, BIOCHEMISTRY-US, V24, P7123, DOI 10.1021/bi00346a016; HENDRICK JP, 1991, J BIOL CHEM, V266, P24596; HONG KL, 1988, BIOCHEMISTRY-US, V27, P3947, DOI 10.1021/bi00411a009; KAWASAKI H, 1989, FEBS LETT, V242, P431, DOI 10.1016/0014-5793(89)80516-2; KELLER SL, 1993, BIOPHYS J, V65, P23, DOI 10.1016/S0006-3495(93)81040-3; KILLIAN JA, 1990, EMBO J, V9, P815, DOI 10.1002/j.1460-2075.1990.tb08178.x; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LI L, 1995, CHEM PHYS LIPIDS, V76, P135, DOI 10.1016/0009-3084(95)02437-N; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; LILL R, 1989, EMBO J, V8, P961, DOI 10.1002/j.1460-2075.1989.tb03458.x; Mizushima T, 1996, J BIOL CHEM, V271, P3633; Park SK, 1997, BIOCHEM BIOPH RES CO, V235, P593, DOI 10.1006/bbrc.1997.6834; Price A, 1996, J BIOL CHEM, V271, P31580, DOI 10.1074/jbc.271.49.31580; RAETZ CRH, 1978, J BIOL CHEM, V253, P3882; RAETZ CRH, 1979, J BACTERIOL, V137, P860, DOI 10.1128/JB.137.2.860-868.1979; RIETVELD AG, 1995, EMBO J, V14, P5506, DOI 10.1002/j.1460-2075.1995.tb00237.x; SIEGEL DP, 1989, BIOCHEMISTRY-US, V28, P5010, DOI 10.1021/bi00438a016; SOMERHARJU PJ, 1985, BIOCHEMISTRY-US, V24, P2773, DOI 10.1021/bi00332a027; Song M, 1997, J BIOCHEM-TOKYO, V122, P1010; Starling AP, 1996, BIOCHEM J, V320, P309, DOI 10.1042/bj3200309; ULBRANDT ND, 1992, J BIOL CHEM, V267, P15184; VASKOVSKY VE, 1975, J CHROMATOGR, V114, P129, DOI 10.1016/S0021-9673(00)85249-8	35	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21692	21698		10.1074/jbc.273.34.21692	http://dx.doi.org/10.1074/jbc.273.34.21692			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705304	hybrid			2022-12-27	WOS:000075492600038
J	Subbaramaiah, K; Chung, WJ; Michaluart, P; Telang, N; Tanabe, T; Inoue, H; Jang, MS; Pezzuto, JM; Dannenberg, AJ				Subbaramaiah, K; Chung, WJ; Michaluart, P; Telang, N; Tanabe, T; Inoue, H; Jang, MS; Pezzuto, JM; Dannenberg, AJ			Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN COLON-CANCER; PROTEIN-KINASE-C; ENDOPEROXIDE SYNTHASE-2 GENE; MOUSE FIBROBLAST CELLS; SELECTIVE-INHIBITION; RESPONSE ELEMENT; AP-1 ACTIVITY; EXPRESSION; PROSTAGLANDIN; GROWTH	We determined whether resveratrol, a phenolic anti-oxidant found in grapes and other food products, inhibited phorbol ester (PMA)-mediated induction of COX-2 in human mammary and oral epithelial cells. Treatment of cells with PMA induces COX-2 and causes a marked increase in the production of prostaglandin E-2. These effects were inhibited by resveratrol, Resveratrol suppressed PMA-mediated increases in COX-2 mRNA and protein. Nuclear run-offs revealed increased rates of COX-2 transcription after treatment with PMA, an effect that was inhibited by resveratrol, PMA caused about a 6-fold increase in COX-2 promoter activity, which was suppressed by resveratrol, Transient transfections utilizing COX-2 promoter deletion constructs and COX-2 promoter constructs, in which specific enhancer elements were mutagenized, indicated that the effects of PMA and resveratrol were mediated via a cyclic AMP response element. Resveratrol inhibited PMA-mediated activation of protein kinase C, Overexpressing protein kinase C-alpha, ERK1, and c-Jun led to 4.7-, 5.1-, and C-fold increases in COX-2 promoter activity, respectively. These effects also were inhibited by resveratrol, Resveratrol blocked PMA-dependent activation of AP-l-mediated gene expression. In addition to the above effects on gene expression, we found that resveratrol also directly inhibited the activity of COX-2, These data are likely to be important for understanding the anti-cancer and anti-inflammatory properties of resveratrol.	Cornell Univ, Med Ctr, New York Hosp, Div Digest Dis,Dept Med, New York, NY 10021 USA; Cornell Univ, Med Ctr, New York Hosp, Dept Surg, New York, NY 10021 USA; Strang Canc Prevent Ctr, Anne Fisher Nutr Ctr, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Surg, Head & Neck Serv, New York, NY 10021 USA; Natl Cardiovasc Ctr, Res Inst, Dept Pharmacol, Osaka, Japan; Univ Illinois, Coll Med, Dept Surg Oncol, Chicago, IL 60612 USA; Univ Illinois, Coll Pharm, Program Collaborat Res Pharmaceu Sci, Dept Med Chem & Pharmacognosy, Chicago, IL 60612 USA	Cornell University; NewYork-Presbyterian Hospital; Cornell University; NewYork-Presbyterian Hospital; Memorial Sloan Kettering Cancer Center; National Cerebral & Cardiovascular Center - Japan; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Dannenberg, AJ (corresponding author), Cornell Univ, Med Ctr, New York Hosp, Div Digest Dis,Dept Med, Room F-231,1300 York Ave, New York, NY 10021 USA.				NATIONAL CANCER INSTITUTE [P01CA029502, R01CA068136, P01CA048112] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA48112, CA68136, P01 CA29502] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BENAV P, 1995, FEBS LETT, V372, P83, DOI 10.1016/0014-5793(95)00956-A; BENNETT A, 1986, PROG LIPID RES, V25, P539, DOI 10.1016/0163-7827(86)90109-8; Caponigro F, 1997, ANTI-CANCER DRUG, V8, P26, DOI 10.1097/00001813-199701000-00003; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; DUBOIS RN, 1994, J CLIN INVEST, V93, P493, DOI 10.1172/JCI116998; Gehm BD, 1997, P NATL ACAD SCI USA, V94, P14138, DOI 10.1073/pnas.94.25.14138; GIERSE JK, 1995, BIOCHEM J, V305, P479, DOI 10.1042/bj3050479; GOODWIN JS, 1983, J CLIN IMMUNOL, V3, P295, DOI 10.1007/BF00915791; Gordge PC, 1996, EUR J CANCER, V32A, P2120, DOI 10.1016/S0959-8049(96)00255-9; HUANG TS, 1991, P NATL ACAD SCI USA, V88, P5292, DOI 10.1073/pnas.88.12.5292; INOUE H, 1995, J BIOL CHEM, V270, P24965, DOI 10.1074/jbc.270.42.24965; INOUE H, 1994, FEBS LETT, V350, P51, DOI 10.1016/0014-5793(94)00731-4; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; JONES DA, 1993, J BIOL CHEM, V268, P9049; JUNG TTK, 1985, LARYNGOSCOPE, V95, P307; KARGMAN SL, 1995, CANCER RES, V55, P2556; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; KAWAMORI T, 1998, CANCER RES, V58, P4809; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; Kutchera W, 1996, P NATL ACAD SCI USA, V93, P4816, DOI 10.1073/pnas.93.10.4816; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SF, 1997, NUTR CANCER, V28, P177, DOI 10.1080/01635589709514572; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lupulescu A, 1996, PROSTAG LEUKOTR ESS, V54, P83, DOI 10.1016/S0952-3278(96)90064-2; MASFERRER JL, 1994, P NATL ACAD SCI USA, V91, P3228, DOI 10.1073/pnas.91.8.3228; Mestre JR, 1997, CANCER RES, V57, P1081; Mestre JR, 1997, CANCER RES, V57, P2890; MULLERDECKER K, 1995, MOL CARCINOGEN, V12, P31, DOI 10.1002/mc.2940120106; OBRIAN CA, 1989, CANCER RES, V49, P3215; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; PARETT ML, 1997, INT J ONCOL, V10, P503; PFAHL M, 1993, ENDOCR REV, V14, P651, DOI 10.1210/er.14.5.651; Ristimaki A, 1997, CANCER RES, V57, P1276; ROLLAND PH, 1980, JNCI-J NATL CANCER I, V64, P1061; Sacks PG, 1996, CANCER METAST REV, V15, P27, DOI 10.1007/BF00049486; Sheng GG, 1997, GASTROENTEROLOGY, V113, P1883, DOI 10.1016/S0016-5085(97)70007-6; Sheng HM, 1998, CANCER RES, V58, P362; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Subbaramaiah K, 1996, CANCER RES, V56, P4424; SUZUKI T, 1991, NUCLEIC ACIDS RES, V19, P5537, DOI 10.1093/nar/19.20.5537; TIANO H, 1997, P AM ASSOC CANC RES, V38, P1727; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TREJO J, 1994, J BIOL CHEM, V269, P21682; Tsujii M, 1997, P NATL ACAD SCI USA, V94, P3336, DOI 10.1073/pnas.94.7.3336; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; WAGNER H, 1986, PLANTA MED, V52, P184; XIE WL, 1995, J BIOL CHEM, V270, P27622, DOI 10.1074/jbc.270.46.27622; YOSHIOKA K, 1995, P NATL ACAD SCI USA, V92, P4972, DOI 10.1073/pnas.92.11.4972; ZHAI YF, 1993, CANCER RES, V53, P2272	49	672	694	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21875	21882		10.1074/jbc.273.34.21875	http://dx.doi.org/10.1074/jbc.273.34.21875			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705326	hybrid			2022-12-27	WOS:000075492600060
J	Yamada, M; Inbe, H; Tanaka, M; Sumi, K; Matsushita, K; Adachi, O				Yamada, M; Inbe, H; Tanaka, M; Sumi, K; Matsushita, K; Adachi, O			Mutant isolation of the Escherichia coli quinoprotein glucose dehydrogenase and analysis of crucial residues Asp-730 and His-775 for its function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHANOL DEHYDROGENASE; ACINETOBACTER-CALCOACETICUS; PYRROLOQUINOLINE QUINONE; NUCLEOTIDE-SEQUENCE; PARACOCCUS-DENITRIFICANS; GLUCONOBACTER-SUBOXYDANS; ALCOHOL-DEHYDROGENASE; UBIQUINONE REDUCTION; ELECTRON-TRANSPORT; RESPIRATORY-CHAIN	Several mutants of quinoprotein glucose dehydrogenase (GDH) in Escherichia coli were obtained and characterized. Of these, significant mutants were further characterized by kinetic analysis after purification or by site-directed mutagenesis to introduce different amino acid substitutions. H775R and H775A showed a pronounced reduction of affinity for a prosthetic group, pyrroloquinoline quinone (PQQ), suggesting that His775 may directly interact with PQQ, D730N and D730A showed low glucose oxidase activity without influence on the affinity for PQQ, Mg2+, or substrate, but D730R showed reduced affinity for PQQ, The spectrum of tryptophan fluorescence revealed that the local structure surrounding PQQ was not changed by D730N mutation. Based on these data, we assume that Asp-730 may occur close to PQQ and function as a proton (and also electron) donor to PQQ or acceptor from PQQH(2). Substitutions of Gly-689, that are located at the end of a unique segment of GDH among homologous quinoprotein dehydrogenases, directed reduction of the affinity for PQQ or GDH activity. Therefore, the unique segment and Asp-730 may play a specific role for GDH, which might be related to the intramolecular electron transfer from PQQ to ubiquinone.	Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi 7538515, Japan	Yamaguchi University	Yamada, M (corresponding author), Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi 7538515, Japan.	yamada@agr.yamaguchi-u.ac.jp		Yamada, Mamoru/0000-0003-4354-7324				AMEYAMA M, 1986, AGR BIOL CHEM TOKYO, V50, P49, DOI 10.1080/00021369.1986.10867348; AMEYAMA M, 1985, AGR BIOL CHEM TOKYO, V49, P1227, DOI 10.1080/00021369.1985.10866884; AMEYAMA M, 1981, FEBS LETT, V130, P179, DOI 10.1016/0014-5793(81)81114-3; Anthony C., 1993, P221; ANTHONY C, 1992, INT J BIOCHEM, V24, P29, DOI 10.1016/0020-711X(92)90226-Q; BLAKE CCF, 1994, NAT STRUCT BIOL, V1, P102, DOI 10.1038/nsb0294-102; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CLETONJANSEN AM, 1991, MOL GEN GENET, V229, P206, DOI 10.1007/BF00272157; CLETONJANSEN AM, 1988, NUCLEIC ACIDS RES, V16, P6228, DOI 10.1093/nar/16.13.6228; CLETONJANSEN AM, 1990, J BACTERIOL, V172, P6308, DOI 10.1128/jb.172.11.6308-6315.1990; CLETONJANSEN AM, 1989, MOL GEN GENET, V217, P430, DOI 10.1007/BF02464914; Cozier GE, 1995, BIOCHEM J, V312, P679, DOI 10.1042/bj3120679; DUINE JA, 1979, FEBS LETT, V108, P443, DOI 10.1016/0014-5793(79)80584-0; DULLEY JR, 1975, ANAL BIOCHEM, V64, P136, DOI 10.1016/0003-2697(75)90415-7; FRIEDRICH T, 1990, FEBS LETT, V265, P37, DOI 10.1016/0014-5793(90)80878-M; HARMS N, 1987, J BACTERIOL, V169, P3969, DOI 10.1128/jb.169.9.3969-3975.1987; HOMMES RWJ, 1984, FEMS MICROBIOL LETT, V24, P329, DOI 10.1016/0378-1097(84)90274-X; INOUE T, 1989, J BACTERIOL, V171, P3115, DOI 10.1128/jb.171.6.3115-3122.1989; MACHLIN SM, 1988, J BACTERIOL, V170, P4739, DOI 10.1128/jb.170.10.4739-4747.1988; MANAYAN R, 1988, J BACTERIOL, V170, P1290, DOI 10.1128/jb.170.3.1290-1296.1988; Maniatis T., 1982, MOL CLONING; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Matsushita K, 1996, J BIOL CHEM, V271, P4850; MATSUSHITA K, 1989, J BIOCHEM, V105, P633, DOI 10.1093/oxfordjournals.jbchem.a122716; MATSUSHITA K, 1987, J BACTERIOL, V169, P205, DOI 10.1128/jb.169.1.205-209.1987; Matsushita K, 1997, MICROBIOL-UK, V143, P3149, DOI 10.1099/00221287-143-10-3149; MATSUSHITA K, 1989, BIOCHEMISTRY-US, V28, P6276, DOI 10.1021/bi00441a020; Miller J.H., 1992, SHORT COURSE BACTERI, P150; SAIER MH, 1972, J BIOL CHEM, V247, P972; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SODE K, 1994, BIOTECHNOL LETT, V16, P455, DOI 10.1007/BF01023325; VANSCHIE BJ, 1985, J BACTERIOL, V163, P493, DOI 10.1128/JB.163.2.493-499.1985; VANSPANNING RJM, 1991, J BACTERIOL, V173, P6948, DOI 10.1128/jb.173.21.6948-6961.1991; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WHITE S, 1993, BIOCHEMISTRY-US, V32, P12955, DOI 10.1021/bi00211a002; XIA ZX, 1992, J BIOL CHEM, V267, P22289; YAMADA M, 1993, J BIOL CHEM, V268, P12812; YAMADA M, 1993, J BACTERIOL, V175, P568, DOI 10.1128/JB.175.2.568-571.1993; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	40	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					22021	22027		10.1074/jbc.273.34.22021	http://dx.doi.org/10.1074/jbc.273.34.22021			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705344	hybrid			2022-12-27	WOS:000075492600078
J	Balbin, M; Fueyo, A; Knauper, V; Pendas, AM; Lopez, JM; Jimenez, MG; Murphy, G; Lopez-Otin, C				Balbin, M; Fueyo, A; Knauper, V; Pendas, AM; Lopez, JM; Jimenez, MG; Murphy, G; Lopez-Otin, C			Collagenase 2 (MMP-8) expression in murine tissue-remodeling processes - Analysis of its potential role in postpartum involution of the uterus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NEUTROPHIL COLLAGENASE; HUMAN MATRIX METALLOPROTEINASE; SMOOTH-MUSCLE CELLS; LEUKOCYTE COLLAGENASE; SUBSTRATE-SPECIFICITY; ALPHA-1-PROTEINASE INHIBITOR; POLYMORPHONUCLEAR LEUKOCYTES; BIOCHEMICAL-CHARACTERIZATION; FIBROBLAST COLLAGENASE; CHROMOSOMAL LOCATION	Neutrophil collagenase or collagenase 2 (MMP-8) is unique among the family of matrix metalloproteinases (MMPs) because of its exclusive pattern of expression in inflammatory conditions. At present, no evidence of the occurrence of this enzyme in tissues other than human has been reported. In this work, we have cloned the murine homologue of human collagenase 2. The isolated cDNA contains an open reading frame coding for a polypeptide of 465 amino acids, which is 74% identical to its human counterpart. The mouse collagenase 2 exhibits the domain structure characteristic of several MMPs, including a signal sequence, a prodomain with the cysteine residue essential for enzyme latency, an activation locus with the Zinc-binding site, and a COOH-terminal fragment with sequence similarity to hemopexin. It also contains the three conserved residues (Tyr-209, Asp-230, and Gly-232) located around the Zinc-binding site and are distinctive of the collagenase subfamily. Northern blot analysis of RNAs isolated from a variety of mouse tissues revealed that collagenase 2 is expressed at late stages during mouse embryogenesis, coinciding with the appearance of hematopoietic cells. In addition, collagenase 2 was highly expressed in the postpartum uterus starting at 1 day postpartum and extending up to 5 days. Enzymatic analysis revealed that matrilysin, another MMP overexpressed in uterine tissue, is able to activate murine procollagenase 2. These data suggest that both enzymes could form an activation cascade resulting in the generation of the collagenolytic activity required during the process of massive connective tissue resumption occurring in the involuting uterus.	Univ Oviedo, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; Univ Oviedo, Fac Med, Dept Biol Func, E-33006 Oviedo, Spain; Univ Oviedo, Fac Med, Dept Morfol & Biol Celular, E-33006 Oviedo, Spain; Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of Oviedo; University of Oviedo; University of Oviedo; University of East Anglia	Lopez-Otin, C (corresponding author), Univ Oviedo, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain.	CLO@DWARF1.QUIMICA.UNIOVI.ES	Fueyo, Antonio/ABH-3243-2020; Balbín, Milagros/I-4206-2015; Pendas, Alberto M/L-1017-2014; López-Otín, Carlos/AAB-2106-2020	Fueyo, Antonio/0000-0002-7121-9398; Balbín, Milagros/0000-0001-5325-0407; López-Otín, Carlos/0000-0001-6964-1904; Pendas, Alberto M/0000-0001-9264-3721; Knauper, Vera/0000-0002-3965-9924; Lopez, Jose Manuel/0000-0003-0589-4763				ABRAMSON SR, 1995, J BIOL CHEM, V270, P16016, DOI 10.1074/jbc.270.27.16016; Balbin M, 1996, J ENDOCRINOL, V149, P405, DOI 10.1677/joe.0.1490405; BASSET P, 1990, NATURE, V348, P699, DOI 10.1038/348699a0; BELAAOUAJ A, 1995, J BIOL CHEM, V270, P14568, DOI 10.1074/jbc.270.24.14568; BERGMANN U, 1989, J CLIN CHEM CLIN BIO, V27, P351; Chubinskaya S, 1996, LAB INVEST, V74, P232; Cole AA, 1996, J BIOL CHEM, V271, P11023, DOI 10.1074/jbc.271.18.11023; CRABBE T, 1992, BIOCHEMISTRY-US, V31, P8500, DOI 10.1021/bi00151a017; DESROCHERS PE, 1992, J BIOL CHEM, V267, P5005; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FOSANG AJ, 1994, BIOCHEM J, V304, P347, DOI 10.1042/bj3040347; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; GAIRE M, 1994, J BIOL CHEM, V269, P2032; GOLDBERG GI, 1986, J BIOL CHEM, V261, P6600; Hanemaaijer R, 1997, J BIOL CHEM, V272, P31504, DOI 10.1074/jbc.272.50.31504; HASTY KA, 1987, J BIOL CHEM, V262, P10048; HASTY KA, 1986, J BIOL CHEM, V261, P5645; HASTY KA, 1990, J BIOL CHEM, V265, P11421; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; HENNEY AM, 1991, P NATL ACAD SCI USA, V88, P8154, DOI 10.1073/pnas.88.18.8154; HENRIET P, 1992, FEBS LETT, V310, P175, DOI 10.1016/0014-5793(92)81323-E; HIROSE T, 1993, P NATL ACAD SCI USA, V90, P2569, DOI 10.1073/pnas.90.7.2569; JEFFREY JJ, 1991, J CELL PHYSIOL, V146, P399, DOI 10.1002/jcp.1041460310; KNAUPER V, 1993, BIOCHEM J, V291, P847; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; KNAUPER V, 1990, FEBS LETT, V263, P355, DOI 10.1016/0014-5793(90)81412-H; KNAUPER V, 1990, EUR J BIOCHEM, V189, P295, DOI 10.1111/j.1432-1033.1990.tb15489.x; Krane SM, 1996, J BIOL CHEM, V271, P28509, DOI 10.1074/jbc.271.45.28509; Lawson ND, 1998, BLOOD, V91, P2517, DOI 10.1182/blood.V91.7.2517.2517_2517_2524; LIU X, 1995, J CELL BIOL, V130, P227, DOI 10.1083/jcb.130.1.227; Llano E, 1997, BIOCHEMISTRY-US, V36, P15101, DOI 10.1021/bi972120y; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; MOOKHTIAR KA, 1990, BIOCHEMISTRY-US, V29, P10620, DOI 10.1021/bi00499a007; MULLIGAN MS, 1993, P NATL ACAD SCI USA, V90, P11523, DOI 10.1073/pnas.90.24.11523; MURPHY G, 1992, J RHEUMATOL, V19, P61; Pak JH, 1997, FEBS LETT, V404, P283, DOI 10.1016/S0014-5793(97)00141-5; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; Pendas AM, 1997, J BIOL CHEM, V272, P4281, DOI 10.1074/jbc.272.7.4281; PENDAS AM, 1995, GENOMICS, V26, P615, DOI 10.1016/0888-7543(95)80186-P; Pendas AM, 1996, GENOMICS, V37, P266, DOI 10.1006/geno.1996.0557; QUINN CO, 1990, J BIOL CHEM, V265, P22342; RudolphOwen LA, 1997, ENDOCRINOLOGY, V138, P4902, DOI 10.1210/en.138.11.4902; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; SCHETTLER A, 1991, EUR J BIOCHEM, V197, P197, DOI 10.1111/j.1432-1033.1991.tb15899.x; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; Stolow MA, 1996, MOL BIOL CELL, V7, P1471, DOI 10.1091/mbc.7.10.1471; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; WEISS SJ, 1982, J CLIN INVEST, V69, P255, DOI 10.1172/JCI110447; WEISS SJ, 1985, SCIENCE, V227, P747, DOI 10.1126/science.2982211; WELGUS HG, 1981, J BIOL CHEM, V256, P9511; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; WERB Z, 1975, J EXP MED, V142, P361, DOI 10.1084/jem.142.2.361; WILCOX BD, 1992, J BIOL CHEM, V267, P20752; Wilson CL, 1996, INT J BIOCHEM CELL B, V28, P123, DOI 10.1016/1357-2725(95)00121-2; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; Wolf K, 1996, ENDOCRINOLOGY, V137, P5429, DOI 10.1210/en.137.12.5429	57	112	120	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23959	23968		10.1074/jbc.273.37.23959	http://dx.doi.org/10.1074/jbc.273.37.23959			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727011	hybrid			2022-12-27	WOS:000075893100052
J	Goalstone, ML; Leitner, JW; Wall, K; Dolgonos, L; Rother, KI; Accili, D; Draznin, B				Goalstone, ML; Leitner, JW; Wall, K; Dolgonos, L; Rother, KI; Accili, D; Draznin, B			Effect of insulin on farnesyltransferase - Specificity of insulin action and potentiation of nuclear effects of insulin-like growth factor-1, epidermal growth factor, and platelet-derived growth factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; 3T3-L1 ADIPOCYTES; RAS; RECEPTOR; MEMBRANE	We have previously demonstrated that insulin activates, farnesyltransferase (FTase) and augments the amounts of farnesylated p21(ras) (Goalstone, NI, L., and Draznin, B. (1996) J. Biol, Chem. 271, 27585-27589). We postulated that this aspect of insulin action might explain the "priming effect" of insulin on the cellular response to other growth factors. In the present study, we show the specificity of the effect of insulin on FTase. Insulin, but not insulin-like growth factor-1 (IGF-1), epidermal growth factor (EGF), or platelet-derived growth factor (PDGF), stimulated the phosphorylation of the alpha-subunit of FTase and the amounts of farnesylated p21(ras). Even though all four growth factors utilized the Ras pathway to stimulate DNA synthesis, only insulin used this pathway to influence FTase, Insulin failed to stimulate FTase in cells expressing the chimeric insulin/ IGF-I receptor and in cells derived from the insulin receptor knock-out animals. Insulin potentiated the effects of IGF-1, EGF, and PDGF on DNA synthesis in cells expressing the wild type insulin receptor, but this potentiation was inhibited in the presence of the FTase inhibitor, alpha-hydroxyfarnesylphosphonic acid. We conclude that the effect of insulin on FTase is specific, requires the presence of an intact insulin receptor and selves as a conduit for the "priming" influence of insulin on the nuclear effects of other growth factors.	Denver Vet Affairs Med Ctr, Res Serv, Denver, CO 80220 USA; Denver Vet Affairs Med Ctr, Dept Med, Denver, CO 80220 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO 80220 USA; NICHD, Dev Endocrinol Branch, NIH, Bethesda, MD 20892 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Draznin, B (corresponding author), VA Hosp 151, 1055 Clermont St, Denver, CO 80220 USA.							ANDRES DA, 1993, J BIOL CHEM, V268, P1383; CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117; FARIA TN, 1994, J BIOL CHEM, V269, P13922; Goalstone M, 1997, BIOCHEM BIOPH RES CO, V239, P42, DOI 10.1006/bbrc.1997.7413; Goalstone M, 1997, ENDOCRINOLOGY, V138, P5119, DOI 10.1210/en.138.12.5119; Goalstone ML, 1996, J BIOL CHEM, V271, P27585, DOI 10.1074/jbc.271.44.27585; GOALSTONE ML, 1998, IN PRESS ENDOCRINOLO; HANCOCK JF, 1989, CELL, V57, P1165; Leitner JW, 1997, ENDOCRINOLOGY, V138, P2211, DOI 10.1210/en.138.5.2211; Macara IG, 1996, FASEB J, V10, P625, DOI 10.1096/fasebj.10.5.8621061; MOORES SL, 1991, J BIOL CHEM, V266, P14603; OLEFSKY JM, 1990, DIABETES, V39, P1009, DOI 10.2337/diabetes.39.9.1009; REISS Y, 1991, J BIOL CHEM, V266, P10672; Rother KI, 1998, J BIOL CHEM, V273, P17491, DOI 10.1074/jbc.273.28.17491; Shepherd PR, 1996, TRENDS CELL BIOL, V6, P92, DOI 10.1016/0962-8924(96)80998-6; STOUT RW, 1996, DIABETES, V45, P45; VOGT A, 1995, J BIOL CHEM, V270, P660, DOI 10.1074/jbc.270.2.660; WIESE RJ, 1995, J BIOL CHEM, V270, P3442, DOI 10.1074/jbc.270.7.3442; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	19	55	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23892	23896		10.1074/jbc.273.37.23892	http://dx.doi.org/10.1074/jbc.273.37.23892			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727002	hybrid			2022-12-27	WOS:000075893100043
J	Reddy, YVR; Rao, DN				Reddy, YVR; Rao, DN			Probing the role of cysteine residues in the EcoP15I DNA methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSYL-L-METHIONINE; ESCHERICHIA-COLI; CATALYTIC PROPERTIES; SEQUENCE MOTIFS; DEPENDENT METHYLTRANSFERASES; S-ADENOSYLMETHIONINE; MODIFICATION SYSTEMS; HOMOGENEOUS ENZYME; CRYSTAL-STRUCTURE; ECORI METHYLASE	Chemical modification using thiol-directed agents and site-directed mutagenesis has been used to investigate the role of cysteine residues of EcoP15I DNA methyltransferase, Irreversible inhibition of enzymatic activity was provoked by chemical modification of the enzyme by N-ethylmaleimide and iodoacetamide, 5,5'-Dithiobis(2-nitrobenzoic acid) titration of the enzyme under nondenaturing and denaturing conditions confirmed the presence of six cysteine residues without any disulfides in the protein. An are that relatively bulky reagents inactivate the methyltransferase by directly occluding the substrate-binding site or by locking the methyltransferase in an inactive conformation, we used site-directed mutagenesis to sequentially replace each of the six cysteines in the protein at positions 30, 213, 344, 434, 553, and 577. All the resultant mutant methylases except for the C344S and C344A enzymes retained significant activity as assessed by in vivo and in vitro assays. The effects of the substitutions on the function of EcoP15I DNA methyltransferase were investigated by substrate binding assays, activity measurements, and steady-state kinetic analysis of catalysis, Our results clearly indicate that the cysteines at positions other than 344 are not essential for activity. In contrast, the C344A enzyme showed a marked loss of enzymatic activity. More importantly, whereas the inactive C344A mutant enzyme bound S-adenosyl-L-Methionine, it failed to bind to DNA. Furthermore, in double and triple mutants where two or three cysteine residues were replaced by serine, all such mutants in which the cysteine at position 344 was changed, were inactive. Taken together, these results convincingly demonstrate that the Cys-344 is necessary for enzyme activity and indicate an essential role for it in DNA binding.	Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Rao, DN (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.							Ahmad I, 1996, CRIT REV BIOCHEM MOL, V31, P361, DOI 10.3109/10409239609108722; Ahmad I, 1996, J MOL BIOL, V259, P229, DOI 10.1006/jmbi.1996.0315; AHMAD I, 1994, GENE, V142, P67, DOI 10.1016/0378-1119(94)90356-5; AHMAD I, 1995, GENE, V157, P143, DOI 10.1016/0378-1119(95)00671-R; AIKEN CR, 1991, J BIOL CHEM, V266, P19063; Bickle TA, 1993, NUCLEASES, P89; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN L, 1991, BIOCHEMISTRY-US, V30, P11018, DOI 10.1021/bi00110a002; CHENG XD, 1995, ANNU REV BIOPH BIOM, V24, P293, DOI 10.1146/annurev.bb.24.060195.001453; CHENG XD, 1993, CELL, V74, P299, DOI 10.1016/0092-8674(93)90421-L; COMMUNI D, 1995, BIOCHEM J, V310, P109, DOI 10.1042/bj3100109; COWARD JK, 1971, J ORG CHEM, V36, P2337, DOI 10.1021/jo00815a032; CREIGHTON TE, 1997, PROTEIN STRUCTURE PR, P287; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; EVERETT EA, 1990, J BIOL CHEM, V265, P17713; GABBARA S, 1995, BIOCHEMISTRY-US, V34, P8914, DOI 10.1021/bi00027a044; Gong WM, 1997, NUCLEIC ACIDS RES, V25, P2702, DOI 10.1093/nar/25.14.2702; HADI SM, 1983, J MOL BIOL, V165, P19, DOI 10.1016/S0022-2836(83)80240-X; HATTMAN S, 1985, J BACTERIOL, V164, P932, DOI 10.1128/JB.164.2.932-937.1985; HERMAN GE, 1982, J BIOL CHEM, V257, P2605; HO DK, 1991, ARCH BIOCHEM BIOPHYS, V284, P264, DOI 10.1016/0003-9861(91)90294-S; HUMBELIN M, 1988, J MOL BIOL, V200, P23, DOI 10.1016/0022-2836(88)90330-0; INGROSSO D, 1989, J BIOL CHEM, V264, P20131; KLIMASAUSKAS S, 1989, NUCLEIC ACIDS RES, V17, P9823, DOI 10.1093/nar/17.23.9823; KNIPE JO, 1979, J AM CHEM SOC, V101, P4339, DOI 10.1021/ja00509a049; KOSSYKH VG, 1995, J BIOL CHEM, V270, P14389, DOI 10.1074/jbc.270.24.14389; KUMAR S, 1994, NUCLEIC ACIDS RES, V91, P10957; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LABAHN J, 1994, P NATL ACAD SCI USA, V91, P10957, DOI 10.1073/pnas.91.23.10957; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAUSTER R, 1989, J MOL BIOL, V206, P305, DOI 10.1016/0022-2836(89)90480-4; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; MEISEL A, 1995, EMBO J, V14, P2958, DOI 10.1002/j.1460-2075.1995.tb07296.x; MEISEL A, 1991, NUCLEIC ACIDS RES, V9, P3997; MI S, 1993, NUCLEIC ACIDS RES, V21, P4811; POGOLOTTI AL, 1988, J BIOL CHEM, V263, P7461; POSFAI J, 1989, NUCLEIC ACIDS RES, V17, P2421, DOI 10.1093/nar/17.7.2421; PROFY AT, 1986, J BIOL CHEM, V261, P15474; RAO DN, 1989, J MOL BIOL, V209, P599, DOI 10.1016/0022-2836(89)90597-4; REICH NO, 1990, J BIOL CHEM, V265, P8966; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; RUBIN RA, 1977, J BIOL CHEM, V252, P7265; SAHA S, 1995, J MOL BIOL, V247, P559, DOI 10.1016/S0022-2836(05)80137-8; Sambrook J., 2002, MOL CLONING LAB MANU; SCHLUCKEBIER G, 1995, J MOL BIOL, V247, P16, DOI 10.1006/jmbi.1994.0117; SZILAK L, 1994, NUCLEIC ACIDS RES, V22, P2876, DOI 10.1093/nar/22.15.2876; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101; WYSZYNSKI MW, 1993, NUCLEIC ACIDS RES, V21, P295, DOI 10.1093/nar/21.2.295	49	13	13	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23866	23876		10.1074/jbc.273.37.23866	http://dx.doi.org/10.1074/jbc.273.37.23866			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726999	hybrid			2022-12-27	WOS:000075893100040
J	Tzeng, YL; Zhou, XZ; Hoch, JA				Tzeng, YL; Zhou, XZ; Hoch, JA			Phosphorylation of the Spo0B response regulator phosphotransferase of the phosphorelay initiating development in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; SIGNAL-TRANSDUCTION SYSTEM; ESCHERICHIA-COLI; MULTISTEP PHOSPHORELAY; BACTERIAL CHEMOTAXIS; SPORULATION; KINASE; TRANSCRIPTION; OPERON; PHOSPHATASE	The initiation of sporulation in Bacillus subtilis is regulated by the phosphorelay, a complex signal transduction system consisting of kinases and response regulators. The key component of a phosphorelay is the phosphotransferase, which recognizes two response regulators and transfers a phosphoryl group between them. In this reaction, the phosphoryl of one response regulator is transferred to a histidine on the phosphotransferase before phosphorylating an aspartate of the second response regulator. The phosphorylated histidine on the Spo0B phosphotransferase was found to be His(30). Site-directed mutation of His(30) to alanine destroyed its phosphotransferase activity in vitro and strains constructed with this mutation were unable to sporulate, None of the other 10 histidines of Spo0B was implicated in the phosphotransferase reaction. A structurally vulnerable site, histidine 23, was also identified through the mutational study. The His(30) of Spo0B resides in a domain with little sequence homology to functionally equivalent domains in the phosphorelays of other bacterial and yeast systems, suggesting that the two types of phosphotransfer domains evolved convergently.	Scripps Res Inst, Dept Mol & Expt Med, Div Cellular Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Hoch, JA (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, Div Cellular Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.				NIGMS NIH HHS [GM19416] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM019416, R01GM019416] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIYAR A, 1996, METHODS MOL BIOL IN; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; BIRD TH, 1993, MOL MICROBIOL, V9, P741, DOI 10.1111/j.1365-2958.1993.tb01734.x; BURBULYS D, 1991, CELL, V64, P545, DOI 10.1016/0092-8674(91)90238-T; HESS JF, 1988, NATURE, V336, P139, DOI 10.1038/336139a0; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOCH JA, 1993, ANNU REV MICROBIOL, V47, P441, DOI 10.1146/annurev.micro.47.1.441; HULTQUIST DE, 1966, BIOCHEMISTRY-US, V5, P322, DOI 10.1021/bi00865a041; JIN SG, 1990, J BACTERIOL, V172, P525, DOI 10.1128/jb.172.2.525-530.1990; Kato M, 1997, CELL, V88, P717, DOI 10.1016/S0092-8674(00)81914-5; KOK J, 1994, J BACTERIOL, V176, P7155, DOI 10.1128/JB.176.23.7155-7160.1994; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY DF, 1994, J BIOL CHEM, V269, P26358; NINFA AJ, 1986, P NATL ACAD SCI USA, V83, P5909, DOI 10.1073/pnas.83.16.5909; NINFA EG, 1991, J BIOL CHEM, V266, P9764; Ogino T, 1998, MOL MICROBIOL, V27, P573, DOI 10.1046/j.1365-2958.1998.00703.x; OHLSEN KL, 1994, P NATL ACAD SCI USA, V91, P1756, DOI 10.1073/pnas.91.5.1756; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; PEREGO M, 1989, J BACTERIOL, V171, P6187, DOI 10.1128/jb.171.11.6187-6196.1989; Perego M, 1996, MOL MICROBIOL, V19, P1151, DOI 10.1111/j.1365-2958.1996.tb02460.x; PEREGO M, 1994, CELL, V79, P1047, DOI 10.1016/0092-8674(94)90035-3; Perego Marta, 1993, P615; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; SANNA MG, 1995, MOL MICROBIOL, V15, P1069, DOI 10.1111/j.1365-2958.1995.tb02282.x; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P701; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Smith R A, 1978, Methods Cell Biol, V19, P153; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; TRACH K, 1989, J BACTERIOL, V171, P1362, DOI 10.1128/jb.171.3.1362-1371.1989; TRACH KA, 1993, MOL MICROBIOL, V8, P69, DOI 10.1111/j.1365-2958.1993.tb01204.x; Uhl MA, 1996, EMBO J, V15, P1028, DOI 10.1002/j.1460-2075.1996.tb00440.x; WEISS V, 1988, P NATL ACAD SCI USA, V85, P8919, DOI 10.1073/pnas.85.23.8919; WELSH KM, 1994, J BACTERIOL, V176, P7161, DOI 10.1128/JB.176.23.7161-7168.1994; Zapf JW, 1996, BIOCHEMISTRY-US, V35, P2926, DOI 10.1021/bi9519361; ZHOU HJ, 1995, BIOCHEMISTRY-US, V34, P13858, DOI 10.1021/bi00042a018; Zhou XZ, 1997, PROTEINS, V27, P597, DOI 10.1002/(SICI)1097-0134(199704)27:4<597::AID-PROT11>3.0.CO;2-F	36	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23849	23855		10.1074/jbc.273.37.23849	http://dx.doi.org/10.1074/jbc.273.37.23849			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726997	hybrid			2022-12-27	WOS:000075893100038
J	Pye, DA; Vives, RR; Turnbull, JE; Hyde, P; Gallagher, JT				Pye, DA; Vives, RR; Turnbull, JE; Hyde, P; Gallagher, JT			Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR DIMERIZATION; EXTRACELLULAR DOMAIN; CELL-PROLIFERATION; BINDING DOMAIN; FGF; IDENTIFICATION; SPECIFICITY; ACTIVATION; GLYCOSAMINOGLYCANS; DISACCHARIDES	The interaction of heparan sulfate (HS) with basic fibroblast growth factor (bFGF) is influential in enabling the growth factor to bind to its cell surface tyrosine kinase receptor. In this study, we have investigated further the structural properties of HS required to mediate the activity of bFGF in a mitogenic assay. We have prepared a library of heparinase m-generated HS oligosaccharides fractionated by both their size (dp6-dp12) and sulfate content. The ability of these oligosaccharides to activate bFGF in a mitogenic assay was then correlated with their length and disaccharide composition. All octa- and hexasaccharide fractions tested were unable to activate bFGF. Dodeca- and decasaccharide fractions were found to contain both activating and nonactivating oligosaccharides, and showed a clear correlation between total sulfate content and the level of activatory activity. Disaccharide analysis of a range of dodeca- and decasaccharide fractions showed that both activating and non-activating oligosaccharides were composed mainly of N-sulfated and IdoA(2S)-containing disaccharides. The only significant difference between activating and non-activating oligosaccharides was the content of 6-O-sulfated disaccharides, in particular the disaccharide IdoA(2S)alpha 1,4GlcNSO(3)(6S). These results show that there is a requirement for B-O-sulfation of N-sulfated glucosamine residues, in addition to the 2-0-sulfation of IdoA, for the promotion of bFGF mitogenic activity by naturally occurring HS oligosaccharides. Analysis of the structure-activity relationships in the dodecasaccharide fractions in particular, suggests that a minimum bFGF activation sequence exists which is dependent on the positioning of at least one 6-O-sulfate group.	Univ Manchester, Christie Hosp, Paterson Inst Canc Res, CRC,Dept Med Oncol, Manchester M20 4BX, Lancs, England; CRC, Dept Drug Dev, Manchester M20 4BX, Lancs, England; Univ Birmingham, Sch Biochem, Birmingham B15 2TT, W Midlands, England	Christie NHS Foundation Trust; Christie Hospital; Paterson Institute for Cancer Research; University of Manchester; University of Birmingham	Pye, DA (corresponding author), Univ Manchester, Christie Hosp, Paterson Inst Canc Res, CRC,Dept Med Oncol, Wilmslow Rd, Manchester M20 4BX, Lancs, England.		Vives, Romain/I-9372-2012					BRICKMAN YG, 1995, J BIOL CHEM, V270, P24941, DOI 10.1074/jbc.270.42.24941; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; DESAI UR, 1993, BIOCHEMISTRY-US, V32, P8140, DOI 10.1021/bi00083a012; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; GAMBARINI AG, 1993, MOL CELL BIOCHEM, V124, P121, DOI 10.1007/BF00929204; GIVOL D, 1992, FASEB J, V6, P3362, DOI 10.1096/fasebj.6.15.1464370; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; HABUCHI H, 1992, BIOCHEM J, V285, P805, DOI 10.1042/bj2850805; ISHIHARA M, 1994, GLYCOBIOLOGY, V4, P451, DOI 10.1093/glycob/4.4.451; ISHIHARA M, 1995, J BIOCHEM-TOKYO, V118, P1255, DOI 10.1093/oxfordjournals.jbchem.a125015; ISHIHARA M, 1993, J BIOL CHEM, V268, P4675; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; LINHARDT RJ, 1990, BIOCHEMISTRY-US, V29, P2611, DOI 10.1021/bi00462a026; MACCARANA M, 1993, J BIOL CHEM, V268, P23898; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; MASON IJ, 1994, CELL, V78, P547, DOI 10.1016/0092-8674(94)90520-7; Miao HQ, 1996, J BIOL CHEM, V271, P4879; Moy FJ, 1997, BIOCHEMISTRY-US, V36, P4782, DOI 10.1021/bi9625455; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; ORNITZ DM, 1995, SCIENCE, V268, P432, DOI 10.1126/science.7536345; PANTOLIANO MW, 1994, BIOCHEMISTRY-US, V33, P10229, DOI 10.1021/bi00200a003; PYE DA, 1994, BBA-MOL CELL RES, V1220, P266, DOI 10.1016/0167-4889(94)90148-1; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; RUSNATI M, 1994, BIOCHEM BIOPH RES CO, V203, P450, DOI 10.1006/bbrc.1994.2203; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; SPRINGER BA, 1994, J BIOL CHEM, V269, P26879; THOMPSON LD, 1994, BIOCHEMISTRY-US, V33, P3831, DOI 10.1021/bi00179a006; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; TURNBULL JE, 1991, BIOCHEM J, V273, P553, DOI 10.1042/bj2730553; WALKER A, 1994, J BIOL CHEM, V269, P931; Wang HM, 1997, BIOCHEM BIOPH RES CO, V235, P369, DOI 10.1006/bbrc.1997.6789; YAMADA S, 1995, J BIOL CHEM, V270, P8696; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	35	237	245	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					22936	22942		10.1074/jbc.273.36.22936	http://dx.doi.org/10.1074/jbc.273.36.22936			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722514	hybrid			2022-12-27	WOS:000075778100014
J	Marron-Terada, PG; Brzycki-Wessell, MA; Dahms, NM				Marron-Terada, PG; Brzycki-Wessell, MA; Dahms, NM			The two mannose 6-phosphate binding sites of the insulin-like growth factor-II mannose 6-phosphate receptor display different ligand binding properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLUCURONIDASE; LYSOSOMAL-ENZYMES; DICTYOSTELIUM-DISCOIDEUM; SEQUENCE-ANALYSIS; CATHEPSIN-D; CARBOHYDRATE-RECOGNITION; CYTOPLASMIC DOMAIN; CARBOXYL-TERMINUS; ARGININE RESIDUES; HUMAN-FIBROBLASTS	The two mannose 6-phosphate (Man-6-P) binding sites of the insulin-like growth factor-II/mannose 6-phosphate receptor (IGF-II/MPR) have been localized to domains 1-3 and 7-9, and studies have shown that Arg(435) in, domain 3 and Arg(1334) in domain 9 are essential for Man-6-P binding. To determine whether the IGF-II/MPR containing a single Man-6-P binding site is functional, clonal mouse L cell Lines stably transfected with either mutant bovine IGF-II/MPR cDNA, containing substitutions at position 435 and/or 1334, or the wild type receptor cDNA were assayed for their ability to sort lysosomal enzymes to the lysosome. Mutant receptors containing a single Man-6-P binding site were similar to 50% less efficient than the wild type receptor in the overall targeting of lysosomal enzymes to the lysosome. Mutant receptors containing a substitution at Arg(1334) (Dom9(Ala)), in contrast to those containing a substitution at Arg(435) (Dom3(Ala)), were unable to target cathepsin D and beta-hexosaminidase to the lysosome. Equilibrium binding assays using I-125-labeled beta-glucuronidase demonstrated that Dom3(Ala) and Dom9(Ala) had a K-d of 2.0 and 4.3 nM, respectively. In addition, Dom3(Ala), unlike Dom9(Ala), was unable to completely dissociate from ligand under acidic pH conditions. These data indicate that the two Man-B-P binding sites of the IGF-II/MPR are not functionally equivalent.	Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Dahms, NM (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK042667, R01DK042667, R56DK042667] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK42667] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAPAT B, 1988, FEBS LETT, V237, P191, DOI 10.1016/0014-5793(88)80199-6; BECCARI T, 1992, BIOCHEM J, V285, P593, DOI 10.1042/bj2850593; CHEN HJ, 1993, J BIOL CHEM, V268, P22338; DAHMS NM, 1989, J BIOL CHEM, V264, P12115; DAHMS NM, 1993, J BIOL CHEM, V268, P5457; DAHMS NM, 1989, J BIOL CHEM, V264, P11458; DAHMS NM, 1994, J BIOL CHEM, V269, P3802; DAHMS NM, 1987, CELL, V50, P181, DOI 10.1016/0092-8674(87)90214-5; FISCHER HD, 1980, J BIOL CHEM, V255, P5069; FREEZE HH, 1983, J BIOL CHEM, V258, P8928; FREEZE HH, 1980, J BIOL CHEM, V255, P1081; FUHLBRIGGE RC, 1988, P NATL ACAD SCI USA, V85, P5649, DOI 10.1073/pnas.85.15.5649; GABEL CA, 1984, J BIOL CHEM, V259, P3762; GABEL CA, 1983, P NATL ACAD SCI-BIOL, V80, P775, DOI 10.1073/pnas.80.3.775; GIESELMANN V, 1983, J CELL BIOL, V97, P1, DOI 10.1083/jcb.97.1.1; GLASER JH, 1973, J LAB CLIN MED, V82, P969; GOLDBERG DE, 1981, J BIOL CHEM, V256, P3060; GOLDSTEIN JL, 1977, CELL, V12, P629, DOI 10.1016/0092-8674(77)90263-X; GONZALEZNORIEGA A, 1980, J CELL BIOL, V85, P839, DOI 10.1083/jcb.85.3.839; GRUSBY MJ, 1990, NUCLEIC ACIDS RES, V18, P4008, DOI 10.1093/nar/18.13.4008; JADOT M, 1992, J BIOL CHEM, V267, P11069; JOHNSON KF, 1992, J BIOL CHEM, V267, P17110; Kasper D, 1996, J CELL BIOL, V134, P615, DOI 10.1083/jcb.134.3.615; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; LI M, 1990, ARCH BIOCHEM BIOPHYS, V283, P150, DOI 10.1016/0003-9861(90)90625-9; LOBEL P, 1989, CELL, V57, P787, DOI 10.1016/0092-8674(89)90793-9; LOBEL P, 1988, J BIOL CHEM, V263, P2563; MA ZM, 1992, J BIOL CHEM, V267, P19017; MunierLehmann H, 1996, BIOCHEM SOC T, V24, P133, DOI 10.1042/bst0240133; NOLAN CM, 1990, CELL REGUL, V1, P197, DOI 10.1091/mbc.1.2.197; PARK JE, 1991, SOMAT CELL MOLEC GEN, V17, P137, DOI 10.1007/BF01232971; PERDUE JF, 1983, J BIOL CHEM, V258, P7800; Roberts DL, 1998, CELL, V93, P639, DOI 10.1016/S0092-8674(00)81192-7; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHMIDT B, 1995, J BIOL CHEM, V270, P14975, DOI 10.1074/jbc.270.25.14975; SHIPLEY JM, 1993, J BIOL CHEM, V268, P12193; Sleat DE, 1997, J BIOL CHEM, V272, P731, DOI 10.1074/jbc.272.2.731; STEIN M, 1987, BIOL CHEM H-S, V368, P413, DOI 10.1515/bchm3.1987.368.1.413; STEIN M, 1987, BIOL CHEM H-S, V368, P937, DOI 10.1515/bchm3.1987.368.2.937; TAIT JF, 1981, J BIOL CHEM, V256, P1086; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; TONG PY, 1988, J BIOL CHEM, V263, P2585; TONG PY, 1989, J BIOL CHEM, V264, P7962; TONG PY, 1989, J BIOL CHEM, V264, P7970; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; WAHEED A, 1988, BIOCHEM BIOPH RES CO, V152, P1248, DOI 10.1016/S0006-291X(88)80419-4; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; WENDLAND M, 1991, J BIOL CHEM, V266, P2917; WENK J, 1991, BIOCHEM INT, V23, P723; WESTCOTT KR, 1987, J BIOL CHEM, V262, P6101; WESTLUND B, 1991, J BIOL CHEM, V266, P23233; WIGLER M, 1979, CELL, V16, P777, DOI 10.1016/0092-8674(79)90093-X	52	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22358	22366		10.1074/jbc.273.35.22358	http://dx.doi.org/10.1074/jbc.273.35.22358			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712856	hybrid			2022-12-27	WOS:000075616600032
J	Sellers, VM; Wang, KF; Johnson, MK; Dailey, HA				Sellers, VM; Wang, KF; Johnson, MK; Dailey, HA			Evidence that the fourth ligand to the [2Fe-2S] cluster in animal ferrochelatase is a cysteine - Characterization of the enzyme from Drosophila melanogaster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; HUMAN ERYTHROPOIETIC PROTOPORPHYRIA; IRON-SULFUR PROTEIN; MAMMALIAN FERROCHELATASE; ESCHERICHIA-COLI; IN-VIVO; BOVINE FERROCHELATASE; MOLECULAR DEFECT; LIVER-FAILURE; IDENTIFICATION	In a previous study, site-directed mutagenesis experiments identified three of the four ligands to the [2Fe-2S] cluster in animal ferrochelatase as conserved cysteines in the COOH terminal extension, Cys-403, Cys-406, and Cys-411 in human ferrochelatase (Crouse, B. R., Sellers, V. M., Finnegan, M. G., Dailey, H. A. & Johnson, M. K. (1996) Biochemistry 35, 16222-16229), The nature of the fourth ligand was left unresolved, and spectroscopic studies raised the possibility of one noncysteinyl, oxygenic ligand, In this work, we report two lines of evidence that strongly suggest the fourth ligand is a cysteine residue. Cysteine at position 196 in human recombinant ferrochelatase when changed to a serine results in an inactive enzyme that is lacking the [2Fe-2S] cluster. Furthermore, whole cell EPR studies demonstrate that in the C196S mutant the cluster fails to assemble. Additionally, the cloning and expression of Drosophila melanogaster ferrochelatase has allowed the identification, by EPR and UV-visible spectroscopy, of a [2Fe-2S](2+) cluster with properties analogous to those of animal ferrochelatases. The observation that Drosophila ferrochelatase contains only four conserved cysteines at positions 196, 403, 406, and 411, is in accord with the proposal that these residues function as cluster ligands, In the case of the ferrochelatase iron-sulfur cluster ligands, NH2-Cys-X-206-Cys-X-2-Cys-X-2-Cys-COOH, the position distant from other ligands may lead to a spatial positioning of the cluster near the enzyme active site or at the interface of two domains, thereby explaining the loss of enzyme activity that accompanies cluster degradation and reinforcing the idea that the cluster functions as a regulatory switch.	Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; Univ Georgia, Dept Chem, Athens, GA 30602 USA; Univ Georgia, Ctr Metalloenzyme Studies, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Dailey, HA (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	dailey@bscr.uga.edu			NIDDK NIH HHS [R56 DK032303, DK32303] Funding Source: Medline; NIGMS NIH HHS [GM51962] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK032303, R01DK032303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051962] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Al-Karadaghi S, 1997, STRUCTURE, V5, P1501, DOI 10.1016/S0969-2126(97)00299-2; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Blackwood ME, 1997, J AM CHEM SOC, V119, P12170, DOI 10.1021/ja971619c; BRENNER DA, 1991, P NATL ACAD SCI USA, V88, P849, DOI 10.1073/pnas.88.3.849; Crouse BR, 1996, BIOCHEMISTRY-US, V35, P16222, DOI 10.1021/bi9620114; Dailey HA, 1997, J BIOL INORG CHEM, V2, P411, DOI 10.1007/s007750050151; DAILEY HA, 1994, J BIOL CHEM, V269, P390; DAILEY HA, 1983, J BIOL CHEM, V258, P1453; DAILEY HA, 1994, BIOCHEMISTRY-US, V33, P403, DOI 10.1021/bi00168a003; DAILEY HA, 1996, MECH METALLOCENTER A, P77; Dailey TA, 1996, PROTEIN SCI, V5, P98; DAY AL, 1998, IN PRESS ARCH BIOCH; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; Ding HG, 1997, P NATL ACAD SCI USA, V94, P8445, DOI 10.1073/pnas.94.16.8445; DUNIN EC, 1997, BIOCHEMISTRY-US, V36, P11811; FERREIRA GC, 1994, J BIOL CHEM, V269, P7062; FIELD L, 1978, J CHEM SOC CHEM COMM, P249, DOI 10.1039/c39780000249; FRUSTACI JM, 1993, J BACTERIOL, V175, P2154, DOI 10.1128/JB.175.7.2154-2156.1993; Gaudu P, 1997, J BIOL CHEM, V272, P5082, DOI 10.1074/jbc.272.8.5082; Gora M, 1996, J BIOL CHEM, V271, P11810, DOI 10.1074/jbc.271.20.11810; JOHNSON MK, 1994, ENCY INORGANIC CHEM, P1896; Jordan PA, 1997, FEBS LETT, V416, P349, DOI 10.1016/S0014-5793(97)01219-2; Khoroshilova N, 1997, P NATL ACAD SCI USA, V94, P6087, DOI 10.1073/pnas.94.12.6087; KOHNO H, 1994, BBA-PROTEIN STRUCT M, V1209, P95, DOI 10.1016/0167-4838(94)90142-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUBARA H, 1992, ADV INORG CHEM, V38, P223, DOI 10.1016/S0898-8838(08)60065-3; MIYAMOTO K, 1991, J MOL BIOL, V219, P393, DOI 10.1016/0022-2836(91)90180-E; NAKAHASHI Y, 1992, P NATL ACAD SCI USA, V89, P281, DOI 10.1073/pnas.89.1.281; NAKAHASHI Y, 1993, HUM MOL GENET, V2, P1069, DOI 10.1093/hmg/2.7.1069; NAKAHASHI Y, 1993, HUM GENET, V91, P303; NAKAHIGASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P784; Rouault TA, 1996, J BIOL INORG CHEM, V1, P494, DOI 10.1007/s007750050083; SARKANY RPE, 1994, LANCET, V343, P1394, DOI 10.1016/S0140-6736(94)92525-9; SARKANY RPE, 1994, J INVEST DERMATOL, V102, P481, DOI 10.1111/1523-1747.ep12373073; SCHRODER I, 1991, J BIOL CHEM, V266, P13572; Sellers VM, 1996, BIOCHEMISTRY-US, V35, P2699, DOI 10.1021/bi952631p; Sellers VM, 1998, BLOOD, V91, P3980; Sellers VM, 1997, METHOD ENZYMOL, V281, P378; SHIBUYA H, 1995, BBA-BIOENERGETICS, V1231, P117, DOI 10.1016/0005-2728(95)00077-V; SMITH JL, 1994, SCIENCE, V264, P1427, DOI 10.1126/science.8197456; TAKETANI S, 1990, J BIOL CHEM, V265, P19377	41	41	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22311	22316		10.1074/jbc.273.35.22311	http://dx.doi.org/10.1074/jbc.273.35.22311			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712849	hybrid			2022-12-27	WOS:000075616600025
J	Wang, ZG; Benkovic, SJ				Wang, ZG; Benkovic, SJ			Purification, characterization, and kinetic studies of a soluble Bacteroides fragilis metallo-beta-lactamase that provides multiple antibiotic resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AEROMONAS-HYDROPHILA AE036; CLINICAL ISOLATE; GENE; IMIPENEM; CLONING; CCRA; CLASSIFICATION; MECHANISMS; REVEALS; TAL3636	Resistance to multiple beta-lactam antibiotics traced to the expression of Zn(II) requiring metallo-beta-lactamases has emerged in clinical isolates of several bacterial strains including Bacteroides fragilis, a pathogen commonly found in suppurative/surgical infections. A soluble B. fragilis metallo-beta-lactamase has been purified to homogeneity from the cell growth medium after expression as a secretory protein in Escherichia coli. The enzyme requires two tightly bound Zn(II) ions for full activity, and the Zn(II) ions can be removed by EDTA hom the enzyme. The apoenzyme is reactivated by stoichiometric amounts of Zn(II) and Co(II) ions. The Co(II)substituted enzyme exhibits a UV-visible spectrum characterized by strong Co(II) d-d transitions at 510, 548, 615, and 635 nm and an EPR spectrum with g values of 5.52, 4.25, and 2.01: features that serve as useful spectroscopic handles for the mechanistic studies of the enzyme. Although steady-state and transient-state kinetic studies of the soluble Zn(II) enzyme with nitrocefin as substrate found no ionizable groups with pK(a) values between 5.25 and 10.0 involved in catalysis, a kinetically significant proton transfer step in turnover was implicated by studies in deuterium oxide. These studies also detected the accumulation of an enzyme-bound intermediate and provide the basis for a minimal kinetic scheme describing metallo-beta-lactamase-catalyzed nitrocefin hydrolysis.	Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Benkovic, SJ (corresponding author), Penn State Univ, Dept Chem, 152 Davey Lab, University Pk, PA 16802 USA.	sjb1@psu.edu			NIGMS NIH HHS [GM18061] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM018061] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMBER RP, 1985, FEBS LETT, V189, P207; AULD DS, 1988, METHOD ENZYMOL, V158, P40; BALDWIN GS, 1978, BIOCHEM J, V175, P441, DOI 10.1042/bj1750441; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Bertini I, 1984, Adv Inorg Biochem, V6, P71; BROOK I, 1989, ANN CLIN LAB SCI, V19, P360; BUSH K, 1989, ANTIMICROB AGENTS CH, V33, P271, DOI 10.1128/AAC.33.3.271; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; CARFI A, 1995, EMBO J, V14, P4914, DOI 10.1002/j.1460-2075.1995.tb00174.x; Christianson DW, 1996, ACCOUNTS CHEM RES, V29, P331, DOI 10.1021/ar9501232; Concha NO, 1996, STRUCTURE, V4, P823, DOI 10.1016/S0969-2126(96)00089-5; Crowder MW, 1996, BIOCHEMISTRY-US, V35, P12126, DOI 10.1021/bi960976h; DAVIES RB, 1974, BIOCHEM J, V143, P129, DOI 10.1042/bj1430129; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; FERSHT A, 1984, ENZYME STRUCTURE MEC, P101; FRERE JM, 1995, MOL MICROBIOL, V16, P385, DOI 10.1111/j.1365-2958.1995.tb02404.x; FRERE JM, 1991, RES MICROBIOL, V142, P705, DOI 10.1016/0923-2508(91)90084-N; FRERE JM, 1995, BIOCHIM BIOPHYS ACTA, V1246, P109; HUSSAIN M, 1985, J BACTERIOL, V164, P223, DOI 10.1128/JB.164.1.223-229.1985; KNOWLES JR, 1985, ACCOUNTS CHEM RES, V18, P97, DOI 10.1021/ar00112a001; Lever A. B. P., 1984, INORGANIC ELECT SPEC; Lew J, 1997, BIOCHEMISTRY-US, V36, P6717, DOI 10.1021/bi963164u; Lipscomb WN, 1996, CHEM REV, V96, P2375, DOI 10.1021/cr950042j; MASSIDDA O, 1991, J BACTERIOL, V173, P4611, DOI 10.1128/jb.173.15.4611-4617.1991; OCALLAGHAN CH, 1972, ANTIMICROB AGENTS CH, V1, P283, DOI 10.1128/AAC.1.4.283; OSANO E, 1994, ANTIMICROB AGENTS CH, V38, P71, DOI 10.1128/AAC.38.1.71; PAGE MI, 1984, ACCOUNTS CHEM RES, V17, P144, DOI 10.1021/ar00100a005; PAYNE DJ, 1993, J MED MICROBIOL, V39, P93, DOI 10.1099/00222615-39-2-93; POSNER B, 1993, GENE, V128, P111, DOI 10.1016/0378-1119(93)90161-U; RASMUSSEN BA, 1990, ANTIMICROB AGENTS CH, V34, P1590, DOI 10.1128/AAC.34.8.1590; Rasmussen BA, 1997, ANTIMICROB AGENTS CH, V41, P223, DOI 10.1128/AAC.41.2.223; Rasmussen BA, 1993, CLIN INFECT DIS, V16, P390; SEGATORE B, 1993, ANTIMICROB AGENTS CH, V37, P1324, DOI 10.1128/AAC.37.6.1324; THOMPSON JS, 1990, J BACTERIOL, V172, P2584, DOI 10.1128/jb.172.5.2584-2593.1990; Toney JH, 1997, PROTEIN EXPRES PURIF, V9, P355, DOI 10.1006/prep.1996.0718; TURNER P, 1995, LANCET, V345, P1275, DOI 10.1016/S0140-6736(95)90927-3; Valladares MH, 1997, BIOCHEMISTRY-US, V36, P11534, DOI 10.1021/bi971056h; WALSH TR, 1994, BBA-GENE STRUCT EXPR, V1218, P199, DOI 10.1016/0167-4781(94)90011-6; YANG YJ, 1992, ANTIMICROB AGENTS CH, V36, P1155, DOI 10.1128/AAC.36.5.1155; [No title captured]	40	105	109	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22402	22408		10.1074/jbc.273.35.22402	http://dx.doi.org/10.1074/jbc.273.35.22402			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712862	hybrid			2022-12-27	WOS:000075616600038
J	Gee, SH; Sekely, SA; Lombardo, C; Kurakin, A; Froehner, SC; Kay, BK				Gee, SH; Sekely, SA; Lombardo, C; Kurakin, A; Froehner, SC; Kay, BK			Cyclic peptides as non-carboxyl-terminal ligands of syntrophin PDZ domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; DENSITY PROTEIN PSD-95; NMDA RECEPTOR SUBUNITS; BINDING CONSTANTS; GUANYLATE KINASES; SURFACE; IDENTIFICATION; RECOGNITION; LIBRARIES; DISPLAY	Syntrophins, a family of intracellular peripheral membrane proteins of the dystrophin-associated protein complex (DAPC), each contain a single PDZ domain. Syntrophin PDZ domains bind C-terminal peptide sequences with the consensus R/K-E-S/T-X-V-COOH, an interaction that mediates association of skeletal muscle sodium channels with the DAPC. Here, we have isolated cyclic peptide ligands for syntrophin PDZ domains from a library of combinatorial peptides displayed at the N terminus of protein III of bacteriophage M13, Affinity selection from a library of X(10)G peptides yielded ligands with the consensus X-(R/K)-E-T-C-L/M-A-G-X-Psi-C, where Psi represents any hydrophobic amino acid. These peptides contain residues (underlined) similar to the C-terminal consensus sequence for binding to syntrophin PDZ domains and bind to the same site on syntrophin PDZ domains as C-terminal peptides, but do not bind to other closely related PDZ domains. PDZ binding is dependent on the formation of an intramolecular disulfide bond ire the peptides, since treatment with dithiothreitol, or substitution of either of the two cysteines with alanines, eliminated this activity. Furthermore, amino acid replacements revealed that most residues in the phage-selected peptides are required for binding. Our results define a new mode of binding to PDZ domains and suggest that proteins containing similar conformationally constrained sequences may be ligands for PDZ domains.	Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA; Univ N Carolina, Dept Physiol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Macromol Interact Facil, Chapel Hill, NC 27599 USA	University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Kay, BK (corresponding author), Univ Wisconsin, Dept Pharmacol, 1300 Univ Ave, Madison, WI 53706 USA.							ADAMS ME, 1995, J BIOL CHEM, V270, P25859, DOI 10.1074/jbc.270.43.25859; Ahn AH, 1996, J BIOL CHEM, V271, P2724, DOI 10.1074/jbc.271.5.2724; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brenman JE, 1996, J NEUROSCI, V16, P7407; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cowburn D, 1996, STRUCTURE, V4, P1005, DOI 10.1016/S0969-2126(96)00106-2; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Gee SH, 1998, J NEUROSCI, V18, P128; Harrison SC, 1996, CELL, V86, P341, DOI 10.1016/S0092-8674(00)80105-1; ITOH M, 1993, J CELL BIOL, V121, P491, DOI 10.1083/jcb.121.3.491; KALININ NL, 1995, ANAL BIOCHEM, V228, P238, DOI 10.1006/abio.1995.1345; KENNEDY MB, 1995, TRENDS BIOCHEM SCI, V20, P350, DOI 10.1016/S0968-0004(00)89074-X; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; MORELOCK MM, 1995, J MED CHEM, V38, P1309, DOI 10.1021/jm00008a009; Myszka DG, 1996, PROTEIN SCI, V5, P2468, DOI 10.1002/pro.5560051209; Niethammer M, 1996, J NEUROSCI, V16, P2157; Oligino L, 1997, J BIOL CHEM, V272, P29046, DOI 10.1074/jbc.272.46.29046; PASQUALINI R, 1995, J CELL BIOL, V130, P1189, DOI 10.1083/jcb.130.5.1189; Pierce HH, 1996, MOL DIVERS, V1, P259, DOI 10.1007/BF01715530; Ponting CP, 1997, PROTEIN SCI, V6, P464; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Saras J, 1997, J BIOL CHEM, V272, P24333, DOI 10.1074/jbc.272.39.24333; Schultz J, 1998, NAT STRUCT BIOL, V5, P19, DOI 10.1038/nsb0198-19; Shieh BH, 1996, NEURON, V16, P991, DOI 10.1016/S0896-6273(00)80122-1; SMITH GP, 1993, GENE, V128, P1, DOI 10.1016/0378-1119(93)90145-S; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; SPARKS AB, 1994, J BIOL CHEM, V269, P23853; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; WOODS DF, 1993, MECH DEVELOP, V44, P85, DOI 10.1016/0925-4773(93)90059-7; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458; Xia HH, 1997, J CELL BIOL, V139, P507, DOI 10.1083/jcb.139.2.507; Yamabhai M, 1997, ANAL BIOCHEM, V247, P143, DOI 10.1006/abio.1997.2040; Yanagisawa J, 1997, J BIOL CHEM, V272, P8539, DOI 10.1074/jbc.272.13.8539	38	60	81	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21980	21987		10.1074/jbc.273.34.21980	http://dx.doi.org/10.1074/jbc.273.34.21980			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705339	hybrid, Green Published			2022-12-27	WOS:000075492600073
J	Muller-Weeks, S; Mastran, B; Caradonna, S				Muller-Weeks, S; Mastran, B; Caradonna, S			The nuclear isoform of the highly conserved human uracil-DNA glycosylase is an M-r 36,000 phosphoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; PROTEIN-KINASE; GENE; PURIFICATION; REPLICATION; SEQUENCE; BACTERIOPHAGE-PBS2; PHOSPHORYLATION; TRANSCRIPTION; SPECIFICITY	We have previously demonstrated that human cells contain multiple forms of uracil-DNA glycosylase (Caradonna, S, J,, Ladner, R., Hansbury, M,, Kosciuk, RI., Lynch, F,, and Muller, S, J, (1996) Exp, Cell Res. 222, 345-359), One of these is an M, 29,000 processed form of the highly conserved uracil-DNA glycosylase (UDG1) located in the mitochondria. The others are located in the nucleus and migrate as a group of at least three distinct bands within the 35,000-37,000 molecular weight range. In this report, we perform a detailed characterization of the M, 35,000-37,000 purified proteins. To accomplish this, uracil-DNA glycosylases were affinity purified from HeLa cell nuclear extracts. The proteins were separated by SDS-PAGE, and their identities were verified by renaturation and activity assays. The three protein bands were individually digested with cyanogen bromide, and the resulting peptide fragments were analyzed by direct amino acid sequencing. Peptide sequence, derived from each band, was identical and corresponded to a recently identified isoform of UDG1, This isoform (UDG1A) has a unique 44-amino acid N-terminal region and a C-terminal region that is identical to UDG1, To bean to study the signals required for nuclear targeting, the N-terminal regions of UDG1 and UDG1A were isolated and cloned into pEGFP-N2 to generate fusions with a redshifted variant of green fluorescent protein (GFP), When these constructs were transfected into NIH3T3 cells, UDG1/pEGFP was targeted to the mitochondria, and UDG1A/pEGFP was targeted to the nucleus, Further studies, using deletion mutants, demonstrate that the nuclear localization signal resides within the first 20 amino acids of UDG1A, To investigate the possibility that the heterogeneity observed on SDS-PAGE results from post-translational modification(s), the UDC/pEGFP fusion constructs were transfected into NIH3T3 cells, and the cells were metabolically labeled with [P-32]orthophosphate. Results from these experiments show that UDG1A is a phosphoprotein, Subsequent phosphoamino acid analysis revealed that UDG1A is phosphorylated on both serine and threonine residues. As a final characterization, RNase protection assays were performed to examine expression of each of these isoforms, These studies demonstrate that UDG1A is expressed in a wide variety of cell types and that message levels are elevated in transformed cells.	Univ Med & Dent New Jersey, Dept Biol Mol, SOM, Sch Osteopath Med, Stratford, NJ 08084 USA	Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center	Muller-Weeks, S (corresponding author), Univ Med & Dent New Jersey, Dept Biol Mol, SOM, Sch Osteopath Med, 2 Med Ctr Dr, Stratford, NJ 08084 USA.	muller@umdnj.edu	Caradonna, Salvatore/AFU-8514-2022	Caradonna, Salvatore/0000-0002-2104-581X	NCI NIH HHS [CA42605] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042605] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALVAREZ E, 1991, J BIOL CHEM, V266, P15277; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRAUER AW, 1984, ANAL BIOCHEM, V137, P134, DOI 10.1016/0003-2697(84)90359-2; Caradonna S, 1996, EXP CELL RES, V222, P345, DOI 10.1006/excr.1996.0044; CONE R, 1980, J BIOL CHEM, V255, P354; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOMENA JD, 1988, BIOCHEMISTRY-US, V27, P6742, DOI 10.1021/bi00418a015; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Gallinari P, 1996, NATURE, V383, P735, DOI 10.1038/383735a0; GLICK BS, 1992, TRENDS BIOCHEM SCI, V17, P453, DOI 10.1016/0968-0004(92)90487-T; Haug T, 1996, GENOMICS, V36, P408, DOI 10.1006/geno.1996.0485; ISAYA G, 1995, METHOD ENZYMOL, V248, P556; KARRAN P, 1981, BIOCHEMISTRY-US, V20, P6092, DOI 10.1021/bi00524a027; Krokan HE, 1997, BIOCHEM J, V325, P1; Lindahl T, 1979, Prog Nucleic Acid Res Mol Biol, V22, P135; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; MILLNS AK, 1994, VIROLOGY, V198, P504, DOI 10.1006/viro.1994.1061; MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2; MULLER SJ, 1991, BIOCHIM BIOPHYS ACTA, V1088, P197, DOI 10.1016/0167-4781(91)90055-Q; MULLER SJ, 1993, J BIOL CHEM, V268, P1310; MullerWeeks SJ, 1996, EXP CELL RES, V226, P346, DOI 10.1006/excr.1996.0235; Nagelhus TA, 1997, J BIOL CHEM, V272, P6561, DOI 10.1074/jbc.272.10.6561; Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750; OLSEN LC, 1989, EMBO J, V8, P3121, DOI 10.1002/j.1460-2075.1989.tb08464.x; PEREZ L, 1993, P NATL ACAD SCI USA, V90, P8113, DOI 10.1073/pnas.90.17.8113; Prichard MN, 1996, J VIROL, V70, P3018, DOI 10.1128/JVI.70.5.3018-3025.1996; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SLUPPHAUG G, 1993, NUCLEIC ACIDS RES, V21, P2579, DOI 10.1093/nar/21.11.2579; SMITH CWJ, 1989, ANNU REV GENET, V23, P527, DOI 10.1146/annurev.genet.23.1.527; STUART DT, 1993, J VIROL, V67, P2503, DOI 10.1128/JVI.67.5.2503-2512.1993; TAKAHASHI I, 1963, NATURE, V197, P794, DOI 10.1038/197794a0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350	34	27	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21909	21917		10.1074/jbc.273.34.21909	http://dx.doi.org/10.1074/jbc.273.34.21909			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705330	hybrid			2022-12-27	WOS:000075492600064
J	Bogdanov, VY; Poon, M; Taubman, MB				Bogdanov, VY; Poon, M; Taubman, MB			Platelet-derived growth factor-specific regulation of the JE promoter in rat aortic smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; MACROPHAGE INFLAMMATORY PROTEIN-2; HUMAN ENDOTHELIAL-CELLS; KINASE-C ACTIVATION; COMPETENCE GENE-JE; CHEMOTACTIC PROTEIN-1; MESSENGER-RNA; ATHEROSCLEROTIC LESIONS; FACTOR INDUCTION; TISSUE FACTOR	JE is a member of the family of "immediate early" genes induced by growth factors and cytokines, JE encodes a low molecular weight secretory glycoprotein analogous to the human monocyte chemoattractant protein, MCP-1, JE and MCP-1 proteins are thought to play an important role in inflammation and in the recruitment of monocyte/macrophages to the vessel wall during the development of atherosclerosis. We have previously reported that the induction of JE in rat aortic smooth muscle cells (SMC) was specific to platelet-derived growth factor (PDGF) and was not seen with other growth agonists, Using a luciferase reporter system and transient transfection assays of rat aortic SMC, we now report the identification of a region in the proximal rat JE promoter that is responsive to PDGF but not to other growth factors (angiotensin II and alpha-thrombin) or cytokines (interleukin 1-beta and tumor necrosis factor-alpha). The fall response to PDGF (similar to 6-fold) requires the cooperative activity of two potentially novel cis-acting elements, at positions -146 to -128 and -84 to -59. While each element produces a different pattern in electrophoretic mobility shift assays, they appear to bind the same PDGF-responsive species. Further analysis of these regions should provide important insights into PDGF-specific responses in vascular SMC.	CUNY Mt Sinai Sch Med, Cardiovasc Inst, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Brookdale Ctr Mol Biol, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Taubman, MB (corresponding author), CUNY Mt Sinai Sch Med, Cardiovasc Inst, New York, NY 10029 USA.	M_Taubman@smtplink.mssm.edu		Bogdanov, Vladimir/0000-0003-4968-1129	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043302] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL43302] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; BERK BC, 1989, HYPERTENSION, V13, P305, DOI 10.1161/01.HYP.13.4.305; BERNSTEIN KE, 1993, AM J KIDNEY DIS, V22, P745, DOI 10.1016/S0272-6386(12)80441-0; CUSHING SD, 1990, P NATL ACAD SCI USA, V87, P5134, DOI 10.1073/pnas.87.13.5134; DZAU VJ, 1994, J HYPERTENS, V12, pS3; FRETER RR, 1992, MOL CELL BIOL, V12, P5288, DOI 10.1128/MCB.12.12.5288; Freter RR, 1996, J BIOL CHEM, V271, P17417, DOI 10.1074/jbc.271.29.17417; FRETER RR, 1995, MOL CELL BIOL, V15, P315, DOI 10.1128/MCB.15.1.315; GEISTERFER AAT, 1989, HYPERTENSION, V14, P413, DOI 10.1161/01.HYP.14.4.413; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; GREEN RS, 1995, LAB INVEST, V73, P476; HALL DJ, 1989, J CELL PHYSIOL, V141, P154, DOI 10.1002/jcp.1041410123; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; HOLYCROSS BJ, 1993, J VASC RES, V30, P80, DOI 10.1159/000158979; HUANG S, 1992, AM J PATHOL, V141, P981; INTRONA M, 1987, J IMMUNOL, V138, P3891; LI YS, 1994, MOL CELL BIOCHEM, V141, P121, DOI 10.1007/BF00926175; LIBBY P, 1983, J CELL PHYSIOL, V115, P217, DOI 10.1002/jcp.1041150217; MARMUR JD, 1992, CIRCULATION, V86, P53; MARRA F, 1993, J CLIN INVEST, V92, P1674, DOI 10.1172/JCI116753; Naito S, 1998, AM J PHYSIOL-CELL PH, V274, pC472, DOI 10.1152/ajpcell.1998.274.2.C472; NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; OWENS GK, 1989, AM J PHYSIOL, V257, pH1755, DOI 10.1152/ajpheart.1989.257.6.H1755; PATTON WF, 1995, J BIOL CHEM, V270, P21404, DOI 10.1074/jbc.270.36.21404; Poon M, 1996, AM J PATHOL, V149, P307; ROLLINS BJ, 1991, CANCER CELL-MON REV, V3, P517; ROLLINS BJ, 1990, AM J PATHOL, V136, P1229; ROLLINS BJ, 1988, P NATL ACAD SCI USA, V85, P3738, DOI 10.1073/pnas.85.11.3738; ROSS R, 1986, CELL, V46, P155, DOI 10.1016/0092-8674(86)90733-6; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; ROTHMAN A, 1994, J BIOL CHEM, V269, P6399; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHWARTZ CJ, 1991, CLIN CARDIOL, V14, P1, DOI 10.1002/clc.4960141302; SCHWARTZ SM, 1990, PHYSIOL REV, V70, P1177, DOI 10.1152/physrev.1990.70.4.1177; SHYY YJ, 1990, BIOCHEM BIOPH RES CO, V169, P346, DOI 10.1016/0006-291X(90)90338-N; TAKESHITA A, 1995, J IMMUNOL, V155, P419; TAKEYA M, 1993, HUM PATHOL, V24, P534, DOI 10.1016/0046-8177(93)90166-E; TAUBMAN MB, 1993, J CLIN INVEST, V91, P547, DOI 10.1172/JCI116234; TAUBMAN MB, 1992, CIRC RES, V70, P314, DOI 10.1161/01.RES.70.2.314; TAUBMAN MB, 1989, J BIOL CHEM, V264, P526; TEKAMPOLSON P, 1990, J EXP MED, V172, P911, DOI 10.1084/jem.172.3.911; Thiruvikraman SV, 1996, LAB INVEST, V75, P451; TIMMERS HT, 1990, NUCLEIC ACIDS RES, V18, P23, DOI 10.1093/nar/18.1.23; Wilcox J N, 1992, J Vasc Surg, V15, P913; XIONG YM, 1991, IN VITRO CELL DEV B, V27, P355; YLAHERTTUALA S, 1991, P NATL ACAD SCI USA, V88, P5252, DOI 10.1073/pnas.88.12.5252; YOSHIMURA T, 1989, FEBS LETT, V244, P487, DOI 10.1016/0014-5793(89)80590-3; YU SF, 1990, J LEUKOCYTE BIOL, V48, P412, DOI 10.1002/jlb.48.5.412; YU XH, 1992, P NATL ACAD SCI USA, V89, P6953, DOI 10.1073/pnas.89.15.6953	50	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24932	24938		10.1074/jbc.273.38.24932	http://dx.doi.org/10.1074/jbc.273.38.24932			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733800	hybrid			2022-12-27	WOS:000076007300092
J	Nakamura, K; Krupnick, JC; Benovic, JL; Ascoli, M				Nakamura, K; Krupnick, JC; Benovic, JL; Ascoli, M			Signaling and phosphorylation-impaired mutants of the rat follitropin receptor reveal an activation- and phosphorylation-independent but arrestin-dependent pathway for internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; FOLLICLE-STIMULATING-HORMONE; MUSCARINIC ACETYLCHOLINE-RECEPTOR; NEPHROGENIC DIABETES-INSIPIDUS; LEYDIG TUMOR-CELLS; BETA(2)-ADRENERGIC RECEPTOR; BETA-ARRESTIN; MEDIATED ENDOCYTOSIS; ALPHA(2A)-ADRENERGIC RECEPTOR; INTRACELLULAR LOOP	We have previously shown that the rat follitropin receptor (rFSHR) expressed in transfected cells becomes phosphorylated upon stimulation of the cells with agonist or a phorbol ester, Peptide mapping and mutagenesis studies have also shown that the agonist- or phorbol ester-induced phosphorylation of the rFSHR maps to Ser/Thr residues present in the first and third intracellular loops. The experiments presented herein were initially designed to test for the presence of additional phosphorylation sites on the second intracellular loop of the rFSHR. Analysis of two new mutants in which the two threonines in the second intracellular loop (rFSHR-2L) or the two threonines in the second intracellular loop and the seven Ser/Thr residues in the third intracellular loop (rFSHR-2L + 3L) were mutated showed that one or more of the two threonines in the second intracellular loop are phosphorylated in response to phorbol ester, but not in response to agonist stimulation. Since rFSHR-2L and rFSHR-2L + 3L displayed a reduction in agonist-induced signaling, two additional mutants (rFSHR-D389N and rFSHR-Y530F) were constructed in an attempt to better understand the relationship between the agonist-induced activation, phosphorylation, and internalization of the rFSHR, These point mutations impaired agonist-stimulated signal transduction and abolished agonist-induced phosphorylation, Co-transfection studies revealed that the phosphorylation of these mutants can be rescued by overexpression of G protein-coupled receptor kinase 2, but this increased phosphorylation only rescues the internalization of rFSHR-D389N, The internalization of both mutants could be rescued by overexpression of arrestin-3, however, Taken together, these results argue that the agonist-induced activation and phosphorylation of the rFSHR are not essential for internalization. while the interaction of the rFSHR with a nonvisual arrestin is essential for internalization.	Univ Iowa, Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA; Thomas Jefferson Univ, Kimmel Canc Inst, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA	University of Iowa; Jefferson University	Ascoli, M (corresponding author), Univ Iowa, Coll Med, Dept Pharmacol, 2-512 BSB, Iowa City, IA 52242 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047417, R37GM047417] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-28962] Funding Source: Medline; NIDDK NIH HHS [DK-25295] Funding Source: Medline; NIGMS NIH HHS [GM-47417] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARORA KK, 1995, J BIOL CHEM, V270, P22820, DOI 10.1074/jbc.270.39.22820; ASCOLI M, 1982, J BIOL CHEM, V257, P13306; ASCOLI M, 1978, P NATL ACAD SCI USA, V75, P99, DOI 10.1073/pnas.75.1.99; BARAK LS, 1994, J BIOL CHEM, V269, P2790; BARAK LS, 1995, BIOCHEMISTRY-US, V34, P15407, DOI 10.1021/bi00047a003; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; CERESA BP, 1994, J BIOL CHEM, V269, P29557; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; Dhanwada KR, 1996, MOL ENDOCRINOL, V10, P544, DOI 10.1210/me.10.5.544; DONOSO LA, 1990, CURR EYE RES, V9, P343, DOI 10.3109/02713689008999622; EASON MG, 1995, J BIOL CHEM, V270, P4681, DOI 10.1074/jbc.270.9.4681; Ferguson SSG, 1996, BIOCHEM SOC T, V24, P953, DOI 10.1042/bst0240953; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Ferguson SSG, 1997, NEWS PHYSIOL SCI, V12, P145; FLETCHER PW, 1984, MOL CELL ENDOCRINOL, V34, P39, DOI 10.1016/0303-7207(84)90157-6; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; HIPKIN RW, 1995, J BIOL CHEM, V270, P26683, DOI 10.1074/jbc.270.44.26683; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HUNYADY L, 1995, J BIOL CHEM, V270, P9702, DOI 10.1074/jbc.270.17.9702; IidaKlein A, 1997, J BIOL CHEM, V272, P6882, DOI 10.1074/jbc.272.11.6882; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Menard L, 1997, MOL PHARMACOL, V51, P800, DOI 10.1124/mol.51.5.800; Nakamura K, 1998, MOL ENDOCRINOL, V12, P580, DOI 10.1210/me.12.4.580; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P14152, DOI 10.1074/jbc.272.22.14152; PALSRYLAARSDAM R, 1995, J BIOL CHEM, V270, P29004, DOI 10.1074/jbc.270.48.29004; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P23682, DOI 10.1074/jbc.272.38.23682; PREMONT RT, 1995, FASEB J, V9, P175, DOI 10.1096/fasebj.9.2.7781920; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; QUINTANA J, 1993, ENDOCRINOLOGY, V133, P2098, DOI 10.1210/en.133.5.2098; QUINTANA J, 1993, MOL ENDOCRINOL, V7, P767, DOI 10.1210/me.7.6.767; QUINTANA J, 1994, J BIOL CHEM, V269, P8772; ROSENTHAL W, 1993, J BIOL CHEM, V268, P13030; Sadeghi H, 1997, MOL ENDOCRINOL, V11, P1806, DOI 10.1210/me.11.12.1806; Simoni M, 1997, ENDOCR REV, V18, P739, DOI 10.1210/er.18.6.739; SPRENGEL R, 1990, MOL ENDOCRINOL, V4, P525, DOI 10.1210/mend-4-4-525; STERNEMARR R, 1993, J BIOL CHEM, V268, P15640; STRADER CD, 1995, FASEB J, V9, P745, DOI 10.1096/fasebj.9.9.7601339; WILEY HS, 1982, J BIOL CHEM, V257, P4222; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	42	59	63	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24346	24354		10.1074/jbc.273.38.24346	http://dx.doi.org/10.1074/jbc.273.38.24346			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733722	hybrid			2022-12-27	WOS:000076007300014
J	Ritzi, M; Baack, M; Musahl, C; Romanowski, P; Laskey, RA; Knippers, R				Ritzi, M; Baack, M; Musahl, C; Romanowski, P; Laskey, RA; Knippers, R			Human minichromosome maintenance proteins and human origin recognition complex 2 protein oil chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION LICENSING SYSTEM; DNA-REPLICATION; MCM-PROTEINS; S-PHASE; YEAST; XENOPUS; BINDING; FAMILY; CELLS; INITIATION	Minichromosome maintenance (Mcm) proteins and the constituents of the origin recognition complex (Orc) are essential components of the eukaryotic replication initiation apparatus. Published evidence strongly suggests that the binding of Mcm proteins to chromatin is contingent upon the prior binding of Ore proteins. Here we use two different approaches to investigate the presence of the human ORC2 protein and of Mcm proteins on chromatin of HeLa cells in various cell cycle phases. First, we mobilized chromatin-bound proteins by micrococcal nuclease and analyzed the resulting digestion products by sucrose gradient centrifugations. Under digestion conditions when Mcm proteins were almost entirely released from chromatin, ORC2 protein was found to be associated with chromatin fragments containing several hundred base pairs of DNA. Second, we used an in vivo cross-linking procedure to covalently link Mcm proteins and ORC2 to DNA by short exposure of intact HeLa cells to formaldehyde. Specific immunoprecipitations revealed that cross-linked nucleoprotein fragments carried either Mcm proteins or ORC2 protein, but not both. Based on the lengths of the DNA fragments in immunoprecipitates, we estimate that the distance between chromatin-bound ORC2 protein and chromatin-bound Mcm proteins must be at least 500-1000 base pairs in HeLa cells.	Univ Konstanz, Dept Biol, D-78457 Constance, Germany; Wellcome CRC Inst, Cambridge CB2 1QR, England	University of Konstanz	Knippers, R (corresponding author), Univ Konstanz, Dept Biol, D-78457 Constance, Germany.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; BURKHART R, 1995, EUR J BIOCHEM, V228, P431; Chong JPJ, 1996, TRENDS BIOCHEM SCI, V21, P102, DOI 10.1016/0968-0004(96)10013-X; CHONG JPJ, 1995, NATURE, V375, P418, DOI 10.1038/375418a0; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; COVERLEY D, 1994, ANNU REV BIOCHEM, V63, P745, DOI 10.1146/annurev.bi.63.070194.003525; DIFFLEY JFX, 1992, NATURE, V357, P169, DOI 10.1038/357169a0; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; GAVIN KA, 1995, SCIENCE, V270, P1667, DOI 10.1126/science.270.5242.1667; Gohring F, 1997, EMBO J, V16, P7361, DOI 10.1093/emboj/16.24.7361; Gohring F, 1997, BIOCHEMISTRY-US, V36, P8276, DOI 10.1021/bi970480f; HANCOCK R, 1974, J MOL BIOL, V86, P649, DOI 10.1016/0022-2836(74)90187-9; Holthoff HP, 1998, J BIOL CHEM, V273, P7320, DOI 10.1074/jbc.273.13.7320; Hopwood B, 1996, P NATL ACAD SCI USA, V93, P12309, DOI 10.1073/pnas.93.22.12309; HU B, 1993, NUCLEIC ACIDS RES, V21, P5289, DOI 10.1093/nar/21.23.5289-a; Hua XQH, 1998, J CELL BIOL, V140, P271, DOI 10.1083/jcb.140.2.271; Ishimi Y, 1996, J BIOL CHEM, V271, P24115, DOI 10.1074/jbc.271.39.24115; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Johnson R. T., 1993, CELL CYCLE PRACTICAL, P1; Kearsey SE, 1996, BIOESSAYS, V18, P183, DOI 10.1002/bies.950180305; Kimura H, 1996, GENES CELLS, V1, P977, DOI 10.1046/j.1365-2443.1996.840284.x; KIMURA H, 1994, EMBO J, V13, P4311, DOI 10.1002/j.1460-2075.1994.tb06751.x; Klemm RD, 1997, CELL, V88, P493, DOI 10.1016/S0092-8674(00)81889-9; KRUDE T, 1991, MOL CELL BIOL, V11, P6257, DOI 10.1128/MCB.11.12.6257; Krude T, 1996, J CELL SCI, V109, P309; KUBOTA Y, 1995, CELL, V81, P601, DOI 10.1016/0092-8674(95)90081-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; MADINE MA, 1995, NATURE, V375, P421, DOI 10.1038/375421a0; MADINE MA, 1995, CURR BIOL, V5, P1270, DOI 10.1016/S0960-9822(95)00253-3; MUSAHL C, 1995, EUR J BIOCHEM, V230, P1096, DOI 10.1111/j.1432-1033.1995.tb20660.x; Newlon CS, 1997, CELL, V91, P717, DOI 10.1016/S0092-8674(00)80459-6; OHYASHIKI JH, 1988, CANCER GENET CYTOGEN, V34, P159, DOI 10.1016/0165-4608(88)90255-5; Richter A, 1997, EUR J BIOCHEM, V247, P136, DOI 10.1111/j.1432-1033.1997.00136.x; Romanowski P, 1996, CURR BIOL, V6, P1416, DOI 10.1016/S0960-9822(96)00746-4; Rowles A, 1996, CELL, V87, P287, DOI 10.1016/S0092-8674(00)81346-X; Schulte D, 1996, EUR J BIOCHEM, V235, P144, DOI 10.1111/j.1432-1033.1996.00144.x; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; TODOROV IT, 1995, J CELL BIOL, V129, P1433, DOI 10.1083/jcb.129.6.1433; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsuruga H, 1997, GENES CELLS, V2, P381, DOI 10.1046/j.1365-2443.1997.1290327.x; Tye Bik-Kwoon, 1994, Trends in Cell Biology, V4, P160, DOI 10.1016/0962-8924(94)90200-3; van Holde K.E., 1988, CHROMATIN; Zou L, 1997, MOL CELL BIOL, V17, P553, DOI 10.1128/MCB.17.2.553	46	96	97	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24543	24549		10.1074/jbc.273.38.24543	http://dx.doi.org/10.1074/jbc.273.38.24543			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733749	hybrid			2022-12-27	WOS:000076007300041
J	de Moissac, D; Mustapha, S; Greenberg, AH; Kirshenbaum, LA				de Moissac, D; Mustapha, S; Greenberg, AH; Kirshenbaum, LA			Bcl-2 activates the transcription factor NF kappa B through the degradation of the cytoplasmic inhibitor I kappa B alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; TUMOR-NECROSIS-FACTOR; CARDIAC GENE-TRANSCRIPTION; VENTRICULAR MYOCYTES; DNA-BINDING; CYCLE PROGRESSION; INDUCED APOPTOSIS; KINASE RAF-1; P65 SUBUNIT; T-CELLS	Nuclear factor kappa B (NF kappa B) is a ubiquitously expressed transcription factor that is regulated by the cytoplasmic inhibitor protein I kappa B alpha. Biological agents such as tumor necrosis factor alpha (TNF alpha), which activate NF kappa B, result in the rapid degradation of I kappa B alpha Adenoviral-mediated gene transfer of Bcl-2 prevents apoptosis of neonatal ventricular myocytes induced by TMF alpha, In view of the growing evidence that NF kappa B may play an important role in regulating apoptosis, we determined whether TNF alpha! and Bcl-2 could modulate the activity of NF kappa B in ventricular myocytes. Stimulation of myocytes with TNFa: resulted in a 2.1-fold increase (p < 0.001) in NF kappa B-dependent gene transcription and nuclear DNA binding Similarly, a 1.9-fold increase (p < 0.0002) ire NF kappa B-dependent gene transcription was observed in myocytes expressing Bcl-2. Nuclear DNA binding activity of NF kappa B was significantly increased in myocytes expressing Bcl-2, with a concomitant reduction in I kappa B alpha protein level. The BcI-2-mediated loss of I kappa B alpha could be prevented by the proteasome inhibitor lactacystin, consistent with the notion that the targeted degradation of I kappa B alpha consequent to overexpression of BcI-2 utilizes the ubiquitin-proteasome pathway. This was further tested in human 293 cells in which the N-terminal region of I kappa B alpha was identified to be an important regulatory site for Bcl-2. Deletion of this region or a serine to alanine substitution mutant at amino acids 32 and 36, which are defective for both phosphorylation and degradation were more resistant than wild type I kappa B alpha to the inhibitory effects of Bcl-2. To our knowledge, this provides the first evidence for the regulation of I kappa B alpha by Eel-2 and suggests a link between Eel-2 and the NF kappa B signaling pathway in the suppression of apoptosis.	St Boniface Gen Hosp, Res Ctr, Inst Cardiovasc Sci, Winnipeg, MB R2H 2A6, Canada; Univ Manitoba, Fac Med, Dept Physiol, Winnipeg, MB R2H 2A6, Canada; Univ Manitoba, Fac Med, Manitoba Inst Cell Biol, Winnipeg, MB R2H 2A6, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; University of Manitoba	Kirshenbaum, LA (corresponding author), St Boniface Gen Hosp, Res Ctr, Inst Cardiovasc Sci, Rm 3042,351 Tache Ave, Winnipeg, MB R2H 2A6, Canada.	Lorrie@SBRC.umanitoba.ca	Kirshenbaum, Lorrie A./F-5742-2014					Agah R, 1997, J CLIN INVEST, V100, P2722, DOI 10.1172/JCI119817; BAEUERLE PA, 1989, GENE DEV, V3, P1689, DOI 10.1101/gad.3.11.1689; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BALLARD DW, 1984, J BIOL CHEM, V259, P3492; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; BEG AA, 1992, GENE DEV, V6, P1899, DOI 10.1101/gad.6.10.1899; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; Bellas RE, 1997, AM J PATHOL, V151, P891; BLANK V, 1992, TRENDS BIOCHEM SCI, V17, P135, DOI 10.1016/0968-0004(92)90321-Y; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; GRILLI M, 1993, INT REV CYTOL, V143, P1; GRIMM S, 1993, BIOCHEM J, V290, P297, DOI 10.1042/bj2900297; HANSEN SK, 1992, EMBO J, V11, P205, DOI 10.1002/j.1460-2075.1992.tb05043.x; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; INOUE JI, 1992, P NATL ACAD SCI USA, V89, P4333, DOI 10.1073/pnas.89.10.4333; ISNER JM, 1995, CIRCULATION, V91, P2703, DOI 10.1161/01.CIR.91.11.2703; IVANOV VN, 1995, INT IMMUNOL, V7, P1709, DOI 10.1093/intimm/7.11.1709; KIRSHENBAUM LA, 1995, J BIOL CHEM, V270, P7791, DOI 10.1074/jbc.270.14.7791; Kirshenbaum LA, 1996, DEV BIOL, V179, P402, DOI 10.1006/dbio.1996.0270; Kirshenbaum LA, 1997, CIRCULATION, V96, P1580, DOI 10.1161/01.CIR.96.5.1580; KRASNOW SW, 1991, CYTOKINE, V3, P372, DOI 10.1016/1043-4666(91)90040-K; KRISHENBAUM LA, 1993, J CLIN INVEST, V92, P381, DOI 10.1172/JCI116577; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; LIN KI, 1995, J CELL BIOL, V131, P1149, DOI 10.1083/jcb.131.5.1149; Linette GP, 1996, P NATL ACAD SCI USA, V93, P9545, DOI 10.1073/pnas.93.18.9545; McKinsey TA, 1996, MOL CELL BIOL, V16, P2083; NOLAN GP, 1991, CELL, V64, P961, DOI 10.1016/0092-8674(91)90320-X; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; RIVIERE Y, 1991, NATURE, V350, P625, DOI 10.1038/350625a0; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Shibasaki F, 1997, NATURE, V386, P728, DOI 10.1038/386728a0; SUBRAMANIAN T, 1995, CELL GROWTH DIFFER, V6, P131; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; TANAKA M, 1994, CIRC RES, V75, P426, DOI 10.1161/01.RES.75.3.426; URBAN MB, 1991, NEW BIOL, V3, P279; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Wahl C, 1998, J CLIN INVEST, V101, P1163, DOI 10.1172/JCI992; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang HG, 1996, P NATL ACAD SCI USA, V93, P7063, DOI 10.1073/pnas.93.14.7063; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; WHITE E, 1992, MOL CELL BIOL, V12, P2570, DOI 10.1128/MCB.12.6.2570; WILLIAMS RS, 1993, AM J MED SCI, V306, P129, DOI 10.1097/00000441-199308000-00013; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Wu M, 1996, EMBO J, V15, P4682, DOI 10.1002/j.1460-2075.1996.tb00845.x; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0	47	111	111	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23946	23951		10.1074/jbc.273.37.23946	http://dx.doi.org/10.1074/jbc.273.37.23946			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727009	hybrid			2022-12-27	WOS:000075893100050
J	Mao, PL; Jiang, YL; Wee, BY; Porter, AG				Mao, PL; Jiang, YL; Wee, BY; Porter, AG			Activation of caspase-1 in the nucleus requires nuclear translocation of pro-caspase-1 mediated by its prodomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; TROPHIC FACTOR WITHDRAWAL; FACTOR-INDUCED APOPTOSIS; CELL-DEATH; PROTEIN; EXPRESSION; ICE; LOCALIZATION; PRECURSOR; PATHWAY	The interleukin-1 beta-converting enzyme-like protease precursor, pro-caspase-1, has an N-terminal prodomain that is removed during cleavage activation of the protease. Here we show that tumor necrosis factor treatment of HeLa cells induced apoptosis without detectable proteolytic activation of caspase-1 in the cytosol. Instead, tumor necrosis factor induced the translocation of procaspase-1 to the nucleus where it was proteolytically activated, releasing the intact prodomain. We identified a nuclear localization signal in the prodomain, which was required for translocation of both pro-caspase-1 as well as its prodomain to the nucleus. Surprisingly, transfected MCF-7 carcinoma or embryonic kidney 293T cells expressing the prodomain alone underwent apoptosis. These results show that death signal-induced nuclear targeting is a novel activity of a caspase prodomain and indicate that caspase-1 and its prodomain may have hitherto unsuspected nuclear functions in apoptosis.	Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117609, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Porter, AG (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, 30 Med Dr, Singapore 117609, Singapore.							Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366; Chandler JM, 1998, J BIOL CHEM, V273, P10815, DOI 10.1074/jbc.273.18.10815; Chin YE, 1997, MOL CELL BIOL, V17, P5328, DOI 10.1128/MCB.17.9.5328; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Duan HJ, 1996, J BIOL CHEM, V271, P1621, DOI 10.1074/jbc.271.3.1621; Friedlander RM, 1996, J EXP MED, V184, P717, DOI 10.1084/jem.184.2.717; Friedlander RM, 1997, J EXP MED, V185, P933, DOI 10.1084/jem.185.5.933; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; GU Y, 1995, EMBO J, V14, P1923, DOI 10.1002/j.1460-2075.1995.tb07184.x; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Han DKM, 1997, P NATL ACAD SCI USA, V94, P11333, DOI 10.1073/pnas.94.21.11333; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; JANICKE RU, 1994, MOL CELL BIOL, V14, P5661; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; MAIER JAM, 1994, MOL CELL BIOL, V14, P1845, DOI 10.1128/MCB.14.3.1845; MAO PL, 1993, J BIOL CHEM, V268, P8131; MIURA M, 1995, P NATL ACAD SCI USA, V92, P8318, DOI 10.1073/pnas.92.18.8318; Nakagawara A, 1997, CANCER RES, V57, P4578; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Troy CM, 1996, P NATL ACAD SCI USA, V93, P5635, DOI 10.1073/pnas.93.11.5635; VanCriekinge W, 1996, J BIOL CHEM, V271, P27245, DOI 10.1074/jbc.271.44.27245; WESSENDORF JHM, 1993, J BIOL CHEM, V268, P22100; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273; Yang XL, 1998, MOL CELL, V1, P319, DOI 10.1016/S1097-2765(00)80032-5	26	71	73	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23621	23624		10.1074/jbc.273.37.23621	http://dx.doi.org/10.1074/jbc.273.37.23621			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726961	hybrid			2022-12-27	WOS:000075893100002
J	Scott, DK; O'Doherty, RM; Stafford, JM; Newgard, CB; Granner, DK				Scott, DK; O'Doherty, RM; Stafford, JM; Newgard, CB; Granner, DK			The repression of hormone-activated PEPCK gene expression by glucose is insulin-independent but requires glucose metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOENOLPYRUVATE-CARBOXYKINASE GENE; PYRUVATE-KINASE GENE; UPSTREAM STIMULATORY FACTOR; ACID RESPONSE ELEMENT; CARBOHYDRATE REGULATION; MESSENGER-RNA; MAMMALIAN GLUCOKINASE; RAT HEPATOCYTES; TRANSGENIC MICE; PRIMARY CULTURE	Phosphoenolpyruvate carboxykinase (PEPCK) is a rate-controlling enzyme in hepatic gluconeogenesis, and it therefore plays a central role in glucose homeostasis, The rate of transcription of the PEPCK gene is increased by glucagon (via cAMP) and glucocorticoids and is inhibited by insulin. Under certain circumstances glucose also decreases PEPCK gene expression, but the mechanism of this effect is poorly understood. The glucose-mediated stimulation of a number of glycolytic and lipogenic genes requires the expression of glucokinase (GK) and increased glucose metabolism. HL1C rat hepatoma cells are a stably transfected line of H4IIE rat hepatoma cells that express a PEPCK promoter-chloramphenicol acetyltransferase fusion gene that is regulated in the same manner as the endogenous PEPCK gene. These cells do not express GK and do not normally exhibit a response of either the endogenous PEPCK gene, or of the trans-gene, to glucose. A recombinant adenovirus that directs the expression of glucokinase (AdCMV-GK) was used to increase glucose metabolism in HL1C cells to test whether increased glucose flux is also required for the repression of PEPCK gene expression. In AdCMV-GK-treated cells glucose strongly inhibits hormone-activated transcription of the endogenous PEPCK gene and of the expressed fusion gene. The glucose effect on PEPCK gene promoter activity is blocked by 5 mM mannoheptulose, a specific inhibitor of GR activity. The glucose analog, 8-deoxyglucose mimics the glucose response, but this effect does not require GK expression. 3-O-methylglucose is ineffective. Glucose exerts its effect on the PEPCK gene within 4 h, at physiologic concentrations, and with an EC50 of 6.5 mm, which approximates the K-m of glucokinase. The effects of glucose and insulin on PEPCK gene expression are additive, but only at suboptimal concentrations of both agents. The results of these studies demonstrate that, by inhibiting PEPCK gene transcription, glucose participates in a feedback control loop that governs its production from gluconeogenesis.	Vanderbilt Univ, Sch Med, Dept Physiol & Mol Biophys, Nashville, TN 37232 USA; Univ Texas, SW Med Ctr, Gifford Labs Diabet Res, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75235 USA	Vanderbilt University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Granner, DK (corresponding author), Vanderbilt Univ, Sch Med, Dept Physiol & Mol Biophys, 221 Kirkland Hall, Nashville, TN 37232 USA.		Stafford, John/K-7763-2017	Stafford, John/0000-0001-6527-959X	NIDDK NIH HHS [DK35107] Funding Source: Medline; PHS HHS [P50H2598801] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK035107, R01DK035107] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEALE EG, 1985, J BIOL CHEM, V260, P748; Beato M, 1996, ENDOCR REV, V17, P587, DOI 10.1210/er.17.6.587; Becker TC, 1996, J BIOL CHEM, V271, P390, DOI 10.1074/jbc.271.1.390; COLOSIA AD, 1988, J BIOL CHEM, V263, P18669; DECAUX JF, 1989, J BIOL CHEM, V264, P11584; DOIRON B, 1994, J BIOL CHEM, V269, P10213; Doiron B, 1996, J BIOL CHEM, V271, P5321, DOI 10.1074/jbc.271.10.5321; DUPRIEX VJ, 1997, DNA CELL BIOL, V9, P1075; Ferre T, 1996, FASEB J, V10, P1213, DOI 10.1096/fasebj.10.10.8751724; Ferre T, 1996, P NATL ACAD SCI USA, V93, P7225, DOI 10.1073/pnas.93.14.7225; FOREST CD, 1990, MOL ENDOCRINOL, V4, P1302, DOI 10.1210/mend-4-9-1302; Girard J, 1997, ANNU REV NUTR, V17, P325, DOI 10.1146/annurev.nutr.17.1.325; GRANNER D, 1990, J BIOL CHEM, V265, P10173; GRANNER DK, 1986, RECENT PROG HORM RES, V42, P111; GUERRA MJMD, 1993, MOL CELL BIOL, V13, P7725, DOI 10.1128/MCB.13.12.7725; HALL RK, 1992, MOL CELL BIOL, V12, P5527, DOI 10.1128/MCB.12.12.5527; Hanson R W, 1994, Adv Enzymol Relat Areas Mol Biol, V69, P203; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; HERZ J, 1993, P NATL ACAD SCI USA, V90, P2812, DOI 10.1073/pnas.90.7.2812; HUGHES SD, 1993, J BIOL CHEM, V268, P15205; IMAI E, 1993, J BIOL CHEM, V268, P5353; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; IYNEDJIAN PB, 1993, BIOCHEM J, V293, P1; KAHN CR, 1989, MOL ENDOCRINOL, V3, P840, DOI 10.1210/mend-3-5-840; Kaytor EN, 1997, J BIOL CHEM, V272, P7525, DOI 10.1074/jbc.272.11.7525; LEFRANCOISMARTINEZ AM, 1995, J BIOL CHEM, V270, P2640, DOI 10.1074/jbc.270.6.2640; LIU JS, 1991, J BIOL CHEM, V266, P19095; LIU ZR, 1993, J BIOL CHEM, V268, P12787; MEYER S, 1991, EUR J BIOCHEM, V202, P985, DOI 10.1111/j.1432-1033.1991.tb16460.x; Mitanchez D, 1997, ENDOCR REV, V18, P520, DOI 10.1210/er.18.4.520; MITCHELL RA, 1971, BIOCHEMISTRY-US, V10, P2049, DOI 10.1021/bi00787a013; NORDEEN SK, 1987, DNA-J MOLEC CELL BIO, V6, P173, DOI 10.1089/dna.1987.6.173; NUDEL U, 1983, NUCLEIC ACIDS RES, V11, P1759, DOI 10.1093/nar/11.6.1759; OBRIEN RM, 1990, SCIENCE, V249, P533, DOI 10.1126/science.2166335; ODoherty RM, 1996, J BIOL CHEM, V271, P20524, DOI 10.1074/jbc.271.34.20524; PETERSEN DD, 1988, MOL CELL BIOL, V8, P96, DOI 10.1128/MCB.8.1.96; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; PRINTZ RL, 1993, ANNU REV NUTR, V13, P463, DOI 10.1146/annurev.nu.13.070193.002335; PRIPBUUS C, 1995, EUR J BIOCHEM, V230, P309, DOI 10.1111/j.1432-1033.1995.tb20564.x; ROSELLA G, 1995, MOL ENDOCRINOL, V9, P1396, DOI 10.1210/me.9.10.1396; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SASAKI K, 1984, J BIOL CHEM, V259, P5242; Scott DK, 1996, J BIOL CHEM, V271, P6260, DOI 10.1074/jbc.271.11.6260; Scott DK, 1996, J BIOL CHEM, V271, P31909, DOI 10.1074/jbc.271.50.31909; SHIH HM, 1995, J BIOL CHEM, V270, P21991, DOI 10.1074/jbc.270.37.21991; Sutherland C, 1997, DIABETES, V46, P17, DOI 10.2337/diabetes.46.1.17; SUTHERLAND C, 1995, J BIOL CHEM, V270, P15501, DOI 10.1074/jbc.270.26.15501; Towle HC, 1997, ANNU REV NUTR, V17, P405, DOI 10.1146/annurev.nutr.17.1.405; TOWLE HC, 1995, J BIOL CHEM, V270, P23235, DOI 10.1074/jbc.270.40.23235; VALERA A, 1994, EUR J BIOCHEM, V222, P533, DOI 10.1111/j.1432-1033.1994.tb18895.x; VALERA A, 1994, P NATL ACAD SCI USA, V91, P9151, DOI 10.1073/pnas.91.19.9151; Vallet VS, 1997, J BIOL CHEM, V272, P21944, DOI 10.1074/jbc.272.35.21944; VAULONT S, 1994, FASEB J, V8, P28, DOI 10.1096/fasebj.8.1.8299888; Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6; XU LZ, 1994, J BIOL CHEM, V269, P27458	55	89	93	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24145	24151		10.1074/jbc.273.37.24145	http://dx.doi.org/10.1074/jbc.273.37.24145			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727036	hybrid			2022-12-27	WOS:000075893100077
J	Sunder-Plassmann, R; Reinherz, EL				Sunder-Plassmann, R; Reinherz, EL			A p56(lck)-independent pathway of CD2 signaling involves Jun kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL ACTIVATION; PROTEIN-TYROSINE KINASES; NATURAL-KILLER-CELLS; LYMPHOCYTE-T; ANTIGEN RECEPTOR; CYTOPLASMIC DOMAIN; INTERLEUKIN-2 GENE; C-JUN; TRANSCRIPTION FACTORS; INOSITOL PHOSPHATES	The p56(lck) Src family non-receptor tyrosine kinase has been shown to be critical for T lymphocyte differentiation and activation. Hence in the absence of p56(lck), T cell receptor triggered activation does not occur. We now provide evidence for a CD2-based signaling pathway which, in contrast to that of the T cell receptor, is independent of p56(lck). CD2-mediated interleukin-a production occurs via activation of Jun kinase in cell lines lacking p56(lck). Jun kinase then facilitates the binding of c-Jun/c-Fos heterodimers to the AP-1 consensus site and the subsequent transcriptional activity of the interleukin-a promoter. These data elucidate differences between TCR and CD2 signaling pathways in the same T cells.	Dana Farber Canc Inst, Immunobiol Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Reinherz, EL (corresponding author), Dana Farber Canc Inst, Immunobiol Lab, 44 Binney St, Boston, MA 02115 USA.	ellis_reinherz@dfci.harvard.edu		Sunder-Plassmann, Raute/0000-0002-8297-118X	NIAID NIH HHS [AI19807, AI21226] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI019807, R56AI019807, R01AI021226, R01AI019807] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALCOVER A, 1988, EMBO J, V7, P1973, DOI 10.1002/j.1460-2075.1988.tb03035.x; ALCOVER A, 1986, P NATL ACAD SCI USA, V83, P2614, DOI 10.1073/pnas.83.8.2614; ANDERSON SJ, 1994, ADV IMMUNOL, V56, P151, DOI 10.1016/S0065-2776(08)60451-4; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ARULANANDAM ARN, 1991, J EXP MED, V173, P859, DOI 10.1084/jem.173.4.859; BELL GM, 1992, MOL CELL BIOL, V12, P5548, DOI 10.1128/MCB.12.12.5548; Bell GM, 1996, J EXP MED, V183, P169, DOI 10.1084/jem.183.1.169; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BIERER BE, 1990, J IMMUNOL, V144, P785; BOCKENSTEDT LK, 1988, J IMMUNOL, V141, P1904; BOUSSIOTIS VA, 1994, J EXP MED, V180, P1665, DOI 10.1084/jem.180.5.1665; BREITMEYER JB, 1987, J IMMUNOL, V139, P2899; BROTTIER P, 1985, J IMMUNOL, V135, P1624; BROWN MH, 1988, EUR J IMMUNOL, V18, P1223, DOI 10.1002/eji.1830180812; BURKHARDT AL, 1994, J BIOL CHEM, V269, P23642; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; CHANG HC, 1989, J EXP MED, V169, P2073, DOI 10.1084/jem.169.6.2073; CHANG HC, 1990, J EXP MED, V172, P351, DOI 10.1084/jem.172.1.351; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; CLAYTON LK, 1988, J IMMUNOL, V140, P3617; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; Crespo P, 1996, ONCOGENE, V13, P455; DEGRAZIA U, 1994, J EXP MED, V180, P1485, DOI 10.1084/jem.180.4.1485; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; FARGNOLI J, 1995, J BIOL CHEM, V270, P26533, DOI 10.1074/jbc.270.44.26533; FISCHER S, 1994, CELL MOL BIOL, V40, P605; FRASER JD, 1991, SCIENCE, V251, P313, DOI 10.1126/science.1846244; GARDNER P, 1989, J BIOL CHEM, V264, P1068; GASSMANN M, 1994, EUR J IMMUNOL, V24, P139, DOI 10.1002/eji.1830240121; GELFAND EW, 1988, EUR J IMMUNOL, V18, P917, DOI 10.1002/eji.1830180613; GOLDSMITH MA, 1987, P NATL ACAD SCI USA, V84, P6879, DOI 10.1073/pnas.84.19.6879; GOLLOB JA, 1995, J EXP MED, V182, P721, DOI 10.1084/jem.182.3.721; Gollob JA, 1996, J IMMUNOL, V157, P1886; GRANELLIPIPERNO A, 1991, J IMMUNOL, V147, P2734; GUPTA S, 1994, J BIOL CHEM, V269, P17349; HE Q, 1988, CELL, V54, P979, DOI 10.1016/0092-8674(88)90112-2; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HOWARD FD, 1992, J EXP MED, V176, P139, DOI 10.1084/jem.176.1.139; HOWARD FD, 1981, J IMMUNOL, V126, P2117; Hubert P, 1996, J IMMUNOL, V157, P4322; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; IMBODEN JB, 1985, J EXP MED, V161, P446, DOI 10.1084/jem.161.3.446; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; IZQUIERDO PM, 1995, IMMUNOL TODAY, V16, P159; JAIN J, 1992, J IMMUNOL, V148, P1240; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JIN YJ, 1990, J IMMUNOL, V144, P647; KAMOUN M, 1981, J EXP MED, V153, P207, DOI 10.1084/jem.153.1.207; KAMPS MP, 1990, MOL CELL BIOL, V10, P5464, DOI 10.1128/MCB.10.10.5464; KANG SM, 1992, SCIENCE, V257, P1134, DOI 10.1126/science.257.5073.1134; King PD, 1996, INT IMMUNOL, V8, P1707, DOI 10.1093/intimm/8.11.1707; KOYASU S, 1994, P NATL ACAD SCI USA, V91, P6693, DOI 10.1073/pnas.91.14.6693; KOYASU S, 1990, P NATL ACAD SCI USA, V87, P2603, DOI 10.1073/pnas.87.7.2603; KRENSKY AM, 1983, J IMMUNOL, V131, P611; Latour S, 1996, J BIOL CHEM, V271, P22782, DOI 10.1074/jbc.271.37.22782; LEY SC, 1991, EUR J IMMUNOL, V21, P2203, DOI 10.1002/eji.1830210931; Li J, 1996, J MOL BIOL, V263, P209, DOI 10.1006/jmbi.1996.0570; MEUER SC, 1984, CELL, V36, P897, DOI 10.1016/0092-8674(84)90039-4; MOINGEON P, 1989, NATURE, V339, P312, DOI 10.1038/339312a0; MOINGEON P, 1992, P NATL ACAD SCI USA, V89, P1492, DOI 10.1073/pnas.89.4.1492; MOINGEON P, 1989, IMMUNOL REV, V111, P111, DOI 10.1111/j.1600-065X.1989.tb00544.x; MOINGEON PE, 1991, EUR J IMMUNOL, V21, P605, DOI 10.1002/eji.1830210311; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MUEGGE K, 1989, SCIENCE, V246, P249, DOI 10.1126/science.2799385; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; PANTALEO G, 1987, EUR J IMMUNOL, V17, P55, DOI 10.1002/eji.1830170110; Parra E, 1997, MOL CELL BIOL, V17, P1314, DOI 10.1128/MCB.17.3.1314; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; QUIAN D, 1997, J EXP MED, V185, P1253; RAMOSMORALES F, 1994, ONCOGENE, V9, P1917; RODEWALD HR, 1993, J EXP MED, V177, P1079, DOI 10.1084/jem.177.4.1079; RYSECK RP, 1991, ONCOGENE, V6, P533; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; SELVARAJ P, 1987, NATURE, V326, P400, DOI 10.1038/326400a0; SERFLING E, 1989, EMBO J, V8, P465, DOI 10.1002/j.1460-2075.1989.tb03399.x; SILICIANO RF, 1985, NATURE, V317, P428, DOI 10.1038/317428a0; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; SunderPlassmann R, 1997, EUR J IMMUNOL, V27, P2001, DOI 10.1002/eji.1830270826; Sundstedt A, 1996, P NATL ACAD SCI USA, V93, P979, DOI 10.1073/pnas.93.3.979; SUZUKI T, 1991, NUCLEIC ACIDS RES, V19, P5537, DOI 10.1093/nar/19.20.5537; Tokiwa G, 1996, SCIENCE, V273, P792, DOI 10.1126/science.273.5276.792; ULLMAN KS, 1993, GENE DEV, V7, P188, DOI 10.1101/gad.7.2.188; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEISS MJ, 1984, P NATL ACAD SCI-BIOL, V81, P6836, DOI 10.1073/pnas.81.21.6836	91	23	26	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24249	24257		10.1074/jbc.273.37.24249	http://dx.doi.org/10.1074/jbc.273.37.24249			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727049	hybrid			2022-12-27	WOS:000075893100090
J	Khuchua, ZA; Qin, WN; Boero, J; Cheng, J; Payne, RM; Saks, VA; Strauss, AW				Khuchua, ZA; Qin, WN; Boero, J; Cheng, J; Payne, RM; Saks, VA; Strauss, AW			Octamer formation and coupling of cardiac sarcomeric mitochondrial creatine kinase are mediated by charged N-terminal residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE; INNER; CARDIOLIPIN; ASSOCIATION; EXPRESSION; ISOENZYMES; BINDING; TISSUE; GENES	Mitochondrial creatine kinases form octameric structures composed of four active and stable dimers. Octamer formation has been postulated to occur via interaction of the charged amino acids in the N-terminal peptide of the mature enzyme. We altered codons for charged amino acids in the N-terminal region of mature sarcomeric mitochondrial creatine kinase (sMtCK) to those encoding neutral amino acids. Transfection of normal sMtCK cDNA or those with the mutations R42G, E43G/H45G, and K46G into rat neonatal cardiomyocytes resulted in enzymatically active sMtCK expression in all. After hypoosmotic treatment of isolated mitochondria, mitochondrial inner membrane-associated and soluble sMtCK from the intermembranous space were measured. The R42G and E43G/H45G double mutation caused destabilization of the octameric structure of sMtCK and a profound reduction in binding of sMtCK to the inner mitochondrial membrane. The other mutant sMtCK proteins had modest reductions in binding. Creatine-stimulated respiration was markedly reduced in mitochondria isolated from cells transfected with the R42G mutant cDNA as compared with those transfected with normal sMtCK cDNA. We conclude that neutralization of charges in N-terminal peptide resulted in destabilization of octamer structure of sMtCK. Thus, charged amino acids at the N-terminal moiety of mature sMtCK are essential for octamer formation, binding of sMtCK with inner mitochondrial membrane, and coupling of sMtCK to oxidative phosphorylation.	St Louis Childrens Hosp, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Pediat, Winston Salem, NC 27157 USA; Inst Chem & Biol Phys, Lab Bioenerget, EE-0026 Tallinn, Estonia	St. Louis Children's Hospital; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Wake Forest University; Wake Forest Baptist Medical Center; National Institute of Chemical Physics & Biophysics (NICPB)	Strauss, AW (corresponding author), St Louis Childrens Hosp, Dept Pediat, Box 8116,1 Childrens Pl, St Louis, MO 63110 USA.	strauss@kids.wustl.edu	Khuchua, Zaza/J-6536-2016	Khuchua, Zaza/0000-0003-3582-5670	FIC NIH HHS [F05 TW05101] Funding Source: Medline; NHLBI NIH HHS [R01 HL52350] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [F05TW005101] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052350] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BESSMAN SP, 1966, BIOCHEM BIOPH RES CO, V22, P597, DOI 10.1016/0006-291X(66)90317-2; BIERMANS W, 1990, BIOCHIM BIOPHYS ACTA, V1018, P225, DOI 10.1016/0005-2728(90)90254-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRDICZKA D, 1994, J BIOL CHEM, V269, P27640; CHENEVAL D, 1988, EUR J BIOCHEM, V171, P1, DOI 10.1111/j.1432-1033.1988.tb13750.x; CHIEN KR, 1985, J CLIN INVEST, V75, P1770, DOI 10.1172/JCI111889; FritzWolf K, 1996, NATURE, V381, P341, DOI 10.1038/381341a0; FURTER R, 1992, BIOCHEM J, V288, P771, DOI 10.1042/bj2880771; GROSS M, 1994, PROTEIN SCI, V3, P1058, DOI 10.1002/pro.5560030708; HAAS RC, 1990, J BIOL CHEM, V265, P6921; HAAS RC, 1989, J BIOL CHEM, V264, P2890; JACOBUS WE, 1985, ANNU REV PHYSIOL, V47, P707; KALDIS P, 1994, BIOCHEMISTRY-US, V33, P952, DOI 10.1021/bi00170a014; KOTKE M, 1991, BIOCHIM BIOPHYS ACTA, V1061, P215; Maniatis T., 1982, MOL CLONING; MULLER M, 1985, J BIOL CHEM, V260, P3839; PAYNE RM, 1991, BIOCHIM BIOPHYS ACTA, V1089, P352, DOI 10.1016/0167-4781(91)90176-M; QIN W, 1998, IN PRESS MOL CELL BI; ROE CR, 1977, ANN CLIN LAB SCI, V7, P201; ROJO M, 1991, J BIOL CHEM, V266, P20290; ROSALKI SB, 1967, J LAB CLIN MED, V69, P696; SAKS VA, 1974, CIRC RES, V35, P138; SAKS VA, 1987, BIOCHIM BIOPHYS ACTA, V891, P138, DOI 10.1016/0005-2728(87)90005-3; SAKS VA, 1986, BIOCHEM BIOPH RES CO, V139, P1262, DOI 10.1016/S0006-291X(86)80314-X; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHLEGEL J, 1990, J BIOL CHEM, V265, P9221; SCHNYDER T, 1991, J CELL BIOL, V112, P95, DOI 10.1083/jcb.112.1.95; SCHOLTE HR, 1973, BIOCHIM BIOPHYS ACTA, V291, P764, DOI 10.1016/0005-2736(73)90479-3; Seraydarian M W, 1986, Adv Exp Med Biol, V194, P41; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; UAUSBEL FM, 1994, CURRENT PROTOCOLS MO; VEKSLER VI, 1987, BIOCHIM BIOPHYS ACTA, V892, P191, DOI 10.1016/0005-2728(87)90174-5	32	60	62	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					22990	22996		10.1074/jbc.273.36.22990	http://dx.doi.org/10.1074/jbc.273.36.22990			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722522	hybrid			2022-12-27	WOS:000075778100022
J	Kornfeld, R; Bao, M; Brewer, K; Noll, C; Canfield, WM				Kornfeld, R; Bao, M; Brewer, K; Noll, C; Canfield, WM			Purification and multimeric structure of bovine N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME	N-Acetylglucosamine-1-phosphodiester alpha-N-Acetylglucosaminidase (EC 3.1.4.45; phosphodiester alpha-GlcNAcase) catalyzes the second step in the synthesis of the mannose 6-phosphate determinant required for efficient intracellular targeting of newly synthesized lysosomal hydrolases to the lysosome, A partially purified preparation of phosphodiester alpha-GlcNAcase from bovine pancreas was used to generate a panel of murine monoclonal antibodies. The anti-phosphodiester alpha-GlcNAcase monoclonal antibody UC1 was coupled to a solid support and used to immunopurify the bovine liver enzyme 670,000-fold in two steps to apparent homogeneity with an overall yield of 14%. The purified phosphodiester alpha-GlcNAcase has a specific activity of 498 mu mol of [H-3]GlcNAc-alpha-phosphomannose-alpha-methyl cleaved per h per mg of protein using 0.5 mM [H-3]GlcNAc-alpha-phosphomannose-alpha-methyl as substrate. The subunit structure of the enzyme was determined using a combination of analytical gel filtration chromatography, SDS-polyacrylamide gel electrophoresis, and amino-terminal sequencing. The data indicate that bovine phosphodiester alpha-GlcNAcase is a 272,000-Da complex of four identical 68,000-Da glycoprotein subunits arranged as two disulfide-linked homodimers. A soluble form of the enzyme, isolated from fetal bovine serum, showed the same subunit structure. Both forms of the enzyme reacted with a rabbit antibody raised to the amino-terminal peptide of the liver enzyme, suggesting that phosphodiester alpha-GlcNAcase is a type I membrane-spanning glycoprotein with its amino terminus in the lumen of the Golgi apparatus.	Washington Univ, Sch Med, Div Hematol, Dept Med, St Louis, MO 63110 USA; Univ Oklahoma, Hlth Sci Ctr, WK Warren Med Res Inst, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA	Washington University (WUSTL); University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Kornfeld, R (corresponding author), Washington Univ, Sch Med, Div Hematol, Dept Med, 660 S Euclid Ave,Box 8125, St Louis, MO 63110 USA.				NCI NIH HHS [CA08759] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA008759, R01CA008759] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bao M, 1996, J BIOL CHEM, V271, P31437, DOI 10.1074/jbc.271.49.31437; BAZIN R, 1989, J IMMUNOL METHODS, V116, P245, DOI 10.1016/0022-1759(89)90210-X; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; DAHMS NM, 1989, J BIOL CHEM, V264, P12115; Harlow E., 1988, ANTIBODIES LAB MANUA; KIORNFELD S, 1987, FASEB J, V1, P462; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; LAMMERS G, 1988, BIOCHEM J, V256, P623, DOI 10.1042/bj2560623; LEE JK, 1995, ARCH BIOCHEM BIOPHYS, V319, P413, DOI 10.1006/abbi.1995.1312; MULLIS KG, 1994, J BIOL CHEM, V269, P1718; MULLIS KG, 1992, ANAL BIOCHEM, V205, P200, DOI 10.1016/0003-2697(92)90424-6; MULLIS KG, 1994, J BIOL CHEM, V269, P1727; Page T, 1996, GLYCOBIOLOGY, V6, P619, DOI 10.1093/glycob/6.6.619; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7	15	25	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23203	23210		10.1074/jbc.273.36.23203	http://dx.doi.org/10.1074/jbc.273.36.23203			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722550	hybrid			2022-12-27	WOS:000075778100050
J	Polakiewicz, RD; Schieferl, SM; Gingras, AC; Sonenberg, N; Comb, MJ				Polakiewicz, RD; Schieferl, SM; Gingras, AC; Sonenberg, N; Comb, MJ			mu-opioid receptor activates signaling pathways implicated in cell survival and translational control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; AVIAN CILIARY GANGLION; HAMSTER OVARY CELLS; P70 S6 KINASE; COUPLED RECEPTORS; PHOSPHOINOSITIDE-3 KINASE; RAT-1 FIBROBLASTS; NEURONAL SURVIVAL; PHOSPHORYLATION; RAPAMYCIN	The mu-opioid receptor mediates the analgesic and addictive properties of morphine. Despite the clinical importance of this G-protein-coupled receptor and many years of pharmacological research, few intracellular signaling mechanisms triggered by morphine and other mu-opioid agonists have been described. We report that mu-opioid agonists stimulate three different effecters of a phosphoinositide 3-kinase (PI3K)-dependent signaling cascade. By using a cell line stably transfected with the mu-opioid receptor cDNA, we show that the specific agonist [D-Ala(2),N-Me-Phe(4),Gly(5)-ol]enkephalin (DAMGO) stimulates the activity of Akt, a serine/threonine protein kinase implicated in protecting neurons from apoptosis, Activation of Akt by DAMGO correlates with its phosphorylation at serine 473, The selective PI3K inhibitors wortmannin and LY294002 blocked phosphorylation of this site, previously shown to be necessary for Akt enzymatic activity. DAMGO also stimulates the phosphorylation of two other downstream effecters of PI3K the p70 S6 kinase and the repressors of mRNA translation, 4E-BP1 and 4E-BP2. Upon mu-opioid receptor stimulation, p70 S6 kinase is activated and phosphorylated at threonine 389 and at threonine 421/serine 424, Phosphorylation of p70 S6 kinase and 4E-BP1 is also repressed by PI3K inhibitors as well as by rapamycin, the selective inhibitor of FRAP/mTOR, Consistent with these findings, DAMGO-stimulated phosphorylation of 4E-BP1 impairs its ability to bind the translation initiation factor eIF-4E. These results demonstrate that the p-opioid receptor activates signaling pathways associated with neuronal survival and translational control, two processes implicated in neuronal development and synaptic plasticity.	New England Biolabs Inc, Cell Signaling Lab, Beverly, MA 01915 USA; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	McGill University	Polakiewicz, RD (corresponding author), New England Biolabs Inc, Cell Signaling Lab, 32 Tozer Rd, Beverly, MA 01915 USA.		Gingras, Anne-Claude/ABA-8341-2020; Gingras, Anne-Claude/E-9982-2010	Gingras, Anne-Claude/0000-0002-6090-4437; Gingras, Anne-Claude/0000-0002-6090-4437	NIDA NIH HHS [DA05706] Funding Source: Medline	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ALESSI D, 1997, CURR BIOL, V8, P69; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Burt AR, 1996, BIOCHEM J, V320, P227, DOI 10.1042/bj3200227; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; CHILDERS SR, 1991, LIFE SCI, V48, P1991, DOI 10.1016/0024-3205(91)90154-4; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Downward J, 1998, SCIENCE, V279, P673, DOI 10.1126/science.279.5351.673; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; FLOTOW H, 1992, J BIOL CHEM, V267, P3074; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fukuda K, 1996, J NEUROCHEM, V67, P1309; Gingras AC, 1996, P NATL ACAD SCI USA, V93, P5578, DOI 10.1073/pnas.93.11.5578; GINGRAS AC, 1998, GENE DEV, V18, P334; GROVE JR, 1991, MOL CELL BIOL, V11, P5541, DOI 10.1128/MCB.11.11.5541; HAN JW, 1995, J BIOL CHEM, V270, P21396, DOI 10.1074/jbc.270.36.21396; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Hauser KF, 1996, BRAIN RES, V720, P191, DOI 10.1016/0006-8993(96)00103-5; Hawes BE, 1996, J BIOL CHEM, V271, P12133, DOI 10.1074/jbc.271.21.12133; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; KAUFMAN DL, 1995, J BIOL CHEM, V270, P15877, DOI 10.1074/jbc.270.26.15877; Li LY, 1996, MOL PHARMACOL, V50, P599; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; MERINEY SD, 1985, SCIENCE, V228, P1451, DOI 10.1126/science.2990029; MERINEY SD, 1991, J NEUROSCI, V11, P3705; MORRIS BJ, 1995, TRENDS NEUROSCI, V18, P350, DOI 10.1016/0166-2236(95)93927-P; PASTERNAK GW, 1988, OPIATE RECEPTORS; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Polakiewicz RD, 1998, J BIOL CHEM, V273, P12402, DOI 10.1074/jbc.273.20.12402; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Schuman EM, 1997, NEURON, V18, P339, DOI 10.1016/S0896-6273(00)81234-9; Sonenberg N, 1996, TRANSLATIONAL CONTRO, P245; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Tian MT, 1997, J EXP MED, V185, P1517, DOI 10.1084/jem.185.8.1517; Tilton B, 1997, J BIOL CHEM, V272, P28096, DOI 10.1074/jbc.272.44.28096; vanBiesen T, 1996, ENDOCR REV, V17, P698, DOI 10.1210/er.17.6.698; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; vonManteuffel SR, 1996, P NATL ACAD SCI USA, V93, P4076, DOI 10.1073/pnas.93.9.4076; vonManteuffel SR, 1997, MOL CELL BIOL, V17, P5426, DOI 10.1128/MCB.17.9.5426; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; WENG QP, 1995, MOL CELL BIOL, V15, P2333; Wilson M, 1996, J BIOL CHEM, V271, P8537, DOI 10.1074/jbc.271.15.8537; Wilson MA, 1997, BIOCHEM J, V325, P217, DOI 10.1042/bj3250217	54	160	179	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23534	23541		10.1074/jbc.273.36.23534	http://dx.doi.org/10.1074/jbc.273.36.23534			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722592	hybrid			2022-12-27	WOS:000075778100092
J	Qin, XZ; Strong, DD; Baylink, DJ; Mohan, S				Qin, XZ; Strong, DD; Baylink, DJ; Mohan, S			Structure-function analysis of the human insulin-like growth factor binding protein-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST-LIKE CELLS; HUMAN BONE-CELLS; FACTOR BINDING-PROTEIN-4; IGF-I; IGFBP-4; FIBROBLASTS; SERUM; SITE; PROTEASES; (IGFBP)-4	To identify the molecular mechanism by which insulin-like growth factor binding protein-4 (IGFBP-4) exerts its inhibitory effects on insulin-like growth factor (IGF) actions, we localized and determined the role of the IGF binding domain in modulating IGF actions in human osteoblasts. Deletion analysis using IGFBP-4 expressed in bacteria revealed that the N-terminal sequence Leu(72)-Ser(91) was essential for IGF binding. The C-terminal fragments (His(121)-Glu(237) or Arg(142)-Glu(237)) did not bind to IGF but loss of these regions decreased IGF binding activity. Detailed deletion analysis identified the residues Cys(205)-Val(214) as the motif to facilitate IGF binding. Mitogenic studies revealed that an IGFBP-4 mutant (His(74) replaced by Pro(74)) and an N-terminal peptide (N terminus to Thr(71)) with little IGF binding activity failed to inhibit IGF-II-induced human osteoblast proliferation. An N-terminal peptide (N terminus to Asn(182)) with reduced IGF binding activity inhibited IGF action but with lower potency. In contrast, an IGFBP-4 mutant (His(74) replaced with Ala(74)) exhibited similar IGF binding activity and potency in inhibiting the activity of IGF-II compared with the wild type. Therefore, the N-terminal sequence (Leu(72)-Ser(91)) and the C-terminal sequence (Cys(205)-Val(214)) are necessary to form the high affinity IGF binding domain, which is the major structural determinant of the IGFBP-4 function.	JL Pettis Mem Vet Med Ctr, Res Serv 151, Dept Mineral Metab, Loma Linda, CA 92357 USA; Loma Linda Univ, Dept Med, Loma Linda, CA 92357 USA; Loma Linda Univ, Dept Biochem, Loma Linda, CA 92357 USA; Loma Linda Univ, Dept Physiol, Loma Linda, CA 92357 USA; Loma Linda Univ, Dept Microbiol & Mol Genet, Loma Linda, CA 92357 USA	Loma Linda University; Loma Linda University; Loma Linda University; Loma Linda University	Mohan, S (corresponding author), JL Pettis Mem Vet Med Ctr, Res Serv 151, Dept Mineral Metab, 11201 Benton St, Loma Linda, CA 92357 USA.	Mohans@llvamc.va.gov			NIAMS NIH HHS [1 RO1 AR31062, 1 RO1 AR07543] Funding Source: Medline; NIDCR NIH HHS [1 RO3 DE12142-01] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE012142] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BRINKMAN A, 1991, MOL ENDOCRINOL, V5, P987, DOI 10.1210/mend-5-7-987; BRINKMAN A, 1991, FEBS LETT, V29, P264; CAMPBELL PG, 1991, J CELL PHYSL, V149, P93; CANALIS E, 1993, BONE, V14, P273, DOI 10.1016/8756-3282(93)90151-Y; CHERNAUSEK SD, 1995, J BIOL CHEM, V270, P11377, DOI 10.1074/jbc.270.19.11377; CHEUNG PT, 1994, ENDOCRINOLOGY, V135, P1328, DOI 10.1210/en.135.4.1328; CHEUNG PT, 1991, ENDOCRINOLOGY, V129, P1006, DOI 10.1210/endo-129-2-1006; CONOVER CA, 1995, J BIOL CHEM, V270, P4395, DOI 10.1074/jbc.270.9.4395; CULOUSCOU JM, 1991, CANCER RES, V51, P2813; DURHAM SK, 1994, J CLIN ENDOCR METAB, V79, P1752, DOI 10.1210/jc.79.6.1752; DURHAM SK, 1994, J BONE MINER RES, V9, P111; FOWLKES J, 1992, ENDOCRINOLOGY, V131, P2071, DOI 10.1210/en.131.5.2071; Fowlkes John L., 1995, Progress in Growth Factor Research, V6, P255, DOI 10.1016/0955-2235(95)00017-8; Hobba GD, 1996, J BIOL CHEM, V271, P30529, DOI 10.1074/jbc.271.48.30529; Honda Y, 1996, J CLIN ENDOCR METAB, V81, P1389, DOI 10.1210/jcem.81.4.8636339; HUHTALA ML, 1986, BIOCHEM BIOPH RES CO, V141, P263, DOI 10.1016/S0006-291X(86)80363-1; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; KANZAKI S, 1994, ENDOCRINOLOGY, V134, P383, DOI 10.1210/en.134.1.383; KNUTSEN R, 1995, ENDOCRINOLOGY, V136, P857, DOI 10.1210/en.136.3.857; Lalou C, 1996, ENDOCRINOLOGY, V137, P3206, DOI 10.1210/en.137.8.3206; Landale EC, 1995, GROWTH FACTORS, V12, P245, DOI 10.3109/08977199509028963; LATOUR D, 1990, MOL ENDOCRINOL, V4, P1806, DOI 10.1210/mend-4-12-1806; Malpe R, 1997, J BONE MINER RES, V12, P423, DOI 10.1359/jbmr.1997.12.3.423; MOHAN S, 1993, GROWTH REGULAT, V3, P67; MOHAN S, 1995, J BIOL CHEM, V270, P20424, DOI 10.1074/jbc.270.35.20424; MOHAN S, 1989, P NATL ACAD SCI USA, V86, P8338, DOI 10.1073/pnas.86.21.8338; MOHSENIZADEH S, 1997, ENDOCRINOLOGY, V138, P3069; Nam TJ, 1996, ENDOCRINOLOGY, V137, P5530, DOI 10.1210/en.137.12.5530; Qin XZ, 1997, BBA-GENE STRUCT EXPR, V1350, P136, DOI 10.1016/S0167-4781(96)00220-5; Rajaram S, 1997, ENDOCR REV, V18, P801, DOI 10.1210/er.18.6.801; RECHLER MM, 1993, VITAM HORM, V47, P1, DOI 10.1016/S0083-6729(08)60444-6; ROGHANI M, 1989, FEBS LETT, V255, P253, DOI 10.1016/0014-5793(89)81101-9; ROSEN C, 1992, J CLIN ENDOCR METAB, V74, P24, DOI 10.1210/jc.74.1.24; ROSEN CJ, 1994, P SOC EXP BIOL MED, V206, P83; SCHARLA SH, 1991, ENDOCRINOLOGY, V129, P3139, DOI 10.1210/endo-129-6-3139; SCHARLA SH, 1992, INT CONGR SER, V1003, P223; SCHARLA SH, 1993, J CLIN ENDOCR METAB, V77, P1190, DOI 10.1210/jc.77.5.1190; Spencer E. Martin, 1995, Progress in Growth Factor Research, V6, P209; VALENTINIS B, 1995, MOL ENDOCRINOL, V9, P361, DOI 10.1210/me.9.3.361; WANG JF, 1988, BIOCHEM BIOPH RES CO, V157, P718, DOI 10.1016/S0006-291X(88)80309-7	40	81	88	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23509	23516		10.1074/jbc.273.36.23509	http://dx.doi.org/10.1074/jbc.273.36.23509			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722589	hybrid			2022-12-27	WOS:000075778100089
J	Migdal, M; Huppertz, B; Tessler, S; Comforti, A; Shibuya, M; Reich, R; Baumann, H; Neufeld, G				Migdal, M; Huppertz, B; Tessler, S; Comforti, A; Shibuya, M; Reich, R; Baumann, H; Neufeld, G			Neuropilin-1 is a placenta growth factor-2 receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VEIN ENDOTHELIAL-CELLS; EXON 7-ENCODED DOMAIN; HIGH-AFFINITY BINDING; TYROSINE KINASE; FACTOR VEGF; PLASMINOGEN-ACTIVATOR; SIGNAL-TRANSDUCTION; IN-VIVO; FLT-1; IDENTIFICATION	Placenta growth factor (PIGF) belongs to the family of vascular endothelial growth factors (VEGFs). It binds to the flt-1 VEGF receptor but not to the KDR/flk-1 receptor which is thought to mediate most of the angiogenic and proliferative effects of VEGF, Three PIGF isoforms are produced by alternative splicing. PlGF-1 and PlGF-3 differ from PlGF-2 since they lack the exon 6 encoded peptide which bestows upon PlGF-2 its heparin binding properties. Cross-linking experiments revealed that I-125-PlGF-2 binds to two endothelial cell surface receptors in a heparin dependent fashion. The binding of I-125-PlGF-2 to these receptors was inhibited by an excess of PlGF-2 and by the 165-amino acid form of VEGF (VEGF(165)), but not at all by VEGF(165) and very marginally if at all by PlGF-1, The apparent molecular weight and the binding characteristics of these receptors correspond to those of the recently identified VEGF(165) specific receptor neuropilin-1, and we therefore conclude that neuropilin-1 is a receptor for PlGF-2. The binding of I-125-PlGF-2 as well as the binding of I-125-VEGF(165) to these receptors was inhibited by a synthetic peptide derived from exon 6 of PlGF. Furthermore, the binding of I-125-PIGF-2, but not that of I-125-VEGF(165), was also inhibited by a synthetic peptide derived from exon 7 of PlGF. These observations indicate that the peptides encoded by these exons probably participate in the formation of the domain which mediates the binding of PlGF-2 to these receptors, We have also determined, using chemically modified heparin species, that the presence of sulfate moieties on the glucosamine-O-6 and on the iduronic acid-O-2 groups of heparin was required for the potentiation of I-125-PlGF-2 binding to these receptors. To determine if PlGF-2 is able to induce biological responses that are not induced by PlGF-1, we compared the effects of PlGF-1 and PlGF-2 on the migration and proliferation of endothelial cells. Both PlGF forms induced migration of endothelial cells. However, there was no quantitative difference between the response to PIGF-2 and the response to PIGF-1. Furthermore, neither PIGF-1 nor PlGF-2 had any effect upon the proliferation of the endothelial cells.	Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; Hebrew Univ Jerusalem, Dept Pharmacol, IL-91120 Jerusalem, Israel; RWTH Aachen, D-52074 Aachen, Germany; Univ Tokyo, Inst Med Sci, Dept Genet, Minato Ku, Tokyo 108, Japan	Technion Israel Institute of Technology; Hebrew University of Jerusalem; University of Tokyo	Neufeld, G (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.	gera@techunix.technion.ac.il	Neufeld, Gera/F-1524-2019					AYOTTE L, 1986, CARBOHYD RES, V145, P267, DOI 10.1016/S0008-6215(00)90434-8; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Cao YH, 1997, BIOCHEM BIOPH RES CO, V235, P493, DOI 10.1006/bbrc.1997.6813; Cao YH, 1996, J BIOL CHEM, V271, P3154, DOI 10.1074/jbc.271.6.3154; CASU B, 1983, ARZNEIMITTELFORSCH, V33-1, P135; Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629; COHEN T, 1995, J BIOL CHEM, V270, P11322, DOI 10.1074/jbc.270.19.11322; Cohen T, 1992, GROWTH FACTORS, V7, P131, DOI 10.3109/08977199209046402; DETHLEFSEN SM, 1994, INVAS METAST, V14, P395; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; DISALVO J, 1995, J BIOL CHEM, V270, P7717, DOI 10.1074/jbc.270.13.7717; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; GENGRINOVITCH S, 1995, J BIOL CHEM, V270, P15059, DOI 10.1074/jbc.270.25.15059; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; GitayGoren H, 1996, J BIOL CHEM, V271, P5519, DOI 10.1074/jbc.271.10.5519; HAUSER S, 1993, GROWTH FACTORS, V9, P259, DOI 10.3109/08977199308991586; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; HUPPERTZ B, 1998, IN PRESS FRONTIERS B, V2; Jonca F, 1997, J BIOL CHEM, V272, P24203, DOI 10.1074/jbc.272.39.24203; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kodama J, 1997, EUR J GYNAECOL ONCOL, V18, P508; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; MAGLIONE D, 1991, P NATL ACAD SCI USA, V88, P9267, DOI 10.1073/pnas.88.20.9267; Malinda KM, 1997, FASEB J, V11, P474, DOI 10.1096/fasebj.11.6.9194528; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; Neufeld G, 1996, CANCER METAST REV, V15, P153, DOI 10.1007/BF00437467; Neufeld Gera, 1994, Progress in Growth Factor Research, V5, P89, DOI 10.1016/0955-2235(94)90019-1; PARK JE, 1994, J BIOL CHEM, V269, P25646; QU ZH, 1995, AM J PATHOL, V147, P564; REICH R, 1988, CANCER RES, V48, P3307; SATO Y, 1988, J CELL BIOL, V107, P1199, DOI 10.1083/jcb.107.3.1199; Sawano A, 1996, CELL GROWTH DIFFER, V7, P213; SCHWEIGERER L, 1987, NATURE, V325, P257, DOI 10.1038/325257a0; SEETHARAM L, 1995, ONCOGENE, V10, P135; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SHIBUYA M, 1990, ONCOGENE, V5, P519; Soker S, 1997, J BIOL CHEM, V272, P31582, DOI 10.1074/jbc.272.50.31582; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Soker S, 1996, J BIOL CHEM, V271, P5761, DOI 10.1074/jbc.271.10.5761; TAKAHASHI A, 1994, CANCER RES, V54, P4233; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; TERMAN BI, 1991, ONCOGENE, V6, P1677; VAISMAN N, 1990, J BIOL CHEM, V265, P19461; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Yates EA, 1996, CARBOHYD RES, V294, P15; Ziche M, 1997, LAB INVEST, V76, P517	48	258	275	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22272	22278		10.1074/jbc.273.35.22272	http://dx.doi.org/10.1074/jbc.273.35.22272			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712843	hybrid			2022-12-27	WOS:000075616600019
J	Mills, EM; Takeda, K; Yu, ZX; Ferrans, V; Katagiri, Y; Jiang, H; Lavigne, MC; Leto, TL; Guroff, G				Mills, EM; Takeda, K; Yu, ZX; Ferrans, V; Katagiri, Y; Jiang, H; Lavigne, MC; Leto, TL; Guroff, G			Nerve growth factor treatment prevents the increase in superoxide produced by epidermal growth factor in PC12 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; SIGNAL-TRANSDUCTION; FACTOR RECEPTORS; RAS; GENERATION; PATHWAYS; RESPOND; KINASE; LIPIDS; LINE	Stimulation of pheochromocytoma (PC12) cells with the mitogen epidermal growth factor (EGF) produced a rapid and robust accumulation of intracellular reactive oxygen species (ROS), an accumulation which, in other systems, has been shown to be essential for mitogenesis, Brief pretreatment of the cells with nerve growth factor (NGF) suppressed the EGF-mediated ROS increase. EGF failed to produce elevations in ROS in a PC12 variant stably expressing a dominant-negative p2(ras) construct (PC12-N17) or in cells pretreated with the MEK inhibitor PD098059, NGF failed to suppress the increase in ROS in the PC12 variant nnr5, which lacks p140(trk) receptors, The suppression of the increase in ROS by NGF was restored in nnr5 cells stably expressing p140(trk) (nnr5-trk), but NGF failed to prevent the increase in ROS in nnr cells expressing mutant p140(trk) receptors that lack binding sites for Shc and phospholipase C gamma, Among several inhibitors of superoxide-generating enzymes, only the lipoxygenase inhibitor, nordihydroguaiaretic acid reduced EGF-mediated ROS accumulation. The inhibitory action of NGF on ROS production was mimicked by the nitric oxide donor, sodium nitroprusside, and was blocked by an inhibitor of nitric-oxide synthetase, L-nitroarginine methyl ester, These results suggest a novel mechanism for the rapid interruption of mitogenic signaling by the neurotrophin NGF.	NICHD, Growth Factors Sect, NIH, Bethesda, MD 20892 USA; NHLBI, Pathol Sect, Bethesda, MD 20892 USA; NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Guroff, G (corresponding author), NICHD, Growth Factors Sect, NIH, Bldg 49,Rm 5A64, Bethesda, MD 20892 USA.	gordong@helix.nih.gov						Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BROWN AB, 1991, J NEUROCHEM, V57, P1740, DOI 10.1111/j.1471-4159.1991.tb06376.x; BURSTEIN DE, 1982, DEV BIOL, V94, P477, DOI 10.1016/0012-1606(82)90364-5; Chen BK, 1997, BBA-LIPID LIPID MET, V1344, P270, DOI 10.1016/S0005-2760(96)00151-8; DICHTER MA, 1977, NATURE, V268, P501, DOI 10.1038/268501a0; Dugan LL, 1997, P NATL ACAD SCI USA, V94, P4086, DOI 10.1073/pnas.94.8.4086; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; Lazarovici P, 1997, J BIOL CHEM, V272, P11026, DOI 10.1074/jbc.272.17.11026; Maccarrone M, 1996, BIOCHEM BIOPH RES CO, V219, P128, DOI 10.1006/bbrc.1996.0193; MOTHE I, 1993, MOL BIOL CELL, V4, P737, DOI 10.1091/mbc.4.7.737; Pahan K, 1998, J BIOL CHEM, V273, P2591, DOI 10.1074/jbc.273.5.2591; PEUNOVA N, 1995, NATURE, V375, P68, DOI 10.1038/375068a0; Quijano C, 1997, BIOCHEM J, V322, P167, DOI 10.1042/bj3220167; RALASCA M, 1995, ONCOGENE, V10, P2113; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Shibutani M, 1998, J BIOL CHEM, V273, P6878, DOI 10.1074/jbc.273.12.6878; STEPHENS RM, 1994, NEURON, V12, P791; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; TSAI MH, 1989, SCIENCE, V243, P522, DOI 10.1126/science.2536192; YU CL, 1990, MOL CELL BIOL, V10, P6683, DOI 10.1128/MCB.10.12.6683	25	59	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22165	22168		10.1074/jbc.273.35.22165	http://dx.doi.org/10.1074/jbc.273.35.22165			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712826	hybrid			2022-12-27	WOS:000075616600002
J	Ishiguro, H; Yamada, K; Ichino, N; Nagatsu, T				Ishiguro, H; Yamada, K; Ichino, N; Nagatsu, T			Identification and characterization of a novel phorbol ester-responsive DNA sequence in the 5 '-flanking region of the human dopamine beta-hydroxylase gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REGULATOR YY1; BINDING PROTEIN; CYCLIC-AMP; SOMATOSTATIN GENE; PROXIMAL PROMOTER; SILENCER ELEMENT; GLOBIN GENE; EXPRESSION; REPRESSION; CELLS	The phorbol ester, 12-O-tetradecanoylphorbol-13-acetate (TPA), enhances transcription of many eukaryotic genes, including that for dopamine P-hydroxylase (DBH). In the present study, we report identification and characterization of a novel sequence motif residing in the 5'-flanking region of the human DBH gene, which mediates transcriptional induction by TPA. Deletional analyses indicated the promoter region between -223 and -187 base pairs to be critical. Whereas this region does not contain any putative regulatory motifs with significant sequence homology to the AP-1 motif, extensive deletional and site-directed mutational analyses indicated that a sequence between -210 and -199 base pairs, B'-ATCCGCCTGTCT-3', may represent a novel TPA-response element (TRE), In addition, alteration of the YY1-binding site decreased TPA-mediated induction of the DBH promoter activity, suggesting that contiguous cis-regulatory element(s) cooperate with this novel sequence motif, Furthermore, insertional mutation analyses between the YY1-binding site and the cyclic AMP-responsive element indicated that the stereospecificity of these motifs is important for intact transcriptional induction by TPA, Taken together, these data suggest that transcriptional up-regulation of the human DBH gene in response to TPA requires coordination of a novel TRE (human DBH TRE, hDTRE), cyclic AMP-responsive element, and the YY1-binding site.	Fujita Hlth Univ, Inst Comprehens Med Sci, Toyoake, Aichi 4701192, Japan	Fujita Health University	Nagatsu, T (corresponding author), Fujita Hlth Univ, Inst Comprehens Med Sci, Toyoake, Aichi 4701192, Japan.	tnagatsu@fujita-hu.ac.jp						Afar R, 1996, MOL BRAIN RES, V36, P79, DOI 10.1016/0169-328X(95)00247-P; AN GH, 1982, MOL CELL BIOL, V2, P1628, DOI 10.1128/MCB.2.12.1628; Austen M, 1997, J BIOL CHEM, V272, P1709, DOI 10.1074/jbc.272.3.1709; BAUKNECHT T, 1992, EMBO J, V11, P4607, DOI 10.1002/j.1460-2075.1992.tb05563.x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FLANAGAN JR, 1992, MOL CELL BIOL, V12, P38, DOI 10.1128/MCB.12.1.38; GASTON K, 1994, FEBS LETT, V347, P289, DOI 10.1016/0014-5793(94)00567-2; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRECO D, 1995, J NEUROCHEM, V65, P510; GUALBERTO A, 1992, MOL CELL BIOL, V12, P4209, DOI 10.1128/MCB.12.9.4209; HARIHARAN N, 1991, P NATL ACAD SCI USA, V88, P9799, DOI 10.1073/pnas.88.21.9799; IANNELLO RC, 1993, J BIOL CHEM, V268, P22581; Ishiguro H, 1995, MOL BRAIN RES, V34, P251, DOI 10.1016/0169-328X(95)00170-W; ISHIGURO H, 1993, J BIOL CHEM, V268, P17984; Kim JS, 1996, NUCLEIC ACIDS RES, V24, P4341, DOI 10.1093/nar/24.21.4341; KIM KS, 1994, J NEUROSCI, V14, P7200; KIM KS, 1993, J BIOL CHEM, V268, P15689; KOBAYASHI K, 1989, NUCLEIC ACIDS RES, V17, P1089, DOI 10.1093/nar/17.3.1089; KRANER SD, 1992, NEURON, V9, P37, DOI 10.1016/0896-6273(92)90218-3; LAMOUROUX A, 1993, J NEUROCHEM, V60, P364, DOI 10.1111/j.1471-4159.1993.tb05861.x; LEE TC, 1992, P NATL ACAD SCI USA, V89, P9814, DOI 10.1073/pnas.89.20.9814; LEE YM, 1994, DNA CELL BIOL, V13, P1029, DOI 10.1089/dna.1994.13.1029; LIU R, 1994, NUCLEIC ACIDS RES, V22, P2453, DOI 10.1093/nar/22.13.2453; LU SY, 1994, MOL CELL BIOL, V14, P6253, DOI 10.1128/MCB.14.9.6253; MACLELLAN WR, 1994, J BIOL CHEM, V269, P16754; MARGOLIS DM, 1994, J VIROL, V68, P905, DOI 10.1128/JVI.68.2.905-910.1994; MEIER VS, 1994, MOL CELL BIOL, V14, P128, DOI 10.1128/MCB.14.1.128; MOMOEDA M, 1994, J VIROL, V68, P7159, DOI 10.1128/JVI.68.11.7159-7168.1994; MONTALVO EA, 1991, J VIROL, V65, P3647, DOI 10.1128/JVI.65.7.3647-3655.1991; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MORI N, 1992, NEURON, V9, P45, DOI 10.1016/0896-6273(92)90219-4; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; NATESAN S, 1993, GENE DEV, V7, P2497, DOI 10.1101/gad.7.12b.2497; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; PARK K, 1991, P NATL ACAD SCI USA, V88, P9804, DOI 10.1073/pnas.88.21.9804; PETERS B, 1993, J BIOL CHEM, V268, P3430; RAUGHT B, 1994, MOL CELL BIOL, V14, P1752, DOI 10.1128/MCB.14.3.1752; RIABOWOL KT, 1988, NATURE, V336, P83, DOI 10.1038/336083a0; RIGGS KJ, 1993, MOL CELL BIOL, V13, P7487, DOI 10.1128/MCB.13.12.7487; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; Seo HM, 1996, J NEUROSCI, V16, P4102; SHASKUS J, 1995, J NEUROCHEM, V64, P52; SHASKUS J, 1992, J BIOL CHEM, V267, P18821; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; TODA K, 1994, J BIOL CHEM, V269, P8099; USHEVA A, 1994, CELL, V76, P1115, DOI 10.1016/0092-8674(94)90387-5; VINCENT CK, 1993, MOL CELL BIOL, V13, P1264, DOI 10.1128/MCB.13.2.1264; WILLIAMS TM, 1989, ANAL BIOCHEM, V176, P28, DOI 10.1016/0003-2697(89)90267-4; Ye JP, 1996, MOL CELL BIOL, V16, P4744; YE JP, 1994, J BIOL CHEM, V269, P25728; YE JP, 1994, NUCLEIC ACIDS RES, V22, P5672, DOI 10.1093/nar/22.25.5672; YOST SE, 1993, MOL CELL BIOL, V13, P5439, DOI 10.1128/MCB.13.9.5439; Zellmer E, 1995, J NEUROSCI, V15, P8109	54	11	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21941	21949		10.1074/jbc.273.34.21941	http://dx.doi.org/10.1074/jbc.273.34.21941			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705334	hybrid			2022-12-27	WOS:000075492600068
J	Carpenter, PB; Dunphy, WG				Carpenter, PB; Dunphy, WG			Identification of a novel 81-kDa component of the Xenopus origin recognition complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CONTROL; DNA-REPLICATION; BUDDING YEAST; MCM PROTEINS; CDC6 PROTEIN; EGG EXTRACTS; CHROMATIN; HOMOLOG; KINASES; CDK	The Xenopus origin recognition complex is essential for chromosomal DNA replication in cell-free extracts. We have immunopurified the Xenopus origin recognition complex with anti-Xorc2 antibodies and analyzed its composition and properties. Xorc2 (p63) is specifically associated with Xorc1 (p115) and up to four additional polypeptides (p81, p78, p45, and p40). The cDNA encoding p81 is highly homologous to various expressed sequence tags from humans and mice encoding a protein of previously unknown function. Immunodepletion of p81 from Xenopus egg extracts, which also results in the removal of Xorc2, completely abolishes chromosomal DNA replication. Thus, p81 appears to play a crucial role at S phase in higher eukaryotes.	CALTECH, Div Biol, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Dunphy, WG (corresponding author), CALTECH, Div Biol, Howard Hughes Med Inst, Pasadena, CA 91125 USA.	dunphy@cco.caltech.edu						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; BELL SP, 1995, CELL, V83, P563, DOI 10.1016/0092-8674(95)90096-9; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Carpenter PB, 1996, NATURE, V379, P357, DOI 10.1038/379357a0; CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; DIFFLEY JFX, 1992, NATURE, V357, P169, DOI 10.1038/357169a0; DIFFLEY JFX, 1994, CELL, V78, P303, DOI 10.1016/0092-8674(94)90299-2; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; GAVIN KA, 1995, SCIENCE, V270, P1667, DOI 10.1126/science.270.5242.1667; GOSSEN M, 1995, SCIENCE, V270, P1674, DOI 10.1126/science.270.5242.1674; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KUMAGAI A, 1995, MOL BIOL CELL, V6, P199, DOI 10.1091/mbc.6.2.199; Leatherwood J, 1996, NATURE, V379, P360, DOI 10.1038/379360a0; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; MUELLER PR, 1995, MOL BIOL CELL, V6, P119, DOI 10.1091/mbc.6.1.119; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Romanowski P, 1996, CURR BIOL, V6, P1416, DOI 10.1016/S0960-9822(96)00746-4; Rowles A, 1996, CELL, V87, P287, DOI 10.1016/S0092-8674(00)81346-X; Sato N, 1997, EMBO J, V16, P4340, DOI 10.1093/emboj/16.14.4340; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766; Shou WY, 1996, MOL BIOL CELL, V7, P457, DOI 10.1091/mbc.7.3.457; SMYTHE C, 1991, METHOD CELL BIOL, V35, P449; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; YAN H, 1995, J CELL BIOL, V129, P1, DOI 10.1083/jcb.129.1.1	30	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24891	24897		10.1074/jbc.273.38.24891	http://dx.doi.org/10.1074/jbc.273.38.24891			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733795	Green Accepted, hybrid			2022-12-27	WOS:000076007300087
J	Damer, CK; Partridge, J; Pearson, WR; Haystead, TAJ				Damer, CK; Partridge, J; Pearson, WR; Haystead, TAJ			Rapid identification of protein phosphatase 1-binding proteins by mixed peptide sequencing and data base searching - Characterization of a novel holoenzymic form of protein phosphatase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE; REGULATORY SUBUNITS; PURIFICATION; MYOSIN; TYROSINE; CDNA; GENE	Microcystin-affinity chromatography was used to purify 15 protein phosphatase 1 (PP1)-binding proteins from the myofibrillar fraction of rabbit skeletal muscle. To reduce the time and amount of material required to identify these proteins, proteome analysis by mixed pep tide sequencing was developed. Proteins are resolved by SDS-polyacrylamide gel electrophoresis, electroblotted to polyvinylidene fluoride membrane, and stained. Bands are sliced from the membrane, cleaved briefly with CnBr, and applied without further purification to an automated Edman sequencer. The mixed peptide sequences generated are sorted and matched against the GenBank using two new programs, FASTF and TFASTF. This technology offers a simple alternative to mass spectrometry for the subpicomolar identification of proteins in polyacrylamide gels. Using this technology, all 15 proteins recovered in PP-1C affinity chromatography were sequenced. One of the proteins, PP-1bp55, was homologous to human myosin phosphatase, MYPT2. A second, PP-1bp80, identified in the EST data bases, contained a putative PP-1C binding site and a nucleotide binding motif. Further affinity purification over ATP-Sepharose isolated PP-1bp80 in a quaternary complex with PP-1C and two other proteins, PP-1bp29 and human p20, Recombinant PP-1bp80 also bound PP-1C and suppressed its activity toward a variety of substrates, suggesting that the protein is a novel regulatory subunit of PP-1.	Univ Virginia, Markey Ctr Cell Signaling & Biochem, Dept Pharmacol, Charlottesville, VA 22908 USA	University of Virginia	Haystead, TAJ (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Pharmacol, Box 448, Charlottesville, VA 22908 USA.		Pearson, William/K-4908-2019	Pearson, William/0000-0002-0727-3680	NHLBI NIH HHS [HL19242] Funding Source: Medline; NIDDK NIH HHS [DK52378A] Funding Source: Medline; NLM NIH HHS [LM04969] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL019242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052378] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM004969] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		BRANDL CJ, 1986, CELL, V44, P597, DOI 10.1016/0092-8674(86)90269-2; Campos M, 1996, J BIOL CHEM, V271, P28478, DOI 10.1074/jbc.271.45.28478; CHEN YH, 1994, FEBS LETT, V356, P51, DOI 10.1016/0014-5793(94)01231-8; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; DENT P, 1992, EUR J BIOCHEM, V210, P1037, DOI 10.1111/j.1432-1033.1992.tb17509.x; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; FLIEGEL L, 1987, P NATL ACAD SCI USA, V84, P1167, DOI 10.1073/pnas.84.5.1167; Fujioka M, 1998, GENOMICS, V49, P59, DOI 10.1006/geno.1998.5222; HANKS SK, 1995, PROTEIN KINASE FACTS, P7; HAYSTEAD CMM, 1993, EUR J BIOCHEM, V214, P459, DOI 10.1111/j.1432-1033.1993.tb17942.x; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; INGEBRITSEN TS, 1983, SCIENCE, V221, P331, DOI 10.1126/science.6306765; KAHN P, 1995, SCIENCE, V270, P369, DOI 10.1126/science.270.5235.369; KATO K, 1994, J BIOL CHEM, V269, P15302; LAI EY, 1994, J MOL BIOL, V235, P377, DOI 10.1016/S0022-2836(05)80045-2; MATTHEWS RJ, 1991, IMMUNOGENETICS, V33, P33; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; SHENOLIKAR S, 1991, ADV SEC MESS PHOSPH, V23, P3; SHIMIZU H, 1994, J BIOL CHEM, V269, P30407; SHIRAZI A, 1994, J BIOL CHEM, V269, P31598; TATUSOV RL, 1994, P NATL ACAD SCI USA, V91, P12091, DOI 10.1073/pnas.91.25.12091; TUNG HYL, 1984, EUR J BIOCHEM, V138, P635, DOI 10.1111/j.1432-1033.1984.tb07962.x; 1996, Patent No. 5536822	23	61	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24396	24405		10.1074/jbc.273.38.24396	http://dx.doi.org/10.1074/jbc.273.38.24396			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733729	hybrid			2022-12-27	WOS:000076007300021
J	Posern, G; Weber, CK; Rapp, UR; Feller, SM				Posern, G; Weber, CK; Rapp, UR; Feller, SM			Activity of Rap1 is regulated by bombesin, cell adhesion, and cell density in NIH3T3 fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; DEPENDENT ACTIVATION; GROWTH-FACTORS; B-RAF; TYROSINE PHOSPHORYLATION; DIFFERENTIAL REGULATION; LYSOPHOSPHATIDIC ACID; SIGNALING PATHWAYS; DNA-SYNTHESIS; CYCLIC-AMP	Rap1 and Ras are homologous GTPases that are implicated in cell proliferation and differentiation. At present, little is known about the regulation of Rap1 activity. Using a recently developed assay with activation-specific probes, we found increased activity of endogenous Rap1 in NIH3T3 cells after stimulation with the neuropeptide growth factor bombesin in a concentration- and time-dependent manner. The activity of endogenous Ras was unaffected. Analysis of putative effecters showed no activation of c-Raf-1 or B-Raf after bombesin stimulation. However, MAPH/Erk-phosphorylation and the proliferation rate was increased. In addition, Rap1 was activated during cell adhesion to coated and uncoated tissue culture plates, as well as in response to various mitogens. Surprisingly, the basal Rap1 activity was observed to be cell density-dependent, with low levels when cells were reaching confluency. The results suggest that Rap1 acts as an important mediator of mitogenic signals distinct to Ras activation.	Univ Wurzburg, Inst Med Strahlenkunde & Zellforsch, Mol Oncol Lab, D-97078 Wurzburg, Germany	University of Wurzburg	Feller, SM (corresponding author), Univ Wurzburg, Inst Med Strahlenkunde & Zellforsch, Mol Oncol Lab, Versbacher Str 5, D-97078 Wurzburg, Germany.							ALTSCHULER DL, 1995, J BIOL CHEM, V270, P10373, DOI 10.1074/jbc.270.18.10373; Bos JL, 1997, BBA-REV CANCER, V1333, pM19, DOI 10.1016/S0304-419X(97)00015-2; Casamassima A, 1997, J BIOL CHEM, V272, P9363; CUTTITTA F, 1985, NATURE, V316, P823, DOI 10.1038/316823a0; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; ERHARDT P, 1995, MOL CELL BIOL, V15, P5524; FAURE M, 1995, MOL BIOL CELL, V6, P1025, DOI 10.1091/mbc.6.8.1025; FELLER SM, 1995, ONCOGENE, V10, P1465; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Marais R, 1998, SCIENCE, V280, P109, DOI 10.1126/science.280.5360.109; MITCHELL FM, 1995, J BIOL CHEM, V270, P8623, DOI 10.1074/jbc.270.15.8623; Posern G, 1998, ONCOGENE, V16, P1903, DOI 10.1038/sj.onc.1201714; REUTER CWM, 1995, J BIOL CHEM, V270, P7644, DOI 10.1074/jbc.270.13.7644; ROCHE S, 1995, MOL CELL BIOL, V15, P1102; ROZENGURT E, 1995, CANCER SURV, V24, P81; SETHI T, 1992, CANCER RES, V52, pS2737; Seufferlein T, 1996, MOL BIOL CELL, V7, P1865, DOI 10.1091/mbc.7.12.1865; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Vuori K, 1996, MOL CELL BIOL, V16, P2606; Wixler V, 1996, FEBS LETT, V385, P131, DOI 10.1016/0014-5793(96)00363-8; Yao H, 1998, J BIOL CHEM, V273, P8240, DOI 10.1074/jbc.273.14.8240; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; YOSHIDA Y, 1992, MOL CELL BIOL, V12, P3407, DOI 10.1128/MCB.12.8.3407	26	57	57	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24297	24300		10.1074/jbc.273.38.24297	http://dx.doi.org/10.1074/jbc.273.38.24297			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733713	hybrid			2022-12-27	WOS:000076007300005
J	Sark, MWJ; Fischer, DF; de Meijer, E; van de Putte, P; Backendorf, C				Sark, MWJ; Fischer, DF; de Meijer, E; van de Putte, P; Backendorf, C			AP-1 and ets transcription factors regulate the expression of the human SPRR1A keratinocyte terminal differentiation marker	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORNIFIED CELL-ENVELOPE; PROLINE-RICH PROTEINS; HUMAN EPIDERMAL-KERATINOCYTES; CROSS-LINKED ENVELOPE; HUMAN-CHROMOSOME 1Q21; GENE-EXPRESSION; PROXIMAL PROMOTER; C-JUN; CHLORAMPHENICOL ACETYLTRANSFERASE; MOUSE KERATINOCYTES	The 173-base pair proximal promoter of SPRR1A is necessary and sufficient for regulated expression in primary keratinocytes induced to differentiate either by increasing extracellular calcium or by 12-O-tetradecanoylphorbol-13-acetate (TPA) treatment. Whereas calcium-induced expression depends both on an AP-1 and an Ets binding site in this region, responsiveness to TPA resides mainly (but not exclusively) on the Ets element, indicating that Ets factors are important targets for protein kinase C signaling during keratinocyte terminal differentiation. This conclusion is further substantiated by the finding that expression of ESE-1, an Ets transcription factor involved in SPRR regulation, is also induced by TPA, with kinetics similar to SPRR1A. The strict AP-1 requirement in SPRR1A for calcium-induced differentiation is not found for SPRR2A, despite the presence of an identical AP-I consensus binding site in this gene. Binding site swapping indicates that both the nucleotides flanking the TGAGTCA core sequence and the global promoter context are essential in determining the contribution of AP-1 factors in gene expression during keratinocyte terminal differentiation. In the distal SPRR1A promoter region, a complex arrangement of positive and negative regulatory elements, which are only conditionally needed for promoter activity, are likely involved in gene-specific fine-tuning of the expression of this member of the SPRR gene family.	Leiden Univ, Leiden Inst Chem, Mol Genet Lab, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Backendorf, C (corresponding author), Leiden Univ, Leiden Inst Chem, Mol Genet Lab, POB 9502, NL-2300 RA Leiden, Netherlands.	Backendo@chem.leidenuniv.nl		Fischer, David/0000-0002-6690-0197				AN G, 1993, J BIOL CHEM, V268, P10977; Andreoli JM, 1997, NUCLEIC ACIDS RES, V25, P4287, DOI 10.1093/nar/25.21.4287; BACKENDORF C, 1992, NAT GENET, V2, P91, DOI 10.1038/ng1092-91; BAUKNECHT T, 1995, J VIROL, V69, P1; Borden P, 1997, CRIT REV EUKAR GENE, V7, P159, DOI 10.1615/CritRevEukarGeneExpr.v7.i1-2.90; BRIATA P, 1993, EXP CELL RES, V204, P136, DOI 10.1006/excr.1993.1018; Byrne C, 1997, BIOESSAYS, V19, P691, DOI 10.1002/bies.950190809; BYRNE C, 1994, DEVELOPMENT, V120, P2369; CARRASCO D, 1995, ONCOGENE, V10, P1069; CREPIEUX P, 1994, CRIT REV ONCOGENESIS, V5, P615; DENNING MF, 1995, CELL GROWTH DIFFER, V6, P1619; DENNING MF, 1995, CELL GROWTH DIFFER, V6, P149; DISEPIO D, 1995, J BIOL CHEM, V270, P10792, DOI 10.1074/jbc.270.18.10792; Eckert RL, 1996, MOL BIOL REP, V23, P59, DOI 10.1007/BF00357073; ELLER MS, 1995, J CELL SCI, V108, P2714; Fischer DF, 1996, MOL CELL BIOL, V16, P5365, DOI 10.1128/mcb.16.10.5365; FUCHS E, 1994, CURR OPIN GENET DEV, V4, P725, DOI 10.1016/0959-437X(94)90140-X; Fujimoto W, 1997, J INVEST DERMATOL, V108, P200, DOI 10.1111/1523-1747.ep12334240; GANDARILLAS A, 1995, ONCOGENE, V11, P1403; GARMYN M, 1995, DERMATOLOGY, V190, P305, DOI 10.1159/000246722; GIBBS S, 1990, NUCLEIC ACIDS RES, V18, P4401, DOI 10.1093/nar/18.15.4401; Gibbs S, 1996, ARCH DERMATOL RES, V288, P729, DOI 10.1007/BF02505289; GIBBS S, 1993, GENOMICS, V16, P630, DOI 10.1006/geno.1993.1240; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; Gruda MC, 1996, ONCOGENE, V12, P2177; HOHL D, 1990, DERMATOLOGICA, V180, P201, DOI 10.1159/000248031; HOHL D, 1993, AM J DERMATOPATH, V15, P20, DOI 10.1097/00000372-199302000-00004; HOHL D, 1995, J INVEST DERMATOL, V104, P902, DOI 10.1111/1523-1747.ep12606176; HOHL D, 1991, J INVEST DERMATOL, V96, P414, DOI 10.1111/1523-1747.ep12469779; Holbrook K., 1994, KERATINOCYTE HDB, P3; Jang SI, 1996, J BIOL CHEM, V271, P24105, DOI 10.1074/jbc.271.39.24105; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kartasova T, 1996, J INVEST DERMATOL, V106, P294, DOI 10.1111/1523-1747.ep12340741; KARTASOVA T, 1988, MOL CELL BIOL, V8, P2195, DOI 10.1128/MCB.8.5.2195; KARTASOVA T, 1988, MOL CELL BIOL, V8, P2204, DOI 10.1128/MCB.8.5.2204; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LaPres JJ, 1996, J BIOL CHEM, V271, P23154, DOI 10.1074/jbc.271.38.23154; Lee JH, 1996, J BIOL CHEM, V271, P4561; LIN S, 1972, J MOL BIOL, V72, P671, DOI 10.1016/0022-2836(72)90184-2; Lohman FP, 1997, EXP CELL RES, V231, P141, DOI 10.1006/excr.1996.3458; Lohman FP, 1997, ONCOGENE, V14, P1623, DOI 10.1038/sj.onc.1200974; LopezBayghen E, 1996, J BIOL CHEM, V271, P512, DOI 10.1074/jbc.271.1.512; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; Marenholz I, 1996, GENOMICS, V37, P295, DOI 10.1006/geno.1996.0563; MARVIN KW, 1992, P NATL ACAD SCI USA, V89, P11026, DOI 10.1073/pnas.89.22.11026; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; Missero C, 1996, MOL CELL DIFFER, V4, P1; NEUMANN JR, 1987, BIOTECHNIQUES, V5, P444; Oettgen P, 1997, MOL CELL BIOL, V17, P4419, DOI 10.1128/MCB.17.8.4419; Parker JN, 1997, CELL GROWTH DIFFER, V8, P751; Ponec M, 1997, ARCH DERMATOL RES, V289, P317, DOI 10.1007/s004030050198; REDDY SPM, 1995, J BIOL CHEM, V270, P26451, DOI 10.1074/jbc.270.44.26451; Rice R.H., 1994, KERATINOCYTE HDB, P259; RICE RH, 1979, CELL, V18, P681, DOI 10.1016/0092-8674(79)90123-5; Robinson NA, 1997, J BIOL CHEM, V272, P12035, DOI 10.1074/jbc.272.18.12035; Rutberg SE, 1997, ONCOGENE, V15, P1337, DOI 10.1038/sj.onc.1201293; Rutberg SE, 1996, ONCOGENE, V13, P167; RYSECK RP, 1991, ONCOGENE, V6, P533; Saunders N, 1996, J DERMATOL SCI, V13, P98, DOI 10.1016/S0923-1811(96)00535-X; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SHRIVASTAVA A, 1994, NUCLEIC ACIDS RES, V22, P5151, DOI 10.1093/nar/22.24.5151; STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702; Steinert PM, 1997, J BIOL CHEM, V272, P2021, DOI 10.1074/jbc.272.3.2021; Tesfaigzi J, 1996, AM J RESP CELL MOL, V14, P478, DOI 10.1165/ajrcmb.14.5.8624253; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; VOLZ A, 1993, GENOMICS, V18, P92, DOI 10.1006/geno.1993.1430; Welter JF, 1995, ONCOGENE, V11, P2681; WELTER JF, 1995, J BIOL CHEM, V270, P12614, DOI 10.1074/jbc.270.21.12614	68	67	68	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24683	24692		10.1074/jbc.273.38.24683	http://dx.doi.org/10.1074/jbc.273.38.24683			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733767	hybrid			2022-12-27	WOS:000076007300059
J	Tian, D; Huang, DL; Short, S; Short, ML; Jungmann, RA				Tian, D; Huang, DL; Short, S; Short, ML; Jungmann, RA			Protein kinase A-regulated instability site in the 3 '-untranslated region of lactate dehydrogenase-A subunit mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; CYCLIC-AMP REGULATION; C6 GLIOMA-CELLS; GENE-EXPRESSION; EUKARYOTIC CELLS; HALF-LIFE; TRANSCRIPTION; PROMOTER; GROWTH; DECAY	Expression of the lactate dehydrogenase A subunit (LDH-A) gene can be controlled by transcriptional as well as posttranscriptional mechanisms, In rat C6 glioma cells, LDH-A mRNA is stabilized by activation and synergistic interaction of protein kinases A and C, In the present study, we aimed to identify the sequence domain which determines and regulates mRNA stability/instability by protein kinase A and focused our attention on the 3'-untranslated region (3'-UTR) of LDH-A mRNA. We have constructed various chimeric globin/lactate dehydrogenase (ldh) genes linked to the c-fos promoter and stably transfected them into rat C6 glioma cells, After their transfection, we determined the half-life of transcribed chimeric globin/ldh mRNAs, The results showed that at least three sequence domains within the LDH-A 3'-UTR consisting of nucleotides 1286-1351, 1453-1471, and 1471-1502 are responsible for the relatively rapid rate of LDH-A mRNA turnover in the cytoplasm, Whereas chimeric globin/ldh mRNAs containing the base sequences 1286-1351 and 1453-1471 were not stabilized by (S-p)-cAMPS, an activator of protein kinase A, instability caused by the 1471-1502 domain was significantly reversed. Additional deletion and mutational analyses demonstrated that the 3'-UTR fragment consisting of the 22 bases 1478-1499 is a critical determinant for the (S-p)-cAMPS-mediated LDH-A mRNA stabilizing activity, Because of its functional characteristics, we named the 22-base region "cAMP-stabilizing region."	Northwestern Univ, Sch Med, Dept Cellular & Mol Biol, Chicago, IL 60611 USA; Northwestern Univ, Ctr Canc, Chicago, IL 60611 USA	Northwestern University; Northwestern University	Jungmann, RA (corresponding author), Northwestern Univ, Sch Med, Dept Cellular & Mol Biol, Chicago, IL 60611 USA.	rjungman@nwu.edu			NIGMS NIH HHS [GM53115] Funding Source: Medline; NINDS NIH HHS [T32NS07140] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007140] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHERN SM, 1993, J BIOL CHEM, V268, P2154; Ausubel FM, 1987, CURRENT PROTOCOLS MO, V1-5; AVIV H, 1976, CELL, V8, P495, DOI 10.1016/0092-8674(76)90217-8; BANDYOPADHYAY R, 1990, MOL CELL BIOL, V10, P2060, DOI 10.1128/MCB.10.5.2060; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; CASEY JL, 1988, SCIENCE, V240, P924, DOI 10.1126/science.2452485; CHEN M, 1993, J BIOL CHEM, V268, P24138; CLEVELAND D W, 1989, New Biologist, V1, P121; DERDA DF, 1980, J BIOL CHEM, V255, P1112; DIAMOND DJ, 1985, J MOL BIOL, V181, P41, DOI 10.1016/0022-2836(85)90323-7; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GUYETTE WA, 1979, CELL, V17, P1013, DOI 10.1016/0092-8674(79)90340-4; HARROLD S, 1991, ANAL BIOCHEM, V198, P19, DOI 10.1016/0003-2697(91)90500-S; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HOD Y, 1988, J BIOL CHEM, V263, P7747; HUANG D, 1995, MOL CELL ENDOCRINOL, V108, P87, DOI 10.1016/0303-7207(94)03459-7; HUANG DL, 1995, MOL ENDOCRINOL, V9, P994, DOI 10.1210/me.9.8.994; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; JONES TR, 1987, MOL CELL BIOL, V7, P4513, DOI 10.1128/MCB.7.12.4513; JUNGMANN RA, 1983, J BIOL CHEM, V258, P5312; KWASTWELFELD J, 1989, J BIOL CHEM, V264, P6941; LEE C, 1979, J NATL CANCER I, V62, P193; LEVINE RA, 1986, MOL CELL BIOL, V6, P4112, DOI 10.1128/MCB.6.11.4112; LI SSL, 1989, CELL BIOL INT REP, V13, P619, DOI 10.1016/0309-1651(89)90112-4; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; LOWENHAUPT K, 1978, CELL, V14, P337, DOI 10.1016/0092-8674(78)90119-8; MALTER JS, 1989, SCIENCE, V246, P664, DOI 10.1126/science.2814487; MARKERT CL, 1962, DEV BIOL, V5, P363, DOI 10.1016/0012-1606(62)90019-2; MATRISIAN LM, 1985, NUCLEIC ACIDS RES, V13, P711, DOI 10.1093/nar/13.3.711; MITCHELL RL, 1985, CELL, V40, P209, DOI 10.1016/0092-8674(85)90324-1; MURPHY D, 1992, MOL CELL BIOL, V12, P2624, DOI 10.1128/MCB.12.6.2624; PALMITER RD, 1974, P NATL ACAD SCI USA, V71, P2357, DOI 10.1073/pnas.71.6.2357; RICHARDS AH, 1972, ENDOCRINOLOGY, V91, P287, DOI 10.1210/endo-91-1-287; RODGERS JR, 1985, METHOD ENZYMOL, V109, P572; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; ROSS J, 1988, MOL BIOL MED, V5, P1; RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0; SAKAUE M, 1991, J BIOL CHEM, V266, P5743; SCHUMPERLI D, 1986, CELL, V45, P471, DOI 10.1016/0092-8674(86)90277-1; Scott W A, 1975, Methods Enzymol, V40, P273; SHAPIRO DJ, 1989, RECENT PROG HORM RES, V45, P29; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; SHORT ML, 1994, BIOCHEM J, V304, P391, DOI 10.1042/bj3040391; SHORT S, 1991, J BIOL CHEM, V266, P22164; SHYU AB, 1989, GENE DEV, V3, P60, DOI 10.1101/gad.3.1.60; TIAN D, 1998, J BIOL CHEM, V273; VANOOYEN A, 1979, SCIENCE, V206, P337, DOI 10.1126/science.482942; VOLLOCH V, 1981, ORG EXPRESSION GLOBI, P251	50	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24861	24866		10.1074/jbc.273.38.24861	http://dx.doi.org/10.1074/jbc.273.38.24861			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733791	hybrid			2022-12-27	WOS:000076007300083
J	Brandt, JM; Djouadi, F; Kelly, DP				Brandt, JM; Djouadi, F; Kelly, DP			Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-SPECIFIC EXPRESSION; ACYL-COA DEHYDROGENASE; BROWN ADIPOSE-TISSUE; OXIDATION ENZYME; RAT-LIVER; HYPERTROPHY; METABOLISM; CDNA; FAILURE; HEART	To explore the gene regulatory mechanisms involved in the metabolic control of cardiac fatty acid oxidative flux, the expression of muscle-type carnitine palmitoyltransferase I (RI-CPT I) was characterized in primary cardiac myocytes in culture following exposure to the long-chain mono-unsaturated fatty acid, oleate, Oleate induced steady-state levels of M-CPT I mRNA 4.5-fold. The transcription of a plasmid construct containing the human M-CPT I gene promoter region fused to a luciferase gene reporter transfected into cardiac myocytes, was induced over 20-fold by long-chain fatty acid in a concentration-dependent and fatty acyl-chain length-specific manner. The M-CPT I gene promoter fatty acid response element (FARE-1) was localized to a hexameric repeat sequence located between 775 and 763 base pairs upstream of the initiator codon. Cotransfection experiments with expression vectors for the peroxisome proliferator-activated receptor alpha (PPAR alpha) demonstrated that FARE-1 isa PPAR alpha response element capable of conferring oleate-mediated transcriptional activation to homologous or heterologous promoters. Electrophoretic mobility shift assays demonstrated that PPAR alpha bound FARE-1 with the retinoid X receptor alpha. The expression of M-CPT I in hearts of mice nub for PPAR alpha was approximately 50% lower than levels in wild-type controls. Moreover, a PPAR alpha activator did not induce cardiac expression of the M-CPT I gene in the PPAR alpha null mice. These results demonstrate that long-chain fatty acids regulate the transcription of a gene encoding a pivotal enzyme in the mitochondrial fatty acid uptake pathway in cardiac myocytes and define a role for PPAR alpha in the control of myocardial lipid metabolism.	Washington Univ, Sch Med, Ctr Cardiovasc Res, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Ctr Cardiovasc Res, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Ctr Cardiovasc Res, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Univ Paris 07, INSERM U319, F-75251 Paris 05, France	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Kelly, DP (corresponding author), Washington Univ, Sch Med, Ctr Cardiovasc Res, Dept Pediat, 660 S Euclid Ave,Campus Box 8086, St Louis, MO 63110 USA.	dkelly@imgate.wustl.edu	DJOUADI, Fatima/C-6187-2019; Kelly, Daniel/ABG-2056-2021	Djouadi, Fatima/0000-0003-0350-0935	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045416, R01DK045416] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL58493] Funding Source: Medline; NIDDK NIH HHS [DK45416] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALPERT NR, 1982, CIRC RES, V50, P491, DOI 10.1161/01.RES.50.4.491; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; AssimacopoulosJeannet F, 1997, J BIOL CHEM, V272, P1659, DOI 10.1074/jbc.272.3.1659; BING RJ, 1955, HARVEY LECT, P27; BISHOP SP, 1970, AM J PHYSIOL, V218, P153, DOI 10.1152/ajplegacy.1970.218.1.153; BRITTON CH, 1995, P NATL ACAD SCI USA, V92, P1984, DOI 10.1073/pnas.92.6.1984; CARTER ME, 1994, MOL CELL BIOL, V14, P4360, DOI 10.1128/MCB.14.7.4360; Chatelain F, 1996, EUR J BIOCHEM, V235, P789, DOI 10.1111/j.1432-1033.1996.00789.x; CHRISTE ME, 1994, J MOL CELL CARDIOL, V26, P1371, DOI 10.1006/jmcc.1994.1155; Disch DL, 1996, MOL CELL BIOL, V16, P4043; Esser V, 1996, J BIOL CHEM, V271, P6972, DOI 10.1074/jbc.271.12.6972; ESSER V, 1993, J BIOL CHEM, V268, P5817; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; GEBEL T, 1992, FEBS LETT, V309, P37, DOI 10.1016/0014-5793(92)80734-X; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; GULICK T, 1994, P NATL ACAD SCI USA, V91, P11012, DOI 10.1073/pnas.91.23.11012; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; KELLY DP, 1989, J BIOL CHEM, V264, P18921; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lemberger T, 1996, ANNU REV CELL DEV BI, V12, P335, DOI 10.1146/annurev.cellbio.12.1.335; LEONE TC, 1995, J BIOL CHEM, V270, P16308, DOI 10.1074/jbc.270.27.16308; LEVY FH, 1997, AM J PHYSIOL, V41, pC457; Mascaro C, 1998, J BIOL CHEM, V273, P8560, DOI 10.1074/jbc.273.15.8560; MASSIE BM, 1995, CIRCULATION, V91, P1814, DOI 10.1161/01.CIR.91.6.1814; MCGARRY JD, 1983, BIOCHEM J, V214, P21, DOI 10.1042/bj2140021; MCGARRY JD, 1995, BIOCHEM SOC T, V23, P321, DOI 10.1042/bst0230321; MCGARRY JD, 1989, DIABETES METAB REV, V5, P271, DOI 10.1002/dmr.5610050305; MOALIC JM, 1993, CIRCULATION, V87, P21; NAGAO M, 1993, J BIOL CHEM, V268, P24114; NEELY J R, 1972, Progress in Cardiovascular Diseases, V15, P289, DOI 10.1016/0033-0620(72)90029-1; Sack MN, 1997, P NATL ACAD SCI USA, V94, P6438, DOI 10.1073/pnas.94.12.6438; Sack MN, 1996, CIRCULATION, V94, P2837, DOI 10.1161/01.CIR.94.11.2837; SCHEUER J, 1993, CIRCULATION, V87, P54; SINGH B, 1984, ANAL BIOCHEM, V138, P107, DOI 10.1016/0003-2697(84)90776-0; TAEGTMEYER H, 1988, HYPERTENSION, V11, P416, DOI 10.1161/01.HYP.11.5.416; TAEGTMEYER H, 1994, CURR PROB CARDIOLOGY, V19, P61, DOI 10.1016/0146-2806(94)90008-6; TAKEYAMA D, 1995, CARDIOVASC RES, V29, P763, DOI 10.1016/S0008-6363(96)88610-X; vanderLeij FR, 1997, BBA-GENE STRUCT EXPR, V1352, P123, DOI 10.1016/S0167-4781(97)00037-7; Yamazaki N, 1997, FEBS LETT, V409, P401, DOI 10.1016/S0014-5793(97)00561-9; YAMAZAKI N, 1995, FEBS LETT, V363, P41, DOI 10.1016/0014-5793(95)00277-G; Yamazaki N, 1996, BBA-GENE STRUCT EXPR, V1307, P157, DOI 10.1016/0167-4781(96)00069-3	43	380	393	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23786	23792		10.1074/jbc.273.37.23786	http://dx.doi.org/10.1074/jbc.273.37.23786			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726988	hybrid			2022-12-27	WOS:000075893100029
J	Klezovitch, O; Edelstein, C; Zhu, LY; Scanu, AM				Klezovitch, O; Edelstein, C; Zhu, LY; Scanu, AM			Apolipoprotein(a) binds via its C-terminal domain to the protein core of the proteoglycan decorin - Implications for the retention of lipoprotein(a) in atherosclerotic lesions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DERMATAN SULFATE PROTEOGLYCANS; CYCLIN-DEPENDENT KINASES; LOW-DENSITY-LIPOPROTEIN; RECOMBINANT APOLIPOPROTEIN(A); EXTRACELLULAR-MATRIX; APO-B; PROTEODERMATAN SULFATE; ARTICULAR-CARTILAGE; GROWTH SUPPRESSION; CORONARY-ARTERIES	Although it is known that lipoprotein(a) (Lp(a)) binds to proteoglycans, the mechanism for this binding has not been fully elucidated. In order to shed light on this subject, we examined the interactions of decorin, a proteoglycan with a well defined protein core and a single glycosaminoglycan (GAG) chain, with Lp(a) and derivatives, namely Lp(a) deprived of apo(a), or Lp(a-), free apo(a), and the two main proteolytic fragments, F1 and F2, By circular dichroism criteria, the decorin preparations used had the same secondary structure as that previously reported for native decorin. Authentic low density lipoprotein from the same human donor was used as a control. In a solid phase system, Lp(a-)and low density lipoprotein hound to decorin in a comparable manner. This binding required Ca2+/Mg2+ ions, was lysine-mediated, and was markedly decreased in the presence of GAG-depleted decorin, suggesting the ionic nature of the interaction likely involving apoB100 and the GAG component of decorin, Free apo(a) also bound to decorin; however, the binding was neither cation-dependent nor lysine-mediated, unaffected by sialic acid depletion of apo(a), and markedly decreased when either reduced and alkylated apo(a) or reduced and alkylated decorin was used in the assay. Of note, the binding of apo(a) was unaffected when it was incubated with a spectrally native decorin that had been renatured from either 4 M guanidine hydrochloride by extensive dialysis or cooled from 65 to 25 degrees C, On the other hand, the binding significantly increased when decorin was depleted of GAGs, which by themselves had no affinity for apo(a), The binding of apo(a) to the decorin protein core was also elicited by the C-terminal domain of apo(a), and it was favored by high NaCl concentrations, 1 to 2 M, No binding was exhibited by the N-terminal domain accounting for the lack of effect of apo(a) size polymorphism on the binding. In the case of whole Lp(a), the binding to immobilized decorin was mostly GAG-dependent and ionic in nature. A minor contribution by apo(a) was detected when GAG-depleted decorin was used in the assay. Our results indicate that the binding of Lp(a) to decorin involves interactions both electrostatic (apoB100-GAG) and hydrophobic (apo(a)-decorin protein core), and that the binding of apo(a) requires decorin protein core to be in its native state.	Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Klezovitch, O (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC5041, Chicago, IL 60637 USA.	oklezovi@medicine.bsd.uchicago.edu			NHLBI NIH HHS [HL-18577] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018577] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adler A J, 1973, Methods Enzymol, V27, P675; ASUNDI VK, 1992, EUR J CELL BIOL, V59, P314; BIHARIVARGA M, 1988, ARTERIOSCLEROSIS, V8, P851, DOI 10.1161/01.ATV.8.6.851; CHANG CT, 1978, ANAL BIOCHEM, V91, P12; CHOI HU, 1989, J BIOL CHEM, V264, P2876; CHRISTNER JE, 1990, ANAL BIOCHEM, V184, P388, DOI 10.1016/0003-2697(90)90698-9; CUSHING GL, 1989, ARTERIOSCLEROSIS, V9, P593, DOI 10.1161/01.ATV.9.5.593; DAHLEN C, 1978, CLIN GENET, V14, P36; DAY AA, 1987, BIOCHEM J, V248, P801, DOI 10.1042/bj2480801; DeLuca A, 1996, J BIOL CHEM, V271, P18961, DOI 10.1074/jbc.271.31.18961; Edelstein C, 1996, J LIPID RES, V37, P1786; Edelstein C, 1995, BIOCHEMISTRY-US, V34, P16483, DOI 10.1021/bi00050a032; Edelstein C, 1997, J BIOL CHEM, V272, P11079; EDELSTEIN C, 1997, CIRCULATION S, V96, P111; ERNST A, 1995, J BIOL CHEM, V270, P6227, DOI 10.1074/jbc.270.11.6227; FLESS GM, 1989, J LIPID RES, V30, P651; FLESS GM, 1986, J BIOL CHEM, V261, P8712; FLESS GM, 1994, BIOCHEMISTRY-US, V33, P13492, DOI 10.1021/bi00249a038; FRANK S, 1995, ARTERIOSCL THROM VAS, V15, P1774, DOI 10.1161/01.ATV.15.10.1774; HARPEL PC, 1989, P NATL ACAD SCI USA, V86, P3847, DOI 10.1073/pnas.86.10.3847; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; HOFF HF, 1993, J LIPID RES, V34, P789; HurtCamejo E, 1997, ARTERIOSCL THROM VAS, V17, P1011, DOI 10.1161/01.ATV.17.6.1011; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; JARVELAINEN HT, 1992, EXP CELL RES, V203, P395, DOI 10.1016/0014-4827(92)90013-X; JARVELAINEN HT, 1991, J BIOL CHEM, V266, P23274; Klezovitch O, 1996, J CLIN INVEST, V98, P185, DOI 10.1172/JCI118765; KLEZOVITCH O, 1997, CIRCULATION S, V96, P112; KRESSE H, 1994, EUR J CLIN CHEM CLIN, V32, P259; KREUZER J, 1994, CHEM PHYS LIPIDS, V67-8, P175, DOI 10.1016/0009-3084(94)90137-6; KRUSIUS T, 1986, P NATL ACAD SCI USA, V83, P7683, DOI 10.1073/pnas.83.20.7683; LACKNER C, 1993, HUM MOL GENET, V2, P933, DOI 10.1093/hmg/2.7.933; LACKNER C, 1991, J CLIN INVEST, V87, P2153, DOI 10.1172/JCI115248; LAWN RM, 1996, ATHEROSCLEROSIS CORO, P151; Libby P, 1997, CIRCULATION, V96, P4095; LIBBY P, 1997, INT J CARDIOL S2, V62, P23; Lin H, 1996, J HEART LUNG TRANSPL, V15, P1223; MARCOVINA SM, 1993, BIOCHEM BIOPH RES CO, V191, P1192, DOI 10.1006/bbrc.1993.1343; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; PEPIN JM, 1991, J LIPID RES, V32, P317; PHILLIPS ML, 1993, BIOCHEMISTRY-US, V32, P3722, DOI 10.1021/bi00065a026; PULKKINEN L, 1992, CYTOGENET CELL GENET, V60, P107, DOI 10.1159/000133314; Ramamurthy P, 1996, J BIOL CHEM, V271, P19578, DOI 10.1074/jbc.271.32.19578; RATH M, 1989, ARTERIOSCLEROSIS, V9, P579, DOI 10.1161/01.ATV.9.5.579; REBLIN T, 1995, ATHEROSCLEROSIS, V113, P179, DOI 10.1016/0021-9150(94)05445-O; RENUGOPALAKRISHNAN V, 1989, BIOPOLYMERS, V28, P1923, DOI 10.1002/bip.360281109; RIESSEN R, 1994, AM J PATHOL, V144, P962; ROSENBERG LC, 1985, J BIOL CHEM, V260, P6304; ROUGHLEY PJ, 1989, BIOCHEM J, V262, P823, DOI 10.1042/bj2620823; ROUY D, 1992, BIOCHEMISTRY-US, V31, P6333, DOI 10.1021/bi00142a024; SALONEN EM, 1989, EMBO J, V8, P4035, DOI 10.1002/j.1460-2075.1989.tb08586.x; Santra M, 1997, J CLIN INVEST, V100, P149, DOI 10.1172/JCI119507; SCANU AM, 1995, BBA-LIPID LIPID MET, V1256, P1, DOI 10.1016/0005-2760(95)00012-2; SCHONHERR E, 1995, J BIOL CHEM, V270, P2776, DOI 10.1074/jbc.270.6.2776; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; SCOTT PG, 1986, BIOCHEM BIOPH RES CO, V138, P1348, DOI 10.1016/S0006-291X(86)80431-4; SMITH EB, 1990, ATHEROSCLEROSIS, V84, P173, DOI 10.1016/0021-9150(90)90088-Z; VANDERHOEK YY, 1993, HUM MOL GENET, V2, P361, DOI 10.1093/hmg/2.4.361; VANDERHOEK YY, 1994, ARTERIOSCLER THROMB, V14, P1792, DOI 10.1161/01.ATV.14.11.1792; WIGHT TN, 1996, ATHEROSCLEROSIS CORO, P421	62	34	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23856	23865		10.1074/jbc.273.37.23856	http://dx.doi.org/10.1074/jbc.273.37.23856			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726998	hybrid			2022-12-27	WOS:000075893100039
J	Meijer, MMC; Boonstra, J; Verkleij, AJ; Verrips, CT				Meijer, MMC; Boonstra, J; Verkleij, AJ; Verrips, CT			Glucose repression in Saccharomyces cerevisiae is related to the glucose concentration rather than the glucose flux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDIVIDUAL HEXOSE TRANSPORTERS; LIMITED CONTINUOUS CULTURES; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; GLYCOLYTIC-ENZYMES; SUC2 GENE; HXT GENES; YEAST; AFFINITY; PHOSPHORYLATION	Glucose plays an important regulatory role in the yeast Saccharomyces cerevisiae, which is mostly reflected at the transcriptional level by glucose regression. The signal that initiates glucose repression is unknown, but data indicate that it is located at or above the level of glucose 6-phosphate, suggesting the involvement of either the intracellular or extracellular glucose concentration or the glucose flux in triggering glucose repression. We have investigated the role of the glucose flux and the extracellular glucose concentration in glucose repression by growing the cells in continuous culture under nitrogen limitation. By a step-wise increase ire the glucose feed concentration, the glucose flux and extracellular glucose concentrations were modulated in an accurate way. Furthermore, the glucose flux and glucose concentrations were modulated undependently of each other by increasing the dilution rate or by the use of fructose as a substrate. Using these approaches we demonstrate that glucose repression is related to the extracellular (or intracellular) glucose concentration rather than the glucose flux, At external glucose concentrations Bower than 14 mM, glucose repression of SUC2 gene transcription was not triggered,, whereas glucose repression of this gene was activated when the glucose concentration exceeded 18 mM. A comparable effect was observed for the glucose-repressible carbon source fructose.	Univ Utrecht, Dept Mol Cell Biol, Biomembrane Inst, NL-3584 CH Utrecht, Netherlands; Unilever Res Labs Vlaardingen, NL-3133 AT Vlaardingen, Netherlands	Utrecht University; Unilever	Meijer, MMC (corresponding author), Univ Utrecht, Dept Mol Cell Biol, Biomembrane Inst, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	M.M.C.Meijer@bio.uu.nl						BISSON LF, 1993, CRIT REV BIOCHEM MOL, V28, P259, DOI 10.3109/10409239309078437; BISSON LF, 1983, P NATL ACAD SCI-BIOL, V80, P1730, DOI 10.1073/pnas.80.6.1730; BROACH JR, 1991, TRENDS GENET, V7, P28, DOI 10.1016/0168-9525(91)90018-L; CARLSON M, 1987, J BACTERIOL, V169, P4873, DOI 10.1128/jb.169.11.4873-4877.1987; COONS DM, 1995, J BACTERIOL, V177, P3251, DOI 10.1128/jb.177.11.3251-3258.1995; DEKONING W, 1992, ANAL BIOCHEM, V204, P118, DOI 10.1016/0003-2697(92)90149-2; ENTIAN KD, 1984, MOL GEN GENET, V198, P50, DOI 10.1007/BF00328699; FIECHTER A, 1981, ADV MICROB PHYSIOL, V22, P123, DOI 10.1016/S0065-2911(08)60327-6; GANCEDO JM, 1992, EUR J BIOCHEM, V206, P297, DOI 10.1111/j.1432-1033.1992.tb16928.x; HARDER W, 1976, CONTINUOUS CULTURE, V6; HAWKINS PT, 1993, J BIOL CHEM, V268, P3374; HERBERT D, 1956, J GEN MICROBIOL, V14, P601, DOI 10.1099/00221287-14-3-601; HU Z, 1995, CURR GENET, V28, P258, DOI 10.1007/BF00309785; JOHNSTON M, 1987, MICROBIOL REV, V51, P458, DOI 10.1128/MMBR.51.4.458-476.1987; JOHNSTON M, 1992, MOL CELLULAR BIOL YE, P193; MA H, 1989, MOL CELL BIOL, V9, P5643, DOI 10.1128/MCB.9.12.5643; NEEDLEMAN R, 1991, MOL MICROBIOL, V5, P2079, DOI 10.1111/j.1365-2958.1991.tb02136.x; NEIGEBORN L, 1984, GENETICS, V108, P845; Ozcan S, 1996, MOL CELL BIOL, V16, P5536; OZCAN S, 1995, MOL CELL BIOL, V15, P1564; Ozcan S, 1996, P NATL ACAD SCI USA, V93, P12428, DOI 10.1073/pnas.93.22.12428; Ozcan S, 1997, YEAST, V13, P127; POSTMA E, 1989, APPL ENVIRON MICROB, V55, P468, DOI 10.1128/AEM.55.2.468-477.1989; REIFENBERGER E, 1995, MOL MICROBIOL, V16, P157, DOI 10.1111/j.1365-2958.1995.tb02400.x; Reifenberger E, 1997, EUR J BIOCHEM, V245, P324, DOI 10.1111/j.1432-1033.1997.00324.x; RONNE H, 1995, TRENDS GENET, V11, P12, DOI 10.1016/S0168-9525(00)88980-5; ROSE M, 1991, EUR J BIOCHEM, V199, P511, DOI 10.1111/j.1432-1033.1991.tb16149.x; SIERKSTRA LN, 1992, J GEN MICROBIOL, V138, P2559, DOI 10.1099/00221287-138-12-2559; SIERKSTRA LN, 1993, YEAST, V9, P787, DOI 10.1002/yea.320090713; Smits HP, 1996, YEAST, V12, P439, DOI 10.1002/(SICI)1097-0061(199604)12:5<439::AID-YEA925>3.3.CO;2-N; TERSCHURE EG, 1995, MICROBIOL-UK, V141, P1101, DOI 10.1099/13500872-141-5-1101; THEVELEIN JM, 1992, ANTON LEEUW INT J G, V62, P109, DOI 10.1007/BF00584466; THEVELEIN JM, 1994, YEAST, V10, P1753, DOI 10.1002/yea.320101308; Thevenod-Fosse P., 1991, J SOFTWARE TESTING V, V1, P5; TRUMBLY RJ, 1992, MOL MICROBIOL, V6, P15, DOI 10.1111/j.1365-2958.1992.tb00832.x; VANDIJKEN JP, 1986, FEMS MICROBIOL LETT, V32, P199, DOI 10.1016/0378-1097(86)90291-0; WALSH MC, 1994, J BACTERIOL, V176, P953, DOI 10.1128/JB.176.4.953-958.1994; WENDELL DL, 1993, J BACTERIOL, V175, P7689, DOI 10.1128/JB.175.23.7689-7696.1993; WEUSTHUIS RA, 1994, MICROBIOL REV, V58, P616, DOI 10.1128/MMBR.58.4.616-630.1994	39	75	77	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24102	24107		10.1074/jbc.273.37.24102	http://dx.doi.org/10.1074/jbc.273.37.24102			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727030	hybrid			2022-12-27	WOS:000075893100071
J	Mattingly, JR; Torella, C; Iriarte, A; Martinez-Carrion, M				Mattingly, JR; Torella, C; Iriarte, A; Martinez-Carrion, M			Conformation of aspartate aminotransferase isozymes folding under different conditions probed by limited proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE TRANSLATION SYSTEM; CHAPERONIN GROEL; DIHYDROFOLATE-REDUCTASE; STRUCTURAL FEATURES; HOMOLOGOUS PROTEINS; CRYSTAL-STRUCTURE; PRECURSOR; BINDING; IMPORT; CELL	The partially homologous mitochondrial (mAAT) and cytosolic (cAAT) aspartate aminotransferase have nearly identical three-dimensional structures but differ in their folding rates in cell-free extracts and in their affinity for binding to molecular chaperones. In its native state, each isozyme is protease-resistant. Using limited proteolysis as an index of their conformational states, we have characterized these proteins (a) during the early stages of spontaneous refolding; (b) as species trapped in stable complexes with the chaperonin GroEL; or (c) as newly translated polypeptides in cell-free extracts. Treatment of the refolding proteins with trypsin generates reproducible patterns of large proteolytic fragments that are consistent with the formation of defined folding domains soon after initiating refolding, Binding to GroEL affords considerable protection to both isozymes against proteolysis, The tryptic fragments are similar in size for both isozymes, suggesting a common distribution of compact and flexible regions in their folding intermediates. cAAT synthesized in cell-free extracts becomes protease-resistant almost instantaneously, whereas trypsin digestion-of the mAAT translation product produces a pattern of fragments qualitatively akin to that observed with the protein refolding in buffer. Analysis of the large tryptic peptides obtained with the GroEL-bound proteins reveals that the cleavage sites are located in analogous regions of the N-terminal portion of each isozyme, These results suggest that (a) binding to GroEL does not cause unfolding of AAT, at least to an extent detectable by proteolysis; (b) the compact folding domains identified in AAT bound to GroEL (or in mAAT fresh translation product) are already present at the early stages of refolding of the proteins in buffer alone; and (c) the two isozymes seem to bind in a similar fashion to GroEL, with the more compact C-terminal portion completely protected and the more flexible N-terminal first 100 residues still partially accessible to proteolysis.	Univ Missouri, Sch Biol Sci, Div Biochem & Mol Biol, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City	Martinez-Carrion, M (corresponding author), Univ Missouri, Sch Biol Sci, Div Biochem & Mol Biol, Kansas City, MO 64110 USA.	mshoemaker@cctr.umkc.edu						Artigues A, 1997, J BIOL CHEM, V272, P16852, DOI 10.1074/jbc.272.27.16852; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Brazil BT, 1997, J BIOL CHEM, V272, P5105, DOI 10.1074/jbc.272.8.5105; Buckle AM, 1997, P NATL ACAD SCI USA, V94, P3571, DOI 10.1073/pnas.94.8.3571; Cai K, 1996, J BIOL CHEM, V271, P2987, DOI 10.1074/jbc.271.6.2987; Clark AC, 1996, BIOCHEMISTRY-US, V35, P5893, DOI 10.1021/bi953051v; Clark AC, 1997, J MOL BIOL, V268, P512, DOI 10.1006/jmbi.1997.0969; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; DOONAN S, 1975, BIOCHEM J, V149, P497, DOI 10.1042/bj1490497d; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; Ellis RJ, 1996, FASEB J, V10, P20, DOI 10.1096/fasebj.10.1.8566542; Fedorov AN, 1997, J BIOL CHEM, V272, P32715, DOI 10.1074/jbc.272.52.32715; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Fenton WA, 1997, PROTEIN SCI, V6, P743; Gervasoni P, 1996, P NATL ACAD SCI USA, V93, P12189, DOI 10.1073/pnas.93.22.12189; Goldberg MS, 1997, P NATL ACAD SCI USA, V94, P1080, DOI 10.1073/pnas.94.4.1080; HUBBARD SJ, 1994, PROTEIN SCI, V3, P757; IRIARTE A, 1984, CHEM BIOL ASPECTS B, P269; Jansonius J.N., 1987, BIOL MACROMOLECULES, P187; LAIN B, 1994, J BIOL CHEM, V269, P15588; LAIN B, 1995, J BIOL CHEM, V270, P24732, DOI 10.1074/jbc.270.42.24732; LAMINET AA, 1990, EMBO J, V9, P2315, DOI 10.1002/j.1460-2075.1990.tb07403.x; MALASHKEVICH VN, 1995, J MOL BIOL, V247, P111, DOI 10.1006/jmbi.1994.0126; MARTINEZCARRION M, 1990, ANN NY ACAD SCI, V585, P346, DOI 10.1111/j.1749-6632.1990.tb28067.x; MATTINGLY JR, 1987, BIOCHEM BIOPH RES CO, V149, P859, DOI 10.1016/0006-291X(87)90487-6; MATTINGLY JR, 1995, J BIOL CHEM, V270, P1138, DOI 10.1074/jbc.270.3.1138; MATTINGLY JR, 1993, J BIOL CHEM, V268, P3925; MATTINGLY JR, 1993, J BIOL CHEM, V268, P26320; MCPHALEN CA, 1992, J MOL BIOL, V225, P495, DOI 10.1016/0022-2836(92)90935-D; Mihara K, 1996, EXPERIENTIA, V52, P1063, DOI 10.1007/BF01952103; Miranker AD, 1996, CURR OPIN STRUC BIOL, V6, P31, DOI 10.1016/S0959-440X(96)80092-3; Parker MJ, 1996, BIOCHEMISTRY-US, V35, P15740, DOI 10.1021/bi961330s; PAVEPREUX M, 1988, J BIOL CHEM, V263, P17459; Persson M, 1996, BBA-PROTEIN STRUCT M, V1298, P191, DOI 10.1016/S0167-4838(96)00125-2; RANSON NA, 1995, J MOL BIOL, V250, P581, DOI 10.1006/jmbi.1995.0399; REYES AM, 1993, J BIOL CHEM, V268, P22281; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; SANDMEIER E, 1980, J BIOL CHEM, V255, P284; Schatz G, 1996, J BIOL CHEM, V271, P31763, DOI 10.1074/jbc.271.50.31763; STANIFORTH RA, 1994, FEBS LETT, V344, P129, DOI 10.1016/0014-5793(94)00348-3; Torella C, 1998, J BIOL CHEM, V273, P3915, DOI 10.1074/jbc.273.7.3915; VIITANEN PV, 1991, BIOCHEMISTRY-US, V30, P9716, DOI 10.1021/bi00104a021; Walter S, 1996, P NATL ACAD SCI USA, V93, P9425, DOI 10.1073/pnas.93.18.9425; Zahn R, 1996, SCIENCE, V271, P642, DOI 10.1126/science.271.5249.642; ZAHN R, 1994, NATURE, V368, P261, DOI 10.1038/368261a0	45	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23191	23202		10.1074/jbc.273.36.23191	http://dx.doi.org/10.1074/jbc.273.36.23191			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722549	hybrid			2022-12-27	WOS:000075778100049
J	Reha-Krantz, LJ; Marquez, LA; Elisseeva, E; Baker, RP; Bloom, LB; Dunford, HB; Goodman, MF				Reha-Krantz, LJ; Marquez, LA; Elisseeva, E; Baker, RP; Bloom, LB; Dunford, HB; Goodman, MF			The proofreading pathway of bacteriophage T4 DNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYRIBONUCLEIC ACID POLYMERASES; 3'->5'-EXONUCLEASE ACTIVITY; REPLICATION FIDELITY; BIOCHEMICAL BASIS; MUTATOR; ANTIMUTATOR; DYNAMICS	The base analog, 2-aminopurine (2AP), was used as a fluorescent reporter of the biochemical steps in the proofreading pathway catalyzed by bacteriophage T4 DNA polymerase, "Mutator" DNA polymerases that are defective in different steps in the exonucleolytic proof-reading pathway were studied so that transient changes in fluorescence intensity could be equated with specific reaction steps. The G255S- and D131N-DNA polymerases can hydrolyze DNA, the final step in the proofreading pathway, but the mutator phenotype indicates a defect in one or more steps that prepare the primer-terminus for the cleavage reaction. The hydrolysis-defective D112A/E114A-DNA polymerase was also examined. Fluorescent enzyme-DNA complexes were preformed in the absence of Mg2+, and then rapid mixing, stopped-flow techniques were used to determine the fate of the fluorescent complexes upon the addition of Mg2+. Comparisons of fluorescence intensity changes between the wild type and mutant DNA polymerases were used to model the exonucleolytic proofreading pathway. These studies are consistent with a proofreading pathway in which the protein loop structure that contains residue Gly(255) functions in strand separation and transfer of the primer strand from the polymerase active center to form a preexonuclease complex. Residue Asp(131) acts at a later step in formation of the preexonuclease complex.	Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; Univ Alberta, Dept Chem, Edmonton, AB, Canada; Univ So Calif, Dept Biol Sci, Mol Biol Sect, Los Angeles, CA 90089 USA	University of Alberta; Arizona State University; Arizona State University-Tempe; University of Alberta; University of Southern California	Reha-Krantz, LJ (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada.		Bloom, Linda B/F-3684-2014; Marquez-Curtis, Leah A/M-7152-2015; Reha-Krantz, Linda/A-3748-2014	Marquez-Curtis, Leah A/0000-0002-4047-2227; Baker, Rosanna/0000-0002-9970-6278; Reha-Krantz, Linda/0000-0003-4497-423X				BAKER R, 1996, THESIS U ALBERTA; Baker RP, 1998, P NATL ACAD SCI USA, V95, P3507, DOI 10.1073/pnas.95.7.3507; BLOOM LB, 1994, BIOCHEMISTRY-US, V33, P7576, DOI 10.1021/bi00190a010; BRUTLAG D, 1972, J BIOL CHEM, V247, P241; CAPSON TL, 1992, BIOCHEMISTRY-US, V31, P10984, DOI 10.1021/bi00160a007; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; LIN TC, 1987, P NATL ACAD SCI USA, V84, P7000, DOI 10.1073/pnas.84.20.7000; Marquez LA, 1996, J BIOL CHEM, V271, P28903, DOI 10.1074/jbc.271.46.28903; MUZYCZKA N, 1972, J BIOL CHEM, V247, P7116; REDDY MK, 1992, J BIOL CHEM, V267, P14157; Reha-Krantz Linda J., 1994, P307; REHAKRANTZ LJ, 1993, J BIOL CHEM, V268, P27100; RehaKrantz LJ, 1995, METHOD ENZYMOL, V262, P323; REHAKRANTZ LJ, 1993, J VIROL, V67, P60, DOI 10.1128/JVI.67.1.60-66.1993; REHAKRANTZ LJ, 1988, J MOL BIOL, V202, P711, DOI 10.1016/0022-2836(88)90552-9; REHAKRANTZ LJ, 1994, J BIOL CHEM, V269, P5635; STOCKI SA, 1995, J MOL BIOL, V254, P15, DOI 10.1006/jmbi.1995.0595; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Wang J, 1996, BIOCHEMISTRY-US, V35, P8110, DOI 10.1021/bi960178r	21	37	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					22969	22976		10.1074/jbc.273.36.22969	http://dx.doi.org/10.1074/jbc.273.36.22969			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722519	hybrid			2022-12-27	WOS:000075778100019
J	Zhao, J; Renner, O; Wightman, L; Sugden, PH; Stewart, L; Miller, AD; Latchman, DS; Marber, MS				Zhao, J; Renner, O; Wightman, L; Sugden, PH; Stewart, L; Miller, AD; Latchman, DS; Marber, MS			The expression of constitutively active isotypes of protein kinase C to investigate preconditioning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC MYOCYTES; ISCHEMIA; RAT; ACTIVATION; HEART; CARDIOPROTECTION; CARDIOMYOCYTES; PROMOTER; INJURY	The role of protein kinase C (PKC) in ischemic preconditioning remains controversial because of difficulties with both its measurement and pharmacological manipulation. We investigated preconditioning in isolated neonatal rat cardiocytes by expressing constitutively active isotypes of PKC. Observations at differing durations of simulated ischemia suggested beta-galactosidase (beta-gal) activity reflected viability within transfected myocytes, Preconditioning with 90 min of ischemia significantly increased beta-gal activity and myocyte survival after 6 h of ischemia; an effect abolished by PKC inhibitors. After co-transfection with plasmids encoding beta-gal and either constitutively active mutants of PKC-delta, PKC-alpha, wild type PKC-delta, or empty vector, cardiocytes were subjected to 6 h of ischemia, Only PKC-delta, rendered constitutively active by a limited deletion within the pseudosubstrate domain, consistently increased resistance to simulated ischemia (beta-gal activity was 85.6 +/- 11.9% versus 53.7 +/- 6.5% (p less than or equal to 0.01) and dead myocytes 46.8 +/- 3.4% versus 68.7 +/- 2.8% (p less than or equal to 0.01)). Since transfection was apparent in only 5-12% of cells, the results suggested a protective bystander effect that was confirmed by co-culture of transfected myocytes with untransfected myocytes, In neonatal cardiocytes expression of active PKC-delta increases resistance to simulated ischemia. This observation may provide further insight into the mechanism and possible avenues for therapeutic exploitation of preconditioning.	United Med & Dent Sch Guys & St Thomass Hosp, St Thomas Hosp, Dept Cardiol, London SE1 7EH, England; Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW3 6LY, England; UCL, Sch Med, Dept Mol Pathol, London W1P 6DB, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Imperial College London; University of London; University College London; UCL Medical School	Marber, MS (corresponding author), United Med & Dent Sch Guys & St Thomass Hosp, St Thomas Hosp, Dept Cardiol, London SE1 7EH, England.	m.marber@rayne.umds.ac.uk	marber, michael/AAW-7916-2021; Miller, Andrew/G-8291-2019; Renner, Oliver/M-7002-2015	Miller, Andrew/0000-0003-0661-249X; Renner, Oliver/0000-0002-4046-0517; Zhao, Jing/0000-0002-8140-3658	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALTON EWFW, 1993, NAT GENET, V5, P135, DOI 10.1038/ng1093-135; ARMSTRONG S, 1994, CARDIOVASC RES, V28, P1700, DOI 10.1093/cvr/28.11.1700; ARSTALL MA, 1996, CIRCULATION S1, V94, P423; BROOKS G, 1991, CANCER RES, V51, P3281; Brooks G, 1996, CIRC RES, V79, P627; COHEN MV, 1994, CIRC RES, V74, P998, DOI 10.1161/01.RES.74.5.998; COHEN MV, 1993, LANCET, V341, P6; Cumming DVE, 1996, J MOL CELL CARDIOL, V28, P2343, DOI 10.1006/jmcc.1996.0227; DECOCK JBJ, 1994, FEBS LETT, V356, P275, DOI 10.1016/0014-5793(94)01283-0; GENOT EM, 1995, J BIOL CHEM, V270, P9833, DOI 10.1074/jbc.270.17.9833; GHO BCG, 1996, CIRCULATION S1, V94, P392; GORMAN C, 1995, DNA CLONING, P143; Gray MO, 1997, J BIOL CHEM, V272, P30945, DOI 10.1074/jbc.272.49.30945; IKONOMIDIS JS, 1996, ISCHAEMIA PRECONDITI, P131; Johnson JA, 1996, CIRC RES, V79, P1086, DOI 10.1161/01.RES.79.6.1086; KARIYA K, 1991, J BIOL CHEM, V266, P10023; KAWAMURA S, 1996, CIRCULATION S1, V94, P392; Kitakaze M, 1996, CIRCULATION, V93, P781, DOI 10.1161/01.CIR.93.4.781; KONING MMG, 1994, ANN NY ACAD SCI, V723, P333, DOI 10.1111/j.1749-6632.1994.tb36739.x; LI YW, 1995, AM J PHYSIOL-HEART C, V268, pH426, DOI 10.1152/ajpheart.1995.268.1.H426; Light PE, 1996, CIRC RES, V79, P399, DOI 10.1161/01.RES.79.3.399; Liu YG, 1996, CIRC RES, V78, P443, DOI 10.1161/01.RES.78.3.443; MARBER MS, 1995, J CLIN INVEST, V95, P1446, DOI 10.1172/JCI117815; MITCHELL MB, 1995, CIRC RES, V76, P73, DOI 10.1161/01.RES.76.1.73; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; PRZYKLENK K, 1995, BRIT HEART J, V74, P575; SPEECHLYDICK ME, 1994, CIRC RES, V75, P586, DOI 10.1161/01.RES.75.3.586; SUGDEN PH, 1995, CARDIOVASC RES, V30, P478, DOI 10.1016/S0008-6363(95)00096-8; Vahlhaus C, 1996, CIRC RES, V79, P407, DOI 10.1161/01.RES.79.3.407; VANWINKLE DM, 1991, CORONARY ARTERY DIS, V2, P613; VANWYLEN DGL, 1994, CIRCULATION, V89, P2283, DOI 10.1161/01.CIR.89.5.2283; WALL TM, 1994, J PHARMACOL EXP THER, V270, P681; WEBSTER KA, 1995, J MOL CELL CARDIOL, V27, P453, DOI 10.1016/S0022-2828(08)80041-7; ZHAO J, 1997, CIRCULATION, V96, P450	36	87	91	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23072	23079		10.1074/jbc.273.36.23072	http://dx.doi.org/10.1074/jbc.273.36.23072			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722533	hybrid			2022-12-27	WOS:000075778100033
J	Akiyama, Y; Kihara, A; Mori, H; Ogura, T; Ito, K				Akiyama, Y; Kihara, A; Mori, H; Ogura, T; Ito, K			Roles of the periplasmic domain of Escherichia coli FtsH (HflB) in protein interactions and activity modulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT PROTEASE; BACTERIOPHAGE-LAMBDA; MEMBRANE-PROTEINS; SECY; GENE; EXPORT; COMPLEX; FORMS; CELL; INVOLVEMENT	FtsH is a membrane-bound and ATP-dependent protease of Escherichia coli, known to degrade SecY, a membrane protein for protein translocation, and CII, a soluble transcription factor for lysis/lysogeny decision of phage lambda. FtsH forms a homo-oligomeric complex as well as a hetero-oligomeric complex with HflKC, a putative modulator of FtsH. Although FtsH has a small periplasmic region, HflKC is mostly exposed to the periplasmic space. We studied the roles of the periplasmic region of FtsH by engineering mutations in this protein. FtsH Delta 236, lacking most of the periplasmic region, retained the in vivo ability to degrade SecY but not CII, resulting in high frequency lysogenization of lambda. Several insertion mutations in the periplasmic region of FtsH also differentially affected the proteolytic activities of FtsH. interestingly purified and detergent-solubilized FtsH Delta 236 was as active as the wild-type enzyme in degrading SecY and CII, although its ATPase activity was lowered 5-fold. Affinity chromatography using histidine-tagged derivatives showed that the periplasmic domain-deleted FtsH no longer interacted with FtsH or HflKC. Although FtsH Delta 236-His(6)-Myc lost the static FtsH-FtsH interaction, it retained the ability to change its conformation in an ATP-dependent manner at 37 degrees C, leading to a limited oligomerization. These results suggest that the periplasmic region of FtsH has crucial roles in the protein-protein interactions of this complex and in the modulation of its proteolytic functions against different substrates.	Kyoto Univ, Inst Virus Res, Dept Cell Biol, Kyoto 6068507, Japan; Kumamoto Univ, Sch Med, Inst Mol Embryol & Genet, Dept Mol Cell Biol, Kumamoto 8620976, Japan	Kyoto University; Kumamoto University	Akiyama, Y (corresponding author), Kyoto Univ, Inst Virus Res, Dept Cell Biol, Kyoto 6068507, Japan.	yaidyama@virus.kyoto-u.ac.jp	KIHARA, AKIO/A-3802-2012	KIHARA, AKIO/0000-0001-5889-0788; Mori, Hiroyuki/0000-0002-0429-1269; Ogura, Teru/0000-0003-3784-0970				Akiyama Y, 1998, MOL MICROBIOL, V28, P803, DOI 10.1046/j.1365-2958.1998.00843.x; AKIYAMA Y, 1994, J BIOL CHEM, V269, P5218; AKIYAMA Y, 1994, J BIOL CHEM, V269, P5225; AKIYAMA Y, 1995, J BIOL CHEM, V270, P23485, DOI 10.1074/jbc.270.40.23485; Akiyama Y, 1996, FEBS LETT, V399, P26, DOI 10.1016/S0014-5793(96)01283-5; Akiyama Y, 1996, J BIOL CHEM, V271, P31196, DOI 10.1074/jbc.271.49.31196; AKIYAMA Y, 1985, EMBO J, V4, P3351, DOI 10.1002/j.1460-2075.1985.tb04088.x; BANUETT F, 1986, J MOL BIOL, V187, P213, DOI 10.1016/0022-2836(86)90229-9; HERMAN C, 1993, P NATL ACAD SCI USA, V90, P10861, DOI 10.1073/pnas.90.22.10861; HERMAN C, 1995, P NATL ACAD SCI USA, V92, P3516, DOI 10.1073/pnas.92.8.3516; HOMMA T, 1995, BIOCHEM BIOPH RES CO, V215, P452, DOI 10.1006/bbrc.1995.2486; HOYT MA, 1982, CELL, V31, P565, DOI 10.1016/0092-8674(82)90312-9; ITO K, 1983, CELL, V32, P789, DOI 10.1016/0092-8674(83)90065-X; ITO K, 1984, MOL GEN GENET, V197, P204, DOI 10.1007/BF00330964; Kihara A, 1996, EMBO J, V15, P6122, DOI 10.1002/j.1460-2075.1996.tb01000.x; Kihara A, 1997, P NATL ACAD SCI USA, V94, P5544, DOI 10.1073/pnas.94.11.5544; KIHARA A, 1995, P NATL ACAD SCI USA, V92, P4532, DOI 10.1073/pnas.92.10.4532; Kihara A, 1998, J MOL BIOL, V279, P175, DOI 10.1006/jmbi.1998.1781; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; MANOIL C, 1985, P NATL ACAD SCI USA, V82, P8129, DOI 10.1073/pnas.82.23.8129; Manoil C, 1997, J MOL BIOL, V267, P250, DOI 10.1006/jmbi.1996.0881; MATSUZAWA H, 1984, J BACTERIOL, V160, P733, DOI 10.1128/JB.160.2.733-739.1984; Miller J.H., 1972, EXPT MOL GENETICS; OGURA T, 1991, RES MICROBIOL, V142, P279, DOI 10.1016/0923-2508(91)90041-8; Qu JN, 1996, J BACTERIOL, V178, P3457, DOI 10.1128/jb.178.12.3457-3461.1996; SHIBA K, 1984, J BACTERIOL, V160, P696, DOI 10.1128/JB.160.2.696-701.1984; SHIMOIKE T, 1995, J BIOL CHEM, V270, P5519, DOI 10.1074/jbc.270.10.5519; Shotland Y, 1997, MOL MICROBIOL, V24, P1303, DOI 10.1046/j.1365-2958.1997.4231796.x; Silhavy T. J., 1984, EXPT GENE FUSIONS; TAURA T, 1993, J BACTERIOL, V175, P7771, DOI 10.1128/JB.175.24.7771-7775.1993; TOMOYASU T, 1993, J BACTERIOL, V175, P1352, DOI 10.1128/JB.175.5.1352-1357.1993; TOMOYASU T, 1995, EMBO J, V14, P2551, DOI 10.1002/j.1460-2075.1995.tb07253.x; TOMOYASU T, 1993, J BACTERIOL, V175, P1344, DOI 10.1128/JB.175.5.1344-1351.1993; Wang RF, 1998, J BACTERIOL, V180, P1929, DOI 10.1128/JB.180.7.1929-1938.1998	34	37	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22326	22333		10.1074/jbc.273.35.22326	http://dx.doi.org/10.1074/jbc.273.35.22326			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712851	hybrid			2022-12-27	WOS:000075616600027
J	Muthusamy, N; Leiden, JM				Muthusamy, N; Leiden, JM			A protein kinase C-, Ras-, and RSK2-dependent signal transduction pathway activates the cAMP-responsive element-binding protein transcription factor following T cell receptor engagement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; ANTIGEN RECEPTOR; FACTOR CREB; FOS TRANSCRIPTION; NUCLEAR FACTOR; PHOSPHORYLATION; GENE; LYMPHOCYTES; INDUCTION; EXPRESSION	The cAMP-responsive element-binding protein (CREB) transcription factor is required for normal T cell activation following stimulation through the T cell antigen receptor (TCR), CREB is present in resting T cells in an unphosphorylated and inactive state, TCR engagement results in the rapid phosphorylation of CREB on Ser(133) and its concomitant activation. In the studies described in this report, we have investigated the signaling pathway(s) that are responsible for CREB activation in normal T cells. Using pharmacological agonists, we show that protein kinase C (PKC)-, calcium/calmodulin-, and protein kinase A-dependent pathways are each capable of independently eliciting CREB phosphorylation in T cells and thymocytes, Pharmacological inhibitor studies demonstrated that the PKC-mediated signaling pathway is required for TCR-mediated activation of CREB, In contrast, inhibitors of protein kinase A and calmodulin kinases had no effect on CREB phosphorylation following TCR cross-linking, T cells lacking the p56(lck) tyrosine kinase failed to phosphorylate CREB in response to TCR engagement. Overexpression of dominant-negative mutant Ras and Raf-1 proteins in Jurkat T cells abolished TCR-mediated CREB phosphorylation, whereas overexpression of the RSK2 serine/threonine kinase significantly potentiated TCR-mediated CREB phosphorylation. Taken together, these experiments are consistent with a model in which TCR engagement leads to the rapid phosphorylation and activation of CREB via a signaling pathway involving the activation of p56(lck), PKC, Ras, Raf-1, MEK, and RSK2, Given the importance of CREB phosphorylation in normal T cell activation, this pathway may be an attractive target for the development of novel immunosuppressive agents.	Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Leiden, JM (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.		Muthusamy, Natarajan/A-6915-2009		NIAID NIH HHS [AI29673] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029673, R37AI029673] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMIN AR, 1993, CELL IMMUNOL, V152, P422, DOI 10.1006/cimm.1993.1302; ANDREW DP, 1995, J IMMUNOL, V155, P1671; Barton K, 1996, NATURE, V379, P81, DOI 10.1038/379081a0; BLEMIS J, 1993, P NATL ACAD SCI USA, V90, P5889; BRINDLE P, 1993, NATURE, V364, P821, DOI 10.1038/364821a0; BRINDLE P, 1995, P NATL ACAD SCI USA, V92, P10521, DOI 10.1073/pnas.92.23.10521; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; CHULAK C, 1995, BRIT J PHARMACOL, V115, P330, DOI 10.1111/j.1476-5381.1995.tb15881.x; DAMBROSIO D, 1994, EUR J IMMUNOL, V24, P616, DOI 10.1002/eji.1830240319; DOWNWARD J, 1992, IMMUNOL TODAY, V13, P89, DOI 10.1016/0167-5699(92)90148-Z; ENSLEN H, 1995, BIOCHEM BIOPH RES CO, V207, P1038, DOI 10.1006/bbrc.1995.1289; ENSLEN H, 1995, J BIOL CHEM, V270, P1038; FEUERSTEIN N, 1995, J IMMUNOL, V154, P68; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GULBINS E, 1993, SCIENCE, V260, P822, DOI 10.1126/science.8484124; HABENER JF, 1990, MOL ENDOCRINOL, V4, P1087, DOI 10.1210/mend-4-8-1087; HIPSKIND RA, 1991, J BIOL CHEM, V266, P19583; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; HUANG DY, 1994, MOL CELL BIOL, V14, P4233, DOI 10.1128/MCB.14.6.4233; IZQUIERDO M, 1993, J EXP MED, V178, P1199, DOI 10.1084/jem.178.4.1199; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LEE KAW, 1993, BIOCHIM BIOPHYS ACTA, V1174, P221, DOI 10.1016/0167-4781(93)90191-F; MACNICOL AM, 1993, CELL, V73, P571, DOI 10.1016/0092-8674(93)90143-E; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; OFIR R, 1991, GENE EXPRESSION, V1, P55; RAO A, 1991, CRIT REV IMMUNOL, V10, P495; SASSONECORSI P, 1988, GENE DEV, V2, P1529, DOI 10.1101/gad.2.12a.1529; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; TANG SH, 1995, MOL PHARMACOL, V47, P863; WEBER JR, 1992, J EXP MED, V176, P373, DOI 10.1084/jem.176.2.373; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WOLLBERG P, 1994, J BIOL CHEM, V269, P19719; WOODROW MA, 1993, J IMMUNOL, V150, P3853; WOTTON D, 1993, J BIOL CHEM, V268, P17975; XIE HJ, 1993, J IMMUNOL, V151, P880; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959	43	57	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22841	22847		10.1074/jbc.273.35.22841	http://dx.doi.org/10.1074/jbc.273.35.22841			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712919	hybrid			2022-12-27	WOS:000075616600095
J	Taylor, WH; Sinha, A; Khan, IA; McDaniel, ST; Esko, JD				Taylor, WH; Sinha, A; Khan, IA; McDaniel, ST; Esko, JD			Primers of glycosaminoglycan biosynthesis from Peruvian Rain Forest plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-D-XYLOSIDE; HUMAN SKIN FIBROBLASTS; GENE-SPECIFIED GLYCOSYLTRANSFERASES; CHONDROITIN SULFATE PROTEOGLYCAN; HAMSTER OVARY CELLS; BLOOD-GROUP-A; GLYCOSIDASE INHIBITORS; HEPARAN-SULFATE; HUMAN-MELANOMA; TUMOR-CELLS	We have developed a rapid, high throughput screening assay for compounds that alter the assembly of glycosaminoglycan chains in Chinese hamster ovary cells. The assay uses autoradiography to measure the binding of newly synthesized [S-35]proteoglycans and [S-35]glycosaminoglycans to a positively charged membrane. Screening over 1000 extracts from a random plant collection obtained from the Amazon rain forest yielded five plants that stimulated glycosaminoglycan assembly in both wild-type cells and a mutant cell line defective in xylosyltransferase (the first committed enzyme involved in glycosaminoglycan biosynthesis). Fractionation of an extract of Maieta guianensis by silica gel and reverse-phase chromatography yielded two pure compounds with stimulatory activity. Spectroscopic analysis by NMR and mass spectrometry revealed that the active principles were xylosides of dimethylated ellagic acid. One of the compounds also contained a galloyl group at C-3 of the xylose moiety. These findings suggest that plants and other natural products may be a source of agents that can potentially alter glycosaminoglycan and proteoglycan formation in animal cells.	Univ Calif San Diego, Dept Med, Div Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Glycobiol Program, La Jolla, CA 92093 USA; Univ Mississippi, Pharmaceut Sci Res Inst, Natl Ctr Dev Nat Prod, University, MS 38677 USA; Mississippi State Univ, Dept Biol Sci, Inst Bot Explorat, Mississippi State, MS 39762 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Mississippi; Mississippi State University	Esko, JD (corresponding author), Univ Calif San Diego, Dept Med, Div Cellular & Mol Med, La Jolla, CA 92093 USA.				NATIONAL CANCER INSTITUTE [R01CA046462] Funding Source: NIH RePORTER; NCI NIH HHS [CA46462] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Asano N, 1997, GLYCOBIOLOGY, V7, P1085, DOI 10.1093/glycob/7.8.1085; BAME KJ, 1989, J BIOL CHEM, V264, P8059; BELLAMY F, 1993, J MED CHEM, V36, P898, DOI 10.1021/jm00059a015; BELLAMY F, 1995, EUR J MED CHEM, V30, P101; Binari RC, 1997, DEVELOPMENT, V124, P2623; CAMBIAZO V, 1990, COMP BIOCHEM PHYS B, V97, P307, DOI 10.1016/0305-0491(90)90286-3; CASTANEDA P, 1993, J NAT PROD, V56, P1575, DOI 10.1021/np50099a017; DENNIS JW, 1989, J NATL CANCER I, V81, P1028, DOI 10.1093/jnci/81.13.1028; DENNIS JW, 1993, BIOCHEM PHARMACOL, V46, P1459, DOI 10.1016/0006-2952(93)90112-A; DENNIS JW, 1990, CANCER RES, V50, P1867; Duke J. A., 1994, AMAZONIAN ETHNOBOTAN; DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167; ELBEIN AD, 1991, FASEB J, V5, P3055, DOI 10.1096/fasebj.5.15.1743438; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; ESKO JD, 1996, CURRENT PROTOCOLS S, V32; Freeze HH, 1996, TRENDS GLYCOSCI GLYC, V8, P65, DOI 10.4052/tigg.8.65; FREEZE HH, 1993, J BIOL CHEM, V268, P1618; FRITZ TA, 1994, J BIOL CHEM, V269, P300; GALLIGANI L, 1975, J BIOL CHEM, V250, P5400; GOSS PE, 1994, CANCER RES, V54, P1450; Hacker U, 1997, DEVELOPMENT, V124, P3565; Haerry TE, 1997, DEVELOPMENT, V124, P3055; HAM RG, 1965, P NATL ACAD SCI USA, V53, P288, DOI 10.1073/pnas.53.2.288; HEIMER R, 1987, ANAL BIOCHEM, V162, P330, DOI 10.1016/0003-2697(87)90400-3; HINDSGAUL O, 1991, J BIOL CHEM, V266, P17858; HUMPHRIES MJ, 1986, CANCER RES, V46, P5215; HUMPHRIES MJ, 1986, P NATL ACAD SCI USA, V83, P1752, DOI 10.1073/pnas.83.6.1752; HUMPHRIES MJ, 1990, CLIN EXP METASTAS, V8, P89, DOI 10.1007/BF00155595; IZUMI J, 1994, J BIOCHEM-TOKYO, V116, P524, DOI 10.1093/oxfordjournals.jbchem.a124556; Jackson SM, 1997, DEVELOPMENT, V124, P4113; KHAC DD, 1990, PHYTOCHEMISTRY, V29, P251, DOI 10.1016/0031-9422(90)89044-A; KHAN SH, 1993, J BIOL CHEM, V268, P2468; KOLSET SO, 1986, BIOCHEM J, V238, P209, DOI 10.1042/bj2380209; KUAN SF, 1989, J BIOL CHEM, V264, P19271; LOWARY TL, 1993, CARBOHYD RES, V249, P163, DOI 10.1016/0008-6215(93)84068-H; LOWARY TL, 1994, CARBOHYD RES, V251, P33, DOI 10.1016/0008-6215(94)84275-2; LOWARY TL, 1994, CARBOHYD RES, V256, P257, DOI 10.1016/0008-6215(94)84212-4; Lugemwa FN, 1996, J BIOL CHEM, V271, P19159, DOI 10.1074/jbc.271.32.19159; LUGEMWA FN, 1991, J BIOL CHEM, V266, P6674; MANZI A, 1995, J BIOL CHEM, V270, P9154, DOI 10.1074/jbc.270.16.9154; Martin NB, 1996, SEMIN THROMB HEMOST, V22, P247, DOI 10.1055/s-2007-999015; MASSON PJ, 1995, J BIOL CHEM, V270, P2662, DOI 10.1074/jbc.270.6.2662; Miura Y, 1997, BIOCHEM BIOPH RES CO, V241, P698, DOI 10.1006/bbrc.1997.7876; MOHLA S, 1990, ANTICANCER RES, V10, P1515; MOLYNEUX RJ, 1993, ARCH BIOCHEM BIOPHYS, V304, P81, DOI 10.1006/abbi.1993.1324; NAKAMURA T, 1994, BIOCHEM J, V304, P731, DOI 10.1042/bj3040731; NAKATO H, 1995, DEVELOPMENT, V121, P3687; NEVILLE DCA, 1995, BIOCHEM J, V307, P791, DOI 10.1042/bj3070791; NEWTON SA, 1989, JNCI-J NATL CANCER I, V81, P1024, DOI 10.1093/jnci/81.13.1024; NICOLAS G, 1995, PHYTOCHEMISTRY, V38, P225, DOI 10.1016/0031-9422(94)00622-Z; Pakulski G, 1996, PHYTOCHEMISTRY, V41, P775, DOI 10.1016/0031-9422(96)89675-0; PAULSEN H, 1995, CARBOHYD RES, V275, P403, DOI 10.1016/0008-6215(95)00056-Y; PEI Y H, 1990, Yaoxue Xuebao, V25, P798; PLATT FM, 1994, J BIOL CHEM, V269, P27108; PLATT FM, 1994, J BIOL CHEM, V269, P8362; Platt FM, 1997, J BIOL CHEM, V272, P19365, DOI 10.1074/jbc.272.31.19365; Portner A, 1996, GLYCOBIOLOGY, V6, P7, DOI 10.1093/glycob/6.1.7; PULVERER G, 1988, J CANCER RES CLIN, V114, P217, DOI 10.1007/BF00417842; RAPRAEGER A, 1989, ANAL BIOCHEM, V179, P361, DOI 10.1016/0003-2697(89)90145-0; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; ROBINSON JA, 1985, BIOCHEM J, V227, P805, DOI 10.1042/bj2270805; Roden L., 1972, METHODS ENZYMOLOGY, V28, P73; Sarkar AK, 1997, J BIOL CHEM, V272, P25608, DOI 10.1074/jbc.272.41.25608; SARKAR AK, 1995, P NATL ACAD SCI USA, V92, P3323, DOI 10.1073/pnas.92.8.3323; Schultes R. E., 1990, HEALING FOREST MED T; SCHWARTZ NB, 1977, J BIOL CHEM, V252, P6316; SCHWARTZ NB, 1976, BIOCHEM BIOPH RES CO, V71, P851, DOI 10.1016/0006-291X(76)90909-8; SHIBATA S, 1995, J BIOL CHEM, V270, P13794, DOI 10.1074/jbc.270.23.13794; Takagaki K, 1996, J BIOCHEM-TOKYO, V119, P697; THOMAS SS, 1995, BBA-MOL BASIS DIS, V1272, P37, DOI 10.1016/0925-4439(95)00065-C; URZUA A, 1995, PHYTOCHEMISTRY, V39, P1489, DOI 10.1016/0031-9422(95)00109-K; URZUA A, 1995, PHYTOCHEMISTRY, V38, P555, DOI 10.1016/0031-9422(94)00590-P; WINCHESTER B, 1992, BIOCHEM SOC T, V20, P699, DOI 10.1042/bst0200699; WINCHESTER B, 1992, GLYCOBIOLOGY, V2, P199, DOI 10.1093/glycob/2.3.199; WOYNAROWSKA B, 1994, J BIOL CHEM, V269, P22797; Woynarowska B, 1996, GLYCOCONJUGATE J, V13, P663, DOI 10.1007/BF00731455; YAGEL S, 1989, INT J CANCER, V44, P685, DOI 10.1002/ijc.2910440422; Yu BY, 1996, PHYTOCHEMISTRY, V43, P201, DOI 10.1016/0031-9422(96)00228-2; ZACHARIAS C, 1994, J BIOL CHEM, V269, P13313; Zhong XN, 1997, PHYTOCHEMISTRY, V46, P943, DOI 10.1016/S0031-9422(97)00366-X; ZHUANG D, 1991, Glycobiology, V1, P425, DOI 10.1093/glycob/1.4.425	81	8	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22260	22266		10.1074/jbc.273.35.22260	http://dx.doi.org/10.1074/jbc.273.35.22260			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712841	hybrid			2022-12-27	WOS:000075616600017
J	Vanhamme, L; Perez-Morga, D; Marchal, C; Speijer, D; Lambert, L; Geuskens, M; Alexandre, S; Ismaili, N; Goringer, U; Benne, R; Pays, E				Vanhamme, L; Perez-Morga, D; Marchal, C; Speijer, D; Lambert, L; Geuskens, M; Alexandre, S; Ismaili, N; Goringer, U; Benne, R; Pays, E			Trypanosoma brucei TBRGG1, a mitochondrial oligo(U)-binding protein that co-localizes with an in vitro RNA editing activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUIDE RNA; GENE-EXPRESSION; IN-VITRO; MESSENGER-RNA; RIBONUCLEOPROTEIN COMPLEXES; POSTTRANSCRIPTIONAL CONTROL; CRITHIDIA-FASCICULATA; AFRICAN TRYPANOSOMES; SURFACE GLYCOPROTEIN; BINDING PROTEIN	We report the characterization of a Trypanosoma brucei 75-kDa protein of the RGG (Arg-Gly-Gly) type, termed TBRGG1, Dicistronic and monocistronic transcripts of the TBRGG1 gene were produced by both alternative splicing and polyadenylation, TBRGG1 was found in two or three forms that differ in their electrophoretic mobility on SDS-polyacrylamide gel electrophoresis gels, one of which was more abundant in the procyclic form of the parasite. TBRGG1 was localized to the mitochondrion and appeared to be more abundant in bloodstream intermediate and stumpy forms in which the mitochondrion reactivates and during the procyclic stage, which possesses a fully functional mitochondrion. This protein was characterized to display oligo(U) binding characteristics and was found to co-localize with an in vitro RNA editing activity in a sedimentation analysis. TBRGG1 most likely corresponds to the 83-kDa oligo (U)-binding protein previously identified by UV cross-linking of guide RNA to mitochondrial lysates (Leegwater, P,, Speijer, D,, and Benne, R, (1995) fur. J, Biochem, 227, 780-786).	Free Univ Brussels, Dept Biol Mol, B-1640 Rhode St Genese, Belgium; Univ Amsterdam, Acad Med Ctr, Dept Biochem, NL-1105 AZ Amsterdam, Netherlands; Max Planck Inst Biochem, Gene Ctr Munich, D-82152 Martinsried, Germany	University of Amsterdam; Academic Medical Center Amsterdam; Max Planck Society	Pays, E (corresponding author), Free Univ Brussels, Dept Biol Mol, 67 Rue Chevaux, B-1640 Rhode St Genese, Belgium.	epays@dbm.ulb.ac.be	Speijer, Dave/AAE-4613-2019	Speijer, Dave/0000-0002-2340-2753; Perez-Morga, David/0000-0002-7168-1865				ADLER BK, 1991, MOL CELL BIOL, V11, P5878, DOI 10.1128/MCB.11.12.5878; BENAMAR MF, 1988, MOL CELL BIOL, V8, P2166, DOI 10.1128/MCB.8.5.2166; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUN R, 1979, ACTA TROP, V36, P289; Byrne EM, 1996, EMBO J, V15, P6758, DOI 10.1002/j.1460-2075.1996.tb01065.x; CHUNG HM, 1992, PARASITOL TODAY, V8, P414, DOI 10.1016/0169-4758(92)90194-7; Clayton C, 1996, MOL BIOCHEM PARASIT, V77, P1, DOI 10.1016/0166-6851(96)02587-X; Corell RA, 1996, MOL CELL BIOL, V16, P1410; CruzReyes J, 1996, P NATL ACAD SCI USA, V93, P8901, DOI 10.1073/pnas.93.17.8901; Das A, 1996, J BIOL CHEM, V271, P15675, DOI 10.1074/jbc.271.26.15675; ERONDU NE, 1992, MOL BIOCHEM PARASIT, V51, P111, DOI 10.1016/0166-6851(92)90206-Y; FEAGIN JE, 1987, CELL, V49, P337, DOI 10.1016/0092-8674(87)90286-8; FERGUSON M, 1992, CELL, V70, P621, DOI 10.1016/0092-8674(92)90431-B; GORINGER HU, 1994, P NATL ACAD SCI USA, V91, P1776, DOI 10.1073/pnas.91.5.1776; GRAHAM SV, 1995, PARASITOL TODAY, V11, P217, DOI 10.1016/0169-4758(95)80081-6; HAJDUK SL, 1996, MOL BIOL PARASITIC P, P134; HARRIS ME, 1990, J BIOL CHEM, V265, P11368; HEHL A, 1994, PARASITOL TODAY, V10, P442, DOI 10.1016/0169-4758(94)90180-5; Kable ML, 1996, SCIENCE, V273, P1189, DOI 10.1126/science.273.5279.1189; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; KOLLER J, 1994, NUCLEIC ACIDS RES, V22, P1988, DOI 10.1093/nar/22.11.1988; Koller J, 1997, J BIOL CHEM, V272, P3749, DOI 10.1074/jbc.272.6.3749; LAPEYRE B, 1987, P NATL ACAD SCI USA, V84, P1472, DOI 10.1073/pnas.84.6.1472; LEEGWATER P, 1995, EUR J BIOCHEM, V227, P780, DOI 10.1111/j.1432-1033.1995.tb20201.x; NAJBAUER J, 1993, J BIOL CHEM, V268, P10501; OPPERDOES FR, 1987, ANNU REV MICROBIOL, V41, P127, DOI 10.1146/annurev.mi.41.100187.001015; PAYS E, 1993, MOL BIOCHEM PARASIT, V61, P107, DOI 10.1016/0166-6851(93)90163-R; PAYS E, 1994, ANNU REV MICROBIOL, V48, P25, DOI 10.1146/annurev.mi.48.100194.000325; PAYS E, 1989, MOL CELL BIOL, V9, P4018, DOI 10.1128/MCB.9.9.4018; PAYS E, 1996, MOL BIOL PARASITIC P, P88; POLLARD VW, 1992, EMBO J, V11, P4429, DOI 10.1002/j.1460-2075.1992.tb05543.x; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; READ LK, 1994, MOL CELL BIOL, V14, P2629, DOI 10.1128/MCB.14.4.2629; REVELARD P, 1993, MOL BIOCHEM PARASIT, V62, P93, DOI 10.1016/0166-6851(93)90181-V; RODITI I, 1989, J CELL BIOL, V108, P737, DOI 10.1083/jcb.108.2.737; Rusche LN, 1997, EMBO J, V16, P4069, DOI 10.1093/emboj/16.13.4069; SALMON D, 1994, CELL, V78, P75, DOI 10.1016/0092-8674(94)90574-6; Seiwert SD, 1996, CELL, V84, P831, DOI 10.1016/S0092-8674(00)81062-4; Sloof P, 1997, TRENDS MICROBIOL, V5, P189, DOI 10.1016/S0966-842X(97)01034-2; STUART K, 1984, J PARASITOL, V70, P747, DOI 10.2307/3281757; ULLU E, 1996, MOL BIOL PARASITIC P, P115	41	85	89	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21825	21833		10.1074/jbc.273.34.21825	http://dx.doi.org/10.1074/jbc.273.34.21825			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705321	hybrid			2022-12-27	WOS:000075492600055
J	Echtay, KS; Bienengraeber, M; Winkler, E; Klingenberg, M				Echtay, KS; Bienengraeber, M; Winkler, E; Klingenberg, M			In the uncoupling protein (UCP-1) His-214 is involved in the regulation of purine nucleoside triphosphate but not diphosphate binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWN-ADIPOSE-TISSUE; NUCLEOTIDE-BINDING; CHEMICAL MODIFICATION; FATTY-ACIDS; HISTIDINE-RESIDUES; MITOCHONDRIA; PH; KINETICS; MECHANISMS; CARRIER	The nucleotide binding to uncoupling protein (UCP-1) of brown adipose tissue is regulated by pH, The binding pocket of the nucleotide phosphate moiety has been pro posed to be controlled by the protonization of a carboxyl group (pK approximate to 4.5) for both nucleoside diphosphates (NDP) and nucleoside triphosphates (NTP) (identified as Glu-190) and of a histidine (pK approximate to 7.2) for NTP only. Here we identify His-214 as a pH sensor specific for NTP binding only. In reconstituted UCP-1 from hamster, DEPC diminishes binding of NTP but not of NDP, It also prevents inhibition of H+ transport by NTP but not by NDP, Hamster UCP-1 expressed in Saccharomyces cerevisiae was mutated to H214N resulting in only moderate change of the binding affinity for NTP (GTP) but a 10-fold affinity decrease with the bulkier substituent in H214W, whereas the affinity for NDP (ADP) was largely unchanged. The steep decrease with pH of the binding affinity for NTP in wild type (from pH 6.0 to 7.5) was much flatter in the mutants. Also, the pH dependence of binding and dissociation rates was diminished in these mutants. The transport of H+ and Cl- was not affected. Thus, His-214 is only involved in nucleotide binding, whereas, as previously shown, His-145 and His-147 are involved only in H+ transport. The results validate the earlier proposal of a histidine regulating the NTP binding in addition to a carboxyl group controlling both NTP and NDP binding. It is proposed that His-214 protrudes into the binding pocket for the gamma-phosphate thus inhibiting NTP binding and that His214H(+) is retracted by a background -CO2- group to give way for the gamma-phosphate.	Univ Munich, Inst Phys Biochem, D-80336 Munich, Germany	University of Munich	Klingenberg, M (corresponding author), Univ Munich, Inst Phys Biochem, Schillerstr 44, D-80336 Munich, Germany.	klingenberg@pbm.med.uni-muenchen.de						Bienengraeber M, 1998, BIOCHEMISTRY-US, V37, P3, DOI 10.1021/bi972463w; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; Bragg PD, 1996, EUR J BIOCHEM, V241, P611, DOI 10.1111/j.1432-1033.1996.00611.x; Brandsch M, 1997, BBA-BIOMEMBRANES, V1324, P251, DOI 10.1016/S0005-2736(96)00231-3; Cesareni G, 1987, GENETIC ENG PRINCIPL, V9, P135, DOI DOI 10.1007/978-1-4684-5377-5_9; Echtay KS, 1997, BIOCHEMISTRY-US, V36, P8253, DOI 10.1021/bi970513r; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; HUANG SG, 1995, EUR J BIOCHEM, V229, P718, DOI 10.1111/j.1432-1033.1995.tb20519.x; HUANG SG, 1995, BIOCHEMISTRY-US, V34, P349, DOI 10.1021/bi00001a043; Huang SG, 1996, BIOCHEMISTRY-US, V35, P7846, DOI 10.1021/bi960244p; Huang SG, 1998, J BIOL CHEM, V273, P859, DOI 10.1074/jbc.273.2.859; Klingenberg M, 1995, METHOD ENZYMOL, V260, P369, DOI 10.1016/0076-6879(95)60151-1; KLINGENBERG M, 1984, BIOCHEM SOC T, V12, P390, DOI 10.1042/bst0120390; KLINGENBERG M, 1988, BIOCHEMISTRY-US, V21, P2950; KOPECKY J, 1987, EUR J BIOCHEM, V164, P687, DOI 10.1111/j.1432-1033.1987.tb11181.x; LANOUE KF, 1986, J BIOL CHEM, V261, P298; LANOUE KF, 1982, J BIOL CHEM, V257, P13740; Lim JS, 1996, FEBS LETT, V381, P188, DOI 10.1016/0014-5793(96)00124-X; LIN CS, 1980, FEBS LETT, V113, P299, DOI 10.1016/0014-5793(80)80613-2; Miles E W, 1977, Methods Enzymol, V47, P431; Modriansky M, 1997, J BIOL CHEM, V272, P24759, DOI 10.1074/jbc.272.40.24759; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; NICHOLLS DG, 1979, BIOCHIM BIOPHYS ACTA, V549, P1, DOI 10.1016/0304-4173(79)90016-8; RIAL E, 1986, EUR J BIOCHEM, V161, P689, DOI 10.1111/j.1432-1033.1986.tb10494.x; RIAL E, 1983, EUR J BIOCHEM, V137, P197, DOI 10.1111/j.1432-1033.1983.tb07815.x; SOBOLL S, 1984, EUR J BIOCHEM, V141, P231, DOI 10.1111/j.1432-1033.1984.tb08180.x; VERKMAN AS, 1989, BIOCHEMISTRY-US, V28, P4240, DOI 10.1021/bi00436a018; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; WINKLER E, 1994, J BIOL CHEM, V269, P2508; Winkler E, 1997, BIOCHEMISTRY-US, V36, P148, DOI 10.1021/bi962178x	30	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24368	24374		10.1074/jbc.273.38.24368	http://dx.doi.org/10.1074/jbc.273.38.24368			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733725	hybrid			2022-12-27	WOS:000076007300017
J	Ouyang, YB; Moore, KL				Ouyang, YB; Moore, KL			Molecular cloning and expression of human and mouse tyrosylprotein sulfotransferase-8 and a tyrosylprotein sulfotransferase homologue in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EFFICIENT THROMBIN CLEAVAGE; VON-WILLEBRAND-FACTOR; TYROSINE SULFATION; FACTOR-VIII; HUMAN-COMPLEMENT; 4TH COMPONENT; P-SELECTIN; FACTOR-V; RESIDUES; IDENTIFICATION	Tyrosine O-sulfation, a common post-translational modification in eukaryotes, is mediated by Gels enzymes that catalyze the transfer of the sulfuryl group from 3'-phosphoadenosine 5'-phosphosulfate to tyrosine residues in polypeptides. We recently isolated cDNAs encoding human and mouse tyrosylprotein sulfotransferase-l (Ouyang, Y. B., Lane, W. S., and Moore, K. L. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 2896-2901). Here we report the isolation of cDNAs encoding a second tyrosylprotein sulfotransferase (TPST), designated TPST-2. The human and mouse TPST-2 cDNAs predict type II transmembrane proteins of 377 and 376 amino acid residues, respectively. The cDNAs encode functional N-glycosylated enzymes when expressed in mammalian cells. In addition, preliminary analysis indicates that TPST-1 and TPST-2 have distinct specificities toward peptide substrates. The human TPST-2 gene is on chromosome 22q12.1, and the mouse gene is in the central region of chromosome 5. We have also identified a cDNA that encodes a TPST in the nematode Caenorhabditis elegans that maps to the right arm of chromosome III. Thus, we have identified two new members of a class of membrane-bound sulfotransferases that catalyze tyrosine O-sulfation. These enzymes may catalyze tyrosine O-sulfation of a variety of protein substrates involved in diverse physiologic functions.	Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Moore, KL (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, 825 NE 13Th St,Mailstop 45, Oklahoma City, OK 73104 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL053602] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL53602] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAEUERLE PA, 1987, J CELL BIOL, V105, P2655, DOI 10.1083/jcb.105.6.2655; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Bundgaard JR, 1997, J BIOL CHEM, V272, P21700, DOI 10.1074/jbc.272.35.21700; COULSON A, 1988, NATURE, V335, P184, DOI 10.1038/335184a0; COULSON A, 1991, BIOESSAYS, V13, P413, DOI 10.1002/bies.950130809; DONG JF, 1994, BIOCHEMISTRY-US, V33, P13946, DOI 10.1021/bi00250a050; Ferrari S, 1996, GENOMICS, V35, P367, DOI 10.1006/geno.1996.0369; FESSLER LI, 1986, EUR J BIOCHEM, V158, P511, DOI 10.1111/j.1432-1033.1986.tb09784.x; HORTIN G, 1986, J BIOL CHEM, V261, P1786; HORTIN G, 1987, J BIOL CHEM, V262, P3082; HORTIN G, 1986, J BIOL CHEM, V261, P5827; HORTIN GL, 1989, P NATL ACAD SCI USA, V86, P1338, DOI 10.1073/pnas.86.4.1338; HORTIN GL, 1990, BLOOD, V76, P946; HUTTNER WB, 1982, NATURE, V299, P273, DOI 10.1038/299273a0; Huttner WB, 1988, MODERN CELL BIOL, V6, P97; JENNE D, 1989, EUR J BIOCHEM, V185, P391, DOI 10.1111/j.1432-1033.1989.tb15127.x; JUKKOLA A, 1990, BIOCHEM BIOPH RES CO, V170, P264, DOI 10.1016/0006-291X(90)91269-X; Kakuta Y, 1998, TRENDS BIOCHEM SCI, V23, P129, DOI 10.1016/S0968-0004(98)01182-7; Kakuta Y, 1997, NAT STRUCT BIOL, V4, P904, DOI 10.1038/nsb1197-904; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEE RWH, 1985, P NATL ACAD SCI USA, V82, P6143, DOI 10.1073/pnas.82.18.6143; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; LEYTE A, 1991, J BIOL CHEM, V266, P740; LIU MC, 1985, P NATL ACAD SCI USA, V82, P34, DOI 10.1073/pnas.82.1.34; MARCHESE P, 1995, J BIOL CHEM, V270, P9571, DOI 10.1074/jbc.270.16.9571; MICHNICK DA, 1994, J BIOL CHEM, V269, P20095; NIEHRS C, 1994, CHEM-BIOL INTERACT, V92, P257, DOI 10.1016/0009-2797(94)90068-X; Ouyang YB, 1998, P NATL ACAD SCI USA, V95, P2896, DOI 10.1073/pnas.95.6.2896; PITTMAN DD, 1994, BIOCHEMISTRY-US, V33, P6952, DOI 10.1021/bi00188a026; PITTMAN DD, 1992, BIOCHEMISTRY-US, V31, P3315, DOI 10.1021/bi00128a003; RENSDOMIANO S, 1989, J BIOL CHEM, V264, P899; ROSA P, 1992, J BIOL CHEM, V267, P12227; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; STONE SR, 1986, BIOCHEMISTRY-US, V25, P4622, DOI 10.1021/bi00364a025; SUIKO M, 1988, BIOCHEM BIOPH RES CO, V154, P1094, DOI 10.1016/0006-291X(88)90253-7; WATERSTON R, 1993, COLD SPRING HARB SYM, V58, P367, DOI 10.1101/SQB.1993.058.01.043; WILKINS PP, 1995, J BIOL CHEM, V270, P22677, DOI 10.1074/jbc.270.39.22677	38	102	114	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24770	24774		10.1074/jbc.273.38.24770	http://dx.doi.org/10.1074/jbc.273.38.24770			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733778	hybrid			2022-12-27	WOS:000076007300070
J	Takatsu, H; Sakurai, M; Shin, HW; Murakami, K; Nakayama, K				Takatsu, H; Sakurai, M; Shin, HW; Murakami, K; Nakayama, K			Identification and characterization of novel clathrin adaptor-related proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COATED VESICLES; BREFELDIN-A; COMPLEX; EXPRESSION; TRANSPORT; SIGNALS; AP-3; YEAST; ACTIVATORS; SUBUNIT	We have identified a human similar to 87-kDa protein, designated as gamma 2-adaptin, that is similar to gamma-adaptin (called gamma 1-adaptin in this paper), a large chain of the AP-1 clathrin-associated adaptor complex, not only in the primary structure (60% amino acid identity) but also in the domain organization. Northern blot analysis has shown that its mRNA is expressed in a variety of tissues. Analysis using a yeast two-hybrid system has revealed that, similarly to gamma 1-adaptin, gamma 2-adaptin is capable of interacting not only with the sigma 1 chain (called as sigma 1A in this paper), the small chain of the AP-1 complex, but also with a novel sigma 1-like protein, designated as sigma 1B, which shows an 87% amino acid identity to sigma 1A; and that, unlike gamma 1-adaptin, it is unable to interact with beta 1-adaptin, another large chain of the AP-1 complex. Immunofluorescence microscopy analysis has revealed that gamma 2-adaptin is localized to paranuclear vesicular structures that are not superimposed on structures containing gamma 1-adaptin. Furthermore, unlike gamma 1-adaptin, gamma 2-adaptin is recruited onto membranes in the presence of a fungal antibiotic, brefeldin A. These data suggest that gamma 2-adaptin constitute a novel adaptor-related complex that participates in a transport step different from that of AP-1.	Univ Tsukuba, Inst Biol Sci, Tsukuba Sci City, Ibaraki 3058572, Japan; Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba Sci City, Ibaraki 3058572, Japan; Univ Tsukuba, Gene Expt Ctr, Tsukuba Sci City, Ibaraki 3058572, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba	Nakayama, K (corresponding author), Univ Tsukuba, Inst Biol Sci, Tsukuba Sci City, Ibaraki 3058572, Japan.		Shin, Hye-Won/P-5398-2018; Nakayama, Kazuhisa/ABF-2924-2020	Shin, Hye-Won/0000-0002-9138-9554; Nakayama, Kazuhisa/0000-0001-7701-7183				AKASAKI K, 1995, EXP CELL RES, V220, P464, DOI 10.1006/excr.1995.1338; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; DellAngelica EC, 1997, J BIOL CHEM, V272, P15078, DOI 10.1074/jbc.272.24.15078; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; Harter C, 1996, BBA-REV BIOMEMBRANES, V1286, P75, DOI 10.1016/0304-4157(96)00003-2; Honing S, 1996, EMBO J, V15, P5230, DOI 10.1002/j.1460-2075.1996.tb00908.x; HORN M, 1994, BIOCHEM J, V301, P69, DOI 10.1042/bj3010069; HOSAKA M, 1994, BIOMED RES-TOKYO, V15, P383, DOI 10.2220/biomedres.15.383; KEEN JH, 1990, ANNU REV BIOCHEM, V59, P415, DOI 10.1146/annurev.biochem.59.1.415; Keller P, 1997, J CELL SCI, V110, P3001; KIRCHHAUSEN T, 1991, J BIOL CHEM, V266, P11153; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Marks MS, 1997, TRENDS CELL BIOL, V7, P124, DOI 10.1016/S0962-8924(96)10057-X; MOSS J, 1995, J BIOL CHEM, V270, P12327, DOI 10.1074/jbc.270.21.12327; NEWMAN LS, 1995, CELL, V82, P773, DOI 10.1016/0092-8674(95)90474-3; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; Ooi CE, 1997, EMBO J, V16, P4508; PAGE LJ, 1995, J CELL BIOL, V131, P619, DOI 10.1083/jcb.131.3.619; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; ROBINSON MS, 1990, J CELL BIOL, V111, P2319, DOI 10.1083/jcb.111.6.2319; Robinson MS, 1997, TRENDS CELL BIOL, V7, P99, DOI 10.1016/S0962-8924(96)10048-9; ROBINSON MS, 1992, CELL, V69, P129, DOI 10.1016/0092-8674(92)90124-U; SAMBROOK J, 1989, MOL CLONING LABORATO, V2, P16; SCHMID SL, 1995, FASEB J, V9, P1445, DOI 10.1096/fasebj.9.14.7589986; Shin HW, 1997, J BIOCHEM-TOKYO, V122, P525; Simpson F, 1996, J CELL BIOL, V133, P749, DOI 10.1083/jcb.133.4.749; Simpson F, 1997, J CELL BIOL, V137, P835, DOI 10.1083/jcb.137.4.835; Stoorvogel W, 1996, J CELL BIOL, V132, P21, DOI 10.1083/jcb.132.1.21; TORII S, 1995, J BIOL CHEM, V270, P11574, DOI 10.1074/jbc.270.19.11574	31	63	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24693	24700		10.1074/jbc.273.38.24693	http://dx.doi.org/10.1074/jbc.273.38.24693			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733768	hybrid			2022-12-27	WOS:000076007300060
J	Derst, C; Wischmeyer, E; Preisig-Muller, R; Spauschus, A; Konrad, M; Hensen, P; Jeck, N; Seyberth, HW; Daut, J; Karschin, A				Derst, C; Wischmeyer, E; Preisig-Muller, R; Spauschus, A; Konrad, M; Hensen, P; Jeck, N; Seyberth, HW; Daut, J; Karschin, A			A hyperprostaglandin E syndrome mutation in Kir1.1 (renal outer medullary potassium) channels reveals a crucial residue for channel function in Kir1.3 channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INWARD-RECTIFIER; K+-CHANNEL; BARTTERS-SYNDROME; CLONING; EXPRESSION; PROTEIN; BRAIN; HYPERCALCIURIA; CHROMOSOME-21; HETEROGENEITY	Loss of function mutations in kidney Kir1.1 (renal outer medullary potassium channel, KCNJ1) inwardly rectifying, potassium channels can be found in patients suffering from hyperprostaglandin E syndrome (HPS), the antenatal form of Bartter syndrome. A novel mutation found in a sporadic case substitutes an asparagine by a positively charged lysine residue at amino acid position 124 in the extracellular M1-H5 linker region, When heterologously expressed in Xenopus oocytes and mammalian cells, current amplitudes from mutant Kir1.1a[N124K] channels were reduced by a factor of similar to 12 as compared with wild type, A lysine at the equivalent position is present in only one of the known Kir subunits, the newly identified Kir1.3, which is also poorly expressed in the recombinant system, When the lysine residue in guinea pig Kir1.3 (gpKir1.3) isolated from a genomic library was changed to an asparagine (reverse HPS mutation), mutant channels yielded macroscopic currents with amplitudes increased B-fold, From single channel analysis it became apparent that the decrease in mutant Kir1.1 channels and the increase in mutant gpKir1.3 macroscopic currents were mainly due to the number of expressed functional channels. Coexpression experiments revealed a dominant-negative effect of Kir1.1a[N124K] and gpKir1.3 on macroscopic current amplitudes when coexpressed with wild type Kir1.1a and gpKir[K110N], respectively. Thus we postulate that in Kir1.3 channels the extracellular positively charged lysine is of crucial functional importance. The HPS phenotype in man call be explained by the lower expression of functional channels by the Kir1.1a[N124K] mutant.	Max Planck Inst Biophys Chem, D-37070 Gottingen, Germany; Philipps Univ Marburg, Inst Physiol, D-35033 Marburg, Germany; Philipps Univ Marburg, Dept Pediat, D-35033 Marburg, Germany	Max Planck Society; Philipps University Marburg; Philipps University Marburg	Karschin, A (corresponding author), Max Planck Inst Biophys Chem, Fassberg 11, D-37070 Gottingen, Germany.	akarsch@gwdg.de						BOIM MA, 1995, AM J PHYSIOL-RENAL, V268, pF1132, DOI 10.1152/ajprenal.1995.268.6.F1132; BOND CT, 1994, RECEPTOR CHANNEL, V2, P183; BREDT DS, 1995, P NATL ACAD SCI USA, V92, P6753, DOI 10.1073/pnas.92.15.6753; Chouabe C, 1997, EMBO J, V16, P5472, DOI 10.1093/emboj/16.17.5472; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; Derst C, 1997, BIOCHEM BIOPH RES CO, V230, P641, DOI 10.1006/bbrc.1996.6024; Doi T, 1996, J BIOL CHEM, V271, P17261, DOI 10.1074/jbc.271.29.17261; GLOWATZKI E, 1995, P ROY SOC B-BIOL SCI, V261, P251, DOI 10.1098/rspb.1995.0145; Gosset P, 1997, GENOMICS, V44, P237, DOI 10.1006/geno.1997.4865; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; Horio Y, 1997, J BIOL CHEM, V272, P12885, DOI 10.1074/jbc.272.20.12885; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; INAGAKI N, 1995, J BIOL CHEM, V270, P5691, DOI 10.1074/jbc.270.11.5691; Isomoto S, 1997, JPN J PHYSIOL, V47, P11, DOI 10.2170/jjphysiol.47.11; Karolyi L, 1997, HUM MOL GENET, V6, P17; Kockerling A, 1996, J PEDIATR-US, V129, P519, DOI 10.1016/S0022-3476(96)70116-6; Kubo Y, 1996, J BIOL CHEM, V271, P15729, DOI 10.1074/jbc.271.26.15729; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; LANG F, 1992, PHYSIOL REV, V72, P1, DOI 10.1152/physrev.1992.72.1.1; LESAGE F, 1994, FEBS LETT, V353, P37, DOI 10.1016/0014-5793(94)01007-2; MCNICHOLAS CM, 1994, P NATL ACAD SCI USA, V91, P8077, DOI 10.1073/pnas.91.17.8077; McNicholas CM, 1996, P NATL ACAD SCI USA, V93, P8083, DOI 10.1073/pnas.93.15.8083; NAVARATNAM DS, 1995, J BIOL CHEM, V270, P19238, DOI 10.1074/jbc.270.33.19238; Ohira M, 1997, GENOME RES, V7, P47, DOI 10.1101/gr.7.1.47; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; SEYBERTH HW, 1985, J PEDIATR-US, V107, P694, DOI 10.1016/S0022-3476(85)80395-4; SEYBERTH HW, 1997, OXFORD TXB CLIN NEPH, P1085; Shuck ME, 1997, J BIOL CHEM, V272, P586; SHUCK ME, 1994, J BIOL CHEM, V269, P24261; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Spauschus A, 1996, J NEUROSCI, V16, P930; TAKUMI T, 1995, J BIOL CHEM, V270, P16339, DOI 10.1074/jbc.270.27.16339; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; Wischmeyer E, 1997, J PHYSIOL-LONDON, V504, P591, DOI 10.1111/j.1469-7793.1997.591bd.x; WISCHMEYER E, 1994, PFLUEGERS ARCH EUR J, V429, P809	36	23	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23884	23891		10.1074/jbc.273.37.23884	http://dx.doi.org/10.1074/jbc.273.37.23884			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727001	hybrid			2022-12-27	WOS:000075893100042
J	Karavitis, M; Fronticelli, C; Brinigar, WS; Vasquez, GB; Militello, V; Leone, M; Cupane, A				Karavitis, M; Fronticelli, C; Brinigar, WS; Vasquez, GB; Militello, V; Leone, M; Cupane, A			Properties of human hemoglobins with increased polarity in the alpha- or beta-heme pocket - Carbonmonoxy derivatives	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPERM WHALE MYOGLOBIN; LIGAND-BINDING; INFRARED-SPECTROSCOPY; DISTAL HISTIDINE; FUNCTIONAL-PROPERTIES; RESONANCE RAMAN; BOUND CO; MUTANTS; PROTEINS; SITE	The spectroscopic, conformational, and functional properties of mutant carbonmonoxy hemoglobins in which either the beta-globin Val(67)(Ell) or the alpha-globin Val(62)(Ell) is replaced by threonine have been investigated. The thermal evolution of the Soret absorption band and the stretching frequency of the bound CO were used to probe the stereodynamic propel-ties of the heme pocket. The functional properties mere investigated by kinetic measurements. The spectroscopic and functional data were related to the conformational properties through molecular analysis. The effects of this nonpolar-to-polar isosteric mutation are: (i) increase of heme pocket anharmonic motions, (ii) stabilization of the A(o) conformer in the IR, spectrum, (iii) increased CO dissociation rates. The spectroscopic data indicate that for the carbonmonoxy derivatives, the Val --> Thr mutation has a larger conformational effect on the beta-subunits than on the alpha-subunits. This is at variance with the deoxy derivatives where the conformational modification was larger in the heme pocket of the alpha-subunit (Cupane, A., Leone, Ri., Militello, V,, Friedman, R. K., Koley, A. P,, Vasquez, G. P,, Brinigar, W, S., Kara; vitis, M., and Fronticelli, C. (1997) J. Biol. Chern. 272, 26271-26278), These effects are attributed to a different electrostatic interaction between O-gamma of Thr(E11) and the bound CO molecule. Molecular analysis indicates a more favorable interaction of the bound CO with Thr OY in the beta-subunit heme pocket.	Univ Palermo, Dipartimento Sci Fis & Astron, I-90123 Palermo, Italy; Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; Temple Univ, Dept Chem, Philadelphia, PA 19122 USA; Univ Maryland, Maryland Biotechnol Inst, Ctr Adv Res Biotechnol, Rockville, MD 20850 USA; Univ Palermo, Ist Nazl Fis Mat, I-90123 Palermo, Italy	University of Palermo; University System of Maryland; University of Maryland Baltimore; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Palermo	Cupane, A (corresponding author), Univ Palermo, Dipartimento Sci Fis & Astron, Via Archirafi 36, I-90123 Palermo, Italy.	cupane@fisica.unipa.it	MILITELLO, VALERIA/F-2664-2011; Leone, Maurizio/F-2353-2010	Leone, Maurizio/0000-0002-0292-7657	NHLBI NIH HHS [HBLBI-48517] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BALASUBRAMANIAN S, 1993, P NATL ACAD SCI USA, V90, P4718, DOI 10.1073/pnas.90.10.4718; BRAUNSTEIN D, 1988, P NATL ACAD SCI USA, V85, P8497, DOI 10.1073/pnas.85.22.8497; BRAUNSTEIN DP, 1993, BIOPHYS J, V65, P2447, DOI 10.1016/S0006-3495(93)81310-9; CAMERON AD, 1993, BIOCHEMISTRY-US, V32, P13061, DOI 10.1021/bi00211a016; CHANEY RH, 1979, J MENT DEFIC RES, V23, P1; CUPANE A, 1995, EUR BIOPHYS J BIOPHY, V23, P385, DOI 10.1007/BF00196825; Cupane A, 1997, J BIOL CHEM, V272, P26271, DOI 10.1074/jbc.272.42.26271; CUPANE A, 1993, EUR BIOPHYS J BIOPHY, V21, P385, DOI 10.1007/BF00185865; DOYLE ML, 1992, BIOCHEMISTRY-US, V31, P8629, DOI 10.1021/bi00151a033; EGEBERG KD, 1990, BIOCHEMISTRY-US, V29, P9783, DOI 10.1021/bi00494a004; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kushkuley B, 1996, BIOPHYS J, V70, P1214, DOI 10.1016/S0006-3495(96)79680-7; LI TS, 1994, BIOCHEMISTRY-US, V33, P1433, DOI 10.1021/bi00172a021; LI XY, 1988, J AM CHEM SOC, V110, P6024, DOI 10.1021/ja00226a017; MILITELLO V, 1995, PROTEINS, V22, P12, DOI 10.1002/prot.340220103; MOORE EG, 1976, J BIOL CHEM, V251, P2788; MORIKIS D, 1989, BIOCHEMISTRY-US, V28, P4791, DOI 10.1021/bi00437a041; OLSON JS, 1981, METHOD ENZYMOL, V76, P625; Pechik I, 1996, BIOCHEMISTRY-US, V35, P1935, DOI 10.1021/bi9519967; PERUTZ MF, 1990, ANNU REV PHYSIOL, V52, P1; POTTER WT, 1990, BIOCHEMISTRY-US, V29, P6283, DOI 10.1021/bi00478a025; POTTER WT, 1983, BIOCHEM BIOPH RES CO, V116, P719, DOI 10.1016/0006-291X(83)90584-3; QUILLIN ML, 1993, J MOL BIOL, V234, P140, DOI 10.1006/jmbi.1993.1569; ROHLFS RJ, 1990, J BIOL CHEM, V265, P3168; SATOW Y, 1986, J MOL BIOL, V190, P593, DOI 10.1016/0022-2836(86)90245-7; SHIMADA H, 1982, J BIOL CHEM, V257, P1893; SMERDON SJ, 1991, BIOCHEMISTRY-US, V30, P6252, DOI 10.1021/bi00239a025; SMERDON SJ, 1993, BIOCHEMISTRY-US, V32, P5132, DOI 10.1021/bi00070a023; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; Uchida T, 1997, J BIOL CHEM, V272, P30108, DOI 10.1074/jbc.272.48.30108; Vasquez GB, 1998, ACTA CRYSTALLOGR D, V54, P355, DOI 10.1107/S0907444997012250	31	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23740	23749		10.1074/jbc.273.37.23740	http://dx.doi.org/10.1074/jbc.273.37.23740			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726982	hybrid			2022-12-27	WOS:000075893100023
J	Laufs, U; Liao, JK				Laufs, U; Liao, JK			Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by rho GTPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; CORONARY-ARTERY DISEASE; HYPERCHOLESTEROLEMIC HUMANS; MESSENGER-RNA; REDUCTASE; PROTEINS; ATHEROSCLEROSIS; DYSFUNCTION; INHIBITION; EXPRESSION	The mechanism by which 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors increase endothelial nitric oxide synthase (eNOS) expression is unknown. To determine whether changes in isoprenoid synthesis affects eNOS expression, human endothelial cells were treated with the HMG-CoA reductase inhibitor, mevastatin (1-10 mu M), in the presence of L-mevalonate (200 mu M), geranylgeranylpyrophosphate (GGPP, 1-10 mu M), farnesylpyrophosphate (FPP, 5-10 mu M), or low density lipoprotein (LDL, 1 mg/ml). Mevastatin increased eNOS mRNA and protein levels by 305 +/- 15% and 180 +/- 11%, respectively, Go-treatment with L-mevalonate or GGPP, but not FPP or LDL, reversed mevastatin's effects. Because Rho GTPases undergo geranylgeranyl modification, we investigated whether Rho regulates eNOS expression. Immunoblot analyses and [S-35]GTP gamma S-binding assays revealed that mevastatin inhibited Rho membrane translocation and GTP binding activity by 60 +/- 5% and 78 +/- 6%, both of which were reversed by co-treatment with GGPP but not FPP. Furthermore, inhibition of Rho by Clostridium botulinum. C3 transferase (50 mu g/ml) or by overexpression of a dominant-negative N19RhoA mutant increased eNOS expression. In contrast, activation of Rho by Escherichia coli cytotoxic necrotizing factor-1 (200 ng/ml) decreased eNOS expression. These findings indicate that Rho negatively regulates eNOS expression and that HMG-CoA reductase inhibitors up-regulate eNOS expression by blocking Rho geranylgeranylation, which is necessary for its membrane-associated activity.	Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Liao, JK (corresponding author), Dept Med, Div Cardiovasc, 221 Longwood Ave,LMRC-322, Boston, MA 02115 USA.	jliao@rics.bwh.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052233] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-52233] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aktories K, 1997, J CLIN INVEST, V100, pS11; ANDERSON TJ, 1995, NEW ENGL J MED, V332, P488, DOI 10.1056/NEJM199502233320802; Bassell G, 1997, CURR OPIN CELL BIOL, V9, P109, DOI 10.1016/S0955-0674(97)80159-7; BLUM CB, 1994, AM J CARDIOL, V73, pD3, DOI 10.1016/0002-9149(94)90626-2; BOKOCH GM, 1994, J BIOL CHEM, V269, P31674; CASEY PJ, 1995, SCIENCE, V268, P221, DOI 10.1126/science.7716512; CHUNG BH, 1986, METHOD ENZYMOL, V128, P181; CREAGER MA, 1990, J CLIN INVEST, V86, P228, DOI 10.1172/JCI114688; Gebbink MFBG, 1997, J CELL BIOL, V137, P1603, DOI 10.1083/jcb.137.7.1603; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gosser YQ, 1997, NATURE, V387, P814, DOI 10.1038/42961; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HOHL RJ, 1995, J BIOL CHEM, V270, P17508, DOI 10.1074/jbc.270.29.17508; Laufs U, 1997, J BIOL CHEM, V272, P31725, DOI 10.1074/jbc.272.50.31725; Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129; LIAO JK, 1995, J BIOL CHEM, V270, P319, DOI 10.1074/jbc.270.1.319; LIAO JK, 1995, J CLIN INVEST, V95, P1457, DOI 10.1172/JCI117816; LIAO JK, 1993, J CLIN INVEST, V92, P2168, DOI 10.1172/JCI116818; LIAO JK, 1994, J BIOL CHEM, V269, P12987; Lin MC, 1997, J CLIN INVEST, V99, P737, DOI 10.1172/JCI119219; MCLENACHAN JM, 1991, CIRCULATION, V84, P1273, DOI 10.1161/01.CIR.84.3.1273; Nasmyth K, 1997, CURR OPIN CELL BIOL, V9, P396, DOI 10.1016/S0955-0674(97)80013-0; ODriscoll G, 1997, CIRCULATION, V95, P1126, DOI 10.1161/01.cir.95.5.1126; OHARA Y, 1993, J CLIN INVEST, V91, P2546, DOI 10.1172/JCI116491; Packard CJ, 1998, CIRCULATION, V97, P1440; PEDERSEN TR, 1994, LANCET, V344, P1383; REDDY KG, 1994, J AM COLL CARDIOL, V23, P833, DOI 10.1016/0735-1097(94)90627-0; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Tamai O, 1997, CIRCULATION, V95, P76, DOI 10.1161/01.CIR.95.1.76; TREASURE CB, 1995, NEW ENGL J MED, V332, P481, DOI 10.1056/NEJM199502233320801; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; WERNS SW, 1989, CIRCULATION, V79, P287, DOI 10.1161/01.CIR.79.2.287; YAGI K, 1976, BIOCHEM MED METAB B, V15, P212, DOI 10.1016/0006-2944(76)90049-1; ZHANG R, 1995, J BIOL CHEM, V270, P15320, DOI 10.1074/jbc.270.25.15320	35	891	945	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24266	24271		10.1074/jbc.273.37.24266	http://dx.doi.org/10.1074/jbc.273.37.24266			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727051	hybrid			2022-12-27	WOS:000075893100092
J	Bai, M; Trivedi, S; Brown, EM				Bai, M; Trivedi, S; Brown, EM			Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPOCALCIURIC HYPERCALCEMIA; NEONATAL SEVERE HYPERPARATHYROIDISM; M2 MUSCARINIC RECEPTORS; CA2+-SENSING RECEPTOR; SIGNAL-TRANSDUCTION; G-PROTEIN; DE-NOVO; MUTATIONS; GENE; HYPOCALCEMIA	The extracellular calcium (Ca-o(2+))-sensing receptor (CaR) is a G protein-coupled receptor that plays important roles in calcium homeostasis, In this study, we employed epitope tagging, cell-surface biotinylation, and immunoprecipitation techniques to demonstrate that the CaR is expressed mostly in the form of a dimer on the surface of transfected human embryonic kidney (HEK293) cells. Western analysis of cell-surface proteins under nonreducing conditions showed that the CaR exists in several forms with molecular masses greater than 200 kDa, Most of these high molecular mass forms of the receptor could be converted to a single monomeric species at 160 kDa under reducing conditions. This result suggests that the CaR forms dimers or even higher oligomers on the cell surface through intermolecular disulfide bonds that are sensitive to reducing agents. Consistent with this hypothesis, use of a cell-surface cross-linking agent substantially increases the proportion of the putative dimeric CaR at 280 kDa relative to the monomeric form of the receptor at 160 kDa under reducing conditions. Dimerization of the CaR in intact cells was further demonstrated when we co-transfected and co-immunoprecipitated the wild type, full-length receptor and a truncated form of the CaR lacking its cytoplasmic tail. Taken together, we conclude from these results that the functional CaR resides on the cell surface of transfected HEK293 cells in the form of a dimer.	Brigham & Womens Hosp, Dept Med, Div Endocrine Hypertens, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Bai, M (corresponding author), Brigham & Womens Hosp, Dept Med, Div Endocrine Hypertens, 221 Longwood Ave, Boston, MA 02115 USA.		Centeno, Patricia Pacios/O-8368-2016		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009436] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK09436] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AVISSAR S, 1983, P NATL ACAD SCI-BIOL, V80, P156, DOI 10.1073/pnas.80.1.156; Bai M, 1997, J CLIN INVEST, V99, P1917, DOI 10.1172/JCI119359; Bai M, 1997, J CLIN INVEST, V99, P88, DOI 10.1172/JCI119137; Bai M, 1996, J BIOL CHEM, V271, P19537, DOI 10.1074/jbc.271.32.19537; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; DeLuca F, 1997, J CLIN ENDOCR METAB, V82, P2710, DOI 10.1210/jc.82.8.2710; DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478; FAJTOVA VT, 1991, AM J PHYSIOL, V261, pE151, DOI 10.1152/ajpendo.1991.261.1.E151; HAWLEY-NELSON P, 1993, FOCUS MADISON, V15, P73; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; HERBERG JT, 1984, J BIOL CHEM, V259, P9285; HIRSCHBERG BT, 1994, J BIOL CHEM, V269, P26127; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Pearce SHS, 1996, J CLIN INVEST, V98, P1860, DOI 10.1172/JCI118987; Pearce SHS, 1996, NEW ENGL J MED, V335, P1115, DOI 10.1056/NEJM199610103351505; POLLAK MR, 1994, NAT GENET, V8, P303, DOI 10.1038/ng1194-303; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; POTTER LT, 1991, MOL PHARMACOL, V39, P211; Ray K, 1997, J BIOL CHEM, V272, P31355, DOI 10.1074/jbc.272.50.31355; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; SCHULZ GE, 1985, PRINCIPLES PROTEIN S, P53; VENTER JC, 1983, FED PROC, V42, P273; Ward DT, 1998, J BIOL CHEM, V273, P14476, DOI 10.1074/jbc.273.23.14476; WESSLINGRESNICK M, 1987, J BIOL CHEM, V262, P3697; WILLARDSON BM, 1993, J BIOL CHEM, V268, P6371	29	334	365	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23605	23610		10.1074/jbc.273.36.23605	http://dx.doi.org/10.1074/jbc.273.36.23605			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722601	hybrid			2022-12-27	WOS:000075778100101
J	Hoppel, CL; Kerner, J; Turkaly, P; Turkaly, J; Tandler, B				Hoppel, CL; Kerner, J; Turkaly, P; Turkaly, J; Tandler, B			The malonyl-CoA-sensitive form of carnitine palmitoyltransferase is not localized exclusively in the outer membrane of rat liver mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-MICROSCOPY; ENERGY-METABOLISM; PROTEINS; TRANSLOCATION; COMPARTMENT; HEART; SITE	The data used to support the idea that malonyl-coenzyme A (CoA)-sensitive carnitine palmitoyltransferase (CPT-I) is localized on the outer mitochondrial membrane are based on harsh techniques that disrupt mitochondrial physiology. We have turned to the use of the French press, which produces a shearing force that denudes mitochondria of their outer membrane without the physiologically disruptive effects characteristic of phosphate swelling. Our results indicate that the mitoplasts contain just 15-19% of the outer membrane marker enzyme activity while retaining 85% of the total CPT activity and 50% of both CPT-I, as well as long-chain acyl-CoA synthase activity, the latter two supposed outer membrane enzymes. These mitoplasts were shown by electron microscopy to have the configuration of mitochondria that merely have been divested of their outer membranes. Carnitine-dependent fatty acid oxidation was retained in the mitoplasts, showing that they were physiologically intact. Moreover, protein immuno blotting analysis showed that CPT-I, as well as the inner CPT-II, was localized in the mitoplast fraction. The outer membrane fraction, which consisted of membrane "ghosts," contained most (50-60%) of marker enzyme activity, monoamine oxidase-B and porin proteins, but only about 27-29% CPT-I activity. Because CPT-I and long-chain acyl-CoA synthetase appear to be associated with both inner and outer membranes, we postulate that these enzymes reside in contact sites, which represent a melding of both limiting membranes.	Case Western Reserve Univ, Sch Med, Dept Vet Affairs Med Ctr, Dept Pharmacol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Vet Affairs Med Ctr, Dept Nutr, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Vet Affairs Med Ctr, Dept Med, Cleveland, OH 44106 USA; Kyushu Dent Coll, Dept Oral Anat 2, Kitakyushu, Fukuoka 803, Japan	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Kyushu Dental University	Hoppel, CL (corresponding author), VA Med Ctr, Med Res Serv 151W, 10701 East Blvd, Cleveland, OH 44106 USA.	CLH5@po.cwru.edu						BRDICZKA D, 1994, MOL CELL BIOCHEM, V133, P69, DOI 10.1007/BF01267948; BRDICZKA D, 1994, BBA-BIOENERGETICS, V1187, P264, DOI 10.1016/0005-2728(94)90124-4; BREMER J, 1967, J BIOL CHEM, V242, P1744; BRENDEL K, 1967, BIOCHIM BIOPHYS ACTA, V137, P98, DOI 10.1016/0005-2760(67)90012-4; BROSNAN JT, 1973, J BIOL CHEM, V248, P4075; DECKER GL, 1977, J ULTRA MOL STRUCT R, V59, P44, DOI 10.1016/S0022-5320(77)80027-0; DECLERCQ PE, 1987, J BIOL CHEM, V262, P9812; Fong J C, 1981, Methods Enzymol, V71 Pt C, P390; Fraser F, 1998, BIOCHEM J, V329, P225, DOI 10.1042/bj3290225; FRASER F, 1977, BIOCHEM J, V323, P711; FRITZ IB, 1963, J LIPID RES, V4, P279; GORNALL AG, 1949, J BIOL CHEM, V177, P751; HOPPEL C, 1979, J BIOL CHEM, V254, P4164; HOPPEL CL, 1972, J BIOL CHEM, V247, P832; HOPPEL CL, 1992, CURRENT CONCEPTS IN CARNITINE RESEARCH, P153; INGALLS ST, 1982, J LABELLED COMPD RAD, V19, P535, DOI 10.1002/jlcr.2580190408; Karnovsky M.J., 1971, P 11 M AM SOC CELL B, P146; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; KOPEC B, 1973, J BIOL CHEM, V248, P4069; KORNBERG A, 1953, J BIOL CHEM, V204, P329; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAYER A, 1993, J CELL BIOL, V121, P1233, DOI 10.1083/jcb.121.6.1233; MCGARRY JD, 1978, J BIOL CHEM, V253, P4128; MILLONIG G, 1961, J BIOPHYS BIOCHEM CY, V11, P736, DOI 10.1083/jcb.11.3.736; MORTON DJ, 1968, BIOCHEM J, V107, P377, DOI 10.1042/bj1070377; MURTHY MSR, 1987, P NATL ACAD SCI USA, V84, P378, DOI 10.1073/pnas.84.2.378; PARSONS DF, 1966, ANN NY ACAD SCI, V137, P643, DOI 10.1111/j.1749-6632.1966.tb50188.x; PON L, 1989, J CELL BIOL, V109, P2603, DOI 10.1083/jcb.109.6.2603; SAGGERSON D, 1992, ADV ENZYME REGUL, V32, P285; SAGGERSON ED, 1981, FEBS LETT, V129, P225, DOI 10.1016/0014-5793(81)80170-6; SCHNAITMAN C, 1967, J CELL BIOL, V32, P719, DOI 10.1083/jcb.32.3.719; SCHNAITMAN C, 1968, J CELL BIOL, V38, P158, DOI 10.1083/jcb.38.1.158; SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415; Srere P.A., 1969, METHOD ENZYMOL, V13, P7; TANDLER B, 1990, J ELECTRON MICR TECH, V16, P81, DOI 10.1002/jemt.1060160110; TANDLER B, 1977, STAIN TECHNOL, V52, P238, DOI 10.3109/10520297709116783; TOMEC RJ, 1975, ARCH BIOCHEM BIOPHYS, V170, P716, DOI 10.1016/0003-9861(75)90169-1; Wharton DC., 1967, METHOD ENZYMOL, P245; YAMAZAKI N, 1995, FEBS LETT, V363, P41, DOI 10.1016/0014-5793(95)00277-G	39	63	64	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23495	23503		10.1074/jbc.273.36.23495	http://dx.doi.org/10.1074/jbc.273.36.23495			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722587	hybrid			2022-12-27	WOS:000075778100087
J	Ianelli, CJ; DeLellis, R; Thorley-Lawson, DA				Ianelli, CJ; DeLellis, R; Thorley-Lawson, DA			CD48 binds to heparan sulfate on the surface of epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSTEIN-BARR-VIRUS; LOW-AFFINITY LIGAND; B-CELL; FLAVOBACTERIUM-HEPARINUM; DEXTRAN SULFATE; FINE-STRUCTURE; HUMAN CD2; RAT CD2; IN-VIVO; ADHESION	CD48 is a member of the immunoglobulin superfamily whose cell surface expression is strikingly up-regulated on the surface of Epstein-Barr virus-infected B cells. To date, no ligand for human CD48 has been characterized. In this study, we show that human recombinant CD48 binds to the glycosaminoglycan heparan sulfate on the surface of human epithelial cells. We have produced a monoclonal antibody (615) against epithelial cell surfaces that blocks this binding and show that it too recognizes heparan sulfate. The specific epitope on heparan sulfate that is recognized by the antibody and is involved in binding is also expressed in vivo on the basolateral surfaces of mucosal epithelium and lamina propria.	Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA	Tufts University	Thorley-Lawson, DA (corresponding author), Tufts Univ, Sch Med, Dept Pathol, 136 Harrison Ave, Boston, MA 02111 USA.				NATIONAL CANCER INSTITUTE [R01CA031893, R01CA065883, R37CA031893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018757] Funding Source: NIH RePORTER; NCI NIH HHS [CA 31893, CA 65883] Funding Source: Medline; NIAID NIH HHS [AI 18757] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARULANANDAM ARN, 1993, J EXP MED, V177, P1439, DOI 10.1084/jem.177.5.1439; BERNFIELD M, 1990, PHILOS T R SOC B, V327, P171, DOI 10.1098/rstb.1990.0052; Brown MH, 1995, EUR J IMMUNOL, V25, P3222, DOI 10.1002/eji.1830251204; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; COLE GJ, 1989, NEURON, V2, P1157, DOI 10.1016/0896-6273(89)90182-7; DELISSER HM, 1993, J BIOL CHEM, V268, P16037; DESAI UR, 1993, ARCH BIOCHEM BIOPHYS, V306, P461, DOI 10.1006/abbi.1993.1538; DESAI UR, 1993, BIOCHEMISTRY-US, V32, P8140, DOI 10.1021/bi00083a012; DIAMOND MS, 1995, J CELL BIOL, V130, P1473, DOI 10.1083/jcb.130.6.1473; ESKO JD, 1992, ADV EXP MED BIOL, V313, P97; Esko JD, 1991, CURR OPIN CELL BIOL, V3, P805, DOI 10.1016/0955-0674(91)90054-3; GALLAGHER JT, 1995, ADV EXP MED BIOL, V376, P125; GALLAGHER JT, 1986, BIOCHEM J, V236, P313, DOI 10.1042/bj2360313; HARDINGHAM TE, 1992, FASEB J, V6, P861, DOI 10.1096/fasebj.6.3.1740236; Ianelli CJ, 1997, J IMMUNOL, V159, P3910; KAPLAN AJ, 1993, J IMMUNOL, V151, P4022; KATO K, 1992, J EXP MED, V176, P1241, DOI 10.1084/jem.176.5.1241; KATO M, 1994, J BIOL CHEM, V269, P18881; KLAMAN LD, 1995, J VIROL, V69, P871, DOI 10.1128/JVI.69.2.871-881.1995; LEDERMAN S, 1989, J IMMUNOL, V143, P1149; LINHARDT RJ, 1991, CURRENT PROTOCOLS MO, V2; Miyashita EM, 1997, J VIROL, V71, P4882, DOI 10.1128/JVI.71.7.4882-4891.1997; MIYASHITA EM, 1995, CELL, V80, P593, DOI 10.1016/0092-8674(95)90513-8; POWELL LD, 1995, J BIOL CHEM, V270, P14243, DOI 10.1074/jbc.270.24.14243; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; SANDERSON RD, 1994, J BIOL CHEM, V269, P13100; SANDERSON RD, 1988, P NATL ACAD SCI USA, V85, P9562, DOI 10.1073/pnas.85.24.9562; SANDRIN MS, 1993, J IMMUNOL, V151, P4606; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STAUNTON DE, 1987, EMBO J, V6, P3695, DOI 10.1002/j.1460-2075.1987.tb02703.x; THORLEYLAWSON DA, 1993, BIOCHEM SOC T, V21, P976, DOI 10.1042/bst0210976; THORLEYLAWSON DA, 1982, CELL, V30, P415, DOI 10.1016/0092-8674(82)90239-2; VANDERMERWE PA, 1993, EMBO J, V12, P4945, DOI 10.1002/j.1460-2075.1993.tb06188.x; WARREN HS, 1990, IMMUNOL CELL BIOL, V68, P199, DOI 10.1038/icb.1990.28; YANG BH, 1994, EMBO J, V13, P286, DOI 10.1002/j.1460-2075.1994.tb06261.x; YOKOYAMA S, 1991, J IMMUNOL, V146, P2192	37	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23367	23375		10.1074/jbc.273.36.23367	http://dx.doi.org/10.1074/jbc.273.36.23367			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722571	hybrid			2022-12-27	WOS:000075778100071
J	Manes, T; Hoylaerts, MF; Muller, R; Lottspeich, F; Holke, W; Millan, JL				Manes, T; Hoylaerts, MF; Muller, R; Lottspeich, F; Holke, W; Millan, JL			Genetic complexity, structure, and characterization of highly active bovine intestinal alkaline phosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL ALKALINE-PHOSPHATASE; UNCOMPETITIVE INHIBITION; ESCHERICHIA-COLI; MECHANISM; MUTATIONS; SEQUENCE; ISOZYME; ENZYMES; GLYCAN	Mammalian alkaline phosphatases (APs) display 10-100-fold higher k(cat) values than do bacterial APs. To begin uncovering the critical residues that determine the catalytic efficiency of mammalian APs, we have compared the sequence of two bovine intestinal APs, i.e. a moderately active isozyme (bovine intestinal alkaline phosphatase, bIAP I, similar to 3,000 units/mg) previously cloned in our laboratory, and a highly active isozyme (bIAP II, similar to 8,000 units/mg) of hitherto unknown sequence. An unprecedented level of complexity was revealed for the bovine AP family of genes during our attempts to clone the bIAP II cDNA from cow intestinal RNAs. We cloned and characterized two novel full-length IAP cDNAs (bIAP III and bIAP IV) and obtained partial sequences for three other IAP cDNAs (bIAP V, VI, and VII). Moreover, we identified and partially cloned a gene coding for a second tissue nonspecific AP (TNAP-2). However, the cDNA for bIAP II, appeared unclonable. The sequence of the entire bIAP II isozyme was determined instead by a classical protein sequencing strategy using trypsin, carboxypeptidase, and endoproteinase Lys-C, Asp-N, and Glu-C digestions, as well as cyanogen bromide cleavage and NH2-terminal sequencing. A chimeric bIAP II cDNA was then constructed by ligating wildtype and mutagenized fragments of bIAP I, III, and IV to build a cDNA encoding the identified bIAP II sequence. Expression and enzymatic characterization of the recombinant bIAP I, II, III, and TV isozymes revealed average k(cat) values of 1800, 5900, 4200, and 6100 s(-1), respectively. Comparison of the bIAP I and bIAP II sequences identified 24 amino acid positions as likely candidates to explain differences in k(cat). Site-directed mutagenesis and kinetic studies revealed that a G322D mutation in bIAP II reduced its k(cat) to 1300 s(-1), while the converse mutation, ie. D322G, in bIAP I increased its k(cat) to 5800 s(-1). Other mutations in bIAP II had no effect on its kinetic properties. Our data clearly indicate that residue 322 is the major determinant of the high catalytic turnover in bovine IAPs. This residue is not directly involved in the mechanism of catalysis but is spatially sufficiently close to the active site to influence substrate positioning and hydrolysis of the phosphoenzyme complex.	Burnham Inst, La Jolla Canc Res Ctr, La Jolla, CA 92037 USA; Umea Univ, Dept Med Genet, S-90185 Umea, Sweden; Katholieke Univ Leuven, Ctr Mol & Vasc Biol, Leuven, Belgium; Boehringer Mannheim GmbH, D-82377 Penzberg, Germany; Max Planck Inst Biochem, D-82152 Martinsried, Germany	Sanford Burnham Prebys Medical Discovery Institute; Umea University; KU Leuven; Max Planck Society	Millan, JL (corresponding author), Burnham Inst, La Jolla Canc Res Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	millan@burnham-inst.org	Millan, Jose Luis/B-6580-2008	Hoylaerts, Marc/0000-0002-6474-3933	NCI NIH HHS [CA 42595] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042595] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BESMAN M, 1985, J BIOL CHEM, V260, P1190; BOSSI M, 1993, J BIOL CHEM, V268, P25409; COLEMAN JE, 1992, ANNU REV BIOPH BIOM, V21, P441, DOI 10.1146/annurev.biophys.21.1.441; ENGLE MJ, 1995, J BIOL CHEM, V270, P11935, DOI 10.1074/jbc.270.20.11935; FISHMAN WH, 1971, ENZYMOLOGIA, V41, P140; GARATTINI E, 1987, GENE, V59, P41, DOI 10.1016/0378-1119(87)90264-2; GHOSH NK, 1966, J BIOL CHEM, V241, P2516; HARRIS H, 1989, CLIN CHIM ACTA, V186, P133; HENTHORN PS, 1988, J BIOL CHEM, V263, P12011; HIROSE S, 1995, METHOD ENZYMOL, V250, P582; HOYLAERTS MF, 1992, BIOCHEM J, V286, P23, DOI 10.1042/bj2860023; Hoylaerts MF, 1997, J BIOL CHEM, V272, P22781, DOI 10.1074/jbc.272.36.22781; HOYLAERTS MF, 1991, EUR J BIOCHEM, V202, P605, DOI 10.1111/j.1432-1033.1991.tb16414.x; HUMMER C, 1991, BIOCHEM J, V274, P91, DOI 10.1042/bj2740091; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; KNOLL BJ, 1988, J BIOL CHEM, V263, P12020; MANES T, 1990, GENOMICS, V8, P541, DOI 10.1016/0888-7543(90)90042-S; McComb Jr RB, 1979, ALKALINE PHOSPHATASE, DOI 10.1007/978-1-4613-2970-1_4; McDougall K, 1998, MOL REPROD DEV, V50, P7, DOI 10.1002/(SICI)1098-2795(199805)50:1&lt;7::AID-MRD2&gt;3.0.CO;2-P; MICANOVIC R, 1988, P NATL ACAD SCI USA, V85, P1398, DOI 10.1073/pnas.85.5.1398; MILLAN JL, 1988, ANTICANCER RES, V8, P995; MILLAN JL, 1988, P NATL ACAD SCI USA, V85, P3024, DOI 10.1073/pnas.85.9.3024; MURPHY JE, 1995, J MOL BIOL, V253, P604, DOI 10.1006/jmbi.1995.0576; OGATA S, 1988, J BIOL CHEM, V263, P10489; Sambrook J., 2002, MOL CLONING LAB MANU; SOWADSKI JM, 1985, J MOL BIOL, V186, P417, DOI 10.1016/0022-2836(85)90115-9; TERAO M, 1990, BIOCHEM J, V268, P641, DOI 10.1042/bj2680641; TOH Y, 1989, EUR J BIOCHEM, V182, P231, DOI 10.1111/j.1432-1033.1989.tb14822.x; TOMIC M, 1990, NUCLEIC ACIDS RES, V18, P1656, DOI 10.1093/nar/18.6.1656; TSONIS PA, 1988, BIOTECHNIQUES, V6, P950; WATANABE T, 1991, J BIOL CHEM, V266, P21174; WEISS MJ, 1988, J BIOL CHEM, V263, P12002; WEISSIG H, 1993, BIOCHEM J, V290, P503, DOI 10.1042/bj2900503	33	40	44	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23353	23360		10.1074/jbc.273.36.23353	http://dx.doi.org/10.1074/jbc.273.36.23353			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722569	hybrid			2022-12-27	WOS:000075778100069
J	Chouinard, RA; Luo, Y; Osborne, TF; Walsh, A; Tall, AR				Chouinard, RA; Luo, Y; Osborne, TF; Walsh, A; Tall, AR			Sterol regulatory element binding protein-1 activates the cholesteryl ester transfer protein gene in vivo but is not required for sterol up-regulation of gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA LEVELS; LIPOPROTEIN RECEPTOR GENE; LEUCINE ZIPPER PROTEIN; COENZYME-A REDUCTASE; TRANSGENIC MICE; CULTURED-CELLS; 3-HYDROXY-3-METHYLGLUTARYL-COENZYME-A REDUCTASE; ADIPOCYTE DETERMINATION; HDL LEVELS; PLASMA	The plasma cholesteryl ester transfer protein (CETP) plays a central role in high density lipoprotein metabolism and reverse cholesterol transport. Plasma CETP levels are increased in response to dietary or endogenous hypercholesterolemia as a result of increased gene transcription in liver and periphery. Deletional analysis in human CETP transgenic mice localized this response to a region of the proximal promoter which contains a tandem repeat of the sterol regulatory element (SRE) of the 3-hydroxy-3-methylglutaryl-CoA reductase gene. The purpose of the present study was to evaluate the role of the SRE-like element in CETP promoter activity. Gel shift assays using CETP promoter fragments containing these elements showed binding of the transcription factors, sterol regulatory element-binding protein-1 (SREBP-1) and Yin Yang-1 (YY-1), Point mutations in the SRE-like element, designated MUT1 and MUT2, resulted in decreased binding of SREBP-1 (MUT1) or SREBP-1 and YY-1 (MUT2), To determine the in vivo significance of this binding activity, CETP transgenic mice were prepared containing these promoter point mutations. MUT1 and MUTE transgenic mice expressed CETP activity and mass in plasma, In response to high fat, high cholesterol diets, both MUT1-CETP and MUT2-CETP transgenic mice displayed induction of plasma CETP activity similar to that observed in natural flanking region (NFR) CETP transgenic mice. Moreover, in stably transfected adipocyte cell lines, MUT1 and MUTE CETP promoter-reporter genes showed significant induction of reporter activity in response to sterols, To evaluate transactivation by SREBP-1, NFR- and MUT1-CETP transgenic mice were crossed with SREBP-1 transgenic mice. Induction of the SREBP transgene in the liver with a low carbohydrate diet resulted in a 3-fold increase in plasma CETP activity in NFR-CETP/SREBP transgenic mice, but there was no significant change in activity in MUT1-CETP/SREBP transgenic mice. Thus, SREBP-1 transactivates the NFR-CETP transgene in vivo, as a result of interaction with the CETP promoter SREs, However, this interaction is not required for positive sterol induction of CETP gene transcription. The results suggest independent regulation of the CETP gene by SREBP-1 and a distinct positive sterol response factor.	Columbia Univ, Dept Med, Div Mol Med, New York, NY 10032 USA; Univ Calif Irvine, Dept Biochem & Mol Biol, Irvine, CA 92697 USA; Rockefeller Univ, Biochem Genet & Metab Lab, New York, NY 10021 USA	Columbia University; University of California System; University of California Irvine; Rockefeller University	Tall, AR (corresponding author), Columbia Univ, Dept Med, Div Mol Med, 630 W 168th St,PH 8-101, New York, NY 10032 USA.		Tall, Alan/AAT-8528-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL054591] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 54591] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGELLON LB, 1992, J BIOL CHEM, V267, P22336; AGELLON LB, 1991, J BIOL CHEM, V266, P10796; Atger V, 1995, J CLIN INVEST, V96, P2613, DOI 10.1172/JCI118326; AUSUBEL FM, 1997, CURRENT PROTOCOLS MO, V2; BENNETT MK, 1995, J BIOL CHEM, V270, P25578, DOI 10.1074/jbc.270.43.25578; BRIGGS MR, 1993, J BIOL CHEM, V268, P14490; Ericsson J, 1997, J BIOL CHEM, V272, P7298, DOI 10.1074/jbc.272.11.7298; Escriva H, 1997, P NATL ACAD SCI USA, V94, P6803, DOI 10.1073/pnas.94.13.6803; Francone OL, 1996, J LIPID RES, V37, P1268; GIL G, 1988, J BIOL CHEM, V263, P19009; HAYEK T, 1995, J CLIN INVEST, V96, P2071, DOI 10.1172/JCI118255; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; JIANG XC, 1995, J BIOL CHEM, V270, P17133, DOI 10.1074/jbc.270.29.17133; JIANG XC, 1992, J CLIN INVEST, V90, P1290, DOI 10.1172/JCI115993; Kawabe Y, 1996, BIOCHEM BIOPH RES CO, V219, P515, DOI 10.1006/bbrc.1996.0265; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Lala DS, 1997, P NATL ACAD SCI USA, V94, P4895, DOI 10.1073/pnas.94.10.4895; Lopez JM, 1996, P NATL ACAD SCI USA, V93, P1049, DOI 10.1073/pnas.93.3.1049; MasucciMagoulas L, 1996, J CLIN INVEST, V97, P154, DOI 10.1172/JCI118384; Oliveira HCF, 1996, J BIOL CHEM, V271, P31831, DOI 10.1074/jbc.271.50.31831; OSBORNE TF, 1991, J BIOL CHEM, V266, P13947; OSBORNE TF, 1992, J BIOL CHEM, V267, P18973; PAPE ME, 1991, ARTERIOSCLER THROMB, V11, P1759, DOI 10.1161/01.ATV.11.6.1759; QUINET E, 1991, J CLIN INVEST, V87, P1559, DOI 10.1172/JCI115169; QUINET EM, 1990, J CLIN INVEST, V85, P357, DOI 10.1172/JCI114446; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; SHRIVASTAVA A, 1994, NUCLEIC ACIDS RES, V22, P5151, DOI 10.1093/nar/22.24.5151; SON YSC, 1986, ARTERIOSCLEROSIS, V6, P345, DOI 10.1161/01.ATV.6.3.345; TALL A, 1995, ANNU REV BIOCHEM, V64, P235; TALL A, 1987, J CLIN INVEST, V79, P1217, DOI 10.1172/JCI112940; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Vallett SM, 1996, J BIOL CHEM, V271, P12247, DOI 10.1074/jbc.271.21.12247; WALSH A, 1989, J BIOL CHEM, V264, P6488; WANG XD, 1993, J BIOL CHEM, V268, P14497; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Zhong SB, 1996, J CLIN INVEST, V97, P2917, DOI 10.1172/JCI118751	43	38	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22409	22414		10.1074/jbc.273.35.22409	http://dx.doi.org/10.1074/jbc.273.35.22409			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712863	hybrid			2022-12-27	WOS:000075616600039
J	Godon, C; Lagniel, G; Lee, J; Buhler, JM; Kieffer, S; Perrot, R; Boucherie, H; Toledano, MB; Labarre, J				Godon, C; Lagniel, G; Lee, J; Buhler, JM; Kieffer, S; Perrot, R; Boucherie, H; Toledano, MB; Labarre, J			The H2O2 stimulon in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENTOSE-PHOSPHATE PATHWAY; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; MOLECULAR CHAPERONES; HEAT-SHOCK; GLUTATHIONE-REDUCTASE; SUPEROXIDE-DISMUTASE; DEPENDENT ACTIVATION; ADAPTIVE RESPONSE; ALDOSE REDUCTASE	The changes in gene expression underlying the yeast adaptive stress response to H2O2 were analyzed by comparative two-dimensional gel electrophoresis of total cell proteins. The synthesis of at least 115 proteins is stimulated by H2O2, whereas 52 other proteins are repressed by this treatment. We have identified 71 of the stimulated and 44 of the repressed targets. The kinetics and dose-response parameters of the H2O2, genomic response were also analyzed. Identification of these proteins and their mapping into specific cellular processes give a distinct picture of the way in which yeast cells adapt to oxidative stress. As expected, H2O2-responsive targets include an important number of heat shock proteins and proteins with reactive oxygen intermediate scavenging activities. Exposure to H2O2 also results in a slowdown of protein biosynthetic processes and a stimulation of protein degradation pathways. Finally, the most remarkable result inferred from this study is the resetting of carbohydrate metabolism minutes after the exposure to H2O2. Carbohydrate fluxes are redirected to the regeneration of NADPH at the expense of glycolysis. This study represents the first genome-wide characterization of a H2O2-inducible stimulon in a eukaryote.	CEA Saclay, Serv Biochim & Genet Mol, F-91191 Gif Sur Yvette, France; Rutgers State Univ, Coll Pharm, Dept Pharmacol & Toxicol, Piscataway, NJ 08855 USA; CNRS, Inst Biochim & Genet Cellulaires, UPR 9026, F-33077 Bordeaux, France; CEA, Dept Biol Mol & Struct, F-38054 Grenoble 09, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Rutgers State University New Brunswick; Centre National de la Recherche Scientifique (CNRS); CEA	Labarre, J (corresponding author), CEA Saclay, Serv Biochim & Genet Mol, Bat 142, F-91191 Gif Sur Yvette, France.	labarre@jonas.saclay.cea.fr						Ahn SM, 1996, BIOCHEM MOL BIOL INT, V39, P1007; BABIYCHUK E, 1995, J BIOL CHEM, V270, P26224, DOI 10.1074/jbc.270.44.26224; BERTHON HA, 1992, BIOCHEMISTRY-US, V31, P12792, DOI 10.1021/bi00166a012; Boucherie H, 1996, ELECTROPHORESIS, V17, P1683, DOI 10.1002/elps.1150171106; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; CHAE HZ, 1994, BIOFACTORS, V4, P177; Ciechanover A, 1995, COLD SPRING HARB SYM, V60, P491, DOI 10.1101/SQB.1995.060.01.053; COLLINSON LP, 1992, J GEN MICROBIOL, V138, P329, DOI 10.1099/00221287-138-2-329; CRAIG EA, 1993, MICROBIOL REV, V57, P402, DOI 10.1128/MMBR.57.2.402-414.1993; CRAWFORD DR, 1994, ENVIRON HEALTH PERSP, V102, P25, DOI 10.2307/3432208; DEMPLE B, 1991, CELL, V67, P837, DOI 10.1016/0092-8674(91)90355-3; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DEVIRGILIO C, 1994, EUR J BIOCHEM, V219, P179; ENGELBERG D, 1994, CELL, V77, P381, DOI 10.1016/0092-8674(94)90153-8; FLATTERYOBRIEN J, 1993, J GEN MICROBIOL, V139, P501, DOI 10.1099/00221287-139-3-501; GAN ZR, 1992, BIOCHEM BIOPH RES CO, V187, P949, DOI 10.1016/0006-291X(92)91289-3; GARRARD LJ, 1989, J BIOL CHEM, V264, P13929; GOUNALAKI N, 1994, EMBO J, V13, P4036, DOI 10.1002/j.1460-2075.1994.tb06720.x; GRALLA EB, 1991, J BACTERIOL, V173, P5918, DOI 10.1128/jb.173.18.5918-5920.1991; GRALLA EB, 1992, ADV GENET, V30, P251, DOI 10.1016/S0065-2660(08)60322-3; Grant CM, 1996, MOL MICROBIOL, V21, P171, DOI 10.1046/j.1365-2958.1996.6351340.x; Grune T, 1996, J BIOL CHEM, V271, P15504, DOI 10.1074/jbc.271.26.15504; HALLIWELL B, 1994, NUTR REV, V52, P253; Halliwell B., 1989, FREE RADICAL BIO MED, P1; Hilt W, 1996, TRENDS BIOCHEM SCI, V21, P96, DOI 10.1016/S0968-0004(96)10012-8; Izawa S, 1996, BIOCHEM J, V320, P61, DOI 10.1042/bj3200061; James P, 1997, SCIENCE, V275, P387, DOI 10.1126/science.275.5298.387; JAMIESON DJ, 1994, MICROBIOL-UK, V140, P3277, DOI 10.1099/13500872-140-12-3277; JAMIESON DJ, 1992, J BACTERIOL, V174, P6678, DOI 10.1128/JB.174.20.6678-6681.1992; Juhnke H, 1996, MOL GEN GENET, V252, P456, DOI 10.1007/BF02173011; KREMS B, 1995, CURR GENET, V27, P427, DOI 10.1007/BF00311211; KUGE S, 1994, EMBO J, V13, P655, DOI 10.1002/j.1460-2075.1994.tb06304.x; KULLIK I, 1994, REDOX REP, P1; Liu HD, 1996, GENE DEV, V10, P592; MAGER WH, 1995, MICROBIOL REV, V59, P506, DOI 10.1128/MMBR.59.3.506-531.1995; MAGER WH, 1993, BIOCHEM J, V290, P1; Maillet I, 1996, J BIOL CHEM, V271, P10263, DOI 10.1074/jbc.271.17.10263; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; MoradasFerreira P, 1996, MOL MICROBIOL, V19, P651, DOI 10.1046/j.1365-2958.1996.403940.x; MORTIMER RK, 1986, GENETICS, V113, P35; Muller EGD, 1996, MOL BIOL CELL, V7, P1805, DOI 10.1091/mbc.7.11.1805; NOGAE I, 1990, GENE, V96, P161, DOI 10.1016/0378-1119(90)90248-P; Norbeck J, 1997, J BIOL CHEM, V272, P5544, DOI 10.1074/jbc.272.9.5544; Parrou JL, 1997, MICROBIOL-UK, V143, P1891, DOI 10.1099/00221287-143-6-1891; RAMACHA M, 1995, MOL CELL BIOL, V15, P4754; RIBEIRO MJS, 1994, BBA-GEN SUBJECTS, V1200, P139, DOI 10.1016/0304-4165(94)90128-7; SCHAAFFGERSTENSCHLAGER I, 1993, CURR GENET, V24, P373, DOI 10.1007/BF00351843; Shang F, 1997, J BIOL CHEM, V272, P23086, DOI 10.1074/jbc.272.37.23086; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SHIMANUKI M, 1995, J CELL SCI, V108, P569; SIKORSKI RS, 1989, GENETICS, V122, P19; Slekar KH, 1996, J BIOL CHEM, V271, P28831, DOI 10.1074/jbc.271.46.28831; Spycher SE, 1997, FASEB J, V11, P181, DOI 10.1096/fasebj.11.2.9039961; Srivastava S, 1995, BIOCHEM BIOPH RES CO, V217, P741, DOI 10.1006/bbrc.1995.2835; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; STORZ G, 1990, TRENDS GENET, V6, P363, DOI 10.1016/0168-9525(90)90278-E; THOMAS D, 1991, EMBO J, V10, P547, DOI 10.1002/j.1460-2075.1991.tb07981.x; VANLOON AP, 1991, P NATL ACAD SCI USA, V83, P3820; WIEMKEN A, 1990, ANTON LEEUW INT J G, V58, P209, DOI 10.1007/BF00548935; ZHRINGER H, 1997, FEBS LETT, V412, P615	60	477	492	3	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22480	22489		10.1074/jbc.273.35.22480	http://dx.doi.org/10.1074/jbc.273.35.22480			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712873	hybrid			2022-12-27	WOS:000075616600049
J	Hoshino, S; Imai, M; Mizutani, M; Kikuchi, Y; Hanaoka, F; Ui, M; Katada, T				Hoshino, S; Imai, M; Mizutani, M; Kikuchi, Y; Hanaoka, F; Ui, M; Katada, T			Molecular cloning of a novel member of the eukaryotic polypeptide chain-releasing factors (eRF) - Its identification as eRF3 interacting with eRF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; OMNIPOTENT SUPPRESSOR-45; HIGH HOMOLOGY; SUP35 GENE; HUMAN CDNA; TERMINATION; PROTEIN; TRANSLATION; DETERMINANT	Yeast GST1 gene, whose product is a GTP-binding protein structurally related to polypeptide chain elongation factor-1 alpha (EF1 alpha), was first described to be essential for the (G) under bar(1) to (S) under bar phase transition (GSPT) of the cell cycle, and the product was recently reported to function as a polypeptide chain release factor 3 (eRF3) in yeast. Although we previously cloned a human homologue (renamed as GSPT1) of the yeast gene, it has remained to be determined whether GSPT1 also functions as eRF3 or if another GSPT may have such a function in mammalian cells. In the present study, we isolated two mouse GSPT genes, the counterpart of human GSPT1 and a novel member of the GSPT gene family, GSPT2. Both the mouse GSPTs had a two domain structure characterized as an amino-terminal no-homologous region (approximately 200 amino acids) and a carboxyl-terminal conserved eukaryotic elongation factor-1 alpha-like domain (428 amino acids), Messenger RNAs of the two GSPTs could be detected in all mouse tissues surveyed, although the level of GSPT2 message appeared to be relatively abundant in the brain. The mouse GSPT1 was expressed in a proliferation-dependent manner in Swiss 3T3 cells, whereas the expression of GSPT2 was constant during the cell-cycle progression. Immunoprecipitation assays in COS-7 cells expressing flag epitope-tagged proteins demonstrated that not only GSPT1 but also GSPT2 was capable of interacting with eRF1. Such interaction between GSPT2 and eRF1 was also confirmed by yeast two-hybrid analysis. Taken together, these data indicated that the novel GSPT2 may interact with eRF1 to function as eRF3 in mammalian cells.	Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Physiol Chem, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo	Hoshino, S (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Physiol Chem, Tokyo 1130033, Japan.			Hoshino, Shinichi/0000-0001-6135-7896				BEAUDET AL, 1971, P NATL ACAD SCI USA, V68, P619, DOI 10.1073/pnas.68.3.619; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CRAIGEN WJ, 1990, MOL MICROBIOL, V4, P861, DOI 10.1111/j.1365-2958.1990.tb00658.x; EUSTICE DC, 1986, J MOL BIOL, V188, P207, DOI 10.1016/0022-2836(86)90305-0; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FINKELSTEIN DB, 1983, MOL CELL BIOL, V3, P1625, DOI 10.1128/MCB.3.9.1625; FROLOVA L, 1994, NATURE, V372, P701, DOI 10.1038/372701a0; GRENETT HE, 1992, GENE, V110, P239, DOI 10.1016/0378-1119(92)90655-9; GRENETT HE, 1992, SOMAT CELL MOLEC GEN, V18, P97, DOI 10.1007/BF01233452; GRENTZMANN G, 1995, J BIOL CHEM, V270, P10595, DOI 10.1074/jbc.270.18.10595; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HOSHINO S, 1989, EMBO J, V8, P3807, DOI 10.1002/j.1460-2075.1989.tb08558.x; INGEVECHTOMOV SG, 1994, GENETIKA+, V30, P1022; JeanJean O, 1996, CR ACAD SCI III-VIE, V319, P487; KIKUCHI Y, 1988, EMBO J, V7, P1175, DOI 10.1002/j.1460-2075.1988.tb02928.x; Kisselev LL, 1995, BIOCHEM CELL BIOL, V73, P1079, DOI 10.1139/o95-116; KONECKI DS, 1977, J BIOL CHEM, V252, P4514; KUSHNIROV VV, 1988, GENE, V66, P45, DOI 10.1016/0378-1119(88)90223-5; Maniatis T., 1982, MOL CLONING LAB MANU; MIKUNI O, 1994, P NATL ACAD SCI USA, V91, P5798, DOI 10.1073/pnas.91.13.5798; Miller J.H., 1972, EXPT MOL GENETICS; OZAWA K, 1992, SOMAT CELL MOLEC GEN, V18, P189, DOI 10.1007/BF01233164; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; STANSFIELD I, 1994, CURR GENET, V25, P385, DOI 10.1007/BF00351776; SURGUCHOV AP, 1980, FEBS LETT, V111, P175, DOI 10.1016/0014-5793(80)80786-1; SURGUCHOV AP, 1988, TRENDS BIOCHEM SCI, V13, P120, DOI 10.1016/0968-0004(88)90062-X; TERAVANESYAN MD, 1994, GENETICS, V137, P671; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	34	96	105	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22254	22259		10.1074/jbc.273.35.22254	http://dx.doi.org/10.1074/jbc.273.35.22254			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712840	hybrid			2022-12-27	WOS:000075616600016
J	Obermoeller, LM; Chen, Z; Schwartz, AL; Bu, G				Obermoeller, LM; Chen, Z; Schwartz, AL; Bu, G			Ca2+ and receptor-associated protein are independently required for proper folding and disulfide bond formation of the low density lipoprotein receptor-related protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; CYSTEINE-RICH REPEAT; LDL-RECEPTOR; ENDOPLASMIC-RETICULUM; FAMILIAL HYPERCHOLESTEROLEMIA; MOLECULAR CHAPERONE; IN-VIVO; CALCIUM; LRP; SUGGEST	The low density lipoprotein receptor-related protein (LRP) is a cysteine-rich, multifunctional receptor that binds and endocytoses a diverse array of ligands. Recent studies have shown that a 39-kDa receptor-associated protein (RAP) facilitates the proper folding and subsequent trafficking of LRP within the early secretory pathway. In the current study, we have examined the potential role of Ca2+ and its relationship to RAP during LRP folding. We found that depletion of Ca2+ following either ionomycin or thapsigargin treatment significantly disrupts the folding process of LRP. The misfolded LRP molecules migrate as high molecular weight aggregates under nonreducing SDS-polyacrylamide gel electrophoresis, suggesting the formation of intermolecular disulfide bonds. This misfolding is reversible because misfolded LRP can be re-folded into functional receptor molecules upon Ca2+ restoration. Using an LRP minireceptor representing the fourth ligand binding domain of LRP, we also observed significant variation in the conformation of monomeric receptor upon Ca2+ depletion. The role of Ca2+ in LRP folding is independent from that of RAP because RAP remains bound to LRP and its minireceptor following Ca2+ depletion. Furthermore, Ca2+ depletion-induced LRP misfolding occurs in RAP-deficient cells. Taken together, these results clearly demonstrate that Ca2+ and RAP independently participate in LRP folding.	Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Physiol & Cell Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Bu, G (corresponding author), Washington Univ, Sch Med, Dept Pediat, CB 8116,1 Childrens Pl, St Louis, MO 63110 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059150] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL59150] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BIERI S, 1995, BIOCHEMISTRY-US, V34, P13059, DOI 10.1021/bi00040a017; Blacklow SC, 1996, NAT STRUCT BIOL, V3, P758, DOI 10.1038/nsb0996-758; BRAAKMAN I, 1992, NATURE, V356, P260, DOI 10.1038/356260a0; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Bu GJ, 1998, TRENDS CELL BIOL, V8, P272, DOI 10.1016/S0962-8924(98)01283-5; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; BU GJ, 1993, J BIOL CHEM, V268, P13002; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; FASOLATO C, 1991, J BIOL CHEM, V266, P20159; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Gilbert HF, 1997, J BIOL CHEM, V272, P29399, DOI 10.1074/jbc.272.47.29399; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; HERZ J, 1991, J BIOL CHEM, V266, P21232; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; LODISH HF, 1992, J BIOL CHEM, V267, P12753; Obermoeller LM, 1997, J BIOL CHEM, V272, P10761; VANDRIEL IR, 1987, J BIOL CHEM, V262, P17443; WARSHAWSKY I, 1995, BIOCHEMISTRY-US, V34, P3404, DOI 10.1021/bi00010a032; Willnow TE, 1996, BIOCHEM J, V313, P71, DOI 10.1042/bj3130071; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; WILLNOW TE, 1994, J BIOL CHEM, V269, P15827; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537	27	39	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22374	22381		10.1074/jbc.273.35.22374	http://dx.doi.org/10.1074/jbc.273.35.22374			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712858	hybrid			2022-12-27	WOS:000075616600034
J	Schlott, B; Guhrs, KH; Hartmann, M; Rocker, A; Collen, D				Schlott, B; Guhrs, KH; Hartmann, M; Rocker, A; Collen, D			NH2-terminal structural motifs in staphylokinase required for plasminogen activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT STAPHYLOKINASE; THROMBOLYTIC THERAPY; ESCHERICHIA-COLI; HUMAN PLASMA; GENE; PURIFICATION; MECHANISM	Staphylokinase (Sak) forms an inactive 1:1 stoichiometric complex with plasminogen which requires both conversion of plasminogen to plasmin and hydrolysis of the Lys(10)-Lys(11) peptide bond of Sak to become a potent plasminogen activator (Schlott, B., Guhrs, K.-H., Hartmann, M,, Rocker, A, and Collen, D, (1997) J. Biol. Chem. 272, 6067-6072). Exposure of a positively charged NH2-terminal amino acid after hydrolysis of Sak is a major determinant of the plasminogen-activating potential, but in itself is neither necessary nor sufficient, Here, the structural motifs of the NH2-terminal region Lys(11)-Gly-Asp-Asp-Ala-Ser(16)-Tyr-Phe-Glu of processed Sak, required for plasminogen activating potential, were studied by deletion and substitution mutagenesis. Expression in Escherichia coli of variants with deletion of 11, 14, 15, or 16 NH2-terminal amino acids yielded correctly processed but inactive molecules. Expression of their homologues with the NH2-terminal amino acid substituted with Lys generated derivatives from which the NH2-terminal initiation Met was no longer removed, yielding inactive (less than or equal to 10%) Sak42D Delta N11(M),G12K, active (>50%) Sak42D Delta N14(M),A15K and Sak42D Delta N15(M), S16K, and inactive Sak42D Delta N16(M),Y17K. Lys variants without NH2-terminal Met, generated from fusion proteins in which a Hiss tag and a factor Xa recognition sequence were linked to the NH, terminus of the Sak variants, were indistinguishable from their NH2-terminal Met-containing counterparts. All variants studied had intact affinities for plasminogen as measured by biospecific interaction analysis. The activity of Sak42D Delta N11(M),G12K could be restored by additional substitution of both Asp(13) and Asp(14) With Asn, yielding active Sak42D Delta N11(M),G12K, D13N, D14N, whereas substitution in Sak42D Delta N16(M),Y17K. of Phe(18) and Glu(19) with Asn yielded inactive Sak42D Delta N16(M),Y17K,F18N,E19N. These data, in combination with the recent finding that the 20 NH2-terminal amino acids of Sak lack secondary structure, suggest that the NH2-terminal region of Sak is not required for binding to plasmin/plasminogen, but that a positively charged amino acid in the ultimate or penultimate NH2-terminal position corresponding to amino acids 11-16 of this flexible region participates in the reconfiguration of the active site of the plasmin molecule to endow it with plasminogen-activating potential.	Inst Mol Biotechnol, D-07745 Jena, Germany; Katholieke Univ Leuven VIB, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven	Schlott, B (corresponding author), Inst Mol Biotechnol, Beukenbergstr 11, D-07745 Jena, Germany.	bschlott@sanger.imb-jena.de		Guehrs, Karl-Heinz/0000-0001-8847-1365				BEHNKE D, 1987, MOL GEN GENET, V210, P528, DOI 10.1007/BF00327208; COLLEN D, 1992, FIBRINOLYSIS, V6, P226, DOI 10.1016/0268-9499(92)90075-S; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; Gase A, 1996, THROMB HAEMOSTASIS, V76, P755; GASE A, 1994, EUR J BIOCHEM, V223, P303, DOI 10.1111/j.1432-1033.1994.tb18995.x; Jonsson U., 1992, ADV BIOSENSOR, P291; KEILER KC, 1995, J BIOL CHEM, V270, P28864, DOI 10.1074/jbc.270.48.28864; LACK CH, 1948, NATURE, V161, P559, DOI 10.1038/161559b0; Ohlenschlager O, 1997, J BIOMOL NMR, V9, P273, DOI 10.1023/A:1018678925512; Rabijns A, 1997, NAT STRUCT BIOL, V4, P357, DOI 10.1038/nsb0597-357; SACHAROV DV, 1996, J BIOL CHEM, V271, P27912; SAKO T, 1983, NUCLEIC ACIDS RES, V11, P7679, DOI 10.1093/nar/11.22.7679; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHLOTT B, 1994, BIO-TECHNOL, V12, P185, DOI 10.1038/nbt0294-185; Schlott B, 1997, J BIOL CHEM, V272, P6067, DOI 10.1074/jbc.272.9.6067; SILENCE K, 1995, J BIOL CHEM, V270, P1; SLILATY SN, 1987, P NATL ACAD SCI USA, V84, P3987, DOI 10.1073/pnas.84.12.3987; Tachias K, 1997, J BIOL CHEM, V272, P28; TSCHANTZ WR, 1993, J BIOL CHEM, V268, P27349; UESHIMA S, 1993, THROMB HAEMOSTASIS, V70, P495; VANDERSCHUEREN S, 1995, CIRCULATION, V92, P2044, DOI 10.1161/01.CIR.92.8.2044; VANDERSCHUEREN S, 1995, CIRCULATION, V92, P2050, DOI 10.1161/01.CIR.92.8.2050	22	24	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22346	22350		10.1074/jbc.273.35.22346	http://dx.doi.org/10.1074/jbc.273.35.22346			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712854	hybrid			2022-12-27	WOS:000075616600030
J	Illidge, C; Kielty, C; Shuttleworth, A				Illidge, C; Kielty, C; Shuttleworth, A			The alpha 1(VIII) and alpha 2(VIII) chains of type VIII collagen can form stable homotrimeric molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE DESCEMETS-MEMBRANE; TRIPLE-HELICAL DOMAIN; SMOOTH-MUSCLE CELLS; ENDOTHELIAL-CELLS; X COLLAGEN; IN-VITRO; EXPRESSION; PROTEINS; CULTURE; TISSUE	Type VIII collagen is a short chain collagen. Two chains have been described, alpha 1(VIII) and alpha 2(VIII), but the chain composition of type VIII collagen is far from resolved. To address this question, we have expressed full-length alpha 1(VIII) and alpha 2(VIII) chains in an in vitro translation system supplemented with semipermeabilized cells. Both chains gave a translation product of similar to 80 kDa that could be shown to produce a chymotrypsin/trypsin-resistant product of similar to 60 kDa, indicating that both chains could form homotrimers. Hydroxylation of proline residues was a prerequisite for stable trimer formation. The melting temperature for the alpha 1(VIII) homotrimer was 45 degrees C, whereas that for alpha 2(VIII) was 42 degrees C. The ability of both chains of type VIII collagen to form stable triple helices suggests that there may be different forms of this collagen and that cells may modulate the chain composition in response to different biological conditions.	Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England	University of Manchester	Shuttleworth, A (corresponding author), Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, 2-205 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	ashuttle@fs1.scg.man.ac.uk						Bendeck MP, 1996, CIRC RES, V79, P524, DOI 10.1161/01.RES.79.3.524; BENYA P D, 1980, Renal Physiology, V3, P30; BENYA PD, 1986, J BIOL CHEM, V261, P4160; BRASS A, 1991, BIOCHEM SOC T, V19, P365; BULLEID NJ, 1988, NATURE, V335, P649, DOI 10.1038/335649a0; CHAN D, 1995, J BIOL CHEM, V270, P4558, DOI 10.1074/jbc.270.9.4558; Chan D, 1996, J BIOL CHEM, V271, P13566, DOI 10.1074/jbc.271.23.13566; Chan VC, 1997, J BIOL CHEM, V272, P31441, DOI 10.1074/jbc.272.50.31441; Frischholz S, 1998, J BIOL CHEM, V273, P4547, DOI 10.1074/jbc.273.8.4547; JUVA K, 1966, SCIENCE, V152, P92, DOI 10.1126/science.152.3718.92; KAPOOR R, 1986, BIOCHEMISTRY-US, V25, P3930, DOI 10.1021/bi00361a029; KITTELBERGER R, 1990, CONNECT TISSUE RES, V24, P303, DOI 10.3109/03008209009152157; KITTELBERGER R, 1989, BIOCHEM BIOPH RES CO, V159, P414, DOI 10.1016/0006-291X(89)90007-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MacBeath JRE, 1996, BIOCHEM J, V319, P993, DOI 10.1042/bj3190993; Mann K, 1996, J MOL BIOL, V261, P255, DOI 10.1006/jmbi.1996.0457; MANN K, 1990, FEBS LETT, V273, P168, DOI 10.1016/0014-5793(90)81076-Z; MIDDLETON RB, 1993, BIOCHEM J, V296, P511, DOI 10.1042/bj2960511; MURAGAKI Y, 1991, J BIOL CHEM, V266, P7721; PAULUS W, 1991, BRIT J CANCER, V63, P367, DOI 10.1038/bjc.1991.87; ROONEY P, 1993, J CELL SCI, V105, P213; Rosenblum ND, 1996, BIOCHEM BIOPH RES CO, V227, P205, DOI 10.1006/bbrc.1996.1490; RUGER B, 1994, INT J EXP PATHOL, V75, P397; SAGE H, 1983, J BIOL CHEM, V258, P3391; SAGE H, 1990, ANN NY ACAD SCI, V580, P17, DOI 10.1111/j.1749-6632.1990.tb17914.x; SAGE H, 1984, LAB INVEST, V50, P219; SAGE H, 1980, BIOCHEMISTRY-US, V19, P5747, DOI 10.1021/bi00566a013; SAKAKIBARA S, 1973, BIOCHIM BIOPHYS ACTA, V303, P198, DOI 10.1016/0005-2795(73)90164-5; SAWADA H, 1990, J CELL BIOL, V110, P219, DOI 10.1083/jcb.110.1.219; Sibinga NES, 1997, CIRC RES, V80, P532, DOI 10.1161/01.RES.80.4.532; WILSON R, 1995, BIOCHEM J, V307, P679, DOI 10.1042/bj3070679; YAMAGUCHI N, 1989, J BIOL CHEM, V264, P16022; Yang W, 1997, J BIOL CHEM, V272, P28837, DOI 10.1074/jbc.272.46.28837	33	30	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					22091	22095		10.1074/jbc.273.34.22091	http://dx.doi.org/10.1074/jbc.273.34.22091			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705353	hybrid			2022-12-27	WOS:000075492600087
J	Benkirane, M; Chun, RF; Xiao, H; Ogryzko, VV; Howard, BH; Nakatani, Y; Jeang, KT				Benkirane, M; Chun, RF; Xiao, H; Ogryzko, VV; Howard, BH; Nakatani, Y; Jeang, KT			Activation of integrated provirus requires histone acetyltransferase - p300 AND P/CAF are coactivators for HIV-1 Tat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RNA-POLYMERASE-II; NF-KAPPA-B; PROTEINS SPECIFICALLY ASSOCIATE; CARBOXYL-TERMINAL DOMAIN; TRANSCRIPTIONAL ACTIVATION; CELLULAR PROTEIN; IN-VITRO; CHROMATIN STRUCTURE; HUMAN CHROMOSOME-12	A unique aspect of the retrovirus life cycle is the obligatory integration of the provirus into host cell chromosomes. Unlike viruses that do not integrate, retroviruses must conserve an ability to activate transcription from a chromatin context. Human immunodeficiency virus (HIV)-1 encodes an unusual and an unusually potent transcriptional transactivator, Tat, which binds to a nascent viral leader RNA, TAR. The action of Tat has been well studied in various reductive model systems; however, the physiological mechanism through which Tat gains access to chromatin-associated proviral long terminal repeats (LTRs) is not understood. We show here that a nuclear histone acetyltransferase activity associates with Tat. Intracellularly, we found that Tat forms a ternary complex with p300 and P/CAF, two histone acetyltransferases (HATs). A murine cell defect in Tat transactivation of the HIV-1 LTR was linked to the reduced abundance of p300 and P/CAF. Thus, overexpression of p300 and P/CAF reconstituted Tat transactivation of the HIV-1 LTR in NIH3T3 cells to a level similar to that observed for human cells. By using transdominant p300 or P/CAF mutants that lack enzymatic activity, we delineated a requirement for the HAT component from the latter but not the former in Tat function. Finally, we observed that Tat-associated HAT is preferentially important for transactivation of integrated, but not unintegrated, HIV-1 LTR.	NIAID, Mol Virol Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; NICHHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA; IGH, UPR 1142, Montpellier, France	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Universite de Montpellier	Jeang, KT (corresponding author), NIAID, Mol Virol Sect, Mol Microbiol Lab, NIH, Bldg 4,Rm 306,9000 Rockville Pike, Bethesda, MD 20892 USA.	kj7e@nih.gov	Ogryzko, Vasily/M-6665-2015; Jeang, Kuan-Teh/A-2424-2008; Chun, Rene/A-9415-2010	Ogryzko, Vasily/0000-0002-8548-1389; Chun, Rene/0000-0002-0190-0807				ADAMS CC, 1993, CELL, V72, P305, DOI 10.1016/0092-8674(93)90109-4; ADAMS M, 1994, P NATL ACAD SCI USA, V91, P3862, DOI 10.1073/pnas.91.9.3862; ARANY Z, 1995, NATURE, V374, P81, DOI 10.1038/374081a0; ARCHER TK, 1991, MOL CELL BIOL, V11, P688, DOI 10.1128/MCB.11.2.688; ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bannister AJ, 1995, ONCOGENE, V11, P2509; BERKHOUT B, 1989, CELL, V59, P273, DOI 10.1016/0092-8674(89)90289-4; BERKHOUT B, 1990, CELL, V62, P757, DOI 10.1016/0092-8674(90)90120-4; Broder CC, 1996, PATHOBIOLOGY, V64, P171, DOI 10.1159/000164032; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; CALNAN BJ, 1991, SCIENCE, V252, P1167, DOI 10.1126/science.252.5009.1167; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Chun RF, 1996, J BIOL CHEM, V271, P27888, DOI 10.1074/jbc.271.44.27888; CORDINGLEY MG, 1987, CELL, V48, P261, DOI 10.1016/0092-8674(87)90429-6; Cujec TP, 1997, MOL CELL BIOL, V17, P1817, DOI 10.1128/MCB.17.4.1817; CULLEN BR, 1993, CELL, V73, P417, DOI 10.1016/0092-8674(93)90126-B; Dai P, 1996, GENE DEV, V10, P528, DOI 10.1101/gad.10.5.528; DESAI K, 1991, P NATL ACAD SCI USA, V88, P8875, DOI 10.1073/pnas.88.20.8875; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DINGWALL C, 1990, EMBO J, V9, P4145, DOI 10.1002/j.1460-2075.1990.tb07637.x; Eckner R, 1996, BIOL CHEM, V377, P685; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Elgin SCR, 1990, CURR OPIN CELL BIOL, V2, P437, DOI 10.1016/0955-0674(90)90125-X; FEINBERG MB, 1991, P NATL ACAD SCI USA, V88, P4045, DOI 10.1073/pnas.88.9.4045; GarciaMartinez LF, 1997, J BIOL CHEM, V272, P6951, DOI 10.1074/jbc.272.11.6951; GarciaMartinez LF, 1997, EMBO J, V16, P2836, DOI 10.1093/emboj/16.10.2836; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Harrich D, 1997, EMBO J, V16, P1224, DOI 10.1093/emboj/16.6.1224; HART CE, 1989, SCIENCE, V246, P488, DOI 10.1126/science.2683071; HERRMANN CH, 1995, J VIROL, V69, P1612, DOI 10.1128/JVI.69.3.1612-1620.1995; HUANG LM, 1994, EMBO J, V13, P2886, DOI 10.1002/j.1460-2075.1994.tb06583.x; HUANG LM, 1993, J VIROL, V67, P6937, DOI 10.1128/JVI.67.12.6937-6944.1993; IZBAN MG, 1991, GENE DEV, V5, P683, DOI 10.1101/gad.5.4.683; Janknecht R, 1996, ONCOGENE, V12, P1961; Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0; Jeang K., 1996, HUMAN RETROVIRUSES A, P3; JEANG KT, 1993, J VIROL, V67, P6224, DOI 10.1128/JVI.67.10.6224-6233.1993; JEANG KT, 1993, J BIOL CHEM, V268, P24940; JONES KA, 1994, ANNU REV BIOCHEM, V63, P717, DOI 10.1146/annurev.bi.63.070194.003441; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; KASHANCHI F, 1994, NATURE, V367, P295, DOI 10.1038/367295a0; Kee BL, 1996, J BIOL CHEM, V271, P2373, DOI 10.1074/jbc.271.5.2373; Keen NJ, 1997, EMBO J, V16, P5260, DOI 10.1093/emboj/16.17.5260; Kingston RE, 1996, GENE DEV, V10, P905, DOI 10.1101/gad.10.8.905; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LEE JS, 1995, GENE DEV, V9, P1188, DOI 10.1101/gad.9.10.1188; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; Mavankal G, 1996, P NATL ACAD SCI USA, V93, P2089, DOI 10.1073/pnas.93.5.2089; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; NELBOCK P, 1990, SCIENCE, V248, P1650, DOI 10.1126/science.2194290; NEWSTEIN M, 1990, J VIROL, V64, P4565, DOI 10.1128/JVI.64.9.4565-4567.1990; Oelgeschlager M, 1996, EMBO J, V15, P2771, DOI 10.1002/j.1460-2075.1996.tb00637.x; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; OHANA B, 1993, P NATL ACAD SCI USA, V90, P138, DOI 10.1073/pnas.90.1.138; PALUDAN K, 1989, J VIROL, V63, P5201, DOI 10.1128/JVI.63.12.5201-5207.1989; Parada CA, 1996, NATURE, V384, P375, DOI 10.1038/384375a0; PAZIN MJ, 1994, SCIENCE, V266, P2007, DOI 10.1126/science.7801129; Pazin MJ, 1996, GENE DEV, V10, P37, DOI 10.1101/gad.10.1.37; Pazin MJ, 1997, CELL, V89, P325, DOI 10.1016/S0092-8674(00)80211-1; Pennisi E, 1997, SCIENCE, V275, P155, DOI 10.1126/science.275.5297.155; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; PRUSS D, 1994, P NATL ACAD SCI USA, V91, P5913, DOI 10.1073/pnas.91.13.5913; PRYCIAK PM, 1992, CELL, V69, P769, DOI 10.1016/0092-8674(92)90289-O; Smith CL, 1997, J BIOL CHEM, V272, P14227, DOI 10.1074/jbc.272.22.14227; Tsukiyama T, 1997, CURR OPIN GENET DEV, V7, P182, DOI 10.1016/S0959-437X(97)80127-X; vanHolde K, 1996, P NATL ACAD SCI USA, V93, P10548, DOI 10.1073/pnas.93.20.10548; VanLint C, 1996, GENE EXPRESSION, V5, P245; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; VERDIN E, 1991, J VIROL, V65, P6790, DOI 10.1128/JVI.65.12.6790-6799.1991; VESCHAMBRE P, 1995, J MOL BIOL, V250, P169, DOI 10.1006/jmbi.1995.0368; Widlak P, 1997, J BIOL CHEM, V272, P17654, DOI 10.1074/jbc.272.28.17654; Wolffe AP, 1996, CELL, V84, P817, DOI 10.1016/S0092-8674(00)81059-4; WUBAER F, 1995, P NATL ACAD SCI USA, V92, P7153, DOI 10.1073/pnas.92.16.7153; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yang XZ, 1996, J VIROL, V70, P4576, DOI 10.1128/JVI.70.7.4576-4584.1996; YU L, 1995, J VIROL, V69, P3007, DOI 10.1128/JVI.69.5.3007-3016.1995; Yuan WC, 1996, J BIOL CHEM, V271, P9009, DOI 10.1074/jbc.271.15.9009; ZHOU QA, 1995, EMBO J, V14, P321, DOI 10.1002/j.1460-2075.1995.tb07006.x; Zhou QA, 1996, SCIENCE, V274, P605, DOI 10.1126/science.274.5287.605	89	241	243	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24898	24905		10.1074/jbc.273.38.24898	http://dx.doi.org/10.1074/jbc.273.38.24898			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733796	hybrid			2022-12-27	WOS:000076007300088
J	Jean, D; Harbison, M; McConkey, DJ; Ronai, Z; Bar-Eli, M				Jean, D; Harbison, M; McConkey, DJ; Ronai, Z; Bar-Eli, M			CREB and its associated proteins act as survival factors for human melanoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MELANOCYTES; GROWTH-FACTOR; SOMATOSTATIN GENE; TUMOR-GROWTH; C-FOS; EXPRESSION; TRANSCRIPTION; BINDING; KINASE; PHOSPHORYLATION	cAMP response element-binding protein (CREB) and activating transcription factor 1 (ATF-1), members of the CREB/ATF family, have been implicated in cAMP- and calcium-induced transcriptional activation. We have previously demonstrated that quenching of CREB-associated proteins in metastatic melanoma cells by a dominant-negative CREB (KCREB) that is mutated within its DNA-binding domain decreased their radiation resistance, and their tumorigenic and metastatic potential in nude mice, As the induction of apoptosis by diverse exogenous signals is dependent on the elevation of intracellular Ca2+, the purpose of this study was to determine the role of CREB and its associated proteins in apoptosis using KCREB, We used thapsigargin (Tg), which inhibits endoplasmic reticulum-dependent Ca2+-ATPase and thereby increases cytosolic Ca2+, to induce apoptosis, MeWo human melanoma cells were transfected with the KCREB expression vector and subsequently analyzed for their susceptibility to Tg-induced apoptosis, Here we demonstrate that expression of KCREB in MeWo cells rendered them susceptible to Tg-induced apoptosis, Tg treatment induced phosphorylation of CREB and possibly ATF-1 transcription factors. Treatment with Tg induced CRE-dependent transcription in parental cells, whereas this activation was reduced in the KCREB-transfected cells. In addition, CAT activity driven by the CRE-dependent promoter was inhibited in parental MeWo cells cotransfected with increasing concentrations of KCREB in a dose-dependent manner. We did not observe any changes in Bcl-2 or Bcl-2-related proteins (Bcl-x, Bax, and Bad) in control or KCREB-transfected cells before or after treatment with Tg, Collectively, these data indicate that CREB and its associated proteins act as survival factors for human melanoma cells, and hence contribute to the acquisition of the malignant phenotype.	Univ Texas, MD Anderson Cancer Ctr, Dept Cell Biol, Houston, TX 77030 USA; CUNY Mt Sinai Sch Med, Ruttenberg Canc Ctr, New York, NY 10029 USA	University of Texas System; UTMD Anderson Cancer Center; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Bar-Eli, M (corresponding author), Univ Texas, MD Anderson Cancer Ctr, Dept Cell Biol, Houston, TX 77030 USA.	mbareli@notes.mdacc.tmc.edu	Jean, Didier/A-1615-2009	Jean, Didier/0000-0001-5823-7404; RONAI, ZEEV/0000-0002-3859-0400	NCI NIH HHS [CA 64137, CA 69676] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA064137, R29CA069676] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABDELHAFIZ HAM, 1993, ONCOGENE, V8, P1161; Barton K, 1996, NATURE, V379, P81, DOI 10.1038/379081a0; BOHM M, 1995, CELL GROWTH DIFFER, V6, P291; BORRELLI E, 1992, Critical Reviews in Oncogenesis, V3, P321; Bussfeld D, 1997, IMMUNOBIOLOGY, V198, P291, DOI 10.1016/S0171-2985(97)80049-6; FIDLER IJ, 1990, CANCER RES, V50, P6130; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HALABAN R, 1993, SEMIN CANCER BIOL, V4, P171; HALABAN R, 1987, IN VITRO CELL DEV B, V23, P47; HALABAN R, 1984, ARCH BIOCHEM BIOPHYS, V230, P383, DOI 10.1016/0003-9861(84)90121-8; HALABAN R, 1983, J CELL BIOL, V97, P480, DOI 10.1083/jcb.97.2.480; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; ISHIKAWA M, 1988, CANCER RES, V48, P665; ISHIZAKI Y, 1995, MOL BIOL CELL, V6, P1443, DOI 10.1091/mbc.6.11.1443; KOPF AW, 1995, CANCER-AM CANCER SOC, V75, P684, DOI 10.1002/1097-0142(19950115)75:2+<684::AID-CNCR2820751411>3.0.CO;2-B; LANSCHULZ WH, 1988, SCIENCE, V240, P1759; LEHMANN JM, 1989, P NATL ACAD SCI USA, V86, P9891, DOI 10.1073/pnas.86.24.9891; LIU F, 1993, J BIOL CHEM, V268, P6714; Lu Chao, 1994, Current Opinion in Oncology, V6, P212, DOI 10.1097/00001622-199403000-00015; LUCA M, 1993, MELANOMA RES, V3, P35, DOI 10.1097/00008390-199304000-00006; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; McConkey DJ, 1996, J LEUKOCYTE BIOL, V59, P775, DOI 10.1002/jlb.59.6.775; MCCONKEY DJ, 1989, ARCH BIOCHEM BIOPHYS, V269, P365, DOI 10.1016/0003-9861(89)90119-7; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MULLER HK, 1994, CELL IMMUNOL, V157, P263, DOI 10.1006/cimm.1994.1221; MUTHUKKUMAR S, 1995, MOL CELL BIOL, V15, P6262; RUTBERG SE, 1994, MOL CARCINOGEN, V10, P82, DOI 10.1002/mc.2940100205; SCHONTHAL A, 1991, P NATL ACAD SCI USA, V88, P7096, DOI 10.1073/pnas.88.16.7096; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; WANDA T, 1991, J VIROL, V65, P557; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; WOLOSHIN PI, 1992, MOL ENDOCRINOL, V6, P1725, DOI 10.1210/me.6.10.1725; XIE HJ, 1995, J IMMUNOL, V154, P1717; Xie SH, 1997, CANCER RES, V57, P2295; Xie SH, 1997, ONCOGENE, V15, P2069, DOI 10.1038/sj.onc.1201358; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; Yang YM, 1996, ONCOGENE, V12, P2223	47	139	140	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24884	24890		10.1074/jbc.273.38.24884	http://dx.doi.org/10.1074/jbc.273.38.24884			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733794	hybrid			2022-12-27	WOS:000076007300086
J	Ni, J; Fernandez, MA; Danielsson, L; Chillakuru, RA; Zhang, JL; Grubb, A; Su, J; Gentz, R; Abrahamson, M				Ni, J; Fernandez, MA; Danielsson, L; Chillakuru, RA; Zhang, JL; Grubb, A; Su, J; Gentz, R; Abrahamson, M			Cystatin F is a glycosylated human low molecular weight cysteine proteinase inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATHEPSIN-B; CELL-LINE; ESCHERICHIA-COLI; GEL ELECTROPHORESIS; CHICKEN CYSTATIN; GAMMA-TRACE; IDENTIFICATION; GENE; EXPRESSION; SEQUENCE	A previously undescribed human member of the cystatin superfamily called cystatin F has been identified by expressed sequence tag sequencing in human cDNA libraries. A full-length cDNA clone was obtained from a library made from mRNA of CD34-depleted cord blood cells. The sequence of the cDNA contained an open reading frame encoding a putative 19-residue signal peptide and a mature protein of 126 amino acids with two disulfide bridges and enzyme-binding motifs homologous to those of Family 2 cystatins. Unlike other human cystatins, cystatin F has 2 additional Cys residues, indicating the presence of an extra disulfide bridge stabilizing the N-terminal region of the molecule. Recombinant cystatin F was produced in a baculovirus expression system and characterized. The mature recombinant protein processed by insect cells had an N-terminal segment 7 residues longer than that of cystatin C and displayed reversible inhibition of papain and cathepsin L (K-i = 1.1 and 0.31 nM, respectively), but not cathepsin B. Like cystatin E/M, cystatin F is a glycoprotein, carrying two N-linked carbohydrate chains at positions 36 and 88. An immunoassay for quantification of cystatin F showed that blood contains low levels of the inhibitor (0.9 ng/ml). Six B cell lines in culture secreted barely detectable amounts of cystatin F, but several T cell lines and especially one myeloid cell line secreted significant amounts of the inhibitor. Northern blot analysis revealed that the cystatin F gene is primarily expressed in peripheral blood cells and spleen. Tissue expression clearly different fi-om that of the ubiquitous inhibitor, cystatin C, was also indicated by a high incidence of cystatin F clones in cDNA libraries from dendritic and T cells, but no clones identified by expressed sequence tag sequencing in several B cell libraries and in >600 libraries from other human tissues and cells.	Human Genome Sci Inc, Rockville, MD 20850 USA; Univ Lund Hosp, Dept Clin Chem, Inst Lab Med, S-22185 Lund, Sweden; Univ Lund, Dept Immunotechnol, S-22007 Lund, Sweden	GlaxoSmithKline; Human Genome Sciences Inc; Lund University; Skane University Hospital; Lund University	Abrahamson, M (corresponding author), Univ Lund Hosp, Dept Clin Chem, Inst Lab Med, S-22185 Lund, Sweden.	Magnus.Abrahamson@klinkem.lu.se	Abrahamson, Magnus/CAG-9507-2022	Grubb, Anders/0000-0002-0125-3662				ABRAHAMSON M, 1988, FEBS LETT, V236, P14, DOI 10.1016/0014-5793(88)80276-X; ABRAHAMSON M, 1987, J BIOL CHEM, V262, P9688; ABRAHAMSON M, 1987, FEBS LETT, V216, P229, DOI 10.1016/0014-5793(87)80695-6; ABRAHAMSON M, 1994, METHOD ENZYMOL, V244, P685; ABRAHAMSON M, 1990, BIOCHEM J, V268, P287, DOI 10.1042/bj2680287; ABRAHAMSON M, 1986, J BIOL CHEM, V261, P1282; ADAMS MD, 1995, NATURE, V377, P3; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ASSFALGMACHLEIDT I, 1988, BIOL CHEM H-S, V369, P263; BALBIN M, 1994, J BIOL CHEM, V269, P23156; BJORCK L, 1990, J VIROL, V64, P941; BJORK I, 1994, BIOCHEM J, V299, P219, DOI 10.1042/bj2990219; Bjorklund HV, 1997, J VIROL, V71, P5658; BLUMBERG S, 1970, EUR J BIOCHEM, V15, P97, DOI 10.1111/j.1432-1033.1970.tb00981.x; BODE W, 1988, EMBO J, V7, P2593, DOI 10.1002/j.1460-2075.1988.tb03109.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buchholz B, 1996, EUR J CANCER, V32A, P2101, DOI 10.1016/S0959-8049(96)00230-4; BUTTLE DJ, 1990, SCAND J CLIN LAB INV, V50, P509, DOI 10.3109/00365519009089165; COLLINS AR, 1998, IN PRESS ORAL MICROB, V12; COX SW, 1989, J PERIODONTAL RES, V24, P353, DOI 10.1111/j.1600-0765.1989.tb00882.x; Ekiel I, 1997, J MOL BIOL, V271, P266, DOI 10.1006/jmbi.1997.1150; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Feng GS, 1996, J BIOL CHEM, V271, P12129, DOI 10.1074/jbc.271.21.12129; FREIJE JP, 1993, J BIOL CHEM, V268, P15737; GABRIJELCIC D, 1990, J CLIN CHEM CLIN BIO, V28, P149; GENTZ R, 1992, EUR J BIOCHEM, V210, P545, DOI 10.1111/j.1432-1033.1992.tb17453.x; GILLIS S, 1980, J EXP MED, V152, P1709, DOI 10.1084/jem.152.6.1709; GRUBB A, 1982, P NATL ACAD SCI-BIOL, V79, P3024, DOI 10.1073/pnas.79.9.3024; GRUBB A, 1984, FEBS LETT, V170, P370, DOI 10.1016/0014-5793(84)81346-0; GUESDON JL, 1979, J HISTOCHEM CYTOCHEM, V27, P1131, DOI 10.1177/27.8.90074; Hakansson K, 1996, COMP BIOCHEM PHYS B, V114, P303, DOI 10.1016/0305-0491(96)00025-9; HARDY MR, 1994, METHOD ENZYMOL, V230, P208; HENDERSON PJ, 1972, BIOCHEM J, V127, P321, DOI 10.1042/bj1270321; ISEMURA S, 1991, J BIOCHEM, V110, P648, DOI 10.1093/oxfordjournals.jbchem.a123634; JEPPSSON JO, 1979, CLIN CHEM, V25, P629; KIMURA M, 1981, P NATL ACAD SCI-BIOL, V78, P454, DOI 10.1073/pnas.78.1.454; KOPPEL P, 1984, EXP CELL BIOL, V52, P293; KORANT BD, 1985, BIOCHEM BIOPH RES CO, V127, P1072, DOI 10.1016/S0006-291X(85)80054-1; KOZAK M, 1981, NUCLEIC ACIDS RES, V9, P5233, DOI 10.1093/nar/9.20.5233; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDAHL P, 1992, BIOCHEM J, V281, P49, DOI 10.1042/bj2810049; LINDAHL P, 1994, BIOCHEMISTRY-US, V33, P4384, DOI 10.1021/bi00180a036; Linnevers C, 1997, FEBS LETT, V405, P253, DOI 10.1016/S0014-5793(97)00118-X; LUCKOW VA, 1989, VIROLOGY, V170, P31, DOI 10.1016/0042-6822(89)90348-6; MENEZES J, 1975, BIOMEDICINE, V22, P276; Ni J, 1997, J BIOL CHEM, V272, P10853; OLAFSSON I, 1988, SCAND J CLIN LAB INV, V48, P573, DOI 10.3109/00365518809085775; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; RAWLINGS ND, 1990, J MOL EVOL, V30, P60, DOI 10.1007/BF02102453; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; SCHNITTGER S, 1993, GENOMICS, V16, P50, DOI 10.1006/geno.1993.1139; Sotiropoulou G, 1997, J BIOL CHEM, V272, P903, DOI 10.1074/jbc.272.2.903; Stenman G, 1997, CYTOGENET CELL GENET, V76, P45, DOI 10.1159/000134512; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WALLENOHMAN M, 1994, INT J CANCER, V57, P544, DOI 10.1002/ijc.2910570418	56	129	137	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24797	24804		10.1074/jbc.273.38.24797	http://dx.doi.org/10.1074/jbc.273.38.24797			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733783	hybrid			2022-12-27	WOS:000076007300075
J	Pickersgill, R; Smith, D; Worboys, K; Jenkins, J				Pickersgill, R; Smith, D; Worboys, K; Jenkins, J			Crystal structure of polygalacturonase from Erwinia carotovora ssp. carotovora	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHAGE-P22 TAILSPIKE PROTEIN; PLANT VIRULENCE FACTOR; PECTATE LYASE; ENDO-POLYGALACTURONASE; GLYCOSYL HYDROLASES; BACILLUS-SUBTILIS; REFINEMENT; MECHANISMS; BINDING; ENDOPOLYGALACTURONASE	The crystal structure of the 40-kDa endo-polygalacturonase from Erwinia carotovora ssp, carotovora was solved by multiple isomorphous replacement and refined at 1.9 Angstrom to a conventional crystallographic R-factor of .198 and R-free of 0.239, This is the first structure of a polygalacturonase and comprises a 10 turn right-handed parallel beta-helix domain with two loop regions forming a "tunnel like" substrate-binding cleft. Sequence conservation indicates that the active site of polygalacturonase is between these two loop regions, and comparison of the structure of polygalacturonase with that of rhamnogalacturonase A from Aspergillus aculeatus enables two conserved aspartates, presumed to be catalytic residues, to be identified. An adjacent histidine, in accord with biochemical results, is also seen. A similarity in overall electrostatic properties of the substrate-binding clefts of polygalacturonase and pectate lyase, which bind and cleave the same substrate, polygalacturonic acid, is also revealed.	Food Res Inst, Reading Lab, Reading RG6 6BZ, Berks, England		Pickersgill, R (corresponding author), Food Res Inst, Reading Lab, Earley Gate,Whiteknights Rd, Reading RG6 6BZ, Berks, England.	richard.pickersgill@bbsrc.ac.uk						Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARRAS F, 1994, ANNU REV PHYTOPATHOL, V32, P201, DOI 10.1146/annurev.py.32.090194.001221; Biely P, 1996, FEBS LETT, V382, P249, DOI 10.1016/0014-5793(96)00171-8; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; Caprari C, 1996, MOL PLANT MICROBE IN, V9, P617, DOI 10.1094/MPMI-9-0617; COLLMER A, 1986, ANNU REV PHYTOPATHOL, V24, P383, DOI 10.1146/annurev.py.24.090186.002123; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; HEMILA H, 1992, GENE, V116, P27, DOI 10.1016/0378-1119(92)90625-Y; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; JENKINS J, 1998, IN PRESS J STRUCT BI; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1992, J APPL CRYSTALLOGR, V24, P946; LIETZKE SE, 1994, PLANT PHYSIOL, V106, P849, DOI 10.1104/pp.106.3.849; Mayans O, 1997, STRUCTURE, V5, P677, DOI 10.1016/S0969-2126(97)00222-0; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; MCNEIL M, 1984, ANNU REV BIOCHEM, V53, P625, DOI 10.1146/annurev.bi.53.070184.003205; *MOL SIM INC, 1994, QUANTA 4 0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Palomaki T, 1997, FEBS LETT, V400, P122, DOI 10.1016/S0014-5793(96)01369-5; Petersen TN, 1997, STRUCTURE, V5, P533, DOI 10.1016/S0969-2126(97)00209-8; PICKERSGILL R, 1994, NAT STRUCT BIOL, V1, P717, DOI 10.1038/nsb1094-717; PICKERSGILL R, 1998, IN PRESS ACTA CRYSTA; Pitson SM, 1998, BIOCHEM BIOPH RES CO, V242, P552, DOI 10.1006/bbrc.1997.8009; Rao MN, 1996, BBA-PROTEIN STRUCT M, V1296, P167; SAARILAHTI HT, 1990, MOL MICROBIOL, V4, P1037, DOI 10.1111/j.1365-2958.1990.tb00676.x; SCHROTER KH, 1994, J MOL BIOL, V243, P351, DOI 10.1006/jmbi.1994.1660; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Steinbacher S, 1996, P NATL ACAD SCI USA, V93, P10584, DOI 10.1073/pnas.93.20.10584; Steinbacher S, 1997, J MOL BIOL, V267, P865, DOI 10.1006/jmbi.1997.0922; Vitali J, 1998, PLANT PHYSIOL, V116, P69, DOI 10.1104/pp.116.1.69; Voragen, 1996, PECTINS PECTINASES; WITHERS SG, 1990, J AM CHEM SOC, V112, P5887, DOI 10.1021/ja00171a043; YODER MD, 1993, SCIENCE, V260, P1503, DOI 10.1126/science.8502994; YODER MD, 1995, ACTA CRYSTALLOGR D, V51, P1097, DOI 10.1107/S0907444995006445	42	143	150	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24660	24664		10.1074/jbc.273.38.24660	http://dx.doi.org/10.1074/jbc.273.38.24660			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733763	hybrid			2022-12-27	WOS:000076007300055
J	Liu, LP; Deber, CM				Liu, LP; Deber, CM			Uncoupling hydrophobicity and helicity in transmembrane segments - alpha-helical propensities of the amino acids in non-polar environments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRAL MEMBRANE-PROTEIN; BETA-SHEET; PEPTIDES; INSERTION; PROLINE; CONFORMATIONS; PARAMETERS; PREDICTION; CHANNEL; KINASE	Although the chains of amino acids in proteins that span the membrane are demonstrably helical and hydrophobic, little attention has been paid toward addressing the range of helical propensities of individual amino acids in the non-polar environment of membranes. Because it is inappropriate to apply soluble protein-based structure prediction algorithms to membrane proteins, we have used de novo designed peptides (KKAAAXAAAAAXAAWAAXAAAKKKK-amide, where X indicates one of the 20 commonly occurring amino acids) that mimic a protein membrane-spanning domain to determine the cu-helical proclivity of each residue in the isotropic non-polar environment of n-butanol, Peptide helicities measured by circular dichroism spectroscopy were found to range from theta(222) = -17,000 degrees (Pro) to -38,800 degrees (ne) in n-butanol, The relative helicity of each amino acid is shown to be well correlated with its occurrence frequency in natural transmembrane segments, indicating that the helical propensity of individual residues in concert with their hydrophobicity may be a key determinant of the conformations of protein segments in membranes.	Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Deber, CM (corresponding author), Hosp Sick Children, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.							ALTMANN KH, 1990, BIOPOLYMERS, V30, P107, DOI 10.1002/bip.360300112; BENEFRAIM I, 1993, BIOCHEMISTRY-US, V32, P2371, DOI 10.1021/bi00060a031; BLABER M, 1993, SCIENCE, V260, P1637, DOI 10.1126/science.8503008; BRANDL CJ, 1988, BIOPOLYMERS, V27, P1171, DOI 10.1002/bip.360270710; CHAKRABARTTY A, 1993, BIOCHEMISTRY-US, V32, P5560, DOI 10.1021/bi00072a010; CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843; Chang DK, 1997, BIOPHYS J, V72, P554, DOI 10.1016/S0006-3495(97)78695-8; Cheng AC, 1997, NATURE, V387, P627, DOI 10.1038/42517; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; Chung LA, 1997, ANAL BIOCHEM, V248, P195, DOI 10.1006/abio.1997.2137; DEBER CM, 1990, BIOPOLYMERS, V29, P149, DOI 10.1002/bip.360290120; DEBER CM, 1995, BIOPOLYMERS, V37, P295, DOI 10.1002/bip.360370503; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; ENGELMAN DM, 1981, CELL, V23, P411, DOI 10.1016/0092-8674(81)90136-7; GARY TM, 1984, J MOL BIOL, V175, P75; Hirota N, 1998, J MOL BIOL, V275, P365, DOI 10.1006/jmbi.1997.1468; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; Kothekar V, 1996, J BIOMOL STRUCT DYN, V14, P303, DOI 10.1080/07391102.1996.10508126; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANDOLTMARTICORENA C, 1993, J MOL BIOL, V229, P602, DOI 10.1006/jmbi.1993.1066; Lee S, 1997, BIOCHEMISTRY-US, V36, P3782, DOI 10.1021/bi962451v; LI SC, 1994, NAT STRUCT BIOL, V1, P368, DOI 10.1038/nsb0694-368; Li SC, 1996, P NATL ACAD SCI USA, V93, P6676, DOI 10.1073/pnas.93.13.6676; LIDE DR, 1991, CRC HDB CHEM PHYSICS; Liu LP, 1996, BIOPOLYMERS, V39, P465, DOI 10.1002/(SICI)1097-0282(199609)39:3<465::AID-BIP17>3.0.CO;2-A; Liu LP, 1997, BIOCHEMISTRY-US, V36, P5476, DOI 10.1021/bi970030n; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; MINOR DL, 1994, NATURE, V367, P660, DOI 10.1038/367660a0; MUNOZ V, 1994, PROTEINS, V20, P301, DOI 10.1002/prot.340200403; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; RAO JKM, 1986, BIOCHIM BIOPHYS ACTA, V869, P197, DOI 10.1016/0167-4838(86)90295-5; REITHMEIER RAF, 1995, CURR OPIN STRUC BIOL, V5, P491, DOI 10.1016/0959-440X(95)80034-4; TAYLOR WR, 1994, PROTEINS, V18, P281, DOI 10.1002/prot.340180309; Vinogradova O, 1997, BIOPHYS J, V72, P2688, DOI 10.1016/S0006-3495(97)78912-4; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512	38	85	86	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23645	23648		10.1074/jbc.273.37.23645	http://dx.doi.org/10.1074/jbc.273.37.23645			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726967	hybrid			2022-12-27	WOS:000075893100008
J	Spadaccini, A; Tilbrook, PA; Sarna, MK; Crossley, M; Bieker, JJ; Klinken, SP				Spadaccini, A; Tilbrook, PA; Sarna, MK; Crossley, M; Bieker, JJ; Klinken, SP			Transcription factor erythroid Kruppel-like factor (ELKF) is essential for the erythropoietin-induced hemoglobin production but not for proliferation, viability, or morphological maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORPHOBILINOGEN DEAMINASE GENE; LEUCINE ZIPPER PROTEIN; DNA-BINDING PROTEIN; HUMAN GAMMA-GLOBIN; FACTOR GATA-1; FACTOR NF-E2; FACTOR EKLF; CELL-LINES; BETA-THALASSEMIA; MESSENGER-RNA	The erythroid Kruppel-like factor (EKLF) is essential for the transcription of beta(maj) globin in erythroid cells. We show here that RNA for this transcription factor did not alter during erythropoietin-induced differentiation of J2E cells; however, EKLF protein content decreased and was inversely related to globin production. This unexpected result was also observed during chemically induced maturation of two murine erythroleukemia cell lines. To explore the role of EKLF in erythroid terminal differentiation, an antisense EKLF construct was introduced into J2E cells. As a consequence EKLF RNA and protein levels fell by approximately 80%, and the cells were unable to manufacture hemoglobin in response to erythropoietin, The failure to produce hemoglobin was due to reduced transcription of not only globin genes but also key heme enzyme genes. However, numerous other genes, including several erythroid transcription factors, were unaffected by the decrease in EKLF. Although hemoglobin synthesis was severely impaired with depleted EKLF levels, morphological maturation in response to erythropoietin continued normally. Moreover, erythropoietin-induced proliferation and viability were unaffected by the decrease in EKLF levels. We conclude that EKLF affects a specific set of genes, which regulates hemoglobin production and has no obvious effect on morphological changes, cell division, or viability in response to erythropoietin.	Dept Biochem, Lab Canc Med, Perth, WA 6001, Australia; Univ Western Australia, Dept Biochem, Nedlands, WA 6907, Australia; Univ Sydney, Dept Biochem, Sydney, NSW 2006, Australia; CUNY Mt Sinai Sch Med, Brookdale Ctr Mol Biol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Biochem, New York, NY 10029 USA	University of Western Australia; University of Sydney; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Klinken, SP (corresponding author), Dept Biochem, Lab Canc Med, Level 6,MRF Bldg,Rear,50 Murray St, Perth, WA 6001, Australia.		Sarna, Mohinder/AAO-9343-2020; Sarna, Mohinder/Q-7834-2016; Crossley, Merlin/D-7888-2011; Sarna, Mohinder/GYR-3271-2022	Sarna, Mohinder/0000-0002-2448-1588; Sarna, Mohinder/0000-0002-2448-1588; Crossley, Merlin/0000-0003-2057-3642; 				ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; ANDREWS NC, 1993, P NATL ACAD SCI USA, V90, P11488, DOI 10.1073/pnas.90.24.11488; APLAN PD, 1992, EMBO J, V11, P4073, DOI 10.1002/j.1460-2075.1992.tb05500.x; BEGLEY CG, 1989, P NATL ACAD SCI USA, V86, P10128, DOI 10.1073/pnas.86.24.10128; BIEKER JJ, 1995, MOL CELL BIOL, V15, P852; BUSFIELD SJ, 1992, BLOOD, V80, P412; BUSFIELD SJ, 1995, EUR J BIOCHEM, V230, P475; BUSFIELD SJ, 1993, GROWTH FACTORS, V9, P307, DOI 10.3109/08977199308991591; CALLUS BA, 1995, HEMOGLOBIN, V19, P7; Chappell D, 1997, CELL DEATH DIFFER, V4, P105, DOI 10.1038/sj.cdd.4400219; Chen XY, 1996, EMBO J, V15, P5888, DOI 10.1002/j.1460-2075.1996.tb00975.x; CHIBA T, 1991, NUCLEIC ACIDS RES, V19, P3843, DOI 10.1093/nar/19.14.3843; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COOPER MC, 1974, P NATL ACAD SCI USA, V71, P1677, DOI 10.1073/pnas.71.5.1677; COX TC, 1991, EMBO J, V10, P1891, DOI 10.1002/j.1460-2075.1991.tb07715.x; CROSSLEY M, 1993, CURR OPIN GENET DEV, V3, P232, DOI 10.1016/0959-437X(93)90028-N; CROSSLEY M, 1994, J BIOL CHEM, V269, P15440; Crossley M, 1996, MOL CELL BIOL, V16, P1695; DALYOT N, 1993, NUCLEIC ACIDS RES, V21, P4031, DOI 10.1093/nar/21.17.4031; DONZE D, 1995, J BIOL CHEM, V270, P1955, DOI 10.1074/jbc.270.4.1955; FENG WC, 1994, J BIOL CHEM, V269, P1493; Ford AM, 1996, P NATL ACAD SCI USA, V93, P10838, DOI 10.1073/pnas.93.20.10838; FRAMPTON J, 1990, MOL CELL BIOL, V10, P3838, DOI 10.1128/MCB.10.7.3838; GRANDCHAMP B, 1984, P NATL ACAD SCI-BIOL, V81, P5036, DOI 10.1073/pnas.81.16.5036; GREEN AR, 1991, EMBO J, V10, P4143; Gregory RC, 1996, BLOOD, V87, P1793, DOI 10.1182/blood.V87.5.1793.bloodjournal8751793; HARTZOG GA, 1993, MOL CELL BIOL, V13, P44, DOI 10.1128/MCB.13.1.44; HOFER E, 1981, CELL, V23, P585, DOI 10.1016/0092-8674(81)90154-9; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; KAIHO SI, 1985, ANAL BIOCHEM, V149, P117, DOI 10.1016/0003-2697(85)90483-X; KLINKEN SP, 1988, P NATL ACAD SCI USA, V85, P8506, DOI 10.1073/pnas.85.22.8506; KOTKOW KJ, 1995, MOL CELL BIOL, V15, P4640; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Lim SK, 1997, BLOOD, V90, P1291, DOI 10.1182/blood.V90.3.1291.1291_1291_1299; LU SJ, 1994, P NATL ACAD SCI USA, V91, P8398, DOI 10.1073/pnas.91.18.8398; MAXAUDIT I, 1993, J BIOL CHEM, V268, P5431; McDevitt MA, 1997, P NATL ACAD SCI USA, V94, P6781, DOI 10.1073/pnas.94.13.6781; MERIKA M, 1995, MOL CELL BIOL, V15, P2437; MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; MORISSON GR, 1965, ANAL CHEM, V37, P1124; MURRELL AM, 1995, ONCOGENE, V11, P131; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; OSADA H, 1995, P NATL ACAD SCI USA, V92, P9585, DOI 10.1073/pnas.92.21.9585; PERKINS AC, 1995, NATURE, V375, P318; Perkins AC, 1996, P NATL ACAD SCI USA, V93, P12267, DOI 10.1073/pnas.93.22.12267; PHILIPSEN S, 1990, EMBO J, V9, P2159, DOI 10.1002/j.1460-2075.1990.tb07385.x; PIECHACZYK M, 1985, CELL, V42, P589, DOI 10.1016/0092-8674(85)90116-3; PIECHACZYK M, 1984, NUCLEIC ACIDS RES, V12, P6951, DOI 10.1093/nar/12.18.6951; Ponka P, 1997, BLOOD, V89, P1; PORCHER C, 1991, J BIOL CHEM, V266, P10562; RAHUEL C, 1992, EMBO J, V11, P4095, DOI 10.1002/j.1460-2075.1992.tb05502.x; RAMSAY RG, 1992, J BIOL CHEM, V267, P5656; RAYNER JR, 1994, MOL CELL BIOL, V14, P880, DOI 10.1128/MCB.14.2.880; ROUGEON F, 1977, GENE, V1, P229, DOI 10.1016/0378-1119(77)90047-6; Smith A, 1997, EMBO J, V16, P451, DOI 10.1093/emboj/16.3.451; Southwood CM, 1996, DEV DYNAM, V206, P248, DOI 10.1002/(SICI)1097-0177(199607)206:3<248::AID-AJA3>3.0.CO;2-I; Surinya KH, 1997, J BIOL CHEM, V272, P26585, DOI 10.1074/jbc.272.42.26585; TAKETANI S, 1992, EUR J BIOCHEM, V205, P217, DOI 10.1111/j.1432-1033.1992.tb16771.x; TAKETANI S, 1990, J BIOL CHEM, V265, P19377; Tilbrook PA, 1996, J BIOL CHEM, V271, P3453; Tilbrook PA, 1996, CELL GROWTH DIFFER, V7, P511; Tilbrook PA, 1997, EMBO J, V16, P1610, DOI 10.1093/emboj/16.7.1610; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; TSAI SF, 1991, GENE DEV, V5, P919, DOI 10.1101/gad.5.6.919; VALGEARCHER VE, 1994, P NATL ACAD SCI USA, V91, P8617, DOI 10.1073/pnas.91.18.8617; WADMAN I, 1994, EMBO J, V13, P4831, DOI 10.1002/j.1460-2075.1994.tb06809.x; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; WALTERS M, 1992, P NATL ACAD SCI USA, V89, P10444, DOI 10.1073/pnas.89.21.10444; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; WETMUR JG, 1986, P NATL ACAD SCI USA, V83, P7703, DOI 10.1073/pnas.83.20.7703; Wijgerde M, 1996, GENE DEV, V10, P2894, DOI 10.1101/gad.10.22.2894; YOSHIMURA A, 1990, P NATL ACAD SCI USA, V87, P4139, DOI 10.1073/pnas.87.11.4139; YOUSSOUFIAN H, 1990, MOL CELL BIOL, V10, P3675, DOI 10.1128/MCB.10.7.3675	75	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23793	23798		10.1074/jbc.273.37.23793	http://dx.doi.org/10.1074/jbc.273.37.23793			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726989	hybrid			2022-12-27	WOS:000075893100030
J	Thevananther, S; Kolli, AH; Devarajan, P				Thevananther, S; Kolli, AH; Devarajan, P			Identification of a novel ankyrin isoform (Ank(G)190) in kidney and lung that associates with the plasma membrane and binds alpha-Na,K-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ERYTHROCYTE ANKYRIN; ALTERNATIVELY SPLICED FORMS; ANION-EXCHANGER; ALPHA-SUBUNIT; DISTINCT SITES; MAJOR ANKYRIN; SPECTRIN; BRAIN; NA,K-ATPASE; PROTEINS	Ankyrins are a family of adapter molecules that mediate linkages between integral membrane and cytoskeletal proteins, Such interactions are crucial to the polarized distribution of membrane proteins in transporting epithelia. We have cloned and characterized a novel 190-kDa member of this family from a rat kidney cDNA library, which me term Ank(G)190 based on the predicted size and homology with the larger neuronal Ank(G) isoform, Ank(G)190 displays a unique 31-residue amino terminus, a repeats domain consisting of 24 repetitive 33-residue motifs, a spectrin binding domain, and a truncated regulatory domain. Probes derived from the unique amino terminus hybridize to an 8-kilobase message exclusively ire kidney and lung and specifically to the kidney outer medullary collecting duets by in situ hybridization. Transfections of Madin-Darby canine kidney and COS-7 epithelial cell limes with a full-length Ank(G)190 construct result in (a) expression at the lateral plasma membrane, (b) functional assembly with the cytoskeleton, and (c) interaction with at least one membrane protein, the Na,K-ATPase. Two independent Na,K-ATPase binding domains on Ank(G)190 are demonstrated as follows: one within the distal 12 ankyrin repeats, and a second site within the spectrin binding domain. Thus, ankyrins may interact with integral membrane proteins in a pleiotropic manner that may involve complex tertiary structural determinants.	Yale Univ, Sch Med, Dept Pediat, Div Pediat Nephrol, New Haven, CT 06520 USA	Yale University	Devarajan, P (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, 111 E 210th St, Bronx, NY 10467 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK047072] Funding Source: NIH RePORTER; NIDDK NIH HHS [R29-DK47072] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BENNETT V, 1992, J BIOL CHEM, V267, P8703; BENNETT V, 1993, ANNU REV CELL BIOL, V9, P27, DOI 10.1146/annurev.cellbio.9.1.27; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAVIS J, 1989, J BIOL CHEM, V264, P6417; DAVIS JQ, 1990, J BIOL CHEM, V265, P17252; DAVIS LH, 1990, J BIOL CHEM, V265, P10589; Devarajan P, 1996, CURR TOP MEMBR, V43, P97; Devarajan P, 1997, P NATL ACAD SCI USA, V94, P10711, DOI 10.1073/pnas.94.20.10711; Devarajan P, 1996, J CELL BIOL, V133, P819, DOI 10.1083/jcb.133.4.819; DEVARAJAN P, 1994, P NATL ACAD SCI USA, V91, P2965, DOI 10.1073/pnas.91.8.2965; DRENCKHAHN D, 1987, EUR J CELL BIOL, V43, P479; Hoock TC, 1997, J CELL BIOL, V136, P1059, DOI 10.1083/jcb.136.5.1059; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; JORDAN C, 1995, J BIOL CHEM, V270, P29971; KASHGARIAN M, 1991, SODIUM PUMP RECENT D, P573; KOOB R, 1987, European Journal of Cell Biology, V45, P230; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; KUNIMOTO M, 1991, J CELL BIOL, V115, P1319, DOI 10.1083/jcb.115.5.1319; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBERT S, 1990, P NATL ACAD SCI USA, V87, P1730, DOI 10.1073/pnas.87.5.1730; LUNA EJ, 1992, SCIENCE, V258, P955, DOI 10.1126/science.1439807; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; MICHAELY P, 1993, J BIOL CHEM, V268, P22703; Michaely P, 1995, J BIOL CHEM, V270, P31298, DOI 10.1074/jbc.270.52.31298; MORROW JS, 1989, J CELL BIOL, V108, P455, DOI 10.1083/jcb.108.2.455; MORROW JS, 1997, HDB PHYSIOL 14, P485; OTTO E, 1991, J CELL BIOL, V114, P241, DOI 10.1083/jcb.114.2.241; PETERS LL, 1993, SEMIN HEMATOL, V30, P85; PETERS LL, 1995, J CELL BIOL, V130, P313, DOI 10.1083/jcb.130.2.313; REPPERT SM, 1991, MOL ENDOCRINOL, V5, P1037, DOI 10.1210/mend-5-8-1037; SABROOK J, 1989, MOL CLONING LAB MANU; SIEGEL NJ, 1994, PEDIATR RES, V36, P129, DOI 10.1203/00006450-199408000-00001; SRINIVASAN Y, 1992, J BIOL CHEM, V267, P7483; Zhou DX, 1997, J CELL BIOL, V136, P621, DOI 10.1083/jcb.136.3.621	34	48	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23952	23958		10.1074/jbc.273.37.23952	http://dx.doi.org/10.1074/jbc.273.37.23952			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727010	hybrid			2022-12-27	WOS:000075893100051
J	Hartung, M; Kisters-Woike, B				Hartung, M; Kisters-Woike, B			Cre mutants with altered DNA binding properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC RECOMBINATION; PROTEIN SECONDARY STRUCTURE; NUCLEOTIDE-SEQUENCE; CRYSTAL-STRUCTURE; INTEGRASE FAMILY; NEURAL NETWORKS; PREDICTION; CLEAVAGE; POLYMERASE; REPRESSION	The recombinase Ore of bacteriophage P1 is a member of the family of site-specific recombinases and integrases that catalyze inter- and intramolecular DNA rearrangements, To understand how this protein specifically recognizes its target sequence, we constructed Ore mutants with amino acid substitutions in different positions of the presumptive DNA binding region. Here we present the results of in vitro DNA binding and in vivo recombination experiments with these Cre mutants. Most substitutions of presumptive DNA-binding amino acids in in vitro tests resulted either in the loss of target binding or in a broadening of target recognition specificity, Of the mutations resulting in a broadening of target specificity, one, N317A, results in a reduced recombination efficiency with the wild-type loxP target but recombines, in contrast to wild-type Ore, in in vivo experiments, with a symmetric variant of the wild-type target sequence. This target variant differs from wildtype loxP by the symmetric C to A replacement in position 6 of the inverted repeats. We propose a common multihelical DNA binding motif for the family of integrases and recombinases, This model implies a major structural rearrangement for the DNA binding region of lambda integrase, analogous to the structural rearrangements of the DNA binding motifs of other proteins when contacting their target DNA.	Univ Cologne, Inst Genet, D-50931 Cologne, Germany	University of Cologne	Kisters-Woike, B (corresponding author), Univ Cologne, Inst Genet, Weyertal 121, D-50931 Cologne, Germany.							ABREMSKI K, 1984, J BIOL CHEM, V259, P1509; ABREMSKI K, 1983, CELL, V32, P1301, DOI 10.1016/0092-8674(83)90311-2; ABREMSKI KE, 1992, PROTEIN ENG, V5, P87, DOI 10.1093/protein/5.1.87; ARGOS P, 1986, EMBO J, V5, P433, DOI 10.1002/j.1460-2075.1986.tb04229.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Cheng CH, 1998, CELL, V92, P841, DOI 10.1016/S0092-8674(00)81411-7; FELLENBERG K, 1998, THESIS U COLOGNE; Grindley NDF, 1997, CURR BIOL, V7, pR608, DOI 10.1016/S0960-9822(06)00314-9; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; HANAHAN D, 1983, J MOL BIOL, V166, P575; Hickman AB, 1997, CELL, V89, P227, DOI 10.1016/S0092-8674(00)80202-0; HOESS R, 1990, J MOL BIOL, V216, P873, DOI 10.1016/S0022-2836(99)80007-2; HOESS R, 1989, STRUCTURE METHODS HU, V1, P203; HOESS RH, 1985, J MOL BIOL, V181, P351, DOI 10.1016/0022-2836(85)90224-4; HOESS RH, 1982, P NATL ACAD SCI-BIOL, V79, P3398, DOI 10.1073/pnas.79.11.3398; HOESS RH, 1986, NUCLEIC ACIDS RES, V14, P2287, DOI 10.1093/nar/14.5.2287; KOLKHOF P, 1994, J MOL BIOL, V242, P23, DOI 10.1006/jmbi.1994.1554; Kwon HJ, 1997, SCIENCE, V276, P126, DOI 10.1126/science.276.5309.126; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MACK A, 1992, NUCLEIC ACIDS RES, V20, P4451, DOI 10.1093/nar/20.17.4451; Miller J. H., 1972, EXPT MOL GENETICS, P432; OEHLER S, 1994, EMBO J, V13, P3348, DOI 10.1002/j.1460-2075.1994.tb06637.x; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; ONEIL KT, 1990, SCIENCE, V249, P774, DOI 10.1126/science.2389143; ONEIL KT, 1991, BIOCHEMISTRY-US, V30, P9030, DOI 10.1021/bi00101a017; ROSE RE, 1988, NUCLEIC ACIDS RES, V16, P355, DOI 10.1093/nar/16.1.355; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; ROST B, 1993, P NATL ACAD SCI USA, V90, P7558, DOI 10.1073/pnas.90.16.7558; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; Sambrook J., 1989, MOL CLONING, pA1; SAUER B, 1987, MOL CELL BIOL, V7, P2087, DOI 10.1128/MCB.7.6.2087; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; STARK WM, 1992, TRENDS GENET, V8, P432, DOI 10.1016/0168-9525(92)90176-5; STERNBERG N, 1978, P NATL ACAD SCI USA, V75, P5594, DOI 10.1073/pnas.75.11.5594; STERNBERG N, 1986, J MOL BIOL, V187, P197, DOI 10.1016/0022-2836(86)90228-7; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; STRNBERG N, 1978, COLD SPRING HARB SYM, V43, P1143; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Subramanya HS, 1997, EMBO J, V16, P5178, DOI 10.1093/emboj/16.17.5178; WIERZBICKI A, 1987, J MOL BIOL, V195, P785, DOI 10.1016/0022-2836(87)90484-0; YANG W, 1995, CELL, V82, P193, DOI 10.1016/0092-8674(95)90307-0	45	44	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					22884	22891		10.1074/jbc.273.36.22884	http://dx.doi.org/10.1074/jbc.273.36.22884			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722507	hybrid			2022-12-27	WOS:000075778100007
J	Martinez-Pomares, L; Mahoney, JA; Kaposzta, R; Linehan, SA; Stahl, PD; Gordon, S				Martinez-Pomares, L; Mahoney, JA; Kaposzta, R; Linehan, SA; Stahl, PD; Gordon, S			A functional soluble form of the murine mannose receptor is produced by macrophages in vitro and is present in mouse serum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; CARBOHYDRATE-RECOGNITION DOMAINS; MONOCLONAL-ANTIBODY NLDC-145; DENDRITIC CELLS; IN-VITRO; TISSUE DISTRIBUTION; MOLECULAR-CLONING; INTERFERON-GAMMA; DEC-205 PROTEIN; DOWN-REGULATION	A soluble form of the mannose receptor (sMR) has been found in conditioned medium of primary macrophages in vitro and in mouse serum, sMR was released as a single species, had a smaller size than the cell-associated form, and accumulated in macrophage-conditioned medium, in a cytokine-regulated manner, to levels comparable with those found for cell-associated mannose receptor. Pulse-chase experiments showed that sMR production in culture occurred by constitutive cleavage of pre-existing full-length protein. A binding assay was developed to determine the sugar specificity of sMR and its ability to interact with pathogens and particulate antigens (i.e. Candida albicans and zymosan). Protease inhibitor studies suggested that sMR was produced by cleavage of an intact mannose receptor by a matrix metalloprotease or ADAM metalloprotease. A role for sMR in the immune response is proposed based on its binding properties, regulation by cytokines, and the previous discovery of putative ligands for the cysteine-rich domain of the mannose receptor in lymph nodes and spleen.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Washington Univ, Sch Med, St Louis, MO 63110 USA	University of Oxford; Washington University (WUSTL)	Martinez-Pomares, L (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.		Stahl, Philip/D-6315-2012	Martinez-Pomares, Luisa/0000-0002-2331-127X				ANCIAN P, 1995, J BIOL CHEM, V270, P8963, DOI 10.1074/jbc.270.15.8963; Avrameas A, 1996, EUR J IMMUNOL, V26, P394, DOI 10.1002/eji.1830260219; BAZIL V, 1991, J IMMUNOL, V147, P1567; BAZIL V, 1995, IMMUNOL TODAY, V16, P135, DOI 10.1016/0167-5699(95)80130-8; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; BLUM JS, 1991, CARBOHYD RES, V213, P145, DOI 10.1016/S0008-6215(00)90605-0; CROWE PD, 1995, J EXP MED, V181, P1205, DOI 10.1084/jem.181.3.1205; DOYLE AG, 1994, EUR J IMMUNOL, V24, P1441, DOI 10.1002/eji.1830240630; EZEKOWITZ RAB, 1990, J EXP MED, V172, P1785, DOI 10.1084/jem.172.6.1785; Fiete D, 1997, J BIOL CHEM, V272, P14629, DOI 10.1074/jbc.272.23.14629; Fiete D, 1997, P NATL ACAD SCI USA, V94, P11256, DOI 10.1073/pnas.94.21.11256; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; HARRIS N, 1992, BLOOD, V80, P2363; INABA K, 1995, CELL IMMUNOL, V163, P148, DOI 10.1006/cimm.1995.1109; ISHIZAKI J, 1994, J BIOL CHEM, V269, P5897; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; KERY V, 1992, ARCH BIOCHEM BIOPHYS, V298, P49, DOI 10.1016/0003-9861(92)90092-B; KRUSKAL BA, 1992, J EXP MED, V176, P1673, DOI 10.1084/jem.176.6.1673; LAMBEAU G, 1994, J BIOL CHEM, V269, P1575; Lunn CA, 1997, FEBS LETT, V400, P333, DOI 10.1016/S0014-5793(96)01410-X; MARODI L, 1991, J IMMUNOL, V146, P2783; MartinezPomares L, 1996, J EXP MED, V184, P1927, DOI 10.1084/jem.184.5.1927; MCGEEHAN GM, 1994, NATURE, V370, P558, DOI 10.1038/370558a0; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Noorman F, 1997, J LEUKOCYTE BIOL, V61, P63, DOI 10.1002/jlb.61.1.63; ODAKE S, 1994, BIOCHEM BIOPH RES CO, V199, P1442, DOI 10.1006/bbrc.1994.1392; PONTOW SE, 1992, INT REV CYTOL, V137B, P221; Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2; Rosendahl MS, 1997, J BIOL CHEM, V272, P24588, DOI 10.1074/jbc.272.39.24588; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; SOUSA CRE, 1993, J EXP MED, V178, P509, DOI 10.1084/jem.178.2.509; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; STERNLICHT M, 1998, GUIDEBOOK EXTRACELLU; Tanaka M, 1998, NAT MED, V4, P31, DOI 10.1038/nm0198-031; TAYLOR ME, 1990, J BIOL CHEM, V265, P12156; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; TAYLOR ME, 1993, J BIOL CHEM, V268, P399; TURNER MW, 1994, BIOCHEM SOC T, V22, P88, DOI 10.1042/bst0220088; VANDENEERTWEGH AJM, 1992, EUR J IMMUNOL, V22, P719, DOI 10.1002/eji.1830220315; Walcheck B, 1996, NATURE, V380, P720, DOI 10.1038/380720a0; WITMERPACK MD, 1995, CELL IMMUNOL, V163, P157, DOI 10.1006/cimm.1995.1110; Wu K, 1996, J BIOL CHEM, V271, P21323, DOI 10.1074/jbc.271.35.21323; YOSHIDA K, 1993, IMMUNOLOGY, V80, P34	44	94	99	8	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23376	23380		10.1074/jbc.273.36.23376	http://dx.doi.org/10.1074/jbc.273.36.23376			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722572	hybrid			2022-12-27	WOS:000075778100072
J	Qiu, Y; Sutton, L; Riggs, AF				Qiu, Y; Sutton, L; Riggs, AF			Identification of myoglobin in human smooth muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESOPHAGOGASTRIC JUNCTION; LUMBRICUS-TERRESTRIS; ESOPHAGEAL BODY; NITRIC-OXIDE; HEMOGLOBIN; OPOSSUM; SPHINCTER; OXIDATION; MECHANISM; DIFFUSION	Myoglobin (Mb) has been believed to be absent generally from mammalian smooth muscle tissue. Examination of human rectal, uterine, bladder, colon, small intestine, arterial, and venous smooth muscle by immunohistochemical techniques shows that each of these tissues is immunopositive for both smooth muscle myosin and human Mb, Rib-specific primers were used for the polymerase chain reaction to generate cDNA from smooth muscle tissues. Southern hybridization with a Mb-specific probe gave a very strong signal with the cDNA from rectum, weaker signals from small intestine and uterus, a faint signal from colon, and no signal from bladder tissue. High performance Liquid chromatography analysis coupled with sequence determination has shown that contaminating heme-binding serum albumin as well as hemoglobin in extracts of smooth muscle seriously compromise any heme-based or spectrophotometric assay of Mb. Combined affinity and size exclusion chromatography, however, provide the necessary resolution. The cDNA-derived amino acid sequence of human smooth muscle Rib was found to be identical to that of Mb from striated muscle.	Univ Texas, Dept Zool, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Riggs, AF (corresponding author), Univ Texas, Dept Zool, Austin, TX 78712 USA.	riggs@uts.cc.utexas.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035847] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 35847] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSEN HT, 1966, PHYSIOL REV, V46, P212, DOI 10.1152/physrev.1966.46.2.212; ANTONINI E, 1965, PHYSIOL REV, V45, P123, DOI 10.1152/physrev.1965.45.1.123; BIORCK G, 1949, ACTA MED SCAND     S, V226, P1; BLESSING MH, 1972, COMP BIOCHEM PHYSIOL, V41, P475, DOI 10.1016/0300-9629(72)90005-9; BLOOM W, 1968, TXB HISTOLOGY, P574; Bollage DM, 1991, PROTEIN METHODS, P96; CHRISTENSEN J, 1983, GASTROENTEROLOGY, V85, P650; CHRISTENSEN J, 1982, P SOC EXP BIOL MED, V170, P194; CHRISTENSEN J, 1973, GASTROENTEROLOGY, V64, P1119; CHRISTENSEN J, 1973, AM J PHYSIOL, V225, P1265, DOI 10.1152/ajplegacy.1973.225.6.1265; Cornfield DN, 1996, P NATL ACAD SCI USA, V93, P8089, DOI 10.1073/pnas.93.15.8089; DEDUVE C, 1948, ACTA CHEM SCAND, V2, P264, DOI 10.3891/acta.chem.scand.02-0264; DOYLE MP, 1981, J INORG BIOCHEM, V14, P351, DOI 10.1016/S0162-0134(00)80291-3; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; FASOLD H, 1970, EUR J BIOCHEM, V15, P122, DOI 10.1111/j.1432-1033.1970.tb00985.x; GALARIS D, 1989, ARCH BIOCHEM BIOPHYS, V273, P497, DOI 10.1016/0003-9861(89)90509-2; HORNIG D, 1975, ANN NY ACAD SCI, V258, P103, DOI 10.1111/j.1749-6632.1975.tb29271.x; JAISLE F, 1966, KLIN WOCHENSCHR, V44, P1182, DOI 10.1007/BF01742095; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; KAGEN LJ, 1967, IMMUNOLOGY, V12, P667; KELM M, 1990, CIRC RES, V66, P1561, DOI 10.1161/01.RES.66.6.1561; LANCASTER JR, 1994, P NATL ACAD SCI USA, V91, P8137, DOI 10.1073/pnas.91.17.8137; Lankester E.R, 1872, P ROY SOC LONDON, V21, P70; LANKESTER ER, 1871, PFLUGERS ARCH GES PH, V4, P315; OWNBY DW, 1993, J BIOL CHEM, V268, P13539; PERCY WH, 1991, DIGEST DIS SCI, V36, P1057, DOI 10.1007/BF01297447; PRASAD R, 1978, EXPERIENTIA, V34, P484, DOI 10.1007/BF01935942; QIU Y, 1995, FASEB J, V9, P1353; SCHUDER S, 1979, ANAL BIOCHEM, V92, P473, DOI 10.1016/0003-2697(79)90687-0; SCHULZEDELRIEU K, 1982, AM J PHYSIOL, V242, pG258, DOI 10.1152/ajpgi.1982.242.3.G258; WELLER P, 1984, EMBO J, V3, P439, DOI 10.1002/j.1460-2075.1984.tb01825.x; WITTENBERG JB, 1965, J GEN PHYSIOL, V49, P57; WITTENBERG JB, 1990, ANNU REV BIOPHYS BIO, V19, P217; WITTENBERG JB, 1970, PHYSIOL REV, V50, P559, DOI 10.1152/physrev.1970.50.4.559; Zhu H, 1996, J BIOL CHEM, V271, P30007, DOI 10.1074/jbc.271.47.30007	35	66	67	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23426	23432		10.1074/jbc.273.36.23426	http://dx.doi.org/10.1074/jbc.273.36.23426			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722578	hybrid			2022-12-27	WOS:000075778100078
J	Shimbara, N; Ogawa, K; Hidaka, Y; Nakajima, H; Yamasaki, N; Niwa, S; Tanahashi, N; Tanaka, K				Shimbara, N; Ogawa, K; Hidaka, Y; Nakajima, H; Yamasaki, N; Niwa, S; Tanahashi, N; Tanaka, K			Contribution of proline residue for efficient production of MHC class I ligands by proteasomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR-HISTOCOMPATIBILITY-COMPLEX; CYTOTOXIC T-LYMPHOCYTES; ANTIGEN PRESENTATION; ORNITHINE DECARBOXYLASE; PROTEIN ACTIVATOR; PEPTIDE; PA28; SUBUNITS; 20S; DEGRADATION	Proteasomes are processing enzymes capable of generating major histocompatibility complex (MHC) class I ligands, but the mechanism of how they excise ligands without destroying them is largely unknown. Previously, we reported that most products of ornithine decarboxylase degraded in vitro by the 26 S ATP-dependent proteasome, which contained one or two Pro residues (Tokunaga, F., Goto, T., Koide, T., Murakami, Y., Hayashi, S., Tamura, T., Tanaka, a, and Ichihara, A. (1994) J. Biol. Chem. 269, 17382-17385), which implied that the Pro residue has a role in the escape from random cleavage by proteasomes. Here, we examine the role of the Pro residue in producing MHC class I ligands in vitro. Proteasomes generated two cytotoxic T lymphocyte-epitopic precursor peptides, SIIPGLPLSL and DMYPHFMPTNL, from the 29-mer and 25-mer peptides harboring these sequences, which are derived hom the c-akt proto-oncogene and the pp89 protein of mouse cytomagalovirus, respectively. Replacement of the first or second Pro residue within these epitopes by Ala resulted in a marked reduction of this epitope-derived production or their random cleavage by proteasomes, irrespective of the presence of PA28, which greatly accelerates the generation of unmodified ligands. Moreover, replacement of a single amino acid residue other than Pro in both epitopic and flanking regions by Ala or Leu had no or little appreciable effect on the SIIPGLPLSL or its derivative production. Thus, Pro residue(s) within these epitopic sequences presumably contributes to efficient production of MHC class I ligands through prevention of their random cleavage by proteasomes.	Sumitomo Elect Ind Ltd, Biomed R&D Dept, Sakae Ku, Yokohama, Kanagawa 2448588, Japan; Japan Sci & Technol Corp, CREST, Bunkyo Ku, Tokyo 1130021, Japan; Tokyo Metropolitan Inst Med Sci, Bunkyo Ku, Tokyo 1130021, Japan	Sumitomo Electric Industries; Japan Science & Technology Agency (JST); Tokyo Metropolitan Institute of Medical Science	Shimbara, N (corresponding author), Sumitomo Elect Ind Ltd, Biomed R&D Dept, Sakae Ku, 1 Taya Cho, Yokohama, Kanagawa 2448588, Japan.	nshinb@opele.sei.co.jp						AHN JY, 1995, FEBS LETT, V366, P37, DOI 10.1016/0014-5793(95)00492-R; Androlewicz MJ, 1996, IMMUNITY, V5, P1, DOI 10.1016/S1074-7613(00)80304-0; BOES B, 1994, J EXP MED, V179, P901, DOI 10.1084/jem.179.3.901; Brusic V, 1998, NUCLEIC ACIDS RES, V26, P368, DOI 10.1093/nar/26.1.368; Cerundolo V, 1997, EUR J IMMUNOL, V27, P336, DOI 10.1002/eji.1830270148; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Craiu A, 1997, P NATL ACAD SCI USA, V94, P10850, DOI 10.1073/pnas.94.20.10850; Craiu A, 1997, J BIOL CHEM, V272, P13437, DOI 10.1074/jbc.272.20.13437; DEL VM, 1991, CELL, V66, P1145; Dick TP, 1996, CELL, V86, P253, DOI 10.1016/S0092-8674(00)80097-5; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; EGGERS M, 1995, J EXP MED, V182, P1865, DOI 10.1084/jem.182.6.1865; Ehring B, 1996, EUR J BIOCHEM, V235, P404, DOI 10.1111/j.1432-1033.1996.00404.x; ELLIOTT T, 1995, J EXP MED, V181, P1481, DOI 10.1084/jem.181.4.1481; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; Groettrup M, 1996, IMMUNOL TODAY, V17, P429, DOI 10.1016/0167-5699(96)10051-7; Groettrup M, 1996, NATURE, V381, P166, DOI 10.1038/381166a0; GROETTRUP M, 1995, J BIOL CHEM, V270, P23808, DOI 10.1074/jbc.270.40.23808; KEIL GM, 1987, J VIROL, V61, P1901, DOI 10.1128/JVI.61.6.1901-1908.1987; MA CP, 1992, J BIOL CHEM, V267, P10515; MOMBURG F, 1994, CURR OPIN IMMUNOL, V6, P32, DOI 10.1016/0952-7915(94)90030-2; Monaco JJ, 1995, ANNU REV GENET, V29, P729, DOI 10.1146/annurev.ge.29.120195.003501; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; NIEDERMANN G, 1995, IMMUNITY, V2, P289, DOI 10.1016/1074-7613(95)90053-5; Niedermann G, 1997, J EXP MED, V186, P209, DOI 10.1084/jem.186.2.209; Ossendorp F, 1996, IMMUNITY, V5, P115, DOI 10.1016/S1074-7613(00)80488-4; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Shimbara N, 1997, GENES CELLS, V2, P785, DOI 10.1046/j.1365-2443.1997.1610359.x; SNYDER HL, 1994, J EXP MED, V180, P2389, DOI 10.1084/jem.180.6.2389; Tanahashi N, 1997, GENES CELLS, V2, P195, DOI 10.1046/j.1365-2443.1997.d01-308.x; TANAKA K, 1988, J BIOL CHEM, V263, P16209; Tanaka K, 1997, ADV IMMUNOL, V64, P1, DOI 10.1016/S0065-2776(08)60885-8; TOKUNAGA F, 1994, J BIOL CHEM, V269, P17382; UENAKA A, 1994, J EXP MED, V180, P1599, DOI 10.1084/jem.180.5.1599; VANKAER L, 1994, IMMUNITY, V1, P533, DOI 10.1016/1074-7613(94)90043-4; WADA H, 1995, CANCER RES, V55, P4780; Yang B, 1996, J EXP MED, V183, P1545, DOI 10.1084/jem.183.4.1545; York IA, 1996, ANNU REV IMMUNOL, V14, P369, DOI 10.1146/annurev.immunol.14.1.369	39	38	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23062	23071		10.1074/jbc.273.36.23062	http://dx.doi.org/10.1074/jbc.273.36.23062			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722532	hybrid			2022-12-27	WOS:000075778100032
J	Wells, MJ; Blajchman, MA				Wells, MJ; Blajchman, MA			In vivo clearance of ternary complexes of vitronectin-thrombin-antithrombin is mediated by hepatic heparan sulfate proteoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED-PROTEIN; LOW-DENSITY-LIPOPROTEIN; PLASMINOGEN-ACTIVATOR INHIBITOR-1; HAMSTER OVARY CELLS; S-PROTEIN; UROKINASE RECEPTOR; ALPHA(2)-MACROGLOBULIN RECEPTOR; ALPHA-2-MACROGLOBULIN RECEPTOR; ENDOTHELIAL-CELLS; CELLULAR INTERNALIZATION	Thrombin is inhibited by its cognate plasma inhibitor antithrombin, through the formation of covalent thrombin-antithrombin (TAT) complexes that are found as ternary complexes with vitronectin (VN-TAT). To determine whether the metabolism of VN-TAT ternary complexes is different from that previously reported for binary TAT complexes, plasma clearance studies were done in rabbits using human VN-TAT. I-125-VN-TAT was shown to be cleared rapidly from the circulation (t(1/2 alpha) = 3.8 min) in a biphasic manner mainly by the liver. I-125-TAT had a similar initial clearance (t(1/2 alpha) = 5.3 min) but had a significantly faster beta-phase clearance (t(1/2 beta) = 42.8 min versus 85.4 min for VN-TAT; p = 0.005). Protamine sulfate and heparin abolished the rapid initial alpha-phase of I-125-VN-TAT clearance and reduced its liver-specific association and in vivo degradation. Heparin also reduced the alpha-phase clearance of I-125-TAT and was associated with the appearance of high molecular weight complexes, suggesting enhanced complex formation between VN and TAT. I-125-VN-TAT binding to HepG2 cells was reduced by competition with VN-TAT or heparin but to a much lesser extent in the presence of TAT. The binding of VN-TAT to HepG2 cells was not inhibited by competition with the low density lipoprotein receptor-related protein ligand, methylamine-alpha(2)-macroglobulin. I-125-VN-TAT binding was also inhibited by treating HepG2 cells with heparinase or by growing the cells in the presence of beta-D-xyloside. Finally, both heparin and chloroquine, but not methylamine-alpha(2)-macroglobulin, reduced the internalization and degradation of VN-TAT by HepG2 cells. Taken together, these data indicate the importance of VN in TAT metabolism and demonstrate that VN-TAT binds to liver-associated heparan sulfate proteoglycans, which mediate its internalization and subsequent intracellular degradation.	McMaster Univ, Med Ctr, Dept Pathol, Hamilton, ON L8N 3Z5, Canada	McMaster University	Blajchman, MA (corresponding author), McMaster Univ, Med Ctr, Dept Pathol, 1200 Main St W,HSC 2N34, Hamilton, ON L8N 3Z5, Canada.							BERRYMAN DE, 1995, J BIOL CHEM, V270, P24525, DOI 10.1074/jbc.270.41.24525; BU GJ, 1992, P NATL ACAD SCI USA, V89, P7427, DOI 10.1073/pnas.89.16.7427; CHAPPEL DA, 1993, J BIOL CHEM, V267, P25764; Chen H, 1996, J BIOL CHEM, V271, P15993, DOI 10.1074/jbc.271.27.15993; CONESE M, 1994, J BIOL CHEM, V269, P17886; CONESE M, 1995, J CELL BIOL, V131, P1609, DOI 10.1083/jcb.131.6.1609; Coutts JC, 1995, IMMUNOL CELL BIOL, V73, P584, DOI 10.1038/icb.1995.92; DAHLBACK B, 1985, BIOCHEMISTRY-US, V24, P2368, DOI 10.1021/bi00330a036; DEBOER HC, 1992, J BIOL CHEM, V267, P2264; deBoer HC, 1995, J BIOL CHEM, V270, P30733, DOI 10.1074/jbc.270.51.30733; DEBOER HC, 1993, J BIOL CHEM, V268, P1279; FLECK A, 1985, ANN CLIN BIOCHEM, V22, P33, DOI 10.1177/000456328502200103; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; GETTINS PGW, 1996, SERPINS STRUCTURE FU, P1; GODYNA S, 1995, J CELL BIOL, V129, P1403, DOI 10.1083/jcb.129.5.1403; GOUINTHIBAULT I, 1995, BRIT J HAEMATOL, V90, P669, DOI 10.1111/j.1365-2141.1995.tb05599.x; Horn IR, 1997, J BIOL CHEM, V272, P13608, DOI 10.1074/jbc.272.21.13608; ILL CR, 1985, J BIOL CHEM, V260, P5610; JOSLIN G, 1993, J BIOL CHEM, V268, P1886; Kanse SM, 1996, EXP CELL RES, V224, P344, DOI 10.1006/excr.1996.0144; Knauer MF, 1997, J BIOL CHEM, V272, P12261, DOI 10.1074/jbc.272.19.12261; Knauer MF, 1997, J BIOL CHEM, V272, P29039, DOI 10.1074/jbc.272.46.29039; Kounnas MZ, 1996, J BIOL CHEM, V271, P6523, DOI 10.1074/jbc.271.11.6523; Krapp A, 1996, J LIPID RES, V37, P926; LIU LB, 1995, THROMB HAEMOSTASIS, V73, P405; MIKHAILENKO I, 1995, J BIOL CHEM, V270, P9543, DOI 10.1074/jbc.270.16.9543; MIMURO J, 1989, J BIOL CHEM, V264, P936; NARITA M, 1995, J BIOL CHEM, V270, P24800, DOI 10.1074/jbc.270.42.24800; NYKJAER A, 1993, J BIOL CHEM, V268, P15048; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; PEAKE PW, 1997, CLIN EXP IMMUNOL, V106, P416; PERLMUTTER DH, 1990, P NATL ACAD SCI USA, V87, P3753, DOI 10.1073/pnas.87.10.3753; PIZZO SV, 1990, AM J MED, V87, pS10; PODACK ER, 1977, J IMMUNOL, V119, P2024; PODACK ER, 1986, J BIOL CHEM, V261, P7387; POLLER W, 1995, J BIOL CHEM, V270, P2841, DOI 10.1074/jbc.270.6.2841; PREISSNER KT, 1991, THROMB HAEMOSTASIS, V66, P123; Preissner KT, 1996, SEMIN THROMB HEMOST, V22, P165, DOI 10.1055/s-2007-999005; PREISSNER KT, 1987, J BIOL CHEM, V262, P12247; PREISSNER KT, 1988, THROMB HAEMOSTASIS, V60, P399; ROVELLI G, 1990, EUR J BIOCHEM, V192, P797, DOI 10.1111/j.1432-1033.1990.tb19293.x; SCHLESSINGER J, 1995, CELL, V83, P357, DOI 10.1016/0092-8674(95)90112-4; SHEFFIELD WP, 1994, THROMB RES, V75, P293, DOI 10.1016/0049-3848(94)90240-2; Sheffield WP, 1995, MOL BASIS THROMBOSIS, P355; Stefansson S, 1996, J BIOL CHEM, V271, P8215, DOI 10.1074/jbc.271.14.8215; STOCKMANN A, 1993, J BIOL CHEM, V268, P22874; STRICKLAND DK, 1995, FASEB J, V9, P890, DOI 10.1096/fasebj.9.10.7615159; Tomasini B R, 1991, Prog Hemost Thromb, V10, P269; TOMASINI BR, 1986, BLOOD, V68, P737; TOMASINI BR, 1988, BLOOD, V72, P903; vanMeijer M, 1997, THROMB HAEMOSTASIS, V77, P516; Warshawsky I, 1996, J BIOL CHEM, V271, P25873, DOI 10.1074/jbc.271.42.25873; Wells MJ, 1997, J BIOL CHEM, V272, P28574, DOI 10.1074/jbc.272.45.28574; WILLNOW TE, 1994, J BIOL CHEM, V269, P15827; Wu SM, 1996, ARCH BIOCHEM BIOPHYS, V326, P39, DOI 10.1006/abbi.1996.0044; Zhuang P, 1997, J BIOL CHEM, V272, P6858, DOI 10.1074/jbc.272.11.6858	56	22	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23440	23447		10.1074/jbc.273.36.23440	http://dx.doi.org/10.1074/jbc.273.36.23440			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722580	hybrid			2022-12-27	WOS:000075778100080
J	Cheng, C; Prince, LS; Snyder, PM; Welsh, MJ				Cheng, C; Prince, LS; Snyder, PM; Welsh, MJ			Assembly of the epithelial Na+ channel evaluated using sucrose gradient sedimentation analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL; CAENORHABDITIS-ELEGANS; ION CHANNELS; SUBUNITS; NEURODEGENERATION; EXPRESSION; STABILITY; CLONING; DOMAIN	Three subunits, alpha, beta, and gamma, contribute to the formation of the epithelial Naf channel. To investigate the oligomeric assembly of the channel complex, we used sucrose gradient sedimentation analysis to determine the sedimentation properties of individual subunits and heteromultimers comprised of multiple subunits. When the alpha subunit was expressed alone, it first formed an oligomeric complex with a sedimentation coefficient of 11 S, and then generated a higher order multimer of 25 S, In contrast, individual beta and gamma subunits predominately assembled into 11 S complexes. We obtained similar results with expression in cells and in vitro. When we co-expressed beta with alpha or with alpha plus gamma, the beta subunit assembled into a 25 S complex. Glycosylation of the alpha subunit was not required for assembly into a 25 S complex. We found that the cu subunit formed intra-chain disulfide bonds. Although such bonds were not required to generate an oligomeric complex, under nonreducing conditions the Lu subunit formed a complex that migrated more homogeneously at 25 S. This suggests that intra-chain disulfide bonds may stabilize the complex. These data suggest that the epithelial Na+ channel subunits form high order oligomeric complexes and that the ct subunit contains the information that facilitates such formation. Interestingly, the ability of the alpha, but not the beta or gamma, subunit to assemble into a 25 S homomeric complex correlates with the ability of these subunits to generate functional channels when expressed alone.	Univ Iowa, Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Program Mol Biol, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Internal Med Physiol & Biophys, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Pediat, Iowa City, IA 52242 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Welsh, MJ (corresponding author), Univ Iowa, Coll Med, Howard Hughes Med Inst, 500 EMRB, Iowa City, IA 52242 USA.	mjwelsh@blue.weeg.uiowa.edu		Welsh, Michael/0000-0002-1646-6206	NHLBI NIH HHS [HL07121] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams CM, 1997, J BIOL CHEM, V272, P27295, DOI 10.1074/jbc.272.43.27295; BENOS DJ, 1995, J MEMBRANE BIOL, V143, P1; BRODSKY FM, 1988, SCIENCE, V242, P1396, DOI 10.1126/science.2904698; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; Corey DP, 1996, SCIENCE, V273, P323, DOI 10.1126/science.273.5273.323; Coscoy S, 1998, J BIOL CHEM, V273, P8317, DOI 10.1074/jbc.273.14.8317; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Kosari F, 1998, J BIOL CHEM, V273, P13469, DOI 10.1074/jbc.273.22.13469; LINGUEGLIA E, 1993, FEBS LETT, V318, P95, DOI 10.1016/0014-5793(93)81336-X; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; MCEWEN CR, 1967, ANAL BIOCHEM, V20, P114, DOI 10.1016/0003-2697(67)90271-0; McNicholas CM, 1997, J GEN PHYSIOL, V109, P681, DOI 10.1085/jgp.109.6.681; North RA, 1996, CURR OPIN CELL BIOL, V8, P474, DOI 10.1016/S0955-0674(96)80023-8; PFAFFINGER PJ, 1995, J BIOL CHEM, V270, P28595, DOI 10.1074/jbc.270.48.28595; Pontiggia L, 1997, BIOCHEM BIOPH RES CO, V231, P755, DOI 10.1006/bbrc.1997.6188; SNYDER PM, 1994, J BIOL CHEM, V269, P24379; Snyder PM, 1998, J BIOL CHEM, V273, P681, DOI 10.1074/jbc.273.2.681; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Young BD, 1984, CENTRIFUGATION PRACT, P127	24	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22693	22700		10.1074/jbc.273.35.22693	http://dx.doi.org/10.1074/jbc.273.35.22693			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712899	hybrid			2022-12-27	WOS:000075616600075
J	Loetscher, P; Gong, JH; Dewald, B; Baggiolini, M; Clark-Lewis, I				Loetscher, P; Gong, JH; Dewald, B; Baggiolini, M; Clark-Lewis, I			N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOCYTE CHEMOATTRACTANT; CHROMOSOMAL LOCALIZATION; HIV-1 ENTRY; 7-TRANSMEMBRANE; INTERLEUKIN-8; INFECTION; CLONING; SDF-1; LESTR/FUSIN; INHIBITOR	Peptides corresponding to the N-terminal 9 residues of stromal cell-derived factor-1 (SDF-1) have SDF-1 activity. SDF-1, 1-8, 1-9, 1-9 dimer, and 1-17 induced intracellular calcium and chemotaxis in T lymphocytes and CEM cells and bound to CXC chemokine receptor 4 (CXCR4). The peptides had similar activities to SDF-1 but were less potent. Whereas native SDF-1 had half-maximal chemoattractant activity at 5 nM, the 1-9 dimer required 500 nM and was therefore 100 fold less potent, The 1-17 and a 1-9 monomer analog were 4 and 36-fold, respectively, less potent than the 1-9 dimer, Both the chemotactic and calcium response of the 1-9 dimer was inhibited by an antibody to CXCR4. The basis for the enhanced activity of the dimer form of SDF-1, 1-9 is uncertain, but it could involve an additional fortuitous binding site on the 1-9 peptide in addition to the normal SDF-1, 1-9 site. A 1-9 analog, 1-9[P2G] dimer, was found to be a CXCR4 antagonist, Overall this study shows that the N-terminal peptides are CXCR4 agonists or antagonists, and these could be leads for high affinity ligands.	Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ Bern, Theodor Kocher Inst, CH-3000 Bern, Switzerland; Univ Hosp Bern, Div Rheumatol, CH-3010 Bern, Switzerland	University of British Columbia; University of British Columbia; University of Bern; University of Bern; University Hospital of Bern	Clark-Lewis, I (corresponding author), Univ British Columbia, Biomed Res Ctr, 2222 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	ian@brc.ubc.ca						Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; CLARKLEWIS I, 1994, J BIOL CHEM, V269, P16075; CLARKLEWIS I, 1995, J LEUKOCYTE BIOL, V57, P703, DOI 10.1002/jlb.57.5.703; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Doranz BJ, 1997, J EXP MED, V186, P1395, DOI 10.1084/jem.186.8.1395; Endres MJ, 1996, CELL, V87, P745, DOI 10.1016/S0092-8674(00)81393-8; FEDERSPPIEL B, 1993, GENOMICS, V16, P707, DOI 10.1006/geno.1993.1251; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Gong JH, 1996, J BIOL CHEM, V271, P10521, DOI 10.1074/jbc.271.18.10521; Jones SA, 1997, J BIOL CHEM, V272, P16166, DOI 10.1074/jbc.272.26.16166; LOETSCHER M, 1994, J BIOL CHEM, V269, P232; LOETSCHER P, 1994, FASEB J, V8, P1055, DOI 10.1096/fasebj.8.13.7926371; Lowman HB, 1996, J BIOL CHEM, V271, P14344, DOI 10.1074/jbc.271.24.14344; Monteclaro FS, 1996, J BIOL CHEM, V271, P19084, DOI 10.1074/jbc.271.32.19084; Murakami T, 1997, J EXP MED, V186, P1389, DOI 10.1084/jem.186.8.1389; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; VONTSCHARNER V, 1986, NATURE, V324, P369, DOI 10.1038/324369a0	24	125	152	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22279	22283		10.1074/jbc.273.35.22279	http://dx.doi.org/10.1074/jbc.273.35.22279			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712844	hybrid			2022-12-27	WOS:000075616600020
J	Wang, KKW; Posmantur, R; Nath, R; McGinnis, K; Whitton, M; Talanian, RV; Glantz, SB; Morrow, JS				Wang, KKW; Posmantur, R; Nath, R; McGinnis, K; Whitton, M; Talanian, RV; Glantz, SB; Morrow, JS			Simultaneous degradation of alpha II- and beta II-spectrin by caspase 3 (CPP32) in apoptotic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEASE-I; SH-SY5Y NEUROBLASTOMA-CELLS; ICE/CED-3 PROTEASE; NEURONAL APOPTOSIS; CYSTEINE PROTEASE; FAMILY PROTEASES; BRAIN SPECTRIN; BINDING-SITE; FODRIN; CALPAIN	The degradation of alpha II- and beta II-spectrin during apoptosis in cultured human neuroblastoma SH-SY5Y cells was investigated. Immunofluorescent staining showed that the collapse of the cortical spectrin cytoskeleton is an early event following staurosporine challenge. This collapse correlated with the generation of a series of prominent spectrin breakdown products (BDPs) derived from both alpha II- and beta II-subunits. Major C-terminal alpha II-spectrin BDPs were detected at approximate to 150, 145, and 120 kDa (alpha II-BDP150, alpha II-BDP145, and alpha II-BDP120, respectively); major C-terminal PII-spectrin BDPs were at approximate to 110 and 85 kDa (beta II-BDP110 and beta II-BDP85, respectively). N-terminal sequencing of the major fragments produced in vitro by caspase 3 revealed that alpha II-BDP150 and alpha II-BDP120 were generated by cleavages at DETD1185*S-1186 and DSLD1478*S-1479, respectively. For PII-spectrin, a major caspase site was detected at DEVD1457*S-1458, and both beta II-BDP110 and beta II-BDP85 shared a common N-terminal sequence starting with Ser(1458). An additional cleavage site near the C terminus, at ETVD2146*S-2147, was found to account for beta II-BDP85. Studies using specific caspase or calpain inhibitors indicate that the pattern of spectrin breakdown during apoptosis differs from that during non-apoptotic cell death. We postulate that in concert with calpain, caspase rapidly targets critical sites in both alpha II- and PII-spectrin and thereby initiates a rapid dissolution of the spectrin-actin cortical cytoskeleton with apoptosis.	Warner Lambert Parke Davis, Parke Davis Pharmaceut Res, Dept Neurosci Therapeut, Lab Neurobiochem, Ann Arbor, MI 48105 USA; Warner Lambert Parke Davis, Parke Davis Pharmaceut Res, Dept Immunopathol, Ann Arbor, MI 48105 USA; Warner Lambert Parke Davis, Parke Davis Pharmaceut Res, Dept Chem, Ann Arbor, MI 48105 USA; Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48106 USA; BASF Biores Corp, Worcester, MA 01605 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA	Pfizer; Pfizer; Pfizer; University of Michigan System; University of Michigan; BASF; Yale University	Wang, KKW (corresponding author), Warner Lambert Parke Davis, Parke Davis Pharmaceut Res, Dept Neurosci Therapeut, Lab Neurobiochem, 2800 Plymouth Rd, Ann Arbor, MI 48105 USA.	Kevin.Wang@WL.com		Wang, Kevin/0000-0002-9343-6473				Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Armstrong RC, 1996, J BIOL CHEM, V271, P16850, DOI 10.1074/jbc.271.28.16850; BERTRAND R, 1994, EXP CELL RES, V211, P314, DOI 10.1006/excr.1994.1093; BUMP NJ, 1995, SCIENCE, V269, P1885, DOI 10.1126/science.7569933; Cryns VL, 1996, J BIOL CHEM, V271, P31277, DOI 10.1074/jbc.271.49.31277; DELCERRO S, 1994, NEUROSCI LETT, V167, P149, DOI 10.1016/0304-3940(94)91049-9; DENG HY, 1995, J CELL BIOL, V128, P71, DOI 10.1083/jcb.128.1.71; Devarajan P, 1996, CURR TOP MEMBR, V43, P97; DISTASI AMM, 1991, NEURON, V6, P445, DOI 10.1016/0896-6273(91)90252-U; Faleiro L, 1997, EMBO J, V16, P2271, DOI 10.1093/emboj/16.9.2271; Fraser A, 1996, CELL, V85, P781, DOI 10.1016/S0092-8674(00)81005-3; GLANTZ SB, 1996, LUNG BIOL HEALTH DIS, V95, P153; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Greidinger EL, 1996, FEBS LETT, V390, P299, DOI 10.1016/0014-5793(96)00678-3; HARRIS AS, 1986, J CELL BIOCHEM, V30, P51, DOI 10.1002/jcb.240300107; HARRIS AS, 1988, J BIOL CHEM, V263, P15754; HARRIS AS, 1989, J BIOL CHEM, V264, P17401; HARRIS AS, 1990, P NATL ACAD SCI USA, V87, P3009, DOI 10.1073/pnas.87.8.3009; HARRIS AS, 1988, J NEUROSCI, V8, P2640; HU RJ, 1992, J BIOL CHEM, V267, P18715; HU RJ, 1991, J BIOL CHEM, V266, P18200; KAMENS J, 1995, J BIOL CHEM, V270, P15250, DOI 10.1074/jbc.270.25.15250; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; LEE JK, 1993, J CELL BIOL, V123, P1797, DOI 10.1083/jcb.123.6.1797; LOKESHWAR VB, 1994, J CELL BIOL, V126, P1099, DOI 10.1083/jcb.126.4.1099; LOMBARDO CR, 1994, J BIOL CHEM, V269, P29212; LYNCH G, 1987, BRAIN RES BULL, V18, P809, DOI 10.1016/0361-9230(87)90220-6; LYNCH G, 1990, PROG BRAIN RES, V83, P233; MARTIN SJ, 1995, J BIOL CHEM, V270, P6425, DOI 10.1074/jbc.270.12.6425; MORROW JS, 1997, HDB PHYSL, V11, P485; MURACHI T, 1989, BIOCHEM INT, V18, P263; Na SQ, 1996, J BIOL CHEM, V271, P11209, DOI 10.1074/jbc.271.19.11209; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Nath R, 1996, NEUROREPORT, V8, P249, DOI 10.1097/00001756-199612200-00050; NELSON WJ, 1990, J CELL BIOL, V110, P349, DOI 10.1083/jcb.110.2.349; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Posmantur R, 1997, J NEUROCHEM, V68, P2328; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; SARIN A, 1994, J IMMUNOL, V153, P862; SARIN A, 1993, J EXP MED, V178, P1693, DOI 10.1084/jem.178.5.1693; SIMAN R, 1989, J NEUROSCI, V9, P1579; SMITH DB, 1986, P NATL ACAD SCI USA, V83, P8703, DOI 10.1073/pnas.83.22.8703; SPEICHER DW, 1993, J BIOL CHEM, V268, P4227; SQUIER MKT, 1994, J CELL PHYSIOL, V159, P229, DOI 10.1002/jcp.1041590206; Stabach PR, 1997, BIOCHEMISTRY-US, V36, P57, DOI 10.1021/bi962034i; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Vanags DM, 1996, J BIOL CHEM, V271, P31075, DOI 10.1074/jbc.271.49.31075; Vaux DL, 1996, P NATL ACAD SCI USA, V93, P2239, DOI 10.1073/pnas.93.6.2239; Wang KKW, 1996, ARCH BIOCHEM BIOPHYS, V331, P208, DOI 10.1006/abbi.1996.0300; Wang KKW, 1996, BIOTECHNIQUES, V20, P662; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Wang XD, 1996, EMBO J, V15, P1012, DOI 10.1002/j.1460-2075.1996.tb00438.x; Zhivotovsky B, 1997, BIOCHEM BIOPH RES CO, V230, P481, DOI 10.1006/bbrc.1996.6016	53	265	269	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22490	22497		10.1074/jbc.273.35.22490	http://dx.doi.org/10.1074/jbc.273.35.22490			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712874	hybrid			2022-12-27	WOS:000075616600050
J	Bosch, M; Gil, J; Bachs, O; Agell, N				Bosch, M; Gil, J; Bachs, O; Agell, N			Calmodulin inhibitor W13 induces sustained activation of ERK2 and expression of p21(cip1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; CELL-CYCLE ARREST; DUAL-SPECIFICITY PHOSPHATASE; NUCLEOTIDE EXCHANGE FACTOR; PROTEIN-KINASE ACTIVATION; DNA-POLYMERASE-ALPHA; SMOOTH-MUSCLE CELLS; MAP KINASE; TYROSINE KINASE; GENE-PRODUCT	One of the major signaling pathways by which extracellular signals induce cell proliferation and differentiation involves the activation of extracellular signal-regulated kinases (ERKs), Because calmodulin is essential for quiescent cells to enter cell cycle, the role of calmodulin on ERK2 activation was studied in cultured fibroblasts. Serum, phorbol esters, or active Ras induced ERK2 activation in NIH 3T3 fibroblasts. This activation was not inhibited by calmodulin blockade. Surprisingly, inhibition of calmodulin prior to fetal bovine serum addition prolonged activation of ERK2, Furthermore, inactivation of calmodulin in serum-starved cells induced ERK2 phosphorylation that was dependent on MAP kinase kinase (MEK). Inactivation of calmodulin in serum-starved cells also induced activation of Ras, Raf, and MEK. On the contrary, tyrosine phosphorylation of tyrosine kinase receptors was not observed. These results indicate that calmodulin inhibits ERK2 activation pathway at the level of Ras. Calmodulin inhibition induced overexpression of p21(cip1) which was dependent on MEK activity. We propose that inhibition of Ras by calmodulin prevents the activation of ERK2 at low serum concentration. Thus, entering into the cell cycle after serum addition would imply the overcoming of the inhibitory effect of calmodulin and consequently ERK2 activation. Furthermore, down-regulation of Ras by calmodulin may be also important to determine the duration of ERK2 activation and to prevent a high p21(cip1) expression that would lead to an inhibition of cell proliferation.	Univ Barcelona, Fac Med, Inst Invest Biomed August Pi & Sunyer, Dept Biol Cellular & Anat Patol, Barcelona 08036, Spain; Univ Barcelona, Dept Ciencies Fisiol 2, Barcelona 08907, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona	Agell, N (corresponding author), Univ Barcelona, Fac Med, Dept Cellular Biol, C-Casanova 143, Barcelona 08036, Spain.		Bosch, Marta/AAU-9099-2020; Agell, Neus/E-9640-2016	Agell, Neus/0000-0002-1205-6074; Gil, Joan/0000-0002-3686-3903; Bosch, Marta/0000-0003-3934-6781				AGELL A, CELL CALCIUM, V23, P115; AGELL N, 1995, CALCIUM CALMODULIN F; Baouz S, 1997, J BIOL CHEM, V272, P6671, DOI 10.1074/jbc.272.10.6671; BOYNTON AL, 1980, BIOCHEM BIOPH RES CO, V95, P745, DOI 10.1016/0006-291X(80)90849-9; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; CEN H, 1992, EMBO J, V11, P4007, DOI 10.1002/j.1460-2075.1992.tb05494.x; CHAFOULEAS JG, 1982, CELL, V28, P41, DOI 10.1016/0092-8674(82)90373-7; CHAFOULEAS JG, 1984, CELL, V36, P73, DOI 10.1016/0092-8674(84)90075-8; COFFER P, 1994, ONCOGENE, V9, P911; Cook SJ, 1997, J BIOL CHEM, V272, P13309, DOI 10.1074/jbc.272.20.13309; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Downward J, 1992, CURR OPIN GENET DEV, V2, P13, DOI 10.1016/S0959-437X(05)80315-6; Eguchi S, 1996, J BIOL CHEM, V271, P14169, DOI 10.1074/jbc.271.24.14169; EILAM Y, 1988, GEN MICROBIOL, V143, P1063; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; Fam NP, 1997, MOL CELL BIOL, V17, P1396, DOI 10.1128/MCB.17.3.1396; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; GUAN KL, 1995, J BIOL CHEM, V270, P7197, DOI 10.1074/jbc.270.13.7197; Guerrero C, 1996, ONCOGENE, V12, P1097; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; HARPER JW, 1993, CELL, V75, P805; HERGET T, 1994, EUR J BIOCHEM, V225, P549, DOI 10.1111/j.1432-1033.1994.t01-1-00549.x; HIDAKA H, 1981, P NATL ACAD SCI-BIOL, V78, P4354, DOI 10.1073/pnas.78.7.4354; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Joyal JL, 1997, J BIOL CHEM, V272, P15419, DOI 10.1074/jbc.272.24.15419; KAHAN C, 1992, J BIOL CHEM, V267, P13369; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; LOPEZGIRONA A, 1992, BIOCHEM BIOPH RES CO, V184, P1517, DOI 10.1016/S0006-291X(05)80055-5; LopezGirona A, 1995, BIOCHEM BIOPH RES CO, V217, P566, DOI 10.1006/bbrc.1995.2813; LOPEZGIRONA A, 1995, CELL CALCIUM, V18, P30, DOI 10.1016/0143-4160(95)90043-8; LORCA T, 1993, NATURE, V366, P270, DOI 10.1038/366270a0; LU KP, 1993, ENDOCR REV, V14, P40, DOI 10.1210/er.14.1.40; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Martin-Nieto J, 1998, BIOCHEMISTRY-US, V37, P227, DOI 10.1021/bi971765v; Mattingly RR, 1996, NATURE, V382, P268, DOI 10.1038/382268a0; MCKENZIE FR, 1998, IN PRESS ANAL BIOCH; MEDEMA JP, 1994, MOL CELL BIOL, V14, P7078, DOI 10.1128/MCB.14.11.7078; MELOCHE S, 1992, MOL ENDOCRINOL, V6, P845, DOI 10.1210/me.6.5.845; Mineo C, 1997, J BIOL CHEM, V272, P10345; MORRISON DK, 1995, METHOD ENZYMOL, V255, P301; Muthalif MM, 1996, J BIOL CHEM, V271, P30149, DOI 10.1074/jbc.271.47.30149; Porfiri E, 1996, J BIOL CHEM, V271, P5871, DOI 10.1074/jbc.271.10.5871; Pumiglia KM, 1997, P NATL ACAD SCI USA, V94, P448, DOI 10.1073/pnas.94.2.448; RASMUSSEN CD, 1989, EMBO J, V8, P73, DOI 10.1002/j.1460-2075.1989.tb03350.x; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; SANJOSE E, 1992, J BIOL CHEM, V267, P15237; Schulman H, 1993, CURR OPIN CELL BIOL, V5, P247, DOI 10.1016/0955-0674(93)90111-3; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; SHOU C, 1992, NATURE, V358, P351, DOI 10.1038/358351a0; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; TAKISHIMA K, 1991, P NATL ACAD SCI USA, V88, P2520, DOI 10.1073/pnas.88.6.2520; TAKUWA N, 1993, J BIOL CHEM, V268, P138; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; WARD Y, 1994, NATURE, V367, P651, DOI 10.1038/367651a0; WATMANN M, 1994, J BIOL CHEM, V269, P6695; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598	71	58	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					22145	22150		10.1074/jbc.273.34.22145	http://dx.doi.org/10.1074/jbc.273.34.22145			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705360	hybrid, Green Published			2022-12-27	WOS:000075492600094
J	Drmota, T; Novotny, J; Kim, GD; Eidne, KA; Milligan, G; Svoboda, P				Drmota, T; Novotny, J; Kim, GD; Eidne, KA; Milligan, G; Svoboda, P			Agonist-induced internalization of the G protein G(11)alpha and thyrotropin-releasing hormone receptors proceed on different time scales	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT PITUITARY-CELLS; DOWN-REGULATION; ALPHA-SUBUNITS; BETA(2)-ADRENERGIC RECEPTOR; ADRENERGIC-RECEPTORS; COUPLED RECEPTOR; PHOSPHOLIPASE-C; BETA-ARRESTIN; CHOLECYSTOKININ RECEPTOR; ACETYLCHOLINE-RECEPTOR	Using a combination of confocal immunofluorescence microscopy and subcellular fractionation, we demonstrate for the first time active internalization, trafficking, and down-regulation of a G protein alpha subunit subsequent to agonist occupation of a receptor, This proceeds on a much slower time scale than internalization of the corresponding receptor. In intact E2M11 HEK293 cells that express high levels of murine G(11)alpha and the rat thyrotropin-releasing hormone (TRH) receptor, the immunofluorescence signal of G(11)alpha was restricted almost exclusively to the plasma membrane. Exposure to TRH (10 mu M) resulted first in partial relocation of G(11)alpha to discrete, segregated patches within the plasma membrane (10-60 min). Further exposure to TRH caused internalization of G(11)alpha to discrete, punctate, intracellular bodies (2-4 h) and subsequently to a virtually complete loss of G(11)alpha from plasma membranes and the cells (8-16 h), Short-term treatment with TRH followed by wash-out of the ligand allowed G(11)alpha immunofluorescence to be restored to the plasma membrane within 12 h. In subcellular membrane fractions, G(11)alpha was centered on plasma membranes, and this was not altered by up to 1-2 h of incubation with TRH. Further exposure to TRH (2-4 h) resulted in transfer of a significant portion of G(11)alpha to light-vesicular and cytosol fractions. At longer time intervals (4-16 h), an overall decrease in G(11)alpha content was observed.	Acad Sci Czech Republ, Inst Physiol, CR-14220 Prague 4, Czech Republic; Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland; MRC, Reprod Biol Unit, Edinburgh EH3 9EW, Midlothian, Scotland	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; University of Glasgow	Svoboda, P (corresponding author), Acad Sci Czech Republ, Inst Physiol, Videnska 1083, CR-14220 Prague 4, Czech Republic.		Svoboda, Petr/C-2619-2012; Milligan, Graeme/F-9426-2011; Novotny, Jiri/B-2163-2012	Svoboda, Petr/0000-0002-3076-4672; Milligan, Graeme/0000-0002-6946-3519; Novotny, Jiri/0000-0002-6372-0131	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARAGAY AM, 1992, J BIOL CHEM, V267, P24983; ASHWORTH R, 1995, P NATL ACAD SCI USA, V92, P512, DOI 10.1073/pnas.92.2.512; Barak LS, 1997, MOL PHARMACOL, V51, P177, DOI 10.1124/mol.51.2.177; CHANG WJ, 1994, J CELL BIOL, V126, P127, DOI 10.1083/jcb.126.1.127; CROUCH MF, 1989, P NATL ACAD SCI USA, V86, P1776, DOI 10.1073/pnas.86.6.1776; CROUCH MF, 1991, FASEB J, V5, P200, DOI 10.1096/fasebj.5.2.1900794; DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Feron O, 1997, J BIOL CHEM, V272, P17744, DOI 10.1074/jbc.272.28.17744; Gaudriault G, 1997, J BIOL CHEM, V272, P2880, DOI 10.1074/jbc.272.5.2880; GERSHENGORN MC, 1994, ENDOCRINOLOGY, V94, P5; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GREEN A, 1990, J BIOL CHEM, V265, P5206; HARAGUCHI K, 1990, P NATL ACAD SCI USA, V87, P1208, DOI 10.1073/pnas.87.3.1208; HEIN L, 1994, J BIOL CHEM, V269, P27719; HINKLE PM, 1982, J BIOL CHEM, V257, P5462; Holtmann MH, 1996, J BIOL CHEM, V271, P23566, DOI 10.1074/jbc.271.38.23566; HSIEH KP, 1992, MOL ENDOCRINOL, V6, P1673, DOI 10.1210/me.6.10.1673; IBARRONDO J, 1995, P NATL ACAD SCI USA, V92, P8413, DOI 10.1073/pnas.92.18.8413; KIM GD, 1994, J BIOL CHEM, V269, P19933; KOBILKA B, 1992, ANNU REV NEUROSCI, V15, P87, DOI 10.1146/annurev.ne.15.030192.000511; LEVIS MJ, 1992, J CELL BIOL, V119, P1297, DOI 10.1083/jcb.119.5.1297; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; LOHSE MJ, 1993, BIOCHIM BIOPHYS ACTA, V1179, P171, DOI 10.1016/0167-4889(93)90139-G; MCKENZIE FR, 1990, J BIOL CHEM, V265, P17084; MILLIGAN G, 1993, TRENDS PHARMACOL SCI, V14, P413, DOI 10.1016/0165-6147(93)90064-Q; MITCHELL FM, 1991, FEBS LETT, V287, P171, DOI 10.1016/0014-5793(91)80043-3; MITCHELL FM, 1993, BIOCHEM J, V293, P495, DOI 10.1042/bj2930495; Molino M, 1997, J BIOL CHEM, V272, P6011, DOI 10.1074/jbc.272.9.6011; MOORE RH, 1995, J CELL SCI, V108, P2983; Muntz Kathryn H., 1994, Trends in Cell Biology, V4, P354, DOI 10.1016/0962-8924(94)90077-9; NEGISHI M, 1992, J BIOL CHEM, V267, P2364; NEUBIG RR, 1994, FASEB J, V8, P939, DOI 10.1096/fasebj.8.12.8088459; PALMER TM, 1995, J BIOL CHEM, V270, P16895, DOI 10.1074/jbc.270.28.16895; Petrou C, 1997, J BIOL CHEM, V272, P2326; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; Raposo G, 1994, Trends Cell Biol, V4, P418, DOI 10.1016/0962-8924(94)90096-5; Roettger BF, 1997, MOL PHARMACOL, V51, P357; ROETTGER BF, 1995, J CELL BIOL, V128, P1029, DOI 10.1083/jcb.128.6.1029; RuizGomez A, 1997, J BIOL CHEM, V272, P9601; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; SELLAR RE, 1993, J MOL ENDOCRINOL, V10, P199, DOI 10.1677/jme.0.0100199; SHAH BH, 1995, P NATL ACAD SCI USA, V92, P1886, DOI 10.1073/pnas.92.6.1886; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P9113, DOI 10.1073/pnas.87.23.9113; Svoboda P, 1996, MOL PHARMACOL, V49, P646; Tolbert LM, 1996, J BIOL CHEM, V271, P17335, DOI 10.1074/jbc.271.29.17335; VANDEWESTERLO E, 1995, BIOCHEM J, V310, P559, DOI 10.1042/bj3100559; VONZASTROW M, 1994, J BIOL CHEM, V269, P18448; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; WANG N, 1990, J BIOL CHEM, V265, P1239; WISE A, 1995, J BIOL CHEM, V270, P17196, DOI 10.1074/jbc.270.29.17196; YAJIMA Y, 1993, MOL CELL ENDOCRINOL, V92, P143, DOI 10.1016/0303-7207(93)90001-Z; YU SS, 1993, J BIOL CHEM, V268, P337; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	55	43	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21699	21707		10.1074/jbc.273.34.21699	http://dx.doi.org/10.1074/jbc.273.34.21699			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705305	hybrid			2022-12-27	WOS:000075492600039
J	Essler, M; Amano, M; Kruse, HJ; Kaibuchi, K; Weber, PC; Aepfelbacher, M				Essler, M; Amano, M; Kruse, HJ; Kaibuchi, K; Weber, PC; Aepfelbacher, M			Thrombin inactivates myosin light chain phosphatase via Rho and its target Rho kinase in human endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN-RHO; SMOOTH-MUSCLE MYOSIN; ACTIN STRESS FIBERS; ADP-RIBOSYLTRANSFERASE; FOCAL ADHESIONS; CYTOPLASMIC DIVISION; RECEPTOR ACTIVATION; PUTATIVE TARGET; GENE-PRODUCT; PHOSPHORYLATION	The role of Rho GTPase and its downstream targets Rho kinase and myosin light chain phosphatase in thrombin-induced endothelial cell contraction was investigated. The specific Rho inactivator C3-transferase from Clostridium botulinum as well as microinjection of the isolated Rho-binding domain of Rho kinase or active myosin light chain phosphatase abolished thrombin-stimulated endothelial cell contraction. Conversely, microinjection of constitutively active V14Rho, constitutively active catalytic domain of Rho kinase, or treatment with the phosphatase inhibitor tautomycin caused contraction. These data are consistent with the notion that thrombin activates Rho/Rho kinase to inactivate myosin light chain phosphatase in endothelial cells. In fact, we demonstrate that thrombin transiently inactivated myosin light chain phosphatase, and this correlated with a peak in myosin light chain phosphorylation. C3-transferase abolished the decrease in myosin light chain phosphatase activity as well as the subsequent increase in myosin light chain phosphorylation and cell contraction. These data suggest that thrombin activates the Rho/Rho kinase pathway to inactivate myosin light chain phosphatase as part of a signaling network that controls myosin light chain phosphorylation/contraction in human endothelial cells.	Univ Munich, Inst Prophylaxe & Epidemiol Kreislaufkrankheiten, D-80336 Munchen, Germany; Max Von Pettenkofer Inst Hyg & Med Microbiol, D-80336 Munchen, Germany; Nara Inst Sci & Technol, Div Signal Transduct, Nara 63001, Japan	University of Munich; University of Munich; Nara Institute of Science & Technology	Essler, M (corresponding author), Univ Munich, Inst Prophylaxe & Epidemiol Kreislaufkrankheiten, Pettenkoferstr 9, D-80336 Munchen, Germany.		Amano, Mutsuki/M-4820-2014	Amano, Mutsuki/0000-0002-0662-1524				AEPFELBACHER M, 1995, BIOCHEM J, V308, P853, DOI 10.1042/bj3080853; Aepfelbacher M, 1996, J IMMUNOL, V157, P5070; Aepfelbacher M, 1997, ARTERIOSCL THROM VAS, V17, P1623, DOI 10.1161/01.ATV.17.9.1623; AKTORIES K, 1987, FEBS LETT, V212, P109, DOI 10.1016/0014-5793(87)81566-1; ALESSI D, 1992, EUR J BIOCHEM, V210, P1023, DOI 10.1111/j.1432-1033.1992.tb17508.x; Allen WE, 1997, J CELL SCI, V110, P707; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; COHEN P, 1989, FEBS LETT, V250, P596, DOI 10.1016/0014-5793(89)80803-8; DILLON ST, 1995, METHOD ENZYMOL, V256, P174; FEIG LA, 1994, CURR OPIN CELL BIOL, V6, P204, DOI 10.1016/0955-0674(94)90137-6; FERNANDEZ A, 1990, J CELL BIOL, V111, P103, DOI 10.1083/jcb.111.1.103; Flatau G, 1997, NATURE, V387, P729, DOI 10.1038/42743; GLOMSET JA, 1994, ANNU REV CELL BIOL, V10, P181, DOI 10.1146/annurev.cellbio.10.1.181; GOECKELER ZM, 1995, J CELL BIOL, V130, P613, DOI 10.1083/jcb.130.3.613; Gohla A, 1998, J BIOL CHEM, V273, P4653, DOI 10.1074/jbc.273.8.4653; Gong MC, 1996, P NATL ACAD SCI USA, V93, P1340, DOI 10.1073/pnas.93.3.1340; Grand RJA, 1996, BIOCHEM J, V313, P353, DOI 10.1042/bj3130353; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; KISHI K, 1993, J CELL BIOL, V120, P1187, DOI 10.1083/jcb.120.5.1187; KOLODNEY MS, 1992, J CELL BIOL, V117, P73, DOI 10.1083/jcb.117.1.73; LAMARCHE N, 1994, TRENDS GENET, V10, P436, DOI 10.1016/0168-9525(94)90114-7; LAMPUGNANI MG, 1991, J CELL BIOL, V112, P479, DOI 10.1083/jcb.112.3.479; LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203; Leung T, 1996, MOL CELL BIOL, V16, P5313; Madaule P, 1995, FEBS LETT, V377, P243, DOI 10.1016/0014-5793(95)01351-2; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; MORII N, 1992, J BIOL CHEM, V267, P20921; NODA M, 1995, FEBS LETT, V367, P246, DOI 10.1016/0014-5793(95)00573-R; PATERSON CE, 1994, MICROVASC RES, V48, P212; PATERSON HF, 1990, J CELL BIOL, V111, P1001, DOI 10.1083/jcb.111.3.1001; Rabiet MJP, 1996, ARTERIOSCL THROM VAS, V16, P488, DOI 10.1161/01.ATV.16.3.488; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; ROSS R, 1976, NEW ENGL J MED, V295, P369, DOI 10.1056/NEJM197608122950707; SAADI S, 1995, J EXP MED, V181, P21, DOI 10.1084/jem.181.1.21; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; SEKINE A, 1989, J BIOL CHEM, V264, P8602; SELLERS JR, 1981, J BIOL CHEM, V256, P3137; SHIMIZU H, 1994, J BIOL CHEM, V269, P30407; SHIRAZI A, 1994, J BIOL CHEM, V269, P31598; TAKAISHI K, 1993, MOL CELL BIOL, V13, P1935; TAPON N, 1997, CURR OPIN CELL BIOL, V9, P89; TOMINAGA T, 1993, J CELL BIOL, V120, P1525; VERIN AD, 1995, AM J PHYSIOL, V269, pL199; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Watanabe G, 1996, SCIENCE, V271, P645, DOI 10.1126/science.271.5249.645; WYSOLMERSKI RB, 1990, P NATL ACAD SCI USA, V87, P16, DOI 10.1073/pnas.87.1.16	53	308	317	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21867	21874		10.1074/jbc.273.34.21867	http://dx.doi.org/10.1074/jbc.273.34.21867			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705325	hybrid			2022-12-27	WOS:000075492600059
J	Smith, CA; Baeten, J; Taylor, JS				Smith, CA; Baeten, J; Taylor, JS			The ability of a variety of polymerases to synthesize past site-specific cis-syn, trans-syn-II, (6-4), and Dewar photoproducts of thymidylyl-(3 '-> 5 ')-thymidine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T7 RNA-POLYMERASE; BACTERIOPHAGE-T7 DNA-POLYMERASE; THYMINE CYCLOBUTANE DIMER; SINGLE-TURNOVER KINETICS; CHAIN-REACTION ASSAY; HUMAN CELL-EXTRACTS; ESCHERICHIA-COLI; SKIN-CANCER; IN-VITRO; EXONUCLEASE ACTIVITY	The role of photoproduct structure, 3' --> 5' exonuclease activity, and processivity on polynucleotide synthesis past photoproducts of thymidylyl-(3' --> S')-thymidine was investigated. Both Moloney murine leukemia virus reverse transcriptase and 3' --> 5' exonuclease-deficient (exo(-)) Vent polymerase were blocked by all photoproducts, whereas Tag polymerase could slowly bypass the cis-syn dimer, T7 RNA polymerase was able to bypass all the photoproducts in the order cis-syn > Dewar > (6-4) > trans-syn-II. Klenow fragment could not bypass any of the photoproducts, but an exo- mutant could bypass the cis-syn dimer to a greater extent than the others. Likewise T7 DNA polymerase, composed of the T7 gene 5 protein and Escherichia call thioredoxin, was blocked by all the photoproducts, but the exo- mutant Sequenase 2.0 was able to bypass them all in the order cis-syn > Dewar > trans-syn-II > (6-4), No bypass occurred with an exo- gene 5 protein in the absence of the thioredoxin processivity factor. Bypass of the cis-syn and trans-syn-II products by Sequenase 2.0 was essentially non-mutagenic, whereas about 20% dTMP was inserted opposite the 5'-T of the Dewar photoproduct. A mechanism involving a transient abasic site is proposed to account for the preferential incorporation of dAMP opposite the 3'-T of the photoproducts.	Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL)	Taylor, JS (corresponding author), Washington Univ, Dept Chem, St Louis, MO 63130 USA.	taylor@wuchem.wustl.edu	Taylor, John-Stephen/AAA-3218-2020	Taylor, John-Stephen/0000-0002-8615-7257; Smith, Colin/0000-0001-5652-0855	NCI NIH HHS [CA40463] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA040463, R01CA040463] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AXELROD JD, 1989, NUCLEIC ACIDS RES, V17, P171, DOI 10.1093/nar/17.1.171; BANERJEE SK, 1990, J BACTERIOL, V172, P2105, DOI 10.1128/jb.172.4.2105-2112.1990; BANERJEE SK, 1988, P NATL ACAD SCI USA, V85, P8141, DOI 10.1073/pnas.85.21.8141; BARAK Y, 1995, J BIOL CHEM, V270, P24174, DOI 10.1074/jbc.270.41.24174; BELGUISEVALLADIER P, 1994, J MOL BIOL, V236, P151, DOI 10.1006/jmbi.1994.1125; BRASH DE, 1988, PHOTOCHEM PHOTOBIOL, V48, P59; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; CADET J, 1990, BIOORGANIC PHOTOCHEM, V1, P1; Carty MP, 1996, J BIOL CHEM, V271, P9637, DOI 10.1074/jbc.271.16.9637; CHANDRASEKHAR D, 1994, J MOL BIOL, V238, P319, DOI 10.1006/jmbi.1994.1295; Chary P, 1997, J BIOL CHEM, V272, P5805, DOI 10.1074/jbc.272.9.5805; CHEN YH, 1993, J BIOL CHEM, V268, P5849; CHOI DJ, 1994, BIOCHEMISTRY-US, V33, P780, DOI 10.1021/bi00169a020; CHRISTNER DF, 1994, BIOCHEMISTRY-US, V33, P14297, DOI 10.1021/bi00251a043; CLARK JM, 1989, BIOCHEMISTRY-US, V28, P775, DOI 10.1021/bi00428a054; COMESS KM, 1992, BIOCHEMISTRY-US, V31, P3975, DOI 10.1021/bi00131a013; DAY CL, 1989, THESIS WASHINGTON U; DERBYSHIRE V, 1988, SCIENCE, V240, P199, DOI 10.1126/science.2832946; DONAHUE BA, 1994, P NATL ACAD SCI USA, V91, P8502, DOI 10.1073/pnas.91.18.8502; DOSANJH MK, 1990, BIOCHEMISTRY-US, V29, P4698, DOI 10.1021/bi00471a026; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; EGER BT, 1992, BIOCHEMISTRY-US, V31, P9227, DOI 10.1021/bi00153a016; Fasman GD., 1975, HDB BIOCH MOL BIOL N, V1, P589; FREIDBERG EC, 1995, DNA REPAIR MUTAGENES; GIBBS PEM, 1993, J BACTERIOL, V175, P2607, DOI 10.1128/JB.175.9.2607-2612.1993; Goodman MF, 1997, P NATL ACAD SCI USA, V94, P10493, DOI 10.1073/pnas.94.20.10493; GREVATT PC, 1992, BIOCHEMISTRY-US, V31, P4181, DOI 10.1021/bi00132a005; GUSCHLBAUER W, 1991, NUCLEIC ACIDS RES, V19, P1753, DOI 10.1093/nar/19.8.1753; Hess MT, 1997, BIOCHEMISTRY-US, V36, P2332, DOI 10.1021/bi961689g; Holmquist GP, 1997, MUTAT RES-REV MUTAT, V386, P69, DOI 10.1016/S1383-5742(96)00045-2; HORSFALL MJ, 1994, J MOL BIOL, V235, P465, DOI 10.1006/jmbi.1994.1006; Horsfall MJ, 1997, J BACTERIOL, V179, P2835, DOI 10.1128/jb.179.9.2835-2839.1997; HRUSZKEWYCZ A, 1992, CARCINOGENESIS, V13, P2347, DOI 10.1093/carcin/13.12.2347; HUBER HE, 1987, J BIOL CHEM, V262, P16224; JIANG N, 1993, BIOCHEMISTRY-US, V32, P472, DOI 10.1021/bi00053a011; KALINOWSKI DP, 1992, NUCLEIC ACIDS RES, V20, P3485, DOI 10.1093/nar/20.13.3485; KAO JLF, 1993, CHEM RES TOXICOL, V6, P561, DOI 10.1021/tx00034a027; KEMMINK J, 1987, NUCLEIC ACIDS RES, V15, P4645, DOI 10.1093/nar/15.11.4645; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; KIM JK, 1995, PHOTOCHEM PHOTOBIOL, V62, P44, DOI 10.1111/j.1751-1097.1995.tb05236.x; LATHAM GJ, 1995, CHEM RES TOXICOL, V8, P422, DOI 10.1021/tx00045a014; LAWRENCE CW, 1990, MOL GEN GENET, V222, P166, DOI 10.1007/BF00283040; LAWRENCE CW, 1993, MUTAT RES, V299, P157, DOI 10.1016/0165-1218(93)90093-S; LECLERC JE, 1991, P NATL ACAD SCI USA, V88, P9685, DOI 10.1073/pnas.88.21.9685; LINDSLEY JE, 1994, BIOCHEMISTRY-US, V33, P764, DOI 10.1021/bi00169a018; LIU FT, 1978, BIOCHEMISTRY-US, V17, P4865, DOI 10.1021/bi00616a003; Liu J, 1996, BIOCHEMISTRY-US, V35, P14999, DOI 10.1021/bi961455x; LIVNEH Z, 1986, J BIOL CHEM, V261, P9526; MATTILA P, 1991, NUCLEIC ACIDS RES, V19, P4967, DOI 10.1093/nar/19.18.4967; McCarthy MJ, 1996, MUTAT RES-DNA REPAIR, V363, P57, DOI 10.1016/0921-8777(95)00061-5; MICHAELS ML, 1987, J BIOL CHEM, V262, P14648; MIKITA T, 1994, BIOCHEMISTRY-US, V33, P9195, DOI 10.1021/bi00197a023; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; MITCHELL DL, 1988, PHOTOCHEM PHOTOBIOL, V48, P51; MOORE PD, 1981, P NATL ACAD SCI-BIOL, V78, P110, DOI 10.1073/pnas.78.1.110; Moran S, 1997, J AM CHEM SOC, V119, P2056, DOI 10.1021/ja963718g; Mozzherin DJ, 1997, P NATL ACAD SCI USA, V94, P6126, DOI 10.1073/pnas.94.12.6126; NATARAJ AJ, 1995, PHOTOCHEM PHOTOBIOL, V62, P218, DOI 10.1111/j.1751-1097.1995.tb05262.x; ODAY CL, 1992, NUCLEIC ACIDS RES, V20, P5403, DOI 10.1093/nar/20.20.5403; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; PazElizur T, 1997, BIOCHEMISTRY-US, V36, P1766, DOI 10.1021/bi9621324; Peng W, 1996, BIOCHEMISTRY-US, V35, P10172, DOI 10.1021/bi960001x; SANCAR A, 1994, SCIENCE, V266, P1954, DOI 10.1126/science.7801120; SAUERBIER W, 1978, ANNU REV GENET, V12, P329, DOI 10.1146/annurev.ge.12.120178.001553; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SELBY CP, 1990, J BIOL CHEM, V265, P21330; SELBY CP, 1993, SCIENCE, V360, P53; SHIBUTANI S, 1993, CHEM RES TOXICOL, V6, P625, DOI 10.1021/tx00035a006; SHIBUTANI S, 1993, BIOCHEMISTRY-US, V32, P7531, DOI 10.1021/bi00080a027; Shibutani S, 1997, BIOCHEMISTRY-US, V36, P1755, DOI 10.1021/bi962275q; SLOANE DL, 1988, NUCLEIC ACIDS RES, V16, P6465, DOI 10.1093/nar/16.14.6465; SMITH CA, 1993, J BIOL CHEM, V268, P11143; Smith CA, 1996, BIOCHEMISTRY-US, V35, P4146, DOI 10.1021/bi951975c; Spector TI, 1997, J AM CHEM SOC, V119, P7095, DOI 10.1021/ja964372c; STRAUSS B, 1982, BIOCHIMIE, V64, P829, DOI 10.1016/S0300-9084(82)80138-7; STRAUSS BS, 1985, CANCER SURV, V4, P493; STRAUSS BS, 1991, BIOESSAYS, V13, P79, DOI 10.1002/bies.950130206; STRAUSS BS, 1990, CARCINOGENESIS, V11, P2103, DOI 10.1093/carcin/11.12.2103; SVOBODA DL, 1993, J BIOL CHEM, V268, P10694; SZYMKOWSKI DE, 1993, P NATL ACAD SCI USA, V90, P9823, DOI 10.1073/pnas.90.21.9823; TABOR S, 1987, J BIOL CHEM, V262, P16212; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TABOR S, 1989, J BIOL CHEM, V264, P6447; TAKESHITA M, 1987, J BIOL CHEM, V262, P10171; TAYLOR JS, 1990, BIOCHEMISTRY-US, V29, P1624, DOI 10.1021/bi00458a038; TAYLOR JS, 1990, BIOCHEMISTRY-US, V29, P8858, DOI 10.1021/bi00489a049; TAYLOR JS, 1994, ACCOUNTS CHEM RES, V27, P76, DOI 10.1021/ar00039a003; TAYLOR JS, 1988, BIOCHEMISTRY-US, V27, P7206, DOI 10.1021/bi00419a007; TAYLOR JS, 1995, PURE APPL CHEM, V67, P183, DOI 10.1351/pac199567010183; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P6298, DOI 10.1074/jbc.270.11.6298; WANG CI, 1992, BIOCHEMISTRY-US, V31, P3671, DOI 10.1021/bi00129a016; Wellinger RE, 1996, NUCLEIC ACIDS RES, V24, P1578, DOI 10.1093/nar/24.8.1578; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; ZHAO XD, 1995, BIOCHEMISTRY-US, V34, P1386, DOI 10.1021/bi00004a033; ZHOU W, 1994, BIOCHEMISTRY-US, V33, P14926, DOI 10.1021/bi00253a032; ZHOU W, 1995, CELL, V82, P577, DOI 10.1016/0092-8674(95)90030-6; ZIEGLER A, 1993, P NATL ACAD SCI USA, V90, P4216, DOI 10.1073/pnas.90.9.4216	97	50	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21933	21940		10.1074/jbc.273.34.21933	http://dx.doi.org/10.1074/jbc.273.34.21933			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705333	hybrid			2022-12-27	WOS:000075492600067
J	Beguin, P; Hasler, U; Beggah, A; Horisberger, JD; Geering, K				Beguin, P; Hasler, U; Beggah, A; Horisberger, JD; Geering, K			Membrane integration of Na,K-ATPase alpha-subunits and beta-subunit assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO TRANSLATION; NEWLY SYNTHESIZED POLYPEPTIDE; INTRACELLULAR-TRANSPORT; PROTEIN TRANSLOCATION; TRANSMEMBRANE HELICES; FUNCTIONAL EXPRESSION; HYDROPHOBIC SEGMENTS; PRIMARY SEQUENCE; TOPOLOGY; OLIGOMERIZATION	The control of membrane insertion of polytopic proteins is still poorly understood, We carried out in vivo translation/insertion experiments in Xenopus oocytes with combined wild type or mutant membrane segments of the alpha-subunit of the heterodimeric Na,K-ATPase linked to a glycosylation reporter sequence. We confirm that the four N-terminaI hydrophobic segments of the alpha-subunit behave as alternating signal anchor/stop transfer motifs necessary for two lipid-inserted membrane pairs, For the six C-terminal membrane segments, however, proper packing depends on specific sequence information and association with the beta-subunit, M5 is a very inefficient signal anchor sequence due to the presence of prolines and polar amino acids. Its correct membrane insertion is probably mediated by posttranslational hairpin formation with M6, which is favored by a proline pair in the connecting loop, M7 has partial signal anchor function, which may be mediated by the presence of glycine and glutamine residues, The formation of a transmembrane M7/M8 pair requires the association of the beta-subunit, which induces a conformational change in the connecting extracytoplasmic loop that favors M7/M8 packing, The formation of the M9/M10 pair appears to be predominantly mediated by the efficient stop transfer function of M10. Mutations that provide signal anchor function to M5, M7, and M9 abolish or impede the transport activity of the enzyme, These data illustrate the importance of specific amino acids near or within hydrophobic regions as well as of subunit oligomerization for correct topographical alignment that is necessary for proper folding and/or activity of oligomeric membrane proteins.	Univ Lausanne, Inst Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland	University of Lausanne	Geering, K (corresponding author), Univ Lausanne, Inst Pharmacol & Toxicol, Rue Bugnon 27, CH-1005 Lausanne, Switzerland.	kaethi.geering@ipharm.unil.ch	Horisberger, Jean-Daniel/A-2538-2009					ACKERMANN U, 1990, FEBS LETT, V269, P105, DOI 10.1016/0014-5793(90)81130-G; ANDERSEN JP, 1995, FEBS LETT, V359, P101, DOI 10.1016/0014-5793(95)00019-6; ARYSTARKHOVA E, 1995, J BIOL CHEM, V270, P8785, DOI 10.1074/jbc.270.15.8785; BAMBERG K, 1994, J BIOL CHEM, V269, P16909; BAYLE D, 1995, J BIOL CHEM, V270, P25678, DOI 10.1074/jbc.270.43.25678; Bayle D, 1997, J RECEPT SIGNAL TR R, V17, P29, DOI 10.3109/10799899709036593; Beguin P, 1997, EMBO J, V16, P4250, DOI 10.1093/emboj/16.14.4250; Colonna TE, 1997, J BIOL CHEM, V272, P12366, DOI 10.1074/jbc.272.19.12366; DALBEY RE, 1995, TRENDS CELL BIOL, V5, P380, DOI 10.1016/S0962-8924(00)89079-0; DEBER CM, 1997, MOL B INT U, P25; Gafvelin G, 1997, J BIOL CHEM, V272, P6119, DOI 10.1074/jbc.272.10.6119; Geering K, 1996, J CELL BIOL, V133, P1193, DOI 10.1083/jcb.133.6.1193; GEERING K, 1997, MOL B INT U, P173; GOLDSHLEGER R, 1995, BIOCHEMISTRY-US, V34, P8668, DOI 10.1021/bi00027a016; High S, 1997, TRENDS CELL BIOL, V7, P206; HOMAREDA H, 1989, MOL CELL BIOL, V9, P5742, DOI 10.1128/MCB.9.12.5742; JAISSER F, 1992, J BIOL CHEM, V267, P16895; JAISSER F, 1994, J GEN PHYSIOL, V103, P605, DOI 10.1085/jgp.103.4.605; JAUNIN P, 1993, J CELL BIOL, V123, P1751, DOI 10.1083/jcb.123.6.1751; Johnson AE, 1997, TRENDS CELL BIOL, V7, P90, DOI 10.1016/S0962-8924(97)01029-5; Karlish SJD, 1997, ANN NY ACAD SCI, V834, P30, DOI 10.1111/j.1749-6632.1997.tb52223.x; Lu Y, 1998, J BIOL CHEM, V273, P568, DOI 10.1074/jbc.273.1.568; LUTSENKO S, 1995, P NATL ACAD SCI USA, V92, P7936, DOI 10.1073/pnas.92.17.7936; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; NELSON RM, 1989, ANAL BIOCHEM, V180, P147, DOI 10.1016/0003-2697(89)90103-6; Ruddon RW, 1997, J BIOL CHEM, V272, P3125, DOI 10.1074/jbc.272.6.3125; SAKAGUCHI M, 1997, MOL B INT U, P135; VERREY F, 1989, AM J PHYSIOL, V256, pF1034, DOI 10.1152/ajprenal.1989.256.6.F1034; VONHEIJNE G, 1991, J MOL BIOL, V218, P499, DOI 10.1016/0022-2836(91)90695-3; WILLIAMS KA, 1991, BIOCHEMISTRY-US, V30, P8919, DOI 10.1021/bi00101a001; Xie YH, 1996, J BIOL CHEM, V271, P2563, DOI 10.1074/jbc.271.5.2563; XIE YH, 1995, J BIOL CHEM, V270, P11985, DOI 10.1074/jbc.270.20.11985; Zhang PJ, 1998, NATURE, V392, P835, DOI 10.1038/33959; [No title captured]	35	64	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24921	24931		10.1074/jbc.273.38.24921	http://dx.doi.org/10.1074/jbc.273.38.24921			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733799	hybrid			2022-12-27	WOS:000076007300091
J	Richardson, RM; Pridgen, BC; Haribabu, B; Ali, H; Snyderman, R				Richardson, RM; Pridgen, BC; Haribabu, B; Ali, H; Snyderman, R			Differential cross-regulation of the human chemokine receptors CXCR1 and CXCR2 - Evidence for time-dependent signal generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INTERLEUKIN-8 RECEPTOR; PLATELET-ACTIVATING-FACTOR; MUSCARINIC CHOLINERGIC RECEPTORS; CHEMOATTRACTANT RECEPTORS; PHOSPHOLIPASE-C; PROTEIN-KINASE; IL-8 RECEPTOR; GRO-GAMMA; PHOSPHORYLATION; DESENSITIZATION	Neutrophils and transfected RBL-2H3 cells were used to investigate the mechanism of cross-regulation of the human interleukin-8 (IL-8) receptors CXCR1 and CXCR2 by chemoattractants. In neutrophils, Ca2+ mobilization by the CXCR2-specific chemokine, growth-related oncogene alpha (Gro alpha), was desensitized by prior exposure to the chemoattractants N-formylated peptides (fMLP) or a complement cleavage product (C5a). In contrast, growth-related oncogene alpha did not desensitize the latter receptors. To investigate this phenomenon, CXCR2 was stably expressed in RBL-2H3 cells and mediated phosphoinositide hydrolysis, Ca2+ mobilization, chemotaxis, and secretion. In cells co-expressing CXCR2 and receptors for either C5a (C5aR) or fMLP (FR), CXCR2 was cross-phosphorylated and cross-desensitized by C5a and fMLP. However, neither C5aR nor FR was cross-phosphorylated or cross-desensitized by CXCR2 activation, although CXCR1 did mediate this process. Receptor internalization induced by IL-8 was more rapid and occurred at lower doses with CXCR2 than CXCR1, although both receptors mediated equipotent chemotaxis and exocytosis in RBL. Truncation of the cytoplasmic tail of CXCR2 (331T) prolonged its signaling relative to CXCR2, increased its resistance to internalization, and induced phospholipase D activation. 331T was resistant to homologous phosphorylation and cross-phosphorylation but not cross-desensitization of its Ca2+ mobilization by fMLP or C5a, indicating an inhibitory site distal to receptor/G protein coupling. In contrast to CXCR2, stimulation of 331T cross-desensitized Ca2+ mobilization by both FR and C5aR. CXCR2 and the mutant 331T induced phospholipase C beta(3) phosphorylation to an extent equivalent to that of CXCR1. Taken together, these results suggest that CXCR1 and CXCR2 bind IL-8 to produce a group of equipotent responses, but their ability to generate other signals, including receptor internalization, cross-desensitization, and phospholipase D activation, are very different. The latter phenomena apparently require prolonged receptor activation, which in the case of CXCR2 is precluded by rapid receptor phosphorylation and internalization. Thus, receptors coupling to identical G; proteins may trigger different cellular responses dependent on the length of their signaling time, which can be regulated by receptor phosphorylation.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University; Duke University	Richardson, RM (corresponding author), Duke Univ, Med Ctr, Dept Med, Box 3680, Durham, NC 27710 USA.		Bodduluri, Haribabu/A-2584-2010	Bodduluri, Haribabu/0000-0002-8261-3294	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL054166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038910, R29AI038910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE003738] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-54166] Funding Source: Medline; NIAID NIH HHS [AI-38910] Funding Source: Medline; NIDCR NIH HHS [DE-03738] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Ahuja SK, 1996, J BIOL CHEM, V271, P20545, DOI 10.1074/jbc.271.34.20545; Ali H, 1998, J BIOL CHEM, V273, P11012, DOI 10.1074/jbc.273.18.11012; Ali H, 1997, J BIOL CHEM, V272, P11706, DOI 10.1074/jbc.272.18.11706; ALI H, 1994, J BIOL CHEM, V269, P24557; ALI H, 1993, J BIOL CHEM, V268, P24247; AMATRUDA TT, 1993, J BIOL CHEM, V268, P10139; BAGGIOLINI M, 1994, IMMUNOL TODAY, V15, P127, DOI 10.1016/0167-5699(94)90156-2; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Blackwood RA, 1996, J LEUKOCYTE BIOL, V60, P88, DOI 10.1002/jlb.60.1.88; CHUNTHARAPAI A, 1995, J IMMUNOL, V155, P2587; DIDSBURY JR, 1991, P NATL ACAD SCI USA, V88, P11564, DOI 10.1073/pnas.88.24.11564; GEISER T, 1993, J BIOL CHEM, V268, P15419; Grimm MC, 1998, J EXP MED, V188, P317, DOI 10.1084/jem.188.2.317; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; HORUK R, 1994, IMMUNOL TODAY, V15, P169, DOI 10.1016/0167-5699(94)90314-X; Liu MY, 1996, NATURE, V382, P83, DOI 10.1038/382083a0; MUELLER SG, 1994, J BIOL CHEM, V269, P1973; Mueller SG, 1997, J BIOL CHEM, V272, P8207, DOI 10.1074/jbc.272.13.8207; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; PARISH CA, 1995, BIOCHEMISTRY-US, V34, P7722, DOI 10.1021/bi00023a019; Prado GN, 1996, J BIOL CHEM, V271, P19186, DOI 10.1074/jbc.271.32.19186; RICHARDON RM, 1995, J BIOL CHEM, V270, P27829, DOI 10.1074/jbc.270.46.27829; Richardson RM, 1996, J BIOL CHEM, V271, P28717, DOI 10.1074/jbc.271.45.28717; RICHARDSON RM, 1993, J BIOL CHEM, V268, P13650; Richardson RM, 1998, J BIOL CHEM, V273, P10690, DOI 10.1074/jbc.273.17.10690; RICHARDSON RM, 1995, BIOCHEMISTRY-US, V34, P14193, DOI 10.1021/bi00043a025; RICHARDSON RM, 1990, BIOCHEMISTRY-US, V29, P8555, DOI 10.1021/bi00489a008; SNYDERMAN R, 1984, ANNU REV IMMUNOL, V2, P257, DOI 10.1146/annurev.immunol.2.1.257; SNYDERMAN R, 1986, J LEUKOCYTE BIOL, V40, P785, DOI 10.1002/jlb.40.6.785; SNYDERMAN R, 1992, INFLAMMATION BASIC P, P421; TOMHAVE E, 1994, J IMMUNOL, V154, P3267; TRUETT AP, 1988, P NATL ACAD SCI USA, V85, P1549, DOI 10.1073/pnas.85.5.1549; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840	34	126	132	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23830	23836		10.1074/jbc.273.37.23830	http://dx.doi.org/10.1074/jbc.273.37.23830			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726994	hybrid			2022-12-27	WOS:000075893100035
J	Buchet, K; Godinot, C				Buchet, K; Godinot, C			Functional F1-ATPase essential in maintaining growth and membrane potential of human mitochondrial DNA-depleted rho degrees cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; ATP SYNTHASE; SACCHAROMYCES-CEREVISIAE; HEART-MITOCHONDRIA; ENZYME COMPLEX; H+-ATPASE; MONOCLONAL-ANTIBODIES; YEAST MITOCHONDRIA; MIT-MUTANTS; HELA-CELLS	F1-ATPase assembly has been studied in human rho degrees cells devoid of mitochondrial DNA (mtDNA), Since, in these cells, oxidative phosphorylation cannot provide ATP, their growth relies on glycolysis, Despite the absence of the mtDNA-coded F0 subunits 6 and 8, rho degrees cells possessed normal levels of F1-ATPase alpha and beta subunits, This F1-ATPase was functional and azide- or aurovertin-sensitive but oligomycin-insensitive. In addition, aurovertin decreased cell growth in rho degrees cells and also reduced their mitochondrial membrane potential, as measured by rhodamine 123 fluorescence. Therefore, a functional F1-ATPase was important to maintain the mitochondrial membrane potential and the growth of these rho degrees cells, Bongkrekic acid, a specific adenine nucleotide translocator (ANT) inhibitor, also reduced rho degrees cell growths and mitochondrial membrane potential. In conclusion, rho degrees cells need both a functional F1-ATPase and a functional ANT to maintain their mitochondrial membrane potential, which is necessary for their growth. ATP hydrolysis catalyzed by F1 must provide ADP(3-) at a sufficient rate to maintain a rapid exchange with the glycolytic ATP(4-) by ANT, this electrogenic exchange inducing a mitochondrial membrane potential efficient enough to sustain cell growth. However, since the effects of bongkrekic acid and of aurovertin were additive, other electrogenic pumps should cooperate with this pathway.	Univ Lyon 1, CNRS, UMR 5534, Ctr Genet Mol & Cellulaire, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Godinot, C (corresponding author), Univ Lyon 1, CNRS, UMR 5534, Ctr Genet Mol & Cellulaire, F-69622 Villeurbanne, France.	godinot@univ-lyon1.fr						ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; AVNER PR, 1973, EUR J BIOCHEM, V32, P312, DOI 10.1111/j.1432-1033.1973.tb02612.x; BERGMEYER HU, 1973, METHOD ENZYMAT AN, P1464; Bouzidi MF, 1996, BBA-MOL BASIS DIS, V1317, P199, DOI 10.1016/S0925-4439(96)00055-5; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; CHANG T, 1973, J BIOL CHEM, V248, P2746; CHEN LB, 1989, METHOD CELL BIOL, V29, P103; CHOO WM, 1985, BIOCHIM BIOPHYS ACTA, V806, P290, DOI 10.1016/0005-2728(85)90108-2; COLLINSON IR, 1994, J MOL BIOL, V242, P408; Enjolras N, 1997, MOL CELL BIOCHEM, V167, P113, DOI 10.1023/B:MCBI.0000009692.67331.d3; GASSER SM, 1982, J BIOL CHEM, V257, P3034; Giraud MF, 1997, EUR J BIOCHEM, V245, P813, DOI 10.1111/j.1432-1033.1997.00813.x; GRIFFITHS EJ, 1993, BIOCHEM J, V290, P489, DOI 10.1042/bj2900489; GRIVELL LA, 1989, EUR J BIOCHEM, V182, P477, DOI 10.1111/j.1432-1033.1989.tb14854.x; HADIKUSUMO RG, 1988, BIOCHIM BIOPHYS ACTA, V933, P212, DOI 10.1016/0005-2728(88)90072-2; HERZBERG NH, 1993, EUR J CELL BIOL, V61, P400; HUNDAL T, 1984, J BIOENERG BIOMEMBR, V16, P535, DOI 10.1007/BF00743244; KOLAROV J, 1974, FEBS LETT, V45, P320, DOI 10.1016/0014-5793(74)80871-9; LARDY HA, 1969, ANNU REV BIOCHEM, V38, P991, DOI 10.1146/annurev.bi.38.070169.005015; LI K, 1995, AM J PHYSIOL-CELL PH, V269, pC1265, DOI 10.1152/ajpcell.1995.269.5.C1265; Linnett P E, 1979, Methods Enzymol, V55, P472; Martinus RD, 1996, EUR J BIOCHEM, V240, P98, DOI 10.1111/j.1432-1033.1996.0098h.x; MARZUKI S, 1989, BIOCHIM BIOPHYS ACTA, V975, P222, DOI 10.1016/S0005-2728(89)80252-X; MORADIAMELI M, 1983, P NATL ACAD SCI-BIOL, V80, P6167, DOI 10.1073/pnas.80.20.6167; MORAIS R, 1994, CANCER RES, V54, P3889; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; NIJTMANS LGJ, 1995, BBA-MOL CELL RES, V1265, P117, DOI 10.1016/0167-4889(94)00203-Q; NORAIS N, 1991, J BIOL CHEM, V266, P16541; ORIAN JM, 1984, J BIOENERG BIOMEMBR, V16, P561, DOI 10.1007/BF00743246; PAUL MF, 1989, EUR J BIOCHEM, V185, P163, DOI 10.1111/j.1432-1033.1989.tb15098.x; PEREIRADASILVA L, 1993, ARCH BIOCHEM BIOPHYS, V304, P310, DOI 10.1006/abbi.1993.1355; PETIT JM, 1994, EUR J BIOCHEM, V220, P871, DOI 10.1111/j.1432-1033.1994.tb18690.x; PULLMAN ME, 1960, J BIOL CHEM, V235, P3322; Saito K, 1997, BIOL PHARM BULL, V20, P345; SANDRI G, 1985, ARCH BIOCHEM BIOPHYS, V239, P595, DOI 10.1016/0003-9861(85)90729-5; SKOWRONEK P, 1992, BIOCHEM BIOPH RES CO, V187, P991, DOI 10.1016/0006-291X(92)91295-2; Suzuki CK, 1997, TRENDS BIOCHEM SCI, V22, P118, DOI 10.1016/S0968-0004(97)01020-7; Taanman JW, 1996, BBA-MOL BASIS DIS, V1315, P199, DOI 10.1016/0925-4439(95)00127-1; TSUZUKI T, 1983, GENE, V25, P223, DOI 10.1016/0378-1119(83)90226-3; TZAGOLOFF A, 1986, ANNU REV BIOCHEM, V55, P249, DOI 10.1146/annurev.bi.55.070186.001341	41	194	195	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					22983	22989		10.1074/jbc.273.36.22983	http://dx.doi.org/10.1074/jbc.273.36.22983			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722521	hybrid			2022-12-27	WOS:000075778100021
J	Kas, K; Voz, ML; Hensen, K; Meyen, E; Van de Ven, WJM				Kas, K; Voz, ML; Hensen, K; Meyen, E; Van de Ven, WJM			Transcriptional activation capacity of the novel PLAG family of zinc finger proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; CELLS; IDENTIFICATION; TRANSLOCATIONS; ADENOMAS; DOMAINS; REGION; TUMORS; YEAST; GLAND	We have isolated and characterized two novel cDNAs encoding C2H2 zinc finger proteins showing high sequence homology to PLAG1, a protein ectopically activated by promoter swapping or promoter substitution in pleomorphic adenomas with chromosomal abnormalities at chromosome 8q12, PLAG1 and the two new PLAG1 family members (PLAGL1 and PLAGL2) constitute a novel subfamily of zinc finger proteins that recognize DNA and/or RNA. To examine the potential of the three human proteins to modulate transcription, we constructed several PLAG/GAL4 DNA binding domain fusion proteins and measured their ability to activate transcription of a reporter gene construct in different mammalian cell lines and in yeast. Although the carboxyl-terminal part of PLAGL1 shows strong overall transcriptional activity in mesenchymal (COS-1) and epithelial cells (293), both PLAG1 and PLAGL2 transactivate in mesenchymal cells only if depleted from a repressing region. This effect is less profound in epithelial cells. These data suggest that the activation in pleomorphic adenomas of PLAG1 most likely results in uncontrolled activation of downstream target genes.	Katholieke Univ Leuven, Ctr Human Genet, Mol Oncol Lab, B-3000 Louvain, Belgium; Flanders Interuniv Inst Biotechnol, B-3000 Louvain, Belgium	KU Leuven	Kas, K (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Mol Oncol Lab, Herestr 49, B-3000 Louvain, Belgium.	koen.kas@med.kuleuven.ac.be						Abdollahi A, 1997, CANCER RES, V57, P2029; Abdollahi A, 1997, ONCOGENE, V14, P1973, DOI 10.1038/sj.onc.1201034; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BOGUSKI MS, 1995, TRENDS BIOCHEM SCI, V20, P295, DOI 10.1016/S0968-0004(00)89051-9; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; EVANS RM, 1988, CELL, V52, P1, DOI 10.1016/0092-8674(88)90522-3; Gietz RD, 1995, METHOD MOL CELL BIOL, V5, P255; Kas K, 1997, NAT GENET, V15, P170, DOI 10.1038/ng0297-170; Kas K, 1997, GENOMICS, V43, P349, DOI 10.1006/geno.1997.4819; Mao SF, 1997, J BIOL CHEM, V272, P5594, DOI 10.1074/jbc.272.9.5594; Milner J, 1997, NATURE, V386, P772, DOI 10.1038/386772a0; PEERS B, 1994, MOL ENDOCRINOL, V8, P1798, DOI 10.1210/me.8.12.1798; PIELER T, 1994, MOL BIOL REP, V20, P1, DOI 10.1007/BF00999848; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; SADOWSKI I, 1992, GENE, V118, P137, DOI 10.1016/0378-1119(92)90261-M; SANDROS J, 1990, CANCER GENET CYTOGEN, V44, P153, DOI 10.1016/0165-4608(90)90042-9; Spengler D, 1997, EMBO J, V16, P2814, DOI 10.1093/emboj/16.10.2814; TRIEZENBERG SJ, 1995, CURR OPIN GENET DEV, V5, P190, DOI 10.1016/0959-437X(95)80007-7; Voz ML, 1998, ONCOGENE, V16, P1409, DOI 10.1038/sj.onc.1201660	19	124	135	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23026	23032		10.1074/jbc.273.36.23026	http://dx.doi.org/10.1074/jbc.273.36.23026			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722527	hybrid			2022-12-27	WOS:000075778100027
J	Matsumoto, K; Kataoka, H; Date, K; Nakamura, T				Matsumoto, K; Kataoka, H; Date, K; Nakamura, T			Cooperative interaction between alpha and beta chains of hepatocyte growth factor on c-Met receptor confers ligand-induced receptor tyrosine phosphorylation and multiple biological responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL MOTILITY; EPITHELIAL-CELLS; MAMMARY-GLAND; FACTOR GENE; HGF; IDENTIFICATION; PURIFICATION; ANTAGONIST; EXPRESSION; DIFFERENTIATION	Hepatocyte growth factor (HGF) is a heterodimeric molecule composed of the alpha-chain containing the N-terminal hairpin domain, four kringle domains, and the serine protease-like beta-chain, We prepared HGF/NK4 and HGF/beta from the entire HGF after single-cut digestion with elastase. HGF/NK4 contains the N-terminal hairpin and four kringle domains, while HGF/beta is composed of the C-terminal 16 amino acids of the alpha-chain and the entire beta-chain, linked by a disulfide bridge. HGF/NK4 competitively inhibited the binding of I-125-RGF to the receptor, and affinity cross-linking analysis indicated that HGF/NK4 alone can bind to the c-Met receptor. In contrast, HGF/beta alone did not competitively inhibit the binding of I-125-HGF to the receptor and did not bind to the c-Met/HGF receptor. Scatchard analysis and affinity cross-linking experiments indicated that HGF/beta specifically binds to c-Met in the presence of HGF/NK4 but not HGF/NK2, Neither HGF/NK4 nor HGF/beta alone induced mitogenic, motogenic (cell scattering), and morphogenic (induction of branching tubulogenesis) responses; however, HGF/beta did induce these biological responses in the presence of HGF/NK4. Consistent with these results, although neither HGF/NK4 alone nor HGF/beta alone induced tyrosine phosphorylation of the c-Met/HGF receptor, HGF/beta induced tyrosine phosphorylation of the receptor when c-Met/HGF receptor was occupied by HGF/NK4. These results indicate that HGF/beta binds to the c-Met/HGF receptor that is occupied by HGF/NK4 and induces receptor tyrosine phosphorylation and the subsequent biological activities of HGF. We propose that there exists a unique cooperative interaction between alpha- and beta-chains, this interaction leading to alpha-chain-dependent receptor tyrosine phosphorylation and subsequent biological responses.	Osaka Univ, Sch Med, Biomed Res Ctr, Div Biochem, Osaka 5650871, Japan	Osaka University	Nakamura, T (corresponding author), Osaka Univ, Sch Med, Biomed Res Ctr, Div Biochem, Osaka 5650871, Japan.		MATSUMOTO, Kunio/D-8441-2015	MATSUMOTO, Kunio/0000-0002-6532-4482				BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; BOROS P, 1995, LANCET, V345, P293, DOI 10.1016/S0140-6736(95)90279-1; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; CHAN AML, 1991, SCIENCE, V254, P1382, DOI 10.1126/science.1720571; Cioce V, 1996, J BIOL CHEM, V271, P13110, DOI 10.1074/jbc.271.22.13110; Date K, 1997, FEBS LETT, V420, P1, DOI 10.1016/S0014-5793(97)01475-0; DONATE LE, 1994, PROTEIN SCI, V3, P2378, DOI 10.1002/pro.5560031222; GALIMI F, 1994, J CELL BIOL, V127, P1743, DOI 10.1083/jcb.127.6.1743; GOHDA E, 1988, J CLIN INVEST, V81, P414, DOI 10.1172/JCI113334; Grano M, 1996, P NATL ACAD SCI USA, V93, P7644, DOI 10.1073/pnas.93.15.7644; GRANT DS, 1993, P NATL ACAD SCI USA, V90, P1937, DOI 10.1073/pnas.90.5.1937; HARTMANN G, 1992, P NATL ACAD SCI USA, V89, P11574, DOI 10.1073/pnas.89.23.11574; ITAKURA Y, 1994, CANCER LETT, V83, P235, DOI 10.1016/0304-3835(94)90325-5; LOKKER NA, 1992, EMBO J, V11, P2503, DOI 10.1002/j.1460-2075.1992.tb05315.x; LOKKER NA, 1993, J BIOL CHEM, V268, P17145; Maina F, 1996, CELL, V87, P531, DOI 10.1016/S0092-8674(00)81372-0; MATSUMOTO K, 1991, BIOCHEM BIOPH RES CO, V181, P691, DOI 10.1016/0006-291X(91)91246-9; Matsumoto K, 1997, BIOCHEM BIOPH RES CO, V239, P639, DOI 10.1006/bbrc.1997.7517; MIYAZAWA K, 1991, EUR J BIOCHEM, V197, P15, DOI 10.1111/j.1432-1033.1991.tb15876.x; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NAKAMURA T, 1987, FEBS LETT, V224, P311, DOI 10.1016/0014-5793(87)80475-1; NOJI S, 1990, BIOCHEM BIOPH RES CO, V173, P42, DOI 10.1016/S0006-291X(05)81018-6; OKIGAKI M, 1992, BIOCHEMISTRY-US, V31, P9555, DOI 10.1021/bi00155a007; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Schwall RH, 1996, J CELL BIOL, V133, P709, DOI 10.1083/jcb.133.3.709; SEKI T, 1990, BIOCHEM BIOPH RES CO, V172, P321, DOI 10.1016/S0006-291X(05)80212-8; SILVAGNO F, 1995, ARTERIOSCL THROM VAS, V15, P1857, DOI 10.1161/01.ATV.15.11.1857; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; SORIANO JV, 1995, J CELL SCI, V108, P413; Takai K, 1997, BLOOD, V89, P1560, DOI 10.1182/blood.V89.5.1560.1560_1560_1565; TAKEBAYASHI T, 1995, J CELL BIOL, V129, P1411, DOI 10.1083/jcb.129.5.1411; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Wang MH, 1997, J BIOL CHEM, V272, P16999, DOI 10.1074/jbc.272.27.16999; WEIDNER KM, 1995, P NATL ACAD SCI USA, V92, P2597, DOI 10.1073/pnas.92.7.2597; Yamada Akira, 1995, Biomedical Research (Tokyo), V16, P105; YANG YM, 1995, J CELL BIOL, V131, P215, DOI 10.1083/jcb.131.1.215; ZARNEGAR R, 1995, J CELL BIOL, V129, P1177, DOI 10.1083/jcb.129.5.1177; ZARNEGAR R, 1989, CANCER RES, V49, P3314; ZHU H, 1994, J BIOL CHEM, V269, P29943	41	80	91	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					22913	22920		10.1074/jbc.273.36.22913	http://dx.doi.org/10.1074/jbc.273.36.22913			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722511	hybrid			2022-12-27	WOS:000075778100011
J	Choice, CV; Howard, MJ; Poy, MN; Hankin, MH; Najjar, SM				Choice, CV; Howard, MJ; Poy, MN; Hankin, MH; Najjar, SM			Insulin stimulates pp120 endocytosis in cells co-expressing insulin receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; ENDOGENOUS SUBSTRATE; INTERNALIZATION; SIGNAL; RECOGNITION; SEQUENCE; DOMAIN	pp120, a substrate of the insulin receptor tyrosine kinase, is a plasma membrane glycoprotein that is ex pressed in the hepatocyte as two spliced isoforms differing by the presence (full-length) or absence (truncated) of most of the intracellular domain including all phosphorylation sites. Go-expression of full-length pp120, but not its phosphorylation-defective isoforms, increased receptor-mediated insulin endocytosis and degradation in NIH 3T3 fibroblasts. We, herein, examined whether internalization of pp120 is required to mediate its effect on insulin endocytosis. The amount of full-length pp120 expressed at the cell surface membrane, as measured by biotin labeling, markedly decreased in response to insulin only when insulin receptors were coexpressed. In contrast, when phosphorylation-defective pp120 mutants were co-expressed, the amount of pp120 expressed at the cell surface did not decrease in response to insulin. Indirect immunofluorescence analysis revealed that upon insulin treatment of cells co-expressing insulin receptors, full-length, but not truncated, pp120 co-localized with alpha-adaptin in the adaptor protein complex that anchors endocytosed proteins to clathrin-coated pits. This suggests that full-length pp120 is part of a complex of proteins required for receptor-mediated insulin endocytosis and that formation of this complex is regulated by insulin-induced pp120 phosphorylation by the receptor tyrosine kinase. In vitro GST binding assays and co-immunoprecipitation experiments in intact cells further revealed that pp120 did not bind directly to the insulin receptor and that its association with the receptor may be mediated by other cellular proteins.	Med Coll Ohio, Dept Pharmacol & Therapeut, Toledo, OH 43614 USA; Med Coll Ohio, Dept Anat & Neurobiol, Toledo, OH 43614 USA		Najjar, SM (corresponding author), Med Coll Ohio, Dept Pharmacol & Therapeut, 3025 Arlington Ave,HSci Bldg,Rm 270, Toledo, OH 43614 USA.	snajjar@mco.edu	Poy, Matthew/F-6914-2017	Poy, Matthew/0000-0002-4904-2426	NICHD NIH HHS [HD28184] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028184, R55HD028184] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BACKER JM, 1990, J BIOL CHEM, V265, P14828; CARPENTIER JL, 1993, HISTOCHEMISTRY, V100, P169, DOI 10.1007/BF00269090; CARPENTIER JL, 1993, J CELL BIOL, V122, P1243, DOI 10.1083/jcb.122.6.1243; FORMISANO P, 1995, J BIOL CHEM, V270, P24073, DOI 10.1074/jbc.270.41.24073; GOLDBERG RI, 1987, J CELL PHYSIOL, V133, P203, DOI 10.1002/jcp.1041330202; GORDEN P, 1978, SCIENCE, V200, P782, DOI 10.1126/science.644321; HARI J, 1987, J BIOL CHEM, V262, P15341; KTISTAKIS NT, 1990, J CELL BIOL, V111, P1393, DOI 10.1083/jcb.111.4.1393; LARKIN JM, 1983, CELL, V33, P273, DOI 10.1016/0092-8674(83)90356-2; LiCalzi S, 1997, AM J PHYSIOL-ENDOC M, V273, pE801, DOI 10.1152/ajpendo.1997.273.4.E801; NAJJAR SM, 1995, BIOCHEMISTRY-US, V34, P9341, DOI 10.1021/bi00029a009; NAJJAR SM, 1993, J BIOL CHEM, V268, P1201; Rapoport I, 1997, EMBO J, V16, P2240, DOI 10.1093/emboj/16.9.2240; ROBINSON MS, 1987, J CELL BIOL, V104, P887, DOI 10.1083/jcb.104.4.887; SALAMOV AA, 1995, J MOL BIOL, V247, P11, DOI 10.1006/jmbi.1994.0116; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; SMITH RM, 1991, J BIOL CHEM, V266, P17522; THOMAS DC, 1994, J BIOL CHEM, V269, P15732; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; YAMADA K, 1995, J BIOL CHEM, V270, P3115, DOI 10.1074/jbc.270.7.3115	20	34	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22194	22200		10.1074/jbc.273.35.22194	http://dx.doi.org/10.1074/jbc.273.35.22194			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712832	hybrid			2022-12-27	WOS:000075616600008
J	Collier, B; Goobar-Larsson, L; Sokolowski, M; Schwartz, S				Collier, B; Goobar-Larsson, L; Sokolowski, M; Schwartz, S			Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogenous ribonucleoprotein K and Poly(rC)-binding proteins 1 and 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NEGATIVE REGULATORY ELEMENT; 3' UNTRANSLATED REGION; LATE MESSENGER-RNAS; AU-RICH; POLIOVIRUS RNA; NUCLEAR; REPLICATION; POLYMERASE; EXPRESSION	Human papillomavirus (HPV) type 16 belongs to the group of "high risk" BPV types that are frequently detected in anogenital cancers. The expression of HPV-16 late genes encoding the virus capsid proteins L1 and L2 is restricted to terminally differentiated epithelial cells in the superficial layers of the squamous epithelium. We have previously identified negative elements in the 3' end of L2 RNA that act in cis to reduce mRNA utilization without substantially affecting mRNA levels. The experiments reported here demonstrate the interaction of cellular proteins with an inhibitory sequence present in the coding region of the L2 mRNA. Using RNA gel shift assays and UV cross-linking, we have detected three cellular proteins interacting specifically with the sense strand of the L2 mRNA, two of which were identified as heterogeneous ribonucleoprotein K (hnRNP K) and the poly(rC) binding- protein (PCBP). Recombinant hnRNP K, PCBP-1, and PCBP-2 that were over expressed in bacteria and partially purified bound to the HPV-16 L2 mRNA in a sequence-specific manner. Interestingly, PCBP-1, PCBP-2, and hnRNP K specifically and efficiently inhibited translation of the HPV-16 L2 mRNA in vitro. Therefore, these proteins may play an important role in the regulation of HPV-16 late gene expression and virus production in vivo.	Univ Uppsala, Ctr Biomed, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden	Uppsala University	Schwartz, S (corresponding author), Univ Uppsala, Ctr Biomed, Dept Med Biochem & Microbiol, Husargatan 3,Box 582, S-75123 Uppsala, Sweden.	Stefan.Schwartz@imim.uu.se		Sokolowski, Marcus/0000-0003-3931-1810				BILLAKANTI SR, 1996, HUMAN PAPILLOMAVIRUS; Blyn LB, 1997, J VIROL, V71, P6243, DOI 10.1128/JVI.71.8.6243-6246.1997; CHOW LT, 1994, INTERVIROLOGY, V37, P150, DOI 10.1159/000150373; Dejgaard K, 1996, EUR J BIOCHEM, V241, P425, DOI 10.1111/j.1432-1033.1996.00425.x; Denisenko ON, 1996, J BIOL CHEM, V271, P27701, DOI 10.1074/jbc.271.44.27701; DietrichGoetz W, 1997, P NATL ACAD SCI USA, V94, P163, DOI 10.1073/pnas.94.1.163; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DILLNER L, 1991, J VIROL, V65, P6862, DOI 10.1128/JVI.65.12.6862-6871.1991; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; FURTH PA, 1994, MOL CELL BIOL, V14, P5278, DOI 10.1128/MCB.14.8.5278; FURTH PA, 1991, J VIROL, V65, P5806, DOI 10.1128/JVI.65.11.5806-5812.1991; Gamarnik AV, 1997, RNA, V3, P882; HAGENSEE ME, 1996, PAPILLOMAVIRUS REV C, P85; Heino P, 1995, VIROLOGY, V214, P349, DOI 10.1006/viro.1995.0044; HOWLEY PM, 1996, VIROLOGY, V2, P2045; KENNEDY IM, 1991, J VIROL, V65, P2093, DOI 10.1128/JVI.65.4.2093-2097.1991; LAIMINS LA, 1993, INFECT AGENT DIS, V2, P74; LEFFERS H, 1995, EUR J BIOCHEM, V230, P447, DOI 10.1111/j.1432-1033.1995.tb20581.x; LUUKKONEN BGM, 1995, J VIROL, V69, P4086, DOI 10.1128/JVI.69.7.4086-4094.1995; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; MATUNIS MJ, 1992, MOL CELL BIOL, V12, P164, DOI 10.1128/MCB.12.1.164; MEYERS C, 1996, PAPILLOMAVIRUS REV C, P79; MYER VE, 1996, EMBO J, V15, P2130; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; ROSS J, 1995, MICROBIOL REV, V59, P15; SCHWARTZ S, 1997, SEMIN VIROL, V8, P1; SEEDORF K, 1985, VIROLOGY, V145, P181, DOI 10.1016/0042-6822(85)90214-4; SHAH KV, 1996, FIELDS VIROLOGY, V2, P2077; Sokolowski M, 1997, ONCOGENE, V15, P2303, DOI 10.1038/sj.onc.1201415; Sokolowski M, 1998, J VIROL, V72, P1504, DOI 10.1128/JVI.72.2.1504-1515.1998; STANLEY MA, 1994, ANTIVIR RES, V24, P1, DOI 10.1016/0166-3542(94)90047-7; TAN W, 1995, J VIROL, V69, P2932, DOI 10.1128/JVI.69.5.2932-2945.1995; TAN W, 1995, J VIROL, V69, P5607, DOI 10.1128/JVI.69.9.5607-5620.1995; Zhao CP, 1996, J VIROL, V70, P3659, DOI 10.1128/JVI.70.6.3659-3667.1996; zur Hausen H, 1996, BIOCHIM BIOPHYS ACTA, V1288, P55	36	165	172	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22648	22656		10.1074/jbc.273.35.22648	http://dx.doi.org/10.1074/jbc.273.35.22648			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712894	hybrid			2022-12-27	WOS:000075616600070
J	Dong, JM; Leung, T; Manser, E; Lim, L				Dong, JM; Leung, T; Manser, E; Lim, L			cAMP-induced morphological changes are counteracted by the activated RhoA small GTPase and the Rho kinase ROK alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN-RHO; NEURO-BLASTOMA CELLS; ACTIN STRESS FIBERS; LYSOPHOSPHATIDIC ACID; CYCLIC-AMP; GROWTH-FACTOR; RECEPTOR ACTIVATION; LEUKOCYTE ADHESION; FOCAL ADHESIONS; FAMILY GTPASES	Dramatic transient changes resulting in a stellate morphology are induced in many cell types on treatment with agents that enhance intracellular cAMP levels. Thrombin fully protects cells from this inductive effect of cAMP through the thrombin receptor. The protective effect of thrombin was shown to be Rho dependent. Clostridium botulinum C3 exoenzyme, which inactivates RhoA functions, abolished the ability of thrombin to protect cells fi om responding to increased cAMP levels. A constitutively activated RhoA(V14) mutant protein also prevented cells from responding to cAMP. RhoA can be specifically phosphorylated at Ser-188 by the cAMP-activated protein kinase A (PKA). We demonstrate that RhoA(V14A188), which cannot be phosphorylated by PKA in vitro, is more effective than RhoA(V14) in preventing cells from responding to cAMP and in inducing actin stress fiber formation. This suggests that PEA phosphorylation of RhoA impairs its biological activity in vivo. ROK alpha, a RhoA-associated serine/threonine kinase can also prevent cells from responding to cAMP with shape changes. Phosphorylation of RhoA by PI(A in vitro decreases the binding of RhoA to ROK alpha. These results indicate that RhoA and cAMP have antagonistic roles in regulating cellular morphology and suggest that cAMP-mediated down-regulation of RhoA binding to its effector ROKa! may be involved in this antagonism.	Glaxo IMCB Grp, Inst Mol & Cell Biol, Singapore 117609, Singapore; UCL, Inst Neurol, London WC1N 1PJ, England	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); GlaxoSmithKline; University of London; University College London	Lim, L (corresponding author), Glaxo IMCB Grp, Inst Mol & Cell Biol, 30 Med Dr, Singapore 117609, Singapore.		Manser, Edward/ABD-2301-2020					Allen WE, 1997, J CELL SCI, V110, P707; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; BAORTO DM, 1992, J CELL BIOL, V117, P357, DOI 10.1083/jcb.117.2.357; BIEDLER JL, 1984, P AM ASSOC CANC RES, V25, P41; CAVANAUGH KP, 1990, J NEUROCHEM, V54, P1735, DOI 10.1111/j.1471-4159.1990.tb01228.x; CICCARONE V, 1989, CANCER RES, V49, P219; EGAN JJ, 1991, J CELL BIOCHEM, V45, P101, DOI 10.1002/jcb.240450117; GOLDMAN JE, 1984, BRAIN RES, V306, P85, DOI 10.1016/0006-8993(84)90358-5; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; JALINK K, 1992, J CELL BIOL, V118, P411, DOI 10.1083/jcb.118.2.411; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; JALINK K, 1993, CELL GROWTH DIFFER, V4, P247; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; KREISBERG JI, 1984, KIDNEY INT, V25, P874, DOI 10.1038/ki.1984.104; LAMB NJC, 1988, J CELL BIOL, V106, P1955, DOI 10.1083/jcb.106.6.1955; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Laudanna C, 1996, SCIENCE, V271, P981, DOI 10.1126/science.271.5251.981; Laudanna C, 1997, J BIOL CHEM, V272, P24141, DOI 10.1074/jbc.272.39.24141; Leung T, 1996, MOL CELL BIOL, V16, P5313; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Lim L, 1996, SEMIN CELL DEV BIOL, V7, P699, DOI 10.1006/scdb.1996.0086; Lim L, 1996, EUR J BIOCHEM, V242, P171, DOI 10.1111/j.1432-1033.1996.0171r.x; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; MOOLENAAR WH, 1995, CURR OPIN CELL BIOL, V7, P203, DOI 10.1016/0955-0674(95)80029-8; NISHIYAMA T, 1994, MOL CELL BIOL, V14, P2447, DOI 10.1128/MCB.14.4.2447; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1993, EMBO J, V12, P5151, DOI 10.1002/j.1460-2075.1993.tb06210.x; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; ROSS RA, 1983, J NATL CANCER I, V71, P741; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; SUIDAN HS, 1992, NEURON, V8, P363, DOI 10.1016/0896-6273(92)90302-T; Tigyi G, 1996, J NEUROCHEM, V66, P549; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V	39	228	232	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22554	22562		10.1074/jbc.273.35.22554	http://dx.doi.org/10.1074/jbc.273.35.22554			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712882	hybrid			2022-12-27	WOS:000075616600058
J	Eichler, J; Rinard, K; Wickner, W				Eichler, J; Rinard, K; Wickner, W			Endogenous SecA catalyzes preprotein translocation at SecYEG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI SECA; PLASMA-MEMBRANE; PROTEIN TRANSLOCATION; CYTOPLASMIC MEMBRANE; STEPWISE MOVEMENT; ATP BINDING; PHOSPHOLIPIDS; INSERTION; PROOMPA; DOMAIN	SecA is found in the cytosol and bound to the plasma membrane of Escherichia coli. Binding occurs either with high affinity at SecYEG or with low affinity to lipid. Domains of 65 and 30 kDa of SecYEG-bound SecA insert into the membrane upon interaction with preprotein and ATP. Azide blocks preprotein translocation, in vivo and in vitro, through interacting with SecA and preventing SecA deinsertion. This provides a measure of the translocation relevance of each form of SecA membrane association. We now report that azide acts exclusively on SecA that is cycling at SecYEG and has no effect on SecA lipid associations. SecA molecules recovered with sucrose gradient-purified inner membrane vesicles ("endogenous" SecA) support translocation at the same rate as "added" SecA molecules bound at SecYEG. Both endogenous and added SecA yield the same proteolytic fragments, which are distinct from those obtained from SecA once it has inserted into membranes at SecYEG or from SecA at lipidic sites. Endogenous and added SecA differ, however, in their resistance to urea extraction. The translocation supported by either endogenous or added SecA is blocked by azide or by antibody to SecY. We conclude that SecA functions in preprotein translocation only through cycling at SecYEG.	Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Wickner, W (corresponding author), Dartmouth Med Sch, Dept Biochem, 7200 Vail, Hanover, NH 03755 USA.		EICHLER, JERRY/F-2351-2012	EICHLER, JERRY/0000-0001-9409-8026				BREUKINK E, 1992, BIOCHEMISTRY-US, V31, P1119, DOI 10.1021/bi00119a021; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; CABELLI RJ, 1991, J BIOL CHEM, V266, P24420; Chen XC, 1996, J BIOL CHEM, V271, P29698, DOI 10.1074/jbc.271.47.29698; Chen XC, 1998, J BACTERIOL, V180, P527, DOI 10.1128/JB.180.3.527-537.1998; CROOKE E, 1988, CELL, V54, P1003, DOI 10.1016/0092-8674(88)90115-8; CUNNINGHAM K, 1989, P NATL ACAD SCI USA, V86, P8630, DOI 10.1073/pnas.86.22.8630; CUNNINGHAM K, 1989, EMBO J, V8, P955, DOI 10.1002/j.1460-2075.1989.tb03457.x; DEVRIJE T, 1988, NATURE, V334, P173, DOI 10.1038/334173a0; DOLAN KM, 1991, J BIOL CHEM, V266, P23329; DOUVILLE K, 1995, J BIOL CHEM, V270, P20106, DOI 10.1074/jbc.270.34.20106; Duong F, 1997, EMBO J, V16, P4871, DOI 10.1093/emboj/16.16.4871; Duong F, 1997, EMBO J, V16, P2756, DOI 10.1093/emboj/16.10.2756; Duong F, 1997, CELL, V91, P567, DOI 10.1016/S0092-8674(00)80444-4; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Eichler J, 1997, EMBO J, V16, P2188, DOI 10.1093/emboj/16.9.2188; EICHLER J, 1997, P NATL ACAD SCI USA, V90, P620; HARDY SJS, 1991, SCIENCE, V251, P439, DOI 10.1126/science.1989077; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; HENDRICK JP, 1991, J BIOL CHEM, V266, P24596; JOLY JC, 1993, EMBO J, V12, P255, DOI 10.1002/j.1460-2075.1993.tb05651.x; KIM YJ, 1994, CELL, V78, P845; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; LILL R, 1989, EMBO J, V8, P961, DOI 10.1002/j.1460-2075.1989.tb03458.x; Matsumoto G, 1997, EMBO J, V16, P6384, DOI 10.1093/emboj/16.21.6384; Nishiyama KI, 1996, CELL, V85, P71, DOI 10.1016/S0092-8674(00)81083-1; OLIVER DB, 1990, P NATL ACAD SCI USA, V87, P8227, DOI 10.1073/pnas.87.21.8227; Price A, 1996, J BIOL CHEM, V271, P31580, DOI 10.1074/jbc.271.49.31580; Ramamurthy V, 1997, J BIOL CHEM, V272, P23239, DOI 10.1074/jbc.272.37.23239; Sato K, 1997, J BIOL CHEM, V272, P5880, DOI 10.1074/jbc.272.9.5880; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; SHINKAI A, 1991, J BIOL CHEM, V266, P5827; Snyders S, 1997, J BIOL CHEM, V272, P11302; Uchida K, 1995, J BIOL CHEM, V270, P30862, DOI 10.1074/jbc.270.52.30862; ULBRANDT ND, 1992, J BIOL CHEM, V267, P15184; van der Does C, 1998, BIOCHEMISTRY-US, V37, P201, DOI 10.1021/bi972105t; van der Wolk JPW, 1997, EMBO J, V16, P7297, DOI 10.1093/emboj/16.24.7297; vanderDoes C, 1996, MOL MICROBIOL, V22, P619, DOI 10.1046/j.1365-2958.1996.d01-1712.x; VANVOORTS F, 1998, IN PRESS BIOCHEMISTR; WATANABE M, 1989, P NATL ACAD SCI USA, V86, P1895, DOI 10.1073/pnas.86.6.1895; WEISS JB, 1988, P NATL ACAD SCI USA, V85, P8978, DOI 10.1073/pnas.85.23.8978	42	34	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21675	21681		10.1074/jbc.273.34.21675	http://dx.doi.org/10.1074/jbc.273.34.21675			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705302	hybrid			2022-12-27	WOS:000075492600036
J	Natochin, M; Granovsky, AE; Artemyev, NO				Natochin, M; Granovsky, AE; Artemyev, NO			Identification of effector residues on photoreceptor G protein, transducin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; HETEROTRIMERIC G-PROTEIN; PHOSPHODIESTERASE GAMMA-SUBUNIT; ROD OUTER SEGMENTS; ALPHA-SUBUNIT; CGMP-PHOSPHODIESTERASE; CRYSTAL-STRUCTURE; ADENYLYL-CYCLASE; BINDING-SITES; RGS PROTEIN	Transducin is a photoreceptor-specific heterotrimeric GTP-binding protein that plays a key role in the vertebrate visual transduction cascade, Here, using scanning site-directed mutagenesis of the chimeric G alpha(t)/G alpha(11);, alpha-subunit (G alpha(t/i)), we identified G alpha(t) residues critical for interaction with the effector enzyme, rod cGMP phosphodiesterase (PDE). Our evidence suggests that residue Ile(208) in the switch II region directly interacts with the effector in the active GTP-bound conformation of G alpha(t). Residues Arg(201), Arg(204), and Trp(207) are essential for the conformation-dependent, G alpha(t)/effector interaction either via direct contacts with the inhibitory PDE gamma-subunit or by forming an effector-competent conformation through the communication network between switch II and the switch III/alpha 3-helix domain of G alpha(t). Residues His(244),and Asn(247) in the alpha 3 helix of G alpha(t) are responsible for the conformatiom-independent effector-specific interaction. Insertion of these residues rendered the G alpha(t/i) chimera with the ability to bind PDE gamma-subunit and stimulate PDE activity approaching that of native G alpha(t). Comparative analysis of the interactions of G alpha(t/i) mutants with PDE and RGS16 revealed two adjacent but distinct interfaces on transducin. This indicates a possibility for a functional trimeric complex, RGS/G alpha/effector, that may play a central role in turn-off mechanisms of G protein signaling systems, particularly in phototransduction.	Univ Iowa, Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa	Artemyev, NO (corresponding author), Univ Iowa, Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA.		Alex, Granovsky/EUV-7323-2022	Artemyev, Nikolai/0000-0002-5266-6854	NATIONAL EYE INSTITUTE [R01EY010843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER; NEI NIH HHS [EY-10843] Funding Source: Medline; NIDDK NIH HHS [DK-25295] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARSHAVSKY VY, 1991, J BIOL CHEM, V266, P18530; ARTEMYEV NO, 1992, BIOCHEM J, V283, P273, DOI 10.1042/bj2830273; ARTEMYEV NO, 1992, J BIOL CHEM, V267, P25067; ARTEMYEV NO, 1993, J BIOL CHEM, V268, P23611; Artemyev NO, 1997, BIOCHEMISTRY-US, V36, P4188, DOI 10.1021/bi963002y; BERLOT CH, 1992, CELL, V68, P911, DOI 10.1016/0092-8674(92)90034-A; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; CHABRE M, 1989, EUR J BIOCHEM, V179, P255, DOI 10.1111/j.1432-1033.1989.tb14549.x; Chen CH, 1997, J BIOL CHEM, V272, P8679, DOI 10.1074/jbc.272.13.8679; Chen CK, 1996, P NATL ACAD SCI USA, V93, P12885, DOI 10.1073/pnas.93.23.12885; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Faurobert E, 1997, P NATL ACAD SCI USA, V94, P2945, DOI 10.1073/pnas.94.7.2945; FAUROBERT E, 1993, EMBO J, V12, P4191, DOI 10.1002/j.1460-2075.1993.tb06103.x; FUNG BKK, 1983, J BIOL CHEM, V258, P503; Grishina G, 1997, J BIOL CHEM, V272, P20619, DOI 10.1074/jbc.272.33.20619; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; Iiri T, 1997, P NATL ACAD SCI USA, V94, P5656, DOI 10.1073/pnas.94.11.5656; ITOH H, 1991, J BIOL CHEM, V266, P16226; KLEUSS C, 1987, J CHROMATOGR, V407, P281, DOI 10.1016/S0021-9673(01)92625-1; KLEUSS C, 1994, P NATL ACAD SCI USA, V91, P9828, DOI 10.1073/pnas.91.21.9828; Koelle MR, 1997, CURR OPIN CELL BIOL, V9, P143, DOI 10.1016/S0955-0674(97)80055-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Li QB, 1997, J BIOL CHEM, V272, P21673, DOI 10.1074/jbc.272.35.21673; Liu Y, 1996, J BIOL CHEM, V271, P26900, DOI 10.1074/jbc.271.43.26900; Mittal R, 1996, SCIENCE, V271, P1413, DOI 10.1126/science.271.5254.1413; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; Natochin M, 1998, J BIOL CHEM, V273, P4300, DOI 10.1074/jbc.273.8.4300; Natochin M, 1997, J BIOL CHEM, V272, P17444, DOI 10.1074/jbc.272.28.17444; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; RARICK HM, 1992, SCIENCE, V256, P1031, DOI 10.1126/science.1317058; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; SPICKOFSKY N, 1994, NAT STRUCT BIOL, V1, P771, DOI 10.1038/nsb1194-771; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; THOMPSON WJ, 1971, BIOCHEMISTRY-US, V10, P311; Venkatakrishnan G, 1996, J BIOL CHEM, V271, P5066; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; YAMANAKA G, 1985, BIOCHEMISTRY-US, V24, P8094, DOI 10.1021/bi00348a039; YAMAZAKI A, 1988, METHOD ENZYMOL, V159, P702; Yan YB, 1997, J BIOL CHEM, V272, P11924, DOI 10.1074/jbc.272.18.11924; YARFITZ S, 1994, J BIOL CHEM, V269, P14329	52	34	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21808	21815		10.1074/jbc.273.34.21808	http://dx.doi.org/10.1074/jbc.273.34.21808			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705319	hybrid			2022-12-27	WOS:000075492600053
J	Scott, DA; de Souza, W; Benchimol, M; Zhong, L; Lu, HG; Moreno, SNJ; Docampo, R				Scott, DA; de Souza, W; Benchimol, M; Zhong, L; Lu, HG; Moreno, SNJ; Docampo, R			Presence of a plant-like proton-pumping pyrophosphatase in acidocalcisomes of Trypanosoma cruzi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATING INORGANIC PYROPHOSPHATASE; SUBSTRATE-BINDING SUBUNIT; VACUOLAR MEMBRANE; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; CYTOPLASMIC PH; CALCIUM-PUMP; CA2+ RELEASE; H+-ATPASE; TONOPLAST	The vacuolar-type proton-translocating pyrophosphatase (V-H+-PPase) is an enzyme previously described in detail only in plants. This paper-demonstrates its presence in the trypanosomatid Trypanosoma cruzi. Pyrophosphate promoted organellar acidification in permeabilized amastigotes, epimastigotes, and trypomastigotes of T. cruzi. This activity was stimulated by K+ ions and was inhibited by Na+ ions and pyrophosphate analogs, as is the plant activity. Separation of epimastigote extracts on Percoll gradients yielded a dense fraction that contained H+-PPase activity measured both by proton uptake and phosphate release but lacked markers for mitochondria, lysosomes, glycosomes, cytosol, and plasma membrane. Antiserum raised against specific sequences of the plant V-H+-RPase cross-reacted with a T. cruzi protein, which was also detectable in the dense Percoll fraction. The organelles in this fraction appeared by electron microscopy to consist mainly of acidocalcisomes (acidic calcium storage organelles). This identification was confirmed by x-ray microanalysis. Immunofluorescence and immunoelectron microscopy indicated that the V-H+-PPase was located in the plasma membrane and acidocalcisomes of the three different forms of the parasite. Pyrophosphate was able to drive calcium uptake in permeabilized T, cruzi, This uptake depended upon a proton gradient and was reversed by a specific V-H+-PPase inhibitor. Our results imply that the phylogenetic distribution of V-H+-PPases is much wider than previously perceived but that the enzyme has a unique subcellular location in trypanosomes.	Univ Illinois, Coll Vet Med, Dept Pathobiol, Mol Parasitol Lab, Urbana, IL 61802 USA; Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil	University of Illinois System; University of Illinois Urbana-Champaign; Universidade Federal do Rio de Janeiro	Docampo, R (corresponding author), Univ Illinois, Coll Vet Med, Dept Pathobiol, Mol Parasitol Lab, 2001 S Lincoln Ave, Urbana, IL 61802 USA.			Scott, David/0000-0002-8668-2449	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI023259, R01AI023259] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-23259] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BENAIM G, 1995, BIOCHEM J, V306, P299, DOI 10.1042/bj3060299; Blumwald E, 1997, ADV BOT RES, V25, P401, DOI 10.1016/S0065-2296(08)60159-7; BRIGHTMAN AO, 1992, BIOCHIM BIOPHYS ACTA, V1104, P188, DOI 10.1016/0005-2736(92)90149-G; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; COOPERMAN BS, 1992, TRENDS BIOCHEM SCI, V17, P262, DOI 10.1016/0968-0004(92)90406-Y; CUNNINGHAM KW, 1994, J EXP BIOL, V196, P157; DOCAMPO R, 1995, BIOCHEM J, V310, P1005, DOI 10.1042/bj3101005; Drose S, 1997, J EXP BIOL, V200, P1; GordonWeeks R, 1997, PLANT PHYSIOL, V114, P901, DOI 10.1104/pp.114.3.901; Jiang SS, 1997, ARCH BIOCHEM BIOPHYS, V346, P105, DOI 10.1006/abbi.1997.0279; KIM EJ, 1994, P NATL ACAD SCI USA, V91, P6128, DOI 10.1073/pnas.91.13.6128; LIU CM, 1978, J BIOL CHEM, V253, P5892; Lommel C, 1997, PLANTA, V201, P477, DOI 10.1007/s004250050092; Long AR, 1997, J PLANT PHYSIOL, V151, P16, DOI 10.1016/S0176-1617(97)80031-4; LONG AR, 1995, J PLANT PHYSIOL, V146, P629, DOI 10.1016/S0176-1617(11)81925-5; Lu HG, 1998, MOL CELL BIOL, V18, P2309, DOI 10.1128/MCB.18.4.2309; Lu HG, 1997, J BIOL CHEM, V272, P9464, DOI 10.1074/jbc.272.14.9464; LUNDIN M, 1992, BIOCHIM BIOPHYS ACTA, V1098, P217, DOI 10.1016/S0005-2728(05)80339-1; MACDONALD JIS, 1988, FEBS LETT, V238, P9, DOI 10.1016/0014-5793(88)80214-X; MAESHIMA M, 1989, J BIOL CHEM, V264, P20068; MAESHIMA M, 1991, EUR J BIOCHEM, V196, P11, DOI 10.1111/j.1432-1033.1991.tb15779.x; Michels PAM, 1997, EUR J BIOCHEM, V250, P698, DOI 10.1111/j.1432-1033.1997.00698.x; Moreno SNJ, 1996, BIOCHEM J, V313, P655, DOI 10.1042/bj3130655; NORE BF, 1991, BIOCHEM BIOPH RES CO, V181, P962, DOI 10.1016/0006-291X(91)92030-N; PALMGREN MG, 1991, ANAL BIOCHEM, V192, P316, DOI 10.1016/0003-2697(91)90542-2; PEREIRADASILVA L, 1993, ARCH BIOCHEM BIOPHYS, V304, P310, DOI 10.1006/abbi.1993.1355; Rea P.A., 1990, METHODS PLANT BIOCH, V3, P385, DOI DOI 10.1016/B978-0-12-461013-2.50035-6; REA PA, 1992, PLANT PHYSIOL, V100, P723, DOI 10.1104/pp.100.2.723; REA PA, 1993, ANNU REV PLANT PHYS, V44, P157, DOI 10.1146/annurev.pp.44.060193.001105; Robinson DG, 1996, PLANTA, V198, P95, DOI 10.1007/BF00197591; SARAFIAN V, 1992, P NATL ACAD SCI USA, V89, P1775, DOI 10.1073/pnas.89.5.1775; SATO MH, 1994, J BIOL CHEM, V269, P6725; Scarpa A, 1979, Methods Enzymol, V56, P301; SCHLATTERER C, 1994, CELL CALCIUM, V16, P101, DOI 10.1016/0143-4160(94)90005-1; SCOTT DA, 1995, BIOCHEM J, V310, P789, DOI 10.1042/bj3100789; Scott DA, 1997, J BIOL CHEM, V272, P28020, DOI 10.1074/jbc.272.44.28020; Scott DA, 1998, BIOCHEM J, V331, P583, DOI 10.1042/bj3310583; TOKUYASU KT, 1989, HISTOCHEM J, V21, P163, DOI 10.1007/BF01007491; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vanderheyden N, 1996, BIOCHEM J, V318, P103, DOI 10.1042/bj3180103; Vercesi AE, 1996, BIOCHEM J, V315, P265, DOI 10.1042/bj3150265; Vercesi AE, 1997, BIOCHEM J, V328, P479; VERCESI AE, 1994, BIOCHEM J, V304, P227, DOI 10.1042/bj3040227; Vianello A, 1997, PLANT CELL PHYSIOL, V38, P87, DOI 10.1093/oxfordjournals.pcp.a029090; WANG YZ, 1986, PLANT PHYSIOL, V81, P497, DOI 10.1104/pp.81.2.497; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; World Health Organization, 1991, WHO TECH REP SER; ZHEN RG, 1994, PLANT PHYSIOL, V104, P153, DOI 10.1104/pp.104.1.153; Zhen RG, 1997, ADV BOT RES, V25, P297, DOI 10.1016/S0065-2296(08)60156-1; ZIEROLD K, 1988, METHOD MICROBIOL, V20, P91, DOI 10.1016/S0580-9517(08)70049-7	50	133	136	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					22151	22158		10.1074/jbc.273.34.22151	http://dx.doi.org/10.1074/jbc.273.34.22151			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705361	hybrid			2022-12-27	WOS:000075492600095
J	Lanchy, JM; Keith, G; Le Grice, SFJ; Ehresmann, B; Ehresmann, C; Marquet, R				Lanchy, JM; Keith, G; Le Grice, SFJ; Ehresmann, B; Ehresmann, C; Marquet, R			Contacts between reverse transcriptase and the primer strand govern the transition from initiation to elongation of HIV-1 reverse transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BINDING-SITE COMPLEMENTARY; DEPENDENT DNA-POLYMERASE; CRYSTAL-STRUCTURE; TRANSFER-RNAS; ANGSTROM RESOLUTION; SECONDARY STRUCTURE; KINETIC-ANALYSIS; THUMB SUBDOMAIN; KLENOW FRAGMENT	HIV-1 reverse transcriptase (RT) utilizes RNA oligomers to prime DNA synthesis. The initiation of reverse transcription requires specific interactions between HIV-1 RNA, primer tRNA(3)(Lys) and RT, We have previously shown that extension of an oligodeoxyribonucleotide, a situation that mimicks elongation, is unspecific and differs from initiation by the polymerization rate and dissociation rate of RT from the primer-template complex, Here, we used replication intermediates to analyze the transition from the initiation to the elongation phases. We found that the 2'-hydroxyl group at the 3' end of tRNA had limited effects on the polymerization and dissociation rate constants. Instead, the polymerization rate increased 3400-fold between addition of the sixth and seventh nucleotide to tRNA(3)(Lys). The same increase in the polymerization rate was observed when an oligoribonucleotide, but not an oligodeoxyribonucleotide, was used as a primer. In parallel, the dissociation rate of RT from the primer-template complex decreased 30-fold between addition of the 17th and 19th nucleotide to tRNA(3)(Lys). The polymerization and dissociation rates are most likely governed by interactions of the primer strand with helix alpha H in the p66 thumb subdomain and the RNase H domain of RT, respectively.	CNRS, Inst Biol Mol & Cellulaire, Unite Propre Rech 9002, F-67084 Strasbourg, France; Case Western Reserve Univ, Sch Med, Div Infect Dis, Cleveland, OH 44106 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Case Western Reserve University	Marquet, R (corresponding author), CNRS, Inst Biol Mol & Cellulaire, Unite Propre Rech 9002, 15 Rue Rene Descartes, F-67084 Strasbourg, France.			Marquet, Roland/0000-0002-4209-3976	PHS HHS [A131147] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AIYAR A, 1994, J VIROL, V68, P611, DOI 10.1128/JVI.68.2.611-618.1994; AIYAR A, 1992, J VIROL, V66, P2464, DOI 10.1128/JVI.66.4.2464-2472.1992; Arts EJ, 1996, J BIOL CHEM, V271, P9054, DOI 10.1074/jbc.271.15.9054; Arts EJ, 1996, P NATL ACAD SCI USA, V93, P10063, DOI 10.1073/pnas.93.19.10063; BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0; BAMBARA RA, 1976, J BIOL CHEM, V251, P4090; BEARD WA, 1994, J BIOL CHEM, V269, P28091; BEARD WA, 1993, BIOCHEMISTRY-US, V32, P9745, DOI 10.1021/bi00088a029; BEBENEK K, 1995, J BIOL CHEM, V270, P19516, DOI 10.1074/jbc.270.33.19516; Bebenek K, 1997, NAT STRUCT BIOL, V4, P194, DOI 10.1038/nsb0397-194; BEESE LS, 1993, BIOCHEMISTRY-US, V32, P14095, DOI 10.1021/bi00214a004; BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; CHAMPOUX JJ, 1993, REVERSE TRANSCRIPTAS, P103; Ding JP, 1997, BIOPOLYMERS, V44, P125, DOI 10.1002/(SICI)1097-0282(1997)44:2&lt;125::AID-BIP2&gt;3.0.CO;2-X; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Eom SH, 1996, NATURE, V382, P278, DOI 10.1038/382278a0; ESNOUF R, 1995, NAT STRUCT BIOL, V2, P303, DOI 10.1038/nsb0495-303; Essink BBO, 1996, J MOL BIOL, V264, P243, DOI 10.1006/jmbi.1996.0638; FEDOROFF OY, 1993, J MOL BIOL, V233, P509, DOI 10.1006/jmbi.1993.1528; Friant S, 1996, NUCLEIC ACIDS RES, V24, P441, DOI 10.1093/nar/24.3.441; GANGLOFF J, 1984, J BIOCHEM BIOPH METH, V9, P201, DOI 10.1016/0165-022X(84)90025-3; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; HERMANN T, 1994, NUCLEIC ACIDS RES, V22, P4625, DOI 10.1093/nar/22.22.4625; Horton NC, 1996, J MOL BIOL, V264, P521, DOI 10.1006/jmbi.1996.0658; HSIEH JC, 1993, J BIOL CHEM, V268, P24607; Huang Y, 1996, J VIROL, V70, P4700, DOI 10.1128/JVI.70.7.4700-4706.1996; HUBER HE, 1987, J BIOL CHEM, V262, P16224; HUBER HE, 1989, J BIOL CHEM, V264, P4669; Isel C, 1998, NUCLEIC ACIDS RES, V26, P1198, DOI 10.1093/nar/26.5.1198; ISEL C, 1993, J BIOL CHEM, V268, P25269; ISEL C, 1995, J MOL BIOL, V247, P236, DOI 10.1006/jmbi.1994.0136; Isel C, 1996, EMBO J, V15, P917, DOI 10.1002/j.1460-2075.1996.tb00426.x; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; Kang SM, 1997, J VIROL, V71, P207, DOI 10.1128/JVI.71.1.207-217.1997; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; KIM Y, 1995, NATURE, V376, P612, DOI 10.1038/376612a0; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Lanchy JM, 1996, EMBO J, V15, P7178, DOI 10.1002/j.1460-2075.1996.tb01109.x; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; Levin HL, 1997, CELL, V88, P5, DOI 10.1016/S0092-8674(00)81851-6; LI XG, 1994, J VIROL, V68, P6198, DOI 10.1128/JVI.68.10.6198-6206.1994; Liang C, 1997, J VIROL, V71, P5750, DOI 10.1128/JVI.71.8.5750-5757.1997; Mak J, 1997, J VIROL, V71, P8087, DOI 10.1128/JVI.71.11.8087-8095.1997; MARQUET R, 1995, BIOCHIMIE, V77, P113, DOI 10.1016/0300-9084(96)88114-4; MARQUET R, 1991, NUCLEIC ACIDS RES, V19, P2349, DOI 10.1093/nar/19.9.2349; MASSIRE C, 1994, J MOL GRAPHICS, V12, P201, DOI 10.1016/0263-7855(94)80088-X; MOORE MJ, 1992, SCIENCE, V256, P992, DOI 10.1126/science.1589782; PATEL PH, 1995, BIOCHEMISTRY-US, V34, P5351, DOI 10.1021/bi00016a006; PELISKA JA, 1992, SCIENCE, V258, P1112, DOI 10.1126/science.1279806; REARDON JE, 1992, BIOCHEMISTRY-US, V31, P4473, DOI 10.1021/bi00133a013; REARDON JE, 1993, J BIOL CHEM, V268, P8743; REARDON JE, 1991, J BIOL CHEM, V266, P14128; SKALKA A, 1993, REVERSE TRANSCRIPTAS; Suo ZC, 1997, BIOCHEMISTRY-US, V36, P12459, DOI 10.1021/bi971217h; Telesnitsky A, 1993, REVERSE TRANSCRIPTAS; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; Wakefield JK, 1996, J VIROL, V70, P966, DOI 10.1128/JVI.70.2.966-975.1996; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; WOHRL BM, 1995, BIOCHEMISTRY-US, V34, P5343; Zhang ZJ, 1996, VIROLOGY, V226, P306, DOI 10.1006/viro.1996.0658	61	57	57	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24425	24432		10.1074/jbc.273.38.24425	http://dx.doi.org/10.1074/jbc.273.38.24425			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733733	hybrid			2022-12-27	WOS:000076007300025
J	Williams, NG; Zhong, HY; Minneman, KP				Williams, NG; Zhong, HY; Minneman, KP			Differential coupling of alpha(1)-, alpha(2)-, and beta-adrenergic receptors to mitogen-activated protein kinase pathways and differentiation in transfected PC12 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; RAS-DEPENDENT ACTIVATION; MAP KINASE; CYCLIC-AMP; SIGNALING PATHWAY; ALPHA-2-ADRENERGIC RECEPTOR; GAMMA-SUBUNITS; HYPERTROPHY; EXPRESSION; TRANSDUCTION	Three adrenergic receptor families that selectively activate three different G proteins (alpha(1)/G(q/11), alpha(2)/G(i), and beta/G(s)) were used to study mitogen-activated protein kinase (MAPK) activation and differentiation in PC12 cells. PC12 cells were stably transfected with alpha(1a)-, alpha(2A)-, or beta(1)-adrenerse receptors (ARs) in an inducible expression vector, and subclones were characterized. Norepinephrine stimulated inositol phosphate formation in alpha(1A)-transfected cells, inhibited cyclic adenosine 3'5'-monophosphate (cAMP) formation in alpha(1A)-transfected cells, and stimulated cAMP formation in beta(1)-transfected cells. Nerve growth factor activated extracellular signal-regulated kinases (ERKs) in all cell lines; however, norepinephrine activated ERKs only in alpha(1A)- and beta(1)-transfected cells but not in alpha(2A)-transfected cells. Norepinephrine also activated c-Jun NH2-terminal kinase and p38 MAPK in alpha(1A)-transfected cells but not in beta(1)- or alpha(2A)-transfected cells. Norepinephrine caused differentiation of PC12 cells expressing alpha(1A)-ARs but not those expressing beta(1)- or alpha(2A)-ARs. However, norepinephrine acted synergitically with nerve growth factor in promoting differentiation of cells expressing beta(1)-ARs. Whereas ERKs are activated by G(i)- but not G(s)-linked receptors in many fibroblastic cell lines, we observed the opposite in PC12 cells. The results show that activation of the different G protein signaling pathways has different effects on MAPKs and differentiation in PC12 cells, with G(q) signaling pathways activating all three major MAPK pathways.	Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University	Minneman, KP (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA.				NINDS NIH HHS [NS32706, NS23756, NS09580] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032706] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBLAS J, 1993, J BIOL CHEM, V268, P22235; ASANO T, 1992, J NEUROCHEM, V58, P2176, DOI 10.1111/j.1471-4159.1992.tb10961.x; BARIBAY JL, 1991, BIOCHIM BIOPHYS ACTA, V1094, P193; Bogoyevitch MA, 1996, BIOCHEM J, V314, P115, DOI 10.1042/bj3140115; BYLUND DB, 1994, PHARMACOL REV, V46, P121; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; COSO OA, 1995, J BIOL CHEM, V270, P5620, DOI 10.1074/jbc.270.10.5620; CRESPO P, 1995, J BIOL CHEM, V270, P25259, DOI 10.1074/jbc.270.42.25259; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; DAMON DH, 1990, J CELL BIOL, V110, P1333, DOI 10.1083/jcb.110.4.1333; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; DUZIC E, 1992, J BIOL CHEM, V267, P24045; ESBENSHADE TA, 1993, MOL PHARMACOL, V44, P76; FAURE M, 1994, J BIOL CHEM, V269, P7851; FRODIN M, 1994, J BIOL CHEM, V269, P6207; GAIDDON C, 1994, J BIOL CHEM, V269, P22663; GATTI G, 1988, BIOCHEM J, V255, P753, DOI 10.1042/bj2550753; GUNNING PW, 1981, J CELL BIOL, V89, P240, DOI 10.1083/jcb.89.2.240; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; HAWES BE, 1995, J BIOL CHEM, V270, P17148, DOI 10.1074/jbc.270.29.17148; Heasley LE, 1996, MOL CELL BIOL, V16, P648; HIRASAWA A, 1993, BIOCHEM BIOPH RES CO, V195, P902, DOI 10.1006/bbrc.1993.2130; HOWE LR, 1993, J BIOL CHEM, V268, P20717; Huang CM, 1996, J NEUROCHEM, V67, P530; ITO A, 1995, FEBS LETT, V368, P183, DOI 10.1016/0014-5793(95)00643-N; KABIR AM, 1993, CELL SIGNAL, V5, P443, DOI 10.1016/0898-6568(93)90084-Y; KOBILKA BK, 1987, SCIENCE, V238, P650, DOI 10.1126/science.2823383; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; LAMORTE VJ, 1994, J BIOL CHEM, V269, P13490; LANGECARTER CA, 1994, SCIENCE, V265, P1458, DOI 10.1126/science.8073291; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; MACHIDA CA, 1990, J BIOL CHEM, V265, P12960; Mark MD, 1997, J BIOL CHEM, V272, P17238, DOI 10.1074/jbc.272.27.17238; MINNEMAN KP, 1994, ANNU REV PHARMACOL, V34, P117; NASSERI A, 1987, MOL PHARMACOL, V32, P655; PRASAD MVVSV, 1995, J BIOL CHEM, V270, P18655, DOI 10.1074/jbc.270.31.18655; Ramirez MT, 1997, J BIOL CHEM, V272, P14057, DOI 10.1074/jbc.272.22.14057; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Sah VP, 1996, J BIOL CHEM, V271, P31185, DOI 10.1074/jbc.271.49.31185; SIMPSON PC, 1991, MOL CELL BIOCHEM, V104, P35; Sugden PH, 1997, CELL SIGNAL, V9, P337, DOI 10.1016/S0898-6568(96)00191-X; THORBURN A, 1993, J BIOL CHEM, V268, P2244; THORBURN J, 1994, BIOCHEM BIOPH RES CO, V202, P1586, DOI 10.1006/bbrc.1994.2113; Tigyi G, 1996, J NEUROCHEM, V66, P549; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; VANBIESEN T, 1995, NATURE, V376, P781, DOI 10.1038/376781a0; VANCORVEN EJ, 1989, CELL, V59, P45, DOI 10.1016/0092-8674(89)90868-4; WILLIAMS NG, 1994, CANCER METAST REV, V13, P105, DOI 10.1007/BF00690421; WILLIAMS NG, 1992, P NATL ACAD SCI USA, V89, P2922, DOI 10.1073/pnas.89.7.2922; WILLIAMS NG, 1993, P NATL ACAD SCI USA, V90, P5772, DOI 10.1073/pnas.90.12.5772; WINITZ S, 1993, J BIOL CHEM, V268, P19196; WOOD KW, 1993, BIOCHIM BIOPHYS ACTA, V1155, P133, DOI 10.1016/0304-419X(93)90002-T; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xin XH, 1997, MOL PHARMACOL, V51, P764, DOI 10.1124/mol.51.5.764; Yamauchi J, 1997, J BIOL CHEM, V272, P7602, DOI 10.1074/jbc.272.12.7602; Yamauchi JJ, 1997, J BIOL CHEM, V272, P27771, DOI 10.1074/jbc.272.44.27771; ZHONG HY, 1993, MOL PHARMACOL, V44, P1085	61	87	89	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 18	1998	273	38					24624	24632		10.1074/jbc.273.38.24624	http://dx.doi.org/10.1074/jbc.273.38.24624			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	121HL	9733758	hybrid			2022-12-27	WOS:000076007300050
J	Deng, XZ; Sun, GR; Zheng, QH; Li, YX				Deng, XZ; Sun, GR; Zheng, QH; Li, YX			Characterization of human TCR V beta gene promoter - Role of the dodecamer motif in promoter activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMP RESPONSE ELEMENT; VARIABLE-REGION GENE; CELL RECEPTOR GENE; NUCLEAR PROTEINS; DECAMER MOTIF; TRANSCRIPTIONAL ENHANCER; MONOCLONAL-ANTIBODY; EXPRESSION; REARRANGEMENT; BINDING	During T-lymphocyte development, the T-cell antigen receptor (TCR) gene expression is controlled by its promoter and enhancer elements and regulated in tissue and development stage-specific manner. To uncover the promoter function and to define positive and negative regulatory elements in TCR gene promoters, the promoter activities from 13 human TCR V beta genes were determined by the transient transfection system and luciferase reporter assay. Although most of the TCR V beta gene promoters that we tested are inactive by themselves, some promoters were found to be constitutively strong. Among them, V beta 6.7 is the strongest. 5'-Deletion and fragmentation experiments have narrowed the full promoter activity of V beta 6.7 to a fragment of 147 base pairs immediately 5' to the transcription initiation site. A decanucleotide motif with the consensus sequence AGTGAYRTCA has been found to be conserved in most TCR V beta gene promoters. There are three such decamer motifs in the promoter region of V beta 6.7, and the contribution of each such motif to the promoter activity has been examined. Further site-directed mutagenesis analyses showed that: 1) when two Ts in the decamer were mutated, the promoter activity was totally abolished; 2) when two additional nucleotides 3' to the end of decamer were mutated, the promoter activity was decreased to two-thirds of the full level; and 3) when the element with the sequence AGTGATGTCACT was inserted into other promoters, the original weak promoters become very strong. Taken together, our data suggest that the positive regulatory element in V beta 6.7 should be considered a dodecamer rather than a decamer and that it confers strong basal transcriptional activity on TCR VP genes.	Cornell Univ, Dept Med, Hosp Special Surg, Coll Med, New York, NY 10021 USA	Cornell University	Li, YX (corresponding author), Cornell Univ, Dept Med, Hosp Special Surg, Coll Med, 535 E 70th St, New York, NY 10021 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI038035] Funding Source: NIH RePORTER; NIAID NIH HHS [AI38035] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON SJ, 1989, MOL CELL BIOL, V9, P4835, DOI 10.1128/MCB.9.11.4835; ANDERSON SJ, 1988, P NATL ACAD SCI USA, V85, P3551, DOI 10.1073/pnas.85.10.3551; BLACKWELL TK, 1986, NATURE, V324, P585, DOI 10.1038/324585a0; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; FONDELL JD, 1992, MOL CELL BIOL, V12, P1480, DOI 10.1128/MCB.12.4.1480; GAO MH, 1993, J IMMUNOL, V150, P4376; GOLDMAN JP, 1993, J EXP MED, V177, P729, DOI 10.1084/jem.177.3.729; GOTTSCHALK LR, 1990, MOL CELL BIOL, V10, P5486, DOI 10.1128/MCB.10.10.5486; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; KRIMPENFORT P, 1988, EMBO J, V7, P745, DOI 10.1002/j.1460-2075.1988.tb02871.x; LANIER ER, 1991, P NATL ACAD SCI USA, V88, P8131, DOI 10.1073/pnas.88.18.8131; LEE MR, 1992, J IMMUNOL, V148, P1906; LEE W, 1987, NATURE, V325, P368, DOI 10.1038/325368a0; LEIDEN JM, 1994, CURR OPIN IMMUNOL, V6, P231, DOI 10.1016/0952-7915(94)90096-5; LI YX, 1991, J EXP MED, V174, P1537, DOI 10.1084/jem.174.6.1537; LI YX, 1990, J EXP MED, V171, P221, DOI 10.1084/jem.171.1.221; MCDOUGALL S, 1988, SCIENCE, V241, P205, DOI 10.1126/science.2968651; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; POSNETT DN, 1986, P NATL ACAD SCI USA, V83, P7888, DOI 10.1073/pnas.83.20.7888; PRASHAR Y, 1991, J IMMUNOL, V147, P3441; ROYER HD, 1987, P NATL ACAD SCI USA, V84, P232, DOI 10.1073/pnas.84.1.232; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; SIU G, 1986, J EXP MED, V164, P1600, DOI 10.1084/jem.164.5.1600; VISSINGA CS, 1994, J IMMUNOL, V152, P1222; WANG YK, 1993, MOL CELL BIOL, V13, P5691, DOI 10.1128/MCB.13.9.5691; WINOTO A, 1989, CELL, V59, P649, DOI 10.1016/0092-8674(89)90010-X	26	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23709	23715		10.1074/jbc.273.37.23709	http://dx.doi.org/10.1074/jbc.273.37.23709			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726977	hybrid			2022-12-27	WOS:000075893100018
J	Dietrich, J; Backstrom, T; Lauritsen, JPH; Kastrup, J; Christensen, MD; von Bulow, F; Palmer, E; Geisler, C				Dietrich, J; Backstrom, T; Lauritsen, JPH; Kastrup, J; Christensen, MD; von Bulow, F; Palmer, E; Geisler, C			The phosphorylation state of CD3 gamma influences T cell responsiveness and controls T cell receptor cycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; ANTIGEN RECEPTOR; SIGNAL-TRANSDUCTION; ACTIN-FILAMENTS; ALPHA-BETA; ACTIVATION; INTERNALIZATION; COMPLEXES; MOTIF; CD3	The T cell receptor (TCR) is internalized following activation of protein kinase C (PBC) via a leucine (Leu)based motif in CD3 gamma. Some studies have indicated that the TCR is recycled back to the cell surface following PKC-mediated internalization. The functional state of recycled TCR and the mechanisms involved in the sorting events following PKC-induced internalization are not known. In this study, we demonstrated that following PKC-induced internalization, the TCR is recycled back to the cell surface ins a functional state. TCR recycling was dependent on dephosphorylation of CD3 gamma, probably mediated by the serine/threonine protein phosphatase-ail but independent on microtubules or actin polymerization. Furthermore, in contrast to ligand-mediated TCR sorting recycling of the TCR was independent of the tyrosine phosphatase CD45 and the Src tyrosine kinases p56(Lck) and p59(Fyn). Studies of mutated TCR and chimeric CD4-CD3 gamma molecules demonstrated that CD3 gamma did not contain a recycling signal in itself. In contrast, the only sorting information in CD3 gamma was the Leu-based motif that mediated lysosomal sorting of chimeric CD4-CD3 gamma molecules. Finally, we found II correlation between the phosphorylation state of CD3 gamma and T cell responsiveness. Based on these observations a physiological role of CD3 gamma and TCR cycling is proposed.	Univ Copenhagen, Panum Inst, Inst Med Microbiol & Immunol, DK-2200 Copenhagen, Denmark; Univ Copenhagen, Panum Inst, Inst Med Anat, DK-2200 Copenhagen, Denmark; Malaghan Inst Med Res, Wellington, New Zealand; Basel Inst Immunol, CH-4005 Basel, Switzerland	University of Copenhagen; University of Copenhagen; Malaghan Institute; Victoria University Wellington	Dietrich, J (corresponding author), Univ Copenhagen, Panum Inst, Inst Med Microbiol & Immunol, Bldg 18-3,Blegdamsvej 3C, DK-2200 Copenhagen, Denmark.	vader@biobase.dk	Geisler, Carsten/A-7056-2012; Bartels, Mette Damkjær/AAY-5809-2020	Geisler, Carsten/0000-0002-8472-0771; Bartels, Mette Damkjær/0000-0002-8187-3684				ALEXANDER D, 1989, EUR J BIOCHEM, V181, P55, DOI 10.1111/j.1432-1033.1989.tb14693.x; ALEXANDER DR, 1992, BIOCHEM J, V288, P69, DOI 10.1042/bj2880069; Backstrom BT, 1996, IMMUNITY, V5, P437, DOI 10.1016/S1074-7613(00)80500-2; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; COUNTAWAY JL, 1992, J BIOL CHEM, V267, P1129; DEMBIC Z, 1986, NATURE, V320, P232, DOI 10.1038/320232a0; Dietrich J, 1996, J CELL BIOL, V132, P299, DOI 10.1083/jcb.132.3.299; DIETRICH J, 1994, EMBO J, V13, P2156, DOI 10.1002/j.1460-2075.1994.tb06492.x; Dietrich J, 1996, J BIOL CHEM, V271, P11441, DOI 10.1074/jbc.271.19.11441; Dietrich J, 1997, J CELL BIOL, V138, P271, DOI 10.1083/jcb.138.2.271; DOro U, 1997, IMMUNITY, V7, P619, DOI 10.1016/S1074-7613(00)80383-0; Durrbach A, 1996, J CELL SCI, V109, P457; GANZ MB, 1996, AM J PHYSIOL, V271, P108; Garland AM, 1996, MOL PHARMACOL, V49, P438; GEISLER C, 1992, J IMMUNOL, V148, P2437; GEISLER C, 1988, SCAND J IMMUNOL, V27, P685, DOI 10.1111/j.1365-3083.1988.tb02402.x; GIANNINI E, 1995, J BIOL CHEM, V270, P19166, DOI 10.1074/jbc.270.32.19166; GIANNINI E, 1995, J IMMUNOL, V154, P4055; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HAUSDORFF WP, 1991, P NATL ACAD SCI USA, V88, P2979, DOI 10.1073/pnas.88.8.2979; HORI M, 1991, FEBS LETT, V285, P145, DOI 10.1016/0014-5793(91)80745-O; HOU XH, 1994, EUR J IMMUNOL, V24, P1228, DOI 10.1002/eji.1830240534; Hou XH, 1996, J BIOL CHEM, V271, P22815, DOI 10.1074/jbc.271.37.22815; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; KONING F, 1990, EUR J IMMUNOL, V20, P299, DOI 10.1002/eji.1830200211; KORETZKY GA, 1991, P NATL ACAD SCI USA, V88, P2037, DOI 10.1073/pnas.88.6.2037; KRISSANSEN GW, 1986, EMBO J, V5, P1799, DOI 10.1002/j.1460-2075.1986.tb04429.x; KUHLMANN J, 1993, SCAND J IMMUNOL, V37, P271, DOI 10.1111/j.1365-3083.1993.tb01766.x; Lauritsen JPH, 1998, J IMMUNOL, V161, P260; LITTMAN DR, 1987, NATURE, V325, P453, DOI 10.1038/325453a0; LU Y, 1994, J IMMUNOL, V153, P1495; LUTON F, 1994, J IMMUNOL, V153, P63; Luton F, 1997, J IMMUNOL, V158, P3140; MANOLIOS N, 1991, EMBO J, V10, P1643, DOI 10.1002/j.1460-2075.1991.tb07687.x; Maples CJ, 1997, J BIOL CHEM, V272, P6741, DOI 10.1074/jbc.272.10.6741; Margulies DH, 1997, CURR OPIN IMMUNOL, V9, P390, DOI 10.1016/S0952-7915(97)80086-6; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; MINAMI Y, 1987, J BIOL CHEM, V262, P13342; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; RUEGG CL, 1992, J BIOL CHEM, V267, P18837; SAITO T, 1987, NATURE, V325, P125, DOI 10.1038/325125a0; Sandoval Ignacio V., 1994, Trends in Cell Biology, V4, P292, DOI 10.1016/0962-8924(94)90220-8; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Valitutti S, 1997, J EXP MED, V185, P1859, DOI 10.1084/jem.185.10.1859; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4	49	41	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24232	24238		10.1074/jbc.273.37.24232	http://dx.doi.org/10.1074/jbc.273.37.24232			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727047	hybrid			2022-12-27	WOS:000075893100088
J	Kanai, Y; Segawa, H; Miyamoto, K; Uchino, H; Takeda, E; Endou, H				Kanai, Y; Segawa, H; Miyamoto, K; Uchino, H; Takeda, E; Endou, H			Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY GLUTAMATE TRANSPORTER; MONOCLONAL-ANTIBODY 4F2; CELL-SURFACE ANTIGEN; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; PROTEIN; SYSTEM; FAMILY; LYMPHOCYTES; OOCYTES	A cDNA was isolated from rat C6 glioma cells by expression cloning which encodes a novel Na+-independent neutral amino acid transporter designated LAT1. For functional expression in Xenopus oocytes, LAT1 required the heavy chain of 4F2 cell surface antigen (CD98), a type II membrane glycoprotein. When co-expressed with 4F2 heavy chain, LAT1 transported neutral amino acids with branched or aromatic side chains and did not accept basic amino acids or acidic amino acids. The transport via LAT1 was Na+-independent and sensitive to a system L-specific inhibitor 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid. These functional properties correspond to those of the classically characterized amino acid transport system L, a major nutrient transporter. In in vitro translation, LAT1 was shown to be a nonglycosylated membrane protein consistent with the property of 4F2 light chain, suggesting LAT1 is at least one of the proteins formerly referred to as 4F2 light chain. LAT1 exhibits relatively low but significant amino acid sequence similarity to mammalian cationic amino acid transporters and amino acid permeases of bacteria and yeasts, indicating LAT1 is a new member of the APC superfamily, Because of highly regulated nature and high level of expression in tumor cell lines, LAT1 is thought to be up-regulated to support the high protein synthesis for cell growth and cell activation. The cloning of LAT1 is expected to facilitate the research on the protein-protein interaction in the transporter field and to provide a clue to the search for still unidentified transporters.	Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Mitaka, Tokyo 181, Japan; Univ Tokushima, Sch Med, Dept Clin Nutr, Tokushima 770, Japan; Kanazawa Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa 920, Japan	Kyorin University; Tokushima University; Kanazawa University	Kanai, Y (corresponding author), Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, 6-20-2 Shinkawa, Mitaka, Tokyo 181, Japan.							BERTRAN J, 1992, P NATL ACAD SCI USA, V89, P5606, DOI 10.1073/pnas.89.12.5606; Broer S, 1997, BIOCHEM J, V324, P535, DOI 10.1042/bj3240535; Chillaron J, 1996, J BIOL CHEM, V271, P17761, DOI 10.1074/jbc.271.30.17761; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; CHRISTENSEN HN, 1975, CURRENT TOPICS MEMBR, V6, P227; CLOSS EI, 1993, J BIOL CHEM, V268, P7538; FEI YJ, 1994, NATURE, V368, P563, DOI 10.1038/368563a0; Fenczik CA, 1997, NATURE, V390, P81, DOI 10.1038/36349; Gallardo MA, 1996, J MEMBRANE BIOL, V152, P57, DOI 10.1007/s002329900085; GAUGITSCH HW, 1992, J BIOL CHEM, V267, P11267; GUIDOTTI GG, 1978, BIOCHIM BIOPHYS ACTA, V515, P329, DOI 10.1016/0304-4157(78)90009-6; HAYNES BF, 1981, J IMMUNOL, V126, P1409; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; HEDIGER MA, 1991, BIOCHIM BIOPHYS ACTA, V1064, P360, DOI 10.1016/0005-2736(91)90323-Z; HEDIGER MA, 1994, J EXP BIOL, V196, P15; HEMLER ME, 1982, J IMMUNOL, V129, P623; Isnard AD, 1996, J MOL BIOL, V262, P473, DOI 10.1006/jmbi.1996.0529; KANAI Y, 1995, J BIOL CHEM, V270, P16561, DOI 10.1074/jbc.270.28.16561; KANAI Y, 1992, AM J PHYSIOL, V263, pF1087, DOI 10.1152/ajprenal.1992.263.6.F1087; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; Kanai Y, 1997, CURR OPIN CELL BIOL, V9, P565, DOI 10.1016/S0955-0674(97)80035-X; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MACLEOD CL, 1994, J EXP BIOL, V196, P109; OXENDER DL, 1963, NATURE, V197, P765, DOI 10.1038/197765a0; PALACIN M, 1994, J EXP BIOL, V196, P123; PARMACEK MS, 1989, NUCLEIC ACIDS RES, V17, P1915, DOI 10.1093/nar/17.5.1915; QUACKENBUSH E, 1987, P NATL ACAD SCI USA, V84, P6526, DOI 10.1073/pnas.84.18.6526; SANG JS, 1995, CANCER RES, V55, P1152; Sekine T, 1997, J BIOL CHEM, V272, P18526, DOI 10.1074/jbc.272.30.18526; Spindler B, 1997, PFLUG ARCH EUR J PHY, V434, P323, DOI 10.1007/s004240050403; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; WEISSBACH L, 1982, J BIOL CHEM, V257, P2006; WELLS RG, 1992, J BIOL CHEM, V267, P15285; Wolf DA, 1996, CANCER RES, V56, P5012; YAGITA H, 1986, CANCER RES, V46, P1478	36	841	880	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23629	23632		10.1074/jbc.273.37.23629	http://dx.doi.org/10.1074/jbc.273.37.23629			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726963	hybrid			2022-12-27	WOS:000075893100004
J	Ke, YH; Wu, JY; Leibold, EA; Walden, WE; Theil, EC				Ke, YH; Wu, JY; Leibold, EA; Walden, WE; Theil, EC			Loops and bulge/loops in iron-responsive element isoforms influence iron regulatory protein binding - Fine-tuning of mRNA regulation?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FERRITIN MESSENGER-RNA; TRANSFERRIN RECEPTOR EXPRESSION; ERYTHROID 5-AMINOLEVULINATE SYNTHASE; TRANSLATIONAL CONTROL; POSTTRANSCRIPTIONAL REGULATION; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL ACONITASE; CYTOSOLIC ACONITASE; HIGH-AFFINITY; REGION	A family of noncoding mRNA sequences, iron-responsive elements (IREs), coordinately regulate several mRNAs through binding a family of mRNA-specific proteins, iron regulatory proteins (IRPs). IREs are hairpins with a constant terminal loop and base-paired stems interrupted by an internal loop/bulge tin ferritin mRNA) or a C-bulge tin m-aconitase, erythroid aminolevulinate synthase, and transferrin receptor mRNAs). IRP2 binding requires the conserved C-G base pair in the terminal loop, whereas IRP1 binding occurs with the C-G or engineered U-A. Here we show the contribution of the IRE internal loop/bulge to IRP2 binding by comparing natural and engineered IRE variants. Conversion of the internal loop/bulge in the ferritin-IRE to a C-bulge, by deletion of U, decreased IRP2 binding by >95%, whereas IRP1 binding changed only 13%. Moreover, IRP2 binding to natural IREs with the C-bulge was similar to the Delta U-6 ferritin-IRE: >90% lower than the ferritin-IRE. The results predict mRNA-specific variation in IRE-dependent regulation in vivo and may relate to previously observed differences in iron-induced ferritin and m-aconitase synthesis in liver and cultured cells. Variations in IRE structure and cellular IRP1/IRP2 ratios can provide a range of finely tuned, mRNA-specific responses to the same (iron) signal.	N Carolina State Univ, Dept Biochem, Raleigh, NC 27695 USA; Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; Univ Utah, Eccles Program Human Mol Biol & Genet, Salt Lake City, UT 84112 USA; Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA	University of North Carolina; North Carolina State University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Theil, EC (corresponding author), Childrens Hosp Oakland, Res Inst, 747 52nd St, Oakland, CA 94609 USA.	etheil@mail.cho.org			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK020251, R01DK047281, R37DK020251, R01DK020251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045201] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK47281, DK20251] Funding Source: Medline; NIGMS NIH HHS [GM45201] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Addess KJ, 1997, J MOL BIOL, V274, P72, DOI 10.1006/jmbi.1997.1377; BASILION JP, 1994, P NATL ACAD SCI USA, V91, P574, DOI 10.1073/pnas.91.2.574; BETTANY AJE, 1992, J BIOL CHEM, V267, P16531; BHASKER CR, 1993, J BIOL CHEM, V268, P12699; Butt J, 1996, P NATL ACAD SCI USA, V93, P4345, DOI 10.1073/pnas.93.9.4345; CASEY JL, 1988, SCIENCE, V240, P924, DOI 10.1126/science.2452485; Chen OS, 1997, J NUTR, V127, P238, DOI 10.1093/jn/127.2.238; COX TC, 1991, EMBO J, V10, P1891, DOI 10.1002/j.1460-2075.1991.tb07715.x; DANDEKAR T, 1991, EMBO J, V10, P1903, DOI 10.1002/j.1460-2075.1991.tb07716.x; DICKEY LF, 1988, J BIOL CHEM, V263, P3071; DIX DJ, 1992, BIOCHEMISTRY-US, V31, P2818, DOI 10.1021/bi00125a024; DIX DJ, 1993, J MOL BIOL, V231, P230, DOI 10.1006/jmbi.1993.1278; EISENSTEIN RS, 1993, J BIOL CHEM, V268, P27363; Frankel AD, 1998, CELL, V92, P149, DOI 10.1016/S0092-8674(00)80908-3; Gdaniec Z, 1998, BIOCHEMISTRY-US, V37, P1505, DOI 10.1021/bi9719814; GUO B, 1995, J BIOL CHEM, V270, P16529, DOI 10.1074/jbc.270.28.16529; GUO B, 1994, J BIOL CHEM, V269, P24252; GUO B, 1995, J BIOL CHEM, V270, P21645, DOI 10.1074/jbc.270.37.21645; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P11735, DOI 10.1073/pnas.89.24.11735; HARRIS HW, 1991, J CLIN INVEST, V88, P1, DOI 10.1172/JCI115263; HENDERSON BR, 1993, J BIOL CHEM, V268, P27327; HENDERSON BR, 1994, J BIOL CHEM, V269, P17481; Henderson ER, 1996, J BIOL CHEM, V271, P4900; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; HENTZE MW, 1991, NUCLEIC ACIDS RES, V19, P1739, DOI 10.1093/nar/19.8.1739; HIRLING H, 1994, EMBO J, V13, P453, DOI 10.1002/j.1460-2075.1994.tb06280.x; Iwai K, 1998, P NATL ACAD SCI USA, V95, P4924, DOI 10.1073/pnas.95.9.4924; IWAI K, 1995, EMBO J, V14, P5350, DOI 10.1002/j.1460-2075.1995.tb00219.x; JONES EW, 1991, METHOD ENZYMOL, V194, P428; Ke Y, 1998, FASEB J, V12, pA1474; KENNEDY MC, 1992, P NATL ACAD SCI USA, V89, P11730, DOI 10.1073/pnas.89.24.11730; Kim HY, 1996, J BIOL CHEM, V271, P24226, DOI 10.1074/jbc.271.39.24226; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; LEIBOLD EA, 1992, ANNU REV NUTR, V12, P345, DOI 10.1146/annurev.nu.12.070192.002021; LEIBOLD EA, 1990, NUCLEIC ACIDS RES, V18, P1819, DOI 10.1093/nar/18.7.1819; LIANG LG, 1996, BIOCHEMISTRY-US, V35, P13585; MELEFORS O, 1993, J BIOL CHEM, V268, P5974; Menotti E, 1998, J BIOL CHEM, V273, P1821, DOI 10.1074/jbc.273.3.1821; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; MULLNER EW, 1989, CELL, V58, P373, DOI 10.1016/0092-8674(89)90851-9; PATINO MM, 1992, J BIOL CHEM, V267, P19011; Phillips JD, 1996, BIOCHEMISTRY-US, V35, P15704, DOI 10.1021/bi960653l; PHILPOTT CC, 1994, P NATL ACAD SCI USA, V91, P7321, DOI 10.1073/pnas.91.15.7321; ROSE MD, 1990, METHODS YEAST GENETI, P179; Rouault TA, 1996, J BIOL INORG CHEM, V1, P494, DOI 10.1007/s007750050083; SAMANIEGO F, 1994, J BIOL CHEM, V269, P30904; Schalinske KL, 1997, P NATL ACAD SCI USA, V94, P10681, DOI 10.1073/pnas.94.20.10681; Schalinske KL, 1996, J BIOL CHEM, V271, P7168, DOI 10.1074/jbc.271.12.7168; Schalinske KL, 1998, J BIOL CHEM, V273, P3740, DOI 10.1074/jbc.273.6.3740; SHULL GE, 1982, J BIOL CHEM, V257, P4187; SIERZPUTOWSKAGRACZ H, 1995, NUCLEIC ACIDS RES, V23, P146, DOI 10.1093/nar/23.1.146; Theil EC, 1998, MET IONS BIOL SYST, V35, P403; Theil EC, 1997, CH MICROBIOL SER, P131; THEIL EC, 1994, BIOCHEM J, V304, P1; WALDEN WE, 1988, P NATL ACAD SCI USA, V85, P9503, DOI 10.1073/pnas.85.24.9503; WANG YH, 1991, BIOL MET, V4, P56, DOI 10.1007/BF01135558; WANG YH, 1990, NUCLEIC ACIDS RES, V18, P4463, DOI 10.1093/nar/18.15.4463	57	114	114	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23637	23640		10.1074/jbc.273.37.23637	http://dx.doi.org/10.1074/jbc.273.37.23637			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726965	hybrid			2022-12-27	WOS:000075893100006
J	Martinez, E; Kundu, TK; Fu, J; Roeder, RG				Martinez, E; Kundu, TK; Fu, J; Roeder, RG			A human SPT3-TAF(II)31-GCN5-L acetylase complex distinct from transcription factor IID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING-PROTEIN; RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; YEAST; SPT3; INITIATION; GCN5; GENE; INTERACTS; ADA2	In yeast, SPT3 is a component of the multiprotein SPT-ADA-GCN5 acetyltransferase (SAGA) complex that integrates proteins with transcription coactivator/adaptor functions (ADAs and GCN5), histone acetyltransferase activity (GCN5), and core promoter-selective functions (SPTs) involving interactions with the TATA-binding protein (TBP). In particular, yeast SPT3 has been shown to interact directly with TBP. Here we report the molecular cloning of a cDNA encoding a human homologue of yeast SPT3. Amino acid sequence comparisons between human SPT3 (hSPT3) and its counterparts in different yeast species reveal three highly conserved domains, with the most conserved ga-amino acid N-terminal domain being 25% identical with human TAF(II)18. Despite the significant sequence similarity with TAF(II)18, native hSPT3 is not a bona fide TAF(II) because it is not associated in vivo either with human TBP/TFIID or with a TFIID-related TBP-free TAF(II) complex. However, we present evidence that hSPT3 is associated in vivo with TAF(II)31 and the recently described longer form of human GCN5 (hGCN5-L) in a novel human complex that has histone acetyltransferase activity, We propose that the human SPT3-TAF(II)31-GCN5-L acetyltransferase (STAGA) complex is a likely homologue of the yeast SAGA complex.	Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA	Rockefeller University	Roeder, RG (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, 1230 York Ave, New York, NY 10021 USA.			Kundu, Tapas/0000-0001-7790-214X	NATIONAL CANCER INSTITUTE [R35CA042567] Funding Source: NIH RePORTER; NCI NIH HHS [CA42567] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Candau R, 1996, MOL CELL BIOL, V16, P593; CHIANG CM, 1993, EMBO J, V12, P2749, DOI 10.1002/j.1460-2075.1993.tb05936.x; Collart MA, 1996, MOL CELL BIOL, V16, P6668; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EISENMANN DM, 1989, CELL, V58, P1183, DOI 10.1016/0092-8674(89)90516-3; EISENMANN DM, 1992, GENE DEV, V6, P1319, DOI 10.1101/gad.6.7.1319; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; HAHN S, 1989, CELL, V58, P1173, DOI 10.1016/0092-8674(89)90515-1; HIRSCHHORN JN, 1988, MOL CELL BIOL, V8, P822, DOI 10.1128/MCB.8.2.822; HISATAKE K, 1995, P NATL ACAD SCI USA, V92, P8195, DOI 10.1073/pnas.92.18.8195; HOFFMANN A, 1991, NUCLEIC ACIDS RES, V19, P6337, DOI 10.1093/nar/19.22.6337; HOFFMANN A, 1996, J BIOL CHEM, V271, P18184; Horiuchi J, 1997, MOL CELL BIOL, V17, P3220, DOI 10.1128/MCB.17.6.3220; Madison JM, 1997, MOL CELL BIOL, V17, P287, DOI 10.1128/MCB.17.1.287; MENGUS G, 1995, EMBO J, V14, P1520, DOI 10.1002/j.1460-2075.1995.tb07138.x; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Smith ER, 1998, NUCLEIC ACIDS RES, V26, P2948, DOI 10.1093/nar/26.12.2948; Tansey WP, 1997, CELL, V88, P729, DOI 10.1016/S0092-8674(00)81916-9; Wieczorek E, 1998, NATURE, V393, P187, DOI 10.1038/30283; Winston, 1992, TRANSCRIPTIONAL REGU, P1271; WINSTON F, 1984, CELL, V39, P675, DOI 10.1016/0092-8674(84)90474-4; WINSTON F, 1987, GENETICS, V115, P649; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0	27	161	170	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23781	23785		10.1074/jbc.273.37.23781	http://dx.doi.org/10.1074/jbc.273.37.23781			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726987	hybrid			2022-12-27	WOS:000075893100028
J	Mayne, GC; Murray, AW				Mayne, GC; Murray, AW			Evidence that protein kinase C epsilon mediates phorbol ester inhibition of calphostin C- and tumor necrosis factor-alpha-induced apoptosis in U937 histiocytic lymphoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; DNA FRAGMENTATION; BINDING-PROTEIN; GENE-EXPRESSION; CERAMIDE; DEATH; TRANSLOCATION; ACTIVATION; INDUCTION; PHOSPHORYLATION	Protein kinase C (PKC) activators, such as the tumor-promoting phorbol esters, have been reported to protect several cell lines from apoptosis induced by a variety of agents. Recent evidence suggests that PKC epsilon is involved in protection of cardiac myocytes from hypoxia-induced cell death (Gray, M. O., Karliner, J. S., and Mochly-Rosen, D. (1997) J. Biol. Chem. 272, 30945-30951). We investigated the protective effects of the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) on U937 histiocytic lymphoma cells induced to undergo apoptosis by tumor necrosis factor-alpha (TNF-alpha) or by the specific PKC inhibitor calphostin C. U937 cells were transiently permeabilized with a peptide (epsilon V1-2) derived from the V1 region of PKC epsilon that has been reported to specifically block translocation of PKC epsilon. The epsilon V1-2 peptide blocked the inhibitory effect of TPA on both TNF-alpha- and calphostin C-induced apoptosis, A scrambled version of epsilon V1-2 and a peptide reported to inhibit PKC beta translocation (beta C2-4) had no effect on the ability of TPA to inhibit apoptosis, These results suggest that PKC epsilon is required for the protective effect of TPA in TNF-alpha- and calphostin C-induced apoptosis, Furthermore, calphostin C reduced membrane-associated PKC epsilon activity and immunoreactivity, suggesting that PKC epsilon may play an important role in leukemic cell survival.	Flinders Univ S Australia, Fac Sci & Engn, Sch Biol Sci, Adelaide, SA 5001, Australia	Flinders University South Australia	Mayne, GC (corresponding author), Flinders Univ S Australia, Fac Sci & Engn, Sch Biol Sci, GPO Box 2100, Adelaide, SA 5001, Australia.	bigcm@flinders.edu.au						BASU A, 1995, INT J CANCER, V63, P597, DOI 10.1002/ijc.2910630422; BRUNS RF, 1991, BIOCHEM BIOPH RES CO, V176, P288, DOI 10.1016/0006-291X(91)90922-T; Chmura SJ, 1996, CANCER RES, V56, P2711; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Durkin JP, 1996, J NEUROCHEM, V66, P951; GEIER A, 1994, IN VITRO CELL DEV-AN, V30A, P867; GONG JP, 1994, ANAL BIOCHEM, V218, P314, DOI 10.1006/abio.1994.1184; Gray MO, 1997, J BIOL CHEM, V272, P30945, DOI 10.1074/jbc.272.49.30945; Gubina E, 1998, BLOOD, V91, P823, DOI 10.1182/blood.V91.3.823.823_823_829; HAIMOVITZFRIEDMAN A, 1994, J EXP MED, V180, P525, DOI 10.1084/jem.180.2.525; HARRINGTON CR, 1990, ANAL BIOCHEM, V186, P285, DOI 10.1016/0003-2697(90)90081-J; Hartfield PJ, 1997, FEBS LETT, V401, P148, DOI 10.1016/S0014-5793(96)01460-3; HUG H, 1993, BIOCHEM J, V291, P329, DOI 10.1042/bj2910329; Hundle B, 1997, J BIOL CHEM, V272, P15028, DOI 10.1074/jbc.272.23.15028; IKEMOTO H, 1995, J NEUROSURG, V83, P1008, DOI 10.3171/jns.1995.83.6.1008; Ito T, 1997, J BIOL CHEM, V272, P11671, DOI 10.1074/jbc.272.18.11671; JARVIS WD, 1994, J BIOL CHEM, V269, P31685; JI L, 1995, FEBS LETT, V358, P211, DOI 10.1016/0014-5793(94)01428-4; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; Jones BA, 1997, AM J PHYSIOL-GASTR L, V272, pG1109, DOI 10.1152/ajpgi.1997.272.5.G1109; JONES MJ, 1995, J BIOL CHEM, V270, P5007, DOI 10.1074/jbc.270.10.5007; KILEY SC, 1995, J CELL SCI, V108, P1003; KIZAKI H, 1989, J BIOCHEM-TOKYO, V105, P673, DOI 10.1093/oxfordjournals.jbchem.a122724; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; LEE HJJ, 1995, J BIOL CHEM, V270, P15979, DOI 10.1074/jbc.270.27.15979; LOTEM J, 1991, BLOOD, V78, P953; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McBain JA, 1996, INT J CANCER, V67, P715, DOI 10.1002/(SICI)1097-0215(19960904)67:5<715::AID-IJC21>3.0.CO;2-2; MCCONKEY DJ, 1989, J BIOL CHEM, V264, P13399; Mihalik R, 1996, INT J BIOCHEM CELL B, V28, P925, DOI 10.1016/1357-2725(96)00020-9; MOCHLYROSEN D, 1991, P NATL ACAD SCI USA, V88, P3997, DOI 10.1073/pnas.88.9.3997; NUNEZ G, 1990, J IMMUNOL, V144, P3602; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Ohizumi H, 1997, ANTICANCER RES, V17, P1051; Oka N, 1997, J BIOL CHEM, V272, P33416, DOI 10.1074/jbc.272.52.33416; Pongracz J, 1996, LEUKEMIA RES, V20, P319, DOI 10.1016/0145-2126(95)00074-7; QUINTANS J, 1994, BIOCHEM BIOPH RES CO, V202, P710, DOI 10.1006/bbrc.1994.1988; RODRIGUEZTARDUCHY G, 1989, BIOCHEM BIOPH RES CO, V164, P1069, DOI 10.1016/0006-291X(89)91778-6; RON D, 1995, J BIOL CHEM, V270, P24180, DOI 10.1074/jbc.270.41.24180; Sawai H, 1997, J BIOL CHEM, V272, P2452; SOLARY E, 1993, BLOOD, V81, P1359; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; TAKANO Y, 1993, PATHOL RES PRACT, V189, P197, DOI 10.1016/S0344-0338(11)80092-0; TAMAOKI T, 1991, METHOD ENZYMOL, V201, P340; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; VANDELOOSDRECHT AA, 1993, EXP HEMATOL, V21, P1628; VOZIYAN PA, 1995, BIOCHEM BIOPH RES CO, V212, P479, DOI 10.1006/bbrc.1995.1995; WAYS DK, 1992, CANCER RES, V52, P5604; WAYS DK, 1994, CELL GROWTH DIFFER, V5, P161; Wilson BE, 1996, MOL CELL BIOL, V16, P5546	50	65	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24115	24121		10.1074/jbc.273.37.24115	http://dx.doi.org/10.1074/jbc.273.37.24115			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727032	hybrid			2022-12-27	WOS:000075893100073
J	Mounier, CM; Hackeng, TM; Schaeffer, F; Faure, G; Bon, C; Griffin, JH				Mounier, CM; Hackeng, TM; Schaeffer, F; Faure, G; Bon, C; Griffin, JH			Inhibition of prothrombinase by human secretory phospholipase A(2) involves binding to factor Xa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-II PHOSPHOLIPASE-A2; ARTHRITIC SYNOVIAL-FLUID; COAGULATION FACTOR-XA; SNAKE-VENOM; HUMAN-PLASMA; PROTEIN-S; FACTOR-VA; PLATELET PHOSPHOLIPASE-A2; INFLAMMATORY DISEASES; ENZYMATIC-ACTIVITY	Human group II secretory phospholipase A(2) (hsPLA(2)) exhibits significant anticoagulant activity that does not require its enzymatic activity. We examined which coagulation factor was targeted by hsPLA(2) and analyzed which region of the protein may be involved in this inhibition. Prothrombin time coagulation assays indicated that hsPLA(2) did not inhibit activated factor V (FVa) activity, whereas activated factor X (FXa) one-stage coagulation assays suggested that FXa was inhibited. The inhibitory effect of hsPLA(2) on prothrombinase activity of FXa, FV, phospholipids, and Ca2+ complex was markedly enhanced upon preincubation of hsPLA(2) with FXa but not with FV, Prothrombinase activity was also strongly inhibited by hsPLA(2) in the absence of FL. High concentrations of FVa in the prothrombinase generation assay reversed the inhibitory effect of hsPLA(2). By using isothermal titration calorimetry, we demonstrated that hsPLA(2) binds to FXa in solution with a 1:1 stoichiometry and a K-d of 230 nM. By using surface plasmon resonance we determined the rate constants, k(on) and k(off) of the FXaksPLA(2) interaction and analyzed the Ca2+ effect on these constants. When preincubated with FXa, synthetic peptides comprising residues 51-74 and 51-62 of hsPLA(2) inhibited prothrombinase assays, providing evidence that this part of the molecule, which shares similarities with a region of FVa that binds to FXa, is likely involved in the anticoagulant interaction of hsPLA(2) with FXa. In conclusion, we propose that residues 51-62 of hsPLA(2) bind to FXa at a FVa-binding site and that hsPLA(2) decreases the prothrombinase generation by preventing FXa FVa complex formation.	Inst Pasteur, Unite Venins, F-75724 Paris 15, France; Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Vasc Biol, La Jolla, CA 92037 USA; Inst Pasteur, Lab Resonance Magnet Nucl, F-75724 Paris, France; Univ Cergy Pontoise, Dept Biol, F-95011 Cergy Pontoise, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Scripps Research Institute; Scripps Research Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CY Cergy Paris Universite	Bon, C (corresponding author), Inst Pasteur, Unite Venins, 25 Rue Dr Roux, F-75724 Paris 15, France.	cbon@pasteur.fr		Griffin, John/0000-0002-4302-2547; Hackeng, Tilman/0000-0003-0142-0843	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021544] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL21544] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BABU AS, 1994, TOXICON, V32, P749, DOI 10.1016/0041-0101(94)90344-1; BHATNAGAR RS, 1995, METHOD ENZYMOL, V250, P467; BUNDLE DR, 1994, METHOD ENZYMOL, V247, P288; CIRINO G, 1993, THROMB RES, V70, P337, DOI 10.1016/0049-3848(93)90106-X; DAVIDSON FF, 1990, J MOL EVOL, V31, P228, DOI 10.1007/BF02109500; DAVIE EW, 1995, THROMB HAEMOSTASIS, V74, P1; DEKRUIJFF B, 1975, BIOCHIM BIOPHYS ACTA, V406, P6, DOI 10.1016/0005-2736(75)90038-3; DENNIS EA, 1991, METHOD ENZYMOL, V197, P3; DISCIPIO RG, 1979, BIOCHEMISTRY-US, V18, P899, DOI 10.1021/bi00572a026; ELSBACH P, 1993, CURR OPIN IMMUNOL, V5, P103, DOI 10.1016/0952-7915(93)90088-A; FOURCADE O, 1995, CELL, V80, P919, DOI 10.1016/0092-8674(95)90295-3; FRANKEN PA, 1992, EUR J BIOCHEM, V203, P89, DOI 10.1111/j.1432-1033.1992.tb19832.x; HACKENG TM, 1994, J BIOL CHEM, V269, P21051; Hackeng TM, 1997, P NATL ACAD SCI USA, V94, P7845, DOI 10.1073/pnas.94.15.7845; Heeb MJ, 1996, PROTEIN SCI, V5, P1883, DOI 10.1002/pro.5560050914; INADA M, 1994, J BIOL CHEM, V269, P26338; ISHIZAKI J, 1994, J BIOL CHEM, V269, P5897; KANE WH, 1981, J BIOL CHEM, V256, P1002; KINI RM, 1987, J BIOL CHEM, V262, P14402; KINI RM, 1989, TOXICON, V27, P613, DOI 10.1016/0041-0101(89)90013-5; KOMATSUBARA T, 1995, CLIN CHIM ACTA, V236, P109, DOI 10.1016/0009-8981(95)06035-9; KRAMER RM, 1989, J BIOL CHEM, V264, P5768; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; KURIHARA H, 1991, BIOCHIM BIOPHYS ACTA, V1082, P285, DOI 10.1016/0005-2760(91)90204-U; LAMBEAU G, 1994, J BIOL CHEM, V269, P1575; LIN LN, 1994, BIOCHEMISTRY-US, V33, P6564, DOI 10.1021/bi00187a025; MANN KG, 1990, BLOOD, V76, P1; MOUNIER C, 1993, EUR J BIOCHEM, V216, P169, DOI 10.1111/j.1432-1033.1993.tb18129.x; MOUNIER C, 1994, BBA-LIPID LIPID MET, V1214, P88, DOI 10.1016/0005-2760(94)90013-2; Mounier C, 1996, EUR J BIOCHEM, V237, P778, DOI 10.1111/j.1432-1033.1996.0778p.x; MUKHERJEE AB, 1992, DNA CELL BIOL, V11, P233, DOI 10.1089/dna.1992.11.233; MURAKAMI M, 1991, FEBS LETT, V294, P247, DOI 10.1016/0014-5793(91)81440-J; MURAKAMI M, 1993, J IMMUNOL, V151, P5675; NEVALAINEN TJ, 1993, CLIN CHEM, V39, P2453; Nieba L, 1996, ANAL BIOCHEM, V234, P155, DOI 10.1006/abio.1996.0067; Nyman KM, 1996, J SURG RES, V60, P7, DOI 10.1006/jsre.1996.0003; OUYANG C, 1992, TOXICON, V30, P945, DOI 10.1016/0041-0101(92)90040-C; OUYANG C, 1978, BIOCHIM BIOPHYS ACTA, V541, P394, DOI 10.1016/0304-4165(78)90198-8; PRUZANSKI W, 1993, J LIPID MEDIATOR, V8, P161; PRYZDIAL ELG, 1991, J BIOL CHEM, V266, P8969; RINTALA E, 1995, SCAND J INFECT DIS, V27, P39; ROSING J, 1988, BIOCHEMISTRY-US, V27, P8, DOI 10.1021/bi00401a002; SCOTT DL, 1991, SCIENCE, V254, P1007, DOI 10.1126/science.1948070; SEILHAMER JJ, 1989, J BIOL CHEM, V264, P5335; STEFANSSON S, 1990, BIOCHEMISTRY-US, V29, P7742, DOI 10.1021/bi00485a024; SUGA H, 1993, EUR J BIOCHEM, V218, P807, DOI 10.1111/j.1432-1033.1993.tb18435.x; TRACY PB, 1982, BLOOD, V60, P59; VERHEIJ HM, 1980, EUR J BIOCHEM, V112, P25, DOI 10.1111/j.1432-1033.1980.tb04982.x; WERY JP, 1991, NATURE, V352, P79, DOI 10.1038/352079a0; WHITE SR, 1993, J CLIN INVEST, V91, P2118, DOI 10.1172/JCI116436; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; ZWAAL RFA, 1992, BIOCHIM BIOPHYS ACTA, V1180, P1, DOI 10.1016/0925-4439(92)90019-J	52	52	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23764	23772		10.1074/jbc.273.37.23764	http://dx.doi.org/10.1074/jbc.273.37.23764			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726985	hybrid			2022-12-27	WOS:000075893100026
J	Rall, SC; Ye, P; Bu, GJ; Wardell, MR				Rall, SC; Ye, P; Bu, GJ; Wardell, MR			The domain structure of human receptor-associated protein - Protease sensitivity and guanidine HCl denaturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							39-KDA PROTEIN; ALPHA-2-MACROGLOBULIN RECEPTOR; MOLECULAR CHAPERONE; HEYMANN NEPHRITIS; AQUEOUS-SOLUTION; BINDING; LRP; CELLS; RAP	The 39-kDa receptor-associated protein (RAP), a specialized chaperone for endocytic receptors of the low density lipoprotein receptor gene family, is a triplicate repeat sequence (residues 1-100, 101-280, and 201-323, respectively), with the three repeats having different functional roles. The goal of the present study was tee use a combination of protease sensitivity and guanidine denaturation analyses to investigate whether human RAP correspondingly contained multiple structural domains, Protease sensitivity analysis using six proteolytic enzymes of varying specificity showed that RAP has two protease-resistant regions contained withins repeat 1 (residues 15-94) and repeat 3 (residues 223-323), Guanidine denaturation analysis showed that RAP has two phases in its denaturation, an early denaturation transition at 0.6 M guanidine HCl, and a broad second transition between 1.(3 and 3.0 M guanidine HCl. Analysis of the denaturation of the individual repeats showed that, despite the similarity in sequence and protease sensitivity between repeats 1 and 3, repeat 1 was a stable structure, with a sharp transition midpoint at 2.4 M guanidine NCl, while repeat 3 was relatively unstable, with a transition midpoint at 0.6 RI guanidine HCl. Repeat 2 had a denaturation profile almost identical to that of repeat 3, Denaturation analysis of the contiguous repeats 1 and 2 (residues 1-210) indicated that repeats 1 and 2 probably interact to form one structural domain represented by the broad transition, while repeat 3 constitutes a separate domain represented by the early transition, A two-domain model of RAP three-dimensional structure is proposed that integrates both structural and functional information, in which a helical segment from repeal 2 interacts with the known three-helix bundle of repeat 1 to form a four-helix bundle structural domain, while repeat 3 forms the other structural domain.	St Louis Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; St Louis Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; St Louis Univ, Sch Med, Dept Cell Biol & Biophys, St Louis, MO 63110 USA; St Louis Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Saint Louis University; Saint Louis University; Saint Louis University; Saint Louis University	Wardell, MR (corresponding author), St Louis Univ, Sch Med, Dept Biochem & Mol Biophys, Campus Box 8231,660 S Euclid Ave, St Louis, MO 63110 USA.	mrw@patmos.wustl.edu			NHLBI NIH HHS [HL 59150] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059150] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGGERBECK LP, 1988, J BIOL CHEM, V263, P6249; Bu GJ, 1998, CURR OPIN LIPIDOL, V9, P149, DOI 10.1097/00041433-199804000-00012; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; BU GJ, 1994, J BIOL CHEM, V269, P29874; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Ellgaard L, 1997, EUR J BIOCHEM, V244, P544, DOI 10.1111/j.1432-1033.1997.00544.x; HERZ J, 1991, J BIOL CHEM, V266, P21232; IADONATO SP, 1993, BIOCHEM J, V296, P867, DOI 10.1042/bj2960867; Kerjaschki D, 1996, J EXP MED, V183, P2007, DOI 10.1084/jem.183.5.2007; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; KRISTENSEN T, 1990, FEBS LETT, V276, P151, DOI 10.1016/0014-5793(90)80530-V; MILETICH JP, 1978, J BIOL CHEM, V253, P6908; Nielsen PR, 1997, P NATL ACAD SCI USA, V94, P7521, DOI 10.1073/pnas.94.14.7521; Obermoeller LM, 1997, J BIOL CHEM, V272, P10761; ORLANDO RA, 1994, P NATL ACAD SCI USA, V91, P3161, DOI 10.1073/pnas.91.8.3161; STRICKLAND DK, 1991, J BIOL CHEM, V266, P13364; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; WARSHAWSKY I, 1993, J BIOL CHEM, V268, P22046; WARSHAWSKY I, 1994, J BIOL CHEM, V269, P3325; WARSHAWSKY I, 1995, BIOCHEMISTRY-US, V34, P3404, DOI 10.1021/bi00010a032; WETTERAU JR, 1988, J BIOL CHEM, V263, P6240; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; WILLNOW TE, 1994, SCIENCE, V264, P1471, DOI 10.1126/science.7515194; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194	26	12	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24152	24157		10.1074/jbc.273.37.24152	http://dx.doi.org/10.1074/jbc.273.37.24152			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727037	hybrid			2022-12-27	WOS:000075893100078
J	Segall, AM				Segall, AM			Analysis of higher order intermediates and synapsis in the bent-L pathway of bacteriophage lambda site-specific recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRATIVE RECOMBINATION; NUCLEASE ACTIVITY; ATTACHMENT SITES; DNA; COMPLEXES; HOMOLOGY; ATTL; INT	The integrase proteins of bacteriophage lambda mediates recombination via four distinct pathways. The recent in vitro reconstitution of the efficient bidirectional reaction between two attLtenP'1 target sites now allows comparisons of this pathway, known as the bent-L pathway, with the inefficient bidirectional straight-L pathway and with the efficient but unidirectional pathways of integration and excision. To this end, a series of higher order intermediates of the bent-L pathway was characterized using gel mobility shift assays, two-dimensional gel analysis, and footprinting. The analysis spans the initial binding of proteins to individual DNA target sites, synapsis of two partner DNA targets, and strand exchange. This study identifies a presynaptic "checkpoint" of recombination. IL shows that synapsis is a slow step in the recombination reaction, while subsequent strand exchange is comparatively fast. Synaptic complexes contain a preponderance of recombinant products, suggesting that an energetically favorable but somewhat subtle conformational change drives strand exchange. In addition, comparison of wild-type integrase with a catalytically defective mutant of integrase, IntF, showed that, ire addition to the catalysis defect, this mutant has different DNA-binding properties than the wild-type protein.	San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; San Diego State Univ, Inst Mol Biol, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University	Segall, AM (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.			Segall, Anca/0000-0002-8454-5248	NIGMS NIH HHS [GM-52847] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052847] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BURGIN AB, 1995, CURR BIOL, V5, P1312, DOI 10.1016/S0960-9822(95)00258-2; DEVARGAS LM, 1988, CELL, V54, P923, DOI 10.1016/0092-8674(88)90107-9; ECHOLS H, 1970, Journal of Molecular Biology, V47, P575, DOI 10.1016/0022-2836(70)90324-4; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; KIKUCHI A, 1985, J MOL BIOL, V52, P30; KIM S, 1992, SCIENCE, V256, P198, DOI 10.1126/science.1533056; LANDY A, 1993, CURR OPIN GENET DEV, V3, P699, DOI 10.1016/S0959-437X(05)80086-3; LANDY A, 1983, LAMBDA, V2, P211; Maxam A M, 1980, Methods Enzymol, V65, P499; MAZUMDER A, 1993, FOOTPRINTING NUCLEIC, P45; Nash H, 1996, ESCHERICHIA COLI SAL, P2363; NASH HA, 1989, EMBO J, V8, P3523, DOI 10.1002/j.1460-2075.1989.tb08518.x; NUMRYCH TE, 1990, NUCLEIC ACIDS RES, V18, P3953, DOI 10.1093/nar/18.13.3953; NUNESDUBY SE, 1995, CURR BIOL, V5, P139, DOI 10.1016/S0960-9822(95)00035-2; PARGELLIS CA, 1988, J BIOL CHEM, V263, P7678; RICHET E, 1988, CELL, V52, P9, DOI 10.1016/0092-8674(88)90526-0; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SEGALL AM, 1993, EMBO J, V12, P4567, DOI 10.1002/j.1460-2075.1993.tb06145.x; Segall AM, 1996, GENES CELLS, V1, P453, DOI 10.1046/j.1365-2443.1996.d01-254.x; SIGMAN DS, 1991, METHOD ENZYMOL, V208, P414; THEDERAHN T, 1990, BIOCHEM BIOPH RES CO, V168, P756, DOI 10.1016/0006-291X(90)92386-E; Tirumalai RS, 1997, P NATL ACAD SCI USA, V94, P6104, DOI 10.1073/pnas.94.12.6104	22	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					24258	24265		10.1074/jbc.273.37.24258	http://dx.doi.org/10.1074/jbc.273.37.24258			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9727050	hybrid			2022-12-27	WOS:000075893100091
J	Tao, WK; Kurschner, C; Morgan, JI				Tao, WK; Kurschner, C; Morgan, JI			Bcl-xS and Bad potentiate the death suppressing activities of Bcl-xL, Bcl-2, and A1 in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; HUMAN FOLLICULAR LYMPHOMA; PROAPOPTOTIC PROTEIN BAX; C-ELEGANS CED-4; MOLECULAR REGULATION; APOPTOSIS; GENE; BCL-X(L); HOMOLOG; FAMILY	Members of the Bc1-2 family can be grouped into three classes based upon their effects on cell death. The first class suppresses death and includes Bcl-2. A second group which includes Bax, is lethal, whereas a third class, including Bcl-xS, potentiates killing although the members are not lethal by themselves. The proteins in the last class ape proposed to exert their activity by binding to anti-apoptotic family members, thereby making the cell more susceptible to killing by another agent. To test this hypothesis, an inducible yeast expression system is reported that permits the functional analysis of three Bcl-2 family members, in yeast. Bax is lethal, and this activity is suppressed by Bcl-xL, Bcl-2, and Al. Co-expression of Bcl-xS did not diminish the ability of any of the anti-apoptotic members to antagonize Bax. Rather, co-expression of Bcl-xS potentiated the anti-death activity of all three proteins. This effect was not the result of changes in either the levels or integrity of Bax or anti-apoptotic proteins. Thus, Bcl-xS can bind to anti-apoptotic family members, but this association does not result in loss of biological activity. Therefore, Bcl-xS may act downstream of Bax and in a pathway that is conserved in yeast.	St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Morgan, JI (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	jim.morgan@stjude.org	Morgan, James/GRO-2905-2022; Morgan, James/N-8104-2018; tao, wei/GXN-4445-2022	Morgan, James/0000-0002-8920-1065; 	NCI NIH HHS [P30 CA21756] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abbas AK, 1996, CELL, V84, P655, DOI 10.1016/S0092-8674(00)81042-9; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Cheng EHY, 1997, P NATL ACAD SCI USA, V94, P690, DOI 10.1073/pnas.94.2.690; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; DALTON S, 1992, CELL, V68, P579; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; Greenhalf W, 1996, FEBS LETT, V380, P169, DOI 10.1016/0014-5793(96)00044-0; GUARENTE L, 1982, P NATL ACAD SCI-BIOL, V79, P7410, DOI 10.1073/pnas.79.23.7410; GUTHRIE C, 1991, METHOD ENZYMOL, V194, P12; Hale AJ, 1996, EUR J BIOCHEM, V236, P1, DOI 10.1111/j.1432-1033.1996.00001.x; HANADA M, 1995, J BIOL CHEM, V270, P11962, DOI 10.1074/jbc.270.20.11962; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; KURSCHNER C, 1995, MOL CELL BIOL, V15, P246, DOI 10.1128/MCB.15.1.246; Kurschner C, 1996, MOL BRAIN RES, V37, P249, DOI 10.1016/0169-328X(95)00323-K; Matsuyama S, 1998, MOL CELL, V1, P327, DOI 10.1016/S1097-2765(00)80033-7; Minn AJ, 1996, J BIOL CHEM, V271, P6306, DOI 10.1074/jbc.271.11.6306; Miura M, 1996, CURR TOP DEV BIOL, V32, P139, DOI 10.1016/S0070-2153(08)60427-5; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; OLTVAI ZN, 1994, CELL, V79, P189, DOI 10.1016/0092-8674(94)90188-0; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Raff MC, 1996, CELL, V86, P173, DOI 10.1016/S0092-8674(00)80087-2; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Sambrook J., 2002, MOL CLONING LAB MANU; SATO T, 1994, P NATL ACAD SCI USA, V91, P9238, DOI 10.1073/pnas.91.20.9238; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Shaham S, 1996, CELL, V86, P201, DOI 10.1016/S0092-8674(00)80092-6; Tao WK, 1997, J BIOL CHEM, V272, P15547, DOI 10.1074/jbc.272.24.15547; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; TSUJIMOTO Y, 1986, P NATL ACAD SCI USA, V83, P5214, DOI 10.1073/pnas.83.14.5214; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; VAUX DL, 1993, P NATL ACAD SCI USA, V90, P786, DOI 10.1073/pnas.90.3.786; WILLIAMS GT, 1994, J PATHOL, V173, P1, DOI 10.1002/path.1711730102; WILLIAMS GT, 1993, CELL, V74, P777, DOI 10.1016/0092-8674(93)90457-2; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Zha HB, 1996, J BIOL CHEM, V271, P7440, DOI 10.1074/jbc.271.13.7440; Zha HB, 1996, MOL CELL BIOL, V16, P6494; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	41	17	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 11	1998	273	37					23704	23708		10.1074/jbc.273.37.23704	http://dx.doi.org/10.1074/jbc.273.37.23704			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119JT	9726976	hybrid			2022-12-27	WOS:000075893100017
J	Gallois, C; Habib, A; Tao, JC; Moulin, S; Maclouf, J; Mallat, A; Lotersztajn, S				Gallois, C; Habib, A; Tao, JC; Moulin, S; Maclouf, J; Mallat, A; Lotersztajn, S			Role of NF-kappa B in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells - Involvement of cyclooxygenase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN ENDOPEROXIDE SYNTHASE-2; GROWTH-INHIBITORY PROPERTIES; SMOOTH-MUSCLE CELLS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; INDUCIBLE CYCLOOXYGENASE; MEDIATED PATHWAY; ACTIVATION; KINASE; PROTEIN	During chronic liver diseases, hepatic stellate cells (HSC) acquire an activated myofibroblast-like phenotype and proliferate and synthesize fibrosis components. Endothelin-1 (ET-1), which inhibited the growth of human myofibroblastic HSC, increased the formation of two NF-kappa B DNA binding complexes; this effect was also observed with tumor necrosis factor-alpha (TNF-alpha). The complexes were identified as the p50/p50 and p50/p65 NP-kappa B dimers. Activation of NF-kappa B was associated with the degradation of the inhibitory protein I kappa B-alpha; no I kappa B-beta was detected. Activation of NF-kappa B and degradation of I kappa B-alpha were prevented by the NF-kappa B inhibitors sodium salicylate and MG-132. In addition to cyclooxygenase-1 (COX-1), COX-2 is also constitutively expressed in human HSC, and the use of dexamethasone and of SC-58125, a selective COX-2 inhibitor, revealed that COX-2 accounts for basal COX activity. Moreover, COX-2 mRNA and protein were up-regulated by ET-1 and TNF-alpha, whereas COX-1 was unaffected. Induction of COX-2 and stimulation of COX activity by ET-1 and TNF-alpha were prevented by sodium salicylate and MG-132, suggesting that activation of NF-kappa B by either factor is needed for stimulation of COX-2, Finally, SC-58125 and dexamethasone reduced the growth inhibitory effect of ET-1 and TNF-alpha, indicating that activation of COX-2 is required for inhibition of HSC proliferation. Taken together, our results suggest that NF-kappa B, by inducing COX-2 expression, may play an important role in the negative regulation of human myofibroblastic HSC proliferation.	Hop Henri Mondor, INSERM, Unite 99, F-94010 Creteil, France; Hop Lariboisiere, Inst Federat Rech Circulat Lariboisiere, INSERM, Unite 348, F-75010 Paris, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Lotersztajn, S (corresponding author), Hop Henri Mondor, INSERM, Unite 99, F-94010 Creteil, France.	loterszt@im3.inserm.fr	Habib, Aida/H-8647-2019; Lotersztajn, Sophie/K-9160-2017	Habib, Aida/0000-0001-6027-0043; lotersztajn, Sophie/0000-0002-0053-7807				Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BALDWIN AS, 1991, MOL CELL BIOL, V11, P4943, DOI 10.1128/MCB.11.10.4943; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bash J, 1997, MOL CELL BIOL, V17, P6526, DOI 10.1128/MCB.17.11.6526; BELLAS RE, 1995, J CLIN INVEST, V96, P2521, DOI 10.1172/JCI118313; BENO DWA, 1994, BBA-MOL CELL RES, V1222, P292, DOI 10.1016/0167-4889(94)90181-3; BENO DWA, 1993, HEPATOLOGY, V17, P707, DOI 10.1002/hep.1840170427; Bornfeldt KE, 1997, J CLIN INVEST, V100, P875, DOI 10.1172/JCI119603; Brand K, 1996, J CLIN INVEST, V97, P1715, DOI 10.1172/JCI118598; Browning DD, 1997, J BIOL CHEM, V272, P7995, DOI 10.1074/jbc.272.12.7995; CREMINON C, 1995, BBA-LIPID LIPID MET, V1254, P333, DOI 10.1016/0005-2760(94)00196-6; DAcquisto F, 1997, FEBS LETT, V418, P175, DOI 10.1016/S0014-5793(97)01377-X; DEBOSSCHER K, 1997, P NATL ACAD SCI USA, V94, P13501; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DuBois RN, 1996, CANCER RES, V56, P733; DUCKETT CS, 1995, J BIOL CHEM, V270, P18836, DOI 10.1074/jbc.270.32.18836; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; Frolich JC, 1997, TRENDS PHARMACOL SCI, V18, P30, DOI 10.1016/S0165-6147(96)01017-6; GEERTS A, 1991, HEPATOLOGY, V13, P1193, DOI 10.1002/hep.1840130628; HABIB A, 1993, J BIOL CHEM, V268, P23448; Hellerbrand C, 1996, HEPATOLOGY, V24, P670; ISRAEL A, 1995, TRENDS GENET, V11, P203, DOI 10.1016/S0168-9525(00)89045-9; Israel A, 1997, NATURE, V388, P519, DOI 10.1038/41433; Kaplan MD, 1997, J BIOL CHEM, V272, P18534, DOI 10.1074/jbc.272.30.18534; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; KESTER M, 1994, J BIOL CHEM, V269, P22574; KRAVCHENKO VV, 1995, J BIOL CHEM, V270, P14928, DOI 10.1074/jbc.270.25.14928; LEE KS, 1995, J CLIN INVEST, V96, P2461, DOI 10.1172/JCI118304; Li JY, 1996, MOL ENDOCRINOL, V10, P252, DOI 10.1210/me.10.3.252; MALLAT A, 1995, J CLIN INVEST, V96, P42, DOI 10.1172/JCI118052; Mallat A, 1996, J CLIN INVEST, V98, P2771, DOI 10.1172/JCI119103; MANCINI R, 1992, J HEPATOL, V15, P361, DOI 10.1016/0168-8278(92)90069-2; MARI B, 1994, J BIOL CHEM, V269, P8517; Marra F, 1996, J CLIN INVEST, V98, P1218, DOI 10.1172/JCI118905; Martinez J, 1997, AM J PHYSIOL-CELL PH, V273, pC1466, DOI 10.1152/ajpcell.1997.273.5.C1466; MATSUOKA M, 1989, LIVER, V9, P71; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; MITCHELL JA, 1993, P NATL ACAD SCI USA, V90, P11693, DOI 10.1073/pnas.90.24.11693; Newton R, 1997, BIOCHEM BIOPH RES CO, V237, P28, DOI 10.1006/bbrc.1997.7064; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pan ZK, 1996, J CLIN INVEST, V98, P2042, DOI 10.1172/JCI119009; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Roshak AK, 1996, J BIOL CHEM, V271, P31496, DOI 10.1074/jbc.271.49.31496; SCHMITTGRAFF A, 1991, AM J PATHOL, V138, P1233; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; Sheng GG, 1997, GASTROENTEROLOGY, V113, P1883, DOI 10.1016/S0016-5085(97)70007-6; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Stoltz RA, 1996, P NATL ACAD SCI USA, V93, P2832, DOI 10.1073/pnas.93.7.2832; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; Weil R, 1997, J BIOL CHEM, V272, P9942; WIN KM, 1993, HEPATOLOGY, V18, P137, DOI 10.1002/hep.1840180121; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; WU HY, 1994, J BIOL CHEM, V269, P20067; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315	57	152	159	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23183	23190		10.1074/jbc.273.36.23183	http://dx.doi.org/10.1074/jbc.273.36.23183			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722548	hybrid			2022-12-27	WOS:000075778100048
J	Lambert, CA; Lapiere, CM; Nusgens, BW				Lambert, CA; Lapiere, CM; Nusgens, BW			An interleukin-1 loop is induced in human skin fibroblasts upon stress relaxation in a three-dimensional collagen gel but is not involved in the up-regulation of matrix metalloproteinase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; GENE-EXPRESSION; CELL-PROLIFERATION; DERMAL FIBROBLASTS; MECHANICAL FORCES; INHIBITOR; INTEGRIN; INDUCTION; REGION; RESPONSES	The integrin-mediated stress relaxation as it occurs in a retracting three-dimensional collagen gel (RCG) is accompanied by a large up-regulation of the interstitial collagenase, matrix metalloproteinase 1 ((MMP-1), EC 3.4.24.7), regulated notably by interleukin-1 (IL-1), phorbol esters, and cytoskeleton-disrupting drugs as cytochalasin D (CD), The repression of MMP-1 up-regulation in RCG by cycloheximide suggested the participation in the regulation process of a de novo synthesized intermediary component. We demonstrate here that culture of human skin fibroblasts in RCG or in CD- and 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated monolayers resulted in the activation of an IL-1 autocrine feedback loop that was switched off by the naturally occurring IL-1 receptor antagonist (IL-1RA), a blocker of the common IL-1 receptor. The IL-1RA did not suppress the MMP-1 up-regulation induced in RCG nor in CD-treated cells, indicating that the up-regulation of MMP-1 and the IL-1 autocrine loop occurred in an independent way,while the TPA-induced MMP-1 expression was suppressed by the receptor antagonist. The RCG- as well as the TPA-, IL-1-, and CD-induced up-regulation of both MMP-1 and IL-1 was totally suppressed by protein tyrosine kinases inhibitors. In contrast bisindoylmaleimide, at a concentration (5 mu M) that inhibits the TPA-induced protein kinase C activity, suppressed the CD-induced MMP-1 expression but did not or barely altered that induced in RCG or by IL-1, None of the other tested inhibitors of a variety of signaling pathways including those used by integrins was able to suppress the RCG or CD-induced MMP-1, These results point to a potent regulation of MMP-1 by mechanical stress relaxation, a process depending on de novo protein synthesis and occurring independently of the activation of an IL-1 autocrine feedback loop.	Univ Liege, Lab Connect Tissue Biol, B-4000 Sart Tilman, Belgium	University of Liege	Nusgens, BW (corresponding author), Univ Liege, Lab Connect Tissue Biol, Tour Pathol B23-3, B-4000 Sart Tilman, Belgium.	LCTB@ulg.ac.be						AHARON T, 1993, MOL CELL BIOL, V13, P1971, DOI 10.1128/MCB.13.3.1971; AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Broberg A, 1996, EXP CELL RES, V228, P29, DOI 10.1006/excr.1996.0295; BROWN MS, 1978, J BIOL CHEM, V253, P1121; CARNEY DH, 1985, CELL, V42, P479, DOI 10.1016/0092-8674(85)90105-9; CHAN BM, 1992, CELL, V68, P1051, DOI 10.1016/0092-8674(92)90077-P; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; DAYER JM, 1986, J CLIN INVEST, V77, P645, DOI 10.1172/JCI112350; DELVOYE P, 1991, J INVEST DERMATOL, V97, P898, DOI 10.1111/1523-1747.ep12491651; FINI ME, 1994, J BIOL CHEM, V269, P11291; HAZUDA DJ, 1990, J BIOL CHEM, V265, P6318; HE YJ, 1994, J CELL BIOL, V126, P457, DOI 10.1083/jcb.126.2.457; HIDAKA H, 1981, P NATL ACAD SCI-BIOL, V78, P4354, DOI 10.1073/pnas.78.7.4354; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5035; Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575; KOSTURA MJ, 1989, P NATL ACAD SCI USA, V86, P5227, DOI 10.1073/pnas.86.14.5227; LAMBERT CA, 1992, LAB INVEST, V66, P444; Langholz O, 1995, J CELL BIOL, V131, P1903, DOI 10.1083/jcb.131.6.1903; LBURGER EH, 1992, J BONE MINER RES, V7, P397; LEAHY JC, 1991, NEUROSCIENCE, V44, P361, DOI 10.1016/0306-4522(91)90061-R; LISCOVITCH M, 1991, BIOCHEM J, V279, P319, DOI 10.1042/bj2790319; LYALL RM, 1989, J BIOL CHEM, V264, P14503; MAUCH C, 1988, EXP CELL RES, V178, P493, DOI 10.1016/0014-4827(88)90417-X; MAUCH C, 1989, FEBS LETT, V250, P301, DOI 10.1016/0014-5793(89)80743-4; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MULLERDECKER K, 1989, BIOCHEM BIOPH RES CO, V162, P198, DOI 10.1016/0006-291X(89)91981-5; NAKANISHI S, 1992, J BIOL CHEM, V267, P2157; NATHAN C, 1991, J CELL BIOL, V113, P981, DOI 10.1083/jcb.113.5.981; NISHIYAMA T, 1993, MATRIX, V13, P447, DOI 10.1016/S0934-8832(11)80111-3; NUSGENS B, 1984, COLLAGEN REL RES, V4, P351; RIIKONEN T, 1995, J BIOL CHEM, V270, P13548, DOI 10.1074/jbc.270.22.13548; Roskelley CD, 1995, BIOCHEM CELL BIOL, V73, P391, DOI 10.1139/o95-046; Ruoslahti E, 1997, SCIENCE, V276, P1345, DOI 10.1126/science.276.5317.1345; Rutter JL, 1997, J CELL BIOCHEM, V66, P322, DOI 10.1002/(SICI)1097-4644(19970901)66:3<322::AID-JCB5>3.3.CO;2-D; SCHIRO JA, 1991, CELL, V67, P403, DOI 10.1016/0092-8674(91)90191-Z; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Shyy JYJ, 1997, CURR OPIN CELL BIOL, V9, P707, DOI 10.1016/S0955-0674(97)80125-1; STEVENSON KM, 1992, J DEV PHYSIOL, V17, P257; THIRYBLAISE LM, 1995, CALCIFIED TISSUE INT, V56, P88, DOI 10.1007/BF00298750; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; UEHARA Y, 1986, MOL CELL BIOL, V6, P2198, DOI 10.1128/MCB.6.6.2198; UNEMORI EN, 1986, J CELL BIOL, V103, P1021, DOI 10.1083/jcb.103.3.1021; VANCORVEN EJ, 1989, CELL, V59, P45, DOI 10.1016/0092-8674(89)90868-4; Varedi M, 1997, J CELL PHYSIOL, V172, P192, DOI 10.1002/(SICI)1097-4652(199708)172:2<192::AID-JCP6>3.0.CO;2-J; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; WERB Z, 1986, J CELL BIOL, V102, P697, DOI 10.1083/jcb.102.3.697; WESTMAYS JA, 1995, P NATL ACAD SCI USA, V92, P6768, DOI 10.1073/pnas.92.15.6768; WestMays JA, 1997, INVEST OPHTH VIS SCI, V38, P1367; Xu JH, 1997, J CELL BIOL, V136, P473, DOI 10.1083/jcb.136.2.473; Yamada KM, 1997, CURR OPIN CELL BIOL, V9, P76, DOI 10.1016/S0955-0674(97)80155-X; YOUNG PR, 1988, J CELL BIOL, V107, P447, DOI 10.1083/jcb.107.2.447	56	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	1998	273	36					23143	23149		10.1074/jbc.273.36.23143	http://dx.doi.org/10.1074/jbc.273.36.23143			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	117JL	9722543	hybrid			2022-12-27	WOS:000075778100043
J	Bisello, A; Adams, AE; Mierke, DF; Pellegrini, M; Rosenblatt, M; Suva, LJ; Chorev, M				Bisello, A; Adams, AE; Mierke, DF; Pellegrini, M; Rosenblatt, M; Suva, LJ; Chorev, M			Parathyroid hormone-receptor interactions identified directly by photocross-linking and molecular modeling studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P NK-1 RECEPTOR; (PTH)/PTH-RELATED PEPTIDE RECEPTOR; PHOTOAFFINITY CROSS-LINKING; HUMAN PTH/PTHRP RECEPTOR; OSTEOBLAST-LIKE CELLS; EXPRESSION CLONING; SUBSTANCE-P; PROTEIN-RECEPTOR; BINDING-SITE; BIMOLECULAR INTERACTIONS	Direct mapping of the interface between parathyroid hormone (PTH) and its receptor (hPTH1-Rc) was carried out by photoaffinity scanning studies. Photoreactive analogs of PTH singularly substituted with a p-benzoyl-phenylalanine (Bpa) at each of the first six N-terminal positions have been prepared. Among these, the analog [Bpa(1),Nle(8,18),Arg(13,26,27),L-2-Nal(23),Tyr(34)] bPTH-(1-34)NH2 (Bpa(1)-PTH-(1-34)) displayed in vitro activity with potency similar to that of PTH-(1-34). The radioiodinated analog I-125-Bpa(1)-PTH-(1-34) cross-linked specifically to the hPTH1-Rc stably expressed in human embryonic kidney cells. A series of chemical and enzymatic digestions of the hPTH1-Rc-I-125-Bpa(1)-PTH-(1-34) conjugate suggested that a methionine residue (either Met(414) or Met(425)) within the contact domain hPTH1-Rc-(409-437), which includes the transmembrane helix 6 and part of the third extracellular loop, as the putative contact point. Site-directed mutagenesis (M414L or M425L) identified Met(425) as the putative contact point. Molecular modeling of the hPTH1-Rc together with the NMR-derived high resolution structure of hPTH-(1-34), guided by the cross-linking data, strongly supports Met(425), at the extracellular end of transmembrane helix 6, as the residue interacting with the N-terminal residue of the hPTH-(1-34). The photocross-linking and molecular modeling studies provide insight into the topologic arrangement of the receptor-ligand complex.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr,Charles A Dana Lab, Div Bone & Mineral Metab HIM 944,Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr,Thorndike Lab, Div Bone & Mineral Metab HIM 944,Dept Med, Boston, MA 02215 USA; Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Toxicol, Worcester, MA 01655 USA; Clark Univ, Dept Chem, Worcester, MA 01610 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; Clark University	Chorev, M (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr,Charles A Dana Lab, Div Bone & Mineral Metab HIM 944,Dept Med, 330 Brookline Ave, Boston, MA 02215 USA.		Pellegrini, Maria/W-6005-2019	Pellegrini, Maria/0000-0003-3817-4412; Suva, Larry/0000-0002-2892-9757	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM054082, R01GM054082] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK47940] Funding Source: Medline; NIGMS NIH HHS [GM54082] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; ADAMS AE, 1995, BIOCHEMISTRY-US, V34, P10553, DOI 10.1021/bi00033a030; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Behar V, 1996, ENDOCRINOLOGY, V137, P2748, DOI 10.1210/en.137.7.2748; Bisello A, 1996, BIOCHEMISTRY-US, V35, P15890, DOI 10.1021/bi962111+; BLANTON MP, 1994, MOL PHARMACOL, V46, P1048; Boyd ND, 1996, P NATL ACAD SCI USA, V93, P433, DOI 10.1073/pnas.93.1.433; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; Chorev Michael, 1994, P139; Chorev Michael, 1996, P305; CIVITELLI R, 1989, ENDOCRINOLOGY, V125, P1204, DOI 10.1210/endo-125-3-1204; DEMPSTER DW, 1993, ENDOCR REV, V14, P690, DOI 10.1210/er.14.6.690; DONNELLY D, 1994, PROTEIN ENG, V7, P645, DOI 10.1093/protein/7.5.645; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; Fitzpatrick Lorraine A., 1996, P339; GARDELLA TJ, 1994, ENDOCRINOLOGY, V135, P1186, DOI 10.1210/en.135.3.1186; Girault S, 1996, EUR J BIOCHEM, V240, P215, DOI 10.1111/j.1432-1033.1996.0215h.x; Huang ZM, 1996, J BIOL CHEM, V271, P33382, DOI 10.1074/jbc.271.52.33382; ISHIHARA T, 1992, NEURON, V8, P811, DOI 10.1016/0896-6273(92)90101-I; ISHIHARA T, 1991, EMBO J, V10, P1635, DOI 10.1002/j.1460-2075.1991.tb07686.x; JELINEK LJ, 1993, SCIENCE, V259, P1614, DOI 10.1126/science.8384375; Ji ZS, 1997, J BIOL CHEM, V272, P24393, DOI 10.1074/jbc.272.39.24393; Juppner H, 1994, Curr Opin Nephrol Hypertens, V3, P371; JUPPNER H, 1994, ENDOCRINOLOGY, V134, P879, DOI 10.1210/en.134.2.879; Kage R, 1996, J BIOL CHEM, V271, P25797, DOI 10.1074/jbc.271.42.25797; KARPF DB, 1987, BIOCHEMISTRY-US, V26, P7825, DOI 10.1021/bi00398a044; KEUTMANN HT, 1993, ENDOCRINOLOGY, V132, P1305, DOI 10.1210/en.132.3.1305; KOJRO E, 1993, BIOCHEMISTRY-US, V32, P13537, DOI 10.1021/bi00212a020; Konopka JB, 1996, P NATL ACAD SCI USA, V93, P6764, DOI 10.1073/pnas.93.13.6764; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE CW, 1995, MOL ENDOCRINOL, V9, P1269, DOI 10.1210/me.9.10.1269; LI YM, 1995, J BIOL CHEM, V270, P1213, DOI 10.1074/jbc.270.3.1213; LIN HY, 1991, SCIENCE, V254, P1022, DOI 10.1126/science.1658940; MILLER WT, 1988, P NATL ACAD SCI USA, V85, P5429, DOI 10.1073/pnas.85.15.5429; NAKAMOTO C, 1995, BIOCHEMISTRY-US, V34, P10546, DOI 10.1021/bi00033a029; Pellegrini M, 1997, J MED CHEM, V40, P99, DOI 10.1021/jm9605389; Pellegrini M, 1998, J BIOL CHEM, V273, P10420, DOI 10.1074/jbc.273.17.10420; Pines M, 1996, BONE, V18, P381, DOI 10.1016/8756-3282(96)00008-7; PINES M, 1994, ENDOCRINOLOGY, V135, P1713, DOI 10.1210/en.135.4.1713; ROSENBLATT M, 1976, J BIOL CHEM, V251, P159; ROUBINI E, 1992, BIOCHEMISTRY-US, V31, P4026, DOI 10.1021/bi00131a018; SCHERTLER GFX, 1993, NATURE, V362, P770, DOI 10.1038/362770a0; SCHIPANI E, 1993, ENDOCRINOLOGY, V132, P2157, DOI 10.1210/en.132.5.2157; SHIGENO C, 1988, J BIOL CHEM, V263, P3872; Spalding TA, 1997, BIOCHEMISTRY-US, V36, P10109, DOI 10.1021/bi970565g; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; USDIN TB, 1995, J BIOL CHEM, V270, P15455, DOI 10.1074/jbc.270.26.15455; USDIN TB, 1993, ENDOCRINOLOGY, V133, P2861, DOI 10.1210/en.133.6.2861; WILLIAMS KP, 1993, J BIOL CHEM, V268, P5361; Zhou AT, 1997, P NATL ACAD SCI USA, V94, P3644, DOI 10.1073/pnas.94.8.3644	50	165	179	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22498	22505		10.1074/jbc.273.35.22498	http://dx.doi.org/10.1074/jbc.273.35.22498			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712875	hybrid			2022-12-27	WOS:000075616600051
J	Pike, LJ; Miller, JM				Pike, LJ; Miller, JM			Cholesterol depletion delocalizes phosphatidylinositol bisphosphate and inhibits hormone-stimulated phosphatidylinositol turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; CAVEOLAE MEMBRANE; SIGNAL-TRANSDUCTION; PROTEIN-COMPONENT; TYROSINE KINASE; CELL-SURFACE; RECEPTOR; DOMAINS; CYCLODEXTRINS; MICRODOMAINS	Caveolae and detergent-insoluble, glycosphingolipid-enriched domains (DIGs) are cholesterol-enriched membrane domains that have been implicated in signal transduction because a variety of signaling proteins as well as phosphatidylinositol bisphosphate (PtdInsP(2)) are compartmentalized in these domains. We report here that depletion of cellular cholesterol leads to the inhibition of epidermal growth factor- and bradykinin-stimulated PtdIns turnover in A431 cells. This is associated with the loss of compartmentalization of epidermal growth factor receptors, G(q), and PtdInsP(2) in the low density membrane domains. Replacement of cellular cholesterol leads to the reorganization of signaling molecules in the low density domains and the reestablishment of hormone-stimulated PtdIns hydrolysis. Oxysterol derivatives show a variable ability to functionally replace the cholesterol in this system. These data are consistent with the hypothesis that localization of signaling proteins and lipids to cholesterol-enriched domains is required for the proper function of hormone-stimulated PtdIns turnover.	Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Pike, LJ (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, 660 So Euclid,Box 8231, St Louis, MO 63110 USA.	pike@biochem.wustl.edu						BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; CHUN MY, 1994, P NATL ACAD SCI USA, V91, P11728, DOI 10.1073/pnas.91.24.11728; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; DOWNES CP, 1981, BIOCHEM J, V198, P133, DOI 10.1042/bj1980133; FIEDLER K, 1993, BIOCHEMISTRY-US, V32, P6365, DOI 10.1021/bi00076a009; FRA AM, 1994, J BIOL CHEM, V269, P30745; Gimpl G, 1997, BIOCHEMISTRY-US, V36, P10959, DOI 10.1021/bi963138w; GIMPL G, 1995, BIOCHEMISTRY-US, V34, P4065; GLENNEY JR, 1989, J CELL BIOL, V108, P2401, DOI 10.1083/jcb.108.6.2401; GLENNEY JR, 1992, P NATL ACAD SCI USA, V89, P10517, DOI 10.1073/pnas.89.21.10517; Hope HR, 1996, MOL BIOL CELL, V7, P843, DOI 10.1091/mbc.7.6.843; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Liu J, 1997, J BIOL CHEM, V272, P7211, DOI 10.1074/jbc.272.11.7211; Liu PS, 1996, J BIOL CHEM, V271, P10299, DOI 10.1074/jbc.271.17.10299; Liu YM, 1998, BIOCHEM BIOPH RES CO, V245, P684, DOI 10.1006/bbrc.1998.8329; MCGUIRE TF, 1993, J BIOL CHEM, V268, P22227; Mineo C, 1996, J BIOL CHEM, V271, P11930, DOI 10.1074/jbc.271.20.11930; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; Oka N, 1997, J BIOL CHEM, V272, P33416, DOI 10.1074/jbc.272.52.33416; PALADE GE, 1953, J APPL PHYS, V24, P1424; PARTON RG, 1995, SCIENCE, V269, P1398, DOI 10.1126/science.7660120; Pike LJ, 1996, J BIOL CHEM, V271, P26453, DOI 10.1074/jbc.271.43.26453; PITHA J, 1985, J PHARM SCI, V74, P987, DOI 10.1002/jps.2600740916; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; SAVAGE CR, 1972, J BIOL CHEM, V247, P7609; Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131; SCHUH SM, 1994, MOL BIOL CELL, V5, P739, DOI 10.1091/mbc.5.7.739; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255	36	338	345	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22298	22304		10.1074/jbc.273.35.22298	http://dx.doi.org/10.1074/jbc.273.35.22298			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712847	hybrid			2022-12-27	WOS:000075616600023
J	Wilson, JR; Ludowyke, RI; Biden, TJ				Wilson, JR; Ludowyke, RI; Biden, TJ			Nutrient stimulation results in a rapid Ca2+-dependent threonine phosphorylation of myosin heavy chain in rat pancreatic islets and RINm5F cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-II; INSULIN-SECRETION; BETA-CELLS; MOTOR PROTEINS; IN-VIVO; B-CELL; NONMUSCLE; CALCIUM; CALMODULIN; LOCALIZATION	Activation of protein kinases plays an important role in the Ca2+-dependent stimulation of insulin secretion by nutrients, The aim of the present study was to identify kinase substrates with the potential to regulate secretion because these have been poorly defined. Nutrient stimulation of the rat insulinoma RINm5F cell line and rat pancreatic islets resulted in an increase in the threonine phosphorylation of a 200-kDa protein. This was secondary to the gating of voltage-dependent Ca2+ channels because it was reproduced by depolarizing KCI concentrations and blocked by the Ca2+ channel antagonist, verapamil. The peak rises in [Ca2+](i) preceded or were coincident with the maximal threonine phosphorylation in response to both glyceraldehyde and KCl. In digitonin-permeabilized RINm5F cells a rise in Ca2+ from 0.1 to 0.15 mu M was sufficient to increase phosphorylation, Protein kinase C, protein kinase A, and Ca2+/calmodulin-dependent kinase II did not appear to be responsible for the phosphorylation, yet the Ca2+ dependence of the response suggests possible involvement of other members of the Ca2+/calmodulin-dependent kinase family. The 200-kDa protein was identified as myosin heavy chain by immunoprecipitation with a polyclonal nonmuscle myosin antibody. Phosphopeptide mapping indicated that the site of phosphorylation on myosin heavy chain was the same for both KCl- and glyceraldehyde-stimulated cells. Phosphoamino acid analysis confirmed a low basal phosphothreonine content of myosin heavy chain, which increased 6-fold in response to KCl. A lesser (a-fold) increase in serine phosphorylation was also detected using this technique. Although myosin IIA and IIB were shown to be present in RINm5F cells and rat islets, myosin IIA was the predominant threonine-phosphorylated species, suggesting that the two myosin species might be independently regulated. Our results identify myosin heavy chain as a novel kinase substrate in pancreatic beta-cells and suggest that it might play an important role in the regulation of insulin secretion.	Garvan Inst Med Res, Sydney, NSW 2010, Australia; Univ New S Wales, St Vincents Hosp, Ctr Immunol, Sydney, NSW 2010, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney	Biden, TJ (corresponding author), Garvan Inst Med Res, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	t.biden@garvan.unsw.edu.au	Biden, Trevor/AAW-2829-2021; Stehn, Justine/G-5115-2013	Stehn, Justine/0000-0002-2136-5450; Biden, Trevor/0000-0001-5211-0234				ADELSTEIN RS, 1987, AM J CARDIOL, V59, pB4, DOI 10.1016/0002-9149(87)90076-2; AMMALA C, 1994, P NATL ACAD SCI USA, V91, P4343, DOI 10.1073/pnas.91.10.4343; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; ASHCROFT SJH, 1994, DIABETOLOGIA, V37, pS21, DOI 10.1007/BF00400822; BENFENATI F, 1992, NATURE, V359, P417, DOI 10.1038/359417a0; Bi GQ, 1997, J CELL BIOL, V138, P999, DOI 10.1083/jcb.138.5.999; BIDEN TJ, 1993, J BIOL CHEM, V268, P11065; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Brzeska H, 1996, J BIOL CHEM, V271, P16983, DOI 10.1074/jbc.271.29.16983; BYRON KL, 1997, AM J PHYSIOL, V273, pC394; CHENEY RE, 1993, CELL MOTIL CYTOSKEL, V24, P215, DOI 10.1002/cm.970240402; Choi OH, 1996, J MUSCLE RES CELL M, V17, P69, DOI 10.1007/BF00140325; COLCA JR, 1983, BIOCHEM J, V212, P819, DOI 10.1042/bj2120819; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; Cote GP, 1997, J BIOL CHEM, V272, P6846, DOI 10.1074/jbc.272.11.6846; Easom RA, 1997, ENDOCRINOLOGY, V138, P2359, DOI 10.1210/en.138.6.2359; EASOM RA, 1990, J BIOL CHEM, V265, P14938; Ebihara K, 1996, ENDOCRINOLOGY, V137, P5255, DOI 10.1210/en.137.12.5255; EGELHOFF TT, 1993, CELL, V75, P363, DOI 10.1016/0092-8674(93)80077-R; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; HARRISON DE, 1984, EXPERIENTIA, V40, P1075, DOI 10.1007/BF01971454; HASSON T, 1995, CURR OPIN CELL BIOL, V7, P587, DOI 10.1016/0955-0674(95)80017-4; HOWELL S L, 1986, Diabetes Metabolism Reviews, V2, P107; IIDA Y, 1997, AM J PHYSIOL-ENDOC M, V36, P782; IKEBE M, 1989, BIOCHEMISTRY-US, V28, P8750, DOI 10.1021/bi00448a011; JANJIC D, 1985, J ENDOCRINOL INVEST, V8, P423, DOI 10.1007/BF03348529; JONES PM, 1992, LIFE SCI, V50, P761, DOI 10.1016/0024-3205(92)90180-W; KAWAMOTO S, 1991, J CELL BIOL, V112, P915, DOI 10.1083/jcb.112.5.915; Kelley CA, 1996, J CELL BIOL, V134, P675, DOI 10.1083/jcb.134.3.675; KELLEY CA, 1995, J BIOL CHEM, V270, P1395, DOI 10.1074/jbc.270.3.1395; KELLEY CA, 1994, CAN J PHYSIOL PHARM, V72, P1351, DOI 10.1139/y94-195; Krueger KA, 1997, J BIOL CHEM, V272, P27464, DOI 10.1074/jbc.272.43.27464; KUCZMARSKI ER, 1980, P NATL ACAD SCI-BIOL, V77, P7292, DOI 10.1073/pnas.77.12.7292; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang JC, 1997, EMBO J, V16, P5837, DOI 10.1093/emboj/16.19.5837; LI GD, 1992, MOL PHARMACOL, V42, P489; LUDOWYKE RI, 1989, J BIOL CHEM, V264, P12492; Ludowyke RI, 1996, J IMMUNOL, V157, P5130; LUDOWYKE RI, 1994, EUR J CELL BIOL, V64, P357; MACDONALD MJ, 1990, DIABETES, V39, P1461, DOI 10.2337/diabetes.39.12.1461; MAUPIN P, 1994, J CELL SCI, V107, P3077; MCKILLOP DFA, 1994, J MUSCLE RES CELL M, V15, P309; MOCHIDA S, 1995, J PHYSIOLOGY-PARIS, V89, P83, DOI 10.1016/0928-4257(96)80555-9; Mohlig M, 1997, ENDOCRINOLOGY, V138, P2577, DOI 10.1210/en.138.6.2577; MOUSSAVI RS, 1993, MOL CELL BIOCHEM, V128, P219, DOI 10.1007/BF01076773; Murakami N, 1998, BIOCHEMISTRY-US, V37, P1989, DOI 10.1021/bi971959a; NAGAI R, 1989, J BIOL CHEM, V264, P9734; PRALONG WF, 1990, EMBO J, V9, P53, DOI 10.1002/j.1460-2075.1990.tb08079.x; PRAZ F, 1983, J IMMUNOL, V131, P1396; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; Rorsman P, 1997, DIABETOLOGIA, V40, P487, DOI 10.1007/s001250050706; Ruchhoeft ML, 1997, J NEUROBIOL, V32, P567, DOI 10.1002/(SICI)1097-4695(19970605)32:6<567::AID-NEU3>3.0.CO;2-Y; Ruppel KM, 1996, ANNU REV CELL DEV BI, V12, P543, DOI 10.1146/annurev.cellbio.12.1.543; Sabry JH, 1997, MOL BIOL CELL, V8, P2605, DOI 10.1091/mbc.8.12.2605; SELLERS JR, 1995, PROTEIN PROFILE, V2, P1323; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; SPUDICH JA, 1989, CELL REGUL, V1, P1; Titus MA, 1997, CURR BIOL, V7, pR301, DOI 10.1016/S0960-9822(06)00143-6; VALLAR L, 1987, J BIOL CHEM, V262, P5049; WENHAM RM, 1992, BIOCHEM BIOPH RES CO, V189, P128, DOI 10.1016/0006-291X(92)91534-W; WOLLHEIM CB, 1986, ANN NY ACAD SCI, V488, P317; WOLLHEIM CB, 1981, PHYSIOL REV, V61, P914, DOI 10.1152/physrev.1981.61.4.914; ZAWALICH WS, 1990, MOL CELL ENDOCRINOL, V70, P119, DOI 10.1016/0303-7207(90)90152-X	63	19	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	1998	273	35					22729	22737		10.1074/jbc.273.35.22729	http://dx.doi.org/10.1074/jbc.273.35.22729			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	114NY	9712904	hybrid			2022-12-27	WOS:000075616600080
J	Horton, NC; Perona, JJ				Horton, NC; Perona, JJ			Recognition of flanking DNA sequences by EcoRV endonuclease involves alternative patterns of water-mediated contacts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTRICTION-ENDONUCLEASE; SUBSTRATE-SPECIFICITY; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; NUCLEIC-ACIDS; COGNATE DNA; BINDING; SITE; COMPLEX; PROTEINS	The 2.1-Angstrom cocrystal structure of EcoRV endonuclease bound to 5'-CGGGATATCCC, in a crystal lattice isomorphous with the cocrystallized undecamer 5'-AAAGATATCTT previously determined, shows novel base recognition in the major groove of the DNA flanking the GATATC target site. Lys(104) Of the enzyme interacts through water molecules with the exocyclic N-4 amino groups of flanking cytosines. Steric exclusion of water molecule-binding sites by the 5-methyl group of thymine drives the adoption of alternative water-mediated contacts with AT versus GC flanks. This structure provides a rare example of structural adaptability in the recognition of different DNA sequences by a protein and suggests preferred strategies for the expansion of target site specificity by EcoRV.	Univ Calif Santa Barbara, Dept Chem, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Interdepartmental Program Biochem & Mol Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Perona, JJ (corresponding author), Univ Calif Santa Barbara, Dept Chem, Santa Barbara, CA 93106 USA.		Horton, Nancy C/E-7881-2011	Horton, Nancy C/0000-0003-2710-8284	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053763] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53763] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGGARWAL A K, 1990, Methods (Orlando), V1, P83, DOI 10.1016/S1046-2023(05)80150-1; Bozic D, 1996, J MOL BIOL, V255, P176, DOI 10.1006/jmbi.1996.0015; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; CHENG XD, 1994, EMBO J, V13, P3927, DOI 10.1002/j.1460-2075.1994.tb06708.x; DAYRINGER HE, 1986, J MOL GRAPHICS, V4, P82; Engler LE, 1997, J MOL BIOL, V269, P82, DOI 10.1006/jmbi.1997.1027; FINZEL BC, 1995, ACTA CRYSTALLOGR D, V51, P450, DOI 10.1107/S0907444994013508; FLORES H, 1995, GENE, V157, P295, DOI 10.1016/0378-1119(94)00863-N; GEWIRTH DT, 1995, NAT STRUCT BIOL, V2, P386, DOI 10.1038/nsb0595-386; HEITMAN J, 1990, EMBO J, V9, P3369, DOI 10.1002/j.1460-2075.1990.tb07538.x; Horton NC, 1998, J MOL BIOL, V277, P779, DOI 10.1006/jmbi.1998.1655; JenJacobson L, 1997, BIOPOLYMERS, V44, P153; JenJacobson L, 1995, METHOD ENZYMOL, V259, P305; KOSTREWA D, 1995, BIOCHEMISTRY-US, V34, P683, DOI 10.1021/bi00002a036; Lanio T, 1996, PROTEIN ENG, V9, P1005, DOI 10.1093/protein/9.11.1005; NEWMAN M, 1994, STRUCTURE, V2, P439, DOI 10.1016/S0969-2126(00)00045-9; NEWMAN M, 1995, SCIENCE, V269, P656, DOI 10.1126/science.7624794; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; Parkinson G, 1996, ACTA CRYSTALLOGR D, V52, P57, DOI 10.1107/S0907444995011115; Perona JJ, 1997, J MOL BIOL, V273, P207, DOI 10.1006/jmbi.1997.1315; PERRY KM, 1990, PROTEINS, V8, P315, DOI 10.1002/prot.340080406; Pingoud A, 1997, EUR J BIOCHEM, V246, P1, DOI 10.1111/j.1432-1033.1997.t01-6-00001.x; Roberts R, 1993, NUCLEASES, P35; Rosenberg JM, 1991, CURR OPIN STRUC BIOL, V1, P104, DOI 10.1016/0959-440X(91)90018-O; SACK JS, 1988, J MOL GRAPHICS, V6, P224, DOI 10.1016/S0263-7855(98)80040-4; SCHILDKRAUT I, 1984, GENE, V27, P327, DOI 10.1016/0378-1119(84)90078-7; SCHWABE JWR, 1995, STRUCTURE, V3, P201, DOI 10.1016/S0969-2126(01)00150-2; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; STEITZ TA, 1990, Q REV BIOPHYS, V23, P205, DOI 10.1017/S0033583500005552; SUCK D, 1988, NATURE, V332, P464, DOI 10.1038/332464a0; TAYLOR JD, 1989, BIOCHEMISTRY-US, V28, P6198, DOI 10.1021/bi00441a011; TAYLOR JD, 1992, BIOCHEMISTRY-US, V31, P90, DOI 10.1021/bi00116a014; Thorogood H, 1996, J BIOL CHEM, V271, P8855, DOI 10.1074/jbc.271.15.8855; TuckerKellogg L, 1997, STRUCTURE, V5, P1047, DOI 10.1016/S0969-2126(97)00256-6; Wah DA, 1997, NATURE, V388, P97, DOI 10.1038/40446; Wenz C, 1996, J BIOL CHEM, V271, P5565, DOI 10.1074/jbc.271.10.5565; WENZ C, 1994, BBA-GENE STRUCT EXPR, V1219, P73, DOI 10.1016/0167-4781(94)90248-8; WESTON SA, 1992, J MOL BIOL, V226, P1237, DOI 10.1016/0022-2836(92)91064-V; WINKLER FK, 1993, EMBO J, V12, P1781, DOI 10.1002/j.1460-2075.1993.tb05826.x	39	33	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21721	21729		10.1074/jbc.273.34.21721	http://dx.doi.org/10.1074/jbc.273.34.21721			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705308	hybrid			2022-12-27	WOS:000075492600042
J	Muskett, FW; Frenkiel, TA; Feeney, J; Freedman, RB; Carr, MD; Williamson, RA				Muskett, FW; Frenkiel, TA; Feeney, J; Freedman, RB; Carr, MD; Williamson, RA			High resolution structure of the N-terminal domain of tissue inhibitor of metalloproteinases-2 and characterization of its interaction site with matrix metalloproteinase-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; COUPLING-CONSTANTS; HETERONUCLEAR NMR; CATALYTIC DOMAIN; LARGER PROTEINS; ACTIVE DOMAIN; SPECTROSCOPY; PROGRAM; ASSIGNMENT; CLONING	The high resolution structure of the N-terminal domain of tissue inhibitor of metalloproteinases-2 (N-TIMP-2) in solution has been determined using multidimensional heteronuclear NMR spectroscopy, with the structural calculations based on an extensive set of constraints, including 3132 nuclear Overhauser effect-based distance constraints, 56 hydrogen bond constraints, and 220 torsion angle constraints tan average of 26.9 constraints/residue). The core of the protein consists of a five-stranded beta-barrel that is homologous to the p-barrel found in the oligosaccharide/oligonucleotide binding protein fold. The binding site for the catalytic domain of matrix metalloproteinases-3 (N-MMP-3) on N-TIMP-2 has been mapped by determining the changes in chemical shifts on complex formation for signals from the protein backbone (N-15, C-13, and H-1). This approach identified a discrete N-MMP-3 binding site on N-TIMP-2 composed of the N terminus of the protein and the loops between beta-strands AB, CD, and EF. The beta-hairpin formed from strands A and B in N-TIMP-2 is significantly longer than the equivalent structure ire TIMP-1, allowing it to make more extensive binding interactions with the MMP catalytic domain. A detailed comparison of the N-TIMP-2 structure with that of TIMP-1 bound to N-MMP-3 (Gomis-Ruth, F.-X., Maskos, B., Betz, M., Bergner, A., Huber, R., Suzuki, K., Yoshida, N,, Nagase, H., Brew, K., Bourne, G. P., Bartunik, H. & Bode, W. (1997) Nature 389, 77-80) revealed that the core p-barrels are very similar in topology but that the loop connecting beta-strands CD (P67-C72) would need to undergo a large conformational change for TIMP-2 to bind in a similar manner to TIMP-1.	Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England; Natl Inst Med Res, MRC, Biomed NMR Ctr, London NW7 1AA, England; Natl Inst Med Res, Div Mol Struct, London NW7 1AA, England	University of Kent; MRC National Institute for Medical Research; MRC National Institute for Medical Research	Williamson, RA (corresponding author), Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England.			Carr, Mark/0000-0002-3939-0996	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		APTE SS, 1994, GENOMICS, V19, P86, DOI 10.1006/geno.1994.1016; ARCHER SJ, 1991, J MAGN RESON, V95, P636, DOI 10.1016/0022-2364(91)90182-S; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; BOONE TC, 1990, P NATL ACAD SCI USA, V87, P2800, DOI 10.1073/pnas.87.7.2800; Carr MD, 1996, EUR J BIOCHEM, V235, P721, DOI 10.1111/j.1432-1033.1996.00721.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DOCHERTY AJP, 1992, TRENDS BIOTECHNOL, V10, P200, DOI 10.1016/0167-7799(92)90214-G; DOCHERTY AJP, 1985, NATURE, V318, P66, DOI 10.1038/318066a0; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Greene J, 1996, J BIOL CHEM, V271, P30375, DOI 10.1074/jbc.271.48.30375; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; GUNTERT P, 1997, MOL BIOL, V273, P283; Huang W, 1997, J BIOL CHEM, V272, P22086, DOI 10.1074/jbc.272.35.22086; HYBERTS SG, 1992, PROTEIN SCI, V1, P736, DOI 10.1002/pro.5560010606; IKURA M, 1990, J MAGN RESON, V86, P204, DOI 10.1016/0022-2364(90)90227-Z; KAY LE, 1989, J MAGN RESON, V84, P72, DOI 10.1016/0022-2364(89)90006-1; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; MARCY AI, 1991, BIOCHEMISTRY-US, V30, P6476, DOI 10.1021/bi00240a018; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; MURPHY G, 1991, BIOCHEMISTRY-US, V30, P8097, DOI 10.1021/bi00247a001; MURPHY G, 1995, METHOD ENZYMOL, V248, P496; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; NEUHAUS D, 1992, J MOL BIOL, V228, P637, DOI 10.1016/0022-2836(92)90846-C; NORWOOD TJ, 1990, J MAGN RESON, V87, P488, DOI 10.1016/0022-2364(90)90306-T; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; WILLIAMSON RA, 1994, BIOCHEMISTRY-US, V33, P11745, DOI 10.1021/bi00205a010; WILLIAMSON RA, 1990, BIOCHEM J, V268, P267, DOI 10.1042/bj2680267; Williamson RA, 1996, EUR J BIOCHEM, V241, P476, DOI 10.1111/j.1432-1033.1996.00476.x; Williamson RA, 1997, BIOCHEMISTRY-US, V36, P13882, DOI 10.1021/bi9712091; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2; Wuthrich K, 1986, NMR PROTEIN NUCL ACI; ZUIDERWEG ERP, 1990, J MAGN RESON, V86, P210, DOI 10.1016/0022-2364(90)90228-2	39	71	73	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21736	21743		10.1074/jbc.273.34.21736	http://dx.doi.org/10.1074/jbc.273.34.21736			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705310	hybrid			2022-12-27	WOS:000075492600044
J	Myslinski, E; Krol, A; Carbon, P				Myslinski, E; Krol, A; Carbon, P			ZNF76 and ZNF143 are two human homologs of the transcriptional activator Staf	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-III; FINGER DNA RECOGNITION; CRYSTAL-STRUCTURE; SEQUENCE ELEMENT; GENE KROX-20; ZINC FINGERS; COMPLEX; ENHANCER; PROMOTER; PROTEINS	The transcriptional activator Staf, originally identified in Xenopus laevis, is implicated in the enhanced transcription of small nuclear RNA (snRNA) and snRNA-type genes by RNA polymerases II (Pol II) and III (Pol III). This zinc finger protein also possesses the capacity to stimulate expression from a Pol II mRNA promoter. Here, we report a study on two human proteins, ZNF76 and ZNF143, that are 64 and 84% identical to their Xenopus counterpart, respectively, Northern blot analysis revealed that ZNF76 and ZNF143 mRNAs were expressed in all normal adult tissues examined, By using in vivo and irt vitro assays, we have analyzed the DNA binding capacities and transcriptional properties of ZNF76 and ZNF143. The binding affinities of ZNF76 and ZNF143 for Staf divergent responsive elements were determined by gel shift assays, which revealed that the two proteins hound a same DNA motif with similar affinities, Also, polypeptide sequences containing the seven zinc fingers of ZNF76 and ZNF143 could efficiently repress in vivo the activated transcription from an snRNA-type promoter. Transfection experiments in Drosophila cells showed that ZNF76 and ZNF143 can activate transcription from an mRNA promoter through the Staf binding site. Finally, chimeric ZNF76 and ZNF143 proteins, carrying a heterologous DNA binding domain, are able to activate a Pol II mRNA promoter and snRNA Pol II and Pol III promoters in Xenopus oocytes, through the heterologous DNA binding site. Taken together, these findings demonstrate that ZNF76 and ZNF143 are two members of a same family of transactivator proteins. ZNF143 constitutes the human ortholog of the Xenopus Staf, and ZNF76 is a novel DNA binding protein related to Staf and ZNF143.	Inst Biol Mol & Cellulaire, UPR 9002 CNRS, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Carbon, P (corresponding author), Inst Biol Mol & Cellulaire, UPR 9002 CNRS, 15 Rue Rene Descartes, F-67084 Strasbourg, France.							ADACHI K, 1993, J BIOL CHEM, V273, P5598; ARES M, 1987, GENE DEV, V1, P808, DOI 10.1101/gad.1.8.808; Carey M, 1991, CURR OPIN CELL BIOL, V3, P452, DOI 10.1016/0955-0674(91)90073-8; CHAVRIER P, 1989, MOL CELL BIOL, V9, P787, DOI 10.1128/MCB.9.2.787; CHAVRIER P, 1990, EMBO J, V9, P1209, DOI 10.1002/j.1460-2075.1990.tb08228.x; Dahlberg JE, 1988, STRUCTURE FUNCTION M, P38, DOI [10.1007/978-3-642- 73020-7_2, DOI 10.1007/978-3-642-73020-7_2]; Dennig J, 1996, EMBO J, V15, P5659, DOI 10.1002/j.1460-2075.1996.tb00950.x; ElrodErickson M, 1996, STRUCTURE, V4, P1171, DOI 10.1016/S0969-2126(96)00125-6; FAIRALL L, 1993, NATURE, V366, P483, DOI 10.1038/366483a0; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; HENRY RW, 1995, NATURE, V374, P653, DOI 10.1038/374653a0; HERNANDEZ N, 1992, TRANSCRIPTIONAL REGU, V1, P281; HERR W, 1992, TRANSCRIPTIONAL REGU, V1, P1103; Houbaviy HB, 1996, P NATL ACAD SCI USA, V93, P13577, DOI 10.1073/pnas.93.24.13577; JANSON L, 1987, NUCLEIC ACIDS RES, V15, P4997, DOI 10.1093/nar/15.13.4997; JOHNSON PF, 1993, J NUTR BIOCHEM, V4, P386, DOI 10.1016/0955-2863(93)90069-9; KRASNOW MA, 1989, CELL, V57, P1031, DOI 10.1016/0092-8674(89)90341-3; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; LESCURE A, 1992, J MOL BIOL, V228, P387, DOI 10.1016/0022-2836(92)90828-8; MURPHY S, 1992, MOL CELL BIOL, V12, P3247, DOI 10.1128/MCB.12.7.3247; MYSLINSKI E, 1993, J MOL BIOL, V234, P311, DOI 10.1006/jmbi.1993.1588; MYSLINSKI E, 1992, NUCLEIC ACIDS RES, V20, P203, DOI 10.1093/nar/20.2.203; Omichinski JG, 1997, NAT STRUCT BIOL, V4, P122, DOI 10.1038/nsb0297-122; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; RAGOUSSIS J, 1992, GENOMICS, V14, P673, DOI 10.1016/S0888-7543(05)80167-3; SADOWSKI CL, 1993, GENE DEV, V7, P1535, DOI 10.1101/gad.7.8.1535; Schaub M, 1997, EMBO J, V16, P173, DOI 10.1093/emboj/16.1.173; SCHOLER HR, 1991, TRENDS GENET, V7, P323, DOI 10.1016/0168-9525(91)90422-M; Schuster C, 1998, MOL CELL BIOL, V18, P2650, DOI 10.1128/MCB.18.5.2650; SCHUSTER C, 1995, EMBO J, V14, P3777, DOI 10.1002/j.1460-2075.1995.tb00047.x; TEBB G, 1989, MOL CELL BIOL, V9, P1682, DOI 10.1128/MCB.9.4.1682; TOMMERUP N, 1995, GENOMICS, V27, P259, DOI 10.1006/geno.1995.1040; VESQUE C, 1992, NUCLEIC ACIDS RES, V20, P2485, DOI 10.1093/nar/20.10.2485; Wang Y, 1998, MOL CELL BIOL, V18, P1570, DOI 10.1128/MCB.18.3.1570; Wuttke DS, 1997, J MOL BIOL, V273, P183, DOI 10.1006/jmbi.1997.1291	36	71	75	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 21	1998	273	34					21998	22006		10.1074/jbc.273.34.21998	http://dx.doi.org/10.1074/jbc.273.34.21998			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	112JY	9705341	hybrid			2022-12-27	WOS:000075492600075
